PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Angulo-Barturen, I; Jimenez-Diaz, MB; Mulet, T; Rullas, J; Herreros, E; Ferrer, S; Jimenez, E; Mendoza, A; Regadera, J; Rosenthal, PJ; Bathurst, I; Pompliano, DL; de las Heras, FG; Gargallo-Viola, D				Angulo-Barturen, Inigo; Belen Jimenez-Diaz, Maria; Mulet, Teresa; Rullas, Joaquin; Herreros, Esperanza; Ferrer, Santiago; Jimenez, Elena; Mendoza, Alfonso; Regadera, Javier; Rosenthal, Philip J.; Bathurst, Ian; Pompliano, David L.; Gomez de las Heras, Federico; Gargallo-Viola, Domingo			A Murine Model of falciparum-Malaria by In Vivo Selection of Competent Strains in Non-Myelodepleted Mice Engrafted with Human Erythrocytes	PLOS ONE			English	Article								To counter the global threat caused by Plasmodium falciparum malaria, new drugs and vaccines are urgently needed. However, there are no practical animal models because P. falciparum infects human erythrocytes almost exclusively. Here we describe a reliable falciparum murine model of malaria by generating strains of P. falciparum in vivo that can infect immunodeficient mice engrafted with human erythrocytes. We infected NODscid/beta 2m-/- mice engrafted with human erythrocytes with P. falciparum obtained from in vitro cultures. After apparent clearance, we obtained isolates of P. falciparum able to grow in peripheral blood of engrafted NODscid/beta 2m-/- mice. Of the isolates obtained, we expanded in vivo and established the isolate Pf3D7(0087/N9) as a reference strain for model development. Pf3D7(0087/N9) caused productive persistent infections in 100% of engrafted mice infected intravenously. The infection caused a relative anemia due to selective elimination of human erythrocytes by a mechanism dependent on parasite density in peripheral blood. Using this model, we implemented and validated a reproducible assay of antimalarial activity useful for drug discovery. Thus, our results demonstrate that P. falciparum contains clones able to grow reproducibly in mice engrafted with human erythrocytes without the use of myeloablative methods.	[Angulo-Barturen, Inigo; Belen Jimenez-Diaz, Maria; Mulet, Teresa; Rullas, Joaquin; Herreros, Esperanza; Ferrer, Santiago; Jimenez, Elena; Mendoza, Alfonso; Gomez de las Heras, Federico; Gargallo-Viola, Domingo] GlaxoSmithKline Inc, ID CEDD, Dis Developing World, Madrid, Spain; [Regadera, Javier] Univ Autonoma Madrid, Fac Med, Dept Anat, Histol & Neurosci, Madrid, Spain; [Rosenthal, Philip J.] Univ Calif San Francisco, San Francisco General Hosp, Dept Med, San Francisco, CA USA; [Bathurst, Ian] MMV, Geneva, Switzerland; [Pompliano, David L.] GlaxoSmithKline Inc, ID CEDD, Collegeville, PA USA	GlaxoSmithKline; Autonomous University of Madrid; University of California System; University of California San Francisco; GlaxoSmithKline	Angulo-Barturen, I (corresponding author), GlaxoSmithKline Inc, ID CEDD, Dis Developing World, Madrid, Spain.	inigo.x.angulo@gsk.com	Ferrer-Bazaga, Santiago/AAA-7749-2021; Mendoza-Losana, Alfonso/AAF-4383-2021; Herreros, Esperanza/GQH-7182-2022	Ferrer-Bazaga, Santiago/0000-0002-6672-551X; Mendoza-Losana, Alfonso/0000-0003-2493-4118; 	GlaxoSmithKline-Diseases of the Developing World	GlaxoSmithKline-Diseases of the Developing World	Maria Belen Jimenez-Diaz, Teresa Mulet and Joaquin Rullas were funded by Medicines for Malaria Venture Miniportfolio Agreement with GlaxoSmithKline-Diseases of the Developing World	Angulo I, 2000, BLOOD, V95, P212; [Anonymous], 1999, HDB ANIMAL MODELS IN; BADELL E, 1995, PARASITOL TODAY, V11, P235, DOI 10.1016/0169-4758(95)80088-3; Badell E, 2000, J EXP MED, V192, P1653, DOI 10.1084/jem.192.11.1653; Barry AE, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030034; BELL CA, 1990, ANTIMICROB AGENTS CH, V34, P1381, DOI 10.1128/AAC.34.7.1381; Bogdanova A, 2007, BLOOD, V110, P762, DOI 10.1182/blood-2006-12-063602; Bouharoun-Tayoun H, 2004, EXP PARASITOL, V108, P47, DOI 10.1016/j.exppara.2004.07.004; Bray PG, 2003, TRENDS PARASITOL, V19, P232, DOI 10.1016/S1471-4922(03)00069-2; BURWELL EL, 1953, AM J PHYSIOL, V172, P718, DOI 10.1152/ajplegacy.1953.172.3.718; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Christianson SW, 1997, J IMMUNOL, V158, P3578; DAS BP, 1977, J MED CHEM, V20, P531, DOI 10.1021/jm00214a014; DEBRUIN D, 1994, P NATL ACAD SCI USA, V91, P619, DOI 10.1073/pnas.91.2.619; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Dondorp AM, 2000, PARASITOL TODAY, V16, P228, DOI 10.1016/S0169-4758(00)01666-5; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Foley M, 1997, INT J PARASITOL, V27, P231, DOI 10.1016/S0020-7519(96)00152-X; FREY T, 1995, CYTOMETRY, V21, P265, DOI 10.1002/cyto.990210307; FROIDEVAUX S, 1991, J IMMUNOL METHODS, V137, P275, DOI 10.1016/0022-1759(91)90034-D; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Gysin Jurg, 1998, P419; HAUGLAND RP, 1996, HDB FLUORESCENT PROB, P143; He HZ, 2002, TRANSPLANTATION, V73, P853, DOI 10.1097/00007890-200203270-00005; HEISCHKEIL R, 1971, Zeitschrift fuer Tropenmedizin und Parasitologie, V22, P243; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Jimenez-Diaz MB, 2005, CYTOM PART A, V67A, P27, DOI 10.1002/cyto.a.20169; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; KLOTZ FW, 1987, J EXP MED, V165, P1713, DOI 10.1084/jem.165.6.1713; Kollet O, 2000, BLOOD, V95, P3102, DOI 10.1182/blood.V95.10.3102.010k14_3102_3105; Landau Irene, 1998, P401; Lavazec C, 2006, NUCLEIC ACIDS RES, V34, P6696, DOI 10.1093/nar/gkl942; Layez C, 2005, BLOOD, V106, P3632, DOI 10.1182/blood-2005-04-1574; Levy JE, 2000, J CLIN INVEST, V105, P1209, DOI 10.1172/JCI9635; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; MOHAN K, 1998, MALARIA PARASITE BIO, P467; MOORE JM, 1995, J EXP MED, V181, P2265, DOI 10.1084/jem.181.6.2265; Moreno A, 2006, INT J PARASITOL, V36, P361, DOI 10.1016/j.ijpara.2005.10.012; Moreno A, 2001, ANTIMICROB AGENTS CH, V45, P1847, DOI 10.1128/AAC.45.6.1847-1853.2001; Moreno A, 2007, TRENDS PARASITOL, V23, P254, DOI 10.1016/j.pt.2007.04.004; Motulsky H. A., 2003, FITTING MODELS BIOLO; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Pichler J, 2002, CYTOMETRY, V50, P231, DOI 10.1002/cyto.10125; Price RN, 2001, AM J TROP MED HYG, V65, P614, DOI 10.4269/ajtmh.2001.65.614; Rajan TV, 1996, PARASITOL TODAY, V12, P479, DOI 10.1016/S0169-4758(96)10066-1; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; ROWE AW, 1968, CRYOBIOLOGY, V5, P119, DOI 10.1016/S0011-2240(68)80154-3; Sabater AM, 2005, PARASITOL RES, V95, P97, DOI 10.1007/s00436-004-1249-7; Sanni Latifu A, 2002, Methods Mol Med, V72, P57, DOI 10.1385/1-59259-271-6:57; SCHLICHTHERLE M, METHODS MALARIA RES, P5; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Su XZ, 1998, EXP PARASITOL, V89, P262, DOI 10.1006/expr.1998.4299; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TSUJI M, 1995, VACCINE, V13, P1389, DOI 10.1016/0264-410X(95)00081-B; WEATHERALL DJ, 1983, CIBA F SYMP, V94, P74; WILLIMANN K, 1995, J EXP MED, V182, P643, DOI 10.1084/jem.182.3.643; Yacoub-Youssef H, 2005, TRANSPL IMMUNOL, V15, P157, DOI 10.1016/j.trim.2005.07.002; Yeramian P, 2005, J INFECT DIS, V192, P319, DOI 10.1086/430928	62	110	120	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2252	10.1371/journal.pone.0002252	http://dx.doi.org/10.1371/journal.pone.0002252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493601	Green Published, gold, Green Submitted			2022-12-27	WOS:000262258700056
J	Dolecek, C; Tran, TPL; Nguyen, NR; Le, TP; Ha, V; Phung, QT; Doan, CD; Nguyen, TBB; Duong, TL; Luong, BH; Nguyen, TB; Nguyen, TAH; Pham, ND; Mai, NL; Phan, VB; Vo, AH; Nguyen, VH; Tran, TTN; Tran, TC; Schultsz, C; Dunstan, SJ; Stepniewska, K; Campbell, JI; To, SD; Basnyat, B; Nguyen, VC; Nguyen, V; Nguyen, TC; Tran, TH; Farrar, J				Dolecek, Christiane; Tran Thi Phi La; Nguyen Ngoc Rang; Le Thi Phuong; Ha Vinh; Phung Quoc Tuan; Doan Cong Du; Nguyen Thi Be Bay; Duong Thanh Long; Luong Bich Ha; Nguyen Trung Binh; Nguyen Thi Anh Hong; Pham Ngoc Dung; Mai Ngoc Lanh; Phan Van Be Bay; Vo Anh Ho; Nguyen Van Minh Hoang; Tran Thu Thi Nga; Tran Thuy Chau; Schultsz, Constance; Dunstan, Sarah J.; Stepniewska, Kasia; Campbell, James Ian; To Song Diep; Basnyat, Buddha; Nguyen Van Vinh Chau; Nguyen Van Sach; Nguyen Tran Chinh; Tran Tinh Hien; Farrar, Jeremy			A Multi-Center Randomised Controlled Trial of Gatifloxacin versus Azithromycin for the Treatment of Uncomplicated Typhoid Fever in Children and Adults in Vietnam	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; OFLOXACIN; THERAPY	Background: Drug resistant typhoid fever is a major clinical problem globally. Many of the first line antibiotics, including the older generation fluoroquinolones, ciprofloxacin and ofloxacin, are failing. Objectives: We performed a randomised controlled trial to compare the efficacy and safety of gatifloxacin (10 mg/kg/day) versus azithromycin (20 mg/kg/day) as a once daily oral dose for 7 days for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. Methods: An open-label multi-centre randomised trial with pre-specified per protocol analysis and intention to treat analysis was conducted. The primary outcome was fever clearance time, the secondary outcome was overall treatment failure (clinical or microbiological failure, development of typhoid fever-related complications, relapse or faecal carriage of S. typhi). Principal Findings: We enrolled 358 children and adults with suspected typhoid fever. There was no death in the study. 287 patients had blood culture confirmed typhoid fever, 145 patients received gatifloxacin and 142 patients received azithromycin. The median FCT was 106 hours in both treatment arms (95% Confidence Interval [CI]; 94-118 hours for gatifloxacin versus 88-112 hours for azithromycin), (logrank test p = 0.984, HR [95% CI] = 1.0 [0.80-1.26]). Overall treatment failure occurred in 13/145 (9%) patients in the gatifloxacin group and 13/140 (9.3%) patients in the azithromycin group, (logrank test p = 0.854, HR [95% CI] = 0.93 [0.43-2.0]). 96% (254/263) of the Salmonella enterica serovar Typhi isolates were resistant to nalidixic acid and 58% (153/263) were multidrug resistant. Conclusions: Both antibiotics showed an excellent efficacy and safety profile. Both gatifloxacin and azithromycin can be recommended for the treatment of typhoid fever particularly in regions with high rates of multidrug and nalidixic acid resistance. The cost of a 7-day treatment course of gatifloxacin is approximately one third of the cost of azithromycin in Vietnam. Trial Registration: Controlled-Trials.com ISRCTN67946944	[Dolecek, Christiane; Phung Quoc Tuan; Tran Thu Thi Nga; Schultsz, Constance; Dunstan, Sarah J.; Stepniewska, Kasia; Campbell, James Ian; Farrar, Jeremy] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Ha Vinh; Nguyen Van Minh Hoang; Tran Thu Thi Nga; Tran Thuy Chau; To Song Diep; Nguyen Van Vinh Chau; Nguyen Tran Chinh; Tran Tinh Hien] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Tran Thi Phi La; Nguyen Ngoc Rang; Doan Cong Du; Nguyen Thi Be Bay; Duong Thanh Long; Luong Bich Ha; Nguyen Trung Binh; Nguyen Thi Anh Hong; Pham Ngoc Dung; Nguyen Van Sach] An Giang Provincial Hosp, Long Xuyen, Vietnam; [Le Thi Phuong; Mai Ngoc Lanh; Phan Van Be Bay; Vo Anh Ho] Dong Thap Provincial Hosp, Cao Lanh, Dong Thap, Vietnam; [Dolecek, Christiane; Schultsz, Constance; Dunstan, Sarah J.; Stepniewska, Kasia; Campbell, James Ian; Farrar, Jeremy] John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford, England; [Dolecek, Christiane; Farrar, Jeremy] London Sch Hyg & Trop Med, London, England; [Basnyat, Buddha] Patan Hosp, Lagankhel, Nepal	University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Dolecek, C (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam.	cdolecek@oucru.org	Farrar, Jeremy J./HGA-7610-2022; Dunstan, Sarah/AAO-9597-2020	Dunstan, Sarah/0000-0001-7873-933X; Stepniewska, Kasia/0000-0002-1713-6209; Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust, UK	Wellcome Trust, UK(Wellcome Trust)	This study was funded by the Wellcome Trust, UK. The funding source did not play any role in the design, conduct, analysis or publication of the study.	Aarestrup FM, 2003, ANTIMICROB AGENTS CH, V47, P827, DOI 10.1128/AAC.47.2.827-829.2003; AM NT, 1993, B SOC PATHOL EXOT, V86, P476; Ambrose PG, 2003, J ANTIMICROB CHEMOTH, V52, P435, DOI 10.1093/jac/dkg370; Baker SE, 2002, ANN PHARMACOTHER, V36, P1722; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; Butler T, 1999, J ANTIMICROB CHEMOTH, V44, P243, DOI 10.1093/jac/44.2.243; Cao X T, 1999, Pediatr Infect Dis J, V18, P245; Chau TT, 2007, ANTIMICROB AGENTS CH, V51, P4315, DOI 10.1128/AAC.00294-07; Chinh NT, 2000, ANTIMICROB AGENTS CH, V44, P1855, DOI 10.1128/AAC.44.7.1855-1859.2000; *CLIN LAB STAND I, 2006, PERF STNAD ANT SUSC; *CLIN LAB STAND I, 2007, MS100S17 CLSI; Collett, 2003, MODELLING SURVIVAL D; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Frenck RW, 2000, CLIN INFECT DIS, V31, P1134, DOI 10.1086/317450; Frenck RW, 2004, CLIN INFECT DIS, V38, P951, DOI 10.1086/382359; Frothingham R, 2005, CLIN INFECT DIS, V41, P1269, DOI 10.1086/496929; Girgis NI, 1999, ANTIMICROB AGENTS CH, V43, P1441, DOI 10.1128/AAC.43.6.1441; HIEN TT, 1995, CLIN INFECT DIS, V20, P917, DOI 10.1093/clinids/20.4.917; Kadhiravan T, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-37; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Lu T, 1999, ANTIMICROB AGENTS CH, V43, P2969, DOI 10.1128/AAC.43.12.2969; MACHIN D, 1997, SAMPLE SIZE TABLES D; Maskey AP, 2006, CLIN INFECT DIS, V42, P1247, DOI 10.1086/503033; Pandit A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000542; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Parry CM, 2007, ANTIMICROB AGENTS CH, V51, P819, DOI 10.1128/AAC.00447-06; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Pichichero ME, 2005, CLIN INFECT DIS, V41, P470, DOI 10.1086/431584; Tam VH, 2007, ANTIMICROB AGENTS CH, V51, P744, DOI 10.1128/AAC.00334-06; Thaver D, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004530.pub2; Vinh H, 1996, ANTIMICROB AGENTS CH, V40, P958, DOI 10.1128/AAC.40.4.958; *WHO, 2003, BACKG DOC DIAGN TREA	33	78	79	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2188	10.1371/journal.pone.0002188	http://dx.doi.org/10.1371/journal.pone.0002188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493312	Green Published, gold			2022-12-27	WOS:000262258700002
J	Angov, E; Hillier, CJ; Kincaid, RL; Lyon, JA				Angov, Evelina; Hillier, Collette J.; Kincaid, Randall L.; Lyon, Jeffrey A.			Heterologous Protein Expression Is Enhanced by Harmonizing the Codon Usage Frequencies of the Target Gene with those of the Expression Host	PLOS ONE			English	Article								Synonymous codon replacement can change protein structure and function, indicating that protein structure depends on DNA sequence. During heterologous protein expression, low expression or formation of insoluble aggregates may be attributable to differences in synonymous codon usage between expression and natural hosts. This discordance may be particularly important during translation of the domain boundaries ( link/end segments) that separate elements of higher ordered structure. Within such regions, ribosomal progression slows as the ribosome encounters clusters of infrequently used codons that preferentially encode a subset of amino acids. To replicate the modulation of such localized translation rates during heterologous expression, we used known relationships between codon usage frequencies and secondary protein structure to develop an algorithm ("codon harmonization'') for identifying regions of slowly translated mRNA that are putatively associated with link/end segments. It then recommends synonymous replacement codons having usage frequencies in the heterologous expression host that are less than or equal to the usage frequencies of native codons in the native expression host. For protein regions other than these putative link/end segments, it recommends synonymous substitutions with codons having usage frequencies matched as nearly as possible to the native expression system. Previous application of this algorithm facilitated E. coli expression, manufacture and testing of two Plasmodium falciparum vaccine candidates. Here we describe the algorithm in detail and apply it to E. coli expression of three additional P. falciparum proteins. Expression of the "recoded'' genes exceeded that of the native genes by 4- to 1,000-fold, representing levels suitable for vaccine manufacture. The proteins were soluble and reacted with a variety of functional conformation-specific mAbs suggesting that they were folded properly and had assumed native conformation. Codon harmonization may further provide a general strategy for improving the expression of soluble functional proteins during heterologous expression in hosts other than E. coli.	[Angov, Evelina; Hillier, Collette J.; Lyon, Jeffrey A.] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD 20910 USA; [Kincaid, Randall L.] Veritas Inc, Rockville, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Angov, E (corresponding author), Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD 20910 USA.	Evelina.angov@us.army.mil			United States Agency for International Development [936 6001, AAG-P-00-98-00006, AAG-P-00-98-00005]; United States Army Medical Research and Materiel Command	United States Agency for International Development(United States Agency for International Development (USAID)); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by the United States Agency for International Development, Project Number 936 6001, Award Number AAG-P-00-98-00006, Award Number AAG-P-00-98-00005, and by the United States Army Medical Research and Materiel Command.	Adzhubei AA, 1996, FEBS LETT, V399, P78, DOI 10.1016/S0014-5793(96)01287-2; ANDERSSON SGE, 1990, MICROBIOL REV, V54, P198, DOI 10.1128/MMBR.54.2.198-210.1990; Angov E, 2003, MOL BIOCHEM PARASIT, V128, P195, DOI 10.1016/S0166-6851(03)00077-X; Baram D, 2005, FEBS LETT, V579, P948, DOI 10.1016/j.febslet.2004.11.063; Berisio R, 2003, NAT STRUCT BIOL, V10, P366, DOI 10.1038/nsb915; BULMER M, 1987, NATURE, V325, P728, DOI 10.1038/325728a0; BURGHAUS PA, 1994, MOL BIOCHEM PARASIT, V64, P165, DOI 10.1016/0166-6851(94)90144-9; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; CHEN GFT, 1990, NUCLEIC ACIDS RES, V18, P1465, DOI 10.1093/nar/18.6.1465; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Etchells SA, 2004, NAT STRUCT MOL BIOL, V11, P391, DOI 10.1038/nsmb0504-391; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Hillier CJ, 2005, INFECT IMMUN, V73, P2109, DOI 10.1128/IAI.73.4.2109-2115.2005; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Kramer G, 2001, INT J BIOCHEM CELL B, V33, P541, DOI 10.1016/S1357-2725(01)00044-9; Kurland C, 1996, CURR OPIN BIOTECH, V7, P489, DOI 10.1016/S0958-1669(96)80050-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindsley D, 2003, MOL MICROBIOL, V48, P1267, DOI 10.1046/j.1365-2958.2003.03514.x; LOCHER CP, 1993, VACCINE, V11, P1119, DOI 10.1016/0264-410X(93)90072-6; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Netzer WJ, 1998, TRENDS BIOCHEM SCI, V23, P68, DOI 10.1016/S0968-0004(97)01171-7; Oresic M, 1998, J MOL BIOL, V281, P31, DOI 10.1006/jmbi.1998.1921; Pan WQ, 1999, NUCLEIC ACIDS RES, V27, P1094, DOI 10.1093/nar/27.4.1094; Phoenix DA, 1997, FEMS MICROBIOL LETT, V155, P63, DOI 10.1016/S0378-1097(97)00367-4; PURVIS IJ, 1987, J MOL BIOL, V193, P413, DOI 10.1016/0022-2836(87)90230-0; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Sauna ZE, 2007, PHARMACOGENOMICS, V8, P527, DOI 10.2217/14622416.8.6.527; Singh S, 2003, INFECT IMMUN, V71, P6766, DOI 10.1128/IAI.71.12.6766-6774.2003; Svetlov MS, 2006, PROTEIN SCI, V15, P242, DOI 10.1110/ps.051752506; TANABE K, 1987, J MOL BIOL, V195, P273, DOI 10.1016/0022-2836(87)90649-8; Thanaraj TA, 1996, PROTEIN SCI, V5, P1973, DOI 10.1002/pro.5560051003; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; VARENNE S, 1984, J MOL BIOL, V180, P549, DOI 10.1016/0022-2836(84)90027-5; WEBER JL, 1987, GENE, V52, P103, DOI 10.1016/0378-1119(87)90399-4; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; ZHANG SP, 1994, J THEOR BIOL, V170, P339, DOI 10.1006/jtbi.1994.1196	47	190	201	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2189	10.1371/journal.pone.0002189	http://dx.doi.org/10.1371/journal.pone.0002189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478103	Green Published, gold, Green Submitted			2022-12-27	WOS:000262172800053
J	Cowling, BJ; Fung, ROP; Cheng, CKY; Fang, VJ; Chan, KH; Seto, WH; Yung, R; Chiu, B; Lee, P; Uyeki, TM; Houck, PM; Peiris, JSM; Leung, GM				Cowling, Benjamin J.; Fung, Rita O. P.; Cheng, Calvin K. Y.; Fang, Vicky J.; Chan, Kwok Hung; Seto, Wing Hong; Yung, Raymond; Chiu, Billy; Lee, Paco; Uyeki, Timothy M.; Houck, Peter M.; Peiris, J. S. Malik; Leung, Gabriel M.			Preliminary Findings of a Randomized Trial of Non-Pharmaceutical Interventions to Prevent Influenza Transmission in Households	PLOS ONE			English	Article							PUBLIC-HEALTH; COMMUNITY; VIRUS; PREDICTORS; INFECTION; DIAGNOSIS; OUTBREAK; CHILDREN; REDUCE; IMPACT	Background: There are sparse data on whether non-pharmaceutical interventions can reduce the spread of influenza. We implemented a study of the feasibility and efficacy of face masks and hand hygiene to reduce influenza transmission among Hong Kong household members. Methodology/Principal Findings: We conducted a cluster randomized controlled trial of households (composed of at least 3 members) where an index subject presented with influenza-like-illness of, 48 hours duration. After influenza was confirmed in an index case by the QuickVue Influenza A+ B rapid test, the household of the index subject was randomized to 1) control or 2) surgical face masks or 3) hand hygiene. Households were visited within 36 hours, and 3, 6 and 9 days later. Nose and throat swabs were collected from index subjects and all household contacts at each home visit and tested by viral culture. The primary outcome measure was laboratory culture confirmed influenza in a household contact; the secondary outcome was clinically diagnosed influenza (by self-reported symptoms). We randomized 198 households and completed follow up home visits in 128; the index cases in 122 of those households had laboratory-confirmed influenza. There were 21 household contacts with laboratory confirmed influenza corresponding to a secondary attack ratio of 6%. Clinical secondary attack ratios varied from 5% to 18% depending on case definitions. The laboratory-based or clinical secondary attack ratios did not significantly differ across the intervention arms. Adherence to interventions was variable. Conclusions/Significance: The secondary attack ratios were lower than anticipated, and lower than reported in other countries, perhaps due to differing patterns of susceptibility, lack of significant antigenic drift in circulating influenza virus strains recently, and/or issues related to the symptomatic recruitment design. Lessons learnt from this pilot have informed changes for the main study in 2008.	[Cowling, Benjamin J.; Fung, Rita O. P.; Cheng, Calvin K. Y.; Fang, Vicky J.; Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Kwok Hung; Peiris, J. S. Malik] Univ Hong Kong, Dept Microbiol, Hong Kong, Peoples R China; [Seto, Wing Hong] Queen Mary Hosp, Hosp Authority, Hong Kong, Peoples R China; [Yung, Raymond] Gov Hong Kong SAR, Dept Hlth, Ctr Hlth Protect, Hong Kong, Peoples R China; [Chiu, Billy] Hong Kong Sanatorium & Hosp, Hong Kong, Peoples R China; [Lee, Paco] St Pauls Hosp, Hong Kong, Peoples R China; [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Houck, Peter M.] Ctr Dis Control & Prevent, Natl Ctr Preparedness, Detect & Control Infect Dis, Div Glob Migrat & Quarantine, Seattle, WA USA	University of Hong Kong; University of Hong Kong; University of Hong Kong; Hong Kong St. Paul's Hospital; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Cowling, BJ (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	gmleung@hku.hk	Chan, Kwok Hung/ABD-5399-2021; Leung, Gabriel Matthew/C-4336-2009; Cowling, Benjamin John/C-4263-2009	Cowling, Benjamin John/0000-0002-6297-7154; Seto, Wing Hong/0000-0002-1139-9200; Leung, Gabriel/0000-0002-2503-6283	US Centers for Disease Control and Prevention [1 U01 CI000439-01]; Research Fund for the Control of Infectious Disease; Food and Health Bureau; Government of the Hong Kong SAR; Area of Excellence Scheme of the Hong Kong University [AoE/M-12/06]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000439] Funding Source: NIH RePORTER	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Research Fund for the Control of Infectious Disease; Food and Health Bureau; Government of the Hong Kong SAR; Area of Excellence Scheme of the Hong Kong University; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work has received financial support from the US Centers for Disease Control and Prevention (grant no. 1 U01 CI000439-01), the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong SAR, and the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant no. AoE/M-12/06). The sponsors had no role in data collection and analysis, or the decision to publish, but the CDC was involved in study design and preparation of the manuscript. This work represents the views of the authors and not their institutions, including the Centers for Disease Control and Prevention.	AIELLO AE, 2008, AM J PUBLIC IN PRESS; Aledort JE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-208; Babcock HM, 2006, INFECT CONT HOSP EP, V27, P266, DOI 10.1086/501539; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bell D, 2006, EMERG INFECT DIS, V12, P88; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; FOX JP, 1980, VIRUSES FAMILIES; Friedman MJ, 2004, ARCH PEDIAT ADOL MED, V158, P391, DOI 10.1001/archpedi.158.4.391; JEFFERSON T, 2007, BMJ IN PRESS; Jefferson T, 2008, BMJ-BRIT MED J, V336, P77, DOI 10.1136/bmj.b3675; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; LARSON EL, 1995, AM J INFECT CONTROL, V23, P251, DOI 10.1016/0196-6553(95)90070-5; Leung GM, 2005, CLIN INFECT DIS, V40, P1713, DOI 10.1086/429923; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Lo JYC, 2005, EMERG INFECT DIS, V11, P1738, DOI 10.3201/eid1111.050729; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Monto AS, 2002, J INFECT DIS, V186, P1582, DOI 10.1086/345722; Monto AS, 1999, PHARMACOECONOMICS, V16, P1, DOI 10.2165/00019053-199916001-00001; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Morse SS, 2006, SCIENCE, V314, P929, DOI 10.1126/science.1135823; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Pepe M. S., 2003, STAT EVALUATION MED; Proenca-Modena JL, 2007, BRAZ J INFECT DIS, V11, P125, DOI 10.1590/S1413-86702007000100027; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Sandora TJ, 2005, PEDIATRICS, V116, P587, DOI 10.1542/peds.2005-0199; Stohr K, 2004, SCIENCE, V306, P2195, DOI 10.1126/science.1108165; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Uyeki TM, 2003, PEDIATR INFECT DIS J, V22, P164; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315; [Anonymous], 2000, JAMA, V284, P3043, DOI 10.1001/jama.2013.281053; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116	40	123	123	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2101	10.1371/journal.pone.0002101	http://dx.doi.org/10.1371/journal.pone.0002101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461182	Green Submitted, Green Published, gold			2022-12-27	WOS:000261642400023
J	Jensen, TE; Schjerling, P; Viollet, B; Wojtaszewski, JFP; Richter, EA				Jensen, Thomas E.; Schjerling, Peter; Viollet, Benoit; Wojtaszewski, Jorgen F. P.; Richter, Erik A.			AMPK alpha(1) Activation Is Required for Stimulation of Glucose Uptake by Twitch Contraction, but Not by H2O2, in Mouse Skeletal Muscle	PLOS ONE			English	Article							5'-AMP-ACTIVATED PROTEIN-KINASE; OXIDATIVE STRESS; AS160 PHOSPHORYLATION; GLYCOGEN-SYNTHESIS; TRANSPORT; INSULIN; EXPRESSION; INHIBITION; GLUT1; GLUCOSE-TRANSPORTER-4	Background: AMPK is a promising pharmacological target in relation to metabolic disorders partly due to its non-insulin dependent glucose uptake promoting role in skeletal muscle. Of the 2 catalytic alpha-AMPK isoforms, alpha(2) AMPK is clearly required for stimulation of glucose transport into muscle by certain stimuli. In contrast, no clear function has yet been determined for alpha(1) AMPK in skeletal muscle, possibly due to alpha-AMPK isoform signaling redundancy. By applying low-intensity twitch-contraction and H2O2 stimulation to activate alpha(1) AMPK, but not alpha(2) AMPK, in wildtype and alpha-AMPK transgenic mouse muscles, this study aimed to define conditions where alpha(1) AMPK is required to increase muscle glucose uptake. Methodology/Principal Findings: Following stimulation with H2O2 (3 mM, 20 min) or twitch-contraction (0.1 ms pulse, 2 Hz, 2 min), signaling and 2-deoxyglucose uptake were measured in incubated soleus muscles from wildtype and muscle-specific kinase-dead AMPK (KD), alpha(1) AMPK knockout or alpha(2) AMPK knockout mice. H2O2 increased the activity of both alpha(1) and alpha(2) AMPK in addition to Akt phosphorylation, and H2O2-stimulated glucose uptake was not reduced in any of the AMPK transgenic mouse models compared with wild type. In contrast, twitch-contraction increased the activity of alpha(1) AMPK, but not alpha(2) AMPK activity nor Akt or AS160 phosphorylation. Glucose uptake was markedly lower in alpha(1) AMPK knockout and KD AMPK muscles, but not in alpha(2) AMPK knockout muscles, following twitch stimulation. Conclusions/Significance: These results provide strong genetic evidence that alpha(1) AMPK, but not alpha(2) AMPK, Akt or AS160, is necessary for regulation of twitch-contraction stimulated glucose uptake. To our knowledge, this is the first report to show a major and essential role of alpha(1) AMPK in regulating a physiological endpoint in skeletal muscle. In contrast, AMPK is not essential for H2O2-stimulated muscle glucose uptake, as proposed by recent studies.	[Jensen, Thomas E.; Wojtaszewski, Jorgen F. P.; Richter, Erik A.] Univ Copenhagen, Copenhagen Muscle Res Ctr, Dept Exercise & Sport Sci, Mol Physiol Grp,Sect Human Physiol, Copenhagen, Denmark; [Schjerling, Peter] Rigshospitalet, Dept Mol Muscle Biol, Copenhagen Muscle Res Ctr, Copenhagen, Denmark; [Schjerling, Peter] Univ Copenhagen, Dept Biomed Sci, Med Muscle Res Cluster, Mol Muscle Biol, Copenhagen, Denmark; [Viollet, Benoit] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Viollet, Benoit] Inserm, U567, Paris, France	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Jensen, TE (corresponding author), Univ Copenhagen, Copenhagen Muscle Res Ctr, Dept Exercise & Sport Sci, Mol Physiol Grp,Sect Human Physiol, Copenhagen, Denmark.	ERichter@ifi.ku.dk	Schjerling, Peter/F-6194-2011; Jensen, Thomas/E-1215-2015; Viollet, Benoit/O-6927-2017; Richter, Erik A./Y-8131-2019; Wojtaszewski, Jørgen FP/P-6583-2014	Schjerling, Peter/0000-0001-7138-3211; Jensen, Thomas/0000-0001-6139-8268; Viollet, Benoit/0000-0002-0121-0224; Richter, Erik A./0000-0002-6850-3056; Wojtaszewski, Jørgen FP/0000-0001-9785-6830; wojtaszewski, jorgen/0000-0001-8185-3408	Novo Nordisk Research Foundation [Hallas Moller Fellowship]; Danish Diabetes Association; European Commission [LSHM-CT-2004-005272]; The Lundbeck Foundation; The Copenhagen Muscle Research Centre; The Danish Medical and Natural Sciences Research Councils	Novo Nordisk Research Foundation(Novo Nordisk Foundation); Danish Diabetes Association; European Commission(European CommissionEuropean Commission Joint Research Centre); The Lundbeck Foundation(Lundbeckfonden); The Copenhagen Muscle Research Centre; The Danish Medical and Natural Sciences Research Councils	The study was supported by the Novo Nordisk Research Foundation, The Danish Diabetes Association, an Integrated Project (LSHM-CT-2004-005272) funded by the European Commission, The Lundbeck Foundation, The Copenhagen Muscle Research Centre and The Danish Medical and Natural Sciences Research Councils. Jorgen F. P. Wojtaszewski was supported by a Hallas Moller Fellowship from The Novo Nordisk Foundation.	Abbud W, 2000, ARCH BIOCHEM BIOPHYS, V380, P347, DOI 10.1006/abbi.2000.1935; Andrade FH, 2001, FASEB J, V15, P309; Barnes K, 2002, J CELL SCI, V115, P2433; Blair AS, 1999, J BIOL CHEM, V274, P36293, DOI 10.1074/jbc.274.51.36293; Cartee GD, 2007, APPL PHYSIOL NUTR ME, V32, P557, DOI 10.1139/H07-026; Daugaard JR, 2004, PFLUG ARCH EUR J PHY, V447, P452, DOI 10.1007/s00424-003-1195-8; Derave W, 2006, AM J PHYSIOL-ENDOC M, V291, pE1250, DOI 10.1152/ajpendo.00060.2006; Frosig C, 2004, AM J PHYSIOL-ENDOC M, V286, pE411, DOI 10.1152/ajpendo.00317.2003; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; FUJII N, 2005, J BIOL CHEM; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; HIDALGO C, 2006, J BIOL CHEM; HIGAKI Y, 2008, AM J PHYSL ENDOCRINO; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V293, pE286, DOI 10.1152/ajpendo.00693.2006; Jing M, 2006, AM J PHYSIOL-CELL PH, V290, pC484, DOI 10.1152/ajpcell.00321.2005; Jing M, 2007, AM J PHYSIOL-CELL PH, V292, pC477, DOI 10.1152/ajpcell.00196.2006; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Kim JS, 2006, FREE RADICAL BIO MED, V41, P818, DOI 10.1016/j.freeradbiomed.2006.05.031; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Kramer HF, 2006, DIABETES, V55, P2067, DOI 10.2337/db06-0150; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Putman CT, 2007, AM J PHYSIOL-REG I, V293, pR1325, DOI 10.1152/ajpregu.00609.2006; RANEY MA, 2008, J APPL PHYSL; RHEE SG, 2000, SCI STKE, pE1; Rubin D, 2004, ARCH BIOCHEM BIOPHYS, V431, P224, DOI 10.1016/j.abb.2004.08.007; Rubin D, 2003, AM J PHYSIOL-CELL PH, V285, pC377, DOI 10.1152/ajpcell.00060.2003; Ryder JW, 1999, BIOCHEM J, V342, P321, DOI 10.1042/0264-6021:3420321; Sakamoto K, 2002, J BIOL CHEM, V277, P11910, DOI 10.1074/jbc.M112410200; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sandstrom ME, 2006, J PHYSIOL-LONDON, V575, P251, DOI 10.1113/jphysiol.2006.110601; Stenbit AE, 1996, J CLIN INVEST, V98, P629, DOI 10.1172/JCI118833; TAYLOR EB, 2008, J BIOL CHEM; Toyoda T, 2006, AM J PHYSIOL-ENDOC M, V290, pE583, DOI 10.1152/ajpendo.00395.2005; Toyoda T, 2004, AM J PHYSIOL-ENDOC M, V287, pE166, DOI 10.1152/ajpendo.00487.2003; Treebak JT, 2006, DIABETES, V55, P2051, DOI 10.2337/db06-0175; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Wright DC, 2004, DIABETES, V53, P330, DOI 10.2337/diabetes.53.2.330; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	41	69	71	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2102	10.1371/journal.pone.0002102	http://dx.doi.org/10.1371/journal.pone.0002102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461163	Green Published, gold, Green Submitted			2022-12-27	WOS:000261642400024
J	Tsirigotis, M; Baldwin, RM; Tang, MY; Lorimer, IAJ; Gray, DA				Tsirigotis, Maria; Baldwin, R. Mitchell; Tang, Matthew Y.; Lorimer, Ian A. J.; Gray, Douglas A.			Activation of p38MAPK Contributes to Expanded Polyglutamine-Induced Cytotoxicity	PLOS ONE			English	Article							PROTEIN-KINASE INHIBITOR; SIGNAL-REGULATED KINASE; HUNTINGTONS-DISEASE; MOUSE MODEL; CELL-DEATH; MUTANT HUNTINGTIN; TRANSGENIC MICE; SPINOCEREBELLAR ATAXIA; MEDIATED TRANSCRIPTION; HIPPOCAMPAL-NEURONS	Background: The signaling pathways that may modulate the pathogenesis of diseases induced by expanded polyglutamine proteins are not well understood. Methodologies/Principal Findings: Herein we demonstrate that expanded polyglutamine protein cytotoxicity is mediated primarily through activation of p38MAPK and that the atypical PKC iota ( PKC iota) enzyme antagonizes polyglutamine-induced cell death through induction of the ERK signaling pathway. We show that pharmacological blockade of p38MAPK rescues cells from polyglutamine-induced cell death whereas inhibition of ERK recapitulates the sensitivity observed in cells depleted of PKCi by RNA interference. We provide evidence that two unrelated proteins with expanded polyglutamine repeats induce p38MAPK in cultured cells, and demonstrate induction of p38MAPK in an in vivo model of neurodegeneration (spinocerebellar ataxia 1, or SCA-1). Conclusions/Significance: Taken together, our data implicate activated p38MAPK in disease progression and suggest that its inhibition may represent a rational strategy for therapeutic intervention in the polyglutamine disorders.	[Tsirigotis, Maria; Baldwin, R. Mitchell; Tang, Matthew Y.; Lorimer, Ian A. J.; Gray, Douglas A.] Ottawa Hlth Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [Baldwin, R. Mitchell; Tang, Matthew Y.; Lorimer, Ian A. J.; Gray, Douglas A.] Univ Ottawa, Dept Biochem, Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Tsirigotis, M (corresponding author), Ottawa Hlth Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada.	dgray@ohri.ca	/U-3554-2018	/0000-0002-8634-4984	Canadian Institutes of Health Research [57737, 62797]; National Cancer Institute of Canada [015343]; Ontario Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	The work was funded by Canadian Institutes of Health Research (grant number 57737 and 62797 awarded DAG and IAJL respectively) and the National Cancer Institute of Canada (grant number 015343 awarded IAJL). RMB is a Research Student of The Terry Fox Foundation through an award from the National Cancer Institute of Canada. MYT is the recipient of an Ontario Graduate Scholarship.	Ackerley S, 2004, MOL CELL NEUROSCI, V26, P354, DOI 10.1016/j.mcn.2004.02.009; Apostol BL, 2006, HUM MOL GENET, V15, P273, DOI 10.1093/hmg/ddi443; Baldwin RM, 2006, ONCOGENE, V25, P2909, DOI 10.1038/sj.onc.1209312; Bandyopadhyay G, 2004, MOL ENDOCRINOL, V18, P373, DOI 10.1210/me.2003-0087; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Bodles AM, 2005, NEUROBIOL AGING, V26, P9, DOI 10.1016/j.neurobiolaging.2004.02.022; Branger J, 2002, J IMMUNOL, V168, P4070, DOI 10.4049/jimmunol.168.8.4070; Branger J, 2003, BLOOD, V101, P4446, DOI 10.1182/blood-2002-11-3338; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Campbell CSG, 2004, LIFE SCI, V76, P57, DOI 10.1016/j.lfs.2004.06.017; Carter RJ, 1999, J NEUROSCI, V19, P3248; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Charroux B, 2006, DEV BIOL, V291, P278, DOI 10.1016/j.ydbio.2005.12.012; Cheung Eric C C, 2004, Sci STKE, V2004, pPE45; Chiang MC, 2005, J BIOL CHEM, V280, P14331, DOI 10.1074/jbc.M413279200; Colognato R, 2006, CLIN NUTR, V25, P135, DOI 10.1016/j.clnu.2005.10.005; Colucci-D'Amato L, 2003, BIOESSAYS, V25, P1085, DOI 10.1002/bies.10355; Cong SY, 2005, MOL CELL NEUROSCI, V30, P12, DOI 10.1016/j.mcn.2005.05.003; Everett CM, 2004, BRAIN, V127, P2385, DOI 10.1093/brain/awh278; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Giovannini MG, 2002, NEUROBIOL DIS, V11, P257, DOI 10.1006/nbdi.2002.0538; Guo Q, 2004, J BIOL CHEM, V279, P4596, DOI 10.1074/jbc.M309811200; Guo Q, 2001, J BIOL CHEM, V276, P16040, DOI 10.1074/jbc.M010996200; Harper SJ, 2001, CELL SIGNAL, V13, P299, DOI 10.1016/S0898-6568(01)00148-6; Hildesheim J, 2004, J INVEST DERMATOL, V122, P497, DOI 10.1111/j.1523-1747.2004.22229.x; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Holasek SS, 2005, BRAIN RES, V1045, P185, DOI 10.1016/j.brainres.2005.03.037; Huang CS, 2000, MOL CARCINOGEN, V27, P65, DOI 10.1002/(SICI)1098-2744(200002)27:2<65::AID-MC2>3.0.CO;2-E; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Jana NR, 2003, J CHEM NEUROANAT, V26, P95, DOI 10.1016/S0891-0618(03)00029-2; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kariya S, 2006, NEUROSCI LETT, V392, P213, DOI 10.1016/j.neulet.2005.09.019; Kaytor MD, 2005, HUM MOL GENET, V14, P1095, DOI 10.1093/hmg/ddi122; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kuida K, 2004, J BIOCHEM, V135, P653, DOI 10.1093/jb/mvh078; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Laurino L, 2005, J CELL SCI, V118, P3653, DOI 10.1242/jcs.02490; Li BS, 2003, J BIOL CHEM, V278, P35702, DOI 10.1074/jbc.M302004200; Li SH, 1999, J NEUROSCI, V19, P5159; Lievens JC, 2005, HUM MOL GENET, V14, P713, DOI 10.1093/hmg/ddi067; Lipinski MM, 2004, CURR OPIN PHARMACOL, V4, P85, DOI 10.1016/j.coph.2003.09.008; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Miyashita T, 2005, BIOCHEM BIOPH RES CO, V333, P1241, DOI 10.1016/j.bbrc.2005.06.032; Monteiro FA, 2006, J NEUROCHEM, V97, P151, DOI 10.1111/j.1471-4159.2006.03716.x; Muscella A, 2004, J CELL PHYSIOL, V200, P428, DOI 10.1002/jcp.20033; Nakazawa T, 2003, CURR EYE RES, V26, P55, DOI 10.1076/ceyr.26.1.55.14254; Nolan Y, 2003, EXP NEUROL, V184, P794, DOI 10.1016/S0014-4886(03)00301-7; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Orr HT, 2000, NEUROBIOL DIS, V7, P129, DOI 10.1006/nbdi.2000.0305; Papoutsaki M, 2005, ONCOGENE, V24, P6970, DOI 10.1038/sj.onc.1208835; Pearse RN, 2005, BLOOD, V105, P4429, DOI 10.1182/blood-2004-08-3096; Poizat C, 2005, MOL CELL BIOL, V25, P2673, DOI 10.1128/MCB.25.7.2673-2687.2005; Puig B, 2004, NEUROPATH APPL NEURO, V30, P491, DOI 10.1111/j.1365-2990.2004.00569.x; Rangone H, 2005, J BIOL CHEM, V280, P22021, DOI 10.1074/jbc.M407528200; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Rouaux C, 2004, BIOCHEM PHARMACOL, V68, P1157, DOI 10.1016/j.bcp.2004.05.035; Sahara N, 2004, J NEUROCHEM, V90, P829, DOI 10.1111/j.1471-4159.2004.02558.x; Senut MC, 2000, J NEUROSCI, V20, P219, DOI 10.1523/JNEUROSCI.20-01-00219.2000; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Silva RM, 2005, MOVEMENT DISORD, V20, P653, DOI 10.1002/mds.20390; Skinner PJ, 2001, AM J PATHOL, V159, P905, DOI 10.1016/S0002-9440(10)61766-X; Song C, 2002, J BIOL CHEM, V277, P6703, DOI 10.1074/jbc.M110338200; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Subramaniam S, 2006, NEUROSCIENCE, V138, P1055, DOI 10.1016/j.neuroscience.2005.12.013; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Sugars KL, 2004, J BIOL CHEM, V279, P4988, DOI 10.1074/jbc.M310226200; Swayne LA, 2005, MOL CELL NEUROSCI, V30, P339, DOI 10.1016/j.mcn.2005.07.016; Tamagno E, 2003, EXP NEUROL, V180, P144, DOI 10.1016/S0014-4886(02)00059-6; Torii S, 2004, J BIOCHEM, V136, P557, DOI 10.1093/jb/mvh159; Tortarolo M, 2003, MOL CELL NEUROSCI, V23, P180, DOI 10.1016/S1044-7431(03)00022-8; Tsirigotis M, 2006, NEUROPATH APPL NEURO, V32, P26, DOI 10.1111/j.1365-2990.2005.00694.x; van de Warrenburg BPC, 2003, NEUROLOGY, V61, P1760, DOI 10.1212/01.WNL.0000098883.79421.73; Van den Blink B, 2004, J CLIN IMMUNOL, V24, P37, DOI 10.1023/B:JOCI.0000018061.58504.75; Vig PJS, 2006, BRAIN RES BULL, V69, P573, DOI 10.1016/j.brainresbull.2006.02.020; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Wu CJ, 2000, ONCOGENE, V19, P3999, DOI 10.1038/sj.onc.1203748; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Xie J, 2005, J BIOL CHEM, V280, P13824, DOI 10.1074/jbc.M411933200; Xie J, 2000, MOL BRAIN RES, V82, P107, DOI 10.1016/S0169-328X(00)00187-X; Xie J, 2001, BRAIN RES, V915, P1, DOI 10.1016/S0006-8993(01)02803-7; Yu XR, 2006, ACTA BIOCH BIOPH SIN, V38, P241, DOI 10.1111/j.1745-7270.2006.00152.x; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x; Zwerina J, 2006, ARTHRITIS RHEUM-US, V54, P463, DOI 10.1002/art.21626	89	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2130	10.1371/journal.pone.0002130	http://dx.doi.org/10.1371/journal.pone.0002130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461158	gold, Green Submitted, Green Published			2022-12-27	WOS:000261642400051
J	Weinfurt, KP; Seils, DM; Tzeng, JP; Lin, L; Schulman, KA; Califf, RM				Weinfurt, Kevin P.; Seils, Damon M.; Tzeng, Janice P.; Lin, Li; Schulman, Kevin A.; Califf, Robert M.			Consistency of Financial Interest Disclosures in the Biomedical Literature: The Case of Coronary Stents	PLOS ONE			English	Article							CONFLICTS-OF-INTEREST; POTENTIAL RESEARCH PARTICIPANTS; COMPETING INTERESTS; CLINICAL-TRIALS; NATIONAL-SURVEY; POLICIES; VIEWS; SPONSORSHIP; EDITORIALS	Background: Disclosure of authors' financial interests has been proposed as a strategy for protecting the integrity of the biomedical literature. We examined whether authors' financial interests were disclosed consistently in articles on coronary stents published in 2006. Methodology/Principal Findings: We searched PubMed for English-language articles published in 2006 that provided evidence or guidance regarding the use of coronary artery stents. We recorded article characteristics, including information about authors' financial disclosures. The main outcome measures were the prevalence, nature, and consistency of financial disclosures. There were 746 articles, 2985 authors, and 135 journals in the database. Eighty-three percent of the articles did not contain disclosure statements for any author (including declarations of no interests). Only 6% of authors had an article with a disclosure statement. In comparisons between articles by the same author, the types of disagreement were as follows: no disclosure statements vs declarations of no interests (64%); specific disclosures vs no disclosure statements (34%); and specific disclosures vs declarations of no interests (2%). Among the 75 authors who disclosed at least 1 relationship with an organization, there were 2 cases (3%) in which the organization was disclosed in every article the author wrote. Conclusions/Significance: In the rare instances when financial interests were disclosed, they were not disclosed consistently, suggesting that there are problems with transparency in an area of the literature that has important implications for patient care. Our findings suggest that the inconsistencies we observed are due to both the policies of journals and the behavior of some authors.	[Weinfurt, Kevin P.; Seils, Damon M.; Tzeng, Janice P.; Lin, Li; Schulman, Kevin A.; Califf, Robert M.] Duke Univ, Sch Med, Duke Clin Res Inst, Duke Translat Med Inst, Durham, NC 27710 USA; [Weinfurt, Kevin P.] Duke Univ, Sch Med, Dept Psychiat & Behavioral Sci, Durham, NC USA; [Schulman, Kevin A.; Califf, Robert M.] Duke Univ, Sch Med, Dept Med, Durham, NC USA	Duke University; Duke University; Duke University	Weinfurt, KP (corresponding author), Duke Univ, Sch Med, Duke Clin Res Inst, Duke Translat Med Inst, Durham, NC 27710 USA.	kevin.weinfurt@duke.edu		Seils, Damon/0000-0001-8257-745X	National Center for Research Resources, a component of the US National Institutes of Health [1UL1RR024128-02]; National Heart, Lung, and Blood Institute [5R01HL075538-04]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075538] Funding Source: NIH RePORTER	National Center for Research Resources, a component of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Drs. Weinfurt and Califf were supported in part by grant 1UL1RR024128-02 from the National Center for Research Resources, a component of the US National Institutes of Health. Drs. Weinfurt and Schulman were supported in part by grant 5R01HL075538-04 from the National Heart, Lung, and Blood Institute. The funding agencies had no role in the design and conduct of the study; the collection, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.	AAMC Task Force on Financial Conflicts of Interest in Clinical Research, 2003, Acad Med, V78, P225; Angeli M, 1996, NEW ENGL J MED, V335, P1055, DOI 10.1056/NEJM199610033351410; ARMSTRONG D, 2007, WALL STREET J   0608, pB6; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Cain Daylian, 2005, CONFLICTS INTEREST, P105; Cain DM, 2005, J LEGAL STUD, V34, P1, DOI 10.1086/426699; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Chaudhry S, 2002, BRIT MED J, V325, P1391, DOI 10.1136/bmj.325.7377.1391; COHEN R, 2006, STAR LEDGER     1205, P25; Cooper RJ, 2006, J GEN INTERN MED, V21, P1248, DOI 10.1111/j.1525-1497.2006.00598.x; Council of Science Editors, 2015, CSES WHIT PAP PROM I; Davidoff F, 2001, JAMA-J AM MED ASSOC, V286, P1232, DOI 10.1001/jama.286.10.1232; DeAngelis CD, 2006, JAMA-J AM MED ASSOC, V296, P996, DOI 10.1001/jama.296.8.jed60051; Ehringhaus S., 2006, PRINCIPLES PROTECTIN; Fontanarosa PB, 2005, JAMA-J AM MED ASSOC, V294, P110, DOI 10.1001/jama.294.1.110; Gross CP, 2003, BRIT MED J, V326, P526, DOI 10.1136/bmj.326.7388.526; Hampson LA, 2006, NEW ENGL J MED, V355, P2330, DOI 10.1056/NEJMsa064160; HARRIS G, 2008, NY TIMES        0326, pA1; HENSCHKE CI, 2008, JAMA IN PRESS; HENSLEY S, 2002, WALL STREET J   0801, pD3; Hussain A, 2001, BRIT MED J, V323, P263, DOI 10.1136/bmj.323.7307.263; *INT COMM MED J ED, BIOMED J UNPUB; *INT COMM MED J ED, J HAV REQ INCL LIST; Kim SYH, 2004, J MED ETHICS, V30, P73, DOI 10.1136/jme.2002.001461; Krimsky S, 1998, JAMA-J AM MED ASSOC, V280, P225, DOI 10.1001/jama.280.3.225; Krimsky S, 2001, PSYCHOTHER PSYCHOSOM, V70, P115, DOI 10.1159/000056236; Krimsky S, 2001, SCI ENG ETHICS, V7, P205, DOI 10.1007/s11948-001-0041-7; Krimsky S., 2004, SCI PRIVATE INTEREST; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; Neill US, 2007, J CLIN INVEST, V117, P506, DOI 10.1172/JCI31587; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Perlis RH, 2005, AM J PSYCHIAT, V162, P1957, DOI 10.1176/appi.ajp.162.10.1957; Riechelmann RP, 2007, J CLIN ONCOL, V25, P4642, DOI 10.1200/JCO.2007.11.2482; Schroter S, 2004, BRIT MED J, V328, P742, DOI 10.1136/bmj.38035.705185.F6; Schulman KA, 2002, NEW ENGL J MED, V347, P1335, DOI 10.1056/NEJMsa020349; SCHWARTZ RS, 2008, N ENGL J ME IN PRESS; Shah JY, 2005, CURR DIR PSYCHOL SCI, V14, P10, DOI 10.1111/j.0963-7214.2005.00325.x; Shuchman M, 2007, NEW ENGL J MED, V356, P325, DOI 10.1056/NEJMp068300; TANNER L, 2007, STUDY RENEWS CONFLIC; Weinfurt Kevin P, 2007, IRB, V29, P1; Weinfurt KP, 2006, J GEN INTERN MED, V21, P901, DOI 10.1111/j.1525-1497.2006.00502.x; Weinfurt KP, 2006, ACAD MED, V81, P113, DOI 10.1097/00001888-200602000-00003; World Association of Medical Editors, WAME REC PUBL ETH PO; 2006, JAMA, V296, P170	44	53	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2128	10.1371/journal.pone.0002128	http://dx.doi.org/10.1371/journal.pone.0002128			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	382YX	18461146	Green Published, gold			2022-12-27	WOS:000261642400049
J	Alboresi, A; Caffarri, S; Nogue, F; Bassi, R; Morosinotto, T				Alboresi, Alessandro; Caffarri, Stefano; Nogue, Fabien; Bassi, Roberto; Morosinotto, Tomas			In Silico and Biochemical Analysis of Physcomitrella patens Photosynthetic Antenna: Identification of Subunits which Evolved upon Land Adaptation	PLOS ONE			English	Article							LIGHT-HARVESTING COMPLEX; PHOTOSYSTEM-I; HIGHER-PLANTS; SUPRAMOLECULAR ORGANIZATION; CHLAMYDOMONAS-REINHARDTII; CHLOROPHYLL FLUORESCENCE; ARABIDOPSIS-THALIANA; THYLAKOID MEMBRANES; OSTREOCOCCUS-TAURI; MESOSTIGMA-VIRIDE	Background: In eukaryotes the photosynthetic antenna system is composed of subunits encoded by the light harvesting complex (Lhc) multigene family. These proteins play a key role in photosynthesis and are involved in both light harvesting and photoprotection. The moss Physcomitrella patens is a member of a lineage that diverged from seed plants early after land colonization and therefore by studying this organism, we may gain insight into adaptations to the aerial environment. Principal Findings: In this study, we characterized the antenna protein multigene family in Physcomitrella patens, by sequence analysis as well as biochemical and functional investigations. Sequence identification and analysis showed that some antenna polypeptides, such as Lhcb3 and Lhcb6, are present only in land organisms, suggesting they play a role in adaptation to the sub-aerial environment. Our functional analysis which showed that photo-protective mechanisms in Physcomitrella patens are very similar to those in seed plants fits with this hypothesis. In particular, Physcomitrella patens also activates Non Photochemical Quenching upon illumination, consistent with the detection of an ortholog of the PsbS protein. As a further adaptation to terrestrial conditions, the content of Photosystem I low energy absorbing chlorophylls also increased, as demonstrated by differences in Lhca3 and Lhca4 polypeptide sequences, in vitro reconstitution experiments and low temperature fluorescence spectra. Conclusions: This study highlights the role of Lhc family members in environmental adaptation and allowed proteins associated with mechanisms of stress resistance to be identified within this large family.	[Alboresi, Alessandro; Caffarri, Stefano; Morosinotto, Tomas] Univ Mediterranee, CNRS, CEA, Lab Genet & Biophys Plantes,UMR 6191, Marseille, France; [Nogue, Fabien] IJPB, INRA, Stn Genet Ameliorat Plantes, Versailles, France; [Bassi, Roberto] Univ Verona, Dipartimento Sci Tecnol, Verona, Italy; [Morosinotto, Tomas] Univ Padua, Dipartimento Biol, Padua, Italy	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Verona; University of Padua	Alboresi, A (corresponding author), Univ Mediterranee, CNRS, CEA, Lab Genet & Biophys Plantes,UMR 6191, Marseille, France.	tomas.morosinotto@unipd.it	Morosinotto, Tomas/AAC-3188-2019; Alboresi, Alessandro/B-5080-2010; Alboresi, Alessandro/Z-1220-2019; Caffarri, Stefano/AAX-8913-2021	Morosinotto, Tomas/0000-0002-0803-7591; Alboresi, Alessandro/0000-0003-4818-7778; Caffarri, Stefano/0000-0002-4729-7679; bassi, roberto/0000-0002-4140-8446; Nogue, Fabien/0000-0003-0619-4638	European Community's Human Potential Program [HPRN-CT-2002-00248]; CEA [fellowship]	European Community's Human Potential Program; CEA(French Atomic Energy Commission)	AA was supported by the European Community's Human Potential Program contract HPRN-CT-2002-00248 (PSICO) and by a CEA fellowship. We thank the FISR grants Idrobio for financial support.	ASHTON NW, 1979, PLANTA, V144, P427, DOI 10.1007/BF00380118; Ballottari M, 2004, EUR J BIOCHEM, V271, P4659, DOI 10.1111/j.1432-1033.2004.04426.x; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BASSI R, 1992, J BIOL CHEM, V267, P25714; BASSI R, 1987, EUR J BIOCHEM, V163, P221, DOI 10.1111/j.1432-1033.1987.tb10791.x; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Caffarri S, 2005, PROTEOMICS, V5, P758, DOI 10.1002/pmic.200402008; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Carbonera D, 2005, BIOCHEMISTRY-US, V44, P8337, DOI 10.1021/bi050260z; COURTIES C, 1994, NATURE, V370, P255, DOI 10.1038/370255a0; Courties C, 1998, J PHYCOL, V34, P844, DOI 10.1046/j.1529-8817.1998.340844.x; Cove D, 2005, ANNU REV GENET, V39, P339, DOI 10.1146/annurev.genet.39.073003.110214; Cove DJ, 1997, TRENDS PLANT SCI, V2, P99, DOI 10.1016/S1360-1385(96)10056-X; Croce R, 1996, BIOCHEMISTRY-US, V35, P8572, DOI 10.1021/bi960214m; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Croce R, 2007, BIOCHEMISTRY-US, V46, P3846, DOI 10.1021/bi602531k; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Durnford DG, 1999, J MOL EVOL, V48, P59, DOI 10.1007/PL00006445; Elrad D, 2004, CURR GENET, V45, P61, DOI 10.1007/s00294-003-0460-x; Espineda CE, 1999, P NATL ACAD SCI USA, V96, P10507, DOI 10.1073/pnas.96.18.10507; Falkowski PG, 2006, SCIENCE, V311, P1724, DOI 10.1126/science.1125937; Finazzi G, 2006, BIOCHEMISTRY-US, V45, P1490, DOI 10.1021/bi0521588; Frigerio S, 2007, J BIOL CHEM, V282, P29457, DOI 10.1074/jbc.M705132200; Ganeteg U, 2004, PLANT MOL BIOL, V54, P641, DOI 10.1023/B:PLAN.0000040813.05224.94; Germano M, 2002, FEBS LETT, V525, P121, DOI 10.1016/S0014-5793(02)03100-9; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunning BES, 1999, AUST J PLANT PHYSIOL, V26, P695, DOI 10.1071/PP99076; Harrer R, 2003, PHOTOSYNTH RES, V75, P249, DOI 10.1023/A:1023952832255; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Heddad M, 2000, P NATL ACAD SCI USA, V97, P3741, DOI 10.1073/pnas.050391397; Hofmann AH, 1999, MOL GEN GENET, V261, P92, DOI 10.1007/s004380050945; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Hutin C, 2003, P NATL ACAD SCI USA, V100, P4921, DOI 10.1073/pnas.0736939100; Jansson S, 1999, PLANT MOL BIOL REP, V17, P221, DOI 10.1023/A:1007620508007; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Kargul J, 2003, J BIOL CHEM, V278, P16135, DOI 10.1074/jbc.M300262200; Klimmek F, 2006, PLANT PHYSIOL, V140, P793, DOI 10.1104/pp.105.073304; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; KOZIOL AG, 2007, PLANT PHYSL; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Larkum AWD, 2003, ADV PHOTO RESPIRAT, V14, P11; LAROCHE J, 1991, PLANT PHYSIOL, V97, P147, DOI 10.1104/pp.97.1.147; Lemieux C, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-2; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Markmann-Mulisch U, 2002, P NATL ACAD SCI USA, V99, P2959, DOI 10.1073/pnas.032668199; Matsubara S, 2007, PLANT PHYSIOL, V144, P926, DOI 10.1104/pp.107.099077; Morosinotto T, 2005, J BIOL CHEM, V280, P31050, DOI 10.1074/jbc.M502935200; Morosinotto T, 2003, J BIOL CHEM, V278, P49223, DOI 10.1074/jbc.M309203200; Morosinotto T, 2006, FEBS J, V273, P4616, DOI 10.1111/j.1742-4658.2006.05465.x; Nedelcu AM, 2006, MOL BIOL EVOL, V23, P1011, DOI 10.1093/molbev/msj108; Nelson N, 2005, BIOESSAYS, V27, P914, DOI 10.1002/bies.20278; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Peers G, 2007, PHOTOSYNTH RES, V91, P250; PETER GF, 1991, J BIOL CHEM, V266, P16745; Quatrano RS, 2007, CURR OPIN PLANT BIOL, V10, P182, DOI 10.1016/j.pbi.2007.01.005; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; RHIEL E, 1993, MOL GEN GENET, V240, P403, DOI 10.1007/BF00280392; Richard C, 2000, PLANT MOL BIOL, V42, P303, DOI 10.1023/A:1006340308077; Rivadossi A, 1999, PHOTOSYNTH RES, V60, P209, DOI 10.1023/A:1006236829711; Rodriguez-Ezpeleta N, 2007, MOL BIOL EVOL, V24, P723, DOI 10.1093/molbev/msl200; Rossini S, 2006, PLANT PHYSIOL, V141, P1264, DOI 10.1104/pp.106.083055; Six C, 2005, MOL BIOL EVOL, V22, P2217, DOI 10.1093/molbev/msi220; Standfuss J, 2004, J BIOL CHEM, V279, P36884, DOI 10.1074/jbc.M402348200; Stauber EJ, 2003, EUKARYOT CELL, V2, P978, DOI 10.1128/EC.2.5.978-994.2003; TRISSL HW, 1993, TRENDS BIOCHEM SCI, V18, P415, DOI 10.1016/0968-0004(93)90136-B; Trouiller B, 2006, NUCLEIC ACIDS RES, V34, P232, DOI 10.1093/nar/gkj423; Turmel M, 2002, MOL BIOL EVOL, V19, P24, DOI 10.1093/oxfordjournals.molbev.a003979; Tzvetkova-Chevolleau T, 2007, PLANT J, V50, P795, DOI 10.1111/j.1365-313X.2007.03090.x; Walters RG, 2005, J EXP BOT, V56, P435, DOI 10.1093/jxb/eri060	80	104	106	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2033	10.1371/journal.pone.0002033	http://dx.doi.org/10.1371/journal.pone.0002033			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446222	Green Published, Green Submitted, gold			2022-12-27	WOS:000261572300006
J	Curtin, JF; Candolfi, M; Fakhouri, TM; Liu, CY; Alden, A; Edwards, M; Lowenstein, PR; Castro, MG				Curtin, James F.; Candolfi, Marianela; Fakhouri, Tamer M.; Liu, Chunyan; Alden, Anderson; Edwards, Matthew; Lowenstein, Pedro R.; Castro, Maria G.			Treg Depletion Inhibits Efficacy of Cancer Immunotherapy: Implications for Clinical Trials	PLOS ONE			English	Article								Background: Regulatory T lymphocytes (Treg) infiltrate human glioblastoma (GBM); are involved in tumor progression and correlate with tumor grade. Transient elimination of Tregs using CD25 depleting antibodies (PC61) has been found to mediate GBM regression in preclinical models of brain tumors. Clinical trials that combine Treg depletion with tumor vaccination are underway to determine whether transient Treg depletion can enhance anti-tumor immune responses and improve long term survival in cancer patients. Findings: Using a syngeneic intracrabial glioblastoma (GBM) mouse model we show that systemic depletion of Tregs 15 days after tumor implantation using PC61 resulted in a decrease in Tregs present in tumors, draining lymph nodes and spleen and improved long-term survival (50% of mice survived > 150 days). No improvement in survival was observed when Tregs were depleted 24 days after tumor implantation, suggesting that tumor burden is an important factor for determining efficacy of Treg depletion in clinical trials. In a T cell dependent model of brain tumor regression elicited by intratumoral delivery of adenoviral vectors (Ad) expressing Fms-like Tyrosine Kinase 3 ligand (Flt3L) and Herpes Simplex Type 1-Thymidine Kinase (TK) with ganciclovir (GCV), we demonstrate that administration of PC61 24 days after tumor implantation (7 days after treatment) inhibited T cell dependent tumor regression and long term survival. Further, depletion with PC61 completely inhibited clonal expansion of tumor antigen-specific T lymphocytes in response to the treatment. Conclusions: Our data demonstrate for the first time, that although Treg depletion inhibits the progression/eliminates GBM tumors, its efficacy is dependent on tumor burden. We conclude that this approach will be useful in a setting of minimal residual disease. Further, we also demonstrate that Treg depletion, using PC61 in combination with immunotherapy, inhibits clonal expansion of tumor antigen-specific T cells, suggesting that new, more specific targets to block Tregs will be necessary when used in combination with therapies that activate anti-tumor immunity.	[Curtin, James F.; Candolfi, Marianela; Fakhouri, Tamer M.; Liu, Chunyan; Alden, Anderson; Edwards, Matthew; Lowenstein, Pedro R.; Castro, Maria G.] Cedars Sinai Med Ctr, Dept Biomed Sci, Gene Therapeut Res Inst, Los Angeles, CA 90048 USA; [Curtin, James F.; Candolfi, Marianela; Liu, Chunyan; Lowenstein, Pedro R.; Castro, Maria G.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehensive Canc Ctr, Brain Res Inst, Dept Med, Los Angeles, CA USA; [Curtin, James F.; Candolfi, Marianela; Liu, Chunyan; Lowenstein, Pedro R.; Castro, Maria G.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehensive Canc Ctr, Brain Res Inst, Dept Mol & Med Pharmacol, Los Angeles, CA USA	Cedars Sinai Medical Center; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Castro, MG (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Gene Therapeut Res Inst, Los Angeles, CA 90048 USA.	castromg@cshs.org	Curtin, James/B-1669-2008; Castro, Maria/ABC-5182-2021	Curtin, James/0000-0002-9320-9254; Castro, Maria/0000-0003-2237-2756; Edwards, Matthew/0000-0002-9701-0736	National Institutes of Health/National Institute of Neurological Disorders & Stroke (NIH/NINDS) [1R01 NS44556.01, NS445561.01, 1R21-NSO54143.01, 1UO1 NS052465.01, 1 RO3 TW006273-01, 1 RO1 NS 054193.01, RO1 NS 42893.01, U54 NS045309-01, 1R21 NS047298-01, 1F32 NS058156.01]; The Bram and Elaine Goldsmith and the Medallions Group Endowed Chairs in Gene Therapeutics; The Linda Tallen & David Paul Kane Foundation Annual Fellowship; Board of Governors at CSMC; FOGARTY INTERNATIONAL CENTER [R03TW006273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS058156, R01NS044556, U54NS045309, R01NS054193, R21NS047298, U01NS052465, R01NS042893] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders & Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); The Bram and Elaine Goldsmith and the Medallions Group Endowed Chairs in Gene Therapeutics; The Linda Tallen & David Paul Kane Foundation Annual Fellowship; Board of Governors at CSMC; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by National Institutes of Health/National Institute of Neurological Disorders & Stroke (NIH/NINDS) Grant 1R01 NS44556.01, Minority Supplement NS445561.01; 1R21-NSO54143.01; 1UO1 NS052465.01, 1 RO3 TW006273-01 to M.G.C.; NIH/NINDS Grants 1 RO1 NS 054193.01; RO1 NS 42893.01, U54 NS045309-01 and 1R21 NS047298-01 to P.R.L. The Bram and Elaine Goldsmith and the Medallions Group Endowed Chairs in Gene Therapeutics to PRL and MGC, respectively, The Linda Tallen & David Paul Kane Foundation Annual Fellowship and the Board of Governors at CSMC. M.C is supported by NIH/NINDS 1F32 NS058156.01.	Alegre ML, 1998, J IMMUNOL, V161, P3347; Ali S, 2004, MOL THER, V10, P1071, DOI 10.1016/j.ymthe.2004.08.025; Ali S, 2005, CANCER RES, V65, P7194, DOI 10.1158/0008-5472.CAN-04-3434; Barao I, 2006, P NATL ACAD SCI USA, V103, P5460, DOI 10.1073/pnas.0509249103; Barzon L, 2006, CANCER GENE THER, V13, P539, DOI 10.1038/sj.cgt.7700930; Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Colombo MP, 2007, NAT REV CANCER, V7, P880, DOI 10.1038/nrc2250; Curtin JF, 2006, J IMMUNOL, V176, P3566, DOI 10.4049/jimmunol.176.6.3566; Curtin JF, 2005, CURR TOP MED CHEM, V5, P1151, DOI 10.2174/156802605774370856; Dewey RA, 1999, NAT MED, V5, P1256, DOI 10.1038/15207; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; El Andaloussi A, 2006, NEURO-ONCOLOGY, V8, P234, DOI 10.1215/15228517-2006-006; El Andaloussi A, 2007, J NEURO-ONCOL, V83, P145, DOI 10.1007/s11060-006-9314-y; El Andaloussi A, 2006, J NEUROSURG, V105, P430, DOI 10.3171/jns.2006.105.3.430; Fecci PE, 2006, CANCER RES, V66, P3294, DOI 10.1158/0008-5472.CAN-05-3773; Fecci PE, 2007, CLIN CANCER RES, V13, P2158, DOI 10.1158/1078-0432.CCR-06-2070; Fecci PE, 2006, CLIN CANCER RES, V12, P4294, DOI 10.1158/1078-0432.CCR-06-0053; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Ghiringhelli F, 2006, IMMUNOL REV, V214, P229, DOI 10.1111/j.1600-065X.2006.00445.x; Gomez GG, 2006, GENE THER MOL BIOL, V10A, P133; Grauer OM, 2007, INT J CANCER, V121, P95, DOI 10.1002/ijc.22607; Hussain SF, 2006, NEURO-ONCOLOGY, V8, P261, DOI 10.1215/15228517-2006-008; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Johnson BD, 2007, J IMMUNOTHER, V30, P203, DOI 10.1097/01.cji.0000211336.91513.dd; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; King GD, 2005, CURR GENE THER, V5, P535, DOI 10.2174/156652305774964631; KING GD, 2007, NEUROONCOL; Liau LM, 2005, CLIN CANCER RES, V11, P5515, DOI 10.1158/1078-0432.CCR-05-0464; Lowenstein PR, 2002, TRENDS IMMUNOL, V23, P23, DOI 10.1016/S1471-4906(01)02063-4; LOWENTHAL JW, 1985, NATURE, V315, P669, DOI 10.1038/315669a0; LOWENTHAL JW, 1985, J IMMUNOL, V135, P3988; McLendon RE, 2003, CANCER-AM CANCER SOC, V98, P1745, DOI 10.1002/cncr.11666; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Onizuka S, 1999, CANCER RES, V59, P3128; Prins RM, 2004, FRONT BIOSCI-LANDMRK, V9, P3124, DOI 10.2741/1465; Qu YY, 2007, INT REV IMMUNOL, V26, P145, DOI 10.1080/08830180701365917; Skog J, 2006, EXPERT REV VACCINES, V5, P793, DOI 10.1586/14760584.5.6.793; Smyth MJ, 2006, J IMMUNOL, V176, P1582, DOI 10.4049/jimmunol.176.3.1582; Sun Z, 2006, AM J TRANSPLANT, V6, P2841, DOI 10.1111/j.1600-6143.2006.01549.x; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Tang J, 2005, CLIN CANCER RES, V11, P5292, DOI 10.1158/1078-0432.CCR-05-0545; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Whiteside TL, 2006, SEMIN CANCER BIOL, V16, P3, DOI 10.1016/j.semcancer.2005.07.008; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Yamanaka R, 2003, BRIT J CANCER, V89, P1172, DOI 10.1038/sj.bjc.6601268; Yi HF, 2006, CELL MOL IMMUNOL, V3, P189	50	99	105	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1983	10.1371/journal.pone.0001983	http://dx.doi.org/10.1371/journal.pone.0001983			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431473	Green Published, gold, Green Submitted			2022-12-27	WOS:000261558700008
J	Roukens, AH; Vossen, AC; Bredenbeek, PJ; van Dissel, JT; Visser, LG				Roukens, Anna H.; Vossen, Ann C.; Bredenbeek, Peter J.; van Dissel, Jaap T.; Visser, Leo G.			Intradermally Administered Yellow Fever Vaccine at Reduced Dose Induces a Protective Immune Response: A Randomized Controlled Non-Inferiority Trial	PLOS ONE			English	Article								Background: Implementation of yellow fever vaccination is currently hampered by limited supply of vaccine. An alternative route of administration with reduced amounts of vaccine but without loss of vaccine efficacy would boost vaccination programmes. Methods and Findings: A randomized, controlled, non-inferiority trial was conducted in a Dutch university center between August 2005 and February 2007. A total of 155 primary vaccinated and 20 previously vaccinated volunteers participated. Participants were randomly assigned in a 1: 1 ratio to receive intradermal (i.d.) vaccination with live attenuated yellow fever 17D vaccine at a reduced dose (1/5(th); 0.1 mL) or the conventional subcutaneous (s.c.) vaccination (0.5 mL). Antibody neutralization titers were determined at 2, 4 and 8 weeks and 1 year after vaccination by counting the reduction in virus-induced plaques in the presence of serial serum dilutions. Adverse events were documented in a 3-week dairy. Viraemia was measured 5 days after vaccination. From 2 weeks up to one year after vaccination, the maximum serum-dilution at which 80% of the virus plaques were neutralized, which indicates protection against yellow fever, did not differ between those given a reduced i.d. dose or standard s.c. dose of vaccine. In all cases the WHO standard of seroprotection (i.e. 80% virus neutralization) was reached (in 77/77 and 78/78, respectively). Similar results were found in the previously vaccinated individuals. Viraemia was detected in half of the primary vaccinated participants, which was not predictive of serological response. In revaccinees no viraemia was detected. Conclusions: Intradermal administration of one fifth of the amount of yellow fever vaccine administered subcutaneously results in protective seroimmunity in all volunteers. Albeit this vaccination route should enable vaccination of five-times as many individuals at risk for disease, these results should now be confirmed in field studies in areas with potential yellow fever virus transmission to change vaccination policy.	[Roukens, Anna H.; van Dissel, Jaap T.; Visser, Leo G.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Vossen, Ann C.] Erasmus Univ, Dept Virol, Rotterdam, Netherlands; [Bredenbeek, Peter J.] Leiden Univ, Med Ctr, Dept Res Virol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Roukens, AH (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	l.g.visser@lumc.nl	Visser, Leo/AAH-5755-2021; Vossen, Ann/HIR-2262-2022	Vossen, Ann/0000-0003-1750-2843; Visser, Leo/0000-0002-3600-9782	Infectious Diseases of the Leiden University Medical Center	Infectious Diseases of the Leiden University Medical Center	Funding was provided by the department of Infectious Diseases of the Leiden University Medical Center.	[Anonymous], 2006, Wkly Epidemiol Rec, V81, P317; [Anonymous], 2007, WKLY EPIDEMIOL REC; Armitage P., 2002, STAT METHODS MED RES; Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352; Belshe RB, 2004, NEW ENGL J MED, V351, P2286, DOI 10.1056/NEJMoa043555; CANNON SA, 1953, ANN TROP MED PARASIT, V47, P381; CDC, MANT TUB SKIN TEST F; Dean CH, 2005, HUM VACCINES, V1, P106, DOI 10.4161/hv.1.3.1797; DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113; DICK GWA, 1952, AM J HYG, V55, P140, DOI 10.1093/oxfordjournals.aje.a119502; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Fox JP, 1943, AM J HYG, V38, P113, DOI 10.1093/oxfordjournals.aje.a118875; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973; Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0; Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553; Monath TP, 1999, VACCINES, P815; Nijhuis M, 2002, J CLIN MICROBIOL, V40, P3666, DOI 10.1128/JCM.40.10.3666-3670.2002; Palmer DR, 2007, J GEN VIROL, V88, P148, DOI 10.1099/vir.0.82272-0; REDFIELD RR, 1985, JAMA-J AM MED ASSOC, V254, P3203, DOI 10.1001/jama.254.22.3203; Reinhardt B, 1998, J MED VIROL, V56, P159, DOI 10.1002/(SICI)1096-9071(199810)56:2&lt;159::AID-JMV10&gt;3.0.CO;2-B; Roberts L, 2007, SCIENCE, V316, P1109, DOI 10.1126/science.316.5828.1109; Robertson SE, 1996, JAMA-J AM MED ASSOC, V276, P1157, DOI 10.1001/jama.276.14.1157; WARRELL MJ, 1983, LANCET, V2, P301; WHO, 1998, WHO TECHN REP SER, V872	25	67	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1993	10.1371/journal.pone.0001993	http://dx.doi.org/10.1371/journal.pone.0001993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431480	Green Submitted, Green Published, gold			2022-12-27	WOS:000261558700015
J	Clement, EA; Richard, A; Thwaites, M; Ailon, J; Peters, S; Dickson, CT				Clement, Elizabeth A.; Richard, Alby; Thwaites, Megan; Ailon, Jonathan; Peters, Steven; Dickson, Clayton T.			Cyclic and Sleep-Like Spontaneous Alternations of Brain State Under Urethane Anaesthesia	PLOS ONE			English	Article								Background: Although the induction of behavioural unconsciousness during sleep and general anaesthesia has been shown to involve overlapping brain mechanisms, sleep involves cyclic fluctuations between different brain states known as active (paradoxical or rapid eye movement: REM) and quiet (slow-wave or non-REM: nREM) stages whereas commonly used general anaesthetics induce a unitary slow-wave brain state. Methodology/Principal Findings: Long-duration, multi-site forebrain field recordings were performed in urethane-anaesthetized rats. A spontaneous and rhythmic alternation of brain state between activated and deactivated electroencephalographic (EEG) patterns was observed. Individual states and their transitions resembled the REM/nREM cycle of natural sleep in their EEG components, evolution, and time frame (similar to 11 minute period). Other physiological variables such as muscular tone, respiration rate, and cardiac frequency also covaried with forebrain state in a manner identical to sleep. The brain mechanisms of state alternations under urethane also closely overlapped those of natural sleep in their sensitivity to cholinergic pharmacological agents and dependence upon activity in the basal forebrain nuclei that are the major source of forebrain acetylcholine. Lastly, stimulation of brainstem regions thought to pace state alternations in sleep transiently disrupted state alternations under urethane. Conclusions/Significance: Our results suggest that urethane promotes a condition of behavioural unconsciousness that closely mimics the full spectrum of natural sleep. The use of urethane anaesthesia as a model system will facilitate mechanistic studies into sleep-like brain states and their alternations. In addition, it could also be exploited as a tool for the discovery of new molecular targets that are designed to promote sleep without compromising state alternations.	[Clement, Elizabeth A.; Peters, Steven; Dickson, Clayton T.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Richard, Alby; Thwaites, Megan; Ailon, Jonathan; Dickson, Clayton T.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Dickson, Clayton T.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Dickson, CT (corresponding author), Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada.	cdickson@ualberta.ca	Sanguansri, Luz/B-6630-2011; Peters, Steven/AAT-5974-2021	Sanguansri, Luz/0000-0003-1908-7604; Peters, Steven/0000-0002-4799-1265; Dickson, Clayton/0000-0002-3849-8110; Clement, Elizabeth/0000-0001-8222-4048	Canadian Institutes of Health [MOP 77625]; Alberta Heritage Foundation for Medical Research (AHFMR) [summer studentships]; Natural Sciences and Engineering Research Council of Canada [summer studentships]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by a Canadian Institutes of Health Research grant (MOP 77625 to CTD). CTD is a Scholar of the Alberta Heritage Foundation for Medical Research (AHFMR). SRP and JA were supported by Natural Sciences and Engineering Research Council of Canada summer studentships. SRP was additionally supported by an AHFMR summer studentship.	ASERINSK.E, 1965, SCIENCE, V150, P763, DOI 10.1126/science.150.3697.763-a; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; BLAND BH, 1993, PROG NEUROBIOL, V41, P157, DOI 10.1016/0301-0082(93)90007-F; BORBELY AA, 1976, BRAIN RES, V114, P305, DOI 10.1016/0006-8993(76)90673-9; BUENO JR, 1968, PSYCHOPHARMACOLOGIA, V12, P400, DOI 10.1007/BF00401345; CARLSSON A, 1957, NATURE, V180, P1200, DOI 10.1038/1801200a0; Carvalho RC, 2006, BRAIN RES, V1122, P179, DOI 10.1016/j.brainres.2006.09.008; CHAPUT M, 1980, J PHYSIOL-PARIS, V76, P551; Contreras D, 1997, J NEUROSCI, V17, P1179; Datta S, 2000, BEHAV NEUROSCI, V114, P1239, DOI 10.1037/0735-7044.114.6.1239; DEMENT W, 1957, ELECTROEN CLIN NEURO, V9, P673, DOI 10.1016/0013-4694(57)90088-3; Detari L, 1997, BRAIN RES, V759, P112, DOI 10.1016/S0006-8993(97)00252-7; DICKSON C, 2007, CAN J NEUROL SCI S, V3; DICKSON C, 2007, SOC NEUROSCI; Dringenberg HC, 1998, NEUROSCI BIOBEHAV R, V22, P243, DOI 10.1016/S0149-7634(97)00012-2; Eschenko O, 2006, J NEUROSCI, V26, P12914, DOI 10.1523/JNEUROSCI.3175-06.2006; Ferrara M, 1999, Sleep Res Online, V2, P15; GRAHN DA, 1989, AM J PHYSIOL, V256, pR840, DOI 10.1152/ajpregu.1989.256.4.R840; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Hobson JA, 2002, NAT REV NEUROSCI, V3, P679, DOI 10.1038/nrn915; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; Horner RL, 1999, NEUROSCIENCE, V93, P215, DOI 10.1016/S0306-4522(99)00126-8; Hunter JD, 1998, RESP PHYSIOL, V112, P71, DOI 10.1016/S0034-5687(98)00018-8; JONES BE, 1993, PROG BRAIN RES, V98, P61; Jones BE, 2003, FRONT BIOSCI-LANDMRK, V8, pS438, DOI 10.2741/1074; Kinney GG, 1998, BRAIN RES, V809, P307, DOI 10.1016/S0006-8993(98)00878-6; Koblin DD, 2002, ANESTH ANALG, V94, P241, DOI 10.1097/00000539-200202000-00002; Lee J, 2004, P NATL ACAD SCI USA, V101, P18195, DOI 10.1073/pnas.0408089101; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; MCCARLEY RW, 1975, SCIENCE, V189, P58, DOI 10.1126/science.1135627; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; Nelson LE, 2003, ANESTHESIOLOGY, V98, P428, DOI 10.1097/00000542-200302000-00024; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Nelson LE, 2004, ANESTHESIOLOGY, V100, P1341, DOI 10.1097/00000542-200406000-00003; NOMEIR AA, 1989, TOXICOL APPL PHARM, V97, P203, DOI 10.1016/0041-008X(89)90326-8; Ocampo-Garces A, 2000, J NEUROPHYSIOL, V84, P2699; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Rechtschaffen A, 2002, SLEEP, V25, p68B, DOI 10.1093/sleep/25.1.68; Rechtschaffen A, 2002, SLEEP, V25, P18, DOI 10.1093/sleep/25.1.18; Rechtschaffen A, 1999, SLEEP, V22, P11, DOI 10.1093/sleep/22.1.11; ROBINSON TE, 1977, BRAIN RES, V124, P544, DOI 10.1016/0006-8993(77)90954-4; ROBINSON TE, 1978, EXP NEUROL, V61, P485, DOI 10.1016/0014-4886(78)90018-3; Sceniak MP, 2006, J NEUROPHYSIOL, V95, P3865, DOI 10.1152/jn.01196.2005; SHAFER A, 1995, ANESTHESIOLOGY, V83, P1331, DOI 10.1097/00000542-199512000-00024; SHOUSE MN, 1992, BRAIN RES, V571, P50, DOI 10.1016/0006-8993(92)90508-7; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; SIEGEL JM, 2005, PRINCIPLES PRACTICE; Sinton CM, 2004, SEMIN NEUROL, V24, P211, DOI 10.1055/s-2004-835067; SOTOMAYOR RE, 1990, TOXICOL IND HEALTH, V6, P71, DOI 10.1177/074823379000600106; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; STERIADE M, 1993, J NEUROSCI, V13, P3266; Steriade M., 1999, ELECTROENCEPHALOGRAP, P28; Tung A, 2004, ANESTHESIOLOGY, V100, P1419, DOI 10.1097/00000542-200406000-00014; Tung A, 2004, SLEEP MED REV, V8, P213, DOI 10.1016/j.smrv.2004.01.003; Tung A, 2002, ANESTHESIOLOGY, V97, P906, DOI 10.1097/00000542-200210000-00024; Tung A, 2001, ANESTH ANALG, V92, P1232; Tung A, 2001, BRAIN RES, V908, P155, DOI 10.1016/S0006-8993(01)02629-4; Tung A, 2001, LIFE SCI, V69, P855, DOI 10.1016/S0024-3205(01)01179-1; VANDERWOLF CH, 1988, INT REV NEUROBIOL, V30, P225; VERTES RP, 1982, PROG NEUROBIOL, V19, P159, DOI 10.1016/0301-0082(82)90005-3; Whelan PJ, 2003, METHODS, V30, P127, DOI 10.1016/S1046-2023(03)00074-4; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; YLINEN A, 1995, J NEUROSCI, V15, P30	65	243	243	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e2004	10.1371/journal.pone.0002004	http://dx.doi.org/10.1371/journal.pone.0002004			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414674	Green Published, gold, Green Submitted			2022-12-27	WOS:000260867300023
J	Atwal, GS; Rabadan, R; Lozano, G; Strong, LC; Ruijs, MWG; Schmidt, MK; van't Veer, LJ; Nevanlinna, H; Tommiska, J; Aittomaki, K; Bougeard, G; Frebourg, T; Levine, AJ; Bond, GL				Atwal, Gurinder Singh; Rabadan, Raul; Lozano, Guillermina; Strong, Louise C.; Ruijs, Marielle W. G.; Schmidt, Marjanka K.; van't Veer, Laura J.; Nevanlinna, Heli; Tommiska, Johanna; Aittomaki, Kristiina; Bougeard, Gaelle; Frebourg, Thierry; Levine, Arnold J.; Bond, Gareth L.			An Information-Theoretic Analysis of Genetics, Gender and Age in Cancer Patients	PLOS ONE			English	Article								Germline genetics, gender and hormonal-signaling pathways are all well described modifiers of cancer risk and progression. Although an improved understanding of how germline genetic variants interact with other cancer risk factors may allow better prevention and treatment of human cancer, measuring and quantifying these interactions is challenging. In other areas of research, Information Theory has been used to quantitatively describe similar multivariate interactions. We implemented a novel information-theoretic analysis to measure the joint effect of a high frequency germline genetic variant of the p53 tumor suppressor pathway (MDM2 SNP309 T/G) and gender on clinical cancer phenotypes. This analysis quantitatively describes synergistic interactions among gender, the MDM2 SNP309 locus, and the age of onset of tumorigenesis in p53 mutation carriers. These results offer a molecular and genetic basis for the observed sexual dimorphism of cancer risk in p53 mutation carriers and a model is proposed that suggests a novel cancer prevention strategy for p53 mutation carriers.	[Atwal, Gurinder Singh; Rabadan, Raul; Levine, Arnold J.; Bond, Gareth L.] Inst Advanced Study, Princeton, NJ USA; [Levine, Arnold J.] Canc Inst New Jersey, New Brunswick, NJ USA; [Lozano, Guillermina; Strong, Louise C.] MD Anderson Canc Ctr, Univ Texas, Houston, TX USA; [Ruijs, Marielle W. G.; van't Veer, Laura J.] Netherlands Canc Inst, Family Canc Clin, Amsterdam, Netherlands; [Schmidt, Marjanka K.] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands; [Ruijs, Marielle W. G.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet & Human Genet, Amsterdam, Netherlands; [Nevanlinna, Heli; Tommiska, Johanna] Helsinki Univ, Central Hosp, Dept Obstet & Gynaecol, Helsinki, Finland; [Aittomaki, Kristiina] Helsinki Univ, Central Hosp, Dept Clin Genet, Helsinki, Finland; [Bougeard, Gaelle; Frebourg, Thierry] Rouen Univ Hosp, Inst Biomed Res, Dept Genet, Inserm U614, Rouen, France	Institute for Advanced Study - USA; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; University of Texas System; UTMD Anderson Cancer Center; Netherlands Cancer Institute; Netherlands Cancer Institute; Vrije Universiteit Amsterdam; University of Helsinki; University of Helsinki; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm)	Atwal, GS (corresponding author), Inst Advanced Study, Princeton, NJ USA.	gareth.bond@ndm.ox.ac.uk	Schmidt, Marjanka K/G-9058-2011; Rabadan, Raul/AAZ-7367-2020; BOUGEARD, Gaëlle/ABI-6642-2020; Frebourg, Thierry/AAK-8390-2020	Schmidt, Marjanka K/0000-0002-2228-429X; BOUGEARD, Gaëlle/0000-0002-1475-0254; Tommiska, Johanna/0000-0001-7958-8262; Frebourg, Thierry/0000-0003-0399-4007; Rabadan, Raul/0000-0001-7946-9255; Nevanlinna, Heli/0000-0002-0916-2976	Breast Cancer Research Foundation; Simons Foundation; Leon Levy Foundation; French National Cancer Institute; Cancer Center [CA16672]; NIH [P01 CA034936]; NATIONAL CANCER INSTITUTE [P30CA016672, P01CA034936] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Simons Foundation; Leon Levy Foundation; French National Cancer Institute(Institut National du Cancer (INCA) France); Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support of this work comes from the Breast Cancer Research Foundation, The Simons Foundation, the Leon Levy Foundation and the French National Cancer Institute. Further support of this work comes from a Cancer Center Support Grant, CA16672, and a NIH Grant to Louise Strong, P01 CA034936.	Alhopuro P, 2005, J MED GENET, V42, P694, DOI 10.1136/jmg.2005.031260; Arva NC, 2005, J BIOL CHEM, V280, P26776, DOI 10.1074/jbc.M505203200; Bond GL, 2007, ONCOGENE, V26, P1317, DOI 10.1038/sj.onc.1210199; Bond GL, 2006, J MED GENET, V43, P950, DOI 10.1136/jmg.2006.043539; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Bond GL, 2005, CANCER RES, V65, P5481, DOI 10.1158/0008-5472.CAN-05-0825; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bougeard G, 2006, J MED GENET, V43, P531, DOI 10.1136/jmg.2005.037952; Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; Chompret A, 2000, BRIT J CANCER, V82, P1932; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; GAT I, 1999, NEURAL INFORM PROCES; Gronwald J, 2006, INT J CANCER, V118, P2281, DOI 10.1002/ijc.21536; Hirata H, 2007, CLIN CANCER RES, V13, P4123, DOI 10.1158/1078-0432.CCR-07-0609; Hong Y, 2005, CANCER RES, V65, P9582, DOI 10.1158/0008-5472.CAN-05-1460; Hu WW, 2007, CANCER RES, V67, P2757, DOI 10.1158/0008-5472.CAN-06-2656; Hwang SJ, 2003, AM J HUM GENET, V72, P975, DOI 10.1086/374567; Khan S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026209; KLEIN KO, 1994, J CLIN INVEST, V94, P2475, DOI 10.1172/JCI117616; Lain S, 2003, EUR J CANCER, V39, P1053, DOI 10.1016/S0959-8049(03)00063-7; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; LI FP, 1992, J NATL CANCER I, V84, P1156, DOI 10.1093/jnci/84.15.1156; Lind H, 2006, INT J CANCER, V119, P718, DOI 10.1002/ijc.21872; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Narod SA, 2000, LANCET, V356, P1876, DOI 10.1016/S0140-6736(00)03258-X; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Paris F, 2002, J CLIN ENDOCR METAB, V87, P791, DOI 10.1210/jc.87.2.791; Province MA, 2001, ADV GENET, V42, P273, DOI 10.1016/S0065-2660(01)42028-1; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ruijs MWG, 2007, EUR J HUM GENET, V15, P110, DOI 10.1038/sj.ejhg.5201715; Sherriff A, 2001, ADV GENET, V42, P287, DOI 10.1016/S0065-2660(01)42029-3; SLONIM NS, 2005, ARXIVCSIT0502017; Tabori U, 2007, CANCER RES, V67, P1415, DOI 10.1158/0008-5472.CAN-06-3682; Tahri-Daizadeh N, 2003, GENOME RES, V13, P1952, DOI 10.1101/gr.1254203	37	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1951	10.1371/journal.pone.0001951	http://dx.doi.org/10.1371/journal.pone.0001951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398474	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000260795500025
J	Li, H; Gu, S; Cai, XY; Speed, WC; Pakstis, AJ; Golub, EI; Kidd, JR; Kidd, KK				Li, Hui; Gu, Sheng; Cai, Xiaoyun; Speed, William C.; Pakstis, Andrew J.; Golub, Efim I.; Kidd, Judith R.; Kidd, Kenneth K.			Ethnic Related Selection for an ADH Class I Variant within East Asia	PLOS ONE			English	Article								Background: The alcohol dehydrogenases (ADH) are widely studied enzymes and the evolution of the mammalian gene cluster encoding these enzymes is also well studied. Previous studies have shown that the ADH1B*47His allele at one of the seven genes in humans is associated with a decrease in the risk of alcoholism and the core molecular region with this allele has been selected for in some East Asian populations. As the frequency of ADH1B*47His is highest in East Asia, and very low in most of the rest of the world, we have undertaken more detailed investigation in this geographic region. Methodology/Principal Findings: Here we report new data on 30 SNPs in the ADH7 and Class I ADH region in samples of 24 populations from China and Laos. These populations cover a wide geographic region and diverse ethnicities. Combined with our previously published East Asian data for these SNPs in 8 populations, we have typed populations from all of the 6 major linguistic phyla (Altaic including Korean-Japanese and inland Altaic, Sino-Tibetan, Hmong-Mien, Austro-Asiatic, Daic, and Austronesian). The ADH1B genotyping data are strongly related to ethnicity. Only some eastern ethnic phyla or subphyla (Korean-Japanese, Han Chinese, Hmong-Mien, Daic, and Austronesian) have a high frequency of ADH1B*47His. ADH1B haplotype data clustered the populations into linguistic subphyla, and divided the subphyla into eastern and western parts. In the Hmong- Mien and Altaic populations, the extended haplotype homozygosity (EHH) and relative EHH (REHH) tests for the ADH1B core were consistent with selection for the haplotype with derived SNP alleles. In the other ethnic phyla, the core showed only a weak signal of selection at best. Conclusions/Significance: The selection distribution is more significantly correlated with the frequency of the derived ADH1B regulatory region polymorphism than the derived amino-acid altering allele ADH1B*47His. Thus, the real focus of selection may be the regulatory region. The obvious ethnicity-related distributions of ADH1B diversities suggest the existence of some culture-related selective forces that have acted on the ADH1B region.	[Li, Hui; Gu, Sheng; Speed, William C.; Pakstis, Andrew J.; Golub, Efim I.; Kidd, Judith R.; Kidd, Kenneth K.] Yale Univ, Sch Med, Dept Genet, Lab Human Polymorphism Studies, New Haven, CT 06510 USA; [Li, Hui; Cai, Xiaoyun] Fudan Univ, Ctr Evolutionary Biol, Sch Life Sci, Inst Biomed Sci, Shanghai, Peoples R China	Yale University; Fudan University	Li, H (corresponding author), Yale Univ, Sch Med, Dept Genet, Lab Human Polymorphism Studies, New Haven, CT 06510 USA.	Kenneth.Kidd@Yale.edu	Li, Hui/A-2014-2010		US NIH [AA009379]; USPHS [GM057672]; NSF [BCS0096588]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM057672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009379] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was funded primarily by US NIH grant AA009379 to KKK, and in part by USPHS grant GM057672 and NSF grant BCS0096588.	AGARWAL DP, 1992, PHARMACOGENETICS, V2, P48, DOI 10.1097/00008571-199204000-00002; Baker Chris, 2005, HIST THAILAND; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Borras E, 2000, HEPATOLOGY, V31, P984, DOI 10.1053/he.2000.5978; Charlton KE, 2005, EUR J CARDIOV PREV R, V12, P355, DOI 10.1097/01.hjr.0000170265.22938.d1; Chen CC, 1999, AM J HUM GENET, V65, P795, DOI 10.1086/302540; Chen JG, 2006, INT J CANCER, V119, P1447, DOI 10.1002/ijc.21952; Chen WJ, 1996, BRIT J PSYCHIAT, V168, P762, DOI 10.1192/bjp.168.6.762; Chen WJ, 1997, BIOL PSYCHIAT, V41, P703, DOI 10.1016/S0006-3223(96)00072-8; Cheung C, 1999, BIOCHEM BIOPH RES CO, V261, P100, DOI 10.1006/bbrc.1999.0943; Cichoz-Lach H, 2006, ALCOHOL ALCOHOLISM, V41, P14, DOI 10.1093/alcalc/agh225; Dannenberg LO, 2006, ALCOHOL CLIN EXP RES, V30, P928, DOI 10.1111/j.1530-0277.2006.00107.x; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dodd PR, 2004, ADDICT BEHAV, V29, P1295, DOI 10.1016/j.addbeh.2004.06.010; Edenberg HJ, 2006, HUM MOL GENET, V15, P1539, DOI 10.1093/hmg/ddl073; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; ERIKSSON CJ, 2001, ALCOHOL CLIN SISBRA, pS157; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GOEDDE HW, 1992, HUM GENET, V88, P344; GOLDMAN D, 1990, WORLD REV NUTR DIET, V63, P143; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; Gu S, 2005, BIOINFORMATICS, V21, P3938, DOI 10.1093/bioinformatics/bti649; GU WN, 2001, AGR ARCHAEOLOGY, V21, P1; Han Y, 2007, AM J HUM GENET, V80, P441, DOI 10.1086/512485; Hasin D, 2002, AM J PSYCHIAT, V159, P1432, DOI 10.1176/appi.ajp.159.8.1432; He P, 2003, J YUNNAN U NATIONALI, V20, P45; HIGUCHI S, 1995, AM J PSYCHIAT, V152, P1219; Homann N, 2006, INT J CANCER, V118, P1998, DOI 10.1002/ijc.21583; Inoue K, 2000, XENOBIOTICA, V30, P285, DOI 10.1080/004982500237677; Issell BF, 2005, CANCER INVEST, V23, P497, DOI 10.1080/07357900500201442; Jia CQ, 2007, THROMB RES, V120, P679, DOI 10.1016/j.thromres.2006.12.023; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Kim JJ, 2005, HUM GENET, V117, P511, DOI 10.1007/s00439-005-1334-8; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Li H, 2007, HUM GENET, V122, P383, DOI 10.1007/s00439-007-0407-2; Li H, 2007, AM J HUM GENET, V81, P842, DOI 10.1086/521201; LIU ZX, 1985, HIST UIGHUR, V1; LIVAK KJ, 1995, NAT GENET, V9, P341, DOI 10.1038/ng0495-341; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; Ma LL, 2005, HEREDITAS, V142, P103, DOI 10.1111/j.1601-5223.2005.01910.x; Mackerras Colin, 1972, UIGHUR EMPIRE ACCORD; Matsuo K, 2007, HUM MUTAT, V28, P506, DOI 10.1002/humu.20477; Mulligan CJ, 2003, HUM GENET, V113, P325, DOI 10.1007/s00439-003-0971-z; MURAMATSU T, 1995, HUM GENET, V96, P151, DOI 10.1007/BF00207371; Neumark YD, 1998, J STUD ALCOHOL, V59, P133, DOI 10.15288/jsa.1998.59.133; Osier M, 1999, AM J HUM GENET, V64, P1147, DOI 10.1086/302317; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; Peters ES, 2005, CANCER EPIDEM BIOMAR, V14, P476, DOI 10.1158/1055-9965.EPI-04-0431; Ramchandani VA, 2001, PATHOL BIOL, V49, P676, DOI 10.1016/S0369-8114(01)00232-2; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Roemer H. R., 2000, HIST TURKIC PEOPLES; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Saccone NL, 2000, AM J MED GENET, V96, P632, DOI 10.1002/1096-8628(20001009)96:5<632::AID-AJMG8>3.0.CO;2-#; Seitz HK, 2005, DIGEST DIS, V23, P297, DOI 10.1159/000090177; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; Shi Y., 1989, QUESTION QUATERNARY; Sinor D., 1990, CAMBRIDGE HIST EARLY; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Tajima A, 2002, HUM GENET, V110, P80, DOI 10.1007/s00439-001-0651-9; THOMASSON HR, 1994, ALCOHOL CLIN EXP RES, V18, P640, DOI 10.1111/j.1530-0277.1994.tb00923.x; Tiemersma EW, 2003, CANCER EPIDEM BIOMAR, V12, P419; Tishkoff SA, 2004, NAT GENET, V36, pS21, DOI 10.1038/ng1438; TONG EZ, 1984, AGR ARCHAEOLOGY, V4, P29; Triano EA, 2003, CANCER RES, V63, P3092; Uhl GR, 2004, NEUROPHARMACOLOGY, V47, P140, DOI 10.1016/j.neuropharm.2004.07.029; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WANG MK, 1999, PRIMORDIAL HIST BROT; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; WENG QH, 1998, TROPICAL GEOGRAPHY, V18, P72; Whitfield JB, 1998, ALCOHOL CLIN EXP RES, V22, P1463; Wilf H.S, 1977, STAT METHODS DIGITAL; Wright S, 1931, GENETICS, V16, P0097; Yao Chung-Tay, 1997, Proceedings of the National Science Council Republic of China Part B Life Sciences, V21, P106; Yin SJ, 1997, GASTROENTEROLOGY, V112, P766, DOI 10.1053/gast.1997.v112.pm9041238; Yokoyama A, 2003, JPN J CLIN ONCOL, V33, P111, DOI 10.1093/jjco/hyg026; YOSHIDA A, 1991, PROG NUCLEIC ACID RE, V40, P255	81	31	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1881	10.1371/journal.pone.0001881	http://dx.doi.org/10.1371/journal.pone.0001881			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382665	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795400016
J	Smith, GI; Atherton, P; Villareal, DT; Frimel, TN; Rankin, D; Rennie, MJ; Mittendorfer, B				Smith, Gordon I.; Atherton, Philip; Villareal, Dennis T.; Frimel, Tiffany N.; Rankin, Debbie; Rennie, Michael J.; Mittendorfer, Bettina			Differences in Muscle Protein Synthesis and Anabolic Signaling in the Postabsorptive State and in Response to Food in 65-80 Year Old Men and Women	PLOS ONE			English	Article							AMINO-ACID-CONCENTRATIONS; ELDERLY-MEN; WHOLE-BODY; GENE-EXPRESSION; TESTOSTERONE; YOUNG; MASS; AGE; METABOLISM; LEUCINE	Women have less muscle than men but lose it more slowly during aging. To discover potential underlying mechanism(s) for this we evaluated the muscle protein synthesis process in postabsorptive conditions and during feeding in twenty-nine 65-80 year old men (n = 13) and women (n = 16). We discovered that the basal concentration of phosphorylated eEF2(Thr56) was similar to 40% less (P < 0.05) and the basal rate of MPS was similar to 30% greater (P = 0.02) in women than in men; the basal concentrations of muscle phosphorylated Akt(Thr308), p70s6k(Thr389), eIF4E(Ser209), and eIF4E-BP1(Thr37/46) were not different between the sexes. Feeding increased (P < 0.05) Akt(Thr308) and p70s6k(Thr389) phosphorylation to the same extent in men and women but increased (P < 0.05) the phosphorylation of eIF4E(Ser209) and eIF4E-BP1(Thr37/46) in men only. Accordingly, feeding increased MPS in men (P < 0.01) but not in women. The postabsorptive muscle mRNA concentrations for myoD and myostatin were not different between sexes; feeding doubled myoD mRNA (P < 0.05) and halved that of myostatin (P < 0.05) in both sexes. Thus, there is sexual dimorphism in MPS and its control in older adults; a greater basal rate of MPS, operating over most of the day may partially explain the slower loss of muscle in older women.	[Smith, Gordon I.; Villareal, Dennis T.; Frimel, Tiffany N.; Mittendorfer, Bettina] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Atherton, Philip; Rankin, Debbie; Rennie, Michael J.] Univ Nottingham, Sch Grad Entry Med & Hlth, Derby, England	Washington University (WUSTL); University of Nottingham	Smith, GI (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.	mittendb@wustl.edu		Hilton, Tiffany/0000-0001-5869-201X; Smith, Gordon/0000-0003-0063-046X; Atherton, Philip/0000-0002-7286-046X	US National Institutes of Health [AR 49869, AG 025501, RR 00036, RR 00954, DK 56341]; University of Nottingham; UK Biotechnology and Biological Sciences Research Council [BB/XX510697/1, BB/C516779/1]; European Union EXEGENESIS program; Research Councils UK fellow; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000036, P41RR000954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025501] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/C516779/1] Funding Source: researchfish	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nottingham; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union EXEGENESIS program; Research Councils UK fellow(UK Research & Innovation (UKRI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The study was supported by US National Institutes of Health grants AR 49869, AG 025501, RR 00036 (General Clinical Research Center), RR 00954 (Biomedical Mass Spectrometry Resource), and DK 56341 (Clinical Nutrition Research Unit), the University of Nottingham, the UK Biotechnology and Biological Sciences Research Council grants BB/XX510697/1 and BB/C516779/1, and a European Union EXEGENESIS program grant. Philip Atherton is a designated Research Councils UK fellow.	ADIBI SA, 1973, J CLIN INVEST, V52, P1586, DOI 10.1172/JCI107335; BERGSTROM J, 1990, CLIN SCI, V79, P331, DOI 10.1042/cs0790331; Bhasin S, 2001, J ENDOCRINOL, V170, P27, DOI 10.1677/joe.0.1700027; Bohe J, 2003, J PHYSIOL-LONDON, V552, P315, DOI 10.1113/jphysiol.2003.050674; Bohe J, 2001, J PHYSIOL-LONDON, V532, P575, DOI 10.1111/j.1469-7793.2001.0575f.x; Boirie Y, 2001, J CLIN ENDOCR METAB, V86, P638, DOI 10.1210/jc.86.2.638; Brodsky IG, 1996, J CLIN ENDOCR METAB, V81, P3469, DOI 10.1210/jc.81.10.3469; BURESOVA M, 1971, J ENDOCRINOL, V50, P643, DOI 10.1677/joe.0.0500643; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Chevalier S, 2005, METABOLISM, V54, P1529, DOI 10.1016/j.metabol.2005.05.021; Cid-Ruzafa J, 1999, J AM DIET ASSOC, V99, P564, DOI 10.1016/S0002-8223(99)00140-6; Clark MG, 2006, CURR OPIN CLIN NUTR, V9, P185, DOI 10.1097/01.mco.0000222097.90890.c2; Crozier SJ, 2005, J NUTR, V135, P376, DOI 10.1093/jn/135.3.376; Cuthbertson D, 2004, FASEB J, V18, P422, DOI 10.1096/fj.04-2640fje; DIETRICHSON P, 1987, J NEUROL NEUROSUR PS, V50, P1461, DOI 10.1136/jnnp.50.11.1461; Ferrando AA, 2003, J CLIN ENDOCR METAB, V88, P358, DOI 10.1210/jc.2002-021041; Ferrando AA, 1998, AM J PHYSIOL-ENDOC M, V275, pE864; FORBES GB, 1970, METABOLIS, V19, P653, DOI 10.1016/0026-0495(70)90062-4; Frost RA, 2007, J APPL PHYSIOL, V103, P378, DOI 10.1152/japplphysiol.00089.2007; Fujita S, 2007, AM J PHYSIOL-ENDOC M, V292, pE77, DOI 10.1152/ajpendo.00173.2006; Gallagher D, 2000, AM J PHYSIOL-ENDOC M, V279, pE366, DOI 10.1152/ajpendo.2000.279.2.E366; Garlick PJ, 2005, J NUTR, V135, p1553S, DOI 10.1093/jn/135.6.1553S; GRIGGS RC, 1989, J APPL PHYSIOL, V66, P498, DOI 10.1152/jappl.1989.66.1.498; GRIGSBY JS, 1976, GROWTH, V40, P303; Guttridge DC, 2004, CURR OPIN CLIN NUTR, V7, P443, DOI 10.1097/01.mco.0000134364.61406.26; Horowitz JF, 2001, AM J CLIN NUTR, V73, P517; Hughes VA, 2002, AM J CLIN NUTR, V76, P473, DOI 10.1093/ajcn/76.2.473; Jahn LA, 1999, J CLIN ENDOCR METAB, V84, P1007, DOI 10.1210/jc.84.3.1007; Jensen-Urstad K, 2001, J INTERN MED, V250, P29, DOI 10.1046/j.1365-2796.2001.00843.x; Kobayashi H, 2003, AM J PHYSIOL-ENDOC M, V284, pE488, DOI 10.1152/ajpendo.00094.2002; Kraegen E W, 1990, Horm Metab Res Suppl, V24, P41; Ledikwe JH, 2004, J AM GERIATR SOC, V52, P589, DOI 10.1111/j.1532-5415.2004.52167.x; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lind L, 2002, CLIN SCI, V102, P241, DOI 10.1042/CS20010013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONG CL, 1981, AM J CLIN NUTR, V34, P1087, DOI 10.1093/ajcn/34.6.1087; McCormick KM, 2004, J MUSCLE RES CELL M, V25, P21, DOI 10.1023/B:JURE.0000021398.78327.39; McMahon CD, 2003, AM J PHYSIOL-ENDOC M, V284, pE377, DOI 10.1152/ajpendo.00282.2002; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; MILLWARD DJ, 1973, NATURE, V241, P204, DOI 10.1038/241204a0; Mingrone G, 2001, METABOLISM, V50, P1004, DOI 10.1053/meta.2001.25650; Mittendorfer B, 2005, J PHYSIOL-LONDON, V563, P203, DOI 10.1113/jphysiol.2004.077180; MOORE D, 2008, EXPT BIOL 2008; Morais JA, 1997, AM J CLIN NUTR, V66, P880, DOI 10.1093/ajcn/66.4.880; Parise G, 2001, J APPL PHYSIOL, V91, P1041, DOI 10.1152/jappl.2001.91.3.1041; Partridge T, 2000, NEUROL SCI, V21, pS939; Patterson BW, 1997, METABOLISM, V46, P943, DOI 10.1016/S0026-0495(97)90084-6; Piccone CM, 2005, EXP PHYSIOL, V90, P87, DOI 10.1113/expphysiol.2004.028373; Pitkanen HT, 2003, AMINO ACIDS, V24, P413, DOI 10.1007/s00726-002-0338-0; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Radegran G, 1999, J APPL PHYSIOL, V87, P2375, DOI 10.1152/jappl.1999.87.6.2375; Remond D, 2007, AM J CLIN NUTR, V85, P1286, DOI 10.1093/ajcn/85.5.1286; Rennie MJ, 2006, J NUTR, V136, p264S, DOI 10.1093/jn/136.1.264S; Rieu I, 2006, J PHYSIOL-LONDON, V575, P305, DOI 10.1113/jphysiol.2006.110742; Rooyackers OE, 1997, ANNU REV NUTR, V17, P457, DOI 10.1146/annurev.nutr.17.1.457; Roubenoff R, 2003, CURR OPIN CLIN NUTR, V6, P295, DOI 10.1097/01.mco.0000068965.34812.62; Rousset S, 2003, BRIT J NUTR, V90, P1107, DOI 10.1079/BJN20031004; Sarabi M, 1999, J INTERN MED, V246, P265, DOI 10.1046/j.1365-2796.1999.00542.x; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Sheffield-Moore M, 1999, J CLIN ENDOCR METAB, V84, P2705, DOI 10.1210/jc.84.8.2705; Toth MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE883, DOI 10.1152/ajpendo.00353.2004; Toth MJ, 2001, AM J PHYSIOL-ENDOC M, V280, pE496, DOI 10.1152/ajpendo.2001.280.3.E496; Tsai PJ, 2000, J FORMOS MED ASSOC, V99, P151; Umpleby AM, 1996, BAILLIERE CLIN ENDOC, V10, P551, DOI 10.1016/S0950-351X(96)80711-7; URBAN RJ, 1995, AM J PHYSIOL-ENDOC M, V269, pE820, DOI 10.1152/ajpendo.1995.269.5.E820; Vary TC, 1999, AM J PHYSIOL-ENDOC M, V277, pE1077, DOI 10.1152/ajpendo.1999.277.6.E1077; Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326; Volpi E, 2001, JAMA-J AM MED ASSOC, V286, P1206, DOI 10.1001/jama.286.10.1206; WATT PW, 1991, P NATL ACAD SCI USA, V88, P5892, DOI 10.1073/pnas.88.13.5892; Welle S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001385; Zamboni M, 2003, AGING CLIN EXP RES, V15, P321, DOI 10.1007/BF03324517; Zierler K, 1999, AM J PHYSIOL-ENDOC M, V276, pE409, DOI 10.1152/ajpendo.1999.276.3.E409	72	109	111	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1875	10.1371/journal.pone.0001875	http://dx.doi.org/10.1371/journal.pone.0001875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365020	Green Published, gold			2022-12-27	WOS:000260762400026
J	Jean, L; Lee, CF; Shaw, M; Vaux, DJ				Jean, Letitia; Lee, Chiu Fan; Shaw, Michael; Vaux, David J.			Structural Elements Regulating Amyloidogenesis: A Cholinesterase Model System	PLOS ONE			English	Article								Polymerization into amyloid fibrils is a crucial step in the pathogenesis of neurodegenerative syndromes. Amyloid assembly is governed by properties of the sequence backbone and specific side-chain interactions, since fibrils from unrelated sequences possess similar structures and morphologies. Therefore, characterization of the structural determinants driving amyloid aggregation is of fundamental importance. We investigated the forces involved in the amyloid assembly of a model peptide derived from the oligomerization domain of acetylcholinesterase (AChE), AChE(586-599), through the effect of single point mutations on beta-sheet propensity, conformation, fibrilization, surfactant activity, oligomerization and fibril morphology. AChE(586-599) was chosen due to its fibrilization tractability and AChE involvement in Alzheimer's disease. The results revealed how specific regions and residues can control AChE(586-599) assembly. Hydrophobic and/or aromatic residues were crucial for maintaining a high beta-strand propensity, for the conformational transition to beta-sheet, and for the first stage of aggregation. We also demonstrated that positively charged side-chains might be involved in electrostatic interactions, which could control the transition to beta-sheet, the oligomerization and assembly stability. Further interactions were also found to participate in the assembly. We showed that some residues were important for AChE(586-599) surfactant activity and that amyloid assembly might preferentially occur at an air-water interface. Consistently with the experimental observations and assembly models for other amyloid systems, we propose a model for AChE(586-599) assembly in which a steric-zipper formed through specific interactions (hydrophobic, electrostatic, cation-pi, SH-aromatic, metal chelation and polar-polar) would maintain the beta-sheets together. We also propose that the stacking between the strands in the beta-sheets along the fiber axis could be stabilized through pi-pi interactions and metal chelation. The dissection of the specific molecular recognition driving AChE(586-599) amyloid assembly has provided further knowledge on such poorly understood and complicated process, which could be applied to protein folding and the targeting of amyloid diseases.	[Jean, Letitia; Shaw, Michael; Vaux, David J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Lee, Chiu Fan] Univ Oxford, Dept Phys, Clarendon Lab, Oxford, England	University of Oxford; University of Oxford	Jean, L (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	david.vaux@path.ox.ac.uk		Jean, Letitia/0000-0002-6450-7148; Vaux, David/0000-0002-4901-9795; Lee, Chiu Fan/0000-0003-4363-9050	Synaptica Ltd	Synaptica Ltd	This work was supported by a research grant from Synaptica Ltd.	Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2002, PEPTIDES, V23, P1343, DOI 10.1016/S0196-9781(02)00070-0; Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200; Bemporad F, 2006, PROTEIN SCI, V15, P862, DOI 10.1110/ps.051915806; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Chakkaravarthi S, 2006, POLYMER, V47, P709, DOI 10.1016/j.polymer.2005.11.059; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Claessens CG, 1997, J PHYS ORG CHEM, V10, P254, DOI 10.1002/(SICI)1099-1395(199705)10:5<254::AID-POC875>3.0.CO;2-3; Cottingham MG, 2004, LAB INVEST, V84, P523, DOI 10.1038/labinvest.3700054; Cottingham MG, 2003, BIOCHEMISTRY-US, V42, P10863, DOI 10.1021/bi034768i; Cottingham MG, 2002, BIOCHEMISTRY-US, V41, P13539, DOI 10.1021/bi0260334; Crowley PB, 2005, PROTEINS, V59, P231, DOI 10.1002/prot.20417; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; de la Paz ML, 2005, J MOL BIOL, V349, P583, DOI 10.1016/j.jmb.2005.03.081; Diamant S, 2006, P NATL ACAD SCI USA, V103, P8628, DOI 10.1073/pnas.0602922103; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Gillard RE, 1997, CHEM-EUR J, V3, P1933, DOI 10.1002/chem.19970031208; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Jack E, 2006, J AM CHEM SOC, V128, P8098, DOI 10.1021/ja0581898; Jean L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000652; Jones CE, 2004, J BIOL CHEM, V279, P32018, DOI 10.1074/jbc.M403467200; KELLIS JT, 1991, BIO-TECHNOL, V9, P994, DOI 10.1038/nbt1091-994; Klimov DK, 2003, STRUCTURE, V11, P295, DOI 10.1016/S0969-2126(03)00031-5; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Kuner P, 2000, J BIOL CHEM, V275, P1673, DOI 10.1074/jbc.275.3.1673; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lin TY, 1996, PROTEIN SCI, V5, P372; Liu ST, 1999, BIOCHEMISTRY-US, V38, P9373, DOI 10.1021/bi990205o; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; Massi F, 2002, PROTEIN SCI, V11, P1639, DOI 10.1110/ps.3150102; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Miura T, 2000, BIOCHEMISTRY-US, V39, P7024, DOI 10.1021/bi0002479; Naito A, 2004, MAGN RESON CHEM, V42, P247, DOI 10.1002/mrc.1323; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Paddock ML, 2005, BIOCHEMISTRY-US, V44, P9619, DOI 10.1021/bi050651d; Pal D, 2001, J BIOMOL STRUCT DYN, V19, P115, DOI 10.1080/07391102.2001.10506725; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Reches M, 2002, J BIOL CHEM, V277, P35475, DOI 10.1074/jbc.M206039200; Rees Tina M., 2005, Current Alzheimer Research, V2, P291, DOI 10.2174/1567205054367847; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Saez-Valero J, 1999, J NEUROCHEM, V72, P1600, DOI 10.1046/j.1471-4159.1999.721600.x; SALEMME FR, 1981, J MOL BIOL, V146, P101, DOI 10.1016/0022-2836(81)90368-5; Samanta U, 2000, PROTEINS, V38, P288, DOI 10.1002/(SICI)1097-0134(20000215)38:3<288::AID-PROT5>3.3.CO;2-Z; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Seilheimer B, 1997, J STRUCT BIOL, V119, P59, DOI 10.1006/jsbi.1997.3859; Shetty AS, 1996, J AM CHEM SOC, V118, P1019, DOI 10.1021/ja9528893; Sikorski P, 2003, STRUCTURE, V11, P915, DOI 10.1016/S0969-2126(03)00149-7; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; SMITH CK, 1995, SCIENCE, V270, P980, DOI 10.1126/science.270.5238.980; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Tarus B, 2005, J MOL BIOL, V345, P1141, DOI 10.1016/j.jmb.2004.11.022; Tenidis K, 2000, J MOL BIOL, V295, P1055, DOI 10.1006/jmbi.1999.3422; Tjernberg L, 2002, J BIOL CHEM, V277, P43243, DOI 10.1074/jbc.M205570200; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Waters ML, 2002, CURR OPIN CHEM BIOL, V6, P736, DOI 10.1016/S1367-5931(02)00359-9; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211; Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x; WOUTERS MA, 1995, PROTEINS, V22, P119, DOI 10.1002/prot.340220205; Wu C, 2005, BIOPHYS J, V88, P2897, DOI 10.1529/biophysj.104.055574; Yang DS, 2000, EUR J BIOCHEM, V267, P6692, DOI 10.1046/j.1432-1327.2000.01767.x; Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604; Yoshida H, 2000, J BIOCHEM-TOKYO, V128, P271, DOI 10.1093/oxfordjournals.jbchem.a022750; Zahn R, 2003, J MOL BIOL, V334, P477, DOI 10.1016/j.jmb.2003.09.048; Zanuy D, 2004, PHYS BIOL, V1, P89, DOI 10.1088/1478-3967/1/2/005; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334	75	11	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1834	10.1371/journal.pone.0001834	http://dx.doi.org/10.1371/journal.pone.0001834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350169	Green Published, gold, Green Submitted			2022-12-27	WOS:000260762300035
J	Zenon, A; Ben Hamed, S; Duhamel, JR; Olivier, E				Zenon, Alexandre; Ben Hamed, Suliann; Duhamel, Jean-Rene; Olivier, Etienne			Spatial and Temporal Dynamics of Attentional Guidance during Inefficient Visual Search	PLOS ONE			English	Article							FOCAL ATTENTION; GUIDED SEARCH; TIME-COURSE; POP-OUT; RESOLUTION; FEATURES; MODEL; TASK; VISION; ACUITY	Spotting a prey or a predator is crucial in the natural environment and relies on the ability to extract quickly pertinent visual information. The experimental counterpart of this behavior is visual search (VS) where subjects have to identify a target amongst several distractors. In difficult VS tasks, it has been found that the reaction time (RT) is influenced by salience factors, such as the target-distractor similarity, and this finding is usually regarded as evidence for a guidance of attention by preattentive mechanisms. However, the use of RT measurements, a parameter which depends on multiple factors, allows only very indirect inferences about the underlying attentional mechanisms. The purpose of the present study was to determine the influence of salience factors on attentional guidance during VS, by measuring directly attentional allocation. We studied attention allocation by using a dual covert VS task in subjects who had 1) to detect a target amongst different items and 2) to report letters briefly flashed inside those items at different delays. As predicted, we showed that parallel processes guide attention towards the most relevant item by virtue of both goal-directed and stimulus-driven factors, and we demonstrated that this attentional selection is a prerequisite for target detection. In addition, we show that when the target is characterized by two features (conjunction VS), the goal-directed effects of both features are initially combined into a unique salience value, but at a later stage, grouping phenomena interact with the salience computation, and lead to the selection of a whole group of items. These results, in line with Guided Search Theory, show that efficient and rapid preattentive processes guide attention towards the most salient item, allowing to reduce the number of attentional shifts needed to find the target.	[Zenon, Alexandre; Olivier, Etienne] Univ Catholique Louvain, Neurophysiol Lab, B-1200 Brussels, Belgium; [Ben Hamed, Suliann; Duhamel, Jean-Rene] CNRS, Inst Sci Cognitives, Bron, France	Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS)	Zenon, A (corresponding author), Univ Catholique Louvain, Neurophysiol Lab, B-1200 Brussels, Belgium.	alexandre.zenon@uclouvain.bc	Zénon, Alexandre/AGN-7203-2022; Duhamel, Jean-René/M-4723-2017; Ben Hamed, Suliann/O-6070-2014	Zénon, Alexandre/0000-0001-7989-1261; Duhamel, Jean-René/0000-0003-0210-1027; Ben Hamed, Suliann/0000-0003-1510-7284	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA); Universite catholique de Louvain (FSR); Fonds de la Recherche Scientifique Medicale (FRSM); Fondation Medicale Reine Elisabeth FMRE	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); Universite catholique de Louvain (FSR); Fonds de la Recherche Scientifique Medicale (FRSM)(Fonds de la Recherche Scientifique - FNRS); Fondation Medicale Reine Elisabeth FMRE	A.Z. is a research assistant supported by a grant from the Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA). This project was supported by research grants from the Universite catholique de Louvain (FSR), the Fonds de la Recherche Scientifique Medicale (FRSM) and the Fondation Medicale Reine Elisabeth (FMRE).	Beirne RO, 2005, VISUAL NEUROSCI, V22, P79, DOI 10.1017/S0952523805221119; Carrasco M, 2001, P NATL ACAD SCI USA, V98, P5363, DOI 10.1073/pnas.081074098; CAVE KR, 1990, COGNITIVE PSYCHOL, V22, P225, DOI 10.1016/0010-0285(90)90017-X; DUNCAN J, 1994, NATURE, V369, P313, DOI 10.1038/369313a0; DUNCAN J, 1995, PERCEPT PSYCHOPHYS, V57, P117, DOI 10.3758/BF03211854; Eckstein MP, 2000, PERCEPT PSYCHOPHYS, V62, P425, DOI 10.3758/BF03212096; EGETH HE, 1984, J EXP PSYCHOL HUMAN, V10, P32, DOI 10.1037/0096-1523.10.1.32; Enns JT, 2004, VISION RES, V44, P1321, DOI 10.1016/j.visres.2003.10.024; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hubner R, 2001, PERCEPT PSYCHOPHYS, V63, P945, DOI 10.3758/BF03194514; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; Kim MS, 1999, J GEN PSYCHOL, V126, P326, DOI 10.1080/00221309909595370; Kim MS, 2001, VISION RES, V41, P611, DOI 10.1016/S0042-6989(00)00285-6; Kim MS, 1995, PSYCHOL SCI, V6, P376, DOI 10.1111/j.1467-9280.1995.tb00529.x; Lamy D, 2003, PSYCHON B REV, V10, P621, DOI 10.3758/BF03196524; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Mackeben M, 1999, SPATIAL VISION, V12, P51, DOI 10.1163/156856899X00030; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; Maljkovic V, 1996, PERCEPT PSYCHOPHYS, V58, P977, DOI 10.3758/BF03206826; MILLODOT M, 1974, VISION RES, V14, P1497, DOI 10.1016/0042-6989(74)90031-5; Moore CM, 1996, PSYCHON B REV, V3, P360, DOI 10.3758/BF03210761; Navalpakkam V, 2005, VISION RES, V45, P205, DOI 10.1016/j.visres.2004.07.042; Nothdurft HC, 1999, VISION RES, V39, P2305, DOI 10.1016/S0042-6989(99)00006-1; Olivers CNL, 2003, J EXP PSYCHOL HUMAN, V29, P650, DOI 10.1037/0096-1523.29.3.650; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/S0042-6989(99)00244-8; Razpurker-Apfeld I, 2007, PERCEPT PSYCHOPHYS, V69, P732, DOI 10.3758/BF03193775; ROVAMO J, 1982, INVEST OPHTH VIS SCI, V23, P666; Schulz MF, 2003, PSYCHOL SCI, V14, P26, DOI 10.1111/1467-9280.01414; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; VanRullen R, 2004, J COGNITIVE NEUROSCI, V16, P4, DOI 10.1162/089892904322755502; Verghese P, 2001, NEURON, V31, P523, DOI 10.1016/S0896-6273(01)00392-0; WOLFE J, 1998, J ANTI-AGING MED, V1, P9; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; Wolfe JM, 2003, TRENDS COGN SCI, V7, P70, DOI 10.1016/S1364-6613(02)00024-4; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Zar J. H., 1996, BIOSTATISTICAL ANAL	39	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2219	10.1371/journal.pone.0002219	http://dx.doi.org/10.1371/journal.pone.0002219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493320	Green Published, Green Submitted, gold			2022-12-27	WOS:000262258700027
J	Jemal, A; Ward, E; Anderson, RN; Murray, T; Thun, MJ				Jemal, Ahmedin; Ward, Elizabeth; Anderson, Robert N.; Murray, Taylor; Thun, Michael J.			Widening of Socioeconomic Inequalities in US Death Rates, 1993-2001	PLOS ONE			English	Article							UNITED-STATES; RISK-FACTORS; ALL-CAUSE; EDUCATIONAL DIFFERENTIALS; CARDIOVASCULAR-DISEASE; MORTALITY; HEALTH; TRENDS; CERTIFICATE; CANCER	Background: Socioeconomic inequalities in death rates from all causes combined widened from 1960 until 1990 in the U. S., largely because cardiovascular death rates decreased more slowly in lower than in higher socioeconomic groups. However, no studies have examined trends in inequalities using recent US national data. Methodology/Principal Findings: We calculated annual age-standardized death rates from 1993-2001 for 25-64 year old non-Hispanic whites and blacks by level of education for all causes and for the seven most common causes of death using death certificate information from 43 states and Washington, D. C. Regression analysis was used to estimate annual percent change. The inequalities in all cause death rates between Americans with less than high school education and college graduates increased rapidly from 1993 to 2001 due to both significant decreases in mortality from all causes, heart disease, cancer, stroke, and other conditions in the most educated and lack of change or increases among the least educated. For white women, the all cause death rate increased significantly by 3.2 percent per year in the least educated and by 0.7 percent per year in high school graduates. The rate ratio (RR) comparing the least versus most educated increased from 2.9 (95% CI, 2.8-3.1) in 1993 to 4.4 (4.1-4.6) in 2001 among white men, from 2.1 (1.8-2.5) to 3.4 (2.9-3-9) in black men, and from 2.6 (2.4-2.7) to 3.8 (3.6-4.0) in white women. Conclusion: Socioeconomic inequalities in mortality are increasing rapidly due to continued progress by educated white and black men and white women, and stable or worsening trends among the least educated.	[Jemal, Ahmedin; Ward, Elizabeth; Murray, Taylor; Thun, Michael J.] Amer Canc Soc, Atlanta, GA 30329 USA; [Anderson, Robert N.] Natl Ctr Health Stat, Ctr Dis Control & Prevent, Div Vital Stat, Hyattsville, MD USA	American Cancer Society; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Jemal, A (corresponding author), Amer Canc Soc, Atlanta, GA 30329 USA.	ajemal@cancer.org			American Cancer Society; Centers for Disease Control and Prevention	American Cancer Society(American Cancer Society); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The American Cancer Society and the Centers for Disease Control and Prevention funded the analysis, interpretation, and compilation of surveillance data. No staff at the American Cancer Society or the Centers for Disease Control and Prevention, other than the study investigators, played a role in designing and conducting the study, including analysis, interpretation, and presentation of the manuscript.	Anderson John E, 2006, Adv Data, P1; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; Arias Elizabeth, 2003, Natl Vital Stat Rep, V52, P1; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; FELDMAN JJ, 1989, AM J EPIDEMIOL, V129, P919, DOI 10.1093/oxfordjournals.aje.a115225; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V38, P96, DOI 10.1097/00126334-200501010-00017; GITTELSOHN A, 1982, VITAL HLTH STAT 2, V2, P1; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; HARRIS JE, 1983, JNCI-J NATL CANCER I, V71, P473; Hayward MD, 2004, DEMOGRAPHY, V41, P87, DOI 10.1353/dem.2004.0005; HSIANGCHING K, 2008, DEATHS FINAL DATA 20; Jemal A, 2003, J NATL CANCER I, V95, P1727, DOI 10.1093/jnci/djg116; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005; Krieger N, 1997, ANNU REV PUBL HEALTH, V18, P341, DOI 10.1146/annurev.publhealth.18.1.341; Laws MB, 2002, TOB CONTROL, V11, pII71; Luke D, 2000, TOB CONTROL, V9, P16, DOI 10.1136/tc.9.1.16; Marcus EN, 2006, NEW ENGL J MED, V355, P339, DOI 10.1056/NEJMp058328; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; National Center for Health Statistics, 2006, HLTH US 2006 CHARTB; National Center for Health Statistics, 2005, HLTH US 2005 CHARTB; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Powell LM, 2007, PREV MED, V44, P189, DOI 10.1016/j.ypmed.2006.08.008; Powell LM, 2006, AM J PUBLIC HEALTH, V96, P1676, DOI 10.2105/AJPH.2005.065573; PRESTON SH, 1995, J AGING HEALTH, V7, P476, DOI 10.1177/089826439500700402; Romley JA, 2007, J STUD ALCOHOL DRUGS, V68, P48, DOI 10.15288/jsad.2007.68.48; ROSENBERG HM, 1999, VITAL HLTH STAT 2, V128, P1; Selik RM, 2003, JAIDS-J ACQ IMM DEF, V32, P62, DOI 10.1097/00126334-200301010-00009; SHAI D, 1989, AM J EPIDEMIOL, V130, P188, DOI 10.1093/oxfordjournals.aje.a115311; Singh GK, 2002, INT J EPIDEMIOL, V31, P600, DOI 10.1093/ije/31.3.600; Smedley BD, 2003, UNEQUAL TREATMENT CO, P764; Sorlie PD, 1996, EPIDEMIOLOGY, V7, P437, DOI 10.1097/00001648-199607000-00017; SORLIE PD, 1992, EPIDEMIOLOGY, V3, P181, DOI 10.1097/00001648-199203000-00018; Steenland K, 2004, AM J PUBLIC HEALTH, V94, P1037, DOI 10.2105/AJPH.94.6.1037; Steenland K, 2002, AM J EPIDEMIOL, V156, P11, DOI 10.1093/aje/kwf001; Thun MJ, 2002, ONCOGENE, V21, P7307, DOI 10.1038/sj.onc.1205807; US Department of Health and Human Services, 2004, NAT HEALTHC DISP REP; *WHO, 1997, INT STAT CLASS DIS R; Winkleby MA, 2003, J EPIDEMIOL COMMUN H, V57, P444, DOI 10.1136/jech.57.6.444; Winkleby MA, 1998, JAMA-J AM MED ASSOC, V280, P356, DOI 10.1001/jama.280.4.356; World Health Organization, 1992, INT STAT CLASS DIS R	47	88	88	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2181	10.1371/journal.pone.0002181	http://dx.doi.org/10.1371/journal.pone.0002181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	390OE	18478119	Green Published, gold			2022-12-27	WOS:000262172800046
J	Li, DN; Li, H; Ou, CY; Lu, Y; Sun, YT; Yang, B; Qin, ZD; Zhou, ZJ; Li, SL; Jin, L				Li, Dongna; Li, Hui; Ou, Caiying; Lu, Yan; Sun, Yuantian; Yang, Bo; Qin, Zhendong; Zhou, Zhenjian; Li, Shilin; Jin, Li			Paternal Genetic Structure of Hainan Aborigines Isolated at the Entrance to East Asia	PLOS ONE			English	Article								Background: At the southern entrance to East Asia, early population migration has affected most of the Y-chromosome variations of East Asians. Methodology/Principal Findings: To assess the isolated genetic structure of Hainan Island and the original genetic structure at the southern entrance, we studied the Y chromosome diversity of 405 Hainan Island aborigines from all the six populations, who have little influence of the recent mainland population relocations and admixtures. Here we report that haplogroups O1a* and O2a* are dominant among Hainan aborigines. In addition, the frequency of the mainland dominant haplogroup O3 is quite low among these aborigines, indicating that they have lived rather isolated. Clustering analyses suggests that the Hainan aborigines have been segregated since about 20 thousand years ago, after two dominant haplogroups entered East Asia (31 to 36 thousand years ago). Conclusions/Significance: Our results suggest that Hainan aborigines have been isolated at the entrance to East Asia for about 20 thousand years, whose distinctive genetic characteristics could be used as important controls in many population genetic studies.	[Li, Dongna; Ou, Caiying; Sun, Yuantian; Zhou, Zhenjian] Hainan Med Coll, Dept Biol, Haikou, Hainan, Peoples R China; [Li, Hui; Lu, Yan; Qin, Zhendong; Li, Shilin; Jin, Li] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai, Peoples R China; [Li, Hui] Yale Univ, Sch Med, Dept Genet, New Haven, CT USA; [Yang, Bo] Third Military Med Univ, Dept Anat, Chongqing, Peoples R China	Hainan Medical University; Fudan University; Yale University; Army Medical University	Li, DN (corresponding author), Hainan Med Coll, Dept Biol, Haikou, Hainan, Peoples R China.	LiHui.Fudan@gmail.com	Anthropology, MOE KeyLab Fudan/A-9454-2010; Li, Hui/A-2014-2010; Jin, Li/M-5063-2019; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415	National Natural Science Foundation of China [30460056]; Ministry of Education of PRC Science and Technology Research Key Project Fund [204160]; Genographic Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of PRC Science and Technology Research Key Project Fund; Genographic Project	This study was supported by the National Natural Science Foundation of China (No. 30460056), Ministry of Education of PRC Science and Technology Research Key Project Fund (No. 204160), and the Genographic Project.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; CHEN SJ, 2002, P INT S ANTHR STUD F; Ellis N, 2002, GENOME RES, V12, P339; Gordon R. G., 2005, ETHNOLOGUE LANGUAGES, V15th; HAO SD, 2003, RETROSPECTION PROSPE, V4, P291; Hao SDHB, 1998, SANYA LUOBIDONG SITE; Hurles ME, 2005, AM J HUM GENET, V76, P894, DOI 10.1086/430051; *INT SOC GEN GEN, 2007, Y DNA HAPL TREE 2007; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Karafev TM, 2005, HUM BIOL, V77, P93, DOI 10.1353/hub.2005.0030; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; LI H, 2005, THESIS FUDAN U SHANG; Li H, 2007, HUM GENET, V122, P383, DOI 10.1007/s00439-007-0407-2; Li H, 2007, AM J HUM GENET, V81, P842, DOI 10.1086/521201; Mona S, 2007, MOL BIOL EVOL, V24, P2546, DOI 10.1093/molbev/msm187; NEI M, 1993, MOL BIOL EVOL, V10, P927; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Shi Y., 1989, QUESTION QUATERNARY; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Thurgood G., 1994, OCEAN LING, V33, P345; Wang XPWJ., 2004, CHINA HLAI; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wen B, 2004, NATURE, V431, P302, DOI 10.1038/nature02878; Wen B, 2004, AM J HUM GENET, V74, P856, DOI 10.1086/386292; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Xiao Chun-Jie, 2000, Acta Genetica Sinica, V27, P1; Xing GY, 2004, HAINAN ARCH, V3, P43; Zhang F, 2007, PHILOS T R SOC B, V362, P987, DOI 10.1098/rstb.2007.2028; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	32	35	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2168	10.1371/journal.pone.0002168	http://dx.doi.org/10.1371/journal.pone.0002168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478090	Green Submitted, gold, Green Published			2022-12-27	WOS:000262172800033
J	Chen, MR; Gan, GL; Wu, Y; Wang, L; Wu, YL; Ding, J				Chen, Maorong; Gan, Geliang; Wu, Ying; Wang, Lu; Wu, Yingliang; Ding, Jiuping			Lysine-Rich Extracellular Rings Formed by h beta 2 Subunits Confer the Outward Rectification of BK Channels	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; AUXILIARY BETA-SUBUNITS; LARGE-CONDUCTANCE; CHROMAFFIN CELLS; MOLECULAR-BASIS; CALCIUM; VOLTAGE; INACTIVATION; CA2+; COLOCALIZATION	The auxiliary beta subunits of large-conductance Ca2+-activated K+ (BK) channels greatly contribute to the diversity of BK (mSlo1 alpha) channels, which is fundamental to the adequate function in many tissues. Here we describe a functional element of the extracellular segment of h beta 2 auxiliary subunits that acts as the positively charged rings to modify the BK channel conductance. Four consecutive lysines of the h beta 2 extracellular loop, which reside sufficiently close to the extracellular entryway of the pore, constitute three positively charged rings. These rings can decrease the extracellular K+ concentration and prevent the Charybdotoxin (ChTX) from approaching the extracellular entrance of channels through electrostatic mechanism, leading to the reduction of K+ inflow or the outward rectification of BK channels. Our results demonstrate that the lysine rings formed by the h beta 2 auxiliary subunits influences the inward current of BK channels, providing a mechanism by which current can be rapidly diminished during cellular repolarization. Furthermore, this study will be helpful to understand the functional diversity of BK channels contributed by different auxiliary beta subunits.	[Chen, Maorong; Wu, Ying; Wang, Lu; Ding, Jiuping] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Gan, Geliang; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Peoples R China	Huazhong University of Science & Technology; Wuhan University	Chen, MR (corresponding author), Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	jpding@mail.hust.edu.cn	Chen, Maorong/AAF-4006-2019	Chen, Maorong/0000-0003-3744-8864	National Science Foundation of China [30770522, 30770519]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants from the National Science Foundation of China (30770522, 30770519).	ANWER K, 1993, AM J PHYSIOL, V265, pC976, DOI 10.1152/ajpcell.1993.265.4.C976; Brelidze TI, 2003, P NATL ACAD SCI USA, V100, P9017, DOI 10.1073/pnas.1532257100; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Ding JP, 1998, BIOPHYS J, V74, P268, DOI 10.1016/S0006-3495(98)77785-9; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; GOLA M, 1993, NEURON, V10, P689, DOI 10.1016/0896-6273(93)90170-V; GUO ZH, 2008, BIOPHYS J IN PRESS; Haug T, 2004, J GEN PHYSIOL, V124, P173, DOI 10.1085/jgp.200308949; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Li W, 2007, J CELL PHYSIOL, V212, P348, DOI 10.1002/jcp.21007; Li ZW, 1999, J NEUROPHYSIOL, V81, P611, DOI 10.1152/jn.1999.81.2.611; Lv CX, 2008, J BIOL CHEM, V283, P2709, DOI 10.1074/jbc.M704440200; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Nimigean CM, 2003, BIOCHEMISTRY-US, V42, P9263, DOI 10.1021/bi0348720; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; TsengCrank J, 1996, P NATL ACAD SCI USA, V93, P9200, DOI 10.1073/pnas.93.17.9200; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wang YW, 2002, J NEUROSCI, V22, P1550, DOI 10.1523/JNEUROSCI.22-05-01550.2002; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Xia XM, 2000, J NEUROSCI, V20, P4890; Zeng XH, 2003, NAT STRUCT BIOL, V10, P448, DOI 10.1038/nsb932; Zeng XH, 2001, J GEN PHYSIOL, V117, P607, DOI 10.1085/jgp.117.6.607	25	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2114	10.1371/journal.pone.0002114	http://dx.doi.org/10.1371/journal.pone.0002114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461166	Green Published, gold, Green Submitted			2022-12-27	WOS:000261642400036
J	McGowan, PO; Sasaki, A; Huang, TCT; Unterberger, A; Suderman, M; Ernst, C; Meaney, MJ; Turecki, G; Szyf, M				McGowan, Patrick O.; Sasaki, Aya; Huang, Tony C. T.; Unterberger, Alexander; Suderman, Matthew; Ernst, Carl; Meaney, Michael J.; Turecki, Gustavo; Szyf, Moshe			Promoter-Wide Hypermethylation of the Ribosomal RNA Gene Promoter in the Suicide Brain	PLOS ONE			English	Article								Background: Alterations in gene expression in the suicide brain have been reported and for several genes DNA methylation as an epigenetic regulator is thought to play a role. rRNA genes, that encode ribosomal RNA, are the backbone of the protein synthesis machinery and levels of rRNA gene promoter methylation determine rRNA transcription. Methodology/Principal Findings: We test here by sodium bisulfite mapping of the rRNA promoter and quantitative realtime PCR of rRNA expression the hypothesis that epigenetic differences in critical loci in the brain are involved in the pathophysiology of suicide. Suicide subjects in this study were selected for a history of early childhood neglect/abuse, which is associated with decreased hippocampal volume and cognitive impairments. rRNA was significantly hypermethylated throughout the promoter and 59 regulatory region in the brain of suicide subjects, consistent with reduced rRNA expression in the hippocampus. This difference in rRNA methylation was not evident in the cerebellum and occurred in the absence of genome-wide changes in methylation, as assessed by nearest neighbor. Conclusions/Significance: This is the first study to show aberrant regulation of the protein synthesis machinery in the suicide brain. The data implicate the epigenetic modulation of rRNA in the pathophysiology of suicide.	[McGowan, Patrick O.; Sasaki, Aya; Ernst, Carl; Meaney, Michael J.; Turecki, Gustavo] Douglas Mental Hlth Univ Inst, Dept Psychiat, Montreal, PQ, Canada; [McGowan, Patrick O.; Sasaki, Aya; Meaney, Michael J.] McGill Univ, McGill Program Study Behaviour, Genes & Env, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [McGowan, Patrick O.; Sasaki, Aya; Huang, Tony C. T.; Unterberger, Alexander; Suderman, Matthew; Meaney, Michael J.; Szyf, Moshe] McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada; [Huang, Tony C. T.; Unterberger, Alexander; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Suderman, Matthew] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Ernst, Carl; Turecki, Gustavo] Douglas Mental Hlth Univ Inst, McGill Grp Suicide Stud, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	McGowan, PO (corresponding author), Douglas Mental Hlth Univ Inst, Dept Psychiat, Montreal, PQ, Canada.	gustvao.turecki@mcgill.ca; moshe.szyf@mcgill.ca	Meaney, Michael/N-5931-2019; Turecki, Gustavo/K-5100-2015	Turecki, Gustavo/0000-0003-4075-2736; Suderman, Matthew/0000-0002-2715-9930	National Cancer Institute; NICHD; HSFP; Maternal Adversity, Vulnerability and Neurodevelopment Project grant from the Canadian Institutes for Health Research (CIHR)	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); HSFP; Maternal Adversity, Vulnerability and Neurodevelopment Project grant from the Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was funded by a grant from the National Cancer Institute to MS, NICHD to MJM and MS, HSFP to MJM and MS, the Maternal Adversity, Vulnerability and Neurodevelopment Project grant from the Canadian Institutes for Health Research (CIHR) to MJM and MS, as well as grants from CIHR to GT. Competing interests: The authors have declared that no competing interests exist.	Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x; Bleich S, 2006, ALCOHOL CLIN EXP RES, V30, P587, DOI 10.1111/j.1530-0277.2006.00068.x; Bonsch D, 2005, NEUROREPORT, V16, P167; Brezo J, 2007, PSYCHOL MED, V37, P1563, DOI 10.1017/S003329170700058X; Brown SE, 2007, MOL CELL BIOL, V27, P4938, DOI 10.1128/MCB.01880-06; Caburet S, 2005, GENOME RES, V15, P1079, DOI 10.1101/gr.3970105; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; CHARBONNEAU H, 1987, NAISSANCE POPULATION; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200; Detich N, 2003, J BIOL CHEM, V278, P20812, DOI 10.1074/jbc.M211813200; Ding QX, 2006, NEUROCHEM RES, V31, P705, DOI 10.1007/s11064-006-9071-5; Ding QX, 2005, J NEUROSCI, V25, P9171, DOI 10.1523/JNEUROSCI.3040-05.2005; Dong E, 2007, P NATL ACAD SCI USA, V104, P4676, DOI 10.1073/pnas.0700529104; Dumais A, 2005, AM J PSYCHIAT, V162, P2116, DOI 10.1176/appi.ajp.162.11.2116; Dwivedi Y, 2005, BIOL PSYCHIAT, V58, P315, DOI 10.1016/j.biopsych.2005.04.014; Dwivedi Y, 2006, ARCH GEN PSYCHIAT, V63, P639, DOI 10.1001/archpsyc.63.6.639; Fergusson DM, 1996, J AM ACAD CHILD PSY, V35, P1365, DOI 10.1097/00004583-199610000-00024; FIRST MB, 1995, J PERS DISORD, V9, P83, DOI 10.1521/pedi.1995.9.2.83; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Grayson DR, 2005, P NATL ACAD SCI USA, V102, P9341, DOI 10.1073/pnas.0503736102; Hedges LV, 2014, STAT METHODS META AN; Hirschler-Laszkiewicz I, 2001, NUCLEIC ACIDS RES, V29, P4114, DOI 10.1093/nar/29.20.4114; Iwamoto K, 2005, J NEUROSCI, V25, P5376, DOI 10.1523/JNEUROSCI.0766-05.2005; Kirk RE, 2007, J STAT PLAN INFER, V137, P1634, DOI 10.1016/j.jspi.2006.09.011; Kuratomi G, 2008, MOL PSYCHIATR, V13, P429, DOI 10.1038/sj.mp.4002001; Machwe A, 2000, FASEB J, V14, P1715, DOI 10.1096/fj.99-0926com; Majumder S, 2006, J BIOL CHEM, V281, P22062, DOI 10.1074/jbc.M601155200; Mann JJ, 2002, ANN INTERN MED, V136, P302, DOI 10.7326/0003-4819-136-4-200202190-00010; McGowan Patrick O., 2008, Environmental Health and Preventive Medicine, V13, P16, DOI 10.1007/s12199-007-0002-0; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Milutinovic S, 2007, CARCINOGENESIS, V28, P560, DOI 10.1093/carcin/bgl167; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Odagaki Y, 2001, BRAIN RES, V898, P224, DOI 10.1016/S0006-8993(01)02188-6; Ramsahoye Bernard H, 2002, Methods Mol Biol, V200, P9; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Razin A, 1998, EMBO J, V17, P4905, DOI 10.1093/emboj/17.17.4905; ROY A, 1995, AM J PSYCHIAT, V152, P1075; ROY A, 1991, ARCH GEN PSYCHIAT, V48, P29; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Schloss P, 2004, PHARMACOL THERAPEUT, V102, P47, DOI 10.1016/j.pharmthera.2004.02.001; Seguin M, 2007, PSYCHOL MED, V37, P1575, DOI 10.1017/S0033291707000955; Sequeira A, 2007, MOL PSYCHIATR, V12, P640, DOI 10.1038/sj.mp.4001969; Sequeira A, 2006, OMICS, V10, P444, DOI 10.1089/omi.2006.10.444; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Stults DM, 2008, GENOME RES, V18, P13, DOI 10.1101/gr.6858507; Szyf M, 2008, ENVIRON MOL MUTAGEN, V49, P46, DOI 10.1002/em.20357; Tochigi M, 2008, NEUROSCI RES, V60, P184, DOI 10.1016/j.neures.2007.10.010; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Turecki G, 2005, J PSYCHIATR NEUROSCI, V30, P398; Turecki G, 2001, BIPOLAR DISORD, V3, P335, DOI 10.1034/j.1399-5618.2001.30608.x; Veldic M, 2007, SCHIZOPHR RES, V91, P51, DOI 10.1016/j.schres.2006.11.029; Vythilingam M, 2002, AM J PSYCHIAT, V159, P2072, DOI 10.1176/appi.ajp.159.12.2072; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Widom CS, 2007, ARCH GEN PSYCHIAT, V64, P49; Zouk H, 2006, J AFFECT DISORDERS, V92, P195, DOI 10.1016/j.jad.2006.01.016	59	249	254	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2085	10.1371/journal.pone.0002085	http://dx.doi.org/10.1371/journal.pone.0002085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461137	Green Submitted, gold, Green Published			2022-12-27	WOS:000261642400008
J	Yu, JKL; Tok, TS; Tsai, JJ; Chang, WS; Dzimadzi, RK; Yen, PH; Makombe, SD; Nkhata, A; Schouten, EJ; Kamoto, K; Harries, AD				Yu, Joseph Kwong-Leung; Tok, Teck-Siang; Tsai, Jih-Jin; Chang, Wu-Shou; Dzimadzi, Rose K.; Yen, Ping-Hsiang; Makombe, Simon D.; Nkhata, Amon; Schouten, Erik J.; Kamoto, Kelita; Harries, Anthony D.			What Happens to Patients on Antiretroviral Therapy Who Transfer Out to Another Facility?	PLOS ONE			English	Article								Background: Long term retention of patients on antiretroviral therapy ( ART) in Africa's rapidly expanding programmes is said to be 60% at 2 years. Many reports from African ART programmes make little mention of patients who are transferred out to another facility, yet Malawi's national figures show a transfer out of 9%. There is no published information about what happens to patients who transfer-out, but this is important because if they transfer-in and stay alive in these other facilities then national retention figures will be better than previously reported. Methodology/Principal Findings: Of all patients started on ART over a three year period in Mzuzu Central Hospital, North Region, Malawi, those who transferred out were identified from the ART register and master cards. Clinic staff attempted to trace these patients to determine whether they had transferred in to a new ART facility and their outcome status. There were 805 patients (19% of the total cohort) who transferred out, of whom 737 (92%) were traced as having transferred in to a new ART facility, with a median time of 1.3 months between transferring-out and transferring-in. Survival probability was superior and deaths were lower in the transfer-out patients compared with those who did not transfer. Conclusion/Significance: In Mzuzu Central Hospital, patients who transfer-out constitute a large proportion of patients not retained on ART at their original clinic of registration. Good documentation of transfer-outs and transfer-ins are needed to keep track of national outcomes. Furthermore, the current practice of regarding transfer-outs as being double counted in national cohorts and subtracting this number from the total national registrations to get the number of new patients started on ART is correct.	[Yu, Joseph Kwong-Leung] Mzuzu Cent Hosp, Taiwan Med Mission Malawi, Mzuzu, Malawi; [Yu, Joseph Kwong-Leung; Tok, Teck-Siang; Yen, Ping-Hsiang] Pingtung Christian Hosp, Int Med Cooperat & Development Ctr, Pingtung, Taiwan; [Yu, Joseph Kwong-Leung; Tsai, Jih-Jin] Kaohsiung Med Univ Hosp, Kaohsiung Med Univ Div Infect Dis, Coll Med, Kaohsiung, Taiwan; [Yu, Joseph Kwong-Leung; Chang, Wu-Shou] Dept Hlth, Bureau Int Cooperation, Taipei, Taiwan; [Dzimadzi, Rose K.] Minist Hlth, Mzuzu Central Hosp, Office Hosp Director, Mzuzu, Malawi; [Makombe, Simon D.; Nkhata, Amon; Schouten, Erik J.; Kamoto, Kelita; Harries, Anthony D.] Minist Hlth, HIV Unit, Lilongwe, Malawi; [Schouten, Erik J.] Management Sci Hlth, Lilongwe, Malawi; [Harries, Anthony D.] Family Hlth Int, Lilongwe, Malawi; [Harries, Anthony D.] London Sch Hyg & Trop Med, London, England	Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of London; London School of Hygiene & Tropical Medicine	Yu, JKL (corresponding author), Mzuzu Cent Hosp, Taiwan Med Mission Malawi, Mzuzu, Malawi.	adharries@malawi.net	TSAI, JIH-JIN/GOP-2776-2022	TSAI, JIH-JIN/0000-0003-2226-8916				Boulle A, 2007, SEX TRANSM INFECT, V83, P503, DOI 10.1136/sti.2007.027748; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Libamba E, 2005, INT J TUBERC LUNG D, V9, P1062; Meijnen S, 2002, INT J TUBERC LUNG D, V6, P666; *MIN HLTH MAL HIV, 2006, ARV THER MAL 30 JUN; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Wester CW, 2005, JAIDS-J ACQ IMM DEF, V40, P336, DOI 10.1097/01.qai.0000159668.80207.5b; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	12	21	21	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2065	10.1371/journal.pone.0002065	http://dx.doi.org/10.1371/journal.pone.0002065			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446230	Green Published, gold, Green Submitted			2022-12-27	WOS:000261572300034
J	Lissek, S; Peters, S; Fuchs, N; Witthaus, H; Nicolas, V; Tegenthoff, M; Juckel, G; Brune, M				Lissek, Silke; Peters, Soren; Fuchs, Nina; Witthaus, Henning; Nicolas, Volkmar; Tegenthoff, Martin; Juckel, Georg; Bruene, Martin			Cooperation and Deception Recruit Different Subsets of the Theory-of-Mind Network	PLOS ONE			English	Article							TEMPORO-PARIETAL JUNCTION; SOCIAL COGNITION; FALSE-BELIEF; MORAL JUDGMENT; NONVERBAL TASK; NEURAL BASIS; BRAIN; FMRI; SCHIZOPHRENIA; CORTEX	The term "theory of mind'' (ToM) describes an evolved psychological mechanism that is necessary to represent intentions and expectations in social interaction. It is thus involved in determining the proclivity of others to cooperate or defect. While in cooperative settings between two parties the intentions and expectations of the protagonists match, they diverge in deceptive scenarios, in which one protagonist is intentionally manipulated to hold a false belief about the intention of the other. In a functional magnetic resonance imaging paradigm using cartoons showing social interactions (including the outcome of the interaction) between two or three story characters, respectively, we sought to determine those brain areas of the ToM network involved in reasoning about cooperative versus deceptive interactions. Healthy volunteers were asked to reflect upon the protagonists' intentions and expectations in cartoons depicting cooperation, deception or a combination of both, where two characters cooperated to deceive a third. Reasoning about the mental states of the story characters yielded substantial differences in activation patterns: both deception and cooperation activated bilateral temporoparietal junction, parietal and cingulate regions, while deception alone additionally recruited orbitofrontal and medial prefrontal regions. These results indicate an important role for prefrontal cortex in processing a mismatch between a character's intention and another's expectations as required in complex social interactions.	[Lissek, Silke; Tegenthoff, Martin] Ruhr Univ Bochum, BG Kliniken Bergmannsheil, Dept Neurol, Bochum, Germany; [Fuchs, Nina; Witthaus, Henning; Juckel, Georg; Bruene, Martin] Ruhr Univ, LWL Hosp Bochum, Dept Psychiat, Bochum, Germany; [Peters, Soren; Nicolas, Volkmar] Ruhr Univ Bochum, BG Klin Bergmannsheil, Dept Radiol, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Lissek, S (corresponding author), Ruhr Univ Bochum, BG Kliniken Bergmannsheil, Dept Neurol, Bochum, Germany.	silke.lissek@rub.de	Brüne, Martin/AAX-3202-2020	Brüne, Martin/0000-0002-2507-0561; Lissek, Silke/0000-0001-8208-8584	University of Bochum [FoRUM-F519-2006]	University of Bochum	Part of the research was funded by a grant of the University of Bochum (FoRUM-F519-2006).	Abe N, 2007, J COGNITIVE NEUROSCI, V19, P287, DOI 10.1162/jocn.2007.19.2.287; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Apperly IA, 2004, J COGNITIVE NEUROSCI, V16, P1773, DOI 10.1162/0898929042947928; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; BARONCOHEN S, 1994, BRIT J PSYCHIAT, V165, P640, DOI 10.1192/bjp.165.5.640; Berthoz S, 2002, BRAIN, V125, P1696, DOI 10.1093/brain/awf190; Brett M., 2002, INT C FUNCT MAPP HUM, V16, DOI 10.1016/S1053-8119(02)90013-3; Brune M, 2007, SCHIZOPHR RES, V92, P151, DOI 10.1016/J.SCHRES.2007.01.006; Brune M, 2006, NEUROSCI BIOBEHAV R, V30, P437, DOI 10.1016/j.neubiorev.2005.08.001; Brune M, 2003, SCHIZOPHR RES, V60, P57, DOI 10.1016/s0920-9964(02)00162-7; Brune M, 2001, PSYCHOPATHOLOGY, V34, P85, DOI 10.1159/000049286; Brune M, 2005, PSYCHIAT RES, V133, P135, DOI 10.1016/j.psychres.2004.10.007; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Byrne R., 1988, MACHIAVELLIAN INTELL; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; den Ouden HEM, 2005, NEUROIMAGE, V28, P787, DOI 10.1016/j.neuroimage.2005.05.001; Finger EC, 2006, NEUROIMAGE, V33, P414, DOI 10.1016/j.neuroimage.2006.06.011; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; GOEL V, 1995, NEUROREPORT, V6, P1741, DOI 10.1097/00001756-199509000-00009; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Happe F, 1996, NEUROREPORT, V8, P197, DOI 10.1097/00001756-199612200-00040; Heatherton TF, 2006, SOC COGN AFFECT NEUR, V1, P18, DOI 10.1093/scan/nsl001; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LESLIE AM, 1987, PSYCHOL REV, V94, P412, DOI 10.1037/0033-295X.94.4.412; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Moll J, 2001, ARQ NEURO-PSIQUIAT, V59, P657, DOI 10.1590/S0004-282X2001000500001; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Samson D, 2004, NAT NEUROSCI, V7, P499, DOI 10.1038/nn1223; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Sommer M, 2007, NEUROIMAGE, V35, P1378, DOI 10.1016/j.neuroimage.2007.01.042; Stone VE, 2006, TRENDS COGN SCI, V10, P3, DOI 10.1016/j.tics.2005.11.010; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Talairach J., 1988, COPLANAR STEREOTAXIC; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Young L, 2007, P NATL ACAD SCI USA, V104, P8235, DOI 10.1073/pnas.0701408104	54	64	65	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2023	10.1371/journal.pone.0002023	http://dx.doi.org/10.1371/journal.pone.0002023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	381TL	18431500	Green Published, Green Submitted, gold			2022-12-27	WOS:000261558700035
J	Jones-Carson, J; Laughlin, J; Hamad, MA; Stewart, AL; Voskuil, MI; Vazquez-Torres, A				Jones-Carson, Jessica; Laughlin, James; Hamad, Mohammed A.; Stewart, Amanda L.; Voskuil, Martin I.; Vazquez-Torres, Andres			Inactivation of [Fe-S] Metalloproteins Mediates Nitric Oxide-Dependent Killing of Burkholderia mallei	PLOS ONE			English	Article								Background: Much remains to be known about the mechanisms by which O-2-dependent host defenses mediate broad antimicrobial activity. Methodology/Principal Findings: We show herein that reactive nitrogen species (RNS) generated by inducible nitric oxide (NO) synthase (iNOS) account for the anti-Burkholderia mallei activity of IFN gamma-primed macrophages. Inducible NOS-mediated intracellular killing may represent direct bactericidal activity, because B. mallei showed an exquisite sensitivity to NO generated chemically. Exposure of B. mallei to sublethal concentrations of NO upregulated transcription of [Fe-S] cluster repair genes, while damaging the enzymatic activity of the [Fe-S] protein aconitase. To test whether [Fe-S] clusters are critical targets for RNS-dependent killing of B. mallei, a mutation was constructed in the NO-induced, [Fe-S] cluster repair regulator iscR. Not only was the iscR mutant hypersusceptible to iNOS-mediated killing, but its aconitase pool was readily oxidized by NO donors as compared to wild-type controls. Although killed by authentic H2O2, which also oxidizes [Fe-S] clusters, B. mallei appear to be resilient to NADPH oxidase-mediated cytotoxicity. The poor respiratory burst elicited by this bacterium likely explains why the NADPH oxidase is nonessential to the killing of B. mallei while it is still confined within phagosomes. Conclusions/Significance: Collectively, these findings have revealed a disparate role for NADPH oxidase and iNOS in the innate macrophage response against the strict aerobe B. mallei. To the best of our knowledge, this is the first instance in which disruption of [Fe-S] clusters is demonstrated as cause of the bactericidal activity of NO congeners.	[Jones-Carson, Jessica; Laughlin, James; Hamad, Mohammed A.; Stewart, Amanda L.; Voskuil, Martin I.; Vazquez-Torres, Andres] Univ Colorado, Dept Microbiol, Hlth Sci Ctr, Aurora, CO 80045 USA; [Jones-Carson, Jessica] Univ Colorado, Hlth Sci Ctr, Dept Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Vazquez-Torres, A (corresponding author), Univ Colorado, Dept Microbiol, Hlth Sci Ctr, Aurora, CO 80045 USA.	andres.vazquez-torres@uchsc.edu	Hamad, Mohammed/HCH-0914-2022		Rocky Mountain Regional Center of Excellence	Rocky Mountain Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support of this work was provided by the Rocky Mountain Regional Center of Excellence	Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Bergman MA, 2005, INFECT IMMUN, V73, P7226, DOI 10.1128/IAI.73.11.7226-7235.2005; Breitbach K, 2006, INFECT IMMUN, V74, P6300, DOI 10.1128/IAI.00966-06; Brett PJ, 2007, MOL MICROBIOL, V63, P379, DOI 10.1111/j.1365-2958.2006.05519.x; BRETT PJ, 2007, CELL MICROBIOL; BRUNELLI L, 1995, ARCH BIOCHEM BIOPHYS, V316, P327, DOI 10.1006/abbi.1995.1044; CASTRO L, 1994, J BIOL CHEM, V269, P29409; CRAIG FF, 1989, J GEN MICROBIOL, V135, P2885; DEGROOTE MA, 1995, P NATL ACAD SCI USA, V92, P6399, DOI 10.1073/pnas.92.14.6399; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; DRAPIER JC, 1986, J CLIN INVEST, V78, P790, DOI 10.1172/JCI112642; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; Johnston RB, 2001, CURR OPIN HEMATOL, V8, P17, DOI 10.1097/00062752-200101000-00004; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; LaCourse R, 2002, INFECT IMMUN, V70, P7179, DOI 10.1128/IAI.70.12.7179-7181.2002; Lehavi O, 2002, HAREFUAH, V141, P88; Lopez J, 2003, MICROBES INFECT, V5, P1125, DOI 10.1016/j.micinf.2003.07.004; Lopez-Jaramillo P, 1998, LANCET, V351, P1176, DOI 10.1016/S0140-6736(05)79119-4; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; McCollister BD, 2005, J EXP MED, V202, P625, DOI 10.1084/jem.20050246; Miyagi K, 1997, INFECT IMMUN, V65, P4108, DOI 10.1128/IAI.65.10.4108-4113.1997; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Pick E, 1986, Methods Enzymol, V132, P407; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Ribot WJ, 2006, INFECT IMMUN, V74, P4349, DOI 10.1128/IAI.01939-05; Rowland CA, 2006, INFECT IMMUN, V74, P5333, DOI 10.1128/IAI.02046-05; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Segal BH, 2003, INFECT IMMUN, V71, P205, DOI 10.1128/IAI.71.1.205-210.2003; Shiloh MU, 1999, IMMUNITY, V10, P29, DOI 10.1016/S1074-7613(00)80004-7; Stevens JM, 2005, J BACTERIOL, V187, P7857, DOI 10.1128/JB.187.22.7857-7862.2005; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; STUEHR DJ, 1985, P NATL ACAD SCI USA, V82, P7738, DOI 10.1073/pnas.82.22.7738; Swanson MS, 2005, AUTOPHAGY, V1, P174, DOI 10.4161/auto.1.3.2067; Tortora V, 2007, FREE RADICAL BIO MED, V42, P1075, DOI 10.1016/j.freeradbiomed.2007.01.007; Utaisincharoen P, 2004, CLIN EXP IMMUNOL, V136, P277, DOI 10.1111/j.1365-2249.2004.02445.x; Utaisincharoen P, 2001, MICROBIOL IMMUNOL, V45, P307, DOI 10.1111/j.1348-0421.2001.tb02623.x; Utaisincharoen P, 2000, CLIN EXP IMMUNOL, V122, P324, DOI 10.1046/j.1365-2249.2000.01386.x; VazquezTorres A, 1996, INFECT IMMUN, V64, P3127, DOI 10.1128/IAI.64.8.3127-3133.1996; VAZQUEZTORRES A, 1995, INFECT IMMUN, V63, P1142, DOI 10.1128/IAI.63.3.1142-1144.1995; VAZQUEZTORRES A, 1999, NITRIC OXIDE INFECT, P475; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; YABUUCHI E, 1992, MICROBIOL IMMUNOL, V36, P1251, DOI 10.1111/j.1348-0421.1992.tb02129.x; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	51	37	38	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1976	10.1371/journal.pone.0001976	http://dx.doi.org/10.1371/journal.pone.0001976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398486	gold, Green Published, Green Submitted			2022-12-27	WOS:000260795500039
J	Wang, FP; Wang, JB; Jian, HH; Zhang, B; Li, SK; Wang, F; Zeng, XW; Gao, L; Bartlett, DH; Yu, J; Hu, SN; Xiao, X				Wang, Fengping; Wang, Jianbin; Jian, Huahua; Zhang, Bing; Li, Shengkang; Wang, Feng; Zeng, Xiaowei; Gao, Lei; Bartlett, Douglas Hoyt; Yu, Jun; Hu, Songnian; Xiao, Xiang			Environmental Adaptation: Genomic Analysis of the Piezotolerant and Psychrotolerant Deep-Sea Iron Reducing Bacterium Shewanella piezotolerans WP3	PLOS ONE			English	Article								Shewanella species are widespread in various environments. Here, the genome sequence of Shewanella piezotolerans WP3, a piezotolerant and psychrotolerant iron reducing bacterium from deep-sea sediment was determined with related functional analysis to study its environmental adaptation mechanisms. The genome of WP3 consists of 5,396,476 base pairs (bp) with 4,944 open reading frames (ORFs). It possesses numerous genes or gene clusters which help it to cope with extreme living conditions such as genes for two sets of flagellum systems, structural RNA modification, eicosapentaenoic acid (EPA) biosynthesis and osmolyte transport and synthesis. And WP3 contains 55 open reading frames encoding putative c-type cytochromes which are substantial to its wide environmental adaptation ability. The mtr-omc gene cluster involved in the insoluble metal reduction in the Shewanella genus was identified and compared. The two sets of flagellum systems were found to be differentially regulated under low temperature and high pressure; the lateral flagellum system was found essential for its motility and living at low temperature.	[Wang, Fengping; Jian, Huahua; Li, Shengkang; Wang, Feng; Xiao, Xiang] State Ocean Adm, Key Lab Marine Biogenet Resources, Xiamen, Peoples R China; [Wang, Fengping; Jian, Huahua; Li, Shengkang; Wang, Feng; Xiao, Xiang] State Oceanic Admin, Third Inst Oceanography, Xiamen, Peoples R China; [Wang, Jianbin; Zhang, Bing; Yu, Jun; Hu, Songnian] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Wang, Jianbin; Zhang, Bing; Zeng, Xiaowei; Yu, Jun; Hu, Songnian] Zhejiang Univ, James D Watson Inst Genome Sci, Hangzhou, Peoples R China; [Gao, Lei] Fudan Univ, T Life Res Ctr, Shanghai, Peoples R China; [Bartlett, Douglas Hoyt] Univ Calif San Diego, Scripps Inst Oceanography, Ctr Marine Biotechnol & Biomed, Marine Biol Res Div, La Jolla, CA USA	State Oceanic Administration; State Oceanic Administration; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Zhejiang University; Fudan University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Wang, FP (corresponding author), State Ocean Adm, Key Lab Marine Biogenet Resources, Xiamen, Peoples R China.	husn@genomics.org.cn; xxwfp@public.xm.fj.cn	xiao, xiang/GWU-6035-2022; Jian, Huahua/E-6732-2016; Wang, Feng/O-8202-2016; 郑, 征/C-8514-2011; Gao, Lei/I-4159-2013; Wang, Jianbin/B-8973-2016; Hu, Songnian/C-6509-2013	Gao, Lei/0000-0002-6488-0292; Wang, Jianbin/0000-0003-3155-894X; Hu, Songnian/0000-0003-3966-3111; Jian, Huahua/0000-0001-5507-497X	China COMRA foundation [DYLY0202-03]; NSFC fund [40625016, 40776095]	China COMRA foundation; NSFC fund(National Natural Science Foundation of China (NSFC))	This work was financially supported by China COMRA foundation DYLY0202-03, NSFC fund (40625016, 40776095).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Bao QY, 2002, GENOME RES, V12, P689, DOI 10.1101/gr.219302; Bartlett DH, 2002, BBA-PROTEIN STRUCT M, V1595, P367, DOI 10.1016/S0167-4838(01)00357-0; Bartlett Douglas H., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P93; BELAS R, 1986, J BACTERIOL, V167, P210, DOI 10.1128/jb.167.1.210-218.1986; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Charette M, 2000, IUBMB LIFE, V49, P341; Chiu CH, 2005, NUCLEIC ACIDS RES, V33, P1690, DOI 10.1093/nar/gki297; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DIANNE KN, 2002, SCIENCE, V296, P1071; Eisen JA, 2000, GENOME BIOL, V1; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gao HC, 2006, INT J SYST EVOL MICR, V56, P1911, DOI 10.1099/ijs.0.64354-0; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gutgsell NS, 2005, RNA, V11, P1141, DOI 10.1261/rna.2550105; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Hou SB, 2004, P NATL ACAD SCI USA, V101, P18036, DOI 10.1073/pnas.0407638102; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kato C, 1997, EXTREMOPHILES, V1, P111, DOI 10.1007/s007920050023; Kato C, 2001, FEMS MICROBIOL ECOL, V35, P223, DOI 10.1016/S0168-6496(00)00100-8; Kato Chiaki, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P87; Khachane AN, 2005, NUCLEIC ACIDS RES, V33, P4016, DOI 10.1093/nar/gki714; Leaphart AB, 2006, J BACTERIOL, V188, P1633, DOI 10.1128/JB.188.4.1633-1642.2006; Li SK, 2006, EXTREMOPHILES, V10, P97, DOI 10.1007/s00792-005-0476-x; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MCCARTER L, 1988, CELL, V54, P345, DOI 10.1016/0092-8674(88)90197-3; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Meyer TE, 2004, OMICS, V8, P57, DOI 10.1089/153623104773547499; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Ofengand J, 2001, COLD SPRING HARB SYM, V66, P147, DOI 10.1101/sqb.2001.66.147; Ofengand J, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P175; Qi J, 2004, J MOL EVOL, V58, P1, DOI 10.1007/s00239-003-2493-7; Roh Y, 2006, APPL ENVIRON MICROB, V72, P3236, DOI 10.1128/AEM.72.5.3236-3244.2006; Russel M, 1997, GENE, V192, P23, DOI 10.1016/S0378-1119(96)00801-3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saunders NFW, 2003, GENOME RES, V13, P1580, DOI 10.1101/gr.1180903; Tamegai H, 2005, EXTREMOPHILES, V9, P247, DOI 10.1007/s00792-005-0439-2; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Wang F, 2007, J BACTERIOL, V189, P7151, DOI 10.1128/JB.00569-07; Wang FP, 2004, EXTREMOPHILES, V8, P165, DOI 10.1007/s00792-003-0365-0; Xiao X, 2007, INT J SYST EVOL MICR, V57, P60, DOI 10.1099/ijs.0.64500-0; Xu MX, 2005, BIODIVERS CONSERV, V14, P3363, DOI 10.1007/s10531-004-0544-z	51	112	460	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1937	10.1371/journal.pone.0001937	http://dx.doi.org/10.1371/journal.pone.0001937			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398463	Green Submitted, Green Published, gold			2022-12-27	WOS:000260795500014
J	Greco, D; Somervuo, P; Di Lieto, A; Raitila, T; Nitsch, L; Castren, E; Auvinen, P				Greco, Dario; Somervuo, Panu; Di Lieto, Antonio; Raitila, Tuomas; Nitsch, Lucio; Castren, Eero; Auvinen, Petri			Physiology, Pathology and Relatedness of Human Tissues from Gene Expression Meta-Analysis	PLOS ONE			English	Article								Background: Development and maintenance of the identity of tissues is of central importance for multicellular organisms. Based on gene expression profiles, it is possible to divide genes in housekeeping genes and those whose expression is preferential in one or a few tissues and which provide specialized functions that have a strong effect on the physiology of the whole organism. Results: We have surveyed the gene expression in 78 normal human tissues integrating publicly available microarray gene expression data. A total amount of 1601 genes were identified as selectively expressed in one or more tissues. The tissue-selective genes covered a wide range of cellular and molecular functions, and could be linked to 361 human diseases with Mendelian inheritance. Based on the gene expression profiles, we were able to form a network of tissues reflecting their functional relatedness and, to certain extent, their development. Using co-citation driven gene network technique and promoter analysis, we predicted a transcriptional module where the co-operation of the transcription factors E2F and NF-kappaB can possibly regulate a number of genes involved in the neurogenesis that takes place in the adult hippocampus. Conclusions: Here we propose that integration of gene expression data from Affymetrix GeneChip experiments is possible through re-annotation and commonly used pre-processing methods. We suggest that some functional aspects of the tissues can be explained by the co-operation of multiple transcription factors that regulate the expression of selected groups of genes.	[Greco, Dario; Somervuo, Panu; Raitila, Tuomas; Auvinen, Petri] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Di Lieto, Antonio; Castren, Eero] Univ Helsinki, Neurosci Ctr, Helsinki, Finland; [Nitsch, Lucio] Univ Federico 2, Dipartimento Biol Patol Cell Mol, Naples, Italy	University of Helsinki; University of Helsinki; University of Naples Federico II	Greco, D (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	dario.greco@helsinki.fi	Castrén, Eero/A-4618-2010; Auvinen, Petri/AAP-8117-2021; Greco, Dario/T-7113-2019; Auvinen, Petri/D-5044-2009	Greco, Dario/0000-0001-9195-9003; Auvinen, Petri/0000-0002-3947-4778; Castren, Eero/0000-0002-1402-2791	Institute of Biotechnology, University of Helsinki; Academy of Finland [117968]	Institute of Biotechnology, University of Helsinki; Academy of Finland(Academy of Finland)	This research was funded by the Institute of Biotechnology, University of Helsinki, and by the Academy of Finland (grant 117968).	Abbas A., 2017, CELLULAR MOL IMMUNOL, P281; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Benson DW, 1999, J CLIN INVEST, V104, P1567, DOI 10.1172/JCI8154; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Denis-Donini S, 2005, DEV BRAIN RES, V154, P81, DOI 10.1016/j.devbrainres.2004.10.010; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Freilich S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r56; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Hirayama-Yamada K, 2005, AM J MED GENET A, V135A, P47, DOI 10.1002/ajmg.a.30684; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janeway CA, 2001, IMMUNOBIOLOGY; Krivan W, 2001, GENOME RES, V11, P1559, DOI 10.1101/gr.180601; Liang S, 2006, PHYSIOL GENOMICS, V26, P158, DOI 10.1152/physiolgenomics.00313.2005; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Swanson LW, 2003, ANN NY ACAD SCI, V985, P174; Timens W, 1997, MICROSC RES TECHNIQ, V39, P387, DOI 10.1002/(SICI)1097-0029(19971201)39:5<387::AID-JEMT1>3.0.CO;2-E; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Vinogradov AE, 2004, TRENDS GENET, V20, P248, DOI 10.1016/j.tig.2004.03.006; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P5212, DOI 10.1093/nar/gkg699; Wasserman WW, 1998, J MOL BIOL, V278, P167, DOI 10.1006/jmbi.1998.1700; Watanabe Y, 2002, J MED GENET, V39, P807, DOI 10.1136/jmg.39.11.807; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595	35	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1880	10.1371/journal.pone.0001880	http://dx.doi.org/10.1371/journal.pone.0001880			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382664	Green Submitted, Green Published, gold			2022-12-27	WOS:000260795400015
J	Lucca, U; Tettamanti, M; Mosconi, P; Apolone, G; Gandini, F; Nobili, A; Tallone, MV; Detoma, P; Giacomin, A; Clerico, M; Tempia, P; Guala, A; Fasolo, G; Riva, E				Lucca, Ugo; Tettamanti, Mauro; Mosconi, Paola; Apolone, Giovanni; Gandini, Francesca; Nobili, Alessandro; Tallone, Maria Vittoria; Detoma, Paolo; Giacomin, Adriano; Clerico, Mario; Tempia, Patrizia; Guala, Adriano; Fasolo, Gilberto; Riva, Emma			Association of Mild Anemia with Cognitive, Functional, Mood and Quality of Life Outcomes in the Elderly: The "Health and Anemia" Study	PLOS ONE			English	Article							DWELLING OLDER WOMEN; MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; PHYSICAL PERFORMANCE; HEMOGLOBIN; RISK; VALIDATION; SCALE; DISABILITY; DEPRESSION	Background: In the elderly persons, hemoglobin concentrations slightly below the lower limit of normal are common, but scant evidence is available on their relationship with significant health indicators. The objective of the present study was to cross-sectionally investigate the association of mild grade anemia with cognitive, functional, mood, and quality of life (QoL) variables in community-dwelling elderly persons. Methods: Among the 4,068 eligible individuals aged 65-84 years, all persons with mild anemia (n = 170) and a randomly selected sample of non-anemic controls (n = 547) were included in the study. Anemia was defined according to World Health Organization (WHO) criteria and mild grade anemia was defined as a hemoglobin concentration between 10.0 and 11.9 g/dL in women and between 10.0 and 12.9 g/dL in men. Cognition and functional status were assessed using measures of selective attention, episodic memory, cognitive flexibility and instrumental and basic activities of daily living. Mood and QoL were evaluated by means of the Geriatric Depression Scale-10, the Short-Form health survey (SF-12), and the Functional Assessment of Cancer Therapy-Anemia. Results: In univariate analyses, mild anemic elderly persons had significantly worse results on almost all cognitive, functional, mood, and QoL measures. In multivariable logistic regressions, after adjustment for a large number of demographic and clinical confounders, mild anemia remained significantly associated with measures of selective attention and disease-specific QoL (all fully adjusted p<.046). When the lower limit of normal hemoglobin concentration according to WHO criteria was raised to define anemia (+0.2 g/dL), differences between mild anemic and non anemic elderly persons tended to increase on almost every variable. Conclusions: Cross-sectionally, mild grade anemia was independently associated with worse selective attention performance and disease-specific QoL ratings.	[Lucca, Ugo; Tettamanti, Mauro; Gandini, Francesca; Nobili, Alessandro; Riva, Emma] Ist Ric Farmacol Mario Negri, Lab Geriatr Neuropsychiat, Milan, Italy; [Mosconi, Paola] Ist Ric Farmacol Mario Negri, Lab Med Res & Consumer Involvement, Milan, Italy; [Apolone, Giovanni] Ist Ric Farmacol Mario Negri, Labf Translat & Outcome Res Oncol, Milan, Italy; [Tallone, Maria Vittoria; Detoma, Paolo] Ospedale Infermi, Lab Anal, Biella, Italy; [Giacomin, Adriano] County Canc Registry, Local Hlth Authority, ASL12, Biella, Italy; [Clerico, Mario; Tempia, Patrizia] Ospedale Infermi, Dept Oncol, Biella, Italy; [Guala, Adriano] Ospedale Infermi, Dept Med & Geriat, Biella, Italy; [Fasolo, Gilberto] Local Hlth Authority, ASL12, Community Med, Biella, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Lucca, U (corresponding author), Ist Ric Farmacol Mario Negri, Lab Geriatr Neuropsychiat, Milan, Italy.	lucca@marionegri.it	Lucca, Ugo/ABC-1460-2020; Paola, Mosconi/K-5596-2016; Nobili, Alessandro/ABG-4516-2020; Alessandro, Nobili/AAA-7512-2020; Apolone, Giovanni/R-9799-2016; Tettamanti, Mauro/U-8925-2017	Lucca, Ugo/0000-0003-0452-3215; Paola, Mosconi/0000-0003-0415-3744; Nobili, Alessandro/0000-0002-7813-0572; Apolone, Giovanni/0000-0001-5179-104X; Tettamanti, Mauro/0000-0001-7345-0887	Amgen Italy	Amgen Italy(Amgen)	This study was supported by a research grant from Amgen Italy. The sponsor of the study had no role in the conception and design of the study; collection, management, analysis, and interpretation of data; preparation and writing of the report or in the decision to submit the manuscript for publication.	Agnihotri P, 2006, J AM GERIATR SOC, V54, pS16; [Anonymous], 1987, Ital J Neurol Sci, VSuppl 8, P1; Atti AR, 2006, NEUROBIOL AGING, V27, P278, DOI 10.1016/j.neurobiolaging.2005.02.007; Beard CM, 1997, ANN EPIDEMIOL, V7, P219, DOI 10.1016/S1047-2797(97)00015-X; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Blanc B., 1968, WHO TECH REP SER, V405, P1; Bonomi AE, 1996, QUAL LIFE RES, V5, P309, DOI 10.1007/BF00433915; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; Caffarra P., 2002, NUOVA RIV NEUROL, V12, P111; Cella D, 1997, SEMIN HEMATOL, V34, P13; Cesari M, 2004, J GERONTOL A-BIOL, V59, P249; Chaves PHM, 2006, J AM GERIATR SOC, V54, P1429, DOI 10.1111/j.1532-5415.2006.00863.x; Chaves PHM, 2002, J AM GERIATR SOC, V50, P1257, DOI 10.1046/j.1532-5415.2002.50313.x; Chaves PHM, 2005, J GERONTOL A-BIOL, V60, P729, DOI 10.1093/gerona/60.6.729; DATH P, 1994, FAM PRACT, V11, P260, DOI 10.1093/fampra/11.3.260; DAVIS PB, 1989, J AM GERIATR SOC, V37, P249, DOI 10.1111/j.1532-5415.1989.tb06815.x; Denny SD, 2006, AM J MED, V119, P327, DOI [10.1016/j.amjmed.2005.08.027, 10.1016/j.amjmed.2005.10.042]; ELWOOD PC, 1971, BRIT J HAEMATOL, V21, P557, DOI 10.1111/j.1365-2141.1971.tb02717.x; Ershler WB, 2005, VALUE HEALTH, V8, P629, DOI 10.1111/j.1524-4733.2005.00058.x; FERRARIO E, 1990, Clinical Gerontologist, V10, P67; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuchs Z, 1998, J GERONTOL A-BIOL, V53, pM447, DOI 10.1093/gerona/53A.6.M447; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Groopman JE, 1999, JNCI-J NATL CANCER I, V91, P1616, DOI 10.1093/jnci/91.19.1616; Herndon JG, 1997, J AM GERIATR SOC, V45, P739, DOI 10.1111/j.1532-5415.1997.tb01480.x; HERZOG AR, 1985, J GERONTOL, V40, P350, DOI 10.1093/geronj/40.3.350; Ishine M, 2005, J AM GERIATR SOC, V53, P733, DOI 10.1111/j.1532-5415.2005.53228_6.x; Kodraliu G, 2001, J Epidemiol Biostat, V6, P305; KOKMEN E, 1991, NEUROLOGY, V41, P1393, DOI 10.1212/WNL.41.9.1393; Kosinski M, 1995, SF 12 SCORE SF 12 PH; Krishnan Gokul, 2006, BMC Pulm Med, V6, P23, DOI 10.1186/1471-2466-6-23; LAGAAY AM, 1992, BRIT MED J, V304, P1091, DOI 10.1136/bmj.304.6834.1091; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lind M, 2002, BRIT J CANCER, V86, P1243, DOI 10.1038/sj.bjc.6600247; LUCCA U, 1995, J NEUROL S2, V242, pS106; LUCCA U, 1996, SPONTANEOUS BEHAV IN, P58; Lugli A, 2002, THESIS U STUDI PAVIA; Masaki K, 2006, J AM GERIATR SOC, V54, pS165; MEASSO G, 1993, DEV NEUROPSYCHOL, V9, P77, DOI 10.1080/87565649109540545; Milward EA, 1999, NEUROREPORT, V10, P2377, DOI 10.1097/00001756-199908020-00029; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Nilsson-Ehle H, 2000, EUR J HAEMATOL, V65, P297, DOI 10.1034/j.1600-0609.2000.065005297.x; Onder G, 2005, J GERONTOL A-BIOL, V60, P1168, DOI 10.1093/gerona/60.9.1168; PARMELEE PA, 1995, J AM GERIATR SOC, V43, P130, DOI 10.1111/j.1532-5415.1995.tb06377.x; Penninx BWJH, 2005, J AM GERIATR SOC, V53, P2106, DOI 10.1111/j.1532-5415.2005.00491.x; Penninx BWJH, 2004, J AM GERIATR SOC, V52, P719, DOI 10.1111/j.1532-5415.2004.52208.x; Penninx BWJH, 2003, AM J MED, V115, P104, DOI 10.1016/S0002-9343(03)00263-8; RIVA E, 2006, ALZHEIMERS DEMENT S1, V2, pS163; Robinson B, 2003, J AM GERIATR SOC, V51, pS14; SPAGNOLI A, 1991, NEUROLOGY, V41, P1726, DOI 10.1212/WNL.41.11.1726; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Valderrabano F, 2000, NEPHROL DIAL TRANSPL, V15, P23, DOI 10.1093/oxfordjournals.ndt.a027972; VENNERI A, 1993, ADV BIOSCI, V87, P81; Ware J.E., 1994, SF 36 PHYS MENTAL HL; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilson Alisa, 2004, Am J Med, V116 Suppl 7A, p50S; Woodman R, 2005, CURR OPIN HEMATOL, V12, P123; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	58	105	111	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1920	10.1371/journal.pone.0001920	http://dx.doi.org/10.1371/journal.pone.0001920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370XC	18382689	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795400042
J	Dudek, P; Picard, D				Dudek, Peter; Picard, Didier			Genomics of Signaling Crosstalk of Estrogen Receptor alpha in Breast Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CYCLIC ADENOSINE-MONOPHOSPHATE; GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; DEPENDENT TRANSCRIPTION; TAMOXIFEN RESISTANCE; MEDIATED TRANSCRIPTION; PROGESTERONE-RECEPTOR; COUPLED RECEPTOR; RESPONSE ELEMENT	Background: The estrogen receptor alpha (ER alpha) is a ligand-regulated transcription factor. However, a wide variety of other extracellular signals can activate ER alpha in the absence of estrogen. The impact of these alternate modes of activation on gene expression profiles has not been characterized. Methodology/Principal Findings: We show that estrogen, growth factors and cAMP elicit surprisingly distinct ER alpha-dependent transcriptional responses in human MCF7 breast cancer cells. In response to growth factors and cAMP, ER alpha primarily activates and represses genes, respectively. The combined treatments with the anti-estrogen tamoxifen and cAMP or growth factors regulate yet other sets of genes. In many cases, tamoxifen is perverted to an agonist, potentially mimicking what is happening in certain tamoxifen-resistant breast tumors and emphasizing the importance of the cellular signaling environment. Using a computational analysis, we predicted that a Hox protein might be involved in mediating such combinatorial effects, and then confirmed it experimentally. Although both tamoxifen and cAMP block the proliferation of MCF7 cells, their combined application stimulates it, and this can be blocked with a dominant-negative Hox mutant. Conclusions/Significance: The activating signal dictates both target gene selection and regulation by ER alpha, and this has consequences on global gene expression patterns that may be relevant to understanding the progression of ER alpha-dependent carcinomas.	[Dudek, Peter; Picard, Didier] Univ Geneva, Dept Biol Cell, Geneva, Switzerland	University of Geneva	Dudek, P (corresponding author), Univ Geneva, Dept Biol Cell, Geneva, Switzerland.	didier.picard@cellbio.unige.ch			Fondation Medic; Swiss National Science Foundation; Canton de Geneve	Fondation Medic; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton de Geneve	Funding for this project was provided by the Fondation Medic, the Swiss National Science Foundation, and the Canton de Geneve.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Al-Dhaheri MH, 2007, MOL ENDOCRINOL, V21, P439, DOI 10.1210/me.2006-0059; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; ARONICA SM, 1993, MOL ENDOCRINOL, V7, P743, DOI 10.1210/me.7.6.743; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Bourdeau V, 2008, NUCLEIC ACIDS RES, V36, P76, DOI 10.1093/nar/gkm945; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Cascio S, 2007, J BIOL CHEM, V282, P3498, DOI 10.1074/jbc.M606244200; Chadwick CC, 2005, P NATL ACAD SCI USA, V102, P2543, DOI 10.1073/pnas.0405841102; Chen DS, 1999, MOL CELL BIOL, V19, P1002; Chen HX, 2003, CANCER BIOL THER, V2, P524, DOI 10.4161/cbt.2.5.525; Creighton CJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r28; Cui Y, 2004, CANCER RES, V64, P9199, DOI 10.1158/0008-5472.CAN-04-2126; Cunliffe HE, 2003, CANCER RES, V63, P7158; Curtis SW, 1996, P NATL ACAD SCI USA, V93, P12626, DOI 10.1073/pnas.93.22.12626; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; DENNER LA, 1990, SCIENCE, V250, P1740, DOI 10.1126/science.2176746; Donze O, 2001, EMBO J, V20, P3771, DOI 10.1093/emboj/20.14.3771; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; FONTANA JA, 1987, J NATL CANCER I, V78, P1107; Frasor J, 2004, CANCER RES, V64, P1522, DOI 10.1158/0008-5472.CAN-03-3326; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Frech K, 1997, J MOL BIOL, V270, P674, DOI 10.1006/jmbi.1997.1140; FUJIMOTO N, 1994, MOL ENDOCRINOL, V8, P296, DOI 10.1210/me.8.3.296; Gburcik Valentina, 2006, Nucl Recept Signal, V4, pe005; Gee JMW, 2001, INT J CANCER, V95, P247, DOI 10.1002/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S; Hewitt SC, 2005, MOL ENDOCRINOL, V19, P657, DOI 10.1210/me.2004-0142; Hom YK, 1998, ENDOCRINOLOGY, V139, P913, DOI 10.1210/en.139.3.913; IGNARTROWBRIDGE DM, 1992, P NATL ACAD SCI USA, V89, P4658, DOI 10.1073/pnas.89.10.4658; IGNARTROWBRIDGE DM, 1993, MOL ENDOCRINOL, V7, P992, DOI 10.1210/me.7.8.992; Kalkhoven E, 1996, INT J CANCER, V65, P682, DOI 10.1002/(SICI)1097-0215(19960301)65:5<682::AID-IJC20>3.0.CO;2-8; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; KATZENELLENBOGEN BS, 1990, ENDOCRINOLOGY, V126, P891, DOI 10.1210/endo-126-2-891; Kininis M, 2007, MOL CELL BIOL, V27, P5090, DOI 10.1128/MCB.00083-07; Klotz DM, 2002, J BIOL CHEM, V277, P8531, DOI 10.1074/jbc.M109592200; Kurokawa H, 2000, CANCER RES, V60, P5887; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lazennec G, 2001, J STEROID BIOCHEM, V77, P193, DOI 10.1016/S0960-0760(01)00060-7; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; MA ZQ, 1994, MOL ENDOCRINOL, V8, P910, DOI 10.1210/me.8.7.910; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Michalides R, 2004, CANCER CELL, V5, P597, DOI 10.1016/j.ccr.2004.05.016; Miller WR, 1997, CLIN CANCER RES, V3, P2399; MILLER WR, 1990, BRIT J CANCER, V61, P263, DOI 10.1038/bjc.1990.48; Nettles KW, 2008, MOL ENDOCRINOL, V22, P263, DOI 10.1210/me.2007-0324; NEWTON CJ, 1994, J STEROID BIOCHEM, V48, P481, DOI 10.1016/0960-0760(94)90197-X; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Picard D, 2003, PURE APPL CHEM, V75, P1743, DOI 10.1351/pac200375111743; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; POWER RF, 1991, SCIENCE, V254, P1636, DOI 10.1126/science.1749936; Prossnitz ER, 2007, MOL CELL ENDOCRINOL, V265, P138, DOI 10.1016/j.mce.2006.12.010; Shim WS, 2000, ENDOCRINOLOGY, V141, P396, DOI 10.1210/en.141.1.396; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Siu YT, 2007, FEBS J, V274, P3224, DOI 10.1111/j.1742-4658.2007.05884.x; Sivaraman VS, 1997, J CLIN INVEST, V99, P1478, DOI 10.1172/JCI119309; VINTERMYR OK, 1995, ENDOCRINOLOGY, V136, P2513, DOI 10.1210/en.136.6.2513; Zwart W, 2007, EMBO J, V26, P3534, DOI 10.1038/sj.emboj.7601791	60	27	28	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1859	10.1371/journal.pone.0001859	http://dx.doi.org/10.1371/journal.pone.0001859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365014	Green Published, gold			2022-12-27	WOS:000260762400020
J	Veerapathran, A; Joshi, R; Goswami, K; Dogra, S; Moodie, EEM; Reddy, MVR; Kalantri, S; Schwartzman, K; Behr, MA; Menzies, D; Pai, M				Veerapathran, Anandharaman; Joshi, Rajnish; Goswami, Kalyan; Dogra, Sandeep; Moodie, Erica E. M.; Reddy, M. V. R.; Kalantri, Shriprakash; Schwartzman, Kevin; Behr, Marcel A.; Menzies, Dick; Pai, Madhukar			T-Cell Assays for Tuberculosis Infection: Deriving Cut-Offs for Conversions Using Reproducibility Data	PLOS ONE			English	Article							INTERFERON-GAMMA ASSAY; HEALTH-CARE WORKERS; LATENT TUBERCULOSIS; SKIN-TEST; RESPONSES; TESTS; AGREEMENT; DIAGNOSIS; ELISPOT; INDIA	Background: Although interferon-gamma release assays (IGRA) are promising alternatives to the tuberculin skin test, interpretation of repeated testing results is hampered by lack of evidence on optimal cut-offs for conversions and reversions. A logical start is to determine the within-person variability of T-cell responses during serial testing. Methodology/Principal Findings: We performed a pilot study in India, to evaluate the short-term reproducibility of QuantiFERON-TB Gold In Tube assay (QFT) among 14 healthcare workers (HCWs) who underwent 4 serial QFT tests on day 0, 3, 9 and 12. QFT ELISA was repeated twice on the same sets of specimens. We assessed two types of reproducibility: 1) test-retest reproducibility (between-test variability), and 2) within-person reproducibility over time. Test-retest reproducibility: with dichotomous test results, extremely high concordance was noticed between two tests performed on the same sets of specimens: of the 56 samples, the test and re-test results agreed for all but 2 individuals (k = 0.94). Discordance was noted in subjects who had IFN-gamma values around the cut-off point, with both increases and decreases noted. With continuous IFN-gamma results, re-test results tended to produce higher estimates of IFN-gamma than the original test. Within-person reproducibility: when continuous IFN-gamma data were analyzed, the within-person reproducibility was moderate to high. While persons with negative QFT results generally stayed negative, positive results tended to vary over time. Our data showed that increases of more than 16% in the IFN-gamma levels are statistically improbable in the short-term. Conclusions: Conservatively assuming that long-term variability might be at least twice higher than short-term, we hypothesize that a QFT conversion requires two conditions to be met: 1) change from negative to positive result, and 2) at least 30% increase in the baseline IFN-gamma response. Larger studies are needed to confirm our preliminary findings, and determine the conversion thresholds for IGRAs.	[Veerapathran, Anandharaman; Joshi, Rajnish; Goswami, Kalyan; Reddy, M. V. R.; Kalantri, Shriprakash] Mahatma Gandhi Inst Med Sci, Dept Biochem, Sevagram, Maharashtra, India; [Veerapathran, Anandharaman; Joshi, Rajnish; Goswami, Kalyan; Reddy, M. V. R.; Kalantri, Shriprakash] Mahatma Gandhi Inst Med Sci, Dept Med, Sevagram, Maharashtra, India; [Joshi, Rajnish] Univ Calif, Sch Public Hlth, Div Epidemiol, Berkeley, CA USA; [Dogra, Sandeep] Acharya Shri Chander Coll Med Sci & Hosp, Jammu, India; [Moodie, Erica E. M.; Schwartzman, Kevin; Behr, Marcel A.; Menzies, Dick; Pai, Madhukar] McGill Univ, Dept Epidemiol, Biostat & Occupat Hlth, Montreal, PQ, Canada; [Schwartzman, Kevin; Menzies, Dick; Pai, Madhukar] McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Behr, Marcel A.] McGill Univ Hlth Ctr, Div Infect Dis & Med Microbiol, Montreal, PQ, Canada	Mahatma Gandhi Institute of Medical Sciences, Sevagram; Mahatma Gandhi Institute of Medical Sciences, Sevagram; University of California System; University of California Berkeley; McGill University; McGill University; McGill University	Veerapathran, A (corresponding author), Mahatma Gandhi Inst Med Sci, Dept Biochem, Sevagram, Maharashtra, India.	madhukar.pai@mcgill.ca	Goswami, Kalyan/H-2825-2019; Dogra, Sandeep/AAS-6079-2021; Kalantri, Shriprakash/ABG-9318-2021; PAL, MRINAL/ABG-9676-2020; Pai, Madhukar/AAX-9901-2021	Kalantri, Shriprakash/0000-0002-1633-1029; PAL, MRINAL/0000-0002-1032-272X; Pai, Madhukar/0000-0003-3667-4536; Joshi, Rajnish/0000-0002-4702-0522	Canadian Institutes of Health Research (CIHR) [MOP-81362, New Investigator Award]; training fellowship Fogarty AIDS International Training Program [AITRP] [1-D43-TW00003-17]; Fonds de la Recherche en Sante du Quebec (FRSQ), Canada; FOGARTY INTERNATIONAL CENTER [D43TW000003] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); training fellowship Fogarty AIDS International Training Program [AITRP]; Fonds de la Recherche en Sante du Quebec (FRSQ), Canada(Fonds de la Recherche en Sante du Quebec); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This project was supported in part by a grant from the Canadian Institutes of Health Research (MOP-81362). MP is supported by a New Investigator Award from the Canadian Institutes of Health Research (CIHR). RJ is a recipient of a training fellowship from the Fogarty AIDS International Training Program [AITRP] (grant 1-D43-TW00003-17), USA. KS, MB and DM are recipients of career awards from the Fonds de la Recherche en Sante du Quebec (FRSQ), Canada. Cellestis Limited (Victoria, Australia) donated the QuantiFERON-TB Gold In Tube kits. This company did not provide funding for this study and was not involved in the preparation, review or submission of this manuscript.	*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, pS221, DOI DOI 10.1164/AJRCCM.161.SUPPLEMENT_; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; CORBETT EL, 2006, INT J TUBERC LUNG D, V10, pS231; DIGGLE PJ, 1988, BIOMETRICS, V44, P959, DOI 10.2307/2531727; Dogra S, 2007, J INFECTION, V54, P267, DOI 10.1016/j.jinf.2006.04.007; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Hill PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000183; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7; Pai M, 2006, EMERG INFECT DIS, V12, P1311, DOI 10.3201/eid1209.051663; Pai M, 2006, INT J TUBERC LUNG D, V10, P942; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC	24	86	87	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1850	10.1371/journal.pone.0001850	http://dx.doi.org/10.1371/journal.pone.0001850			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365006	Green Submitted, gold, Green Published			2022-12-27	WOS:000260762400012
J	Kalil, AC; Sun, JF				Kalil, Andre C.; Sun, Junfeng			Why Are Clinicians Not Embracing the Results from Pivotal Clinical Trials in Severe Sepsis? A Bayesian Analysis	PLOS ONE			English	Article							ACTIVATED PROTEIN-C; INTENSIVE INSULIN THERAPY; RESPIRATORY-DISTRESS-SYNDROME; HIGH-DOSE METHYLPREDNISOLONE; VOLUME VENTILATORY STRATEGY; MAXIMIZING OXYGEN DELIVERY; END-EXPIRATORY PRESSURE; GOAL-DIRECTED THERAPY; CRITICALLY-ILL; SEPTIC SHOCK	Background: Five pivotal clinical trials (Intensive Insulin Therapy; Recombinant Human Activated Protein C [rhAPC]; Low-Tidal Volume; Low-Dose Steroid; Early Goal-Directed Therapy [EGDT]) demonstrated mortality reduction in patients with severe sepsis and expert guidelines have recommended them to clinical practice. Yet, the adoption of these therapies remains low among clinicians. Objectives: We selected these five trials and asked: Question 1-What is the current probability that the new therapy is not better than the standard of care in my patient with severe sepsis? Question 2-What is the current probability of reducing the relative risk of death (RRR) of my patient with severe sepsis by meaningful clinical thresholds (RRR > 15% > 20% > 25%)? Methods: Bayesian methodologies were applied to this study. Odds ratio (OR) was considered for Question 1, and RRR was used for Question 2. We constructed prior distributions (enthusiastic; mild, moderate, and severe skeptic) based on various effective sample sizes of other relevant clinical trials (unfavorable evidence). Posterior distributions were calculated by combining the prior distributions and the data from pivotal trials (favorable evidence). Main Findings: Answer 1-The analysis based on mild skeptic prior shows beneficial results with the Intensive Insulin, rhAPC, and Low-Tidal Volume trials, but not with the Low-Dose Steroid and EGDT trials. All trials' results become unacceptable by the analyses using moderate or severe skeptic priors. Answer 2-If we aim for a RRR. 15%, the mild skeptic analysis shows that the current probability of reducing death by this clinical threshold is 88% for the Intensive Insulin, 62-65% for the Low-Tidal Volume, rhAPC, EGDT trials, and 17% for the Low-Dose Steroid trial. The moderate and severe skeptic analyses show no clinically meaningful reduction in the risk of death for all trials. If we aim for a RRR > 20% or > 25%, all probabilities of benefits become lower independent of the degree of skepticism. Conclusions: Our clinical threshold analysis offers a new bedside tool to be directly applied to the care of patients with severe sepsis. Our results demonstrate that the strength of evidence (statistical and clinical) is weak for all trials, particularly for the Low-Dose Steroid and EGDT trials. It is essential to replicate the results of each of these five clinical trials in confirmatory studies if we want to provide patient care based on scientifically sound evidence.	[Kalil, Andre C.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA; [Sun, Junfeng] Univ Nebraska, Coll Publ Hlth, Dept Biostat, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System	Kalil, AC (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA.	akalil@unmc.edu						Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Abroug F, 2002, NEW ENGL J MED, V346, P1025; Alia I, 1999, CHEST, V115, P453, DOI 10.1378/chest.115.2.453; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2003, CRIT CARE MED, V31, P1868, DOI 10.1097/01.CCM.0000063445.91548.20; Barton P, 2004, PEDIATRICS, V113, P7, DOI 10.1542/peds.113.1.7; Bernard GR, 2001, CRIT CARE MED, V29, P2051, DOI 10.1097/00003246-200111000-00003; Bernard GR, 2004, CHEST, V125, P2206, DOI 10.1378/chest.125.6.2206; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Biffl W, 2007, J TRAUMA, V62, P1375; Bollaert PE, 1998, CRIT CARE MED, V26, P645, DOI 10.1097/00003246-199804000-00010; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; Briegel J, 1999, CRIT CARE MED, V27, P723, DOI 10.1097/00003246-199904000-00025; Brochard L, 1998, AM J RESP CRIT CARE, V158, P1831, DOI 10.1164/ajrccm.158.6.9801044; BROPHY JM, 1995, JAMA-J AM MED ASSOC, V273, P871, DOI 10.1001/jama.273.11.871; Brower RG, 1999, CRIT CARE MED, V27, P1492, DOI 10.1097/00003246-199908000-00015; Brower RG, 2004, NEW ENGL J MED, V351, P327; BROWNER WS, 1987, JAMA-J AM MED ASSOC, V257, P2459, DOI 10.1001/jama.257.18.2459; Burton PR, 1998, J EPIDEMIOL COMMUN H, V52, P318, DOI 10.1136/jech.52.5.318; Clayton SB, 2006, CRIT CARE MED, V34, P2974, DOI 10.1097/01.CCM.0000248906.10399.CF; Davidoff F, 1999, ANN INTERN MED, V130, P1019, DOI 10.7326/0003-4819-130-12-199906150-00022; De Block C, 2006, DIABETES CARE, V29, P1750, DOI 10.2337/dc05-2353; de Durante G, 2002, AM J RESP CRIT CARE, V165, P1271, DOI 10.1164/rccm.2105050; Deans KJ, 2005, CRIT CARE MED, V33, P1141, DOI 10.1097/01.CCM.0000162384.71993.A3; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Diamond GA, 2004, J AM COLL CARDIOL, V43, P1929, DOI 10.1016/j.jacc.2004.01.035; Eichacker PQ, 2006, NEW ENGL J MED, V355, P1640, DOI 10.1056/NEJMp068197; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; Eichacker PQ, 2005, CRIT CARE MED, V33, P2426, DOI 10.1097/01.CCM.0000183002.26587.FF; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1510, DOI 10.1164/rccm.200208-956OC; Ellger B, 2008, ANAESTHESIST, V57, P43, DOI 10.1007/s00101-007-1285-7; Friedrich JO, 2006, CRIT CARE, V10, DOI 10.1186/cc5022; Friedrich JO, 2006, NEW ENGL J MED, V354, P94; Gandhi GY, 2007, ANN INTERN MED, V146, P233, DOI 10.7326/0003-4819-146-4-200702200-00002; GATTINONI L, 1995, NEW ENGL J MED, V333, P1025, DOI 10.1056/NEJM199510193331601; Gill CJ, 2005, BRIT MED J, V330, P1080, DOI 10.1136/bmj.330.7499.1080; Goldstein B, 2006, PEDIATR CRIT CARE ME, V7, P200, DOI 10.1097/01.PCC.0000217470.68764.36; Goodman SN, 2005, CLIN TRIALS, V2, P282, DOI 10.1191/1740774505cn098oa; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Greenland S, 2006, INT J EPIDEMIOL, V35, P765, DOI 10.1093/ije/dyi312; Group CS, 1963, JAMA-J AM MED ASSOC, V183, P462, DOI DOI 10.1001/JAMA.1963.63700060029012; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; Harrell FE, 2001, INT J TECHNOL ASSESS, V17, P17, DOI 10.1017/S0266462301104034; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Ho BCH, 2006, CRIT CARE, V10, DOI 10.1186/cc4918; KLASTERSKY J, 1971, NEW ENGL J MED, V284, P1248, DOI 10.1056/NEJM197106032842206; Lacherade JC, 2007, INTENS CARE MED, V33, P814, DOI 10.1007/s00134-007-0543-0; Lin SM, 2006, SHOCK, V26, P551, DOI 10.1097/01.shk.0000232271.09440.8f; Loisa P, 2007, CRIT CARE, V11, DOI 10.1186/cc5696; LUCAS CE, 1984, ARCH SURG-CHICAGO, V119, P537; LUCE JM, 1988, AM REV RESPIR DIS, V138, P62, DOI 10.1164/ajrccm/138.1.62; Mackenzie AF, 2005, INTENS CARE MED, V31, P1624, DOI 10.1007/s00134-005-2829-4; Marik PE, 2002, NEW ENGL J MED, V346, P1025; Mitchell I, 2006, INTENS CARE MED, V32, P867, DOI 10.1007/s00134-006-0135-4; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5; Natanson Charles, 2002, ACP J Club, V136, P90; PEDUZZI P, 1987, NEW ENGL J MED, V317, P659; Petersen JL, 2004, JAMA-J AM MED ASSOC, V292, P89, DOI 10.1001/jama.292.1.89; Ricard JD, 2003, AM J RESP CRIT CARE, V167, P1297, DOI 10.1164/rccm.2303003; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; RUBENFELD GD, 2001, AM J RESP CRIT CARE; Sarkar Samir, 2002, N Engl J Med, V346, P1025; Schultz MJ, 2006, PLOS MED, V3, P2177, DOI 10.1371/journal.pmed.0030456; Schultz MJ, 2005, J CRIT CARE, V20, P199, DOI 10.1016/j.jcrc.2005.05.007; SCHUMER W, 1976, ANN SURG, V184, P333, DOI 10.1097/00000658-197609000-00011; Siraux V, 2005, CRIT CARE MED, V33, P2479, DOI 10.1097/01.CCM.0000185641.87051.7C; Spiegelhalter D J, 2000, Health Technol Assess, V4, P1; Spiegelhalter DJ, 1999, BRIT MED J, V319, P508, DOI 10.1136/bmj.319.7208.508; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; SPRUNG CL, 1984, NEW ENGL J MED, V311, P1137, DOI 10.1056/NEJM198411013111801; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Stewart TE, 1998, NEW ENGL J MED, V338, P355, DOI 10.1056/NEJM199802053380603; THOMPSON WL, 1976, CLIN RES, V24, pA258; Tobin MJ, 2003, AM J RESP CRIT CARE, V168, P511, DOI 10.1164/rccm.2307001; Toschlog EA, 2007, J TRAUMA, V62, P1370, DOI 10.1097/TA.0b013e318047b7dc; TUCHSCHMIDT J, 1992, CHEST, V102, P216, DOI 10.1378/chest.102.1.216; Van den Berghe G, 2003, CRIT CARE MED, V31, P359, DOI 10.1097/01.CCM.0000045568.12881.10; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; Vriesendorp TM, 2006, CRIT CARE MED, V34, P96, DOI 10.1097/01.CCM.0000194536.89694.06; Warren HS, 2002, NEW ENGL J MED, V347, P1027, DOI 10.1056/NEJMsb020574; Wiedermann CJ, 2006, INTENS CARE MED, V32, P604, DOI 10.1007/s00134-006-0086-9; Wiedermann CJ, 2005, WIEN KLIN WOCHENSCHR, V117, P442, DOI 10.1007/s00508-005-0396-x; XIAOZHI W, 2007, CHIN CRIT CARE MED, V18, P661; Yildiz O, 2002, CRIT CARE, V6, P251, DOI 10.1186/cc1498; Yu MH, 1998, CRIT CARE MED, V26, P1011, DOI 10.1097/00003246-199806000-00018; YU MH, 1993, CRIT CARE MED, V21, P830, DOI 10.1097/00003246-199306000-00009; 2002, N ENGL J MED, V342, P1301	92	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2291	10.1371/journal.pone.0002291	http://dx.doi.org/10.1371/journal.pone.0002291			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509455	gold, Green Submitted, Green Published			2022-12-27	WOS:000262268500031
J	Castoe, TA; Jiang, ZJ; Gu, WJ; Wang, ZO; Pollock, DD				Castoe, Todd A.; Jiang, Zhi J.; Gu, Wanjun; Wang, Zhengyuan O.; Pollock, David D.			Adaptive Evolution and Functional Redesign of Core Metabolic Proteins in Snakes	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; MITOCHONDRIAL-DNA SEQUENCES; MOLECULAR EVOLUTION; PHYLOGENETIC ANALYSIS; SUBSTITUTION RATES; PROTON; AMPHISBAENIANS; ADAPTATION; RESIDUES; PROGRAM	Background: Adaptive evolutionary episodes in core metabolic proteins are uncommon, and are even more rarely linked to major macroevolutionary shifts. Methodology/Principal Findings: We conducted extensive molecular evolutionary analyses on snake mitochondrial proteins and discovered multiple lines of evidence suggesting that the proteins at the core of aerobic metabolism in snakes have undergone remarkably large episodic bursts of adaptive change. We show that snake mitochondrial proteins experienced unprecedented levels of positive selection, coevolution, convergence, and reversion at functionally critical residues. We examined Cytochrome C oxidase subunit I (COI) in detail, and show that it experienced extensive modification of normally conserved residues involved in proton transport and delivery of electrons and oxygen. Thus, adaptive changes likely altered the flow of protons and other aspects of function in CO, thereby influencing fundamental characteristics of aerobic metabolism. We refer to these processes as "evolutionary redesign" because of the magnitude of the episodic bursts and the degree to which they affected core functional residues. Conclusions/Significance: The evolutionary redesign of snake COI coincided with adaptive bursts in other mitochondrial proteins and substantial changes in mitochondrial genome structure. It also generally coincided with or preceded major shifts in ecological niche and the evolution of extensive physiological adaptations related to lung reduction, large prey consumption, and venom evolution. The parallel timing of these major evolutionary events suggests that evolutionary redesign of metabolic and mitochondrial function may be related to, or underlie, the extreme changes in physiological and metabolic efficiency, flexibility, and innovation observed in snake evolution.	[Castoe, Todd A.; Gu, Wanjun; Pollock, David D.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA; [Jiang, Zhi J.; Wang, Zhengyuan O.] Louisiana State Univ, Biol Comp & Visualizat Ctr, Dept Bioll Sci, Baton Rouge, LA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Louisiana State University System; Louisiana State University	Castoe, TA (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA.	David.Pollock@uchsc.edu	wang, zhengyuan/HGA-0435-2022; Gu, Wanjun/B-3998-2010; Wang, Zhengyuan/GWV-6069-2022; Pollock, David D/M-4740-2016; Gu, Wanjun/P-5389-2019	wang, zhengyuan/0000-0002-8447-9674; Pollock, David D/0000-0002-7627-4214; Gu, Wanjun/0000-0003-4501-0539	NIH [LM009451, GM065612, GM065580]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM065612, R24GM065580, R33GM065612] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM009451] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Support is gratefully acknowledged from an NIH training grant LM009451 (TAC) and NIH grants GM065612 and GM065580 (DDP). These funding sources had no role whatsoever in the design, conduct, collection, analysis, interpretation, or preparation of the manuscript.	Adkins RM, 1996, MOL BIOL EVOL, V13, P1393, DOI 10.1093/oxfordjournals.molbev.a025586; Andersen JB, 2005, NATURE, V434, P37, DOI 10.1038/434037a; Andrews TD, 1998, J MOL EVOL, V47, P249, DOI 10.1007/PL00006382; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Coates M, 2000, TRENDS ECOL EVOL, V15, P503, DOI 10.1016/S0169-5347(00)01999-6; Dalziel AC, 2006, J MOL EVOL, V62, P319, DOI 10.1007/s00239-005-0110-7; Dong S, 2005, J MOL EVOL, V61, P12, DOI 10.1007/s00239-004-0190-9; FETTER JR, 1995, P NATL ACAD SCI USA, V92, P1604, DOI 10.1073/pnas.92.5.1604; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328; Greene H. W., 1997, SNAKES EVOLUTION MYS; Grossman LI, 2001, MOL PHYLOGENET EVOL, V18, P26, DOI 10.1006/mpev.2000.0890; Holman, 2000, FOSSIL SNAKES N AM O; Jiang ZJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-123; Kumazawa Y, 2004, DNA RES, V11, P137, DOI 10.1093/dnares/11.2.137; Kumazawa Y, 1996, MOL BIOL EVOL, V13, P1242, DOI 10.1093/oxfordjournals.molbev.a025690; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lynch VJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-2; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; Mccue MD, 2007, ZOOLOGY, V110, P318, DOI 10.1016/j.zool.2007.02.004; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Qian J, 2004, BIOCHEMISTRY-US, V43, P5748, DOI 10.1021/bi036279o; Raina SZ, 2005, GENOME RES, V15, P665, DOI 10.1101/gr.3128605; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russell F. E., 1967, ANIMAL TOXINS COLLEC; SECOR SM, 1995, J EXP BIOL, V198, P1313; Secor SM, 1998, NATURE, V395, P659, DOI 10.1038/27131; Shimokata K, 2007, P NATL ACAD SCI USA, V104, P4200, DOI 10.1073/pnas.0611627104; Slack KE, 2003, GENE, V302, P43, DOI 10.1016/S0378111902010533; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; THOMAS JW, 1993, BIOCHEMISTRY-US, V32, P10923, DOI 10.1021/bi00091a048; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Wang ZYO, 2005, METHOD ENZYMOL, V395, P779, DOI 10.1016/S0076-6879(05)95040-4; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yoshikawa S, 2006, BBA-BIOENERGETICS, V1757, P1110, DOI 10.1016/j.bbabio.2006.06.004	47	93	93	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2201	10.1371/journal.pone.0002201	http://dx.doi.org/10.1371/journal.pone.0002201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493604	Green Submitted, Green Published, gold			2022-12-27	WOS:000262258700010
J	Hunter, JH; Pang, CKT; Gujjar, R; Rathod, PK				Hunter, Joshua H.; Pang, Cullen K. T.; Gujjar, Ramesh; Rathod, Pradipsinh K.			Kinetics and Ligand-Binding Preferences of Mycobacterium tuberculosis Thymidylate Synthases, ThyA and ThyX	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CATALYTIC MECHANISM; DIHYDROOROTATE DEHYDROGENASE; FUNCTIONAL-ANALYSIS; SELECTIVE ACTIVITY; MALARIA PARASITE; ACTIVE-SITE; DRUG DESIGN; INHIBITORS; FLAVIN	Background: Mycobacterium tuberculosis kills approximately 2 million people each year and presents an urgent need to identify new targets and new antitubercular drugs. Thymidylate synthase (TS) enzymes from other species offer good targets for drug development and the M. tuberculosis genome contains two putative TS enzymes, a conventional ThyA and a flavin-based ThyX. In M. tuberculosis, both TS enzymes have been implicated as essential for growth, either based on drug-resistance studies or genome-wide mutagenesis screens. To facilitate future small molecule inhibitors against these proteins, a detailed enzymatic characterization was necessary. Methodology/Principal Findings: After cloning, overexpression, and purification, the thymidylate-synthesizing ability of ThyA and ThyX gene products were directly confirmed by HPLC analysis of reaction products and substrate saturation kinetics were established. 5-Fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP) was a potent inhibitor of both ThyA and ThyX, offering important clues to double-targeting strategies. In contrast, the folate-based 1843U89 was a potent inhibitor of ThyA but not ThyX suggesting that it should be possible to find ThyX-specific antifolates. A turnover-dependent kinetic assay, combined with the active-site titration approach of Ackermann and Potter, revealed that both M. tuberculosis enzymes had very low k(cat) values. One possible explanation for the low catalytic activity of M. tuberculosis ThyX is that its true biological substrates remain to be identified. Alternatively, this slow-growing pathogen, with low demands for TMP, may have evolved to down-regulate TS activities by altering the turnover rate of individual enzyme molecules, perhaps to preserve total protein quantities for other purposes. In many organisms, TS is often used as a part of larger complexes of macromolecules that control replication and DNA repair. Conclusions/Significance: Thus, the present enzymatic characterization of ThyA and ThyX from M. tuberculosis provides a framework for future development of cell-active inhibitors and the biological roles of these TS enzymes in M. tuberculosis.	[Hunter, Joshua H.; Pang, Cullen K. T.; Gujjar, Ramesh; Rathod, Pradipsinh K.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Rathod, Pradipsinh K.] Univ Washington, Dept Glob Hlth, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hunter, JH (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	rathod@chem.washington.edu			NIH [AI26912, AI60360]; Ellison Medical Foundation [Senior Scholar Award in Global Infectious Diseases]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026912, P01AI060360, R29AI026912] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI26912 and AI60360 and a Senior Scholar Award in Global Infectious Diseases from the Ellison Medical Foundation (PKR).	ACKERMANN WW, 1949, P SOC EXP BIOL MED, V72, P1; Agrawal N, 2004, BIOCHEMISTRY-US, V43, P10295, DOI 10.1021/bi0490439; Baldwin J, 2005, J BIOL CHEM, V280, P21847, DOI 10.1074/jbc.M501100200; Baldwin J, 2002, J BIOL CHEM, V277, P41827, DOI 10.1074/jbc.M206854200; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2177, DOI 10.1016/0006-2952(75)90050-7; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2187, DOI 10.1016/0006-2952(75)90051-9; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CHU E, 1993, P NATL ACAD SCI USA, V90, P517, DOI 10.1073/pnas.90.2.517; CHU E, 1991, P NATL ACAD SCI USA, V88, P8977, DOI 10.1073/pnas.88.20.8977; CURTIN NJ, 1991, CANCER RES, V51, P2346; DAVISSON VJ, 1989, J BIOL CHEM, V264, P9145; DEV IK, 1994, J BIOL CHEM, V269, P1873; DOLNICK BJ, 1977, J BIOL CHEM, V252, P7697; du Toit LC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-118; Gattis SG, 2005, J AM CHEM SOC, V127, P832, DOI 10.1021/ja0432214; GOMEZ ZM, 1990, ANTIMICROB AGENTS CH, V34, P1371, DOI 10.1128/AAC.34.7.1371; Graziani S, 2004, J BIOL CHEM, V279, P54340, DOI 10.1074/jbc.M409121200; Graziani S, 2006, J BIOL CHEM, V281, P24048, DOI 10.1074/jbc.M600745200; Griffin J, 2005, J BIOL CHEM, V280, P5456, DOI 10.1074/jbc.M412415200; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; Harper C, 2007, NAT MED, V13, P309, DOI 10.1038/nm0307-309; HekmatNejad M, 1996, ANTIMICROB AGENTS CH, V40, P1628, DOI 10.1128/AAC.40.7.1628; INGRAHAM HA, 1986, BIOCHEMISTRY-US, V25, P3225, DOI 10.1021/bi00359a022; Jiang L, 2000, ANTIMICROB AGENTS CH, V44, P1047, DOI 10.1128/AAC.44.4.1047-1050.2000; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Kuhn P, 2002, PROTEINS, V49, P142, DOI 10.1002/prot.10202; Leduc D, 2004, P NATL ACAD SCI USA, V101, P7252, DOI 10.1073/pnas.0401365101; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113; PENDERGAST W, 1994, J MED CHEM, V37, P838, DOI 10.1021/jm00032a019; PHILLIPS MA, 2008, J MED CHEM IN PRESS; RATHOD PK, 1992, ANTIMICROB AGENTS CH, V36, P704, DOI 10.1128/AAC.36.4.704; RATHOD PK, 1989, ANTIMICROB AGENTS CH, V33, P1090, DOI 10.1128/AAC.33.7.1090; Rengarajan J, 2004, MOL MICROBIOL, V53, P275, DOI 10.1111/j.1365-2958.2004.04120.x; Sampathkumar P, 2005, J MOL BIOL, V352, P1091, DOI 10.1016/j.jmb.2005.07.071; Sampathkumar P, 2006, J MOL BIOL, V360, P1, DOI 10.1016/j.jmb.2006.04.061; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Stout TJ, 1999, BIOCHEMISTRY-US, V38, P1607, DOI 10.1021/bi9815896; Touroutoglou N, 1996, CLIN CANCER RES, V2, P227; Ulmer JE, 2008, J BACTERIOL, V190, P2056, DOI 10.1128/JB.01094-07; Van Triest B, 2000, ANN ONCOL, V11, P385, DOI 10.1023/A:1008351221345; WHITAKER JR, 1963, ANAL CHEM, V35, P1950, DOI 10.1021/ac60205a048; Zhang K, 2002, SCIENCE, V296, P545, DOI 10.1126/science.1068274	46	29	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2237	10.1371/journal.pone.0002237	http://dx.doi.org/10.1371/journal.pone.0002237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493582	gold, Green Published, Green Submitted			2022-12-27	WOS:000262258700045
J	Makovski, T; Vazquez, GA; Jiang, YV				Makovski, Tal; Vazquez, Gustavo A.; Jiang, Yuhong V.			Visual Learning in Multiple-Object Tracking	PLOS ONE			English	Article								Background: Tracking moving objects in space is important for the maintenance of spatiotemporal continuity in everyday visual tasks. In the laboratory, this ability is tested using the Multiple Object Tracking ( MOT) task, where participants track a subset of moving objects with attention over an extended period of time. The ability to track multiple objects with attention is severely limited. Recent research has shown that this ability may improve with extensive practice (e.g., from action videogame playing). However, whether tracking also improves in a short training session with repeated trajectories has rarely been investigated. In this study we examine the role of visual learning in multiple-object tracking and characterize how varieties of attention interact with visual learning. Methodology/Principal Findings: Participants first conducted attentive tracking on trials with repeated motion trajectories for a short session. In a transfer phase we used the same motion trajectories but changed the role of tracking targets and nontargets. We found that compared with novel trials, tracking was enhanced only when the target subset was the same as that used during training. Learning did not transfer when the previously trained targets and nontargets switched roles or mixed up. However, learning was not specific to the trained temporal order as it transferred to trials where the motion was played backwards. Conclusions/Significance: These findings suggest that a demanding task of tracking multiple objects can benefit from learning of repeated motion trajectories. Such learning potentially facilitates tracking in natural vision, although learning is largely confined to the trajectories of attended objects. Furthermore, we showed that learning in attentive tracking relies on relational coding of all target trajectories. Surprisingly, learning was not specific to the trained temporal context, probably because observers have learned motion paths of each trajectory independently of the exact temporal order.	[Makovski, Tal; Vazquez, Gustavo A.; Jiang, Yuhong V.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Vazquez, Gustavo A.] Univ Santiago, Dept Psychol, Santiago, Spain; [Jiang, Yuhong V.] Univ Minnesota, Ctr Cognitive Sci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Universidade de Santiago de Compostela; University of Minnesota System; University of Minnesota Twin Cities	Makovski, T (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.	tal.makovski@gmail.com		Makovski, Tal/0000-0002-6670-5834	NSF [0733764]; NIH [071788]	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by NSF 0733764 and NIH 071788. These grants provided financial support but the funders had no other roles.	ALVAREZ GA, 2007, J VISION; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Chun MM, 1999, PSYCHOL SCI, V10, P360, DOI 10.1111/1467-9280.00168; Fiser J, 2001, PSYCHOL SCI, V12, P499, DOI 10.1111/1467-9280.00392; Jiang YH, 2004, PERCEPT PSYCHOPHYS, V66, P454, DOI 10.3758/BF03194893; Jones J, 2007, PSYCHON B REV, V14, P295, DOI 10.3758/BF03194067; Keane BP, 2006, COGNITIVE PSYCHOL, V52, P346, DOI 10.1016/j.cogpsych.2005.12.001; KUNAR MA, WE USE CONTEXT UNPUB; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; OGAWA H, 2002, TECHNICAL REPORT ATT, V1, P1; Olson IR, 2001, J EXP PSYCHOL LEARN, V27, P1299, DOI 10.1037/0278-7393.27.5.1299; PYLYSHYN Z, 1989, COGNITION, V32, P65, DOI 10.1016/0010-0277(89)90014-0; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Shim WM, 2008, PSYCHON B REV, V15, P390, DOI 10.3758/PBR.15.2.390; TOMBU M, COGNITION IN PRESS; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y	17	26	28	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2228	10.1371/journal.pone.0002228	http://dx.doi.org/10.1371/journal.pone.0002228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493599	Green Submitted, gold, Green Published			2022-12-27	WOS:000262258700036
J	Ohnishi, Y; Tamura, Y; Yoshida, M; Tokunaga, K; Hohjoh, H				Ohnishi, Yusuke; Tamura, Yoshiko; Yoshida, Mariko; Tokunaga, Katsushi; Hohjoh, Hirohiko			Enhancement of Allele Discrimination by Introduction of Nucleotide Mismatches into siRNA in Allele-Specific Gene Silencing by RNAi	PLOS ONE			English	Article								Allele-specific gene silencing by RNA interference (RNAi) is therapeutically useful for specifically inhibiting the expression of disease-associated alleles without suppressing the expression of corresponding wild-type alleles. To realize such allele-specific RNAi (ASP-RNAi), the design and assessment of small interfering RNA (siRNA) duplexes conferring ASP-RNAi is vital; however, it is also difficult. In a previous study, we developed an assay system to assess ASP-RNAi with mutant and wildtype reporter alleles encoding the Photinus and Renilla luciferase genes. In line with experiments using the system, we realized that it is necessary and important to enhance allele discrimination between mutant and corresponding wild-type alleles. Here, we describe the improvement of ASP-RNAi against mutant alleles carrying single nucleotide variations by introducing base substitutions into siRNA sequences, where original variations are present in the central position. Artificially mismatched siRNAs or short-hairpin RNAs (shRNAs) against mutant alleles of the human Prion Protein (PRNP) gene, which appear to be associated with susceptibility to prion diseases, were examined using this assessment system. The data indicates that introduction of a one-base mismatch into the siRNAs and shRNAs was able to enhance discrimination between the mutant and wild-type alleles. Interestingly, the introduced mismatches that conferred marked improvement in ASP-RNAi, appeared to be largely present in the guide siRNA elements, corresponding to the 'seed region' of microRNAs. Due to the essential role of the 'seed region' of microRNAs in their association with target RNAs, it is conceivable that disruption of the base-pairing interactions in the corresponding seed region, as well as the central position (involved in cleavage of target RNAs), of guide siRNA elements could influence allele discrimination. In addition, we also suggest that nucleotide mismatches at the 3'-ends of sense-strand siRNA elements, which possibly increase the assembly of antisensestrand (guide) siRNAs into RNA-induced silencing complexes (RISCs), may enhance ASP-RNAi in the case of inert siRNA duplexes. Therefore, the data presented here suggest that structural modification of functional portions of an siRNA duplex by base substitution could greatly influence allele discrimination and gene silencing, thereby contributing to enhancement of ASP-RNAi.	[Ohnishi, Yusuke; Tamura, Yoshiko; Yoshida, Mariko; Hohjoh, Hirohiko] NCNP, Natl Inst Neurosci, Dept Mol Genet, Tokyo, Japan; [Ohnishi, Yusuke; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; University of Tokyo	Ohnishi, Y (corresponding author), NCNP, Natl Inst Neurosci, Dept Mol Genet, Tokyo, Japan.	hohjohh@ncnp.go.jp			Ministry of Health, Labor, Welfare in Japan; Japan Society for the Promotion of Science [Research Fellowships, Grant-in-Aid]	Ministry of Health, Labor, Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by research grants from the Ministry of Health, Labor, Welfare in Japan, and from Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists, and also by a Grant-in-Aid from the Japan Society for the Promotion of Science.	Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bonini NM, 2005, NEURON, V48, P715, DOI 10.1016/j.neuron.2005.11.008; Caplen NJ, 2004, GENE THER, V11, P1241, DOI 10.1038/sj.gt.3302324; Chen SG, 1997, NAT MED, V3, P1009, DOI 10.1038/nm0997-1009; Collinge J, 1997, HUM MOL GENET, V6, P1699, DOI 10.1093/hmg/6.10.1699; Denovan-Wright EM, 2006, GENE THER, V13, P525, DOI 10.1038/sj.gt.3302664; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hohjoh H, 2004, FEBS LETT, V557, P193, DOI 10.1016/S0014-5793(03)01492-3; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; Jackson GS, 2001, J CLIN PATHOL-MOL PA, V54, P393; Karagiannis TC, 2005, CANCER GENE THER, V12, P787, DOI 10.1038/sj.cgt.7700857; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Maxwell MM, 2004, P NATL ACAD SCI USA, V101, P3178, DOI 10.1073/pnas.0308726100; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miller VM, 2004, NUCLEIC ACIDS RES, V32, P661, DOI 10.1093/nar/gkh208; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Ohnishi Y, 2005, BIOCHEM BIOPH RES CO, V329, P516, DOI 10.1016/j.bbrc.2005.02.012; Ohnishi Yusuke, 2006, J RNAi Gene Silencing, V2, P154; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Rodriguez-Lebron E, 2006, GENE THER, V13, P576, DOI 10.1038/sj.gt.3302702; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Victor M, 2002, EMBO REP, V3, P50, DOI 10.1093/embo-reports/kvf006; Wood M, 2007, PLOS GENET, V3, P845, DOI 10.1371/journal.pgen.0030109; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Yamada M, 1999, NEUROLOGY, V53, P181, DOI 10.1212/WNL.53.1.181; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	35	44	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2248	10.1371/journal.pone.0002248	http://dx.doi.org/10.1371/journal.pone.0002248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493311	Green Published, Green Submitted, gold			2022-12-27	WOS:000262258700055
J	Yang, Y; Iwanaga, K; Raso, MG; Wislez, M; Hanna, AE; Wieder, ED; Molldrem, JJ; Wistuba, II; Powis, G; Demayo, FJ; Kim, CF; Kurie, JM				Yang, Yanan; Iwanaga, Kentaro; Raso, Maria Gabriela; Wislez, Marie; Hanna, Amy E.; Wieder, Eric D.; Molldrem, Jeffrey J.; Wistuba, Ignacio I.; Powis, Garth; Demayo, Francesco J.; Kim, Carla F.; Kurie, Jonathan M.			Phosphatidylinositol 3-Kinase Mediates Bronchioalveolar Stem Cell Expansion in Mouse Models of Oncogenic K-ras-Induced Lung Cancer	PLOS ONE			English	Article								Background: Non-small cell lung cancer (NSCLC) is the most common cause of cancer-related death in Western countries. Developing more effective NSCLC therapeutics will require the elucidation of the genetic and biochemical bases for this disease. Bronchioalveolar stem cells (BASCs) are a putative cancer stem cell population in mouse models of oncogenic K-ras-induced lung adenocarcinoma, an histologic subtype of NSCLC. The signals activated by oncogenic K-ras that mediate BASC expansion have not been fully defined. Methodology/Principal Findings: We used genetic and pharmacologic approaches to modulate the activity of phosphatidylinositol 3-kinase (PI3K), a key mediator of oncogenic K-ras, in two genetic mouse models of lung adenocarcinoma. Oncogenic K-ras-induced BASC accumulation and tumor growth were blocked by treatment with a small molecule PI3K inhibitor and enhanced by inactivation of phosphatase and tensin homologue deleted from chromosome 10, a negative regulator of PI3K. Conclusions/Significance: We conclude that PI3K is a critical regulator of BASC expansion, supporting treatment strategies to target PI3K in NSCLC patients.	[Yang, Yanan; Iwanaga, Kentaro; Hanna, Amy E.; Wistuba, Ignacio I.; Kurie, Jonathan M.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Raso, Maria Gabriela; Wistuba, Ignacio I.] Univ Texas M D Anderson Canc Ctr, Dept Pathol, Houston, TX USA; [Wislez, Marie] Univ Paris 06, UFR Pierre Marie Curie, Hop Tenon, Assistance Publ Hop Paris AP HP, Paris, France; [Wieder, Eric D.; Molldrem, Jeffrey J.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplant Res, Houston, TX USA; [Powis, Garth] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA; [Demayo, Francesco J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX USA; [Kim, Carla F.] Harvard Med Sch, Harvard Stem Cell Inst, Dept Genet, Childrens Hosp Stem Cell Program, Boston, MA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Harvard University; Harvard Medical School	Yang, Y (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA.	jkurie@mdanderson.org	Yang, Yanan/F-1592-2010; DeMayo, Francesco/C-6255-2019; raso, maria/AAS-2118-2020; Raso, Maria Gabriela/J-9898-2019	DeMayo, Francesco/0000-0002-9480-7336; raso, maria/0000-0003-2105-5556; wislez, marie/0000-0001-7518-7859	 [R01 CA117965];  [R01 CA105155];  [U01 CA105352]; NATIONAL CANCER INSTITUTE [R01CA117965, U01CA105352, R01CA105155, P50CA070907] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R01 CA117965, R01 CA105155, U01 CA105352	Angulo B, 2008, J PATHOL, V214, P347, DOI 10.1002/path.2267; Aviel-Ronen S, 2006, CLIN LUNG CANCER, V8, P30, DOI 10.3816/CLC.2006.n.030; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Forgacs E, 1998, ONCOGENE, V17, P1557, DOI 10.1038/sj.onc.1202070; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Gupta S, 2007, CELL, V129, P957, DOI 10.1016/j.cell.2007.03.051; Ihle NT, 2004, MOL CANCER THER, V3, P763; Iwanaga K, 2008, CANCER RES, V68, P1119, DOI 10.1158/0008-5472.CAN-07-3117; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Marsit CJ, 2005, HUM PATHOL, V36, P768, DOI 10.1016/j.humpath.2005.05.006; Mori M, 1996, CANCER, V77, P665, DOI 10.1002/(SICI)1097-0142(19960215)77:4<665::AID-CNCR12>3.0.CO;2-Z; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Soria JC, 2002, CLIN CANCER RES, V8, P1178; Wislez M, 2005, CANCER RES, V65, P3226, DOI 10.1158/0008-5472.CAN-04-4420; Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	24	63	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2220	10.1371/journal.pone.0002220	http://dx.doi.org/10.1371/journal.pone.0002220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493606	gold, Green Submitted, Green Published			2022-12-27	WOS:000262258700028
J	Huang, J; Ma, L; Yang, F; Fei, SZ; Li, LJ				Huang, Jing; Ma, Lu; Yang, Fei; Fei, Shui-zhang; Li, Lijia			45S rDNA Regions Are Chromosome Fragile Sites Expressed as Gaps In Vitro on Metaphase Chromosomes of Root-Tip Meristematic Cells in Lolium spp	PLOS ONE			English	Article							RIBOSOMAL DNA; HOMOZYGOUS DELETIONS; GENE AMPLIFICATION; COMMON; CHECKPOINT; BREAKAGE; CANCER; REARRANGEMENTS; SEQUENCE; CLONING	Background: In humans, chromosome fragile sites are regions that are especially prone to forming non-staining gaps, constrictions or breaks in one or both of the chromatids on metaphase chromosomes either spontaneously or following partial inhibition of DNA synthesis and have been well identified. So far, no plant chromosome fragile sites similar to those in human chromosomes have been reported. Methods and Results: During the course of cytological mapping of rDNA on ryegrass chromosomes, we found that the number of chromosomes plus chromosome fragments was often more than the expected 14 in most cells for Lolium perenne L. cv. Player by close cytological examination using a routine chromosome preparation procedure. Further fluorescent in situ hybridization (FISH) using 45S rDNA as a probe indicated that the root-tip cells having more than a 14-chromosome plus chromosome fragment count were a result of chromosome breakage or gap formation in vitro (referred to as chromosome lesions) at 45S rDNA sites, and 86% of the cells exhibited chromosome breaks or gaps and all occurred at the sites of 45S rDNA in Lolium perenne L. cv. Player, as well as in L. multiflorum Lam. cv. Top One. Chromatin depletion or decondensation occurred at various locations within the 45S rDNA regions, suggesting heterogeneity of lesions of 45S rDNA sites with respect to their position within the rDNA region. Conclusions: The chromosome lesions observed in this study are very similar cytologically to that of fragile sites observed in human chromosomes, and thus we conclude that the high frequency of chromosome lesions in vitro in Lolium species is the result of the expression of 45S rDNA fragile sites. Possible causes for the spontaneous expression of fragile sites and their potential biological significance are discussed.	[Huang, Jing; Ma, Lu; Yang, Fei; Li, Lijia] Wuhan Univ, Coll Life Sci, Key Lab, Minist Educ MOE Plant Dev Biol, Wuhan 430072, Peoples R China; [Fei, Shui-zhang] Iowa State Univ, Dept Horticult & Interdept Plant Physiol, Mol Biol, Ames, IA USA	Wuhan University; Iowa State University	Huang, J (corresponding author), Wuhan Univ, Coll Life Sci, Key Lab, Minist Educ MOE Plant Dev Biol, Wuhan 430072, Peoples R China.	ljli@whu.edu.cn		Huang, Jing/0000-0001-6411-8356; Ma, Lu/0000-0001-5271-0686	National Natural Science Foundation of China [30771204]; Program for New Century Excellent Talents in University [NCET-07-0634]; Natural Science Foundation of Hubei Province [2005ABA097]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This research was supported by grants from the National Natural Science Foundation of China (No. 30771204), Program for New Century Excellent Talents in University (NCET-07-0634) and the Natural Science Foundation of Hubei Province (No. 2005ABA097).	Arlt MF, 2004, MOL CELL BIOL, V24, P6701, DOI 10.1128/mcb.24.15.6701-6709.2004; Boldog F, 1997, HUM MOL GENET, V6, P193, DOI 10.1093/hmg/6.2.193; BOLDOG FL, 1994, GENE CHROMOSOME CANC, V11, P216, DOI 10.1002/gcc.2870110403; BUTLER DK, 1992, GENETICS, V131, P581; Buttel I, 2004, ANN NY ACAD SCI, V1028, P14, DOI 10.1196/annals.1322.002; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cimprich KA, 2003, CURR BIOL, V13, pR231, DOI 10.1016/S0960-9822(03)00158-1; Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; Culligan K, 2004, PLANT CELL, V16, P1091, DOI 10.1105/tpc.018903; Durand-Dubief M, 2007, EMBO J, V26, P2477, DOI 10.1038/sj.emboj.7601690; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Fan QC, 2000, NUCLEIC ACIDS RES, V28, P895, DOI 10.1093/nar/28.4.895; Gatei M, 2001, ONCOGENE, V20, P289, DOI 10.1038/sj.onc.1204111; Gericke GS, 1999, MED HYPOTHESES, V52, P201, DOI 10.1054/mehy.1997.0643; Glover TW, 2006, CANCER LETT, V232, P4, DOI 10.1016/j.canlet.2005.08.032; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Gu YH, 1996, NAT GENET, V13, P109, DOI 10.1038/ng0596-109; Handt O, 2000, CHROMOSOME RES, V8, P677, DOI 10.1023/A:1026737203447; Huang Y, 2002, NUCLEIC ACIDS RES, V30, P1465, DOI 10.1093/nar/30.7.1465; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; LAIRD C, 1987, TRENDS GENET, V3, P274, DOI 10.1016/0168-9525(87)90268-X; Lamming DW, 2006, SCIENCE, V312, DOI 10.1126/science.1124767; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Li LJ, 2001, THEOR APPL GENET, V102, P658, DOI 10.1007/s001220051694; MAGENIS RE, 1970, SCIENCE, V170, P85, DOI 10.1126/science.170.3953.85; McStay B, 2006, GENE DEV, V20, P1207, DOI 10.1101/gad.1436906; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; Morgan W. G., 2000, Cytologia (Tokyo), V65, P173, DOI 10.1508/cytologia.65.173; NELSON DL, 1995, SEMIN CELL BIOL, V6, P5, DOI 10.1016/1043-4682(95)90009-8; PERKINS DD, 1995, GENETICS, V141, P909; POMPONI MG, 1994, AM J MED GENET, V51, P447, DOI 10.1002/ajmg.1320510428; Popescu NC, 2003, CANCER LETT, V192, P1, DOI 10.1016/S0304-3835(02)00596-7; RAMANATHAN B, 1989, J BIOL CHEM, V264, P11026; RASSOOL FV, 1991, P NATL ACAD SCI USA, V88, P6657, DOI 10.1073/pnas.88.15.6657; Richards RI, 2001, TRENDS GENET, V17, P339, DOI 10.1016/S0168-9525(01)02303-4; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; ROBERTFORTEL I, 1993, CHROMOSOMA, V102, P146, DOI 10.1007/BF00387729; SCHUBERT I, 1985, CHROMOSOMA, V92, P143, DOI 10.1007/BF00328466; Schwartz M, 2006, CANCER LETT, V232, P13, DOI 10.1016/j.canlet.2005.07.039; Siroky J, 2003, CHROMOSOMA, V112, P116, DOI 10.1007/s00412-003-0251-7; SONG YC, 1995, THEOR APPL GENET, V90, P113, DOI 10.1007/BF00221003; Sutherland GR, 1998, TRENDS GENET, V14, P501, DOI 10.1016/S0168-9525(98)01628-X; SUTHERLAND GR, 1984, AM J HUM GENET, V36, P110; Thomas HM, 2001, CHROMOSOME RES, V9, P585, DOI 10.1023/A:1012499303514; Thomas HM, 1996, CHROMOSOME RES, V4, P486, DOI 10.1007/BF02261775; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Wang YH, 2006, CANCER LETT, V232, P70, DOI 10.1016/j.canlet.2005.07.040; Wang YH, 1996, J BIOL CHEM, V271, P22937, DOI 10.1074/jbc.271.38.22937; WINFIELD MO, 1995, GENOME, V38, P869, DOI 10.1139/g95-115; YAO MC, 1981, CELL, V24, P765, DOI 10.1016/0092-8674(81)90102-1; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yu S, 1997, CELL, V88, P367, DOI 10.1016/S0092-8674(00)81875-9	54	64	69	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2167	10.1371/journal.pone.0002167	http://dx.doi.org/10.1371/journal.pone.0002167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478113	Green Published, gold, Green Submitted			2022-12-27	WOS:000262172800032
J	Olesen, KM; Auger, AP				Olesen, Kristin M.; Auger, Anthony P.			Dopaminergic Activation of Estrogen Receptors Induces Fos Expression within Restricted Regions of the Neonatal Female Rat Brain	PLOS ONE			English	Article								Steroid receptor activation in the developing brain influences a variety of cellular processes that endure into adulthood, altering both behavior and physiology. Recent data suggests that dopamine can regulate expression of progestin receptors within restricted regions of the developing rat brain by activating estrogen receptors in a ligand-independent manner. It is unclear whether changes in neuronal activity induced by dopaminergic activation of estrogen receptors are also region specific. To investigate this question, we examined where the dopamine D1-like receptor agonist, SKF 38393, altered Fos expression via estrogen receptor activation. We report that dopamine D1-like receptor agonist treatment increased Fos protein expression within many regions of the developing female rat brain. More importantly, prior treatment with an estrogen receptor antagonist partially reduced D1-like receptor agonist-induced Fos expression only within the bed nucleus of the stria terminalis and the central amygdala. These data suggest that dopaminergic activation of estrogen receptors alters neuronal activity within restricted regions of the developing rat brain. This implies that ligand-independent activation of estrogen receptors by dopamine might organize a unique set of behaviors during brain development in contrast to the more wide spread ligand activation of estrogen receptors by estrogen.	[Olesen, Kristin M.; Auger, Anthony P.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Olesen, KM (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	apauger@wisc.edu			NIMH [R01MH072956, K01MH002035]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072956, K01MH002035] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by NIMH grants R01MH072956 and K01MH002035 to APA.	Altman J. B. S., 1995, ATLAS PRENATAL RAT B; Amateau SK, 2004, ENDOCRINOLOGY, V145, P2906, DOI 10.1210/en.2003-1363; Apostolakis EM, 2000, MOL ENDOCRINOL, V14, P1086, DOI 10.1210/me.14.7.1086; ARONICA SM, 1993, MOL ENDOCRINOL, V7, P743, DOI 10.1210/me.7.6.743; Arrieta I, 2000, BRAIN RES, V867, P100, DOI 10.1016/S0006-8993(00)02244-7; AUGER AP, 1995, J NEUROSCI, V15, P2272, DOI 10.1523/JNEUROSCI.15-03-02272.1995; Auger AP, 2000, P NATL ACAD SCI USA, V97, P7551, DOI 10.1073/pnas.97.13.7551; Auger AP, 2004, HORM BEHAV, V45, P168, DOI 10.1016/j.yhbeh.2003.09.013; Auger AP, 1997, ENDOCRINOLOGY, V138, P511, DOI 10.1210/en.138.1.511; Auger AP, 2002, ENDOCRINOLOGY, V143, P3009, DOI 10.1210/en.143.8.3009; BEACH FA, 1946, J EXP ZOOL, V101, P91, DOI 10.1002/jez.1401010107; Blaustein JD, 2004, ENDOCRINOLOGY, V145, P1075, DOI 10.1210/en.2003-1485; Blaustein JD, 2002, J NEUROENDOCRINOL, V14, P109, DOI 10.1046/j.0007-1331.2001.00743.x; BOYSON SJ, 1986, J NEUROSCI, V6, P3177; CATTANEO E, 1990, EUR J PHARM-MOLEC PH, V188, P153, DOI 10.1016/0922-4106(90)90050-8; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; Cushing BS, 2003, DEV BRAIN RES, V143, P129, DOI 10.1016/S0165-3806(03)00105-6; Eaton MJ, 1996, BRAIN RES, V738, P60, DOI 10.1016/0006-8993(96)00765-2; ElTanani MKK, 1997, MOL ENDOCRINOL, V11, P928, DOI 10.1210/me.11.7.928; FEDER HH, 1966, J ENDOCRINOL, V34, P131, DOI 10.1677/joe.0.0340131; Finn PD, 2005, HORM BEHAV, V47, P123, DOI 10.1016/j.yhbeh.2004.08.008; Giannakopoulou M, 2001, NEUROENDOCRINOLOGY, V73, P387, DOI 10.1159/000054657; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; HUANG Q, 1992, P NATL ACAD SCI USA, V89, P11988, DOI 10.1073/pnas.89.24.11988; IGNARTROWBRIDGE DM, 1992, P NATL ACAD SCI USA, V89, P4658, DOI 10.1073/pnas.89.10.4658; INSEL TR, 1990, ENDOCRINOLOGY, V126, P1849, DOI 10.1210/endo-126-4-1849; Klotz DM, 2002, J BIOL CHEM, V277, P8531, DOI 10.1074/jbc.M109592200; Lazarov NE, 1998, HISTOCHEM CELL BIOL, V109, P271, DOI 10.1007/s004180050227; Mani SK, 1997, HORM BEHAV, V31, P244, DOI 10.1006/hbeh.1997.1393; MANI SK, 1994, SCIENCE, V265, P1246, DOI 10.1126/science.7915049; McCarthy MM, 1997, DEV NEUROSCI-BASEL, V19, P488, DOI 10.1159/000111246; MCCARTHY MM, 1993, ENDOCRINOLOGY, V133, P433, DOI 10.1210/en.133.2.433; MEANEY MJ, 1981, PHYSIOL BEHAV, V26, P467, DOI 10.1016/0031-9384(81)90175-X; Meredith JM, 1997, J NEUROENDOCRINOL, V9, P385, DOI 10.1046/j.1365-2826.1997.00594.x; Mong JA, 1999, J NEUROBIOL, V40, P602, DOI 10.1002/(SICI)1097-4695(19990915)40:4<602::AID-NEU14>3.0.CO;2-O; Olesen KM, 2007, J NEUROENDOCRINOL, V19, P481, DOI 10.1111/j.1365-2826.2007.01554.x; Olesen KM, 2005, ENDOCRINOLOGY, V146, P3705, DOI 10.1210/en.2005-0498; Olesen KM, 2005, J NEUROENDOCRINOL, V17, P255, DOI 10.1111/j.1365-2826.2005.01302.x; OUIMET CC, 1991, BRAIN RES, V562, P85, DOI 10.1016/0006-8993(91)91190-C; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Perez-Martin M, 2003, EUR J NEUROSCI, V18, P923, DOI 10.1046/j.1460-9568.2003.02830.x; POWER RF, 1991, SCIENCE, V254, P1636, DOI 10.1126/science.1749936; Quysner A, 2001, BRAIN RES, V921, P173, DOI 10.1016/S0006-8993(01)03116-X; Riby JE, 2000, BIOCHEM PHARMACOL, V60, P167, DOI 10.1016/S0006-2952(00)00307-5; SCHALLING M, 1990, MOL BRAIN RES, V7, P139, DOI 10.1016/0169-328X(90)90091-Q; Shearman LP, 1997, DEV BRAIN RES, V102, P105, DOI 10.1016/S0165-3806(97)00091-6; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; SOKKA TA, 1995, BIOL REPROD, V52, P1404, DOI 10.1095/biolreprod52.6.1404; STUMPF WE, 1976, J STEROID BIOCHEM, V7, P1163, DOI 10.1016/0022-4731(76)90050-9; Tsai HW, 2004, ENDOCRINOLOGY, V145, P2730, DOI 10.1210/en.2003-1470; Vagell ME, 1996, BRAIN RES BULL, V41, P121, DOI 10.1016/S0361-9230(96)00158-X; Vagell ME, 1998, HORM BEHAV, V33, P163, DOI 10.1006/hbeh.1998.1445; Vagell ME, 1997, J NEUROENDOCRINOL, V9, P797, DOI 10.1046/j.1365-2826.1997.d01-1047.x; VANDEVELDE P, 1994, J STEROID BIOCHEM, V48, P187, DOI 10.1016/0960-0760(94)90144-9; Wagner CK, 2001, J NEUROBIOL, V47, P176, DOI 10.1002/neu.1025; WEINER DM, 1991, P NATL ACAD SCI USA, V88, P1859, DOI 10.1073/pnas.88.5.1859; WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306; WENIGER JP, 1993, REPROD NUTR DEV, V33, P129, DOI 10.1051/rnd:19930205; WHALEN RE, 1967, ANAT RECORD, V157, P173, DOI 10.1002/ar.1091570208	60	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2177	10.1371/journal.pone.0002177	http://dx.doi.org/10.1371/journal.pone.0002177			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478050	Green Published, Green Submitted, gold			2022-12-27	WOS:000262172800042
J	Rodriguez-Cattaneo, A; Pereira, AC; Aguilera, PA; Crampton, WGR; Caputi, AA				Rodriguez-Cattaneo, Alejo; Pereira, Ana Carolina; Aguilera, Pedro A.; Crampton, William G. R.; Caputi, Angel A.			Species-Specific Diversity of a Fixed Motor Pattern: The Electric Organ Discharge of Gymnotus	PLOS ONE			English	Article							WAVE-FORM GENERATION; ELECTROMOTOR SYSTEM; FREQUENCY-RESPONSE; FISH GYMNOTOIDEI; CARAPO; ELECTRORECEPTION; ELECTROLOCATION; DISCRIMINATION; GYMNOTIFORMES; INNERVATION	Understanding fixed motor pattern diversity across related species provides a window for exploring the evolution of their underlying neural mechanisms. The electric organ discharges of weakly electric fishes offer several advantages as paradigmatic models for investigating how a neural decision is transformed into a spatiotemporal pattern of action. Here, we compared the far fields, the near fields and the electromotive force patterns generated by three species of the pulse generating New World gymnotiform genus Gymnotus. We found a common pattern in electromotive force, with the far field and near field diversity determined by variations in amplitude, duration, and the degree of synchronization of the different components of the electric organ discharges. While the rostral regions of the three species generate similar profiles of electromotive force and local fields, most of the species-specific differences are generated in the main body and tail regions of the fish. This causes that the waveform of the field is highly site dependant in all the studied species. These findings support a hypothesis of the relative separation of the electrolocation and communication carriers. The presence of early head negative waves in the rostral region, a species-dependent early positive wave at the caudal region, and the different relationship between the late negative peak and the main positive peak suggest three points of lability in the evolution of the electrogenic system: a) the variously timed neuronal inputs to different groups of electrocytes; b) the appearance of both rostrally and caudally innervated electrocytes, and c) changes in the responsiveness of the electrocyte membrane.	[Rodriguez-Cattaneo, Alejo; Pereira, Ana Carolina; Aguilera, Pedro A.; Caputi, Angel A.] Inst Invest Biol Clemente Estable, Dept Integrat & Computat Neurosci, Montevideo, Uruguay; [Crampton, William G. R.] Univ Cent Florida, Dept Biol, Orlando, FL USA	Instituto de Investigaciones Biologicas Clemente Estable Uruguay; State University System of Florida; University of Central Florida	Rodriguez-Cattaneo, A (corresponding author), Inst Invest Biol Clemente Estable, Dept Integrat & Computat Neurosci, Montevideo, Uruguay.	angel@iibce.edu.uy	Crampton, William/AAP-3608-2020		National Science Foundation [0614334]	National Science Foundation(National Science Foundation (NSF))	This research was partially supported by National Science Foundation grant 0614334: The Evolution of Species and Signal Diversity in the Neotropical Electric Fish Gymnotus (PI W. Crampton).	Aguilera PA, 2003, J EXP BIOL, V206, P989, DOI 10.1242/jeb.00198; Aguilera PA, 2001, J EXP BIOL, V204, P185; Albert James S., 2003, Zootaxa, V287, P1; Albert JS, 2005, SPR HDB AUD, V21, P360; Arnegard ME, 2006, J EXP BIOL, V209, P2182, DOI 10.1242/jeb.02239; Arnegard ME, 2003, ENVIRON BIOL FISH, V67, P321, DOI 10.1023/A:1025882914527; Assad C, 1999, J EXP BIOL, V202, P1185; BASTIAN J, 1976, J COMP PHYSIOL, V112, P165, DOI 10.1007/BF00606536; BASTIAN J, 1977, J COMP PHYSIOL, V121, P53, DOI 10.1007/BF00614180; BENNETT MVL, 1959, J GEN PHYSIOL, V42, P1067, DOI 10.1085/jgp.42.5.1067; Bennett MVL., 1971, FISH PHYSIOL, P347, DOI DOI 10.1016/S1546-5098(08)60051-5; Bullock T.H., 1986, ELECTRORECEPTION; Bullock TH, 2005, ELECTRORECEPTION; CAPUTI A, 1995, J COMPUT NEUROSCI, V2, P131, DOI 10.1007/BF00961884; CAPUTI A, 1989, J COMP PHYSIOL A, V165, P361, DOI 10.1007/BF00619355; CAPUTI A, 1993, J COMP PHYSIOL A, V173, P227; Caputi A, 1996, J COMP PHYSIOL A, V179, P827; CAPUTI A, 1994, BRAIN BEHAV EVOLUT, V44, P166, DOI 10.1159/000113588; Caputi AA, 2006, J COMP PHYSIOL A, V192, P587, DOI 10.1007/s00359-006-0100-2; Caputi AA, 1999, J EXP BIOL, V202, P1229; Caputi AA, 2004, J PHYSIOL-PARIS, V98, P81, DOI 10.1016/j.jphysparis.2004.03.002; Caputi AA, 2002, J PHYSIOLOGY-PARIS, V96, P493, DOI 10.1016/S0928-4257(03)00005-6; Caputi AA, 2005, SPR HDB AUD, V21, P410; Castello ME, 2000, J EXP BIOL, V203, P3279; Crampton W.G.R., 2006, COMMUNICATION FISHES, P647; Crampton WGR, 2005, COPEIA, P48, DOI 10.1643/CI-04-056R1; Crampton WGR, 2006, COMMUNICATION FISHES, P696; Crampton William G.R., 2003, Zootaxa, V348, P1; Fessard A, 1974, HDB SENSORY PHYSL, VIII/3; Franchina CR, 1997, J COMP PHYSIOL A, V181, P111, DOI 10.1007/s003590050098; HOPKINS CD, 1974, BEHAVIOUR, V50, P270, DOI 10.1163/156853974X00499; HOPKINS CD, 1978, BEHAV ECOL SOCIOBIOL, V3, P113, DOI 10.1007/BF00294985; HOPKINS CD, 1981, AM ZOOL, V21, P211; Hopkins CD, 1995, CURR OPIN NEUROBIOL, V5, P769, DOI 10.1016/0959-4388(95)80105-7; KEYNES RD, 1961, BIOELECTROGENESIS, P102; Keynes RD, 1961, BIOELECTROGENESIS, P14; Kirschbaum F, 2002, J PHYSIOLOGY-PARIS, V96, P557, DOI 10.1016/S0928-4257(03)00011-1; KIRSCHBAUM F, 1975, EXPERIENTIA, V31, P1290, DOI 10.1007/BF01945786; KIRSCHBAUM F, 1977, NATURWISSENSCHAFTEN, V64, P387, DOI 10.1007/BF00368748; KIRSCHBAUM F, 1983, NATURWISSENSCHAFTEN, V70, P205, DOI 10.1007/BF01047569; Kramer B., 1981, SENSORY PHYSL AQUATI, P195, DOI DOI 10.1016/B978-0-08-027352-5.50018-5; LISSMANN HW, 1958, J EXP BIOL, V35, P156; LISSMANN HW, 1958, J EXP BIOL, V35, P451; Llinas R., 2002, I VORTEX NEURONS SEL; LORENZO D, 1988, J COMP PHYSIOL A, V162, P141, DOI 10.1007/BF01342711; LORENZO D, 1990, J COMP PHYSIOL A, V167, P447; LORENZO D, 1993, J COMP PHYSIOL A, V173, P221; MACADAR O, 1989, J COMP PHYSIOL A, V165, P353, DOI 10.1007/BF00619354; Macadar O., 1993, Journal of Comparative Physiology A Sensory Neural and Behavioral Physiology, V173, P728; MEYER JH, 1982, J COMP PHYSIOL, V145, P459; MOHRES FP, 1957, NATURWISSENSCHAFTEN, V44, P431; Moller P., 1995, ELECT FISHES HIST BE; Pereira AC, 2007, J EXP BIOL, V210, P800, DOI 10.1242/jeb.000638; Scheich H., 1974, P201; Silva A, 2003, ENVIRON BIOL FISH, V66, P329, DOI 10.1023/A:1023986600069; Sullivan J.P., 1997, THESIS DUKE U DURHAM; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; TRUJILLOCENOZ O, 1989, J COMP PHYSIOL A, V165, P343, DOI 10.1007/BF00619353; TRUJILLOCENOZ O, 1984, J NEUROBIOL, V15, P273, DOI 10.1002/neu.480150404; VONDEREMDE G, 1990, J COMP PHYSIOL A, V167, P413, DOI 10.1007/BF00192576	60	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2038	10.1371/journal.pone.0002038	http://dx.doi.org/10.1371/journal.pone.0002038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461122	Green Published, gold, Green Submitted			2022-12-27	WOS:000261642400002
J	Habjan, M; Andersson, I; Klingstrom, J; Schumann, M; Martin, A; Zimmermann, P; Wagner, V; Pichlmair, A; Schneider, U; Muhlberger, E; Mirazimi, A; Weber, F				Habjan, Matthias; Andersson, Ida; Klingstrom, Jonas; Schuemann, Michael; Martin, Arnold; Zimmermann, Petra; Wagner, Valentina; Pichlmair, Andreas; Schneider, Urs; Muehlberger, Elke; Mirazimi, Ali; Weber, Friedemann			Processing of Genome 5 ' Termini as a Strategy of Negative-Strand RNA Viruses to Avoid RIG-I-Dependent Interferon Induction	PLOS ONE			English	Article								Innate immunity is critically dependent on the rapid production of interferon in response to intruding viruses. The intracellular pathogen recognition receptors RIG-I and MDA5 are essential for interferon induction by viral RNAs containing 59 triphosphates or double-stranded structures, respectively. Viruses with a negative-stranded RNA genome are an important group of pathogens causing emerging and re-emerging diseases. We investigated the ability of genomic RNAs from substantial representatives of this virus group to induce interferon via RIG-I or MDA5. RNAs isolated from particles of Ebola virus, Nipah virus, Lassa virus, and Rift Valley fever virus strongly activated the interferon-beta promoter. Knockdown experiments demonstrated that interferon induction depended on RIG-I, but not MDA5, and phosphatase treatment revealed a requirement for the RNA 59 triphosphate group. In contrast, genomic RNAs of Hantaan virus, Crimean-Congo hemorrhagic fever virus and Borna disease virus did not trigger interferon induction. Sensitivity of these RNAs to a 59 monophosphate-specific exonuclease indicates that the RIG-I-activating 59 triphosphate group was removed posttranscriptionally by a viral function. Consequently, RIG-I is unable to bind the RNAs of Hantaan virus, Crimean-Congo hemorrhagic fever virus and Borna disease virus. These results establish RIG-I as a major intracellular recognition receptor for the genome of most negative-strand RNA viruses and define the cleavage of triphosphates at the RNA 59 end as a strategy of viruses to evade the innate immune response.	[Habjan, Matthias; Martin, Arnold; Zimmermann, Petra; Wagner, Valentina; Schneider, Urs; Weber, Friedemann] Univ Freiburg, Dept Virol, Freiburg, Germany; [Andersson, Ida; Klingstrom, Jonas; Mirazimi, Ali] Karolinska Inst, Dept Microbiol, Tumor & Cell Biol, Stockholm, Sweden; [Andersson, Ida; Klingstrom, Jonas; Mirazimi, Ali] Swedish Inst Infect Dis Control, Ctr Microbiol Preparedness, Solna, Sweden; [Schuemann, Michael; Muehlberger, Elke] Univ Marburg, Dept Virol, Marburg, Germany; [Pichlmair, Andreas] London Res Inst, Canc Res UK, Immunobiol Lab, London, England	University of Freiburg; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Philipps University Marburg; Cancer Research UK	Habjan, M (corresponding author), Univ Freiburg, Dept Virol, Freiburg, Germany.	friedemann.weber@uniklinik-freiburg.de	Weber, Friedemann/AAB-3425-2019; Muhlberger, Elke/AAD-6924-2019	Weber, Friedemann/0000-0001-9737-337X; Muhlberger, Elke/0000-0003-3547-9376; Habjan, Matthias/0000-0002-3623-4496; Klingstrom, Jonas/0000-0001-9076-1441; , Ali/0000-0003-2371-6055	Deutsche Forschungsgemeinschaft; Swedish Medicine Council [K2007-56X-20349-01-3]; Swedish Society for Medical Research;  [We 2616/5-1];  [SFB 535]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Medicine Council; Swedish Society for Medical Research; ; 	Work in the authors laboratories is supported by the grants We 2616/5-1 (FW) and SFB 535 (MS, EM) from the Deutsche Forschungsgemeinschaft, by the grant K2007-56X-20349-01-3 from the Swedish Medicine Council (AM), and by the Swedish Society for Medical Research (JK).	Alff PJ, 2006, J VIROL, V80, P9676, DOI 10.1128/JVI.00508-06; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; BANERJEE AK, 1980, MICROBIOL REV, V44, P175, DOI 10.1128/MMBR.44.2.175-205.1980; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Blakqori G, 2007, J VIROL, V81, P4991, DOI 10.1128/JVI.01933-06; BOWIE AG, 2007, RIG 1 TRIING DISCRIM; Brzozka K, 2005, J VIROL, V79, P7673, DOI 10.1128/JVI.79.12.7673-7681.2005; Cardenas WB, 2006, J VIROL, V80, P5168, DOI 10.1128/JVI.02199-05; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Elliott R.M., 1996, BUNYAVIRIDAE; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Feldmann H, 2003, NAT REV IMMUNOL, V3, P677, DOI 10.1038/nri1154; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; GARCIN D, 1995, J VIROL, V69, P5754, DOI 10.1128/JVI.69.9.5754-5762.1995; Geisbert TW, 2004, NAT MED, V10, pS110, DOI 10.1038/nm1142; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; HORNUNG V, 2006, SCIENCE, P314; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jaaskelainen KM, 2007, J MED VIROL, V79, P1527, DOI 10.1002/jmv.20948; JIN H, 1993, J GEN VIROL, V74, P2293, DOI 10.1099/0022-1317-74-10-2293; Kash JC, 2006, J VIROL, V80, P3009, DOI 10.1128/JVI.80.6.3009-3020.2006; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; Meyer BJ, 2000, TRENDS MICROBIOL, V8, P61, DOI 10.1016/S0966-842X(99)01658-3; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Prescott JB, 2007, J IMMUNOL, V179, P1796, DOI 10.4049/jimmunol.179.3.1796; Schlee M, 2007, CURR TOP MICROBIOL, V316, P207; Schneider U, 2005, P NATL ACAD SCI USA, V102, P3441, DOI 10.1073/pnas.0405965102; SCHNEIDER U, 2007, CELL MOL LIFE SCI; Shaw ML, 2005, J VIROL, V79, P6078, DOI 10.1128/JVI.79.10.6078-6088.2005; Spiropoulou CF, 2007, J VIROL, V81, P2769, DOI 10.1128/JVI.02402-06; STAUNTON D, 1989, J GEN VIROL, V70, P2811, DOI 10.1099/0022-1317-70-10-2811; Stoltz M, 2007, J VIROL, V81, P8685, DOI 10.1128/JVI.00415-07; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; tenOever BR, 2004, J VIROL, V78, P10636, DOI 10.1128/JVI.78.19.10636-10649.2004; tenOever BR, 2002, J VIROL, V76, P3659, DOI 10.1128/JVI.76.8.3659-3669.2002; Unterstab G, 2005, P NATL ACAD SCI USA, V102, P13640, DOI 10.1073/pnas.0502883102; Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200	49	238	247	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2032	10.1371/journal.pone.0002032	http://dx.doi.org/10.1371/journal.pone.0002032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446221	Green Published, gold, Green Submitted			2022-12-27	WOS:000261572300005
J	Humphries, MD; Gurney, K				Humphries, Mark D.; Gurney, Kevin			Network 'Small-World-Ness': A Quantitative Method for Determining Canonical Network Equivalence	PLOS ONE			English	Article							SCALE-FREE; STATISTICS; DYNAMICS; INTERNET; MOTIFS	Background: Many technological, biological, social, and information networks fall into the broad class of 'small-world' networks: they have tightly interconnected clusters of nodes, and a shortest mean path length that is similar to a matched random graph (same number of nodes and edges). This semi-quantitative definition leads to a categorical distinction ('small/not-small') rather than a quantitative, continuous grading of networks, and can lead to uncertainty about a network's small-world status. Moreover, systems described by small-world networks are often studied using an equivalent canonical network model-the Watts-Strogatz (WS) model. However, the process of establishing an equivalent WS model is imprecise and there is a pressing need to discover ways in which this equivalence may be quantified. Methodology/Principal Findings: We defined a precise measure of 'small-world-ness' S based on the trade off between high local clustering and short path length. A network is now deemed a 'small-world' if S. 1-an assertion which may be tested statistically. We then examined the behavior of S on a large data-set of real-world systems. We found that all these systems were linked by a linear relationship between their S values and the network size n. Moreover, we show a method for assigning a unique Watts-Strogatz (WS) model to any real-world network, and show analytically that the WS models associated with our sample of networks also show linearity between S and n. Linearity between S and n is not, however, inevitable, and neither is S maximal for an arbitrary network of given size. Linearity may, however, be explained by a common limiting growth process. Conclusions/Significance: We have shown how the notion of a small-world network may be quantified. Several key properties of the metric are described and the use of WS canonical models is placed on a more secure footing.	[Humphries, Mark D.; Gurney, Kevin] Univ Sheffield, Dept Psychol, Adapt Behav Res Grp, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Humphries, MD (corresponding author), Univ Sheffield, Dept Psychol, Adapt Behav Res Grp, Sheffield S10 2TN, S Yorkshire, England.	m.d.humphries@sheffield.ac.uk	Humphries, Mark/E-5765-2010	Humphries, Mark/0000-0002-1906-2581	EU Framework 6 [IST-027819-IP]; EPSRC [EP/C516303/1]; Engineering and Physical Sciences Research Council [EP/C516303/1] Funding Source: researchfish	EU Framework 6; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	MDH acknowledges support by the EU Framework 6 IST-027819-IP (ICEA) project. KG acknowledges the support of EPSRC grant EP/C516303/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Adamic LA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046135; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Barrat A, 2000, EUR PHYS J B, V13, P547, DOI 10.1007/s100510050067; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bollobas M, 2001, RANDOM GRAPHS; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Cancho RFI, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046119; Cohen R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.058701; Conyon MJ, 2006, J BUS FINAN ACCOUNT, V33, P1321, DOI 10.1111/j.1468-5957.2006.00634.x; De Castro R, 1999, MATH INTELL, V21, P51, DOI 10.1007/BF03025416; Delre S. A., 2007, Computational & Mathematical Organization Theory, V13, P185, DOI 10.1007/s10588-006-9007-2; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.035103; EFRON B, 1979, SIAM REV, V21, P460, DOI 10.1137/1021092; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Huxham M, 1996, OIKOS, V76, P284, DOI 10.2307/3546201; JANSSEN MA, 2001, FASHIONS HABITS CHAN; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Khanin R, 2006, J COMPUT BIOL, V13, P810, DOI 10.1089/cmb.2006.13.810; Klemm K, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.057102; Knuth DE., 1993, STANFORD GRAPH BASE; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Little LR, 2007, ECOL MODEL, V204, P379, DOI 10.1016/j.ecolmodel.2007.01.013; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Newman MEJ, 2000, PHYS REV LETT, V84, P3201, DOI 10.1103/PhysRevLett.84.3201; Nishikawa T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.014101; Ozgur A, 2004, LECT NOTES COMPUT SC, V3280, P688; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; ROXIN A, 2004, PHYS REV LETT, V92, P19801, DOI DOI 10.1103/PHYSREVLETT.92.198101; Saramaki J, 2005, J THEOR BIOL, V234, P413, DOI 10.1016/j.jtbi.2004.12.003; Sen P, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.036106; Sporns O, 2006, BIOSYSTEMS, V85, P55, DOI 10.1016/j.biosystems.2006.02.008; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Tian L, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.046103; Valverde S, 2002, EUROPHYS LETT, V60, P512, DOI 10.1209/epl/i2002-00248-2; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Watts D. J, 1999, SMALL WORLDS DYNAMIC; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhigulin VP, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.238701	60	829	843	8	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e0002051	10.1371/journal.pone.0002051	http://dx.doi.org/10.1371/journal.pone.0002051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446219	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000261572300020
J	Xu, J; Clancy, CE				Xu, Jun; Clancy, Colleen E.			Ionic Mechanisms of Endogenous Bursting in CA3 Hippocampal Pyramidal Neurons: A Model Study	PLOS ONE			English	Article								A critical property of some neurons is burst firing, which in the hippocampus plays a primary role in reliable transmission of electrical signals. However, bursting may also contribute to synchronization of electrical activity in networks of neurons, a hallmark of epilepsy. Understanding the ionic mechanisms of bursting in a single neuron, and how mutations associated with epilepsy modify these mechanisms, is an important building block for understanding the emergent network behaviors. We present a single-compartment model of a CA3 hippocampal pyramidal neuron based on recent experimental data. We then use the model to determine the roles of primary depolarizing currents in burst generation. The single compartment model incorporates accurate representations of sodium (Na+) channels (NaV1.1) and T-type calcium (Ca2+) channel subtypes (CaV3.1, CaV3.2, and CaV3.3). Our simulations predict the importance of Na+ and T-type Ca2+ channels in hippocampal pyramidal cell bursting and reveal the distinct contribution of each subtype to burst morphology. We also performed fastslow analysis in a reduced comparable model, which shows that our model burst is generated as a result of the interaction of two slow variables, the T-type Ca2+ channel activation gate and the Ca2+-dependent potassium (K+) channel activation gate. The model reproduces a range of experimentally observed phenomena including afterdepolarizing potentials, spike widening at the end of the burst, and rebound. Finally, we use the model to simulate the effects of two epilepsy-linked mutations: R1648H in NaV1.1 and C456S in CaV3.2, both of which result in increased cellular excitability.	[Xu, Jun; Clancy, Colleen E.] Cornell Univ, Weill Med Coll, Inst Computat Biomed, Dept Phys & Biophys, New York, NY 10021 USA	Cornell University	Xu, J (corresponding author), Cornell Univ, Weill Med Coll, Inst Computat Biomed, Dept Phys & Biophys, New York, NY 10021 USA.	clc7003@med.cornell.edu	Clancy, Colleen/B-2528-2010		National Institutes of Health NHLBI [RO1-HL-085592]; American Heart Association; National Epilepsy Foundation; Alfred P. Sloan Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085592] Funding Source: NIH RePORTER	National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); National Epilepsy Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The research was supported by grants from the National Institutes of Health NHLBI RO1-HL-085592, The American Heart Association, the National Epilepsy Foundation and the Alfred P. Sloan Foundation to CEC.	ALDRICH RW, 1979, J PHYSIOL-LONDON, V291, P531, DOI 10.1113/jphysiol.1979.sp012829; Avery RB, 1996, J NEUROSCI, V16, P5567; Borg-Graham LJ, 1999, CEREBRAL CORTEX, P19; Buckmaster PS, 2001, J COMP NEUROL, V430, P264, DOI 10.1002/1096-9861(20010205)430:2<264::AID-CNE1030>3.0.CO;2-3; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Clancy CE, 2004, BIOPHYS J, V86, P2606, DOI 10.1016/S0006-3495(04)74315-5; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; FISHER RE, 1990, J NEUROPHYSIOL, V64, P91, DOI 10.1152/jn.1990.64.1.91; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Golomb D, 2006, J NEUROPHYSIOL, V96, P1912, DOI 10.1152/jn.00205.2006; HABLITZ JJ, 1981, CELL MOL NEUROBIOL, V1, P325, DOI 10.1007/BF00716267; JAFFE DB, 1994, J NEUROPHYSIOL, V71, P1065, DOI 10.1152/jn.1994.71.3.1065; Jefferys JGR, 2003, EPILEPSIA, V44, P44, DOI 10.1111/j.0013-9580.2003.12004.x; JOHNSTON D, 1980, NATURE, V286, P391, DOI 10.1038/286391a0; Kahlig KM, 2006, J NEUROSCI, V26, P10958, DOI 10.1523/JNEUROSCI.3378-06.2006; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Ma MH, 1996, J NEUROSCI, V16, P4089; MASUKAWA LM, 1982, BRAIN RES, V242, P341, DOI 10.1016/0006-8993(82)90320-1; Metz AE, 2005, J NEUROSCI, V25, P5763, DOI 10.1523/JNEUROSCI.0624-05.2005; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; MIGLIORE M, 1995, J NEUROPHYSIOL, V73, P1157, DOI 10.1152/jn.1995.73.3.1157; MOGUL DJ, 1991, J PHYSIOL-LONDON, V433, P259, DOI 10.1113/jphysiol.1991.sp018425; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Rhodes TH, 2005, J PHYSIOL-LONDON, V569, P433, DOI 10.1113/jphysiol.2005.094326; RINZEL J, 1998, METHODS NEURONAL MOD, P251; Rush AM, 2005, J PHYSIOL-LONDON, V564, P803, DOI 10.1113/jphysiol.2005.083089; Sabatini BL, 1997, J NEUROSCI, V17, P3425; SAH P, 1988, J GEN PHYSIOL, V91, P373, DOI 10.1085/jgp.91.3.373; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Sipila ST, 2006, EUR J NEUROSCI, V23, P2330, DOI 10.1111/j.1460-9568.2006.04757.x; Spampanato J, 2004, J NEUROPHYSIOL, V91, P2040, DOI 10.1152/jn.00982.2003; Swensen AM, 2003, J NEUROSCI, V23, P9650; Talley EM, 1999, J NEUROSCI, V19, P1895; Traub R.D., 1991, NEURONAL NETWORKS HI; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; TRAUB RD, 1994, J PHYSIOL-LONDON, V481, P79, DOI 10.1113/jphysiol.1994.sp020420; Vitko I, 2005, J NEUROSCI, V25, P4844, DOI 10.1523/JNEUROSCI.0847-05.2005; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; WONG RKS, 1981, J NEUROPHYSIOL, V45, P86, DOI 10.1152/jn.1981.45.1.86	43	32	34	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2056	10.1371/journal.pone.0002056	http://dx.doi.org/10.1371/journal.pone.0002056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446231	gold, Green Published, Green Submitted			2022-12-27	WOS:000261572300025
J	Kattan, Z; Marchal, S; Brunner, E; Ramacci, C; Leroux, A; Merlin, JL; Domenjoud, L; Dauca, M; Becuwe, P				Kattan, Zilal; Marchal, Sophie; Brunner, Emilie; Ramacci, Carole; Leroux, Agnes; Merlin, Jean Louis; Domenjoud, Lionel; Dauca, Michel; Becuwe, Philippe			Damaged DNA Binding Protein 2 Plays a Role in Breast Cancer Cell Growth	PLOS ONE			English	Article								The Damaged DNA binding protein 2 (DDB2), is involved in nucleotide excision repair as well as in other biological processes in normal cells, including transcription and cell cycle regulation. Loss of DDB2 function may be related to tumor susceptibility. However, hypothesis of this study was that DDB2 could play a role in breast cancer cell growth, resulting in its well known interaction with the proliferative marker E2F1 in breast neoplasia. DDB2 gene was overexpressed in estrogen receptor (ER)-positive (MCF-7 and T47D), but not in ER-negative breast cancer (MDA-MB231 and SKBR3) or normal mammary epithelial cell lines. In addition, DDB2 expression was significantly (3.0-fold) higher in ER-positive than in ER-negative tumor samples (P=0.0208) from 16 patients with breast carcinoma. Knockdown of DDB2 by small interfering RNA in MCF-7 cells caused a decrease in cancer cell growth and colony formation. Inversely, introduction of the DDB2 gene into MDA-MB231 cells stimulated growth and colony formation. Cell cycle distribution and 5 Bromodeoxyuridine incorporation by flow cytometry analysis showed that the growth-inhibiting effect of DDB2 knockdown was the consequence of a delayed G1/S transition and a slowed progression through the S phase of MCF-7 cells. These results were supported by a strong decrease in the expression of S phase markers (Proliferating Cell Nuclear Antigen, cyclin E and dihydrofolate reductase). These findings demonstrate for the first time that DDB2 can play a role as oncogene and may become a promising candidate as a predictive marker in breast cancer.	[Kattan, Zilal; Brunner, Emilie; Domenjoud, Lionel; Dauca, Michel; Becuwe, Philippe] Nancy Univ, Univ Henri Poincare, Lab Biol Cellulaire Dev, EA 3446, Vandoeuvre Les Nancy, France; [Marchal, Sophie] Nancy Univ, Univ Henri Poincare, Inst Polytech Lorraine, Ctr Alexis Vautrin, UMR 7039, CNRS, Vandoeuvre Les Nancy, France; [Ramacci, Carole; Leroux, Agnes; Merlin, Jean Louis] Nancy Univ, Unite Biol Tumeurs Ctr Alexis Vautrin, EA3452, Vandoeuvre Les Nancy, France	Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Institut de cancerologie de Lorraine (ICL); Universite de Lorraine; Universite de Lorraine	Becuwe, P (corresponding author), Nancy Univ, Univ Henri Poincare, Lab Biol Cellulaire Dev, EA 3446, Vandoeuvre Les Nancy, France.	becuwe@scbiol.uhp-nancy.fr			Ligue contre le Cancer comite Meuse; Association pour la Recherche sur le Cancer; Henri Poincare's University	Ligue contre le Cancer comite Meuse; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Henri Poincare's University	Funding from Ligue contre le Cancer comite Meuse and Meurthe et Moselle, from Association pour la Recherche sur le Cancer, and from Henri Poincare's University.	Alekseev S, 2005, CANCER RES, V65, P10298, DOI 10.1158/0008-5472.CAN-05-2295; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Datta A, 2001, MUTAT RES-DNA REPAIR, V486, P89, DOI 10.1016/S0921-8777(01)00082-9; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; DUALAN R, 1995, GENOMICS, V29, P62, DOI 10.1006/geno.1995.1215; ELBOUHTOURY F, 1992, J PATHOL, V166, P27, DOI 10.1002/path.1711660106; Elstner E, 2002, BREAST CANCER RES TR, V74, P155, DOI 10.1023/A:1016114026769; Hartman AR, 2003, J MOL MED-JMM, V81, P700, DOI 10.1007/s00109-003-0477-0; Hartman AR, 2002, NAT GENET, V32, P180, DOI 10.1038/ng953; Hayes S, 1998, MOL CELL BIOL, V18, P240, DOI 10.1128/MCB.18.1.240; Hu ZB, 2006, CARCINOGENESIS, V27, P1475, DOI 10.1093/carcin/bgi350; Hwang BJ, 1998, MOL CELL BIOL, V18, P4391, DOI 10.1128/MCB.18.7.4391; Inoki T, 2004, BIOCHEM BIOPH RES CO, V314, P1036, DOI 10.1016/j.bbrc.2004.01.003; Itoh T, 2003, MOL CELL BIOL, V23, P7540, DOI 10.1128/MCB.23.21.7540-7553.2003; Itoh T, 2007, HUM MOL GENET, V16, P1578, DOI 10.1093/hmg/ddm107; JOHNSON DG, 1994, P NATL ACAD SCI USA, V91, P12823, DOI 10.1073/pnas.91.26.12823; KATTAN Z, 2007, BREAST CANC IN PRESS; KEENEY S, 1993, J BIOL CHEM, V268, P21293; Kulaksiz G, 2005, MOL CELL BIOL, V25, P9784, DOI 10.1128/MCB.25.22.9784-9792.2005; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Mirjolet JF, 2002, CYTOMETRY, V48, P6, DOI 10.1002/cyto.10087; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Nag A, 2001, MOL CELL BIOL, V21, P6738, DOI 10.1128/MCB.21.20.6738-6747.2001; Nichols AF, 2000, J BIOL CHEM, V275, P21422, DOI 10.1074/jbc.M000960200; Nichols AF, 1996, J BIOL CHEM, V271, P24317, DOI 10.1074/jbc.271.40.24317; Nichols AF, 2003, NUCLEIC ACIDS RES, V31, P562, DOI 10.1093/nar/gkg152; Nielsen NH, 1997, ONCOGENE, V14, P295, DOI 10.1038/sj.onc.1200833; OLNES MJ, 1994, BIOTECHNIQUES, V17, P828; PAYNE A, 1994, MUTAT RES-FUND MOL M, V310, P89, DOI 10.1016/0027-5107(94)90012-4; Prost S, 2007, ONCOGENE, V26, P3572, DOI 10.1038/sj.onc.1210151; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309; Stevens C, 2004, DNA REPAIR, V3, P1071, DOI 10.1016/j.dnarep.2004.03.034; Takimoto R, 2002, CANCER BIOL THER, V1, P177, DOI 10.4161/cbt.65; Tan T, 2002, MOL CELL BIOL, V22, P3247, DOI 10.1128/MCB.22.10.3247-3254.2002; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Yoon T, 2005, ONCOGENE, V24, P469, DOI 10.1038/sj.onc.1208211; Zhang SY, 2000, CANCER EPIDEM BIOMAR, V9, P395	40	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2002	10.1371/journal.pone.0002002	http://dx.doi.org/10.1371/journal.pone.0002002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431487	Green Published, gold, Green Submitted			2022-12-27	WOS:000261558700022
J	Guyader, S; Burch, CL				Guyader, Sebastien; Burch, Christina L.			Optimal Foraging Predicts the Ecology but Not the Evolution of Host Specialization in Bacteriophages	PLOS ONE			English	Article								We explore the ability of optimal foraging theory to explain the observation among marine bacteriophages that host range appears to be negatively correlated with host abundance in the local marine environment. We modified Charnov's classic diet composition model to describe the ecological dynamics of the related generalist and specialist bacteriophages phi X174 and G4, and confirmed that specialist phages are ecologically favored only at high host densities. Our modified model accurately predicted the ecological dynamics of phage populations in laboratory microcosms, but had only limited success predicting evolutionary dynamics. We monitored evolution of attachment rate, the phenotype that governs diet breadth, in phage populations adapting to both low and high host density microcosms. Although generalist phi X174 populations evolved even broader diets at low host density, they did not show a tendency to evolve the predicted specialist foraging strategy at high host density. Similarly, specialist G4 populations were unable to evolve the predicted generalist foraging strategy at low host density. These results demonstrate that optimal foraging models developed to explain the behaviorally determined diets of predators may have only limited success predicting the genetically determined diets of bacteriophage, and that optimal foraging probably plays a smaller role than genetic constraints in the evolution of host specialization in bacteriophages.	[Guyader, Sebastien; Burch, Christina L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Guyader, S (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	cburch@bio.unc.edu	Guyader, Sébastien/A-8980-2012	Guyader, Sébastien/0000-0001-5438-8790; Burch, Christina/0000-0001-7830-0124	NSF	NSF(National Science Foundation (NSF))	This work was supported by an NSF grant to CLB.	ABEDON ST, 1989, MICROB ECOL, V18, P79, DOI 10.1007/BF02030117; Abedon ST, 2001, APPL ENVIRON MICROB, V67, P4233, DOI 10.1128/AEM.67.9.4233-4241.2001; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Boivin G, 2004, OECOLOGIA, V138, P640, DOI 10.1007/s00442-003-1469-z; Bull JJ, 1997, GENETICS, V147, P1497; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; Charnov EL, 1973, THESIS U WASHINGTON; Chen F, 2002, APPL ENVIRON MICROB, V68, P2589, DOI 10.1128/AEM.68.5.2589-2594.2002; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; GAREN A, 1951, J EXP MED, V94, P177, DOI 10.1084/jem.94.3.177; GARNICK E, 1992, THEOR POPUL BIOL, V42, P62, DOI 10.1016/0040-5809(92)90005-E; Holder KK, 2001, GENETICS, V159, P1393; Jiang SC, 1998, APPL ENVIRON MICROB, V64, P535; Kemp PF, 2004, FEMS MICROBIOL ECOL, V47, P161, DOI 10.1016/S0168-6496(03)00257-5; KREBS JR, 1977, ANIM BEHAV, V25, P30, DOI 10.1016/0003-3472(77)90064-1; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; McDaniel L, 2002, NATURE, V415, P496, DOI 10.1038/415496a; McPeek MA, 1996, AM NAT, V148, pS124, DOI 10.1086/285906; Middelboe M, 2001, MICROBIAL ECOL, V42, P395, DOI 10.1007/s00248-001-0012-1; MOEBUS K, 1980, HELGOLANDER MEERESUN, V34, P1, DOI 10.1007/BF01983537; MOEBUS K, 1981, HELGOLANDER MEERESUN, V34, P375, DOI 10.1007/BF02074130; MOEBUS K, 1992, HELGOLANDER MEERESUN, V46, P275, DOI 10.1007/BF02367099; MOEBUS K, 1992, HELGOLANDER MEERESUN, V45, P411; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Ripp S, 1998, MICROBIOL-UK, V144, P2225, DOI 10.1099/00221287-144-8-2225; Stent G., 1963, MOL BIOL BACTERIAL V; STEWART FM, 1984, THEOR POPUL BIOL, V26, P93, DOI 10.1016/0040-5809(84)90026-1; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; SUTTLE CA, 1993, MAR ECOL PROG SER, V92, P99, DOI 10.3354/meps092099; TESSMAN I, 1968, VIROLOGY, V35, P330, DOI 10.1016/0042-6822(68)90275-4; VIA S, 1990, ANNU REV ENTOMOL, V35, P421, DOI 10.1146/annurev.en.35.010190.002225; Wang IN, 1996, EVOL ECOL, V10, P545, DOI 10.1007/BF01237884; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Wells LE, 2006, AQUAT MICROB ECOL, V45, P15, DOI 10.3354/ame045015; WERNER EE, 1981, ECOLOGY, V62, P116, DOI 10.2307/1936675; WERNER EE, 1974, ECOLOGY, V55, P1042, DOI 10.2307/1940354; Wichels A, 1998, APPL ENVIRON MICROB, V64, P4128; WIKNER J, 1993, FEMS MICROBIOL ECOL, V12, P237; Williamson SJ, 2002, APPL ENVIRON MICROB, V68, P4307, DOI 10.1128/AEM.68.9.4307-4314.2002; Wilson WH, 1996, J PHYCOL, V32, P506, DOI 10.1111/j.0022-3646.1996.00506.x; Wolf A, 2004, AQUAT MICROB ECOL, V35, P131, DOI 10.3354/ame035131; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; Yoshida T, 2006, APPL ENVIRON MICROB, V72, P1239, DOI 10.1128/AEM.72.2.1239-1247.2006	44	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1946	10.1371/journal.pone.0001946	http://dx.doi.org/10.1371/journal.pone.0001946			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414655	Green Published, Green Submitted, gold			2022-12-27	WOS:000260867300004
J	Zychlinska, M; Herrmann, H; Zimber-Strobl, U; Hammerschmidt, W				Zychlinska, Magdalena; Herrmann, Heidrun; Zimber-Strobl, Ursula; Hammerschmidt, Wolfgang			Restricted Expression of Epstein-Barr Virus Latent Genes in Murine B Cells Derived from Embryonic Stem Cells	PLOS ONE			English	Article								Background: Several human malignancies are associated with Epstein-Barr virus (EBV) and more than 95% of the adult human population carries this virus lifelong. EBV efficiently infects human B cells and persists in this cellular compartment latently. EBV-infected B cells become activated and growth transformed, express a characteristic set of viral latent genes, and acquire the status of proliferating lymphoblastoid cell lines in vitro. Because EBV infects only primate cells, it has not been possible to establish a model of infection in immunocompetent rodents. Such a model would be most desirable in order to study EBV's pathogenesis and latency in a suitable and amenable host. Methodology/Principal Findings: We stably introduced recombinant EBV genomes into mouse embryonic stem cells and induced their differentiation to B cells in vitro to develop the desired model. In vitro differentiated murine B cells maintained the EBV genomes but expression of viral genes was restricted to the latent membrane proteins (LMPs). In contrast to human B cells, EBV's nuclear antigens (EBNAs) were not expressed detectably and growth transformed murine B cells did not arise in vitro. Aberrant splicing and premature termination of EBNA mRNAs most likely prevented the expression of EBNA genes required for B-cell transformation. Conclusions/Significance: Our findings indicate that fundamental differences in gene regulation between mouse and man might block the route towards a tractable murine model for EBV.	[Zychlinska, Magdalena; Herrmann, Heidrun; Hammerschmidt, Wolfgang] German Res Ctr Environm & Hlth, Helmholtz Ctr Munich, Dept Gene Vectors, Munich, Germany; [Zimber-Strobl, Ursula] German Res Ctr Env & Hlth, Helmholtz Ctr Munich, Inst Clin Mol Biol & Tumor Genet, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Hammerschmidt, W (corresponding author), German Res Ctr Environm & Hlth, Helmholtz Ctr Munich, Dept Gene Vectors, Munich, Germany.	hammerschmidt@helmholtz-muenchen.de	Hammerschmidt, Wolfgang/ABG-3921-2021; Zimber-Strobl, Ursula/M-4618-2014	Hammerschmidt, Wolfgang/0000-0002-4659-0427; Zimber-Strobl, Ursula/0000-0002-9765-5251	Deutsche Forschungsgemeinschaft [SPP 1230, SFB 455, SFB-Transregio 36]; Krebshilfe [107277]; National Institutes of Health [CA70723-11]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Krebshilfe(Deutsche Krebshilfe); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by institutional intramural grants, grants by the Deutsche Forschungsgemeinschaft (grants SPP 1230, SFB 455, SFB-Transregio 36), Krebshilfe grant 107277, and the National Institutes of Health grant CA70723-11.	Altmann M, 2006, P NATL ACAD SCI USA, V103, P14188, DOI 10.1073/pnas.0605985103; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bornkamm GW, 2001, PHILOS T R SOC B, V356, P437, DOI 10.1098/rstb.2000.0781; Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; GREGORY CD, 1987, EUR J IMMUNOL, V17, P1199, DOI 10.1002/eji.1830170818; Haan KM, 2001, J VIROL, V75, P3016, DOI 10.1128/JVI.75.6.3016-3020.2001; Hammerschmidt Wolfgang, 2006, V47, P687; HANSSON M, 1983, J EXP MED, V158, P616, DOI 10.1084/jem.158.2.616; Humme S, 2003, P NATL ACAD SCI USA, V100, P10989, DOI 10.1073/pnas.1832776100; KATAMINE S, 1984, NATURE, V309, P369, DOI 10.1038/309369a0; KEMPKES B, 1995, P NATL ACAD SCI USA, V92, P5875, DOI 10.1073/pnas.92.13.5875; KEMPKES B, 1995, J VIROL, V69, P231, DOI 10.1128/JVI.69.1.231-238.1995; Kieff E, 2007, FIELDS VIROLOGY, P2603; KRYSAN PJ, 1993, GENE, V136, P137, DOI 10.1016/0378-1119(93)90457-E; Lemischka IR, 2006, CELL CYCLE, V5, P347, DOI 10.4161/cc.5.4.2424; Li QX, 1997, J VIROL, V71, P4657, DOI 10.1128/JVI.71.6.4657-4662.1997; Maeda A, 2001, J HUMAN VIROL, V4, P227; Mancao C, 2007, BLOOD, V110, P3715, DOI 10.1182/blood-2007-05-090142; Mansilla A, 2005, EMBO REP, V6, P1182, DOI 10.1038/sj.embor.7400539; Marchbank KJ, 2000, J IMMUNOL, V165, P2354, DOI 10.4049/jimmunol.165.5.2354; MILLER G, 1972, P NATL ACAD SCI USA, V69, P383, DOI 10.1073/pnas.69.2.383; Minarovits J, 2006, CURR TOP MICROBIOL, V310, P61; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; NEMEROW GR, 1989, CELL, V56, P369, DOI 10.1016/0092-8674(89)90240-7; Olivadoti M, 2007, COMPARATIVE MED, V57, P44; Pulvertaft JV, 1964, LANCET, V1, P238; Ren CP, 2006, STEM CELLS, V24, P1338, DOI 10.1634/stemcells.2005-0338; RICKINSON AB, 2007, FIELDS VIROLOGY, P2655; Schneider F, 2008, PLOS BIOL, V6, P86, DOI 10.1371/journal.pbio.0060008; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Son GH, 2003, J BIOL CHEM, V278, P18037, DOI 10.1074/jbc.M209850200; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Thomae AW, 2008, P NATL ACAD SCI USA, V105, P1692, DOI 10.1073/pnas.0707260105; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; 1997, EPSTEIN BARR VIRUS K, V8	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1996	10.1371/journal.pone.0001996	http://dx.doi.org/10.1371/journal.pone.0001996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414672	Green Published, Green Submitted, gold			2022-12-27	WOS:000260867300021
J	Peters, EJ; Slager, SL; Kraft, JB; Jenkins, GD; Reinalda, MS; McGrath, PJ; Hamilton, SP				Peters, Eric J.; Slager, Susan L.; Kraft, Jeffrey B.; Jenkins, Greg D.; Reinalda, Megan S.; McGrath, Patrick J.; Hamilton, Steven P.			Pharmacokinetic Genes Do Not Influence Response or Tolerance to Citalopram in the STAR*D Sample	PLOS ONE			English	Article								Background: We sought to determine whether clinical response or tolerance to the Selective Serotonin Reuptake Inhibitor (SSRI) citalopram is associated with genetic polymorphisms in potentially relevant pharmacokinetic enzymes. Methodology: We used a two-stage case-control study design in which we split the sample of 1,953 subjects from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial into a discovery (n = 831) and validation set (n = 1,046). Fifteen polymorphisms from five (CYP2D6, ABCB1, CYP2C19, CYP3A4, and CYP3A5) pharmacokinetic genes were genotyped. We examined the associations between these polymorphisms and citalopram response and tolerance. Significant associations were validated in the second stage for those polymorphism found to be statistically significant in the first stage. Conclusions: No genetic polymorphism in the pharmacokinetic genes examined was significantly associated with our response or tolerance phenotypes in both stages. For managing pharmacological treatment with citalopram, routine screening of the common pharmacokinetic DNA variants that we examined appears to be of limited clinical utility.	[Peters, Eric J.; Kraft, Jeffrey B.; Hamilton, Steven P.] Univ Calif San Francisco, Inst Human Genet, Dept Psychiat, San Francisco, CA USA; [Slager, Susan L.; Jenkins, Greg D.; Reinalda, Megan S.] Mayo Clinic, Dept Hlth Sci Res, Rochester, MN USA; [McGrath, Patrick J.] Columbia Univ Coll Physicians & Surgeons, New York State Psychiat Inst, Dept Psychiat, New York, NY USA	University of California System; University of California San Francisco; Mayo Clinic; Columbia University; New York State Psychiatry Institute	Peters, EJ (corresponding author), Univ Calif San Francisco, Inst Human Genet, Dept Psychiat, San Francisco, CA USA.	SteveH@lppi.ucsf.edu	McGrath, Patrick/I-6410-2013	McGrath, Patrick/0000-0001-7217-7321; Hamilton, Steven/0000-0001-8106-6260	National Institute of Mental Health [MH072802, N01MH90003]; HHMI Pre-Doctoral Fellowship; State of New York; National Cancer Institute [CA94919]; NATIONAL CANCER INSTITUTE [K07CA094919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [N01MH090003, R01MH072802] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); HHMI Pre-Doctoral Fellowship(Howard Hughes Medical Institute); State of New York; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (SPH, MH072802), HHMI Pre-Doctoral Fellowship (EJP), and by the State of New York (PJM), and the National Cancer Institute (SLS, CA94919). STAR*D was funded by NIMH contract N01MH90003 to the University of Texas Southwestern Medical Center at Dallas (A. John Rush, PI). The funding agencies played no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Berg AO, 2007, GENET MED, V9, P819, DOI 10.1097/GIM.0b013e31815bf9a3; Bondolfi G, 1996, PSYCHOPHARMACOLOGY, V128, P421, DOI 10.1007/s002130050152; Bradford LD, 2002, PHARMACOGENOMICS, V3, P229, DOI 10.1517/14622416.3.2.229; Brosen K, 2004, THERAPIE, V59, P5, DOI 10.2515/therapie:2004003; Brosen K, 2001, EUR NEUROPSYCHOPHARM, V11, P275, DOI 10.1016/S0924-977X(01)00101-8; Cascorbi I, 2001, CLIN PHARMACOL THER, V69, P169, DOI 10.1067/mcp.2001.114164; De Leon J, 2006, PSYCHOSOMATICS, V47, P75, DOI 10.1176/appi.psy.47.1.75; Eichelbaum M, 2006, ANNU REV MED, V57, P119, DOI 10.1146/annurev.med.56.082103.104724; Goldstein DB, 2003, NEW ENGL J MED, V348, P553, DOI 10.1056/NEJMe020173; Grasmader K, 2004, EUR J CLIN PHARMACOL, V60, P329, DOI 10.1007/s00228-004-0766-8; Gutierrez MM, 2003, CLIN THER, V25, P1200, DOI 10.1016/S0149-2918(03)80076-0; Herrlin K, 2003, BRIT J CLIN PHARMACO, V56, P415, DOI 10.1046/j.1365-2125.2003.01874.x; Hersberger M, 2000, CLIN CHEM, V46, P1072; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Illmer T, 2002, CANCER RES, V62, P4955; Kirchheiner J, 2004, MOL PSYCHIATR, V9, P442, DOI 10.1038/sj.mp.4001494; Kraft JB, 2007, BIOL PSYCHIAT, V61, P734, DOI 10.1016/j.biopsych.2006.07.017; Lunshof JE, 2006, PHARMACOGENOMICS, V7, P237, DOI 10.2217/14622416.7.2.237; McMahon FJ, 2006, AM J HUM GENET, V78, P804, DOI 10.1086/503820; Mrazek DA, 2006, CNS SPECTRUMS, V11, P1; MRAZEK DA, 2004, CURR PSYCHAIAT, V3, P11; Murphy GM, 2003, AM J PSYCHIAT, V160, P1830, DOI 10.1176/appi.ajp.160.10.1830; QUITKIN FM, 1987, ARCH GEN PSYCHIAT, V44, P259; Rasmussen BB, 2000, THER DRUG MONIT, V22, P143, DOI 10.1097/00007691-200004000-00001; Rau T, 2004, CLIN PHARMACOL THER, V75, P386, DOI 10.1016/j.clpt.2003.12.015; Reis M, 2003, THER DRUG MONIT, V25, P183, DOI 10.1097/00007691-200304000-00007; Rodriguez-Antona C, 2005, BIOCHEM BIOPH RES CO, V338, P299, DOI 10.1016/j.bbrc.2005.09.020; Ross DC, 2002, J CLIN PSYCHOPHARM, V22, P414, DOI 10.1097/00004714-200208000-00013; Rudberg I, 2006, THER DRUG MONIT, V28, P102, DOI 10.1097/01.ftd.0000189899.23931.76; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Satagopan JM, 2004, BIOMETRICS, V60, P589, DOI 10.1111/j.0006-341X.2004.00207.x; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Suzuki Y, 2006, NEUROPSYCHOPHARMACOL, V31, P825, DOI 10.1038/sj.npp.1300919; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Tate SK, 2005, P NATL ACAD SCI USA, V102, P5507, DOI 10.1073/pnas.0407346102; Tomalik-Scharte D, 2008, PHARMACOGENOMICS J, V8, P4, DOI 10.1038/sj.tpj.6500462; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Uhr M, 2003, J PSYCHIAT RES, V37, P179, DOI 10.1016/S0022-3956(03)00022-0; Uhr M, 2008, NEURON, V57, P203, DOI 10.1016/j.neuron.2007.11.017; Yin OQP, 2006, J CLIN PSYCHOPHARM, V26, P367, DOI 10.1097/01.jcp.0000227355.54074.14; Yu BN, 2003, DRUG METAB DISPOS, V31, P1255, DOI 10.1124/dmd.31.10.1255	42	131	137	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1872	10.1371/journal.pone.0001872	http://dx.doi.org/10.1371/journal.pone.0001872			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382661	Green Submitted, Green Published, gold			2022-12-27	WOS:000260795400012
J	Zhu, H; Sommer, I; Lengauer, T; Domingues, FS				Zhu, Hongbo; Sommer, Ingolf; Lengauer, Thomas; Domingues, Francisco S.			Alignment of Non-Covalent Interactions at Protein-Protein Interfaces	PLOS ONE			English	Article								Background: The study and comparison of protein-protein interfaces is essential for the understanding of the mechanisms of interaction between proteins. While there are many methods for comparing protein structures and protein binding sites, so far no methods have been reported for comparing the geometry of non-covalent interactions occurring at protein-protein interfaces. Methodology/Principal Findings: Here we present a method for aligning non-covalent interactions between different protein-protein interfaces. The method aligns the vector representations of van der Waals interactions and hydrogen bonds based on their geometry. The method has been applied to a dataset which comprises a variety of protein-protein interfaces. The alignments are consistent to a large extent with the results obtained using two other complementary approaches. In addition, we apply the method to three examples of protein mimicry. The method successfully aligns respective interfaces and allows for recognizing conserved interface regions. Conclusions/Significance: The Galinter method has been validated in the comparison of interfaces in which homologous subunits are involved, including cases of mimicry. The method is also applicable to comparing interfaces involving non-peptidic compounds. Galinter assists users in identifying local interface regions with similar patterns of non-covalent interactions. This is particularly relevant to the investigation of the molecular basis of interaction mimicry.	[Zhu, Hongbo; Sommer, Ingolf; Lengauer, Thomas; Domingues, Francisco S.] Max Planck Inst Informat, Saarbrucken, Germany	Max Planck Society	Zhu, H (corresponding author), Max Planck Inst Informat, Saarbrucken, Germany.	hzhu@mpi-inf.mpg.de	sommer, iris/D-1190-2014	sommer, iris/0000-0002-2682-5313; Domingues, Francisco/0000-0003-4567-4562	International Max Planck Research School for Computer Science (IMPRS-CS); EU Network of Excellence BioSapiens [LSHG-CT-2003-503265]	International Max Planck Research School for Computer Science (IMPRS-CS); EU Network of Excellence BioSapiens	HZ is supported by the International Max Planck Research School for Computer Science (IMPRS-CS). FD is supported by the EU Network of Excellence BioSapiens (EU grant No. LSHG-CT-2003-503265).	Aloy P, 2003, J MOL BIOL, V332, P989, DOI 10.1016/j.jmb.2003.07.006; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biswal BK, 2005, J BIOL CHEM, V280, P18202, DOI 10.1074/jbc.M413410200; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Branden C., 1999, INTRO PROTEIN STRUCT; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng Z, 2004, J MED CHEM, V47, P337, DOI 10.1021/jm030331x; DOMINGUES FS, 2007, BIOINFORMATICS GENOM, V3, P1211; GRINDLEY HM, 1993, J MOL BIOL, V229, P707, DOI 10.1006/jmbi.1993.1074; Henschel A, 2006, BIOINFORMATICS, V22, P550, DOI 10.1093/bioinformatics/bti782; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Keskin O, 2005, PROTEIN ENG DES SEL, V18, P11, DOI 10.1093/protein/gzh095; Keskin O, 2004, PROTEIN SCI, V13, P1043, DOI 10.1110/ps.03484604; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Kim WK, 2006, PLOS COMPUT BIOL, V2, P1151, DOI 10.1371/journal.pcbi.0020124; Koch I, 1996, J COMPUT BIOL, V3, P289, DOI 10.1089/cmb.1996.3.289; Levi G., 1973, CALCOLO, V9, P341, DOI 10.1007/BF02575586; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Mintz S, 2005, PROTEINS, V61, P6, DOI 10.1002/prot.20580; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Najmanovich RJ, 2007, BIOINFORMATICS, V23, pE104, DOI 10.1093/bioinformatics/btl292; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Rodier F, 2005, PROTEINS, V60, P36, DOI 10.1002/prot.20478; Schmitt S, 2002, J MOL BIOL, V323, P387, DOI 10.1016/S0022-2836(02)00811-2; Sheinerman FB, 2000, CURR OPIN STRUC BIOL, V10, P153, DOI 10.1016/S0959-440X(00)00065-8; Shulman-Peleg A, 2005, LECT NOTES COMPUT SC, V3695, P91; Shulman-Peleg A, 2004, LECT NOTES COMPUT SC, V3240, P194; Shulman-Peleg A, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-43; Swint-Kruse L, 2005, BIOINFORMATICS, V21, P3327, DOI 10.1093/bioinformatics/bti511; Swint-Kruse L, 2004, BIOCHEMISTRY-US, V43, P10886, DOI 10.1021/bi049450k; Thanos CD, 2003, J AM CHEM SOC, V125, P15280, DOI 10.1021/ja0382617; Thanos CD, 2006, P NATL ACAD SCI USA, V103, P15422, DOI 10.1073/pnas.0607058103; Tsai CJ, 1996, J MOL BIOL, V260, P604, DOI 10.1006/jmbi.1996.0424; Wallace AC, 1996, PROTEIN SCI, V5, P1001; Winter C, 2006, NUCLEIC ACIDS RES, V34, pD310, DOI 10.1093/nar/gkj099; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	46	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1926	10.1371/journal.pone.0001926	http://dx.doi.org/10.1371/journal.pone.0001926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382693	Green Submitted, Green Published, gold			2022-12-27	WOS:000260795400046
J	Harris, IM; Dux, PE; Benito, CT; Leek, EC				Harris, Irina M.; Dux, Paul E.; Benito, Claire T.; Leek, E. Charles			Orientation Sensitivity at Different Stages of Object Processing: Evidence from Repetition Priming and Naming	PLOS ONE			English	Article							ROTATED OBJECTS; 3-DIMENSIONAL OBJECTS; NATURAL OBJECTS; RECOGNITION; REPRESENTATIONS; INVARIANCE; FAMILIAR; VISION; TRANSFORMATIONS; INDIVIDUATION	Background: An ongoing debate in the object recognition literature centers on whether the shape representations used in recognition are coded in an orientation-dependent or orientation-invariant manner. In this study, we asked whether the nature of the object representation (orientation-dependent vs orientation-invariant) depends on the information-processing stages tapped by the task. Methodology/Findings: We employed a repetition priming paradigm in which briefly presented masked objects (primes) were followed by an upright target object which had to be named as rapidly as possible. The primes were presented for variable durations (ranging from 16 to 350 ms) and in various image-plane orientations (from 0 degrees to 180 degrees, in 30 degrees steps). Significant priming was obtained for prime durations above 70 ms, but not for prime durations of 16 ms and 47 ms, and did not vary as a function of prime orientation. In contrast, naming the same objects that served as primes resulted in orientation-dependent reaction time costs. Conclusions/Significance: These results suggest that initial processing of object identity is mediated by orientation-independent information and that orientation costs in performance arise when objects are consolidated in visual short-term memory in order to be reported.	[Harris, Irina M.; Benito, Claire T.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Dux, Paul E.] Vanderbilt Univ, Dept Psychol, Nashville, TN USA; [Leek, E. Charles] Univ Wales, Sch Psychol, Bangor, Gwynedd, Wales	University of Sydney; Vanderbilt University; Bangor University	Harris, IM (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	irina@psych.usyd.edu.au	Dux, Paul/I-1098-2014	Dux, Paul/0000-0002-4270-2583; Leek, Charles/0000-0001-9258-7504; Harris, Irina/0000-0001-9777-2290	ARC; Queen Elizabeth II Fellowship;  [DP0557590]	ARC(Australian Research Council); Queen Elizabeth II Fellowship; 	This work was supported by ARC grant DP0557590 and a Queen Elizabeth II Fellowship to IMH.	Arguin M, 2003, PERCEPT PSYCHOPHYS, V65, P469, DOI 10.3758/BF03194576; BIEDERMAN I, 1991, PERCEPTION, V20, P585, DOI 10.1068/p200585; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; COLTHEART M, 1980, PHILOS T ROY SOC B, V290, P57, DOI 10.1098/rstb.1980.0082; CORBALLIS MC, 1978, MEM COGNITION, V6, P98, DOI 10.3758/BF03197434; Dux PE, 2007, COGNITION, V104, P47, DOI 10.1016/j.cognition.2006.05.004; EDELMAN S, 1992, VISION RES, V32, P2385, DOI 10.1016/0042-6989(92)90102-O; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Gauthier I, 1997, PERCEPTION, V26, P51, DOI 10.1068/p260051; Graf M, 2005, PSYCHOL SCI, V16, P214, DOI 10.1111/j.0956-7976.2005.00806.x; Harris IM, 2005, PERCEPT PSYCHOPHYS, V67, P1010, DOI 10.3758/BF03193627; Harris IM, 2005, COGNITION, V95, P73, DOI 10.1016/j.cognition.2004.02.006; Harris IM, 2001, J COGNITIVE NEUROSCI, V13, P800, DOI 10.1162/08989290152541467; HUMMEL JE, 1992, PSYCHOL REV, V99, P480, DOI 10.1037/0033-295X.99.3.480; Hummel JE, 2000, COGNITIVE DYNAMICS, P157; Hummel JE, 2001, VIS COGN, V8, P489, DOI 10.1080/13506280143000214; JOLICOEUR P, 1985, MEM COGNITION, V13, P289, DOI 10.3758/BF03202498; KANWISHER NG, 1987, COGNITION, V27, P117, DOI 10.1016/0010-0277(87)90016-3; Lawson R, 1996, J EXP PSYCHOL HUMAN, V22, P395, DOI 10.1037/0096-1523.22.2.395; Leek EC, 2006, VIS COGN, V13, P573, DOI 10.1080/13506280544000048; Leek EC, 2005, J EXP PSYCHOL HUMAN, V31, P668, DOI 10.1037/0096-1523.31.4.668; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; McKone E, 1999, PERCEPT PSYCHOPHYS, V61, P1590, DOI 10.3758/BF03213120; MURRAY JE, 1995, PSYCHON B REV, V2, P239, DOI 10.3758/BF03210963; Murray JE, 1995, PSYCHON B REV, V2, P534, DOI 10.3758/BF03210989; Perrett DI, 1998, COGNITION, V67, P111, DOI 10.1016/S0010-0277(98)00015-8; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; SRINIVAS K, 1995, J EXP PSYCHOL LEARN, V21, P1019, DOI 10.1037/0278-7393.21.4.1019; TARR MJ, 1995, PSYCHON B REV, V2, P55, DOI 10.3758/BF03214412; Thoma V, 2004, J EXP PSYCHOL HUMAN, V30, P257, DOI 10.1037/0096-1523.30.2.257; Thoma V, 2007, VIS COGN, V15, P179, DOI 10.1080/13506280500155627; Turnbull OH, 1997, NEUROPSYCHOLOGIA, V35, P153, DOI 10.1016/S0028-3932(96)00063-2; ULLMAN S, 1989, COGNITION, V32, P193, DOI 10.1016/0010-0277(89)90036-X; Wong ACN, 2005, J EXP PSYCHOL HUMAN, V31, P110, DOI 10.1037/0096-1523.31.1.110	35	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2256	10.1371/journal.pone.0002256	http://dx.doi.org/10.1371/journal.pone.0002256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391XW	18509451	Green Published, Green Submitted, gold			2022-12-27	WOS:000262268500008
J	Irla, M; Saade, M; Kissenpfennig, A; Poulin, LF; Leserman, L; Marche, PN; Jouvin-Marche, E; Berger, F; Nguyen, C				Irla, Magali; Saade, Murielle; Kissenpfennig, Adrien; Poulin, Lionel Franz; Leserman, Lee; Marche, Patrice N.; Jouvin-Marche, Evelyne; Berger, Francois; Nguyen, Catherine			ZAP-70 Restoration in Mice by In Vivo Thymic Electroporation	PLOS ONE			English	Article							NONVIRAL GENE-TRANSFER; NEGATIVE SELECTION; THERAPY; CELLS; IMMUNODEFICIENCY; TRANSFECTION; DELIVERY; SPLEEN; ALPHA	Viral and non-viral vectors have been developed for gene therapy, but their use is associated with unresolved problems of efficacy and safety. Efficient and safe methods of DNA delivery need to be found for medical application. Here we report a new monopolar system of non-viral electro-gene transfer into the thymus in vivo that consists of the local application of electrical pulses after the introduction of the DNA. We assessed the proof of concept of this approach by correcting ZAP-70 deficient severe combined immunodeficiency ( SCID) in mice. The thymic electro-gene transfer of the pCMV-ZAP-70-IRES-EGFP vector in these mice resulted in rapid T cell differentiation in the thymus with mature lymphocytes detected by three weeks in secondary lymphoid organs. Moreover, this system resulted in the generation of long-term functional T lymphocytes. Peripheral reconstituted T cells displayed a diversified T cell receptor (TCR) repertoire, and were responsive to alloantigens in vivo. This process applied to the thymus could represent a simplified and effective alternative for gene therapy of T cell immunodeficiencies.	[Irla, Magali; Saade, Murielle; Nguyen, Catherine] Univ Mediterranee, Parc Sci Luminy, INSERM U928, Marseille, France; [Kissenpfennig, Adrien] Queens Univ Belfast, CCRCB, Belfast, Antrim, North Ireland; [Kissenpfennig, Adrien; Poulin, Lionel Franz; Leserman, Lee] Univ Mediterranee, Ctr Immunol Marseille Luminy, INSERM U631, CNRS UMR6102, Marseille, France; [Marche, Patrice N.; Jouvin-Marche, Evelyne] INSERM, U823, Grenoble, France; [Marche, Patrice N.; Jouvin-Marche, Evelyne] Univ Joseph Fourier Grenoble I, Inst Albert Bonniot, UMR S823, Grenoble, France; [Berger, Francois] INSERM U836, Grenoble, France; [Berger, Francois] Univ Joseph Fourier Grenoble I, Grenoble Inst Neurosci, UMR S836, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Queens University Belfast; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Irla, M (corresponding author), Univ Mediterranee, Parc Sci Luminy, INSERM U928, Marseille, France.	nguyen@tagc.univ-mrs.fr	JOUVIN MARCHE, Evelyne/L-8648-2013; Marche, Patrice N/K-5060-2013; IRLA, Magali/AAH-7941-2019; saade, murielle/Y-5050-2019; Nguyen, Catherine/M-4119-2016; Poulin, Lionel F. F/U-7794-2018	JOUVIN MARCHE, Evelyne/0000-0001-8616-138X; Marche, Patrice N/0000-0002-8930-9340; IRLA, Magali/0000-0001-8803-9708; saade, murielle/0000-0002-3937-4291; Nguyen, Catherine/0000-0001-9376-6360; Poulin, Lionel F. F/0000-0003-4272-4659; Kissenpfennig, Adrien/0000-0002-9633-3111	Institut National de la Sante Et de la Recherche Medicale (INSERM); Association pour la Recherche sur le Cancer (ARC) [PhD fellowship]; Association Francaise contre les Myopathies (AFM); Ligue Contre le Cancer en Isere	Institut National de la Sante Et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Ligue Contre le Cancer en Isere	This work was supported by Institut National de la Sante Et de la Recherche Medicale (INSERM). M. Irla is supported by a PhD fellowship from the Association pour la Recherche sur le Cancer (ARC) and M. Saade is supported by a grant from the Association Francaise contre les Myopathies (AFM). We acknowledge Ligue Contre le Cancer en Isere and the ARC for their help in obtaining equipment necessary for this work.	Adjali O, 2005, P NATL ACAD SCI USA, V102, P13586, DOI 10.1073/pnas.0504268102; Adjali O, 2005, J CLIN INVEST, V115, P2287, DOI 10.1172/JCI23966; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Berzins SP, 1999, P NATL ACAD SCI USA, V96, P9787, DOI 10.1073/pnas.96.17.9787; BILLINGHAM RE, 1951, J EXP BIOL, V28, P385; Chinen J, 2004, J ALLERGY CLIN IMMUN, V113, P595, DOI 10.1016/j.jaci.2004.01.765; Favard C, 2007, CURR GENE THER, V7, P67, DOI 10.2174/156652307779940207; Fischer A, 2002, NAT REV IMMUNOL, V2, P615, DOI 10.1038/nri859; Fischer A, 2001, LANCET, V357, P1863, DOI 10.1016/S0140-6736(00)04959-X; Gallagher M, 2001, J IMMUNOL, V167, P1447, DOI 10.4049/jimmunol.167.3.1447; Gehl J, 2003, ACTA PHYSIOL SCAND, V177, P437, DOI 10.1046/j.1365-201X.2003.01093.x; Girish V, 2004, Indian J Cancer, V41, P47; Golzio M, 2002, BBA-BIOMEMBRANES, V1563, P23, DOI 10.1016/S0005-2736(02)00369-3; Grayson MH, 2003, AM J PHYSIOL-HEART C, V284, pH2213, DOI 10.1152/ajpheart.00999.2002; Hamrouni A, 2003, J EXP MED, V197, P601, DOI 10.1084/jem.20021945; Kadlecek TA, 1998, J IMMUNOL, V161, P4688; Kohn DB, 2003, NAT REV CANCER, V3, P477, DOI 10.1038/nrc1122; Le Moine A, 1999, J IMMUNOL, V163, P3778; Maloy KJ, 2001, P NATL ACAD SCI USA, V98, P3299, DOI 10.1073/pnas.051630798; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Moylett EH, 2004, J ALLERGY CLIN IMMUN, V114, P206, DOI 10.1016/j.jaci.2004.01.782; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Pasqual N, 2002, J EXP MED, V196, P1163, DOI 10.1084/jem.20021074; Poulin LF, 2005, EUR CYTOKINE NETW, V16, P233; Prud'homme GJ, 2006, CURR GENE THER, V6, P243, DOI 10.2174/156652306776359504; SCHWACHTGEN JL, 1994, BIOTECHNIQUES, V17, P882; TAKAHASHI M, 1991, EXP HEMATOL, V19, P343; TAKAHASHI M, 1991, EXP HEMATOL, V5, P324; Tupin E, 2003, GENE THER, V10, P569, DOI 10.1038/sj.gt.3301914; Ushiki T, 1997, ARCH HISTOL CYTOL, V60, P89, DOI 10.1679/aohc.60.89; Vicat JM, 2000, HUM GENE THER, V11, P909, DOI 10.1089/10430340050015518; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Woods NB, 2006, NATURE, V440, P1123, DOI 10.1038/4401123a; ZunigaPflucker JC, 1996, CURR OPIN IMMUNOL, V8, P215, DOI 10.1016/S0952-7915(96)80060-4	35	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2059	10.1371/journal.pone.0002059	http://dx.doi.org/10.1371/journal.pone.0002059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446234	Green Submitted, Green Published, gold			2022-12-27	WOS:000261572300028
J	van Beers, RJ				van Beers, Robert J.			Saccadic Eye Movements Minimize the Consequences of Motor Noise	PLOS ONE			English	Article								The durations and trajectories of our saccadic eye movements are remarkably stereotyped. We have no voluntary control over these properties but they are determined by the movement amplitude and, to a smaller extent, also by the movement direction and initial eye orientation. Here we show that the stereotyped durations and trajectories are optimal for minimizing the variability in saccade endpoints that is caused by motor noise. The optimal duration can be understood from the nature of the motor noise, which is a combination of signal-dependent noise favoring long durations, and constant noise, which prefers short durations. The different durations of horizontal vs. vertical and of centripetal vs. centrifugal saccades, and the somewhat surprising properties of saccades in oblique directions are also accurately predicted by the principle of minimizing movement variability. The simple and sensible principle of minimizing the consequences of motor noise thus explains the full stereotypy of saccadic eye movements. This suggests that saccades are so stereotyped because that is the best strategy to minimize movement errors for an open-loop motor system.	[van Beers, Robert J.] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [van Beers, Robert J.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands	Utrecht University; Erasmus University Rotterdam; Erasmus MC	van Beers, RJ (corresponding author), Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands.	r.j.vanbeers@phys.uu.nl	van Beers, Robert J/R-7248-2018	van Beers, Robert J/0000-0003-3847-8918	Netherlands Organization for Scientific Research (NWO) [451-02-013]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The author was supported by Netherlands Organization for Scientific Research (NWO) Grant 451-02-013.	[Anonymous], 1991, OPTIMAL CONTROL INTR; BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; BAHILL AT, 1981, INVEST OPHTH VIS SCI, V21, P116; BALOH RW, 1975, NEUROLOGY, V25, P1065, DOI 10.1212/WNL.25.11.1065; BARMACK NH, 1976, J NEUROPHYSIOL, V39, P1009, DOI 10.1152/jn.1976.39.5.1009; BECKER W, 1990, VISION RES, V30, P893, DOI 10.1016/0042-6989(90)90057-R; Becker W., 1989, NEUROBIOLOGY SACCADI, P13; BOGHEN D, 1974, INVEST OPHTH VISUAL, V13, P619; Carpenter RHS, 1988, MOVEMENTS EYES; CLARK MR, 1975, IEEE T AUTOMAT CONTR, VAC20, P345, DOI 10.1109/TAC.1975.1100955; COLLEWIJN H, 1977, J PHYSIOL-LONDON, V266, P471, DOI 10.1113/jphysiol.1977.sp011778; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P183, DOI 10.1113/jphysiol.1988.sp017285; COLLEWIJN H, 1988, J PHYSIOL-LONDON, V404, P157, DOI 10.1113/jphysiol.1988.sp017284; COLLEWIJN H, 1998, VISION RES PRACTICAL, P245; COLLINS CC, 1975, J PHYSIOL-LONDON, V245, P351, DOI 10.1113/jphysiol.1975.sp010850; DEMER JL, 1995, INVEST OPHTH VIS SCI, V36, P1125; ENDERLE JD, 1987, IEEE T BIO-MED ENG, V34, P43, DOI 10.1109/TBME.1987.326014; EVINGER C, 1978, J PHYSIOL-LONDON, V285, P209, DOI 10.1113/jphysiol.1978.sp012568; Feng JF, 2002, J PHYS A-MATH GEN, V35, P7287, DOI 10.1088/0305-4470/35/34/304; Frens MA, 2002, J NEUROPHYSIOL, V88, P692, DOI 10.1152/jn.00457.2001; FUCHS AF, 1967, J PHYSIOL-LONDON, V191, P609, DOI 10.1113/jphysiol.1967.sp008271; GOMEZ C, 1986, BRAIN RES, V381, P401, DOI 10.1016/0006-8993(86)90099-5; Hamilton AFD, 2004, EXP BRAIN RES, V157, P417, DOI 10.1007/s00221-004-1856-7; Harris CM, 2006, BIOL CYBERN, V95, P21, DOI 10.1007/s00422-006-0064-x; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Harris CM, 1998, J NEUROSCI METH, V83, P73, DOI 10.1016/S0165-0270(98)00063-6; HASLWANTER T, 1995, VISION RES, V35, P1727, DOI 10.1016/0042-6989(94)00257-M; HEPP K, 1995, VISION RES, V35, P3237, DOI 10.1016/0042-6989(95)00104-M; Hu XT, 2007, P NATL ACAD SCI USA, V104, P8137, DOI 10.1073/pnas.0702799104; KELLER EL, 1971, J NEUROPHYSIOL, V34, P908, DOI 10.1152/jn.1971.34.5.908; KING WM, 1986, J NEUROPHYSIOL, V56, P769, DOI 10.1152/jn.1986.56.3.769; Kirk D.E., 1998, OPTIMAL CONTROL THEO; KUBO T, 1991, ACTA OTO-LARYNGOL, P382; PASTOR AM, 1991, J NEUROPHYSIOL, V66, P2125, DOI 10.1152/jn.1991.66.6.2125; PELISSON D, 1988, VISION RES, V28, P87, DOI 10.1016/0042-6989(88)90010-7; Raphan T, 1998, J NEUROPHYSIOL, V79, P2653, DOI 10.1152/jn.1998.79.5.2653; ROBINSON DA, 1964, J PHYSIOL-LONDON, V174, P245, DOI 10.1113/jphysiol.1964.sp007485; ROBINSON DA, 1986, BIOL CYBERN, V55, P43, DOI 10.1007/BF00363977; SCHMIDT D, 1979, AVIAT SPACE ENVIR MD, V50, P393; SCHNABOLK C, 1994, J NEUROPHYSIOL, V71, P623, DOI 10.1152/jn.1994.71.2.623; Schutte S, 2006, VISION RES, V46, P1724, DOI 10.1016/j.visres.2005.11.022; SMIT AC, 1990, EXP BRAIN RES, V81, P325, DOI 10.1007/BF00228123; SMIT AC, 1990, EXP BRAIN RES, V81, P335, DOI 10.1007/BF00228124; STAHL JS, 1995, J NEUROPHYSIOL, V73, P1383, DOI 10.1152/jn.1995.73.4.1383; Tanaka H, 2006, J NEUROPHYSIOL, V95, P3875, DOI 10.1152/jn.00751.2005; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; TWEED D, 1987, J NEUROPHYSIOL, V58, P823; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 2007, J NEUROSCI, V27, P8757, DOI 10.1523/JNEUROSCI.2311-07.2007; van der Geest JN, 2002, J NEUROSCI METH, V114, P185, DOI 10.1016/S0165-0270(01)00527-1; VANOPSTAL AJ, 1989, VISION RES, V29, P1183, DOI 10.1016/0042-6989(89)90064-3; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	52	46	46	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2070	10.1371/journal.pone.0002070	http://dx.doi.org/10.1371/journal.pone.0002070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446209	gold, Green Published			2022-12-27	WOS:000261572300039
J	Gurtner, A; Fuschi, P; Magi, F; Colussi, C; Gaetano, C; Dobbelstein, M; Sacchi, A; Piaggio, G				Gurtner, Aymone; Fuschi, Paola; Magi, Fiorenza; Colussi, Claudia; Gaetano, Carlo; Dobbelstein, Matthias; Sacchi, Ada; Piaggio, Giulia			NF-Y Dependent Epigenetic Modifications Discriminate between Proliferating and Postmitotic Tissue	PLOS ONE			English	Article							CCAAT-BINDING ACTIVITY; RNA-POLYMERASE-II; CYCLIN B1 GENE; TRANSCRIPTION FACTOR; CELL-CYCLE; HISTONE ACETYLTRANSFERASES; DOWN-REGULATION; CHROMATIN; EXPRESSION; ACETYLATION	The regulation of gene transcription requires posttranslational modifications of histones that, in concert with chromatin remodeling factors, shape the structure of chromatin. It is currently under intense investigation how this structure is modulated, in particular in the context of proliferation and differentiation. Compelling evidence suggests that the transcription factor NF-Y acts as a master regulator of cell cycle progression, activating the transcription of many cell cycle regulatory genes. However, the underlying molecular mechanisms are not yet completely understood. Here we show that NF-Y exerts its effect on transcription through the modulation of the histone "code''. NF-Y colocalizes with nascent RNA, while RNA polymerase II is I phosphorylated on serine 2 of the YSPTSPS repeats within its carboxyterminal domain and histones are carrying modifications that represent activation signals of gene expression (H3K9ac and PAN-H4ac). Comparing postmitotic muscle tissue from normal mice and proliferating muscles from mdx mice, we demonstrate by chromatin immunoprecipitation (ChIP) that NF-Y DNA binding activity correlates with the accumulation of acetylated histones H3 and H4 on promoters of key cell cycle regulatory genes, and with their active transcription. Accordingly, p300 is recruited onto the chromatin of NF-Y target genes in a NF-Y-dependent manner, as demonstrated by Re-ChIP. Conversely, the loss of NF-Y binding correlates with a decrease of acetylated histones, the recruitment of HDAC1, and a repressed heterochromatic state with enrichment of histones carrying modifications known to mediate silencing of gene expression (H3K9me3, H3K27me2 and H4K20me3). As a consequence, NF-Y target genes are downregulated in this context. In conclusion, our data indicate a role of NF-Y in modulating the structure and transcriptional competence of chromatin in vivo and support a model in which NF-Y-dependent histone "code'' changes contribute to the proper discrimination between proliferating and postmitotic cells in vivo and in vitro.	[Gurtner, Aymone; Fuschi, Paola; Magi, Fiorenza; Sacchi, Ada; Piaggio, Giulia] Regina Elena Inst Canc Res, Dept Expt Oncol, Mol Oncogenesis Lab, Rome, Italy; [Colussi, Claudia; Gaetano, Carlo] Ist Ricovero Cura Carattere Sci IRCCS, Ist Dermopat Immacolata, Lab Vas Pathol, Rome, Italy; [Dobbelstein, Matthias] Gottingen Ctr Mol Biosci GZMB, Dept Mol Oncol, Gottingen, Germany; [Piaggio, Giulia] Regina Elena Inst Canc Res, Rome Oncogenom Ctr, Expt Oncol Dept, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Gurtner, A (corresponding author), Regina Elena Inst Canc Res, Dept Expt Oncol, Mol Oncogenesis Lab, Rome, Italy.	piaggio@ifo.it	gurtner, aymone/AAB-8843-2020; Piaggio, Giulia/J-7214-2018; Gurtner, Aymone/J-7217-2018; Piaggio, Giulia/AAD-7336-2022; Gaetano, Carlo/P-9997-2019; Colussi, Claudia/H-8609-2019	gurtner, aymone/0000-0002-7661-9059; Piaggio, Giulia/0000-0003-2114-1892; Gurtner, Aymone/0000-0002-7661-9059; Gaetano, Carlo/0000-0002-5238-1832; Colussi, Claudia/0000-0002-7727-8911; Dobbelstein, Matthias/0000-0001-5052-3967	Associazione Italiana Ricerca sul Cancro (AIRC); Ministero della Sanita [ICS-120.4/RA00-90, R.F.02/184]; Istituto Superiore di Sanita [N.ACC2/R7.5]; EU 6th Framework Program [UE-LHSB-CT-04-502988]; German Research Foundation (DFG); German Cancer Aid; Wilhelm Sander Stiftung; FIRB [RBLA035A4X-1-FIRB]; AIRC; AFM [MNM2-06, DdT2-06]	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero della Sanita(Ministry of Health, Italy); Istituto Superiore di Sanita; EU 6th Framework Program(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); German Cancer Aid(Deutsche Krebshilfe); Wilhelm Sander Stiftung; FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); AIRC(Fondazione AIRC per la ricerca sul cancro); AFM(Association Francaise contre les Myopathies)	This work has been supported by grants to GP from Associazione Italiana Ricerca sul Cancro (AIRC), Ministero della Sanita (ICS-120.4/RA00-90; R.F.02/184) and Istituto Superiore di Sanita (N.ACC2/R7.5). MD's work was supported by the EU 6th Framework Program (Integrated Project Active p53), the German Research Foundation (DFG), the German Cancer Aid/Dr. Mildred Scheel Stiftung, and the Wilhelm Sander Stiftung. CG's work has been supported by: FIRB # RBLA035A4X-1-FIRB, AIRC regional grant, UE FP6 grant # UE-LHSB-CT-04-502988 and AFM grants # MNM2-06 and #DdT2-06.	AGGER K, 2007, NATURE          0822; Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Amati B., 2001, BIOCHIM BIOPHYS ACTA, V1471, P135; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhattacharya A, 2003, CANCER RES, V63, P8167; Bolognese F, 1999, ONCOGENE, V18, P1845, DOI 10.1038/sj.onc.1202494; Brehm A, 2000, EMBO J, V19, P4332, DOI 10.1093/emboj/19.16.4332; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Caretti G, 1999, MOL CELL BIOL, V19, P8591; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; Cho EJ, 2007, EXP MOL MED, V39, P247, DOI 10.1038/emm.2007.28; Currie RA, 1998, J BIOL CHEM, V273, P1430, DOI 10.1074/jbc.273.3.1430; de Wit E, 2007, PLOS GENET, V3, P346, DOI 10.1371/journal.pgen.0030038; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Ehrenhofer-Murray AE, 2004, EUR J BIOCHEM, V271, P2335, DOI 10.1111/j.1432-1033.2004.04162.x; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Farina A, 1999, ONCOGENE, V18, P2818, DOI 10.1038/sj.onc.1202472; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Grskovic M, 2007, PLOS GENET, V3, P1524, DOI 10.1371/journal.pgen.0030145; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Gurtner A, 2003, MOL BIOL CELL, V14, P2706, DOI 10.1091/mbc.E02-09-0600; Hu QH, 2000, J BIOL CHEM, V275, P4435, DOI 10.1074/jbc.275.6.4435; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Jin SK, 1998, MOL CELL BIOL, V18, P4377, DOI 10.1128/MCB.18.7.4377; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee WR, 2006, J CELL BIOCHEM, V99, P209, DOI 10.1002/jcb.20902; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li Q, 1998, EMBO J, V17, P6300, DOI 10.1093/emboj/17.21.6300; Linhart C, 2005, CELL CYCLE, V4, P1788, DOI 10.4161/cc.4.12.2173; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Matsui T, 2004, J BIOL CHEM, V279, P25093, DOI 10.1074/jbc.M403232200; Matuoka K, 1999, EXP CELL RES, V253, P365, DOI 10.1006/excr.1999.4605; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Miao F, 2005, MOL CELL BIOL, V25, P4650, DOI 10.1128/MCB.25.11.4650-4661.2005; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Okamura H, 2004, INT J ONCOL, V25, P1031; Park SH, 2007, CLIN CANCER RES, V13, P858, DOI 10.1158/1078-0432.CCR-06-1461; PENG Y, 2007, ONCOGENE        0618; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Salsi V, 2003, J BIOL CHEM, V278, P6642, DOI 10.1074/jbc.M210065200; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Sciortino S, 2001, EMBO REP, V2, P1018, DOI 10.1093/embo-reports/kve223; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; vanGinkel PR, 1997, J BIOL CHEM, V272, P18367, DOI 10.1074/jbc.272.29.18367; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; WIENCHE JK, 2007, ONCOGENE        1029; [No title captured]	61	51	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2047	10.1371/journal.pone.0002047	http://dx.doi.org/10.1371/journal.pone.0002047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431504	Green Submitted, Green Published, gold			2022-12-27	WOS:000261558700039
J	Rands, SA; Whitney, HM				Rands, Sean A.; Whitney, Heather M.			Floral Temperature and Optimal Foraging: Is Heat a Feasible Floral Reward for Pollinators?	PLOS ONE			English	Article							WARM-UP; NECTAR; BEES; HONEYBEES; BIOLOGY; PLANT; EFFICIENCY; FLOWERS	As well as nutritional rewards, some plants also reward ectothermic pollinators with warmth. Bumble bees have some control over their temperature, but have been shown to forage at warmer flowers when given a choice, suggesting that there is some advantage to them of foraging at warm flowers (such as reducing the energy required to raise their body to flight temperature before leaving the flower). We describe a model that considers how a heat reward affects the foraging behaviour in a thermogenic central-place forager (such as a bumble bee). We show that although the pollinator should spend a longer time on individual flowers if they are warm, the increase in total visit time is likely to be small. The pollinator's net rate of energy gain will be increased by landing on warmer flowers. Therefore, if a plant provides a heat reward, it could reduce the amount of nectar it produces, whilst still providing its pollinator with the same net rate of gain. We suggest how heat rewards may link with plant life history strategies.	[Rands, Sean A.] Univ Bristol, Ctr Behav Biol, Sch Clin Vet Sci, Bristol, Avon, England; [Whitney, Heather M.] Univ Cambridge, Dept Plant Sci, Cambridge, England	University of Bristol; University of Cambridge	Rands, SA (corresponding author), Univ Bristol, Ctr Behav Biol, Sch Clin Vet Sci, Bristol, Avon, England.	sean.rands@bristol.ac.uk	Rands, Sean A/B-2243-2008	Rands, Sean A/0000-0002-7400-005X; Whitney, Heather/0000-0001-6450-8266	NERC	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	HMW was supported as a postdoctoral researcher on a NERC research grant awarded to Beverley J. Glover (University of Cambridge) and Lars Chittka (Queen Mary, University of London). The sponsors played no role in any aspect of the work described in the manuscript.	Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bishop JA, 1999, FUNCT ECOL, V13, P711, DOI 10.1046/j.1365-2435.1999.00351.x; CASEY TM, 1992, AM ZOOL, V32, P225; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chittka L., 2001, ANIMAL BEHAV FLORAL; Corbet S.A., 1978, Linnean Society Symposium Series, P21; Dyer AG, 2006, NATURE, V442, P525, DOI 10.1038/442525a; GOULSON D, 2003, BUMBLEBEES BEHAVIOUR; Goulson Dave, 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P185, DOI 10.1078/1433-8319-00070; HARDER LD, 1983, OECOLOGIA, V57, P274, DOI 10.1007/BF00379591; HEINRICH B, 1975, J COMP PHYSIOL, V96, P155, DOI 10.1007/BF00706595; Heinrich B., 1993, The hot-blooded insects: strategies and mechanisms of thermoregulation.; Heinrich B., 1979, BUMBLEBEE EC; HERAN H, 1952, Z VERGL PHYSIOL, V34, P179; HERRERA CM, 1995, ECOLOGY, V76, P218, DOI 10.2307/1940644; HUBER H, 1956, PLANTA, V48, P47, DOI 10.1007/BF01911144; Ivancic A, 2008, J PLANT RES, V121, P73, DOI 10.1007/s10265-007-0129-5; JAKOBSEN HB, 1994, ANN BOT-LONDON, V74, P327, DOI 10.1006/anbo.1994.1125; KACELNIK A, 1986, BEHAV ECOL SOCIOBIOL, V19, P19, DOI 10.1007/BF00303838; Kevan P.G., 1989, International Congress Series, V871, P747; KEVAN PG, 1983, ANNU REV ENTOMOL, V28, P407, DOI 10.1146/annurev.en.28.010183.002203; Luzar N, 2001, ARCT ANTARCT ALP RES, V33, P93, DOI 10.2307/1552282; McKee J, 1998, BOT J LINN SOC, V128, P369; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; NICOLSON SW, 1995, FUNCT ECOL, V9, P584, DOI 10.2307/2390148; Orueta D, 2002, ECOLOGY, V83, P3073, DOI 10.1890/0012-9658(2002)083[3073:TRBCAI]2.0.CO;2; Pacini E, 2003, PLANT SYST EVOL, V238, P7, DOI 10.1007/s00606-002-0277-y; Pellmyr Olle, 2002, P157; PYKE GH, 1991, NATURE, V350, P58, DOI 10.1038/350058a0; Rasheed SA, 1997, ANIM BEHAV, V54, P911, DOI 10.1006/anbe.1997.0487; Sapir Y, 2006, OECOLOGIA, V147, P53, DOI 10.1007/s00442-005-0246-6; SCHMIDHEMPEL P, 1987, J ANIM ECOL, V56, P219, DOI 10.2307/4811; SCHMIDHEMPEL P, 1985, BEHAV ECOL SOCIOBIOL, V17, P61, DOI 10.1007/BF00299430; SCHMIDHEMPEL P, 1987, J ANIM ECOL, V56, P209, DOI 10.2307/4810; Seymour RS, 1998, PHILOS T ROY SOC B, V353, P935, DOI 10.1098/rstb.1998.0258; Seymour RS, 2003, NATURE, V426, P243, DOI 10.1038/426243a; Seymour RS, 1997, ENDEAVOUR, V21, P125, DOI 10.1016/S0160-9327(97)80222-0; Seymour RS, 2001, BIOSCIENCE REP, V21, P223, DOI 10.1023/A:1013608627084; SMITH A P, 1975, Biotropica, V7, P284, DOI 10.2307/2989741; SOUTHWICK EE, 1984, ECOLOGY, V65, P1775, DOI 10.2307/1937773; Stephens D.W., 1986, pi; STONE GN, 1993, J EXP BIOL, V174, P299; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Whitney HM, 2007, ARTHROPOD-PLANT INTE, V1, P147, DOI 10.1007/s11829-007-9014-3	44	49	50	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2007	10.1371/journal.pone.0002007	http://dx.doi.org/10.1371/journal.pone.0002007			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431488	Green Submitted, Green Published, gold			2022-12-27	WOS:000261558700023
J	Cabral, LG; Foley, BR; Nuzhdin, SV				Cabral, Larry G.; Foley, Brad R.; Nuzhdin, Sergey V.			Does Sex Trade with Violence among Genotypes in Drosophila melanogaster?	PLOS ONE			English	Article								The evolutionary forces shaping the ability to win competitive interactions, such as aggressive encounters, are still poorly understood. Given a fitness advantage for competitive success, variance in aggressive and sexual display traits should be depleted, but a great deal of variation in these traits is consistently found. While life history tradeoffs have been commonly cited as a mechanism for the maintenance of variation, the variability of competing strategies of conspecifics may mean there is no single optimum strategy. We measured the genetically determined outcomes of aggressive interactions, and the resulting effects on mating success, in a panel of diverse inbred lines representing both natural variation and artificially selected genotypes. Males of one genotype which consistently lost territorial encounters with other genotypes were nonetheless successful against males that were artificially selected for supernormal aggression and dominated all other lines. Intransitive patterns of territorial success could maintain variation in aggressive strategies if there is a preference for territorial males. Territorial success was not always associated with male mating success however and females preferred 'winners' among some male genotypes, and 'losers' among other male genotypes. This suggests that studying behaviour from the perspective of population means may provide limited evolutionary and genetic insight. Overall patterns of competitive success among males and mating transactions between the sexes are consistent with mechanisms proposed for the maintenance of genetic variation due to nonlinear outcomes of competitive interactions.	[Cabral, Larry G.] Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA; [Foley, Brad R.; Nuzhdin, Sergey V.] Univ Calif Davis, Evolut & Ecol, Davis, CA USA; [Nuzhdin, Sergey V.] Univ Southern Calif, Mol & Comp Biol, Los Angeles, CA USA	California State University System; California State University Sacramento; University of California System; University of California Davis; University of Southern California	Cabral, LG (corresponding author), Calif State Univ Sacramento, Dept Biol Sci, Sacramento, CA 95819 USA.	Cabral@csus.edu; s4020793@student.uq.edu.au			NSF [1R24GM065513, DEB 0548991]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM065513] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NSF grants 1R24GM065513, DEB 0548991	Baier A, 2002, J EXP BIOL, V205, P1233; Boake CRB, 2002, AM NAT, V160, pS143, DOI 10.1086/342902; Brooks R, 2001, EVOLUTION, V55, P1644, DOI 10.1111/j.0014-3820.2001.tb00684.x; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; Droney DC, 2001, J INSECT BEHAV, V14, P621, DOI 10.1023/A:1012275201320; Edwards AC, 2006, PLOS GENET, V2, P1386, DOI 10.1371/journal.pgen.0020154; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Harris WE, 2008, EVOLUTION, V62, P337, DOI 10.1111/j.1558-5646.2007.00302.x; Hine E, 2004, EVOLUTION, V58, P2754, DOI 10.1111/j.0014-3820.2004.tb01627.x; HOFFMANN AA, 1987, ANIM BEHAV, V35, P807, DOI 10.1016/S0003-3472(87)80117-3; HOFFMANN AA, 1990, ANIM BEHAV, V40, P526, DOI 10.1016/S0003-3472(05)80533-0; HOFFMANN AA, 1988, ANIM BEHAV, V36, P1180, DOI 10.1016/S0003-3472(88)80077-0; HOFFMANN AA, 1989, ANIM BEHAV, V38, P23, DOI 10.1016/S0003-3472(89)80062-4; Lasbleiz C, 2006, ANIM BEHAV, V72, P1001, DOI 10.1016/j.anbehav.2006.01.027; Matthews IM, 1997, P ROY SOC B-BIOL SCI, V264, P695, DOI 10.1098/rspb.1997.0099; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Sih A, 2005, BEHAVIOUR, V142, P1417, DOI 10.1163/156853905774539454; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Stamps J, 2005, ANIM BEHAV, V70, P609, DOI 10.1016/j.anbehav.2004.11.018; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; Tomkins JL, 2004, TRENDS ECOL EVOL, V19, P323, DOI 10.1016/j.tree.2004.03.029; Wolf JB, 1999, AM NAT, V153, P254, DOI 10.1086/303168; Yang HP, 2003, MOL BIOL EVOL, V20, P800, DOI 10.1093/molbev/msg087	29	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1986	10.1371/journal.pone.0001986	http://dx.doi.org/10.1371/journal.pone.0001986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414669	Green Published, gold, Green Submitted			2022-12-27	WOS:000260867300018
J	Gammie, SC; Edelmann, MN; Mandel-Brehm, C; D'Anna, KL; Auger, AP; Stevenson, SA				Gammie, Stephen C.; Edelmann, Michelle N.; Mandel-Brehm, Caleigh; D'Anna, Kimberly L.; Auger, Anthony P.; Stevenson, Sharon A.			Altered Dopamine Signaling in Naturally Occurring Maternal Neglect	PLOS ONE			English	Article							MEDIAL PREOPTIC AREA; INNERVATED BRAIN-REGIONS; TYROSINE-HYDROXYLASE PHOSPHORYLATION; PROGESTIN RECEPTOR EXPRESSION; WHEEL-RUNNING BEHAVIOR; NUCLEUS-ACCUMBENS; CHILD NEGLECT; ARTIFICIAL SELECTION; COCAINE TREATMENT; VENTRAL PALLIDUM	Background: Child neglect is the most common form of child maltreatment, yet the biological basis of maternal neglect is poorly understood and a rodent model is lacking. Methodology/Principal Findings: The current study characterizes a population of mice (MaD1) which naturally exhibit maternal neglect (little or no care of offspring) at an average rate of 17% per generation. We identified a set of risk factors that can predict future neglect of offspring, including decreased self-grooming and elevated activity. At the time of neglect, neglectful mothers swam significantly more in a forced swim test relative to nurturing mothers. Cross-fostered offspring raised by neglectful mothers in turn exhibit increased expression of risk factors for maternal neglect and decreased maternal care as adults, suggestive of possible epigenetic contributions to neglect. Unexpectedly, offspring from neglectful mothers elicited maternal neglect from cross-fostered nurturing mothers, suggesting that factors regulating neglect are not solely within the mother. To identify a neurological pathway underlying maternal neglect, we examined brain activity in neglectful and nurturing mice. c-Fos expression was significantly elevated in neglectful relative to nurturing mothers in the CNS, particularly within dopamine associated areas, such as the zona incerta (ZI), ventral tegmental area (VTA), and nucleus accumbens. Phosphorylated tyrosine hydroxylase (a marker for dopamine production) was significantly elevated in ZI and higher in VTA (although not significantly) in neglectful mice. Tyrosine hydroxylase levels were unaltered, suggesting a dysregulation of dopamine activity rather than cell number. Phosphorylation of DARPP-32, a marker for dopamine D1-like receptor activation, was elevated within nucleus accumbens and caudate-putamen in neglectful versus nurturing dams. Conclusions/Significance: These findings suggest that atypical dopamine activity within the maternal brain, especially within regions involved in reward, is involved in naturally occurring neglect and that MaD1 mice are a useful model for understanding the basis of naturally occurring neglect.	[Gammie, Stephen C.; Mandel-Brehm, Caleigh; D'Anna, Kimberly L.; Stevenson, Sharon A.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Gammie, Stephen C.; Edelmann, Michelle N.; Auger, Anthony P.] Univ Wisconsin Madison, Neurosci Training Program, Madison, WI USA; [Auger, Anthony P.] Univ Wisconsin Madison, Dept Psychol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gammie, SC (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	scgammie@wisc.edu		D'Anna-Hernandez, Kimberly/0000-0001-7647-1640; mandel-brehm, caleigh/0000-0001-7764-6529	National Institutes of Health [R01 MH066086, R01 MH072956]; National Research Service Award (NRSA) [GM007507]; University of Wisconsin Hilldale Undergraduate Research Fellowship; American Psychological Association Diversity Program in Neuroscience Fellowship; Ford Foundation Dissertation Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072956, R01MH066086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Hilldale Undergraduate Research Fellowship; American Psychological Association Diversity Program in Neuroscience Fellowship; Ford Foundation Dissertation Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants R01 MH066086 to S.C.G. and R01 MH072956 to A.P.A., by the National Research Service Award (NRSA) GM007507 to M.N.E., a University of Wisconsin Hilldale Undergraduate Research Fellowship to C. M.-B, and an American Psychological Association Diversity Program in Neuroscience Fellowship and Ford Foundation Dissertation Fellowship to K.L.D.	ABLER B, 2007, NEUROPSYCHOPHARMACOL; Afonso VM, 2008, BRAIN RES, V1198, P115, DOI 10.1016/j.brainres.2007.12.042; Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Bakowska JC, 1995, BRAIN RES, V703, P191, DOI 10.1016/0006-8993(95)01097-1; Bale TL, 2003, J NEUROSCI, V23, P5295; Bouwknecht J. Adriaan, 2002, Behavioural Brain Research, V136, P489, DOI 10.1016/S0166-4328(02)00200-0; BRAYDEN RM, 1992, J PEDIATR-US, V120, P426, DOI 10.1016/S0022-3476(05)80912-6; Byrnes EM, 2002, PHARMACOL BIOCHEM BE, V73, P869, DOI 10.1016/S0091-3057(02)00941-3; Carelli Regina M, 2002, Behav Cogn Neurosci Rev, V1, P281, DOI 10.1177/1534582302238338; Champagne F, 2001, Prog Brain Res, V133, P287; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; Cryan JF, 2005, PSYCHOPHARMACOLOGY, V182, P335, DOI 10.1007/s00213-005-0093-5; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; D'Anna KL, 2006, J NEUROENDOCRINOL, V18, P553, DOI 10.1111/j.1365-2826.2006.01448.x; D'Anna KL, 2005, BEHAV NEUROSCI, V119, P1061, DOI 10.1037/0735-7044.119.4.1061; De Bellis MD, 2005, CHILD MALTREATMENT, V10, P150, DOI 10.1177/1077559505275116; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Ferris CF, 2005, J NEUROSCI, V25, P149, DOI 10.1523/JNEUROSCI.3156-04.2005; Francis DD, 2002, J NEUROENDOCRINOL, V14, P349, DOI 10.1046/j.0007-1331.2002.00776.x; Fresiello A, 2002, BEHAV BRAIN RES, V130, P111, DOI 10.1016/S0166-4328(01)00426-0; GAFFORI O, 1979, PHYSIOL BEHAV, V23, P317, DOI 10.1016/0031-9384(79)90373-1; Gammie SC, 2005, BEHAV BRAIN RES, V160, P169, DOI 10.1016/j.bbr.2004.11.026; Gammie SC, 2004, BEHAV NEUROSCI, V118, P805, DOI 10.1037/0735-7044.118.4.805; Gammie SC, 2003, HORM BEHAV, V44, P209, DOI 10.1016/S0018-506X(03)00140-5; Gammie SC, 2006, BEHAV GENET, V36, P713, DOI 10.1007/s10519-006-9071-x; Gimenez-Llort L, 2002, EUR J NEUROSCI, V16, P547, DOI 10.1046/j.1460-9568.2002.02122.x; Girard I, 2002, BEHAV PROCESS, V57, P37, DOI 10.1016/S0376-6357(01)00206-6; HANSEN S, 1991, BEHAV NEUROSCI, V105, P588, DOI 10.1037/0735-7044.105.4.588; HANSEN S, 1991, PHARMACOL BIOCHEM BE, V39, P71, DOI 10.1016/0091-3057(91)90399-M; Harada K, 1996, J NEUROCHEM, V67, P629; Hasen NS, 2005, PHYSIOL BEHAV, V84, P681, DOI 10.1016/j.physbeh.2005.02.010; HEMMINGS HC, 1984, J NEUROSCI, V4, P99; Henry B, 2006, J NEUROSCI, V26, P9142, DOI 10.1523/JNEUROSCI.1494-06.2006; Hildyard KL, 2002, CHILD ABUSE NEGLECT, V26, P679, DOI 10.1016/S0145-2134(02)00341-1; Johns JM, 2005, BEHAV NEUROSCI, V119, P1605, DOI 10.1037/0735-7044.119.6.1605; JOHNS JM, 1994, BEHAV NEUROSCI, V108, P107, DOI 10.1037/0735-7044.108.1.107; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kumer SC, 1996, J NEUROCHEM, V67, P443; Lang AJ, 2006, CHILD ABUSE NEGLECT, V30, P17, DOI 10.1016/j.chiabu.2005.07.006; Langley KC, 1997, NEUROSCIENCE, V78, P977, DOI 10.1016/S0306-4522(96)00583-0; Lavi-Avnon Y, 2008, PSYCHOPHARMACOLOGY, V196, P281, DOI 10.1007/s00213-007-0961-2; Lee A, 2000, BEHAV BRAIN RES, V108, P213, DOI 10.1016/s0166-4328(98)00109-0; Light KC, 2004, ADDICT BEHAV, V29, P1541, DOI 10.1016/j.addbeh.2004.02.062; Lindgren N, 2002, EUR J NEUROSCI, V15, P769, DOI 10.1046/j.1460-9568.2002.01901.x; LOOKINGLAND KJ, 1985, BRAIN RES, V348, P205, DOI 10.1016/0006-8993(85)90438-X; Lounds JJ, 2004, CHILD MALTREATMENT, V9, P371, DOI 10.1177/1077559504269536; Lounds JJ, 2006, CHILD MALTREATMENT, V11, P281, DOI 10.1177/1077559506289864; Maestripieri D, 1998, PSYCHOL BULL, V123, P211, DOI 10.1037/0033-2909.123.3.211; Mani SK, 2000, SCIENCE, V287, P1053, DOI 10.1126/science.287.5455.1053; Mattson BJ, 2001, BEHAV NEUROSCI, V115, P683, DOI 10.1037/0735-7044.115.3.683; Miller SM, 2005, BEHAV NEUROSCI, V119, P1072, DOI 10.1037/0735-7044.119.4.1072; Murray C, 2006, J ABNORM PSYCHOL, V115, P52, DOI 10.1037/0021-843X.115.1.52; Numan M, 2005, BEHAV NEUROSCI, V119, P1588, DOI 10.1037/0735-7044.119.6.1588; NUMAN M, 1984, BEHAV NEUROSCI, V98, P712, DOI 10.1037/0735-7044.98.4.712; Numan M, 2005, BEHAV BRAIN RES, V158, P53, DOI 10.1016/j.bbr.2004.08.008; Numan M., 2003, HORM BR BEHAV; Olesen KM, 2007, J NEUROENDOCRINOL, V19, P481, DOI 10.1111/j.1365-2826.2007.01554.x; Olesen KM, 2005, ENDOCRINOLOGY, V146, P3705, DOI 10.1210/en.2005-0498; Olesen KM, 2005, J NEUROENDOCRINOL, V17, P255, DOI 10.1111/j.1365-2826.2005.01302.x; OUIMET CC, 1984, J NEUROSCI, V4, P111; Prickaerts J, 2006, J NEUROSCI, V26, P9022, DOI 10.1523/JNEUROSCI.5216-05.2006; Rhodes JS, 2005, INTEGR COMP BIOL, V45, P438, DOI 10.1093/icb/45.3.438; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1243, DOI 10.1037/0735-7044.117.6.1243; Risinger FO, 2001, J NEUROSCI, V21, P340, DOI 10.1523/JNEUROSCI.21-01-00340.2001; Shipman K, 2005, CHILD ABUSE NEGLECT, V29, P1015, DOI 10.1016/j.chiabu.2005.01.006; Silva MRP, 2001, PHARMACOL BIOCHEM BE, V68, P461, DOI 10.1016/S0091-3057(01)00471-3; Sita LV, 2003, BRAIN RES, V970, P232, DOI 10.1016/S0006-8993(03)02345-X; Solanto MV, 2002, BEHAV BRAIN RES, V130, P65, DOI 10.1016/S0166-4328(01)00431-4; Stolzenberg DS, 2007, BEHAV NEUROSCI, V121, P907, DOI 10.1037/0735-7044.121.5.907; Strathearn L, 2001, PEDIATRICS, V108, P142, DOI 10.1542/peds.108.1.142; Swallow JG, 1998, BEHAV GENET, V28, P227, DOI 10.1023/A:1021479331779; *US DEP HHS, 2004, CHILD MALTR 2002 SUM; WAGNER CK, 1995, BRAIN RES, V677, P229, DOI 10.1016/0006-8993(95)00128-D; WALAAS SI, 1984, J NEUROSCI, V4, P84; Wilson SL, 2005, CHILD ABUSE NEGLECT, V29, P985, DOI 10.1016/j.chiabu.2005.03.007; Zachariou V, 2006, NEUROPSYCHOPHARMACOL, V31, P555, DOI 10.1038/sj.npp.1300832; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215	77	22	22	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1974	10.1371/journal.pone.0001974	http://dx.doi.org/10.1371/journal.pone.0001974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370XD	18398484	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795500037
J	Woolley, SM; Posada, D; Crandall, KA				Woolley, Steven M.; Posada, David; Crandall, Keith A.			A Comparison of Phylogenetic Network Methods Using Computer Simulation	PLOS ONE			English	Article								Background: We present a series of simulation studies that explore the relative performance of several phylogenetic network approaches (statistical parsimony, split decomposition, union of maximum parsimony trees, neighbor-net, simulated history recombination upper bound, median-joining, reduced median joining and minimum spanning network) compared to standard tree approaches, (neighbor-joining and maximum parsimony) in the presence and absence of recombination. Principal Findings: In the absence of recombination, all methods recovered the correct topology and branch lengths nearly all of the time when the substitution rate was low, except for minimum spanning networks, which did considerably worse. At a higher substitution rate, maximum parsimony and union of maximum parsimony trees were the most accurate. With recombination, the ability to infer the correct topology was halved for all methods and no method could accurately estimate branch lengths. Conclusions: Our results highlight the need for more accurate phylogenetic network methods and the importance of detecting and accounting for recombination in phylogenetic studies. Furthermore, we provide useful information for choosing a network algorithm and a framework in which to evaluate improvements to existing methods and novel algorithms developed in the future.	[Woolley, Steven M.] Washington Univ, Sch Med, Computat Biol Program, St Louis, MO 63130 USA; [Posada, David] Univ Vigo, Fac Ciencias, Dept Bioquim Genet Inmunol, Vigo, Spain; [Crandall, Keith A.] Brigham Young Univ, Dept Biol, Provo, UT USA	Washington University (WUSTL); Universidade de Vigo; Brigham Young University	Woolley, SM (corresponding author), Washington Univ, Sch Med, Computat Biol Program, St Louis, MO 63130 USA.	stevenwoolley@wustl.edu	Crandall, Keith A./H-2789-2019; Posada, David/C-4502-2008	Crandall, Keith A./0000-0002-0836-3389; Posada, David/0000-0003-1407-3406	NIH [GM66276]; Brigham Young University Office of Research and Creative Activities; NSF Graduate Research Fellowship; Spanish Ministry of Education and Science [BFU2004-02700]; Spanish government; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066276] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brigham Young University Office of Research and Creative Activities; NSF Graduate Research Fellowship(National Science Foundation (NSF)); Spanish Ministry of Education and Science(Spanish Government); Spanish government(Spanish GovernmentEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH GM66276 (KAC, DP) and the Brigham Young University Office of Research and Creative Activities (SMW). SMW is also supported by an NSF Graduate Research Fellowship. DP is supported by grant BFU2004-02700 of the Spanish Ministry of Education and Science, and by the "Ramon y Cajal" program of the Spanish government.	BANDELT HJ, 1995, GENETICS, V141, P743; CARDONA G, 2007, COMP TREE CHILD PHYL; Cassens I, 2005, SYST BIOL, V54, P363, DOI 10.1080/10635150590945377; Cassens I, 2003, MOL ECOL, V12, P1781, DOI 10.1046/j.1365-294X.2003.01876.x; CAVALLISFORZA LL, 1967, EVOLUTION, V32, P550; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CRANDALL KA, 1994, SYST BIOL, V43, P222, DOI 10.2307/2413463; EXCOFFIER L, 1994, GENETICS, V136, P343; Forster M., 2007, NETWORK VERSION 4 2; GRIFFITHS RC, 1981, THEOR POPUL BIOL, V19, P169, DOI 10.1016/0040-5809(81)90016-2; HILLIS DM, 1992, SCIENCE, V255, P589, DOI 10.1126/science.1736360; HILLIS DM, 1995, SYST BIOL, V44, P3, DOI 10.2307/2413480; Holland B, 2007, SYST BIOL, V56, P57, DOI 10.1080/10635150601167013; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; JUKES T H, 1969, P21; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Li W. H, 1997, MOL EVOLUTION; Moret BME, 2004, IEEE ACM T COMPUT BI, V1, P13, DOI 10.1109/TCBB.2004.10; Nguyen NB, 2007, J COMB OPTIM, V13, P223, DOI 10.1007/s10878-006-9025-5; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Perez-Losada M, 2006, INFECT GENET EVOL, V6, P97, DOI 10.1016/j.meegid.2005.02.003; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Rannala B, 1998, SYST BIOL, V47, P702, DOI 10.1080/106351598260680; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; RZHETSKY A, 1993, MOL BIOL EVOL, V10, P1073; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schaal BA, 2000, P NATL ACAD SCI USA, V97, P7024, DOI 10.1073/pnas.97.13.7024; Schierup MH, 2000, GENETICS, V156, P879; Schneider S., 2000, ARLEQUIN VERSION 20; Shioura A, 1997, SIAM J COMPUT, V26, P678, DOI 10.1137/S0097539794270881; SONG JS, 2006, ALGORITHMS DISTINGUI, P231; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Templeton AR, 2005, GENETICS, V169, P441, DOI 10.1534/genetics.104.030080; TEMPLETON AR, 1992, GENETICS, V132, P619; Vriesendorp B, 2005, TAXON, V54, P593, DOI 10.2307/25065417; Wain-Hobson S, 2003, J GEN VIROL, V84, P885, DOI 10.1099/vir.0.18894-0; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0	42	91	95	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1913	10.1371/journal.pone.0001913	http://dx.doi.org/10.1371/journal.pone.0001913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398452	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795500003
J	Maenpaa, HO; Heikkonen, J; Vaalavirta, L; Tenhunen, M; Joensuu, H				Maenpaa, Hanna O.; Heikkonen, Jorma; Vaalavirta, Leila; Tenhunen, Mikko; Joensuu, Heikki			Low vs. High Radioiodine Activity to Ablate the Thyroid after Thyroidectomy for Cancer: A Randomized Study	PLOS ONE			English	Article							REMNANT ABLATION; SERUM THYROGLOBULIN; CLINICAL-TRIAL; I-131; CARCINOMA; STIMULATION; PAPILLARY; THERAPY; SCAN	Background: Radioactive iodine is commonly administered following thyroidectomy for differentiated thyroid carcinoma to ablate the thyroid remnant. The optimal administered activity of radioiodine is unknown. Methodology/Principal Findings: Adult subjects (n = 160) diagnosed with papillary or follicular thyroid carcinoma were randomly allocated to receive either 1100 MBq (30 mCi) or 3700 MBq (100 mCi) activity of radioiodine (131 I) following thyroidectomy. The study participants were prepared for ablation using thyroid hormone withdrawal. Ablation was considered successful when serum thyroglobulin concentration was less than 1 ng/mL and no uptake was present in 131 I scan. Ablation was successful following one administration of radioiodine in 42 (52%; 95% CI, 41% to 63%) of the 81 evaluable study participants who received 1100 MBq, and in 43 (56%, 45% to 67%) of the 77 subjects who received 3700 MBq activity (P =. 61). There was no difference between the groups in the numbers of repeat radioiodine treatments needed to complete ablation (P =. 27). The higher activity was associated with more nausea and taste disturbances, and a longer stay in a radioprotected isolation unit. None of the participants died from thyroid cancer during a median follow up of 51 months; three subjects in the 3700 MBq group and none in the 1100 MBq group were diagnosed with distant metastases during follow-up. In a meta-analysis of four randomized studies that compared the 1100 and 3700 MBq activities, the 1100 MBq activity tended to be associated with a higher risk of unsuccessful ablation (relative risk 1.148, 95% CI 0.974 to 1.353, P = .10). Conclusions/Significance: The results provide no conclusive evidence that 3700 MBq activity is more effective for ablation of the thyroid remnant than 1100 MBq activity. The 3700 MBq activity is associated with more adverse effects.	[Maenpaa, Hanna O.; Heikkonen, Jorma; Vaalavirta, Leila; Tenhunen, Mikko; Joensuu, Heikki] Univ Helsinki, Ctr Hosp, Dept Oncol, Helsinki, Finland	University of Helsinki	Maenpaa, HO (corresponding author), Univ Helsinki, Ctr Hosp, Dept Oncol, Helsinki, Finland.	heikki.joensuu@hus.fi			Helsinki University Central Hospital Research Funds	Helsinki University Central Hospital Research Funds	The study was supported by the Helsinki University Central Hospital Research Funds. The funding organization had no role in conducting the study or in preparing the manuscript.	Bal C, 1996, CANCER, V77, P2574, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2574::AID-CNCR22>3.0.CO;2-O; Bal CS, 2004, J CLIN ENDOCR METAB, V89, P1666, DOI 10.1210/jc.2003-031152; Ceccarelli C, 2001, J CLIN ENDOCR METAB, V86, P3512, DOI 10.1210/jc.86.8.3512; CREUTZIG H, 1987, EUR J NUCL MED, V12, P500, DOI 10.1007/BF00620474; Gawkowska-Suwinska M, 2001, Wiad Lek, V54 Suppl 1, P278; Hackshaw A, 2007, J CLIN ENDOCR METAB, V92, P28, DOI 10.1210/jc.2006-1345; Haugen BR, 2002, THYROID, V12, P37, DOI 10.1089/105072502753451959; Hedinger C, 1988, WHO HISTOLOGICAL TYP; Jarzab B, 2005, ENDOCR-RELAT CANCER, V12, P773, DOI 10.1677/erc.1.00880; JOHANSEN K, 1991, J NUCL MED, V32, P252; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; *NAT COMPR CANC NE, CLIN PRACT GUID ONCL; Pacini F, 2005, EUR J ENDOCRINOL, V153, P651, DOI 10.1530/eje.1.02014; PACINI F, 1994, J NUCL MED, V35, P1418; Roos DE, 1999, INT J RADIAT ONCOL, V44, P493, DOI 10.1016/S0360-3016(98)00553-7; Rubino C, 2003, BRIT J CANCER, V89, P1638, DOI 10.1038/sj.bjc.6601319; Sandeep TC, 2006, J CLIN ENDOCR METAB, V91, P1819, DOI 10.1210/jc.2005-2009; Sherman SI, 2003, LANCET, V361, P501, DOI 10.1016/S0140-6736(03)12488-9; SIRISALIPOCH S, 2004, WORLD J NUCL MED, V3, pS36; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; THOMAS SR, 1977, RADIOLOGY, V122, P731, DOI 10.1148/122.3.731; Torlontano M, 2003, EUR J ENDOCRINOL, V148, P19, DOI 10.1530/eje.0.1480019	22	80	93	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1885	10.1371/journal.pone.0001885	http://dx.doi.org/10.1371/journal.pone.0001885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382668	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795400019
J	Semyonov, J; Park, JI; Chang, CL; Hsu, SYT				Semyonov, Jenia; Park, Jae-Il; Chang, Chia Lin; Hsu, Sheau Yu Teddy			GPCR Genes Are Preferentially Retained after Whole Genome Duplication	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ADAPTIVE EVOLUTION; PROVIDES EVIDENCE; TELEOST FISH; PSI-BLAST; REPERTOIRE; IDENTIFICATION; SENSITIVITY; ROBUSTNESS; DIVERGENCE	One of the most interesting questions in biology is whether certain pathways have been favored during evolution, and if so, what properties could cause such a preference. Due to the lack of experimental evidence, whether select gene families have been preferentially retained over time after duplication in metazoan organisms remains unclear. Here, by syntenic mapping of nonchemosensory G protein-coupled receptor genes (nGPCRs which represent half the receptome for transmembrane signaling) in the vertebrate genomes, we found that, as opposed to the 8-15% retention rate for whole genome duplication (WGD)-derived gene duplicates in the entire genome of pufferfish, greater than 27.8% of WGD-derived nGPCRs which interact with a nonpeptide ligand were retained after WGD in pufferfish Tetraodon nigroviridis. In addition, we show that concurrent duplication of cognate ligand genes by WGD could impose selection of nGPCRs that interact with a polypeptide ligand. Against less than 2.25% probability for parallel retention of a pair of WGD-derived ligands and a pair of cognate receptor duplicates, we found a more than 8.9% retention of WGD-derived ligand-nGPCR pairs-threefold greater than one would surmise. These results demonstrate that gene retention is not uniform after WGD in vertebrates, and suggest a Darwinian selection of GPCR-mediated intercellular communication in metazoan organisms.	[Semyonov, Jenia; Park, Jae-Il; Hsu, Sheau Yu Teddy] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Biol, Stanford, CA 94305 USA; [Chang, Chia Lin] Chang Gung Memorial Hosp, Dept Obstet & Gynecol, Chang Gung Univ, Sch Med, Tao Yuan, Taiwan	Stanford University; Chang Gung Memorial Hospital; Chang Gung University	Semyonov, J (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Reprod Biol, Stanford, CA 94305 USA.	teddyhsu@stanford.edu			SCCPRR Center at the Stanford University School of Medicine; NIH [HD31398, R21 HD47606, RO1 DK70652]; March of Dimes research grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD031398, R21HD047606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070652] Funding Source: NIH RePORTER	SCCPRR Center at the Stanford University School of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes research grant(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	J. Semyonov is supported by the Bioinformatics Core of the SCCPRR Center at the Stanford University School of Medicine (NIH, HD31398). The authors also acknowledge the support of NIH awards (R21 HD47606 and RO1 DK70652, SYH) and the March of Dimes research grant (SYH).	Alioto TS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-173; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Ben-Shlomo Izhar, 2003, Sci STKE, V2003, pRE9, DOI 10.1126/stke.2003.187.re9; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brunet FG, 2006, MOL BIOL EVOL, V23, P1808, DOI 10.1093/molbev/msl049; Chen NS, 2005, P NATL ACAD SCI USA, V102, P146, DOI 10.1073/pnas.0408307102; Choi SS, 2003, GENOME RES, V13, P2252, DOI 10.1101/gr.1431603; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Courseaux A, 2001, SCIENCE, V291, P1293, DOI 10.1126/science.1057284; Feldman M, 1997, GENETICS, V147, P1381; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Force A, 1999, GENETICS, V151, P1531; Francino MP, 2005, NAT GENET, V37, P573, DOI 10.1038/ng1579; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; FRYXELL KJ, 1995, J MOL EVOL, V41, P85, DOI 10.1007/BF00174044; Gilad Y, 2005, GENOME RES, V15, P224, DOI 10.1101/gr.2846405; Gimelbrant AA, 2004, P NATL ACAD SCI USA, V101, P9019, DOI 10.1073/pnas.0401566101; Gloriam DEI, 2005, MOL PHYLOGENET EVOL, V35, P470, DOI 10.1016/j.ympev.2004.12.003; Goodstadt L, 2006, PLOS COMPUT BIOL, V2, P1134, DOI 10.1371/journal.pcbi.0020133; Grus WE, 2005, P NATL ACAD SCI USA, V102, P5767, DOI 10.1073/pnas.0501589102; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; He XL, 2005, CURR BIOL, V15, P1016, DOI 10.1016/j.cub.2005.04.035; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hsu SY, 1999, MOL ENDOCRINOL, V13, P2163, DOI 10.1210/me.13.12.2163; Hsu SY, 2000, MOL ENDOCRINOL, V14, P594, DOI 10.1210/me.14.5.594; Hsu SY, 2002, MOL ENDOCRINOL, V16, P1538, DOI 10.1210/me.16.7.1538; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; Hubbard T, 2005, NUCLEIC ACIDS RES, V33, pD447, DOI 10.1093/nar/gki138; Huerta-Cepas J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r109; Hughes AL, 2005, P NATL ACAD SCI USA, V102, P8791, DOI 10.1073/pnas.0503922102; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mulley J, 2004, NATURE, V431, P916, DOI 10.1038/431916a; Ohno S., 1970, EVOLUTION GENE DUPLI; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Rodriguez I, 2005, P NATL ACAD SCI USA, V102, P6639, DOI 10.1073/pnas.0502318102; Roest Crollius H, 2005, GENOME RES, V15, P1675, DOI 10.1101/gr.3735805; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Shiu SH, 2006, P NATL ACAD SCI USA, V103, P2232, DOI 10.1073/pnas.0510388103; Small Kersten M, 2003, Am J Pharmacogenomics, V3, P65, DOI 10.2165/00129785-200303010-00008; Steel M, 2005, TRENDS GENET, V21, P307, DOI 10.1016/j.tig.2005.04.001; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Taylor JS, 2001, TRENDS GENET, V17, P299, DOI 10.1016/S0168-9525(01)02318-6; Terai Y, 2006, PLOS BIOL, V4, P2244, DOI 10.1371/journal.pbio.0040433; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornton JW, 2005, TRENDS GENET, V21, P310, DOI 10.1016/j.tig.2005.04.002; Van de Peer Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-250; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Yang J, 2003, P NATL ACAD SCI USA, V100, P15661, DOI 10.1073/pnas.2536672100; Yokoyama S, 2002, NAT GENET, V30, P350, DOI 10.1038/ng0402-350; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	75	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1903	10.1371/journal.pone.0001903	http://dx.doi.org/10.1371/journal.pone.0001903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382678	gold, Green Submitted, Green Published			2022-12-27	WOS:000260795400030
J	van Baarsen, LGM; Vosslamber, S; Tijssen, M; Baggen, JMC; van der Voort, LF; Killestein, J; Kraan, TCTMVDP; Polman, CH; Verweij, CL				van Baarsen, Lisa G. M.; Vosslamber, Saskia; Tijssen, Marianne; Baggen, Josefien M. C.; van der Voort, Laura F.; Killestein, Joep; Kraan, Tineke C. T. M. van der Pouw; Polman, Chris H.; Verweij, Cornelis L.			Pharmacogenomics of Interferon-beta Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients	PLOS ONE			English	Article								Background: Multiple sclerosis (MS) is a heterogeneous disease. In order to understand the partial responsiveness to IFN beta in Relapsing Remitting MS (RRMS) we studied the pharmacological effects of IFN beta therapy. Methodology: Large scale gene expression profiling was performed on peripheral blood of 16 RRMS patients at baseline and one month after the start of IFN beta therapy. Differential gene expression was analyzed by Significance Analysis of Microarrays. Subsequent expression analyses on specific genes were performed after three and six months of treatment. Peripheral blood mononuclear cells (PBMC) were isolated and stimulated in vitro with IFN beta. Genes of interest were measured and validated by quantitative realtime PCR. An independent group of 30 RRMS patients was used for validation. Principal Findings: Pharmacogenomics revealed a marked variation in the pharmacological response to IFN beta between patients. A total of 126 genes were upregulated in a subset of patients whereas in other patients these genes were downregulated or unchanged after one month of IFN beta therapy. Most interestingly, we observed that the extent of the pharmacological response correlates negatively with the baseline expression of a specific set of 15 IFN response genes (R = -0.7208; p = 0.0016). The negative correlation was maintained after three (R = -0.7363; p = 0.0027) and six (R = -0.8154; p = 0.0004) months of treatment, as determined by gene expression levels of the most significant correlating gene. Similar results were obtained in an independent group of patients (n = 30; R = -0.4719; p = 0.0085). Moreover, the ex vivo results could be confirmed by in vitro stimulation of purified PBMCs at baseline with IFN beta indicating that differential responsiveness to IFN beta is an intrinsic feature of peripheral blood cells at baseline. Conclusion: These data imply that the expression levels of IFN response genes in the peripheral blood of MS patients prior to treatment could serve a role as biomarker for the differential clinical response to IFN beta..	[van Baarsen, Lisa G. M.; Vosslamber, Saskia; Baggen, Josefien M. C.; Kraan, Tineke C. T. M. van der Pouw; Verweij, Cornelis L.] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [van Baarsen, Lisa G. M.; Vosslamber, Saskia; Tijssen, Marianne; Verweij, Cornelis L.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [van der Voort, Laura F.; Killestein, Joep; Polman, Chris H.] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Baarsen, LGM (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	c.verweij@vumc.nl	van Baarsen, Lisa G/N-3646-2015	van Baarsen, Lisa G/0000-0003-3346-8921; Killestein, Joep/0000-0002-6347-5957	Dutch MS Research Foundation (Voorschoten, Netherlands) [04-549 MS]; Centre for Medical Systems Biology	Dutch MS Research Foundation (Voorschoten, Netherlands)(Netherlands Government); Centre for Medical Systems Biology	This study was funded in part by the Dutch MS Research Foundation (Voorschoten, Netherlands) and by the Centre for Medical Systems Biology (a center of excellence approved by the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research). Furthermore, the Dutch MS Research Foundation also supports S. Vosslamber (grant 04-549 MS). The funding sources of this study had no involvement in study design, in the collection, analyses and interpretation of data, in the writing of the report, and in the decision to submit the paper for publication.	Alam J, 1997, PHARMACEUT RES, V14, P546, DOI 10.1023/A:1012128406432; Ball CA, 2005, NUCLEIC ACIDS RES, V33, pD580; Baranzini SE, 2005, PLOS BIOL, V3, P166, DOI 10.1371/journal.pbio.0030002; Brierley MM, 2005, J BIOL CHEM, V280, P13029, DOI 10.1074/jbc.M500426200; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dupont SA, 2002, J INTERF CYTOK RES, V22, P491, DOI 10.1089/10799900252952280; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng X, 2002, J NEUROIMMUNOL, V129, P205, DOI 10.1016/S0165-5728(02)00182-0; Ghislain JJ, 1996, J BIOL CHEM, V271, P12408, DOI 10.1074/jbc.271.21.12408; Ghislain JJ, 2001, J INTERF CYTOK RES, V21, P379, DOI 10.1089/107999001750277853; Gilli F, 2005, J NEUROIMMUNOL, V158, P195, DOI 10.1016/j.jneuroim.2004.08.006; GRESSER I, 1990, J INVEST DERMATOL, V95, pS66, DOI 10.1111/1523-1747.ep12874776; Hafler DA, 2005, IMMUNOL REV, V204, P208, DOI 10.1111/j.0105-2896.2005.00240.x; KRAAN TCV, 2007, ARTHRITIS RES; Kracke A, 2000, NEUROLOGY, V54, P193, DOI 10.1212/WNL.54.1.193; Lehtonen A, 1997, J IMMUNOL, V159, P794; Li XX, 1996, J BIOL CHEM, V271, P5790, DOI 10.1074/jbc.271.10.5790; Markowitz CE, 2007, NEUROLOGY, V68, pS8, DOI 10.1212/01.wnl.0000277703.74115.d2; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Ravandi F, 1999, CLIN CANCER RES, V5, P3990; Reske D, 2004, ACTA NEUROL SCAND, V109, P66, DOI 10.1034/j.1600-0404.2003.00180.x; Revel M, 2003, PHARMACOL THERAPEUT, V100, P49, DOI 10.1016/S0163-7258(03)00085-8; Rice GPA, 1999, NEUROLOGY, V52, P1277, DOI 10.1212/WNL.52.6.1277; Rudick RA, 2004, ANN NEUROL, V56, P548, DOI 10.1002/ana.20224; Rudick RA, 2006, ANN NEUROL, V60, P236, DOI 10.1002/ana.20883; Salmon P, 1996, J INTERF CYTOK RES, V16, P759, DOI 10.1089/jir.1996.16.759; SIBLEY WA, 1985, LANCET, V1, P1313; Sturzebecher S, 2003, BRAIN, V126, P1419, DOI 10.1093/brain/awg147; Sturzebecher S, 1999, J INTERF CYTOK RES, V19, P1257, DOI 10.1089/107999099312920; Takaoka A, 2003, CANCER SCI, V94, P405, DOI 10.1111/j.1349-7006.2003.tb01455.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Baarsen LGM, 2006, GENES IMMUN, V7, P522, DOI 10.1038/sj.gene.6364324; Vartanian TK, 2004, NEUROLOGY, V63, pS42, DOI 10.1212/WNL.63.11_suppl_5.S42; Weinstock-Guttman B, 2003, J IMMUNOL, V171, P2694, DOI 10.4049/jimmunol.171.5.2694; Zhuang HY, 2006, ARTHRITIS RHEUM-US, V54, P1573, DOI 10.1002/art.21800	36	89	98	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1927	10.1371/journal.pone.0001927	http://dx.doi.org/10.1371/journal.pone.0001927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382694	Green Published, gold			2022-12-27	WOS:000260795400047
J	Bhattacharya, C; Aggarwal, S; Kumar, M; Ali, A; Matin, A				Bhattacharya, Chitralekha; Aggarwal, Sita; Kumar, Madhu; Ali, Amatul; Matin, Angabin			Mouse Apolipoprotein B Editing Complex 3 (APOBEC3) Is Expressed in Germ Cells and Interacts with Dead-End (DND1)	PLOS ONE			English	Article								Background: The dead-end (Dnd1) gene is essential for maintaining the viability of germ cells. Inactivation of Dnd1 results in sterility and testicular tumors. The Dnd1 encoded protein, DND1, is able to bind to the 3'-untranslated region (UTR) of messenger RNAs (mRNAs) to displace micro-RNA (miRNA) interaction with mRNA. Thus, one function of DND1 is to prevent miRNA mediated repression of mRNA. We report that DND1 interacts specifically with APOBEC3. APOBEC3 is a multifunctional protein. It inhibits retroviral replication. In addition, recent studies show that APOBEC3 interacts with cellular RNA-binding proteins and to mRNA to inhibit miRNA-mediated repression of mRNA. Methodology/Principal Findings: Here we show that DND1 specifically interacts with another cellular protein, APOBEC3. We present our data which shows that DND1 co-immunoprecipitates APOBEC3 from mammalian cells and also endogenous APOBEC3 from mouse gonads. Whether the two proteins interact directly remains to be elucidated. We show that both DND1 and APOBEC3 are expressed in germ cells and in the early gonads of mouse embryo. Expression of fluorescently-tagged DND1 and APOBEC3 indicate they localize to the cytoplasm and when DND1 and APOBEC3 are expressed together in cells, they sequester near peri-nuclear sites. Conclusions/Significance: The 39-UTR of mRNAs generally encode multiple miRNA binding sites as well as binding sites for a variety of RNA binding proteins. In light of our findings of DND1-APOBEC3 interaction and taking into consideration reports that DND1 and APOBEC3 bind to mRNA to inhibit miRNA mediated repression, our studies implicate a possible role of DND1-APOBEC3 interaction in modulating miRNA-mediated mRNA repression. The interaction of DND1 and APOBEC3 could be one mechanism for maintaining viability of germ cells and for preventing germ cell tumor development.	[Bhattacharya, Chitralekha; Aggarwal, Sita; Kumar, Madhu; Ali, Amatul; Matin, Angabin] Univ Texas MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Bhattacharya, C (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA.	amatin@mdanderson.org			National Cancer Institute [CA093754]; David Carmine Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA093754] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); David Carmine Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute grant CA093754, David Carmine Cancer Research Fund	Anant S, 2003, TRENDS MOL MED, V9, P147, DOI 10.1016/S1471-4914(03)00032-7; Bhattacharya C, 2007, BIOCHEM BIOPH RES CO, V355, P194, DOI 10.1016/j.bbrc.2007.01.138; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; De Miguel MP, 2003, METHOD ENZYMOL, V365, P353; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Hakata Y, 2006, J BIOL CHEM, V281, P36624, DOI 10.1074/jbc.M604980200; Hammond S, 2007, MAMM GENOME, V18, P832, DOI 10.1007/s00335-007-9075-8; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Horvay K, 2006, DEV BIOL, V291, P1, DOI 10.1016/j.ydbio.2005.06.013; Huang J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705116200; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Ketting RF, 2007, CELL, V131, P1226, DOI 10.1016/j.cell.2007.12.004; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Kobayashi M, 2004, J VIROL, V78, P8238, DOI 10.1128/JVI.78.15.8238-8244.2004; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Lellek H, 2000, J BIOL CHEM, V275, P19848, DOI 10.1074/jbc.M001786200; Liao W, 1999, BIOCHEM BIOPH RES CO, V260, P398, DOI 10.1006/bbrc.1999.0925; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Matin A, 2007, CELL MOL LIFE SCI, V64, P1317, DOI 10.1007/s00018-007-6433-3; Mehta A, 2000, MOL CELL BIOL, V20, P1846, DOI 10.1128/MCB.20.5.1846-1854.2000; Mikl MC, 2005, MOL CELL BIOL, V25, P7270, DOI 10.1128/MCB.25.16.7270-7277.2005; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Petersen-Mahrt S, 2005, IMMUNOL REV, V203, P80, DOI 10.1111/j.0105-2896.2005.00232.x; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Rogozin IB, 2005, CELL CYCLE, V4, P1281, DOI 10.4161/cc.4.9.1994; Russell RA, 2005, J VIROL, V79, P8724, DOI 10.1128/JVI.79.14.8724-8731.2005; SAKURAI T, 1995, DEV GROWTH DIFFER, V37, P293, DOI 10.1046/j.1440-169X.1995.t01-2-00007.x; Sasada A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-32; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Wylie C, 2000, CURR OPIN GENET DEV, V10, P410, DOI 10.1016/S0959-437X(00)00105-2; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004; Zhu R, 2007, ANN NY ACAD SCI, V1120, P181, DOI 10.1196/annals.1411.006	58	20	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2315	10.1371/journal.pone.0002315	http://dx.doi.org/10.1371/journal.pone.0002315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509452	Green Published, gold, Green Submitted			2022-12-27	WOS:000262268500043
J	Rasgon, JL				Rasgon, Jason L.			Stable Isotope Analysis Can Potentially Identify Completely-Digested Bloodmeals in Mosquitoes	PLOS ONE			English	Article								Background: Vertebrate bloodfeeding is a critical component of a mosquito's ability to transmit pathogens that cause diseases such as malaria, dengue fever and viral encephalitis. Due to degradation by the digestive process, current methods to identify mosquito bloodmeal sources are only useful for approximately 36 hours post-feeding. A critical need exists for technologies to extend this window and gain a more complete picture of mosquito feeding behavior for epidemiological studies. Stable isotopes are useful for investigating organism feeding behavior because the isotopic ratio of an organism's tissues reflects that of the material it ingests. Methodology/Principal Findings: Proof-of-principle data indicates that after bloodfeeding, Aedes albopictus mosquitoes acquire diagnostic Carbon and Nitrogen stable isotope profiles from their vertebrate hosts that can be accurately identified one week post-feeding, approximately 4 days after the entire bloodmeal has been digested. Total C/N ratio served as a biomarker marker for bloodfeeding (P < 0.02), while delta N was the most informative variable which could distinguish between unfed, chicken-fed and human-fed mosquitoes (P < 0.01). By plotting C/N vs. delta N, all feeding treatments could be identified in a double-blind analysis. Conclusions/Significance: These proof-of-principle experiments indicate that analysis of stable isotopes can be used to distinguish bloodfed from unfed mosquitoes, and also distinguish between different vertebrate bloodmeal sources even after all blood has been digested. The development of stable isotope-based assays for mosquito bloodmeal identification may be a powerful tool to investigate mosquito feeding ecology and the dynamics of vector-borne pathogens.	[Rasgon, Jason L.] Johns Hopkins Univ, Johns Hopkins Malaria Res Inst, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA	Johns Hopkins University	Rasgon, JL (corresponding author), Johns Hopkins Univ, Johns Hopkins Malaria Res Inst, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	jrasgon@jhsph.edu		Rasgon, Jason/0000-0002-4050-8429	Johns Hopkins Malaria Research Institute	Johns Hopkins Malaria Research Institute	Funding was provided by the Johns Hopkins Malaria Research Institute.	Andreadis TG, 2004, VECTOR-BORNE ZOONOT, V4, P360, DOI 10.1089/vbz.2004.4.360; BEIER JC, 1988, J MED ENTOMOL, V25, P9, DOI 10.1093/jmedent/25.1.9; Boakye DA, 1999, MED VET ENTOMOL, V13, P282, DOI 10.1046/j.1365-2915.1999.00193.x; CHOW E, 1993, J AM MOSQUITO CONTR, V9, P196; Chow-Shaffer E, 2000, J MED ENTOMOL, V37, P492, DOI 10.1603/0022-2585-37.4.492; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; Gaye-Siessegger J, 2004, OECOLOGIA, V138, P175, DOI 10.1007/s00442-003-1429-7; Gomes LAM, 2001, MEM I OSWALDO CRUZ, V96, P693, DOI 10.1590/S0074-02762001000500020; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; GRUPE G, 1990, SCI TOTAL ENVIRON, V90, P227, DOI 10.1016/0048-9697(90)90195-Z; Hobson KA, 2004, OECOLOGIA, V141, P477, DOI 10.1007/s00442-004-1671-7; Iko WM, 2003, ISOT ENVIRON HEALT S, V39, P159, DOI 10.1080/1025601031000108679; Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336; Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364; Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196; Kutz FW, 2003, J AM MOSQUITO CONTR, V19, P190; Lee JH, 2002, AM J TROP MED HYG, V66, P599, DOI 10.4269/ajtmh.2002.66.599; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Mukabana WR, 2002, TRENDS PARASITOL, V18, P505, DOI 10.1016/S1471-4922(02)02364-4; Sardelis MR, 2002, J AM MOSQUITO CONTR, V18, P284; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; TEMPELIS CH, 1963, AM J TROP MED HYG, V12, P825, DOI 10.4269/ajtmh.1963.12.825; WADA E, 1991, CRIT REV FOOD SCI, V30, P361, DOI 10.1080/10408399109527547; Werner RA, 2001, RAPID COMMUN MASS SP, V15, P501, DOI 10.1002/rcm.258	24	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2198	10.1371/journal.pone.0002198	http://dx.doi.org/10.1371/journal.pone.0002198			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493314	Green Published, gold, Green Submitted			2022-12-27	WOS:000262258700007
J	Sinnayah, P; Jobst, EE; Rathner, JA; Caldera-Siu, AD; Tonelli-Lemos, L; Eusterbrock, AJ; Enriori, PJ; Pothos, EN; Grove, KL; Cowley, MA				Sinnayah, Puspha; Jobst, Erin E.; Rathner, Joseph A.; Caldera-Siu, Angela D.; Tonelli-Lemos, Luciana; Eusterbrock, Aaron J.; Enriori, Pablo J.; Pothos, Emmanuel N.; Grove, Kevin L.; Cowley, Michael A.			Feeding Induced by Cannabinoids Is Mediated Independently of the Melanocortin System	PLOS ONE			English	Article							DECREASES EXTRACELLULAR DOPAMINE; MELANIN-CONCENTRATING HORMONE; VENTRAL TEGMENTAL AREA; FOOD-INTAKE; RECEPTOR ANTAGONIST; NUCLEUS-ACCUMBENS; WEIGHT-LOSS; FOS EXPRESSION; BRAIN REWARD; SR 141716	Background: Cannabinoids, the active components of marijuana, stimulate appetite, and cannabinoid receptor-1 (CB1-R) antagonists suppress appetite and promote weight loss. Little is known about how CB1-R antagonists affect the central neurocircuitry, specifically the melanocortin system that regulates energy balance. Methodology/Principal Findings: Here, we show that peripherally administered CB1-R antagonist (AM251) or agonist equally suppressed or stimulated feeding respectively in A(y), which lack a functional melanocortin system, and wildtype mice, demonstrating that cannabinoid effects on feeding do not require melanocortin circuitry. CB1-R antagonist or agonist administered into the ventral tegmental area (VTA) equally suppressed or stimulated feeding respectively, in both genotypes. In addition, peripheral and central cannabinoid administration similarly induced c-Fos activation in brain sites suggesting mediation via motivational dopaminergic circuitry. Amperometry-detected increases in evoked dopamine (DA) release by the CB1-R antagonist in nucleus accumbens slices indicates that AM251 modulates DA release from VTA terminals. Conclusions/Significance: Our results demonstrate that the effects of cannabinoids on energy balance are independent of hypothalamic melanocortin circuitry and is primarily driven by the reward system.	[Sinnayah, Puspha; Jobst, Erin E.; Tonelli-Lemos, Luciana; Eusterbrock, Aaron J.; Enriori, Pablo J.; Grove, Kevin L.; Cowley, Michael A.] Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA; [Jobst, Erin E.] Pacific Univ, Sch Physical Therapy, Hillsboro, OR USA; [Rathner, Joseph A.] Neurol Sci Inst, Beaverton, OR USA; [Caldera-Siu, Angela D.; Pothos, Emmanuel N.] Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut & Program Neurosci, Boston, MA USA; [Cowley, Michael A.] Monash Univ, Fac Med, Dept Physiol, Clayton, Vic, Australia	Oregon Health & Science University; Oregon National Primate Research Center; Tufts University; Monash University	Sinnayah, P (corresponding author), Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Portland, OR 97201 USA.	michael.cowley@med.monash.edu.au	Cowley, Michael A/B-9428-2008; Sinnayah, Puspha/M-4351-2014	Cowley, Michael A/0000-0001-7811-134X; Sinnayah, Puspha/0000-0002-9811-7236; Pothos, Emmanuel/0000-0001-8825-7852; Rathner, Joseph/0000-0002-8734-9402	National Institutes of Health [RR0163, DK62202, DK60685, DK065872]; Tufts Center for Neuroscience Research [P30 NS047243]; Tufts GRASP Center [P30 DK34928]; Medical Foundation [Smith Family New Investigator Award]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062202, P30DK034928, R01DK065872, R56DK062202, R01DK060685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts Center for Neuroscience Research; Tufts GRASP Center; Medical Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (RR0163, DK62202 and DK60685). The work in the Pothos laboratory was supported by DK065872, P30 NS047243 (Tufts Center for Neuroscience Research), P30 DK34928 (Tufts GRASP Center) and a Smith Family New Investigator Award through the Medical Foundation. OHSU and Dr. Cowley have a significant financial interest in Orexigen Therapeutics Inc., a company that may have a commercial interest in the results of this research and technology. This potential conflict has been reviewed and managed by the OHSU Conflict of Interest in Research Committee and the Integrity Program Oversight Council.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Alonso R, 1999, NEUROSCIENCE, V91, P607, DOI 10.1016/S0306-4522(98)00675-7; Arnold JC, 2001, BRAIN RES, V921, P240, DOI 10.1016/S0006-8993(01)03127-4; Arnone M, 1997, PSYCHOPHARMACOLOGY, V132, P104, DOI 10.1007/s002130050326; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Cerri M, 2005, NEUROSCIENCE, V135, P627, DOI 10.1016/j.neuroscience.2005.06.039; Cheer JF, 2004, J NEUROSCI, V24, P4393, DOI 10.1523/JNEUROSCI.0529-04.2004; Cheer JF, 2003, NEUROPHARMACOLOGY, V44, P633, DOI 10.1016/S0028-3908(03)00029-7; Clegg DJ, 2002, ENDOCRINOLOGY, V143, P2995, DOI 10.1210/en.143.8.2995; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cota D, 2006, BRAIN RES REV, V51, P85, DOI 10.1016/j.brainresrev.2005.10.004; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gardner EL, 2005, PHARMACOL BIOCHEM BE, V81, P263, DOI 10.1016/j.pbb.2005.01.032; Hagan MM, 2001, ENDOCRINOLOGY, V142, P1050, DOI 10.1210/en.142.3.1050; Hentges ST, 2005, J NEUROSCI, V25, P9746, DOI 10.1523/JNEUROSCI.2769-05.2005; HERNANDEZ L, 1988, PHYSIOL BEHAV, V44, P599, DOI 10.1016/0031-9384(88)90324-1; Hildebrandt AL, 2003, EUR J PHARMACOL, V462, P125, DOI 10.1016/S0014-2999(03)01343-8; HO J, 2007, CANNABINOID INDUCED; Huang H, 2007, J NEUROSCI, V27, P4870, DOI 10.1523/JNEUROSCI.0732-07.2007; IVERSON L, 2000, SCI MARIJUANA OXFORD; Jamshidi N, 2001, BRIT J PHARMACOL, V134, P1151, DOI 10.1038/sj.bjp.0704379; Jo YH, 2005, NEURON, V48, P1055, DOI 10.1016/j.neuron.2005.10.021; Kask A, 1998, BIOCHEM BIOPH RES CO, V245, P90, DOI 10.1006/bbrc.1998.8389; Korotkova TM, 2003, J NEUROSCI, V23, P7; Madden CJ, 2004, AM J PHYSIOL-REG I, V286, pR320, DOI 10.1152/ajpregu.00515.2003; Mahler SV, 2007, NEUROPSYCHOPHARMACOL, V32, P2267, DOI 10.1038/sj.npp.1301376; Molavi B, 2006, CURR OPIN CARDIOL, V21, P479, DOI 10.1097/01.hco.0000240586.76344.f5; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Paladini CA, 2003, P NATL ACAD SCI USA, V100, P2866, DOI 10.1073/pnas.0138018100; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Phillips AG, 2003, NEUROSCI BIOBEHAV R, V27, P543, DOI 10.1016/j.neubiorev.2003.09.002; Pothos EN, 1995, OBES RES, V3, pS525, DOI 10.1002/j.1550-8528.1995.tb00222.x; POTHOS EN, 1995, J NEUROSCI, V15, P6640; Pothos EN, 1998, APPETITE, V31, P405, DOI 10.1006/appe.1998.0210; Pritchard LE, 2005, PEPTIDES, V26, P1759, DOI 10.1016/j.peptides.2004.11.036; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Simiand J, 1998, BEHAV PHARMACOL, V9, P179; Singh ME, 2004, NEUROPHARMACOLOGY, V47, P1157, DOI 10.1016/j.neuropharm.2004.08.008; Skuladottir GV, 1999, BRIT J PHARMACOL, V126, P27, DOI 10.1038/sj.bjp.0702264; Solinas M, 2007, PHARMACOL RES, V56, P393, DOI 10.1016/j.phrs.2007.09.005; STELLAR E, 1954, PSYCHOL REV, V61, P5, DOI 10.1037/0033-295X.101.2.301; Szabo B, 2002, EUR J NEUROSCI, V15, P2057, DOI 10.1046/j.1460-9568.2002.02041.x; TOWELL A, 1988, PSYCHOPHARMACOLOGY, V96, P135, DOI 10.1007/BF02431545; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Verty ANA, 2004, ENDOCRINOLOGY, V145, P3224, DOI 10.1210/en.2004-0059; Vickers SP, 2003, PSYCHOPHARMACOLOGY, V167, P103, DOI 10.1007/s00213-002-1384-8; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Wu XF, 2000, NEUROPHARMACOLOGY, V39, P391, DOI 10.1016/S0028-3908(99)00140-9; Zangen A, 2006, J NEUROSCI, V26, P4901, DOI 10.1523/JNEUROSCI.3554-05.2006; Zhou D, 2004, PHARMACOL BIOCHEM BE, V77, P117, DOI 10.1016/j.pbb.2003.10.015	55	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2202	10.1371/journal.pone.0002202	http://dx.doi.org/10.1371/journal.pone.0002202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493584	gold, Green Accepted, Green Published			2022-12-27	WOS:000262258700011
J	Albeanu, DF; Soucy, E; Sato, TF; Meister, M; Murthy, VN				Albeanu, Dinu F.; Soucy, Edward; Sato, Tomokazu F.; Meister, Markus; Murthy, Venkatesh N.			LED Arrays as Cost Effective and Efficient Light Sources for Widefield Microscopy	PLOS ONE			English	Article							ILLUMINATION; PROTEIN	New developments in fluorophores as well as in detection methods have fueled the rapid growth of optical imaging in the life sciences. Commercial widefield microscopes generally use arc lamps, excitation/emission filters and shutters for fluorescence imaging. These components can be expensive, difficult to maintain and preclude stable illumination. Here, we describe methods to construct inexpensive and easy-to-use light sources for optical microscopy using light-emitting diodes (LEDs). We also provide examples of its applicability to biological fluorescence imaging.	[Albeanu, Dinu F.; Meister, Markus; Murthy, Venkatesh N.] Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; [Albeanu, Dinu F.; Soucy, Edward; Sato, Tomokazu F.; Meister, Markus; Murthy, Venkatesh N.] Harvard Univ, Ctr Brain Sci, Cambridge, MA USA; [Sato, Tomokazu F.; Meister, Markus; Murthy, Venkatesh N.] Harvard Med Sch, Harvard Biophys Program, Boston, MA USA; [Meister, Markus; Murthy, Venkatesh N.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Harvard University	Albeanu, DF (corresponding author), Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA.	vnmurthy@fas.harvard.edu		Albeanu, Dinu/0000-0001-7825-7744; Meister, Markus/0000-0003-2136-6506; Murthy, Venkatesh/0000-0003-2443-4252	Harvard University	Harvard University	Support was only from start up funds provided by Harvard University to the senior authors. These funds have no restrictions and the University does not direct the research in any way.	Bormuth V, 2007, J MICROSC-OXFORD, V226, P1, DOI 10.1111/j.1365-2818.2007.01756.x; Born M, 2005, PRINCIPLES OPTICS, V7th edn; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Herman P, 2001, J MICROSC-OXFORD, V203, P176, DOI 10.1046/j.1365-2818.2001.00943.x; Holman B, 2007, BIOMED INSTRUM TECHN, V41, P461; Koren P. E., 2000, FAMILY EMPOWERMENT S; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; Martin G, 2005, BIOTECHNIQUES, V38, P204, DOI 10.2144/05382BM06; Meister M, 2001, J NEUROSCI, V21, P1351; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Round H.J., 1907, ELECT WORLD, V49, P309; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Salzberg BM, 2005, J NEUROSCI METH, V141, P165, DOI 10.1016/j.jneumeth.2004.06.009; Tsien RY, 2003, NAT REV MOL CELL BIO, pSS16, DOI 10.1038/nrm1196; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Zheludev N, 2007, NAT PHOTONICS, V1, P189, DOI 10.1038/nphoton.2007.34	19	46	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2146	10.1371/journal.pone.0002146	http://dx.doi.org/10.1371/journal.pone.0002146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478056	Green Accepted, Green Published, gold			2022-12-27	WOS:000262172800011
J	Krishnan, A; Giuliani, A; Zbilut, JP; Tomita, M				Krishnan, Arun; Giuliani, Alessandro; Zbilut, Joseph P.; Tomita, Masaru			Implications from a Network-Based Topological Analysis of Ubiquitin Unfolding Simulations	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; PROTEIN STRUCTURES; PRINCIPLES; TRANSITION; NUCLEATION; HELIX; COIL	Background: The architectural organization of protein structures has been the focus of intense research since it can hopefully lead to an understanding of how proteins fold. In earlier works we had attempted to identify the inherent structural organization in proteins through a study of protein topology. We obtained a modular partitioning of protein structures with the modules correlating well with experimental evidence of early folding units or "foldons". Residues that connect different modules were shown to be those that were protected during the transition phase of folding. Methodology/Principal Findings: In this work, we follow the topological path of ubiquitin through molecular dynamics unfolding simulations. We observed that the use of recurrence quantification analysis (RQA) could lead to the identification of the transition state during unfolding. Additionally, our earlier contention that the modules uncovered through our graph partitioning approach correlated well with early folding units was vindicated through our simulations. Moreover, residues identified from native structure as connector hubs and which had been shown to be those that were protected during the transition phase of folding were indeed more stable (less flexible) well beyond the transition state. Further analysis of the topological pathway suggests that the all pairs shortest path in a protein is minimized during folding. Conclusions: We observed that treating a protein native structure as a network by having amino acid residues as nodes and the non-covalent interactions among them as links allows for the rationalization of many aspects of the folding process. The possibility to derive this information directly from 3D structure opens the way to the prediction of important residues in proteins, while the confirmation of the minimization of APSP for folding allows for the establishment of a potentially useful proxy for kinetic optimality in the validation of sequence-structure predictions.	[Krishnan, Arun; Tomita, Masaru] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Giuliani, Alessandro] Ist Superiore Sanita, Dept Env & Hlth, Rome, Italy; [Zbilut, Joseph P.] Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL USA	Keio University; Istituto Superiore di Sanita (ISS); Rush University	Krishnan, A (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	krishnan@ttck.keio.ac.jp	Giuliani, Alessandro/K-7589-2016; Giuliani, Alessandro/AAF-1740-2020	Giuliani, Alessandro/0000-0002-4640-804X; Giuliani, Alessandro/0000-0002-4640-804X				Allen M., 2017, COMPUTER SIMULATIONS, V2nd; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; BRYGELSON JD, 1995, PROTEIN-STRUCT FUNCT, V21, P167; CHOTHIA C, 1984, ANNU REV BIOCHEM, V53, P537; Condamin S, 2007, NATURE, V450, P77, DOI 10.1038/nature06201; Cruz L, 2005, P NATL ACAD SCI USA, V102, P18258, DOI 10.1073/pnas.0509276102; DASTIDAR SG, 2007, PHYS REV E, V72, P1; del Sol A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r92; DEMACKERELL A, 1998, J PHYS CHEM B, V102, P3586; DILL KA, 1995, PROTEIN SCI, V4, P561; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P8637, DOI 10.1073/pnas.122076099; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P15711, DOI 10.1073/pnas.0704459104; Giuliani A, 1998, AM J PHYSIOL-HEART C, V275, pH1455, DOI 10.1152/ajpheart.1998.275.4.H1455; Giuliani A, 2000, PROTEIN ENG, V13, P671, DOI 10.1093/protein/13.10.671; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; JAENICKE R, 1987, PROG BIOPHYS MOL BIO, V49, P117, DOI 10.1016/0079-6107(87)90011-3; JANIN J, 1979, B I PASTEUR, V77, P337; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; Krishnan A, 2007, J PROTEOME RES, V6, P3924, DOI 10.1021/pr070162v; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; LEVITT M, 1976, NATURE, V261, P552, DOI 10.1038/261552a0; LI AJ, 1994, P NATL ACAD SCI USA, V91, P10430, DOI 10.1073/pnas.91.22.10430; LIFSON S, 1961, J CHEM PHYS, V34, P1963, DOI 10.1063/1.1731802; Manetti C, 1999, PHYS REV E, V59, P992, DOI 10.1103/PhysRevE.59.992; ONUCHIE JN, 1995, ADV PROTEIN CHEM, V53, P87; PAN YQ, 1992, BIOCHEMISTRY-US, V31, P11405, DOI 10.1021/bi00161a019; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SINGH J, 1991, ATLAS PROTEIN SIDE C; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; THOMAS H, 1990, INTRO ALGORITHMS; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Yon JM, 2002, J CELL MOL MED, V6, P307, DOI 10.1111/j.1582-4934.2002.tb00511.x; Zbilut JP, 2007, PROTEINS, V66, P621, DOI 10.1002/prot.21179; Zbilut JP, 2006, FEBS LETT, V580, P4861, DOI 10.1016/j.febslet.2006.07.076; ZIMM BH, 1959, J CHEM PHYS, V31, P526, DOI 10.1063/1.1730390	40	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2149	10.1371/journal.pone.0002149	http://dx.doi.org/10.1371/journal.pone.0002149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478068	Green Published, Green Submitted, gold			2022-12-27	WOS:000262172800014
J	Casas, J; Steinmann, T; Dangles, O				Casas, Jerome; Steinmann, Thomas; Dangles, Olivier			The Aerodynamic Signature of Running Spiders	PLOS ONE			English	Article							FORAGING MODE; CRICKET; ESCAPE; LOCOMOTION; COCKROACH; SYSTEM; HAIRS	Many predators display two foraging modes, an ambush strategy and a cruising mode. These foraging strategies have been classically studied in energetic, biomechanical and ecological terms, without considering the role of signals produced by predators and perceived by prey. Wolf spiders are a typical example; they hunt in leaf litter either using an ambush strategy or by moving at high speed, taking over unwary prey. Air flow upstream of running spiders is a source of information for escaping prey, such as crickets and cockroaches. However, air displacement by running arthropods has not been previously examined. Here we show, using digital particle image velocimetry, that running spiders are highly conspicuous aerodynamically, due to substantial air displacement detectable up to several centimetres in front of them. This study explains the bimodal distribution of spider's foraging modes in terms of sensory ecology and is consistent with the escape distances and speeds of cricket prey. These findings may be relevant to the large and diverse array of arthropod prey-predator interactions in leaf litter.	[Casas, Jerome; Steinmann, Thomas] Univ Tours, Inst Rech Biol Insecte, CNRS, UMR 6035, F-37200 Tours, France; [Dangles, Olivier] CNRS, UPR 9034, LEGS, UR 072,IRD, F-91198 Gif Sur Yvette, France; [Dangles, Olivier] Univ Paris Sud 11, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Casas, J (corresponding author), Univ Tours, Inst Rech Biol Insecte, CNRS, UMR 6035, F-37200 Tours, France.	casas@univ-tours.fr	Casas, Jérôme/D-9620-2011; Dangles, Olivier/C-4924-2009	Casas, Jérôme/0000-0003-1666-295X; Dangles, Olivier/0000-0002-1987-8433	CICADA [IST-2001-34718]; CILIA [FP6-IST-016039]; Information Society Technologies-IST Program, Future and emergent Technologies (FET)	CICADA; CILIA; Information Society Technologies-IST Program, Future and emergent Technologies (FET)	This work is part of the research conducted within the Cricket Inspired perCeption and Autonomous Decision Automata (CICADA) project (IST-2001-34718) and within the Customized Intelligent Life Inspired Arrays (CILIA) project (FP6-IST-016039). These projects are both funded by the European Community under the Information Society Technologies-IST Program, Future and emergent Technologies (FET).	Camhi JM, 1984, NEUROETHOLOGY NERVE; Cooper WE, 2005, J ZOOL, V267, P179, DOI 10.1017/S0952836905007375; Curio E., 1976, ETHOLOGY PREDATION; Dangles O, 2006, ANIM BEHAV, V72, P603, DOI 10.1016/j.anbehav.2005.11.018; Dangles O, 2006, J EXP BIOL, V209, P393, DOI 10.1242/jeb.02000; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; EDWARDS JS, 1974, PROC R SOC SER B-BIO, V185, P83, DOI 10.1098/rspb.1974.0007; Foelix R., 2011, BIOL SPIDERS, V3; FULL RJ, 1991, J EXP BIOL, V156, P215; Gnatzy W., 1996, DIGGER WASP VS CRICK; Grimaldi David, 2005, pi; HUEY RB, 1981, ECOLOGY, V62, P991, DOI 10.2307/1936998; Koehl MAR, 2001, SCIENCE, V294, P1948, DOI 10.1126/science.1063724; Kramer DL, 2001, AM ZOOL, V41, P137, DOI 10.1668/0003-1569(2001)041[0137:TBEOIL]2.0.CO;2; Kronestedt T, 2007, ZOOTAXA, P25; Labandeira Conrad C., 2002, Paleontological Society Papers, V8, P211; Lauder GV, 2008, ANNU REV PHYSIOL, V70, P143, DOI 10.1146/annurev.physiol.70.113006.100438; Nishikawa K, 2007, INTEGR COMP BIOL, V47, P16, DOI 10.1093/icb/icm024; PLUMMER MR, 1981, J COMP PHYSIOL, V142, P347, DOI 10.1007/BF00605447; Riechert Susan E., 1992, P313, DOI 10.1002/9781444314076.ch13; Rinberg D, 2003, J COMP PHYSIOL A, V189, P867, DOI 10.1007/s00359-003-0460-9; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; SHIMOZAWA T, 1984, J COMP PHYSIOL, V155, P485, DOI 10.1007/BF00611913; Shimozawa T, 2003, SENSORS AND SENSING IN BIOLOGY AND ENGINEERING, P145; Steinmann T, 2006, J EXP BIOL, V209, P4398, DOI 10.1242/jeb.02506; TAUBER E, 1995, J EXP BIOL, V198, P1895; Tautz J, 1989, MEDIENBEWEGUNG SINNE; Taylor GK, 2003, NATURE, V425, P707, DOI 10.1038/nature02000; Warrick DR, 2005, NATURE, V435, P1094, DOI 10.1038/nature03647	31	37	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2116	10.1371/journal.pone.0002116	http://dx.doi.org/10.1371/journal.pone.0002116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461167	Green Published, gold			2022-12-27	WOS:000261642400038
J	Chan, PK; Wai, A; Philipsen, S; Tan-Un, KC				Chan, Ping Kei; Wai, Albert; Philipsen, Sjaak; Tan-Un, Kian-Cheng			5 ' HS5 of the Human beta-globin Locus Control Region Is Dispensable for the Formation of the beta-globin Active Chromatin Hub	PLOS ONE			English	Article								Hypersensitive site 5 (5'HS5) of the beta-globin Locus Control Region functions as a developmental stage-specific border in erythroid cells. Here, we have analyzed the role of 5'HS5 in the three dimensional organization of the beta-gene locus using the Chromatin Conformation Capture (3C) technique. The results show that when 5'HS5 is deleted from the locus, both remote and internal regulatory elements are still able to interact with each other in a three-dimensional configuration termed the Active Chromatin Hub. Thus, the absence of 5'HS5 does not have an appreciable effect on the three dimensional organization of the beta-globin locus. This rules out models in which 5'HS5 nucleates interactions with remote and/or internal regulatory elements. We also determined the binding of CTCF, the only defined insulator protein in mammalian cells, to 5'HS5 by using chromatin immunoprecipitation (ChIP) assays. We detect low levels of CTCF binding to 5'HS5 in primitive erythroid cells, in which it functions as a border element. Surprisingly, we also observe binding levels of CTCF to 59HS5 in definitive erythroid cells. Thus, binding of CTCF to 59HS5 per se does not render it a functional border element. This is consistent with the previous data suggesting that CTCF has dual functionality.	[Chan, Ping Kei; Tan-Un, Kian-Cheng] Univ Hong Kong, Dept Zool, Hong Kong, Hong Kong, Peoples R China; [Wai, Albert; Philipsen, Sjaak] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands	University of Hong Kong; Erasmus University Rotterdam; Erasmus MC	Chan, PK (corresponding author), Univ Hong Kong, Dept Zool, Kadoorie Biol Sci Bldg, Hong Kong, Hong Kong, Peoples R China.	j.philipsen@erasmusmc.nl; kctanun@hkucc.hku.hk			HKU School of Professional and Continuing Education (HKU SPACE)	HKU School of Professional and Continuing Education (HKU SPACE)	This work was supported by the HKU School of Professional and Continuing Education (HKU SPACE).	Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bulger M, 1999, P NATL ACAD SCI USA, V96, P5129, DOI 10.1073/pnas.96.9.5129; Bulger M, 2003, MOL CELL BIOL, V23, P5234, DOI 10.1128/MCB.23.15.5234-5244.2003; Bungert J, 1999, MOL CELL BIOL, V19, P3062; Capelson M, 2006, EMBO J, V25, P1906, DOI 10.1038/sj.emboj.7601068; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dillon N, 1997, MOL CELL, V1, P131, DOI 10.1016/S1097-2765(00)80014-3; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Farrell CM, 2002, MOL CELL BIOL, V22, P3820, DOI 10.1128/MCB.22.11.3820-3831.2002; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; FORRESTER WC, 1987, NUCLEIC ACIDS RES, V15, P10159, DOI 10.1093/nar/15.24.10159; FRASER P, 1993, GENE DEV, V7, P106, DOI 10.1101/gad.7.1.106; Gribnau J, 1998, EMBO J, V17, P6020, DOI 10.1093/emboj/17.20.6020; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Grosveld F, 1987, Prog Clin Biol Res, V251, P133; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; HEBBES TR, 1994, EMBO J, V13, P1823, DOI 10.1002/j.1460-2075.1994.tb06451.x; Imam AMA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e65; Levings PP, 2002, EUR J BIOCHEM, V269, P1589, DOI 10.1046/j.1432-1327.2002.02797.x; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; STROUBOULIS J, 1992, GENE DEV, V6, P1857, DOI 10.1101/gad.6.10.1857; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; TUAN DYH, 1989, P NATL ACAD SCI USA, V86, P2554, DOI 10.1073/pnas.86.8.2554; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Wai AWK, 2003, EMBO J, V22, P4489, DOI 10.1093/emboj/cdg437; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; Zhou JM, 1996, GENE DEV, V10, P3195, DOI 10.1101/gad.10.24.3195	35	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2134	10.1371/journal.pone.0002134	http://dx.doi.org/10.1371/journal.pone.0002134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461170	Green Published, gold, Green Submitted			2022-12-27	WOS:000261642400055
J	Todi, SV; Sivan-Loukianova, E; Jacobs, JS; Kiehart, DP; Eberl, DF				Todi, Sokol V.; Sivan-Loukianova, Elena; Jacobs, Julie S.; Kiehart, Daniel P.; Eberl, Daniel F.			Myosin VIIA, Important for Human Auditory Function, Is Necessary for Drosophila Auditory Organ Development	PLOS ONE			English	Article								Background: Myosin VIIA (MyoVIIA) is an unconventional myosin necessary for vertebrate audition [1-5]. Human auditory transduction occurs in sensory hair cells with a staircase-like arrangement of apical protrusions called stereocilia. In these hair cells, MyoVIIA maintains stereocilia organization [6]. Severe mutations in the Drosophila MyoVIIA orthologue, crinkled (ck), are semi-lethal [7] and lead to deafness by disrupting antennal auditory organ (Johnston's Organ, JO) organization [8]. ck/MyoVIIA mutations result in apical detachment of auditory transduction units (scolopidia) from the cuticle that transmits antennal vibrations as mechanical stimuli to JO. Principal Findings: Using flies expressing GFP-tagged NompA, a protein required for auditory organ organization in Drosophila, we examined the role of ck/MyoVIIA in JO development and maintenance through confocal microscopy and extracellular electrophysiology. Here we show that ck/MyoVIIA is necessary early in the developing antenna for initial apical attachment of the scolopidia to the articulating joint. ck/MyoVIIA is also necessary to maintain scolopidial attachment throughout adulthood. Moreover, in the adult JO, ck/MyoVIIA genetically interacts with the non-muscle myosin II (through its regulatory light chain protein and the myosin binding subunit of myosin II phosphatase). Such genetic interactions have not previously been observed in scolopidia. These factors are therefore candidates for modulating MyoVIIA activity in vertebrates. Conclusions: Our findings indicate that MyoVIIA plays evolutionarily conserved roles in auditory organ development and maintenance in invertebrates and vertebrates, enhancing our understanding of auditory organ development and function, as well as providing significant clues for future research.	[Todi, Sokol V.; Eberl, Daniel F.] Univ Iowa, Neurosci Grad Program, Iowa City, IA USA; [Todi, Sokol V.; Sivan-Loukianova, Elena; Jacobs, Julie S.; Eberl, Daniel F.] Univ Iowa, Dept Biol, Iowa City, IA USA; [Kiehart, Daniel P.] Duke Univ, Dept Biol, Durham, NC USA	University of Iowa; University of Iowa; Duke University	Todi, SV (corresponding author), Univ Iowa, Neurosci Grad Program, Iowa City, IA USA.	daniel-eberl@uiowa.edu	Eberl, Daniel F./AAN-3359-2020	Eberl, Daniel F./0000-0001-9982-9895; TODI, SOKOL/0000-0003-4399-5549	AHA predoctoral fellowship [0410077Z]; NIH [DC07673, DC04848]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007673, R01DC004848] Funding Source: NIH RePORTER	AHA predoctoral fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by AHA predoctoral fellowship #0410077Z to SVT, and NIH grants #DC07673 to DPK and #DC04848 to DFE. These agencies had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Adato A, 2005, HUM MOL GENET, V14, P3921, DOI 10.1093/hmg/ddi416; Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Chung YD, 2001, NEURON, V29, P415, DOI 10.1016/S0896-6273(01)00215-X; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189; Franke JD, 2006, CELL MOTIL CYTOSKEL, V63, P604, DOI 10.1002/cm.20148; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Hartshorne DJ, 1998, J MUSCLE RES CELL M, V19, P325, DOI 10.1023/A:1005385302064; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Kiehart DP, 2004, GENETICS, V168, P1337, DOI 10.1534/genetics.104.026369; Krasnow RE, 1995, DEVELOPMENT, V121, P4095; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Kussel-Andermann P, 2000, J BIOL CHEM, V275, P29654, DOI 10.1074/jbc.M004393200; LI CL, 1995, J NEUROBIOL, V28, P363, DOI 10.1002/neu.480280309; LIENHARD MC, 1991, DEVELOPMENT, V112, P1063; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; MILNER MJ, 1979, ROUX ARCH DEV BIOL, V185, P363, DOI 10.1007/BF00848522; Mizuno T, 1999, GENE, V238, P437, DOI 10.1016/S0378-1119(99)00351-0; Mizuno T, 2002, DEVELOPMENT, V129, P1215; Mlodzik M, 1999, EMBO J, V18, P6873, DOI 10.1093/emboj/18.24.6873; Self T, 1998, DEVELOPMENT, V125, P557; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Sokol S, 2000, NAT CELL BIOL, V2, pE124, DOI 10.1038/35017136; Tan CG, 2003, DEVELOPMENT, V130, P671, DOI 10.1242/dev.00298; TAN JL, 1992, ANNU REV BIOCHEM, V61, P721, DOI 10.1146/annurev.bi.61.070192.003445; Todi SV, 2005, CURR BIOL, V15, P862, DOI 10.1016/j.cub.2005.03.050; Todi SV, 2004, MICROSC RES TECHNIQ, V63, P388, DOI 10.1002/jemt.20053; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209	40	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2115	10.1371/journal.pone.0002115	http://dx.doi.org/10.1371/journal.pone.0002115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461180	Green Submitted, Green Published, gold			2022-12-27	WOS:000261642400037
J	Proell, M; Riedl, SJ; Fritz, JH; Rojas, AM; Schwarzenbacher, R				Proell, Martina; Riedl, Stefan J.; Fritz, Joerg H.; Rojas, Ana M.; Schwarzenbacher, Robert			The Nod-Like Receptor (NLR) Family: A Tale of Similarities and Differences	PLOS ONE			English	Article								Innate immunity represents an important system with a variety of vital processes at the core of many diseases. In recent years, the central role of the Nod-like receptor (NLR) protein family became increasingly appreciated in innate immune responses. NLRs are classified as part of the signal transduction ATPases with numerous domains (STAND) clade within the AAA+ ATPase family. They typically feature an N-terminal effector domain, a central nucleotide-binding domain (NACHT) and a C-terminal ligand-binding region that is composed of several leucine-rich repeats (LRRs). NLRs are believed to initiate or regulate host defense pathways through formation of signaling platforms that subsequently trigger the activation of inflammatory caspases and NF-kB. Despite their fundamental role in orchestrating key pathways in innate immunity, their mode of action in molecular terms remains largely unknown. Here we present the first comprehensive sequence and structure modeling analysis of NLR proteins, revealing that NLRs posses a domain architecture similar to the apoptotic initiator protein Apaf-1. Apaf-1 performs its cellular function by the formation of a heptameric platform, dubbed apoptosome, ultimately triggering the controlled demise of the affected cell. The mechanism of apoptosome formation by Apaf-1 potentially offers insight into the activation mechanisms of NLR proteins. Multiple sequence alignment analysis and homology modeling revealed Apaf-1-like structural features in most members of the NLR family, suggesting a similar biochemical behaviour in catalytic activity and oligomerization. Evolutionary tree comparisons substantiate the conservation of characteristic functional regions within the NLR family and are in good agreement with domain distributions found in distinct NLRs. Importantly, the analysis of LRR domains reveals surprisingly low conservation levels among putative ligand-binding motifs. The same is true for the effector domains exhibiting distinct interfaces ensuring specific interactions with downstream target proteins. All together these factors suggest specific biological functions for individual NLRs.	[Proell, Martina; Schwarzenbacher, Robert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Riedl, Stefan J.] Burnham Inst Med Res, La Jolla, CA USA; [Fritz, Joerg H.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Rojas, Ana M.] Spanish Natl Canc Res Ctr, Structural Computat Biol Grp, Madrid, Spain	Salzburg University; Sanford Burnham Prebys Medical Discovery Institute; University of Toronto; Centro Nacional de Investigaciones Oncologicas (CNIO)	Proell, M (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	robert.schwarzenbacher@sbg.ac.at	IBIS, BIOINFORMATICA/O-1882-2015; Rojas, Ana M/C-3022-2008; Rojas, Ana M/D-5777-2011; Rojas, Ana M./I-2882-2019	Rojas, Ana M/0000-0003-0750-9099; Rojas, Ana M./0000-0003-0750-9099	Austrian Academy of Sciences [APART-fellowship]; V-foundation [fellow];  [MCEXT-033534];  [MIRG-CT-2005-016499];  [DOC-FFORTE-fellowship]	Austrian Academy of Sciences; V-foundation; ; ; 	This work was supported by MCEXT-033534 to RS and MIRG-CT-2005-016499 to AMR. MP was supported by a DOC-FFORTE-fellowship and JHF by an APART-fellowship of the Austrian Academy of Sciences. SJR is a fellow of the V-foundation.	Albrecht M, 2006, BIOCHEM BIOPH RES CO, V339, P459, DOI 10.1016/j.bbrc.2005.10.074; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Colonna M, 2007, NAT IMMUNOL, V8, P554, DOI 10.1038/ni0607-554; Diemand AV, 2006, J STRUCT BIOL, V156, P230, DOI 10.1016/j.jsb.2006.04.011; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Faustin B, 2008, TRENDS CELL BIOL, V18, P4, DOI 10.1016/j.tcb.2007.10.004; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hu YM, 1998, J BIOL CHEM, V273, P33489, DOI 10.1074/jbc.273.50.33489; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hysi P, 2005, HUM MOL GENET, V14, P935, DOI 10.1093/hmg/ddi087; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Liepinsh E, 2003, J MOL BIOL, V332, P1155, DOI 10.1016/j.jmb.2003.07.007; Lu CF, 2005, BIOCHEM BIOPH RES CO, V331, P1114, DOI 10.1016/j.bbrc.2005.04.027; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2007, EUR J IMMUNOL, V37, P3003, DOI 10.1002/eji.200737871; Martinon F, 2007, SEMIN IMMUNOPATHOL, V29, P213, DOI 10.1007/s00281-007-0079-y; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Natarajan A, 2006, J BIOL CHEM, V281, P31863, DOI 10.1074/jbc.M605458200; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Papageorgiou AC, 1997, EMBO J, V16, P5162, DOI 10.1093/emboj/16.17.5162; Price SR, 1998, NATURE, V394, P645, DOI 10.1038/29234; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Tattoli I, 2007, SEMIN IMMUNOPATHOL, V29, P289, DOI 10.1007/s00281-007-0083-2; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Werts C, 2006, CELL DEATH DIFFER, V13, P798, DOI 10.1038/sj.cdd.4401890; Yamada K, 2001, P NATL ACAD SCI USA, V98, P1442, DOI 10.1073/pnas.031470598; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; YE Z, 2007, MOL CELL BIOL; Yu XC, 2006, J MOL BIOL, V355, P577, DOI 10.1016/j.jmb.2005.10.040	52	255	260	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2119	10.1371/journal.pone.0002119	http://dx.doi.org/10.1371/journal.pone.0002119			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446235	gold, Green Published, Green Submitted			2022-12-27	WOS:000261572300049
J	Rolf, HJ; Kierdorf, U; Kierdorf, H; Schulz, J; Seymour, N; Schliephake, H; Napp, J; Niebert, S; Wolfel, H; Wiese, KG				Rolf, Hans J.; Kierdorf, Uwe; Kierdorf, Horst; Schulz, Jutta; Seymour, Natascha; Schliephake, Henning; Napp, Joanna; Niebert, Sabine; Woelfel, Helmuth; Wiese, K. Guenter			Localization and Characterization of STRO-1(+) Cells in the Deer Pedicle and Regenerating Antler	PLOS ONE			English	Article							HUMAN BONE-MARROW; STEM-CELLS; GROWING TIP; POPULATION; IDENTIFICATION; PERIOSTEUM; GROWTH; KEY	The annual regeneration of deer antlers is a unique developmental event in mammals, which as a rule possess only a very limited capacity to regenerate lost appendages. Studying antler regeneration can therefore provide a deeper insight into the mechanisms that prevent limb regeneration in humans and other mammals, and, with regard to medical treatments, may possibly even show ways how to overcome these limitations. Traditionally, antler regeneration has been characterized as a process involving the formation of a blastema from de-differentiated cells. More recently it has, however, been hypothesized that antler regeneration is a stem cell-based process. Thus far, direct evidence for the presence of stem cells in primary or regenerating antlers was lacking. Here we demonstrate the presence of cells positive for the mesenchymal stem cell marker STRO-1 in the chondrogenic growth zone and the perivascular tissue of the cartilaginous zone in primary and regenerating antlers as well as in the pedicle of fallow deer (Dama dama). In addition, cells positive for the stem cell/progenitor cell markers STRO-1, CD133 and CD271 (LNGFR) were isolated from the growth zones of regenerating fallow deer antlers as well as the pedicle periosteum and cultivated for extended periods of time. We found evidence that STRO-1(+) cells isolated from the different locations are able to differentiate in vitro along the osteogenic and adipogenic lineages. Our results support the view that the annual process of antler regeneration might depend on the periodic activation of mesenchymal progenitor cells located in the pedicle periosteum. The findings of the present study indicate that not only limited tissue regeneration, but also extensive appendage regeneration in a postnatal mammal can occur as a stem cell-based process.	[Rolf, Hans J.; Schulz, Jutta; Seymour, Natascha; Schliephake, Henning; Napp, Joanna; Niebert, Sabine; Wiese, K. Guenter] Univ Gottingen, Dept Maxillofacial Surg, Univ Hosp, Gottingen, Germany; [Kierdorf, Uwe; Kierdorf, Horst] Univ Hildesheim, Dept Biol, Hildesheim, Germany; [Woelfel, Helmuth] Univ Gottingen, Fac Forest Sci & Forest Ecol, Wildlife Biol & Game Management, Gottingen, Germany	University of Gottingen; University of Hildesheim; University of Gottingen	Rolf, HJ (corresponding author), Univ Gottingen, Dept Maxillofacial Surg, Univ Hosp, Gottingen, Germany.	hrolf@uni-goettingen.de	Kierdorf, Uwe/F-2539-2012; Schliephake, Henning/I-8911-2019	Kierdorf, Uwe/0000-0003-0531-2460; Wiese, K. Gunter/0000-0001-6436-0468; Kierdorf, Horst/0000-0001-6411-9631; Napp, Joanna/0000-0002-9034-9980	German Research Society [RO 2520 1-1, 1-3]	German Research Society(German Research Foundation (DFG))	This research was supported by grants from the German Research Society (DFG/grant numbers: RO 2520 1-1, 1-3).	Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Berg DK, 2007, BIOL REPROD, V77, P384, DOI 10.1095/biolreprod.106.058172; Brachvogel B, 2005, DEVELOPMENT, V132, P2657, DOI 10.1242/dev.01846; Cegielski M, 2006, B VET I PULAWY, V50, P247; CHRISTOV C, 2007, MOL BIOL CELL; Clark DE, 2006, ANAT REC PART A, V288A, P973, DOI 10.1002/ar.a.20364; DELLING G, 1972, BEITR PATHOL, V145, P100; Dennis JE, 2002, CELLS TISSUES ORGANS, V170, P73, DOI 10.1159/000046182; Francis SM, 1998, J EXP ZOOL, V281, P36, DOI 10.1002/(SICI)1097-010X(19980501)281:1&lt;36::AID-JEZ6&gt;3.0.CO;2-D; Goss R.J., 1983, DEER ANTLERS REGENER; Goss R.J., 1984, SOFT HARD TISSUE REP, P554; GOSS RJ, 1995, ANAT REC, V241, P291, DOI 10.1002/ar.1092410302; GOSS RJ, 1980, CLIN ORTHOP RELAT R, P270; GOSS RJ, 1985, J EXP ZOOL, V235, P359, DOI 10.1002/jez.1402350307; Goss RJ., 1972, EPIDERMAL WOUND HEAL, P219; GRONTHOS S, 1994, BLOOD, V84, P4164, DOI 10.1182/blood.V84.12.4164.bloodjournal84124164; HARTWIG H, 1974, Zeitschrift fuer Jagdwissenschaft, V20, P1, DOI 10.1007/BF01901843; Jones EA, 2002, ARTHRITIS RHEUM-US, V46, P3349, DOI 10.1002/art.10696; Jones EA, 2006, CYTOM PART B-CLIN CY, V70B, P391, DOI 10.1002/cyto.b.20118; KIERDORF H, 2001, ROLE ANTLEROGENIC PE, P33; KIERDORF H, 1992, STATE DETERMINATION, P525; Kierdorf U, 2003, ANAT REC PART A, V273A, P741, DOI 10.1002/ar.a.10082; Kierdorf U, 2002, Z JAGDWISS, V48, P22, DOI 10.1007/BF02285354; KIERDORF U, 1994, ANN ANAT, V176, P251; KIERDORF U, 2004, BONE FORMATION ANTLE, P55; Kierdorf U, 2007, J MORPHOL, V268, P726, DOI 10.1002/jmor.10546; Li CY, 2007, J EXP ZOOL PART A, V307A, P95, DOI 10.1002/jez.a.352; Li CY, 2007, CELL TISSUE RES, V328, P65, DOI 10.1007/s00441-006-0333-y; Li CY, 2005, ANAT REC PART A, V282A, P163, DOI 10.1002/ar.a.20148; Matich J, 2003, CELL BIOL INT, V27, P625, DOI 10.1016/S1065-6995(03)00118-5; Morrison JI, 2006, J CELL BIOL, V172, P433, DOI 10.1083/jcb.200509011; MOUNT JG, 2006, ANTLERS MAY REGENERA, V161; NAPP J, 2006, ADV DEER BIOL DEER C; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Price J, 2005, CURR TOP DEV BIOL, V67, P1, DOI 10.1016/S0070-2153(05)67001-9; Price JS, 2005, J ANAT, V207, P603, DOI 10.1111/j.1469-7580.2005.00478.x; ROLF HJ, 2006, ADV DEER BIOL DEER C; ROLF HJ, 2006, OSTEOLOGY, V15, P245; Romeis B., 1989, MIKROSKOPISCHE TECHN; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129; Sieber-Blum Maya, 2004, Birth Defects Res C Embryo Today, V72, P162, DOI 10.1002/bdrc.20008; SIMMONS PJ, 1991, BLOOD, V78, P55; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Wislocki GB, 1942, AM J ANAT, V71, P371, DOI 10.1002/aja.1000710304; Yu H, 2006, AM J PATHOL, V168, P1879, DOI 10.2353/ajpath.2006.051170	47	57	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2064	10.1371/journal.pone.0002064	http://dx.doi.org/10.1371/journal.pone.0002064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446198	Green Submitted, Green Published, gold			2022-12-27	WOS:000261572300033
J	Vaitaitis, GM; Wagner, DH				Vaitaitis, Gisela M.; Wagner, David H., Jr.			High Distribution of CD40 and TRAF2 in Th40 T Cell Rafts Leads to Preferential Survival of this Auto-Aggressive Population in Autoimmunity	PLOS ONE			English	Article								Background: CD40-CD154 interactions have proven critical in autoimmunity, with the identification of CD4(lo)CD40(+) T cells (Th40 cells) as harboring an autoaggressive T cell population shedding new insights into those disease processes. Th40 cells are present at contained levels in non-autoimmune individuals but are significantly expanded in autoimmunity. Th40 cells are necessary and sufficient in transferring type 1 diabetes in mouse models. However, little is known about CD40 signaling in T cells and whether there are differences in that signaling and subsequent outcome depending on disease conditions. When CD40 is engaged, CD40 and TNF-receptor associated factors, TRAFs, become associated with lipid raft microdomains. Dysregulation of T cell homeostasis is emerging as a major contributor to autoimmune disease and thwarted apoptosis is key in breaking homeostasis. Methodology/Principal Findings: Cells were sorted into CD4(hi) and CD4(lo) (Th40 cells) then treated and assayed either as whole or fractionated cell lysates. Protein expression was assayed by western blot and Nf-kappa B DNA-binding activity by electrophoretic mobility shifts. We demonstrate here that autoimmune NOD Th40 cells have drastically exaggerated expression of CD40 on a per-cell-basis compared to non-autoimmune BALB/c. Immediately ex-vivo, untreated Th40 cells from NOD mice have high levels of CD40 and TRAF2 associated with the raft microdomain while Th40 cells from NOR and BALB/c mice do not. CD40 engagement of Th40 cells induces Nf-kappa B DNA-binding activity and anti-apoptotic Bcl-X-L expression in all three mouse strains. However, only in NOD Th40 cells is anti-apoptotic cFLIP(p43) induced which leads to preferential survival and proliferation. Importantly, CD40 engagement rescues NOD Th40 cells from Fas-induced death. Conclusions/Significance: CD40 may act as a switch between life and death promoting signals and NOD Th40 cells are poised for survival via this switch. This may explain how they expand in autoimmunity to thwart T cell homeostasis.	[Vaitaitis, Gisela M.; Wagner, David H., Jr.] Univ Colorado, Dept Med, Webb Waring Inst, Denver, CO 80202 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Vaitaitis, GM (corresponding author), Univ Colorado, Dept Med, Webb Waring Inst, Denver, CO 80202 USA.	David.Wagner@uchsc.edu		Vaitaitis, Gisela/0000-0001-6413-8322	National Institutes of Health [DK07501]; American Diabetes Association; Juvenile Diabetes Research Foundation; Kleberg Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK007501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Kleberg Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from National Institutes of Health (grant # DK07501), the American Diabetes Association, the Juvenile Diabetes Research Foundation and the Kleberg Foundation.	Adorini L, 2003, ANN NY ACAD SCI, V987, P258, DOI 10.1111/j.1749-6632.2003.tb06057.x; Andrade RM, 2005, J IMMUNOL, V175, P6014, DOI 10.4049/jimmunol.175.9.6014; Balasa B, 1997, J IMMUNOL, V159, P4620; Benson RJ, 2006, EUR J IMMUNOL, V36, P2535, DOI 10.1002/eji.200535483; Bishop GA, 2003, CYTOKINE GROWTH F R, V14, P297, DOI 10.1016/S1359-6101(03)00024-8; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Bortner CD, 2002, ANNU REV PHARMACOL, V42, P259, DOI 10.1146/annurev.pharmtox.42.083101.143836; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Christensen JE, 2001, INT IMMUNOL, V13, P593, DOI 10.1093/intimm/13.4.593; Cooper CJ, 2004, J IMMUNOL, V173, P6532, DOI 10.4049/jimmunol.173.11.6532; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; Gregori S, 2002, DIABETES, V51, P1367, DOI 10.2337/diabetes.51.5.1367; Harding SA, 2004, ATHEROSCLEROSIS, V176, P321, DOI 10.1016/j.atherosclerosis.2004.05.008; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; HULEATT JW, 1995, J IMMUNOL, V154, P5684; Issazadeh S, 2000, J CLIN INVEST, V105, P1109, DOI 10.1172/JCI8607; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; KAWAKAMI K, 1995, IMMUNOL LETT, V46, P143, DOI 10.1016/0165-2478(95)00034-3; Khoshnan A, 2000, J IMMUNOL, V165, P1743, DOI 10.4049/jimmunol.165.4.1743; Kobata T, 2000, Rev Immunogenet, V2, P74; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Lafaille JJ, 1998, CYTOKINE GROWTH F R, V9, P139, DOI 10.1016/S1359-6101(98)00009-4; Lamhamedi-Cherradi SE, 1998, DIABETOLOGIA, V41, P178, DOI 10.1007/s001250050887; Lepault F, 2000, J IMMUNOL, V164, P240, DOI 10.4049/jimmunol.164.1.240; Liblau RS, 2002, IMMUNITY, V17, P1, DOI 10.1016/S1074-7613(02)00338-2; Munroe ME, 2004, J BIOL CHEM, V279, P53222, DOI 10.1074/jbc.M410539200; Munroe ME, 2007, J IMMUNOL, V178, P671, DOI 10.4049/jimmunol.178.2.671; Nakamura H, 1999, LAB INVEST, V79, P261; Ott PA, 2005, CELL IMMUNOL, V235, P1, DOI 10.1016/j.cellimm.2005.05.003; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Quezada SA, 2003, ARTHRITIS RHEUM, V48, P2541, DOI 10.1002/art.11230; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Santamaria P, 2003, ANN NY ACAD SCI, V1005, P88, DOI 10.1196/annals.1288.010; Seetharaman R, 1999, J IMMUNOL, V163, P1577; SERREZE DV, 1994, J EXP MED, V180, P1553, DOI 10.1084/jem.180.4.1553; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Solanilla A, 2005, BLOOD, V105, P215, DOI 10.1182/blood-2003-07-2367; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Suda T, 1997, J ALLERGY CLIN IMMUN, V100, pS97, DOI 10.1016/S0091-6749(97)70013-7; Thome M, 2001, NAT REV IMMUNOL, V1, P50, DOI 10.1038/35095508; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Toubi E, 2004, AUTOIMMUNITY, V37, P457, DOI 10.1080/08916930400002386; Vaitaitis GM, 2003, J IMMUNOL, V170, P3455, DOI 10.4049/jimmunol.170.7.3455; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Varo Nerea, 2005, Diab Vasc Dis Res, V2, P81, DOI 10.3132/dvdr.2005.014; Wagner DH, 2002, P NATL ACAD SCI USA, V99, P3782, DOI 10.1073/pnas.052247099; Wagner DH, 1999, INT J MOL MED, V4, P231; Waid DM, 2007, CLIN IMMUNOL, V124, P138, DOI 10.1016/j.clim.2007.05.003; Waid DM, 2004, EUR J IMMUNOL, V34, P1488, DOI 10.1002/eji.200324703; WAID DM, J LEUKOC BI IN PRESS; Wang X, 2004, FASEB J, V18, P1826, DOI 10.1096/fj.04-2047com; Wang XB, 2002, J IMMUNOL, V168, P2046, DOI 10.4049/jimmunol.168.4.2046; Xie P, 2006, J IMMUNOL, V176, P5388, DOI 10.4049/jimmunol.176.9.5388; Yan JC, 2004, CLIN CHIM ACTA, V339, P85, DOI 10.1016/j.cccn.2003.09.007; Yu SG, 2001, J AUTOIMMUN, V16, P37, DOI 10.1006/jaut.2000.0458; Zhu N, 2002, J IMMUNOL, V168, P744, DOI 10.4049/jimmunol.168.2.744	58	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2076	10.1371/journal.pone.0002076	http://dx.doi.org/10.1371/journal.pone.0002076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446238	Green Published, Green Submitted, gold			2022-12-27	WOS:000261572300045
J	Yao, K; Gagnon, S; Akhyani, N; Williams, E; Fotheringham, J; Frohman, E; Stuve, O; Monson, N; Racke, MK; Jacobson, S				Yao, Karen; Gagnon, Susan; Akhyani, Nahid; Williams, Elizabeth; Fotheringham, Julie; Frohman, Elliot; Stuve, Olaf; Monson, Nancy; Racke, Michael K.; Jacobson, Steven			Reactivation of Human Herpesvirus-6 in Natalizumab Treated Multiple Sclerosis Patients	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; JC VIRUS; HUMAN-HERPESVIRUS-6; INFECTION; VARIANT; HHV-6; ASSOCIATION; PREVALENCE; THERAPY; BRAIN	The alpha(4) integrin antagonist natalizumab was shown to be effective in patients with immune-mediated disorders but was unexpectedly associated with JC polyomavirus associated progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis (MS) and one Crohn's disease patients. Impaired immune surveillance due to natalizumab treatment may have contributed to the JCV reactivation. As HHV-6 has been suggested to play a role in MS, we asked whether this virus could also have been reactivated during natalizumab therapy. Matched sera and CSF from a limited set of MS patients treated with and without natalizumab were examined for evidence of HHV-6. In addition, we also superinfected a persistent JC virus infected glial cell with HHV-6A to determine if JC virus can be increased. Elevated serum HHV6 IgG and HHV-6A DNA was detected in the CSF of a subset of patients but not controls. We confirmed that superinfection with HHV-6 of a JC virus infected glial cells increased expression of JCV. These results support the hypothesis that treatment with natalizumab may be associated with reduced immune surveillance resulting in reactivation of viruses associated with MS pathogenesis.	[Yao, Karen; Gagnon, Susan; Akhyani, Nahid; Williams, Elizabeth; Fotheringham, Julie; Jacobson, Steven] NIH, Viral Immunol Sect, Bethesda, MD 20892 USA; [Frohman, Elliot; Stuve, Olaf; Monson, Nancy; Racke, Michael K.] Univ Texas, SW Med Ctr, Ctr Immunol, Dept Neurol, Dallas, TX USA; [Yao, Karen] Johns Hopkins Univ, Dept Biol, Baltimore, MD USA	National Institutes of Health (NIH) - USA; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University	Yao, K (corresponding author), NIH, Viral Immunol Sect, Bldg 10, Bethesda, MD 20892 USA.	jacobsons@ninds.nih.gov	Calabrese, Massimiliano/I-6195-2012		National Institutes of Health, National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003040, Z01NS003040, Z01NS002817, ZIANS002817] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the National Institutes of Health, National Institute of Neurological Disorders and Stroke.	Ablashi DV, 1998, MULT SCLER, V4, P490, DOI 10.1177/135245859800400606; Ahlqvist J, 2005, J NEUROVIROL, V11, P384, DOI 10.1080/13550280591002379; Akhyani N, 2000, J INFECT DIS, V182, P1321, DOI 10.1086/315893; Alvarez-Lafuente R, 2006, BRAIN PATHOL, V16, P20, DOI 10.1111/j.1750-3639.2006.tb00558.x; Alvarez-Lafuente R, 2004, ARCH NEUROL-CHICAGO, V61, P1523, DOI 10.1001/archneur.61.10.1523; Alvarez-Lafuente R, 2002, ACTA NEUROL SCAND, V105, P95, DOI 10.1034/j.1600-0404.2002.1o050.x; Andre-Garnier E, 2004, J GEN VIROL, V85, P3333, DOI 10.1099/vir.0.80319-0; Bennett JL, 2006, NEUROL RES, V28, P291, DOI 10.1179/016164106X98189; Berger JR, 2005, NEW ENGL J MED, V353, P414, DOI 10.1056/NEJMe058122; Birnbaum T, 2005, CLIN INFECT DIS, V40, P887, DOI 10.1086/427943; BROWN P, 1975, AM J EPIDEMIOL, V102, P331, DOI 10.1093/oxfordjournals.aje.a112169; Cermelli C, 2003, J INFECT DIS, V187, P1377, DOI 10.1086/368166; Cermelli C, 2000, VIRAL IMMUNOL, V13, P255, DOI 10.1089/08828240050144590; CHALLONER PB, 1995, P NATL ACAD SCI USA, V92, P7440, DOI 10.1073/pnas.92.16.7440; Dewhurst Stephen, 2004, Herpes, V11 Suppl 2, p105A; Dominguez G, 1999, J VIROL, V73, P8040, DOI 10.1128/JVI.73.10.8040-8052.1999; Donati D, 2003, NEUROLOGY, V61, P1405, DOI 10.1212/01.WNL.0000094357.10782.F9; Donati D, 2005, J VIROL, V79, P9439, DOI 10.1128/JVI.79.15.9439-9448.2005; Fotheringham J, 2007, J INFECT DIS, V195, P450, DOI 10.1086/510757; FRENKEL N, 1994, BONE MARROW TRANSPL, V14, P839; Gentile Giuseppe, 2000, Herpes, V7, P24; Gilden DH, 2005, LANCET NEUROL, V4, P195, DOI 10.1016/S1474-4422(05)01017-3; HOUFF SA, 1989, AIDS, V3, P843, DOI 10.1097/00002030-198912000-00010; Isaacson E, 2005, CLIN INFECT DIS, V40, P890, DOI 10.1086/427944; Jacobson S, 1998, J NEUROVIROL, V4, P471, DOI 10.3109/13550289809113491; Khalili K, 2007, NEUROLOGY, V68, P985, DOI 10.1212/01.wnl.0000257832.38943.2b; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Kroon FP, 1997, CLIN INFECT DIS, V25, P600, DOI 10.1086/513750; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Luppi M, 1999, J VIROL, V73, P754, DOI 10.1128/JVI.73.1.754-759.1999; Maeda Y, 2000, LEUKEMIA LYMPHOMA, V39, P229, DOI 10.3109/10428190009065823; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McFarland HF, 2006, ARCH NEUROL-CHICAGO, V63, P1366, DOI 10.1001/archneur.63.10.1366; Mock DJ, 1999, J NEUROVIROL, V5, P363, DOI 10.3109/13550289909029477; Ongradi J, 1999, J NEUROVIROL, V5, P529, DOI 10.3109/13550289909045382; Opsahl ML, 2005, BRAIN, V128, P516, DOI 10.1093/brain/awh390; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Ransohoff RM, 2005, NAT NEUROSCI, V8, P1275, DOI 10.1038/nn1005-1275; Rice GPA, 2005, NEUROLOGY, V64, P1336, DOI 10.1212/01.WNL.0000158329.30470.D0; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Ryschkewitsch C, 2004, J VIROL METHODS, V121, P217, DOI 10.1016/j.jviromet.2004.06.021; SECCHIERO P, 1995, J INFECT DIS, V171, P273, DOI 10.1093/infdis/171.2.273; Soldan SS, 2000, ANN NEUROL, V47, P306, DOI 10.1002/1531-8249(200003)47:3<306::AID-ANA5>3.0.CO;2-A; Soldan SS, 1997, NAT MED, V3, P1394, DOI 10.1038/nm1297-1394; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Stuve O, 2006, ANN NEUROL, V59, P743, DOI 10.1002/ana.20858; Stuve O, 2006, ARCH NEUROL-CHICAGO, V63, P1383, DOI 10.1001/archneur.63.10.1383; Tishon A, 1996, NAT MED, V2, P1250, DOI 10.1038/nm1196-1250; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; Villoslada P, 2003, NEUROLOGY, V60, P1944, DOI 10.1212/01.WNL.0000069461.53733.F7; Winklhofer KF, 2000, VIROLOGY, V275, P323, DOI 10.1006/viro.2000.0503; YAMANISHI K, 1988, LANCET, V1, P1065; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693	55	45	47	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2028	10.1371/journal.pone.0002028	http://dx.doi.org/10.1371/journal.pone.0002028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446218	Green Submitted, Green Published, gold			2022-12-27	WOS:000261572300002
J	Rodriguez, A; Ehlenberger, DB; Dickstein, DL; Hof, PR; Wearne, SL				Rodriguez, Alfredo; Ehlenberger, Douglas B.; Dickstein, Dara L.; Hof, Patrick R.; Wearne, Susan L.			Automated Three-Dimensional Detection and Shape Classification of Dendritic Spines from Fluorescence Microscopy Images	PLOS ONE			English	Article							CALCIUM DYNAMICS; NEURONS; PLASTICITY; STABILITY; MORPHOLOGY; DIFFUSION; NEOCORTEX; CORTEX; CA1	A fundamental challenge in understanding how dendritic spine morphology controls learning and memory has been quantifying three-dimensional (3D) spine shapes with sufficient precision to distinguish morphologic types, and sufficient throughput for robust statistical analysis. The necessity to analyze large volumetric data sets accurately, efficiently, and in true 3D has been a major bottleneck in deriving reliable relationships between altered neuronal function and changes in spine morphology. We introduce a novel system for automated detection, shape analysis and classification of dendritic spines from laser scanning microscopy (LSM) images that directly addresses these limitations. The system is more accurate, and at least an order of magnitude faster, than existing technologies. By operating fully in 3D the algorithm resolves spines that are undetectable with standard two-dimensional (2D) tools. Adaptive local thresholding, voxel clustering and Rayburst Sampling generate a profile of diameter estimates used to classify spines into morphologic types, while minimizing optical smear and quantization artifacts. The technique opens new horizons on the objective evaluation of spine changes with synaptic plasticity, normal development and aging, and with neurodegenerative disorders that impair cognitive function.	[Rodriguez, Alfredo; Ehlenberger, Douglas B.; Dickstein, Dara L.; Hof, Patrick R.; Wearne, Susan L.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Rodriguez, Alfredo; Ehlenberger, Douglas B.; Wearne, Susan L.] Mt Sinai Sch Med, Lab Biomath, New York, NY USA; [Rodriguez, Alfredo; Ehlenberger, Douglas B.; Dickstein, Dara L.; Hof, Patrick R.; Wearne, Susan L.] Mt Sinai Sch Med, Computat Neurobiol & Imaging Ctr, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Rodriguez, A (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.	susan.wearne@mssm.edu	Dickstein, Dara/AAH-6603-2020; Dickstein, Dara/F-3036-2013		NIH [MH71818, DC05669, MH58911, AG05138]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058911, R01MH071818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005669] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by NIH grants MH71818 and DC05669 (SLW) and MH58911 and AG05138 (PRH).	Al-Kofahi KA, 2002, IEEE T INF TECHNOL B, V6, P171, DOI 10.1109/TITB.2002.1006304; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Bloodgood BL, 2007, CURR OPIN NEUROBIOL, V17, P345, DOI 10.1016/j.conb.2007.04.003; BLOOM FE, 1997, NEUROINFORMATICS OVE, P83; Borgefors G, 1999, PATTERN RECOGN, V32, P1225, DOI 10.1016/S0031-3203(98)00082-X; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Cheng J, 2007, J NEUROSCI METH, V165, P122, DOI 10.1016/j.jneumeth.2007.05.020; Dailey ME, 1996, J NEUROSCI, V16, P2983; Duan HL, 2003, CEREB CORTEX, V13, P950, DOI 10.1093/cercor/13.9.950; GLASER JR, 1990, COMPUT MED IMAG GRAP, V14, P307, DOI 10.1016/0895-6111(90)90105-K; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HARRIS KM, 1992, J NEUROSCI, V12, P2685; He W, 2003, MICROSC MICROANAL, V9, P296, DOI 10.1017/S143192760303040X; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Holthoff K, 2002, NEURON, V33, P425, DOI 10.1016/S0896-6273(02)00576-7; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; JACKINS CL, 1980, COMPUT VISION GRAPH, V14, P249, DOI 10.1016/0146-664X(80)90055-6; JONES EG, 1969, J CELL SCI, V5, P509; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Koh IYY, 2002, NEURAL COMPUT, V14, P1283, DOI 10.1162/089976602753712945; Krichmar JL, 2002, BRAIN RES, V941, P11, DOI 10.1016/S0006-8993(02)02488-5; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Page TL, 2002, NEUROSCI LETT, V317, P37, DOI 10.1016/S0304-3940(01)02428-4; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Rodriguez A, 2006, NAT PROTOC, V1, P2152, DOI 10.1038/nprot.2006.313; Santamaria F, 2006, NEURON, V52, P635, DOI 10.1016/j.neuron.2006.10.025; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Schmitt S, 2004, NEUROIMAGE, V23, P1283, DOI 10.1016/j.neuroimage.2004.06.047; SCORCIONI R, 2001, LECT NOTES COMP SCI, V2084, P30; STRATFORD K, 1989, COMP NEUR S, P296; Streekstra GJ, 2002, NETWORK-COMP NEURAL, V13, P381, DOI 10.1088/0954-898X/13/3/308; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhang Y, 2007, NEUROIMAGE, V36, P346, DOI 10.1016/j.neuroimage.2007.02.044; Zhou Q, 2004, TRENDS NEUROSCI, V27, P378, DOI 10.1016/j.tins.2004.05.006; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	49	403	406	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1997	10.1371/journal.pone.0001997	http://dx.doi.org/10.1371/journal.pone.0001997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431482	Green Published, Green Submitted, gold			2022-12-27	WOS:000261558700017
J	Azadpour, M; Balaban, E				Azadpour, Mahan; Balaban, Evan			Phonological Representations Are Unconsciously Used when Processing Complex, Non-Speech Signals	PLOS ONE			English	Article								Neuroimaging studies of speech processing increasingly rely on artificial speech-like sounds whose perceptual status as speech or non-speech is assigned by simple subjective judgments; brain activation patterns are interpreted according to these status assignments. The naive perceptual status of one such stimulus, spectrally-rotated speech (not consciously perceived as speech by naive subjects), was evaluated in discrimination and forced identification experiments. Discrimination of variation in spectrally-rotated syllables in one group of naive subjects was strongly related to the pattern of similarities in phonological identification of the same stimuli provided by a second, independent group of naive subjects, suggesting either that (1) naive rotated syllable perception involves phonetic-like processing, or (2) that perception is solely based on physical acoustic similarity, and similar sounds are provided with similar phonetic identities. Analysis of acoustic (Euclidean distances of center frequency values of formants) and phonetic similarities in the perception of the vowel portions of the rotated syllables revealed that discrimination was significantly and independently influenced by both acoustic and phonological information. We conclude that simple subjective assessments of artificial speech-like sounds can be misleading, as perception of such sounds may initially and unconsciously utilize speech-like, phonological processing.	[Azadpour, Mahan; Balaban, Evan] SISSA, Int Sch Adv Studies, Cognit Neurosci Sector, I-34014 Trieste, Italy; [Balaban, Evan] McGill Univ, Behav Neurosci Program, Montreal, PQ, Canada	International School for Advanced Studies (SISSA); McGill University	Balaban, E (corresponding author), SISSA, Int Sch Adv Studies, Cognit Neurosci Sector, I-34014 Trieste, Italy.	evan.balaban@mcgill.ca	Balaban, Evan/AAV-2353-2020	Balaban, Evan/0000-0002-0391-3433; Azadpour, Mahan/0000-0001-5714-7140	Scuola Internazionale Superiore di Studi Avanzati SISSA (Italy); NSERC (Canada); Canadian Fund for Innovation	Scuola Internazionale Superiore di Studi Avanzati SISSA (Italy); NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Fund for Innovation	This work was supported by the Scuola Internazionale Superiore di Studi Avanzati SISSA (Italy), NSERC (Canada), and the Canadian Fund for Innovation.	BLESSER B, 1972, J SPEECH HEAR RES, V15, P5, DOI 10.1044/jshr.1501.05; Boersma Paul, 2006, PRAAT DOING PHONETIC; Dehaene-Lambertz G, 2005, NEUROIMAGE, V24, P21, DOI 10.1016/j.neuroimage.2004.09.039; Fava Elisabetta, 1976, STUDI FONETICA FONOL, P35; LIBERMAN AM, 1989, SCIENCE, V243, P489, DOI 10.1126/science.2643163; Manly BFJ, 1997, RANDOMIZATION BOOTST; Maurer D, 2000, INT J NEUROSCI, V100, P39, DOI 10.3109/00207450008999677; Narain C, 2003, CEREB CORTEX, V13, P1362, DOI 10.1093/cercor/bhg083; Obleser J, 2006, CEREB CORTEX, V16, P1069, DOI 10.1093/cercor/bhj047; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Pulvermuller F, 2006, P NATL ACAD SCI USA, V103, P7865, DOI 10.1073/pnas.0509989103; ROSEN S, 2002, ARO ABSTR, V25, P50; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Scott SK, 2006, J ACOUST SOC AM, V120, P1075, DOI 10.1121/1.2216725; SIEGEL S, 1988, NONPARAMETRIC STAT; Whalen DH, 2006, J ACOUST SOC AM, V119, P575, DOI 10.1121/1.2139627; Wright Richard, 2004, PHONETICALLY BASED P, P34, DOI DOI 10.1017/CBO9780511486401.002	18	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1966	10.1371/journal.pone.0001966	http://dx.doi.org/10.1371/journal.pone.0001966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414663	Green Submitted, Green Published, gold			2022-12-27	WOS:000260867300012
J	Duncan, GE; Goldberg, J; Noonan, C; Moudon, AV; Hurvitz, P; Buchwald, D				Duncan, Glen E.; Goldberg, Jack; Noonan, Carolyn; Moudon, Anne Vernez; Hurvitz, Philip; Buchwald, Dedra			Unique Environmental Effects on Physical Activity Participation: A Twin Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GENETIC-FACTORS; EXERCISE; HEALTH; INTERVENTION; PREVENTION; INTENSITY; ZYGOSITY; MODERATE	Background: The health benefits of regular physical activity are well established. However, the relative contribution of heritable and environmental factors to physical activity participation remains controversial. Using a cut-point of 60 minutes of total activity per week, data from the GenomEUtwin project revealed consistent genetic influence on physical activity participation in 37,051 twin pairs from seven countries. We hypothesized that the heritability of physical activity participation would be attenuated using the CDC/ACSM recommended minimum threshold of 150 minutes of moderate intensity activity per week. Methods: Data were obtained from 1,389 twin pairs from the community-based University of Washington Twin Registry. Twin similarity in physical activity participation using both cut-points was analyzed using tetrachoric correlations and structural equation modeling in all same-sex pairs. Results: Correlations were higher in monozygotic (r(MZ) = 0.43, 95% CI = 0.33-0.54) than dizygotic pairs (r(DZ) = 0.30, 95% CI = 0.12-0.47) using the 60 minute cut-point. However, differences were attenuated using the 150 minute standard (r(MZ) = 0.30, 95% CI = 0.20-0.40; r(DZ) = 0.25, 95% CI = 0.07-0.42). Using the lower cut-point, the best fitting model of twin resemblance only included additive genetics and unique environment, with a heritability of 45%. In contrast, using the higher threshold, the best fitting model included the common and unique environment, with the unique environment contributing 72% of the variance. Conclusion: Unique environment factors provide the strongest influence on physical activity participation at levels recommended for health benefits.	[Duncan, Glen E.; Goldberg, Jack; Moudon, Anne Vernez] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Goldberg, Jack] Seattle VA Epidemiol Res & Educat Ctr, Vietnam Era Twin Registry, Seattle, WA USA; [Noonan, Carolyn; Buchwald, Dedra] Univ Washington Twin Registry, Univ Washington, Dept Med, Seattle, WA USA; [Moudon, Anne Vernez; Hurvitz, Philip] Univ Washington, Dept Urban Design & Planning, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Duncan, GE (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	duncag@u.washington.edu	Duncan, Glen/A-3771-2008	Duncan, Glen/0000-0001-6909-1869; Hurvitz, Philip/0000-0002-2944-0785	National Institutes of Health [R21AG032232]; NATIONAL INSTITUTE ON AGING [R21AG032232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding to defray the cost of publication charges was provided by National Institutes of Health grant R21AG032232. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Allender S, 2007, J EPIDEMIOL COMMUN H, V61, P344, DOI 10.1136/jech.2006.050807; Bianchini Franca, 2002, Obes Rev, V3, P5, DOI 10.1046/j.1467-789X.2002.00046.x; Carlsson S, 2006, MED SCI SPORT EXER, V38, P1396, DOI 10.1249/01.mss.0000228941.17034.c1; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1208; Duncan GE, 2005, ARCH INTERN MED, V165, P2362, DOI 10.1001/archinte.165.20.2362; Duncan GE, 2004, PREV MED, V39, P894, DOI 10.1016/j.ypmed.2004.03.012; EISEN S, 1989, CLIN GENET, V35, P423, DOI 10.1111/j.1399-0004.1989.tb02967.x; Eriksson M, 2006, BEHAV GENET, V36, P238, DOI 10.1007/s10519-005-9018-7; Haase A, 2004, PREV MED, V39, P182, DOI 10.1016/j.ypmed.2004.01.028; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Joosen AMCP, 2005, AM J CLIN NUTR, V82, P1253, DOI 10.1093/ajcn/82.6.1253; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kruger J, 2007, MED SCI SPORT EXER, V39, P788, DOI 10.1249/mss.0b013e3180333efc; Lauderdale DS, 1997, MED SCI SPORT EXER, V29, P1062, DOI 10.1097/00005768-199708000-00012; Leon AS, 1997, INT J SPORTS MED, V18, pS208, DOI 10.1055/s-2007-972717; Maia JAR, 2002, AM J PREV MED, V23, P87, DOI 10.1016/S0749-3797(02)00478-6; National Heart Lung and Blood Institute, 2004, PRED OB WEIGHT GAIN; NEALE MC, 1992, METHODOLOGY GENETIC, P149; O'Donovan G, 2005, J APPL PHYSIOL, V98, P1619, DOI 10.1152/japplphysiol.01310.2004; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; PERUSSE L, 1989, AM J EPIDEMIOL, V129, P1012, DOI 10.1093/oxfordjournals.aje.a115205; Simonen RL, 2002, MED SCI SPORT EXER, V34, P1137, DOI 10.1097/00005768-200207000-00014; Stubbe JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000022; TORGERSEN S, 1979, ACTA GENET MED GEMEL, V28, P225, DOI 10.1017/S0001566000009077; *US DEP HHS, 1996, PHYS ACT HLTH REP SU, P3; Wannamethee SG, 2001, SPORTS MED, V31, P101, DOI 10.2165/00007256-200131020-00003	27	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e2019	10.1371/journal.pone.0002019	http://dx.doi.org/10.1371/journal.pone.0002019			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414678	Green Submitted, gold, Green Published			2022-12-27	WOS:000260867300028
J	Rebetz, J; Tian, DP; Persson, A; Widegren, B; Salford, LG; Englund, E; Gisselsson, D; Fan, X				Rebetz, Johan; Tian, Dongping; Persson, Annette; Widegren, Bengt; Salford, Leif G.; Englund, Elisabet; Gisselsson, David; Fan, Xiaolong			Glial Progenitor-Like Phenotype in Low-Grade Glioma and Enhanced CD133-Expression and Neuronal Lineage Differentiation Potential in High-Grade Glioma	PLOS ONE			English	Article								Background: While neurosphere-as well as xenograft tumor-initiating cells have been identified in gliomas, the resemblance between glioma cells and neural stem/progenitor cells as well as the prognostic value of stem/progenitor cell marker expression in glioma are poorly clarified. Methodology/Principal Findings: Viable glioma cells were characterized for surface marker expression along the glial genesis hierarchy. Six low-grade and 17 high-grade glioma specimens were flow-cytometrically analyzed for markers characteristics of stem cells (CD133); glial progenitors (PDGFR alpha, A2B5, O4, and CD44); and late oligodendrocyte progenitors (O1). In parallel, the expression of glial fibrillary acidic protein (GFAP), synaptophysin and neuron-specific enolase (NSE) was immunohistochemically analyzed in fixed tissue specimens. Irrespective of the grade and morphological diagnosis of gliomas, glioma cells concomitantly expressed PDGFRa, A2B5, O4, CD44 and GFAP. In contrast, O1 was weakly expressed in all low-grade and the majority of high-grade glioma specimens analyzed. Co-expression of neuronal markers was observed in all high-grade, but not low-grade, glioma specimens analyzed. The rare CD133 expressing cells in low-grade glioma specimens typically co-expressed vessel endothelial marker CD31. In contrast, distinct CD133 expression profiles in up to 90% of CD45-negative glioma cells were observed in 12 of the 17 high-grade glioma specimens and the majority of these CD133 expressing cells were CD31 negative. The CD133 expression correlates inversely with length of patient survival. Surprisingly, cytogenetic analysis showed that gliomas contained normal and abnormal cell karyotypes with hitherto indistinguishable phenotype. Conclusions/Significance: This study constitutes an important step towards clarification of lineage commitment and differentiation blockage of glioma cells. Our data suggest that glioma cells may resemble expansion of glial lineage progenitor cells with compromised differentiation capacity downstream of A2B5 and O4 expression. The concurrent expression of neuronal markers demonstrates that high-grade glioma cells are endowed with multi-lineage differentiation potential in vivo. Importantly, enhanced CD133 expression marks a poor prognosis in gliomas.	[Rebetz, Johan; Tian, Dongping; Widegren, Bengt; Salford, Leif G.; Fan, Xiaolong] Univ Lund Hosp, Div Neurosurg, Rausing Lab, S-22185 Lund, Sweden; [Fan, Xiaolong] Lund Univ, Strategic Res Ctr Stem Cell Biol & Cell Therapy, Lund, Sweden; [Widegren, Bengt] Lund Univ, Dept Cell & Mol Biol, Lund, Sweden; [Gisselsson, David] Lund Univ Hosp, Dept Clin Genet, Lund, Sweden; [Persson, Annette; Englund, Elisabet] Lund Univ Hosp, Dept Pathol, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Rebetz, J (corresponding author), Univ Lund Hosp, Div Neurosurg, Rausing Lab, S-22185 Lund, Sweden.	Xiaolong.Fan@med.lu.se	Rebetz, Johan/AAK-9569-2021	Rebetz, Johan/0000-0003-1673-0684; Englund, Elisabet/0000-0002-2708-2443	Swedish Cancer Society; Swedish Pediatric Cancer Foundation; Swedish Research Council; Lund University Medical Faculty; Hans and Marit Rausing charitable foundation; VFK Krebsforschung gGmbH; Gunnar Nilsson Cancer Foundation; Swedish Foundation for Strategic Research	Swedish Cancer Society(Swedish Cancer Society); Swedish Pediatric Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Lund University Medical Faculty; Hans and Marit Rausing charitable foundation; VFK Krebsforschung gGmbH; Gunnar Nilsson Cancer Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This study was supported by the Swedish Cancer Society, the Swedish Pediatric Cancer Foundation, The Swedish Research Council, Lund University Medical Faculty, Hans and Marit Rausing charitable foundation, VFK Krebsforschung gGmbH and Gunnar Nilsson Cancer Foundation. Lund Strategic Research Center for Stem Cell Biology and Cell Therapy is supported by a Center of Excellence grant from Swedish Foundation for Strategic Research. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfei L, 1999, EUR J HISTOCHEM, V43, P29; ARMSTRONG RC, 1992, J NEUROSCI, V12, P1538; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Baeten CIM, 2002, BRIT J CANCER, V87, P344, DOI 10.1038/sj.bjc.6600457; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; BISHOP M, 1989, AM J PATHOL, V135, P517; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bouvier C, 2003, J NEUROSURG, V99, P344, DOI 10.3171/jns.2003.99.2.0344; Cai JL, 2004, J NEUROCHEM, V88, P212, DOI 10.1046/j.1471-4159.2003.02184.x; Castor A, 2005, NAT MED, V11, P630, DOI 10.1038/nm1253; Dietrich J, 2002, GLIA, V40, P65, DOI 10.1002/glia.10116; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; ELLISON JA, 1994, J NEUROSCI RES, V37, P116, DOI 10.1002/jnr.490370116; Fan XL, 2007, SEMIN CANCER BIOL, V17, P214, DOI 10.1016/j.semcancer.2006.04.002; Frederick L, 2000, CANCER RES, V60, P1383; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Glanz C, 2007, NEUROPATH APPL NEURO, V33, P440, DOI 10.1111/j.1365-2990.2007.00832.x; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Gregori N, 2002, J NEUROSCI, V22, P248, DOI 10.1523/JNEUROSCI.22-01-00248.2002; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hill RP, 2006, CANCER RES, V66, P1891, DOI 10.1158/0008-5472.CAN-05-3450; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kornblum HI, 1998, J NEUROSCI RES, V53, P697, DOI 10.1002/(SICI)1097-4547(19980915)53:6<697::AID-JNR8>3.3.CO;2-M; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Liu Y, 2004, BIOL CELL, V96, P279, DOI 10.1016/j.biolcel.2004.02.001; Louis DN, 2001, AM J PATHOL, V159, P779, DOI 10.1016/S0002-9440(10)61750-6; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; Murayama A, 2002, J NEUROSCI RES, V69, P837, DOI 10.1002/jnr.10339; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Piper DR, 2001, J NEUROSCI RES, V66, P356, DOI 10.1002/jnr.1228; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Scolding N, 1998, BRAIN, V121, P2221, DOI 10.1093/brain/121.12.2221; Scolding NJ, 1999, NEUROSCIENCE, V89, P1, DOI 10.1016/S0306-4522(98)00548-X; Shoshan Y, 1999, P NATL ACAD SCI USA, V96, P10361, DOI 10.1073/pnas.96.18.10361; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Taubert H, 2007, ONCOGENE, V26, P7170, DOI 10.1038/sj.onc.1210530; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Wolswijk G, 1998, J NEUROSCI, V18, P601; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; Xia CL, 2003, INT J ONCOL, V23, P353; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhang SC, 1999, P NATL ACAD SCI USA, V96, P4089, DOI 10.1073/pnas.96.7.4089	61	91	94	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1936	10.1371/journal.pone.0001936	http://dx.doi.org/10.1371/journal.pone.0001936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398462	Green Submitted, Green Published, gold			2022-12-27	WOS:000260795500013
J	Ali, NA; Gaughan, AA; Orosz, CG; Baran, CP; McMaken, S; Wang, YJ; Eubank, TD; Hunter, M; Lichtenberger, FJ; Flavahan, NA; Lawler, J; Marsh, CB				Ali, Naeem A.; Gaughan, Alice A.; Orosz, Charles G.; Baran, Chris P.; McMaken, Sara; Wang, Yijie; Eubank, Timothy D.; Hunter, Melissa; Lichtenberger, Frank J.; Flavahan, Nicholas A.; Lawler, Jack; Marsh, Clay B.			Latency Associated Peptide Has In Vitro and In Vivo Immune Effects Independent of TGF-beta 1	PLOS ONE			English	Article								Latency Associated Peptide (LAP) binds TGF-beta 1, forming a latent complex. Currently, LAP is presumed to function only as a sequestering agent for active TGF-beta 1. Previous work shows that LAP can induce epithelial cell migration, but effects on leukocytes have not been reported. Because of the multiplicity of immunologic processes in which TGF-beta 1 plays a role, we hypothesized that LAP could function independently to modulate immune responses. In separate experiments we found that LAP promoted chemotaxis of human monocytes and blocked inflammation in vivo in a murine model of the delayed-type hypersensitivity response (DTHR). These effects did not involve TGF-beta 1 activity. Further studies revealed that disruption of specific LAP-thrombospondin-1 (TSP-1) interactions prevented LAP-induced responses. The effect of LAP on DTH inhibition depended on IL-10. These data support a novel role for LAP in regulating monocyte trafficking and immune modulation.	[Ali, Naeem A.; Baran, Chris P.; McMaken, Sara; Wang, Yijie; Eubank, Timothy D.; Hunter, Melissa; Lichtenberger, Frank J.; Marsh, Clay B.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Gaughan, Alice A.; Orosz, Charles G.] Ohio State Univ, Dept Surg, Columbus, OH USA; [Ali, Naeem A.; Gaughan, Alice A.; Orosz, Charles G.; Baran, Chris P.; McMaken, Sara; Wang, Yijie; Eubank, Timothy D.; Hunter, Melissa; Lichtenberger, Frank J.; Marsh, Clay B.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH USA; [Flavahan, Nicholas A.] Johns Hopkins Univ, Dept Anesthesiol & Critical Care Med, Baltimore, MD USA; [Lawler, Jack] Harvard Med Sch, Beth Israel Deaconess Med Sch, Dept Pathol, Boston, MA USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Johns Hopkins University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ali, NA (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	clay.marsh@osumc.edu	Eubank, Tim/E-3043-2011; Lawler, Jack/AAJ-1379-2020	ALI, NORA'AINI/0000-0003-1391-2757; Eubank, Tim/0000-0002-8225-7824	Davis-Bremer Medical Research Grant;  [K23 RR019544-01A2];  [T32 HL07946-01];  [RO-1HL68003];  [RO-1HL 66108];  [RO-1HL67176];  [RO-1 HL63800];  [PO-1 HL70294-02]; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR019544] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068003, R01HL063800, R01HL066108, T32HL007946, P01HL070294, R01HL067176] Funding Source: NIH RePORTER	Davis-Bremer Medical Research Grant; ; ; ; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the following grants: K23 RR019544-01A2, T32 HL07946-01 and Davis-Bremer Medical Research Grant (NAA), RO-1HL68003 (JL), RO-1HL 66108, RO-1HL67176 and RO-1 HL63800 (CBM), and PO-1 HL70294-02 (CGO and CBM). The sponsor played no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bickerstaff AA, 2000, TRANSPLANTATION, V69, P1517, DOI 10.1097/00007890-200004150-00055; Bickerstaff AA, 2002, AM J TRANSPLANT, V2, P819, DOI 10.1034/j.1600-6143.2002.20903.x; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Ebert EC, 2005, CELL IMMUNOL, V237, P106, DOI 10.1016/j.cellimm.2005.10.003; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Fukasawa H, 2004, KIDNEY INT, V65, P63, DOI 10.1111/j.1523-1755.2004.00393.x; Gandhi R, 2007, J IMMUNOL, V178, P4017, DOI 10.4049/jimmunol.178.7.4017; GRAZIANO RF, 1987, J IMMUNOL, V139, P3536; JANSSENS K, 2002, J BIOL CHEM; JANSSENS K, 2005, J MED GENET; KHALIL N, 1993, J CLIN INVEST, V92, P1812, DOI 10.1172/JCI116771; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lawler J, 1998, J CLIN INVEST, V101, P982, DOI 10.1172/JCI1684; Lu M, 2002, J CELL SCI, V115, P4641, DOI 10.1242/jcs.00145; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Munger JS, 1998, MOL BIOL CELL, V9, P2627, DOI 10.1091/mbc.9.9.2627; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; POSTLETHWAITE AE, 1995, J CELL PHYSIOL, V164, P587, DOI 10.1002/jcp.1041640317; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26783; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; Sheppard D, 2001, CHEST, V120, p49S, DOI 10.1378/chest.120.1_suppl.S49; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Sirak J, 1997, TRANSPLANTATION, V63, P1300, DOI 10.1097/00007890-199705150-00018; VanBuskirk AM, 2000, J CLIN INVEST, V106, P145, DOI 10.1172/JCI9171; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; Wei JY, 1997, J LEUKOCYTE BIOL, V61, P397, DOI 10.1002/jlb.61.4.397; Xiao YQ, 2006, J IMMUNOL, V176, P1209, DOI 10.4049/jimmunol.176.2.1209; Yehualaeshet T, 1999, AM J PATHOL, V155, P841, DOI 10.1016/S0002-9440(10)65183-8; Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200; Young GD, 2004, J BIOL CHEM, V279, P38032, DOI 10.1074/jbc.M405658200; Zhang Y, 2003, J INVEST DERMATOL, V121, P713, DOI 10.1046/j.1523-1747.2003.12517.x	36	21	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1914	10.1371/journal.pone.0001914	http://dx.doi.org/10.1371/journal.pone.0001914			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18392110	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795400038
J	Anestal, K; Prast-Nielsen, S; Cenas, N; Arner, ESJ				Anestal, Karin; Prast-Nielsen, Stefanie; Cenas, Narimantas; Arner, Elias S. J.			Cell Death by SecTRAPs: Thioredoxin Reductase as a Prooxidant Killer of Cells	PLOS ONE			English	Article							MAMMALIAN THIOREDOXIN; GLUTATHIONE-REDUCTASE; ESCHERICHIA-COLI; REDOX REGULATION; HUMAN PLACENTA; ACTIVE-SITE; SELENOCYSTEINE; SELENOPROTEIN; INHIBITION; EXPRESSION	Background: SecTRAPs ((se) under bar lenium (c) under bar ompromised (t) under bar hioredoxin (r) under bar eductase-derived (a) under bar poptotic (p) under bar rotein (s) under bar) can be formed from the selenoprotein thioredoxin reductase (TrxR) by targeting of its selenocysteine ( Sec) residue with electrophiles, or by its removal through C-terminal truncation. SecTRAPs are devoid of thioredoxin reductase activity but can induce rapid cell death in cultured cancer cell lines by a gain of function. Principal Findings: Both human and rat SecTRAPs killed human A549 and HeLa cells. The cell death displayed both apoptotic and necrotic features. It did not require novel protein synthesis nor did it show extensive nuclear fragmentation, but it was attenuated by use of caspase inhibitors. The redox active disulfide/dithiol motif in the N-terminal domain of TrxR had to be maintained for manifestation of SecTRAP cytotoxicity. Stopped-flow kinetics showed that NADPH can reduce the FAD moiety in SecTRAPs at similar rates as in native TrxR and purified SecTRAPs could maintain NADPH oxidase activity, which was accelerated by low molecular weight substrates such as juglone. In a cellular context, SecTRAPs triggered extensive formation of reactive oxygen species (ROS) and consequently antioxidants could protect against the cell killing by SecTRAPs. Conclusions: We conclude that formation of SecTRAPs could contribute to the cytotoxicity seen upon exposure of cells to electrophilic agents targeting TrxR. SecTRAPs are prooxidant killers of cells, triggering mechanisms beyond those of a mere loss of thioredoxin reductase activity.	[Anestal, Karin; Prast-Nielsen, Stefanie; Arner, Elias S. J.] Karolinska Inst, Dept Med Biochem, Med Nobel Inst Biochem, Stockholm, Sweden; [Cenas, Narimantas] Inst Biochem, Vilnius, Lithuania	Karolinska Institutet; Vilnius University	Anestal, K (corresponding author), Karolinska Inst, Dept Med Biochem, Med Nobel Inst Biochem, Stockholm, Sweden.	Elias.Arner@ki.se	Prast-Nielsen, Stefanie/W-6946-2019; Arnér, Elias S.J./J-5832-2012; Arnér, Elias/K-6737-2019	Prast-Nielsen, Stefanie/0000-0001-5877-7988; Arnér, Elias S.J./0000-0002-4807-6114; Arnér, Elias/0000-0002-4807-6114	Karolinska Institutet; The Royal Swedish Academy of Sciences; Swedish Cancer Society	Karolinska Institutet(Karolinska Institutet); The Royal Swedish Academy of Sciences; Swedish Cancer Society(Swedish Cancer Society)	Financial support was received from Karolinska Institutet, The Royal Swedish Academy of Sciences and the Swedish Cancer Society. These funding bodies had no influence on the content of this study beyond that of providing research funding.	Andersson M, 1996, J BIOL CHEM, V271, P10116, DOI 10.1074/jbc.271.17.10116; Anestal K, 2003, J BIOL CHEM, V278, P15966, DOI 10.1074/jbc.M210733200; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; Arner ESJ, 2002, METHOD ENZYMOL, V347, P226; Arner ESJ, 1996, BIOCHEM BIOPH RES CO, V225, P268, DOI 10.1006/bbrc.1996.1165; Arner ESJ, 2001, FREE RADICAL BIO MED, V31, P1170, DOI 10.1016/S0891-5849(01)00698-0; ARNER ESJ, 2000, CURRENT PROTOCOLS TO; Arscott LD, 1997, P NATL ACAD SCI USA, V94, P3621, DOI 10.1073/pnas.94.8.3621; Bar-Noy S, 2001, FREE RADICAL BIO MED, V30, P51, DOI 10.1016/S0891-5849(00)00448-2; Becker K, 2000, EUR J BIOCHEM, V267, P6118, DOI 10.1046/j.1432-1327.2000.01703.x; Becker K, 2001, J MED CHEM, V44, P2784, DOI 10.1021/jm001014i; Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; Biterova EI, 2005, P NATL ACAD SCI USA, V102, P15018, DOI 10.1073/pnas.0504218102; Cassidy PB, 2006, CARCINOGENESIS, V27, P2538, DOI 10.1093/carcin/bgl111; Cenas N, 2006, J BIOL CHEM, V281, P5593, DOI 10.1074/jbc.M511972200; Cenas N, 2004, J BIOL CHEM, V279, P2583, DOI 10.1074/jbc.M310292200; Cheng Q, 2006, NAT PROTOC, V1, P604, DOI 10.1038/nprot.2006.87; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Crosley LK, 2007, ARCH BIOCHEM BIOPHYS, V459, P178, DOI 10.1016/j.abb.2006.12.029; Enoksson M, 2004, J BIOL CHEM, V279, P49575, DOI 10.1074/jbc.C400374200; Fadeel B, 2000, LEUKEMIA, V14, P1514, DOI 10.1038/sj.leu.2401871; Fang JG, 2006, J AM CHEM SOC, V128, P1879, DOI 10.1021/ja057358l; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; Gan L, 2005, J CELL BIOCHEM, V96, P653, DOI 10.1002/jcb.20585; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Gromer S, 1997, FEBS LETT, V412, P318, DOI 10.1016/S0014-5793(97)00816-8; Hofman ER, 1998, MOL CELL BIOL, V18, P6493, DOI 10.1128/MCB.18.11.6493; Johansson L, 2004, NAT METHODS, V1, P61, DOI 10.1038/NMETH707; Johansson L, 2005, BBA-GEN SUBJECTS, V1726, P1, DOI 10.1016/j.bbagen.2005.05.010; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Lee SR, 2000, P NATL ACAD SCI USA, V97, P2521, DOI 10.1073/pnas.050579797; Li L, 2004, SCIENCE, V305, P1471, DOI 10.1126/science.1098231; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lindner DJ, 2000, BBA-MOL CELL RES, V1496, P196, DOI 10.1016/S0167-4889(00)00021-5; Lindner DJ, 2002, CLIN CANCER RES, V8, P3210; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; LUNDSTROMLJUNG J, 1995, FEBS LETT, V357, P305, DOI 10.1016/0014-5793(94)01386-F; Ma XR, 2002, J BIOL CHEM, V277, P22460, DOI 10.1074/jbc.M202286200; Ma XR, 2001, J BIOL CHEM, V276, P24843, DOI 10.1074/jbc.M100380200; Marzano C, 2007, FREE RADICAL BIO MED, V42, P872, DOI 10.1016/j.freeradbiomed.2006.12.021; May JM, 1997, J BIOL CHEM, V272, P22607, DOI 10.1074/jbc.272.36.22607; Miranda-Vizuete A, 1999, EUR J BIOCHEM, V261, P405, DOI 10.1046/j.1432-1327.1999.00286.x; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Nalvarte I, 2004, J BIOL CHEM, V279, P54510, DOI 10.1074/jbc.M408494200; Nordberg J, 1998, J BIOL CHEM, V273, P10835, DOI 10.1074/jbc.273.18.10835; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Rengby O, 2007, APPL ENVIRON MICROB, V73, P432, DOI 10.1128/AEM.02019-06; Rigobello MP, 1998, FREE RADICAL BIO MED, V24, P370, DOI 10.1016/S0891-5849(97)00216-5; Robertson JD, 2004, EMBO REP, V5, P643, DOI 10.1038/sj.embor.7400153; Rundlof AK, 2004, FREE RADICAL BIO MED, V36, P641, DOI 10.1016/j.freeradbiomed.2003.12.004; Rundlof AK, 2004, ANTIOXID REDOX SIGN, V6, P41, DOI 10.1089/152308604771978336; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Sandalova T, 2001, P NATL ACAD SCI USA, V98, P9533, DOI 10.1073/pnas.171178698; Sasada T, 1999, FREE RADICAL BIO MED, V27, P504, DOI 10.1016/S0891-5849(99)00101-X; Schweizer A, 2007, STRUCTURE, V15, P625, DOI 10.1016/j.str.2007.03.014; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; Trigona WL, 2006, BIOCHEM J, V394, P207, DOI 10.1042/BJ20050712; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004; Urig S, 2006, FEBS LETT, V580, P3595, DOI 10.1016/j.febslet.2006.05.038; WATSON WH, 2008, BIOCH BIOPHYS RES CO; Witte AB, 2005, FREE RADICAL BIO MED, V39, P696, DOI 10.1016/j.freeradbiomed.2005.04.025; Xia L, 2003, J BIOL CHEM, V278, P2141, DOI 10.1074/jbc.M210456200; Yarimizu J, 2000, ANTIOXID REDOX SIGN, V2, P643, DOI 10.1089/ars.2000.2.4-643; Yoo MH, 2006, J BIOL CHEM, V281, P13005, DOI 10.1074/jbc.C600012200; Yoo MH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001112; Zhon LW, 1998, J BIOL CHEM, V273, P8581, DOI 10.1074/jbc.273.15.8581; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	79	124	124	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1846	10.1371/journal.pone.0001846	http://dx.doi.org/10.1371/journal.pone.0001846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382651	Green Submitted, Green Published, gold			2022-12-27	WOS:000260795400001
J	Lin, JC; Tsao, D; Barras, P; Bastarrachea, RA; Boyd, B; Chou, J; Rosete, R; Long, H; Forgie, A; Abdiche, Y; Dilley, J; Stratton, J; Garcia, C; Sloane, DL; Comuzzie, AG; Rosenthal, A				Lin, John C.; Tsao, David; Barras, Paul; Bastarrachea, Raul A.; Boyd, Bob; Chou, Joyce; Rosete, Rodnie; Long, Hua; Forgie, Alison; Abdiche, Yasmina; Dilley, Jeanette; Stratton, Jennifer; Garcia, Carlos; Sloane, David L.; Comuzzie, Anthony G.; Rosenthal, Arnon			Appetite Enhancement and Weight Gain by Peripheral Administration of TrkB Agonists in Non-Human Primates	PLOS ONE			English	Article								Loss of function mutations in the receptor tyrosine kinase TrkB pathway resulted in hyperphagia and morbid obesity in human and rodents. Conversely, peripheral or central stimulation of TrkB by its natural ligands BDNF or NT4 reduced body weight and food intake in mice, supporting the idea that TrkB is a key anorexigenic signal downstream of the melanocortin-4 receptor (Mc4r) system. Here we show that in non-human primates TrkB agonists were anorexigenic when applied centrally, but surprisingly orexigenic, leading to gain in appetite, body weight, fat deposits and serum leptin levels, when given peripherally. The orexigenic and pro-obesity effects of peripherally administered TrkB agonists appear to be dose dependent, not associated with fluid retention nor with evidence of receptor down regulation. Our findings revealed that TrkB signaling exerts dual control on energy homeostasis in the primates that could be targeted for the treatment of either wasting disorders or obesity.	[Lin, John C.; Tsao, David; Chou, Joyce; Rosete, Rodnie; Long, Hua; Forgie, Alison; Abdiche, Yasmina; Dilley, Jeanette; Stratton, Jennifer; Garcia, Carlos; Sloane, David L.; Rosenthal, Arnon] Pfizer Inc, Rinat, San Francisco, CA USA; [Bastarrachea, Raul A.; Comuzzie, Anthony G.] Southwest Fdn Biomed Res, San Antonio, TX USA; [Barras, Paul] Alpha Genesis Inc, Yemassee, SC USA; [Boyd, Bob] Northern Biomed Res, Muskegon, MI USA	Pfizer; Texas Biomedical Research Institute	Lin, JC (corresponding author), Pfizer Inc, Rinat, San Francisco, CA USA.	john.lin@rinat.pfizer.com	Bastarrachea, Raul/B-5920-2019	Bastarrachea, Raul/0000-0002-4034-3062	Pfizer Inc.	Pfizer Inc.(Pfizer)	Pfizer Inc. funded and approved the publication of this work.	BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; KONONEN J, 1994, MOL BRAIN RES, V27, P347, DOI 10.1016/0169-328X(94)90022-1; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Monteleone P, 2005, PSYCHOL MED, V35, P897, DOI 10.1017/S0033291704003368; Monteleone P, 2004, PSYCHOSOM MED, V66, P744, DOI 10.1097/01.psy.0000138119.12956.99; Nakazato M, 2003, BIOL PSYCHIAT, V54, P485, DOI 10.1016/S0006-3223(02)01746-8; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Suwa M, 2006, METABOLISM, V55, P852, DOI 10.1016/j.metabol.2006.02.012; Tonra JR, 1999, DIABETES, V48, P588, DOI 10.2337/diabetes.48.3.588; TSAO D, 2008, ENDOCRINOLOGY; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; YAMAMOTO H, 1990, J NEUROSCI, V10, P3469; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336	21	41	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1900	10.1371/journal.pone.0001900	http://dx.doi.org/10.1371/journal.pone.0001900			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382675	Green Submitted, gold, Green Published			2022-12-27	WOS:000260795400027
J	Yerushalmi, U; Teicher, M				Yerushalmi, Uri; Teicher, Mina			Inevitable Evolutionary Temporal Elements in Neural Processing: A Study Based on Evolutionary Simulations	PLOS ONE			English	Article								Recent studies have suggested that some neural computational mechanisms are based on the fine temporal structure of spiking activity. However, less effort has been devoted to investigating the evolutionary aspects of such mechanisms. In this paper we explore the issue of temporal neural computation from an evolutionary point of view, using a genetic simulation of the evolutionary development of neural systems. We evolve neural systems in an environment with selective pressure based on mate finding, and examine the temporal aspects of the evolved systems. In repeating evolutionary sessions, there was a significant increase during evolution in the mutual information between the evolved agent's temporal neural representation and the external environment. In ten different simulated evolutionary sessions, there was an increased effect of time - related neural ablations on the agents' fitness. These results suggest that in some fitness landscapes the emergence of temporal elements in neural computation is almost inevitable. Future research using similar evolutionary simulations may shed new light on various biological mechanisms.	[Yerushalmi, Uri; Teicher, Mina] Bar Ilan Univ, Leslie & Susan Gonda Interdisciplinary Brain Res, Ramat Gan, Israel	Bar Ilan University	Yerushalmi, U (corresponding author), Bar Ilan Univ, Leslie & Susan Gonda Interdisciplinary Brain Res, Ramat Gan, Israel.	uri.yerushalmi@gmail.com			DIP	DIP	This research was supported by the DIP grant for compositionality	Abeles M, 2004, J COMPUT NEUROSCI, V17, P179, DOI 10.1023/B:JCNS.0000037682.18051.5f; ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Abeles M, 2001, J NEUROSCI METH, V107, P141, DOI 10.1016/S0165-0270(01)00364-8; Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Aharonov-Barki R, 2001, NEURAL COMPUT, V13, P691, DOI 10.1162/089976601300014529; AYERS DR, 2001, EVOLVING COLUMNAR CI; BAILEY WJ, 1991, REPROD BEHAVIOUR INS; Beer RD, 1999, J COMPUT NEUROSCI, V7, P119, DOI 10.1023/A:1008920021246; BIENENSTOCK EGS, 1994, HDB BRAIN THEORY NEU; Cangelosi A, 1997, NEURAL PROCESS LETT, V6, P91, DOI 10.1023/A:1009615807222; Chiel HJ, 1999, J COMPUT NEUROSCI, V7, P99, DOI 10.1023/A:1008923704408; Conway Morris Simon, 2003, LIFES SOLUTION INEVI; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; GOTOH O, 1982, J MOL BIOL, V162, P705, DOI 10.1016/0022-2836(82)90398-9; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Hertz J, 1996, NETWORK-COMP NEURAL, V7, P357, DOI 10.1088/0954-898X/7/2/017; Hertz JA, 2018, INTRO THEORY NEURAL; HOLLAND JH, 1975, ADAPTATION NATURAL A, P8; HOPFIELD JJ, 1994, PHYS TODAY, V47, P40, DOI 10.1063/1.881412; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; Ijspeert AJ, 1999, ADAPT BEHAV, V7, P151, DOI 10.1177/105971239900700202; Levy N, 2001, NEURAL NETWORKS, V14, P815, DOI 10.1016/S0893-6080(01)00044-2; Maass W, 1997, NEURAL NETWORKS, V10, P1659, DOI 10.1016/S0893-6080(97)00011-7; McAdams HH, 1998, ANNU REV BIOPH BIOM, V27, P199, DOI 10.1146/annurev.biophys.27.1.199; MJOLSNESS E, 1991, J THEOR BIOL, V152, P429, DOI 10.1016/S0022-5193(05)80391-1; MODDEMEIJER R, 1989, SIGNAL PROCESS, V16, P233, DOI 10.1016/0165-1684(89)90132-1; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Ruppin E, 2002, NAT REV NEUROSCI, V3, P132, DOI 10.1038/nrn729; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; THOMAS B, 1993, EVOL COMPUT, V1, P1; VILLA AEP, 1990, BRAIN RES, V509, P325, DOI 10.1016/0006-8993(90)90558-S; Wolpert L, 2002, NATURE, V420, P745, DOI 10.1038/420745a; YERUSHALMI U, 2006, REGULATION NETWORK B; Yerushalmi U, 2007, B MATH BIOL, V69, P2261, DOI 10.1007/s11538-007-9219-8; YERUSHALMI UT, 2007, NEUROCOMPUT IN PRESS	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1863	10.1371/journal.pone.0001863	http://dx.doi.org/10.1371/journal.pone.0001863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382654	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795400004
J	Zamir, E; Geiger, B; Kam, Z				Zamir, Eli; Geiger, Benjamin; Kam, Zvi			Quantitative Multicolor Compositional Imaging Resolves Molecular Domains in Cell-Matrix Adhesions	PLOS ONE			English	Article								Background: Cellular processes occur within dynamic and multi-molecular compartments whose characterization requires analysis at high spatio-temporal resolution. Notable examples for such complexes are cell-matrix adhesion sites, consisting of numerous cytoskeletal and signaling proteins. These adhesions are highly variable in their morphology, dynamics, and apparent function, yet their molecular diversity is poorly defined. Methodology/Principal Findings: We present here a compositional imaging approach for the analysis and display of multicomponent compositions. This methodology is based on microscopy-acquired multicolor data, multi-dimensional clustering of pixels according to their composition similarity and display of the cellular distribution of these composition clusters. We apply this approach for resolving the molecular complexes associated with focal-adhesions, and the time-dependent effects of Rho-kinase inhibition. We show here compositional variations between adhesion sites, as well as ordered variations along the axis of individual focal-adhesions. The multicolor clustering approach also reveals distinct sensitivities of different focal-adhesion-associated complexes to Rho-kinase inhibition. Conclusions/Significance: Multicolor compositional imaging resolves "molecular signatures'' characteristic to focal-adhesions and related structures, as well as sub-domains within these adhesion sites. This analysis enhances the spatial information with additional "contents-resolved'' dimensions. We propose that compositional imaging can serve as a powerful tool for studying complex multi-molecular assemblies in cells and for mapping their distribution at sub-micron resolution.	[Zamir, Eli; Geiger, Benjamin; Kam, Zvi] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel	Weizmann Institute of Science	Zamir, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.	benny.geiger@weizmann.ac.il		Zamir, Eli/0000-0001-8226-5480	Israel Science Foundation; US-Israel Bi-National Foundation; Kahn fund for Systems Biology at the Weizmann Institute of Science; The Cell Migration Consortium; NIH [U54 GM64346]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); US-Israel Bi-National Foundation(US-Israel Binational Science Foundation); Kahn fund for Systems Biology at the Weizmann Institute of Science; The Cell Migration Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the Israel Science Foundation, the US-Israel Bi-National Foundation, the Kahn fund for Systems Biology at the Weizmann Institute of Science and The Cell Migration Consortium (NIH Grant U54 GM64346).	Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Altelaar AFM, 2007, NAT PROTOC, V2, P1185, DOI 10.1038/nprot.2007.117; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Borrmann CM, 2000, ANN NY ACAD SCI, V915, P144; Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730; Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017; De Rosa SC, 2001, NAT MED, V7, P245, DOI 10.1038/84701; Gao XH, 2005, CURR OPIN BIOTECH, V16, P63, DOI 10.1016/j.copbio.2004.11.003; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hutter H, 2004, J MICROSC-OXFORD, V215, P213, DOI 10.1111/j.0022-2720.2004.01367.x; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Kam Z, 2001, TRENDS CELL BIOL, V11, P329, DOI 10.1016/S0962-8924(01)02067-0; Kingsmore SF, 2006, NAT REV DRUG DISCOV, V5, P310, DOI 10.1038/nrd2006; Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836; Lichtenstein N, 2003, CYTOM PART A, V54A, P8, DOI 10.1002/cyto.a.10053; Ma B, 2007, MICROSC RES TECHNIQ, V70, P171, DOI 10.1002/jemt.20401; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Padilla-Nash HM, 2006, NAT PROTOC, V1, P3129, DOI 10.1038/nprot.2006.358; Perret E, 2005, CURR OPIN CELL BIOL, V17, P423, DOI 10.1016/j.ceb.2005.06.008; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zamir E, 2001, J CELL SCI, V114, P3583; Zamir E, 1999, J CELL SCI, V112, P1655; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0	33	31	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1901	10.1371/journal.pone.0001901	http://dx.doi.org/10.1371/journal.pone.0001901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382676	gold, Green Submitted, Green Published			2022-12-27	WOS:000260795400028
J	De Luigi, A; Colombo, L; Diomede, L; Capobianco, R; Mangieri, M; Miccolo, C; Limido, L; Forloni, G; Tagliavini, F; Salmona, M				De Luigi, Ada; Colombo, Laura; Diomede, Luisa; Capobianco, Raffaella; Mangieri, Michela; Miccolo, Claudia; Limido, Lucia; Forloni, Gianluigi; Tagliavini, Fabrizio; Salmona, Mario			The Efficacy of Tetracyclines in Peripheral and Intracerebral Prion Infection	PLOS ONE			English	Article							MOLECULAR-BIOLOGY; AMYLOID FIBRILS; AMPHOTERICIN-B; MINOCYCLINE; DOXYCYCLINE; MODEL; EPIDEMIOLOGY; QUINACRINE; INFUSION; BEHAVIOR	We have previously shown that tetracyclines interact with and reverse the protease resistance of pathological prion protein extracted from scrapie-infected animals and patients with all forms of Creutzfeldt-Jakob disease, lowering the prion titre and prolonging survival of cerebrally infected animals. To investigate the effectiveness of these drugs as anti-prion agents Syrian hamsters were inoculated intramuscularly or subcutaneously with 263K scrapie strain at a 10(-4) dilution. Tetracyclines were injected intramuscularly or intraperitoneally at the dose of 10 mg/kg. A single intramuscular dose of doxycycline one hour after infection in the same site of inoculation prolonged median survival by 64%. Intraperitoneal doses of tetracyclines every two days for 40 or 44 days increased survival time by 25% (doxycycline), 32% (tetracycline); and 81% (minocycline) after intramuscular infection, and 35% (doxycycline) after subcutaneous infection. To extend the therapeutic potential of tetracyclines, we investigated the efficacy of direct infusion of tetracyclines in advanced infection. Since intracerebroventricular infusion of tetracycline solutions can cause overt acute toxicity in animals, we entrapped the drugs in liposomes. Animals were inoculated intracerebrally with a 10(-4) dilution of the 263K scrapie strain. A single intracerebroventricular infusion of 25 mu g/20 mu l of doxycycline or minocycline entrapped in liposomes was administered 60 days after inoculation, when 50% of animals showed initial symptoms of the disease. Median survival increased of 8.1% with doxycycline and 10% with minocycline. These data suggest that tetracyclines might have therapeutic potential for humans.	[De Luigi, Ada; Colombo, Laura; Diomede, Luisa; Salmona, Mario] Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Milan, Italy; [Forloni, Gianluigi] Ist Ricerche Farmacol, Dept Neurosci, Milan, Italy; [Capobianco, Raffaella; Mangieri, Michela; Miccolo, Claudia; Limido, Lucia; Tagliavini, Fabrizio] Fdn IRCCS Ist Neurol, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	De Luigi, A (corresponding author), Ist Ric Farmacol Mario Negri, Dept Mol Biochem & Pharmacol, Milan, Italy.	salmona@marionegri.it	salmona, mario/AAA-7116-2020; colombo, laura/AAA-6716-2020; Forloni, Gianluigi/AAB-2115-2020; salmona, mario/ABI-4066-2020; Miccolo, Claudia/AAR-8386-2020; Tagliavini, Fabrizio/AAO-7891-2021; Diomede, Luisa/P-3417-2014; De Luigi, Ada/ABF-7913-2020	salmona, mario/0000-0002-9098-9873; colombo, laura/0000-0002-3243-0270; Forloni, Gianluigi/0000-0001-5374-3914; Tagliavini, Fabrizio/0000-0003-1039-7315; Diomede, Luisa/0000-0002-2258-0531; De Luigi, Ada/0000-0001-7907-7139	European Union; Neuroprion and ExpTheraprion; Fondazione Cariplo [NOBEL-Guard]; Italian Ministry of University and Research [RBNE03PX83]; Italian Ministry of Health	European Union(European Commission); Neuroprion and ExpTheraprion; Fondazione Cariplo(Fondazione Cariplo); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the European Union within the frame of Neuroprion and ExpTheraprion, Fondazione Cariplo (Grant NOBEL-Guard), the Italian Ministry of University and Research (FIRB, RBNE03PX83), and the Italian Ministry of Health.	Adjou KT, 2000, J COMP PATHOL, V122, P3, DOI 10.1053/jcpa.1999.0338; Aitken JF, 2003, BIOCHEM J, V374, P779, DOI 10.1042/BJ20030422; Benito-Leon J, 2004, CLIN NEUROPHARMACOL, V27, P201, DOI 10.1097/01.wnf.0000134853.36429.0e; Bruce ME, 2003, BRIT MED BULL, V66, P99, DOI 10.1093/bmb/66.1.99; Caramelli M, 2006, CNS DRUGS, V20, P15, DOI 10.2165/00023210-200620010-00002; Cardoso I, 2006, FASEB J, V20, P234, DOI 10.1096/fj.05-4509com; Cardoso I, 2003, FASEB J, V17, P803, DOI 10.1096/fj.02-0764com; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Clarke AR, 2001, PHILOS T ROY SOC B, V356, P185, DOI 10.1098/rstb.2000.0764; Colovic M, 2003, J CHROMATOGR B, V791, P337, DOI 10.1016/S1570-0232(03)00247-2; Cosentino U, 2005, J MOL MODEL, V11, P17, DOI 10.1007/s00894-004-0213-x; DEMAIMAY R, 1994, J GEN VIROL, V75, P2499, DOI 10.1099/0022-1317-75-9-2499; Demaimay R, 1999, J VIROL, V73, P3511, DOI 10.1128/JVI.73.4.3511-3513.1999; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Domercq M, 2004, TRENDS PHARMACOL SCI, V25, P609, DOI 10.1016/j.tips.2004.10.001; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Forloni G, 2002, P NATL ACAD SCI USA, V99, P10849, DOI 10.1073/pnas.162195499; Forloni G, 2001, FEBS LETT, V487, P404, DOI 10.1016/S0014-5793(00)02380-2; Forloni Gianluigi, 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P185, DOI 10.2174/1568013033483456; Giaccone G, 2000, BRAIN PATHOL, V10, P31, DOI 10.1111/j.1750-3639.2000.tb00240.x; Hersch S, 2003, ANN NEUROL, V54, P841, DOI 10.1002/ana.21891; Konings AW, 1984, LIPOSOME TECHNOLOGY, P139; Korth C, 2006, ARCH NEUROL-CHICAGO, V63, P497, DOI 10.1001/archneur.63.4.497; Malmo C, 2006, FASEB J, V20, P346, DOI 10.1096/fj.05-4652fje; Mohan J, 2005, IMMUNOLOGY, V114, P225, DOI 10.1111/j.1365-2567.2004.02074.x; Moon JE, 2006, ANTIMICROB AGENTS CH, V50, P1989, DOI 10.1128/AAC.01467-05; Murakami-Kubo I, 2004, J VIROL, V78, P1281, DOI 10.1128/JVI.78.3.1281-1288.2004; Nakajima M, 2004, DEMENT GERIATR COGN, V17, P158, DOI 10.1159/000076350; Ono K, 2006, J NEUROCHEM, V97, P105, DOI 10.1111/j.1471-4159.2006.03707.x; Otto M, 2004, NEUROLOGY, V62, P714, DOI 10.1212/01.WNL.0000113764.35026.EF; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ragg E, 1999, EUR J BIOCHEM, V266, P1192, DOI 10.1046/j.1432-1327.1999.00985.x; Rainov NG, 2007, EXPERT OPIN BIOL TH, V7, P713, DOI 10.1517/14712598.7.5.713; Riesner D, 2003, BRIT MED BULL, V66, P21, DOI 10.1093/bmb/66.1.21; Seabrook TJ, 2006, GLIA, V53, P776, DOI 10.1002/glia.20338; Smith DL, 2003, ANN NEUROL, V54, P186, DOI 10.1002/ana.10614; Tagliavini F, 1997, SCIENCE, V276, P1119, DOI 10.1126/science.276.5315.1119; Tagliavini F, 2000, J MOL BIOL, V300, P1309, DOI 10.1006/jmbi.2000.3840; Todd NV, 2005, J INFECTION, V50, P394, DOI 10.1016/j.jinf.2004.07.015; Truccolo J, 2002, ANTIMICROB AGENTS CH, V46, P848, DOI 10.1128/AAC.46.3.848-853.2002; Weissmann C, 2005, ANNU REV MED, V56, P321, DOI 10.1146/annurev.med.56.062404.172936	42	74	78	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1888	10.1371/journal.pone.0001888	http://dx.doi.org/10.1371/journal.pone.0001888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365024	Green Published, Green Submitted, gold			2022-12-27	WOS:000260762400030
J	Mazari-Hiriart, M; Ponce-de-Leon, S; Lopez-Vidal, Y; Islas-Macias, P; Amieva-Fernandez, RI; Quinones-Falconi, F				Mazari-Hiriart, Marisa; Ponce-de-Leon, Sergio; Lopez-Vidal, Yolanda; Islas-Macias, Pilar; Isabel Amieva-Fernandez, Rosa; Quinones-Falconi, Francisco			Microbiological Implications of Periurban Agriculture and Water Reuse in Mexico City	PLOS ONE			English	Article							HELICOBACTER-PYLORI; WASTE-WATER; COLIFORMS	Background: Recycled treated or untreated wastewater represents an important health challenge in developing countries due to potential water related microbiological exposure. Our aim was to assess water quality and health implications in a Mexico City periurban agricultural area. Methodology/Principal Findings: A longitudinal study in the Xochimilco wetland area was conducted, and 42 sites were randomly selected from 211, including irrigation water canals and effluents of treatment plants. Sample collection took place during rainy and dry seasons (2000-2001). Microbiological parameters (total coliforms, fecal coliforms, streptococci/enterococci, and bacteria other than Vibrio grown on TCBS), Helicobacter pylori, and physicochemical parameters including trihalomethanes (THM) were determined. Fecal coliforms and fecal streptococci are appropriate indicators of human or animal fecal contamination. Fecal coliform counts surpass Mexican and World Health Organization irrigation water guidelines. Identified microorganisms associated with various pathologies in humans and domestic animals comprise Escherichia coli, Klebsiella spp., Salmonella spp., Enterobacter spp., Enterococcus spp., and Pseudomonas spp; H. pylori was also present in the water. An environmental characteristic of the canal system showed high Total Organic Carbon content and relatively low dissolved oxygen concentration; residual chlorine as a disinfection control is not efficient, but THMs do not represent a problem. During the rainy season, temperature and conductivity were higher; in contrast, pH, dissolved oxygen, ammonia, and residual chlorine were lower. This is related with the continuous load of feces from human and animal sources, and to the aquatic systems, which vary seasonally and exhibit evidence of lower water quality in effluents from treatment plants. Conclusions/Significance: There is a need for improvement of wastewater treatment systems, as well as more efficient monitoring, regulation, and enforcement procedures for wastewater disposal into bodies of water.	[Mazari-Hiriart, Marisa; Islas-Macias, Pilar] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Biodiversidad, Mexico City 04510, DF, Mexico; [Ponce-de-Leon, Sergio] Unidad Epidemiol Clin, Inst Nacl Ciencias Med Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Lopez-Vidal, Yolanda; Isabel Amieva-Fernandez, Rosa] Univ Nacl Autonoma Mexico, Lab Inmunol Mol Microbiana, Fac Med, Mexico City, DF, Mexico; [Quinones-Falconi, Francisco] Inst Nacl Enfermedades Resp, Serv Microbiol Clin, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico	Mazari-Hiriart, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Biodiversidad, Mexico City 04510, DF, Mexico.	mazari@servidor.unam.mx	López-Vidal, Yolanda/ABE-9501-2021	López-Vidal, Yolanda/0000-0001-7111-8813	Consejo Nacional de Ciencia y Tecnologia [32505-T]; Direccion General de Asuntos del Personal Academico, UNAM [IN219303]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico, UNAM(Universidad Nacional Autonoma de Mexico)	The authors would like to acknowledge the support of the Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) in conducting the project Calidad microbiologica y quimica del agua en sistemas acuaticos de la Ciudad de Mexico (#32505-T) from 1999 2001, and the Direccion General de Asuntos del Personal Academico, UNAM, in carrying out the project Evaluacion de la desinfeccion en sistemas acuaticos en funcion de bacterias, virus y bacteriofagos (#IN219303) from 2003 2005.	AGUILAR J, 2003, 4 INT S WAST RECL RE; Alonso JL, 1999, APPL ENVIRON MICROB, V65, P3746; *AM PUBL HTTH ASS, 1998, STAND METH EX WAT WA; [Anonymous], 1989, HLTH GUID US WAST AG; [Anonymous], ED DRINK WAT STAND H; ARMILLAS P, 1971, SCIENCE, V174, P653, DOI 10.1126/science.174.4010.653; Asano T, 2004, WATER RES, V38, P1941, DOI [10.1016/j.watres.2004.01.023, 10.1016/J.watres.2004.01.023]; Blumenthal UJ, 2000, B WORLD HEALTH ORGAN, V78, P1104; BURLINGAME GA, 1984, APPL ENVIRON MICROB, V47, P56, DOI 10.1128/AEM.47.1.56-60.1984; Castillo-Rojas G, 2002, EUR J GASTROEN HEPAT, V14, P1113, DOI 10.1097/00042737-200210000-00012; Chao Kuo-Kuang, 2003, Journal of Microbiology Immunology and Infection, V36, P288; Crossley PL, 2004, AGR HUM VALUES, V21, P191, DOI 10.1023/B:AHUM.0000029395.84972.5e; *DIAR OF FED, 1998, NOM003ECOL1997 DIAR; *DIAR OF FED, 2004, LEY FED DER DISP APL, P186; *DIAR OF FED, 1997, NOM001ECOL1996 DIAR; ESPINOSAGARCIA AC, 2003, 4 INT S WAST RECL RE; GELDREICH EE, 1969, J WATER POLLUT CON F, V41, pR336; Gerba CP, 2000, ENVIRON MICROBIOL, P491; Howard K. W. F., 2003, INTENSIVE USE GROUND; Jimenez B., 2006, International Review for Environmental Strategies, V6, P229; JIMENEZ B, 2001, NAVIGATING ROUGH WAT, P139; JIMENEZ JJ, 1995, CTR INVESTIGACIONES, P19; Levine AD, 2004, ENVIRON SCI TECHNOL, V38, p201A, DOI 10.1021/es040504n; Mara DD, 2007, J WATER HEALTH, V5, P39, DOI 10.2166/wh.2006.055; Mazari-Hiriart M, 2005, APPL ENVIRON MICROB, V71, P5129, DOI 10.1128/AEM.71.9.5129-5137.2005; Mazari-Hiriart M, 2001, WATER SCI TECHNOL, V43, P93, DOI 10.2166/wst.2001.0718; Mazari-Hiriart M, 2001, ARCH MED RES, V32, P458, DOI 10.1016/S0188-4409(01)00304-6; MAZARIHIRIART M, 2000, URBAN ECOSYST, V4, P91, DOI DOI 10.1023/A:1011334326405; *METC EDD INC, 1991, WAST ENG TREATM DISP, P107; Park JE, 2006, WATER SCI TECHNOL, V54, P185, DOI 10.2166/wst.2006.467; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Rojas T., 1995, PRESENTE PASADO FUTU, P324; Salas H. J., 2001, METODOLOGIAS SIMPLIF; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANTIAGOMERCADO J, 1987, APPL ENVIRON MICROB, V53, P2922, DOI 10.1128/AEM.53.12.2922-2928.1987; Scott TM, 2002, APPL ENVIRON MICROB, V68, P5796, DOI 10.1128/AEM.68.12.5796-5803.2002; Sondergaard M, 2002, HANDBOOK OF ECOLOGICAL RESTORATION, VOL 1, P184; TORANZOS GA, 2007, MANUAL ENV MICROBIOL, P253; TSUCHIHASHI R, 2002, HLTH ASPECTS GROUNDW; UNESCO, 2003, WAT PEOPL WAT LIF UN; UNESCO World Water Assessment Programme, 2006, 2 UNESCO; *UNESCO XOCH, 2006, XOCH PROC GEST PART; WHO, 2006, WHO GUID SAF US WAST	43	47	48	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2305	10.1371/journal.pone.0002305	http://dx.doi.org/10.1371/journal.pone.0002305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509453	gold, Green Published, Green Submitted			2022-12-27	WOS:000262268500040
J	Purushothaman, S; Gupta, G; Srivastava, R; Ramu, VG; Surolia, A				Purushothaman, Sudha; Gupta, Garima; Srivastava, Richa; Ramu, Vasanthakumar Ganga; Surolia, Avadhesha			Ligand Specificity of Group I Biotin Protein Ligase of Mycobacterium tuberculosis	PLOS ONE			English	Article								Background: Fatty acids are indispensable constituents of mycolic acids that impart toughness & permeability barrier to the cell envelope of M. tuberculosis. Biotin is an essential co-factor for acetyl-CoA carboxylase (ACC) the enzyme involved in the synthesis of malonyl-CoA, a committed precursor, needed for fatty acid synthesis. Biotin carboxyl carrier protein (BCCP) provides the co-factor for catalytic activity of ACC. Methodology/Principal Findings: BPL/BirA (Biotin Protein Ligase), and its substrate, biotin carboxyl carrier protein (BCCP) of Mycobacterium tuberculosis (Mt) were cloned and expressed in E. coli BL21. In contrast to EcBirA and PhBPL, the similar to 29.5 kDa MtBPL exists as a monomer in native, biotin and bio-5'AMP liganded forms. This was confirmed by molecular weight profiling by gel filtration on Superdex S-200 and Dynamic Light Scattering (DLS). Computational docking of biotin and bio-5'AMP to MtBPL show that adenylation alters the contact residues for biotin. MtBPL forms 11 H-bonds with biotin, relative to 35 with bio-5'AMP. Docking simulations also suggest that bio-5'AMP hydrogen bonds to the conserved 'GRGRRG' sequence but not biotin. The enzyme catalyzed transfer of biotin to BCCP was confirmed by incorporation of radioactive biotin and by Avidin blot. The K(m) for BCCP was similar to 5.2 mu M and similar to 420 nM for biotin. MtBPL has low affinity (K(b) = 1.06 x 10(-6) M) for biotin relative to EcBirA but their K(m) are almost comparable suggesting that while the major function of MtBPL is biotinylation of BCCP, tight binding of biotin/bio-5'AMP by EcBirA is channeled for its repressor activity. Conclusions/Significance: These studies thus open up avenues for understanding the unique features of MtBPL and the role it plays in biotin utilization in M. tuberculosis.	[Purushothaman, Sudha; Gupta, Garima; Srivastava, Richa; Ramu, Vasanthakumar Ganga; Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Surolia, Avadhesha] Natl Inst Immunol, New Delhi, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Purushothaman, S (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	surolia@nii.res.in		Ramu, Vasanthakumar/0000-0002-3397-8051	Department of Biotechnology (DBT), Government of India [Centre of excellence grant]; DBT; Department of Science and Technology, Government of India [J.C. Bose Fellow]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was supported by Centre of excellence grant from the Department of Biotechnology (DBT), Government of India to A.S. and by another DBT grant to A.S. A.S. is also J.C. Bose Fellow of the Department of Science and Technology, Government of India.	Bagautdinov B, 2005, J MOL BIOL, V353, P322, DOI 10.1016/j.jmb.2005.08.032; BARRY BR, 1992, SCIENCE, V257, P1055; Brown PH, 2005, BIOCHEMISTRY-US, V44, P3112, DOI 10.1021/bi047792k; Brown PH, 2004, J MOL BIOL, V337, P857, DOI 10.1016/j.jmb.2004.01.041; Chapman-Smith A, 1999, TRENDS BIOCHEM SCI, V24, P359, DOI 10.1016/S0968-0004(99)01438-3; Chapman-Smith A, 1999, J NUTR, V129, p477S, DOI 10.1093/jn/129.2.477S; Chapman-Smith A, 1999, J BIOL CHEM, V274, P1449, DOI 10.1074/jbc.274.3.1449; Choi-Rhee E, 2003, J BIOL CHEM, V278, P30806, DOI 10.1074/jbc.M302507200; Clarke DJ, 2003, EUR J BIOCHEM, V270, P1277, DOI 10.1046/j.1432-1033.2003.03493.x; Cole ST, 2007, BIOCHEM SOC T, V35, P1321, DOI 10.1042/BST0351321; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cox H, 2003, LANCET, V362, P1858, DOI 10.1016/S0140-6736(03)14918-5; JOHNSSON K, 1995, J AM CHEM SOC, V117, P5009, DOI 10.1021/ja00122a038; Kwon K, 2000, PROTEIN SCI, V9, P1530, DOI 10.1110/ps.9.8.1530; Kwon K, 2002, PROTEIN SCI, V11, P558, DOI 10.1110/ps.33502; LANE MD, 1964, J BIOL CHEM, V239, P2865; Marrakchi H, 2000, MICROBIOL-UK, V146, P289, DOI 10.1099/00221287-146-2-289; MUKHOPADHYAY B, 2001, J BAC, V183, P3802; Polyak SW, 1999, J BIOL CHEM, V274, P32847, DOI 10.1074/jbc.274.46.32847; Reche P, 1998, BIOCHEM J, V329, P589, DOI 10.1042/bj3290589; Reche P, 1999, EMBO J, V18, P2673, DOI 10.1093/emboj/18.10.2673; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Streaker ED, 2003, J MOL BIOL, V325, P937, DOI 10.1016/S0022-2836(02)01308-6; Streaker ED, 2006, BIOCHEMISTRY-US, V45, P6417, DOI 10.1021/bi052599r; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Weaver LH, 2001, P NATL ACAD SCI USA, V98, P6045, DOI 10.1073/pnas.111128198; WILSON KP, 1992, P NATL ACAD SCI USA, V89, P9257, DOI 10.1073/pnas.89.19.9257; WINDER F G, 1970, Journal of General Microbiology, V63, P41; WINDER FG, 1979, BIOCHEM J, V117, pP127; Wood ZA, 2006, J MOL BIOL, V357, P509, DOI 10.1016/j.jmb.2005.12.066; Wu SC, 2004, ANAL BIOCHEM, V331, P340, DOI 10.1016/j.ab.2004.03.056; Xu Y, 1995, BIOCHEMISTRY-US, V34, P16624, DOI 10.1021/bi00051a010; Xu Y, 1996, BIOCHEMISTRY-US, V35, P1783, DOI 10.1021/bi952269e; Xu Y, 1996, BIOCHEMISTRY-US, V35, P5509, DOI 10.1021/bi9600658	35	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2320	10.1371/journal.pone.0002320	http://dx.doi.org/10.1371/journal.pone.0002320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509457	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000262268500047
J	Little, AC; Jones, BC; Waitt, C; Tiddeman, BP; Feinberg, DR; Perrett, DI; Apicella, CL; Marlowe, FW				Little, Anthony C.; Jones, Benedict C.; Waitt, Corri; Tiddeman, Bernard P.; Feinberg, David R.; Perrett, David I.; Apicella, Coren L.; Marlowe, Frank W.			Symmetry Is Related to Sexual Dimorphism in Faces: Data Across Culture and Species	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; DEVELOPMENTAL STABILITY; FACIAL ATTRACTIVENESS; ONE ORNAMENT; SELECTION; TESTOSTERONE; PREFERENCES; SIGNALS; APPEARANCE; ESTROGEN	Background: Many animals both display and assess multiple signals. Two prominently studied traits are symmetry and sexual dimorphism, which, for many animals, are proposed cues to heritable fitness benefits. These traits are associated with other potential benefits, such as fertility. In humans, the face has been extensively studied in terms of attractiveness. Faces have the potential to be advertisements of mate quality and both symmetry and sexual dimorphism have been linked to the attractiveness of human face shape. Methodology/Principal Findings: Here we show that measurements of symmetry and sexual dimorphism from faces are related in humans, both in Europeans and African hunter-gatherers, and in a non-human primate. Using human judges, symmetry measurements were also related to perceived sexual dimorphism. In all samples, symmetric males had more masculine facial proportions and symmetric females had more feminine facial proportions. Conclusions/Significance: Our findings support the claim that sexual dimorphism and symmetry in faces are signals advertising quality by providing evidence that there must be a biological mechanism linking the two traits during development. Such data also suggests that the signalling properties of faces are universal across human populations and are potentially phylogenetically old in primates.	[Little, Anthony C.] Univ Stirling, Sch Psychol, Stirling FK9 4LA, Scotland; [Jones, Benedict C.] Univ Aberdeen, Sch Psychol, Aberdeen, Scotland; [Waitt, Corri] Univ Oxford, Dept Zool, Oxford, England; [Tiddeman, Bernard P.] Univ St Andrews, Sch Comp Sci, St Andrews, Fife, Scotland; [Feinberg, David R.] McMaster Univ, Dept Psychol, Hamilton, ON, Canada; [Perrett, David I.] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland; [Apicella, Coren L.] Harvard Univ, Dept Anthropol, Cambridge, MA USA; [Marlowe, Frank W.] Florida State Univ, Dept Anthropol, Tallahassee, FL USA	University of Stirling; University of Aberdeen; University of Oxford; University of St Andrews; McMaster University; University of St Andrews; Harvard University; State University System of Florida; Florida State University	Little, AC (corresponding author), Univ Stirling, Sch Psychol, Stirling FK9 4LA, Scotland.	anthony.little@stir.ac.uk	Jones, Benedict C/A-7850-2008; Little, Anthony C/B-8497-2009; Little, Anthony/W-2732-2019; Feinberg, David/C-1249-2009; Marlowe, Frank/G-9752-2012	Jones, Benedict C/0000-0001-7777-0220; Little, Anthony C/0000-0001-9100-1903; Little, Anthony/0000-0001-9100-1903; Feinberg, David/0000-0003-4179-1446; Apicella, Coren/0000-0002-9661-6998; Perrett, David/0000-0002-6025-0939; Tiddeman, Bernard/0000-0001-7570-1192	Royal Society University Research Fellowship; National Science Foundation [0650574]; Unilever research	Royal Society University Research Fellowship(Royal Society of London); National Science Foundation(National Science Foundation (NSF)); Unilever research(Unilever)	Anthony Little is supported by a Royal Society University Research Fellowship. Frank Marlowe is sponsored by the National Science Foundation grant # 0650574. David Perrett is supported by Unilever research. No funders had any role in the conduct or any other aspect of this paper.	ALEXANDER J, 1988, PARASITOL TODAY, V4, P189, DOI 10.1016/0169-4758(88)90077-4; Andersson Malte, 1994; [Anonymous], [No title captured]; BALMFORD A, 1993, NATURE, V361, P628, DOI 10.1038/361628a0; BARDIN CW, 1981, SCIENCE, V211, P1285, DOI 10.1126/science.7010603; BENSON PJ, 1993, PERCEPTION, V22, P257, DOI 10.1068/p220257; BOROD JC, 1981, CORTEX, V17, P381, DOI 10.1016/S0010-9452(81)80025-1; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; CHANGIZI MA, BIOL LETT IN PRESS; Darwin C., 1871, P423; Enlow D.H., 1982, HDB FACIAL GROWTH; ENQUIST M, 1993, NATURE, V361, P446, DOI 10.1038/361446a0; ENQUIST M, 1994, NATURE, V372, P169, DOI 10.1038/372169a0; Feinberg DR, 2005, EVOL HUM BEHAV, V26, P398, DOI 10.1016/j.evolhumbehav.2005.04.001; Fisher RA, 1930, GENETICAL THEORY NAT; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Gangestad SW, 2003, EVOL HUM BEHAV, V24, P231, DOI 10.1016/S1090-5138(03)00017-5; Getty T, 2002, AM NAT, V159, P363, DOI 10.1086/338992; Grammer K, 2003, BIOL REV, V78, P385, DOI 10.1017/S1464793102006085; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Gray PB, 2002, ANN HUM BIOL, V29, P495, DOI 10.1080/03014460110112060; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; JOHNSTONE RA, 1994, NATURE, V372, P172, DOI 10.1038/372172a0; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; Kanda N, 1996, CLIN EXP IMMUNOL, V106, P410, DOI 10.1046/j.1365-2249.1996.d01-842.x; Koehler N, 2004, P ROY SOC B-BIOL SCI, V271, pS233, DOI 10.1098/rsbl.2003.0146; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Little AC, 2003, P ROY SOC B-BIOL SCI, V270, P1759, DOI 10.1098/rspb.2003.2445; Little AC, 2002, P ROY SOC B-BIOL SCI, V269, P1095, DOI 10.1098/rspb.2002.1984; Little AC, 2007, P ROY SOC B-BIOL SCI, V274, P3113, DOI 10.1098/rspb.2007.0895; Manning JT, 1998, EVOL HUM BEHAV, V19, P273, DOI 10.1016/S1090-5138(98)00024-5; MANNING JT, 1993, P ROY SOC B-BIOL SCI, V251, P83, DOI 10.1098/rspb.1993.0012; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Moller AP, 1997, AM NAT, V149, P916, DOI 10.1086/286030; MOLLER AP, 1991, P ROY SOC B-BIOL SCI, V245, P1, DOI 10.1098/rspb.1991.0080; MOLLER AP, 1990, ANIM BEHAV, V40, P1185, DOI 10.1016/S0003-3472(05)80187-3; Palmer AR, 1997, J EVOLUTION BIOL, V10, P39; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P229, DOI 10.1016/j.evolhumbehav.2004.04.003; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Perrett DI, 1999, EVOL HUM BEHAV, V20, P295, DOI 10.1016/S1090-5138(99)00014-8; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; RHODES G, 2003, DOES SEXUAL DIMORPHI; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; RYAN MJ, 1990, EVOLUTION, V44, P305, DOI 10.1111/j.1558-5646.1990.tb05200.x; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Service RF, 1998, SCIENCE, V279, P1631, DOI 10.1126/science.279.5357.1631; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Thornhill R, 1999, EVOL HUM BEHAV, V20, P105, DOI 10.1016/S1090-5138(98)00044-0; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; VALEN LV, 1962, EVOLUTION, V16, P125, DOI DOI 10.2307/2406192; Waitt C, 2006, INT J PRIMATOL, V27, P133, DOI 10.1007/s10764-005-9015-y; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	56	133	141	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2106	10.1371/journal.pone.0002106	http://dx.doi.org/10.1371/journal.pone.0002106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461131	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000261642400028
J	Chung, W; Kwabi-Addo, B; Ittmann, M; Jelinek, J; Shen, L; Yu, YH; Issa, JPJ				Chung, Woonbok; Kwabi-Addo, Bernard; Ittmann, Michael; Jelinek, Jaroslav; Shen, Lanlan; Yu, Yinhua; Issa, Jean-Pierre J.			Identification of Novel Tumor Markers in Prostate, Colon and Breast Cancer by Unbiased Methylation Profiling	PLOS ONE			English	Article								DNA hypermethylation is a common epigenetic abnormality in cancer and may serve as a useful marker to clone cancer-related genes as well as a marker of clinical disease activity. To identify CpG islands methylated in prostate cancer, we used methylated CpG island amplification (MCA) coupled with representational difference analysis (RDA) on prostate cancer cell lines. We isolated 34 clones that corresponded to promoter CpG islands, including 5 reported targets of hypermethylation in cancer. We confirmed the data for 17 CpG islands by COBRA and/or pyrosequencing. All 17 genes were methylated in at least 2 cell lines of a 21-cancer cell line panel containing prostate cancer, colon cancer, leukemia, and breast cancer. Based on methylation in primary tumors compared to normal adjacent tissues, NKX2-5, CLSTN1, SPOCK2, SLC16A12, DPYS and NSE1 are candidate biomarkers for prostate cancer (methylation range 50%-85%). The combination of NSE1 or SPOCK2 hypermethylation showed a sensitivity of 80% and specificity of 95% in differentiating cancer from normal. Similarly NKX2-5, SPOCK2, SLC16A12, DPYS and GALR2 are candidate biomarkers for colon cancer (methylation range 60%-95%) and GALR2 hypermethylation showed a sensitivity of 85% and specificity of 95%. Finally, SLC16A12, GALR2, TOX, SPOCK2, EGFR5 and DPYS are candidate biomarkers for breast cancer (methylation range 33%-79%) with the combination of EGFR5 or TOX hypermethylation showing a sensitivity of 92% and specificity of 92%. Expression analysis for eight genes that had the most hypermethylation confirmed the methylation associated silencing and reactivation with 5-aza-2'-deoxycytidine treatment. Our data identify new targets of transcriptional silencing in cancer, and provide new biomarkers that could be useful in screening for prostate cancer and other cancers.	[Chung, Woonbok; Jelinek, Jaroslav; Shen, Lanlan; Issa, Jean-Pierre J.] Baylor Coll Med, Dept Leukemia, Houston, TX 77030 USA; [Kwabi-Addo, Bernard; Ittmann, Michael] Baylor Coll Med, Dept Pathol, Houston, TX USA; [Yu, Yinhua] Baylor Coll Med, Monroe Dunaway M. D. Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Chung, W (corresponding author), Baylor Coll Med, Dept Leukemia, Houston, TX 77030 USA.	jpissa@mdanderson.org	Jelinek, Jaroslav/O-6876-2019; Kwabi-Addo, Bernard/A-6993-2016	Kwabi-Addo, Bernard/0000-0003-3692-6350; Issa, Jean-Pierre/0000-0003-2258-5030	National Institutes of Health [CA100632, CA098006]; NATIONAL CANCER INSTITUTE [P50CA100632, R01CA098006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants CA100632 and CA098006.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baylin SB, 1998, ADV CANCER RES, V72, P141; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; CHRISTIAN BJ, 1987, CANCER RES, V47, P6066; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Cottrell SE, 2003, ANN NY ACAD SCI, V983, P120, DOI 10.1111/j.1749-6632.2003.tb05967.x; Estecio MRH, 2007, GENOME RES, V17, P1529, DOI 10.1101/gr.6417007; GRAFF JR, 1995, CANCER RES, V55, P5195; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Huang S, 1998, EMBO J, V17, P4358, DOI 10.1093/emboj/17.15.4358; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kang GH, 2004, J PATHOL, V202, P233, DOI 10.1002/path.1503; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Liu LM, 2002, ONCOGENE, V21, P6835, DOI 10.1038/sj.onc.1205814; Nakayama T, 2001, LAB INVEST, V81, P1049, DOI 10.1038/labinvest.3780316; Schmutte C, 1998, BIOL CHEM, V379, P377; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Singal R, 2001, CANCER RES, V61, P4820; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Suh ER, 2002, J BIOL CHEM, V277, P35795, DOI 10.1074/jbc.M205567200; Toyota M, 1999, CANCER RES, V59, P2307; Webber MM, 1996, CARCINOGENESIS, V17, P1641, DOI 10.1093/carcin/17.8.1641; Wimmer K, 2002, GENE CHROMOSOME CANC, V33, P285, DOI 10.1002/gcc.10030; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yamada Y, 2003, CANCER SCI, V94, P536, DOI 10.1111/j.1349-7006.2003.tb01479.x; Yamanaka M, 2003, INT J CANCER, V106, P382, DOI 10.1002/ijc.11227; Yegnasubramanian S, 2004, CANCER RES, V64, P1975, DOI 10.1158/0008-5472.CAN-03-3972; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78	32	100	115	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2079	10.1371/journal.pone.0002079	http://dx.doi.org/10.1371/journal.pone.0002079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446232	Green Published, Green Submitted, gold			2022-12-27	WOS:000261572300047
J	Folkesson, A; Haagensen, JAJ; Zampaloni, C; Sternberg, C; Molin, S				Folkesson, Anders; Haagensen, Janus A. J.; Zampaloni, Claudia; Sternberg, Claus; Molin, Soren			Biofilm Induced Tolerance towards Antimicrobial Peptides	PLOS ONE			English	Article								Increased tolerance to antimicrobial agents is thought to be an important feature of microbes growing in biofilms. We address the question of how biofilm organization affects antibiotic susceptibility. We established Escherichia coli biofilms with differential structural organization due to the presence of IncF plasmids expressing altered forms of the transfer pili in two different biofilm model systems. The mature biofilms were subsequently treated with two antibiotics with different molecular targets, the peptide antibiotic colistin and the fluoroquinolone ciprofloxacin. The dynamics of microbial killing were monitored by viable count determination, and confocal laser microscopy. Strains forming structurally organized biofilms show an increased bacterial survival when challenged with colistin, compared to strains forming unstructured biofilms. The increased survival is due to genetically regulated tolerant subpopulation formation and not caused by a general biofilm property. No significant difference in survival was detected when the strains were challenged with ciprofloxacin. Our data show that biofilm formation confers increased colistin tolerance to cells within the biofilm structure, but the protection is conditional being dependent on the structural organization of the biofilm, and the induction of specific tolerance mechanisms.	[Folkesson, Anders; Haagensen, Janus A. J.; Sternberg, Claus; Molin, Soren] Tech Univ Denmark, BioCentrum DTU, Infect Microbiol Grp, DK-2800 Lyngby, Denmark; [Zampaloni, Claudia] Univ Camerino, Dept Mol Cell Anim Biol, Camerino, Italy	Technical University of Denmark; University of Camerino	Folkesson, A (corresponding author), Tech Univ Denmark, BioCentrum DTU, Infect Microbiol Grp, DK-2800 Lyngby, Denmark.	anf@bio.dtu.dk	Sternberg, Claus/Y-1737-2019; Sternberg, Claus/E-4300-2010	Sternberg, Claus/0000-0002-2572-0288; Sternberg, Claus/0000-0002-2572-0288; Folkesson, Anders/0000-0002-2175-830X; Molin, Soren/0000-0002-7973-2639	Danish research councils; FEMS Research Fellowship	Danish research councils(Det Frie Forskningsrad (DFF)); FEMS Research Fellowship	This work was supported by the Danish research councils to Soren Molin and a FEMS Research Fellowship to Claudia Zampaloni.	Amorena B, 1999, J ANTIMICROB CHEMOTH, V44, P43, DOI 10.1093/jac/44.1.43; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; ANWAR H, 1992, ANTIMICROB AGENTS CH, V36, P1208, DOI 10.1128/AAC.36.6.1208; Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Ceri H, 1999, J CLIN MICROBIOL, V37, P1771, DOI 10.1128/JCM.37.6.1771-1776.1999; CHANDLER M, 1983, J MOL BIOL, V170, P61, DOI 10.1016/S0022-2836(83)80227-7; Christensen BB, 1998, APPL ENVIRON MICROB, V64, P2247; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; CONRAD RS, 1989, ANTIMICROB AGENTS CH, V33, P1724, DOI 10.1128/AAC.33.10.1724; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; DAME JB, 1979, J BACTERIOL, V137, P1043, DOI 10.1128/JB.137.2.1043-1047.1979; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Desai M, 1998, J ANTIMICROB CHEMOTH, V42, P153, DOI 10.1093/jac/42.2.153; DIEDERICH L, 1992, PLASMID, V28, P14, DOI 10.1016/0147-619X(92)90032-6; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Dudley EG, 2006, INFECT IMMUN, V74, P2102, DOI 10.1128/IAI.74.4.2102-2114.2006; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Gilbert P, 1997, Adv Dent Res, V11, P160; GRISTINA AG, 1989, ANTIMICROB AGENTS CH, V33, P813, DOI 10.1128/AAC.33.6.813; Haagensen JAJ, 2007, J BACTERIOL, V189, P28, DOI 10.1128/JB.00720-06; Hagiwara D, 2004, BIOSCI BIOTECH BIOCH, V68, P1758, DOI 10.1271/bbb.68.1758; Harada K, 2005, J VET MED SCI, V67, P999, DOI 10.1292/jvms.67.999; Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395; Heydorn A, 2002, APPL ENVIRON MICROB, V68, P2008, DOI 10.1128/AEM.68.4.2008-2017.2002; Hill D, 2005, J CLIN MICROBIOL, V43, P5085, DOI 10.1128/JCM.43.10.5085-5090.2005; Hooper DC, 1999, DRUGS, V58, P6, DOI 10.2165/00003495-199958002-00002; KATHIR P, 1991, PLASMID, V26, P40, DOI 10.1016/0147-619X(91)90035-U; Kim W, 2003, J BACTERIOL, V185, P3111, DOI 10.1128/JB.185.10.3111-3117.2003; Kim Wook, 2003, Biological Procedures Online, V5, P189, DOI 10.1251/bpo61; Kuehn M, 1998, APPL ENVIRON MICROB, V64, P4115; KUMON H, 1995, ANTIMICROB AGENTS CH, V39, P1038, DOI 10.1128/AAC.39.5.1038; Larsen T, 1996, APMIS, V104, P280, DOI 10.1111/j.1699-0463.1996.tb00718.x; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Li J, 2005, INT J ANTIMICROB AG, V25, P11, DOI 10.1016/j.ijantimicag.2004.10.001; Littlewood JM, 2000, RESP MED, V94, P632, DOI 10.1053/rmed.2000.0834; Maloy SR., 1996, GENETIC ANAL PATHOGE; Maneewannakul K, 1996, MOL MICROBIOL, V22, P197, DOI 10.1046/j.1365-2958.1996.00087.x; MANEEWANNAKUL K, 1995, J BACTERIOL, V177, P2957, DOI 10.1128/jb.177.11.2957-2964.1995; MANEEWANNAKUL K, 1993, J BACTERIOL, V175, P1384, DOI 10.1128/JB.175.5.1384-1391.1993; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Molin S, 2003, CURR OPIN BIOTECH, V14, P255, DOI 10.1016/S0958-1669(03)00036-3; MOORE D, 1993, J BACTERIOL, V175, P1375, DOI 10.1128/JB.175.5.1375-1383.1993; NICKEL JC, 1985, ANTIMICROB AGENTS CH, V27, P619, DOI 10.1128/AAC.27.4.619; PANICKER MM, 1985, J BACTERIOL, V162, P584, DOI 10.1128/JB.162.2.584-590.1985; Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x; Reisner A, 2006, J BACTERIOL, V188, P3572, DOI 10.1128/JB.188.10.3572-3581.2006; Reisner A, 2006, J BACTERIOL, V188, P3582, DOI 10.1128/JB.188.10.3582-3588.2006; Schroder G, 2002, J BACTERIOL, V184, P2767, DOI 10.1128/JB.184.10.2767-2779.2002; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Sternberg C, 1999, APPL ENVIRON MICROB, V65, P4108; STORM DR, 1977, ANNU REV BIOCHEM, V46, P723, DOI 10.1146/annurev.bi.46.070177.003451; Trent MS, 2001, J BIOL CHEM, V276, P43132, DOI 10.1074/jbc.M106962200; VAARA M, 1981, FEBS LETT, V129, P145, DOI 10.1016/0014-5793(81)80777-6; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998; VORACHIT M, 1993, ANTIMICROB AGENTS CH, V37, P2000, DOI 10.1128/AAC.37.9.2000; Williams I, 1997, MICROBIOL-UK, V143, P2407, DOI 10.1099/00221287-143-7-2407; Wimpenny J, 2000, FEMS MICROBIOL REV, V24, P661, DOI 10.1111/j.1574-6976.2000.tb00565.x; Winfield MD, 2004, P NATL ACAD SCI USA, V101, P17162, DOI 10.1073/pnas.0406038101; Xu KD, 2000, MICROBIOL-UK, V146, P547, DOI 10.1099/00221287-146-3-547; Xu KD, 1998, APPL ENVIRON MICROB, V64, P4035; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2	67	63	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1891	10.1371/journal.pone.0001891	http://dx.doi.org/10.1371/journal.pone.0001891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382672	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795400023
J	Funderburg, N; Luciano, AA; Jiang, W; Rodriguez, B; Sieg, SF; Lederman, MM				Funderburg, Nicholas; Luciano, Angel A.; Jiang, Wei; Rodriguez, Benigno; Sieg, Scott F.; Lederman, Michael M.			Toll-Like Receptor Ligands Induce Human T Cell Activation and Death, a Model for HIV Pathogenesis	PLOS ONE			English	Article								Background: Recently, heightened systemic translocation of microbial products was found in persons with chronic HIV infection and this was linked to immune activation and CD4(+) T cell homeostasis. Methodology: We examined here the effects of microbial Toll-like receptor (TLR) ligands on T cell activation in vitro. Conclusions/Findings: We show that exposure to TLR ligands results in activation of memory and effector CD4(+) and CD8(+) T cells. After exposure to each of 8 different ligands that activate TLRs 2, 3, 4, 5, 7, 8, and 9, CD8(+) T cells are activated and gain expression of the C type lectin CD69 that may promote their retention in lymphoid tissues. In contrast, CD4(+) T cells rarely increase CD69 expression but instead enter cell cycle. Despite activation and cell cycle entry, CD4(+) T cells divide poorly and instead, disproportionately undergo activation-induced cell death. Systemic exposure to TLR agonists may therefore increase immune activation, effector cell sequestration in lymphoid tissues and T cell turnover. These events may contribute to the pathogenesis of immune dysfunction and CD4+ T cell losses in chronic infection with the human immunodeficiency virus.	[Funderburg, Nicholas; Lederman, Michael M.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Luciano, Angel A.] Rainbow Babies & Childrens Hosp, Dept Pediat, Div Neonatol, Cleveland, OH USA; [Luciano, Angel A.; Jiang, Wei; Rodriguez, Benigno; Sieg, Scott F.; Lederman, Michael M.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Ctr AIDS Res, Dept Med, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Case Western Reserve University Hospital	Lederman, MM (corresponding author), Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	michael.lederman@case.edu	Rodriguez, Benigno/C-3365-2009; Sieg, Scott/AAV-2429-2021; Funderburg, Nicholas/L-8022-2013	Rodriguez, Benigno/0000-0001-9736-7957; Funderburg, Nicholas/0000-0003-3113-1217	Center for AIDS Research [AI 36219, AI 38858]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, U01AI038858] Funding Source: NIH RePORTER	Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Center for AIDS Research AI 36219 AI 38858. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS DI, 1984, ANN INTERN MED, V100, P801, DOI 10.7326/0003-4819-100-6-801; Altfeld M, 2002, J CLIN INVEST, V109, P837, DOI 10.1172/JCI0214789; Andersson J, 1998, AIDS, V12, pF123, DOI 10.1097/00002030-199811000-00004; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; CHEYNIER R, 1994, CELL, V78, P373, DOI 10.1016/0092-8674(94)90417-0; Crellin NK, 2005, J IMMUNOL, V175, P8051, DOI 10.4049/jimmunol.175.12.8051; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jiang W, 2007, EUR J IMMUNOL, V37, P2205, DOI 10.1002/eji.200636984; Kovacs JA, 2001, J EXP MED, V194, P1731, DOI 10.1084/jem.194.12.1731; Lempicki RA, 2000, P NATL ACAD SCI USA, V97, P13778, DOI 10.1073/pnas.250472097; Liu Z, 1998, J ACQ IMMUN DEF SYND, V18, P332, DOI 10.1097/00042560-199808010-00004; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Picker LJ, 2004, J EXP MED, V200, P1299, DOI 10.1084/jem.20041049; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sieg SF, 2005, J INFECT DIS, V192, P62, DOI 10.1086/430620; Silvestri G, 2003, IMMUNITY, V18, P441, DOI 10.1016/S1074-7613(03)00060-8; TENNERRACZ K, 1993, AM J PATHOL, V142, P1750; Wilson CM, 2004, AIDS RES HUM RETROV, V20, P263, DOI 10.1089/088922204322996482; Zanin-Zhorov A, 2007, J IMMUNOL, V179, P41, DOI 10.4049/jimmunol.179.1.41	32	102	111	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1915	10.1371/journal.pone.0001915	http://dx.doi.org/10.1371/journal.pone.0001915			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382686	Green Submitted, Green Published, gold			2022-12-27	WOS:000260795400039
J	Caut, S; Fossette, S; Guirlet, E; Angulo, E; Das, K; Girondot, M; Georges, JY				Caut, Stephane; Fossette, Sabrina; Guirlet, Elodie; Angulo, Elena; Das, Krishna; Girondot, Marc; Georges, Jean-Yves			Isotope Analysis Reveals Foraging Area Dichotomy for Atlantic Leatherback Turtles	PLOS ONE			English	Article							FEEDING HABITAT USE; STABLE-ISOTOPES; DERMOCHELYS-CORIACEA; SEA-TURTLES; CARETTA-CARETTA; NUTRITIONAL STRESS; MOVEMENT PATTERNS; CARBON ISOTOPES; NESTING NUMBERS; MARINE TURTLES	Background: The leatherback turtle (Dermochelys coriacea) has undergone a dramatic decline over the last 25 years, and this is believed to be primarily the result of mortality associated with fisheries bycatch followed by egg and nesting female harvest. Atlantic leatherback turtles undertake long migrations across ocean basins from subtropical and tropical nesting beaches to productive frontal areas. Migration between two nesting seasons can last 2 or 3 years, a time period termed the remigration interval (RI). Recent satellite transmitter data revealed that Atlantic leatherbacks follow two major dispersion patterns after nesting season, through the North Gulf Stream area or more eastward across the North Equatorial Current. However, information on the whole RI is lacking, precluding the accurate identification of feeding areas where conservation measures may need to be applied. Methodology/Principal Findings: Using stable isotopes as dietary tracers we determined the characteristics of feeding grounds of leatherback females nesting in French Guiana. During migration, 3-year RI females differed from 2-year RI females in their isotope values, implying differences in their choice of feeding habitats (offshore vs. more coastal) and foraging latitude (North Atlantic vs. West African coasts, respectively). Egg-yolk and blood isotope values are correlated in nesting females, indicating that egg analysis is a useful tool for assessing isotope values in these turtles, including adults when not available. Conclusions/Significance: Our results complement previous data on turtle movements during the first year following the nesting season, integrating the diet consumed during the year before nesting. We suggest that the French Guiana leatherback population segregates into two distinct isotopic groupings, and highlight the urgent need to determine the feeding habitats of the turtle in the Atlantic in order to protect this species from incidental take by commercial fisheries. Our results also emphasize the use of eggs, a less-invasive sampling material than blood, to assess isotopic data and feeding habits for adult female leatherbacks.	[Caut, Stephane; Das, Krishna] B6C Liege Univ, MARE Ctr, Lab Oceanol, Liege, Belgium; [Guirlet, Elodie; Angulo, Elena; Girondot, Marc] Univ Paris Sud, Lab Ecol, Syst Evolut, Orsay, France; [Girondot, Marc] Museum Natl Histoire Naturelle Paris, Dept Evolut Syst, Paris, France; [Fossette, Sabrina; Georges, Jean-Yves] CNRS Univ Strasbourg, UMR 7178, Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol Ethiol, Strasbourg, France	University of Liege; UDICE-French Research Universities; Universite Paris Saclay; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Caut, S (corresponding author), B6C Liege Univ, MARE Ctr, Lab Oceanol, Liege, Belgium.	stephane.caut@u-psud.fr; elodie.guirlet@u-psud.fr	Angulo, Elena/A-8107-2013; Das, Krishna/AAB-7273-2020; Girondot, Marc/A-7663-2010	Angulo, Elena/0000-0001-5545-4032; Das, Krishna/0000-0003-2689-3348; Girondot, Marc/0000-0001-6645-8530	DIREN-Guyane; FNRS-FRS; University of Liege [post-doctoral grant]; ANR-Biodiversite project; French Ministry of Research [studentship]; Programme Amazonie du CNRS; ANR through Projet MIRETTE	DIREN-Guyane; FNRS-FRS(Fonds de la Recherche Scientifique - FNRS); University of Liege(University of Liege); ANR-Biodiversite project(French National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Programme Amazonie du CNRS; ANR through Projet MIRETTE(French National Research Agency (ANR))	This work was supported by DIREN-Guyane. Krishna Das received a grant from FNRS-FRS and Stephane Caut received a post-doctoral grant from the University of Liege. Elena Angulo acknowledges funding by the ANR-Biodiversite project. SF was supported by a studentship from the French Ministry of Research. JYG was supported by Programme Amazonie du CNRS and ANR through Projet MIRETTE.	Benson SR, 2007, CHELONIAN CONSERV BI, V6, P150, DOI 10.2744/1071-8443(2007)6[150:PMOLTD]2.0.CO;2; Biasatti DM, 2004, PALAEOGEOGR PALAEOCL, V206, P203, DOI 10.1016/j.palaeo.2004.01.004; BJORNDAL KA, 1997, BIOL SEA TURTLES, P237; Broderick AC, 2001, P ROY SOC B-BIOL SCI, V268, P1481, DOI 10.1098/rspb.2001.1695; Burton RK, 1999, OECOLOGIA, V119, P578, DOI 10.1007/s004420050822; Burton RK, 2001, OECOLOGIA, V128, P107, DOI 10.1007/s004420100631; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; Das K, 2003, MAR ECOL PROG SER, V263, P287, DOI 10.3354/meps263287; Davenport J., 1998, British Herpetological Society Bulletin, V62, P4; DeNiro M.J., 1976, GEOL SOC AM ABSTR, V8, P834; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DOYLE TK, 2007, ENDANGERED SPECIES R, V3, P15; DUNTON KH, 1989, MAR ECOL PROG SER, V56, P89, DOI 10.3354/meps056089; Duron M, 1980, COURRIER NATURE, V69, P37; Eckert SA, 2002, J EXP BIOL, V205, P3689; Eckert SA, 2006, CHELONIAN CONSERV BI, V5, P239, DOI 10.2744/1071-8443(2006)5[239:IAPMAF]2.0.CO;2; Eckert SA, 2006, MAR BIOL, V149, P1257, DOI 10.1007/s00227-006-0262-z; Ferraroli S, 2004, NATURE, V429, P521, DOI 10.1038/429521a; Fossette S, 2007, MAR ECOL PROG SER, V338, P233, DOI 10.3354/meps338233; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Georges JY, 2007, MAR ECOL PROG SER, V338, P225, DOI 10.3354/meps338225; Girondot M, 2002, ANIM CONSERV, V5, P75, DOI 10.1017/S1367943002001099; Girondot Marc, 1996, Chelonian Conservation and Biology, V2, P204; Godley BJ, 1998, MAR ECOL PROG SER, V166, P277, DOI 10.3354/meps166277; GODLEY BJ, 2007, ENDANGERED SPECIES R, V3, P16; GOERICKE R, 1994, GLOBAL BIOGEOCHEM CY, V8, P85, DOI 10.1029/93GB03272; Hatase H, 2002, MAR ECOL PROG SER, V233, P273, DOI 10.3354/meps233273; Hatase H, 2006, OECOLOGIA, V149, P52, DOI 10.1007/s00442-006-0431-2; Hays GC, 2004, ANIM BEHAV, V67, P733, DOI 10.1016/j.anbehav.2003.08.011; Hays GC, 2000, J THEOR BIOL, V206, P221, DOI 10.1006/jtbi.2000.2116; Hays GC, 2004, NATURE, V429, P522, DOI 10.1038/429522a; Hilderbrand GV, 1996, CAN J ZOOL, V74, P2080, DOI 10.1139/z96-236; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; HOBSON KA, 1995, CONDOR, V97, P752, DOI 10.2307/1369183; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; James MC, 2006, CAN J ZOOL, V84, P754, DOI 10.1139/Z06-046; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; James MC, 2005, P ROY SOC B-BIOL SCI, V272, P1547, DOI 10.1098/rspb.2005.3110; James Michael C., 2001, Chelonian Conservation and Biology, V4, P202; James MC, 2006, J EXP MAR BIOL ECOL, V335, P221, DOI 10.1016/j.jembe.2006.03.013; Kaplan IC, 2005, CAN J FISH AQUAT SCI, V62, P1710, DOI 10.1139/F05-121; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kempster B, 2007, OECOLOGIA, V151, P365, DOI 10.1007/s00442-006-0597-7; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Miller Jeffrey D., 1997, P51; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Myers AE, 2006, MAR ECOL PROG SER, V322, P259, DOI 10.3354/meps322259; Oelbermann K, 2002, OECOLOGIA, V130, P337, DOI 10.1007/s004420100813; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Price E. R., 2006, ENDANGER SPECIES RES, V1, P41, DOI DOI 10.3354/ESR001041; RAU GH, 1982, DEEP-SEA RES, V29, P1035, DOI 10.1016/0198-0149(82)90026-7; Reich KJ, 2007, BIOL LETTERS, V3, P712, DOI 10.1098/rsbl.2007.0394; Reina RD, 2005, J EXP MAR BIOL ECOL, V316, P1, DOI 10.1016/j.jembe.2004.10.002; Revelles M, 2007, J MAR BIOL ASSOC UK, V87, P805, DOI 10.1017/S0025315407054707; Revelles M, 2007, SCI MAR, V71, P87, DOI 10.3989/scimar.2007.71n187; Rivalan P, 2005, OECOLOGIA, V145, P564, DOI 10.1007/s00442-005-0159-4; Rostal DC, 1998, GEN COMP ENDOCR, V109, P232, DOI 10.1006/gcen.1997.7026; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Saba VS, 2007, J APPL ECOL, V44, P395, DOI 10.1111/j.1365-2664.2007.01276.x; Sale A, 2006, J EXP MAR BIOL ECOL, V328, P197, DOI 10.1016/j.jembe.2005.07.006; Martinez LS, 2007, CHELONIAN CONSERV BI, V6, P70, DOI 10.2744/1071-8443(2007)6[70:CABOTL]2.0.CO;2; SAS Institute Inc, 2004, SAS 9 1 3 HELP DOC; Seminoff JA, 2006, MAR ECOL PROG SER, V308, P271, DOI 10.3354/meps308271; Seminoff JA, 2007, COPEIA, P534, DOI 10.1643/0045-8511(2007)2007[534:SCANID]2.0.CO;2; Solow AR, 2002, ECOL LETT, V5, P742, DOI 10.1046/j.1461-0248.2002.00374.x; StatSoft Inc. Statistica, 2001, DAT AN SOFTW SYST VE; Takai N, 2000, J MAR BIOL ASSOC UK, V80, P675, DOI 10.1017/S0025315400002502; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; VOIGT CC, 2007, J EXP BIOL, V207, P1741; Wallace BP, 2005, J EXP BIOL, V208, P3873, DOI 10.1242/jeb.01860; Wallace BP, 2007, CHELONIAN CONSERV BI, V6, P147, DOI 10.2744/1071-8443(2007)6[147:ATFOBS]2.0.CO;2; Wallace BP, 2006, MAR BIOL, V149, P953, DOI 10.1007/s00227-006-0247-y; Williams CT, 2007, OECOLOGIA, V153, P11, DOI 10.1007/s00442-007-0717-z; Witt MJ, 2007, MAR ECOL PROG SER, V337, P231, DOI 10.3354/meps337231	80	63	67	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1845	10.1371/journal.pone.0001845	http://dx.doi.org/10.1371/journal.pone.0001845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365003	Green Published, gold			2022-12-27	WOS:000260762400009
J	Emes, RD; Yang, ZH				Emes, Richard D.; Yang, Ziheng			Duplicated Paralogous Genes Subject to Positive Selection in the Genome of Trypanosoma brucei	PLOS ONE			English	Article								Background: Whole genome studies have highlighted duplicated genes as important substrates for adaptive evolution. We have investigated adaptive evolution in this class of genes in the human parasite Trypanosoma brucei, as indicated by the ratio of non-synonymous (amino-acid changing) to synonymous (amino acid retaining) nucleotide substitution rates. Methodology/Principal Findings: We have identified duplicated genes that are most rapidly evolving in this important human parasite. This is the first attempt to investigate adaptive evolution in this species at the codon level. We identify 109 genes within 23 clusters of paralogous gene expansions to be subject to positive selection. Conclusions/Significance: Genes identified include surface antigens in both the mammalian and insect host life cycle stage suggesting that competitive interaction is not solely with the adaptive immune system of the mammalian host. Also surface transporters related to drug resistance and genes related to developmental progression are detected. We discuss how adaptive evolution of these genes may highlight lineage specific processes essential for parasite survival. We also discuss the implications of adaptive evolution of these targets for parasite biology and control.	[Emes, Richard D.] Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England; [Emes, Richard D.; Yang, Ziheng] UCL, Dept Biol, London, England	Keele University; University of London; University College London	Emes, RD (corresponding author), Keele Univ, Inst Sci & Technol Med, Stoke On Trent, Staffs, England.	r.d.emes@hfac.keele.ac.uk	Yang, Ziheng/C-1358-2008; Emes, Richard D/C-5341-2008	Emes, Richard D/0000-0001-6855-5481	MRC UK Bioinformatics Training Fellowship; BBSRC; Medical Research Council [G90/112] Funding Source: researchfish; MRC [G90/112] Funding Source: UKRI	MRC UK Bioinformatics Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by an MRC UK Bioinformatics Training Fellowship to RDE, and a BBSRC grant to ZY.	Acosta-Serrano A, 1999, J BIOL CHEM, V274, P29763, DOI 10.1074/jbc.274.42.29763; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2003, GENETICS, V164, P1229; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Audran R, 2005, INFECT IMMUN, V73, P8017, DOI 10.1128/IAI.73.12.8017-8026.2005; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bieger B, 2000, ACTA CRYSTALLOGR D, V56, P359, DOI 10.1107/S0907444900000287; Bieger B, 2001, EMBO J, V20, P433, DOI 10.1093/emboj/20.3.433; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; de Koning HP, 2001, ACTA TROP, V80, P245, DOI 10.1016/S0001-706X(01)00177-2; de Oliveira T, 2004, GENETICS, V167, P1047, DOI 10.1534/genetics.103.018135; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Emes RD, 2003, HUM MOL GENET, V12, P701, DOI 10.1093/hmg/ddg078; Fitzpatrick DA, 2005, J MOL EVOL, V61, P90, DOI 10.1007/s00239-004-0290-6; FRAIDENRAICH D, 1993, P NATL ACAD SCI USA, V90, P10140, DOI 10.1073/pnas.90.21.10140; Fraidenraich Diego, 1993, Biological Research, V26, P279; Haag J, 1998, MOL BIOCHEM PARASIT, V91, P37, DOI 10.1016/S0166-6851(97)00185-0; Hertz-Fowler C, 2007, TRYPANOSOMES GENOME; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Jackson AP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-26; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; JUKES T H, 1969, P21; Magnusson U, 2004, J BIOL CHEM, V279, P8747, DOI 10.1074/jbc.M311890200; Maser P, 1999, SCIENCE, V285, P242, DOI 10.1126/science.285.5425.242; Matovu E, 2001, MOL BIOCHEM PARASIT, V117, P73, DOI 10.1016/S0166-6851(01)00332-2; McGwire BS, 2003, INFECT IMMUN, V71, P1008, DOI 10.1128/IAI.71.2.1008-1010.2003; Nielsen R, 1998, GENETICS, V148, P929; O'Hara BP, 2000, PROTEIN ENG, V13, P129, DOI 10.1093/protein/13.2.129; Osier FHA, 2007, PARASITE IMMUNOL, V29, P387, DOI 10.1111/j.1365-3024.2007.00951.x; Otto SP, 2002, ADV GENET, V46, P451; PEARL L, 1994, EMBO J, V13, P5810, DOI 10.1002/j.1460-2075.1994.tb06924.x; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; SACK JS, 1989, J MOL BIOL, V206, P193, DOI 10.1016/0022-2836(89)90532-9; Saul A, 2007, J INFECT DIS, V195, P171, DOI 10.1086/509813; Seebeck T, 2001, INT J PARASITOL, V31, P491, DOI 10.1016/S0020-7519(01)00164-3; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stevens JR, 2001, ADV PARASIT, V48, P1, DOI 10.1016/S0065-308X(01)48003-1; Suzuki Y, 2004, GENE, V328, P127, DOI 10.1016/j.gene.2003.11.020; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Urwyler S, 2005, PLOS PATHOG, V1, P225, DOI 10.1371/journal.ppat.0010022; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yang Z, 2006, COMPUTATIONAL MOL EV, DOI [10.1093/acprof:oso/9780198567028.001.0001, DOI 10.1093/ACPROF:OSO/9780198567028.001.0001]; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; ZIEGELBAUER K, 1992, J BIOL CHEM, V267, P10791	57	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2295	10.1371/journal.pone.0002295	http://dx.doi.org/10.1371/journal.pone.0002295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509460	Green Published, gold, Green Submitted			2022-12-27	WOS:000262268500034
J	Varshavsky, R; Horn, D; Linial, M				Varshavsky, Roy; Horn, David; Linial, Michal			Global Considerations in Hierarchical Clustering Reveal Meaningful Patterns in Data	PLOS ONE			English	Article							EXPRESSION DATA; CLASSIFICATION; DISCOVERY; ALGORITHM	Background: A hierarchy, characterized by tree-like relationships, is a natural method of organizing data in various domains. When considering an unsupervised machine learning routine, such as clustering, a bottom-up hierarchical (BU, agglomerative) algorithm is used as a default and is often the only method applied. Methodology/Principal Findings: We show that hierarchical clustering that involve global considerations, such as topdown (TD, divisive), or glocal (global-local) algorithms are better suited to reveal meaningful patterns in the data. This is demonstrated, by testing the correspondence between the results of several algorithms (TD, glocal and BU) and the correct annotations provided by experts. The correspondence was tested in multiple domains including gene expression experiments, stock trade records and functional protein families. The performance of each of the algorithms is evaluated by statistical criteria that are assigned to clusters (nodes of the hierarchy tree) based on expert-labeled data. Whereas TD algorithms perform better on global patterns, BU algorithms perform well and are advantageous when finer granularity of the data is sought. In addition, a novel TD algorithm that is based on genuine density of the data points is presented and is shown to outperform other divisive and agglomerative methods. Application of the algorithm to more than 500 protein sequences belonging to ion-channels illustrates the potential of the method for inferring overlooked functional annotations. ClustTree, a graphical Matlab toolbox for applying various hierarchical clustering algorithms and testing their quality is made available. Conclusions: Although currently rarely used, global approaches, in particular, TD or glocal algorithms, should be considered in the exploratory process of clustering. In general, applying unsupervised clustering methods can leverage the quality of manually-created mapping of proteins families. As demonstrated, it can also provide insights in erroneous and missed annotations.	[Varshavsky, Roy] Hebrew Univ Jerusalem, Sch Engn & Comp Sci, Jerusalem, Israel; [Horn, David] Tel Aviv Univ, Sch Phys & Astron, Tel Aviv, Israel; [Linial, Michal] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, Jerusalem, Israel	Hebrew University of Jerusalem; Tel Aviv University; Hebrew University of Jerusalem	Varshavsky, R (corresponding author), Hebrew Univ Jerusalem, Sch Engn & Comp Sci, Jerusalem, Israel.	roy.varshavsky@mail.huji.ac.il	Linial, Michal/AAQ-9259-2020; Linial, Michal/B-9143-2011	Linial, Michal/0000-0002-9357-4526; Horn, David/0000-0003-2708-186X	Sudarsky Center for Computational Biology at the Hebrew University of Jerusalem; EU Framework VI consortium	Sudarsky Center for Computational Biology at the Hebrew University of Jerusalem; EU Framework VI consortium	R.V. is supported by SCCB, the Sudarsky Center for Computational Biology at the Hebrew University of Jerusalem. This study was supported by the EU Framework VI consortium.	Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P44, DOI 10.1093/nar/29.1.44; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERRIDGE M, 2004, CONFORMATIONAL COUPL, pPE33; BOLEY D, 1998, PRINCIPAL DIRECTION, P325; Cangelosi R, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-2; Chipman H, 2006, BIOSTATISTICS, V7, P286, DOI 10.1093/biostatistics/kxj007; Cimiano P, 2004, FR ART INT, V110, P435; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Duda R.O., 2000, PATTERN CLASSIFICATI; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Getz G, 2000, P NATL ACAD SCI USA, V97, P12079, DOI 10.1073/pnas.210134797; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; HANSEN P, 1978, J AM STAT ASSOC, V73, P397, DOI 10.2307/2286672; Horn D, 2003, BIOINFORMATICS, V19, P1110, DOI 10.1093/bioinformatics/btg053; HORN D, 2002, PHYS REV LETT, V88; Jain AK., 1988, TECHNOMETRICS; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kaplan N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-196; Kruskal J., 1981, MULTIDIMENSIONAL SCA; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; *MATH WORLD, 2007, MATL STAT TOOLB 6 1; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Planet PJ, 2001, GENOME RES, V11, P1149, DOI 10.1101/gr.187601; Ren QH, 2005, PLOS COMPUT BIOL, V1, P190, DOI 10.1371/journal.pcbi.0010027; RUNE M, 2007, PROTEOMICS, V7, P2815; Sasson O, 2003, NUCLEIC ACIDS RES, V31, P348, DOI 10.1093/nar/gkg096; SAVARESI MS, 2004, INTELL DATA ANAL, V8, P345; Sharan R, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P307; Slonim N, 2005, P NATL ACAD SCI USA, V102, P18297, DOI 10.1073/pnas.0507432102; STEINBACH M, 2000, COMPARISON DOCUMENT; Torrente A, 2005, BIOINFORMATICS, V21, P3993, DOI 10.1093/bioinformatics/bti644; Varshavsky R, 2005, LECT NOTES COMPUT SC, V3759, P159; Varshavsky R, 2007, LECT N BIOINFORMAT, V4463, P85; Wang XF, 2002, 2002 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-4, PROCEEDINGS, P515, DOI 10.1109/ICMLC.2002.1176809; ZORUMSKI CF, 1992, PROG NEUROBIOL, V39, P295, DOI 10.1016/0301-0082(92)90020-F	39	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2247	10.1371/journal.pone.0002247	http://dx.doi.org/10.1371/journal.pone.0002247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493326	Green Published, Green Submitted, gold			2022-12-27	WOS:000262258700054
J	Tang, F; Liu, W; Zhang, F; Xin, ZT; Wei, MT; Zhang, PH; Yang, H; Ly, H; Cao, WC				Tang, Fang; Liu, Wei; Zhang, Fang; Xin, Zhong-Tao; Wei, Mao-Ti; Zhang, Pan-He; Yang, Hong; Ly, Hinh; Cao, Wu-Chun			IL-12 RB1 Genetic Variants Contribute to Human Susceptibility to Severe Acute Respiratory Syndrome Infection among Chinese	PLOS ONE			English	Article								Background: Cytokines play important roles in antiviral action. We examined whether polymorphisms of interleukin (IL)-12 receptor B1 (IL-12RB1) affect the susceptibility to and outcome of severe acute respiratory syndrome (SARS). Methods: A case-control study was carried out in Chinese SARS patients and healthy controls. The genotypes of 4SNPs on IL-12 RB1 gene, +705A/G,+1158T/C, +1196G/C and +1664 C/T, were determined by PCR-RFLP. Haplotypes were estimated from the genotype data using the expectation-maximisation algorithm. Results: Comparison between patients and close contacts showed that individuals with the +1664 C/T (CT and TT) genotype had a 2.09-fold (95% confidence interval [CI], 1.90-7.16) and 2.34-fold (95% CI, 1.79-13.37) increased risk of developing SARS, respectively. For any of the other three polymorphisms, however, no significant difference can be detected in allele or genotype frequencies between patients and controls. Additionally, estimation of the frequencies of multiple-locus haplotypes revealed potential risk haplotypes (GCCT) for SARS infection. Conclusions: Our data indicate that genetic variants of IL12RB1 confer genetic susceptibility to SARS infection, but not necessary associated with the progression of the disease in Chinese population.	[Tang, Fang; Zhang, Fang; Yang, Hong; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China; [Liu, Wei; Zhang, Pan-He; Cao, Wu-Chun] State Key Lab Pathogen & Biosecurity, Beijing, Peoples R China; [Xin, Zhong-Tao; Ly, Hinh] Emory Univ, Sch Med, Pathol & Lab Med Dept, Atlanta, GA USA; [Wei, Mao-Ti] Affiliated Hosp APFCP Med Coll, Tianjin, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Emory University	Tang, F (corresponding author), Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China.	caowc@nic.bmi.ac.cn			National Science Fund for Distinguished Scholars [30725032]; Commission of the European Community [003824]	National Science Fund for Distinguished Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Commission of the European Community(European Commission)	This work was supported by the grants from the National Science Fund for Distinguished Scholars (No. 30725032) and the Commission of the European Community, as part of the project Effective and Acceptable Strategies for the Control of SARS and New Emerging Infections in China and Europe (Contract No. 003824). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; Caragol I, 2003, CLIN INFECT DIS, V37, P302, DOI 10.1086/375587; Chan JWM, 2003, THORAX, V58, P686, DOI 10.1136/thorax.58.8.686; Chan KYK, 2007, J INFECT DIS, V196, P271, DOI 10.1086/518892; Chiu RWK, 2004, CLIN CHEM, V50, P1683, DOI 10.1373/clinchem.2004.035436; Chong WP, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-82; CHUA AO, 1994, J IMMUNOL, V153, P128; Dorman SE, 2000, CYTOKINE GROWTH F R, V11, P321, DOI 10.1016/S1359-6101(00)00010-1; Fieschi C, 2003, J EXP MED, V197, P527, DOI 10.1084/jem.20021769; He J, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-106; Ip WKE, 2005, J INFECT DIS, V191, P1697, DOI 10.1086/429631; Itoyama S, 2005, AM J MED GENET A, V136A, P52, DOI 10.1002/ajmg.a.30779; Itoyama S, 2004, BIOCHEM BIOPH RES CO, V323, P1124, DOI 10.1016/j.bbrc.2004.08.208; KENNEDY MK, 1994, EUR J IMMUNOL, V24, P2271, DOI 10.1002/eji.1830241002; Lau YL, 2005, CURR OPIN IMMUNOL, V17, P404, DOI 10.1016/j.coi.2005.05.009; Leal SM, 2005, GENET EPIDEMIOL, V29, P204, DOI 10.1002/gepi.20086; Lee HW, 2005, RESPIRATION, V72, P365, DOI 10.1159/000086249; MANETTI R, 1994, J EXP MED, V179, P1273, DOI 10.1084/jem.179.4.1273; Ng MW, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-50; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Presky DH, 1995, RES IMMUNOL, V146, P439, DOI 10.1016/0923-2494(96)83013-6; Sakai T, 2001, BLOOD, V97, P2688, DOI 10.1182/blood.V97.9.2688; Staretz-Haham O, 2003, CLIN INFECT DIS, V37, P137, DOI 10.1086/375229; Trinchieri G, 1998, Int Rev Immunol, V16, P365, DOI 10.3109/08830189809043002; Van Reeth K, 2002, VET IMMUNOL IMMUNOP, V87, P161, DOI 10.1016/S0165-2427(02)00047-8; *WHO, 2003, CAS DEF SURV SEV RES; Wong CK, 2004, CLIN EXP IMMUNOL, V136, P95, DOI 10.1111/j.1365-2249.2004.02415.x; Zhang HX, 2005, J INFECT DIS, V192, P1355, DOI 10.1086/491479	30	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2183	10.1371/journal.pone.0002183	http://dx.doi.org/10.1371/journal.pone.0002183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478121	Green Published, gold, Green Submitted			2022-12-27	WOS:000262172800048
J	Thomas, ML; Simmons, LW				Thomas, Melissa L.; Simmons, Leigh W.			Rival Male Relatedness Does Not Affect Ejaculate Allocation as Predicted by Sperm Competition Theory	PLOS ONE			English	Article							MALE CRICKETS ADJUST; OLFACTORY MEMORY; KIN RECOGNITION; EVOLUTION; SELF; VIABILITY; QUALITY; NUMBERS; CUES	When females are sexually promiscuous, the intensity of sperm competition for males depends on how many partners females mate with. To maximize fitness, males should adjust their copulatory investment in relation to this intensity. However, fitness costs associated with sperm competition may not only depend on how many males a female has mated with, but also how related rival males are. According to theoretical predictions, males should adjust their copulatory investment in response to the relatedness of their male rival, and transfer more sperm to females that have first mated with a non-sibling male than females that have mated to a related male. Here, for the first time, we empirically test this theory using the Australian field cricket Teleogryllus oceanicus. We expose male crickets to sperm competition from either a full sibling or non-sibling male, by using both the presence of a rival male and the rival male's actual competing ejaculate as cues. Contrary to predictions, we find that males do not adjust ejaculates in response to the relatedness of their male rival. Instead, males with both full-sibling and non-sibling rivals allocate sperm of similar quality to females. This lack of kin biased behaviour is independent of any potentially confounding effect of strong competition between close relatives; kin biased behaviour was absent irrespective of whether males were raised in full sibling or mixed relatedness groups.	[Thomas, Melissa L.; Simmons, Leigh W.] Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Crawley, Australia	University of Western Australia	Thomas, ML (corresponding author), Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Crawley, Australia.	mlthomas@cyllene.uwa.edu.au	Simmons, Leigh W/B-1815-2011	Simmons, Leigh W/0000-0003-0562-1474	Australian Research Council; University of Western Australia; West Australian Centres of Excellence in Science and Innovation Program	Australian Research Council(Australian Research Council); University of Western Australia; West Australian Centres of Excellence in Science and Innovation Program	This work was supported by funding from the Australian Research Council, the University of Western Australia, and the West Australian Centres of Excellence in Science and Innovation Program. These organisations had no role except to provide funding.	Bourke A. F., 1995, SOCIAL EVOLUTION ANT; Cameron E, 2007, AM NAT, V169, pE158, DOI 10.1086/516718; Cornwallis CK, 2007, AM NAT, V170, P758, DOI 10.1086/521955; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Fellowes MDE, 1998, ECOL ENTOMOL, V23, P223, DOI 10.1046/j.1365-2311.1998.00128.x; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Gardner A, 2007, CURR BIOL, V17, pR810, DOI 10.1016/j.cub.2007.07.030; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; HALPIN ZT, 1991, KIN RECOGNITION, P220; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hauber ME, 2001, TRENDS NEUROSCI, V24, P609, DOI 10.1016/S0166-2236(00)01916-0; Hedges LV, 2014, STAT METHODS META AN; Ivy TM, 2005, P ROY SOC B-BIOL SCI, V272, P2475, DOI 10.1098/rspb.2005.3222; Kilgallon SJ, 2005, BIOL LETTERS, V1, P253, DOI 10.1098/rsbl.2005.0324; LACY RC, 1983, AM NAT, V121, P489, DOI 10.1086/284078; MacDiarmid AB, 1999, BEHAV ECOL SOCIOBIOL, V46, P14, DOI 10.1007/s002650050587; Marconato A, 1996, ANIM BEHAV, V52, P971, DOI 10.1006/anbe.1996.0245; Matsumoto Y, 2002, J COMP PHYSIOL A, V188, P295, DOI 10.1007/s00359-002-0303-0; Matsumoto Y, 2006, BIOL LETT-UK, V2, P608, DOI 10.1098/rsbl.2006.0540; Parker GA, 2000, P ROY SOC B-BIOL SCI, V267, P1027, DOI 10.1098/rspb.2000.1106; Poiani A, 2006, BEHAV ECOL SOCIOBIOL, V60, P289, DOI 10.1007/s00265-006-0178-0; REEVE HK, 1989, AM NAT, V133, P407, DOI 10.1086/284926; Rousset F, 2007, EVOLUTION, V61, P2320, DOI 10.1111/j.1558-5646.2007.00191.x; Sherman Paul W., 1997, P69; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2007, BIOL LETTERS, V3, P520, DOI 10.1098/rsbl.2007.0328; Simmons LW, 2006, MOL ECOL, V15, P3817, DOI 10.1111/j.1365-294X.2006.03035.x; Simmons LW, 2005, SCIENCE, V310, P1119; SIMMONS LW, 1990, ANIM BEHAV, V40, P192, DOI 10.1016/S0003-3472(05)80683-9; Simmons LW, 2003, BEHAV ECOL, V14, P539, DOI 10.1093/beheco/arg038; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Starks PT, 2004, ANN ZOOL FENN, V41, P689; Thomas ML, 2007, AM NAT, V170, P190, DOI 10.1086/519404; THOMAS ML, J EXPT BIOL; Tsutsui ND, 2004, ANN ZOOL FENN, V41, P713; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; West SA, 2001, NATURE, V409, P510, DOI 10.1038/35054057; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; Wiens JD, 2006, CONDOR, V108, P253, DOI 10.1093/condor/108.2.253	39	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2151	10.1371/journal.pone.0002151	http://dx.doi.org/10.1371/journal.pone.0002151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478102	Green Submitted, Green Published, gold			2022-12-27	WOS:000262172800016
J	Brindley, AA; Pickersgill, RW; Partridge, JC; Dunstan, DJ; Hunt, DM; Warren, MJ				Brindley, Amanda A.; Pickersgill, Richard W.; Partridge, Julian C.; Dunstan, David J.; Hunt, David M.; Warren, Martin J.			Enzyme Sequence and Its Relationship to Hyperbaric Stability of Artificial and Natural Fish Lactate Dehydrogenases	PLOS ONE			English	Article								The cDNAs of lactate dehydrogenase b (LDH-b) from both deep-sea and shallow living fish species, Corphaenoides armatus and Gadus morhua respectively, have been isolated, sequenced and their encoded products overproduced as recombinant enzymes in E. coli. The proteins were characterised in terms of their kinetic and physical properties and their ability to withstand high pressures. Although the two proteins are very similar in terms of their primary structure, only 21 differences at the amino acid level exist between them, the enzyme from the deep-sea species has a significantly increased tolerance to pressure and a higher thermostability. It was possible to investigate whether the changes in the N-terminal or C-terminal regions played a greater role in barophilic adaptation by the construction of two chimeric enzymes by use of a common restriction site within the cDNAs. One of these hybrids was found to have even greater pressure stability than the recombinant enzyme from the deep-living fish species. It was possible to conclude that the major adaptive changes to pressure tolerance must be located in the N-terminal region of the protein. The types of changes that are found and their spatial location within the protein structure are discussed. An analysis of the kinetic parameters of the enzymes suggests that there is clearly a trade off between Km and kcat values, which likely reflects the necessity of the deep-sea enzyme to operate at low temperatures.	[Brindley, Amanda A.; Warren, Martin J.] Univ Kent, Dept Biosci, Canterbury, Kent, England; [Pickersgill, Richard W.] Univ London, Queen Mary, Sch Biol & Chem Sci, London, England; [Partridge, Julian C.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Dunstan, David J.] Univ London, Queen Mary, Dept Phys, London, England; [Hunt, David M.] UCL, Inst Ophthalmol, London, England	University of Kent; University of London; Queen Mary University London; University of Bristol; University of London; Queen Mary University London; University of London; University College London	Brindley, AA (corresponding author), Univ Kent, Dept Biosci, Canterbury, Kent, England.	a.a.brindley@kent.ac.uk	Dunstan, David J/F-9830-2012; Hunt, David M/K-6024-2012; Partridge, Julian C/F-2097-2014	Hunt, David M/0000-0002-9264-3948; Partridge, Julian C/0000-0003-3788-2900; Warren, Martin/0000-0002-6028-6456	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by a grant from the Biotechnology and Biological Sciences Research Council (BBSRC). No role was played by the sponsors in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	COHEN DM, 1990, FAO FISH SYNOP, V10, P1; Gerday C, 1997, BBA-PROTEIN STRUCT M, V1342, P119, DOI 10.1016/S0167-4838(97)00093-9; GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x; HENNESSEY JP, 1987, J EXP ZOOL, V241, P9, DOI 10.1002/jez.1402410103; HENNESSEY JP, 1985, J COMP PHYSIOL B, V155, P647, DOI 10.1007/BF00694577; HOCHACHKA PW, 2002, BIOCH APADTATION MEC; Holland LZ, 1997, BIOCHEMISTRY-US, V36, P3207, DOI 10.1021/bi962664k; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Morita T, 2003, J BIOL CHEM, V278, P28060, DOI 10.1074/jbc.M302328200; Read JA, 2001, PROTEINS, V43, P175, DOI 10.1002/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#; Scandurra R, 1998, BIOCHIMIE, V80, P933, DOI 10.1016/S0300-9084(00)88890-2; SCHMID G, 1979, EUR J BIOCHEM, V97, P407, DOI 10.1111/j.1432-1033.1979.tb13128.x; SIEBENALLER J, 1978, SCIENCE, V201, P255, DOI 10.1126/science.208149; SIEBENALLER JF, 1984, BIOCHIM BIOPHYS ACTA, V786, P161, DOI 10.1016/0167-4838(84)90085-2; SOMERO GN, 1992, ANNU REV PHYSIOL, V54, P557, DOI 10.1146/annurev.ph.54.030192.003013; SOMERO GN, 1979, NATURE, V282, P100, DOI 10.1038/282100a0; SOMERO GN, 1992, EXPERIENTIA, V48, P537, DOI 10.1007/BF01920236; SWEZEY RR, 1982, BIOCHEMISTRY-US, V21, P4496, DOI 10.1021/bi00261a047; WEBER G, 1983, Q REV BIOPHYS, V16, P89, DOI 10.1017/S0033583500004935; Yancey PH, 2004, CELL MOL BIOL, V50, P371; Yancey PH, 1999, J EXP BIOL, V202, P3597; Yancey PH, 2001, J EXP ZOOL, V289, P172, DOI 10.1002/1097-010X(20010215)289:3<172::AID-JEZ3>3.0.CO;2-J	22	30	30	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2042	10.1371/journal.pone.0002042	http://dx.doi.org/10.1371/journal.pone.0002042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446214	Green Published, Green Submitted, gold			2022-12-27	WOS:000261572300014
J	Shelburne, CE; Shelburne, PS; Dhople, VM; Sweier, DG; Giannobile, WV; Kinney, JS; Coulter, WA; Mullally, BH; Lopatin, DE				Shelburne, Charles E.; Shelburne, P. Sandra; Dhople, Vishnu M.; Sweier, Domenica G.; Giannobile, William V.; Kinney, Janet S.; Coulter, Wilson A.; Mullally, Brian H.; Lopatin, Dennis E.			Serum Antibodies to Porphyromonas gingivalis Chaperone HtpG Predict Health in Periodontitis Susceptible Patients	PLOS ONE			English	Article								Background: Chaperones are ubiquitous conserved proteins critical in stabilization of new proteins, repair/removal of defective proteins and immunodominant antigens in innate and adaptive immunity. Periodontal disease is a chronic inflammatory infection associated with infection by Porphyromonas gingivalis that culminates in the destruction of the supporting structures of the teeth. We previously reported studies of serum antibodies reactive with the human chaperone Hsp90 in gingivitis, a reversible form of gingival disease confined to the oral soft tissues. In those studies, antibodies were at their highest levels in subjects with the best oral health. We hypothesized that antibodies to the HSP90 homologue of P. gingivalis (HtpG) might be associated with protection/resistance against destructive periodontitis. Methodology/Principal Findings: ELISA assays using cloned HtpG and peptide antigens confirmed gingivitis subjects colonized with P. gingivalis had higher serum levels of anti-HtpG and, concomitantly, lower levels of attachment loss. Additionally, serum antibody levels to P. gingivalis HtpG protein were higher in healthy subjects compared to patients with either chronic or aggressive periodontitis. We found a negative association between tooth attachment loss and anti-P. gingivalis HtpG (p = 0.043) but not anti-Fusobacterium nucleatum (an oral opportunistic commensal) HtpG levels. Furthermore, response to periodontal therapy was more successful in subjects having higher levels of anti-P. gingivalis HtpG before treatment (p = 0.018). There was no similar relationship to anti-F. nucleatum HtpG levels. Similar results were obtained when these experiments were repeated with a synthetic peptide of a region of P. gingivalis HtpG. Conclusions/Significance: Our results suggest: 1) anti-P. gingivalis HtpG antibodies are protective and therefore predict health periodontitis-susceptable patients; 2) may augment the host defence to periodontitis and 3) a unique peptide of P. gingivalis HtpG offers significant potential as an effective diagnostic target and vaccine candidate. These results are compatible with a novel immune control mechanism unrelated to direct binding of bacteria.	[Shelburne, Charles E.; Shelburne, P. Sandra; Dhople, Vishnu M.; Lopatin, Dennis E.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Sweier, Domenica G.] Univ Michigan, Sch Dent, Dept Cariol, Restorat Sci & Endodont, Ann Arbor, MI USA; [Giannobile, William V.; Kinney, Janet S.] Univ Michigan, Sch Dent, Michigan Ctr Oral Hlth Res, Dept Periodont & Oral Med, Ann Arbor, MI USA; [Coulter, Wilson A.; Mullally, Brian H.] Queens Univ, Ctr Oral Res, Belfast, Antrim, North Ireland	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Queens University Belfast	Shelburne, CE (corresponding author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	ceshelbu@umich.edu	Dhople, Vishnu M/J-5377-2014	Giannobile, William/0000-0002-7102-9746	NIH/NIDCR [DE11117, U01-DE-14961]; NIH/NCRR [M01-RR000042]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE011117, U01DE014961] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by NIH/NIDCR DE11117 (DEL) and patient sample collections were supported by NIH grants NIH/NIDCR U01-DE-14961 and NIH/NCRR M01-RR000042 (WVG). The sponsors of this work had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data and in the preparation, review, or approval of the manuscript.	BAGRAMIAN RA, 1993, J CLIN PERIODONTOL, V20, P269, DOI 10.1111/j.1600-051X.1993.tb00356.x; BAGRAMIAN RA, 1994, J CLIN PERIODONTOL, V21, P386, DOI 10.1111/j.1600-051X.1994.tb00734.x; Burnie JR, 2006, FEMS MICROBIOL REV, V30, P53, DOI 10.1111/j.1574-6976.2005.00001.x; Chatterjee A, 2007, AM J RESP CRIT CARE, V176, P667, DOI 10.1164/rccm.200702-291OC; Goulhen F, 2003, CRIT REV ORAL BIOL M, V14, P399, DOI 10.1177/154411130301400603; Hosokawa Y, 2006, CLIN EXP IMMUNOL, V146, P540, DOI 10.1111/j.1365-2249.2006.03233.x; Huszti Z, 2004, INFLAMM RES, V53, P551, DOI 10.1007/s00011-004-1296-7; Kinane DF, 1999, PERIODONTOL 2000, V20, P289, DOI 10.1111/j.1600-0757.1999.tb00164.x; Koets A, 2006, VACCINE, V24, P2550, DOI 10.1016/j.vaccine.2005.12.019; Kozarov E, 2006, MICROBES INFECT, V8, P687, DOI 10.1016/j.micinf.2005.09.004; Lee JY, 2006, J PERIODONTAL RES, V41, P10, DOI 10.1111/j.1600-0765.2005.00832.x; Lin SN, 2005, J MED MICROBIOL, V54, P225, DOI 10.1099/jmm.0.45871-0; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; Lopatin DE, 1999, J PERIODONTOL, V70, P1185, DOI 10.1902/jop.1999.70.10.1185; LUOMA J, 1994, J CLIN INVEST, V93, P2014, DOI 10.1172/JCI117195; MATTHEWS RC, 1991, IMMUNOLOGY, V74, P20; Mullally BH, 2000, J PERIODONTAL RES, V35, P232, DOI 10.1034/j.1600-0765.2000.035004232.x; Offenbacher Steven, 2005, J Int Acad Periodontol, V7, P157; Okada H, 1998, CRIT REV ORAL BIOL M, V9, P248, DOI 10.1177/10454411980090030101; Progulske-Fox A, 1999, J PERIODONTAL RES, V34, P393, DOI 10.1111/j.1600-0765.1999.tb02272.x; Prohaszka Z, 2004, MOL IMMUNOL, V41, P29, DOI 10.1016/j.molimm.2004.02.001; Rams TE, 2006, J PERIODONTAL RES, V41, P228, DOI 10.1111/j.1600-0765.2005.00860.x; Shamaei-Tousi A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001198; Shelburne CE, 2000, J MICROBIOL METH, V39, P97, DOI 10.1016/S0167-7012(99)00106-2; Shelburne CE, 2007, CELL MICROBIOL, V9, P1611, DOI 10.1111/j.1462-5822.2007.00897.x; Silness J, 1966, Acta Odontol Scand, V24, P747, DOI 10.3109/00016356609028739; Socransky S S, 1997, Ann Periodontol, V2, P3; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sudheesh PS, 2007, DIS AQUAT ORGAN, V74, P37, DOI 10.3354/dao074037; Sweier DG, 2004, J IMMUNOL METHODS, V285, P165, DOI 10.1016/j.jim.2003.11.009; Takenaka R, 2004, HELICOBACTER, V9, P194, DOI 10.1111/j.1083-4389.2004.00225.x; VANPOPERIN N, 1991, J CLIN MICROBIOL, V29, P2554, DOI 10.1128/JCM.29.11.2554-2558.1991; WOLFF LF, 1988, J PERIODONTAL RES, V23, P170, DOI 10.1111/j.1600-0765.1988.tb01353.x; Yamaguchi H, 2000, INFECT IMMUN, V68, P3448, DOI 10.1128/IAI.68.6.3448-3454.2000; Yamazaki K, 2004, CLIN EXP IMMUNOL, V135, P478, DOI 10.1111/j.1365-2249.2003.02375.x; YOUNG D, 1988, P NATL ACAD SCI USA, V85, P4267, DOI 10.1073/pnas.85.12.4267; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	37	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1984	10.1371/journal.pone.0001984	http://dx.doi.org/10.1371/journal.pone.0001984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431474	Green Published, Green Submitted, gold			2022-12-27	WOS:000261558700009
J	Sachidanandan, C; Yeh, JRJ; Peterson, QP; Peterson, RT				Sachidanandan, Chetana; Yeh, Jing-Ruey J.; Peterson, Quinn P.; Peterson, Randall T.			Identification of a Novel Retinoid by Small Molecule Screening with Zebrafish Embryos	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; ACID RECEPTORS; CANCER; HINDBRAIN; GENETICS; PATTERN; TARGET; GENES; DIFFERENTIATION; SPECIFICATION	Small molecules have played an important role in delineating molecular pathways involved in embryonic development and disease pathology. The need for novel small molecule modulators of biological processes has driven a number of targeted screens on large diverse libraries. However, due to the specific focus of such screens, the majority of the bioactive potential of these libraries remains unharnessed. In order to identify a higher proportion of compounds with interesting biological activities, we screened a diverse synthetic library for compounds that perturb the development of any of the multiple organs in zebrafish embryos. We identified small molecules that affect the development of a variety of structures such as heart, vasculature, brain, and body-axis. We utilized the previously known role of retinoic acid in anterior-posterior (A-P) patterning to identify the target of DTAB, a compound that caused A-P axis shortening in the zebrafish embryo. We show that DTAB is a retinoid with selective activity towards retinoic acid receptors gamma and beta. Thus, conducting zebrafish developmental screens using small molecules will not only enable the identification of compounds with diverse biological activities in a large chemical library but may also facilitate the identification of the target pathways of these biologically active molecules.	[Sachidanandan, Chetana; Yeh, Jing-Ruey J.; Peterson, Quinn P.; Peterson, Randall T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA	Harvard University; Massachusetts General Hospital	Peterson, RT (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA.	peterson@cvrc.mgh.harvard.edu		Peterson, Quinn/0000-0001-8701-0575; Yeh, Jing-Ruey Joanna/0000-0002-7768-4901; Peterson, Randall/0000-0003-0727-3469	Novartis Institutes for Biomedical Research NIH - NHLBI [HL079267]; Postdoctoral Fellowship from Massachusetts General Hospital Fund for Medical Discovery; Tosteson Fellowship from the Massachusetts Biomedical Research Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079267] Funding Source: NIH RePORTER	Novartis Institutes for Biomedical Research NIH - NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Postdoctoral Fellowship from Massachusetts General Hospital Fund for Medical Discovery; Tosteson Fellowship from the Massachusetts Biomedical Research Corporation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for R.T.P. from Sponsored Research Agreement from Novartis Institutes for Biomedical Research NIH - NHLBI HL079267. C.S. was supported by Postdoctoral Fellowship from Massachusetts General Hospital Fund for Medical Discovery. J.-R.J.Y. was supported by a Tosteson Fellowship from the Massachusetts Biomedical Research Corporation. None of the funders played any role in the conduct, interpretation, preparation, or approval of the manuscript.	Aerne B, 2004, DEVELOPMENT, V131, P3391, DOI 10.1242/dev.01222; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Asou N, 2007, INTERNAL MED, V46, P91, DOI 10.2169/internalmedicine.46.1780; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Begemann G, 2001, DEVELOPMENT, V128, P3081; Begemann G, 2001, BIOESSAYS, V23, P981, DOI 10.1002/bies.1142; Chandraratna RAS, 1997, J AM ACAD DERMATOL, V37, pS12, DOI 10.1016/S0190-9622(97)80395-7; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; Diez del Corral R, 2003, NEURON, V40, P65; Dobbs-McAuliffe B, 2004, MECH DEVELOP, V121, P339, DOI 10.1016/j.mod.2004.02.008; Emoto Y, 2005, DEV BIOL, V278, P415, DOI 10.1016/j.ydbio.2004.11.023; Holmes WF, 2000, J CELL PHYSIOL, V185, P61, DOI 10.1002/1097-4652(200010)185:1<61::AID-JCP5>3.0.CO;2-0; Katano M, 2005, CANCER LETT, V227, P99, DOI 10.1016/j.canlet.2004.11.030; Katoh Y, 2005, CANCER BIOL THER, V4, P1050, DOI 10.4161/cbt.4.10.2184; Kawasumi M, 2007, J INVEST DERMATOL, V127, P1577, DOI 10.1038/sj.jid.5700853; KEELER RF, 1968, TERATOLOGY, V1, P5, DOI 10.1002/tera.1420010103; Langdon SP, 1998, CANCER CHEMOTH PHARM, V42, P429, DOI 10.1007/s002800050841; MacRae CA, 2003, CHEM BIOL, V10, P901, DOI 10.1016/j.chembiol.2003.10.003; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Mullins MC, 1996, DEVELOPMENT, V123, P81; Njar VCO, 2006, BIOORGAN MED CHEM, V14, P4323, DOI 10.1016/j.bmc.2006.02.041; Ortholand JY, 2004, CURR OPIN CHEM BIOL, V8, P271, DOI 10.1016/j.cbpa.2004.04.011; Purton LE, 2006, J EXP MED, V203, P1283, DOI 10.1084/jem.20052105; REES J, 1992, BRIT J DERMATOL, V126, P97, DOI 10.1111/j.1365-2133.1992.tb07804.x; Robert B, 2006, DEV DYNAM, V235, P2337, DOI 10.1002/dvdy.20890; Ross AC, 2003, J NUTR, V133, p291S, DOI 10.1093/jn/133.1.291S; Savchuk NP, 2004, CURR OPIN CHEM BIOL, V8, P412, DOI 10.1016/j.cbpa.2004.06.003; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P843; Shaw A, 2007, J UROLOGY, V177, P832, DOI 10.1016/j.juro.2006.10.061; Stadler R, 2006, SEMIN ONCOL, V33, pS7, DOI 10.1053/j.seminoncol.2005.12.016; Thisse B., 2001, EXPRESSION ZEBRAFISH; Wagner M, 2007, EXP BIOL MED, V232, P866; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Weindl G, 2006, AM J CLIN DERMATOL, V7, P85, DOI 10.2165/00128071-200607020-00002; Xavier-Neto J, 2001, GENESIS, V31, P97, DOI 10.1002/gene.10009; YU PB, 2008, NAT CHEM BI IN PRESS	41	50	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1947	10.1371/journal.pone.0001947	http://dx.doi.org/10.1371/journal.pone.0001947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398471	gold, Green Published, Green Submitted			2022-12-27	WOS:000260795500022
J	Shamgar, L; Haitin, Y; Yisharel, I; Malka, E; Schottelndreier, H; Peretz, A; Paas, Y; Attali, B				Shamgar, Liora; Haitin, Yoni; Yisharel, Ilanit; Malka, Eti; Schottelndreier, Hella; Peretz, Asher; Paas, Yoav; Attali, Bernard			KCNE1 Constrains the Voltage Sensor of Kv7.1 K+ Channels	PLOS ONE			English	Article								Kv7 potassium channels whose mutations cause cardiovascular and neurological disorders are members of the superfamily of voltage-gated K+ channels, comprising a central pore enclosed by four voltage-sensing domains (VSDs) and sharing a homologous S4 sensor sequence. The Kv7.1 pore-forming subunit can interact with various KCNE auxiliary subunits to form K+ channels with very different gating behaviors. In an attempt to characterize the nature of the promiscuous gating of Kv7.1 channels, we performed a tryptophan-scanning mutagenesis of the S4 sensor and analyzed the mutation-induced perturbations in gating free energy. Perturbing the gating energetics of Kv7.1 bias most of the mutant channels towards the closed state, while fewer mutations stabilize the open state or the inactivated state. In the absence of auxiliary subunits, mutations of specific S4 residues mimic the gating phenotypes produced by co-assembly of Kv7.1 with either KCNE1 or KCNE3. Many S4 perturbations compromise the ability of KCNE1 to properly regulate Kv7.1 channel gating. The tryptophan-induced packing perturbations and cysteine engineering studies in S4 suggest that KCNE1 lodges at the inter-VSD S4-S1 interface between two adjacent subunits, a strategic location to exert its striking action on Kv7.1 gating functions.	[Shamgar, Liora; Haitin, Yoni; Yisharel, Ilanit; Malka, Eti; Schottelndreier, Hella; Peretz, Asher; Attali, Bernard] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Paas, Yoav] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University	Attali, B (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	battali@post.tau.ac.il	Haitin, Yoni/AAQ-4571-2021	Haitin, Yoni/0000-0002-1648-6792	Israel Science Foundation [ISF 672/05]; Israel Ministry of Science Tashtiot program; Keren Wolfson Family funds	Israel Science Foundation(Israel Science Foundation); Israel Ministry of Science Tashtiot program; Keren Wolfson Family funds	This work is supported by the Israel Science Foundation (ISF 672/05), the Israel Ministry of Science Tashtiot program (2007 2009) and the Keren Wolfson Family funds to BA.	Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; Ashcroft FM, 2000, ION CHANNELS DIS; Attali B, 1996, NATURE, V384, P24, DOI 10.1038/384024a0; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Franqueza L, 1999, J BIOL CHEM, V274, P21063, DOI 10.1074/jbc.274.30.21063; Gibor G, 2007, BIOPHYS J, V93, P4159, DOI 10.1529/biophysj.107.107987; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jentsch TJ, 2004, NAT CELL BIOL, V6, P1039, DOI 10.1038/ncb1104-1039; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; Melman YF, 2002, TRENDS CARDIOVAS MED, V12, P182, DOI 10.1016/S1050-1738(02)00158-5; Melman YF, 2004, NEURON, V42, P927, DOI 10.1016/j.neuron.2004.06.001; Nakajo K, 2007, J GEN PHYSIOL, V130, P269, DOI 10.1085/jgp.200709805; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Rocheleau JM, 2008, J GEN PHYSIOL, V131, P59, DOI 10.1085/jgp.200709816; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Swartz KJ, 2004, NAT REV NEUROSCI, V5, P905, DOI 10.1038/nrn1559; Tapper AR, 2001, J BIOL CHEM, V276, P38249; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Wang KW, 1996, NEURON, V16, P571, DOI 10.1016/S0896-6273(00)80076-8; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978	27	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1943	10.1371/journal.pone.0001943	http://dx.doi.org/10.1371/journal.pone.0001943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398469	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795500020
J	Lal, A; Kim, HH; Abdelmohsen, K; Kuwano, Y; Pullmann, R; Srikantan, S; Subrahmanyam, R; Martindale, JL; Yang, XL; Ahmed, F; Navarro, F; Dykxhoorn, D; Lieberman, J; Gorospe, M				Lal, Ashish; Kim, Hyeon Ho; Abdelmohsen, Kotb; Kuwano, Yuki; Pullmann, Rudolf; Srikantan, Subramanya; Subrahmanyam, Ramesh; Martindale, Jennifer L.; Yang, Xiaoling; Ahmed, Fariyal; Navarro, Francisco; Dykxhoorn, Derek; Lieberman, Judy; Gorospe, Myriam			p16(INK4a) Translation Suppressed by miR-24	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; MESSENGER-RNA; REPLICATIVE SENESCENCE; EXPRESSION; MICRORNA; INITIATION; PROTEINS; REPRESSION; INK4A/ARF; INK4/ARF	Background: Expression of the tumor suppressor p16(INK4a) increases during aging and replicative senescence. Methodology/Principal Findings: Here, we report that the microRNA miR-24 suppresses p16 expression in human diploid fibroblasts and cervical carcinoma cells. Increased p16 expression with replicative senescence was associated with decreased levels of miR-24, a microRNA that was predicted to associate with the p16 mRNA coding and 3'-untranslated regions. Ectopic miR-24 overexpression reduced p16 protein but not p16 mRNA levels. Conversely, introduction of antisense (AS)-miR-24 blocked miR-24 expression and markedly enhanced p16 protein levels, p16 translation, and the production of EGFP-p16 reporter bearing the miR-24 target recognition sites. Conclusions/Significance: Together, our results suggest that miR-24 represses the initiation and elongation phases of p16 translation.	[Lal, Ashish; Kim, Hyeon Ho; Abdelmohsen, Kotb; Kuwano, Yuki; Pullmann, Rudolf; Srikantan, Subramanya; Subrahmanyam, Ramesh; Martindale, Jennifer L.; Yang, Xiaoling; Gorospe, Myriam] NIA, IRP, Cellular & Mol Biol Lab, NIH, Baltimore, MD 21224 USA; [Lal, Ashish; Ahmed, Fariyal; Navarro, Francisco; Dykxhoorn, Derek; Lieberman, Judy] Harvard Med Sch, CBR Inst Biomed Res, Dept Pediat, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Lal, A (corresponding author), NIA, IRP, Cellular & Mol Biol Lab, NIH, Baltimore, MD 21224 USA.	alal@cbrinstitute.org; myriam-gorospe@nih.gov	Martindale, Jennifer Luethy/AAD-1963-2022; Lieberman, Judy/A-2717-2015; Dykxhoorn, Derek M/D-1357-2015; Subrahmanyam, Ramesh/K-5503-2012; Abdelmohsen, Kotb/AAX-4191-2020	Martindale, Jennifer Luethy/0000-0002-3234-6861; Abdelmohsen, Kotb/0000-0001-6240-5810; srikantan, subramanya/0000-0003-1810-6519	National Institute on Aging - Intramural Research Program; NATIONAL INSTITUTE ON AGING [Z01AG000391, Z01AG000394, ZIAAG000391, ZIAAG000511, ZIAAG000394, Z01AG000511] Funding Source: NIH RePORTER	National Institute on Aging - Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging - Intramural Research Program	Alani RM, 2001, P NATL ACAD SCI USA, V98, P7812, DOI 10.1073/pnas.141235398; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Ben-Saadon R, 2004, J BIOL CHEM, V279, P41414, DOI 10.1074/jbc.M407201200; Campisi J, 1997, EUR J CANCER, V33, P703, DOI 10.1016/S0959-8049(96)00058-5; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; GEORGE AD, 2006, RNA BIOL, V3, P2; Gonzalez S, 2006, NATURE, V440, P702, DOI 10.1038/nature04585; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nielsen GP, 1999, LAB INVEST, V79, P1137; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Serrano M, 1997, EXP CELL RES, V237, P7, DOI 10.1006/excr.1997.3824; Shapiro GI, 2000, CELL BIOCHEM BIOPHYS, V33, P189, DOI 10.1385/CBB:33:2:189; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang WG, 2005, EMBO REP, V6, P158, DOI 10.1038/sj.embor.7400346; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhu DG, 2002, J CELL PHYSIOL, V193, P19, DOI 10.1002/jcp.10147; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	40	209	222	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1864	10.1371/journal.pone.0001864	http://dx.doi.org/10.1371/journal.pone.0001864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365017	gold, Green Submitted, Green Published			2022-12-27	WOS:000260762400023
J	Proulx, MJ; Stoerig, P; Ludowig, E; Knoll, I				Proulx, Michael J.; Stoerig, Petra; Ludowig, Eva; Knoll, Inna			Seeing 'Where' through the Ears: Effects of Learning-by-Doing and Long-Term Sensory Deprivation on Localization Based on Image-to-Sound Substitution	PLOS ONE			English	Article							AUDITORY SUBSTITUTION; CORTEX; BLIND; PLASTICITY; PERCEPTION; SYSTEM	Background: Sensory substitution devices for the blind translate inaccessible visual information into a format that intact sensory pathways can process. We here tested image-to-sound conversion-based localization of visual stimuli (LEDs and objects) in 13 blindfolded participants. Methods and Findings: Subjects were assigned to different roles as a function of two variables: visual deprivation (blindfolded continuously (Bc) for 24 hours per day for 21 days; blindfolded for the tests only (Bt)) and system use (system not used (Sn); system used for tests only (St); system used continuously for 21 days (Sc)). The effect of learning-by-doing was assessed by comparing the performance of eight subjects (BtSt) who only used the mobile substitution device for the tests, to that of three subjects who, in addition, practiced with it for four hours daily in their normal life (BtSc and BcSc); two subjects who did not use the device at all (BtSn and BcSn) allowed assessment of its use in the tasks we employed. The impact of long-term sensory deprivation was investigated by blindfolding three of those participants throughout the three week-long experiment (BcSn, BcSn/c, and BcSc); the other ten subjects were only blindfolded during the tests (BtSn, BtSc, and the eight BtSt subjects). Expectedly, the two subjects who never used the substitution device, while fast in finding the targets, had chance accuracy, whereas subjects who used the device were markedly slower, but showed much better accuracy which improved significantly across our four testing sessions. The three subjects who freely used the device daily as well as during tests were faster and more accurate than those who used it during tests only; however, long-term blindfolding did not notably influence performance. Conclusions: Together, the results demonstrate that the device allowed blindfolded subjects to increasingly know where something was by listening, and indicate that practice in naturalistic conditions effectively improved "visual'' localization performance.	[Proulx, Michael J.; Stoerig, Petra; Ludowig, Eva; Knoll, Inna] Univ Dusseldorf, Inst Expt Psychol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Proulx, MJ (corresponding author), Univ Dusseldorf, Inst Expt Psychol, Dusseldorf, Germany.	Michael.Proulx@uni-duesseldorf.de	Proulx, Michael J/A-1045-2008	Proulx, Michael/0000-0003-4066-3645	Volkswagen Stiftung [I/80 742]; Anton-Betz-Stiftung	Volkswagen Stiftung(Volkswagen); Anton-Betz-Stiftung	We gratefully acknowledge financial support by the Volkswagen Stiftung (I/80 742) and the Anton-Betz-Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedi A, 2005, CURR DIR PSYCHOL SCI, V14, P306, DOI 10.1111/j.0963-7214.2005.00387.x; Arno P, 1999, PERCEPTION, V28, P1013, DOI 10.1068/p2607; Auvray M, 2007, PERCEPTION, V36, P416, DOI 10.1068/p5631; Bach-y-Rita P, 2003, TRENDS COGN SCI, V7, P541, DOI 10.1016/j.tics.2003.10.013; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cronly-Dillon J, 2000, P ROY SOC B-BIOL SCI, V267, P2231, DOI 10.1098/rspb.2000.1273; Cronly-Dillon J, 1999, P ROY SOC B-BIOL SCI, V266, P2427, DOI 10.1098/rspb.1999.0942; Kauffman T, 2002, NEUROREPORT, V13, P571, DOI 10.1097/00001756-200204160-00007; Killeen PR, 2005, PSYCHOL SCI, V16, P345, DOI 10.1111/j.0956-7976.2005.01538.x; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; MEIJER PBL, 1992, IEEE T BIO-MED ENG, V39, P112, DOI 10.1109/10.121642; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Poirier C, 2006, APPL COGNITIVE PSYCH, V20, P447, DOI 10.1002/acp.1186; Pollok B, 2005, EXP BRAIN RES, V167, P287, DOI 10.1007/s00221-005-0060-8; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; Renier L, 2005, NEUROIMAGE, V26, P573, DOI 10.1016/j.neuroimage.2005.01.047; Segond H, 2005, PERCEPTION, V34, P1231, DOI 10.1068/p3409	18	57	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1840	10.1371/journal.pone.0001840	http://dx.doi.org/10.1371/journal.pone.0001840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370KZ	18364998	Green Published, gold, Green Submitted			2022-12-27	WOS:000260762400004
J	Laiolo, P; Vogeli, M; Serrano, D; Tella, JL				Laiolo, Paola; Vogeli, Matthias; Serrano, David; Tella, Jose L.			Song Diversity Predicts the Viability of Fragmented Bird Populations	PLOS ONE			English	Article								In the global scenario of increasing habitat fragmentation, finding appropriate indicators of population viability is a priority for conservation. We explored the potential of learned behaviours, specifically acoustic signals, to predict the persistence over time of fragmented bird populations. We found an association between male song diversity and the annual rate of population change, population productivity and population size, resulting in birds singing poor repertoires in populations more prone to extinction. This is the first demonstration that population viability can be predicted by a cultural trait ( acquired via social learning). Our results emphasise that cultural attributes can reflect not only individual-level characteristics, but also the emergent population-level properties. This opens the way to the study of animal cultural diversity in the increasingly common human-altered landscapes.	[Laiolo, Paola; Vogeli, Matthias; Serrano, David; Tella, Jose L.] CSIC, Estac Biol Donana, E-41080 Seville, Spain; [Laiolo, Paola] Univ Oviedo, Inst Cantabrico Biodivers, Oviedo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Oviedo	Laiolo, P (corresponding author), CSIC, Estac Biol Donana, E-41080 Seville, Spain.	paola@ebd.csic.es	Tella, José L/I-3707-2015; Laiolo, Paola/Q-3747-2019; Serrano, David/B-5352-2013; Laiolo, Paola/B-6566-2014; Vögeli, Matthias/G-1815-2010; Vögeli, Matthias/M-4269-2019	Tella, José L/0000-0002-3038-7424; Laiolo, Paola/0000-0002-2009-6797; Serrano, David/0000-0001-6205-386X; Laiolo, Paola/0000-0002-2009-6797; Vögeli, Matthias/0000-0002-3408-0972; Vögeli, Matthias/0000-0002-3408-0972	Marie Curie Intra-European Fellowship; Spanish Ministry of Education and Science; Spanish Research Council (CSIC) [I3P pre-doctoral fellowship, I3P post-doctoral contract]; Excellence Project of the Junta the Andalucia	Marie Curie Intra-European Fellowship(European Commission); Spanish Ministry of Education and Science(Spanish Government); Spanish Research Council (CSIC); Excellence Project of the Junta the Andalucia	We were financially supported by a Marie Curie Intra-European Fellowship within the 6th European Framework Program and by a Ramon y Cajal contract of the Spanish Ministry of Education and Science (PL), by an I3P pre-doctoral fellowship from the Spanish Research Council (CSIC) (MV), by an I3P post-doctoral contract from the CSIC (DS), and by an Excellence Project of the Junta the Andalucia to J.L. Tella (PL, MV, DS, JLT).	Ahtiainen JJ, 2004, P ROY SOC B-BIOL SCI, V271, P1839, DOI 10.1098/rspb.2004.2791; Birdlife International, 2000, THREAT BIRDS WORLD; Buchholz R, 2007, TRENDS ECOL EVOL, V22, P401, DOI 10.1016/j.tree.2007.06.002; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Byers BE, 2007, BEHAV ECOL, V18, P130, DOI 10.1093/beheco/arl058; Caro T, 2007, TRENDS ECOL EVOL, V22, P394, DOI 10.1016/j.tree.2007.06.003; Catchpole C.K., 1995, BIRD SONG; Catchpole CK, 1996, TRENDS ECOL EVOL, V11, P358, DOI 10.1016/0169-5347(96)30042-6; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Choquet R., 2005, U CARE 2 2 USERS MAN; Collins Sarah, 2004, P39, DOI 10.1016/B978-012473070-0/50005-0; Cramp S., 1988, BIRDS W PALEARCTIC; Crystal D., 2000, LANGUAGE DEATH; De Leo GA, 2004, ECOL MODEL, V177, P313, DOI 10.1016/j.ecolmodel.2003.11.017; Doutrelant C, 2000, J AVIAN BIOL, V31, P360, DOI 10.1034/j.1600-048X.2000.310312.x; Garamszegi LZ, 2007, ETHOLOGY, V113, P246, DOI 10.1111/j.1439-0310.2007.01337.x; Gerber LR, 2006, FRONT ECOL ENVIRON, V4, P419, DOI 10.1890/1540-9295(2006)4[419:IBDIDM]2.0.CO;2; Gil D, 2000, BEHAV ECOL SOCIOBIOL, V47, P319, DOI 10.1007/s002650050672; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Hultsch Henrike, 2004, P80, DOI 10.1016/B978-012473070-0/50006-2; KRAUSS M, 1992, LANGUAGE, V68, P4, DOI 10.1353/lan.1992.0075; Kroodsma DE, 2001, CONDOR, V103, P855, DOI 10.1650/0010-5422(2001)103[0855:SVACWW]2.0.CO;2; Kroodsma Don, 2004, P108, DOI 10.1016/B978-012473070-0/50007-4; Laiolo P, 2005, J APPL ECOL, V42, P1183, DOI 10.1111/j.1365-2664.2005.01093.x; Laiolo P, 2005, ARDEOLA, V52, P167; Laiolo P, 2007, FRONT ECOL ENVIRON, V5, P68, DOI 10.1890/1540-9295(2007)5[68:EOACIF]2.0.CO;2; Laiolo P, 2007, J AVIAN BIOL, V38, P672, DOI 10.1111/j.2007.0908-8857.04006.x; Laiolo P, 2007, TRENDS ECOL EVOL, V22, P5, DOI 10.1016/j.tree.2006.10.007; Laiolo P, 2006, ENVIRON CONSERV, V33, P223, DOI 10.1017/S0376892906003146; Laiolo P, 2006, ECOLOGY, V87, P1203, DOI 10.1890/0012-9658(2006)87[1203:LBADOT]2.0.CO;2; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Linklater WL, 2004, BIOSCIENCE, V54, P352, DOI 10.1641/0006-3568(2004)054[0352:WFCRBE]2.0.CO;2; Miller PS., 2005, VORTEX STOCHASTIC SI; Penteriani V, 2003, IBIS, V145, pE127, DOI 10.1046/j.1474-919X.2003.00173.x; REED JM, 1993, TRENDS ECOL EVOL, V8, P253, DOI 10.1016/0169-5347(93)90201-Y; RENDEL LE, 2003, P R SOC B, V270, P223; SEARCY WA, 1990, BEHAV ECOL SOCIOBIOL, V27, P123, DOI 10.1007/BF00168455; Sutherland W.J., 1996, INDIVIDUAL BEHAV POP; Tella JL, 2005, ORYX, V39, P90, DOI 10.1017/S0030605305000165; Vaughan C, 2005, BIRD CONSERV INT, V15, P119; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitlock MC, 2000, EVOLUTION, V54, P1855, DOI 10.1111/j.0014-3820.2000.tb01232.x; Yanes M, 1996, CONSERV BIOL, V10, P881, DOI 10.1046/j.1523-1739.1996.10030881.x	45	69	69	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1822	10.1371/journal.pone.0001822	http://dx.doi.org/10.1371/journal.pone.0001822			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350158	gold, Green Submitted, Green Published			2022-12-27	WOS:000260762300024
J	Ronkainen, PHA; Pollanen, E; Tormakangas, T; Tiainen, K; Koskenvuo, M; Kaprio, J; Rantanen, T; Sipila, S; Kovanen, V				Ronkainen, Paula H. A.; Pollanen, Eija; Tormakangas, Timo; Tiainen, Kristina; Koskenvuo, Markku; Kaprio, Jaakko; Rantanen, Taina; Sipila, Sarianna; Kovanen, Vuokko			Catechol-O-Methyltransferase Gene Polymorphism Is Associated with Skeletal Muscle Properties in Older Women Alone and Together with Physical Activity	PLOS ONE			English	Article								Background: Muscle strength declines on average by one percent annually from midlife on. In postmenopausal women this decrement coincides with a rapid decline in estrogen production. The genetics underlying the effects of estrogen on skeletal muscle remains unclear. In the present study, we examined whether polymorphisms within COMT and ESR1 are associated with muscle properties and assessed their interaction and their combined effects with physical activity. Methodology/Principal Findings: A cross-sectional data analysis was conducted with 434 63-76-year-old women from the population-based Finnish Twin Study on Aging. Body anthropometry, muscle cross-sectional area (mCSA), isometric hand grip and knee extension strengths, and leg extension power were measured. COMT Val158Met and ESR1 PvuII genotypes were determined by the RFLP method. mCSA differed by COMT genotypes (p = 0.014) being significantly larger in LL than HL individuals in unadjusted (p = 0.001) and age- and height-adjusted model (p = 0.004). When physical activity and age were entered into GEE model, COMT genotype had a significant main effect (p = 0.038) on mCSA. Furthermore, sedentary individuals with the HH genotype had lower muscle mass, strength and power, but they also appeared to benefit the most from physical activity. No association of ESR1 PvuII polymorphism with any of the muscle outcomes was observed. Conclusions/Significance: The present study suggests that the COMT polymorphism, affecting the activity of the enzyme, is associated with muscle mass. Furthermore, sedentary individuals with potential high enzyme activity were the weakest group, but they may potentially benefit the most from physical activity. This observation elucidates the importance of both environmental and genetic factors in muscle properties.	[Ronkainen, Paula H. A.; Pollanen, Eija; Tormakangas, Timo; Tiainen, Kristina; Rantanen, Taina; Sipila, Sarianna; Kovanen, Vuokko] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Ronkainen, Paula H. A.; Pollanen, Eija; Tormakangas, Timo; Tiainen, Kristina; Rantanen, Taina; Sipila, Sarianna] Univ Jyvaskyla, Finnish Ctr Interdisciplin Gerontol, Jyvaskyla, Finland; [Koskenvuo, Markku] Univ Turku, Dept Public Hlth, Turku, Finland; [Kaprio, Jaakko] Univ Helsinki, Dept Public Hlth, Helsinki, Finland; [Kaprio, Jaakko] Natl Public Hlth Inst, Dept Mental Hlth & Alcohol Res, Helsinki, Finland	University of Jyvaskyla; University of Jyvaskyla; University of Turku; University of Helsinki; Finland National Institute for Health & Welfare	Ronkainen, PHA (corresponding author), Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland.	paula.ronkainen@sport.jyu.fi	Kaprio, Jaakko/A-1820-2008; Laakkonen, Eija/G-3345-2017; Rantanen, Taina/O-6579-2016; Tiainen, Kristina/AAI-2195-2021	Kaprio, Jaakko/0000-0002-3716-2455; Laakkonen, Eija/0000-0001-6655-9489; Rantanen, Taina/0000-0002-1604-1945; Tiainen, Kristina/0000-0003-2810-1885; Sipila, Sarianna/0000-0001-5934-7728; Tormakangas, Timo/0000-0001-7268-5297	Academy of Finland; Finnish Ministry of Education; Lapland Fund of the Finnish Cultural Foundation; Academy of Finland Center of Excellence in Complex Disease Genetics	Academy of Finland(Academy of Finland); Finnish Ministry of Education; Lapland Fund of the Finnish Cultural Foundation; Academy of Finland Center of Excellence in Complex Disease Genetics(Academy of Finland)	This study was supported by the Academy of Finland, Finnish Ministry of Education and the Lapland Fund of the Finnish Cultural Foundation. The Finnish Twin Cohort is part of the Academy of Finland Center of Excellence in Complex Disease Genetics for 2006-2011.	Al-Hendy A, 2006, J SOC GYNECOL INVEST, V13, P136, DOI 10.1016/j.jsgi.2005.10.007; BASSEY EJ, 1990, EUR J APPL PHYSIOL, V60, P385, DOI 10.1007/BF00713504; Beunen G, 2004, EXERC SPORT SCI REV, V32, P148; Bjornerem A, 2004, J CLIN ENDOCR METAB, V89, P6039, DOI 10.1210/jc.2004-0735; CASTAGNOLI A, 1987, NUCLEIC ACIDS RES, V15, P866, DOI 10.1093/nar/15.2.866; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Dobs AS, 2002, J CLIN ENDOCR METAB, V87, P1509, DOI 10.1210/jc.87.4.1509; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Dunning AM, 2004, JNCI-J NATL CANCER I, V96, P936, DOI 10.1093/jnci/djh167; Eriksson AL, 2005, PEDIATR RES, V58, P71, DOI 10.1203/01.PDR.0000163383.49747.B5; FUJITA Y, 1995, J CLIN EPIDEMIOL, V48, P1349, DOI 10.1016/0895-4356(95)00533-1; Greenlund LJS, 2003, MECH AGEING DEV, V124, P287, DOI 10.1016/S0047-6374(02)00196-3; GRIMBY G, 1986, ACTA MED SCAND, P233; Harridge SDR, 2007, EXP PHYSIOL, V92, P783, DOI 10.1113/expphysiol.2006.036525; Herrington DM, 2002, CIRCULATION, V105, P1879, DOI 10.1161/01.CIR.0000016173.98826.88; Kaprio J, 2002, TWIN RES, V5, P366, DOI 10.1375/136905202320906101; Kaprio J, 1978, Prog Clin Biol Res, V24 Pt B, P179; Kenny AM, 2005, J AM GERIATR SOC, V53, P1973, DOI 10.1111/j.1532-5415.2005.53567.x; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lee JS, 2006, J CLIN ENDOCR METAB, V91, P3791, DOI 10.1210/jc.2005-2378; Lemoine S, 2003, MED SCI SPORT EXER, V35, P439, DOI 10.1249/01.MSS.0000053654.14410.78; Loos R, 1997, J APPL PHYSIOL, V82, P1802, DOI 10.1152/jappl.1997.82.6.1802; Lorentzon M, 2004, J BONE MINER RES, V19, P2005, DOI 10.1359/JBMR.040909; LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008; Lurie G, 2005, CANCER EPIDEM BIOMAR, V14, P1521, DOI 10.1158/1055-9965.EPI-04-0746; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Nader GA, 2005, INT J BIOCHEM CELL B, V37, P1985, DOI 10.1016/j.biocel.2005.02.026; Natarajan S, 2007, STAT MODEL, V7, P175, DOI 10.1177/1471082X0700700204; PHILLIPS SK, 1993, CLIN SCI, V84, P95, DOI 10.1042/cs0840095; PUAH JA, 1985, ENDOCRINOLOGY, V117, P1336, DOI 10.1210/endo-117-4-1336; RANCE NE, 1984, ENDOCRINOLOGY, V115, P862, DOI 10.1210/endo-115-3-862; Rantanen T, 1997, J AM GERIATR SOC, V45, P1439, DOI 10.1111/j.1532-5415.1997.tb03193.x; Rantanen T, 1998, J APPL PHYSIOL, V85, P2047, DOI 10.1152/jappl.1998.85.6.2047; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Rantanen T, 2001, J AM GERIATR SOC, V49, P21, DOI 10.1046/j.1532-5415.2001.49005.x; Rantanen T., 2016, J AGING PHYS ACTIV, V2, P206, DOI 10.1123/japa.2.3.206; Ribom EL, 2002, MATURITAS, V42, P225, DOI 10.1016/S0378-5122(02)00079-8; Roubenoff R, 2001, JAMA-J AM MED ASSOC, V286, P1230, DOI 10.1001/jama.286.10.1230; Salmen T, 2002, ANN MED, V34, P64, DOI 10.1080/078538902317338661; Samson MM, 2000, AGE AGEING, V29, P235, DOI 10.1093/ageing/29.3.235; SCANLON PD, 1979, SCIENCE, V203, P63, DOI 10.1126/science.758679; Sipila S, 2001, CLIN SCI, V101, P147, DOI 10.1042/CS20000271; Sipila S, 1996, ACTA PHYSIOL SCAND, V156, P457, DOI 10.1046/j.1365-201X.1996.461177000.x; Skelton DA, 1999, CLIN SCI, V96, P357, DOI 10.1042/CS19980318; SODERGARD R, 1982, J STEROID BIOCHEM, V16, P801, DOI 10.1016/0022-4731(82)90038-3; STOLK L, 2007, J CLIN ENDOCRINOL ME; Taaffe DR, 2005, CLIN PHYSIOL FUNCT I, V25, P297, DOI 10.1111/j.1475-097X.2005.00628.x; Tanko LB, 2002, MENOPAUSE, V9, P117, DOI 10.1097/00042192-200203000-00006; Thomis MA, 1997, J APPL PHYSIOL, V82, P959, DOI 10.1152/jappl.1997.82.3.959; Tiainen K, 2004, J APPL PHYSIOL, V96, P173, DOI 10.1152/japplphysiol.00200.2003; Tworoger SS, 2004, CANCER EPIDEM BIOMAR, V13, P94, DOI 10.1158/1055-9965.EPI-03-0026; Vandevyver C, 1999, J BONE MINER RES, V14, P1576, DOI 10.1359/jbmr.1999.14.9.1576; Worda C, 2003, HUM REPROD, V18, P262, DOI 10.1093/humrep/deg059; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	55	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1819	10.1371/journal.pone.0001819	http://dx.doi.org/10.1371/journal.pone.0001819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350156	Green Published, Green Submitted, gold			2022-12-27	WOS:000260762300022
J	Wagner, W; Horn, P; Castoldi, M; Diehlmann, A; Bork, S; Saffrich, R; Benes, V; Blake, J; Pfister, S; Eckstein, V; Ho, AD				Wagner, Wolfgang; Horn, Patrick; Castoldi, Mirco; Diehlmann, Anke; Bork, Simone; Saffrich, Rainer; Benes, Vladimir; Blake, Jonathon; Pfister, Stefan; Eckstein, Volker; Ho, Anthony D.			Replicative Senescence of Mesenchymal Stem Cells: A Continuous and Organized Process	PLOS ONE			English	Article							MARROW STROMAL CELLS; HUMAN BONE-MARROW; LIFE-SPAN; MICRORNA EXPRESSION; INTERNATIONAL-SOCIETY; PROGENITOR CELLS; CORD BLOOD; DIFFERENTIATION; EXPANSION; TELOMERASE	Mesenchymal stem cells (MSC) comprise a promising tool for cellular therapy. These cells are usually culture expanded prior to their application. However, a precise molecular definition of MSC and the sequel of long-term in vitro culture are yet unknown. In this study, we have addressed the impact of replicative senescence on human MSC preparations. Within 43 to 77 days of cultivation (7 to 12 passages), MSC demonstrated morphological abnormalities, enlargement, attenuated expression of specific surface markers, and ultimately proliferation arrest. Adipogenic differentiation potential decreased whereas the propensity for osteogenic differentiation increased. mRNA expression profiling revealed a consistent pattern of alterations in the global gene expression signature of MSC at different passages. These changes are not restricted to later passages, but are continuously acquired with increasing passages. Genes involved in cell cycle, DNA replication and DNA repair are significantly down-regulated in late passages. Genes from chromosome 4q21 were over-represented among differentially regulated transcripts. Differential expression of 10 genes has been verified in independent donor samples as well as in MSC that were isolated under different culture conditions. Furthermore, miRNA expression profiling revealed an up-regulation of hsa-mir-371, hsa-mir-369-5P, hsa-mir-29c, hsa-mir-499 and hsa-let-7f upon in vitro propagation. Our studies indicate that replicative senescence of MSC preparations is a continuous process starting from the first passage onwards. This process includes far reaching alterations in phenotype, differentiation potential, global gene expression patterns, and miRNA profiles that need to be considered for therapeutic application of MSC preparations.	[Wagner, Wolfgang; Horn, Patrick; Diehlmann, Anke; Bork, Simone; Saffrich, Rainer; Eckstein, Volker; Ho, Anthony D.] Heidelberg Univ, Dept Med 5, Heidelberg, Germany; [Wagner, Wolfgang] Heidelberg Univ, Dept Physiol & Pathophysiol, Heidelberg, Germany; [Benes, Vladimir; Blake, Jonathon] European Mol Biol Lab, Genom Core Facil, Heidelberg, Germany; [Castoldi, Mirco; Pfister, Stefan] Heidelberg Univ, Dept Pediat Oncol, Heidelberg, Germany; [Bork, Simone] Heidelberg Acad Sci & Humanities, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg	Wagner, W (corresponding author), Heidelberg Univ, Dept Med 5, Bergheimer Str 58, Heidelberg, Germany.	wolfgang_wagner@med.uni-heidelberg.de	Pfister, Stefan M/F-6860-2013	Pfister, Stefan M/0000-0002-5447-5322; Wagner, Wolfgang/0000-0002-1971-3217; Benes, Vladimir/0000-0002-0352-2547; Saffrich, Rainer/0000-0002-0547-4550; Ho, Anthony D./0000-0002-1656-0833	German Ministry of Education and Research (BMBF) [EP-S19T01]; German Research Foundation DFG [HO 914/7-1]; Joachim Siebeneicher-Stiftung; Academy of Sciences and Humanities, Heidelberg	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation DFG(German Research Foundation (DFG)); Joachim Siebeneicher-Stiftung; Academy of Sciences and Humanities, Heidelberg	This work was supported by the German Ministry of Education and Research (BMBF) within the National Genome Research Network NGFN-2 (EP-S19T01) and within the supporting program cell based regenerative medicine (START-MSC), the German Research Foundation DFG (HO 914/7-1), the Joachim Siebeneicher-Stiftung, Germany and the Academy of Sciences and Humanities, Heidelberg (WIN-Kolleg).	Abdelmagid SM, 2007, J CELL PHYSIOL, V210, P26, DOI 10.1002/jcp.20841; Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; Blake J, 2006, BIOINFORMATICS, V22, P765, DOI 10.1093/bioinformatics/btk022; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; Bryce SD, 2002, NEOPLASIA, V4, P544, DOI 10.1038/sj.neo.7900268; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Castoldi M, 2007, METHODS, V43, P146, DOI 10.1016/j.ymeth.2007.04.009; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Di Donna S, 2003, MOL CANCER RES, V1, P643; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fehrer C, 2005, EXP GERONTOL, V40, P926, DOI 10.1016/j.exger.2005.07.006; Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x; HAUNER H, 1989, J CLIN INVEST, V84, P1663, DOI 10.1172/JCI114345; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hayflick L, 2007, ANN NY ACAD SCI, V1100, P1, DOI 10.1196/annals.1395.001; HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2; Hennig T, 2007, J CELL PHYSIOL, V211, P682, DOI 10.1002/jcp.20977; Ho AD, 2005, EMBO REP, V6, pS35, DOI 10.1038/sj.embor.7400436; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681; Niemeyer P, 2004, CELLS TISSUES ORGANS, V177, P68, DOI 10.1159/000079182; NING Y, 1991, P NATL ACAD SCI USA, V88, P5635, DOI 10.1073/pnas.88.13.5635; Noer A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-18; O'Hare MJ, 2001, P NATL ACAD SCI USA, V98, P646, DOI 10.1073/pnas.98.2.646; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Puca AA, 2001, P NATL ACAD SCI USA, V98, P10505, DOI 10.1073/pnas.181337598; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schoch G, 2006, PLOS MED, V3, P236, DOI 10.1371/journal.pmed.0030014; Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wagner W, 2006, EXP HEMATOL, V34, P536, DOI 10.1016/j.exphem.2006.01.002; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Wagner WG, 2007, STEM CELLS, V25, P2638, DOI 10.1634/stemcells.2007-0280; Weibel J, 2006, ANN NY ACAD SCI, V1067, P317, DOI 10.1196/annals.1354.043; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang H, 2003, P NATL ACAD SCI USA, V100, P3251, DOI 10.1073/pnas.2627983100	58	758	804	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2213	10.1371/journal.pone.0002213	http://dx.doi.org/10.1371/journal.pone.0002213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493317	Green Submitted, Green Published, gold			2022-12-27	WOS:000262258700022
J	Yoon, J; Lee, KS; Park, JS; Yu, K; Paik, SG; Kang, YK				Yoon, Jeongheon; Lee, Kyu-Sun; Park, Jung Sun; Yu, Kweon; Paik, Sang-Gi; Kang, Yong-Kook			dSETDB1 and SU(VAR)3-9 Sequentially Function during Germline-Stem Cell Differentiation in Drosophila melanogaster	PLOS ONE			English	Article								Germline-stem cells (GSCs) produce gametes and are thus true "immortal stem cells''. In Drosophila ovaries, GSCs divide asymmetrically to produce daughter GSCs and cystoblasts, and the latter differentiate into germline cysts. Here we show that the histone-lysine methyltransferase dSETDB1, located in pericentric heterochromatin, catalyzes H3-K9 trimethylation in GSCs and their immediate descendants. As germline cysts differentiate into egg chambers, the dSETDB1 function is gradually taken over by another H3-K9-specific methyltransferase, SU(VAR)3-9. Loss-of-function mutations in dsetdb1 or Su(var)3-9 abolish both H3K9me3 and heterochromatin protein-1 (HP1) signals from the anterior germarium and the developing egg chambers, respectively, and cause localization of H3K9me3 away from DNA-dense regions in most posterior germarium cells. These results indicate that dSETDB1 and SU(VAR)3-9 act together with distinct roles during oogenesis, with dsetdb1 being of particular importance due to its GSC-specific function and more severe mutant phenotype.	[Yoon, Jeongheon; Lee, Kyu-Sun; Park, Jung Sun; Yu, Kweon; Kang, Yong-Kook] KRIBB, Ctr Regenerat Med, Taejon, South Korea; [Yoon, Jeongheon; Paik, Sang-Gi] Chungnam Natl Univ, Dept Biol, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University	Yoon, J (corresponding author), KRIBB, Ctr Regenerat Med, Taejon, South Korea.	ykkang@kribb.re.kr		Yu, Kweon/0000-0002-4942-2576	KRIBB Research Initiative Program [KGM1310713]	KRIBB Research Initiative Program	This work was supported by KRIBB Research Initiative Program (KGM1310713).	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; Clough E, 2007, DEVELOPMENT, V134, P157, DOI 10.1242/dev.02698; COOLEY L, 1994, SCIENCE, V266, P590, DOI 10.1126/science.7939713; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; Deng W, 2001, INT REV CYTOL, V203, P93; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Donovan PJ, 2001, NATURE, V414, P92, DOI 10.1038/35102154; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; Forbes AJ, 1996, DEVELOPMENT, V122, P3283; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Ichimura T, 2005, J BIOL CHEM, V280, P13928, DOI 10.1074/jbc.M413654200; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Jia ST, 2004, CELL, V119, P469, DOI 10.1016/j.cell.2004.10.020; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; King R. C., 1970, OVARIAN DEV DROSOPHI; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Larsson J, 2004, P NATL ACAD SCI USA, V101, P9728, DOI 10.1073/pnas.0400978101; Larsson J, 2001, P NATL ACAD SCI USA, V98, P6273, DOI 10.1073/pnas.111581298; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Locke J, 2000, GENETICS, V155, P1175; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mis J, 2006, MOL GENET GENOMICS, V275, P513, DOI 10.1007/s00438-006-0116-x; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Riddle NC, 2006, CHROMOSOME RES, V14, P405, DOI 10.1007/s10577-006-1061-6; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Seum C, 2007, PLOS GENET, V3, P709, DOI 10.1371/journal.pgen.0030076; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; SPRADLING AC, 1993, CELL, V72, P649, DOI 10.1016/0092-8674(93)90393-5; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Stabell M, 2006, NUCLEIC ACIDS RES, V34, P4609, DOI 10.1093/nar/gkl640; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Tzeng TY, 2007, P NATL ACAD SCI USA, V104, P12691, DOI 10.1073/pnas.0705534104; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099	53	54	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2234	10.1371/journal.pone.0002234	http://dx.doi.org/10.1371/journal.pone.0002234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493619	Green Submitted, Green Published, gold			2022-12-27	WOS:000262258700042
J	Ilmonen, P; Kotrschal, A; Penn, DJ				Ilmonen, Petteri; Kotrschal, Alexander; Penn, Dustin J.			Telomere Attrition Due to Infection	PLOS ONE			English	Article								Background: Telomeres-the terminal caps of chromosomes-become shorter as individuals age, and there is much interest in determining what causes telomere attrition since this process may play a role in biological aging. The leading hypothesis is that telomere attrition is due to inflammation, exposure to infectious agents, and other types of oxidative stress, which damage telomeres and impair their repair mechanisms. Several lines of evidence support this hypothesis, including observational findings that people exposed to infectious diseases have shorter telomeres. Experimental tests are still needed, however, to distinguish whether infectious diseases actually cause telomere attrition or whether telomere attrition increases susceptibility to infection. Experiments are also needed to determine whether telomere erosion reduces longevity. Methodology/Principal Findings: We experimentally tested whether repeated exposure to an infectious agent, Salmonella enterica, causes telomere attrition in wild-derived house mice (Mus musculus musculus). We repeatedly infected mice with a genetically diverse cocktail of five different S. enterica strains over seven months, and compared changes in telomere length with sham-infected sibling controls. We measured changes in telomere length of white blood cells (WBC) after five infections using a real-time PCR method. Our results show that repeated Salmonella infections cause telomere attrition in WBCs, and particularly for males, which appeared less disease resistant than females. Interestingly, we also found that individuals having long WBC telomeres at early age were relatively disease resistant during later life. Finally, we found evidence that more rapid telomere attrition increases mortality risk, although this trend was not significant. Conclusions/Significance: Our results indicate that infectious diseases can cause telomere attrition, and support the idea that telomere length could provide a molecular biomarker for assessing exposure and ability to cope with infectious diseases.	[Ilmonen, Petteri; Kotrschal, Alexander; Penn, Dustin J.] Austrian Acad Sci, Konrad Lorenz Inst Ethol, A-1010 Vienna, Austria	Austrian Academy of Sciences	Ilmonen, P (corresponding author), Austrian Acad Sci, Konrad Lorenz Inst Ethol, A-1010 Vienna, Austria.	p.ilmonen@klivv.oeaw.ac.at	Kotrschal, Alexander/ABB-8987-2021; Kotrschal, Alexander/AEV-1376-2022	Kotrschal, Alexander/0000-0003-3473-1402	Austrian Academy of Sciences	Austrian Academy of Sciences	The work was funded by the Austrian Academy of Sciences. There were no sponsors or funders which would have played any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript	Aikata H, 2000, GASTROENTEROLOGY, V118, pA905, DOI 10.1016/S0016-5085(00)85756-X; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Campisi J, 2003, EXP GERONTOL, V38, P5, DOI 10.1016/S0531-5565(02)00152-3; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Goronzy JJ, 2006, EXP GERONTOL, V41, P246, DOI 10.1016/j.exger.2005.12.002; Grabowski P, 2005, BLOOD, V105, P4807, DOI 10.1182/blood-2004-11-4394; Hayflick L, 2000, BRIT J CANCER, V83, P841, DOI 10.1054/bjoc.2000.1296; Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474; Herrera E, 2000, EMBO J, V19, P472, DOI 10.1093/emboj/19.3.472; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Kotrschal A, 2007, BIOL LETTERS, V3, P128, DOI 10.1098/rsbl.2006.0594; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Liaudet L, 2002, INFECT IMMUN, V70, P192, DOI 10.1128/IAI.70.1.192-198.2002; Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; MCCLEARN GE, 1997, ILAR J, V38; Miller RA, 2002, EXP BIOL MED, V227, P500, DOI 10.1177/153537020222700715; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Ravindran R, 2005, IMMUNOLOGY, V114, P450, DOI 10.1111/j.1365-2567.2005.02140.x; RICE WR, 1994, TRENDS ECOL EVOL, V9, P235, DOI 10.1016/0169-5347(94)90258-5; Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367; Sekoguchi S, 2007, J GASTROEN HEPATOL, V22, P182, DOI 10.1111/j.1440-1746.2006.04454.x; Sheppard M, 2003, CELL MICROBIOL, V5, P593, DOI 10.1046/j.1462-5822.2003.00296.x; Valenzuela HF, 2002, CLIN IMMUNOL, V105, P117, DOI 10.1006/clim.2002.5271; Vallejo AN, 2004, TRENDS MOL MED, V10, P119, DOI 10.1016/j.molmed.2004.01.002; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; von Zglinicki T, 2005, CURR MOL MED, V5, P197; von Zglinicki T, 2001, EXP GERONTOL, V36, P1049, DOI 10.1016/S0531-5565(01)00111-5; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; WENG NP, 1995, P NATL ACAD SCI USA, V92, P11091, DOI 10.1073/pnas.92.24.11091; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com	36	117	119	16	695	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2143	10.1371/journal.pone.0002143	http://dx.doi.org/10.1371/journal.pone.0002143			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478110	Green Published, gold, Green Submitted			2022-12-27	WOS:000262172800008
J	Niewiarowski, PH; Lopez, S; Ge, L; Hagan, E; Dhinojwala, A				Niewiarowski, Peter H.; Lopez, Stephanie; Ge, Liehui; Hagan, Emily; Dhinojwala, Ali			Sticky Gecko Feet: The Role of Temperature and Humidity	PLOS ONE			English	Article								Gecko adhesion is expected to be temperature insensitive over the range of temperatures typically experienced by geckos. Previous work is limited and equivocal on whether this expectation holds. We tested the temperature dependence of adhesion in Tokay and Day geckos and found that clinging ability at 12 degrees C was nearly double the clinging ability at 32 degrees C. However, rather than confirming a simple temperature effect, our data reveal a complex interaction between temperature and humidity that can drive differences in adhesion by as much as two-fold. Our findings have important implications for inferences about the mechanisms underlying the exceptional clinging capabilities of geckos, including whether performance of free-ranging animals is based solely on a dry adhesive model. An understanding of the relative contributions of van der Waals interactions and how humidity and temperature variation affects clinging capacities will be required to test hypotheses about the evolution of gecko toepads and is relevant to the design and manufacture of synthetic mimics.	[Niewiarowski, Peter H.; Lopez, Stephanie] Univ Akron, Dept Biol, Program Integrated Biosci, Akron, OH 44325 USA; [Ge, Liehui; Hagan, Emily; Dhinojwala, Ali] Univ Akron, Dept Polymer Sci, Akron, OH USA	University System of Ohio; University of Akron; University System of Ohio; University of Akron	Niewiarowski, PH (corresponding author), Univ Akron, Dept Biol, Program Integrated Biosci, Akron, OH 44325 USA.	phn@uakron.edu	Ge, Liehui/N-7881-2015; niewiarowski, peter/AAA-7060-2022	niewiarowski, peter/0000-0002-8952-3013; Ge, Liehui/0000-0002-1990-5681	Integrated Bioscience Program, University of Akron [DMR 0353746]; NSF-NIRT [0609077]	Integrated Bioscience Program, University of Akron; NSF-NIRT(National Science Foundation (NSF))	Partial support for this project was provided by the Integrated Bioscience Program, University of Akron (PHN and AD), by E.H. research experience for undergraduates (DMR 0353746) and NSF-NIRT 0609077 (AD).	Alibardi L, 2005, TISSUE CELL, V37, P423, DOI 10.1016/j.tice.2005.05.005; Alibardi L, 2003, TISSUE CELL, V35, P288, DOI 10.1016/S0040-8166(03)00050-8; Alibardi L, 2007, J ANAT, V211, P104, DOI 10.1111/j.1469-7580.2007.00752.x; Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Autumn K, 2006, AM SCI, V94, P124, DOI 10.1511/2006.58.124; Autumn K, 2002, INTEGR COMP BIOL, V42, P1081, DOI 10.1093/icb/42.6.1081; Bergmann PJ, 2005, J EXP ZOOL PART A, V303A, P785, DOI 10.1002/jez.a.210; Hawthorn AC, 2003, J EXP BIOL, V206, P3905, DOI 10.1242/jeb.00618; Hawthorn AC, 2002, BIOL J LINN SOC, V77, P1, DOI 10.1046/j.1095-8312.2002.00099.x; Huber G, 2005, P NATL ACAD SCI USA, V102, P16293, DOI 10.1073/pnas.0506328102; HUEY RB, 1989, PHYSIOL ZOOL, V62, P488, DOI 10.1086/physzool.62.2.30156181; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; Irschick DJ, 2006, J COMP PHYSIOL A, V192, P1169, DOI 10.1007/s00359-006-0145-2; Kim TW, 2008, J R SOC INTERFACE, V5, P319, DOI 10.1098/rsif.2007.1078; Losos J.B., 1990, Asiatic Herpetological Research, V3, P54; MADERSON P F A, 1970, Forma et Functio, V3, P179; Pianka ER, 2005, BIOESSAYS, V27, P647, DOI 10.1002/bies.20237; Qian LM, 2003, TRIBOL LETT, V15, P169, DOI 10.1023/A:1024868532575; Russell AP, 2002, INTEGR COMP BIOL, V42, P1154, DOI 10.1093/icb/42.6.1154; Sun WX, 2005, BIOPHYS J, V89, pL14, DOI 10.1529/biophysj.105.065268; Toni M, 2007, J PROTEOME RES, V6, P1792, DOI 10.1021/pr060626+; WILLIAMS EE, 1982, SCIENCE, V215, P1509, DOI 10.1126/science.215.4539.1509	22	98	99	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2192	10.1371/journal.pone.0002192	http://dx.doi.org/10.1371/journal.pone.0002192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478106	gold, Green Published, Green Submitted			2022-12-27	WOS:000262172800056
J	Salehi, A; Abaraviciene, SM; Jimenez-Feltstrom, J; Ostenson, CG; Efendic, S; Lundquist, I				Salehi, Albert; Abaraviciene, Sandra Meidute; Jimenez-Feltstrom, Javier; Ostenson, Claes-Goran; Efendic, Suad; Lundquist, Ingmar			Excessive Islet NO Generation in Type 2 Diabetic GK Rats Coincides with Abnormal Hormone Secretion and Is Counteracted by GLP-1	PLOS ONE			English	Article								Background: A distinctive feature of type 2 diabetes is inability of insulin-secreting beta-cells to properly respond to elevated glucose eventually leading to beta-cell failure. We have hypothesized that an abnormally increased NO production in the pancreatic islets might be an important factor in the pathogenesis of b-cell dysfunction. Principal Findings: We show now that islets of type 2 spontaneous diabetes in GK rats display excessive NO generation associated with abnormal iNOS expression in insulin and glucagon cells, increased ncNOS activity, impaired glucose-stimulated insulin release, glucagon hypersecretion, and impaired glucose-induced glucagon suppression. Pharmacological blockade of islet NO production by the NOS inhibitor N(G)-nitro-L-arginine methyl ester ( L-NAME) greatly improved hormone secretion from GK islets suggesting islet NOS activity being an important target to inactivate for amelioration of islet cell function. The incretin hormone GLP-1, which is used in clinical practice suppressed iNOS and ncNOS expression and activity with almost full restoration of insulin release and partial restoration of glucagon release. GLP-1 suppression of iNOS expression was reversed by PKA inhibition but unaffected by the proteasome inhibitor MG132. Injection of glucose plus GLP-1 in the diabetic rats showed that GLP-1 amplified the insulin response but induced a transient increase and then a poor depression of glucagon. Conclusion: The results suggest that abnormally increased NO production within islet cells is a significant player in the pathogenesis of type 2 diabetes being counteracted by GLP-1 through PKA-dependent, nonproteasomal mechanisms.	[Salehi, Albert; Abaraviciene, Sandra Meidute; Jimenez-Feltstrom, Javier] UMAS, Dept Clin Sci, Div Endocrine Pharmacol, Karolinska Inst, Stockholm, Sweden; [Ostenson, Claes-Goran; Efendic, Suad] Lund Univ, Karolinska Inst, Dept Mol Med, Stockholm, Sweden; [Lundquist, Ingmar] Karolinska Inst, Dept Expt Med Sci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Lund University; Karolinska Institutet	Salehi, A (corresponding author), UMAS, Dept Clin Sci, Div Endocrine Pharmacol, Karolinska Inst, Stockholm, Sweden.	S_Albert.Salehi@med.lu.se	Salehi, Albert/F-7768-2018	Salehi, Albert/0000-0001-6120-3539	Swedish Science Council [04X-20029]; Medical Faculty (University of Lund); NOVO Nordic; Swedish Diabetes Foundations	Swedish Science Council; Medical Faculty (University of Lund); NOVO Nordic; Swedish Diabetes Foundations	This study was supported by the Swedish Science Council (04X-20029), the Medical Faculty (University of Lund), NOVO Nordic, Magnus Bergvall, Albert Pahlsson, Crafoord and Swedish Diabetes Foundations.	Ahren B, 2004, J CLIN ENDOCR METAB, V89, P2078, DOI 10.1210/jc.2003-031907; AHREN B, 1982, DIABETOLOGIA, V22, P258, DOI 10.1007/BF00281302; Akesson B, 1999, J ENDOCRINOL, V163, P39, DOI 10.1677/joe.0.1630039; Akesson B, 1999, ENDOCRINE, V11, P99, DOI 10.1385/ENDO:11:1:99; Akesson B, 1999, J PHYSIOL-LONDON, V515, P463, DOI 10.1111/j.1469-7793.1999.463ac.x; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Alm P, 1999, DIABETOLOGIA, V42, P978, DOI 10.1007/s001250051256; AMMON HPT, 1985, CELL BIOCHEM FUNCT, V3, P157, DOI 10.1002/cbf.290030302; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Drucker DJ, 2003, ENDOCRINOLOGY, V144, P5145, DOI 10.1210/en.2003-1147; Efendic S, 2004, HORM METAB RES, V36, P742, DOI 10.1055/s-2004-826157; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707; GROSS R, 1995, BRIT J PHARMACOL, V116, P1965, DOI 10.1111/j.1476-5381.1995.tb16399.x; GUENIFI A, 1995, PANCREAS, V10, P148, DOI 10.1097/00006676-199503000-00007; HEDING LG, 1966, SIMPLIFIED INSULIN R, P345; Henningsson R, 1999, DIABETES, V48, P66, DOI 10.2337/diabetes.48.1.66; Henningsson R, 2002, AM J PHYSIOL-CELL PH, V283, pC296, DOI 10.1152/ajpcell.00537.2001; Henningsson R, 2001, AM J PHYSIOL-CELL PH, V280, pC1242, DOI 10.1152/ajpcell.2001.280.5.C1242; Henningsson R, 2000, AM J PHYSIOL-ENDOC M, V279, pE95, DOI 10.1152/ajpendo.2000.279.1.E95; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jiang BB, 2004, J BIOL CHEM, V279, P1323, DOI 10.1074/jbc.M307521200; Jimenez-Feltstrom J, 2005, CELL TISSUE RES, V319, P221, DOI 10.1007/s00441-004-1013-4; Kaneko Y, 2003, AM J PHYSIOL-CELL PH, V284, pC1215, DOI 10.1152/ajpcell.00223.2002; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kitiphongspattana K, 2005, J BIOL CHEM, V280, P15727, DOI 10.1074/jbc.M410876200; Lajoix AD, 2004, DIABETES, V53, P1467, DOI 10.2337/diabetes.53.6.1467; Lajoix AD, 2001, DIABETES, V50, P1311, DOI 10.2337/diabetes.50.6.1311; Mori T, 2001, METABOLISM, V50, P703, DOI 10.1053/meta.2001.23301; Mosen H, 2006, J ENDOCRINOL, V190, P681, DOI 10.1677/joe.1.06890; Musial A, 2001, J BIOL CHEM, V276, P24268, DOI 10.1074/jbc.M100725200; Novelli M, 2004, MOL CELL ENDOCRINOL, V219, P77, DOI 10.1016/j.mce.2004.01.010; OSTENSON CG, 1993, DIABETOLOGIA, V36, P3, DOI 10.1007/BF00399086; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; PANAGIOTIDIS G, 1995, BRIT J PHARMACOL, V114, P289, DOI 10.1111/j.1476-5381.1995.tb13225.x; PANAGIOTIDIS G, 1992, DIABETES RES CLIN PR, V18, P167, DOI 10.1016/0168-8227(92)90142-E; Qader SS, 2007, AM J PHYSIOL-ENDOC M, V292, pE1447, DOI 10.1152/ajpendo.00172.2006; Salehi A, 1996, AM J PHYSIOL-CELL PH, V270, pC1634, DOI 10.1152/ajpcell.1996.270.6.C1634; Salehi A, 2001, ENDOCRINE, V16, P97, DOI 10.1385/ENDO:16:2:097; Salehi A, 2003, HORM METAB RES, V35, P48, DOI 10.1055/s-2003-38391; Salehi A, 1999, ENDOCRINOLOGY, V140, P3045, DOI 10.1210/en.140.7.3045; Salehi A, 1998, CELL SIGNAL, V10, P645, DOI 10.1016/S0898-6568(98)00005-9; SHAFRIR E, 1992, DIABETES METAB REV, V8, P179, DOI 10.1002/dmr.5610080302; Smukler SR, 2002, DIABETES, V51, P3450, DOI 10.2337/diabetes.51.12.3450; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P8087, DOI 10.1073/pnas.89.17.8087; Takamura T, 1998, J BIOL CHEM, V273, P2493, DOI 10.1074/jbc.273.5.2493; TSUURA Y, 1993, DIABETES, V42, P1446, DOI 10.2337/diabetes.42.10.1446; TSUURA Y, 1994, J GEN PHYSIOL, V104, P1079, DOI 10.1085/jgp.104.6.1079; UNGER RH, 1976, DIABETES, V25, P136, DOI 10.2337/diab.25.2.136; Weber SM, 2004, AM J PHYSIOL-ENDOC M, V287, pE1171, DOI 10.1152/ajpendo.00331.2004	51	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2165	10.1371/journal.pone.0002165	http://dx.doi.org/10.1371/journal.pone.0002165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478125	gold, Green Published, Green Submitted			2022-12-27	WOS:000262172800030
J	Zeki, S; Hulme, OJ; Roulston, B; Atiyah, M				Zeki, Semir; Hulme, Oliver J.; Roulston, Barrie; Atiyah, Michael			The Encoding of Temporally Irregular and Regular Visual Patterns in the Human Brain	PLOS ONE			English	Article								In the work reported here, we set out to study the neural systems that detect predictable temporal patterns and departures from them. We used functional magnetic resonance imaging (fMRI) to locate activity in the brains of subjects when they viewed temporally regular and irregular patterns produced by letters, numbers, colors and luminance. Activity induced by irregular sequences was located within dorsolateral prefrontal cortex, including an area that was responsive to irregular patterns regardless of the type of visual stimuli producing them. Conversely, temporally regular arrangements resulted in activity in the right frontal lobe (medial frontal gyrus), in the left orbito-frontal cortex and in the left pallidum. The results show that there is an abstractive system in the brain for detecting temporal irregularity, regardless of the source producing it.	[Zeki, Semir; Hulme, Oliver J.; Roulston, Barrie] UCL, Wellcome Lab Neurobiol, Dept Anat, London, England; [Atiyah, Michael] Univ Edinburgh, Sch Math, Edinburgh, Midlothian, Scotland	University of London; University College London; University of Edinburgh	Zeki, S (corresponding author), UCL, Wellcome Lab Neurobiol, Dept Anat, London, England.	zeki.pa@ucl.ac.uk	Zeki, Semir/AAA-1789-2020; Hulme, Oliver J/I-2997-2016	Hulme, Oliver J/0000-0003-3139-4324	Wellcome Trust, London, UK	Wellcome Trust, London, UK(Wellcome Trust)	Funded by the Wellcome Trust, London, UK. The Trust did not participate in any stage of the study.	Bartels A, 2000, EUR J NEUROSCI, V12, P172, DOI 10.1046/j.1460-9568.2000.00905.x; Clark VP, 2000, J NEUROPHYSIOL, V83, P3133, DOI 10.1152/jn.2000.83.5.3133; Fletcher PC, 2001, NAT NEUROSCI, V4, P1043, DOI 10.1038/nn733; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; KAISER PK, 1971, J OPT SOC AM, V61, P966, DOI 10.1364/JOSA.61.000966; Kirino E, 2000, J NEUROSCI, V20, P6612, DOI 10.1523/JNEUROSCI.20-17-06612.2000; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; McCarthy G, 1997, J NEUROPHYSIOL, V77, P1630, DOI 10.1152/jn.1997.77.3.1630; McKeefry DJ, 1997, BRAIN, V120, P2229, DOI 10.1093/brain/120.12.2229; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Self MW, 2005, CEREB CORTEX, V15, P1270, DOI 10.1093/cercor/bhi010; Stevens AA, 2000, MAGN RESON IMAGING, V18, P495, DOI 10.1016/S0730-725X(00)00128-4; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5; Zeki S, 1998, BRAIN, V121, P1669, DOI 10.1093/brain/121.9.1669; ZEKI S, 1991, J NEUROSCI, V11, P641; Zeki S, 2005, PHILOS T R SOC B, V360, P1145, DOI 10.1098/rstb.2005.1666	19	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2180	10.1371/journal.pone.0002180	http://dx.doi.org/10.1371/journal.pone.0002180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478105	Green Published, gold, Green Submitted			2022-12-27	WOS:000262172800045
J	Erceg, S; Lainez, S; Ronaghi, M; Stojkovic, P; Perez-Arago, MA; Moreno-Manzano, V; Moreno-Palanques, R; Planells-Cases, R; Stojkovic, M				Erceg, Slaven; Lainez, Sergio; Ronaghi, Mohammad; Stojkovic, Petra; Perez-Arago, Maria Amparo; Moreno-Manzano, Victoria; Moreno-Palanques, Ruben; Planells-Cases, Rosa; Stojkovic, Miodrag			Differentiation of Human Embryonic Stem Cells to Regional Specific Neural Precursors in Chemically Defined Medium Conditions	PLOS ONE			English	Article								Background: Human embryonic stem cells (hESC) provide a unique model to study early events in human development. The hESC-derived cells can potentially be used to replace or restore different tissues including neuronal that have been damaged by disease or injury. Methodology and Principal Findings: The cells of two different hESC lines were converted to neural rosettes using adherent and chemically defined conditions. The progenitor cells were exposed to retinoic acid (RA) or to human recombinant basic fibroblast growth factor (bFGF) in the late phase of the rosette formation. Exposing the progenitor cells to RA suppressed differentiation to rostral forebrain dopamine neural lineage and promoted that of spinal neural tissue including motor neurons. The functional characteristics of these differentiated neuronal precursors under both, rostral (bFGF) and caudalizing (RA) signals were confirmed by patch clamp analysis. Conclusions/Significance: These findings suggest that our differentiation protocol has the capacity to generate region-specific and electrophysiologically active neurons under in vitro conditions without embryoid body formation, co-culture with stromal cells and without presence of cells of mesodermal or endodermal lineages.	[Erceg, Slaven; Ronaghi, Mohammad; Stojkovic, Petra; Perez-Arago, Maria Amparo; Moreno-Manzano, Victoria; Moreno-Palanques, Ruben; Stojkovic, Miodrag] CIPF, Cellular Reprogramming Lab, Valencia, Spain; [Lainez, Sergio; Planells-Cases, Rosa] CIPF, Sensorial Biol Lab, Valencia, Spain	Prince Felipe Research Center; Prince Felipe Research Center	Erceg, S (corresponding author), CIPF, Cellular Reprogramming Lab, Valencia, Spain.	mstojkovic@cipf.es	Erceg, Slaven/ABC-4946-2021; Moreno, Victoria/B-4175-2014	Moreno, Victoria/0000-0002-6035-9491; Erceg, Slaven/0000-0003-3208-7705; Stojkovic, Miodrag/0000-0001-7526-6573	Regional Government Health Department; Instituto Carlos III belonging to the Spanish Ministry of Health and Consumer Affairs; Spanish Ministry of Education and Science [SAF2004-05684]	Regional Government Health Department; Instituto Carlos III belonging to the Spanish Ministry of Health and Consumer Affairs; Spanish Ministry of Education and Science(Spanish Government)	This work was supported by funds for research in the field of Regenerative Medicine from the Regional Government Health Department (Generalitat Valenciana), the Instituto Carlos III belonging to the Spanish Ministry of Health and Consumer Affairs, and through a grant from the Spanish Ministry of Education and Science SAF2004-05684. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Benzing C, 2006, NEUROREPORT, V17, P1675, DOI 10.1097/01.wnr.0000236861.01210.72; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Broccoli V, 1999, NATURE, V401, P164, DOI 10.1038/43670; BURKE AC, 1995, DEVELOPMENT, V121, P333; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; CEPEDA C, 1993, P NATL ACAD SCI USA, V90, P9576, DOI 10.1073/pnas.90.20.9576; Cheng LP, 2003, J NEUROSCI, V23, P9961; DAVIDSON D, 1988, DEVELOPMENT, V104, P305; Dhara SK, 2008, DIFFERENTIATION, V76, P454, DOI 10.1111/j.1432-0436.2007.00256.x; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; Dottori M, 2008, STEM CELLS, V26, P1146, DOI 10.1634/stemcells.2007-1118; Du ZW, 2004, STEM CELLS DEV, V13, P372, DOI 10.1089/scd.2004.13.372; Freed WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001422; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Jelitai M, 2007, J NEUROSCI RES, V85, P1606, DOI 10.1002/jnr.21282; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Joannides AJ, 2007, STEM CELLS, V25, P731, DOI 10.1634/stemcells.2006-0562; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Ko JY, 2007, J NEUROCHEM, V103, P1417, DOI 10.1111/j.1471-4159.2007.04898.x; Le WD, 1999, EXP NEUROL, V159, P451, DOI 10.1006/exnr.1999.7191; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Nat R, 2007, GLIA, V55, P385, DOI 10.1002/glia.20463; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Pagani F, 2006, J NEUROSCI RES, V83, P1494, DOI 10.1002/jnr.20835; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Roybon L, 2005, EXP NEUROL, V196, P373, DOI 10.1016/j.expneurol.2005.08.023; Sakurada K, 1999, DEVELOPMENT, V126, P4017; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schuldiner M, 2001, BRAIN RES, V913, P201, DOI 10.1016/S0006-8993(01)02776-7; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; Simon HH, 2004, CELL TISSUE RES, V318, P53, DOI 10.1007/s00441-004-0973-8; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; Tyzio R, 1999, J NEUROSCI, V19, P10372; Wallen A, 1999, EXP CELL RES, V253, P737, DOI 10.1006/excr.1999.4691; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhou YH, 2000, DEVELOPMENT, V127, P3829	62	101	107	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2122	10.1371/journal.pone.0002122	http://dx.doi.org/10.1371/journal.pone.0002122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461168	Green Submitted, gold, Green Published			2022-12-27	WOS:000261642400043
J	Noor, AM; Moloney, G; Borle, M; Fegan, GW; Shewchuk, T; Snow, RW				Noor, Abdisalan M.; Moloney, Grainne; Borle, Mohamed; Fegan, Greg W.; Shewchuk, Tanya; Snow, Robert W.			The Use of Mosquito Nets and the Prevalence of Plasmodium falciparum Infection in Rural South Central Somalia	PLOS ONE			English	Article								Background: There have been resurgent efforts in Africa to estimate the public health impact of malaria control interventions such as insecticide treated nets (ITNs) following substantial investments in scaling-up coverage in the last five years. Little is known, however, on the effectiveness of ITN in areas of Africa that support low transmission. This hinders the accurate estimation of impact of ITN use on disease burden and its cost-effectiveness in low transmission settings. Methods and Principal Findings: Using a stratified two-stage cluster sample design, four cross-sectional studies were undertaken between March-June 2007 across three livelihood groups in an area of low intensity malaria transmission in South Central Somalia. Information on bed net use; age; and sex of all participants were recorded. A finger prick blood sample was taken from participants to examine for parasitaemia. Mantel-Haenzel methods were used to measure the effect of net use on parasitaemia adjusting for livelihood; age; and sex. A total of 10,587 individuals of all ages were seen of which 10,359 provided full information. Overall net use and parasite prevalence were 12.4% and 15.7% respectively. Age-specific protective effectiveness (PE) of bed net ranged from 39% among,5 years to 72% among 5-14 years old. Overall PE of bed nets was 54% (95% confidence interval 44%-63%) after adjusting for livelihood; sex; and age. Conclusions and Significance: Bed nets confer high protection against parasite infection in South Central Somalia. In such areas where baseline transmission is low, however, the absolute reductions in parasitaemia due to wide-scale net use will be relatively small raising questions on the cost-effectiveness of covering millions of people living in such settings in Africa with nets. Further understanding of the progress of disease upon infection against the cost of averting its consequent burden in low transmission areas of Africa is therefore required.	[Noor, Abdisalan M.; Fegan, Greg W.; Snow, Robert W.] Wellcome Trust Res Programme, Kenya Med Res Inst, Ctr Geog Med Res Coast, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, John Radcliffe Hosp, Ctr Trop Med, Oxford, England; [Moloney, Grainne; Borle, Mohamed] Food Security Analysis Unit Somalia, Nairobi, Kenya; [Fegan, Greg W.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Infect Dis Epidemiol Unit, London, England; [Shewchuk, Tanya] Somalia Support Ctr, United Nations Childrens Fund, Nairobi, Kenya	Kenya Medical Research Institute; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Noor, AM (corresponding author), Wellcome Trust Res Programme, Kenya Med Res Inst, Ctr Geog Med Res Coast, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya.	anoor@nairobi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022; Fegan, Greg W/O-8079-2018	Snow, Robert William/0000-0003-3725-6088; Fegan, Greg W/0000-0002-2663-2765	OFDA-USAID; UNICEF; SIDA; EC; GFATM [SOM-202-G01-M-00]; Wellcome Trust [081829, 079081]; Kenyan Medical Research Institute	OFDA-USAID(United States Agency for International Development (USAID)); UNICEF; SIDA; EC(European CommissionEuropean Commission Joint Research Centre); GFATM; Wellcome Trust(Wellcome TrustEuropean Commission); Kenyan Medical Research Institute	FFSAU funded training of assessment teams, data collection, paid enumerators and data entry clerks. FSAU nutrition surveillance project is funded primarily by OFDA-USAID and receives support from UNICEF, SIDA and EC for conducting nutrition assessments in Somalia. RDTs and anti-malarial treatment were provided by UNICEF through GFATM funding (SOM-202-G01-M-00). AMN is supported by the Wellcome Trust as a Research Training Fellow (#081829). RWS is supported by the Wellcome Trust as Principal Research Fellow (#079081). Both AMN and RWS acknowledge the support of the Kenyan Medical Research Institute. The funders did not have a role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Abdulla S, 2001, BMJ-BRIT MED J, V322, P270, DOI 10.1136/bmj.322.7281.270; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2004, BIODIVERSITE PALUDIS; Babiker HA, 1998, T ROY SOC TROP MED H, V92, P585, DOI 10.1016/S0035-9203(98)90774-X; Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; *FAO SWALIM, 2007, DAT; Fraser-Hurt N, 1999, T ROY SOC TROP MED H, V93, pS47, DOI 10.1016/S0035-9203(99)90327-9; *FSAU, 2005, AN SYST; *FSAU, 2006, PROJ BACKGR; *GFATM, 2002, ROUND 2 SOM PROJ PRO; *GFATM, 2006, ROUND 6 SOM PROJ PRO; Giha HA, 2000, T ROY SOC TROP MED H, V94, P645, DOI 10.1016/S0035-9203(00)90218-9; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P298, DOI 10.1046/j.1365-3156.2002.00874.x; Habluetzel A, 1999, TROP MED INT HEALTH, V4, P557, DOI 10.1046/j.1365-3156.1999.00455.x; Hamad AA, 2000, PARASITOLOGY, V120, P447, DOI 10.1017/S0031182099005818; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Henry MC, 2005, AM J TROP MED HYG, V73, P859, DOI 10.4269/ajtmh.2005.73.859; Howard SC, 2000, T ROY SOC TROP MED H, V94, P357, DOI 10.1016/S0035-9203(00)90103-2; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Roper C, 1998, PARASITOLOGY, V116, P501, DOI 10.1017/S0031182098002650; *SACB, 2000, STRAT FRAM SUPP HLTH, V1; SEXTON JD, 1990, AM J TROP MED HYG, V43, P11, DOI 10.4269/ajtmh.1990.43.11; SNOW RW, 1987, T ROY SOC TROP MED H, V81, P563, DOI 10.1016/0035-9203(87)90408-1; Snow RW, 1996, AM J TROP MED HYG, V55, P144, DOI 10.4269/ajtmh.1996.55.2.TM0550020144; SNOW RW, 1988, T ROY SOC TROP MED H, V82, P212, DOI 10.1016/0035-9203(88)90414-2; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; SNOW RW, 1988, T ROY SOC TROP MED H, V82, P838, DOI 10.1016/0035-9203(88)90011-9; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P100, DOI 10.4269/ajtmh.2003.68.100; Thomson M, 1996, SOC SCI MED, V43, P101, DOI 10.1016/0277-9536(95)00346-0; THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6; *UNICEF, 2006, SOM MULT IND CLUST S; WARSAME M, 1989, TROP MED PARASITOL, V40, P412; [No title captured]; [No title captured]; GLOBAL FUND MALARIA; [No title captured]	38	50	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2081	10.1371/journal.pone.0002081	http://dx.doi.org/10.1371/journal.pone.0002081			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461178	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000261642400005
J	Taylor, JG; Nolan, VG; Mendelsohn, L; Kato, GJ; Gladwin, MT; Steinberg, MH				Taylor, James G. V., I; Nolan, Vikki G.; Mendelsohn, Laurel; Kato, Gregory J.; Gladwin, Mark T.; Steinberg, Martin H.			Chronic Hyper-Hemolysis in Sickle Cell Anemia: Association of Vascular Complications and Mortality with Less Frequent Vasoocclusive Pain	PLOS ONE			English	Article								Background: Intravascular hemolysis in sickle cell anemia could contribute to complications associated with nitric oxide deficiency, advancing age, and increased mortality. We have previously reported that intense hemolysis is associated with increased risk of vascular complications in a small cohort of adults with sickle cell disease. These observations have not been validated in other populations. Methods: The distribution of serum lactic dehydrogenase (LDH) values was used as a surrogate measure of intravascular hemolysis in a contemporaneous patient group and an historical adult population from the Cooperative Study of Sickle Cell Disease (CSSCD), all with sickle cell anemia. Chronic hyper-hemolysis was defined by the top LDH quartile and was compared to the lowest LDH quartile. Results: Hyper-hemolysis subjects had higher systolic blood pressure, higher prevalence of leg ulcers (OR 3.27, 95% CI 1.925.53, P, 0.0001), priapism (OR 2.62, 95% CI 1.13-6.90, P = 0.03) and pulmonary hypertension (OR 4.32, 95% CI 2.12-8.60, P < 0.0001), while osteonecrosis (OR 0.32, 95% CI 0.19-0.54, P < 0.0001) and pain (OR 0.23, 95% CI 0.09-0.55, P = 0.0004) were less prevalent. Hyper-hemolysis was influenced by fetal hemoglobin and a thalassemia, and was a risk factor for early death in the CSSCD population (Hazard Ratio = 1.97, P = 0.02). Conclusions: Steady state LDH measurements can identify a chronic hyper-hemolysis phenotype which includes less frequent vasooclusive pain and earlier mortality. Clinicians should consider sickle cell specific therapies for these patients, as is done for those with more frequent acute pain. The findings also suggest that an important class of disease modifiers in sickle cell anemia affect the rate of hemolysis.	[Taylor, James G. V., I; Mendelsohn, Laurel; Kato, Gregory J.; Gladwin, Mark T.] NHLBI, Pulm & Vasc Med Branch, NIH, Bethesda, MD 20892 USA; [Nolan, Vikki G.; Steinberg, Martin H.] Boston Univ, Sch Med, Dept Med, Boston, MA USA; [Kato, Gregory J.; Gladwin, Mark T.] NIH, Clin Ctr, Crit Care Med Dept, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Taylor, JG (corresponding author), NHLBI, Pulm & Vasc Med Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	jamesta@mail.nih.gov	Taylor, James G./AAH-4782-2021; Kato, Gregory J/I-7615-2014	Taylor, James G./0000-0002-4421-1809; Kato, Gregory J/0000-0003-4465-3217; Steinberg, Martin/0000-0001-8800-8020	Intramural NIH research program [R01 HL68970, U54 HL70819, T32 HL007501]; NHLBI [R01 HL68970, U54 HL70819, T32 HL007501]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068970, T32HL007501, U54HL070819, ZIAHL006012] Funding Source: NIH RePORTER; CLINICAL CENTER [Z01CL001174] Funding Source: NIH RePORTER	Intramural NIH research program; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CLINICAL CENTER	This study was supported by the Intramural NIH research program and NHLBI grants R01 HL68970 (MHS); U54 HL70819 (MHS) and T32 HL007501 (VGN). The sponsor had no role in the design, data analysis, interpretation, or writing of the report. The manuscript was reviewed and cleared for publication by the Division of Intramural Research, National Institutes of Health prior to submission.	Alexander N, 2004, BRIT J HAEMATOL, V126, P606, DOI 10.1111/j.1365-2141.2004.05025.x; Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; Ballas SK, 1999, BRIT J HAEMATOL, V105, P491, DOI 10.1111/j.1365-2141.1999.01339.x; BALLAS SK, 1991, AM J HEMATOL, V36, P122, DOI 10.1002/ajh.2830360211; BAUM KF, 1987, ARCH INTERN MED, V147, P1231, DOI 10.1001/archinte.147.7.1231; CASTRO O, 1994, BLOOD, V84, P643, DOI 10.1182/blood.V84.2.643.643; CHRISTAKIS J, 1990, LANCET, V335, P637, DOI 10.1016/0140-6736(90)90419-6; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; DOVER GJ, 1992, BLOOD, V80, P816; EMBURY SH, 1982, NEW ENGL J MED, V306, P270, DOI 10.1056/NEJM198202043060504; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; French JA, 1997, BLOOD, V89, P4591, DOI 10.1182/blood.V89.12.4591; Garner C, 2004, BLOOD, V104, P2184, DOI 10.1182/blood-2004-02-0527; Garner C, 1998, AM J HUM GENET, V62, P1468, DOI 10.1086/301859; GASTON M, 1987, CONTROL CLIN TRIALS, V8, pS131; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Hassan M, 2003, J NATL MED ASSOC, V95, P939; HIGGS DR, 1982, NEW ENGL J MED, V306, P1441, DOI 10.1056/NEJM198206173062402; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kato GJ, 2006, AM J HEMATOL, V81, P503, DOI 10.1002/ajh.20642; KOSHY M, 1989, BLOOD, V74, P1403; LANDE WM, 1988, BLOOD, V72, P2056; Lezcano NE, 2006, STROKE, V37, P1424, DOI 10.1161/01.STR.0000221173.97108.01; Machado RF, 2006, JAMA-J AM MED ASSOC, V296, P310, DOI 10.1001/jama.296.3.310; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; MILNER PF, 1993, CLIN ORTHOP RELAT R, P136; MILNER PF, 1991, NEW ENGL J MED, V325, P1476, DOI 10.1056/NEJM199111213252104; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; Nolan VG, 2006, BRIT J HAEMATOL, V133, P570, DOI 10.1111/j.1365-2141.2006.06074.x; Nolan VG, 2005, BLOOD, V106, P3264, DOI 10.1182/blood-2005-04-1594; O'Driscoll S, 2008, BRIT J HAEMATOL, V140, P206, DOI 10.1111/j.1365-2141.2007.06894.x; Ohene-Frempong K, 1998, BLOOD, V91, P288; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; POILLON WN, 1993, P NATL ACAD SCI USA, V90, P5039, DOI 10.1073/pnas.90.11.5039; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Sebastiani P, 2007, BLOOD, V110, P2727, DOI 10.1182/blood-2007-04-084921; Steinberg MH, 2008, AM J HEMATOL, V83, P1, DOI 10.1002/ajh.21033; STEINBERG MH, 1984, BLOOD, V63, P1353; Taylor JG, 2008, AM J HEMATOL, V83, P6, DOI 10.1002/ajh.21035	44	134	136	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2095	10.1371/journal.pone.0002095	http://dx.doi.org/10.1371/journal.pone.0002095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461136	Green Published, Green Submitted, gold			2022-12-27	WOS:000261642400017
J	Zavala, JA; Giri, AP; Jongsma, MA; Baldwin, IT				Zavala, Jorge A.; Giri, Ashok P.; Jongsma, Maarten A.; Baldwin, Ian T.			Digestive Duet: Midgut Digestive Proteinases of Manduca sexta Ingesting Nicotiana attenuata with Manipulated Trypsin Proteinase Inhibitor Expression	PLOS ONE			English	Article							ARMIGERA GUT PROTEINASES; HELICOVERPA-ARMIGERA; PROTEASE INHIBITORS; TRANSGENIC TOBACCO; PLANT DEFENSE; ADAPTATION; QUALITY; RESISTANCE; INSECTS; LEPIDOPTERA	Background: The defensive effect of endogenous trypsin proteinase inhibitors (NaTPIs) on the herbivore Manduca sexta was demonstrated by genetically altering NaTPI production in M. sexta's host plant, Nicotiana attenuata. To understand how this defense works, we studied the effects of NaTPI on M. sexta gut proteinase activity levels in different larval instars of caterpillars feeding freely on untransformed and transformed plants. Methodology/Principal Findings: Second and third instars larvae that fed on NaTPI-producing (WT) genotypes were lighter and had less gut proteinase activity compared to those that fed on genotypes with either little or no NaTPI activity. Unexpectedly, NaTPI activity in vitro assays not only inhibited the trypsin sensitive fraction of gut proteinase activity but also halved the NaTPI-insensitive fraction in third-instar larvae. Unable to degrade NaTPI, larvae apparently lacked the means to adapt to NaTPI in their diet. However, caterpillars recovered at least part of their gut proteinase activity when they were transferred from NaTPI-producing host plants to NaTPI-free host plants. In addition extracts of basal leaves inhibited more gut proteinase activity than did extracts of middle stem leaves with the same protein content. Conclusions/Significance: Although larvae can minimize the effects of high NaTPI levels by feeding on leaves with high protein and low NaTPI activity, the host plant's endogenous NaTPIs remain an effective defense against M. sexta, inhibiting gut proteinase and affecting larval performance.	[Zavala, Jorge A.; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany; [Giri, Ashok P.] Natl Chem Lab, Div Biochem Sci, Plant Mol Biol Unit, Pune, Maharashtra, India; [Jongsma, Maarten A.] Wageningen Univ, Res Ctr WageningenUR, Plant Res Int BV, Wageningen, Netherlands	Max Planck Society; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Plant Research International; Wageningen University & Research	Zavala, JA (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Jena, Germany.	Baldwin@ice.mpg.de	Baldwin, Ian T/K-1809-2013; Giri, Ashok/E-5196-2012; Jongsma, Maarten A/A-2118-2010	Jongsma, Maarten A/0000-0001-5799-2301; Zavala, Jorge/0000-0001-6265-0920; Baldwin, Ian/0000-0001-5371-2974	Max Planck Gesellschaft	Max Planck Gesellschaft(Max Planck Society)	Funded by the Max Planck Gesellschaft.	Ahn JE, 2007, INSECT MOL BIOL, V16, P295, DOI 10.1111/j.1365-2583.2007.00726.x; Awmack CS, 2002, ANNU REV ENTOMOL, V47, P817, DOI 10.1146/annurev.ento.47.091201.145300; Baldwin IT, 2001, PLANT PHYSIOL, V127, P1449, DOI 10.1104/pp.010762; BALDWIN IT, 1994, J CHEM ECOL, V20, P2345, DOI 10.1007/BF02033207; Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; BAUMHOVER AH, 1985, HDB INSECT REARING, V2, P387; Bayes A, 2005, P NATL ACAD SCI USA, V102, P16602, DOI 10.1073/pnas.0505489102; BERNAYS EA, 1984, J INSECT PHYSIOL, V30, P489, DOI 10.1016/0022-1910(84)90029-5; BIRK Y, 2003, WOUND INDUCED PROTEI; Bown DP, 2004, PHYSIOL ENTOMOL, V29, P278, DOI 10.1111/j.0307-6962.2004.00402.x; Brioschi D, 2007, INSECT BIOCHEM MOLEC, V37, P1283, DOI 10.1016/j.ibmb.2007.07.016; BROADWAY RM, 1988, J INSECT PHYSIOL, V34, P1111, DOI 10.1016/0022-1910(88)90213-2; BROADWAY RM, 1995, J INSECT PHYSIOL, V41, P107, DOI 10.1016/0022-1910(94)00101-L; BROADWAY RM, 1986, J INSECT PHYSIOL, V32, P827, DOI 10.1016/0022-1910(86)90097-1; Bubner B, 2006, PLANT CELL REP, V25, P668, DOI 10.1007/s00299-005-0111-4; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; Chougule NP, 2005, INSECT BIOCHEM MOLEC, V35, P355, DOI 10.1016/j.ibmb.2005.01.006; Christeller JT, 2005, FEBS J, V272, P5710, DOI 10.1111/j.1742-4658.2005.04975.x; Cloutier C, 2000, ARCH INSECT BIOCHEM, V44, P69, DOI 10.1002/1520-6327(200006)44:2&lt;69::AID-ARCH2&gt;3.0.CO;2-6; Damle MS, 2005, PHYTOCHEMISTRY, V66, P2659, DOI 10.1016/j.phytochem.2005.09.006; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Denno R.F., 1983, VARIABLE PLANTS HERB; Duffey SS, 1996, ARCH INSECT BIOCHEM, V32, P3, DOI 10.1002/(SICI)1520-6327(1996)32:1&lt;3::AID-ARCH2&gt;3.0.CO;2-1; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; Gatehouse LN, 1997, INSECT BIOCHEM MOLEC, V27, P929, DOI 10.1016/S0965-1748(97)00074-X; Giri AP, 1998, PLANT PHYSIOL, V116, P393, DOI 10.1104/pp.116.1.393; Giri AP, 2003, PHYTOCHEMISTRY, V63, P523, DOI 10.1016/S0031-9422(03)00181-X; Glawe GA, 2003, ECOLOGY, V84, P79, DOI 10.1890/0012-9658(2003)084[0079:ECABCW]2.0.CO;2; Gruden K, 1998, INSECT BIOCHEM MOLEC, V28, P549, DOI 10.1016/S0965-1748(98)00051-4; Gruden K, 2004, INSECT BIOCHEM MOLEC, V34, P365, DOI 10.1016/j.ibmb.2004.01.003; Harsulkar AM, 1999, PLANT PHYSIOL, V121, P497, DOI 10.1104/pp.121.2.497; HILDER VA, 1987, NATURE, V330, P160, DOI 10.1038/330160a0; Horn M, 2005, PLANT PHYSIOL, V139, P375, DOI 10.1104/pp.105.064006; JOHNSON R, 1989, P NATL ACAD SCI USA, V86, P9871, DOI 10.1073/pnas.86.24.9871; Jongsma MA, 1997, J INSECT PHYSIOL, V43, P885, DOI 10.1016/S0022-1910(97)00040-1; JONGSMA MA, 1995, P NATL ACAD SCI USA, V92, P8041, DOI 10.1073/pnas.92.17.8041; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; KAROWE DN, 1989, J INSECT PHYSIOL, V35, P699, DOI 10.1016/0022-1910(89)90089-9; Kessler A, 2002, ECOLOGY, V83, P2346, DOI 10.1890/0012-9658(2002)083[2346:MQSOOI]2.0.CO;2; LAING W, 2002, PROTEIN PROTEIN INTE, P77; Larcher W, 2003, PHYSL PLANT ECOLOGY; Lopes AR, 2004, ARCH INSECT BIOCHEM, V55, P140, DOI 10.1002/arch.10134; Marchetti S, 1998, INSECT BIOCHEM MOLEC, V28, P449, DOI 10.1016/S0965-1748(98)00010-1; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; McManus MT, 1999, TRANSGENIC RES, V8, P383, DOI 10.1023/A:1008957610872; PETERSON AM, 1995, INSECT BIOCHEM MOLEC, V25, P765, DOI 10.1016/0965-1748(94)00092-V; PETERSON AM, 1994, INSECT BIOCHEM MOLEC, V24, P463, DOI 10.1016/0965-1748(94)90041-8; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; RYAN CA, 1972, SCIENCE, V175, P776; Schoonhoven L. M., 2005, Insect-plant biology; SCRIBER JM, 1981, ANNU REV ENTOMOL, V26, P183, DOI 10.1146/annurev.en.26.010181.001151; Simpson S.J., 1990, P111; Slansky F. Jr, 1985, P87; Strauss Sharon Y., 2002, P77; Tatar M, 2000, TRENDS ECOL EVOL, V15, P207, DOI 10.1016/S0169-5347(00)01834-6; Van Dam NM, 2001, J CHEM ECOL, V27, P547, DOI 10.1023/A:1010341022761; Volpicella M, 2003, EUR J BIOCHEM, V270, P10, DOI 10.1046/j.1432-1033.2003.03368.x; Winterer J., 2002, AgBiotechNet, V4, P1; Winterer J, 2001, MOL ECOL, V10, P1069, DOI 10.1046/j.1365-294X.2001.01239.x; Woods HA, 2004, FUNCT ECOL, V18, P103, DOI 10.1111/j.1365-2435.2004.00823.x; Wu YR, 1997, MOL BREEDING, V3, P371, DOI 10.1023/A:1009681323131; Zalucki MP, 2002, ANNU REV ENTOMOL, V47, P361, DOI 10.1146/annurev.ento.47.091201.145220; Zavala JA, 2004, PLANT PHYSIOL, V134, P1181, DOI 10.1104/pp.103.035634; Zavala JA, 2004, P NATL ACAD SCI USA, V101, P1607, DOI 10.1073/pnas.0305096101; Zavala JA, 2006, PLANT CELL ENVIRON, V29, P1751, DOI 10.1111/j.1365-3040.2006.01551.x; Zavala Jorge A., 2004, BMC Ecology, V4, P11, DOI 10.1186/1472-6785-4-11	66	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2008	10.1371/journal.pone.0002008	http://dx.doi.org/10.1371/journal.pone.0002008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431489	Green Submitted, gold, Green Published			2022-12-27	WOS:000261558700024
J	Firestein, R; Blander, G; Michan, S; Oberdoerffer, P; Ogino, S; Campbell, J; Bhimavarapu, A; Luikenhuis, S; de Cabo, R; Fuchs, C; Hahn, WC; Guarente, LP; Sinclair, DA				Firestein, Ron; Blander, Gil; Michan, Shaday; Oberdoerffer, Philipp; Ogino, Shuji; Campbell, Jennifer; Bhimavarapu, Anupama; Luikenhuis, Sandra; de Cabo, Rafael; Fuchs, Charles; Hahn, William C.; Guarente, Leonard P.; Sinclair, David A.			The SIRT1 Deacetylase Suppresses Intestinal Tumorigenesis and Colon Cancer Growth	PLOS ONE			English	Article								Numerous longevity genes have been discovered in model organisms and altering their function results in prolonged lifespan. In mammals, some have speculated that any health benefits derived from manipulating these same pathways might be offset by increased cancer risk on account of their propensity to boost cell survival. The Sir2/SIRT1 family of NAD(+)-dependent deacetylases is proposed to underlie the health benefits of calorie restriction (CR), a diet that broadly suppresses cancer in mammals. Here we show that CR induces a two-fold increase SIRT1 expression in the intestine of rodents and that ectopic induction of SIRT1 in a beta-catenin-driven mouse model of colon cancer significantly reduces tumor formation, proliferation, and animal morbidity in the absence of CR. We show that SIRT1 deacetylates beta-catenin and suppresses its ability to activate transcription and drive cell proliferation. Moreover, SIRT1 promotes cytoplasmic localization of the otherwise nuclear-localized oncogenic form of beta-catenin. Consistent with this, a significant inverse correlation was found between the presence of nuclear SIRT1 and the oncogenic form of beta-catenin in 81 human colon tumor specimens analyzed. Taken together, these observations show that SIRT1 suppresses intestinal tumor formation in vivo and raise the prospect that therapies targeting SIRT1 may be of clinical use in beta-catenin-driven malignancies.	[Firestein, Ron; Michan, Shaday; Oberdoerffer, Philipp; Campbell, Jennifer; Luikenhuis, Sandra; Sinclair, David A.] Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA; [Blander, Gil; Bhimavarapu, Anupama; Guarente, Leonard P.] Massachusetts Inst Technol, Dept Biol, Cambridge, MA USA; [Firestein, Ron; Ogino, Shuji] Brigham & Womens Hospital, Harvard Med Sch, Dept Pathol, Boston, MA USA; [Firestein, Ron; Ogino, Shuji] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; [de Cabo, Rafael] NIH, NIA, Lab Expt Gerontol, Bethesda, MD USA; [Firestein, Ron; Fuchs, Charles; Hahn, William C.] Massachusetts Inst Technol, Broad Inst Harvard, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Broad Institute	Sinclair, DA (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs Biol Mech Aging, Boston, MA 02115 USA.	david_sinclair@hms.harvard.edu	de Cabo, Rafael/E-7996-2010; de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	de Cabo, Rafael/0000-0003-2830-5693; de Cabo, Rafael Carlos/0000-0003-2830-5693; de Cabo, Rafael/0000-0002-3354-2442; Ogino, Shuji/0000-0002-3909-2323; Sinclair, David/0000-0002-9936-436X	NIH [T32]; Estee Lauder [postdoctoral fellowship]; National Space Biomedical Research Institute; Intramural Research Program of the NIH/NIA; Paul F. Glenn Foundation; NATIONAL INSTITUTE ON AGING [R01AG028730, R01AG019719, Z01AG000363] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Estee Lauder; National Space Biomedical Research Institute; Intramural Research Program of the NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Paul F. Glenn Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	RF was supported by the NIH T32 Grant. GB by an Estee Lauder postdoctoral fellowship. PO by a National Space Biomedical Research Institute Grant. DAS, SO, CSF and LG by grants from NIH; RD in part by the Intramural Research Program of the NIH/NIA. DS is also supported by a gift from the Paul F. Glenn Foundation.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dai JM, 2007, J CELL PHYSIOL, V210, P161, DOI 10.1002/jcp.20831; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; LIM CS, 2006, MED HYPOTHESES; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mai V, 2003, CANCER RES, V63, P1752; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Narala SR, 2008, MOL BIOL CELL; Ogino S, 2006, NEOPLASIA, V8, P458, DOI 10.1593/neo.06247; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Simcha I, 1998, J CELL BIOL, V141, P1433, DOI 10.1083/jcb.141.6.1433; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854; Xu WQ, 2007, J CELL SCI, V120, P3337, DOI 10.1242/jcs.013771; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	33	471	494	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e2020	10.1371/journal.pone.0002020	http://dx.doi.org/10.1371/journal.pone.0002020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414679	gold, Green Published, Green Submitted			2022-12-27	WOS:000260867300029
J	Owen, LA; Kowalewski, AA; Lessnick, SL				Owen, Leah A.; Kowalewski, Ashley A.; Lessnick, Stephen L.			EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma	PLOS ONE			English	Article							HISTONE DEACETYLASE; CHROMOSOME-TRANSLOCATION; GENE; FUSION; PROTEIN; DOMAIN; EXPRESSION; GROUCHO; BINDING; FAMILY	EWS/FLI is a master regulator of Ewing's sarcoma formation. Gene expression studies in A673 Ewing's sarcoma cells have demonstrated that EWS/FLI downregulates more genes than it upregulates, suggesting that EWS/FLI, and/or its targets, function as transcriptional repressors. One critical EWS/FLI target, NKX2.2, is a transcription factor that contains both transcriptional activation and transcriptional repression domains, raising the possibility that it mediates portions of the EWS/FLI transcriptional signature. We now report that microarray analysis demonstrated that the transcriptional profile of NKX2.2 consists solely of downregulated genes, and overlaps with the EWS/FLI downregulated signature, suggesting that NKX2.2 mediates oncogenic transformation via transcriptional repression. Structure-function analysis revealed that the DNA binding and repressor domains in NKX2.2 are required for oncogenesis in Ewing's sarcoma cells, while the transcriptional activation domain is completely dispensable. Furthermore, blockade of TLE or HDAC function, two protein families thought to mediate the repressive function of NKX2.2, inhibited the transformed phenotype and reversed the NKX2.2 transcriptional profile in Ewing's sarcoma cells. Whole genome localization studies (ChIP-chip) revealed that a significant portion of the NKX2.2-repressed gene expression signature was directly mediated by NKX2.2 binding. These data demonstrate that the transcriptional repressive function of NKX2.2 is necessary, and sufficient, for the oncogenic phenotype of Ewing's sarcoma, and suggest a therapeutic approach to this disease.	[Owen, Leah A.; Kowalewski, Ashley A.; Lessnick, Stephen L.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Owen, Leah A.; Lessnick, Stephen L.] Univ Utah, Sch Med, Salt Lake City, UT USA; [Lessnick, Stephen L.] Univ Utah, Huntsman Canc Inst, Ctr Children, Salt Lake City, UT USA; [Lessnick, Stephen L.] Univ Utah, Div Pediat Hematol Oncol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Lessnick, SL (corresponding author), Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	stephen.lessnick@hci.utah.edu		Owen, Leah/0000-0003-3802-3868	Terri Anna Perine Sarcoma Fund; American Cancer Society [MGO-111812]; Huntsman Cancer Institute Director's Translational Research Initiative; NIH [P30 CA42014];  [T32 HD007491]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007491] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER	Terri Anna Perine Sarcoma Fund; American Cancer Society(American Cancer Society); Huntsman Cancer Institute Director's Translational Research Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	L.A.O. is supported by T32 HD007491. S.L.L. is supported by the Terri Anna Perine Sarcoma Fund, American Cancer Society Research Scholar Grant MGO-111812, and a Huntsman Cancer Institute Director's Translational Research Initiative Grant. We also acknowledge NIH support to Huntsman Cancer Institute via P30 CA42014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Doyle MJ, 2007, DEVELOPMENT, V134, P515, DOI 10.1242/dev.02763; Fujimura Y, 1996, ONCOGENE, V12, P159; Grier HE, 1997, PEDIATR CLIN N AM, V44, P991, DOI 10.1016/S0031-3955(05)70541-1; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Guidez F, 1998, BLOOD, V91, P2634, DOI 10.1182/blood.V91.8.2634.2634_2634_2642; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hu-Lieskovan S, 2005, CANCER RES, V65, P8984, DOI 10.1158/0008-5472.CAN-05-0565; Jaboin J, 2002, CANCER RES, V62, P6108; Kinsey M, 2006, MOL CANCER RES, V4, P851, DOI 10.1158/1541-7786.MCR-06-0090; Lambert G, 2000, BIOCHEM BIOPH RES CO, V279, P401, DOI 10.1006/bbrc.2000.3963; Lessnick SL, 2002, CANCER CELL, V1, P393, DOI 10.1016/S1535-6108(02)00056-9; LESSNICK SL, 1995, ONCOGENE, V10, P423; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; McAllister Nancy R, 2005, Curr Treat Options Oncol, V6, P461, DOI 10.1007/s11864-005-0025-y; Minucci S, 1999, SEMIN CELL DEV BIOL, V10, P215, DOI 10.1006/scdb.1999.0303; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Owen LA, 2006, CELL CYCLE, V5, P2049, DOI 10.4161/cc.5.18.3213; PRASAD DDK, 1994, ONCOGENE, V9, P3717; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Rodriguez-Galindo C, 2003, MED PEDIATR ONCOL, V40, P276, DOI 10.1002/mpo.10240; Sakimura R, 2005, INT J CANCER, V116, P784, DOI 10.1002/ijc.21069; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Smith SB, 1999, MOL CELL BIOL, V19, P8272; SONNEMANN J, 2007, J CANC RES CLIN ONCO; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; SUBLETT JE, 1995, ONCOGENE, V11, P545; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sussel L, 1998, DEVELOPMENT, V125, P2213; Tetsuka T, 2000, J BIOL CHEM, V275, P4383, DOI 10.1074/jbc.275.6.4383; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; Watada H, 2000, P NATL ACAD SCI USA, V97, P9443, DOI 10.1073/pnas.97.17.9443; Wei Q, 2005, J BIOL CHEM, V280, P16284, DOI 10.1074/jbc.M500491200	36	95	100	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1965	10.1371/journal.pone.0001965	http://dx.doi.org/10.1371/journal.pone.0001965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414662	gold, Green Published, Green Submitted			2022-12-27	WOS:000260867300011
J	van Loggerenberg, F; Mlisana, K; Williamson, C; Auld, SC; Morris, L; Gray, CM; Karim, QA; Grobler, A; Barnabas, N; Iriogbe, I; Karim, SSA				van Loggerenberg, Francois; Mlisana, Koleka; Williamson, Carolyn; Auld, Sara C.; Morris, Lynn; Gray, Clive M.; Karim, Quarraisha Abdool; Grobler, Anneke; Barnabas, Nomampondo; Iriogbe, Itua; Karim, Salim S. Abdool		CAPRISA 002 Acute Infection Study Team	Establishing a Cohort at High Risk of HIV Infection in South Africa: Challenges and Experiences of the CAPRISA 002 Acute Infection Study	PLOS ONE			English	Article								Objectives: To describe the baseline demographic data, clinical characteristics and HIV-incidence rates of a cohort at high risk for HIV infection in South Africa as well as the challenges experienced in establishing and maintaining the cohort. Methodology/Principle Findings: Between August 2004 and May 2005 a cohort of HIV-uninfected women was established for the CAPRISA 002 Acute Infection Study, a natural history study of HIV-1 subtype C infection. Volunteers were identified through peer-outreach. The cohort was followed monthly to determine HIV infection rates and clinical presentation of early HIV infection. Risk reduction counselling and male and female condoms were provided. After screening 775 individuals, a cohort of 245 uninfected high-risk women was established. HIV-prevalence at screening was 59.6% (95% CI: 55.9% to 62.8%) posing a challenge in accruing HIV-uninfected women. The majority of women (78.8%) were self-identified as sex-workers with a median of 2 clients per day. Most women (95%) reported more than one casual sexual partner in the previous 3 months (excluding clients) and 58.8% reported condom use in their last sexual encounter. Based on laboratory testing, 62.0% had a sexually transmitted infection at baseline. During 390 person-years of follow-up, 28 infections occurred yielding seroincidence rate of 7.2 (95% CI: 4.5 to 9.8) per 100 person-years. Despite the high mobility of this sex worker cohort retention rate after 2 years was 86.1%. High co-morbidity created challenges for ancillary care provision, both in terms of human and financial resources. Conclusions/Significance: Challenges experienced were high baseline HIV-prevalence, lower than anticipated HIV-incidence and difficulties retaining participants. Despite challenges, we have successfully accrued this cohort of HIV-uninfected women with favourable retention, enabling us to study the natural history of HIV-1 during acute HIV-infection. Our experiences provide lessons for others establishing similar cohorts, which will be key for advancing the vaccine and prevention research agenda in resource-constrained settings.	[van Loggerenberg, Francois; Mlisana, Koleka; Williamson, Carolyn; Auld, Sara C.; Morris, Lynn; Gray, Clive M.; Karim, Quarraisha Abdool; Grobler, Anneke; Barnabas, Nomampondo; Iriogbe, Itua; Karim, Salim S. Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, Durban, South Africa; [Williamson, Carolyn] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Auld, Sara C.; Karim, Quarraisha Abdool; Karim, Salim S. Abdool] Columbia Univ, New York, NY USA; [Morris, Lynn; Gray, Clive M.] Natl Inst Communicable Dis, Johannesburg, South Africa	University of Kwazulu Natal; University of Cape Town; Columbia University; National Institute for Communicable Diseases (NICD)	van Loggerenberg, F (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, Durban, South Africa.	loggerenbergf@ukzn.ac.za	Abdool Karim, Quarraisha/GVS-1160-2022; Morris, Lynn/V-3941-2018; Karim, Salim Safurdeen Abdool/N-5947-2013; Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Abdool/P-3117-2019; Mlisana, Koleka/N-6204-2013	Abdool Karim, Quarraisha/0000-0002-0985-477X; Morris, Lynn/0000-0003-3961-7828; Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Karim, Salim Abdool/0000-0002-4986-2133; Grobler, Anneke/0000-0002-7809-7688; Gray, Clive/0000-0002-9293-901X; van Loggerenberg, Francois/0000-0001-5317-7983; , Carolyn/0000-0003-0125-1226; Mlisana, Koleka/0000-0002-8436-3268	National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH) [U19 AI51794]; US Department of Health and Human Services (DHHS) [U19 AI51794]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Department of Health and Human Services (DHHS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CAPRISA received support for the CAPRISA 002 Acute Infection Study from the Comprehensive International Program of Research on AIDS (CIPRA) funded by the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH) and the US Department of Health and Human Services (DHHS) (Grant#1 U19 AI51794). The funders supported the initial development of the protocol but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOOLKARIM Q, 1995, AM J PUBLIC HEALTH, V85, P1521; Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Begaud E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-35; Bollinger RC, 1997, JAMA-J AM MED ASSOC, V278, P2085, DOI 10.1001/jama.278.23.2085; Costello C, 2005, INT J EPIDEMIOL, V34, P577, DOI 10.1093/ije/dyi023; Deschamps MM, 2000, AIDS, V14, P2515, DOI 10.1097/00002030-200011100-00014; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Fowke KR, 1998, AIDS RES HUM RETROV, V14, P1521, DOI 10.1089/aid.1998.14.1521; GOUWS E, 2005, HIV AIDS S AFRICA, P67; Hecht FM, 2002, AIDS, V16, P1119, DOI 10.1097/00002030-200205240-00005; Karim SSA, 2007, AIDS, V21, P653, DOI 10.1097/QAD.0b013e3280327923; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Lavreys L, 2000, CLIN INFECT DIS, V30, P486, DOI 10.1086/313718; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Martin G, 2004, CLIN IMMUNOL, V111, P275, DOI 10.1016/j.clim.2004.02.004; Mlisana K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001626; Paxton WA, 1996, NAT MED, V2, P412, DOI 10.1038/nm0496-412; Ramjee G, 1998, SEX TRANSM DIS, V25, P346, DOI 10.1097/00007435-199808000-00004; Ramjee G, 2000, AIDS, V14, P2553, DOI 10.1097/00002030-200011100-00018; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; Saah AJ, 1998, AIDS, V12, P2107, DOI 10.1097/00002030-199816000-00005; SHISANA O, 2005, S AFRICAN NATL HIV P, P33; Steyn K, 2001, J HYPERTENS, V19, P1717, DOI 10.1097/00004872-200110000-00004; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Truong LX, 2003, AIDS, V17, P1425, DOI 10.1097/00002030-200307040-00002; Vanhems P, 2003, JAIDS-J ACQ IMM DEF, V32, P542, DOI 10.1097/00126334-200304150-00012; West GR, 2007, AIDS EDUC PREV, V19, P275, DOI 10.1521/aeap.2007.19.4.275	27	146	148	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1954	10.1371/journal.pone.0001954	http://dx.doi.org/10.1371/journal.pone.0001954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414658	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000260867300007
J	Boultwood, J; Pellagatti, A; Nikpour, M; Pushkaran, B; Fidler, C; Cattan, H; Littlewood, TJ; Malcovati, L; Della Porta, MG; Jadersten, M; Killick, S; Giagounidis, A; Bowen, D; Hellstrom-Lindberg, E; Cazzola, M; Wainscoat, JS				Boultwood, Jacqueline; Pellagatti, Andrea; Nikpour, Maryam; Pushkaran, Beena; Fidler, Carrie; Cattan, Helen; Littlewood, Tim J.; Malcovati, Luca; Della Porta, Matteo G.; Jadersten, Martin; Killick, Sally; Giagounidis, Aristoteles; Bowen, David; Hellstrom-Lindberg, Eva; Cazzola, Mario; Wainscoat, James S.			The Role of the Iron Transporter ABCB7 in Refractory Anemia with Ring Sideroblasts	PLOS ONE			English	Article							GENE-EXPRESSION; MUTATION; ATAXIA; CELLS; IDENTIFICATION; CANDIDATE; COMPLEX; IMPACT	Refractory Anemia with Ring Sideroblasts (RARS) is an acquired myelodysplastic syndrome (MDS) characterized by an excess iron accumulation in the mitochondria of erythroblasts. The pathogenesis of RARS and the cause of this unusual pattern of iron deposition remain unknown. We considered that the inherited X-linked sideroblastic anemia with ataxia (XLSA/A) might be informative for the acquired disorder, RARS. XLSA/A is caused by partial inactivating mutations of the ABCB7 ATP-binding cassette transporter gene, which functions to enable transport of iron from the mitochondria to the cytoplasm. Furthermore, ABCB7 gene silencing in HeLa cells causes an accumulation of iron in the mitochondria. We have studied the role of ABCB7 in RARS by DNA sequencing, methylation studies, and gene expression studies in primary CD34(+) cells and in cultured erythroblasts. The DNA sequence of the ABCB7 gene is normal in patients with RARS. We have investigated ABCB7 gene expression levels in the CD34(+) cells of 122 MDS cases, comprising 35 patients with refractory anemia (RA), 33 patients with RARS and 54 patients with RA with excess blasts (RAEB), and in the CD34(+) cells of 16 healthy controls. We found that the expression levels of ABCB7 are significantly lower in the RARS group. RARS is thus characterized by lower levels of ABCB7 gene expression in comparison to other MDS subtypes. Moreover, we find a strong relationship between increasing percentage of bone marrow ring sideroblasts and decreasing ABCB7 gene expression levels. Erythroblast cell cultures confirm the low levels of ABCB7 gene expression levels in RARS. These data provide an important link between inherited and acquired forms of sideroblastic anemia and indicate that ABCB7 is a strong candidate gene for RARS.	[Boultwood, Jacqueline; Pellagatti, Andrea; Pushkaran, Beena; Fidler, Carrie; Cattan, Helen; Littlewood, Tim J.; Wainscoat, James S.] John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, LRF Mol Haematol Unit, Oxford OX3 9DU, England; [Nikpour, Maryam; Jadersten, Martin; Hellstrom-Lindberg, Eva] Karolinska Inst, Dept Med, Div Hematol, Stockholm, Sweden; [Malcovati, Luca; Della Porta, Matteo G.; Cazzola, Mario] Univ Pavia, Med Sch, IRCCS Policlinico S Matteo, Pavia, Italy; [Killick, Sally] Royal Bournemouth Hosp, Dept Haematol, Bournemouth, Dorset, England; [Giagounidis, Aristoteles] St Johannes Hosp, Medizinische Klin 2, Duisburg, Germany; [Bowen, David] Leeds Teaching Hosp, Haematol Dept, Leeds, W Yorkshire, England	University of Oxford; Karolinska Institutet; IRCCS Fondazione San Matteo; University of Pavia; St. Johannes Hospital; University of Leeds	Boultwood, J (corresponding author), John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, LRF Mol Haematol Unit, Oxford OX3 9DU, England.	jacqueline.boultwood@ndcls.ox.ac.uk	Cazzola, Mario/AAQ-8854-2021; Malcovati, Luca/CAJ-1695-2022; Giagounidis, Aristoteles/S-7097-2019; Giagounidis, Aristoteles/ABE-3927-2020	Cazzola, Mario/0000-0001-6984-8817; Malcovati, Luca/0000-0002-1460-1611; Giagounidis, Aristoteles/0000-0003-4083-4109; Pellagatti, Andrea/0000-0002-6122-0221; Boultwood, Jacqueline/0000-0002-4330-2928; Della Porta, Matteo Giovanni/0000-0002-6915-5970	Leukaemia Research Fund of the UK; AIRC (Associazione Italiana per la Ricerca sul Cancro), Milan; Fondazione IRCCS Policlinico San Matteo, Pavia	Leukaemia Research Fund of the UK; AIRC (Associazione Italiana per la Ricerca sul Cancro), Milan(Fondazione AIRC per la ricerca sul cancro); Fondazione IRCCS Policlinico San Matteo, Pavia	This work was supported by the Leukaemia Research Fund of the UK, and in part by grants from AIRC (Associazione Italiana per la Ricerca sul Cancro), Milan, and Fondazione IRCCS Policlinico San Matteo, Pavia, to M.C.	Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Bekri S, 2000, BLOOD, V96, P3256; BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; Breccia M, 2006, LEUKEMIA RES, V30, P178, DOI 10.1016/j.leukres.2005.06.015; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; Cazzola M, 2003, BLOOD, V101, P1996, DOI 10.1182/blood-2002-07-2006; COTTER PD, 1994, BLOOD, V84, P3915, DOI 10.1182/blood.V84.11.3915.bloodjournal84113915; Furuyama K, 2002, CELL MOL BIOL, V48, P5; Gibbons RJ, 2003, NAT GENET, V34, P446, DOI 10.1038/ng1213; Greenberg Peter L, 2002, Hematology Am Soc Hematol Educ Program, P136; Heaney ML, 1999, NEW ENGL J MED, V340, P1649, DOI 10.1056/NEJM199905273402107; HINES J D, 1970, Seminars in Hematology, V7, P86; Kim JH, 2002, P NATL ACAD SCI USA, V99, P1241, DOI 10.1073/pnas.251672198; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Oscarson M, 2006, CLIN PHARMACOL THER, V80, P440, DOI 10.1016/j.clpt.2006.08.013; Pellagatti A, 2007, P NATL ACAD SCI USA, V104, P11406, DOI 10.1073/pnas.0610477104; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Pondarre C, 2007, BLOOD, V109, P3567, DOI 10.1182/blood-2006-04-015768; Shimada Y, 1998, J HUM GENET, V43, P115, DOI 10.1007/s100380050051; Steensma DP, 2007, LEUKEMIA RES, V31, P623, DOI 10.1016/j.leukres.2006.06.005; Tehranchi R, 2003, BLOOD, V101, P1080, DOI 10.1182/blood-2002-06-1774; Warner MH, 2007, MOL CELL BIOL, V27, P6103, DOI 10.1128/MCB.00772-07; WEATHERALL DJ, 1970, LANCET, V2, P744; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	26	92	100	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1970	10.1371/journal.pone.0001970	http://dx.doi.org/10.1371/journal.pone.0001970			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398482	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795500035
J	Siegel, M; Strnad, P; Watts, RE; Choi, KH; Jabri, B; Omary, MB; Khosla, C				Siegel, Matthew; Strnad, Pavel; Watts, R. Edward; Choi, Kihang; Jabri, Bana; Omary, M. Bishr; Khosla, Chaitan			Extracellular Transglutaminase 2 Is Catalytically Inactive, but Is Transiently Activated upon Tissue Injury	PLOS ONE			English	Article								Transglutaminase 2 (TG2) is a multifunctional mammalian protein with transamidase and signaling properties. Using selective TG2 inhibitors and tagged nucleophilic amine substrates, we show that the majority of extracellular TG2 is inactive under normal physiological conditions in cell culture and in vivo. However, abundant TG2 activity was detected around the wound in a standard cultured fibroblast scratch assay. To demonstrate wounding-induced activation of TG2 in vivo, the toll-like receptor 3 ligand, polyinosinic-polycytidylic acid (poly(I:C)), was injected in mice to trigger small intestinal injury. Although no TG2 activity was detected in vehicle-treated mice, acute poly(I:C) injury resulted in rapid TG2 activation in the small intestinal mucosa. Our findings provide a new basis for understanding the role of TG2 in physiology and disease.	[Siegel, Matthew; Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Strnad, Pavel; Omary, M. Bishr] VA Palo Alto Hlth Care Syst, Dept Med, Palo Alto, CA USA; [Watts, R. Edward; Choi, Kihang; Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA USA; [Jabri, Bana] Univ Chicago, Dept Pathol, Med & Pediat, Chicago, IL USA; [Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; University of Chicago; Stanford University	Siegel, M (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	khosla@stanford.edu	Strnad, Pavel/E-8555-2010	Khosla, Chaitan/0000-0001-6529-495X; Omary, Bishr/0000-0002-8624-2347; Choi, Kihang/0000-0001-5196-4107	NIH [DK063158, DK052951, DK067180]; Department of Veterans Affairs; Stanford-NIH Digestive Disease Center [DK056339]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067180, R01DK063158, P30DK056339, R56DK052951, R01DK052951] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Stanford-NIH Digestive Disease Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was jointly supported by NIH grant DK063158 (C.K.), NIH grant DK052951 and the Department of Veterans Affairs (M.B.O.), NIH grant DK067180 (B.J.) and the Stanford-NIH Digestive Disease Center (DK056339). The NIH played no role in the design or conduction of the study.	AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, J CELL SCI, V114, P2989; Antonyak MA, 2004, J BIOL CHEM, V279, P41461, DOI 10.1074/jbc.M404976200; Begg GE, 2006, J BIOL CHEM, V281, P12603, DOI 10.1074/jbc.M600146200; Bernassola F, 2002, FASEB J, V16, P1371, DOI 10.1096/fj.01-0689com; Case A, 2003, BIOCHEMISTRY-US, V42, P9466, DOI 10.1021/bi030084z; Choi K, 2005, CHEM BIOL, V12, P469, DOI 10.1016/j.chembiol.2005.02.007; DARGENIO G, 1989, GUT, V30, P950, DOI 10.1136/gut.30.7.950; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; Esposito C, 2003, AM J GASTROENTEROL, V98, P1813, DOI [10.1016/S0002-9270(03)00431-3, 10.1111/j.1572-0241.2003.07582.x]; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Hoffner G, 2005, FRONT BIOSCI-LANDMRK, V10, P3078, DOI 10.2741/1764; Korponay-Szabo IR, 2003, GUT, V52, P199, DOI 10.1136/gut.52.2.199; Kulka A, 2006, MOL IMMUNOL, V43, P1579, DOI 10.1016/j.molimm.2005.09.019; LORAND L, 1972, ANAL BIOCHEM, V50, P623, DOI 10.1016/0003-2697(72)90074-7; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Maiuri L, 2005, GASTROENTEROLOGY, V129, P1400, DOI 10.1053/j.gastro.2005.07.054; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mangala LS, 2005, PROG EXP TUMOR RES, V38, P125; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Molberg O, 2001, EUR J IMMUNOL, V31, P1317, DOI 10.1002/1521-4141(200105)31:5<1317::AID-IMMU1317>3.0.CO;2-I; Molberg O, 2000, J PEDIATR GASTR NUTR, V30, P232, DOI 10.1097/00005176-200003000-00005; Nakamaru M, 1998, CANCER CHEMOTH PHARM, V41, P98; NANDA N, J BIOL CHEM, V276, P20678; Naruhashi K, 2000, CLIN EXP PHARMACOL P, V27, P980, DOI 10.1046/j.1440-1681.2000.03380.x; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Piper JL, 2004, J PHARMACOL EXP THER, V311, P213, DOI 10.1124/jpet.104.068429; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Siegel M, 2007, PHARMACOL THERAPEUT, V115, P232, DOI 10.1016/j.pharmthera.2007.05.003; Smethurst PA, 1996, BIOCHEM J, V313, P803, DOI 10.1042/bj3130803; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Strnad P, 2006, FEBS LETT, V580, P2351, DOI 10.1016/j.febslet.2006.03.051; Strnad P, 2007, GASTROENTEROLOGY, V132, P1515, DOI 10.1053/j.gastro.2007.02.020; Szebeni B, 2007, J PEDIATR GASTR NUTR, V45, P187, DOI 10.1097/MPG.0b013e318064514a; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; Watts RE, 2006, J MED CHEM, V49, P7493, DOI 10.1021/jm060839a; Wodzinska JM, 2005, MINI-REV MED CHEM, V5, P279, DOI 10.2174/1389557053175416; Xia J, 2006, J AM CHEM SOC, V128, P1859, DOI 10.1021/ja056423o; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Yuan L, 2005, MOL CANCER THER, V4, P1293, DOI 10.1158/1535-7163.MCT-04-0328; ZEMSKOV EA, 2006, FRONT BIOSCI, V11, P173; Zhang JW, 1998, J BIOL CHEM, V273, P2288, DOI 10.1074/jbc.273.4.2288; Zhang JW, 1998, J NEUROCHEM, V71, P240; Zhou RB, 2007, J IMMUNOL, V178, P4548, DOI 10.4049/jimmunol.178.7.4548	46	145	145	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1861	10.1371/journal.pone.0001861	http://dx.doi.org/10.1371/journal.pone.0001861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365016	Green Submitted, Green Published, gold			2022-12-27	WOS:000260762400022
J	Beard, DA; Vinnakota, KC; Wu, F				Beard, Daniel A.; Vinnakota, Kalyan C.; Wu, Fan			Detailed Enzyme Kinetics in Terms of Biochemical Species: Study of Citrate Synthase	PLOS ONE			English	Article								The compulsory-ordered ternary catalytic mechanism for two-substrate two-product enzymes is analyzed to account for binding of inhibitors to each of the four enzyme states and to maintain the relationship between the kinetic constants and the reaction equilibrium constant. The developed quasi-steady flux expression is applied to the analysis of data from citrate synthase to determine and parameterize a kinetic scheme in terms of biochemical species, in which the effects of pH, ionic strength, and cation binding to biochemical species are explicitly accounted for in the analysis of the data. This analysis provides a mechanistic model that is consistent with the data that have been used support competing hypotheses regarding the catalytic mechanism of this enzyme.	[Beard, Daniel A.; Vinnakota, Kalyan C.; Wu, Fan] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Beard, DA (corresponding author), Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA.	dbeard@mcw.edu	Vinnakota, Kalyan/G-4706-2010	Vinnakota, Kalyan/0000-0003-2185-2213; Wu, Fan/0000-0001-8339-4049	NIH [GM068610, HL072011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068610] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH grants GM068610 and HL072011	Alberty R. A., 2003, THERMODYNAMICS BIOCH; ALBERTY RA, 1993, BIOPHYS J, V65, P1243, DOI 10.1016/S0006-3495(93)81146-9; Alberty RA, 2006, BIOPHYS CHEM, V124, P11, DOI 10.1016/j.bpc.2006.05.024; Beard DA, 2008, CAMB TEXT BIOMED ENG, P69; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; FRIEDEN C, 1955, J BIOL CHEM, V212, P859; Jamshidi N, 2001, BIOINFORMATICS, V17, P286, DOI 10.1093/bioinformatics/17.3.286; KING EL, 1956, J PHYS CHEM-US, V60, P1375, DOI 10.1021/j150544a010; Lambeth MJ, 2002, ANN BIOMED ENG, V30, P808, DOI 10.1114/1.1492813; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; MATSUOKA Y, 1973, J BIOL CHEM, V248, P8022; Mulquiney PJ, 1999, BIOCHEM J, V342, P581, DOI 10.1042/0264-6021:3420581; SEGEL IH, 1975, ENZYME KINETICS BEHA, pR22; SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597; SMITH CM, 1971, FEBS LETT, V18, P35, DOI 10.1016/0014-5793(71)80400-3; SRERE PA, 1966, J BIOL CHEM, V241, P2157; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; Vinnakota K, 2006, BIOPHYS J, V91, P1264, DOI 10.1529/biophysj.105.073296	18	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1825	10.1371/journal.pone.0001825	http://dx.doi.org/10.1371/journal.pone.0001825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350161	gold, Green Submitted, Green Published			2022-12-27	WOS:000260762300027
J	Moghadas, SM; Bowman, CS; Rost, G; Wu, JH				Moghadas, Seyed M.; Bowman, Christopher S.; Rost, Gergely; Wu, Jianhong			Population-Wide Emergence of Antiviral Resistance during Pandemic Influenza	PLOS ONE			English	Article								Background: The emergence of neuraminidase inhibitor resistance has raised concerns about the prudent use of antiviral drugs in response to the next influenza pandemic. While resistant strains may initially emerge with compromised viral fitness, mutations that largely compensate for this impaired fitness can arise. Understanding the extent to which these mutations affect the spread of disease in the population can have important implications for developing pandemic plans. Methodology/Principal Findings: By employing a deterministic mathematical model, we investigate possible scenarios for the emergence of population-wide resistance in the presence of antiviral drugs. The results show that if the treatment level (the fraction of clinical infections which receives treatment) is maintained constant during the course of the outbreak, there is an optimal level that minimizes the final size of the pandemic. However, aggressive treatment above the optimal level can substantially promote the spread of highly transmissible resistant mutants and increase the total number of infections. We demonstrate that resistant outbreaks can occur more readily when the spread of disease is further delayed by applying other curtailing measures, even if treatment levels are kept modest. However, by changing treatment levels over the course of the pandemic, it is possible to reduce the final size of the pandemic below the minimum achieved at the optimal constant level. This reduction can occur with low treatment levels during the early stages of the pandemic, followed by a sharp increase in drug-use before the virus becomes widely spread. Conclusions/Significance: Our findings suggest that an adaptive antiviral strategy with conservative initial treatment levels, followed by a timely increase in the scale of drug-use, can minimize the final size of a pandemic while preventing large outbreaks of resistant infections.	[Moghadas, Seyed M.; Bowman, Christopher S.] Natl Res Council Canada, Inst Biodiagnost, Winnipeg, MB R3B 1Y6, Canada; [Moghadas, Seyed M.] Univ Winnipeg, Dept Math & Statist, Winnipeg, MB, Canada; [Bowman, Christopher S.] Univ Manitoba, Dept Electrical & Comp Engn, Winnipeg, MB, Canada; [Rost, Gergely] Univ Szeged, Hungarian Acad Sci, Bolyai Inst, Anal & Stochast Res Grp, Szeged, Hungary; [Rost, Gergely; Wu, Jianhong] York Univ, Dept Math & Statist, Toronto, ON, Canada; [Wu, Jianhong] York Univ, York Inst Hlth Res, Ctr Dis Modelling, Toronto, ON, Canada	National Research Council Canada; University of Winnipeg; University of Manitoba; Hungarian Academy of Sciences; Szeged University; York University - Canada; York University - Canada	Moghadas, SM (corresponding author), Natl Res Council Canada, Inst Biodiagnost, 435 Ellice Ave, Winnipeg, MB R3B 1Y6, Canada.	Seyed.Moghadas@nrc-cnrc.gc.ca	Röst, Gergely/B-8622-2008; Rost, Gergely/L-9376-2016; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Rost, Gergely/0000-0001-9476-3284; Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507				Alexander ME, 2008, B MATH BIOL, V70, P382, DOI 10.1007/s11538-007-9257-2; Alexander ME, 2007, P R SOC B, V274, P1675, DOI 10.1098/rspb.2007.0422; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Debarre F, 2007, J R SOC INTERFACE, V4, P893, DOI 10.1098/rsif.2007.1126; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Gani R, 2005, EMERG INFECT DIS, V11, P1355; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Handel A, 2006, PLOS COMPUT BIOL, V2, P1262, DOI 10.1371/journal.pcbi.0020137; HKISO MH, 2004, LANCET, V364, P759; LIPSITCH M, 2007, PLOS MED; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Rimmelzwaan GF, 2005, J GEN VIROL, V86, P1801, DOI 10.1099/vir.0.80867-0; WARD P, 2005, ANTIMICROB AGENT SS1, V55, pI51; Yen HL, 2005, ANTIMICROB AGENTS CH, V49, P4075, DOI 10.1128/AAC.49.10.4075-4084.2005	21	58	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1839	10.1371/journal.pone.0001839	http://dx.doi.org/10.1371/journal.pone.0001839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350174	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000260762300040
J	Weedall, GD; Polley, SD; Conway, DJ				Weedall, Gareth D.; Polley, Spencer D.; Conway, David J.			Gene-Specific Signatures of Elevated Non-Synonymous Substitution Rates Correlate Poorly across the Plasmodium Genus	PLOS ONE			English	Article								Background: Comparative genome analyses of parasites allow large scale investigation of selective pressures shaping their evolution. An acute limitation to such analysis of Plasmodium falciparum is that there is only very partial low-coverage genome sequence of the most closely related species, the chimpanzee parasite P. reichenowi. However, if orthologous genes have been under similar selective pressures throughout the Plasmodium genus then positive selection on the P. falciparum lineage might be predicted to some extent by analysis of other lineages. Principal Findings: Here, three independent pairs of closely related species in different sub-generic clades (P. falciparum and P. reichenowi; P. vivax and P. knowlesi; P. yoelii and P. berghei) were compared for a set of 43 candidate ligand genes considered likely to be under positive directional selection and a set of 102 control genes for which there was no selective hypothesis. The ratios of non-synonymous to synonymous substitutions (dN/dS) were significantly elevated in the candidate ligand genes compared to control genes in each of the three clades. However, the rank order correlation of dN/dS ratios for individual candidate genes was very low, less than the correlation for the control genes. Significance: The inability to predict positive selection on a gene in one lineage by identifying elevated dN/dS ratios in the orthologue within another lineage needs to be noted, as it reflects that adaptive mutations are generally rare events that lead to fixation in individual lineages. Thus it is essential to complete the genome sequences of particular species of phylogenetic importance, such as P. reichenowi.	[Weedall, Gareth D.; Polley, Spencer D.; Conway, David J.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Conway, David J.] MRC Labs, Banjul, Gambia	University of London; London School of Hygiene & Tropical Medicine; MRC Laboratory Molecular Biology	Weedall, GD (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	gweedall@hotmail.com	Polley, Spencer/F-7766-2013	Weedall, Gareth/0000-0002-8927-1063; Conway, David/0000-0002-8711-3037	UK Medical Research Council PhD studentship; Wellcome Trust [074695/Z/04/B]	UK Medical Research Council PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by a UK Medical Research Council PhD studentship for GDW, and Wellcome Trust programme grant 074695/Z/04/B to DJC.	Arisue N, 2007, J MOL EVOL, V65, P82, DOI 10.1007/s00239-006-0253-1; Black CG, 2003, MOL BIOCHEM PARASIT, V127, P59, DOI 10.1016/S0166-6851(02)00308-0; BORRE MB, 1991, MOL BIOCHEM PARASIT, V49, P119, DOI 10.1016/0166-6851(91)90135-S; Burns JM, 1999, INFECT IMMUN, V67, P675, DOI 10.1128/IAI.67.2.675-680.1999; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Chattopadhyay R, 2003, J BIOL CHEM, V278, P25977, DOI 10.1074/jbc.M300865200; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cowman AF, 2000, FEBS LETT, V476, P84, DOI 10.1016/S0014-5793(00)01703-8; Dessens JT, 2001, INFECT IMMUN, V69, P4041, DOI 10.1128/IAI.69.6.4041-4047.2001; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Eksi S, 2006, MOL MICROBIOL, V61, P991, DOI 10.1111/j.1365-2958.2006.05284.x; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; FREVERT U, 1993, J EXP MED, V177, P1287, DOI 10.1084/jem.177.5.1287; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gaur D, 2007, P NATL ACAD SCI USA, V104, P17789, DOI 10.1073/pnas.0708772104; Ghai M, 2002, MOL BIOCHEM PARASIT, V123, P35, DOI 10.1016/S0166-6851(02)00123-8; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hisaeda H, 2000, INFECT IMMUN, V68, P6618, DOI 10.1128/IAI.68.12.6618-6623.2000; HOWARD RF, 1990, EXP PARASITOL, V71, P330, DOI 10.1016/0014-4894(90)90038-E; Hughes AL, 2005, MOL BIOCHEM PARASIT, V142, P170, DOI 10.1016/j.molbiopara.2005.02.014; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Ishino T, 2005, MOL MICROBIOL, V58, P1264, DOI 10.1111/j.1365-2958.2005.04801.x; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Kadota K, 2004, P NATL ACAD SCI USA, V101, P16310, DOI 10.1073/pnas.0406187101; Kaneko O, 2005, MOL BIOCHEM PARASIT, V143, P20, DOI 10.1016/j.molbiopara.2005.05.003; Kaneko O, 2002, MOL BIOCHEM PARASIT, V121, P275, DOI 10.1016/S0166-6851(02)00042-7; Kariu T, 2006, MOL MICROBIOL, V59, P1369, DOI 10.1111/j.1365-2958.2005.05024.x; Kariu T, 2002, J EXP MED, V195, P1317, DOI 10.1084/jem.20011876; Kato K, 2005, P NATL ACAD SCI USA, V102, P5552, DOI 10.1073/pnas.0501594102; Kushwaha A, 2002, MOL BIOCHEM PARASIT, V122, P45, DOI 10.1016/S0166-6851(02)00077-4; Li XR, 2004, J BIOL CHEM, V279, P5765, DOI 10.1074/jbc.M308716200; Ling IT, 2004, MOL MICROBIOL, V52, P107, DOI 10.1111/j.1365-2958.2003.03969.x; Ling IT, 2003, MOL BIOCHEM PARASIT, V127, P47, DOI 10.1016/S0166-6851(02)00302-X; LUSTIGMAN S, 1988, MOL BIOCHEM PARASIT, V30, P217, DOI 10.1016/0166-6851(88)90090-4; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Marshall VM, 1997, INFECT IMMUN, V65, P4460, DOI 10.1128/IAI.65.11.4460-4467.1997; Marshall VM, 1998, MOL BIOCHEM PARASIT, V94, P13, DOI 10.1016/S0166-6851(98)00045-0; McCormick CJ, 1999, MOL BIOCHEM PARASIT, V100, P111, DOI 10.1016/S0166-6851(99)00052-3; Mu JB, 2002, NATURE, V418, P323, DOI 10.1038/nature00836; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; MULLER HM, 1993, EMBO J, V12, P2881, DOI 10.1002/j.1460-2075.1993.tb05950.x; Narum DL, 2002, MOL BIOCHEM PARASIT, V119, P159, DOI 10.1016/S0166-6851(01)00428-5; Nielsen R, 2001, HEREDITY, V86, P641, DOI 10.1046/j.1365-2540.2001.00895.x; Pearce JA, 2005, MOL BIOCHEM PARASIT, V139, P141, DOI 10.1016/j.molbiopara.2004.09.012; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; Preiser P, 2004, INFECT IMMUN, V72, P3604, DOI 10.1128/IAI.72.6.3604-3608.2004; QUAKYI IA, 1987, J IMMUNOL, V139, P4213; Rich SM, 2003, ADV PARASIT, V54, P255, DOI 10.1016/S0065-308X(03)54005-2; RIDLEY RG, 1991, MOL BIOCHEM PARASIT, V47, P245, DOI 10.1016/0166-6851(91)90184-8; Sanders PR, 2006, INFECT IMMUN, V74, P4330, DOI 10.1128/IAI.00054-06; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Shi QF, 2006, MOL BIOCHEM PARASIT, V149, P231, DOI 10.1016/j.molbiopara.2006.06.002; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Sidjanski SP, 1997, MOL BIOCHEM PARASIT, V90, P33, DOI 10.1016/S0166-6851(97)00124-2; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Sterkers Y, 2007, J INFECT DIS, V196, P617, DOI 10.1086/519685; Stoeckert CJ, 2006, TRENDS PARASITOL, V22, P543, DOI 10.1016/j.pt.2006.09.005; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Thompson J, 2004, MOL BIOCHEM PARASIT, V134, P225, DOI 10.1016/j.molbiopara.2003.12.003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson JK, 2001, MOL MICROBIOL, V41, P47, DOI 10.1046/j.1365-2958.2001.02484.x; Tomas AM, 2001, EMBO J, V20, P3975, DOI 10.1093/emboj/20.15.3975; Topolska AE, 2004, J BIOL CHEM, V279, P4648, DOI 10.1074/jbc.M307859200; Trenholme KR, 2000, P NATL ACAD SCI USA, V97, P4029, DOI 10.1073/pnas.040561197; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Tsai YL, 2001, INFECT IMMUN, V69, P4048, DOI 10.1128/IAI.69.6.4048-4054.2001; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; van Schaijk BCL, 2006, MOL BIOCHEM PARASIT, V149, P216, DOI 10.1016/j.molbiopara.2006.05.015; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yuda M, 1999, J EXP MED, V190, P1711, DOI 10.1084/jem.190.11.1711; Yuda M, 2001, MOL BIOCHEM PARASIT, V116, P65, DOI 10.1016/S0166-6851(01)00304-8	78	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2281	10.1371/journal.pone.0002281	http://dx.doi.org/10.1371/journal.pone.0002281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509456	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000262268500025
J	Jakobsdottir, J; Conley, YP; Weeks, DE; Ferrell, RE; Gorin, MB				Jakobsdottir, Johanna; Conley, Yvette P.; Weeks, Daniel E.; Ferrell, Robert E.; Gorin, Michael B.			C2 and CFB Genes in Age-Related Maculopathy and Joint Action with CFH and LOC387715 Genes	PLOS ONE			English	Article							COMPLEMENT-FACTOR-H; HTRA1 PROMOTER POLYMORPHISM; MACULAR DEGENERATION; CIGARETTE-SMOKING; Y402H VARIANT; JAPANESE POPULATION; SUSCEPTIBILITY LOCI; GEOGRAPHIC ATROPHY; HEMICENTIN-1 GENES; STRONG ASSOCIATION	Background: Age-related maculopathy (ARM) is a common cause of visual impairment in the elderly populations of industrialized countries and significantly affects the quality of life of those suffering from the disease. Variants within two genes, the complement factor H (CFH) and the poorly characterized LOC387715 (ARMS2), are widely recognized as ARM risk factors. CFH is important in regulation of the alternative complement pathway suggesting this pathway is involved in ARM pathogenesis. Two other complement pathway genes, the closely linked complement component receptor (C2) and complement factor B (CFB), were recently shown to harbor variants associated with ARM. Methods/Principal Findings: We investigated two SNPs in C2 and two in CFB in independent case-control and family cohorts of white subjects and found rs547154, an intronic SNP in C2, to be significantly associated with ARM in both our case-control (P-value 0.00007) and family data (P-value 0.00001). Logistic regression analysis suggested that accounting for the effect at this locus significantly (P-value 0.002) improves the fit of a genetic risk model of CFH and LOC387715 effects only. Modeling with the generalized multifactor dimensionality reduction method showed that adding C2 to the two-factor model of CFH and LOC387715 increases the sensitivity (from 63% to 73%). However, the balanced accuracy increases only from 71% to 72%, and the specificity decreases from 80% to 72%. Conclusions/Significance: C2/CFB significantly influences AMD susceptibility and although accounting for effects at this locus does not dramatically increase the overall accuracy of the genetic risk model, the improvement over the CFH-LOC387715 model is statistically significant.	[Jakobsdottir, Johanna; Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Dept Hlth Promot & Dev, Pittsburgh, PA USA; [Conley, Yvette P.; Weeks, Daniel E.; Ferrell, Robert E.; Gorin, Michael B.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA USA; [Gorin, Michael B.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA USA; [Gorin, Michael B.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jakobsdottir, J (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA.	gorin@jsei.ucla.edu	Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228; Jakobsdottir, Johanna/0000-0002-8019-9683	NEI [R01EY009859]; The Steinbach Foundation, New York; Research to Prevent Blindness, New York; Eye and Ear Foundation of Pittsburgh; American Health Assistance Foundation, Clarksburg, Maryland; Jules Stein Eye Institute, Los Angeles, California; NATIONAL EYE INSTITUTE [R01EY009859] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); The Steinbach Foundation, New York; Research to Prevent Blindness, New York(Research to Prevent Blindness (RPB)); Eye and Ear Foundation of Pittsburgh; American Health Assistance Foundation, Clarksburg, Maryland; Jules Stein Eye Institute, Los Angeles, California; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by NEI grant R01EY009859, The Steinbach Foundation, New York, Research to Prevent Blindness, New York, the Eye and Ear Foundation of Pittsburgh, American Health Assistance Foundation, Clarksburg, Maryland, and the Jules Stein Eye Institute, Los Angeles, California (all to M.B.G.).	Baird PN, 2006, INVEST OPHTH VIS SCI, V47, P4194, DOI 10.1167/iovs.05-1285; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Browning SR, 2005, GENET EPIDEMIOL, V28, P110, DOI 10.1002/gepi.20051; Cameron DJ, 2007, CELL CYCLE, V6, P1122, DOI 10.4161/cc.6.9.4157; Chen LJ, 2006, MOL VIS, V12, P1536; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Conley YP, 2006, HUM MOL GENET, V15, P3206, DOI 10.1093/hmg/ddl396; DeAngelis MM, 2007, ARCH OPHTHALMOL-CHIC, V125, P49, DOI 10.1001/archopht.125.1.49; Despriet DDG, 2006, JAMA-J AM MED ASSOC, V296, P301, DOI 10.1001/jama.296.3.301; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dinu V, 2007, GENET EPIDEMIOL, V31, P224, DOI 10.1002/gepi.20204; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ennis S, 2007, BRIT J OPHTHALMOL, V91, P966, DOI 10.1136/bjo.2007.114090; Fisher SA, 2007, BRIT J OPHTHALMOL, V91, P576, DOI 10.1136/bjo.2006.105577; Francis PJ, 2007, HUM HERED, V63, P212, DOI 10.1159/000100046; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fuse N, 2006, AM J OPHTHALMOL, V142, P1074, DOI 10.1016/j.ajo.2006.07.030; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gorin MB, 2007, ARCH OPHTHALMOL-CHIC, V125, P21, DOI 10.1001/archopht.125.1.21; Gotoh N, 2006, HUM GENET, V120, P139, DOI 10.1007/s00439-006-0187-0; Hageman GS, 1999, MOL VIS, V5; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Johnson LV, 2000, EXP EYE RES, V70, P441, DOI 10.1006/exer.1999.0798; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Kaur I, 2006, INVEST OPHTH VIS SCI, V47, P3729, DOI 10.1167/iovs.05-1430; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lau LI, 2006, INVEST OPHTH VIS SCI, V47, P3242, DOI 10.1167/iovs.05-1532; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Mori K, 2007, INVEST OPHTH VIS SCI, V48, P5315, DOI 10.1167/iovs.07-0426; Mori K, 2007, J HUM GENET, V52, P636, DOI 10.1007/s10038-007-0162-1; Mukhopadhyay N, 2004, HUM HERED, V58, P175, DOI 10.1159/000083545; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Narayanan R, 2007, OPHTHALMOLOGY, V114, P1327, DOI 10.1016/j.ophtha.2006.10.035; North BV, 2005, HUM HERED, V59, P79, DOI 10.1159/000085222; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Okamoto H, 2006, MOL VIS, V12, P156; R Development Core Team, 2005, R LANG ENV STAT COMP; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Ross RJ, 2007, INVEST OPHTH VIS SCI, V48, P1128, DOI 10.1167/iovs.06-0999; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P55, DOI 10.1001/archopht.125.1.55; Schaumberg DA, 2006, INVEST OPHTH VIS SCI, V47, P2336, DOI 10.1167/iovs.05-1456; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Seddon Johanna M., 2004, International Ophthalmology Clinics, V44, P17, DOI 10.1097/00004397-200404440-00004; Seitsonen S, 2006, MOL VIS, V12, P796; Sepp T, 2006, INVEST OPHTH VIS SCI, V47, P536, DOI 10.1167/iovs.05-1143; Simonelli F, 2006, BRIT J OPHTHALMOL, V90, P1142, DOI 10.1136/bjo.2006.096487; Sivaprasad S, 2007, ARCH OPHTHALMOL-CHIC, V125, P515, DOI 10.1001/archopht.125.4.515; Souied EH, 2005, MOL VIS, V11, P1135; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; Tanimoto S, 2007, NEUROSCI LETT, V414, P71, DOI 10.1016/j.neulet.2006.12.011; Tedeschi-Blok N, 2007, OPHTHALMOLOGY, V114, P99, DOI 10.1016/j.ophtha.2006.07.043; THOMPSON CL, 2007, HUM MOL GENET; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Tuo JS, 2006, P NATL ACAD SCI USA, V103, P9256, DOI 10.1073/pnas.0603485103; Uka J, 2006, RETINA-J RET VIT DIS, V26, P985, DOI 10.1097/01.iae.0000244068.18520.3e; van Leeuwen R, 2003, EUR J EPIDEMIOL, V18, P845, DOI 10.1023/A:1025643303914; WANG JJ, 2007, LOC387715 POLYMORPHI; WARNES G, 2006, POPULATION GENETICS; Weeks DE, 2000, HUM MOL GENET, V9, P1329, DOI 10.1093/hmg/9.9.1329; Weeks DE, 2004, AM J HUM GENET, V75, P174, DOI 10.1086/422476; Wegscheider BJ, 2007, OPHTHALMOLOGY, V114, P738, DOI 10.1016/j.ophtha.2006.07.048; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; YATES JR, 2007, COMPLEMENT C3 VARIAN; Yoshida T, 2007, MOL VIS, V13, P545; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	78	73	88	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2199	10.1371/journal.pone.0002199	http://dx.doi.org/10.1371/journal.pone.0002199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493315	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000262258700008
J	Natsume, T; Tsutsui, Y; Sutani, T; Dunleavy, EM; Pidoux, AL; Iwasaki, H; Shirahige, K; Allshire, RC; Yamao, F				Natsume, Toyoaki; Tsutsui, Yasuhiro; Sutani, Takashi; Dunleavy, Elaine M.; Pidoux, Alison L.; Iwasaki, Hiroshi; Shirahige, Katsuhiko; Allshire, Robin C.; Yamao, Fumiaki			A DNA Polymerase alpha Accessory Protein, Mcl1, Is Required for Propagation of Centromere Structures in Fission Yeast	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; CENP-A; HISTONE DEACETYLATION; EPIGENETIC CONTROL; REPLICATION; HETEROCHROMATIN; COMPLEX; KINETOCHORE; ESTABLISHMENT; DOMAINS	Specialized chromatin exists at centromeres and must be precisely transmitted during DNA replication. The mechanisms involved in the propagation of these structures remain elusive. Fission yeast centromeres are composed of two chromatin domains: the central CENP-A(Cnp1) kinetochore domain and flanking heterochromatin domains. Here we show that fission yeast Mcl1, a DNA polymerase alpha (Pol alpha) accessory protein, is critical for maintenance of centromeric chromatin. In a screen for mutants that alleviate both central domain and outer repeat silencing, we isolated several cos mutants, of which cos1 is allelic to mcl1. The mcl1-101 mutation causes reduced CENP-A(Cnp1) in the central domain and an aberrant increase in histone acetylation in both domains. These phenotypes are also observed in a mutant of swi7(+), which encodes a catalytic subunit of Pol alpha. Mcl1 forms S-phase-specific nuclear foci, which colocalize with those of PCNA and Pol alpha. These results suggest that Mcl1 and Pol alpha are required for propagation of centromere chromatin structures during DNA replication.	[Natsume, Toyoaki; Tsutsui, Yasuhiro; Yamao, Fumiaki] Natl Inst Genet, Div Mutagenesis, Mishima, Shizuoka, Japan; [Sutani, Takashi; Shirahige, Katsuhiko] Tokyo Inst Technol, Ctr Biol Resources & Informat, Lab Genome Structure & Function, Yokohama, Kanagawa, Japan; [Dunleavy, Elaine M.; Pidoux, Alison L.; Allshire, Robin C.] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Iwasaki, Hiroshi] Yokohama City Univ, Int Grad Sch Arts & Sci, Div Mol & Cellular Biol, Yokohama, Kanagawa, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tokyo Institute of Technology; University of Edinburgh; Yokohama City University	Natsume, T (corresponding author), Natl Inst Genet, Div Mutagenesis, Mishima, Shizuoka, Japan.	ytsutsui@lab.nig.ac.jp	Iwasaki, Hiroshi/Y-7946-2018; Natsume, Toyoaki/S-1936-2018	Iwasaki, Hiroshi/0000-0002-0153-6873; Natsume, Toyoaki/0000-0002-3544-4491; Sutani, Takashi/0000-0002-9959-9513; Allshire, Robin/0000-0002-8005-3625	Ministry of Education, Culture, Sports, Science, and Technology of Japan [Grants-in Aids]; Wellcome Trust [065061/Z, 069286]; Association for International Cancer Research [00-0297]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Wellcome Trust(Wellcome TrustEuropean Commission); Association for International Cancer Research	Grants-in Aids from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Wellcome Trust Program Grant 065061/Z and 069286/AICR: Association for International Cancer Research Grant: 00-0297	Ahmed S, 2001, J BIOL CHEM, V276, P47814, DOI 10.1074/jbc.M109186200; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baum M, 2006, P NATL ACAD SCI USA, V103, P14877, DOI 10.1073/pnas.0606958103; Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; Castillo AG, 2007, PLOS GENET, V3, P1264, DOI 10.1371/journal.pgen.0030121; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Dunleavy EM, 2007, MOL CELL, V28, P1029, DOI 10.1016/j.molcel.2007.10.010; Ekwall K, 1999, GENETICS, V153, P1153; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Ekwall K, 1996, J CELL SCI, V109, P2637; Freeman-Cook LL, 2005, GENETICS, V169, P1243, DOI 10.1534/genetics.104.032714; Freeman-Cook LL, 1999, MOL BIOL CELL, V10, P3171, DOI 10.1091/mbc.10.10.3171; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gregan J, 2007, CURR BIOL, V17, P1190, DOI 10.1016/j.cub.2007.06.044; Grewal SIS, 1998, GENETICS, V150, P563; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kim SM, 2003, GENE DEV, V17, P330, DOI 10.1101/gad.1046203; Kitamura E, 2006, CELL, V125, P1297, DOI 10.1016/j.cell.2006.04.041; KOUPRINA N, 1993, YEAST, V9, P11, DOI 10.1002/yea.320090103; KOUPRINA N, 1992, MOL CELL BIOL, V12, P5736, DOI 10.1128/MCB.12.12.5736; Lejeune E, 2007, CURR BIOL, V17, P1219, DOI 10.1016/j.cub.2007.06.028; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Mamnun YM, 2006, BIOCHEM BIOPH RES CO, V350, P125, DOI 10.1016/j.bbrc.2006.09.024; MARSCHALL LG, 1995, J CELL BIOL, V128, P445, DOI 10.1083/jcb.128.4.445; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; MILES J, 1992, P NATL ACAD SCI USA, V89, P1276, DOI 10.1073/pnas.89.4.1276; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morris CA, 2007, CELL, V128, P647, DOI 10.1016/j.cell.2007.02.002; Mythreye K, 2003, J CELL BIOL, V160, P833, DOI 10.1083/jcb.200211116; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; Okuno Y, 1997, NUCLEIC ACIDS RES, V25, P530, DOI 10.1093/nar/25.3.530; Partridge J.F., 1999, PRACT APPROACH SER, P38; Partridge JF, 2000, GENE DEV, V14, P783; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Pidoux AL, 2000, J CELL SCI, V113, P4177; POLIZZI C, 1991, J CELL BIOL, V112, P191, DOI 10.1083/jcb.112.2.191; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Taddei A, 1999, J CELL BIOL, V147, P1153, DOI 10.1083/jcb.147.6.1153; Takahashi K, 2005, PHILOS T R SOC B, V360, P595, DOI 10.1098/rstb.2004.1614; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Tsutsui Y, 2005, CURR GENET, V48, P34, DOI 10.1007/s00294-005-0584-2; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Walfridsson J, 2005, NUCLEIC ACIDS RES, V33, P2868, DOI 10.1093/nar/gki579; Williams DR, 2005, EUKARYOT CELL, V4, P166, DOI 10.1128/EC.4.1.166-177.2005; Williams DR, 2002, EUKARYOT CELL, V1, P758, DOI 10.1128/EC.1.5.758-773.2002; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang J, 1998, J PORPHYR PHTHALOCYA, V2, P93, DOI 10.1002/(SICI)1099-1409(199803/04)2:2<93::AID-JPP81>3.3.CO;2-O; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhou YJ, 2004, MOL CELL BIOL, V24, P9568, DOI 10.1128/MCB.24.21.9568-9579.2004	68	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2221	10.1371/journal.pone.0002221	http://dx.doi.org/10.1371/journal.pone.0002221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493607	Green Submitted, Green Published, gold			2022-12-27	WOS:000262258700029
J	Sahni, M; Verma, N; Narula, D; Varghese, RM; Sreenivas, V; Puliyel, JM				Sahni, Mohit; Verma, Neeraj; Narula, D.; Varghese, Raji Mathew; Sreenivas, V.; Puliyel, Jacob M.			Missing Girls in India: Infanticide, Feticide and Made-to-Order Pregnancies? Insights from Hospital-Based Sex-Ratio-at-Birth over the Last Century	PLOS ONE			English	Article							HEPATITIS-B VIRUS; SELECTIVE ABORTIONS; MORTALITY; CHILDREN; WOMEN	Background: There are 44 million missing women in India. Gender bias; neglect of girls, infanticides and feticides are responsible. The sex ratio at birth can be used to examine the influence of antenatal sex selection on the sex ratio. Materials and Methods: Records from 321,991 deliveries at one hospital over 11 decades were utilized. The middle year in each decade was taken as representative of the decade. Data from 33,524 deliveries were then analyzed. Data for each decade was combined with that of previous decades and compared to the data of subsequent decades to look for any change in the trend. Sex ratio in the second children against sex of the first child was studied separately. Results: The mean sex ratio for the 110 years examined was 910 girls to 1000 boys (95% CI; 891 to 930). The sex ratio dropped significantly from 935 (CI: 905 to 967) before 1979, to 892 (CI: 868 to 918) after 1980 (P = 0.04). The sex ratio in the second child was significantly lower if the first child was a girl [716 (CI: 672 to 762] (P < 0.001). On the other hand, there was an excess of girls born to mothers whose first child was boy [1140 girls per 1000 boys (CI: 1072 to 1212 P < 0.001)]. Conclusions: The sex ratio fell significantly after 1980 when ultra sound machines for antenatal sex determination became available. The sex ratio in second children if the first was a girl was even lower. Sex selective abortions after antenatal sex determination are thus implicated. However data on second children especially the excess of girls born to mothers who have a previous boy seen in the decade before the advent of antenatal ultra sound machines, suggests that other means of sex selection are also used.	[Sahni, Mohit; Verma, Neeraj; Narula, D.; Varghese, Raji Mathew; Puliyel, Jacob M.] St Stephens Hosp, Dept Neonatol & Pediat, Delhi, India; [Sreenivas, V.] All India Inst Med Sci, Dept Biostat, New Delhi, India	St. Stephen's Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi	Puliyel, JM (corresponding author), St Stephens Hosp, Dept Neonatol & Pediat, Delhi, India.	puliyel@vsnl.com	Hizukuri, Tatiana/H-6593-2016					Arnold F, 2002, POPUL DEV REV, V28, P759, DOI 10.1111/j.1728-4457.2002.00759.x; BAGGA C, 2005, TIMES INDIA     0714; CHALNAZARIAN A, 1988, J BIOSOC SCI, V20, P357; Chatterjee M, 1990, REPORT INDIAN WOMEN; Das Gupta M, 2005, POPUL DEV REV, V31, P529; DasGupta M, 1997, POP STUD-J DEMOG, V51, P307, DOI 10.1080/0032472031000150076; DREW JS, 1978, SCIENCE, V201, P687, DOI 10.1126/science.566954; DREW JS, 1986, HUM BIOL, V58, P115; Fukuda M, 2002, LANCET, V359, P1407, DOI 10.1016/S0140-6736(02)08362-9; GANGADHARAN S, 1991, EC TIMES        0418; GEORGE S, 1998, SEARCH B, V12, P18; GEORGE S, FEMALE INFANTICIDE T; George SM, 2006, LANCET, V367, P1725, DOI 10.1016/S0140-6736(06)68758-8; George SM, 2002, REPROD HEALTH MATTER, V10, P190, DOI 10.1016/S0968-8080(02)00034-4; GHOSH S, 1987, B NUTR FDN INDIA, V8, P4; Grover A, 2006, LANCET, V367, P1726, DOI 10.1016/S0140-6736(06)68760-6; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; HESSER JE, 1975, HUM BIOL, V47, P415; JAISING I, 2004, PRECONCEPTION PRENAT; James WH, 1996, J THEOR BIOL, V180, P271, DOI 10.1006/jtbi.1996.0102; Jha P, 2006, LANCET, V367, P211, DOI 10.1016/S0140-6736(06)67930-0; Kankova S, 2007, NATURWISSENSCHAFTEN, V94, P122, DOI 10.1007/s00114-006-0166-2; Khanna R, 2003, BRIT MED J, V327, P126, DOI 10.1136/bmj.327.7407.126; KLASEN S, 1994, WORLD DEV, V22, P1061, DOI 10.1016/0305-750X(94)90148-1; LEIDL P, 2005, SILENT SPRINGS TRAGE; Oster E, 2005, J POLIT ECON, V113, P1163, DOI 10.1086/498588; PATEL V, 1989, B CONCERN ASIA SCHOL, V21, P2, DOI 10.1080/14672715.1989.10413186; RAMANAMMA A, 1980, SOC SCI MED-MED ANTH, V14, P107, DOI 10.1016/0160-7987(80)90059-9; SEN A, 1992, BRIT MED J, V304, P587, DOI 10.1136/bmj.304.6827.587; Sen A, 2003, BMJ-BRIT MED J, V327, P1297, DOI 10.1136/bmj.327.7427.1297; Sen Amartya, 2001, FRONTLINE, V18, P4; Sudha S, 1999, DEV CHANGE, V30, P585, DOI 10.1111/1467-7660.00130; TANDON BN, 1991, INDIAN J MED RES-A, V93, P337; *UN WORLD POP PROS, 200 REV HIGHL; *UNFPA, 2001, SEX SEL AB FERT DEC; VISARIA P, 1991, EC TIMES        0418; WALDRON I, 1993, SOC SCI MED, V36, P451, DOI 10.1016/0277-9536(93)90407-U; WILLIAMS RJ, 1992, SOC BIOL, V39, P285; ZENG Y, 1993, POPUL DEV REV, V19, P283; CENSUS INDIA 2001 PR	40	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2224	10.1371/journal.pone.0002224	http://dx.doi.org/10.1371/journal.pone.0002224			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493614	Green Published, Green Submitted, gold			2022-12-27	WOS:000262258700032
J	Schulp, AS; Al-Wosabi, M; Stevens, NJ				Schulp, Anne S.; Al-Wosabi, Mohammed; Stevens, Nancy J.			First Dinosaur Tracks from the Arabian Peninsula	PLOS ONE			English	Article								Background: The evolutionary history of Mesozoic terrestrial vertebrates from the Arabian Peninsula is virtually unknown. Despite vast exposures of rocky outcrops, only a handful of fossils have yet been described from the region. Here we report a multi-taxon dinosaur track assemblage near Madar village, 47 km north of Sana'a, Republic of Yemen. This represents the first dinosaur tracksite from the Arabian Peninsula, and the only multi-taxon dinosaur ichnosite in the Middle East. Methodology/Findings: Measurements were taken directly from trackway impressions, following standard ichnological conventions. The presence of bipedal trackmakers is evidenced by a long series of pes imprints preserving smoothly rounded posterior margins, no evidence of a hallux, bluntly rounded digit tips and digital divarication angles characteristic of ornithopod dinosaurs. Nearby, eleven parallel quadrupedal trackways document a sauropod herd that included large and small individuals traveling together. Based on the morphology of manus impressions along with a narrow-gauged stance, the quadrupedal trackways were made by non-titanosauriform neosauropods. Additional isolated tracks and trackways of sauropod and ornithopod dinosaurs are preserved nearby. Conclusions/Significance: Taken together, these discoveries present the most evocative window to date into the evolutionary history of dinosaurs of the Arabian Peninsula. Given the limited Mesozoic terrestrial record from the region, this discovery is of both temporal and geographic significance, and massive exposures of similarly-aged outcrops nearby offer great promise for future discoveries.	[Schulp, Anne S.] Nat Hist Museum, Maastricht, Netherlands; [Al-Wosabi, Mohammed] Sanaa Univ, Dept Geol, Sanaa, Yemen; [Stevens, Nancy J.] Ohio Univ, Coll Osteopath Med, Dept Biomed Sci, Athens, OH USA	University System of Ohio; Ohio University	Schulp, AS (corresponding author), Nat Hist Museum, Maastricht, Netherlands.	stevensn@ohio.edu	Schulp, Anne/AAM-9015-2020; Stevens, Nancy J/E-6928-2013	Schulp, Anne/0000-0001-9389-1540; 	Yemen Geological Survey; Ohio University	Yemen Geological Survey; Ohio University	Partial funding for this work provided by the Yemen Geological Survey, Mr. T. Saleh, and Ohio University.	Ahmed AAK, 2004, LETHAIA, V37, P467, DOI 10.1080/00241160410002162; ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; ALWOSABI MA, 2001, THESIS SANAS U; AVNIMELECH M, 1962, NATURE, V196, P264, DOI 10.1038/196264a0; Avnimelech M., 1962, CRAS GEOL, V8, P233; AVNIMELECH MA, 1966, ISR ACAD SCI HUM P S, V1; BEYDOUN ZR, 1998, IUGS PUB, V34; Buffetaut E, 2006, NATURWISSENSCHAFTEN, V93, P440, DOI 10.1007/s00114-006-0124-z; Carrano MT, 2001, PALEOBIOLOGY, V27, P564, DOI 10.1666/0094-8373(2001)027<0564:TDATTT>2.0.CO;2; CROMPTON AW, 1962, NATURE, V196, P1074, DOI 10.1038/1961074a0; DUTUIT JM, 1980, MEM SOC GEOL FRANCE, V139, P95; Farlow James O., 1997, P519; GINSBURG L, 1966, CR ACAD SCI D NAT, V263, P28; Goodwin MB, 1999, J VERTEBR PALEONTOL, V19, P728, DOI 10.1080/02724634.1999.10011185; GOODWIN MB, 1996, J VERT PALEONT S, V16, pA38; GOW CE, 1975, ZOOL J LINN SOC-LOND, V57, P335, DOI 10.1111/j.1096-3642.1975.tb01895.x; Henderson DM, 2006, J VERTEBR PALEONTOL, V26, P907, DOI 10.1671/0272-4634(2006)26[907:BGCOMS]2.0.CO;2; HOOIJER DA, 1968, PROC K NED AKAD B-PH, V71, P150; Howarth Michael K., 1998, Bulletin of the Natural History Museum Geology Series, V54, P1; Ishigaki S., 1989, P83; Jacobs L.L., 1989, P349; JACOBS LL, 1990, NATL GEOGR RES, V6, P196; Jacobs LL, 1999, FOSSIL VERTEBRATES OF ARABIA, P454; Lamare P, 1930, MEMOIRS SOC GEOLOGIQ, V14, P49; MARTILL DM, 1996, NEUES JB GEOLOGIE PA, V199, P147; Moreno K, 2005, J S AM EARTH SCI, V20, P253, DOI 10.1016/j.jsames.2005.05.012; NOLAN SC, 1990, GEOL SOC LOND SPEC P, V49, P495; Schulp Anne S., 1999, Ichnos, V6, P239; Schulp AS, 2000, CRETACEOUS RES, V21, P851, DOI 10.1006/cres.2000.0235; Thulborn T., 1990, DINOSAUR TRACKS; Weishampel DB, 2004, DINOSAURIA, 2ND EDITION, P517; Wilson JA, 2005, PALEOBIOLOGY, V31, P400, DOI 10.1666/0094-8373(2005)031[0400:IIABFR]2.0.CO;2; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Yates AM, 2003, P ROY SOC B-BIOL SCI, V270, P1753, DOI 10.1098/rspb.2003.2417	34	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2243	10.1371/journal.pone.0002243	http://dx.doi.org/10.1371/journal.pone.0002243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493306	Green Published, Green Submitted, gold			2022-12-27	WOS:000262258700051
J	Zuena, AR; Mairesse, J; Casolini, P; Cinque, C; Alema, GS; Morley-Fletcher, S; Chiodi, V; Spagnoli, LG; Gradini, R; Catalani, A; Nicoletti, F; Maccari, S				Zuena, Anna Rita; Mairesse, Jerome; Casolini, Paola; Cinque, Carlo; Alema, Giovanni Sebastiano; Morley-Fletcher, Sara; Chiodi, Valentina; Spagnoli, Luigi Giusto; Gradini, Roberto; Catalani, Assia; Nicoletti, Ferdinando; Maccari, Stefania			Prenatal Restraint Stress Generates Two Distinct Behavioral and Neurochemical Profiles in Male and Female Rats	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; MESSENGER-RNA EXPRESSION; ELEVATED PLUS-MAZE; ADULT HIPPOCAMPAL NEUROGENESIS; ANXIETY-RELATED BEHAVIOR; NEUROTROPHIC FACTOR; SPATIAL MEMORY; DENTATE GYRUS; VENTRAL HIPPOCAMPUS	Prenatal Restraint Stress (PRS) in rats is a validated model of early stress resulting in permanent behavioral and neurobiological outcomes. Although sexual dimorphism in the effects of PRS has been hypothesized for more than 30 years, few studies in this long period have directly addressed the issue. Our group has uncovered a pronounced gender difference in the effects of PRS (stress delivered to the mothers 3 times per day during the last 10 days of pregnancy) on anxiety, spatial learning, and a series of neurobiological parameters classically associated with hippocampus-dependent behaviors. Adult male rats subjected to PRS ("PRS rats'') showed increased anxiety-like behavior in the elevated plus maze (EPM), a reduction in the survival of newborn cells in the dentate gyrus, a reduction in the activity of mGlu1/5 metabotropic glutamate receptors in the ventral hippocampus, and an increase in the levels of brain-derived neurotrophic factor (BDNF) and pro-BDNF in the hippocampus. In contrast, female PRS rats displayed reduced anxiety in the EPM, improved learning in the Morris water maze, an increase in the activity of mGlu1/5 receptors in the ventral and dorsal hippocampus, and no changes in hippocampal neurogenesis or BDNF levels. The direction of the changes in neurogenesis, BDNF levels and mGlu receptor function in PRS animals was not consistent with the behavioral changes, suggesting that PRS perturbs the interdependency of these particular parameters and their relation to hippocampus-dependent behavior. Our data suggest that the epigenetic changes in hippocampal neuroplasticity induced by early environmental challenges are critically sex-dependent and that the behavioral outcome may diverge in males and females.	[Zuena, Anna Rita; Mairesse, Jerome; Morley-Fletcher, Sara; Maccari, Stefania] Univ Lille 1, Perinatal Stress Lab, F-59655 Villeneuve Dascq, France; [Zuena, Anna Rita; Mairesse, Jerome; Casolini, Paola; Cinque, Carlo; Alema, Giovanni Sebastiano; Chiodi, Valentina; Catalani, Assia; Nicoletti, Ferdinando; Maccari, Stefania] Univ Roma La Sapienza, Dept Human Physiol & Pharmacol, Rome, Italy; [Gradini, Roberto; Nicoletti, Ferdinando] Ist Neurol Mediterraneo Neuromed, Pozzilli, Italy; [Spagnoli, Luigi Giusto] Tor Vergata Univ, Inst Anatom Pathol, Rome, Italy; [Gradini, Roberto] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy	Universite de Lille - ISITE; Universite de Lille; Sapienza University Rome; IRCCS Neuromed; University of Rome Tor Vergata; Sapienza University Rome	Zuena, AR (corresponding author), Univ Lille 1, Perinatal Stress Lab, F-59655 Villeneuve Dascq, France.	stefania.maccari@univ-lille1.fr	Maccari, Stefania/P-1641-2019; Nicoletti, Ferdinando/T-4898-2019; Nicoletti, Ferdinando/K-4410-2016; Alemà, Giovanni Sebastiano/D-2672-2009; Cinque, Carlo/AAD-6216-2019; Nicoletti, Ferdinando/A-2446-2010	Maccari, Stefania/0000-0002-8336-5990; Alemà, Giovanni Sebastiano/0000-0003-2350-6365; NICOLETTI, Ferdinando/0000-0003-3366-7269; Morley-Fletcher, Sara/0000-0003-0423-5563; CHIODI, VALENTINA/0000-0002-9783-0005; Spagnoli, Luigi Giusto/0000-0002-0684-5501; Nicoletti, Ferdinando/0000-0003-0917-443X	University of Lille 1; Sapienza University of Rome; Ministere des Affaires Etrangers; Lavoisier, EGIDE	University of Lille 1; Sapienza University of Rome; Ministere des Affaires Etrangers; Lavoisier, EGIDE	This research was supported by the University of Lille 1 and the Sapienza University of Rome (under the framework of an agreement signed between the 2 universities on 15/02/2007). Anna Rita Zuena was funded by the Ministere des Affaires Etrangers. Jerome Mairesse was funded by the Lavoisier, EGIDE.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Alves SH, 2004, BEHAV PHARMACOL, V15, P37, DOI 10.1097/00008877-200402000-00005; Ballard TM, 2005, PSYCHOPHARMACOLOGY, V179, P218, DOI 10.1007/s00213-005-2211-9; Balschun D, 2002, PHARMACOL BIOCHEM BE, V73, P375, DOI 10.1016/S0091-3057(02)00847-X; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Becker S, 2007, TRENDS COGN SCI, V11, P70, DOI 10.1016/j.tics.2006.10.013; Bendel O, 2005, J CEREBR BLOOD F MET, V25, P1586, DOI 10.1038/sj.jcbfm.9600153; Bertoglio LJ, 2006, BEHAV BRAIN RES, V175, P183, DOI 10.1016/j.bbr.2006.08.021; Bortolotto ZA, 2005, NEUROPHARMACOLOGY, V49, P13, DOI 10.1016/j.neuropharm.2005.05.020; Bowman RE, 2005, J NEUROENDOCRINOL, V17, P526, DOI 10.1111/j.1365-2826.2005.01335.x; Bowman RE, 2004, ENDOCRINOLOGY, V145, P3778, DOI 10.1210/en.2003-1759; Brazel CY, 2005, NEUROSCIENCE, V131, P55, DOI 10.1016/j.neuroscience.2004.10.038; Brodkin J, 2002, PHARMACOL BIOCHEM BE, V73, P359, DOI 10.1016/S0091-3057(02)00828-6; Bruel-Jungerman E, 2007, REV NEUROSCIENCE, V18, P93; Canossa M, 2001, EMBO J, V20, P1640, DOI 10.1093/emboj/20.7.1640; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Darnaudery M, 2006, NEUROBIOL AGING, V27, P119, DOI 10.1016/j.neurobiolaging.2005.01.008; Darnaudery M, 2008, BRAIN RES REV, V57, P571, DOI 10.1016/j.brainresrev.2007.11.004; De Blasi A, 2001, TRENDS PHARMACOL SCI, V22, P114, DOI 10.1016/S0165-6147(00)01635-7; Degroot A, 2002, BRAIN RES, V949, P60, DOI 10.1016/S0006-8993(02)02965-7; Di Giorgi-Gerevini V, 2005, CELL DEATH DIFFER, V12, P1124, DOI 10.1038/sj.cdd.4401639; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Dringenberg HC, 2008, BEHAV BRAIN RES, V186, P143, DOI 10.1016/j.bbr.2007.07.030; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; File SE, 1996, PHARMACOL BIOCHEM BE, V54, P123, DOI 10.1016/0091-3057(95)02108-6; Francesconi W, 2004, BRAIN RES, V1022, P12, DOI 10.1016/j.brainres.2004.06.060; Furutani K, 2006, P NATL ACAD SCI USA, V103, P8528, DOI 10.1073/pnas.0600497103; GENAZZANI AA, 1994, BRAIN RES, V659, P10, DOI 10.1016/0006-8993(94)90857-5; Gomez-Pinilla F, 2005, EXP NEUROL, V192, P235, DOI 10.1016/j.expneurol.2004.12.001; Gomez-Pinilla F, 2001, BRAIN RES, V904, P13, DOI 10.1016/S0006-8993(01)02394-0; Gooney M, 2002, BEHAV NEUROSCI, V116, P455, DOI 10.1037//0735-7044.116.3.455; Gorski JA, 2003, NEUROSCIENCE, V121, P341, DOI 10.1016/S0306-4522(03)00426-3; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Jaako-Movits K, 2005, INT J DEV NEUROSCI, V23, P627, DOI 10.1016/j.ijdevneu.2005.07.005; Jia ZP, 1998, LEARN MEMORY, V5, P331; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Katoh-Semba R, 2002, FASEB J, V16, P1328, DOI 10.1096/fj.02-0143fje; Kesslak JP, 2003, NEUROSCI LETT, V353, P95, DOI 10.1016/j.neulet.2003.08.078; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Lante F, 2006, HIPPOCAMPUS, V16, P345, DOI 10.1002/hipo.20146; Leal-Galicia P, 2007, DEV NEUROBIOL, V67, P395, DOI 10.1002/dneu.20322; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Lee Y, 2006, NEUROSCI LETT, V398, P328, DOI 10.1016/j.neulet.2006.01.021; Lemaire V, 2006, EUR J NEUROSCI, V23, P3368, DOI 10.1111/j.1460-9568.2006.04870.x; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Li XH, 2007, CHINESE MED J-PEKING, V120, P669, DOI 10.1097/00029330-200704020-00011; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Lu YM, 1997, J NEUROSCI, V17, P5196; Luo CX, 2007, J NEUROSCI RES, V85, P1637, DOI 10.1002/jnr.21317; MACCARI S, 1995, J NEUROSCI, V15, P110; Maccari S, 2007, PSYCHONEUROENDOCRINO, V32, pS10, DOI 10.1016/j.psyneuen.2007.06.005; Mairesse J, 2007, PSYCHONEUROENDOCRINO, V32, P765, DOI 10.1016/j.psyneuen.2007.03.013; Manahan-Vaughan D, 2005, CEREB CORTEX, V15, P1703, DOI 10.1093/cercor/bhi047; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Matarredona ER, 2001, J NEUROCHEM, V76, P351, DOI 10.1046/j.1471-4159.2001.00056.x; MCCORMICK CM, 1995, DEV BRAIN RES, V84, P55, DOI 10.1016/0165-3806(94)00153-Q; McHugh SB, 2004, BEHAV NEUROSCI, V118, P63, DOI 10.1037/0735-7044.118.1.63; Montaron ME, 2004, NEUROTOX RES, V6, P571, DOI 10.1007/BF03033453; Naie K, 2004, CEREB CORTEX, V14, P189, DOI 10.1093/cercor/bhg118; NICOLETTI F, 1986, J NEUROCHEM, V46, P40, DOI 10.1111/j.1471-4159.1986.tb12922.x; NICOLETTI F, 1993, EUR J PHARM-MOLEC PH, V245, P297, DOI 10.1016/0922-4106(93)90111-L; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Palucha A, 2007, PHARMACOL THERAPEUT, V115, P116, DOI 10.1016/j.pharmthera.2007.04.007; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pietraszek M, 2005, EUR J PHARMACOL, V514, P25, DOI 10.1016/j.ejphar.2005.03.028; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Porter RHP, 2005, J PHARMACOL EXP THER, V315, P711, DOI 10.1124/jpet.105.089839; Rex A, 2005, EUR J NEUROSCI, V22, P1185, DOI 10.1111/j.1460-9568.2005.04251.x; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Robertson DAF, 2005, EUR J NEUROSCI, V21, P1511, DOI 10.1111/j.1460-9568.2005.03990.x; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Rubino T, 2008, NEUROPHARMACOLOGY, V54, P151, DOI 10.1016/j.neuropharm.2007.06.024; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Scerri C, 2006, PSYCHOPHARMACOLOGY, V184, P540, DOI 10.1007/s00213-005-0086-4; Schaaf MJM, 2001, BRAIN RES, V915, P227, DOI 10.1016/S0006-8993(01)02855-4; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Schoepp DD, 1996, NEUROPHARMACOLOGY, V35, P1661, DOI 10.1016/S0028-3908(96)00121-9; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Silhol M, 2007, NEUROSCIENCE, V146, P962, DOI 10.1016/j.neuroscience.2007.02.013; Simonyi A, 2005, DRUG NEWS PERSPECT, V18, P353, DOI 10.1358/dnp.2005.18.6.927927; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Spooren W, 2004, DRUG NEWS PERSPECT, V17, P251, DOI 10.1358/dnp.2004.17.4.829052; Steckler T, 2005, PSYCHOPHARMACOLOGY, V179, P198, DOI 10.1007/s00213-004-2056-7; Swanson CJ, 2005, NAT REV DRUG DISCOV, V4, P131, DOI 10.1038/nrd1630; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takahashi LK, 1998, INT J DEV NEUROSCI, V16, P199, DOI 10.1016/S0736-5748(98)00020-3; Tatarczynska E, 2001, PSYCHOPHARMACOLOGY, V158, P94, DOI 10.1007/s002130100798; Tatarczynska E, 2001, BRIT J PHARMACOL, V132, P1423, DOI 10.1038/sj.bjp.0703923; Topolnik L, 2006, J PHYSIOL-LONDON, V575, P115, DOI 10.1113/jphysiol.2006.112896; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Ueda S, 2005, NEUROSCIENCE, V135, P395, DOI 10.1016/j.neuroscience.2005.06.065; Vallee M, 1999, EUR J NEUROSCI, V11, P2906, DOI 10.1046/j.1460-9568.1999.00705.x; Vallee M, 1997, J NEUROSCI, V17, P2626; Van den Hove DLA, 2005, DEV NEUROSCI-BASEL, V27, P313, DOI 10.1159/000086711; van Praag H, 1998, BEHAV BRAIN RES, V92, P21, DOI 10.1016/S0166-4328(97)00117-4; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Venero JL, 2002, NEUROSCIENCE, V113, P857, DOI 10.1016/S0306-4522(02)00232-4; Viltart O, 2006, PSYCHONEUROENDOCRINO, V31, P769, DOI 10.1016/j.psyneuen.2006.02.007; Viveros MP, 2007, BEHAV PHARMACOL, V18, P375, DOI 10.1097/FBP.0b013e3282d28fb4; WARD IL, 1972, SCIENCE, V175, P82, DOI 10.1126/science.175.4017.82; Wati H, 2006, NEUROSCI LETT, V399, P171, DOI 10.1016/j.neulet.2006.01.056; Weinstock M, 2007, NEUROCHEM RES, V32, P1730, DOI 10.1007/s11064-007-9339-4; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yan XB, 2007, NEUROPHARMACOLOGY, V53, P487, DOI 10.1016/j.neuropharm.2007.06.020; Zagron G, 2006, BEHAV BRAIN RES, V175, P323, DOI 10.1016/j.bbr.2006.09.003; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	116	244	260	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2170	10.1371/journal.pone.0002170	http://dx.doi.org/10.1371/journal.pone.0002170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478112	Green Submitted, Green Published, gold			2022-12-27	WOS:000262172800035
J	May, JS; Smith, CM; Gill, MB; Stevenson, PG				May, Janet S.; Smith, Christopher M.; Gill, Michael B.; Stevenson, Philip G.			An Essential Role for the Proximal but Not the Distal Cytoplasmic Tail of Glycoprotein M in Murid Herpesvirus 4 Infection	PLOS ONE			English	Article								Murid herpesvirus-4 (MuHV-4) provides a tractable model with which to define common, conserved features of gammaherpesvirus biology. The multi-membrane spanning glycoprotein M (gM) is one of only 4 glycoproteins that are essential for MuHV-4 lytic replication. gM binds to gN and is thought to function mainly secondary envelopment and virion egress, for which several predicted trafficking motifs in its C-terminal cytoplasmic tail could be important. We tested the contribution of the gM cytoplasmic tail to MuHV-4 lytic replication by making recombinant viruses with varying C-terminal deletions. Removing an acidic cluster and a distal YXX Phi motif altered the capsid distribution somewhat in infected cells but had little effect on virus replication, either in vitro or in vivo. In contrast, removing a proximal YXX Phi motif as well completely prevented productive replication. gM was still expressed, but unlike its longer forms showed only limited colocalization with co-transfected gN, and in the context of whole virus appeared to support gN expression less well. We conclude that some elements of the gM cytoplasmic tail are dispensible for MuHV-4 replication, but the tail as a whole is not.	[May, Janet S.; Smith, Christopher M.; Gill, Michael B.; Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	University of Cambridge	May, JS (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	pgs27@cam.ac.uk	Stevenson, Philip g/F-9688-2014; Stevenson, Philip/F-6651-2011	Stevenson, Philip g/0000-0002-3520-5060; 	C.J. Martin fellowship; Wellcome Trust Senior Clinical Fellow [GR076956MA]; Medical Research Council [G0400427, G9800903]; CR-UK [C19612/A6189]; Medical Research Council [G9800943] Funding Source: researchfish; MRC [G0400427, G9800943] Funding Source: UKRI	C.J. Martin fellowship(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust Senior Clinical Fellow(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CR-UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CMS was supported by a C.J. Martin fellowship. PGS is a Wellcome Trust Senior Clinical Fellow (GR076956MA). This work was also supported by Medical Research Council grants G0400427 and G9800903, and CR-UK grant C19612/A6189.	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; BLASKOVIC D, 1980, ACTA VIROL, V24, P468; Bortz E, 2003, J VIROL, V77, P13425, DOI 10.1128/JVI.77.24.13425-13432.2003; Brack AR, 1999, J VIROL, V73, P5364, DOI 10.1128/JVI.73.7.5364-5372.1999; Browne H, 2004, J VIROL, V78, P1039, DOI 10.1128/JVI.78.2.1039-1041.2004; Coleman HM, 2003, J VIROL, V77, P2410, DOI 10.1128/JVI.77.4.2410-2417.2003; Crump CM, 2004, J GEN VIROL, V85, P3517, DOI 10.1099/vir.0.80361-0; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; Dijkstra JM, 1996, J VIROL, V70, P5684, DOI 10.1128/JVI.70.8.5684-5688.1996; Doherty PC, 2001, PHILOS T R SOC B, V356, P581, DOI 10.1098/rstb.2000.0786; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1355, DOI 10.1099/0022-1317-71-6-1355; Gillet L, 2007, J VIROL, V81, P280, DOI 10.1128/JVI.01616-06; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803; Hobom U, 2000, J VIROL, V74, P7720, DOI 10.1128/JVI.74.17.7720-7729.2000; Jenner RG, 2002, BBA-REV CANCER, V1602, P1, DOI 10.1016/S0304-419X(01)00040-3; Jons A, 1998, J VIROL, V72, P550; Kapadia SB, 2002, IMMUNITY, V17, P143, DOI 10.1016/S1074-7613(02)00369-2; Koyano S, 2003, J GEN VIROL, V84, P1485, DOI 10.1099/vir.0.18941-0; KOZUCH O, 1993, ACTA VIROL, V37, P101; Krzyzaniak M, 2007, J VIROL, V81, P10316, DOI 10.1128/JVI.00375-07; Lake CM, 2000, J VIROL, V74, P11162, DOI 10.1128/JVI.74.23.11162-11172.2000; Lee BJ, 2003, J IMMUNOL, V170, P243, DOI 10.4049/jimmunol.170.1.243; Mach M, 2005, J VIROL, V79, P2160, DOI 10.1128/JVI.79.4.2160-2170.2005; Mach M, 2000, J VIROL, V74, P11881, DOI 10.1128/JVI.74.24.11881-11892.2000; May JS, 2005, TRAFFIC, V6, P780, DOI 10.1111/j.1600-0854.2005.00316.x; May JS, 2005, J VIROL, V79, P5059, DOI 10.1128/JVI.79.8.5059-5068.2005; May JS, 2005, J GEN VIROL, V86, P919, DOI 10.1099/vir.0.80661-0; May JS, 2005, J VIROL, V79, P3459, DOI 10.1128/JVI.79.6.3459-3467.2005; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Moorman NJ, 2004, J VIROL, V78, P10282, DOI 10.1128/JVI.78.19.10282-10290.2004; Moorman NJ, 2003, VIROLOGY, V307, P179, DOI 10.1016/S0042-6822(02)00023-5; NASH AA, 1994, CURR OPIN IMMUNOL, V6, P560, DOI 10.1016/0952-7915(94)90141-4; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Rosa GT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000560; SCALZO AA, 1995, J GEN VIROL, V76, P2895, DOI 10.1099/0022-1317-76-11-2895; Smith CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001048; Song MJ, 2005, P NATL ACAD SCI USA, V102, P3805, DOI 10.1073/pnas.0404521102; Stevenson PG, 2005, VIRAL IMMUNOL, V18, P445, DOI 10.1089/vim.2005.18.445; Stevenson PG, 2004, CURR OPIN IMMUNOL, V16, P456, DOI 10.1016/j.coi.2004.05.002; Stevenson PG, 2002, MICROBES INFECT, V4, P1177, DOI 10.1016/S1286-4579(02)01643-X; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P3275, DOI 10.1099/0022-1317-73-12-3275; Tischer BK, 2002, J GEN VIROL, V83, P997, DOI 10.1099/0022-1317-83-5-997; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Virgin HW, 1999, CURR OPIN IMMUNOL, V11, P371, DOI 10.1016/S0952-7915(99)80063-6; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x; Ziegler C, 2005, J GEN VIROL, V86, P11, DOI 10.1099/vir.0.80393-0	49	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2131	10.1371/journal.pone.0002131	http://dx.doi.org/10.1371/journal.pone.0002131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461133	Green Submitted, Green Published, gold			2022-12-27	WOS:000261642400052
J	Todryk, SM; Bejon, P; Mwangi, T; Plebanski, M; Urban, B; Marsh, K; Hill, AVS; Flanagan, KL				Todryk, Stephen M.; Bejon, Philip; Mwangi, Tabitha; Plebanski, Magdalena; Urban, Britta; Marsh, Kevin; Hill, Adrian V. S.; Flanagan, Katie L.			Correlation of Memory T Cell Responses against TRAP with Protection from Clinical Malaria, and CD4(+) CD25(high) T Cells with Susceptibility in Kenyans	PLOS ONE			English	Article								Background: Immunity to malaria develops naturally in endemic regions, but the protective immune mechanisms are poorly understood. Many vaccination strategies aim to induce T cells against diverse pre-erythrocytic antigens, but correlates of protection in the field have been limited. The objective of this study was to investigate cell-mediated immune correlates of protection in natural malaria. Memory T cells reactive against thrombospondin-related adhesive protein (TRAP) and circumsporozoite (CS) protein, major vaccine candidate antigens, were measured, as were frequencies of CD4(+) CD25(high) T cells, which may suppress immunity, and CD56(+) NK cells and gamma delta T cells, which may be effectors or may modulate immunity. Methodology and Principal Findings: 112 healthy volunteers living in rural Kenya were entered in the study. Memory T cells reactive against TRAP and CS were measured using a cultured IFN gamma ELISPOT approach, whilst CD4(+) CD25(high) T cells, CD56(+) NK cells, and gamma delta T cells were measured by flow cytometry. We found that T cell responses against TRAP were established early in life (< 5 years) in contrast to CS, and cultured ELISPOT memory T cell responses did not correlate with ex-vivo IFN gamma ELISPOT effector responses. Data was examined for associations with risk of clinical malaria for a period of 300 days. Multivariate logistic analysis incorporating age and CS response showed that cultured memory T cell responses against TRAP were associated with a significantly reduced incidence of malaria (p = 0.028). This was not seen for CS responses. Higher numbers of CD4(+) CD25(high) T cells, potentially regulatory T cells, were associated with a significantly increased risk of clinical malaria (p = 0.039). Conclusions: These data demonstrate a role for central memory T cells in natural malarial immunity and support current vaccination strategies aimed at inducing durable protective T cell responses against the TRAP antigen. They also suggest that CD4(+) CD25(high) T cells may negatively affect naturally acquired malarial immunity.	[Todryk, Stephen M.; Bejon, Philip; Urban, Britta; Hill, Adrian V. S.] Univ Oxford, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Todryk, Stephen M.; Bejon, Philip; Mwangi, Tabitha; Urban, Britta; Marsh, Kevin; Flanagan, Katie L.] Kenya Med Res Inst KEMRI, Ctr Geograph Med Res Coast, Wellcome Trust Collaborat Res Programme, Kilifi, Kenya; [Hill, Adrian V. S.] Wellcome Trust Ctr Human Genet, Oxford, England; [Plebanski, Magdalena] Monash Univ, Dept Immunol, Clayton, Vic, Australia; [Flanagan, Katie L.] Med Res Council MRC Lab, Fajara, Gambia; [Todryk, Stephen M.] Northumbria Univ, Sch Appl Sci, Newcastle Upon Tyne, Tyne & Wear, England	University of Oxford; Kenya Medical Research Institute; University of Oxford; Wellcome Centre for Human Genetics; Monash University; University of London; London School of Hygiene & Tropical Medicine; Northumbria University	Todryk, SM (corresponding author), Univ Oxford, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England.	stephen.todryk@unn.ac.uk	Todryk, Stephen/AAA-3950-2019; Plebanski, Magdalena/AAU-3144-2021; Urban, Britta/W-6087-2018	Todryk, Stephen/0000-0003-4566-0793; Urban, Britta/0000-0002-4197-8393; , Magdalena/0000-0001-6889-3667; Flanagan, Katie/0000-0002-1575-1953	Wellcome Trust [fellowship]; Medical Research council	Wellcome Trust(Wellcome Trust); Medical Research council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge funding support from the Wellcome Trust and the Medical Research council. KF was supported by a Wellcome Trust fellowship in Clinical Tropical Medicine. AVSH is a Wellcome Trust Principal Research Fellow. Funders had no role in any aspect of this project.	Bejon P, 2006, CLIN INFECT DIS, V42, P1102, DOI 10.1086/501459; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Doolan DL, 2000, J IMMUNOL, V165, P1453, DOI 10.4049/jimmunol.165.3.1453; FERREIRA A, 1986, SCIENCE, V232, P881, DOI 10.1126/science.3085218; Flanagan KL, 1999, EUR J IMMUNOL, V29, P1943, DOI 10.1002/(SICI)1521-4141(199906)29:06&lt;1943::AID-IMMU1943&gt;3.0.CO;2-1; Flanagan KL, 2003, AM J TROP MED HYG, V68, P421, DOI 10.4269/ajtmh.2003.68.421; Flanagan KL, 2001, J IMMUNOL, V167, P4729, DOI 10.4049/jimmunol.167.8.4729; Godkin AJ, 2002, J IMMUNOL, V169, P2210, DOI 10.4049/jimmunol.169.4.2210; Hill AVS, 2006, NAT REV IMMUNOL, V6, P21, DOI 10.1038/nri1746; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Luty AJF, 1999, J INFECT DIS, V179, P980, DOI 10.1086/314689; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; RILEY EM, 1990, T ROY SOC TROP MED H, V84, P648, DOI 10.1016/0035-9203(90)90133-Y; Roetynck S, 2006, IMMUNOL REV, V214, P251, DOI 10.1111/j.1600-065X.2006.00446.x; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Taniguchi T, 2007, IMMUNOLOGY, V122, P514, DOI 10.1111/j.1365-2567.2007.02661.x; Vuola JM, 2005, J IMMUNOL, V174, P449, DOI 10.4049/jimmunol.174.1.449; Walther M, 2006, INFECT IMMUN, V74, P2706, DOI 10.1128/IAI.74.5.2706-2716.2006; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001; White KL, 1996, J IMMUNOL, V156, P3374	28	77	77	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2027	10.1371/journal.pone.0002027	http://dx.doi.org/10.1371/journal.pone.0002027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446217	Green Published, gold, Green Accepted			2022-12-27	WOS:000261572300001
J	Gilbert, P; Ciccarone, D; Gansky, SA; Bangsberg, DR; Clanon, K; McPhee, SJ; Calderon, SH; Bogetz, A; Gerbert, B				Gilbert, Paul; Ciccarone, Daniel; Gansky, Stuart A.; Bangsberg, David R.; Clanon, Kathleen; McPhee, Stephen J.; Calderon, Sophia H.; Bogetz, Alyssa; Gerbert, Barbara			Interactive "Video Doctor" Counseling Reduces Drug and Sexual Risk Behaviors among HIV-Positive Patients in Diverse Outpatient Settings	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; INFECTED PATIENTS; BISEXUAL MEN; PREVENTION; ADHERENCE; INTERVENTION; REDUCTION	Background: Reducing substance use and unprotected sex by HIV-positive persons improves individual health status while decreasing the risk of HIV transmission. Despite recommendations that health care providers screen and counsel their HIV-positive patients for ongoing behavioral risks, it is unknown how to best provide "prevention with positives'' in clinical settings. Positive Choice, an interactive, patient-tailored computer program, was developed in the United States to improve clinic-based assessment and counseling for risky behaviors. Methodology and Findings: We conducted a parallel groups randomized controlled trial (December 2003-September 2006) at 5 San Francisco area outpatient HIV clinics. Eligible patients (HIV-positive English-speaking adults) completed an in-depth computerized risk assessment. Participants reporting substance use or sexual risks (n = 476) were randomized in stratified blocks. The intervention group received tailored risk-reduction counseling from a "Video Doctor'' via laptop computer and a printed Educational Worksheet; providers received a Cueing Sheet on reported risks. Compared with control, fewer intervention participants reported continuing illicit drug use (RR 0.81, 95% CI: 0.689, 0.957, p = 0.014 at 3 months; and RR 0.65, 95% CI: 0.540, 0.785, p < 0.001 at 6 months) and unprotected sex (RR 0.88, 95% CI: 0.773, 0.993, p = 0.039 at 3 months; and RR 0.80, 95% CI: 0.686, 0.941, p = 0.007 at 6 months). Intervention participants reported fewer mean days of ongoing illicit drug use (-4.0 days vs. -1.3 days, p = 0.346, at 3 months; and -4.7 days vs. -0.7 days, p = 0.130, at 6 months) than did controls, and had fewer casual sex partners at (22.3 vs. 21.4, p = 0.461, at 3 months; and 22.7 vs. 20.6, p = 0.042, at 6 months). Conclusions: The Positive Choice intervention achieved significant cessation of illicit drug use and unprotected sex at the group-level, and modest individual-level reductions in days of ongoing drug use and number of casual sex partners compared with the control group. Positive Choice, including Video Doctor counseling, is an efficacious and appropriate adjunct to risk-reduction efforts in outpatient settings, and holds promise as a public health HIV intervention.	[Gilbert, Paul; Calderon, Sophia H.; Bogetz, Alyssa; Gerbert, Barbara] Univ Calif San Francisco, Div Behav Sci Professionalism & Eth, San Francisco, CA 94143 USA; [Ciccarone, Daniel] Univ Calif San Francisco, Dept Family & Commun Med, San Francisco, CA USA; [Ciccarone, Daniel] Univ Calif San Francisco, Dept Anthropol, History & Social Med, San Francisco, CA USA; [Gansky, Stuart A.] Univ Calif San Francisco, Div Oral Epidemiol & Dent Publ Hlth, San Francisco, CA USA; [Bangsberg, David R.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Infect Dis & Positive Hlth Program, Epidemiol & Prevent Interventions EPI Ctr, San Francisco, CA USA; [Clanon, Kathleen] East Bay AIDS Ed & Training Ctr, Oakland, CA USA; [McPhee, Stephen J.] Univ Calif San Francisco, Dept Med, Div Gen Intern Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gilbert, P (corresponding author), Univ Calif San Francisco, Div Behav Sci Professionalism & Eth, San Francisco, CA 94143 USA.	barbara.gerbert@ucsf.edu	Ciccarone, Daniel/I-5404-2013	Ciccarone, Daniel/0000-0002-2355-5477	US DHHS National Institute on Drug Abuse [R01DA15016, K23DA16165]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015016, K23DA016165] Funding Source: NIH RePORTER	US DHHS National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Positive Choice was sponsored by a grant from the US DHHS National Institute on Drug Abuse (R01DA15016). Dr. Ciccarone was supported by a training grant from the National Institute on Drug Abuse (K23DA16165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Aharonovich E, 2006, AIDS CARE, V18, P561, DOI 10.1080/09540120500264134; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bluespruce J, 2001, AIDS PATIENT CARE ST, V15, P243, DOI 10.1089/10872910152050766; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; *CDCP, 1998, SCIENCE, V280, P1905; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; CLOTTEY C, 1993, INFECT DIS CLIN N AM, V7, P753; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Duan N, 2001, PSYCHIATR SERV, V52, P413, DOI 10.1176/appi.ps.52.4.413; Elford J, 2006, CURR OPIN INFECT DIS, V19, P26, DOI 10.1097/01.qco.0000199018.50451.e1; Gebo KA, 2003, J GEN INTERN MED, V18, P104, DOI 10.1046/j.1525-1497.2003.10801.x; Gerbert B, 1999, MED CARE, V37, P104, DOI 10.1097/00005650-199901000-00014; Gerbert B, 2006, AIDS PATIENT CARE ST, V20, P19, DOI 10.1089/apc.2006.20.19; Gerbert B, 2001, AIDS PATIENT CARE ST, V15, P321, DOI 10.1089/108729101750279696; Gerbert Barbara, 2003, Health Promot Pract, V4, P249, DOI 10.1177/1524839903004003009; Golin CE, 2006, JAIDS-J ACQ IMM DEF, V42, P42, DOI 10.1097/01.qai.0000219771.97303.0a; Halkitis PN, 2003, AIDS CARE, V15, P89, DOI 10.1080/095401221000039798; Hays RB, 1997, AIDS, V11, P1495, DOI 10.1097/00002030-199712000-00014; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Johnson BT, 2006, JAIDS-J ACQ IMM DEF, V41, P642, DOI 10.1097/01.qai.0000194495.15309.47; Kalichman SC, 1997, HEALTH PSYCHOL, V16, P369, DOI 10.1037/0278-6133.16.4.369; Kalichman SC, 2002, ANN BEHAV MED, V24, P229, DOI 10.1207/S15324796ABM2403_08; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Kiene SM, 2006, J ADOLESCENT HEALTH, V39, P404, DOI 10.1016/j.jadohealth.2005.12.029; Lee LM, 2001, JAMA-J AM MED ASSOC, V285, P1308, DOI 10.1001/jama.285.10.1308; Lightfoot M, 2007, AIDS CARE, V19, P757, DOI 10.1080/09540120600971117; Lyles CM, 2007, AM J PUBLIC HEALTH, V97, P133, DOI 10.2105/AJPH.2005.076182; Lyles CM, 2006, AIDS EDUC PREV, V18, P21, DOI 10.1521/aeap.2006.18.supp.21; Metsch LR, 2004, AM J PUBLIC HEALTH, V94, P1186, DOI 10.2105/AJPH.94.7.1186; Metzger DS, 2000, AM J EPIDEMIOL, V152, P99, DOI 10.1093/aje/152.2.99; Morin SF, 2004, JAIDS-J ACQ IMM DEF, V36, P960, DOI 10.1097/00126334-200408010-00010; Morin SF, 2007, JAIDS-J ACQ IMM DEF, V44, P213, DOI 10.1097/QAI.0b013e31802c0cae; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Parsons JT, 2005, AIDS, V19, pS13, DOI 10.1097/01.aids.0000167348.15750.9a; Purcell DW, 2007, JAIDS-J ACQ IMM DEF, V46, pS35, DOI 10.1097/QAI.0b013e31815767c4; Rollnick S, 1992, J MENT HEALTH, V1, P25, DOI DOI 10.3109/09638239209034509; Rollnick S, 1995, BEHAV COGN PSYCHOTH, V23, P325, DOI DOI 10.1017/S135246580001643X; Schneider E., 2006, Morbidity and Mortality Weekly Report, V55, P589; Steward WT, 2006, AIDS BEHAV, V10, P3, DOI 10.1007/s10461-005-9024-z	42	88	88	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1988	10.1371/journal.pone.0001988	http://dx.doi.org/10.1371/journal.pone.0001988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	381TL	18431475	gold, Green Published, Green Submitted			2022-12-27	WOS:000261558700010
J	Batelli, S; Albani, D; Rametta, R; Polito, L; Prato, F; Pesaresi, M; Negro, A; Forloni, G				Batelli, Sara; Albani, Diego; Rametta, Raffaela; Polito, Letizia; Prato, Francesca; Pesaresi, Marzia; Negro, Alessandro; Forloni, Gianluigi			DJ-1 Modulates alpha-Synuclein Aggregation State in a Cellular Model of Oxidative Stress: Relevance for Parkinson's Disease and Involvement of HSP70	PLOS ONE			English	Article								Background: Parkinson's disease (PD) is a neurodegenerative pathology whose molecular etiopathogenesis is not known. Novel contributions have come from familial forms of PD caused by alterations in genes with apparently unrelated physiological functions. The gene coding for alpha-synuclein (alpha-syn) (PARK1) has been investigated as alpha-syn is located in Lewy bodies (LB), intraneuronal inclusions in the substantia nigra (SN) of PD patients. A-syn has neuroprotective chaperone-like and antioxidant functions and is involved in dopamine storage and release. DJ-1 (PARK7), another family-PD-linked gene causing an autosomal recessive form of the pathology, shows antioxidant and chaperone-like activities too. Methodology/Principal Findings: The present study addressed the question whether alpha-syn and DJ-1 interact functionally, with a view to finding some mechanism linking DJ-1 inactivation and alpha-syn aggregation and toxicity. We developed an in vitro model of alpha-syn toxicity in the human neuroblastoma cell line SK-N-BE, influencing DJ-1 and alpha-syn intracellular concentrations by exogenous addition of the fusion proteins TAT-alpha-syn and TAT-DJ-1; DJ-1 was inactivated by the siRNA method. On a micromolar scale TAT-alpha-syn aggregated and triggered neurotoxicity, while on the nanomolar scale it was neuroprotective against oxidative stress (induced by H2O2 or 6-hydroxydopamine). TAT-DJ-1 increased the expression of HSP70, while DJ-1 silencing made SK-N-BE cells more susceptible to oxidative challenge, rendering TAT-alpha-syn neurotoxic at nanomolar scale, with the appearance of TAT-alpha-syn aggregates. Conclusion/Significance: DJ-1 inactivation may thus promote alpha-syn aggregation and the related toxicity, and in this model HSP70 is involved in the antioxidant response and in the regulation of alpha-syn fibril formation.	[Batelli, Sara; Albani, Diego; Polito, Letizia; Prato, Francesca; Pesaresi, Marzia; Forloni, Gianluigi] Mario Negri Inst Pharmacol Res, Dept Neurosci, I-20157 Milan, Italy; [Rametta, Raffaela] Univ Milan, Mangiagalli Regina Elena Fdn IRCCS, Dept Internal Med, Milan, Italy; [Negro, Alessandro] Univ Padua, Dept Biochem, Padua, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Padua	Batelli, S (corresponding author), Mario Negri Inst Pharmacol Res, Dept Neurosci, Via Eritrea 62, I-20157 Milan, Italy.	albani@marionegri.it	Forloni, Gianluigi/AAB-2115-2020; ALBANI, DIEGO/I-5183-2018	Forloni, Gianluigi/0000-0001-5374-3914; ALBANI, DIEGO/0000-0002-7050-6723; rametta, raffaela/0000-0003-0091-9394; NEGRO, ALESSANDRO/0000-0003-3142-7632; Polito, Letizia/0000-0001-7014-9677	Italian Istituto Superiore di Sanita [N.530/F-A13]; Cenci-Gallingani Foundation post-graduate fellowship	Italian Istituto Superiore di Sanita; Cenci-Gallingani Foundation post-graduate fellowship	This work was supported by the public grant N.530/F-A13 from Italian Istituto Superiore di Sanita. L.P. is recipient of a Cenci-Gallingani Foundation post-graduate fellowship.	Abeliovich A, 2006, J NEUROCHEM, V99, P1062, DOI 10.1111/j.1471-4159.2006.04102.x; Ahn M, 2006, BIOCHEM BIOPH RES CO, V346, P1142, DOI 10.1016/j.bbrc.2006.05.213; Albani D, 2004, FASEB J, V18, P1713, DOI 10.1096/fj.04-1621fje; Bonifati V, 2004, J MOL MED, V82, P163, DOI 10.1007/s00109-003-0512-1; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Di Monte DA, 2003, LANCET NEUROL, V2, P531, DOI 10.1016/S1474-4422(03)00501-5; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; Eerola J, 2003, NEUROLOGY, V61, P1000, DOI 10.1212/01.WNL.0000083992.28066.7E; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Fleming Sheila M, 2005, NeuroRx, V2, P495, DOI 10.1602/neurorx.2.3.495; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Gosal D, 2006, EUR J NEUROL, V13, P616, DOI 10.1111/j.1468-1331.2006.01336.x; Hardy J, 2003, LANCET NEUROL, V2, P221, DOI 10.1016/S1474-4422(03)00350-8; Hashimoto M, 2003, ANN NY ACAD SCI, V991, P171; Hedrich K, 2004, NEUROLOGY, V62, P389, DOI 10.1212/01.WNL.0000113022.51739.88; HUANG C, 2006, J MOL BIOL; JELLINGER KA, 2006, J NEUROL SCI; Klein C, 2006, NAT CLIN PRACT NEURO, V2, P136, DOI 10.1038/ncpneuro0126; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Klucken J, 2006, FASEB J, V20, P2050, DOI 10.1096/fj.05-5422com; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lykkebo S, 2002, NEUROMOL MED, V2, P115, DOI 10.1385/NMM:2:2:115; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Nishioka K, 2006, ANN NEUROL, V59, P298, DOI 10.1002/ana.20753; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Ved R, 2005, J BIOL CHEM, V280, P42655, DOI 10.1074/jbc.M505910200; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Wersinger C, 2003, MOL CELL NEUROSCI, V24, P91, DOI 10.1016/S1044-7431(03)00124-6; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200; Zhou WB, 2004, J BIOL CHEM, V279, P10128, DOI 10.1074/jbc.M307563200	38	113	118	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1884	10.1371/journal.pone.0001884	http://dx.doi.org/10.1371/journal.pone.0001884			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382667	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795400018
J	Clark, K; Middelbeek, J; Morrice, NA; Figdor, CG; Lasonder, E; van Leeuwen, FN				Clark, Kristopher; Middelbeek, Jeroen; Morrice, Nick A.; Figdor, Carl G.; Lasonder, Edwin; van Leeuwen, Frank N.			Massive Autophosphorylation of the Ser/Thr-Rich Domain Controls Protein Kinase Activity of TRPM6 and TRPM7	PLOS ONE			English	Article								TRPM6 and TRPM7 are bifunctional proteins expressing a TRP channel fused to an atypical alpha-kinase domain. While the gating properties of TRPM6 and TRPM7 channels have been studied in detail, little is known about the mechanisms regulating kinase activity. Recently, we found that TRPM7 associates with its substrate myosin II via a kinase-dependent mechanism suggesting a role for autophosphorylation in substrate recognition. Here, we demonstrate that the cytosolic C-terminus of TRPM7 undergoes massive autophosphorylation (32 +/- 4 mol/mol), which strongly increases the rate of substrate phosphorylation. Phosphomapping by mass spectrometry indicates that the majority of autophosphorylation sites (37 out of 46) map to a Ser/Thr-rich region immediately N-terminal of the catalytic domain. Deletion of this region prevents substrate phosphorylation without affecting intrinsic catalytic activity suggesting that the Ser/Thr-rich domain contributes to substrate recognition. Surprisingly, the TRPM6-kinase is regulated by an analogous mechanism despite a lack of sequence conservation with the TRPM7 Ser/Thr-rich domain. In conclusion, our findings support a model where massive autophosphorylation outside the catalytic domain of TRPM6 and TRPM7 may facilitate kinase-substrate interactions leading to enhanced phosphorylation of those substrates.	[Clark, Kristopher; Figdor, Carl G.; van Leeuwen, Frank N.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands; [Middelbeek, Jeroen; van Leeuwen, Frank N.] Radboud Univ Nijmegen Med Ctr, Med Ctr, Nijmegen Ctr Mol Life Sci, Lab Pediat Oncol, Nijmegen, Netherlands; [Lasonder, Edwin] Radboud Univ Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Ctr Mol & Biomol Informat, Nijmegen, Netherlands; [Morrice, Nick A.] Univ Dundee, James Black Ctr, MRC Protein Phosphorylat Unit, Dundee, Scotland	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Dundee	Clark, K (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands.	FN.vanleeuwen@cukz.umcn.nl	Middelbeek, Jeroen/A-1126-2010; van Leeuwen, Frank/AAQ-6799-2020; Figdor, Carl G/A-4232-2010	van Leeuwen, Frank/0000-0003-1107-6513; Figdor, Carl G/0000-0002-2366-9212; Lasonder, Edwin/0000-0003-2582-3444	FEBS; Dutch Cancer Society [KUN 2002-2593, KUN 2007-3733]	FEBS; Dutch Cancer Society(KWF Kankerbestrijding)	The work was supported by a short-term fellowship from FEBS to KC and grants from the Dutch Cancer Society to FvL (KUN 2002-2593/KUN 2007-3733).	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Boedding M., 2007, V179, P299; Clancy CE, 1997, J BIOL CHEM, V272, P11812, DOI 10.1074/jbc.272.18.11812; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Clark K, 2007, TRENDS CELL BIOL, V17, P178, DOI 10.1016/j.tcb.2007.02.002; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Diggle TA, 1999, FEBS LETT, V457, P189, DOI 10.1016/S0014-5793(99)01034-0; Dorovkov MV, 2004, J BIOL CHEM, V279, P50643, DOI 10.1074/jbc.C400441200; Drennan D, 2004, PROG BIOPHYS MOL BIO, V85, P1, DOI 10.1016/S0079-6107(03)00060-9; Hanano T, 2004, J PHARMACOL SCI, V95, P403, DOI 10.1254/jphs.FP0040273; Hermosura MC, 2005, P NATL ACAD SCI USA, V102, P11510, DOI 10.1073/pnas.0505149102; Kolman MF, 1997, J BIOL CHEM, V272, P16904, DOI 10.1074/jbc.272.27.16904; Kozak JA, 2003, BIOPHYS J, V84, P922, DOI 10.1016/S0006-3495(03)74909-1; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Langeslag M, 2007, J BIOL CHEM, V282, P232, DOI 10.1074/jbc.M605300200; Liang WC, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-19; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; MEDLEY QG, 1990, BIOCHEMISTRY-US, V29, P8992, DOI 10.1021/bi00490a016; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Numata T, 2007, AM J PHYSIOL-CELL PH, V292, pC460, DOI 10.1152/ajpcell.00367.2006; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pavur KS, 2000, BIOCHEMISTRY-US, V39, P12216, DOI 10.1021/bi0007270; Penner R., 2007, V179, P313; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; Ryazanova LV, 2004, J BIOL CHEM, V279, P3708, DOI 10.1074/jbc.M308820200; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2005, J BIOL CHEM, V280, P37763, DOI 10.1074/jbc.M509175200; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Steimle PA, 2001, J BIOL CHEM, V276, P6853, DOI 10.1074/jbc.M008992200; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8	39	74	78	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1876	10.1371/journal.pone.0001876	http://dx.doi.org/10.1371/journal.pone.0001876			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365021	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000260762400027
J	Kasahara, T; Kubota, M; Miyauchi, T; Ishiwata, M; Kato, T				Kasahara, Takaoki; Kubota, Mie; Miyauchi, Taeko; Ishiwata, Mizuho; Kato, Tadafumi			A Marked Effect of Electroconvulsive Stimulation on Behavioral Aberration of Mice with Neuron-Specific Mitochondrial DNA Defects	PLOS ONE			English	Article								We developed transgenic (Tg) mice modeling an autosomally inherited mitochondrial disease, chronic progressive external ophthalmoplegia, patients with which sometimes have comorbid mood disorders. The mutant animals exhibited bipolar disorder-like phenotypes, such as a distorted day-night rhythm and a robust activity change with a period of 4-5 days, and the behavioral abnormalities were improved by lithium. In this study, we tested the effect of electroconvulsive stimulation (ECS) on the behavioral abnormalities of the model. Electroconvulsive therapy, which has long been used in clinical practice, provides fast-acting relief to depressive patients and drug-resistant patients. We performed long-term recordings of wheel-running activity of Tg and non-Tg mice. While recording, we administrated a train of ECS to mice, six times over two weeks or three times over a week. The treatment ameliorated the distorted day-night rhythm within three times of ECS, but it had no effect on the activity change with a period of 4-5 days in the female mice. To study the mechanism of the action, we investigated whether ECS could alter the circadian phase but found no influence on the circadian clock system. The potent and fast-acting efficacy of ECS in the mutant mice supports the predictive validity of the mice as a model of bipolar disorder. This model will be useful in developing a safe and effective alternative to lithium or electroconvulsive therapy.	[Kasahara, Takaoki; Kubota, Mie; Miyauchi, Taeko; Ishiwata, Mizuho; Kato, Tadafumi] RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama, Japan	RIKEN	Kasahara, T (corresponding author), RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama, Japan.	casa@brain.riken.jp	Kasahara, Takaoki/AAJ-5367-2020; Kato, Tadafumi/J-3583-2014	Kasahara, Takaoki/0000-0002-0953-5146; Kato, Tadafumi/0000-0001-7856-3952	Laboratory for Molecular Dynamics of Mental Disorders, RIKEN BSI; Japanese Ministry of Health and Labor [Grant-in-Aid]; Japanese Ministry of Education, Culture, Sports, Science and Technology [Grant-in-Aid]	Laboratory for Molecular Dynamics of Mental Disorders, RIKEN BSI; Japanese Ministry of Health and Labor; Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants to the Laboratory for Molecular Dynamics of Mental Disorders, RIKEN BSI; a Grant-in-Aid from the Japanese Ministry of Health and Labor; and Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altar CA, 2004, J NEUROSCI, V24, P2667, DOI 10.1523/JNEUROSCI.5377-03.2004; *AM PSYCH ASS, 2001, PRACT ECT RECOMM TRE; Angelucci F, 2003, INT J NEUROPSYCHOPH, V6, P225, DOI 10.1017/S1461145703003468; Angelucci F, 2003, NEUROPEPTIDES, V37, P51, DOI 10.1016/S0143-4179(03)00004-0; Crow TJ, 2007, AM J PSYCHIAT, V164, P13, DOI 10.1176/appi.ajp.164.1.13; Daly JJ, 2001, BIPOLAR DISORD, V3, P95, DOI 10.1034/j.1399-5618.2001.030208.x; Einat H, 2007, NEUROSCI BIOBEHAV R, V31, P850, DOI 10.1016/j.neubiorev.2006.12.001; Fukumoto T, 2001, PSYCHOPHARMACOLOGY, V158, P100, DOI 10.1007/s002130100871; Goodwin F, 1990, MANIC DEPRESSIVE ILL; Gould TD, 2007, NEUROSCI BIOBEHAV R, V31, P825, DOI 10.1016/j.neubiorev.2007.05.007; Honrado GI, 1996, J COMP PHYSIOL A, V178, P563; Ji RR, 1998, P NATL ACAD SCI USA, V95, P15635, DOI 10.1073/pnas.95.26.15635; Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824; Kato T, 2007, CNS DRUGS, V21, P1, DOI 10.2165/00023210-200721010-00001; Kato T, 2007, PSYCHIAT CLIN NEUROS, V61, P3, DOI 10.1111/j.1440-1819.2007.01604.x; Kubota M, 2006, J NEUROSCI, V26, P12314, DOI 10.1523/JNEUROSCI.3933-06.2006; Newton SS, 2003, J NEUROSCI, V23, P10841; PERRIS C, 1966, ACTA PSYCHIAT SCAND, VS 42, P153; T, 2007, NEUROSCI BIOBEHAV R, V31, P832; Travnickova Z, 1996, AM J PHYSIOL-REG I, V271, pR825, DOI 10.1152/ajpregu.1996.271.4.R825; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034	21	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1877	10.1371/journal.pone.0001877	http://dx.doi.org/10.1371/journal.pone.0001877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365022	Green Published, gold, Green Submitted			2022-12-27	WOS:000260762400028
J	Tseng, H; Chou, WC; Wang, JW; Zhang, XH; Zhang, SL; Schultz, RM				Tseng, Hung; Chou, Weichin; Wang, Junwen; Zhang, Xiaohong; Zhang, Shengliang; Schultz, Richard M.			Mouse Ribosomal RNA Genes Contain Multiple Differentially Regulated Variants	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; PROTEIN-SYNTHESIS; LENGTH HETEROGENEITY; MOLECULAR-BASIS; HUMAN RDNA; DNA; METHYLATION; CELL; BASONUCLIN; AMPLIFICATION	Background: Previous cytogenetic studies suggest that various rDNA chromosomal loci are not equally active in different cell types. Consistent with this variability, rDNA polymorphism is well documented in human and mouse. However, attempts to identify molecularly rDNA variant types, which are regulated individually (i.e., independent of other rDNA variants) and tissue-specifically, have not been successful. We report here the molecular cloning and characterization of seven mouse rDNA variants (v-rDNA). The identification of these v-rDNAs was based on restriction fragment length polymorphisms (RFLPs), which are conserved among individuals and mouse strains. The total copy number of the identified variants is less than 100 and the copy number of each individual variant ranges from 4 to 15. Sequence analysis of the cloned v-rDNA identified variant-specific single nucleotide polymorphisms (SNPs) in the transcribed region. These SNPs were used to develop a set of variant-specific PCR assays, which permitted analysis of the v-rDNAs' expression profiles in various tissues. These profiles show that three v-rDNAs are expressed in all tissues (constitutively active), two are expressed in some tissues (selectively active), and two are not expressed (silent). These expression profiles were observed in six individuals from three mouse strains, suggesting the pattern is not randomly determined. Thus, the mouse rDNA array likely consists of genetically distinct variants, and some are regulated tissue-specifically. Our results provide the first molecular evidence for cell-type-specific regulation of a subset of rDNA.	[Tseng, Hung; Chou, Weichin; Zhang, Xiaohong; Zhang, Shengliang] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Tseng, Hung] Univ Penn, Cell & Dev Biol, Philadelphia, PA USA; [Tseng, Hung; Schultz, Richard M.] Univ Penn, Ctr Res Reproduct & Womens Hlth, Philadelphia, PA USA; [Wang, Junwen] Univ Penn, Ctr Bioinformat, Dept Genet, Philadelphia, PA USA; [Wang, Junwen] Univ Penn, Dept Comp & Informat Sci, Philadelphia, PA USA; [Schultz, Richard M.] Univ Penn, Dept Biol, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Tseng, H (corresponding author), Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA.	htsengpe@mail.med.upenn.edu	Wang, Junwen/C-4432-2009; Wang, Junwen/D-3700-2011	Wang, Junwen/0000-0002-4432-4707	NIH [AG14456, EY13637, HD22681]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD022681] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD022681] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014456] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants AG14456, EY13637 to HT, and HD22681 to RMS. The funding agencies had no role in the conception, design, conduct, analysis and reporting of this work.	ARNHEIM N, 1979, J MOL BIOL, V134, P743, DOI 10.1016/0022-2836(79)90483-2; ARNHEIM N, 1977, CELL, V11, P363, DOI 10.1016/0092-8674(77)90053-8; ARNHEIM N, 1982, P NATL ACAD SCI-BIOL, V79, P4677, DOI 10.1073/pnas.79.15.4677; Bachvarova R, 1985, Dev Biol (N Y 1985), V1, P453; BIRD AP, 1982, ADV EXP MED BIOL, V158, P375; BROWN DD, 1968, SCIENCE, V160, P272, DOI 10.1126/science.160.3825.272; Caburet S, 2005, GENOME RES, V15, P1079, DOI 10.1101/gr.3970105; Comai L, 2004, ADV PROTEIN CHEM, V67, P123; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CORY S, 1977, CELL, V11, P795, DOI 10.1016/0092-8674(77)90292-6; DECAPOA A, 1985, HUM GENET, V69, P212, DOI 10.1007/BF00293027; DECAPOA A, 1985, J CELL SCI, V74, P21; DEV VG, 1977, GENETICS, V86, P389; ELSEVIER SM, 1975, CHROMOSOMA, V52, P219, DOI 10.1007/BF00332112; ERICKSON JM, 1985, AM J HUM GENET, V37, P311; FLAVELL RB, 1986, PHILOS T ROY SOC B, V314, P385, DOI 10.1098/rstb.1986.0060; Gogel E, 1996, CHROMOSOMA, V104, P511, DOI 10.1007/BF00352115; GONZALEZ IL, 1990, MOL BIOL EVOL, V7, P203; Gonzalez IL, 2001, GENOMICS, V73, P255, DOI 10.1006/geno.2001.6540; GONZALEZ IL, 1985, P NATL ACAD SCI USA, V82, P7666, DOI 10.1073/pnas.82.22.7666; Green H, 2005, MOL B INT U, P207; Grozdanov P, 2003, GENOMICS, V82, P637, DOI 10.1016/S0888-7543(03)00199-X; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; GUNDERSON JH, 1987, SCIENCE, V238, P933, DOI 10.1126/science.3672135; HENDERSON AS, 1974, CHROMOSOMA, V49, P155, DOI 10.1007/BF00348887; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; KUEHN M, 1983, NUCLEIC ACIDS RES, V11, P211, DOI 10.1093/nar/11.1.211; Kuo BA, 1996, NUCLEIC ACIDS RES, V24, P4817, DOI 10.1093/nar/24.23.4817; LABELLA T, 1989, GENOMICS, V5, P752, DOI 10.1016/0888-7543(89)90117-1; LATHAM KE, 1991, DEVELOPMENT, V112, P921; LATHAM KE, 1994, DEV BIOL, V163, P341, DOI 10.1006/dbio.1994.1153; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Ma J, 2006, DEVELOPMENT, V133, P2053, DOI 10.1242/dev.02371; Mahoney MG, 1998, BIOL REPROD, V59, P388, DOI 10.1095/biolreprod59.2.388; Mauro VP, 2007, CELL CYCLE, V6, P2246, DOI 10.4161/cc.6.18.4739; Mauro VP, 2002, P NATL ACAD SCI USA, V99, P12031, DOI 10.1073/pnas.192442499; McStay B, 2006, GENE DEV, V20, P1207, DOI 10.1101/gad.1436906; McStay B, 2002, GENE EXPRESSION, V10, P263, DOI 10.3727/000000002783992415; MILLER DA, 1976, GENETICS, V84, P67; MILLER KG, 1981, CELL, V27, P165, DOI 10.1016/0092-8674(81)90370-6; MOSS T, 1983, NATURE, V302, P223, DOI 10.1038/302223a0; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; Oh B, 2000, DEVELOPMENT, V127, P3795; Osheim YN, 1996, J CELL BIOL, V133, P943, DOI 10.1083/jcb.133.5.943; PERKOWSKA E, 1968, NATURE, V217, P649, DOI 10.1038/217649a0; Qin XL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r63; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; REEDER RH, 1984, CELL, V38, P349, DOI 10.1016/0092-8674(84)90489-6; ROCHAIX JD, 1974, J MOL BIOL, V87, P473, DOI 10.1016/0022-2836(74)90098-9; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; SOGO JM, 1984, J MOL BIOL, V178, P897, DOI 10.1016/0022-2836(84)90318-8; Stancheva I, 1997, NUCLEIC ACIDS RES, V25, P1727, DOI 10.1093/nar/25.9.1727; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; TSENG H, 1988, CELL, V54, P491, DOI 10.1016/0092-8674(88)90070-0; Tseng H, 1998, Front Biosci, V3, pD985; Tseng H, 2006, BIOESSAYS, V28, P719, DOI 10.1002/bies.20430; Wang QX, 1997, MOL REPROD DEV, V47, P265, DOI 10.1002/(SICI)1098-2795(199707)47:3&lt;265::AID-MRD5&gt;3.0.CO;2-J; WATERS AP, 1989, NATURE, V342, P438, DOI 10.1038/342438a0; WELLAUER PK, 1976, J MOL BIOL, V105, P461, DOI 10.1016/0022-2836(76)90229-1; WELLAUER PK, 1976, J MOL BIOL, V105, P487, DOI 10.1016/0022-2836(76)90230-8; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Zhang SL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000902; Zhang XH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001087	65	42	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1843	10.1371/journal.pone.0001843	http://dx.doi.org/10.1371/journal.pone.0001843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365001	gold, Green Published, Green Submitted			2022-12-27	WOS:000260762400007
J	Miretti, S; Roato, I; Taulli, R; Ponzetto, C; Cilli, M; Olivero, M; Di Renzo, MF; Godio, L; Albini, A; Buracco, P; Ferracini, R				Miretti, Silvia; Roato, Ilaria; Taulli, Riccardo; Ponzetto, Carola; Cilli, Michele; Olivero, Martina; Di Renzo, Maria Flavia; Godio, Laura; Albini, Adriana; Buracco, Paolo; Ferracini, Riccardo			A Mouse Model of Pulmonary Metastasis from Spontaneous Osteosarcoma Monitored In Vivo by Luciferase Imaging	PLOS ONE			English	Article								Background: Osteosarcoma (OSA) is lethal when metastatic after chemotherapy and/or surgical treatment. Thus animal models are necessary to study the OSA metastatic spread and to validate novel therapies able to control the systemic disease. We report the development of a syngeneic (Balb/c) murine OSA model, using a cell line derived from a spontaneous murine tumor. Methodology: The tumorigenic and metastatic ability of OSA cell lines were assayed after orthotopic injection in mice distal femur. Expression profiling was carried out to characterize the parental and metastatic cell lines. Cells from metastases were propagated and engineered to express Luciferase, in order to follow metastases in vivo. Principal Findings: Luciferase bioluminescence allowed to monitor the primary tumor growth and revealed the appearance of spontaneous pulmonary metastases. In vivo assays showed that metastasis is a stable property of metastatic OSA cell lines after both propagation in culture and luciferase trasduction. When compared to parental cell line, both unmodified and genetically marked metastatic cells, showed comparable and stable differential expression of the enpp4, pfn2 and prkcd genes, already associated to the metastatic phenotype in human cancer. Conclusions: This OSA animal model faithfully recapitulates some of the most important features of the human malignancy, such as lung metastatization. Moreover, the non-invasive imaging allows monitoring the tumor progression in living mice. A great asset of this model is the metastatic phenotype, which is a stable property, not modifiable after genetic manipulation.	[Miretti, Silvia] Univ Turin, Sch Vet Med, Dept Morphophysiol, Turin, Italy; [Roato, Ilaria; Taulli, Riccardo; Ponzetto, Carola] Ctr Expt Res & Med Stud, Turin, Italy; [Taulli, Riccardo; Ponzetto, Carola] Univ Turin, Dept Anat, Pharmacol & Forensic Med, Turin, Italy; [Cilli, Michele] Natl Inst Canc Res, Anim Res Facil, Genoa, Italy; [Olivero, Martina; Di Renzo, Maria Flavia] Univ Turin, Sch Med, IRCC, Lab Canc Genet, Turin, Italy; [Godio, Laura] ASO San Giovanni Battista, Dept Pathol, Lab Pathol, Turin, Italy; [Albini, Adriana] IRCCS Multimedica Sci & Technol Pk, Milan, Italy; [Buracco, Paolo] Univ Turin, Sch Vet Med, Dept Anim Pathol, Turin, Italy; [Ferracini, Riccardo] ASO San Giovanni Battista, Dept Orthopaed, Turin, Italy	University of Turin; University of Turin; University of Genoa; IRCCS AOU San Martino IST; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; IRCCS Multimedica; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Miretti, S (corresponding author), Univ Turin, Sch Vet Med, Dept Morphophysiol, Turin, Italy.	silvia.miretti@unito.it	olivero, martina/J-4811-2018; Ferracini, Riccardo/AAL-4622-2020; DI RENZO, Maria Flavia/B-6091-2012; Albini, Adriana/J-3701-2018; TAULLI, Riccardo/J-7347-2018; Buracco, Paolo/J-8251-2014; Cilli, Michele/AAB-8529-2019	olivero, martina/0000-0002-6815-3498; DI RENZO, Maria Flavia/0000-0002-5093-3373; TAULLI, Riccardo/0000-0003-1277-6263; Buracco, Paolo/0000-0002-0181-0887; Cilli, Michele/0000-0003-4083-8986; Roato, Ilaria/0000-0003-3029-4743; Albini, Adriana/0000-0002-9624-5103; MIRETTI, SILVIA/0000-0002-6693-2527	Fondazione Internazionale di Ricerca in Medicina Sperimentale (FIRMS); Compagnia di San Paolo	Fondazione Internazionale di Ricerca in Medicina Sperimentale (FIRMS); Compagnia di San Paolo(Compagnia di San Paolo)	This work was mainly supported by a grant from Fondazione Internazionale di Ricerca in Medicina Sperimentale (FIRMS) and from Compagnia di San Paolo, "Special Project Oncology". Xenogen IVIS imaging system was supported by San Paolo foundation.	Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; ARESU O, 1991, INVAS METAST, V11, P2; Asai T, 1998, INT J CANCER, V76, P418, DOI 10.1002/(SICI)1097-0215(19980504)76:3<418::AID-IJC21>3.3.CO;2-E; Bell RS, 1997, J BONE JOINT SURG AM, V79A, P1663, DOI 10.2106/00004623-199711000-00008; Cairns RA, 2004, CLIN EXP METASTAS, V21, P275, DOI 10.1023/B:CLIN.0000037729.75981.9e; CANON JR, 2007, CLIN EXP METASTASIS; Choy G, 2003, BIOTECHNIQUES, V35, P1022, DOI 10.2144/03355rr02; Cook SH, 2003, J VIROL, V77, P5333, DOI 10.1128/JVI.77.9.5333-5338.2003; DAVIS AM, 1994, J CLIN ONCOL, V12, P423, DOI 10.1200/JCO.1994.12.2.423; Deroose CM, 2007, J NUCL MED, V48, P295; DORFMAN HD, 1995, CANCER, V75, P203, DOI 10.1002/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO;2-V; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; Gomes CMF, 2007, EUR J NUCL MED MOL I, V34, P1793, DOI 10.1007/s00259-007-0480-8; GOORIN AM, 1991, J CLIN ONCOL, V9, P600, DOI 10.1200/JCO.1991.9.4.600; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Jia SF, 1999, CLIN EXP METASTAS, V17, P501, DOI 10.1023/A:1006623001465; Kadurugamuwa JL, 2004, ANTIMICROB AGENTS CH, V48, P2283, DOI 10.1128/AAC.48.6.2283-2287.2004; Khanna C, 2001, CANCER RES, V61, P3750; Kruger JS, 2003, MOL CANCER RES, V1, P801; Lee MS, 2005, MOL CELL BIOL, V25, P6921, DOI 10.1128/MCB.25.16.6921-6936.2005; Link M P, 1993, Cancer Treat Res, V62, P383; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; Mankin HJ, 2004, CLIN ORTHOP RELAT R, P286, DOI 10.1097/01.blo.0000145991.65770.e6; McClatchey AI, 1999, ONCOGENE, V18, P5334, DOI 10.1038/sj.onc.1203086; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Patane S, 2006, CANCER RES, V66, P4750, DOI 10.1158/0008-5472.CAN-05-4422; SCHMIDT J, 1988, DIFFERENTIATION, V39, P151, DOI 10.1111/j.1432-0436.1988.tb00090.x; Tsuchiya H, 2002, J CLIN ONCOL, V20, P3470, DOI 10.1200/JCO.2002.11.028; WARD WG, 1994, J CLIN ONCOL, V12, P1849, DOI 10.1200/JCO.1994.12.9.1849; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P380, DOI 10.1128/AAC.49.1.380-387.2005; Zhang WS, 2003, DRUG METAB DISPOS, V31, P1054, DOI 10.1124/dmd.31.8.1054	34	35	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1828	10.1371/journal.pone.0001828	http://dx.doi.org/10.1371/journal.pone.0001828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350164	gold, Green Published, Green Submitted			2022-12-27	WOS:000260762300030
J	Bourke, J; Wroe, S; Moreno, K; McHenry, C; Clausen, P				Bourke, Jason; Wroe, Stephen; Moreno, Karen; McHenry, Colin; Clausen, Philip			Effects of Gape and Tooth Position on Bite Force and Skull Stress in the Dingo (Canis lupus dingo) Using a 3-Dimensional Finite Element Approach	PLOS ONE			English	Article								Models of the mammalian jaw have predicted that bite force is intimately linked to jaw gape and to tooth position. Despite widespread use, few empirical studies have provided evidence to validate these models in non-human mammals and none have considered the influence of gape angle on the distribution of stress. Here using a multi-property finite element (FE) model of Canis lupus dingo, we examined the influence of gape angle and bite point on both bite force and cranial stress. Bite force data in relation to jaw gape and along the tooth row, are in broad agreement with previously reported results. However stress data showed that the skull of C. l. dingo is mechanically suited to withstand stresses at wide gapes; a result that agreed well with previously held views regarding carnivoran evolution. Stress data, combined with bite force information, suggested that there is an optimal bite angle of between 25 degrees and 35 degrees in C. l. dingo. The function of these rather small bite angles remains unclear.	[Bourke, Jason; Wroe, Stephen; Moreno, Karen; McHenry, Colin] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [McHenry, Colin] Univ Newcastle, Sch Env & Life Sci, Callaghan, NSW, Australia; [McHenry, Colin; Clausen, Philip] Univ Newcastle, Sch Engn, Callaghan, NSW, Australia	University of New South Wales Sydney; University of Newcastle; University of Newcastle	Bourke, J (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	archosaur@gmail.com	Wroe, Stephen/A-4462-2010; Moreno, Karen/B-6127-2009; Clausen, Philip/G-7337-2013	Wroe, Stephen/0000-0002-5813-9182; Moreno, Karen/0000-0002-5949-133X; Clausen, Philip/0000-0003-1186-6419; Wroe, Stephen/0000-0002-6365-5915	ARC Discovery; ARC QE2 Research Fellowship; UNSW Strategic Research Initiatives; University of Newcastle	ARC Discovery(Australian Research Council); ARC QE2 Research Fellowship(Australian Research Council); UNSW Strategic Research Initiatives; University of Newcastle	This work was funded by ARC Discovery, ARC QE2 Research Fellowship and UNSW Strategic Research Initiatives grants to S.W., and an Internal Grant (University of Newcastle) to P.C.	Aguirre LF, 2002, P ROY SOC B-BIOL SCI, V269, P1271, DOI 10.1098/rspb.2002.2011; Binder WJ, 2000, J ZOOL, V252, P273, DOI 10.1111/j.1469-7998.2000.tb00622.x; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; DECHOW PC, 1983, J BIOMECH, V16, P797, DOI 10.1016/0021-9290(83)90003-9; Dumont ER, 2003, J EXP BIOL, V206, P2117, DOI 10.1242/jeb.00375; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; EMERSON SB, 1980, PALEOBIOLOGY, V6, P295, DOI 10.1017/S0094837300006813; FIELDS HW, 1986, J DENT RES, V65, P135, DOI 10.1177/00220345860650020901; GREAVES WS, 1982, J MAMMAL, V63, P261, DOI 10.2307/1380635; HERRING SW, 1974, AM NAT, V108, P561, DOI 10.1086/282934; Husak JF, 2006, COPEIA, P301, DOI 10.1643/0045-8511(2006)6[301:BPPDIM]2.0.CO;2; HYLANDER WL, 1979, J MORPHOL, V159, P253, DOI 10.1002/jmor.1051590208; HYLANDER WL, 1977, AM J PHYS ANTHROPOL, V46, P309, DOI 10.1002/ajpa.1330460212; LINDAUER SJ, 1993, J DENT RES, V72, P51, DOI 10.1177/00220345930720010701; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; PRUIM GJ, 1980, J BIOMECH, V13, P755, DOI 10.1016/0021-9290(80)90237-7; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Ross CF, 2005, ANAT REC PART A, V283A, P288, DOI 10.1002/ar.a.20170; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Thomason JJ, 2005, ANAT REC PART A, V283A, P366, DOI 10.1002/ar.a.20173; Thompson EN, 2003, J EXP BIOL, V206, P923, DOI 10.1242/jeb.00181; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; WROE S, J ZOOLOGY L IN PRESS; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; Wroe S, 2007, ANAT REC, V290, P1248, DOI 10.1002/ar.20594	25	60	60	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2200	10.1371/journal.pone.0002200	http://dx.doi.org/10.1371/journal.pone.0002200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493603	Green Published, Green Submitted, gold			2022-12-27	WOS:000262258700009
J	Cairns, M; Carneiro, I; Milligan, P; Owusu-Agyei, S; Awine, T; Gosling, R; Greenwood, B; Chandramohan, D				Cairns, Matthew; Carneiro, Ilona; Milligan, Paul; Owusu-Agyei, Seth; Awine, Timothy; Gosling, Roly; Greenwood, Brian; Chandramohan, Daniel			Duration of Protection against Malaria and Anaemia Provided by Intermittent Preventive Treatment in Infants in Navrongo, Ghana	PLOS ONE			English	Article								Background: Intermittent preventive treatment for malaria in Infants (IPTi) has been shown to give effective and safe protection against malaria. It has been suggested that IPTi might have long-lasting beneficial effects but, in most settings, the protection provided by IPTi appears to be short-lived. Knowledge of the duration of protection given by IPTi would help interpret the results of existing trials and suggest optimal delivery schedules for IPTi. This study investigated how the protective efficacy of IPTi against malaria and anaemia changes over time. Methods and Findings: A secondary analysis of data from a cluster-randomised, placebo-controlled trial of IPTi using sulfadoxine-pyrimethamine (SP) in Ghana was conducted. In this trial IPTi was given to 2485 infants at 3, 4, 9 and 12 months of age; children remained in follow-up until two years of age. Poisson regression with a random effect to adjust for the cluster-randomised design was used to determine protective efficacy of IPTi against clinical malaria and anaemia in defined time strata following administration of IPTi. Analysis of first-or-only clinical malaria episode following the individual IPTi doses showed that some protection against malaria lasted between 4 to 6 weeks. A similar pattern was seen when the incidence of all malaria episodes up to 2 years of age was analysed in relation to the most recent IPT, by pooling the incidence of malaria after the individual IPTi doses. Protective efficacy within four weeks of IPTi was 75.2% (95% CI: 66-82) against malaria, 78.9% (95% CI: 69-86) against high parasite density malaria, and 93.8% (95% CI: 73-99) against anaemia. Protection against these outcomes was short-lived, with evidence of any effect lasting for only 6, 6 and 4 weeks respectively. Protection in children who were parasitaemic when receiving IPTi appeared to be of shorter duration than in uninfected children. There was no evidence of any benefit of IPTi after the immediate period following the IPTi doses. Conclusions: Intermittent preventive treatment provides considerable protection against malaria and anaemia for short periods, even in an area of intense seasonal transmission. Due to the relatively short duration of protection provided by each dose of IPTi, this treatment will be of most benefit when delivered at the time of peak malaria incidence.	[Cairns, Matthew; Milligan, Paul] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Carneiro, Ilona; Gosling, Roly; Greenwood, Brian; Chandramohan, Daniel] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England; [Owusu-Agyei, Seth; Awine, Timothy] Kintampo Hlth Res Ctr, Kintampo, Ghana; Navrongo Hlth Res Ctr, Navrongo, Ghana	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Kintampo Health Research Centre; Navrongo Health Research Center	Cairns, M (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.	matthew.cairns@lshtm.ac.uk	Milligan, Paul/D-8985-2017	Milligan, Paul/0000-0003-3430-3395; Awine, Timothy/0000-0002-7340-6111; Owusu-Agyei, Seth/0000-0002-0807-1781	United Kingdom Medical Research Council (MRC) [PhD studentship]; United Kingdom Department for International Development (DFID); Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United Kingdom Department for International Development (DFID); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MC is funded by a United Kingdom Medical Research Council (MRC) PhD studentship. The Navrongo IPTi Study was funded by the United Kingdom Department for International Development (DFID). Neither funding source had any role in the work described or the decision to submit for publication.	Aalen O O, 1994, Stat Methods Med Res, V3, P227, DOI 10.1177/096228029400300303; Achtman AH, 2005, CURR TOP MICROBIOL, V297, P71; Appawu M, 2004, TROP MED INT HEALTH, V9, P164, DOI 10.1046/j.1365-3156.2003.01162.x; Barnes KI, 2006, CLIN PHARMACOL THER, V80, P582, DOI 10.1016/j.clpt.2006.08.016; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; CHANDRAMOHAN D, 2007, TROP MED INT HEALTH, V12, P1; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; DICKO A, 2004, AM J TROP MED HYG  S, V71, P6; Dzinjalamala FK, 2005, ANTIMICROB AGENTS CH, V49, P3601, DOI 10.1128/AAC.49.9.3601-3606.2005; Greenwood B, 2006, TROP MED INT HEALTH, V11, P983, DOI 10.1111/j.1365-3156.2006.01657.x; Grobusch MP, 2007, J INFECT DIS, V196, P1595, DOI 10.1086/522160; Hills, 1993, STAT MODELS EPIDEMIO; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Macete E, 2006, J INFECT DIS, V194, P276, DOI 10.1086/505431; Massaga JJ, 2003, LANCET, V361, P1853, DOI 10.1016/S0140-6736(03)13504-0; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; Njama-Meya D, 2004, TROP MED INT HEALTH, V9, P862, DOI 10.1111/j.1365-3156.2004.01277.x; Oduro AR, 2004, ANN TROP MED PARASIT, V98, P433, DOI 10.1179/000349804225003532; Olliaro P, 2008, TROP MED INT HEALTH, V13, P83, DOI 10.1111/j.1365-3156.2007.01977.x; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schofield L, 2006, CURR MOL MED, V6, P205, DOI 10.2174/156652406776055221; Smith T, 1999, T ROY SOC TROP MED H, V93, pS59; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; Sutherland CJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-161; von Seidlein L, 2003, T ROY SOC TROP MED H, V97, P217, DOI 10.1016/S0035-9203(03)90125-8; Watkins WM, 1997, PARASITOL TODAY, V13, P459, DOI 10.1016/S0169-4758(97)01124-1; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-9; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; White NJ, 2002, TRENDS PARASITOL, V18, P458, DOI 10.1016/S1471-4922(02)02373-5	32	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2227	10.1371/journal.pone.0002227	http://dx.doi.org/10.1371/journal.pone.0002227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493597	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000262258700035
J	Djogbenou, L; Chandre, F; Berthomieu, A; Dabire, R; Koffi, A; Alout, H; Weill, M				Djogbenou, Luc; Chandre, Fabrice; Berthomieu, Arnaud; Dabire, Roch; Koffi, Alphonsine; Alout, Haoues; Weill, Mylene			Evidence of Introgression of the ace-1(R) Mutation and of the ace-1 Duplication in West African Anopheles gambiae s. s.	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; HIGH WOLBACHIA DENSITY; INSECTICIDE RESISTANCE; INCIPIENT SPECIATION; DNA ANALYSIS; GENE FLOW; MOSQUITOS; ACETYLCHOLINESTERASE; POPULATIONS; COST	Background: The role of inter-specific hybridisation is of particular importance in mosquito disease vectors for predicting the evolution of insecticide resistance. Two molecular forms of Anopheles gambiae s.s., currently recognized as S and M taxa, are considered to be incipient sibling species. Hybrid scarcity in the field was suggested that differentiation of M and S taxa is maintained by limited or absent gene flow. However, recent studies have revealed shared polymorphisms within the M and S forms, and a better understanding of the occurrence of gene flow is needed. One such shared polymorphism is the G119S mutation in the ace-1 gene (which is responsible for insecticide resistance); this mutation has been described in both the M and S forms of A. gambiae s.s. Methods and Results: To establish whether the G119S mutation has arisen independently in each form or by genetic introgression, we analysed coding and non-coding sequences of ace-1 alleles in M and S mosquitoes from representative field populations. Our data revealed many polymorphic sites shared by S and M forms, but no diversity was associated with the G119S mutation. These results indicate that the G119S mutation was a unique event and that genetic introgression explains the observed distribution of the G119S mutation within the two forms. However, it was impossible to determine from our data whether the mutation occurred first in the S form or in the M form. Unexpectedly, sequence analysis of some resistant individuals revealed a duplication of the ace-1 gene that was observed in both A. gambiae s.s. M and S forms. Again, the distribution of this duplication in the two forms most likely occurred through introgression. Conclusions: These results highlight the need for more research to understand the forces driving the evolution of insecticide resistance in malaria vectors and to regularly monitor resistance in mosquito populations of Africa.	[Djogbenou, Luc; Chandre, Fabrice] Inst Rech Dev, Cotonou, Benin; [Djogbenou, Luc] Ctr Rech Entomol Cotonou CREC, Cotonou, Benin; [Berthomieu, Arnaud; Alout, Haoues; Weill, Mylene] Univ Montpellier 2, Montpellier, France; [Berthomieu, Arnaud; Alout, Haoues; Weill, Mylene] Inst Sci Evolut, Equipe Genet Adapt, CNRS, Montpellier, France; [Dabire, Roch] Inst Region Sci Sante, Lab Entomol Parasitol, Bobo Dioulasso, Burkina Faso; [Koffi, Alphonsine] Inst Natl Sante Publ, Inst Pierre Richet IPR, Abidjan, Cote Ivoire	Institut de Recherche pour le Developpement (IRD); Entomological Research Center of Cotonou (CREC); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Djogbenou, L (corresponding author), Inst Rech Dev, Cotonou, Benin.	mylene.weill@univ-montp2.fr	Chandre, Fabrice/Q-3429-2019; Dabire, Roch Kounbobr/ABF-3525-2020; Alout, Haoues/N-9556-2016	Chandre, Fabrice/0000-0002-1994-9705; Alout, Haoues/0000-0001-7917-2697; DJOGBENOU, Salako Luc/0000-0002-7381-6321; Weill, Mylene/0000-0002-4043-1601	PAL+Programme, Ministere delegue a la Recherche [2002-45]; Institut de Recherche Pour le Developpement; ANR Morevol Sante-Environnement, Ministere delegue a la Recherche; Institut des Sciences de L'Evolution de Montpellier [2008-024, UMR CNRS-UM2 5554]	PAL+Programme, Ministere delegue a la Recherche; Institut de Recherche Pour le Developpement; ANR Morevol Sante-Environnement, Ministere delegue a la Recherche(French National Research Agency (ANR)); Institut des Sciences de L'Evolution de Montpellier	This work received financial support in part by the PAL+Programme, no. 2002-45 (Ministere delegue a la Recherche) and Institut de Recherche Pour le Developpement. It was also financed by the ANR Morevol Sante-Environnement (Ministere delegue a la Recherche) and Contribution 2008-024 of the Institut des Sciences de L'Evolution de Montpellier (UMR CNRS-UM2 5554).	ALOUT H, 2008, COMP BIOCH IN PRESS; Alout H, 2007, J MED ENTOMOL, V44, P463, DOI 10.1603/0022-2585(2007)44[463:DASCIR]2.0.CO;2; Arbogast BS, 2002, ANNU REV ECOL SYST, V33, P707, DOI 10.1146/annurev.ecolsys.33.010802.150500; Berticat C, 2004, GENET RES, V83, P189, DOI 10.1017/S0016672304006792; Berticat C, 2002, P ROY SOC B-BIOL SCI, V269, P1413, DOI 10.1098/rspb.2002.2022; Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X; Bourguet D, 1996, PESTIC BIOCHEM PHYS, V55, P122, DOI 10.1006/pest.1996.0041; Bourguet D, 1996, BIOCHEM GENET, V34, P351, DOI 10.1007/BF00554410; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; COLUZZI M, 1985, B ZOOL, V52, P45, DOI 10.1080/11250008509440343; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1964, Riv Malariol, V43, P197; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cui F, 2006, J MED ENTOMOL, V43, P878, DOI 10.1603/0022-2585(2006)43[878:REOIAI]2.0.CO;2; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Djogbenou L, 2008, AM J TROP MED HYG, V78, P298, DOI 10.4269/ajtmh.2008.78.298; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; Duron O, 2006, EVOLUTION, V60, P303, DOI 10.1111/j.0014-3820.2006.tb01108.x; Edillo FE, 2002, J MED ENTOMOL, V39, P70, DOI 10.1603/0022-2585-39.1.70; Elissa N, 1994, Sante, V4, P95; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Fehrer J, 1996, MOL BIOL EVOL, V13, P7, DOI 10.1093/oxfordjournals.molbev.a025572; Gentile G, 2001, INSECT MOL BIOL, V10, P25, DOI 10.1046/j.1365-2583.2001.00237.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HELMBYCHOWSKI K, 1993, MOL BIOL EVOL, V10, P1196; Labbe P, 2007, MOL BIOL EVOL, V24, P1056, DOI 10.1093/molbev/msm025; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Lenormand T, 1998, EVOLUTION, V52, P1705, DOI [10.2307/2411343, 10.1111/j.1558-5646.1998.tb02250.x]; MASSOULIE J, 1992, MULTIDISCIPLINARY APPROACHES TO CHOLINESTERASE FUNCTIONS, P285; N'Guessan R, 2003, MED VET ENTOMOL, V17, P19, DOI 10.1046/j.1365-2915.2003.00406.x; NEI M, 1990, GENETICS, V125, P873; Nei M., 1987, MOL EVOLUTIONARY GEN; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SCHNEIDER S, 1997, ARLEQUIN VERSION 1 1; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Stump AD, 2005, P NATL ACAD SCI USA, V102, P15930, DOI 10.1073/pnas.0508161102; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Taylor C, 2001, GENETICS, V157, P743; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Tripet F, 2003, AM J TROP MED HYG, V68, P1; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Weill M., 2005, P397, DOI 10.1079/9780851998121.0397; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122	47	99	103	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2172	10.1371/journal.pone.0002172	http://dx.doi.org/10.1371/journal.pone.0002172			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478097	Green Submitted, Green Published, gold			2022-12-27	WOS:000262172800037
J	French, D; Yang, WJ; Hamilton, LH; Neale, G; Fan, YP; Downing, JR; Cox, NJ; Pui, CH; Evans, WE; Relling, MV				French, Deborah; Yang, Wenjian; Hamilton, Leo H.; Neale, Geoffrey; Fan, Yiping; Downing, James R.; Cox, Nancy J.; Pui, Ching-Hon; Evans, William E.; Relling, Mary V.			Concordant Gene Expression in Leukemia Cells and Normal Leukocytes Is Associated with Germline cis-SNPs	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; COPY NUMBER; GENOME; IDENTIFICATION; CLASSIFICATION; DISCOVERY; PROFILES; PATTERNS; MOUSE; DNA	The degree to which gene expression covaries between different primary tissues within an individual is not well defined. We hypothesized that expression that is concordant across tissues is more likely influenced by genetic variability than gene expression which is discordant between tissues. We quantified expression of 11,873 genes in paired samples of primary leukemia cells and normal leukocytes from 92 patients with acute lymphoblastic leukemia (ALL). Genetic variation at >500,000 single nucleotide polymorphisms (SNPs) was also assessed. The expression of only 176/11,783 (1.5%) genes was correlated (p < 0.008, FDR = 25%) in the two tissue types, but expression of a high proportion (20 of these 176 genes) was significantly related to cis-SNP genotypes (adjusted p < 0.05). In an independent set of 134 patients with ALL, 14 of these 20 genes were validated as having expression related to cis-SNPs, as were 9 of 20 genes in a second validation set of HapMap cell lines. Genes whose expression was concordant among tissue types were more likely to be associated with germline cis-SNPs than genes with discordant expression in these tissues; genes affected were involved in housekeeping functions (GSTM2, GAPDH and NCOR1) and purine metabolism.	[French, Deborah; Yang, Wenjian; Hamilton, Leo H.; Evans, William E.; Relling, Mary V.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Neale, Geoffrey; Fan, Yiping] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN USA; [Downing, James R.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN USA; [Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN USA; [Pui, Ching-Hon; Evans, William E.; Relling, Mary V.] Univ Tennessee, Memphis, TN USA; [Cox, Nancy J.] Univ Chicago, Dept Human Genet, Chicago, IL USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Chicago	French, D (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	mary.relling@stjude.org	Pui, Ching-Hon/N-8076-2018; Relling, Mary/N-5032-2018; Downing, James R./N-8102-2018; Evans, William E./C-2069-2012	Pui, Ching-Hon/0000-0003-0303-5658; Evans, William E./0000-0002-9333-5322	NCI [CA51001, T32-CA070089, CA78224, CA21765]; NIH/NIGMS [U01 GM61393, U01GM61374, PS207679]; Phelan Foundation; State of Tennessee [Center of Excellence grant]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [P30CA021765, R01CA078224, R01CA051001, T32CA070089, R29CA051001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393, U01GM061374] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Phelan Foundation; State of Tennessee; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI CA51001, T32-CA070089, CA78224, CA21765 and the NIH/NIGMS Pharmacogenetics Research Network and Database (U01 GM61393, U01GM61374 http://pharmgkb.org/ PS207679) from the National Institutes of Health; by the Phelan Foundation; by a Center of Excellence grant from the State of Tennessee; and by American Lebanese Syrian Associated Charities (ALSAC).	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bergen AW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-296; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cheok MH, 2006, NAT REV CANCER, V6, P117, DOI 10.1038/nrc1800; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eady JJ, 2005, PHYSIOL GENOMICS, V22, P402, DOI 10.1152/physiolgenomics.00080.2005; French D, 2005, HUM MOL GENET, V14, P1621, DOI 10.1093/hmg/ddi170; Glinsky GV, 2006, CELL CYCLE, V5, P2613, DOI 10.4161/cc.5.22.3498; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Hartford C, 2007, LEUKEMIA, V21, P2128, DOI 10.1038/sj.leu.2404885; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Huang RS, 2007, AM J HUM GENET, V81, P427, DOI 10.1086/519850; Kishi S, 2007, BLOOD, V109, P4151, DOI 10.1182/blood-2006-10-054528; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lugthart S, 2005, CANCER CELL, V7, P375, DOI 10.1016/j.ccr.2005.03.002; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Pui C.-H., 2004, Annals of Hematology, V83, pS124; Radich JP, 2004, GENOMICS, V83, P980, DOI 10.1016/j.ygeno.2003.12.013; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rocha JCC, 2005, BLOOD, V105, P4752, DOI 10.1182/blood-2004-11-4544; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Shyamsundar R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r22; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Thomas DJ, 2007, NUCLEIC ACIDS RES, V35, pD716, DOI 10.1093/nar/gkl953; Tu ZD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-31; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhang W, 2007, PHARMACOGENET GENOM, V17, P447, DOI 10.1097/FPC.0b013e3280121ffe	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2144	10.1371/journal.pone.0002144	http://dx.doi.org/10.1371/journal.pone.0002144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478092	Green Submitted, gold, Green Published			2022-12-27	WOS:000262172800009
J	Galan, RF				Galan, Roberto F.			On How Network Architecture Determines the Dominant Patterns of Spontaneous Neural Activity	PLOS ONE			English	Article								In the absence of sensory stimulation, neocortical circuits display complex patterns of neural activity. These patterns are thought to reflect relevant properties of the network, including anatomical features like its modularity. It is also assumed that the synaptic connections of the network constrain the repertoire of emergent, spontaneous patterns. Although the link between network architecture and network activity has been extensively investigated in the last few years from different perspectives, our understanding of the relationship between the network connectivity and the structure of its spontaneous activity is still incomplete. Using a general mathematical model of neural dynamics we have studied the link between spontaneous activity and the underlying network architecture. In particular, here we show mathematically how the synaptic connections between neurons determine the repertoire of spatial patterns displayed in the spontaneous activity. To test our theoretical result, we have also used the model to simulate spontaneous activity of a neural network, whose architecture is inspired by the patchy organization of horizontal connections between cortical columns in the neocortex of primates and other mammals. The dominant spatial patterns of the spontaneous activity, calculated as its principal components, coincide remarkably well with those patterns predicted from the network connectivity using our theory. The equivalence between the concept of dominant pattern and the concept of attractor of the network dynamics is also demonstrated. This in turn suggests new ways of investigating encoding and storage capabilities of neural networks.	[Galan, Roberto F.] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University	Galan, RF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.	rfgalan@case.edu		Fernandez Galan, Roberto/0000-0003-1426-1917	Mount Sinai Health Care Foundation	Mount Sinai Health Care Foundation	The author is grateful to the Mount Sinai Health Care Foundation for financial support.	Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Cossart R, 2005, CELL CALCIUM, V37, P451, DOI 10.1016/j.ceca.2005.01.013; Froemke RC, 2002, TRENDS CARDIOVAS MED, V12, P247, DOI 10.1016/S1050-1738(02)00169-X; Galan RF, 2006, NEURAL COMPUT, V18, P10, DOI 10.1162/089976606774841558; Galan RF, 2004, NEURAL COMPUT, V16, P999, DOI 10.1162/089976604773135078; Haken H., 1991, SYNERGETIC COMPUTERS; Haken H., 1983, ADV SYNERGETICS INST; Hertz JA, 2018, INTRO THEORY NEURAL; HONERKAMP J, 1998, STOCHASTISCHE DYNAMI; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HOPPENSTEADT F, 1997, WEAKLY CONNECTED NEU; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Laing CR, 2002, SIAM J APPL MATH, V63, P62, DOI 10.1137/S0036139901389495; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; LUND JS, 1993, CEREB CORTEX, V3, P148, DOI 10.1093/cercor/3.2.148; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Mokeichev A, 2007, NEURON, V53, P413, DOI 10.1016/j.neuron.2007.01.017; Neumaier A, 2001, ACM T MATH SOFTWARE, V27, P27, DOI 10.1145/382043.382304; PRIESTLEY MB, 2001, SPECTRAL ANAL TIME S; RUMMELHART DE, 1987, EXPLORATIONS MICROST, V2; Rummelhart DE, 1986, EXPLORATIONS MICROST, V1; Schiff SJ, 2005, NEUROIMAGE, V28, P1043, DOI 10.1016/j.neuroimage.2005.06.059; Schiff SJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.178102; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; Steuer R, 2003, BIOCHEM SOC T, V31, P1476; Steuer R, 2003, BIOINFORMATICS, V19, P1019, DOI 10.1093/bioinformatics/btg120; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Zemanova L, 2006, PHYSICA D, V224, P202, DOI 10.1016/j.physd.2006.09.008; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	39	131	132	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2148	10.1371/journal.pone.0002148	http://dx.doi.org/10.1371/journal.pone.0002148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478091	gold, Green Published			2022-12-27	WOS:000262172800013
J	Cannon, NA; Donlin, MJ; Fan, XF; Aurora, R; Tavis, JE				Cannon, Nathan A.; Donlin, Maureen J.; Fan, Xiaofeng; Aurora, Rajeev; Tavis, John E.		Virahep-C Study Grp	Hepatitis C Virus Diversity and Evolution in the Full Open-Reading Frame during Antiviral Therapy	PLOS ONE			English	Article								Background: Pegylated interferon plus ribavirin therapy for hepatitis C virus (HCV) fails in approximately half of genotype 1 patients. Treatment failure occurs either by nonresponse (minimal declines in viral titer) or relapse (robust initial responses followed by rebounds of viral titers during or after therapy). HCV is highly variable genetically. To determine if viral genetic differences contribute to the difference between response and relapse, we examined the inter-patient genetic diversity and mutation pattern in the full open reading frame HCV genotype 1a consensus sequences. Methodology/Principal Findings: Pre- and post-therapy sequences were analyzed for 10 nonresponders and 10 relapsers from the Virahep-C clinical study. Pre- therapy interpatient diversity among the relapsers was higher than in the nonresponders in the viral NS2 and NS3 genes, and post-therapy diversity was higher in the relapsers for most of HCV's ten genes. Pre- therapy diversity among the relapsers was intermediate between that of the non-responders and responders to therapy. The average mutation rate was just 0.9% at the amino acid level and similar numbers of mutations occurred in the nonresponder and relapser sequences, but the mutations in NS2 of relapsers were less conservative than in nonresponders. Finally, the number and distribution of regions under positive selection was similar between the two groups, although the nonresponders had more foci of positive selection in E2. Conclusions/Significance: The HCV sequences were unexpectedly stable during failed antiviral therapy, both nonresponder and relapser sequences were under selective pressure during therapy, and variation in NS2 may have contributed to the difference in response between the nonresponder and relapser groups. These data support a role for viral genetic variability in determining the outcome of anti-HCV therapy, with those sequences that are more distant from an optimal sequence being less able to resist the pressures of interferon-based therapy.	[Cannon, Nathan A.; Donlin, Maureen J.; Aurora, Rajeev; Tavis, John E.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA; [Fan, Xiaofeng] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO USA; [Tavis, John E.] St Louis Univ, Sch Med, St Louis Univ Liver Ctr, St Louis, MO USA	Saint Louis University; Saint Louis University; Saint Louis University	Cannon, NA (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.	tavisje@slu.edu	Donlin, Maureen J./M-4709-2019	Aurora, Rajeev/0000-0002-6609-6055; Donlin, Maureen/0000-0001-7312-079X	United States of America National Institutes of Health [DK60345]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK060345] Funding Source: NIH RePORTER	United States of America National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grant number DK60345 from the United States of America National Institutes of Health. The funding agency had no role in designing or performing the study.	Abbate I, 2004, J HEPATOL, V40, P831, DOI 10.1016/j.jhep.2004.01.019; Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; Arataki K, 2006, INTERVIROLOGY, V49, P352, DOI 10.1159/000095155; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Baker Danial E, 2003, Rev Gastroenterol Disord, V3, P93; Branch AD, 2005, SEMIN LIVER DIS, V25, P105, DOI 10.1055/s-2005-864786; Brown RJP, 2005, J GEN VIROL, V86, P1931, DOI 10.1099/vir.0.80957-0; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Chambers TJ, 2005, J VIROL, V79, P3071, DOI 10.1128/JVI.79.5.3071-3083.2005; Chayama K, 2000, HEPATOLOGY, V32, P1138, DOI 10.1053/jhep.2000.19364; Chen S, 2002, WORLD J GASTROENTERO, V8, P686, DOI 10.3748/wjg.v8.i4.686; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; DAL PF, 2007, J INFECT DIS, V196, P998; Donlin MJ, 2007, J VIROL, V81, P8211, DOI 10.1128/JVI.00487-07; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fan XF, 2006, BIOCHEM BIOPH RES CO, V346, P1163, DOI 10.1016/j.bbrc.2006.06.039; Fares MA, 2004, BIOINFORMATICS, V20, P2867, DOI 10.1093/bioinformatics/bth303; Forns X, 1999, TRENDS MICROBIOL, V7, P402, DOI 10.1016/S0966-842X(99)01590-5; Francois C, 2000, J VIROL, V74, P5587, DOI 10.1128/JVI.74.12.5587-5596.2000; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Gaudieri S, 2006, J VIROL, V80, P11094, DOI 10.1128/JVI.00912-06; Gaudy C, 2005, J CLIN MICROBIOL, V43, P750, DOI 10.1128/JCM.43.2.750-754.2005; Gerotto M, 2000, GASTROENTEROLOGY, V119, P1649, DOI 10.1053/gast.2000.20230; Gupta R, 2006, J CLIN MICROBIOL, V44, P709, DOI 10.1128/JCM.44.3.709-715.2006; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hamano K, 2005, J GASTROEN HEPATOL, V20, P1401, DOI 10.1111/j.1440-1746.2005.04024.x; Hung CH, 2003, J VIRAL HEPATITIS, V10, P87, DOI 10.1046/j.1365-2893.2003.00414.x; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Kaukinen P, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-66; Kim WR, 2002, HEPATOLOGY, V36, P227, DOI 10.1053/jhep.2002.34734; Kohashi T, 2006, J VIRAL HEPATITIS, V13, P582, DOI 10.1111/j.1365-2893.2006.00739.x; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lorenz IC, 2006, NATURE, V442, P831, DOI 10.1038/nature04975; Macdonald A, 2004, J GEN VIROL, V85, P721, DOI 10.1099/vir.0.19691-0; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Morishima C, 2006, J INFECT DIS, V193, P931, DOI 10.1086/500952; O'Farrell D, 2003, J MOL BIOL, V326, P1025, DOI 10.1016/S0022-2836(02)01439-0; Odeberg J, 1998, J MED VIROL, V56, P33, DOI 10.1002/(SICI)1096-9071(199809)56:1<33::AID-JMV6>3.0.CO;2-O; Pawlotsky JM, 1999, J VIROL, V73, P6490, DOI 10.1128/JVI.73.8.6490-6499.1999; Polyak SJ, 1998, J VIROL, V72, P4288, DOI 10.1128/JVI.72.5.4288-4296.1998; Poon AFY, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030045; Puig-Basagoiti F, 2001, J MED VIROL, V65, P35, DOI 10.1002/jmv.1098; Robertson B, 1998, ARCH VIROL, V143, P2493, DOI 10.1007/s007050050479; Sarrazin C, 2001, VIROLOGY, V289, P150, DOI 10.1006/viro.2001.1092; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Taylor DR, 1999, SCIENCE, V285, P107, DOI 10.1126/science.285.5424.107; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; VANDOORN LJ, 1995, J VIROL, V69, P773, DOI 10.1128/JVI.69.2.773-778.1995; Varaklioti A, 2002, J BIOL CHEM, V277, P17713, DOI 10.1074/jbc.M201722200; Veillon P, 2007, WORLD J GASTROENTERO, V13, P1195, DOI 10.3748/wjg.v13.i8.1195; VON WM, 2003, J VIRAL HEPATITUS, V10, P413; Vuillermoz I, 2004, J MED VIROL, V74, P41, DOI 10.1002/jmv.20144; Walewski JL, 2002, RNA, V8, P557, DOI 10.1017/S1355838202029023; Walewski JL, 2001, RNA, V7, P710, DOI 10.1017/S1355838201010111; Yang SS, 2003, LIVER INT, V23, P426, DOI 10.1111/j.1478-3231.2003.00875.x; Yao E, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-88; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; 2004, J CLIN PHARM, V44, P20	66	41	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2123	10.1371/journal.pone.0002123	http://dx.doi.org/10.1371/journal.pone.0002123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18463735	gold, Green Submitted, Green Published			2022-12-27	WOS:000261642400044
J	Nakav, S; Chaimovitz, C; Sufaro, Y; Lewis, EC; Shaked, G; Czeiger, D; Zlotnik, M; Douvdevani, A				Nakav, Sigal; Chaimovitz, Cidio; Sufaro, Yuval; Lewis, Eli C.; Shaked, Gad; Czeiger, David; Zlotnik, Moshe; Douvdevani, Amos			Anti-Inflammatory Preconditioning by Agonists of Adenosine A1 Receptor	PLOS ONE			English	Article							PERITONEAL MESOTHELIAL CELLS; ADENOSINE RECEPTORS; DOWN-REGULATION; UP-REGULATION; EXPRESSION; INVOLVEMENT; INHIBITION; CYTOKINES; MURINE; MICE	Background: Adenosine levels rise during inflammation and modulate inflammatory responses by engaging with four different G protein-coupled receptors. It is suggested that adenosine exhibits pro-inflammatory effects through its A(1) receptor (A(1)R), and anti-inflammatory effects through A(2A) receptor (A(2A)R). Therefore, understanding of the mechanisms that govern adenosine receptor regulation may advance treatment of various inflammatory disorders. We previously reported that peak A(1)R expression during leukocyte recruitment, is followed by a peak in A(2A)R during inflammation resolution. Principal Findings: Here, we examined whether A(1)R activation sequentially induces A(2A)R expression and by this reverses inflammation. The effect of adenosine on A(1)R mediated A(2A)R expression was examined in peritoneal macrophages (PM Phi) and primary peritoneal mesothelial cells (PMC) in vitro. Induction of A(2A)R was inhibited by pertussis toxin (PTX) and partly dependent on A(2A)R stimulation. Administration of A(1)R agonists to healthy mice reduced A(1)R expression and induced A(2A)R production in PMC. Mice that were preconditioned with A(1)R agonists 24 hours before E. coli inoculation exhibited decreased TNF alpha and IL-6 sera levels and reduced leukocytes recruitment. Preconditioning was blocked by pretreatment with A(1)R antagonist, as well as, or by late treatment with A(2A)R antagonist, and was absent in A(2A)R(-/-) mice. Conclusions: Our data suggest that preconditioning by an A(1)R-agonist promotes the resolution of inflammation by inducing the production of A(2A)R. Future implications may include early treatment during inflammatory disorders or pretreatment before anticipated high risk inflammatory events, such as invasive surgery and organ transplantation.	[Nakav, Sigal; Sufaro, Yuval; Lewis, Eli C.; Douvdevani, Amos] Soroka Med Univ Ctr, Dept Clin Biochem, Beer Sheva, Israel; [Chaimovitz, Cidio; Zlotnik, Moshe; Douvdevani, Amos] Ben Gurion Univ Negev, Soroka Med Univ Ctr, Dept Nephrol, Beer Sheva, Israel; [Shaked, Gad; Czeiger, David] Ben Gurion Univ Negev, Soroka Med Univ Ctr, Dept Gen Surg, Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center	Nakav, S (corresponding author), Soroka Med Univ Ctr, Dept Clin Biochem, Beer Sheva, Israel.	amosd@bgu.ac.il	LEWIS, ELI C/F-1552-2012	LEWIS, ELI C/0000-0002-4189-2207; Douvdevani, Amos/0000-0002-0197-6481	Israeli Science Foundation [558/06]; Dr. Montague Robin Fleisher Kidney Transplant Unit Fund	Israeli Science Foundation(Israel Science Foundation); Dr. Montague Robin Fleisher Kidney Transplant Unit Fund	This work was supported by a grant of the Israeli Science Foundation (Grant #558/06) and by the Dr. Montague Robin Fleisher Kidney Transplant Unit Fund.	Andresen BT, 1999, J PHARMACOL EXP THER, V291, P76; Arslan G, 1997, NEUROPHARMACOLOGY, V36, P1319, DOI 10.1016/S0028-3908(97)00090-7; Basok A, 2001, J AM SOC NEPHROL, V12, P695, DOI 10.1681/ASN.V124695; ChungWelch N, 1997, MICROVASC RES, V54, P108, DOI 10.1006/mvre.1997.2038; COOPER JA, 1995, BRIT J CLIN PHARMACO, V40, P43, DOI 10.1111/j.1365-2125.1995.tb04533.x; CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5, DOI 10.1152/jappl.1994.76.1.5; CRONSTEIN BN, 1992, J IMMUNOL, V148, P2201; DOUVDEVANI A, 1994, KIDNEY INT, V46, P993, DOI 10.1038/ki.1994.359; Einbinder T, 2003, KIDNEY INT, V63, P2103, DOI 10.1046/j.1523-1755.2003.00014.x; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hausmann MJ, 2000, KIDNEY INT, V57, P476, DOI 10.1046/j.1523-1755.2000.00867.x; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Koshiba M, 1997, J BIOL CHEM, V272, P25881, DOI 10.1074/jbc.272.41.25881; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Man L, 2003, KIDNEY INT, V64, P2064, DOI 10.1046/j.1523-1755.2003.00338.x; Mazar J, 2005, ANESTHESIOLOGY, V102, P1174, DOI 10.1097/00000542-200506000-00017; McColl SR, 2005, FASEB J, V19, P187, DOI 10.1096/fj.05-4804fje; Murphree LJ, 2005, BIOCHEM J, V391, P575, DOI 10.1042/BJ20050888; Navarro A, 1999, BRAIN RES, V816, P47, DOI 10.1016/S0006-8993(98)01062-2; OLAH ME, 1995, ARCH INT PHARMACOD T, V329, P135; Olah ME, 2000, PHARMACOL THERAPEUT, V85, P55, DOI 10.1016/S0163-7258(99)00051-0; OLAH ME, 1995, ANNU REV PHARMACOL, V35, P581, DOI 10.1146/annurev.pa.35.040195.003053; Pastor-Anglada M, 2001, MOL MEMBR BIOL, V18, P81, DOI 10.1080/096876800110033783; Ralevic V, 1998, PHARMACOL REV, V50, P413; Ren HZ, 1999, MOL PHARMACOL, V55, P309, DOI 10.1124/mol.55.2.309; Rogachev B, 2006, KIDNEY INT, V70, P675, DOI 10.1038/sj.ki.5001609; ROSE FR, 1988, J EXP MED, V167, P1186, DOI 10.1084/jem.167.3.1186; SALMON JE, 1993, J IMMUNOL, V151, P2775; Schnurr M, 2004, BLOOD, V103, P1391, DOI 10.1182/blood-2003-06-1959; STYLIANOU E, 1990, KIDNEY INT, V37, P1563, DOI 10.1038/ki.1990.150; Sullivan GW, 2001, BRIT J PHARMACOL, V132, P1017, DOI 10.1038/sj.bjp.0703893; Sullivan GW, 2004, J INFECT DIS, V189, P1897, DOI 10.1086/386311; TOPLEY N, 1995, PERITON DIALYSIS INT, V15, pS35; Trincavelli ML, 2002, BIOCHEM PHARMACOL, V64, P625, DOI 10.1016/S0006-2952(02)01222-4	34	50	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2107	10.1371/journal.pone.0002107	http://dx.doi.org/10.1371/journal.pone.0002107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461129	Green Published, Green Submitted, gold			2022-12-27	WOS:000261642400029
J	Nakamura, T; Takumi, T; Takano, A; Aoyagi, N; Yoshiuchi, K; Struzik, ZR; Yamamoto, Y				Nakamura, Toru; Takumi, Toru; Takano, Atsuko; Aoyagi, Naoko; Yoshiuchi, Kazuhiro; Struzik, Zbigniew R.; Yamamoto, Yoshiharu			Of Mice and Men - Universality and Breakdown of Behavioral Organization	PLOS ONE			English	Article								Mental or cognitive brain functions, and the effect on them of abnormal psychiatric diseases, are difficult to approach through molecular biological techniques due to the lack of appropriate assay systems with objective measures. We therefore study laws of behavioral organization, specifically how resting and active periods are interwoven throughout daily life, using objective criteria, and first discover that identical laws hold both for healthy humans subject to the full complexity of daily life, and wild-type mice subject to maximum environmental constraints. We find that active period durations with physical activity counts successively above a predefined threshold, when rescaled with individual means, follow a universal stretched exponential (gamma-type) cumulative distribution, while resting period durations below the threshold obey a universal power-law cumulative distribution with identical parameter values for both of the mammalian species. Further, by analyzing the behavioral organization of mice with a circadian clock gene (Period2) eliminated, and humans suffering from major depressive disorders, we find significantly lower parameter values (power-law scaling exponents) for the resting period durations in both these cases. Such a universality and breakdown of the behavioral organization of mice and humans, revealed through objective measures, is expected to facilitate the understanding of the molecular basis of the pathophysiology of neurobehavioral diseases, including depression, and lay the foundations for formulating a range of neuropsychiatric behavioral disorder models.	[Nakamura, Toru] Osaka Univ, Ctr Adv Med Engn & Informat, Osaka, Japan; [Takumi, Toru; Takano, Atsuko] Osaka Biosci Inst, Osaka, Japan; [Aoyagi, Naoko; Struzik, Zbigniew R.; Yamamoto, Yoshiharu] Univ Tokyo, Grad Sch Education, Ed Physiol Lab, Tokyo, Japan; [Yoshiuchi, Kazuhiro] Univ Tokyo, Grad Sch Med, Dept Psychosomat Med, Tokyo, Japan	Osaka University; University of Tokyo; University of Tokyo	Nakamura, T (corresponding author), Osaka Univ, Ctr Adv Med Engn & Informat, Osaka, Japan.	yamamoto@p.u-tokyo.ac.jp	Struzik, Zbigniew/E-4295-2012; nakamura, Toru/A-4535-2010	Struzik, Zbigniew/0000-0002-1352-8897; Yamamoto, Yoshiharu/0000-0002-1132-0355; nakamura, toru/0000-0002-5340-6333	Ministry of Education, Culture, Sports, Science and Technology of Japan; Nippon Boehringer Ingelheim Co., Ltd.; Sony Corporation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nippon Boehringer Ingelheim Co., Ltd.(Boehringer Ingelheim); Sony Corporation	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Nippon Boehringer Ingelheim Co., Ltd., and Sony Corporation (to T. T.).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Corral A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.108501; Harris TE, 1989, THEORY BRANCHING PRO; HEAGY JF, 1994, PHYS REV E, V49, P1140, DOI 10.1103/PhysRevE.49.1140; Lippiello E, 2006, EUROPHYS LETT, V76, P979, DOI 10.1209/epl/i2006-10365-4; Nakamura T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.138103; Pan WD, 2007, MOVEMENT DISORD, V22, P1308, DOI 10.1002/mds.21527; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; Press W. H., 1992, ART SCI COMPUTING; SCHULZ H, 1985, PSYCHIAT RES, V16, P65, DOI 10.1016/0165-1781(85)90029-0; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SIEVER LJ, 1985, AM J PSYCHIAT, V142, P1017; Stanley HE, 1999, REV MOD PHYS, V71, pS358, DOI 10.1103/RevModPhys.71.S358; TEICHER MH, 1995, HARVARD REV PSYCHIAT, V3, P18, DOI 10.3109/10673229509017161; TEICHER MH, 1988, ARCH GEN PSYCHIAT, V45, P913; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Vazquez A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.248701; Yamamoto Y, 2005, ANN NEUROL, V58, P175, DOI 10.1002/ana.20574; ZAPPERI S, 1995, PHYS REV LETT, V75, P4071, DOI 10.1103/PhysRevLett.75.4071; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	24	67	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2050	10.1371/journal.pone.0002050	http://dx.doi.org/10.1371/journal.pone.0002050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446212	gold, Green Published, Green Submitted			2022-12-27	WOS:000261572300019
J	Schutzer, SE; Schlater, LRK; Ronning, CM; DeShazer, D; Luft, BJ; Dunn, JJ; Ravel, J; Fraser-Liggett, CM; Nierman, WC				Schutzer, Steven E.; Schlater, Linda R. K.; Ronning, Catherine M.; DeShazer, David; Luft, Benjamin J.; Dunn, John J.; Ravel, Jacques; Fraser-Liggett, Claire M.; Nierman, William C.			Characterization of Clinically-Attenuated Burkholderia mallei by Whole Genome Sequencing: Candidate Strain for Exclusion from Select Agent Lists	PLOS ONE			English	Article							GLANDERS; MODEL	Background: Burkholderia mallei is an understudied biothreat agent responsible for glanders which can be lethal in humans and animals. Research with this pathogen has been hampered in part by constraints of Select Agent regulations for safety reasons. Whole genomic sequencing (WGS) is an apt approach to characterize newly discovered or poorly understood microbial pathogens. Methodology/Principal Findings: We performed WGS on a strain of B. mallei, SAVP1, previously pathogenic, that was experimentally infected in 6 equids ( 4 ponies, 1 mule, 1 donkey), natural hosts, for purposes of producing antibodies. Multiple high inocula were used in some cases. Unexpectedly SAVP1 appeared to be avirulent in the ponies and mule, and attenuated in the donkey, but induced antibodies. We determined the genome sequence of SAVP1 and compared it to a strain that was virulent in horses and a human. In comparison, this phenotypic avirulent SAVP1 strain was missing multiple genes including all the animal type III secretory system (T3SS) complex of genes demonstrated to be essential for virulence in mice and hamster models. The loss of these genes in the SAVP1 strain appears to be the consequence of a multiple gene deletion across insertion sequence ( IS) elements in the B. mallei genome. Therefore, the strain by itself is unlikely to revert naturally to its virulent phenotype. There were other genes present in one strain and not the other and vice-versa. Conclusion/Significance: The discovery that this strain of B. mallei was both avirulent in the natural host ponies, and did not possess T3SS associated genes may be fortuitous to advance biodefense research. The deleted virulence-essential T3SS is not likely to be re-acquired naturally. These findings may provide a basis for exclusion of SAVP1 from the Select Agent regulation or at least discussion of what else would be required for exclusion. This exclusion could accelerate research by investigators not possessing BSL-3 facilities and facilitate the production of reagents such as antibodies without the restraints of Select Agent regulation.	[Schutzer, Steven E.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Schlater, Linda R. K.] USDA, Ames, IA USA; [Ronning, Catherine M.; Nierman, William C.] J Craig Venter Inst, Rockville, MD USA; [DeShazer, David] US Army Med Res Inst Infect Dis, Fort Detrick, MD USA; [Luft, Benjamin J.] SUNY Stony Brook, Dept Med, Stony Brook, NY USA; [Dunn, John J.] Brookhaven Natl Lab, Biol Dept, Upton, NY USA; [Ravel, Jacques; Fraser-Liggett, Claire M.] Univ Maryland, Sch Med, Dept Med, Inst Genome Sci, Baltimore, MD USA; [Ravel, Jacques; Fraser-Liggett, Claire M.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Inst Genome Sc, Baltimore, MD USA; [Nierman, William C.] George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; United States Department of Agriculture (USDA); J. Craig Venter Institute; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Brookhaven National Laboratory; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; George Washington University	Schutzer, SE (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, 185 S Orange Ave, Newark, NJ 07103 USA.	schutzer@umdnj.edu	Ravel, Jacques/D-2530-2009	Fraser, Claire/0000-0003-1462-2428; Luft, Benjamin/0000-0001-9008-7004; Ravel, Jacques/0000-0002-0851-2233	National Institutes of Health [N01-AI30071, U01 AI056480, AI063757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI063757, U01AI056480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work was funded in part by several grants from the National Institutes of Health (N01-AI30071, U01 AI056480, AI063757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*CDC, 2000, GLAND BURKH MALL; *CDCP, 2006, SEL AG PROGR NOT EXC; *CDCP, 2005, SEL AG PROGR; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P532; DeShazer D, 2001, MICROB PATHOGENESIS, V30, P253, DOI 10.1006/mpat.2000.0430; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Franz DR, 1997, JAMA-J AM MED ASSOC, V278, P399, DOI 10.1001/jama.278.5.399; Fraser CM., 1991, MERCK VET MANUAL HDB, V7th; Fritz DL, 1999, VET PATHOL, V36, P276, DOI 10.1354/vp.36-4-276; Fritz DL, 2000, VET PATHOL, V37, P626, DOI 10.1354/vp.37-6-626; Geissler Erhard, 1999, BIOL TOXIN WEAPONS R; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koenig RL, 2006, 4 HORSEMAN ONE MANS; KORTPETER M, 2001, USAMRIIDS MED MANAGE; Lopez J, 2003, MICROBES INFECT, V5, P1125, DOI 10.1016/j.micinf.2003.07.004; Mandell GL, 1995, MANDELL DOUGLAS BENN; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; SHEA D, 2004, SMALL SCALE TERRORIS; Srinivasan A, 2001, NEW ENGL J MED, V345, P256, DOI 10.1056/NEJM200107263450404; Ulrich RL, 2004, INFECT IMMUN, V72, P6589, DOI 10.1128/IAI.72.11.6589-6596.2004; WATERMAN MS, 1988, METHOD ENZYMOL, V164, P765; Wheelis M, 1998, NATURE, V395, P213, DOI 10.1038/26089; Whitlock GC, 2007, FEMS MICROBIOL LETT, V277, P115, DOI 10.1111/j.1574-6968.2007.00949.x; WILKINSON L, 1981, MED HIST, V25, P363, DOI 10.1017/S0025727300034876; YABUUCHI E, 1992, MICROBIOL IMMUNOL, V36, P1251, DOI 10.1111/j.1348-0421.1992.tb02129.x; 2005, FED REG, V70, P13242	29	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2058	10.1371/journal.pone.0002058	http://dx.doi.org/10.1371/journal.pone.0002058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446194	Green Submitted, gold, Green Published			2022-12-27	WOS:000261572300027
J	Wilson, AB; Teugels, GG; Meyer, A				Wilson, Anthony B.; Teugels, Guy G.; Meyer, Axel			Marine Incursion: The Freshwater Herring of Lake Tanganyika Are the Product of a Marine Invasion into West Africa	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; MITOCHONDRIAL-DNA SEQUENCE; CICHLID FISHES; SPECIES FLOCK; EXPLOSIVE SPECIATION; LEVEL FLUCTUATIONS; ANCIENT LAKES; EVOLUTION; PHYLOGENY; DIVERGENCE	The spectacular marine-like diversity of the endemic fauna of Lake Tanganyika, the oldest of the African Great Lakes, led early researchers to suggest that the lake must have once been connected to the ocean. Recent geophysical reconstructions clearly indicate that Lake Tanganyika formed by rifting in the African subcontinent and was never directly linked to the sea. Although the Lake has a high proportion of specialized endemics, the absence of close relatives outside Tanganyika has complicated phylogeographic reconstructions of the timing of lake colonization and intralacustrine diversification. The freshwater herring of Lake Tanganyika are members of a large group of pellonuline herring found in western and southern Africa, offering one of the best opportunities to trace the evolutionary history of members of Tanganyika's biota. Molecular phylogenetic reconstructions indicate that herring colonized West Africa 25-50MYA, at the end of a major marine incursion in the region. Pellonuline herring subsequently experienced an evolutionary radiation in West Africa, spreading across the continent and reaching East Africa's Lake Tanganyika during its early formation. While Lake Tanganyika has never been directly connected with the sea, the endemic freshwater herring of the lake are the descendents of an ancient marine incursion, a scenario which may also explain the origin of other Tanganyikan endemics.	[Wilson, Anthony B.; Meyer, Axel] Univ Konstanz, Dept Biol, Constance, Germany; [Wilson, Anthony B.] Univ Zurich, Zool Museum, Zurich, Switzerland; [Teugels, Guy G.] Royal Museum Cent Africa, Ichthyol Lab, Tervuren, Belgium	University of Konstanz; University of Zurich; Royal Museum for Central Africa	Wilson, AB (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	tony.wilson@zm.uzh.ch	Wilson, Anthony B/D-2907-2011; Meyer, Axel/C-9826-2009	Meyer, Axel/0000-0002-0888-8193; Wilson, Anthony/0000-0002-2848-8816	National Research Council; Swiss National Science Foundation; Deutsche Forschungsgemeinschaft	National Research Council; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by research grants from the National Research Council and Swiss National Science Foundation to ABW and a grant from the Deutsche Forschungsgemeinschaft to AM. The funding agencies played no role in the analysis or interpretation of the data presented here.	Albrecht C, 2006, ORG DIVERS EVOL, V6, P294, DOI 10.1016/j.ode.2005.12.003; Arambourg C, 1943, B SOC GEOLOGIQUE FRA, VXIII, P281, DOI [10.2113/gssgfbull.S5-XIII.4-6.281, DOI 10.2113/GSSGFBULL.S5-XIII.4-6.281]; Barker FK, 2002, SYST BIOL, V51, P625, DOI 10.1080/10635150290102302; Beadle LC., 1974, INLAND WATERS AFRICA; Brandstatter A, 2005, MOL PHYLOGENET EVOL, V34, P382, DOI 10.1016/j.ympev.2004.10.019; BRANISA L., 1964, BULL MUS NAT HIST NATUR, V36, P279; Briggs JC, 2005, J BIOGEOGR, V32, P287, DOI 10.1111/j.1365-2699.2004.01170.x; Broughton RE, 2001, GENOME RES, V11, P1958, DOI 10.1101/gr.156801; CAVENDER TM, 1991, CYPRINID FISHES SYST, P34; CHANG YS, 1994, J MOL EVOL, V38, P138, DOI 10.1007/BF00166161; Cohen AS, 1997, BASIN RES, V9, P107, DOI 10.1046/j.1365-2117.1997.00038.x; Coulter G. W., 1991, LAKE TANGANYIKA ITS; Di Dario F, 2002, COPEIA, P496; Duftner N, 2005, J MOL EVOL, V60, P277, DOI 10.1007/s00239-004-0017-8; Durand JD, 2005, MOL PHYLOGENET EVOL, V36, P277, DOI 10.1016/j.ympev.2005.01.019; Giresse P, 2005, J AFR EARTH SCI, V43, P301, DOI 10.1016/j.jafrearsci.2005.07.009; Gorthner A., 1994, ARCH HYDROBIOL, V44, P97; Gourene Germain, 1994, Journal of African Zoology, V108, P77; GRANDE L, 1985, American Museum Novitates, P1; GRANDE L, 1985, B AM MUS NAT HIST, V181, P235; Guiraud R, 2005, J AFR EARTH SCI, V43, P83, DOI 10.1016/j.jafrearsci.2005.07.017; Guiraud R, 2001, PALAEOTECTONIC ATLAS; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hauser L, 1998, J FISH BIOL, V53, P413, DOI 10.1006/jfbi.1998.0826; Hrbek T, 1999, EVOLUTION, V53, P1200, DOI 10.1111/j.1558-5646.1999.tb04533.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inoue JG, 2000, FISHERIES SCI, V66, P924, DOI 10.1046/j.1444-2906.2000.00148.x; Inoue JG, 2001, FISHERIES SCI, V67, P828, DOI 10.1046/j.1444-2906.2001.00329.x; Joyce DA, 2005, NATURE, V435, P90, DOI 10.1038/nature03489; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Koblmuller S, 2005, J MOL EVOL, V60, P297, DOI 10.1007/s00239-004-0033-8; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kontula T, 2003, MOL PHYLOGENET EVOL, V27, P143, DOI 10.1016/S1055-7903(02)00376-7; Lavoue S, 2005, MOL PHYLOGENET EVOL, V37, P165, DOI 10.1016/j.ympev.2005.03.024; Lavoue S, 2007, MOL PHYLOGENET EVOL, V43, P1096, DOI 10.1016/j.ympev.2006.09.018; Li CH, 2007, MOL PHYLOGENET EVOL, V44, P386, DOI 10.1016/j.ympev.2006.10.030; Marijnissen SAE, 2006, MOL PHYLOGENET EVOL, V40, P628, DOI 10.1016/j.ympev.2006.03.025; Martens K, 1994, SPECIATION ANCIENT L; Michel E, 2000, ADV ECOL RES, V31, P275, DOI 10.1016/S0065-2504(00)31016-9; MILLER RR, 1982, J PALEONTOL, V56, P423; Moore J. E. S., 1897, NATURE, V56, P198, DOI DOI 10.1038/056198C0; Moore JES, 1903, TANGANYIKA PROBLEM; NISHIDA M, 1991, EXPERIENTIA, V47, P974, DOI 10.1007/BF01929896; PAABO S, 1991, J MOL EVOL, V33, P426, DOI 10.1007/BF02103134; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Phiri H, 1999, FISH RES, V41, P63, DOI 10.1016/S0165-7836(99)00008-9; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rutschmann F., 2005, BAYESIAN MOL DATING; Saitoh K, 2003, J MOL EVOL, V56, P464, DOI 10.1007/s00239-002-2417-y; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Salzburger W, 2002, SYST BIOL, V51, P113, DOI 10.1080/106351502753475907; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SNOEKS J, 1994, ARCH HYDROBIOLOGIE S, P355; Stiassny MLJ, 1999, SCI AM, V280, P64, DOI 10.1038/scientificamerican0299-64; Stiassny MLJ, 2002, COPEIA, P67, DOI 10.1643/0045-8511(2002)002[0067:ROSBCP]2.0.CO;2; Streelman JT, 2003, TRENDS ECOL EVOL, V18, P126; Sturmbauer C, 2001, MOL BIOL EVOL, V18, P144, DOI 10.1093/oxfordjournals.molbev.a003788; Sturmbauer C, 1998, J FISH BIOL, V53, P18; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Tiercelin J.J., 1991, LAKE TANGANYIKA ITS, P7; Turner GF, 2001, MOL ECOL, V10, P793, DOI 10.1046/j.1365-294x.2001.01200.x; TZENG CS, 1992, NUCLEIC ACIDS RES, V20, P4853, DOI 10.1093/nar/20.18.4853; Van Damme D, 2003, HYDROBIOLOGIA, V498, P1, DOI 10.1023/A:1026298512117; Verheyen E, 1996, PHILOS T ROY SOC B, V351, P797, DOI 10.1098/rstb.1996.0074; von Rintelen T, 2004, P ROY SOC B-BIOL SCI, V271, P2541, DOI 10.1098/rspb.2004.2842; Waddell PJ, 2000, MOL BIOL EVOL, V17, P1988, DOI 10.1093/oxfordjournals.molbev.a026300; Wang HY, 2002, MOL BIOL EVOL, V19, P138, DOI 10.1093/oxfordjournals.molbev.a004066; Waters JM, 2000, SYST BIOL, V49, P777, DOI 10.1080/106351500750049824; Whitehead P.J.P., 1985, FAO FISH, V125, P1; WHITEHEAD PJ, 1988, FAO FISHERIES SYNOPS, V125, P1; Whitehead PJP, 1985, AM MUSEUM NOVIT, V2835, P1, DOI [10.2307/772463, DOI 10.2307/772463]; Wilson AB, 2004, P ROY SOC B-BIOL SCI, V271, P529, DOI 10.1098/rspb.2003.2624; Wilson AB, 2001, J HERED, V92, P159, DOI 10.1093/jhered/92.2.159; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yabumoto Y, 1988, B KITAKYUSHU MUS NAT, V8, P55; Yang Z., 2000, PHYLOGENETIC ANAL MA; Zwickl D. J, 2006, GENETIC ALGORITHM AP	81	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1979	10.1371/journal.pone.0001979	http://dx.doi.org/10.1371/journal.pone.0001979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431469	Green Published, Green Submitted, gold			2022-12-27	WOS:000261558700004
J	Sauvat, F; Capito, C; Sarnacki, S; Poirot, C; Bachelot, A; Meduri, G; Dandolo, L; Binart, N				Sauvat, Frederique; Capito, Carmen; Sarnacki, Sabine; Poirot, Catherine; Bachelot, Anne; Meduri, Geri; Dandolo, Luisa; Binart, Nadine			Immature Cryopreserved Ovary Restores Puberty and Fertility in Mice without Alteration of Epigenetic Marks	PLOS ONE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; ASSISTED REPRODUCTIVE TECHNOLOGY; MONOZYGOTIC TWINS DISCORDANT; BONE-MARROW-TRANSPLANTATION; IN-VITRO FERTILIZATION; TERM-FOLLOW-UP; TISSUE CRYOPRESERVATION; MOUSE OVARIES; CHILDHOOD-CANCER; H19	Background: Progress in oncology could improve survival rate in children, but would probably lead to impaired fertility and puberty. In pre-pubertal girls, the only therapeutic option is the cryopreservation of one ovary. Three births have been reported after reimplantation of cryopreserved mature ovary. Conversely, reimplantation of ovary preserved before puberty (defined as immature ovary) has never been performed in humans. Methodology/Principal Findings: In order to analyze ovarian function, we performed transplantation using fresh or cryopreserved immature grafts in pre-pubertal or adult mice. Puberty as well as cyclic hormonal activity was restored. All follicle populations were present although a significant reduction in follicle density was observed with or without cryopreservation. Although fertility was restored, the graft is of limited life span. Because ex vivo ovary manipulation and cryopreservation procedure, the status of genomic imprinting was investigated. Methylation status of the H19 and Lit1 Imprinting Control Regions in kidney, muscle and tongue of offsprings from grafted mice does not show significant alteration when compared to those of unoperated mice. Conclusions/Significance: These results demonstrate that immature ovarian grafting can restore spontaneous puberty and fertility. However, these data suggest that follicle depletion leads to premature ovarian failure. This study addresses the very important epigenetics issue, and provides valuable information to the study of ovarian transplantation suggesting that these procedures do not perturb normal epigenetics marks. These results are highly relevant to the reimplantation question of immature cortex in women.	[Sauvat, Frederique; Capito, Carmen; Bachelot, Anne; Binart, Nadine] INSERM, Unit 845, Paris, France; [Sauvat, Frederique; Capito, Carmen; Bachelot, Anne; Binart, Nadine] Univ Paris 05, Fac Med Rene Descartes, Paris 5 Necker Site, UMR S845, Paris, France; [Sauvat, Frederique; Sarnacki, Sabine] Hosp Necker Enfants Malades, Dept Pediat Surg, AP HP, Paris, France; [Poirot, Catherine] GH Pitie Salpetriere, Unit Biol Reprod, AP HP, Paris, France; [Bachelot, Anne] GH Pitie Salpetriere, Dept Endocrinol & Reprod Med, AP PH, Paris, France; [Meduri, Geri] Inserm, Unit 693, Le Kremlin Bicetre, France; [Meduri, Geri] GH Bicetre, Dept Mol Biochem, AP PH, Le Kremlin Bicetre, France; [Dandolo, Luisa] Univ Paris 05, Inst Cochin, Dept Genet & Dev, CNRS UMR 8104, Inserm U 567, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Binart, N (corresponding author), INSERM, Unit 845, Paris, France.	binart@necker.fr	Bachelot, Anne/GQZ-0551-2022; Binart, Nadine/F-2949-2013; Sarnacki, Sabine/I-2692-2017	Binart, Nadine/0000-0002-5606-3866; Sarnacki, Sabine/0000-0003-4304-5578	ARC [3695]; Inserm	ARC(Australian Research Council); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This study was supported by a grant from ARC #3695 and Inserm. F. Sauvat was supported by a fellowship from Inserm.	Akar M, 2005, TRENDS ENDOCRIN MET, V16, P374, DOI 10.1016/j.tem.2005.06.011; Bakker B, 2000, EUR J PEDIATR, V159, P31, DOI 10.1007/s004310050006; Bath LE, 2004, HUM REPROD, V19, P2569, DOI 10.1093/humrep/deh472; BenEzra D, 2005, BRIT J OPHTHALMOL, V89, P393, DOI 10.1136/bjo.2004.056739; Blatt J, 1999, MED PEDIATR ONCOL, V33, P29, DOI 10.1002/(SICI)1096-911X(199907)33:1<29::AID-MPO6>3.0.CO;2-2; BLEYER WA, 1990, CA-CANCER J CLIN, V40, P355, DOI 10.3322/canjclin.40.6.355; Buiting K, 2003, AM J HUM GENET, V72, P571, DOI 10.1086/367926; Candy CJ, 2000, HUM REPROD, V15, P1300, DOI 10.1093/humrep/15.6.1300; Chang AS, 2005, FERTIL STERIL, V83, P349, DOI 10.1016/j.fertnstert.2004.07.964; Constancia M, 2004, NATURE, V432, P53, DOI 10.1038/432053a; Cox SL, 2000, FERTIL STERIL, V74, P366, DOI 10.1016/S0015-0282(00)00635-X; Cox SL, 1996, J REPROD FERTIL, V107, P315, DOI 10.1530/jrf.0.1070315; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Demeestere I, 2007, ONCOLOGIST, V12, P1437, DOI 10.1634/theoncologist.12-12-1437; Desandes E, 2006, EUR J CANCER, V42, P403, DOI 10.1016/j.ejca.2005.07.035; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Donnez J, 2004, LANCET, V364, P1405, DOI 10.1016/S0140-6736(04)17222-X; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Fitzpatrick DR, 2003, CLIN IMMUNOL, V109, P37, DOI 10.1016/S1521-6616(03)00205-5; Frisk P, 2004, BONE MARROW TRANSPL, V33, P205, DOI 10.1038/sj.bmt.1704324; Gicquel C, 2003, AM J HUM GENET, V72, P1338, DOI 10.1086/374824; GOSDEN RG, 1994, HUM REPROD, V9, P597, DOI 10.1093/oxfordjournals.humrep.a138556; GOSDEN RG, 1992, J ASSIST REPROD GEN, V9, P118, DOI 10.1007/BF01203750; Gosden RG, 2007, NEW ENGL J MED, V356, P731, DOI 10.1056/NEJMe068284; Gunasena KT, 1997, HUM REPROD, V12, P101, DOI 10.1093/humrep/12.1.101; Hamish W, 2004, LANCET, V364, P2093, DOI 10.1016/S0140-6736(04)17544-2; Hubinont C, 2004, LANCET, V364, P2093, DOI 10.1016/S0140-6736(04)17543-0; JONES EC, 1960, J ENDOCRINOL, V20, P135, DOI 10.1677/joe.0.0200135; Kim SS, 2006, FERTIL STERIL, V85, P1, DOI 10.1016/j.fertnstert.2005.04.071; Kim SS, 2004, FERTIL STERIL, V82, P930, DOI 10.1016/j.fertnstert.2004.02.137; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Lewis A, 2006, DEVELOPMENT, V133, P4203, DOI 10.1242/dev.02612; Liu J, 2002, HUM REPROD, V17, P605, DOI 10.1093/humrep/17.3.605; Lo Presti A, 2004, EUR J OBSTET GYN R B, V113, pS33, DOI 10.1016/j.ejogrb.2003.11.008; Lobo RA, 2005, NEW ENGL J MED, V353, P64, DOI 10.1056/NEJMra043475; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Ludwig M, 2005, J MED GENET, V42, P289, DOI 10.1136/jmg.2004.026930; Maher ER, 2003, J MED GENET, V40, P62, DOI 10.1136/jmg.40.1.62; Maher ER, 2005, HUM MOL GENET, V14, pR133, DOI 10.1093/hmg/ddi107; Mancini-DiNardo D, 2003, HUM MOL GENET, V12, P283, DOI 10.1093/hmg/ddg024; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Mann MRW, 2003, BIOL REPROD, V69, P902, DOI 10.1095/biolreprod.103.017293; Meirow D, 1999, FERTIL STERIL, V71, P948, DOI 10.1016/S0015-0282(99)00067-9; Meirow D, 2005, NEW ENGL J MED, V353, P318, DOI 10.1056/NEJMc055237; Meirow D, 2007, FERTIL STERIL, V87, DOI 10.1016/j.fertnstert.2006.05.086; Meirow D, 2007, LEUKEMIA LYMPHOMA, V48, P1569, DOI 10.1080/10428190701471957; Migishima F, 2006, FERTIL STERIL, V86, P1080, DOI 10.1016/j.fertnstert.2006.03.023; Muller J, 2002, BEST PRACT RES CL EN, V16, P91, DOI 10.1053/beem.2002.0183; MUSSETT MV, 1961, J REPROD FERTIL, V2, P80, DOI 10.1530/jrf.0.0020080; Myers M, 2004, REPRODUCTION, V127, P569, DOI 10.1530/rep.1.00095; Navarro-Costa P, 2005, HUM REPROD, V20, P1607, DOI 10.1093/humrep/deh787; Niemitz EL, 2004, AM J HUM GENET, V74, P599, DOI 10.1086/382897; Oktay K, 2004, LANCET, V363, P837, DOI 10.1016/S0140-6736(04)15728-0; Oktay K, 2004, LANCET, V364, P2091, DOI 10.1016/S0140-6736(04)17541-7; Oktay K, 2006, HUM REPROD, V21, P1345, DOI 10.1093/humrep/del007; Paulsen M, 2001, J PATHOL, V195, P97, DOI 10.1002/path.890; Poirot C, 2005, Gynecol Obstet Fertil, V33, P799, DOI 10.1016/j.gyobfe.2005.07.032; Poirot CJ, 2007, PEDIATR BLOOD CANCER, V49, P74, DOI 10.1002/pbc.21027; Pritchard-Jones K, 2006, EUR J CANCER, V42, P2183, DOI 10.1016/j.ejca.2006.06.006; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Salle B, 2003, FERTIL STERIL, V80, P172, DOI 10.1016/S0015-0282(03)00554-5; Shaw JM, 2000, MOL CELL ENDOCRINOL, V161, P103, DOI 10.1016/S0303-7207(99)00230-0; Siegel-Itzkovich J, 2005, BRIT MED J, V331, P8, DOI 10.1136/bmj.331.7507.8-a; Silber SJ, 2007, NEW ENGL J MED, V356, P1382, DOI 10.1056/NEJMc066574; Silber SJ, 2005, NEW ENGL J MED, V353, P58, DOI 10.1056/NEJMoa043157; SILBER SJ, 2008, HUM REPROD; Skinner R, 2006, LANCET ONCOL, V7, P489, DOI 10.1016/S1470-2045(06)70724-0; Sklar CA, 2006, J NATL CANCER I, V98, P890, DOI 10.1093/jnci/djj243; THE VL, 1989, MOL ENDOCRINOL, V3, P1310, DOI 10.1210/mend-3-8-1310; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Wallace WHB, 2005, LANCET ONCOL, V6, P209, DOI 10.1016/S1470-2045(05)70092-9; Wang HB, 2002, AM J OBSTET GYNECOL, V187, P370, DOI 10.1067/mob.2002.123606; Young LE, 2003, MECH DEVELOP, V120, P1433, DOI 10.1016/j.mod.2003.09.006	73	28	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1972	10.1371/journal.pone.0001972	http://dx.doi.org/10.1371/journal.pone.0001972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414667	gold, Green Published, Green Submitted			2022-12-27	WOS:000260867300016
J	Haitin, Y; Yisharel, I; Malka, E; Shamgar, L; Schottelndreier, H; Peretz, A; Paas, Y; Attali, B				Haitin, Yoni; Yisharel, Ilanit; Malka, Eti; Shamgar, Liora; Schottelndreier, Hella; Peretz, Asher; Paas, Yoav; Attali, Bernard			S1 Constrains S4 in the Voltage Sensor Domain of Kv7.1 K+ Channels	PLOS ONE			English	Article								Voltage-gated K+ channels comprise a central pore enclosed by four voltage-sensing domains (VSDs). While movement of the S4 helix is known to couple to channel gate opening and closing, the nature of S4 motion is unclear. Here, we substituted S4 residues of Kv7.1 channels by cysteine and recorded whole-cell mutant channel currents in Xenopus oocytes using the two-electrode voltage-clamp technique. In the closed state, disulfide and metal bridges constrain residue S225 (S4) nearby C136 (S1) within the same VSD. In the open state, two neighboring I227 (S4) are constrained at proximity while residue R228 (S4) is confined close to C136 (S1) of an adjacent VSD. Structural modeling predicts that in the closed to open transition, an axial rotation (similar to 190 degrees) and outward translation of S4 (similar to 12 angstrom) is accompanied by VSD rocking. This large sensor motion changes the intra-VSD S1-S4 interaction to an inter-VSD S1-S4 interaction. These constraints provide a ground for cooperative subunit interactions and suggest a key role of the S1 segment in steering S4 motion during Kv7.1 gating.	[Haitin, Yoni; Yisharel, Ilanit; Malka, Eti; Shamgar, Liora; Schottelndreier, Hella; Peretz, Asher; Attali, Bernard] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Paas, Yoav] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Tel Aviv University; Sackler Faculty of Medicine; Bar Ilan University	Attali, B (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	battali@post.tau.ac.il	Haitin, Yoni/AAQ-4571-2021	Haitin, Yoni/0000-0002-1648-6792	Israel Science Foundation [ISF 672/05]; Israel Ministry of Science Tashtiot program; Keren Wolfson Family	Israel Science Foundation(Israel Science Foundation); Israel Ministry of Science Tashtiot program; Keren Wolfson Family	This work is supported by the Israel Science Foundation (ISF 672/05), the Israel Ministry of Science Tashtiot program and the Keren Wolfson Family funds to BA.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2004, TRENDS NEUROSCI, V27, P303, DOI 10.1016/j.tins.2004.03.008; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; Aziz QH, 2002, J BIOL CHEM, V277, P42719, DOI 10.1074/jbc.M207258200; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Elliott DJS, 2004, EMBO J, V23, P4717, DOI 10.1038/sj.emboj.7600484; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Gibor G, 2004, J GEN PHYSIOL, V124, P83, DOI 10.1085/jgp.200409068; Gibor G, 2007, BIOPHYS J, V93, P4159, DOI 10.1529/biophysj.107.107987; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Mannuzzu LM, 2000, J GEN PHYSIOL, V115, P257, DOI 10.1085/jgp.115.3.257; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Nguyen TP, 2002, J GEN PHYSIOL, V120, P419, DOI 10.1085/jgp.20028636; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Yang NB, 1997, BIOPHYS J, V73, P2260, DOI 10.1016/S0006-3495(97)78258-4; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103	27	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1935	10.1371/journal.pone.0001935	http://dx.doi.org/10.1371/journal.pone.0001935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398461	Green Submitted, gold, Green Published			2022-12-27	WOS:000260795500012
J	Scott-Algara, D; Arnold, V; Didier, C; Kattan, T; Pirozzi, G; Barre-Sinoussi, F; Pancino, G				Scott-Algara, Daniel; Arnold, Vincent; Didier, Celine; Kattan, Tarek; Pirozzi, Gianluca; Barre-Sinoussi, Francoise; Pancino, Gianfranco			The CD85j(+) NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells	PLOS ONE			English	Article								Natural killer (NK) cells and dendritic cells (DC) are thought to play critical roles in the first phases of HIV infection. In this study, we examined changes in the NK cell repertoire and functions occurring in response to early interaction with HIV-infected DC, using an autologous in vitro NK/DC coculture system. We show that NK cell interaction with HIV-1-infected autologous monocyte-derived DC (MDDC) modulates NK receptor expression. In particular, expression of the CD85j receptor on NK cells was strongly down-regulated upon coculture with HIV-1-infected MDDC. We demonstrate that CD85j(+) NK cells exert potent control of HIV-1 replication in single-round and productively HIV-1-infected MDDC, whereas CD85j(-) NK cells induce a modest and transient decrease of HIV-1 replication. HIV-1 suppression in MDCC by CD85j(+) NK cells required cell-to-cell contact and did not appear mediated by cytotoxicity or by soluble factors. HIV-1 inhibition was abolished when NK-MDDC interaction through the CD85j receptor was blocked with a recombinant CD85j molecule, whereas inhibition was only slightly counteracted by blocking HLA class I molecules, which are known CD85j ligands. After masking HLA class I molecules with specific antibodies, a fraction of HIV-1 infected MDDC was still strongly stained by a recombinant CD85j protein. These results suggest that CD85j(+) NK cell inhibition of HIV-1 replication in MDDC is mainly mediated by CD85j interaction with an unknown ligand (distinct from HLA class I molecules) preferentially expressed on HIV-1-infected MDDC.	[Scott-Algara, Daniel; Arnold, Vincent; Didier, Celine; Kattan, Tarek; Pirozzi, Gianluca; Barre-Sinoussi, Francoise; Pancino, Gianfranco] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Scott-Algara, D (corresponding author), Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France.	scott@pasteur.fr	Pancino, Gianfranco/A-5519-2010; Scott, Daniel/AFK-5428-2022; Barre-Sinoussi, Françoise/G-8355-2011	Scott-Algara, Daniel/0000-0003-1851-503X	Sidaction; National Agency for AIDS Research (ANRS), France	Sidaction; National Agency for AIDS Research (ANRS), France(ANRS)	This study was supported by grants from Sidaction and the National Agency for AIDS Research (ANRS), France.	Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Alter G, 2007, J INFECT DIS, V195, P1452, DOI 10.1086/513878; Alter G, 2006, CURR MOL MED, V6, P621, DOI 10.2174/156652406778195035; Ancuta P, 2006, VIROLOGY, V344, P267, DOI 10.1016/j.virol.2005.10.027; Bottino C, 2006, CURR TOP MICROBIOL, V298, P175; Boyton RJ, 2007, CLIN EXP IMMUNOL, V149, P1, DOI 10.1111/j.1365-2249.2007.03424.x; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Donaghy H, 2006, J LEUKOCYTE BIOL, V80, P1001, DOI 10.1189/jlb.0306158; Fauci AS, 2005, NAT REV IMMUNOL, V5, P835, DOI 10.1038/nri1711; Fortis C, 2002, J BIOL REG HOMEOS AG, V16, P30; Kottilil S, 2004, J INFECT DIS, V189, P1193, DOI 10.1086/382090; Kottilil S, 2003, J INFECT DIS, V187, P1038, DOI 10.1086/368222; Lopez-Botet M, 2004, TISSUE ANTIGENS, V63, P195, DOI 10.1111/j.1399-0039.2004.00210.x; Marcenaro E, 2006, TRANSPL IMMUNOL, V17, P16, DOI 10.1016/j.trim.2006.09.019; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; Mavilio D, 2006, J EXP MED, V203, P2339, DOI 10.1084/jem.20060894; Moretta A, 2005, TRENDS IMMUNOL, V26, P668, DOI 10.1016/j.it.2005.09.008; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; O'Connor GM, 2007, CLIN IMMUNOL, V124, P277, DOI 10.1016/j.clim.2007.05.016; Oliva A, 1998, J CLIN INVEST, V102, P223, DOI 10.1172/JCI2323; Perez-Bercoff D, 2003, J VIROL, V77, P4081, DOI 10.1128/JVI.77.7.4081-4094.2003; Ravet S, 2007, BLOOD, V109, P4296, DOI 10.1182/blood-2006-08-040238; Scott-Algara D, 2003, J IMMUNOL, V171, P5663, DOI 10.4049/jimmunol.171.11.5663; SCOTTALGARA D, 1992, CLIN EXP IMMUNOL, V90, P181; Tasca S, 2003, AIDS, V17, P2291, DOI 10.1097/00002030-200311070-00003; Vales-Gomez M, 2005, J VIROL, V79, P2251, DOI 10.1128/JVI.79.4.2251-2260.2005	29	33	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1975	10.1371/journal.pone.0001975	http://dx.doi.org/10.1371/journal.pone.0001975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398485	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795500038
J	Chehab, EW; Kaspi, R; Savchenko, T; Rowe, H; Negre-Zakharov, F; Kliebenstein, D; Dehesh, K				Chehab, E. Wassim; Kaspi, Roy; Savchenko, Tatyana; Rowe, Heather; Negre-Zakharov, Florence; Kliebenstein, Dan; Dehesh, Katayoon			Distinct Roles of Jasmonates and Aldehydes in Plant-Defense Responses	PLOS ONE			English	Article							HYDROPEROXIDE LYASE; BOTRYTIS-CINEREA; ARABIDOPSIS-THALIANA; SALICYLIC-ACID; BIOSYNTHESIS; RESISTANCE; VOLATILES; METABOLITES; HERBIVORES; CAMALEXIN	Background: Many inducible plant-defense responses are activated by jasmonates (JAs), C-6-aldehydes, and their corresponding derivatives, produced by the two main competing branches of the oxylipin pathway, the allene oxide synthase (AOS) and hydroperoxide lyase (HPL) branches, respectively. In addition to competition for substrates, these branch-pathway-derived metabolites have substantial overlap in regulation of gene expression. Past experiments to define the role of C-6-aldehydes in plant defense responses were biased towards the exogenous application of the synthetic metabolites or the use of genetic manipulation of HPL expression levels in plant genotypes with intact ability to produce the competing AOS-derived metabolites. To uncouple the roles of the C-6-aldehydes and jasmonates in mediating direct and indirect plant-defense responses, we generated Arabidopsis genotypes lacking either one or both of these metabolites. These genotypes were subsequently challenged with a phloem-feeding insect (aphids: Myzus persicae), an insect herbivore (leafminers: Liriomyza trifolii), and two different necrotrophic fungal pathogens (Botrytis cinerea and Alternaria brassicicola). We also characterized the volatiles emitted by these plants upon aphid infestation or mechanical wounding and identified hexenyl acetate as the predominant compound in these volatile blends. Subsequently, we examined the signaling role of this compound in attracting the parasitoid wasp (Aphidius colemani), a natural enemy of aphids. Principal Findings: This study conclusively establishes that jasmonates and C-6-aldehydes play distinct roles in plant defense responses. The jasmonates are indispensable metabolites in mediating the activation of direct plant-defense responses, whereas the C-6-aldehyes are not. On the other hand, hexenyl acetate, an acetylated C-6-aldehyde, is the predominant wound-inducible volatile signal that mediates indirect defense responses by directing tritrophic (plant-herbivore-natural enemy) interactions. Significance: The data suggest that jasmonates and hexenyl acetate play distinct roles in mediating direct and indirect plant-defense responses. The potential advantage of this "division of labor'' is to ensure the most effective defense strategy that minimizes incurred damages at a reduced metabolic cost.	[Chehab, E. Wassim; Kaspi, Roy; Savchenko, Tatyana; Dehesh, Katayoon] Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA; [Rowe, Heather; Negre-Zakharov, Florence; Kliebenstein, Dan] Univ Calif Davis, Dept Plant Sci, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis	Chehab, EW (corresponding author), Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA.	kdehesh@ucdavis.edu	Savchenko, Tatyana/E-7091-2014; Rowe, Heather C/C-9284-2011	Savchenko, Tatyana/0000-0003-0126-4932; Kliebenstein, Daniel/0000-0001-5759-3175; Zakharov, Florence/0000-0003-3327-6145	NSF [0543904];  [0606838]	NSF(National Science Foundation (NSF)); 	This work was supported by NSF grants 0543904 and 0606838 awarded to KD	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; Blee E, 2002, TRENDS PLANT SCI, V7, P315, DOI 10.1016/S1360-1385(02)02290-2; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Chehab EW, 2006, PLANT PHYSIOL, V141, P121, DOI 10.1104/pp.106.078592; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Denby KJ, 2004, PLANT J, V38, P473, DOI 10.1111/j.0960-7412.2004.02059.x; Devoto A, 2003, ANN BOT-LONDON, V92, P329, DOI 10.1093/aob/mcg151; Duan H, 2005, PLANT PHYSIOL, V139, P1529, DOI 10.1104/pp.105.067249; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Engelberth J, 2003, ANAL BIOCHEM, V312, P242, DOI 10.1016/S0003-2697(02)00466-9; Farag MA, 2005, PLANTA, V220, P900, DOI 10.1007/s00425-004-1404-5; Ferrari S, 2003, PLANT J, V35, P193, DOI 10.1046/j.1365-313X.2003.01794.x; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Halitschke R, 2004, PLANT J, V40, P35, DOI 10.1111/j.1365-313X.2004.02185.x; Halitschke R, 2003, PLANT J, V36, P794, DOI 10.1046/j.1365-313X.2003.01921.x; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; HERMAN PL, 1989, PLANT CELL, V1, P1051, DOI 10.1105/tpc.1.11.1051; HILDEBRAND DF, 1993, J CHEM ECOL, V19, P1875, DOI 10.1007/BF00983793; Kaspi R, 2006, J ECON ENTOMOL, V99, P1168, DOI 10.1603/0022-0493-99.4.1168; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Kishimoto K, 2005, PLANT CELL PHYSIOL, V46, P1093, DOI 10.1093/pcp/pci122; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; McCarthy DA, 1998, ABSTR PAP AM CHEM S, V216, pU900; Paiva NL, 2000, J PLANT GROWTH REGUL, V19, P131; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Pareja M, 2007, J CHEM ECOL, V33, P695, DOI 10.1007/s10886-007-9260-y; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Rowe HC, 2007, MOL PLANT MICROBE IN, V20, P1126, DOI 10.1094/MPMI-20-9-1126; Royo J, 1999, P NATL ACAD SCI USA, V96, P1146, DOI 10.1073/pnas.96.3.1146; Schmelz EA, 2003, PLANT PHYSIOL, V133, P295, DOI 10.1104/pp.103.024174; SCHOONHOVEN LM, 1998, PLANT GROWTH REGUL, V28, P217; Shiojiri K, 2006, P NATL ACAD SCI USA, V103, P16672, DOI 10.1073/pnas.0607780103; ULLAND S, 2007, CHEM SENSES; van Poecke RMP, 2004, PLANT BIOLOGY, V6, P387, DOI 10.1055/s-2004-820887; Vancanneyt G, 2001, P NATL ACAD SCI USA, V98, P8139, DOI 10.1073/pnas.141079498; Walley JW, 2007, PLOS GENET, V3, P1800, DOI 10.1371/journal.pgen.0030172; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Weber H, 1999, PLANT CELL, V11, P485, DOI 10.1105/tpc.11.3.485; Wei JN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000852; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419	47	102	115	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1904	10.1371/journal.pone.0001904	http://dx.doi.org/10.1371/journal.pone.0001904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382679	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795400031
J	Bedhomme, S; Prasad, NG; Jiang, PP; Chippindale, AK				Bedhomme, Stephanie; Prasad, Nagaraj G.; Jiang, Pan-Pan; Chippindale, Adam K.			Reproductive Behaviour Evolves Rapidly When Intralocus Sexual Conflict Is Removed	PLOS ONE			English	Article								Background: Intralocus sexual conflict can inhibit the evolution of each sex towards its own fitness optimum. In a previous study, we confirmed this prediction through the experimental removal of female selection pressures in Drosophila melanogaster, achieved by limiting the expression of all major chromosomes to males. Compared to the control populations (C1-4) where the genomes are exposed to selection in both sexes, the populations with male-limited genomes (ML1-4) showed rapid increases in male fitness, whereas the fitness of females expressing ML-evolved chromosomes decreased [1]. Methodology/Principal Findings: Here we examine the behavioural phenotype underlying this sexual antagonism. We show that males expressing the ML genomes have a reduced courtship level but acquire the same number of matings. On the other hand, our data suggest that females expressing the ML genomes had reduced attractiveness, stimulating a lower rate of courtship from males. Moreover, females expressing ML genomes tend to display reduced yeast-feeding behaviour, which is probably linked to the reduction of their fecundity. Conclusion/Significance: These results suggest that reproductive behaviour is shaped by opposing selection on males and females, and that loci influencing attractiveness and foraging were polymorphic for alleles with sexually antagonistic expression patterns prior to ML selection. Hence, intralocus sexual conflict appears to play a role in the evolution of a wide range of fitness-related traits and may be a powerful mechanism for the maintenance of genetic variation in fitness.	[Bedhomme, Stephanie; Prasad, Nagaraj G.; Jiang, Pan-Pan; Chippindale, Adam K.] Queens Univ, Dept Biol, Kingston, ON, Canada	Queens University - Canada	Bedhomme, S (corresponding author), Queens Univ, Dept Biol, Kingston, ON, Canada.	sbedh_01@uni-muenster.de	bedhomme, stéphanie/C-8912-2014	Prasad, N G/0000-0002-0410-5518; Bedhomme, Stephanie/0000-0001-8075-0968	NSERC; Canada Research Chairs program; Canadian Foundation for Innovation; Ontario Innovation Trust; French government [Lavoisier Award]; Queen's University [ARC postdoctoral fellowship]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; French government; Queen's University	This work was supported by an NSERC Discovery grant, the Canada Research Chairs program, the Canadian Foundation for Innovation and the Ontario Innovation Trust to AKC. SB was supported in part by a Lavoisier Award from the French government and a Queen's University ARC postdoctoral fellowship.	Albert AYK, 2005, SCIENCE, V310, P119, DOI 10.1126/science.1115328; Arnqvist Goran, 2005, pUnpaginated; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bedhomme Stephanie, 2007, P185; Blows MW, 2002, P ROY SOC B-BIOL SCI, V269, P1113, DOI 10.1098/rspb.2002.2002; Bourguet D, 2000, J EVOLUTION BIOL, V13, P515, DOI 10.1046/j.1420-9101.2000.00179.x; Byrne PG, 2006, P ROY SOC B-BIOL SCI, V273, P917, DOI 10.1098/rspb.2005.3372; Calsbeek R, 2004, J EVOLUTION BIOL, V17, P464, DOI 10.1046/j.1420-9101.2003.00665.x; Camperio-Ciani A, 2004, P ROY SOC B-BIOL SCI, V271, P2217, DOI 10.1098/rspb.2004.2872; CHAPMAN T, 1994, J EVOLUTION BIOL, V7, P51, DOI 10.1046/j.1420-9101.1994.7010051.x; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Chippindale AK, 2003, J GENET, V82, P133, DOI 10.1007/BF02715814; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P5677, DOI 10.1073/pnas.101456898; Chippindale AK, 1997, J EVOLUTION BIOL, V10, P269, DOI 10.1007/s000360050023; Crompton B, 2003, P ROY SOC B-BIOL SCI, V270, P1991, DOI 10.1098/rspb.2003.2477; Day T, 2004, GENETICS, V167, P1537, DOI 10.1534/genetics.103.026211; Delph LF, 2004, EVOLUTION, V58, P1936, DOI 10.1111/j.0014-3820.2004.tb00481.x; Drapeau MD, 2006, GENETICS, V172, P1009, DOI 10.1534/genetics.105.045666; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; Foley B, 2007, GENETICS, V175, P1465, DOI 10.1534/genetics.106.065771; FORSMAN A, 1995, J EVOLUTION BIOL, V8, P53, DOI 10.1046/j.1420-9101.1995.8010053.x; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Friberg U, 2003, J EVOLUTION BIOL, V16, P797, DOI 10.1046/j.1420-9101.2003.00597.x; Gibson JR, 2002, P ROY SOC B-BIOL SCI, V269, P499, DOI 10.1098/rspb.2001.1863; Gleason JM, 2002, HEREDITY, V89, P1, DOI 10.1038/sj.hdy.6800099; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; Howard RW, 2003, J CHEM ECOL, V29, P961, DOI 10.1023/A:1022992002239; JALLON JM, 1987, EVOLUTION, V41, P294, DOI 10.1111/j.1558-5646.1987.tb05798.x; Jones AG, 2001, P ROY SOC B-BIOL SCI, V268, P2531, DOI 10.1098/rspb.2001.1841; Lew TA, 2006, EVOLUTION, V60, P97; Linder JE, 2005, J EVOLUTION BIOL, V18, P568, DOI 10.1111/j.1420-9101.2004.00872.x; Long TAF, 2007, P ROY SOC B-BIOL SCI, V274, P3105, DOI 10.1098/rspb.2007.1140; MARKOW TA, 1987, P NATL ACAD SCI USA, V84, P6200, DOI 10.1073/pnas.84.17.6200; Moehring AJ, 2004, GENETICS, V167, P1249, DOI 10.1534/genetics.103.024372; Moller AP, 1998, AM NAT, V151, P174, DOI 10.1086/286110; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Parker G.A., 1979, P123; Pischedda A, 2006, PLOS BIOL, V4, P2099, DOI 10.1371/journal.pbio.0040356; Pitnick S, 2002, P ROY SOC B-BIOL SCI, V269, P1821, DOI 10.1098/rspb.2002.2090; Polak M, 2007, P ROY SOC B-BIOL SCI, V274, P3133, DOI 10.1098/rspb.2007.1272; Prasad NG, 2007, AM NAT, V169, P29, DOI 10.1086/509941; Raihani G, 2006, ANIM BEHAV, V71, P833, DOI 10.1016/j.anbehav.2005.06.013; RICE WR, 1994, SCIENCE, V263, P230, DOI 10.1126/science.8284674; Rice WR, 1998, P NATL ACAD SCI USA, V95, P6217, DOI 10.1073/pnas.95.11.6217; Rice WR, 1997, BEHAV ECOL SOCIOBIOL, V41, P1, DOI 10.1007/s002650050357; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; RICE WR, 1987, GENETICS, V116, P161; Rice WR, 2001, J EVOLUTION BIOL, V14, P685, DOI 10.1046/j.1420-9101.2001.00319.x; Rice WR, 1996, NATURE, V381, P232, DOI 10.1038/381232a0; Robinson MR, 2006, EVOLUTION, V60, P2168, DOI 10.1111/j.0014-3820.2006.tb01854.x; Rose MR, 2002, EVOLUTION, V56, P1982; Savarit F, 1999, P NATL ACAD SCI USA, V96, P9015, DOI 10.1073/pnas.96.16.9015; Shakarad M, 2001, J GENET, V80, P1, DOI 10.1007/BF02811412; STEELE RH, 1988, ANIM BEHAV, V36, P1190, DOI 10.1016/S0003-3472(88)80078-2; Stewart AD, 2005, P ROY SOC B-BIOL SCI, V272, P2029, DOI 10.1098/rspb.2005.3182; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Talyn BC, 2004, ANIM BEHAV, V68, P1165, DOI 10.1016/j.anbehav.2003.11.023; TOMPKINS L, 1980, J INSECT PHYSIOL, V26, P689, DOI 10.1016/0022-1910(80)90042-6; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051	64	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2187	10.1371/journal.pone.0002187	http://dx.doi.org/10.1371/journal.pone.0002187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478127	Green Submitted, gold, Green Published			2022-12-27	WOS:000262172800052
J	Parajes, S; Quinteiro, C; Dominguez, F; Loidi, L				Parajes, Silvia; Quinteiro, Celsa; Dominguez, Fernando; Loidi, Lourdes			High Frequency of Copy Number Variations and Sequence Variants at CYP21A2 Locus: Implication for the Genetic Diagnosis of 21-Hydroxylase Deficiency	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; MUTATION ANALYSIS; CLASSICAL FORMS; RCCX MODULE; HAPLOTYPES; PHENOTYPE; DISEASE; IDENTIFICATION; POPULATION; SWEDEN	Background:The systematic study of the human genome indicates that the inter-individual variability is greater than expected and it is not only related to sequence polymorphisms but also to gene copy number variants (CNVs). Congenital Adrenal Hyperplasia due to 21-hydroxylase deficiency (21OHD) is the most common autosomal recessive disorder with a carrier frequency of 1:25 to 1:10. The gene that encodes 21-hydroxylase enzyme, CYP21A2, is considered to be one of the most polymorphic human genes. Copy number variations, such as deletions, which are severe mutations common in 21OHD patients, or gene duplications, which have been reported as rare events, have also been described. The correct characterization of 21OHD alleles is important for disease carrier detection and genetic counselling Methodology and Findings:CYP21A2 genotyping by sequencing has been performed in a random sample of the Spanish population, where 144 individuals recruited from university students and employees of the hospital were studied. The frequency of CYP21A2 mutated alleles in our sample was 15.3% (77.3% were mild mutations, 9% were severe mutations and 13.6% were novel variants). Gene dosage assessment was also performed when CYP21A2 gene duplication was suspected. This analysis showed that 7% of individuals bore a chromosome with a duplicated CYP21A2 gene, where one of the copies was mutated. Conclusions:As far as we know, the present study has shown the highest frequency of 21OHD carriers reported by a genotyping analysis. In addition, a high frequency of alleles with CYP21A2 duplications, which could be misinterpreted as 21OHD alleles, was found. Moreover, a high frequency of novel genetic variations with an unknown effect on 21-hydroxylase activity was also found. The high frequency of gene duplications, as well as novel variations, should be considered since they have an important involvement in carrier testing and genetic counseling.	[Parajes, Silvia; Quinteiro, Celsa; Dominguez, Fernando; Loidi, Lourdes] Hosp Clin Univ, Fdn Publ Galega Med Xenom, Unidad Med Mol, Santiago De Compostela, A Coruna, Spain; [Dominguez, Fernando] Univ Santiago Compostela, Dept Fisiol, La Coruna, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Parajes, S (corresponding author), Hosp Clin Univ, Fdn Publ Galega Med Xenom, Unidad Med Mol, Santiago De Compostela, A Coruna, Spain.	lloidi@usc.es	Parajes, Silvia/J-1582-2012	dominguez, fernando/0000-0002-5003-4335				Balsamo A, 2000, CLIN ENDOCRINOL, V53, P117, DOI 10.1046/j.1365-2265.2000.01048.x; Baradaran-Heravi A, 2007, CLIN ENDOCRINOL, V67, P335, DOI 10.1111/j.1365-2265.2007.02886.x; Barbaro M, 2006, J MOL MED, V84, P521, DOI 10.1007/s00109-006-0043-7; Baumgartner-Parzer SM, 2007, J CLIN ENDOCR METAB, V92, P1164, DOI 10.1210/jc.2006-2189; Baumgartner-Parzer SM, 2005, J CLIN ENDOCR METAB, V90, P775, DOI 10.1210/jc.2004-1728; Blanchong CA, 2000, J EXP MED, V191, P2183, DOI 10.1084/jem.191.12.2183; Brosnan PG, 1999, ARCH PEDIAT ADOL MED, V153, P1272, DOI 10.1001/archpedi.153.12.1272; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Deneux C, 2001, J CLIN ENDOCR METAB, V86, P207, DOI 10.1210/jc.86.1.207; Fitness J, 1999, J CLIN ENDOCR METAB, V84, P960, DOI 10.1210/jc.84.3.960; Friaes A, 2006, MOL GENET METAB, V88, P58, DOI 10.1016/j.ymgme.2005.11.015; Grischuk Y, 2006, J CLIN ENDOCR METAB, V91, P4976, DOI 10.1210/jc.2006-0777; HAGLUNDSTENGLER B, 1991, P NATL ACAD SCI USA, V88, P8352, DOI 10.1073/pnas.88.19.8352; Koppens PFJ, 2002, HUM GENET, V111, P405, DOI 10.1007/s00439-002-0810-7; Krone N, 1999, Hum Mutat, V14, P90, DOI 10.1002/(SICI)1098-1004(1999)14:1<90::AID-HUMU20>3.0.CO;2-H; Krone N, 2000, J CLIN ENDOCR METAB, V85, P1059, DOI 10.1210/jc.85.3.1059; Krone N, 2006, EXP CLIN ENDOCR DIAB, V114, P111, DOI 10.1055/s-2005-872841; Krone N, 2007, CLIN ENDOCRINOL, V66, P162, DOI 10.1111/j.1365-2265.2006.02740.x; Lee HH, 2004, GENOMICS, V83, P944, DOI 10.1016/j.ygeno.2003.11.006; LISTE MTR, 2004, CRIBADO NEONATAL HIP; Loidi L, 2006, CLIN ENDOCRINOL, V64, P330, DOI 10.1111/j.1365-2265.2006.02465.x; New MI, 2006, J CLIN ENDOCR METAB, V91, P4205, DOI 10.1210/jc.2006-1645; Parajes S, 2007, CLIN CHEM, V53, P1577, DOI 10.1373/clinchem.2007.087361; Robins T, 2007, J MOL MED, V85, P243, DOI 10.1007/s00109-006-0121-x; Rumsby G, 1998, CLIN ENDOCRINOL, V48, P707, DOI 10.1046/j.1365-2265.1998.00402.x; SINNOTT PJ, 1991, HUM GENET, V87, P361; Speiser PW, 2003, NEW ENGL J MED, V349, P776, DOI 10.1056/NEJMra021561; Steigert M, 2002, J CLIN ENDOCR METAB, V87, P4106, DOI 10.1210/jc.2002-012093; Stikkelbroeck NMML, 2003, J CLIN ENDOCR METAB, V88, P3852, DOI 10.1210/jc.2002-021681; Therrell BL, 1998, PEDIATRICS, V101, P583, DOI 10.1542/peds.101.4.583; Thilen A, 1998, PEDIATRICS, V101, part. no., DOI 10.1542/peds.101.4.e11; van der Kamp HJ, 2004, EUR J ENDOCRINOL, V151, pU71, DOI 10.1530/eje.0.151U071; WEDELL A, 1994, HUM GENET, V94, P50, DOI 10.1007/BF02272841; WEDELL A, 1994, J CLIN ENDOCR METAB, V78, P1145, DOI 10.1210/jc.78.5.1145; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; Yang ZY, 1999, J BIOL CHEM, V274, P12147, DOI 10.1074/jbc.274.17.12147; ZERAH M, 1990, J CLIN ENDOCR METAB, V70, P1662, DOI 10.1210/jcem-70-6-1662	37	55	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2138	10.1371/journal.pone.0002138	http://dx.doi.org/10.1371/journal.pone.0002138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478071	Green Published, gold, Green Submitted			2022-12-27	WOS:000262172800003
J	Lin, JM; Bohland, JW; Andrews, P; Burns, GAPC; Allen, CB; Mitra, PP				Lin, John M.; Bohland, Jason W.; Andrews, Peter; Burns, Gully A. P. C.; Allen, Cara B.; Mitra, Partha P.			An Analysis of the Abstracts Presented at the Annual Meetings of the Society for Neuroscience from 2001 to 2006	PLOS ONE			English	Article							SCIENTIFIC LITERATURE; TRENDS; TEXT	Annual meeting abstracts published by scientific societies often contain rich arrays of information that can be computationally mined and distilled to elucidate the state and dynamics of the subject field. We extracted and processed abstract data from the Society for Neuroscience (SFN) annual meeting abstracts during the period 2001-2006 in order to gain an objective view of contemporary neuroscience. An important first step in the process was the application of data cleaning and disambiguation methods to construct a unified database, since the data were too noisy to be of full utility in the raw form initially available. Using natural language processing, text mining, and other data analysis techniques, we then examined the demographics and structure of the scientific collaboration network, the dynamics of the field over time, major research trends, and the structure of the sources of research funding. Some interesting findings include a high geographical concentration of neuroscience research in the north eastern United States, a surprisingly large transient population (66% of the authors appear in only one out of the six studied years), the central role played by the study of neurodegenerative disorders in the neuroscience community, and an apparent growth of behavioral/systems neuroscience with a corresponding shrinkage of cellular/molecular neuroscience over the six year period. The results from this work will prove useful for scientists, policy makers, and funding agencies seeking to gain a complete and unbiased picture of the community structure and body of knowledge encapsulated by a specific scientific domain.	[Lin, John M.; Bohland, Jason W.; Andrews, Peter; Allen, Cara B.; Mitra, Partha P.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Burns, Gully A. P. C.] Univ So Calif, Informat Sci Inst, Los Angeles, CA USA	Cold Spring Harbor Laboratory; University of Southern California	Lin, JM (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	jlin@cshl.edu	Bohland, Jason/L-4807-2016	Bohland, Jason/0000-0002-6305-5848; Mitra, Partha/0000-0001-8818-6804; Burns, Gully/0000-0003-1493-865X	W. M. Keck Foundation [061984]; Cold Spring Harbor Laboratory [Crick-Clay Professorship]; NATIONAL LIBRARY OF MEDICINE [R01LM007061] Funding Source: NIH RePORTER	W. M. Keck Foundation(W.M. Keck Foundation); Cold Spring Harbor Laboratory; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported in part by a grant (#061984) from the W. M. Keck Foundation and the Crick-Clay Professorship from Cold Spring Harbor Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthonisse J.M, 1971, RUSH DIRECTED GRAPH; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; BERRY M, 1999, UNDERSTANDING SEARCH; Berry MW, 1995, SIAM REV, V37, P573, DOI 10.1137/1037127; Bilenko M, 2003, IEEE INTELL SYST, V18, P16, DOI 10.1109/MIS.2003.1234765; Bilke S, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.036106; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bollen J, 2006, SCIENTOMETRICS, V69, P669, DOI 10.1007/s11192-006-0176-z; Borner K, 2003, ANNU REV INFORM SCI, V37, P179, DOI 10.1002/aris.1440370106; Boyack KW, 2004, P NATL ACAD SCI USA, V101, P5192, DOI 10.1073/pnas.0307509100; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; BOYACK KW, 2004, MAPPING MEDLINE PAPE; Chen CM, 2001, COMPUTER, V34, P65, DOI 10.1109/2.910895; COHEN W, 2004, EXPLOITING DICT NAME, P89; Cormen Thomas H., 2009, INTRO ALGORITHMS; Crasto CJ, 2003, NEUROINFORMATICS, V1, P215, DOI 10.1385/NI:1:3:215; Douglas S. M., 2005, GENOME BIOL, V6; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; Golub GH., 2013, MATRIX COMPUTATIONS; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hoffmann R, 2003, TRENDS GENET, V19, P79, DOI 10.1016/S0168-9525(02)00014-8; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hull DA, 1996, J AM SOC INFORM SCI, V47, P70, DOI 10.1002/(SICI)1097-4571(199601)47:1<70::AID-ASI7>3.0.CO;2-#; Ioannidis JPA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000005; Kaski S, 1998, NEUROCOMPUTING, V21, P101, DOI 10.1016/S0925-2312(98)00039-3; Kim JT, 2006, TEXT MINING BIOL BIO, P179; Landauer TK, 2004, P NATL ACAD SCI USA, V101, P5214, DOI 10.1073/pnas.0400341101; LIN CY, 2000, COLING C STRASB FRAN; Martinson BC, 2007, NATURE, V449, P141, DOI 10.1038/449141a; National Science Foundation Division of Science Resources Statistics, 2006, SCI ENG IND; NEWMAN D, 2006, STAT ENTITYTOPIC MOD; Newman M, 2001, P NATL ACAD SCI USA, V98, P5955, DOI 10.1073/pnas.121190498; NEWMAN MEJ, 2001, PHYS REV E, V6401; Nielsen FA, 2004, NEUROINFORMATICS, V2, P369, DOI 10.1385/NI:2:4:369; PANTEL P, 2002, DOCUMENT CLUSTERING; Perez-Iratxeta C, 2007, BRIEF BIOINFORM, V8, P88, DOI 10.1093/bib/bbl035; Pfeiffer T, 2007, P NATL ACAD SCI USA, V104, P12052, DOI 10.1073/pnas.0701315104; Plake C, 2006, BIOINFORMATICS, V22, P2444, DOI 10.1093/bioinformatics/btl408; PRICE DDS, 1986, BIG SCI LITTLE SCI; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Rebholz-Schuhman D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S18; Redner S, 2005, PHYS TODAY, V58, P49, DOI 10.1063/1.1996475; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; SHEN W, 2007, SOURCE AWARE ENTITY, P196; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Shiffrin RM, 2004, P NATL ACAD SCI USA, V101, P5183, DOI 10.1073/pnas.0307852100; Viator JA, 2001, J ACOUST SOC AM, V109, P1779, DOI 10.1121/1.1366711; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; ZIMAN J, 1990, WHAT IS HAPPENING SC	54	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2052	10.1371/journal.pone.0002052	http://dx.doi.org/10.1371/journal.pone.0002052			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	381YR	18446237	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000261572300021
J	Southern, P; Horbul, J; Maher, D; Davis, DA				Southern, Peter; Horbul, Julie; Maher, Diane; Davis, Dana A.			C. albicans Colonization of Human Mucosal Surfaces	PLOS ONE			English	Article								Background: Candida albicans is a low level commensal organism in normal human populations with the continuous potential to expand and cause a spectrum of clinical conditions. Methodology/Principal Findings: Using ex vivo human organ cultures and populations of primary human cells, we have developed several related experimental systems to examine early-stage interactions between C. albicans and mucosal surfaces. Experiments have been conducted both with exogenously added C. albicans and with overtly normal human mucosal surfaces supporting pre-existing infections with natural isolates of Candida. Under different culture conditions, we have demonstrated the formation of C. albicans colonies on human target cells and filament formation, equivalent to tissue invasion. Conclusions/Significance: These organ culture systems provide a valuable new resource to examine the molecular and cellular basis for Candida colonization of human mucosal surfaces.	[Southern, Peter; Horbul, Julie; Maher, Diane; Davis, Dana A.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Southern, P (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.	south003@umn.edu			NIH [DE 15090]; Burroughs Wellcome Fund [Investigators in Pathogenesis of Infectious Disease Award]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE015090] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	NIH: DE 15090 (PS) Investigators in Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund (DAD).	Andrei G, 2006, ANTIVIR RES, V71, P96, DOI 10.1016/j.antiviral.2006.05.023; Ayehunie S, 2006, TOXICOL IN VITRO, V20, P689, DOI 10.1016/j.tiv.2005.10.002; Baczynska A, 2007, HUM REPROD, V22, P968, DOI 10.1093/humrep/del455; Barousse MM, 2005, INFECT IMMUN, V73, P7765, DOI 10.1128/IAI.73.11.7765-7767.2005; Cannon RD, 1999, CRIT REV ORAL BIOL M, V10, P359, DOI 10.1177/10454411990100030701; Cassone A, 2007, INFECT IMMUN, V75, P4675, DOI 10.1128/IAI.00083-07; Chapman RL, 2007, SEMIN PERINATOL, V31, P39, DOI 10.1053/j.semperi.2007.01.006; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; de Repentigny L, 2004, CLIN MICROBIOL REV, V17, P729, DOI 10.1128/CMR.17.4.729-759.2004; Dieterich C, 2002, MICROBIOL-SGM, V148, P497, DOI 10.1099/00221287-148-2-497; Dongari-Bagtzoglou A, 2006, MICROB PATHOGENESIS, V40, P271, DOI 10.1016/j.micpath.2006.02.004; Dongari-Bagtzoglou A, 2006, NAT PROTOC, V1, P2012, DOI 10.1038/nprot.2006.323; Ellepola ANB, 2000, CRIT REV ORAL BIOL M, V11, P172, DOI 10.1177/10454411000110020301; Feng Z, 2005, J DENT RES, V84, P445, DOI 10.1177/154405910508400509; Fidel PL, 2007, AM J REPROD IMMUNOL, V57, P2, DOI 10.1111/j.1600-0897.2006.00450.x; Fidel Paul L Jr, 2005, Curr Opin Infect Dis, V18, P107; Fidel PL, 2004, TRENDS MICROBIOL, V12, P220, DOI 10.1016/j.tim.2004.03.006; Fu Y, 1998, INFECT IMMUN, V66, P1783, DOI 10.1128/IAI.66.4.1783-1786.1998; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gipson IK, 2001, J CLIN ENDOCR METAB, V86, P594, DOI 10.1210/jc.86.2.594; Guenthner PC, 2005, INFECT IMMUN, V73, P4155, DOI 10.1128/IAI.73.7.4155-4160.2005; HOROWITZ BJ, 1987, OBSTET GYNECOL, V69, P883; Jayatilake JAMS, 2005, J ORAL PATHOL MED, V34, P240, DOI 10.1111/j.1600-0714.2005.00307.x; Johnson AS, 2005, J VIROL, V79, P13769, DOI 10.1128/JVI.79.21.13769-13777.2005; JOKINEN K, 1976, J LARYNGOL OTOL, V90, P945, DOI 10.1017/S0022215100082955; Kaufman D A, 2007, Minerva Ginecol, V59, P311; Krunkosky TM, 2007, MICROB PATHOGENESIS, V42, P98, DOI 10.1016/j.micpath.2006.11.003; Kumamoto CA, 2005, ANNU REV MICROBIOL, V59, P113, DOI 10.1146/annurev.micro.59.030804.121034; Lackner A, 2005, AM J RHINOL, V19, P125, DOI 10.1177/194589240501900203; MAGEE BB, 1987, J BACTERIOL, V169, P1639, DOI 10.1128/jb.169.4.1639-1643.1987; Maher D, 2005, P NATL ACAD SCI USA, V102, P11504, DOI 10.1073/pnas.0500848102; Maher D, 2004, J INFECT DIS, V190, P1989, DOI 10.1086/425423; Maher DM, 2005, J HISTOCHEM CYTOCHEM, V53, P631, DOI 10.1369/jhc.4A6534.2005; Malic S, 2007, ORAL MICROBIOL IMMUN, V22, P188, DOI 10.1111/j.1399-302X.2007.00344.x; Mendling W, 2000, MYCOSES, V43, P387, DOI 10.1111/j.1439-0507.2000.00604.x; Mostefaoui Y, 2004, CYTOKINE, V25, P162, DOI 10.1016/j.cyto.2003.11.015; Mylonakis E, 2007, PLOS PATHOG, V3, P859, DOI 10.1371/journal.ppat.0030101; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; NORVELL MK, 1984, J REPROD MED, V29, P269; Perry M, 1998, IMMUNOL TODAY, V19, P414, DOI 10.1016/S0167-5699(98)01307-3; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Reed BD, 2003, J WOMENS HEALTH, V12, P979, DOI 10.1089/154099903322643901; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Rupp S, 2007, FUTURE MICROBIOL, V2, P141, DOI 10.2217/17460913.2.2.141; Sandovsky-Losica H, 2006, MED MYCOL, V44, P329, DOI 10.1080/13693780500434701; Schaller M, 1998, MOL MICROBIOL, V29, P605, DOI 10.1046/j.1365-2958.1998.00957.x; Schaller M, 2003, INFECT IMMUN, V71, P3227, DOI 10.1128/IAI.71.6.3227-3234.2003; Selmecki A, 2006, SCIENCE, V313, P367, DOI 10.1126/science.1128242; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; SOUTHGATE J, 1987, LAB INVEST, V56, P211; Steele C, 2000, J INFECT DIS, V182, P1479, DOI 10.1086/315872; Urban CF, 2006, CELL MICROBIOL, V8, P1687, DOI 10.1111/j.1462-5822.2006.00792.x; Wang BN, 2006, P NATL ACAD SCI USA, V103, P2380, DOI 10.1073/pnas.0506668103	54	37	37	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2067	10.1371/journal.pone.0002067	http://dx.doi.org/10.1371/journal.pone.0002067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446191	gold, Green Published, Green Submitted			2022-12-27	WOS:000261572300036
J	Awasthi, S; Agarwal, G; Kabra, SK; Singhi, S; Kulkarni, M; More, V; Niswade, A; Pillai, RM; Luke, R; Srivastava, NM; Suresh, S; Verghese, VP; Raghupathy, P; Lodha, R; Walter, SD				Awasthi, Shally; Agarwal, Girdhar; Kabra, Sushil K.; Singhi, Sunit; Kulkarni, Madhuri; More, Vaishali; Niswade, Abhimanyu; Pillai, Raj Mohan; Luke, Ravi; Srivastava, Neeraj M.; Suresh, Saradha; Verghese, Valsan P.; Raghupathy, P.; Lodha, R.; Walter, Stephen D.			Does 3-Day Course of Oral Amoxycillin Benefit Children of Non-Severe Pneumonia with Wheeze: A Multicentric Randomised Controlled Trial	PLOS ONE			English	Article								Background: WHO-defined pneumonias, treated with antibiotics, are responsible for a significant proportion of childhood morbidity and mortality in the developing countries. Since substantial proportion pneumonias have a viral etiology, where children are more likely to present with wheeze, there is a concern that currently antibiotics are being over-prescribed for it. Hence the current trial was conducted with the objective to show the therapeutic equivalence of two treatments (placebo and amoxycillin) for children presenting with non-severe pneumonia with wheeze, who have persistent fast breathing after nebulisation with salbutamol, and have normal chest radiograph. Methodology: This multi-centric, randomised placebo controlled double blind clinical trial intended to investigate equivalent efficacy of placebo and amoxicillin and was conducted in ambulatory care settings in eight government hospitals in India. Participants were children aged 2-59 months of age, who received either oral amoxycillin (31-54 mg/Kg/day, in three divided doses for three days) or placebo, and standard bronchodilator therapy. Primary outcome was clinical failure on or before day-4. Principal Findings: We randomized 836 cases in placebo and 835 in amoxycillin group. Clinical failures occurred in 201 (24.0%) on placebo and 166 (19.9%) on amoxycillin (risk difference 4.2% in favour of antibiotic, 95% CI: 0.2 to 8.1). Adherence for both placebo and amoxycillin was.96% and 98.9% subjects were followed up on day-4. Clinical failure was associated with (i) placebo treatment (adjusted OR = 1.28, 95% CI: 1.01 to1.62), (ii) excess respiratory rate of > 10 breaths per minute (adjusted OR = 1.51, 95% CI: 1.19, 1.92), (iii) vomiting at enrolment (adjusted OR = 1.49, 95% CI: 1.13, 1.96), (iv) history of use of broncho-dilators (adjusted OR = 1.71, 95% CI: 1.30, 2.24) and (v) non-adherence (adjusted OR = 8.06, 95% CI: 4.36, 14.92). Conclusions: Treating children with non-severe pneumonia and wheeze with a placebo is not equivalent to treatment with oral amoxycillin.	[Awasthi, Shally; Srivastava, Neeraj M.] King Georges Med Univ, Lucknow, Uttar Pradesh, India; [Agarwal, Girdhar] Lucknow Univ, Lucknow, Uttar Pradesh, India; [Kabra, Sushil K.; Lodha, R.] All India Inst Med Sci, New Delhi, India; [Singhi, Sunit] Post Grad Inst Med Sci, Chandigarh, India; [Kulkarni, Madhuri; More, Vaishali] Lok Manya Tilak Med Coll, Mumbai, India; [Niswade, Abhimanyu] Govt Med Coll, Nagpur, Maharashtra, India; [Pillai, Raj Mohan] Govt Med Coll, Trivandrum, Kerala, India; [Luke, Ravi; Suresh, Saradha] Madras Med Coll & Govt Gen Hosp, Chennai, India; [Verghese, Valsan P.; Raghupathy, P.] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Walter, Stephen D.] McMaster Univ, Hamilton, ON, Canada	King George's Medical University; Lucknow University; All India Institute of Medical Sciences (AIIMS) New Delhi; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Madras Medical College & General Hospital; Christian Medical College & Hospital (CMCH) Vellore; McMaster University	Awasthi, S (corresponding author), King Georges Med Univ, Lucknow, Uttar Pradesh, India.	sawasthi@sancharnet.in	Walter, Stephen/AAB-5548-2022; Agarwal, Girdhar/AAD-9909-2020	Walter, Stephen/0000-0003-4157-8928; Agarwal, Girdhar/0000-0003-4902-4436	INCLEN; IndiaClen	INCLEN; IndiaClen	US AID through INCLEN and IndiaClen	Awasthi S, 2004, BMJ-BRIT MED J, V328, P791; Broor S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000491; Chow SC, 2002, CONTROL CLIN TRIALS, V23, P515, DOI 10.1016/S0197-2456(02)00222-2; Christensen E, 2007, J HEPATOL, V46, P947, DOI 10.1016/j.jhep.2007.02.015; Hazir T, 2004, ARCH DIS CHILD, V89, P1049, DOI 10.1136/adc.2003.035741; Hazir T, 2002, LANCET, V360, P835; Kallstrom Thomas J, 2004, Respir Care, V49, P783; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Lazzaro T, 2007, J PAEDIATR CHILD H, V43, P29, DOI 10.1111/j.1440-1754.2007.00998.x; Mulholland K, 1999, LANCET, V354, P590, DOI 10.1016/S0140-6736(98)10238-6; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Sachdev H P, 2001, Indian Pediatr, V38, P827; Simoes E.A.F., 2006, ACUTE RESP INFECT CH, P483; Straus WL, 1998, LANCET, V352, P270, DOI 10.1016/S0140-6736(97)10294-X; *WHO, 2000, HDB IMCI INT MAN CHI; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World Health 0rganization, 1995, MAN AC RESP INF CHIL	17	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1991	10.1371/journal.pone.0001991	http://dx.doi.org/10.1371/journal.pone.0001991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431478	gold, Green Submitted, Green Published			2022-12-27	WOS:000261558700013
J	Egelhofer, TA; Villen, J; McCusker, D; Gygi, SP; Kellogg, DR				Egelhofer, Thea A.; Villen, Judit; McCusker, Derek; Gygi, Steven P.; Kellogg, Douglas R.			The Septins Function in G1 Pathways that Influence the Pattern of Cell Growth in Budding Yeast	PLOS ONE			English	Article								The septins are a conserved family of proteins that have been proposed to carry out diverse functions. In budding yeast, the septins become localized to the site of bud emergence in G1 but have not been thought to carry out important functions at this stage of the cell cycle. We show here that the septins function in redundant mechanisms that are required for formation of the bud neck and for the normal pattern of cell growth early in the cell cycle. The Shs1 septin shows strong genetic interactions with G1 cyclins and is directly phosphorylated by G1 cyclin-dependent kinases, consistent with a role in early cell cycle events. However, Shs1 phosphorylation site mutants do not show genetic interactions with the G1 cyclins or obvious defects early in the cell cycle. Rather, they cause an increased cell size and aberrant cell morphology that are dependent upon inhibitory phosphorylation of Cdk1 at the G2/M transition. Shs1 phosphorylation mutants also show defects in interaction with the Gin4 kinase, which associates with the septins during G2/M and plays a role in regulating inhibitory phosphorylation of Cdk1. Phosphorylation of Shs1 by G1 cyclin-dependent kinases plays a role in events that influence Cdk1 inhibitory phosphorylation.	[Egelhofer, Thea A.; McCusker, Derek; Kellogg, Douglas R.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Villen, Judit; Gygi, Steven P.] Harvard Med Sch, Taplin Biol Mass Spectrometry Facil, Dept Cell Biol, Boston, MA USA	University of California System; University of California Santa Cruz; Harvard University; Harvard Medical School	Kellogg, DR (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	kellogg@biology.ucsc.edu		Villen, Judit/0000-0002-1005-1739; McCusker, Derek/0000-0003-1455-1711	Spanish Ministry of Education and Science [postdoctoral fellowship]; NIH [GM53959]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053959] Funding Source: NIH RePORTER	Spanish Ministry of Education and Science(Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	J. Villen was supported by a postdoctoral fellowship from the Spanish Ministry of Education and Science. This work was supported by NIH Grant GM53959.	ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Altman R, 1997, J CELL BIOL, V138, P119, DOI 10.1083/jcb.138.1.119; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; ANDERSON CW, 1973, J VIROL, V12, P241, DOI 10.1128/JVI.12.2.241-252.1973; Andrews B, 1998, TRENDS GENET, V14, P66, DOI 10.1016/S0168-9525(97)01322-X; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Beites CL, 2005, BIOCHEM J, V385, P347, DOI 10.1042/BJ20041090; Beites CL, 2001, METHOD ENZYMOL, V329, P499; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; Carroll CW, 1998, J CELL BIOL, V143, P709, DOI 10.1083/jcb.143.3.709; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; Cid VJ, 2001, MICROBIOL-SGM, V147, P1437, DOI 10.1099/00221287-147-6-1437; Cooper JA, 1996, J CELL BIOL, V134, P1345, DOI 10.1083/jcb.134.6.1345; CROSS FR, 1991, CELL, V65, P875, DOI 10.1016/0092-8674(91)90394-E; CROSS FR, 1990, MOL CELL BIOL, V10, P6482, DOI 10.1128/MCB.10.12.6482; CVRCKOVA F, 1995, GENE DEV, V9, P1817, DOI 10.1101/gad.9.15.1817; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611; Evangelista M, 2002, NAT CELL BIOL, V4, P32, DOI 10.1038/ncb718; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Field CM, 1999, TRENDS CELL BIOL, V9, P387, DOI 10.1016/S0962-8924(99)01632-3; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; Finger FP, 2005, BIOESSAYS, V27, P5, DOI 10.1002/bies.20167; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; FORD SK, 1991, DEV GENET, V12, P281, DOI 10.1002/dvg.1020120405; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; Gladfelter AS, 2005, J CELL SCI, V118, P1617, DOI 10.1242/jcs.02286; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Huang DQ, 2002, MOL CELL BIOL, V22, P5076, DOI 10.1128/MCB.22.14.5076-5088.2002; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; KELLOGG DR, 1995, J CELL BIOL, V130, P675, DOI 10.1083/jcb.130.3.675; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Longtine MS, 1998, J CELL BIOL, V143, P719, DOI 10.1083/jcb.143.3.719; McCusker D, 2007, NAT CELL BIOL, V9, P506, DOI 10.1038/ncb1568; MEASDAY V, 1994, SCIENCE, V266, P1391, DOI 10.1126/science.7973731; Measday V, 1997, MOL CELL BIOL, V17, P1212, DOI 10.1128/MCB.17.3.1212; Mimura S, 2004, NATURE, V431, P1118, DOI 10.1038/nature03024; Mino A, 1998, BIOCHEM BIOPH RES CO, V251, P732, DOI 10.1006/bbrc.1998.9541; Moffat J, 2004, NAT CELL BIOL, V6, P59, DOI 10.1038/ncb1078; Morgan D. O., 2006, CELL CYCLE PRINCIPLE; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; Mosch HU, 1997, GENETICS, V145, P671; Ozaki-Kuroda K, 2001, MOL CELL BIOL, V21, P827, DOI 10.1128/MCB.21.3.827-839.2001; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Pruyne D, 2004, MOL BIOL CELL, V15, P4971, DOI 10.1091/mbc.E04-04-0296; RICHARDSON HE, 1989, CELL, V59, P1127, DOI 10.1016/0092-8674(89)90768-X; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Sheu YJ, 2000, MOL CELL BIOL, V20, P5235, DOI 10.1128/MCB.20.14.5235-5247.2000; Sinha I, 2007, DEV CELL, V13, P421, DOI 10.1016/j.devcel.2007.06.011; Smolka MB, 2006, J CELL BIOL, V175, P743, DOI 10.1083/jcb.200605081; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; Vega IE, 2003, NEUROREPORT, V14, P31, DOI 10.1097/00001756-200301200-00006; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Zahner JE, 1996, MOL CELL BIOL, V16, P1857; Zimmerman ZA, 2001, MOL BIOL CELL, V12, P201, DOI 10.1091/mbc.12.1.201	71	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2022	10.1371/journal.pone.0002022	http://dx.doi.org/10.1371/journal.pone.0002022			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431499	Green Published, gold, Green Submitted			2022-12-27	WOS:000261558700034
J	Fu, XA; Wan, S; Lyu, YL; Liu, LF; Qi, HY				Fu, Xuan; Wan, Shan; Lyu, Yi Lisa; Liu, Leroy F.; Qi, Haiyan			Etoposide Induces ATM-Dependent Mitochondrial Biogenesis through AMPK Activation	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA CELLS; NUCLEAR RESPIRATORY FACTORS; N-ACETYL CYSTEINE; PROTEIN-KINASE; DNA-DAMAGE; DEFICIENT MICE; OXIDATIVE STRESS; SKELETAL-MUSCLE; LKB1-INDEPENDENT MANNER; TRANSCRIPTION FACTOR	Background: DNA damage such as double-stranded DNA breaks (DSBs) has been reported to stimulate mitochondrial biogenesis. However, the underlying mechanism is poorly understood. The major player in response to DSBs is ATM (ataxia telangiectasia mutated). Upon sensing DSBs, ATM is activated through autophosphorylation and phosphorylates a number of substrates for DNA repair, cell cycle regulation and apoptosis. ATM has been reported to phosphorylate the a subunit of AMP-activated protein kinase (AMPK), which senses AMP/ATP ratio in cells, and can be activated by upstream kinases. Here we provide evidence for a novel role of ATM in mitochondrial biogenesis through AMPK activation in response to etoposide-induced DNA damage. Methodology/Principal Findings: Three pairs of human ATM+ and ATM- cells were employed. Cells treated with etoposide exhibited an ATM- dependent increase in mitochondrial mass as measured by 10-N-Nonyl-Acridine Orange and MitoTracker Green FM staining, as well as an increase in mitochondrial DNA content. In addition, the expression of several known mitochondrial biogenesis regulators such as the major mitochondrial transcription factor NRF-1, PGC-1 alpha and TFAM was also elevated in response to etoposide treatment as monitored by RT-PCR. Three pieces of evidence suggest that etoposide-induced mitochondrial biogenesis is due to ATM- dependent activation of AMPK. First, etoposide induced ATM- dependent phosphorylation of AMPK a subunit at Thr172, indicative of AMPK activation. Second, inhibition of AMPK blocked etoposide-induced mitochondrial biogenesis. Third, activation of AMPK by AICAR (an AMP analogue) stimulated mitochondrial biogenesis in an ATM- dependent manner, suggesting that ATM may be an upstream kinase of AMPK in the mitochondrial biogenesis pathway. Conclusions/Significance: These results suggest that activation of ATM by etoposide can lead to mitochondrial biogenesis through AMPK activation. We propose that ATM-dependent mitochondrial biogenesis may play a role in DNA damage response and ROS regulation, and that defect in ATM-dependent mitochondrial biogenesis could contribute to the manifestations of A-T disease.	[Fu, Xuan; Wan, Shan; Lyu, Yi Lisa; Liu, Leroy F.; Qi, Haiyan] UMDNJ Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Liu, LF (corresponding author), UMDNJ Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ USA.	lliu@umdnj.edu; qiha@umdnj.edu		Liu, Leroy/0000-0001-9396-763X	NIH [CA102463, CA39662]; NATIONAL CANCER INSTITUTE [R01CA039662, R01CA102463] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants CA102463 and CA39662. Funders played no role in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; AMBROSE M, 2007, HUM MOL GENET; AMMANN AJ, 1971, J PEDIATR-US, V78, P821, DOI 10.1016/S0022-3476(71)80353-0; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; BAR RS, 1978, NEW ENGL J MED, V298, P1164, DOI 10.1056/NEJM197805252982103; BARBE J, 1983, BIOCHEM BIOPH RES CO, V117, P556, DOI 10.1016/0006-291X(83)91236-6; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; BODER E, 1985, ATAXIA TELANGIECTASI, P1; Browne SE, 2004, FREE RADICAL BIO MED, V36, P938, DOI 10.1016/j.freeradbiomed.2004.01.003; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen SJ, 2004, BIOCHEM BIOPH RES CO, V317, P1037, DOI 10.1016/j.bbrc.2004.03.149; Chun HH, 2004, DNA REPAIR, V3, P1187, DOI 10.1016/j.dnarep.2004.04.010; CLAYTON DA, 1992, INT REV CYTOL, V141, P217, DOI 10.1016/S0074-7696(08)62067-7; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Eaton JS, 2007, J CLIN INVEST, V117, P2723, DOI 10.1172/JCI31604; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; GATTI RA, 1991, MEDICINE, V70, P99, DOI 10.1097/00005792-199103000-00003; Gilad S, 1996, HUM MOL GENET, V5, P2033, DOI 10.1093/hmg/5.12.2033; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; GOTOFF SP, 1967, AM J DIS CHILD, V114, P617, DOI 10.1001/archpedi.1967.02090270073006; GUERRERO R, 1984, J GEN MICROBIOL, V130, P2247; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Ito K, 2007, J IMMUNOL, V178, P103, DOI 10.4049/jimmunol.178.1.103; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004; Karpinich NO, 2002, J BIOL CHEM, V277, P16547, DOI 10.1074/jbc.M110629200; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kluza J, 2004, ONCOGENE, V23, P7018, DOI 10.1038/sj.onc.1207936; Lee CF, 2005, ANN NY ACAD SCI, V1042, P246, DOI 10.1196/annals.1338.027; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Marecki JC, 2002, ARCH BIOCHEM BIOPHYS, V402, P227, DOI 10.1016/S0003-9861(02)00078-4; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; McFarlin D E, 1971, Res Publ Assoc Res Nerv Ment Dis, V49, P275; Meiners S, 2001, J NEUROSCI, V21, P7215, DOI 10.1523/JNEUROSCI.21-18-07215.2001; MEREDITH MJ, 1987, CANCER RES, V47, P4576; Miyoshi N, 2007, INT J CANCER, V120, P484, DOI 10.1002/ijc.22350; MORGAN JL, 1968, AM J DIS CHILD, V116, P557, DOI 10.1001/archpedi.1968.02100020561022; MORRELL D, 1990, CANCER GENET CYTOGEN, V50, P119, DOI 10.1016/0165-4608(90)90245-6; MORRELL D, 1986, J NATL CANCER I, V77, P89; Nisoli E, 2004, P NATL ACAD SCI USA, V101, P16507, DOI 10.1073/pnas.0405432101; Pan Q, 2002, EUR J IMMUNOL, V32, P1300, DOI 10.1002/1521-4141(200205)32:5<1300::AID-IMMU1300>3.0.CO;2-L; QI H, 2006, CANCER, V66; Quick KL, 2001, ANN NEUROL, V49, P627, DOI 10.1002/ana.1005; Reichenbach J, 1999, CLIN EXP IMMUNOL, V117, P535; Reichenbach J, 2002, ANTIOXID REDOX SIGN, V4, P465, DOI 10.1089/15230860260196254; REIPERT S, 1995, EXP CELL RES, V221, P281, DOI 10.1006/excr.1995.1376; Reliene R, 2004, CANCER RES, V64, P5148, DOI 10.1158/0008-5472.CAN-04-0442; Reliene R, 2006, DNA REPAIR, V5, P852, DOI 10.1016/j.dnarep.2006.05.003; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Sadun AA, 2003, ARCH OPHTHALMOL-CHIC, V121, P1342, DOI 10.1001/archopht.121.9.1342-b; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Schubert R, 2004, HUM MOL GENET, V13, P1793, DOI 10.1093/hmg/ddh189; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Sun Y, 2007, MOL CELL BIOCHEM, V306, P239, DOI 10.1007/s11010-007-9575-6; Suzuki A, 2004, BIOCHEM BIOPH RES CO, V324, P986, DOI 10.1016/j.bbrc.2004.09.145; SWIFT M, 1990, CANCER GENET CYTOGEN, V46, P21, DOI 10.1016/0165-4608(90)90004-T; Tanaka T, 2007, CELL CYCLE, V6, P371, DOI 10.4161/cc.6.3.3835; TANIZAWA A, 1989, EXP CELL RES, V185, P237, DOI 10.1016/0014-4827(89)90052-9; Tavani F, 2003, NEURORADIOLOGY, V45, P315, DOI 10.1007/s00234-003-0945-9; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Tyagi A, 2005, CARCINOGENESIS, V26, P1978, DOI 10.1093/carcin/bgi165; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu J, 2007, J BIOENERG BIOMEMBR, V39, P195, DOI 10.1007/s10863-007-9077-y; Zeviani M, 2003, CURR OPIN NEUROL, V16, P585, DOI 10.1097/00019052-200310000-00004; Zeviani M, 2003, CURR OPIN GENET DEV, V13, P262, DOI 10.1016/S0959-437X(03)00052-2; Zhang AL, 2006, J BIOL CHEM, V281, P35997, DOI 10.1074/jbc.M604149200; Zhang N, 1997, P NATL ACAD SCI USA, V94, P8021, DOI 10.1073/pnas.94.15.8021; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou N, 2003, J BIOL CHEM, V278, P29532, DOI 10.1074/jbc.M301877200; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	90	139	146	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2009	10.1371/journal.pone.0002009	http://dx.doi.org/10.1371/journal.pone.0002009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431490	gold, Green Submitted, Green Published			2022-12-27	WOS:000261558700025
J	Mok, BW; Ribacke, U; Rasti, N; Kironde, F; Chen, QJ; Nilsson, P; Wahlgren, M				Mok, Bobo W.; Ribacke, Ulf; Rasti, Niloofar; Kironde, Fred; Chen, Qijun; Nilsson, Peter; Wahlgren, Mats			Default Pathway of var2csa Switching and Translational Repression in Plasmodium falciparum	PLOS ONE			English	Article								Antigenic variation is a subtle process of fundamental importance to the survival of a microbial pathogen. In Plasmodium falciparum malaria, PfEMP1 is the major variable antigen and adhesin expressed at the surface of the infected erythrocyte, which is encoded for by members of a family of 60 var-genes. Peri-nuclear repositioning and epigenetic mechanisms control their mono-allelic expression. The switching of PfEMP1 depends in part on variable transition rates and short-lived immune responses to shared minor epitopes. Here we show var-genes to switch to a common gene that is highly transcribed, but sparsely translated into PfEMP1 and not expressed at the erythrocyte surface. Highly clonal and adhesive P. falciparum, which expressed distinct var-genes and the corresponding PfEMP1s at onset, were propagated without enrichment or panning. The parasites successively and spontaneously switched to transcribe a shared var-gene (var2csa) matched by the loss of PfEMP1 surface expression and host cell-binding. The var2csa gene repositioned in the peri-nuclear area upon activation, away from the telomeric clusters and heterochromatin to transcribe spliced, full-length RNA. Despite abundant transcripts, the level of intracellular PfEMP1 was low suggesting post-transcriptional mechanisms to partake in protein expression. In vivo, off-switching and translational repression may constitute one pathway, among others, coordinating PfEMP1 expression.	[Mok, Bobo W.; Ribacke, Ulf; Rasti, Niloofar; Chen, Qijun; Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Mok, Bobo W.; Ribacke, Ulf; Rasti, Niloofar; Chen, Qijun; Wahlgren, Mats] Swedish Inst Infect Dis Control SMI, Stockholm, Sweden; [Kironde, Fred] Makerere Univ, Fac Med, Dept Biochem, Kampala, Uganda; [Nilsson, Peter] Royal Inst Technol, Sch Biotechnol, Dept Gene Technol, Stockholm, Sweden	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Makerere University; Royal Institute of Technology	Mok, BW (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	mats.wahlgren@ki.se	Nilsson, Peter/E-4547-2010	Nilsson, Peter/0000-0002-4657-8532; Mok, Bobo/0000-0003-3187-2736; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Kironde, Fred/0000-0003-4981-6417	Swedish Institute for Infectious Disease Control; European Union (BioMalPar); Swedish Research Council; Swedish International Development Cooperation Agency (Sida/ SAREC)	Swedish Institute for Infectious Disease Control; European Union (BioMalPar)(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency (Sida/ SAREC)	The work was funded by grants from the Swedish Institute for Infectious Disease Control (SMI), the European Union (BioMalPar), the Swedish Research Council and the Swedish International Development Cooperation Agency (Sida/ SAREC).	Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; BARNWELL JW, 1983, CIBA F SYMP, V94, P117; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; DAVID PH, 1983, P NATL ACAD SCI-BIOL, V80, P5075, DOI 10.1073/pnas.80.16.5075; Duffy MF, 2002, MOL MICROBIOL, V43, P1285, DOI 10.1046/j.1365-2958.2002.02822.x; Duffy MF, 2005, MOL MICROBIOL, V56, P774, DOI 10.1111/j.1365-2958.2005.04577.x; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Frank M, 2006, J BIOL CHEM, V281, P9942, DOI 10.1074/jbc.M513067200; Frank M, 2007, MOL MICROBIOL, V64, P1486, DOI 10.1111/j.1365-2958.2007.05736.x; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gatton ML, 2003, TRENDS PARASITOL, V19, P202, DOI 10.1016/S1471-4922(03)00067-9; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; HOMMEL M, 1983, J EXP MED, V157, P1137, DOI 10.1084/jem.157.4.1137; Horrocks P, 2004, P NATL ACAD SCI USA, V101, P11129, DOI 10.1073/pnas.0402347101; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kaestli M, 2004, J INFECT DIS, V189, P1942, DOI 10.1086/383250; Kyes SA, 2003, MOL MICROBIOL, V48, P1339, DOI 10.1046/j.1365-2958.2003.03505.x; Kyes S, 2007, MOL MICROBIOL, V63, P1237, DOI 10.1111/j.1365-2958.2007.05587.x; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Mair GR, 2006, SCIENCE, V313, P667, DOI 10.1126/science.1125129; Mok BW, 2007, MOL BIOCHEM PARASIT, V151, P184, DOI 10.1016/j.molbiopara.2006.11.006; Nielsen MA, 2005, J INFECT DIS, V192, P520, DOI 10.1086/431678; Noviyanti R, 2001, MOL BIOCHEM PARASIT, V114, P227, DOI 10.1016/S0166-6851(01)00266-3; Qazi KR, 2005, VACCINE, V23, P1114, DOI 10.1016/j.vaccine.2004.08.033; Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102; Rasti N, 2006, P NATL ACAD SCI USA, V103, P13795, DOI 10.1073/pnas.0601519103; Ribacke U, 2007, MOL BIOCHEM PARASIT, V155, P33, DOI 10.1016/j.molbiopara.2007.05.005; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407; Voss TS, 2003, MOL MICROBIOL, V48, P1593, DOI 10.1046/j.1365-2958.2003.03528.x; Winter G, 2003, MOL BIOCHEM PARASIT, V127, P179, DOI 10.1016/S0166-6851(03)00004-5; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	47	44	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1982	10.1371/journal.pone.0001982	http://dx.doi.org/10.1371/journal.pone.0001982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431472	Green Submitted, gold, Green Published			2022-12-27	WOS:000261558700007
J	Slaughter, BD; Huff, JM; Wiegraebe, W; Schwartz, JW; Li, R				Slaughter, Brian D.; Huff, Joseph M.; Wiegraebe, Winfried; Schwartz, Joel W.; Li, Rong			SAM Domain-Based Protein Oligomerization Observed by Live-Cell Fluorescence Fluctuation Spectroscopy	PLOS ONE			English	Article								Sterile-alpha-motif (SAM) domains are common protein interaction motifs observed in organisms as diverse as yeast and human. They play a role in protein homo- and hetero-interactions in processes ranging from signal transduction to RNA binding. In addition, mutations in SAM domain and SAM-mediated oligomers have been linked to several diseases. To date, the observation of heterogeneous SAM-mediated oligomers in vivo has been elusive, which represents a common challenge in dissecting cellular biochemistry in live-cell systems. In this study, we report the oligomerization and binding stoichiometry of high-order, multi-component complexes of (SAM) domain proteins Ste11 and Ste50 in live yeast cells using fluorescence fluctuation methods. Fluorescence cross-correlation spectroscopy (FCCS) and 1-dimensional photon counting histogram (1dPCH) confirm the SAM-mediated interaction and oligomerization of Ste11 and Ste50. Two-dimensional PCH (2dPCH), with endogenously expressed proteins tagged with GFP or mCherry, uniquely indicates that Ste11 and Ste50 form a heterogeneous complex in the yeast cytosol comprised of a dimer of Ste11 and a monomer of Ste50. In addition, Ste50 also exists as a high order oligomer that does not interact with Ste11, and the size of this oligomer decreases in response to signals that activate the MAP kinase cascade. Surprisingly, a SAM domain mutant of Ste50 disrupted not only the Ste50 oligomers but also Ste11 dimerization. These results establish an in vivo model of Ste50 and Ste11 homo- and heterooligomerization and highlight the usefulness of 2dPCH for quantitative dissection of complex molecular interactions in genetic model organisms such as yeast.	[Slaughter, Brian D.; Huff, Joseph M.; Wiegraebe, Winfried; Schwartz, Joel W.; Li, Rong] Stowers Inst Med Res, Kansas City, MO USA	Stowers Institute for Medical Research	Slaughter, BD (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	rli@stowers-institute.org			NIH [GM057063, F32 GM077923-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077923, R01GM057063] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH grant GM057063 to RL and NIH fellowship F32 GM077923-01A1 to BS.	Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bacia K, 2003, METHODS, V29, P74, DOI 10.1016/S1046-2023(02)00291-8; Bhattacharjya S, 2005, PROTEIN SCI, V14, P828, DOI 10.1110/ps.041122105; Bhattacharjya S, 2004, J MOL BIOL, V344, P1071, DOI 10.1016/j.jmb.2004.09.018; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Chen Y, 2005, BIOPHYS J, V88, P2177, DOI 10.1529/biophysj.104.048413; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Chen Y, 2002, BIOPHYS J, V82, P133, DOI 10.1016/S0006-3495(02)75380-0; Cicero DO, 2006, CELL BIOCHEM BIOPHYS, V44, P475, DOI 10.1385/CBB:44:3:475; DIGMAN MA, 2007, BIOPHYS J; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Grimshaw SJ, 2004, J BIOL CHEM, V279, P2192, DOI 10.1074/jbc.M305605200; Haustein E, 2003, METHODS, V29, P153, DOI 10.1016/S1046-2023(02)00306-7; Hillesheim LN, 2006, BIOPHYS J, V91, P4273, DOI 10.1529/biophysj.106.085845; HINK MA, 2007, BIOPHYS J; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; Kantaputra PN, 2003, J DENT RES, V82, P433, DOI 10.1177/154405910308200606; Kask P, 1999, P NATL ACAD SCI USA, V96, P13756, DOI 10.1073/pnas.96.24.13756; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Kwan JJ, 2006, J MOL BIOL, V356, P142, DOI 10.1016/j.jmb.2005.11.012; Kwan JJ, 2004, J MOL BIOL, V342, P681, DOI 10.1016/j.jmb.2004.06.064; Lamson RE, 2002, MOL CELL BIOL, V22, P2939, DOI 10.1128/MCB.22.9.2939-2951.2002; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Posas F, 1998, MOL CELL BIOL, V18, P5788, DOI 10.1128/MCB.18.10.5788; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Ramezani-Rad M, 2003, CURR GENET, V43, P161, DOI 10.1007/s00294-003-0383-6; Rigler R, 1998, J BIOTECHNOL, V63, P97, DOI 10.1016/S0168-1656(98)00079-0; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; Sahin MT, 2004, CLIN EXP DERMATOL, V29, P486, DOI 10.1111/j.1365-2230.2004.01584.x; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Tatebayashi K, 2006, EMBO J, V25, P3033, DOI 10.1038/sj.emboj.7601192; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Thompson NL, 2002, CURR OPIN STRUC BIOL, V12, P634, DOI 10.1016/S0959-440X(02)00368-8; Tognon CE, 2004, MOL CELL BIOL, V24, P4636, DOI 10.1128/MCB.24.11.4636-4650.2004; Truckses DM, 2006, MOL CELL BIOL, V26, P912, DOI 10.1128/MCB.26.3.912-928.2006; Wu CL, 2006, GENE DEV, V20, P734, DOI 10.1101/gad.1375706	45	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1931	10.1371/journal.pone.0001931	http://dx.doi.org/10.1371/journal.pone.0001931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431466	Green Published, gold, Green Submitted			2022-12-27	WOS:000261558700001
J	Kaitaniemi, P				Kaitaniemi, Pekka			How to Derive Biological Information from the Value of the Normalization Constant in Allometric Equations	PLOS ONE			English	Article								Allometric equations are widely used in many branches of biological science. The potential information content of the normalization constant b in allometric equations of the form Y=bX(a) has, however, remained largely neglected. To demonstrate the potential for utilizing this information, I generated a large number of artificial datasets that resembled those that are frequently encountered in biological studies, i.e., relatively small samples including measurement error or uncontrolled variation. The value of X was allowed to vary randomly within the limits describing different data ranges, and a was set to a fixed theoretical value. The constant b was set to a range of values describing the effect of a continuous environmental variable. In addition, a normally distributed random error was added to the values of both X and Y. Two different approaches were then used to model the data. The traditional approach estimated both a and b using a regression model, whereas an alternative approach set the exponent a at its theoretical value and only estimated the value of b. Both approaches produced virtually the same model fit with less than 0.3% difference in the coefficient of determination. Only the alternative approach was able to precisely reproduce the effect of the environmental variable, which was largely lost among noise variation when using the traditional approach. The results show how the value of b can be used as a source of valuable biological information if an appropriate regression model is selected.	Univ Helsinki, Hyytiala Forestry Field Stn, Korkeakoski, Finland	University of Helsinki	Kaitaniemi, P (corresponding author), Univ Helsinki, Hyytiala Forestry Field Stn, Korkeakoski, Finland.	Pekka.J.Kaitaniemi@helsinki.fi	Kaitaniemi, Pekka/A-2022-2008; Stegen, James/Q-3078-2016	Kaitaniemi, Pekka/0000-0002-5162-242X; Stegen, James/0000-0001-9135-7424	Academy of Finland [208661]	Academy of Finland(Academy of Finland)	The study was funded by the Academy of Finland (grant 208661).	Chen XW, 2003, ACTA OECOL, V24, P125, DOI 10.1016/S1146-609X(03)00062-6; Dodds PS, 2001, J THEOR BIOL, V209, P9, DOI 10.1006/jtbi.2000.2238; Enquist BJ, 2007, NATURE, V449, P218, DOI 10.1038/nature06061; Etienne RS, 2006, FUNCT ECOL, V20, P394, DOI 10.1111/j.1365-2435.2006.01136.x; Haefner J. W., 1996, MODELING BIOL SYSTEM; ISOBE T, 1990, ASTROPHYS J, V364, P104, DOI 10.1086/169390; Kaitaniemi P, 2004, J THEOR BIOL, V228, P149, DOI 10.1016/j.jtbi.2003.12.007; Lumer H, 1936, AM NAT, V70, P188, DOI 10.1086/280654; Mahmood I, 2006, BRIT J CLIN PHARMACO, V61, P545, DOI 10.1111/j.1365-2125.2006.02622.x; Makela A, 2006, ECOLOGY, V87, P2967, DOI 10.1890/0012-9658(2006)87[2967:CRIASI]2.0.CO;2; Marquet PA, 2005, J EXP BIOL, V208, P1749, DOI 10.1242/jeb.01588; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Savage VM, 2004, FUNCT ECOL, V18, P257, DOI 10.1111/j.0269-8463.2004.00856.x; Tang HD, 2005, DRUG METAB DISPOS, V33, P1294, DOI 10.1124/dmd.105.004135; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; White CR, 2005, COMP BIOCHEM PHYS A, V142, P74, DOI 10.1016/j.cbpa.2005.07.013	16	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1932	10.1371/journal.pone.0001932	http://dx.doi.org/10.1371/journal.pone.0001932			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398458	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795500009
J	Tringe, SG; Zhang, T; Liu, XG; Yu, YT; Lee, WH; Yap, J; Yao, F; Suan, ST; Ing, SK; Haynes, M; Rohwer, F; Wei, CL; Tan, P; Bristow, J; Rubin, EM; Ruan, YJ				Tringe, Susannah G.; Zhang, Tao; Liu, Xuguo; Yu, Yiting; Lee, Wah Heng; Yap, Jennifer; Yao, Fei; Suan, Sim Tiow; Ing, Seah Keng; Haynes, Matthew; Rohwer, Forest; Wei, Chia Lin; Tan, Patrick; Bristow, James; Rubin, Edward M.; Ruan, Yijun			The Airborne Metagenome in an Indoor Urban Environment	PLOS ONE			English	Article								The indoor atmosphere is an ecological unit that impacts on public health. To investigate the composition of organisms in this space, we applied culture-independent approaches to microbes harvested from the air of two densely populated urban buildings, from which we analyzed 80 megabases genomic DNA sequence and 6000 16S rDNA clones. The air microbiota is primarily bacteria, including potential opportunistic pathogens commonly isolated from human-inhabited environments such as hospitals, but none of the data contain matches to virulent pathogens or bioterror agents. Comparison of air samples with each other and nearby environments suggested that the indoor air microbes are not random transients from surrounding outdoor environments, but rather originate from indoor niches. Sequence annotation by gene function revealed specific adaptive capabilities enriched in the air environment, including genes potentially involved in resistance to desiccation and oxidative damage. This baseline index of air microbiota will be valuable for improving designs of surveillance for natural or man-made release of virulent pathogens.	[Tringe, Susannah G.; Bristow, James; Rubin, Edward M.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Tringe, Susannah G.; Bristow, James; Rubin, Edward M.] Lawrence Berkeley Natl Lab, Genomics Div, Berkeley, CA USA; [Zhang, Tao; Liu, Xuguo; Yu, Yiting; Lee, Wah Heng; Yao, Fei; Wei, Chia Lin; Tan, Patrick; Ruan, Yijun] Genome Inst Singapore, Singapore, Singapore; [Yap, Jennifer] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore; [Suan, Sim Tiow; Ing, Seah Keng] Natl Univ Singapore, Dept Microbiol, Singapore, Singapore; [Haynes, Matthew; Rohwer, Forest] San Diego State Univ, Ctr Microbial Sci, Biol Dept, San Diego, CA USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; California State University System; San Diego State University	Tringe, SG (corresponding author), Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov; ruanyj@gis.a-star.edu.sg	Rohwer, Forest/AAC-5315-2019; Yu, Yiting/C-8443-2009; Tringe, Susannah Green/T-9431-2019	Tringe, Susannah Green/0000-0001-6479-8427; Rohwer, Forest/0000-0003-1548-5429	Agency for Science, Technology and Research (A*STAR), Singapore; US Department of Energy's Office of Science, Biological and Environmental Research Program; University of California, Lawrence Livermore National Laboratory [W-7405-Eng-48]; Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Los Alamos National Laboratory [DE-AC02-06NA25396]	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); US Department of Energy's Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); University of California, Lawrence Livermore National Laboratory(University of California System); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory)	This work was supported by the Agency for Science, Technology and Research (A*STAR), Singapore, and under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Livermore National Laboratory under Contract No. W-7405-Eng-48, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396.	Abraham WR, 1999, INT J SYST BACTERIOL, V49, P1053, DOI 10.1099/00207713-49-3-1053; Angenent LT, 2005, P NATL ACAD SCI USA, V102, P4860, DOI 10.1073/pnas.0501235102; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Cook GM, 1998, MICROBIOL-UK, V144, P3297, DOI 10.1099/00221287-144-12-3297; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Endley S, 2001, J BACTERIOL, V183, P2454, DOI 10.1128/JB.183.8.2454-2462.2001; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Gilad J, 2000, SCAND J INFECT DIS, V32, P90, DOI 10.1080/00365540050164290; Han XY, 2005, J ANTIMICROB CHEMOTH, V55, P853, DOI 10.1093/jac/dki139; Hoppe P, 1998, INT J BIOMETEOROL, V42, P1, DOI 10.1007/s004840050075; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Kawamura Y, 2001, MICROBIOL IMMUNOL, V45, P819, DOI 10.1111/j.1348-0421.2001.tb01321.x; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; OjanenReuhs T, 1997, J BACTERIOL, V179, P1280, DOI 10.1128/jb.179.4.1280-1290.1997; OSTERHOLM M, 2005, EPIDEMIOLOGY INFECT, P161; Paster BJ, 2002, J CLIN MICROBIOL, V40, P2187, DOI 10.1128/JCM.40.6.2187-2191.2002; Radosevich JL, 2002, LETT APPL MICROBIOL, V34, P162, DOI 10.1046/j.1472-765x.2002.01048.x; Ravaoarinoro M, 1999, INT J ANTIMICROB AG, V12, P27, DOI 10.1016/S0924-8579(98)00095-8; Shaffer BT, 1997, MICROBIAL ECOL, V34, P167, DOI 10.1007/s002489900046; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; STREIFEL A, 2004, DESIGN MAINTENANCE H, P1577; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Valdezate S, 2004, J CLIN MICROBIOL, V42, P693, DOI 10.1128/JCM.42.2.693-699.2003; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Way SS, 1999, J BACTERIOL, V181, P1229, DOI 10.1128/JB.181.4.1229-1237.1999; Wu PC, 2005, INDOOR AIR, V15, P19, DOI 10.1111/j.1600-0668.2004.00313.x; Xu J, 2004, J HOSP INFECT, V57, P52, DOI 10.1016/j.jhin.2004.01.011	35	157	168	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1862	10.1371/journal.pone.0001862	http://dx.doi.org/10.1371/journal.pone.0001862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382653	Green Submitted, Green Published, gold			2022-12-27	WOS:000260795400003
J	Bethune, MT; Ribka, E; Khosla, C; Sestak, K				Bethune, Michael T.; Ribka, Erin; Khosla, Chaitan; Sestak, Karol			Transepithelial Transport and Enzymatic Detoxification of Gluten in Gluten-Sensitive Rhesus Macaques	PLOS ONE			English	Article								Background and Aims: In a previous report, we characterized a condition of gluten sensitivity in juvenile rhesus macaques that is similar in many respects to the human condition of gluten sensitivity, celiac disease. This animal model of gluten sensitivity may therefore be useful toward studying both the pathogenesis and the treatment of celiac disease. Here, we perform two pilot experiments to demonstrate the potential utility of this model for studying intestinal permeability toward an immunotoxic gluten peptide and pharmacological detoxification of gluten in vivo by an oral enzyme drug candidate. Methods: Intestinal permeability was investigated in age-matched gluten-sensitive and control macaques by using mass spectrometry to detect and quantify an orally dosed, isotope labeled 33-mer gluten peptide delivered across the intestinal epithelium to the plasma. The protective effect of a therapeutically promising oral protease, EP-B2, was evaluated in a gluten-sensitive macaque by administering a daily gluten challenge with or without EP-B2 supplementation. ELISA-based antibody assays and blinded clinical evaluations of this macaque and of an age-matched control were conducted to assess responses to gluten. Results: Labeled 33-mer peptide was detected in the plasma of a gluten-sensitive macaque, both in remission and during active disease, but not in the plasma of healthy controls. Administration of EP-B2, but not vehicle, prevented clinical relapse in response to a dietary gluten challenge. Unexpectedly, a marked increase in anti-gliadin (IgG and IgA) and anti-transglutaminase (IgG) antibodies was observed during the EP-B2 treatment phase. Conclusions: Gluten-sensitive rhesus macaques may be an attractive resource for investigating important aspects of celiac disease, including enhanced intestinal permeability and pharmacology of oral enzyme drug candidates. Orally dosed EP-B2 exerts a protective effect against ingested gluten. Limited data suggest that enhanced permeability of short gluten peptides generated by gastrically active glutenases may trigger an elevated antibody response, but that these antibodies are not necessarily causative of clinical illness.	[Bethune, Michael T.; Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Ribka, Erin; Sestak, Karol] Tulane Natl Primate Res Ctr, Covington, LA USA; [Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA USA; [Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA USA; [Sestak, Karol] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA USA	Stanford University; Tulane University; Stanford University; Stanford University; Tulane University	Bethune, MT (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	ksestak@tulane.edu		Sestak, Karol/0000-0003-3951-2719; Khosla, Chaitan/0000-0001-6529-495X	Stanford University; TNPRC [P51 RR00164, U24 RR018111];  [R21 AI54146];  [R01 DK063158]; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR018111, P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI054146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076653, R01DK063158] Funding Source: NIH RePORTER	Stanford University(Stanford University); TNPRC; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant support: This research was jointly supported by R21 AI54146 to K.S., R01 DK063158 to C.K., and grants P51 RR00164 and U24 RR018111 to the TNPRC. M.T.B. was a recipient of an NIH Cellular and Molecular Biology Training Grant through Stanford University at the outset of this work.	Bethune MT, 2006, CHEM BIOL, V13, P637, DOI 10.1016/j.chembiol.2006.04.008; BETHUNE MT, 2008, PLOS ONE IN PRESS; BJARNASON I, 1983, LANCET, V1, P323; BJARNASON I, 1985, GUT, V26, P1214, DOI 10.1136/gut.26.11.1214; BJARNASON I, 1984, GUT, V25, P145, DOI 10.1136/gut.25.2.145; BJARNASON I, 1985, GUT, V26, P579, DOI 10.1136/gut.26.6.579; Cerf-Bensussan N, 2007, GUT, V56, P157, DOI 10.1136/gut.2005.090498; Ciacci C, 2002, DIGESTION, V66, P178, DOI 10.1159/000066757; Cornell HJ, 2005, SCAND J GASTROENTERO, V40, P1304, DOI 10.1080/00365520510023855; DICKE W K, 1953, Acta Paediatr, V42, P34, DOI 10.1111/j.1651-2227.1953.tb05563.x; Esposito C, 2002, GUT, V51, P177, DOI 10.1136/gut.51.2.177; Fleckenstein B, 2002, J BIOL CHEM, V277, P34109, DOI 10.1074/jbc.M204521200; Gass J, 2007, GASTROENTEROLOGY, V133, P472, DOI 10.1053/j.gastro.2007.05.028; Gass J, 2006, J PHARMACOL EXP THER, V318, P1178, DOI 10.1124/jpet.106.104315; Green PHR, 2006, ANNU REV MED, V57, P207, DOI 10.1146/annurev.med.57.051804.122404; Hausch F, 2003, CHEM BIOL, V10, P225, DOI 10.1016/S1074-5521(03)00045-0; Hausch F, 2002, AM J PHYSIOL-GASTR L, V283, pG996, DOI 10.1152/ajpgi.00136.2002; Jabri B, 2005, IMMUNOL REV, V206, P219, DOI 10.1111/j.0105-2896.2005.00294.x; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Korponay-Szabo IR, 2004, GUT, V53, P641, DOI 10.1136/gut.2003.024836; Korponay-Szabo IR, 2003, GUT, V52, P199, DOI 10.1136/gut.52.2.199; MAYER M, 1991, GUT, V32, P881, DOI 10.1136/gut.32.8.881; Pietzak MM, 2005, GASTROENTEROLOGY, V128, pS135, DOI 10.1053/j.gastro.2005.02.025; PINKAS DM, 2007, PLOS BIOL, V327, P2; Piper JL, 2002, BIOCHEMISTRY-US, V41, P386, DOI 10.1021/bi011715x; Qiao SW, 2004, J IMMUNOL, V173, P1757, DOI 10.4049/jimmunol.173.3.1757; Quarsten H, 1999, EUR J IMMUNOL, V29, P2506, DOI 10.1002/(SICI)1521-4141(199908)29:08<2506::AID-IMMU2506>3.0.CO;2-9; Schulzke JD, 1998, PEDIATR RES, V43, P435, DOI 10.1203/00006450-199804000-00001; See Jacalyn, 2006, Nutr Clin Pract, V21, P1, DOI 10.1177/011542650602100101; Shan L, 2005, J PROTEOME RES, V4, P1732, DOI 10.1021/pr050173t; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Siegel M, 2006, CHEM BIOL, V13, P649, DOI 10.1016/j.chembiol.2006.04.009; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Spurkland A, 1997, TISSUE ANTIGENS, V49, P29, DOI 10.1111/j.1399-0039.1997.tb02706.x; Stepniak D, 2006, TRENDS BIOTECHNOL, V24, P433, DOI 10.1016/j.tibtech.2006.08.003; Teahon K, 1996, GUT, V38, P864, DOI 10.1136/gut.38.6.864; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vora H, 2007, BIOTECHNOL BIOENG, V98, P177, DOI 10.1002/bit.21423; Xia J, 2005, BIOCHEMISTRY-US, V44, P4442, DOI 10.1021/bi047747c	40	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1857	10.1371/journal.pone.0001857	http://dx.doi.org/10.1371/journal.pone.0001857			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365012	Green Published, gold, Green Submitted			2022-12-27	WOS:000260762400018
J	Hermine, O; Lortholary, O; Leventhal, PS; Catteau, A; Soppelsa, F; Baude, C; Cohen-Akenine, A; Palmerini, F; Hanssens, K; Yang, Y; Sobol, H; Fraytag, S; Ghez, D; Suarez, F; Barete, S; Casassus, P; Sans, B; Arock, M; Kinet, JP; Dubreuil, P; Moussy, A				Hermine, Olivier; Lortholary, Olivier; Leventhal, Phillip S.; Catteau, Adeline; Soppelsa, Frederique; Baude, Cedric; Cohen-Akenine, Annick; Palmerini, Fabienne; Hanssens, Katia; Yang, Ying; Sobol, Hagay; Fraytag, Sylvie; Ghez, David; Suarez, Felipe; Barete, Stephane; Casassus, Philippe; Sans, Beatrice; Arock, Michel; Kinet, Jean Pierre; Dubreuil, Patrice; Moussy, Alain			Case-Control Cohort Study of Patients' Perceptions of Disability in Mastocytosis	PLOS ONE			English	Article								Background: Indolent forms of mastocytosis account for more than 90% of all cases, but the types and type and severity of symptoms and their impact on the quality of life have not been well studied. We therefore performed a case-control cohort study to examine self-reported disability and impact of symptoms on the quality of life in patients with mastocytosis. Methodology/Principal Findings: In 2004, 363 mastocytosis patients and 90 controls in France were asked to rate to their overall disability (OPA score) and the severity of 38 individual symptoms. The latter was used to calculate a composite score (AFIRMM score). Of the 363 respondents, 262 were part of an ongoing pathophysiological study so that the following data were available: World Health Organization classification, standard measures of physical and psychological disability, existence of the D816V KIT mutation, and serum tryptase level. The mean OPA and AFIRMM scores and the standard measures of disability indicated that most mastocytosis patients suffer from disabilities due to the disease. Surprisingly, the patient's measurable and perceived disabilities did not differ according to disease classification or presence or absence of the D816V KIT mutation or an elevated (>= 20 ng/mL) serum tryptase level. Also, 32 of the 38 AFIRMM symptoms were more common in patients than controls, but there were not substantial differences according to disease classification, presence of the D816V mutation, or the serum tryptase level. Conclusions: On the basis of these results and for the purposes of treatment, we propose that mastocytosis be first classified as aggressive or indolent and that indolent mastocytosis then be categorized according to the severity of patients' perceived symptoms and their impact on the quality of life. In addition, it appears that mastocytosis patients suffer from more symptoms and greater disability than previously thought, that mastocytosis may therefore be under-diagnosed, and that the symptoms of the indolent forms of mastocytosis might be due more to systemic release of mediators than mast cell burden.	[Hermine, Olivier; Ghez, David; Barete, Stephane] Hop Necker Enfants Malad, Ctr Reference Mastocytose, Serv Dermatol, Paris, France; [Hermine, Olivier; Ghez, David; Suarez, Felipe] Hop Necker Enfants Malad, Ctr Reference Mastocytose, Serv Hematol Adulte, Paris, France; [Hermine, Olivier; Lortholary, Olivier; Leventhal, Phillip S.; Catteau, Adeline; Soppelsa, Frederique; Baude, Cedric; Cohen-Akenine, Annick; Palmerini, Fabienne; Hanssens, Katia; Sobol, Hagay; Casassus, Philippe; Kinet, Jean Pierre; Dubreuil, Patrice; Moussy, Alain] AFIRMM, Paris, France; [Lortholary, Olivier; Palmerini, Fabienne; Hanssens, Katia; Yang, Ying; Dubreuil, Patrice] Ctr Rech Cancerol Marseille, Lab Hematopoiese Mol Fonctionnelle, INSERM UMR599, Marseille, France; [Palmerini, Fabienne; Hanssens, Katia; Fraytag, Sylvie; Dubreuil, Patrice] Hop Necker Enfants Malad, Ctr Reference Mastocytose, Serv Anatomopathol, Paris, France; [Sobol, Hagay] Inst Paoli Calmettes, Ctr Reference Mastocytose, Dept Oncol Genet, Marseille, France; [Barete, Stephane] Univ Paris 06, Assistance Publ Hop Paris, Ctr Reference Mastocytose, Hop Tenon, Paris, France; [Casassus, Philippe] Univ Paris 13, CHU Bobigny, Hop Avicennes, Service Hematol, Paris, France; [Sans, Beatrice] Hop Purpan, Serv Dermatol, Venerol Allergol, Toulouse, France; [Arock, Michel] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Ctr Reference Mastocytoses, Dept Infect & Trop Dis, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Institut Paoli-Calmette (IPC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Hermine, O (corresponding author), Hop Necker Enfants Malad, Ctr Reference Mastocytose, Serv Dermatol, Paris, France.	hermine@necker.fr	Dubreuil, Patrice/V-4816-2019; Hermine, Olivier/Q-7072-2018; dubreuil, patrice/F-5346-2011	Dubreuil, Patrice/0000-0003-1155-1150; dubreuil, patrice/0000-0003-1155-1150; Hermine, Olivier/0000-0003-2574-3874	Association Francaise pour les Initiatives et la Recherche sur le Mastocyte et les Mastocytoses (AFIRMM)	Association Francaise pour les Initiatives et la Recherche sur le Mastocyte et les Mastocytoses (AFIRMM)	Financial support for this study was provided by the Association Francaise pour les Initiatives et la Recherche sur le Mastocyte et les Mastocytoses (AFIRMM).	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Akin C, 2004, ANNU REV MED, V55, P419, DOI 10.1146/annurev.med.55.091902.103822; Akin C, 2007, CLIN IMMUNOL, V123, P268, DOI 10.1016/j.clim.2007.02.007; Boncoraglio GB, 2005, NEUROLOGY, V65, P332, DOI 10.1212/01.wnl.0000168897.35545.61; D'Inca M, 1996, Ann Ital Med Int, V11, P52; Escribano Luis, 2006, Inflammation & Allergy Drug Targets, V5, P61, DOI 10.2174/187152806775269303; Feger F, 2002, INT ARCH ALLERGY IMM, V127, P110, DOI 10.1159/000048179; Hedlund J.L., 1979, J OPER PSYCHIATR, V10, P149, DOI DOI 10.1192/BJP.BP.106.032532; Hogan DJ, EMEDICINE; Jensen RT, 2000, HEMATOL ONCOL CLIN N, V14, P579, DOI 10.1016/S0889-8588(05)70298-7; Proelss J, 2007, J AM ACAD DERMATOL, V56, P453, DOI 10.1016/j.jaad.2006.09.020; ROGERS MP, 1986, PSYCHOSOM MED, V48, P437, DOI 10.1097/00006842-198607000-00006; Schwartz LB, 2006, IMMUNOL ALLERGY CLIN, V26, P451, DOI 10.1016/j.iac.2006.05.010; SCHWARTZ LB, 1994, J CLIN IMMUNOL, V14, P190, DOI 10.1007/BF01533368; SOTER NA, 1979, NEW ENGL J MED, V301, P465, DOI 10.1056/NEJM197908303010903; Sperr WR, 2001, BLOOD, V98, P2200, DOI 10.1182/blood.V98.7.2200; Valent P, 2005, LEUKEMIA LYMPHOMA, V46, P35, DOI 10.1080/10428190400010775; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Zappulla JP, 2005, J EXP MED, V202, P1635, DOI 10.1084/jem.20050807	19	110	116	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2266	10.1371/journal.pone.0002266	http://dx.doi.org/10.1371/journal.pone.0002266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509466	Green Published, gold, Green Submitted			2022-12-27	WOS:000262268500013
J	Perrin-Cocon, L; Agaugue, S; Diaz, O; Vanbervliet, B; Dollet, S; Guironnet-Paquet, A; Andre, P; Lotteau, V				Perrin-Cocon, Laure; Agaugue, Sophie; Diaz, Olivier; Vanbervliet, Beatrice; Dollet, Sandra; Guironnet-Paquet, Aurelie; Andre, Patrice; Lotteau, Vincent			Th1 Disabled Function in Response to TLR4 Stimulation of Monocyte-Derived DC from Patients Chronically-Infected by Hepatitis C Virus	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; PLASMACYTOID DENDRITIC CELLS; ACTIVATED PROTEIN-KINASE; TOLL-LIKE RECEPTOR-4; SIGNALING PATHWAY; MATURATION; LIPOPOLYSACCHARIDE; DYSFUNCTION; RECOGNITION; ASSOCIATION	Background: Lack of protective antibodies and inefficient cytotoxic responses are characteristics of chronic hepatitis C infection. A defect in dendritic cell (DC) function has thus been suspected, but this remains a controversial issue. Methods and Findings: Here we show that monocyte-derived DC (MoDC) from chronically-infected patients can mature in response to TLR1/2, TLR2/6 or TLR3 ligands. In contrast, when stimulated with the TLR4 ligand LPS, MoDC from patients show a profound defect in inducing IFN gamma secretion by allogeneic T cells. This defect is not due to defective phenotypic maturation or to the presence of HCV-RNA in DC or monocytes but is correlated to reduced IL-12 secretion by DC. Restoration of DC ability to stimulate IFN gamma secretion can be obtained by blocking MEK activation in DC, indicating that MEK/ERK pathway is involved in the Th1 defect of MoDC. Monocytes from HCV patients present increased spontaneous secretion of cytokines and chemokines, especially MIP-1 beta. Addition of MIP-1 beta on healthy monocytes during differentiation results in DC that have Th1 defect characteristic of MoDC from HCV patients, suggesting that MIP-1 beta secretion by HCV monocytes participates in the Th1 defect of DC. Conclusions: Our data indicate that monocytes from HCV patients are activated in vivo. This interferes with their differentiation into DC, leading to deficient TLR4 signaling in these cells that are enable to induce a Th1 response. This specific defect is linked to the activation of the MEK/ERK pathway.	[Perrin-Cocon, Laure; Agaugue, Sophie; Diaz, Olivier; Vanbervliet, Beatrice; Dollet, Sandra; Guironnet-Paquet, Aurelie; Andre, Patrice; Lotteau, Vincent] INSERM, U851, F-69008 Lyon, France; [Perrin-Cocon, Laure; Agaugue, Sophie; Diaz, Olivier; Vanbervliet, Beatrice; Dollet, Sandra; Guironnet-Paquet, Aurelie; Andre, Patrice; Lotteau, Vincent] Univ Lyon, IFR128 BioSci Lyon Gerland, Lyon, France; [Andre, Patrice; Lotteau, Vincent] Hop Croix Rousse, Lab Virol, Hospices Civils Lyon, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Perrin-Cocon, L (corresponding author), INSERM, U851, F-69008 Lyon, France.	laure.perrin@inserm.fr	André, Patrice/M-8139-2014; lotteau, vincent/M-8143-2014; Perrin-Cocon, Laure A/M-8099-2014; diaz, olivier/M-8112-2014; Carlet-Dollet, Sandra/X-8945-2019	André, Patrice/0000-0002-5834-7395; Perrin-Cocon, Laure A/0000-0003-0501-6733; diaz, olivier/0000-0002-3451-9914; Carlet-Dollet, Sandra/0000-0003-3908-6051; Lotteau, Vincent/0000-0003-0997-3282; Marteil, Gaelle/0000-0002-0064-571X	Agence Nationale de la Recherche sur le Sida et les hepatites (ANRS); Institut National de la Sante et de la Recherche Medicale (Inserm); les Hospices Civils de Lyon (HCL); Association pour la Recherche sur le Cancer [doctoral scholarship]	Agence Nationale de la Recherche sur le Sida et les hepatites (ANRS)(ANRSFrench National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); les Hospices Civils de Lyon (HCL); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	This work was supported by the Agence Nationale de la Recherche sur le Sida et les hepatites (ANRS), Institut National de la Sante et de la Recherche Medicale (Inserm) and les Hospices Civils de Lyon (HCL). S.A was recipient of a doctoral scholarship from the Association pour la Recherche sur le Cancer.	Abe T, 2007, J VIROL, V81, P8953, DOI 10.1128/JVI.00649-07; Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Agaugue S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000330; Agaugue S, 2006, J IMMUNOL, V177, P2061, DOI 10.4049/jimmunol.177.4.2061; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Auffermann-Gratzinger S, 2001, BLOOD, V97, P3171, DOI 10.1182/blood.V97.10.3171; Averill L, 2007, CLIN IMMUNOL, V123, P40, DOI 10.1016/j.clim.2006.12.001; Bain C, 2001, GASTROENTEROLOGY, V120, P512, DOI 10.1053/gast.2001.21212; BESNARD NC, 1994, J CLIN MICROBIOL, V32, P1887, DOI 10.1128/JCM.32.8.1887-1893.1994; Bieback K, 2002, J VIROL, V76, P8729, DOI 10.1128/JVI.76.17.8729-8736.2002; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Coutant F, 2004, J IMMUNOL, V172, P54, DOI 10.4049/jimmunol.172.1.54; Deforges S, 2004, J GEN VIROL, V85, P2515, DOI 10.1099/vir.0.80071-0; Della Bella S, 2007, IMMUNOLOGY, V121, P283, DOI 10.1111/j.1365-2567.2007.02577.x; Diaz O, 2008, J MED VIROL, V80, P242, DOI 10.1002/jmv.21037; Diaz O, 2006, J GEN VIROL, V87, P2983, DOI 10.1099/vir.0.82033-0; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Hoofnagle JH, 1997, HEPATOLOGY, V26, pS15, DOI 10.1002/hep.510260703; Jude BA, 2003, NAT IMMUNOL, V4, P573, DOI 10.1038/ni926; Kanto T, 2005, INTERVIROLOGY, V49, P58, DOI 10.1159/000087264; Kanto T, 2004, J INFECT DIS, V190, P1919, DOI 10.1086/425425; Kanto T, 1999, J IMMUNOL, V162, P5584; Komurian-Pradel F, 2001, J VIROL METHODS, V95, P111, DOI 10.1016/S0166-0934(01)00300-7; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Lichterfeld M, 2002, J INFECT DIS, V185, P1803, DOI 10.1086/340829; Longman RS, 2005, J INFECT DIS, V192, P497, DOI 10.1086/431523; Longman RS, 2004, BLOOD, V103, P1026, DOI 10.1182/blood-2003-04-1339; Lupo G, 2005, BBA-MOL CELL BIOL L, V1735, P135, DOI 10.1016/j.bbalip.2005.05.008; MILLER RH, 1990, P NATL ACAD SCI USA, V87, P2057, DOI 10.1073/pnas.87.6.2057; Murakami H, 2004, CLIN EXP IMMUNOL, V137, P559, DOI 10.1111/j.1365-2249.2004.02550.x; Napolitano M, 2007, J MED VIROL, V79, P254, DOI 10.1002/jmv.20793; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Perrin-Cocon L, 2001, J IMMUNOL, V167, P3785, DOI 10.4049/jimmunol.167.7.3785; Piccioli D, 2005, J HEPATOL, V42, P61, DOI 10.1016/j.jhep.2004.09.014; Puig-Kroger A, 2001, BLOOD, V98, P2175, DOI 10.1182/blood.V98.7.2175; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Rodrigue-Gervais IG, 2007, J VIROL, V81, P5537, DOI 10.1128/JVI.01741-06; Rui LX, 2006, J IMMUNOL, V177, P5337, DOI 10.4049/jimmunol.177.8.5337; Sato A, 2006, P NATL ACAD SCI USA, V103, P17343, DOI 10.1073/pnas.0605102103; Tomkowicz B, 2006, BLOOD, V108, P1145, DOI 10.1182/blood-2005-12-012815; Tsubouchi E, 2004, J GASTROENTEROL, V39, P754, DOI 10.1007/s00535-003-1385-3; Tsubouchi E, 2004, CLIN EXP IMMUNOL, V137, P417, DOI 10.1111/j.1365-2249.2004.02544.x; Velarde V, 2001, J APPL PHYSIOL, V91, P1412, DOI 10.1152/jappl.2001.91.3.1412; Waggoner SN, 2007, J LEUKOCYTE BIOL, V82, P1407, DOI 10.1189/jlb.0507268; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; Walton KA, 2006, J LIPID RES, V47, P1967, DOI 10.1194/jlr.M600060-JLR200; Zeyda M, 2005, J BIOL CHEM, V280, P14293, DOI 10.1074/jbc.M410000200; Zhao LJ, 2006, J LEUKOCYTE BIOL, V80, P424, DOI 10.1189/jlb.0106014	54	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2260	10.1371/journal.pone.0002260	http://dx.doi.org/10.1371/journal.pone.0002260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509450	Green Submitted, gold, Green Published			2022-12-27	WOS:000262268500009
J	Giuliani, M; Giron-Michel, J; Negrini, S; Vacca, P; Durali, D; Caignard, A; Le Bousse-Kerdiles, MC; Chouaib, S; Devocelle, A; Bahri, R; Durrbach, A; Taoufik, Y; Ferrini, S; Croce, M; Mingari, MC; Moretta, L; Azzarone, B				Giuliani, Massimo; Giron-Michel, Julien; Negrini, Simone; Vacca, Paola; Durali, Deniz; Caignard, Anne; Le Bousse-Kerdiles, M. Caroline; Chouaib, Salem; Devocelle, Aurore; Bahri, Rajia; Durrbach, Antoine; Taoufik, Yassine; Ferrini, Silvano; Croce, Michela; Mingari, Maria Cristina; Moretta, Lorenzo; Azzarone, Bruno			Generation of a Novel Regulatory NK Cell Subset from Peripheral Blood CD34(+) Progenitors Promoted by Membrane-Bound IL-15	PLOS ONE			English	Article							NATURAL-KILLER-CELL; MESENCHYMAL STEM-CELLS; DENDRITIC CELLS; T-CELLS; HLA-G; GROWTH-FACTOR; CUTTING EDGE; BONE-MARROW; BETA-CHAIN; IFN-GAMMA	Background: NK cells have been long time considered as cytotoxic lymphocytes competent in killing virus-infected cells and tumors. However, NK cells may also play essential immuno-regulatory functions. In this context, the real existence of a defined NK subset with negative regulatory properties has been hypothesized but never clearly demonstrated. Methodology/Principal Findings: Herein, we show the in vitro generation from human peripheral blood haematopoietic progenitors (PB-HP), of a novel subset of non-cytolytic NK cells displaying a mature phenotype and remarkable immunoregulatory functions (NK-ireg). The main functional hallmark of these NK-ireg cells is represented by the surface expression/release of HLA-G, a major immunosuppressive molecule. In addition, NK-ireg cells secrete two powerful immuno-regulatory factors: IL-10 and IL-21. Through these factors, NK-ireg cells act as effectors of the down-regulation of the immune response: reconverting mature myeloid DC (mDC) into immature/tolerogenic DC, blocking cytolytic functions on conventional NK cells and inducing HLA-G membrane expression on PB-derived monocytes. The generation of "NK-ireg'' cells is obtained, by default, in culture conditions favouring cell-to-cell contacts, and it is strictly dependent on reciprocal trans-presentation of membrane-bound IL-15 forms constitutively and selectively expressed by human CD34(+) PB-HP. Finally, a small subset of NKp46(+) HLA-G(+) IL-10(+) is detected within freshly isolated decidual NK cells, suggesting that these cells could represent an in vivo counterpart of the NK-ireg cells. Conclusions/Significance: In conclusion, NK-ireg cells represent a novel truly differentiated non-cytolytic NK subset with a self-sustainable phenotype (CD56(+) CD16(+) NKp30(+) NKp44(+) NKp46(+) CD94(+) CD69(+) CCR7(+)) generated from specific pSTAT6(+) GATA3(+) precursors. NK-ireg cells could be employed to develop new immuno-suppressive strategies in autoimmune diseases, transplant rejection or graft versus host diseases. In addition, NK-ireg cells can be easily derived from peripheral blood of the patients and could constitute an autologous biotherapic tool to be used combined or in alternative to other immuno-regulatory cells.	[Giuliani, Massimo; Giron-Michel, Julien; Negrini, Simone; Durali, Deniz; Devocelle, Aurore; Bahri, Rajia; Durrbach, Antoine; Azzarone, Bruno] Univ Paris 11, Hop Paul Brousse, INSERM, UMR 542, Villejuif, France; [Giuliani, Massimo; Giron-Michel, Julien; Vacca, Paola; Moretta, Lorenzo] Ist Giannina Gaslini, Genoa, Italy; [Negrini, Simone] Univ Genoa, Dipartimento Med Interna, Genoa, Italy; [Vacca, Paola; Mingari, Maria Cristina] Univ Genoa, Ctr Eccelenza Ricerca Biomed, Genoa, Italy; [Vacca, Paola; Mingari, Maria Cristina] Ist Nazl Ricerca Canc, Genoa, Italy; [Durali, Deniz; Taoufik, Yassine] Univ Paris 11, Kremlin Bicetre, INSERM UMR 802, Villejuif, France; [Caignard, Anne; Chouaib, Salem] Univ Paris 11, IGR, INSERM UMR 753, Villejuif, France; [Le Bousse-Kerdiles, M. Caroline] Univ Paris 11, Hop Paul Brousse, INSERM UMR 602, Villejuif, France; [Ferrini, Silvano; Croce, Michela] Ist Nazl Ricerca Canc, Lab Immunotherapy, Genoa, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Genoa; IRCCS AOU San Martino IST	Giuliani, M (corresponding author), Univ Paris 11, Hop Paul Brousse, INSERM, UMR 542, Villejuif, France.	bazzarone@hotmail.com	DURALI, Deniz/Y-6325-2019; Bahri, Rajia/ABE-1725-2021; Mingari, Maria Cristina/AAB-1315-2019; Giron-michel, Julien/GNP-7299-2022; Moretta, Lorenzo/AAA-7239-2020; NEGRINI, Simone/AAC-6823-2021; Caignard, Anne/F-8159-2013; Croce, Michela/AAA-8966-2020; Azzarone, Bruno/AAH-9251-2019; Chouaib, Salem/F-7939-2016; Giron-Michel, Julien/Q-4503-2018; Vacca, Paola/ABC-9416-2021; Le Bousse-Kerdiles, Marie-Caroline/Q-4029-2018	Giron-michel, Julien/0000-0001-6613-6099; Moretta, Lorenzo/0000-0003-4658-1747; NEGRINI, Simone/0000-0003-1267-4320; Caignard, Anne/0000-0001-9923-6045; Croce, Michela/0000-0003-4683-4951; Azzarone, Bruno/0000-0002-5962-3849; Giron-Michel, Julien/0000-0001-6613-6099; Vacca, Paola/0000-0002-0757-0108; Le Bousse-Kerdiles, Marie-Caroline/0000-0003-0863-5222; Ferrini, Silvano/0000-0001-7254-2616	Association pour la Recherche sur le Cancer [post-doctoral fellowship]; NRB-Vaincre le Cancer [post-doctoral fellowship]; Italian Association for Cancer Research (AIRC); Italian Ministry of health and CNR Functional Genomics; EMBO [post-doctoral fellowship]; Fondazione Italiana Neuroblastoma	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NRB-Vaincre le Cancer; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of health and CNR Functional Genomics; EMBO(European Molecular Biology Organization (EMBO)); Fondazione Italiana Neuroblastoma	This work was supported by grants from the Association pour la Recherche sur le Cancer (ARC, N 3690), NRB-Vaincre le Cancer, Italian Association for Cancer Research (AIRC), and the Italian Ministry of health and CNR Functional Genomics, M.G. and D.D. are recipient of post doctoral NRB-Vaincre le Cancer fellowships. S.N. is recipient of post-doctoral fellowships from EMBO and ARC. M.C. is recipient of a Fellowship from Fondazione Italiana Neuroblastoma. I declare, on behalf of all authors, that there are no financial, personal, or professional interests that could be construed to have influenced the paper.	Alvarado J, 2005, IMMUNOL LETT, V99, P109, DOI 10.1016/j.imlet.2005.02.005; Barton BE, 2006, EXPERT OPIN THER TAR, V10, P459, DOI 10.1517/14728222.10.3.459; Brady J, 2004, J IMMUNOL, V172, P2048, DOI 10.4049/jimmunol.172.4.2048; Brandt K, 2003, BLOOD, V102, P4090, DOI 10.1182/blood-2003-03-0669; Briard D, 2005, CLIN EXP IMMUNOL, V140, P265, DOI 10.1111/j.1365-2249.2005.02792.x; Briard D, 2002, J IMMUNOL, V168, P4326, DOI 10.4049/jimmunol.168.9.4326; Budagian V, 2004, J BIOL CHEM, V279, P42192, DOI 10.1074/jbc.M403182200; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Burkett PR, 2003, P NATL ACAD SCI USA, V100, P4724, DOI 10.1073/pnas.0737048100; Cai GF, 1999, EUR J IMMUNOL, V29, P2658, DOI 10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.3.CO;2-7; Capsoni F, 1998, CELL IMMUNOL, V189, P51, DOI 10.1006/cimm.1998.1349; Carayol G, 1998, EUR J IMMUNOL, V28, P1991, DOI 10.1002/(SICI)1521-4141(199806)28:06<1991::AID-IMMU1991>3.0.CO;2-7; CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1; Chaouat G, 2002, J REPROD IMMUNOL, V53, P241, DOI 10.1016/S0165-0378(01)00119-X; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; Cooper MA, 2004, TRENDS IMMUNOL, V25, P47, DOI 10.1016/j.it.2003.10.012; De Maria A, 2007, EUR J IMMUNOL, V37, P445, DOI 10.1002/eji.200635989; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Gandhi R, 2007, J IMMUNOL, V178, P4017, DOI 10.4049/jimmunol.178.7.4017; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Giron-Michel J, 2005, BLOOD, V106, P2302, DOI 10.1182/blood-2005-01-0064; Giron-Michel J, 2003, BLOOD, V102, P109, DOI 10.1182/blood-2002-09-2760; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Harada M, 2006, J EXP MED, V203, P2929, DOI 10.1084/jem.20062206; Hunt JS, 2006, IMMUNOL REV, V213, P36, DOI 10.1111/j.1600-065X.2006.00436.x; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Kaplan MH, 1998, J LEUKOCYTE BIOL, V64, P2, DOI 10.1002/jlb.64.1.2; Kennedy P, 2000, LAT TRADE, V8, P15; Kim DH, 2005, CYTOKINE, V31, P119, DOI 10.1016/j.cyto.2005.04.004; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Koka R, 2003, J EXP MED, V197, P977, DOI 10.1084/jem.20021836; Kuwajima S, 2006, NAT IMMUNOL, V7, P740, DOI 10.1038/ni1348; Le Bouteiller P, 1999, HUM REPROD UPDATE, V5, P223, DOI 10.1093/humupd/5.3.223; Leichtman AB, 2007, NEW ENGL J MED, V357, P2625, DOI 10.1056/NEJMe078181; LeMaoult J, 2005, FASEB J, V19, P662, DOI 10.1096/fj.04-1617fje; LeMaoult J, 2005, AUTOIMMUN REV, V4, P503, DOI 10.1016/j.autrev.2005.04.006; Li ZQ, 2005, J IMMUNOL, V174, P5187, DOI 10.4049/jimmunol.174.9.5187; Lidstrom C, 2003, AM J REPROD IMMUNOL, V50, P444, DOI 10.1046/j.8755-8920.2003.00112.x; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Loza MJ, 2001, NAT IMMUNOL, V2, P917, DOI 10.1038/ni1001-917; Marcenaro E, 2006, TRANSPL IMMUNOL, V17, P16, DOI 10.1016/j.trim.2006.09.019; Ostroukhova M, 2004, J CLIN INVEST, V114, P28, DOI 10.1172/JC1200420509; Parrish-Novak J, 2002, J LEUKOCYTE BIOL, V72, P856; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Rebmann V, 2007, TISSUE ANTIGENS, V69, P143, DOI 10.1111/j.1399-0039.2006.763_5.x; Schluns KS, 2004, P NATL ACAD SCI USA, V101, P5616, DOI 10.1073/pnas.0307442101; Schwenger GTF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1065, DOI 10.1007/s10541-005-0225-x; Sivori S, 2003, EUR J IMMUNOL, V33, P3439, DOI 10.1002/eji.200324533; Sivori S, 2002, P NATL ACAD SCI USA, V99, P4526, DOI 10.1073/pnas.072065999; SPAGGIARI GM, 2007, BLOOD; Spits H, 2007, IMMUNITY, V26, P11, DOI 10.1016/j.immuni.2007.01.004; Trinder P, 1999, INT J ONCOL, V14, P23; Vacca P, 2006, BLOOD, V108, P4078, DOI 10.1182/blood-2006-04-017343; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Yang JS, 2000, IMMUNOLOGY, V101, P397, DOI 10.1046/j.1365-2567.2000.00115.x; Yu HX, 1998, BLOOD, V92, P3647, DOI 10.1182/blood.V92.10.3647.422k43_3647_3657; Zhang C, 2006, CELL MOL IMMUNOL, V3, P241; Zhou M, 2003, IMMUNOL RES, V28, P25, DOI 10.1385/IR:28:1:25; Zitvogel L, 2006, CURR TOP MICROBIOL, V298, P157	60	42	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2241	10.1371/journal.pone.0002241	http://dx.doi.org/10.1371/journal.pone.0002241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493613	Green Published, gold, Green Submitted			2022-12-27	WOS:000262258700049
J	Suh, JM; Stenesen, D; Peters, JM; Inoue, A; Cade, A; Graff, JM				Suh, Jae Myoung; Stenesen, Drew; Peters, John M.; Inoue, Akiko; Cade, Angela; Graff, Jonathan M.			An RGS-Containing Sorting Nexin Controls Drosophila Lifespan	PLOS ONE			English	Article								The pursuit of eternal youth has existed for centuries and recent data indicate that fat-storing tissues control lifespan. In a D. melanogaster fat body insertional mutagenic enhancer trap screen designed to isolate genes that control longevity, we identified a regulator of G protein signaling (RGS) domain containing sorting nexin, termed snazarus (sorting nexin lazarus, snz). Flies with insertions into the 5' UTR of snz live up to twice as long as controls. Transgenic expression of UAS-Snz from the snz Gal4 enhancer trap insertion, active in fat metabolic tissues, rescued lifespan extension. Further, the lifespan extension of snz mutants was independent of endosymbiont, e. g., Wolbachia, effects. Notably, old snz mutant flies remain active and fertile indicating that snz mutants have prolonged youthfulness, a goal of aging research. Since mammals have snz-related genes, it is possible that the functions of the snz family may be conserved to humans.	[Suh, Jae Myoung; Stenesen, Drew; Peters, John M.; Inoue, Akiko; Cade, Angela; Graff, Jonathan M.] Univ Texas SW Med Ctr, Dept Dev Biol, Dallas, TX 75390 USA; [Graff, Jonathan M.] Univ Texas SW Med Ctr, Dept Mol Biol, Dallas, TX USA; [Graff, Jonathan M.] Univ Texas SW Med Ctr, Dept Internal Med, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Graff, JM (corresponding author), Univ Texas SW Med Ctr, Dept Dev Biol, Dallas, TX 75390 USA.	Jon.Graff@utsouthwestern.edu	Suh, Jae Myoung/B-3268-2015	Suh, Jae Myoung/0000-0001-8097-4662	NIH NIDDK	NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by awards to JMG from the NIH and the NIDDK.	Arrese EL, 2001, INSECT BIOCHEM MOLEC, V31, P7, DOI 10.1016/S0965-1748(00)00102-8; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Barzilai N, 2001, J NUTR, V131, p903S, DOI 10.1093/jn/131.3.903S; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beinert N, 2004, CHROMOSOMA, V113, P271, DOI 10.1007/s00412-004-0313-5; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Carlton J, 2005, TRAFFIC, V6, P75, DOI 10.1111/j.1600-0854.2005.00260.x; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; DAVID J, 1975, EXP GERONTOL, V10, P17, DOI 10.1016/0531-5565(75)90011-X; ECONOMOS AC, 1979, MECH AGEING DEV, V10, P233, DOI 10.1016/0047-6374(79)90037-X; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Gullapalli A, 2004, MOL BIOL CELL, V15, P2143, DOI 10.1091/mbc.E03-09-0711; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Haft CR, 1998, MOL CELL BIOL, V18, P7278, DOI 10.1128/MCB.18.12.7278; Helfand SL, 2003, ANNU REV GENET, V37, P329, DOI 10.1146/annurev.genet.37.040103.095211; Holliday R, 2006, ANN NY ACAD SCI, V1067, P1, DOI 10.1196/annals.1354.002; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Mollereau B, 2000, MECH DEVELOP, V93, P151, DOI 10.1016/S0925-4773(00)00287-2; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Picard F, 2005, INT J OBESITY, V29, pS36, DOI 10.1038/sj.ijo.0802912; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; ROSE MR, 1992, EXP GERONTOL, V27, P241, DOI 10.1016/0531-5565(92)90048-5; ROSEMAN RR, 1995, GENETICS, V141, P1061; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Suh JM, 2007, CELL METAB, V6, P195, DOI 10.1016/j.cmet.2007.08.001; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Summers SA, 2000, INT J OBESITY, V24, pS67, DOI 10.1038/sj.ijo.0801509; TAKASUISHIKAWA E, 1992, MOL GEN GENET, V232, P17, DOI 10.1007/BF00299132; Toivonen JM, 2007, PLOS GENET, V3, P973, DOI 10.1371/journal.pgen.0030095; Tong JJY, 2007, NAT GENET, V39, P476, DOI 10.1038/ng2004; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Xie GX, 2007, J MOL BIOL, V366, P349, DOI 10.1016/j.jmb.2006.11.045; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757; Zhong Q, 2002, P NATL ACAD SCI USA, V99, P6767, DOI 10.1073/pnas.092142699	64	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2152	10.1371/journal.pone.0002152	http://dx.doi.org/10.1371/journal.pone.0002152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478054	Green Published, gold, Green Submitted			2022-12-27	WOS:000262172800017
J	Bakkum, DJ; Chao, ZC; Potter, SM				Bakkum, Douglas J.; Chao, Zenas C.; Potter, Steve M.			Long-Term Activity-Dependent Plasticity of Action Potential Propagation Delay and Amplitude in Cortical Networks	PLOS ONE			English	Article								Background: The precise temporal control of neuronal action potentials is essential for regulating many brain functions. From the viewpoint of a neuron, the specific timings of afferent input from the action potentials of its synaptic partners determines whether or not and when that neuron will fire its own action potential. Tuning such input would provide a powerful mechanism to adjust neuron function and in turn, that of the brain. However, axonal plasticity of action potential timing is counter to conventional notions of stable propagation and to the dominant theories of activity-dependent plasticity focusing on synaptic efficacies. Methodology/Principal Findings: Here we show the occurrence of activity-dependent plasticity of action potential propagation delays ( up to 4 ms or 40% after minutes and 13 ms or 74% after hours) and amplitudes ( up to 87%). We used a multi-electrode array to induce, detect, and track changes in propagation in multiple neurons while they adapted to different patterned stimuli in controlled neocortical networks in vitro. The changes did not occur when the same stimulation was repeated while blocking ionotropic gabaergic and glutamatergic receptors. Even though induction of changes in action potential timing and amplitude depended on synaptic transmission, the expression of these changes persisted in the presence of the synaptic receptor blockers. Conclusions/Significance: We conclude that, along with changes in synaptic efficacy, propagation plasticity provides a cellular mechanism to tune neuronal network function in vitro and potentially learning and memory in the brain.	[Bakkum, Douglas J.; Chao, Zenas C.; Potter, Steve M.] Georgia Inst Technol, Coulter Dept Biomed Engn, Lab Neuroengn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Bakkum, DJ (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, Lab Neuroengn, Atlanta, GA 30332 USA.	steve.potter@bme.gatech.edu			National Institutes of Health (NIH)-National Institute of Neurological Disorders and Stroke [NS38628]; NIH-National Institute of Biomedical Imaging and Bioengineering [EB00786]; ArtsWA; Whitaker Foundation; National Science Foundation Center for Behavioral Neuroscience; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038628] Funding Source: NIH RePORTER	National Institutes of Health (NIH)-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); ArtsWA; Whitaker Foundation; National Science Foundation Center for Behavioral Neuroscience; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH)-National Institute of Neurological Disorders and Stroke Grants NS38628, NIH-National Institute of Biomedical Imaging and Bioengineering Grant EB00786, ArtsWA, the Whitaker Foundation, and the National Science Foundation Center for Behavioral Neuroscience.	Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Anderson JC, 2002, J NEUROCYTOL, V31, P211, DOI 10.1023/A:1024113707630; Bakkum DJ, 2004, EMBODIED ARTIFICIAL; Bakkum Douglas J, 2007, Front Neurorobot, V1, P5, DOI 10.3389/neuro.12.005.2007; Baruchi I, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.050901; BEDLACK RS, 1994, NEURON, V13, P1187, DOI 10.1016/0896-6273(94)90056-6; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Carp JS, 2001, EXP BRAIN RES, V136, P269, DOI 10.1007/s002210000608; CHAO ZC, 2008, PLOS COMP B IN PRESS; Chao ZC, 2007, J NEURAL ENG, V4, P294, DOI 10.1088/1741-2560/4/3/015; Clark B, 2006, CURR BIOL, V16, pR585, DOI 10.1016/j.cub.2006.07.007; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; Darbon P, 2002, EUR J NEUROSCI, V15, P671, DOI 10.1046/j.1460-9568.2002.01904.x; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Eurich CW, 1999, PHYS REV LETT, V82, P1594, DOI 10.1103/PhysRevLett.82.1594; Faisal AA, 2007, PLOS COMPUT BIOL, V3, P783, DOI 10.1371/journal.pcbi.0030079; Fields RD, 2005, NEUROSCIENTIST, V11, P528, DOI 10.1177/1073858405282304; Foss J, 2000, J NEUROPHYSIOL, V84, P975, DOI 10.1152/jn.2000.84.2.975; Ganguly K, 2000, NAT NEUROSCI, V3, P1018, DOI 10.1038/79838; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; HALTER JA, 1995, J NEUROPHYSIOL, V73, P867, DOI 10.1152/jn.1995.73.2.867; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; Kawaguchi H, 1998, EXP BRAIN RES, V122, P378, DOI 10.1007/s002210050526; Latham PE, 2000, J NEUROPHYSIOL, V83, P828, DOI 10.1152/jn.2000.83.2.828; LIPSKI J, 1981, J NEUROSCI METH, V4, P1, DOI 10.1016/0165-0270(81)90015-7; Ma JF, 2007, NEURAL COMPUT, V19, P2124, DOI 10.1162/neco.2007.19.8.2124; MANOR Y, 1991, BIOPHYS J, V60, P1424, DOI 10.1016/S0006-3495(91)82179-8; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; McIntyre CC, 2000, ANN BIOMED ENG, V28, P219, DOI 10.1114/1.262; Milton JG, 2000, J PHYSIOL-PARIS, V94, P489, DOI 10.1016/S0928-4257(00)01102-5; Nakanishi K, 1998, BRAIN RES, V795, P137, DOI 10.1016/S0006-8993(98)00283-2; Patolsky F, 2006, SCIENCE, V313, P1100, DOI 10.1126/science.1128640; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; POTTER SM, 2006, ADV NETWORK ELECTROP; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; SIK A, 1995, J NEUROSCI, V15, P6651; SUGIHARA I, 1993, J PHYSIOL-LONDON, V470, P243, DOI 10.1113/jphysiol.1993.sp019857; Suzuki I, 2007, BIOCHEM BIOPH RES CO, V356, P470, DOI 10.1016/j.bbrc.2007.03.006; SWADLOW HA, 1985, J NEUROPHYSIOL, V54, P1346, DOI 10.1152/jn.1985.54.5.1346; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Wagenaar D. A., 2005, IEEE EMBS C NEUR ENG; Wagenaar DA, 2004, J NEUROSCI METH, V138, P27, DOI 10.1016/j.jneumeth.2004.03.005; Wagenaar DA, 2002, J NEUROSCI METH, V120, P113, DOI 10.1016/S0165-0270(02)00149-8; Wagenaar DA, 2004, J NEURAL ENG, V1, DOI 10.1088/1741-2560/1/1/006; WAXMAN SG, 1972, NATURE-NEW BIOL, V238, P217, DOI 10.1038/newbio238217a0; Waxman SG, 1997, CURR BIOL, V7, pR406, DOI 10.1016/S0960-9822(06)00203-X; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Xu J, 2005, J NEUROSCI, V25, P1750, DOI 10.1523/JNEUROSCI.4217-04.2005; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	57	77	77	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2088	10.1371/journal.pone.0002088	http://dx.doi.org/10.1371/journal.pone.0002088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461127	gold, Green Published, Green Submitted			2022-12-27	WOS:000261642400011
J	Rudick, CN; Bryce, PJ; Guichelaar, LA; Berry, RE; Klumpp, DJ				Rudick, Charles N.; Bryce, Paul J.; Guichelaar, Laura A.; Berry, Ruth E.; Klumpp, David J.			Mast Cell-Derived Histamine Mediates Cystitis Pain	PLOS ONE			English	Article								Background: Mast cells trigger inflammation that is associated with local pain, but the mechanisms mediating pain are unclear. Interstitial cystitis (IC) is a bladder disease that causes debilitating pelvic pain of unknown origin and without consistent inflammation, but IC symptoms correlate with elevated bladder lamina propria mast cell counts. We hypothesized that mast cells mediate pelvic pain directly and examined pain behavior using a murine model that recapitulates key aspects of IC. Methods and Findings: Infection of mice with pseudorabies virus (PRV) induces a neurogenic cystitis associated with lamina propria mast cell accumulation dependent upon tumor necrosis factor alpha (TNF), TNF-mediated bladder barrier dysfunction, and pelvic pain behavior, but the molecular basis for pelvic pain is unknown. In this study, both PRV-induced pelvic pain and bladder pathophysiology were abrogated in mast cell-deficient mice but were restored by reconstitution with wild type bone marrow. Pelvic pain developed normally in TNF-and TNF receptor-deficient mice, while bladder pathophysiology was abrogated. Conversely, genetic or pharmacologic disruption of histamine receptor H1R or H2R attenuated pelvic pain without altering pathophysiology. Conclusions: These data demonstrate that mast cells promote cystitis pain and bladder pathophysiology through the separable actions of histamine and TNF, respectively. Therefore, pain is independent of pathology and inflammation, and histamine receptors represent direct therapeutic targets for pain in IC and other chronic pain conditions.	[Rudick, Charles N.; Guichelaar, Laura A.; Berry, Ruth E.; Klumpp, David J.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Klumpp, David J.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL USA; [Bryce, Paul J.] Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Rudick, CN (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.	d-klumpp@northwestern.edu			NIDDK [R01DK066112, T32DK062716-05]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK062716, R01DK066112] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK R01DK066112 (D.J.K.) and T32DK062716-05 (C.N.R.).	Barbara G, 2004, GASTROENTEROLOGY, V126, P693, DOI 10.1053/j.gastro.2003.11.055; Barbara G, 2007, GASTROENTEROLOGY, V132, P26, DOI 10.1053/j.gastro.2006.11.039; Berkley KJ, 2005, SCIENCE, V308, P1587, DOI 10.1126/science.1111445; BOUCHER W, 1995, BRIT J UROL, V76, P94, DOI 10.1111/j.1464-410X.1995.tb07840.x; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen MC, 2006, J UROLOGY, V175, P754, DOI 10.1016/S0022-5347(05)00171-0; Chen MC, 2007, AM J PHYSIOL-RENAL, V292, pF1372, DOI 10.1152/ajprenal.00472.2006; Chen MC, 2006, AM J PHYSIOL-RENAL, V291, pF741, DOI 10.1152/ajprenal.00081.2006; Dasgupta P, 2001, BJU INT, V88, P183, DOI 10.1046/j.1464-410x.2001.02258.x; Doggweiler R, 1998, J UROLOGY, V160, P1551, DOI 10.1016/S0022-5347(01)62611-9; Dozmorov I, 2003, PHYSIOL GENOMICS, V12, P239, DOI 10.1152/physiolgenomics.00141.2002; Dunford PJ, 2006, J IMMUNOL, V176, P7062, DOI 10.4049/jimmunol.176.11.7062; Elbadawi A, 1997, UROLOGY, V49, P14, DOI 10.1016/S0090-4295(99)80329-X; ELMANSOURY M, 1994, J UROLOGY, V152, P350, DOI 10.1016/S0022-5347(17)32737-4; Fang X, 2006, J NEUROSCI, V26, P7281, DOI 10.1523/JNEUROSCI.1072-06.2006; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Guerios SD, 2006, NEUROSCI LETT, V392, P193, DOI 10.1016/j.neulet.2005.09.026; HANNO P, 2007, CAMPBELLWALSH UROLOG, P631; Hwang SJ, 2005, BRAIN RES, V1062, P86, DOI 10.1016/j.brainres.2005.09.026; Jasmin L, 1998, J NEUROSCI, V18, P10016; Jasmin L, 2000, J UROLOGY, V164, P852, DOI 10.1016/S0022-5347(05)67326-0; Jones CA, 1997, UROLOGY, V49, P2, DOI 10.1016/S0090-4295(99)80327-6; Laird JMA, 2001, PAIN, V92, P335, DOI 10.1016/S0304-3959(01)00275-5; Laird JMA, 2002, J NEUROSCI, V22, P8352; Leiby BE, 2007, J UROLOGY, V177, P142, DOI 10.1016/j.juro.2006.08.096; Mobarakeh JI, 2006, NEUROPHARMACOLOGY, V51, P612, DOI 10.1016/j.neuropharm.2006.05.003; Mobarakeh JI, 2000, EUR J PHARMACOL, V391, P81, DOI 10.1016/S0014-2999(00)00060-1; Mukerji Gaurav, 2006, BMC Urol, V6, P6, DOI 10.1186/1471-2490-6-6; Mukerji G, 2006, J UROLOGY, V176, P797, DOI 10.1016/j.juro.2006.03.074; Novi JM, 2005, J UROLOGY, V174, P937, DOI 10.1097/01.ju.0000169258.31345.5d; PARSONS CL, 1994, NEUROUROL URODYNAM, V13, P515, DOI 10.1002/nau.1930130503; Rudick CN, 2007, AM J PHYSIOL-REG I, V293, pR1191, DOI 10.1152/ajpregu.00411.2007; Ruscheweyh R, 2007, J COMP NEUROL, V502, P325, DOI 10.1002/cne.21311; Saban R, 2002, AM J PHYSIOL-RENAL, V283, pF616, DOI 10.1152/ajprenal.00096.2002; Sant GR, 2003, J UROLOGY, V170, P810, DOI 10.1097/01.ju.0000083020.06212.3d; SIMONE DA, 1991, SOMATOSENS MOT RES, V8, P271, DOI 10.3109/08990229109144750; Sturge WA, 1883, BRAIN, V5, P492, DOI [10.1093/brain/5.4.492, DOI 10.1093/BRAIN/5.4.492]; Thilagarajah R, 2001, BJU INT, V87, P207, DOI 10.1046/j.1464-410x.2001.02031.x; Tomaszewski JE, 2001, UROLOGY, V57, P67, DOI 10.1016/S0090-4295(01)01166-9; Tsai M, 2005, CHEM IMMUNOL ALLERGY, V87, P179, DOI 10.1159/000087644; Ustinova EE, 2007, AM J PHYSIOL-RENAL, V292, pF123, DOI 10.1152/ajprenal.00162.2006; Wesselmann U, 2001, WORLD J UROL, V19, P180, DOI 10.1007/s003450100201; Winnard KP, 2006, AM J PHYSIOL-REG I, V291, pR1592, DOI 10.1152/ajpregu.00455.2006; Xu XA, 2006, J EXP MED, V203, P2907, DOI 10.1084/jem.20061232; Yu S, 2007, AM J PHYSIOL-GASTR L, V293, pG850, DOI 10.1152/ajpgi.00277.2007	45	76	81	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2096	10.1371/journal.pone.0002096	http://dx.doi.org/10.1371/journal.pone.0002096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461160	Green Published, Green Submitted, gold			2022-12-27	WOS:000261642400018
J	Stevens, W; Kamali, A; Karita, E; Anzala, O; Sanders, EJ; Jaoko, W; Kaleebu, P; Mulenga, J; Dally, L; Fast, P; Gilmour, J; Farah, B; Birungi, J; Hughes, P; Manigart, O; Stevens, G; Yates, S; Thomson, H; von Lieven, A; Krebs, M; Price, MA; Stoll-Johnson, L; Ketter, N				Stevens, Wendy; Kamali, Anatoli; Karita, Etienne; Anzala, Omu; Sanders, Eduard J.; Jaoko, Walter; Kaleebu, Pontiano; Mulenga, Joseph; Dally, Len; Fast, Pat; Gilmour, Jill; Farah, Bashir; Birungi, Josephine; Hughes, Peter; Manigart, Olivier; Stevens, Gwynn; Yates, Sarah; Thomson, Helen; von Lieven, Andrea; Krebs, Marietta; Price, Matt A.; Stoll-Johnson, Lisa; Ketter, Nzeera			Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials	PLOS ONE			English	Article							IMMUNOHEMATOLOGICAL REFERENCE RANGES; HEPATITIS-C-VIRUS; COUNT; NEUTROPENIA; CHILDREN; UGANDA; SEX	Background: An understanding of the health of potential volunteers in Africa is essential for the safe and efficient conduct of clinical trials, particularly for trials of preventive technologies such as vaccines that enroll healthy individuals. Clinical safety laboratory values used for screening, enrolment and follow-up of African clinical trial volunteers have largely been based on values derived from industrialized countries in Europe and North America. This report describes baseline morbidity during recruitment for a multi-center, African laboratory reference intervals study. Methods: Asymptomatic persons, aged 18-60 years, were invited to participate in a cross-sectional study at seven sites (Kigali, Rwanda; Masaka and Entebbe, Uganda; Kangemi, Kenyatta National Hospital and Kilifi, Kenya; and Lusaka, Zambia). Gender equivalency was by design. Individuals who were acutely ill, pregnant, menstruating, or had significant clinical findings were not enrolled. Each volunteer provided blood for hematology, immunology, and biochemistry parameters and urine for urinalysis. Enrolled volunteers were excluded if found to be positive for HIV, syphilis or Hepatitis B and C. Laboratory assays were conducted under Good Clinical Laboratory Practices (GCLP). Results and Conclusions: Of the 2990 volunteers who were screened, 2387 (80%) were enrolled, and 2107 (71%) were included in the analysis (52% men, 48% women). Major reasons for screening out volunteers included abnormal findings on physical examination (228/603, 38%), significant medical history (76, 13%) and inability to complete the informed consent process (73, 13%). Once enrolled, principle reasons for exclusion from analysis included detection of Hepatitis B surface antigen (106/280, 38%) and antibodies against Hepatitis C (95, 34%). This is the first large scale, multi-site study conducted to the standards of GCLP to describe African laboratory reference intervals applicable to potential volunteers in clinical trials. Approximately one-third of all potential volunteers screened were not eligible for analysis; the majority were excluded for medical reasons.	[Stevens, Wendy] Univ Witwatersrand, Contract Lab Serv CLS, Johannesburg, South Africa; [Kamali, Anatoli; Kaleebu, Pontiano; Hughes, Peter] Uganda Virus Res Inst UVRI, Unit on AIDS, Med Res Council MRC, Entebbe, Uganda; [Karita, Etienne] Projet San Francisco PSF, Kigali, Rwanda; [Anzala, Omu; Jaoko, Walter; Farah, Bashir] Kenyatta Natl Hosp & Kangemi, Kenya AIDS Vaccine Initiative KAVI, Nairobi, Kenya; [Sanders, Eduard J.] Kenya Med Res Inst KEMRI, Ctr Geograph Med Res Coast CGMRC, Kilifi, Kenya; [Mulenga, Joseph; Manigart, Olivier] Zambia Emory HIV Res Project ZEHRP, Lusaka, Zambia; [Dally, Len] The EMMES Corp, Washington, DC USA; [Fast, Pat; Gilmour, Jill; Stevens, Gwynn; Yates, Sarah; Thomson, Helen; von Lieven, Andrea; Krebs, Marietta; Price, Matt A.] Int AIDS Vaccine Initiative IAVI, New York, NY USA; [Birungi, Josephine] Uganda Virus Res Inst UVRI, IAVI, HIV Vaccine Program, Entebbe, Uganda; [Stoll-Johnson, Lisa] Novartis, Boston, MA USA; [Ketter, Nzeera] Johnson & Johnson, New Brunswick, NJ USA	University of Witwatersrand; Kenyatta National Hospital; Kenya Medical Research Institute; Emmes Corporation; International AIDS Vaccine Initiative; International AIDS Vaccine Initiative; Novartis; Johnson & Johnson; Johnson & Johnson USA	Stevens, W (corresponding author), Univ Witwatersrand, Contract Lab Serv CLS, Johannesburg, South Africa.	mprice@iavi.org	Jaoko, Walter/AAN-5048-2020; Price, Matt/AAK-6881-2021	Price, Matt/0000-0002-2918-1373; Jaoko, Walter/0000-0002-7134-6581	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	Funding was from the United States Agency for International Development (USAID). The study sponsor, IAVI, designed the study, data collection analysis and interpretation was done in concert with the site investigators.	Aboul-Hassan Samir, 1997, Journal of the Egyptian Society of Parasitology, V27, P47; AZIKIWE AN, 1984, E AFR MED J, V61, P482; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Bedu-Addo G, 2002, LANCET, V360, P449, DOI 10.1016/S0140-6736(02)09680-0; BEIGHTON P, 1974, ANN RHEUM DIS, V33, P442, DOI 10.1136/ard.33.5.442; Biggar RJ, 2006, EMERG INFECT DIS, V12, P1440, DOI 10.3201/eid1209.041068; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Booth M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-13; BRICKMAN AS, 1993, AM J HYPERTENS, V6, P46, DOI 10.1093/ajh/6.1.46; Excler JL, 2000, J HUMAN VIROL, V3, P193; EZEILO GC, 1972, LANCET, V2, P1003; FAST PE, 2007, AIDS VACCINE DEV CHA, P87; GILL GV, 1979, T ROY SOC TROP MED H, V73, P111, DOI 10.1016/0035-9203(79)90142-1; Gilmour JW, 2007, CURR OPIN HIV AIDS, V2, P201, DOI 10.1097/COH.0b013e3280eec77a; GLENNCROSS D, 2005, RESULTS WHO NHLS QAS; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Kasili E G, 1969, East Afr Med J, V46, P676; KOH ET, 1980, AM J CLIN NUTR, V33, P1828, DOI 10.1093/ajcn/33.8.1828; Lugada ES, 2004, SCAND J IMMUNOL, V59, P203, DOI 10.1111/j.0300-9475.2004.01376.x; MALONE JL, 1990, J ACQ IMMUN DEF SYND, V3, P144; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; National Committee on Clinical Laboratory Standards (NCCLS), 2000, C28A2 NCCLS, V20; Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016; SEEDAT YK, 1981, S AFR MED J, V60, P7; SHAPER AG, 1971, LANCET, V2, P1021; Stiles T, 2003, GOOD CLIN LAB PRACTI; Tess BH, 2000, AM J TROP MED HYG, V62, P138, DOI 10.4269/ajtmh.2000.62.138; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; TUGUME SB, 1995, CLIN DIAGN LAB IMMUN, V2, P233, DOI 10.1128/CDLI.2.2.233-235.1995; UNAIDS, 2006, REP GLOB AIDS EP; Van Rooyen J. M., 2002, Ethnicity and Disease, V12, P69	31	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2043	10.1371/journal.pone.0002043	http://dx.doi.org/10.1371/journal.pone.0002043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446196	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000261572300015
J	Cheng, C; Li, LM				Cheng, Chao; Li, Lei M.			Inferring MicroRNA Activities by Combining Gene Expression with MicroRNA Target Prediction	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL REGULATION; SYSTEMATIC IDENTIFICATION; TRANSCRIPTION FACTORS; LET-7; INVOLVEMENT; PROFILES; GENOMICS; DATABASE; MIRNAS; TOOLS	Background: MicroRNAs (miRNAs) play crucial roles in a variety of biological processes via regulating expression of their target genes at the mRNA level. A number of computational approaches regarding miRNAs have been proposed, but most of them focus on miRNA gene finding or target predictions. Little computational work has been done to investigate the effective regulation of miRNAs. Methodology/Principal Findings: We propose a method to infer the effective regulatory activities of miRNAs by integrating microarray expression data with miRNA target predictions. The method is based on the idea that regulatory activity changes of miRNAs could be reflected by the expression changes of their target transcripts measured by microarray. To validate this method, we apply it to the microarray data sets that measure gene expression changes in cell lines after transfection or inhibition of several specific miRNAs. The results indicate that our method can detect activity enhancement of the transfected miRNAs as well as activity reduction of the inhibited miRNAs with high sensitivity and specificity. Furthermore, we show that our inference is robust with respect to false positives of target prediction. Conclusions/Significance: A huge amount of gene expression data sets are available in the literature, but miRNA regulation underlying these data sets is largely unknown. The method is easy to be implemented and can be used to investigate the miRNA effective regulation underlying the expression change profiles obtained from microarray experiments.	[Cheng, Chao; Li, Lei M.] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA; [Li, Lei M.] Univ So Calif, Dept Math, Los Angeles, CA USA	University of Southern California; University of Southern California	Li, LM (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.	lilei@usc.edu	Li, Lei M/C-7196-2009	Li, Lei M/0000-0002-6571-1079	NIH [R01 GM75308-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075308] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work is supported by the NIH grant R01 GM75308-01.	Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen PY, 2005, BIOL CHEM, V386, P1205, DOI 10.1515/BC.2005.139; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheng C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-116; Cheng C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-452; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dugas DV, 2004, CURR OPIN PLANT BIOL, V7, P512, DOI 10.1016/j.pbi.2004.07.011; Enright AJ, 2004, GENOME BIOL, V5; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; VOLINIA S, 2006, P NATL; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P152, DOI 10.1093/nar/gkl1032	49	83	89	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1989	10.1371/journal.pone.0001989	http://dx.doi.org/10.1371/journal.pone.0001989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431476	Green Published, Green Submitted, gold			2022-12-27	WOS:000261558700011
J	Kawakami, R; Dobi, A; Shigemoto, R; Ito, I				Kawakami, Ryosuke; Dobi, Alice; Shigemoto, Ryuichi; Ito, Isao			Right Isomerism of the Brain in Inversus Viscerum Mutant Mice	PLOS ONE			English	Article								Left-right (L-R) asymmetry is a fundamental feature of higher-order neural function. However, the molecular basis of brain asymmetry remains unclear. We recently reported L-R asymmetry of hippocampal circuitry caused by differential allocation of N-methyl-D-aspartate receptor (NMDAR) subunit GluR epsilon 2 (NR2B) in hippocampal synapses. Using electrophysiology and immunocytochemistry, here we analyzed the hippocampal circuitry of the inversus viscerum (iv) mouse that has a randomized laterality of internal organs. The iv mouse hippocampus lacks L-R asymmetry, it exhibits right isomerism in the synaptic distribution of the epsilon 2 subunit, irrespective of the laterality of visceral organs. This independent right isomerism of the hippocampus is the first evidence that a distinct mechanism downstream of the iv mutation generates brain asymmetry.	[Kawakami, Ryosuke; Ito, Isao] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Kawakami, Ryosuke; Dobi, Alice; Shigemoto, Ryuichi] Grad Univ Advanced Stud, Sch Life Sci, Natl Inst Physiol Sci, Div Cerebral Structure, Okazaki, Aichi, Japan; [Shigemoto, Ryuichi] Japan Sci & Technol Agcy, Solution Oriented Res Sci & Technol, Kawaguchi, Japan	Kyushu University; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST)	Ito, I (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.	isitoscb@mbox.nc.kyushu-u.ac.jp	Kawakami, Ryosuke/AAU-6087-2020; 良介, 川上/E-2029-2012; Shigemoto, Ryuichi/E-3628-2013	Shigemoto, Ryuichi/0000-0001-8761-9444	Solution Oriented Research or Science and Technology from the Japan Science and Technology Corporation; Brain Science Foundation; Yamada Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [19300114, 17021032, 18019030, 16300101]; Grant-in-Aid for JSPS Fellows; Cooperative Study Program of National Institute for Physiological Sciences	Solution Oriented Research or Science and Technology from the Japan Science and Technology Corporation; Brain Science Foundation; Yamada Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant-in-Aid for JSPS Fellows(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cooperative Study Program of National Institute for Physiological Sciences	This work was supported by Solution Oriented Research or Science and Technology from the Japan Science and Technology Corporation (R.S. and I.I.), the Brain Science Foundation (I.I.), the Yamada Science Foundation (I.I.), Grant-in-Aid for Scientific Research Grants 19300114 (R.S.), 17021032, 18019030, 16300101 (I.I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grant-in-Aid for JSPS Fellows (R.K.), and the Cooperative Study Program of National Institute for Physiological Sciences.	Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Chizh BA, 2001, TRENDS PHARMACOL SCI, V22, P636, DOI 10.1016/S0165-6147(00)01863-0; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hummel K. P., 1959, Journal of Heredity, V50, P9; Ito I, 1996, NEUROSCI LETT, V203, P69, DOI 10.1016/0304-3940(95)12258-3; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Matsubara A, 1996, J NEUROSCI, V16, P4457; Mutel V, 1998, J NEUROCHEM, V70, P2147; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Nusser Z, 1998, J NEUROSCI, V18, P1693; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; ROGERS LJ, 1988, EXP BRAIN RES, V70, P378; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; Supp DM, 1999, DEVELOPMENT, V126, P5495; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Wu Y, 2005, J NEUROSCI, V25, P9213, DOI 10.1523/JNEUROSCI.2134-05.2005	24	33	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1945	10.1371/journal.pone.0001945	http://dx.doi.org/10.1371/journal.pone.0001945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414654	Green Published, Green Submitted, gold			2022-12-27	WOS:000260867300003
J	Syme, AE; Poore, GCB				Syme, Anna E.; Poore, Gary C. B.			A Supplementary Description of Cypridina mariae and Rediagnosis of the Genus Cylindroleberis (Ostracoda: Myodocopa: Cylindroleberididae)	PLOS ONE			English	Article							CRUSTACEA	The ostracod family Cylindroleberididae is based on the genus Cylindroleberis Brady, 1868, and has a complicated nomenclatural history. The type species of Cylindroleberis is Cypridina mariae Baird, 1850. Baird described only the carapace, which had been considered lost. Thus, there was no reference point for the concept C. mariae or the genus Cylindroleberis. Baird's material has now been found in the Natural History Museum, London, U. K., and is illustrated here. To clarify the taxonomic status of C. mariae and Cylindroleberis, specimens were obtained from near the type locality, and a supplementary description is presented. This includes description of appendages, particularly the first antenna and mandible, which contain important diagnostic characters. This supplementary description provides important information about C. mariae, allowing a revision of the genus Cylindroleberis, and establishing a framework for future biological research on this ostracod group.	[Syme, Anna E.; Poore, Gary C. B.] Victoria & Albert Museum, Melbourne, Vic, Australia		Syme, AE (corresponding author), Victoria & Albert Museum, Melbourne, Vic, Australia.	asyme@museum.vic.gov.au		Syme, Anna/0000-0002-9906-0673				Baird W., 1850, P ZOOL SOC LONDON, V18, P254; Brady G.S., 1896, SCI T ROYAL DUBLIN S, V5, P621; Brady G. S., 1868, INTELLECTUAL OBSERVE, V12, P110; BRADY GS, 1868, T LINN SOC LOND, V26, P353, DOI DOI 10.1111/J.1096-3642.1968.TB00199.X; BRADY GS, 1871, P ZOO SOC LOND, V19, P289; Corbari L, 2005, J EXP BIOL, V208, P661, DOI 10.1242/jeb.01427; Cushman Joseph A., 1906, Boston Proc Soc Nat Hist, V32, P359; HARTMANN G, 1984, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V81, P117; Juday C., 1907, U CALIFORNIA PUBLICA, V3, P135; JUDAY CH, 1906, U CAL PUBL ZOOL, V3; Kornicker L., 1992, SMITHSONIAN CONTRIBU, V531, P1; Kornicker L.S., 1974, Smithsonian Contributions to Zoology, VNo. 178, P1; Kornicker L. S., 1970, Smithson. Contr. Zool., VNo. 39, P1; Kornicker L.S., 1975, Smithsonian Contributions to Zoology, VNo. 163, P1; Kornicker L. S., 1981, SMITHSONIAN CONTRIBU, V319, P1; KORNICKER LS, 1991, SMITHSONIAN CONTRIBU, V505, P1; Kornicker LS, 1976, SMITHSONIAN CONTRIBU, V214, P1; Kornicker LS, 1974, SMITHSON CONTRIB ZOO, V179, P78; MULLER GW, 1912, TIERREICH, V31, pR33; Muller GW, 1906, SIBOGA EXPEDITION, V30; Oakley TH, 2005, HYDROBIOLOGIA, V538, P179, DOI 10.1007/s10750-004-4961-5; PHILIPPI A, 1840, ARCH NATURGESCHICTE, V6, P186; Poulsen EM, 1965, DANA REPORTS; Skogsberg T., 1920, ZOOLOGISKA BIDRAG FR, V1, P784; STRAND EMBRIK, 1928, ARCH NATURGESCH ABT A, V92, P30; Sylvester-Bradley P. C, 1961, TREATISE INVERTEBR Q, P387; Syme AE, 2006, ZOOTAXA, P51, DOI 10.11646/zootaxa.1305.1.5; Syme Anna E., 2006, Museum Victoria Science Reports, V9, P1	28	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1960	10.1371/journal.pone.0001960	http://dx.doi.org/10.1371/journal.pone.0001960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414661	Green Published, gold			2022-12-27	WOS:000260867300010
J	Wasserstrom, A; Adar, R; Shefer, G; Frumkin, D; Itzkovitz, S; Stern, T; Shur, I; Zangi, L; Kaplan, S; Harmelin, A; Reisner, Y; Benayahu, D; Tzahor, E; Segal, E; Shapiro, E				Wasserstrom, Adam; Adar, Rivka; Shefer, Gabi; Frumkin, Dan; Itzkovitz, Shalev; Stern, Tomer; Shur, Irena; Zangi, Lior; Kaplan, Shai; Harmelin, Alon; Reisner, Yair; Benayahu, Dafna; Tzahor, Eldad; Segal, Eran; Shapiro, Ehud			Reconstruction of Cell Lineage Trees in Mice	PLOS ONE			English	Article							DNA MISMATCH-REPAIR; SELF-RENEWAL; BONE-MARROW; FATE; PROGENITORS; POPULATION; NEMATODE	The cell lineage tree of a multicellular organism represents its history of cell divisions from the very first cell, the zygote. A new method for high-resolution reconstruction of parts of such cell lineage trees was recently developed based on phylogenetic analysis of somatic mutations accumulated during normal development of an organism. In this study we apply this method in mice to reconstruct the lineage trees of distinct cell types. We address for the first time basic questions in developmental biology of higher organisms, namely what is the correlation between the lineage relation among cells and their (1) function, (2) physical proximity and (3) anatomical proximity. We analyzed B-cells, kidney-, mesenchymal- and hematopoietic-stem cells, as well as satellite cells, which are adult skeletal muscle stem cells isolated from their niche on the muscle fibers (myofibers) from various skeletal muscles. Our results demonstrate that all analyzed cell types are intermingled in the lineage tree, indicating that none of these cell types are single exclusive clones. We also show a significant correlation between the physical proximity of satellite cells within muscles and their lineage. Furthermore, we show that satellite cells obtained from a single myofiber are significantly clustered in the lineage tree, reflecting their common developmental origin. Lineage analysis based on somatic mutations enables performing high resolution reconstruction of lineage trees in mice and humans, which can provide fundamental insights to many aspects of their development and tissue maintenance.	[Wasserstrom, Adam; Adar, Rivka; Frumkin, Dan; Kaplan, Shai; Shapiro, Ehud] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Itzkovitz, Shalev; Stern, Tomer; Segal, Eran; Shapiro, Ehud] Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel; [Shur, Irena; Zangi, Lior; Reisner, Yair; Tzahor, Eldad] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Harmelin, Alon] Weizmann Inst Sci, Dept Vet Resources, Rehovot, Israel; [Shefer, Gabi; Benayahu, Dafna] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, Tel Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine	Wasserstrom, A (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Ehud.Shapiro@weizmann.ac.il	Segal, Eran/AAF-4855-2019; Reisner, Yair/AAA-4772-2019; TZAHOR, ELDAD/AAD-9886-2021	Segal, Eran/0000-0002-6859-1164; Reisner, Yair/0000-0002-3354-6945; Stern, Tomer/0000-0003-4279-3558	Israel Academy of Science and Humanities (Bikura); Yeshaya Horowitz association through the center for Complexity Science; Kenneth and Sally Leafman Appelbaum Discovery Fund; Estate of Karl Felix Jakubskind; Clore Center for Biological Physics; Louis Chor Memorial Trust	Israel Academy of Science and Humanities (Bikura); Yeshaya Horowitz association through the center for Complexity Science; Kenneth and Sally Leafman Appelbaum Discovery Fund; Estate of Karl Felix Jakubskind; Clore Center for Biological Physics; Louis Chor Memorial Trust	This research was supported by The Israel Academy of Science and Humanities (Bikura), by The Yeshaya Horowitz association through the center for Complexity Science, by The Research Grant from Dr. Mordecai Roshwald, by The Grant from Kenneth and Sally Leafman Appelbaum Discovery Fund, by The Estate of Karl Felix Jakubskind, by The Clore Center for Biological Physics, and by a Research Grant from The Louis Chor Memorial Trust.	Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; BENAYAHU D, 1991, CALCIFIED TISSUE INT, V49, P202, DOI 10.1007/BF02556119; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; CHISHOLM A, 2000, ENCY GENETICS; Clarke JDW, 1999, NAT CELL BIOL, V1, pE103, DOI 10.1038/12105; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Collins CA, 2005, CELL CYCLE, V4, P1338, DOI 10.4161/cc.4.10.2114; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; Dekel B, 2006, J AM SOC NEPHROL, V17, P3300, DOI 10.1681/ASN.2005020195; DEKEL N, 1988, ANN NY ACAD SCI, V541, P211, DOI 10.1111/j.1749-6632.1988.tb22258.x; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; Frumkin D, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-17; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; HERMISTON ML, 1993, P NATL ACAD SCI USA, V90, P8866, DOI 10.1073/pnas.90.19.8866; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Lasken RS, 2003, TRENDS BIOTECHNOL, V21, P531, DOI 10.1016/j.tibtech.2003.09.010; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Liu ZD, 2000, J CELL BIOCHEM, V76, P509, DOI 10.1002/(SICI)1097-4644(20000301)76:3<509::AID-JCB17>3.0.CO;2-R; Mathis L, 2002, TRENDS GENET, V18, P627, DOI 10.1016/S0168-9525(02)02806-8; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; OHLEN C, 1990, J IMMUNOL, V145, P52; Pal R, 2007, STEM CELLS DEV, V16, P3, DOI 10.1089/scd.2006.0109; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Salipante SJ, 2006, P NATL ACAD SCI USA, V103, P5448, DOI 10.1073/pnas.0601265103; Salipante SJ, 2007, CURR TOP DEV BIOL, V79, P157, DOI 10.1016/S0070-2153(06)79006-8; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; SLACK JMW, 2000, NATURE GENETICS, V24; Stent GS, 1998, INT J DEV BIOL, V42, P237; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Vilkki S, 2001, CANCER RES, V61, P4541; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; WASSERSTROM A, 2008, PLOS COMPUT IN PRESS; Wei K, 2002, TRENDS MOL MED, V8, P346, DOI 10.1016/S1471-4914(02)02359-6	38	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1939	10.1371/journal.pone.0001939	http://dx.doi.org/10.1371/journal.pone.0001939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398465	Green Published, gold			2022-12-27	WOS:000260795500016
J	Neznanov, N; Dragunsky, EM; Chumakov, KM; Neznanova, L; Wek, RC; Gudkov, AV; Banerjee, AK				Neznanov, Nickolay; Dragunsky, Eugenia M.; Chumakov, Konstantin M.; Neznanova, Lubov; Wek, Ronald C.; Gudkov, Andrei V.; Banerjee, Amiya K.			Different Effect of Proteasome Inhibition on Vesicular Stomatitis Virus and Poliovirus Replication	PLOS ONE			English	Article								Proteasome activity is an important part of viral replication. In this study, we examined the effect of proteasome inhibitors on the replication of vesicular stomatitis virus (VSV) and poliovirus. We found that the proteasome inhibitors significantly suppressed VSV protein synthesis, virus accumulation, and protected infected cells from toxic effect of VSV replication. In contrast, poliovirus replication was delayed, but not diminished in the presence of the proteasome inhibitors MG132 and Bortezomib. We also found that inhibition of proteasomes stimulated stress-related processes, such as accumulation of chaperone hsp70, phosphorylation of eIF2 alpha, and overall inhibition of translation. VSV replication was sensitive to this stress with significant decline in replication process. Poliovirus growth was less sensitive with only delay in replication. Inhibition of proteasome activity suppressed cellular and VSV protein synthesis, but did not reduce poliovirus protein synthesis. Protein kinase GCN2 supported the ability of proteasome inhibitors to attenuate general translation and to suppress VSV replication. We propose that different mechanisms of translational initiation by VSV and poliovirus determine their sensitivity to stress induced by the inhibition of proteasomes. To our knowledge, this is the first study that connects the effect of stress induced by proteasome inhibition with the efficiency of viral infection.	[Neznanov, Nickolay; Neznanova, Lubov; Banerjee, Amiya K.] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA; [Dragunsky, Eugenia M.; Chumakov, Konstantin M.] FDA, Ctr Biol Evaluat & Res, Rockville, MD USA; [Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA; [Gudkov, Andrei V.] Roswell Park Canc Inst, Dept Cell Stress Biol, Buffalo, NY USA; [Gudkov, Andrei V.] Cleveland Biolabs Inc, Buffalo, NY USA	Cleveland Clinic Foundation; US Food & Drug Administration (FDA); Indiana University System; Indiana University-Purdue University Indianapolis; Roswell Park Cancer Institute	Neznanov, N (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Genet, 9500 Euclid Ave, Cleveland, OH 44195 USA.	neznann@ccf.org		Gudkov, Andrei/0000-0003-2548-0154	NIH [AI26585, CA60730, CA88071]; Lerner Research Institute; NATIONAL CANCER INSTITUTE [R01CA088071, R01CA060730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026585] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lerner Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the grant from NIH to Amiya K. Banerjee (AI26585), by the grants from NIH to Andrei V. Gudkov (CA60730 and CA88071), and funds provided by Lerner Research Institute to Nickolay Neznanov.	Ahmed M, 1998, J VIROL, V72, P8413, DOI 10.1128/JVI.72.10.8413-8419.1998; Ahmed M, 2003, J VIROL, V77, P4646, DOI 10.1128/JVI.77.8.4646-4657.2003; Barik S, 2004, VIRUS RES, V102, P27, DOI 10.1016/j.virusres.2004.01.012; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; BONNEAU AM, 1985, J CELL BIOL, V100, P1209, DOI 10.1083/jcb.100.4.1209; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; BREZINA R, 1975, ACTA VIROL, V19, P496; BUCKLEY B, 1987, J BIOL CHEM, V262, P13599; Caraglia M, 2005, J CELL PHYSIOL, V202, P323, DOI 10.1002/jcp.20137; Clemens MJ, 2005, SEMIN CELL DEV BIOL, V16, P13, DOI 10.1016/j.semcdb.2004.11.011; COLL JM, 1995, ARCH VIROL, V140, P827, DOI 10.1007/BF01314961; Connor JH, 2005, J BIOL CHEM, V280, P13512, DOI 10.1074/jbc.M501156200; Cowan JL, 2004, EUR J BIOCHEM, V271, P3596, DOI 10.1111/j.0014-2956.2004.04306.x; Desforges M, 2001, VIRUS RES, V76, P87, DOI 10.1016/S0168-1702(01)00251-9; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; FRIELLE DW, 1989, VIROLOGY, V172, P274, DOI 10.1016/0042-6822(89)90129-3; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Harty RN, 2001, J VIROL, V75, P10623, DOI 10.1128/JVI.75.22.10623-10629.2001; Hatakeyama S, 2003, J BIOCHEM, V134, P1, DOI 10.1093/jb/mvg106; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; HELLEN CUT, 1991, J VIROL, V65, P4226, DOI 10.1128/JVI.65.8.4226-4231.1991; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Holmberg CI, 2000, CELL STRESS CHAPERON, V5, P219, DOI 10.1379/1466-1268(2000)005<0219:FONHGV>2.0.CO;2; Imai J, 2003, CELL CYCLE, V2, P585, DOI 10.4161/cc.2.6.586; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; KAPLAN G, 1985, P NATL ACAD SCI USA, V82, P8424, DOI 10.1073/pnas.82.24.8424; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Klinger Patricia P, 2005, Expert Rev Anti Infect Ther, V3, P61, DOI 10.1586/14787210.3.1.61; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; KRAUSSLICH HG, 1987, J VIROL, V61, P2711; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; LLOYD RE, 1988, J VIROL, V62, P4216, DOI 10.1128/JVI.62.11.4216-4223.1988; Luo HL, 2003, AM J PATHOL, V163, P381, DOI 10.1016/S0002-9440(10)63667-X; Mathur M, 1996, J VIROL, V70, P2252, DOI 10.1128/JVI.70.4.2252-2259.1996; Melnick J L, 1970, CRC Crit Rev Clin Lab Sci, V1, P87, DOI 10.3109/10408367009014720; Mitsiades N, 2002, P NATL ACAD SCI USA, V99, P14374, DOI 10.1073/pnas.202445099; Molina S, 2007, VIROLOGY, V363, P430, DOI 10.1016/j.virol.2007.02.001; Neznanov N, 2005, J BIOL CHEM, V280, P24153, DOI 10.1074/jbc.M502303200; Neznanov N, 2001, J VIROL, V75, P10409, DOI 10.1128/JVI.75.21.10409-10420.2001; ONEILL RE, 1989, J VIROL, V63, P5069, DOI 10.1128/JVI.63.12.5069-5075.1989; Ott DE, 2003, J VIROL, V77, P3384, DOI 10.1128/JVI.77.6.3384-3393.2003; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Roos-Mattjus P, 2004, ANN MED, V36, P285, DOI 10.1080/07853890310016324; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Sasaki J, 1999, J VIROL, V73, P1219, DOI 10.1128/JVI.73.2.1219-1226.1999; SCHMID M, 1994, ARCH VIROL, P279; Shackelford J, 2005, ESSAYS BIOCHEM, V41, P139, DOI 10.1042/EB0410139; SLEAT DE, 1993, J VIROL, V67, P1334, DOI 10.1128/JVI.67.3.1334-1339.1993; Spataro V, 1998, BRIT J CANCER, V77, P448, DOI 10.1038/bjc.1998.71; Thomas M, 1999, ONCOGENE, V18, P7690, DOI 10.1038/sj.onc.1202953; Wang JS, 2006, CELL MOL IMMUNOL, V3, P255; Watanabe H, 2005, MICROBIOL IMMUNOL, V49, P835, DOI 10.1111/j.1348-0421.2005.tb03672.x; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Yang Q, 1997, NUCLEIC ACIDS RES, V25, P2800, DOI 10.1093/nar/25.14.2800; YU SF, 1991, VIROLOGY, V182, P615, DOI 10.1016/0042-6822(91)90602-8; Yuan H, 1998, VIROLOGY, V251, P383, DOI 10.1006/viro.1998.9413; Yuan H, 2001, J VIROL, V75, P4453, DOI 10.1128/JVI.75.9.4453-4458.2001; Zhang HG, 2004, ONCOGENE, V23, P2009, DOI 10.1038/sj.onc.1207373	71	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1887	10.1371/journal.pone.0001887	http://dx.doi.org/10.1371/journal.pone.0001887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382670	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795400021
J	Song, LZ; Nakaar, V; Kavita, U; Price, A; Huleatt, J; Tang, J; Jacobs, A; Liu, G; Huang, Y; Desai, P; Maksymiuk, G; Takahashi, V; Umlauf, S; Reiserova, L; Bell, R; Li, H; Zhang, Y; McDonald, WF; Powell, TJ; Tussey, L				Song, Langzhou; Nakaar, Valerian; Kavita, Uma; Price, Albert; Huleatt, Jim; Tang, Jie; Jacobs, Andrea; Liu, Ge; Huang, Yan; Desai, Priyanka; Maksymiuk, Gail; Takahashi, Virginia; Umlauf, Scott; Reiserova, Lucia; Bell, Rodney; Li, Hong; Zhang, Yi; McDonald, William F.; Powell, T. J.; Tussey, Lynda			Efficacious Recombinant Influenza Vaccines Produced by High Yield Bacterial Expression: A Solution to Global Pandemic and Seasonal Needs	PLOS ONE			English	Article								It is known that physical linkage of TLR ligands and vaccine antigens significantly enhances the immunopotency of the linked antigens. We have used this approach to generate novel influenza vaccines that fuse the globular head domain of the protective hemagglutinin (HA) antigen with the potent TLR5 ligand, flagellin. These fusion proteins are efficiently expressed in standard E. coli fermentation systems and the HA moiety can be faithfully refolded to take on the native conformation of the globular head. In mouse models of influenza infection, the vaccines elicit robust antibody responses that mitigate disease and protect mice from lethal challenge. These immunologically potent vaccines can be efficiently manufactured to support pandemic response, pre-pandemic and seasonal vaccines.	[Song, Langzhou; Kavita, Uma; Liu, Ge; Umlauf, Scott; Reiserova, Lucia; Bell, Rodney; Li, Hong; Zhang, Yi; Tussey, Lynda] VaxInnate Corp, Cranbury, NJ USA; [Nakaar, Valerian; Price, Albert; Huleatt, Jim; Tang, Jie; Jacobs, Andrea; Huang, Yan; Desai, Priyanka; Maksymiuk, Gail; Takahashi, Virginia; McDonald, William F.; Powell, T. J.] VaxInnate Corp, New Haven, CT USA		Song, LZ (corresponding author), VaxInnate Corp, Cranbury, NJ USA.	langzhou.song@vaxinnate.com			VaxInnate Corporation	VaxInnate Corporation	The work is supported by the VaxInnate Corporation	BIZEBARD T, 1995, NATURE, V376, P92, DOI 10.1038/376092a0; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Bright RA, 2003, VIROLOGY, V308, P270, DOI 10.1016/S0042-6822(03)00008-4; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Jeon SH, 2002, VIRAL IMMUNOL, V15, P165, DOI 10.1089/088282402317340314; KILBOURNE ED, 1988, P NATL ACAD SCI USA, V85, P8098, DOI 10.1073/pnas.85.21.8098; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0	18	92	112	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2257	10.1371/journal.pone.0002257	http://dx.doi.org/10.1371/journal.pone.0002257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493310	Green Published, gold, Green Submitted			2022-12-27	WOS:000262258700057
J	Tribouillard-Tanvier, D; Dos Reis, S; Gug, F; Voisset, C; Beringue, V; Sabate, R; Kikovska, E; Talarek, N; Bach, S; Huang, CH; Desban, N; Saupe, SJ; Supattapone, S; Thuret, JY; Chedin, S; Vilette, D; Galons, H; Sanyal, S; Blondel, M				Tribouillard-Tanvier, Deborah; Dos Reis, Suzana; Gug, Fabienne; Voisset, Cecile; Beringue, Vincent; Sabate, Raimon; Kikovska, Ema; Talarek, Nicolas; Bach, Stephane; Huang, Chenhui; Desban, Nathalie; Saupe, Sven J.; Supattapone, Surachai; Thuret, Jean-Yves; Chedin, Stephane; Vilette, Didier; Galons, Herve; Sanyal, Suparna; Blondel, Marc			Protein Folding Activity of Ribosomal RNA Is a Selective Target of Two Unrelated Antiprion Drugs	PLOS ONE			English	Article							IN-VITRO; ESCHERICHIA-COLI; PRION PROTEIN; SCRAPIE AGENT; NUCLEIC-ACID; YEAST; GENERATION; ASSAY; SHEEP; URE3	Background: 6-Aminophenanthridine (6AP) and Guanabenz (GA, a drug currently in use for the treatment of hypertension) were isolated as antiprion drugs using a yeast-based assay. These structurally unrelated molecules are also active against mammalian prion in several cell-based assays and in vivo in a mouse model for prion-based diseases. Methodology/Principal Findings: Here we report the identification of cellular targets of these drugs. Using affinity chromatography matrices for both drugs, we demonstrate an RNA-dependent interaction of 6AP and GA with the ribosome. These specific interactions have no effect on the peptidyl transferase activity of the ribosome or on global translation. In contrast, 6AP and GA specifically inhibit the ribosomal RNA-mediated protein folding activity of the ribosome. Conclusion/Significance: 6AP and GA are therefore the first compounds to selectively inhibit the protein folding activity of the ribosome. They thus constitute precious tools to study the yet largely unexplored biological role of this protein folding activity.	[Tribouillard-Tanvier, Deborah; Voisset, Cecile; Blondel, Marc] INSERM, U613, Brest, France; [Tribouillard-Tanvier, Deborah; Voisset, Cecile; Blondel, Marc] Univ Brest, Fac Med Sci Sante, UMR S613, Brest, France; [Tribouillard-Tanvier, Deborah; Voisset, Cecile; Blondel, Marc] Etab Francais Sang EFS Bretagne, Brest, France; [Tribouillard-Tanvier, Deborah; Voisset, Cecile; Blondel, Marc] Lab Genet Mol, Hop Morvan, CHU Brest, Brest, France; [Tribouillard-Tanvier, Deborah; Bach, Stephane; Desban, Nathalie] Protein Phosphoryl & Dis Lab, Stn Biol, CNRS UPS2682, Roscoff, France; [Dos Reis, Suzana; Kikovska, Ema; Huang, Chenhui; Sanyal, Suparna] Uppsala Univ, Inst Cell & Mol Biol, Uppsala, Sweden; [Gug, Fabienne; Galons, Herve] Univ Paris 05, Lab Chim Organ 2, INSERM U648, Paris, France; [Beringue, Vincent; Vilette, Didier] INRA, UR892, Jouy En Josas, France; [Sabate, Raimon; Saupe, Sven J.] Univ Bordeaux 2, IBGC UMR CNRS 5095, Lab Genet Mol Champignons, Bordeaux, France; [Talarek, Nicolas] Univ Fribourg, Dept Med Biochem, Fribourg, Switzerland; [Supattapone, Surachai] Dartmouth Med Sch, Dept Med, Hanover, NH USA; [Supattapone, Surachai] Dartmouth Med Sch, Dept Biochem, Hanover, NH USA; [Thuret, Jean-Yves; Chedin, Stephane] iBiTec S, CEA, Gif Sur Yvette, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; UDICE-French Research Universities; Sorbonne Universite; Uppsala University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite de Bordeaux; University of Fribourg; Dartmouth College; Dartmouth College; CEA; UDICE-French Research Universities; Universite Paris Saclay	Tribouillard-Tanvier, D (corresponding author), INSERM, U613, Brest, France.	marc.blondel@univ-brest.fr	Blondel, Marc/AAJ-9049-2020; Voisset, Cecile/AAK-1636-2020; Talarek, Nicolas/Q-4648-2019; BACH, Stéphane/ABD-5865-2020; Talarek, Nicolas/P-6870-2019; sabate, raimon/I-7849-2014	Blondel, Marc/0000-0003-4897-2995; Talarek, Nicolas/0000-0003-2804-7372; saupe, sven/0000-0002-5589-721X; Thuret, Jean-Yves/0000-0001-5385-7620; Voisset, Cecile/0000-0001-7505-1927; Dos Reis, Suzana/0000-0002-9117-7316; sabate, raimon/0000-0003-3894-2362; Tribouillard-Tanvier, Deborah/0000-0002-2290-5375	GIS Infections a prion; ACI Jeune Chercheur from the French government; CRITT Sante Bretagne; Ministere de la Recherche; FRM; CNRS [Ingenieur de valorisation fellowship]; French government; Swedish Research Council; Goran Gustafsson; EMBO [postdoctoral fellowship]; INSERM; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046478] Funding Source: NIH RePORTER	GIS Infections a prion; ACI Jeune Chercheur from the French government; CRITT Sante Bretagne; Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); FRM(Fondation pour la Recherche Medicale); CNRS(Centre National de la Recherche Scientifique (CNRS)); French government; Swedish Research Council(Swedish Research CouncilEuropean Commission); Goran Gustafsson; EMBO(European Molecular Biology Organization (EMBO)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the following grants: GIS Infections a prion, ACI Jeune Chercheur from the French government, CRITT Sante Bretagne to MB, Ministere de la Recherche and FRM grants (to DTT), Ingenieur de valorisation fellowship from the CNRS and ANR blanche from the French government to MB, SJS, HG and DV, Swedish Research Council (VR) and Goran Gustafsson grants to SS. SDR was supported by an EMBO postdoctoral fellowship and CV by a Junior Contract from INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoun A, 2006, EMBO J, V25, P2539, DOI 10.1038/sj.emboj.7601140; Archer F, 2004, J VIROL, V78, P482, DOI 10.1128/JVI.78.1.482-490.2004; Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855; BACH S, 2006, EVALUATION CDK INHIB, P103; Bach S, 2006, METHODS, V39, P72, DOI 10.1016/j.ymeth.2006.04.005; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P598, DOI 10.1016/j.bbrc.2007.11.143; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P592, DOI 10.1016/j.bbrc.2007.11.142; BENKEMOUN L, 2006, FUNGAL GENET BIOL; Boye-Harnasch M, 2006, J BIOTECHNOL, V125, P222, DOI 10.1016/j.jbiotec.2006.03.006; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Brachmann A, 2006, METHODS, V39, P35, DOI 10.1016/j.ymeth.2006.04.008; Brown JL, 1997, GENE DEV, V11, P2972, DOI 10.1101/gad.11.22.2972; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 2003, NATURE, V425, P673, DOI 10.1038/425673a; Chattopadhyay S, 1996, P NATL ACAD SCI USA, V93, P8284, DOI 10.1073/pnas.93.16.8284; Chattopadhyay S, 1999, BBA-PROTEIN STRUCT M, V1429, P293, DOI 10.1016/S0167-4838(98)00179-4; CHATTOPADHYAY S, 1994, BIOCHEM J, V300, P717, DOI 10.1042/bj3000717; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; DAI H, 1986, Current Genetics, V11, P79, DOI 10.1007/BF00389429; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Das Gupta C, 1999, CURR SCI INDIA, V77, P568; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Gilch S, 2007, J MOL BIOL, V371, P362, DOI 10.1016/j.jmb.2007.05.052; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; HOLMES B, 1983, DRUGS, V26, P212, DOI 10.2165/00003495-198326030-00003; Jones GW, 2005, BIOESSAYS, V27, P823, DOI 10.1002/bies.20267; KERRIDGE D, 1958, J GEN MICROBIOL, V19, P497, DOI 10.1099/00221287-19-3-497; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; KOVALIC D, 1995, BIOCHEMISTRY-US, V34, P15838, DOI 10.1021/bi00048a029; Krasemann S, 1996, MOL MED, V2, P725, DOI 10.1007/BF03401656; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; LEE KM, 1986, PREP BIOCHEM, V16, P247, DOI 10.1080/00327488608062469; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Pavlov MY, 1996, ARCH BIOCHEM BIOPHYS, V328, P9, DOI 10.1006/abbi.1996.0136; Pavlov MY, 1997, J MOL BIOL, V273, P389, DOI 10.1006/jmbi.1997.1324; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; RODNINA MV, 1995, P NATL ACAD SCI USA, V92, P1945, DOI 10.1073/pnas.92.6.1945; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; SAMANTA D, 2008, J BACTERIOL; Sanyal SC, 2002, NUCLEIC ACIDS RES, V30, P2390, DOI 10.1093/nar/30.11.2390; Savvateeva-Popova E, 2007, CELL STRESS CHAPERON, V12, P9, DOI 10.1379/CSC-222R.1; Schlumpberger M, 2001, MOL CELL BIOL, V21, P7035, DOI 10.1128/MCB.21.20.7035-7046.2001; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singh R, 2002, FEBS LETT, V527, P234, DOI 10.1016/S0014-5793(02)03243-X; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Tribouillard Deborah, 2006, Biotechnology Journal, V1, P58, DOI 10.1002/biot.200500001; Tuite MF, 2004, MOL CELL, V14, P541, DOI 10.1016/j.molcel.2004.05.012; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; Vido K, 2001, J BIOL CHEM, V276, P8469, DOI 10.1074/jbc.M008708200; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	59	49	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2174	10.1371/journal.pone.0002174	http://dx.doi.org/10.1371/journal.pone.0002174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478094	Green Published, Green Submitted, gold			2022-12-27	WOS:000262172800039
J	Kolodziejczyk, A; Sun, XJ; Meinertzhagen, IA; Nassel, DR				Kolodziejczyk, Agata; Sun, Xuejun; Meinertzhagen, Ian A.; Nassel, Dick R.			Glutamate, GABA and Acetylcholine Signaling Components in the Lamina of the Drosophila Visual System	PLOS ONE			English	Article							CHLORIDE CHANNEL SUBUNITS; CHOLINE-ACETYLTRANSFERASE; NERVOUS-SYSTEM; OPTIC LOBE; IMMUNOCYTOCHEMICAL LOCALIZATION; SYNAPTIC POPULATIONS; ACID DECARBOXYLASE; MUSCA-DOMESTICA; LIGAND-BINDING; WILD-TYPE	Synaptic connections of neurons in the Drosophila lamina, the most peripheral synaptic region of the visual system, have been comprehensively described. Although the lamina has been used extensively as a model for the development and plasticity of synaptic connections, the neurotransmitters in these circuits are still poorly known. Thus, to unravel possible neurotransmitter circuits in the lamina of Drosophila we combined Gal4 driven green fluorescent protein in specific lamina neurons with antisera to gamma-aminobutyric acid (GABA), glutamic acid decarboxylase, a GABA(B) type of receptor, L-glutamate, a vesicular glutamate transporter (vGluT), ionotropic and metabotropic glutamate receptors, choline acetyltransferase and a vesicular acetylcholine transporter. We suggest that acetylcholine may be used as a neurotransmitter in both L4 monopolar neurons and a previously unreported type of wide-field tangential neuron (Cha-Tan). GABA is the likely transmitter of centrifugal neurons C2 and C3 and GABA(B) receptor immunoreactivity is seen on these neurons as well as the Cha-Tan neurons. Based on an rdl-Gal4 line, the ionotropic GABA(A) receptor subunit RDL may be expressed by L4 neurons and a type of tangential neuron (rdl-Tan). Strong vGluT immunoreactivity was detected in alpha-processes of amacrine neurons and possibly in the large monopolar neurons L1 and L2. These neurons also express glutamate-like immunoreactivity. However, antisera to ionotropic and metabotropic glutamate receptors did not produce distinct immunosignals in the lamina. In summary, this paper describes novel features of two distinct types of tangential neurons in the Drosophila lamina and assigns putative neurotransmitters and some receptors to a few identified neuron types.	[Kolodziejczyk, Agata; Nassel, Dick R.] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Sun, Xuejun; Meinertzhagen, Ian A.] Dalhousie Univ, Life Sci Ctr, Halifax, NS, Canada	Stockholm University; Dalhousie University	Kolodziejczyk, A (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	dnassel@zoologi.su.se	Kolodziejczyk, Agata Maria/AAI-9174-2020	Kolodziejczyk, Agata Maria/0000-0002-7030-3555; Meinertzhagen, Ian/0000-0002-6578-4526	Swedish Research Council [VR 621-2004-3715]; NIH [EY-03592]; NATIONAL EYE INSTITUTE [R01EY003592] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Swedish Research Council (VR 621-2004-3715 to DRN) and by NIH grant EY-03592 (to IAM).	BARBER RP, 1989, J COMP NEUROL, V280, P533, DOI 10.1002/cne.902800404; Barth M, 1997, J NEUROSCI, V17, P1493; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; BICKER G, 1988, J NEUROSCI, V8, P2108; Bogdanik L, 2004, J NEUROSCI, V24, P9105, DOI 10.1523/JNEUROSCI.2724-04.2004; BOSCHEK CB, 1971, Z ZELLFORSCH MIK ANA, V118, P369; BRAITENBERG V, 1967, EXP BRAIN RES, V3, P271; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUCHNER E, 1986, CELL TISSUE RES, V246, P57; BUCHNER E, 1988, CELL TISSUE RES, V253, P357, DOI 10.1007/BF00222292; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0; COOMBE PE, 1989, J COMP PHYSIOL A, V166, P23, DOI 10.1007/BF00190206; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; DATUM KH, 1986, J COMP PHYSIOL A, V159, P241, DOI 10.1007/BF00612306; DATUM KH, 1989, CELL TISSUE RES, V256, P153; Douglass JK, 2005, VISUAL NEUROSCI, V22, P345, DOI 10.1017/S095252380522309X; Douglass JK, 2003, MICROSC RES TECHNIQ, V62, P132, DOI 10.1002/jemt.10367; Douglass JK, 2007, J COMP PHYSIOL A, V193, P233, DOI 10.1007/s00359-006-0185-7; Enell L, 2007, J COMP NEUROL, V505, P18, DOI 10.1002/cne.21472; Eroglu C, 2003, P NATL ACAD SCI USA, V100, P10219, DOI 10.1073/pnas.1737042100; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Gorska-Andrzejak J, 2005, PHOTOCH PHOTOBIO SCI, V4, P721, DOI 10.1039/b417023g; Hamasaka Y, 2005, J NEUROBIOL, V65, P225, DOI 10.1002/neu.20184; Hamasaka Y, 2007, J COMP NEUROL, V505, P32, DOI 10.1002/cne.21471; Hardie R.C., 1989, P235; HARDIE RC, 1987, J COMP PHYSIOL A, V161, P201, DOI 10.1007/BF00615241; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HARRISON JB, 1995, J NEUROENDOCRINOL, V7, P347, DOI 10.1111/j.1365-2826.1995.tb00768.x; HAUSER H, 1975, THESIS E KARLS U TUB; HEPLER JR, 1988, J HISTOCHEM CYTOCHEM, V36, P13, DOI 10.1177/36.1.2891743; Hiesinger PR, 2006, CURR BIOL, V16, P1835, DOI 10.1016/j.cub.2006.07.047; Hiesinger PR, 2001, J COMP NEUROL, V429, P277, DOI 10.1002/1096-9861(20000108)429:2<277::AID-CNE8>3.0.CO;2-8; Homberg U, 2002, MICROSC RES TECHNIQ, V56, P189, DOI 10.1002/jemt.10024; Hosie AM, 1997, TRENDS NEUROSCI, V20, P578, DOI 10.1016/S0166-2236(97)01127-2; ITOH N, 1986, P NATL ACAD SCI USA, V83, P4081, DOI 10.1073/pnas.83.11.4081; JACKSON FR, 1990, J NEUROCHEM, V54, P1068, DOI 10.1111/j.1471-4159.1990.tb02359.x; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; JANSONIUS NM, 1993, J COMP PHYSIOL A, V173, P187, DOI 10.1007/BF00192977; JARVILEHTO M, 1973, Z ZELLFORSCH MIK ANA, V136, P291, DOI 10.1007/BF00307446; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; JONAS PE, 1994, J NEUROBIOL, V25, P1494, DOI 10.1002/neu.480251203; Juusola M, 1996, TRENDS NEUROSCI, V19, P292, DOI 10.1016/S0166-2236(96)10028-X; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kitamoto T, 2000, J NEUROBIOL, V42, P161, DOI 10.1002/(SICI)1097-4695(20000205)42:2<161::AID-NEU1>3.0.CO;2-P; Kitamoto T, 1998, J BIOL CHEM, V273, P2706, DOI 10.1074/jbc.273.5.2706; Klemm N, 1976, Prog Neurobiol, V7, P99, DOI 10.1016/0301-0082(76)90014-9; LAUGHLIN SB, 1989, J EXP BIOL, V144, P113; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; MADL JE, 1986, J HISTOCHEM CYTOCHEM, V34, P317, DOI 10.1177/34.3.2419390; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Meinertzhagen I. A., 1996, Society for Neuroscience Abstracts, V22, P655; Meinertzhagen I A, 2001, Prog Brain Res, V131, P53; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; MEINERTZHAGEN IA, 1993, PROG RETIN RES, V12, P13, DOI 10.1016/0278-4327(93)90003-C; Meinertzhagen IA, 1999, MICROSC RES TECHNIQ, V45, P96, DOI 10.1002/(SICI)1097-0029(19990415)45:2<96::AID-JEMT4>3.0.CO;2-L; Meinertzhagen IA, 2000, EUR J NEUROSCI, V12, P1342, DOI 10.1046/j.1460-9568.2000.00033.x; Meinertzhagen Ian A., 1993, P1363; MELAMED J, 1967, J ULTRA MOL STRUCT R, V21, P313, DOI 10.1016/S0022-5320(67)80098-4; MEYER EP, 1986, HISTOCHEMISTRY, V84, P207, DOI 10.1007/BF00495784; Mezler M, 2001, EUR J NEUROSCI, V13, P477, DOI 10.1046/j.1460-9568.2001.01410.x; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Nassel DR, 2006, CELL TISSUE RES, V326, P1, DOI 10.1007/s00441-006-0210-8; NASSEL DR, 1991, PROG NEUROBIOL, V37, P179, DOI 10.1016/0301-0082(91)90027-X; NASSEL DR, 1988, CELL TISSUE RES, V253, P639; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; NICOL D, 1982, J COMP NEUROL, V207, P29, DOI 10.1002/cne.902070104; Okabe S, 1999, J NEUROSCI, V19, P7781; Panneels V, 2003, PROTEIN EXPRES PURIF, V30, P275, DOI 10.1016/S1046-5928(03)00100-1; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Prokop A, 2006, SEMIN CELL DEV BIOL, V17, P20, DOI 10.1016/j.semcdb.2005.11.010; PYZA E, 1995, J NEUROSCI, V15, P407; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4; Sanchez D., 1915, TRAB LAB INVEST BIOL, V13, P1, DOI DOI 10.5962/BHL.TITLE.37839; SARTHY PV, 1991, J NEUROCHEM, V57, P1757, DOI 10.1111/j.1471-4159.1991.tb06378.x; Sattelle DB, 2005, BIOESSAYS, V27, P366, DOI 10.1002/bies.20207; SATTELLE DB, 1991, NEUROCHEM RES, V16, P363, DOI 10.1007/BF00966100; SCHUSTER R, 1993, J COMP NEUROL, V335, P149, DOI 10.1002/cne.903350202; SHAW SR, 1986, P NATL ACAD SCI USA, V83, P7961, DOI 10.1073/pnas.83.20.7961; SHAW SR, 1981, NEURONES IMPULSES, P61; Sinakevitch I, 2004, J COMP NEUROL, V468, P6, DOI 10.1002/cne.10929; Sinakevitch I, 2003, J COMP NEUROL, V467, P150, DOI 10.1002/cne.10925; STRAUSFELD NJ, 1977, SCIENCE, V195, P894, DOI 10.1126/science.841315; STRAUSFELD NJ, 1971, Z ZELLFORSCH MIK ANA, V121, P377, DOI 10.1007/BF00337640; STRAUSFELD NJ, 1980, HDB SENSORY PHYSL, P1; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; Stuart AE, 2007, PROG NEUROBIOL, V82, P202, DOI 10.1016/j.pneurobio.2007.03.006; Takagawa K, 1996, NEUROSCI RES, V24, P237, DOI 10.1016/0168-0102(95)00999-X; TRUJILLO.O, 1965, J ULTRA MOL STRUCT R, V13, P1, DOI 10.1016/S0022-5320(65)80086-7; ULTSCH A, 1993, FEBS LETT, V324, P171, DOI 10.1016/0014-5793(93)81387-F; UUSITALO RO, 1995, J NEUROPHYSIOL, V73, P1782, DOI 10.1152/jn.1995.73.5.1782; Warrant E, 2006, INVERTEBRATE VISION, pXIX; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Witte I, 2002, J NEUROCHEM, V83, P504, DOI 10.1046/j.1471-4159.2002.01076.x; Yasuyama K, 1996, J NEUROBIOL, V30, P205, DOI 10.1002/(SICI)1097-4695(199606)30:2<205::AID-NEU3>3.0.CO;2-9; Yasuyama K, 1999, MICROSC RES TECHNIQ, V45, P65, DOI 10.1002/(SICI)1097-0029(19990415)45:2<65::AID-JEMT2>3.0.CO;2-0; YASUYAMA K, 1995, J COMP NEUROL, V361, P25, DOI 10.1002/cne.903610103; Zheng YC, 2002, J BIOL CHEM, V277, P2000, DOI 10.1074/jbc.M107635200	104	82	84	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2110	10.1371/journal.pone.0002110	http://dx.doi.org/10.1371/journal.pone.0002110			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18464935	Green Submitted, Green Published, gold			2022-12-27	WOS:000261642400032
J	Matynia, A; Anagnostaras, SG; Wiltgen, BJ; Lacuesta, M; Fanselow, MS; Silva, AJ				Matynia, Anna; Anagnostaras, Stephan G.; Wiltgen, Brian J.; Lacuesta, Maress; Fanselow, Michael S.; Silva, Alcino J.			A High Through-Put Reverse Genetic Screen Identifies Two Genes Involved in Remote Memory in Mice	PLOS ONE			English	Article								Previous studies have revealed that the initial stages of memory formation require several genes involved in synaptic, transcriptional and translational mechanisms. In contrast, very little is known about the molecular and cellular mechanisms underlying later stages of memory, including remote memory (i.e. 7-day memory). To identify genes required for remote memory, we screened randomly selected mouse strains harboring known mutations. In our primary reverse genetic screen, we identified 4 putative remote memory mutant strains out of a total of 54 lines analyzed. Additionally, we found 11 other mutant strains with other abnormal profiles. Secondary screens confirmed that mutations of integrin beta 2 (Itg beta 2) and steryl-O-acyl transferase 1 (Soat1) specifically disrupted remote memory. This study identifies some of the first genes required for remote memory, and suggests that screens of targeted mutants may be an efficient strategy to identify molecular requirements for this process.	[Matynia, Anna; Anagnostaras, Stephan G.; Lacuesta, Maress; Silva, Alcino J.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; [Matynia, Anna; Anagnostaras, Stephan G.; Lacuesta, Maress; Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; [Wiltgen, Brian J.; Fanselow, Michael S.; Silva, Alcino J.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Matynia, A (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.	alcinojsilva@gmail.com	Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Anagnostaras, Stephan/0000-0002-6906-1181; Silva, Alcino/0000-0001-5525-0494	 [RO1 MH61094];  [P50 MH077972]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077972, R01MH061094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013622] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant to AJS and MSF (RO1 MH61094) and P50 MH077972 to AJS.	Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Apicelli AJ, 2003, GLIA, V42, P225, DOI 10.1002/glia.10214; BAILEY CH, 1989, J NEUROSCI, V9, P1774; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Cook MN, 2007, MAMM GENOME, V18, P559, DOI 10.1007/s00335-007-9035-3; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Frankland PW, 2001, NATURE, V411, P309, DOI 10.1038/35077089; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Geinisman Y, 2001, J NEUROSCI, V21, P5568, DOI 10.1523/JNEUROSCI.21-15-05568.2001; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Hailer NP, 1997, HIPPOCAMPUS, V7, P341, DOI 10.1002/(SICI)1098-1063(1997)7:3<341::AID-HIPO8>3.0.CO;2-N; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; Herrick TM, 2002, DEVELOPMENT, V129, P787; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Jiang MS, 2001, P NATL ACAD SCI USA, V98, P3577, DOI 10.1073/pnas.051632598; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; MAKRYDIMAS G, 1995, PRENATAL DIAG, V15, P325, DOI 10.1002/pd.1970150405; Matynia A, 2002, ANNU REV GENET, V36, P687, DOI 10.1146/annurev.genet.36.062802.091007; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Nwokoro NA, 2001, MOL GENET METAB, V74, P105, DOI 10.1006/mgme.2001.3226; PAYLOR R, 1994, BEHAV NEUROSCI, V108, P810, DOI 10.1037/0735-7044.108.4.810; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Reijmers LG, 2006, LEARN MEMORY, V13, P143, DOI 10.1101/lm.98606; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Rowe WB, 2007, J NEUROSCI, V27, P3098, DOI 10.1523/JNEUROSCI.4163-06.2007; Sayah DM, 2000, MOL PSYCHIATR, V5, P369, DOI 10.1038/sj.mp.4000742; Schmitz G, 2001, NEUROCHEM RES, V26, P1045, DOI 10.1023/A:1012357106398; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; TAYLOR GM, 1988, CLIN EXP IMMUNOL, V71, P324; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wehner J. M., 1996, MENTAL RETARDATION D, V2, P243, DOI DOI 10.1002/(SICI)1098-2779(1996)2:4<243::AID-; Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; Wollmer MA, 2003, MOL PSYCHIATR, V8, P635, DOI 10.1038/sj.mp.4001296; YAMAMOTO T, 1994, BEHAV BRAIN RES, V65, P123, DOI 10.1016/0166-4328(94)90097-3; YAMAMOTO T, 1995, NEUROSCI RES, V22, P31, DOI 10.1016/0168-0102(95)00875-T	56	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2121	10.1371/journal.pone.0002121	http://dx.doi.org/10.1371/journal.pone.0002121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18464936	Green Published, gold			2022-12-27	WOS:000261642400042
J	Shlush, LI; Behar, DM; Yudkovsky, G; Templeton, A; Hadid, Y; Basis, F; Hammer, M; Itzkovitz, S; Skorecki, K				Shlush, Liran I.; Behar, Doron M.; Yudkovsky, Guennady; Templeton, Alan; Hadid, Yarin; Basis, Fuad; Hammer, Michael; Itzkovitz, Shalev; Skorecki, Karl			The Druze: A Population Genetic Refugium of the Near East	PLOS ONE			English	Article								Background: Phylogenetic mitochondrial DNA haplogroups are highly partitioned across global geographic regions. A unique exception is the X haplogroup, which has a widespread global distribution without major regions of distinct localization. Principal Findings: We have examined mitochondrial DNA sequence variation together with Y-chromosome-based haplogroup structure among the Druze, a religious minority with a unique socio-demographic history residing in the Near East. We observed a striking overall pattern of heterogeneous parental origins, consistent with Druze oral tradition, together with both a high frequency and a high diversity of the mitochondrial DNA (mtDNA) X haplogroup within a confined regional subpopulation. Furthermore demographic modeling indicated low migration rates with nearby populations. Conclusions: These findings were enabled through the use of a paternal kindred based sampling approach, and suggest that the Galilee Druze represent a population isolate, and that the combination of a high frequency and diversity of the mtDNA X haplogroup signifies a phylogenetic refugium, providing a sample snapshot of the genetic landscape of the Near East prior to the modern age.	[Shlush, Liran I.; Yudkovsky, Guennady; Hadid, Yarin; Skorecki, Karl] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Behar, Doron M.; Skorecki, Karl] Rambam Hlth Care Campus, Lab Mol Med, Haifa, Israel; [Templeton, Alan] Washington Univ, Fac Biol & Engn, St Louis, MO USA; [Basis, Fuad] Rambam Hlth Care Campus, Dept Emergency Med, Haifa, Israel; [Hammer, Michael] Univ Arizona, Div Biotechnol, Tucson, AZ USA; [Itzkovitz, Shalev] Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Washington University (WUSTL); Rambam Health Care Campus; University of Arizona; Weizmann Institute of Science	Shlush, LI (corresponding author), Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel.	skorecki@tx.technion.ac.il	Templeton, Alan R./F-5963-2011; Basis, Fuad/AAN-6963-2020	Templeton, Alan/0000-0002-0167-845X	Israel Science Foundation; Canadian and American Technion Societies	Israel Science Foundation(Israel Science Foundation); Canadian and American Technion Societies	Israel Science Foundation, Canadian and American Technion Societies	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Arcos-Burgos M, 2002, CLIN GENET, V61, P233, DOI 10.1034/j.1399-0004.2002.610401.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Behar DM, 2004, EUR J HUM GENET, V12, P355, DOI 10.1038/sj.ejhg.5201156; BROSHI M, 1979, B AM SCH ORIENT RES, V236, P7; *CBS, 2005, DRUZ POP ISR; DIAMOND JM, 1994, NATURE, V368, P291, DOI 10.1038/368291a0; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; FALAH S, 2000, DRUZE MIDDLE E, P88; Falah S., 2000, DRUZE MIDDLE E, P112; Fix AG, 2004, AM J HUM BIOL, V16, P387, DOI 10.1002/ajhb.20044; FIX AG, 1978, ANN HUM GENET, V41, P329, DOI 10.1111/j.1469-1809.1978.tb01900.x; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Jobling M.A., 2004, HUMAN EVOLUTIONARY G, P392; Karafet TM, 2002, HUM BIOL, V74, P761, DOI 10.1353/hub.2003.0006; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; KOHLBERG E, 1975, J AM ORIENTAL SOC, V95, P395, DOI 10.2307/599351; LATTER BDH, 1973, GENETICS, V73, P147; Lee JSM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-189; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; NEI MK, 2000, MOL EVOLUTIONAL PHYL, P245; Nielsen R, 2001, GENETICS, V158, P885; OHTA T, 1992, GENETICS, V130, P917; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; Redd AJ, 2002, FORENSIC SCI INT, V130, P97, DOI 10.1016/S0379-0738(02)00347-X; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, AM J HUM GENET, V72, P1058, DOI 10.1086/374384; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; ROTHMAN ED, 1974, GENETICS, V78, P943; SHERRY ST, 1994, HUM BIOL, V66, P761; SLATKIN M, 1978, P NATL ACAD SCI USA, V75, P3531, DOI 10.1073/pnas.75.7.3531; SLATKIN M, 1991, GENETICS, V129, P555; SLATKIN M, 1977, THEOR POPUL BIOL, V12, P253, DOI 10.1016/0040-5809(77)90045-4; Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Thomas MG, 2002, AM J HUM GENET, V70, P1411, DOI 10.1086/340609; Vardi-Saliternik R, 2002, ANN HUM BIOL, V29, P422, DOI 10.1080/03014460110100928; VOLNEY CF, 1798, TRAVELS SYRIA EGYPT; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; Wynn RM, 2001, J BIOL CHEM, V276, P36550, DOI 10.1074/jbc.M105862200; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	54	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2105	10.1371/journal.pone.0002105	http://dx.doi.org/10.1371/journal.pone.0002105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461126	Green Published, gold			2022-12-27	WOS:000261642400027
J	Bianucci, R; Jeziorska, M; Lallo, R; Mattutino, G; Massimelli, M; Phillips, G; Appenzeller, O				Bianucci, Raffaella; Jeziorska, Maria; Lallo, Rudy; Mattutino, Grazia; Massimelli, Massimo; Phillips, Genevieve; Appenzeller, Otto			A Pre-Hispanic Head	PLOS ONE			English	Article								This report on a male head revealed biologic rhythms, as gleaned from hydrogen isotope ratios in hair, consistent with a South-American origin and Atomic Mass Spectrometry radiocarbon dating (AMS) compatible with the last pre-Hispanic period (1418-1491 AD, 95.4% probability). Biopsies showed exceptionally well-preserved tissues. The hair contained high levels of toxic elements (lead, arsenic and mercury) incompatible with life. There was no evidence for lead deposition in bone consistent with post-mortem accumulation of this toxic element in the hair. We propose that the high content of metals in hair was the result of metabolic activity of bacteria leading to metal complexation in extra cellular polymeric substances (EPS). This is a recognized protective mechanism for bacteria that thrive in toxic environments. This mechanism may account for the tissues preservation and gives a hint at soil composition where the head was presumably buried. Our results have implications for forensic toxicology which has, hitherto, relied on hair analyses as one means to reconstruct premortem metabolism and for detecting toxic elements accumulated during life. Our finding also has implications for other archaeological specimens where similar circumstances may distort the results of toxicological studies.	[Bianucci, Raffaella] Univ Turin, Dept Anim & Human Biol, Lab Anthropol, Turin, Italy; [Jeziorska, Maria] Univ Manchester, Div Regenerat Med, Manchester, Lancs, England; [Lallo, Rudy] Fdn Pinna Pintor & Studio Futura, Turin, Italy; [Mattutino, Grazia] Univ Turin, Dept Anat, Pharmacol & Legal Med, Lab Criminalist Sci, Turin, Italy; [Massimelli, Massimo] Legal Med Office, Turin, Italy; [Phillips, Genevieve] Univ New Mexico, Canc Res & Treatment Ctr, Fluorescence Microscopy Facil, Albuquerque, NM USA; [Appenzeller, Otto] Marathon Clin Res Fdn, New Mexico Hlth Enhancement, Albuquerque, NM USA	University of Turin; University of Manchester; University of Turin; University of New Mexico	Bianucci, R (corresponding author), Univ Turin, Dept Anim & Human Biol, Lab Anthropol, Turin, Italy.	raffaella.bianucci@unito.it	Bianucci, Raffaella/AAW-1433-2020; Jeziorska, Maria/P-1731-2015	Jeziorska, Maria/0000-0002-3492-0177	NMHEMC Research Foundation, Albuquerque NM USA	NMHEMC Research Foundation, Albuquerque NM USA	NMHEMC Research Foundation, Albuquerque NM USA	Appenzeller O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000636; Aufderheide A.C., 2003, SCI STUDY MUMMIES; Bowman CA, 2003, EPISODES, V26, P270, DOI 10.18814/epiiugs/2003/v26i4/001; Fern?ndez J., 1999, GEOARCHAEOLOGY, V14, P27, DOI DOI 10.1002/(SICI)1520-6548(199901)14:1<LESS; Guibaud G, 2005, CHEMOSPHERE, V59, P629, DOI 10.1016/j.chemosphere.2004.10.028; Guibaud G, 2006, CHEMOSPHERE, V64, P1955, DOI 10.1016/j.chemosphere.2006.01.012; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; HASTORF CA, 1990, AM ANTIQUITY, V55, P262, DOI 10.2307/281647; Higham TFG, 2006, RADIOCARBON, V48, P179, DOI 10.1017/S0033822200066388; JEZIORSKA M, 2005, P 5 WORLD C MUMM STU, V53, P229; LALLO R, 2005, P 5 WORLD C MUMM STU, V53, P107; Macko SA, 1999, PHILOS T ROY SOC B, V354, P65, DOI 10.1098/rstb.1999.0360; Massadeh AM, 2005, BIOL TRACE ELEM RES, V108, P259, DOI 10.1385/BTER:108:1-3:259; MEAGLIA D, 2005, P 5 WORLD C MUMM STU, V53, P110; Nee S, 2007, NATURE, V448, P413, DOI 10.1038/448413a; Ramsey CB, 2004, RADIOCARBON, V46, P17, DOI 10.1017/S0033822200039308; Ramsey CB, 2004, RADIOCARBON, V46, P155, DOI 10.1017/S0033822200039473; Reith F, 2006, SCIENCE, V313, P233, DOI 10.1126/science.1125878; Sharp ZD, 2003, J ARCHAEOL SCI, V30, P1709, DOI 10.1016/S0305-4403(03)00071-2; Torre C, 2000, J FORENSIC SCI, V45, P865	20	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2053	10.1371/journal.pone.0002053	http://dx.doi.org/10.1371/journal.pone.0002053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446229	Green Submitted, Green Published, gold			2022-12-27	WOS:000261572300022
J	Rudrappa, T; Splaine, RE; Biedrzycki, ML; Bais, HP				Rudrappa, Thimmaraju; Splaine, Robert E.; Biedrzycki, Meredith L.; Bais, Harsh P.			Cyanogenic Pseudomonads Influence Multitrophic Interactions in the Rhizosphere	PLOS ONE			English	Article							BIOFILM FORMATION; CYANIDE PRODUCTION; BACILLUS-SUBTILIS; CAENORHABDITIS-ELEGANS; MASTER REGULATOR; AERUGINOSA; GROWTH; AUXIN; RHIZOBACTERIA; BIOCONTROL	In the rhizosphere, plant roots cope with both pathogenic and beneficial bacterial interactions. The exometabolite production in certain bacterial species may regulate root growth and other root-microbe interactions in the rhizosphere. Here, we elucidated the role of cyanide production in pseudomonad virulence affecting plant root growth and other rhizospheric processes. Exposure of Arabidopsis thaliana Col-0 seedlings to both direct (with KCN) and indirect forms of cyanide from different pseudomonad strains caused significant inhibition of primary root growth. Further, we report that this growth inhibition was caused by the suppression of an auxin responsive gene, specifically at the root tip region by pseudomonad cyanogenesis. Additionally, pseudomonad cyanogenesis also affected other beneficial rhizospheric processes such as Bacillus subtilis colonization by biofilm formation on A. thaliana Col-0 roots. The effect of cyanogenesis on B. subtilis biofilm formation was further established by the down regulation of important B. subtilis biofilm operons epsA and yqxM. Our results show, the functional significance of pseudomonad cyanogenesis in regulating multitrophic rhizospheric interactions.	[Rudrappa, Thimmaraju; Splaine, Robert E.; Biedrzycki, Meredith L.; Bais, Harsh P.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA; [Rudrappa, Thimmaraju; Splaine, Robert E.; Biedrzycki, Meredith L.; Bais, Harsh P.] Delaware Biotechnol Inst, Newark, DE USA	University of Delaware	Rudrappa, T (corresponding author), Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA.	hbais@udel.edu	Rechsteiner, Cynthia/C-5894-2011		University of Delaware; EPSCoR	University of Delaware; EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	HPB acknowledges the University of Delaware and EPSCoR for faculty start-up grant. RES acknowledges the Science and Engineering program at University of Delaware for the undergraduate research funding support.	Albury MS, 1996, J BIOL CHEM, V271, P17062, DOI 10.1074/jbc.271.29.17062; ALSTROM S, 1989, BIOL FERT SOILS, V7, P232, DOI 10.1007/BF00709654; [Anonymous], [No title captured]; Antoun H, 1998, PLANT SOIL, V204, P57, DOI 10.1023/A:1004326910584; ASKELAND RA, 1983, APPL ENVIRON MICROB, V45, P1802, DOI 10.1128/AEM.45.6.1802-1807.1983; AUDUS LJ, 1960, ENCY PLANT PHYSL 2, V12, P360; Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; Ballhorn DJ, 2005, J CHEM ECOL, V31, P1445, DOI 10.1007/s10886-005-5791-2; Bano N, 2003, CURR MICROBIOL, V46, P324, DOI 10.1007/s00284-002-3857-8; BEGONIA MFT, 1994, FEMS MICROBIOL ECOL, V15, P227, DOI 10.1111/j.1574-6941.1994.tb00246.x; Blumer C, 2000, ARCH MICROBIOL, V173, P170, DOI 10.1007/s002039900127; BONNER J, 1952, ANNU REV PLANT PHYS, V3, P59, DOI 10.1146/annurev.pp.03.060152.000423; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Brinker A.M., 1989, PHYTOCHEMISTRY B, V21, P24; Britigan BE, 1999, INFECT IMMUN, V67, P1207, DOI 10.1128/IAI.67.3.1207-1212.1999; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; BUDZIKIEWICZ H, 1993, FEMS MICROBIOL LETT, V104, P209, DOI 10.1111/j.1574-6968.1993.tb05868.x; CALDOGNO FR, 1978, CELLULAR MOL LIFE SC, V34, P1948; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Castric P.A., 1981, CYANIDE BIOL, P233; CASTRIC PA, 1977, J BACTERIOL, V130, P826, DOI 10.1128/JB.130.2.826-831.1977; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; De Vleesschauwer D, 2006, MOL PLANT MICROBE IN, V19, P1406, DOI 10.1094/MPMI-19-1406; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Fukaki H, 2007, INT REV CYTOL, V256, P111, DOI 10.1016/S0074-7696(07)56004-3; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; GROSSMANN K, 1995, PLANT GROWTH REGUL, V16, P183, DOI 10.1007/BF00029539; Grossmann K, 2003, J PLANT GROWTH REGUL, V22, P109, DOI 10.1007/s00344-003-0020-0; Hamon MA, 2004, MOL MICROBIOL, V52, P847, DOI 10.1111/j.1365-2958.2004.04023.x; Hayden KJ, 2002, EVOL ECOL RES, V4, P155; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Jandhyala D, 2003, APPL ENVIRON MICROB, V69, P4794, DOI 10.1128/AEM.69.8.4794-4805.2003; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; KNOWLES CJ, 1986, ADV MICROB PHYSIOL, V27, P73, DOI 10.1016/S0065-2911(08)60304-5; Kremer RJ, 2001, CURR MICROBIOL, V43, P182, DOI 10.1007/s002840010284; Kremer RJ, 1996, WEED TECHNOL, V10, P601, DOI 10.1017/S0890037X00040525; Laville J, 1998, J BACTERIOL, V180, P3187, DOI 10.1128/JB.180.12.3187-3196.1998; LEONOVA LA, 1985, J PLANT GROWTH REGUL, V4, P169, DOI 10.1007/BF02266954; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Olvera C, 1999, FEMS MICROBIOL LETT, V179, P85, DOI 10.1111/j.1574-6968.1999.tb08712.x; Pessi G, 2000, J BACTERIOL, V182, P6940, DOI 10.1128/JB.182.24.6940-6949.2000; Raghavendra AS, 2003, TRENDS PLANT SCI, V8, P546, DOI 10.1016/j.tplants.2003.09.015; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rennert T, 2002, J ENVIRON QUAL, V31, P745, DOI 10.2134/jeq2002.0745; RODGERS PB, 1978, J GEN MICROBIOL, V108, P261, DOI 10.1099/00221287-108-2-261; RUDRAPPA T, 2007, PLANT SIGNAL BEHAV, V2, pE1; RUDRAPPA T, 2007, PLANT SIGNAL BEHAV, V2, P5; Rudrappa T, 2007, PLANTA, V226, P283, DOI 10.1007/s00425-007-0480-8; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; SIEDOW JN, 2000, BIOCHIM BIOPHYS ACTA, V15, P432; Silo-Suh L, 2002, P NATL ACAD SCI USA, V99, P15699, DOI 10.1073/pnas.242343999; Tattersall DB, 2001, SCIENCE, V293, P1826, DOI 10.1126/science.1062249; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; Terada LS, 1999, INFECT IMMUN, V67, P2371, DOI 10.1128/IAI.67.5.2371-2376.1999; Ulmasov T, 1997, SCIENCE, V276, P1865, DOI 10.1126/science.276.5320.1865; Umbach AL, 2006, BBA-BIOENERGETICS, V1757, P135, DOI 10.1016/j.bbabio.2005.12.005; VINING LC, 1990, ANNU REV MICROBIOL, V44, P395, DOI 10.1146/annurev.mi.44.100190.002143; VOISARD C, 1994, MOLECULAR ECOLOGY OF RHIZOSPHERE MICROORGANISMS, P67, DOI 10.1002/9783527615810.ch6; Walker TS, 2004, PLANT PHYSIOL, V134, P320, DOI 10.1104/pp.103.027888; Wood WB, 1988, NEMATODE CAENORHABDI; Zeller SL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000846; Zlosnik JEA, 2004, LETT APPL MICROBIOL, V38, P360, DOI 10.1111/j.1472-765X.2004.01489.x	67	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2073	10.1371/journal.pone.0002073	http://dx.doi.org/10.1371/journal.pone.0002073			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446201	Green Published, gold, Green Submitted			2022-12-27	WOS:000261572300042
J	Van Raam, BJ; Sluiter, W; de Wit, E; Roos, D; Verhoeven, AJ; Kuijpers, TW				Van Raam, Bram J.; Sluiter, Wim; de Wit, Elly; Roos, Dirk; Verhoeven, Arthur J.; Kuijpers, Taco W.			Mitochondrial Membrane Potential in Human Neutrophils Is Maintained by Complex III Activity in the Absence of Supercomplex Organisation	PLOS ONE			English	Article								Background: Neutrophils depend mainly on glycolysis for their energy provision. Their mitochondria maintain a membrane potential (Delta psi(m)), which is usually generated by the respiratory chain complexes. We investigated the source of Dym in neutrophils, as compared to peripheral blood mononuclear leukocytes and HL-60 cells, and whether neutrophils can still utilise this Dym for the generation of ATP. Methods and Principal Findings: Individual activity of the oxidative phosphorylation complexes was significantly reduced in neutrophils, except for complex II and V, but Dym was still decreased by inhibition of complex III, confirming the role of the respiratory chain in maintaining Dym. Complex V did not maintain Dym by consumption of ATP, as has previously been suggested for eosinophils. We show that complex III in neutrophil mitochondria can receive electrons from glycolysis via the glycerol-3-phosphate shuttle. Furthermore, respiratory supercomplexes, which contribute to efficient coupling of the respiratory chain to ATP synthesis, were lacking in neutrophil mitochondria. When HL-60 cells were differentiated to neutrophil-like cells, they lost mitochondrial supercomplex organisation while gaining increased aerobic glycolysis, just like neutrophils. Conclusions: We show that neutrophils can maintain Dym via the glycerol-3-phosphate shuttle, whereby their mitochondria play an important role in the regulation of aerobic glycolysis, rather than producing energy themselves. This peculiar mitochondrial phenotype is acquired during differentiation from myeloid precursors.	[Van Raam, Bram J.; Roos, Dirk; Verhoeven, Arthur J.; Kuijpers, Taco W.] Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, Amsterdam, Netherlands; [Van Raam, Bram J.; Kuijpers, Taco W.] Univ Amsterdam, Dept Paediat Immunol, Academ Med Ctr, Emma Childrens Hosp, Amsterdam, Netherlands; [Sluiter, Wim; de Wit, Elly] Erasmus MC, Mitochondrial Res Unit, Dept Biochem, Rotterdam, Netherlands	University of Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC	Van Raam, BJ (corresponding author), Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, Amsterdam, Netherlands.	a.verhoeven@sanquin.nl	van Raam, Bram/C-4121-2011	van Raam, Bram/0000-0002-6500-2731	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [917.46.319]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission)	This work was supported by a grant from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO-Vidi scheme 917.46.319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; ALLEN RD, 1989, J CELL BIOL, V108, P2233, DOI 10.1083/jcb.108.6.2233; Antonicka H, 2003, J BIOL CHEM, V278, P43081, DOI 10.1074/jbc.M304998200; BERKICH DA, 1991, J BIOL CHEM, V266, P123; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Boekema EJ, 2007, J BIOL CHEM, V282, P1, DOI 10.1074/jbc.R600031200; BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; Carrozzo R, 2006, ANN NEUROL, V59, P265, DOI 10.1002/ana.20729; D'Aurelio M, 2006, HUM MOL GENET, V15, P2157, DOI 10.1093/hmg/ddl141; de Wit LEA, 2007, J IMMUNOL METHODS, V326, P76, DOI 10.1016/j.jim.2007.07.009; Dudkina NV, 2005, FEBS LETT, V579, P5769, DOI 10.1016/j.febslet.2005.09.065; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Fossati G, 2003, J IMMUNOL, V170, P1964, DOI 10.4049/jimmunol.170.4.1964; Gao YQ, 2005, CELL, V123, P195, DOI 10.1016/j.cell.2005.10.001; Genova Maria Luisa, 2003, Ital J Biochem, V52, P58; Kuijpers TW, 2004, BLOOD, V103, P3915, DOI 10.1182/blood-2003-11-3940; Lefebvre-Legendre L, 2003, MOL MICROBIOL, V47, P1329, DOI 10.1046/j.1365-2958.2003.03371.x; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; Matmati M, 2007, J LEUKOCYTE BIOL, V81, P440, DOI 10.1189/jlb.0406276; Murphy BM, 2003, J EXP MED, V197, P625, DOI 10.1084/jem.20021862; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; Peachman KK, 2001, P NATL ACAD SCI USA, V98, P1717, DOI 10.1073/pnas.98.4.1717; Peyssonnaux C, 2004, CELL CYCLE, V3, P168; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Roos D, 2003, MICROBES INFECT, V5, P1307, DOI 10.1016/j.micinf.2003.09.009; Roos D, 1986, Methods Enzymol, V132, P225; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; Schagger H, 2001, J BIOL CHEM, V276, P37861; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; SYROESHKIN AV, 1995, FEBS LETT, V366, P29, DOI 10.1016/0014-5793(95)00487-T; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006	38	102	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2013	10.1371/journal.pone.0002013	http://dx.doi.org/10.1371/journal.pone.0002013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431494	Green Submitted, Green Published, gold			2022-12-27	WOS:000261558700029
J	Weldingh, K; Andersen, P				Weldingh, Karin; Andersen, Peter			ESAT-6/CFP10 Skin Test Predicts Disease in M-tuberculosis-Infected Guinea Pigs	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; SUBUNIT VACCINE; ANTIGENS; DIAGNOSIS; PROTEIN; FUSION; CATTLE; GAMMA	Background: Targeted preventive chemotherapy of individuals with progressive subclinical (incipient) disease before it becomes contagious would break the chain of tuberculosis transmission in high endemic regions. We have studied the ability of a skin test response to ESAT-6 and CFP10 (E6/C10) to predict later development of tuberculosis disease in the guinea pig model. Methods and Findings: Guinea pigs, either vaccinated with BCG or unvaccinated, were infected with a low dose of Mycobacterium tuberculosis by the aerosol route and the development of delayed type hypersensitivity responses to E6/C10 and to purified protein derivative (PPD) were followed until the onset of clinical disease. We demonstrated a negative correlation between the size of the skin test response and the time to the onset of clinical disease; a large E6/C10 skin test response correlated to a shorter survival time post skin testing, while a small E6/C10 skin test reaction correlated with a longer survival time (r = 20.6 and P < 0.0001). No correlation was found using PPD. Conclusions: Our data suggest that it may be possible to develop a prognostic skin test based on E6/C10 that will allow the identification of individuals with incipient disease, who have the highest risk of developing active tuberculosis in the near future.	[Weldingh, Karin; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Weldingh, K (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	kwe@ssi.dk		Andersen, Peter/0000-0002-5869-2551				ANDERSEN P, 1995, J IMMUNOL, V154, P3359; Andersen P, 2007, TRENDS MOL MED, V13, P175, DOI 10.1016/j.molmed.2007.03.004; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; AREND SM, 2007, TUBERCULOSIS ED 1221; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Buddle BM, 1999, CLIN DIAGN LAB IMMUN, V6, P1; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Doherty TM, 2005, CLIN MICROBIOL REV, V18, P687, DOI 10.1128/CMR.18.4.687-702.2005; Doherty TM, 2002, J CLIN MICROBIOL, V40, P704, DOI 10.1128/JCM.40.2.704-706.2002; Harboe M, 1998, INFECT IMMUN, V66, P717, DOI 10.1128/IAI.66.2.717-723.1998; Hill PC, 2005, CLIN INFECT DIS, V40, P273, DOI 10.1086/427030; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Olsen AW, 2004, INFECT IMMUN, V72, P6148, DOI 10.1128/IAI.72.10.6148-6150.2004; Orme IM, 2001, TRENDS MICROBIOL, V9, P115, DOI 10.1016/S0966-842X(00)01949-1; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Shi L, 2004, INFECT IMMUN, V72, P2420, DOI 10.1128/IAI.72.4.2420-2424.2004; Styblo K, 1980, Adv Tuberc Res, V20, P1; van Pinxteren LAH, 2000, CLIN DIAGN LAB IMMUN, V7, P155, DOI 10.1128/CDLI.7.2.155-160.2000; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Whalen CC, 2005, JAMA-J AM MED ASSOC, V293, P2785, DOI 10.1001/jama.293.22.2785; *WHO, 2006, GLOB TUB CONTR SURV; WHO/UNAIDS, 1999, WEEKLY EPIDEMIOLOGIC, V74, P385; Williams A, 2005, TUBERCULOSIS, V85, P29, DOI 10.1016/j.tube.2004.09.009	25	26	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1978	10.1371/journal.pone.0001978	http://dx.doi.org/10.1371/journal.pone.0001978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431468	Green Submitted, Green Published, gold			2022-12-27	WOS:000261558700003
J	Yang, ZJ; Price, CD; Bosco, G; Tucci, M; El-Badri, NS; Mangar, D; Camporesi, EM				Yang, Zhong-Jin; Price, Chrystal D.; Bosco, Gerardo; Tucci, Micheal; El-Badri, Nagwa S.; Mangar, Devanand; Camporesi, Enrico M.			The Effect of Isovolemic Hemodilution with Oxycyte (R), a Perfluorocarbon Emulsion, on Cerebral Blood Flow in Rats	PLOS ONE			English	Article								Background: Cerebral blood flow (CBF) is auto-regulated to meet the brain's metabolic requirements. Oxycyte (R) is a perfluorocarbon emulsion that acts as a highly effective oxygen carrier compared to blood. The aim of this study is to determine the effects of Oxycyte (R) on regional CBF (rCBF), by evaluating the effects of stepwise isovolemic hemodilution with Oxycyte (R) on CBF. Methodology: Male rats were intubated and ventilated with 100% O-2 under isoflurane anesthesia. The regional (striatum) CBF (rCBF) was measured with a laser doppler flowmeter (LDF). Stepwise isovolemic hemodilution was performed by withdrawing 4ml of blood and substituting the same volume of 5% albumin or 2 ml Oxycyte (R) plus 2 ml albumin at 20-minute intervals until the hematocrit (Hct) values reached 5%. Principal Findings: In the albumin-treated group, rCBF progressively increased to approximately twice its baseline level (208 +/- 30%) when Hct levels were less than 10%. In the Oxycyte (R)-treated group on the other hand, rCBF increased by significantly smaller increments, and this group's mean rCBF was only slightly higher than baseline (118 +/- 18%) when Hct levels were less than 10%. Similarly, in the albumin-treated group, rCBF started to increase when hemodilution with albumin caused the CaO2 to decrease below 17.5 ml/dl. Thereafter, the increase in rCBF was accompanied by a nearly proportional decrease in the CaO2 level. In the Oxycyte (R)-treated group, the increase in rCBF was significantly smaller than in the albumin-treated group when the CaO2 level dropped below 10 ml/dl (142 +/- 20% vs. 186 +/- 26%), and rCBF returned to almost baseline levels (106 +/- 15) when the CaO2 level was below 7 ml/dl. Conclusions/Significance: Hemodilution with Oxycyte (R) was accompanied with higher CaO2 and PO2 than control group treated with albumin alone. This effect may be partially responsible for maintaining relatively constant CBF and not allowing the elevated blood flow that was observed with albumin.	[Price, Chrystal D.; El-Badri, Nagwa S.; Mangar, Devanand; Camporesi, Enrico M.] Univ S Florida, Dept Anesthesiol, Tampa, FL USA; [Yang, Zhong-Jin; Tucci, Micheal] SUNY Upstate Med Univ, Dept Anesthesiol, Syracuse, NY USA; [Bosco, Gerardo] Univ G dAnnunzio, Dept Physiol, Chieti, Italy	State University System of Florida; University of South Florida; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; G d'Annunzio University of Chieti-Pescara	Camporesi, EM (corresponding author), Univ S Florida, Dept Anesthesiol, Tampa, FL USA.	ecampore@health.usf.edu		BOSCO, GERARDO/0000-0001-6595-7944	Synthetic Blood International Inc. Costa Mesa, CA	Synthetic Blood International Inc. Costa Mesa, CA	The authors thank Synthetic Blood International Inc (Synthetic Blood International Inc. Costa Mesa, CA) for providing Oxycyte and an education grant that partially supported this work.	Briceno JC, 1997, ASAIO J, V43, P13; Briceno JC, 1999, ASAIO J, V45, P322, DOI 10.1097/00002480-199907000-00013; Cabrales P, 2004, AM J PHYSIOL-HEART C, V287, pH320, DOI 10.1152/ajpheart.01166.2003; Daugherty WP, 2004, NEUROSURGERY, V54, P1223, DOI 10.1227/01.NEU.0000119238.68938.5D; ECKSTEIN EC, 1989, T AM SOC ART INT ORG, V35, P188; FAITHFULL NS, 1992, BIOMAT ARTIF CELL IM, V20, P797, DOI 10.3109/10731199209119721; Faithfull NS, 2003, ADV EXP MED BIOL, V530, P271; Harada H, 2005, BRAIN RES PROTOC, V14, P165, DOI 10.1016/j.brainresprot.2004.12.007; Hill SE, 2005, ANN THORAC SURG, V80, P1401, DOI 10.1016/j.athoracsur.2005.03.107; HIRAGA S, 1987, CANCER RES, V47, P3296; HOLMAN WL, 1995, J THORAC CARDIOV SUR, V110, P774, DOI 10.1016/S0022-5223(95)70111-7; Jouan-Hureaux V, 2006, TRANSFUSION, V46, P1892, DOI 10.1111/j.1537-2995.2006.01000.x; KEIPERT PE, 1994, ADV EXP MED BIOL, V345, P197; KLINE RA, 1991, AM J SURG, V162, P103, DOI 10.1016/0002-9610(91)90168-D; LEE PA, 1988, AM J PHYSIOL, V254, pH719, DOI 10.1152/ajpheart.1988.254.4.H719; LEE PA, 1986, EXP MED BIOL, V200, P59; Lowe KC, 2001, J FLUORINE CHEM, V109, P59, DOI 10.1016/S0022-1139(01)00374-8; Lowe KC, 1999, BLOOD REV, V13, P171, DOI 10.1054/blre.1999.0113; Nolte D, 2000, ANESTHESIOLOGY, V93, P1261, DOI 10.1097/00000542-200011000-00020; Paxinos G, 1988, RAT BRAIN STEREOTAXI; PEERLESS SJ, 1981, STROKE, V12, P558, DOI 10.1161/01.STR.12.5.558; TODD MM, 1994, AM J PHYSIOL-HEART C, V267, pH2025, DOI 10.1152/ajpheart.1994.267.5.H2025; Todd MM, 1997, J CEREBR BLOOD F MET, V17, P1319, DOI 10.1097/00004647-199712000-00007; Tomiyama Y, 1999, AM J PHYSIOL-HEART C, V276, pH1190, DOI 10.1152/ajpheart.1999.276.4.H1190; Tomiyama Y, 2000, AM J PHYSIOL-HEART C, V279, pH1949, DOI 10.1152/ajpheart.2000.279.4.H1949; Tonnesen J, 2005, EXP PHYSIOL, V90, P349, DOI 10.1113/expphysiol.2004.029512; Vocelka C, 1995, J Extra Corpor Technol, V27, P6; WASCHKE KF, 1994, ANESTH ANALG, V79, P874; Woitzik J, 2005, NEUROL RES, V27, P509, DOI 10.1179/016164105X15677; Woitzik J, 2007, J NEUROSURG, V106, P872, DOI 10.3171/jns.2007.106.5.872	30	9	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2010	10.1371/journal.pone.0002010	http://dx.doi.org/10.1371/journal.pone.0002010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431491	Green Published, Green Submitted, gold			2022-12-27	WOS:000261558700026
J	Bronmark, C; Skov, C; Brodersen, J; Nilsson, PA; Hansson, LA				Broenmark, Christer; Skov, Christian; Brodersen, Jakob; Nilsson, P. Anders; Hansson, Lars-Anders			Seasonal Migration Determined by a Trade-Off between Predator Avoidance and Growth	PLOS ONE			English	Article							ROACH; FISH; RISK; DIEL; TEMPERATURE; COMMUNITY; REFUGES; SHIFTS; MODEL	Migration is a common phenomenon in many organisms, terrestrial as well as aquatic, and considerable effort has been spent to understand the evolution of migratory behaviour and its consequences for population and community dynamics. In aquatic systems, studies on migration have mainly been focused on commercially important fish species, such as salmon and trout. However, seasonal mass-migrations may occur also among other freshwater fish, e. g. in cyprinids that leave lakes and migrate into streams and wetlands in the fall and return back to the lake in spring. In a conceptual model, we hypothesized that this is an adaptive behaviour in response to seasonal changes in predation (P) and growth (G) and that migrating fish change habitat so as to minimise the ratio between predation mortality and growth rate (P/G). Estimates from bioenergetic modelling showed that seasonal changes in the ratio between predator consumption rate and prey growth rate followed the predictions from the conceptual model and also gave more precise predictions for the timing of the habitat change. By quantifying the migration of more than 1800 individually marked fish, we showed that actual migration patterns followed predictions with a remarkable accuracy, suggesting that migration patterns have evolved in response to seasonally fluctuating trade-offs between predator avoidance and foraging gains. Thus, the conceptual model provides a mechanistic understanding to mass-migration in prey fish. Further, we also show that the dominant prey fish is actually absent from the lake during a major part of the year, which should have strong implications for the dynamics of the lake ecosystem through direct and indirect food-web interactions.	[Broenmark, Christer; Brodersen, Jakob; Nilsson, P. Anders; Hansson, Lars-Anders] Lund Univ, Dept Ecol, S-22362 Lund, Sweden; [Skov, Christian] Danish Inst Fisheries Res, Silkeborg, Denmark	Lund University	Bronmark, C (corresponding author), Lund Univ, Dept Ecol, S-22362 Lund, Sweden.	christer.bronmark@limnol.lu.se	Nilsson, Anders/H-6836-2014; Skov, Christian/X-6511-2019; Hansson, Lars-Anders/HCI-2735-2022	Nilsson, Anders/0000-0002-3541-9835; Skov, Christian/0000-0002-8547-6520; Hansson, Lars-Anders/0000-0002-3035-1317	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Danish National Science Research Council	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Danish National Science Research Council	Funding was received from the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning. Additional funds were received from the Danish National Science Research Council. These are governmental research councils financing basic and applied research. They have no role in the actual study or preparation of manuscript.	BAKER R R, 1978, P1012; Borcherding J, 2002, J FISH BIOL, V61, P1154, DOI 10.1006/jfbi.2002.2129; BRABRAND A, 1993, OECOLOGIA, V95, P38, DOI 10.1007/BF00649504; BRODERSEN J, 2008, OIKOS IN PRESS; CASSELMAN JM, 1978, AM FISH SOC SPEC PUB, V11, P114; Castro-Santos T, 1996, FISH RES, V28, P253, DOI 10.1016/0165-7836(96)00514-0; CERRI RD, 1983, AM NAT, V121, P552, DOI 10.1086/284082; CLARK CW, 1988, AM NAT, V131, P271, DOI 10.1086/284789; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Dodson Julian J., 1997, P10; EKLOV P, 1995, BEHAV ECOL SOCIOBIOL, V37, P169, DOI 10.1007/s002650050178; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; GAUTHREAUX SA, 1980, ANIMAL MIGRATION ORI, P387; GILLIAM JF, 1987, ECOLOGY, V68, P1856, DOI 10.2307/1939877; Hansson LA, 2007, LIMNOL OCEANOGR, V52, P696, DOI 10.4319/lo.2007.52.2.0696; HE X, 1990, T AM FISH SOC, V119, P825, DOI 10.1577/1548-8659(1990)119<0825:DAIEOP>2.3.CO;2; Jepsen N, 2002, HYDROBIOLOGIA, V483, P167, DOI 10.1023/A:1021379528719; Jobling M., 1994, FISH BIOENERGETICS, P309; Johnson, 1997, FISH BIOENERGETICS; JONSSON B, 1993, REV FISH BIOL FISHER, V3, P348, DOI 10.1007/BF00043384; JORDAN DR, 1985, J FISH BIOL, V27, P163, DOI 10.1111/j.1095-8649.1985.tb03239.x; KAUFMANN R, 1992, ENVIRON BIOL FISH, V33, P87, DOI 10.1007/BF00002556; Koyama A, 2005, CAN J FISH AQUAT SCI, V62, P518, DOI [10.1139/f04-220, 10.1139/F04-220]; LESSMARK O, 1983, THESIS LUND U LUND; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lucas MC., 2001, MIGRATION FRESHWATER, DOI [10.1002/9780470999653, DOI 10.1002/9780470999653]; MAGNUSON JJ, 1985, ENVIRON BIOL FISH, V14, P241, DOI 10.1007/BF00002627; NASLUND I, 1990, J FISH BIOL, V36, P401, DOI 10.1111/j.1095-8649.1990.tb05620.x; Nilsson PA, 2006, OIKOS, V113, P251; Nilsson PA, 2000, OIKOS, V88, P539, DOI 10.1034/j.1600-0706.2000.880310.x; Northcote T.G., 1978, P326; PETTERSSON LB, 1993, OECOLOGIA, V95, P353, DOI 10.1007/BF00320988; Romare P, 2003, LIMNOL OCEANOGR, V48, P1956, DOI 10.4319/lo.2003.48.5.1956; Schindler DE, 1999, CAN J FISH AQUAT SCI, V56, P61, DOI 10.1139/cjfas-56-S1-61; Skov C, 2005, J FISH BIOL, V67, P1195, DOI 10.1111/j.1095-8649.2005.00814.x; Tarling G, 2000, CAN J FISH AQUAT SCI, V57, P38, DOI 10.1139/cjfas-57-S3-38; TURNER AM, 1990, ECOLOGY, V71, P2241, DOI 10.2307/1938636; van Dijk PLM, 2002, OECOLOGIA, V130, P496, DOI 10.1007/s00442-001-0830-3; WERNER EE, 1983, ECOLOGY, V64, P1525, DOI 10.2307/1937507; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; [No title captured]	41	99	100	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1957	10.1371/journal.pone.0001957	http://dx.doi.org/10.1371/journal.pone.0001957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414660	Green Submitted, Green Published, gold			2022-12-27	WOS:000260867300009
J	Charlier, C; Dromer, F; Leveque, C; Chartier, L; Cordoliani, YS; Fontanet, A; Launay, O; Lortholary, O				Charlier, Caroline; Dromer, Francoise; Leveque, Christophe; Chartier, Loic; Cordoliani, Yves-Sebastien; Fontanet, Arnaud; Launay, Odile; Lortholary, Olivier		French Cryptococcosis Study Grp	Cryptococcal Neuroradiological Lesions Correlate with Severity during Cryptococcal Meningoencephalitis in HIV-Positive Patients in the HAART Era	PLOS ONE			English	Article							INTRACEREBRAL MASS LESIONS; UNCONTROLLABLE INTRACRANIAL HYPERTENSION; RECONSTITUTION INFLAMMATORY SYNDROME; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; CNS CRYPTOCOCCOSIS; VENTRICULOPERITONEAL SHUNTS; NEOFORMANS INFECTION; CEREBROSPINAL-FLUID; AIDS PATIENTS; MENINGITIS	Cryptococcal meningoencephalitis has an overall global mortality rate of 20% in AIDS patients despite antifungals. There is a need for additional means of precise assessment of disease severity. We thus studied the radiological brain images available from 62 HIV-positive patients with cryptococcocal meningoencephalitis to analyse the brain lesions associated with cryptococcosis in relationship with disease severity, and the respective diagnostic contribution of magnetic resonance (MR) versus computed tomography (CT). In this retrospective multicenter analysis, two neuroradiologists blindly reviewed the brain imaging. Prospectively acquired clinical and mycological data were available at baseline and during follow-up. Baseline images were abnormal on 92% of the MR scans contrasting with 53% of the CT scans. MR/CT cryptococcosis-related lesions included mass(es) (21%/9%), dilated perivascular spaces (46%/5%) and pseudocysts (8%/4%). The presence compared to absence of cryptococcosis-related lesions was significantly associated with high serum (78% vs. 42%, p = 0.008) and CSF (81% vs. 50%, p = 0.024) antigen titers, independently of neurological abnormalities. MR detected significantly more cryptococcosis-related lesions than CT for 17 patients who had had both investigations (76% vs. 24%, p = 0.005). In conclusion, MR appears more effective than CT for the evaluation of AIDS-associated cerebral cryptococcosis. Furthermore, brain imaging is an effective tool to assess the initial disease severity in this setting. Given this, we suggest that investigation for cryptococcosis-related lesions is merited, even in the absence of neurological abnormality, if a high fungal burden is suspected on the basis of high serum and/or CSF antigen titers.	[Charlier, Caroline; Dromer, Francoise; Lortholary, Olivier] Inst Pasteur, CNRS, Ctr Natl Reference Mycol & Antifong,URA 3012, Unite Mycol Mol, Paris, France; [Charlier, Caroline; Lortholary, Olivier] Ctr Infectiol Necker Pasteur, Serv Maladies Infect Trop, Hop Necker Enfants Malades, Fac Med Paris 5 Rene Descartes, Paris, France; [Leveque, Christophe; Cordoliani, Yves-Sebastien] Hop Val De Grace, Serv Radiodiagnost, Paris, France; [Chartier, Loic; Fontanet, Arnaud] Inst Pasteur, Unite Rech Expertise Epidemiol Malad Emergent, Paris, France; [Launay, Odile] CIC Vaccinol Cochin Pasteur, Pole Med Interne, Hop Cochin, Fac Med, Univ Paris Descartes, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Val-de-Grace Hospital; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Charlier, C (corresponding author), Inst Pasteur, CNRS, Ctr Natl Reference Mycol & Antifong,URA 3012, Unite Mycol Mol, Paris, France.	olortho@pasteur.fr	BRETAGNE, Stephane/H-6655-2019; Charlier, Caroline/AAH-8547-2020	BRETAGNE, Stephane/0000-0001-6870-3800; Charlier, Caroline/0000-0002-9375-3620; Baril, Laurence/0000-0003-2346-883X; , arnaud/0000-0002-5239-6110; Lozeron, Pierre/0000-0003-0816-6526	fellowship from the Assistance Publique-Hopitaux de Paris; CNRS; CANAM; Ensemble contre le SIDA - SIDACTION; Institut Pasteur	fellowship from the Assistance Publique-Hopitaux de Paris; CNRS(Centre National de la Recherche Scientifique (CNRS)); CANAM; Ensemble contre le SIDA - SIDACTION; Institut Pasteur(European Commission)	C. Charlier had a fellowship from the Assistance Publique-Hopitaux de Paris: medaille de l'Internat 2006 and from the Assistance Publique-Hopitaux de Paris, CNRS and CANAM: poste assistant hospitalier de recherche 2006 2007. The CryptoA/D study was financially supported by grants from Ensemble contre le SIDA - SIDACTION and from Institut Pasteur (Programme de recherches cliniques).	ANDREULA CF, 1993, J COMPUT ASSIST TOMO, V17, P438, DOI 10.1097/00004728-199305000-00019; Angstwurm K, 2004, EUR J NEUROL, V11, P353, DOI 10.1111/j.1468-1331.2004.00803.x; Arayawichanont Arkhom, 1999, Journal of the Medical Association of Thailand, V82, P991; Berkefeld J, 1999, NEURORADIOLOGY, V41, P129, DOI 10.1007/s002340050717; Bouffard JP, 2003, MOVEMENT DISORD, V18, P1354, DOI 10.1002/mds.10546; BOUREKAS EC, 1995, J COMPUT ASSIST TOMO, V19, P299, DOI 10.1097/00004728-199503000-00024; CENCI E, 2007, J INFECT; Charlier C, 2005, AM J PATHOL, V166, P421, DOI 10.1016/S0002-9440(10)62265-1; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Cheng Yu-Chen, 2003, J Chin Med Assoc, V66, P19; Chretien F, 2002, J INFECT DIS, V186, P522, DOI 10.1086/341564; CIRICILLO SF, 1990, J NEUROSURG, V73, P720, DOI 10.3171/jns.1990.73.5.0720; CORDOLIANI YS, 1997, ENCY MEDICOCHIRURGIC; CORNELL SH, 1982, RADIOLOGY, V143, P703, DOI 10.1148/radiology.143.3.7079496; DarrasJoly C, 1996, CLIN INFECT DIS, V23, P369, DOI 10.1093/clinids/23.2.369; DENNING DW, 1991, AM J MED, V91, P267, DOI 10.1016/0002-9343(91)90126-I; Dromer F, 2004, AIDS, V18, P555, DOI 10.1097/00002030-200402200-00024; Dromer F, 2007, PLOS MED, V4, P297, DOI 10.1371/journal.pmed.0040021; Einsiedel L, 2004, CLIN INFECT DIS, V39, pE78, DOI 10.1086/424746; FUJITA NK, 1981, ANN INTERN MED, V94, P382, DOI 10.7326/0003-4819-94-3-382; GARCIA CA, 1985, NEUROLOGY, V35, P731, DOI 10.1212/WNL.35.5.731; Gray F, 2003, J NEUROPATH EXP NEUR, V62, P429, DOI 10.1093/jnen/62.5.429; Graybill JR, 2000, CLIN INFECT DIS, V30, P47, DOI 10.1086/313603; Hospenthal DR, 2000, CLIN INFECT DIS, V31, P1303, DOI 10.1086/317434; Kumwenda JJ, 2005, STROKE, V36, P960, DOI 10.1161/01.STR.0000162585.97216.ef; Lee SC, 1996, HUM PATHOL, V27, P839, DOI 10.1016/S0046-8177(96)90459-1; Lee VW, 1999, RADIOLOGY, V211, P507, DOI 10.1148/radiology.211.2.r99ma37507; Leveque C, 2002, ANN MED INTERNE, V153, P338; Liliang PC, 2002, CLIN INFECT DIS, V34, pE64, DOI 10.1086/340525; Lortholary O, 2005, AIDS, V19, P1043, DOI 10.1097/01.aids.0000174450.70874.30; Lortholary O, 1999, INFECT IMMUN, V67, P6314; Lortholary O, 2001, J INFECT DIS, V183, P294, DOI 10.1086/317937; MALESSA R, 1994, CLIN INVESTIGATOR, V72, P1020, DOI 10.1007/BF00577748; MATHEWS VP, 1992, AM J NEURORADIOL, V13, P1477; Mirza SA, 2003, CLIN INFECT DIS, V36, P789, DOI 10.1086/368091; Miszkiel KA, 1996, CLIN RADIOL, V51, P842, DOI 10.1016/S0009-9260(96)80080-8; Monari C, 2005, J INFECT DIS, V191, P307, DOI 10.1086/426828; Moosa MYS, 1997, CLIN INFECT DIS, V24, P131, DOI 10.1093/clinids/24.2.131; Park MK, 1999, CLIN INFECT DIS, V28, P629, DOI 10.1086/515161; POPOVICH MJ, 1990, AM J ROENTGENOL, V154, P603, DOI 10.2214/ajr.154.3.2106227; POST MJD, 1985, AM J ROENTGENOL, V145, P929, DOI 10.2214/ajr.145.5.929; Rambeloarisoa J, 2002, J INFECTION, V44, P185, DOI 10.1053/jinf.2001.0955; Ruiz A, 1997, J COMPUT ASSIST TOMO, V21, P175, DOI 10.1097/00004728-199703000-00003; Saag MS, 2000, CLIN INFECT DIS, V30, P710, DOI 10.1086/313757; SanchezPortocarrero J, 1997, DIAGN MICR INFEC DIS, V29, P193, DOI 10.1016/S0732-8893(97)81809-3; SCHMIDT S, 1995, CLIN NEUROL NEUROSUR, V97, P23, DOI 10.1016/0303-8467(94)00063-C; Schroeder PC, 2006, NEURORADIOLOGY, V48, P715, DOI 10.1007/s00234-006-0123-y; Skiest Daniel J, 2005, J Infect, V51, pe289, DOI 10.1016/j.jinf.2005.02.031; Skiest DJ, 2000, J INFECTION, V40, P274, DOI 10.1053/jinf.2000.0664; TIEN RD, 1991, AM J NEURORADIOL, V12, P283; Torres OH, 2000, ACTA NEUROL SCAND, V102, P340, DOI 10.1034/j.1600-0404.2000.102005340.x; Troncoso Alcides, 2002, J Int Assoc Physicians AIDS Care (Chic), V1, P131, DOI 10.1177/154510970200100404; van Toorn R, 2005, EUR J PAEDIATR NEURO, V9, P355, DOI 10.1016/j.ejpn.2005.02.002; van Toorn R, 2005, EUR J PAEDIATR NEURO, V9, P81, DOI 10.1016/j.ejpn.2005.01.001; Venkataramana A, 2006, NEUROLOGY, V67, P383, DOI 10.1212/01.wnl.0000227922.22293.93; WEHN SM, 1989, J COMPUT ASSIST TOMO, V13, P756, DOI 10.1097/00004728-198909000-00002; Woodworth GF, 2005, SURG NEUROL, V63, P529, DOI 10.1016/j.surneu.2004.08.069; ZUGER A, 1986, ANN INTERN MED, V104, P234, DOI 10.7326/0003-4819-104-2-234	58	78	82	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1950	10.1371/journal.pone.0001950	http://dx.doi.org/10.1371/journal.pone.0001950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414656	Green Published, gold, Green Submitted			2022-12-27	WOS:000260867300005
J	Rempel, H; Calosing, C; Sun, B; Pulliam, L				Rempel, Hans; Calosing, Cyrus; Sun, Bing; Pulliam, Lynn			Sialoadhesin Expressed on IFN-Induced Monocytes Binds HIV-1 and Enhances Infectivity	PLOS ONE			English	Article								Background: HIV-1 infection dysregulates the immune system and alters gene expression in circulating monocytes. Differential gene expression analysis of CD14(+) monocytes from subjects infected with HIV-1 revealed increased expression of sialoadhesin (Sn, CD169, Siglec 1), a cell adhesion molecule first described in a subset of macrophages activated in chronic inflammatory diseases. Methodology/Principal Findings: We analyzed sialoadhesin expression on CD14+ monocytes by flow cytometry and found significantly higher expression in subjects with elevated viral loads compared to subjects with undetectable viral loads. In cultured CD14(+) monocytes isolated from healthy individuals, sialoadhesin expression was induced by interferon-alpha and interferon-gamma but not tumor necrosis factor-alpha. Using a stringent binding assay, sialoadhesin-expressing monocytes adsorbed HIV-1 through interaction with the sialic acid residues on the viral envelope glycoprotein gp120. Furthermore, monocytes expressing sialoadhesin facilitated HIV-1 trans infection of permissive cells, which occurred in the absence of monocyte self-infection. Conclusions/Significance: Increased sialoadhesin expression on CD14(+) monocytes occurred in response to HIV-1 infection with maximum expression associated with high viral load. We show that interferons induce sialoadhesin in primary CD14(+) monocytes, which is consistent with an antiviral response during viremia. Our findings suggest that circulating sialoadhesin-expressing monocytes are capable of binding HIV-1 and effectively delivering virus to target cells thereby enhancing the distribution of HIV-1. Sialoadhesin could disseminate HIV-1 to viral reservoirs during monocyte immunosurveillance or migration to sites of inflammation and then facilitate HIV-1 infection of permissive cells.	[Rempel, Hans; Calosing, Cyrus; Sun, Bing; Pulliam, Lynn] Vet Affairs Med Ctr, Dept Lab Med, San Francisco, CA 94121 USA; [Pulliam, Lynn] Univ Calif San Francisco, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Rempel, H (corresponding author), Vet Affairs Med Ctr, Dept Lab Med, San Francisco, CA 94121 USA.	lynn.pulliam@ucsf.edu			National Institutes of Health (NIMH) [R01MH073478]; University of California, Universitywide AIDS Research Program (UARP) [ID06-NCIRE-245]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073478] Funding Source: NIH RePORTER	National Institutes of Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of California, Universitywide AIDS Research Program (UARP)(University of California System); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grants from the National Institutes of Health (NIMH) R01MH073478 (LP) and a University of California, Universitywide AIDS Research Program (UARP) grant ID06-NCIRE-245 (LP).	Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Boggiano C, 2007, J VIROL, V81, P2519, DOI 10.1128/JVI.01661-06; Burleigh L, 2006, J VIROL, V80, P2949, DOI 10.1128/JVI.80.6.2949-2957.2006; Crocker P R, 1998, Glycobiology, V8, pv; CROCKER PR, 1991, EMBO J, V10, P1661, DOI 10.1002/j.1460-2075.1991.tb07689.x; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; FITZGERALDBOCARSLY P, 1993, PHARMACOL THERAPEUT, V60, P39, DOI 10.1016/0163-7258(93)90021-5; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; Kirchberger S, 2005, J IMMUNOL, V175, P1145, DOI 10.4049/jimmunol.175.2.1145; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Leon B, 2005, SEMIN IMMUNOL, V17, P313, DOI 10.1016/j.smim.2005.05.013; Liu YL, 2000, J NEUROVIROL, V6, pS70; MCELRATH MJ, 1991, J CLIN INVEST, V87, P27, DOI 10.1172/JCI114981; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Munday J, 1999, J LEUKOCYTE BIOL, V66, P705, DOI 10.1002/jlb.66.5.705; PARSEVAL AF, 2005, J BIOL CHEM, V280, P39493; Pulliam L, 2004, J NEUROIMMUNOL, V157, P93, DOI 10.1016/j.jneuroim.2004.08.039; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; Schmidt B, 2005, VIROLOGY, V343, P256, DOI 10.1016/j.virol.2005.09.059; SINICCO A, 1993, AIDS, V7, P1167, DOI 10.1097/00002030-199309000-00003; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Stylianou E, 2000, CLIN EXP IMMUNOL, V119, P479, DOI 10.1046/j.1365-2249.2000.01144.x; Sun JF, 2001, VIROLOGY, V284, P26, DOI 10.1006/viro.2001.0889; Tilton JC, 2006, J VIROL, V80, P11486, DOI 10.1128/JVI.00324-06; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; van den Berg TK, 2001, J IMMUNOL, V166, P3637, DOI 10.4049/jimmunol.166.6.3637; van der Kuyl AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000257; VANDENBERG TK, 1992, J EXP MED, V176, P647, DOI 10.1084/jem.176.3.647; Vanderheijden N, 2003, J VIROL, V77, P8207, DOI 10.1128/JVI.77.15.8207-8215.2003; VONSYDOW M, 1991, AIDS RES HUM RETROV, V7, P375, DOI 10.1089/aid.1991.7.375; Wang CY, 1999, P NATL ACAD SCI USA, V96, P10367, DOI 10.1073/pnas.96.18.10367; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WHITELAW DM, 1972, CELL TISSUE KINET, V5, P311, DOI 10.1111/j.1365-2184.1972.tb00369.x; Williams K, 2005, J CLIN INVEST, V115, P2534, DOI 10.1172/JCI22953; Wu LJ, 1997, J EXP MED, V185, P1681, DOI 10.1084/jem.185.9.1681	41	121	122	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1967	10.1371/journal.pone.0001967	http://dx.doi.org/10.1371/journal.pone.0001967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414664	Green Published, gold, Green Submitted			2022-12-27	WOS:000260867300013
J	Menendez, C; Bardaji, A; Sigauque, B; Romagosa, C; Sanz, S; Serra-Casas, E; Macete, E; Berenguera, A; David, C; Dobano, C; Naniche, D; Mayor, A; Ordi, J; Mandomando, I; Aponte, JJ; Mabunda, S; Alonso, PL				Menendez, Clara; Bardaji, Azucena; Sigauque, Betuel; Romagosa, Cleofe; Sanz, Sergi; Serra-Casas, Elisa; Macete, Eusebio; Berenguera, Anna; David, Catarina; Dobano, Carlota; Naniche, Denise; Mayor, Alfredo; Ordi, Jaume; Mandomando, Inacio; Aponte, John J.; Mabunda, Samuel; Alonso, Pedro L.			A Randomized Placebo-Controlled Trial of Intermittent Preventive Treatment in Pregnant Women in the Context of Insecticide Treated Nets Delivered through the Antenatal Clinic	PLOS ONE			English	Article								Background: Current recommendations to prevent malaria in African pregnant women rely on insecticide treated nets (ITNs) and intermittent preventive treatment (IPTp). However, there is no information on the safety and efficacy of their combined use. Methods: 1030 pregnant Mozambican women of all gravidities received a long-lasting ITN during antenatal clinic (ANC) visits and, irrespective of HIV status, were enrolled in a randomised, double blind, placebo-controlled trial, to assess the safety and efficacy of 2-dose sulphadoxine-pyrimethamine (SP). The main outcome was the reduction in low birth weight. Findings: Two-dose SP was safe and well tolerated, but was not associated with reductions in anaemia prevalence at delivery (RR, 0.92 [95% CI, 0.79-1.08]), low birth weight (RR, 0.99 [95% CI, 0.70-1.39]), or overall placental infection (p = 0.964). However, the SP group showed a 40% reduction (95% CI, 7.40-61.20]; p = 0.020) in the incidence of clinical malaria during pregnancy, and reductions in the prevalence of peripheral parasitaemia (7.10% vs 15.15%) (p < 0.001), and of actively infected placentas (7.04% vs 13.60%) (p = 0.002). There was a reduction in severe anaemia at delivery of borderline statistical significance (p = 0.055). These effects were not modified by gravidity or HIV status. Reported ITN's use was more than 90% in both groups. Conclusions: Two-dose SP was associated with a reduction in some indicators, but these were not translated to significant improvement in other maternal or birth outcomes. The use of ITNs during pregnancy may reduce the need to administer IPTp. ITNs should be part of the ANC package in sub-Saharan Africa. Trial Registration: ClinicalTrials. gov NCT00209781	[Menendez, Clara; Bardaji, Azucena; Romagosa, Cleofe; Sanz, Sergi; Serra-Casas, Elisa; Berenguera, Anna; David, Catarina; Dobano, Carlota; Naniche, Denise; Mayor, Alfredo; Ordi, Jaume; Mandomando, Inacio; Aponte, John J.; Alonso, Pedro L.] Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, IDIBAPS, Dept Pathol Hosp Clin, Barcelona, Spain; [Menendez, Clara; Bardaji, Azucena; Sigauque, Betuel; Romagosa, Cleofe; Macete, Eusebio; Berenguera, Anna; Dobano, Carlota; Aponte, John J.; Alonso, Pedro L.] Manhica Hlth Res Ctr CISM, Maputo, Mozambique; [Sigauque, Betuel] Ministry Hlth, Natl Director Hlth & Natl Malaria Control Program, Maputo, Mozambique; [Macete, Eusebio; David, Catarina; Mandomando, Inacio; Mabunda, Samuel] Ministry Hlth, NIH, Maputo, Mozambique	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centro de Investigacao em Saude de Manhica	Menendez, C (corresponding author), Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, IDIBAPS, Dept Pathol Hosp Clin, Barcelona, Spain.	menendez@clinic.ub.es	Menéndez, Clara/Q-3446-2016; Dobaño, Carlota/N-4119-2014; Bardají, Azucena/AAE-9145-2019; Alonso, Pedro L/AAZ-3645-2020; Sanz, Sergi/AAY-7211-2020; Pérez-Portabell, Cleofé Romagosa/Q-3342-2016; Ordi, Jaume/X-4524-2018; Naniche, Denise S/S-1814-2018; Mayor, Alfredo/H-7488-2017; Mandomando, Inacio/ABD-8007-2020; Alonso, Azucena Bardají/V-5978-2018	Menéndez, Clara/0000-0002-2641-6907; Dobaño, Carlota/0000-0002-6751-4060; Alonso, Pedro L/0000-0003-3292-3443; Ordi, Jaume/0000-0002-4820-7954; Naniche, Denise S/0000-0002-4495-6325; Mayor, Alfredo/0000-0003-3890-2897; Mandomando, Inacio/0000-0002-1078-2187; Alonso, Azucena Bardají/0000-0002-5135-0540; Sanz Bravo, Sergi/0000-0001-5010-4527; Berenguera, Anna/0000-0002-0889-2002	Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III [CM03/00125]; Banco de Bilbao, Vizcaya, Argentaria Foundation [BBVA 02-0]; Spanish Agency for International Cooperation (AECI)	Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III(Instituto de Salud Carlos III); Banco de Bilbao, Vizcaya, Argentaria Foundation; Spanish Agency for International Cooperation (AECI)	Cleofe Romagosa was supported by a grant from the "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" through a career development fellowship (number CM03/00125). The study received financial support from the Banco de Bilbao, Vizcaya, Argentaria Foundation (grant number BBVA 02-0). The Centro de Investigacao em Saude de Manhica (CISM), receives major core funding from the Spanish Agency for International Cooperation (AECI). The funding source did not have any involvement in study design, collection, analysis and interpretation of data; writing of the report, or in the decision to submit the paper for publication.	Abacassamo F, 2004, TROP MED INT HEALTH, V9, P200, DOI 10.1046/j.1365-3156.2003.01182.x; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; BRABIN B, 1991, INT J EPIDEMIOL, V20, P276, DOI 10.1093/ije/20.1.276; Challis K, 2004, TROP MED INT HEALTH, V9, P1066, DOI 10.1111/j.1365-3156.2004.01307.x; DUBOWITZ LM, 1970, J PEDIATR-US, V77, P1, DOI 10.1016/S0022-3476(70)80038-5; Filler SJ, 2006, J INFECT DIS, V194, P286, DOI 10.1086/505080; Gamble C, 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003755.PUB2; Granja AC, 1998, ANN TROP MED PARASIT, V92, P257, DOI 10.1080/00034989859816; GREENWOOD BM, 1989, T ROY SOC TROP MED H, V83, P589, DOI 10.1016/0035-9203(89)90362-3; *INDEPTH NETW, 2006, POP HLTH DEV COUNTR; Ismail MR, 2000, HUM PATHOL, V31, P85, DOI 10.1016/S0046-8177(00)80203-8; Macete E, 2006, J INFECT DIS, V194, P276, DOI 10.1086/505431; Mbaye A, 2006, TROP MED INT HEALTH, V11, P992, DOI 10.1111/j.1365-3156.2006.01649.x; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Menendez C, 2007, LANCET INFECT DIS, V7, P126, DOI 10.1016/S1473-3099(07)70024-5; Njagi JK, 2003, T ROY SOC TROP MED H, V97, P277, DOI 10.1016/S0035-9203(03)90141-6; Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Rogerson SJ, 2003, J CLIN MICROBIOL, V41, P1370, DOI 10.1128/JCM.41.4.1370-1374.2003; Romagosa C, 2007, TROP MED INT HEALTH, V12, P62, DOI 10.1111/j.1365-3156.2006.01755.x; SCHULTZ LJ, 1994, AM J TROP MED HYG, V51, P515, DOI 10.4269/ajtmh.1994.51.515; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Ter Kuile FO, 2004, AM J TROP MED HYG, V71, P41, DOI 10.4269/ajtmh.2004.71.41; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P50, DOI 10.4269/ajtmh.2003.68.50; TERKUILE FO, 2005, CAN TREATMENT RESPON; *WHO, WHO EXP CONS COTR PR; *WHO, 2006, AFRMAL0401 WHO	28	131	131	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1934	10.1371/journal.pone.0001934	http://dx.doi.org/10.1371/journal.pone.0001934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398460	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795500011
J	Smit, C; Hallett, TB; Lange, J; Garnett, G; de Wolf, F				Smit, Colette; Hallett, Timothy B.; Lange, Joep; Garnett, Geoff; de Wolf, Frank			Late Entry to HIV Care Limits the Impact of Anti-Retroviral Therapy in the Netherlands	PLOS ONE			English	Article								Objective: To explain differences in survival in the first three years of combination anti-retroviral therapy (cART) between HIV treatment centres in the Netherlands. Methodology/Principal Findings: We developed a mathematical simulation model, parameterised using data from the ATHENA cohort that describes patients entering care, being monitored and starting cART. Three scenarios were used to represent three treatment centres with widely varying mortality rates on cART that were differentiated by: (i) the distribution of CD4 counts of patients entering care; (ii) the age distribution of patients entering care; (iii) the average rate of monitoring the patients not on cART. At the level of the treatment centre, the fraction of Dutch MSM dying in the first three years of treatment ranged from 0% to 8%. The mathematical model captured the large variation in observed mortality between the three treatment centres. Manipulating the age-distribution of patients or the frequency of monitoring did not affect the model predictions. In contrast, when the same national average distribution of CD4 count at entry was used in all the scenarios, the variation in predicted mortality between all centres was diminished. Conclusions/Significance: Patients entering care with low CD4 counts appears to be the main source of variation in the mortality rates between Dutch treatment centres. Recruiting HIV-infected individuals to care earlier could lead to substantial improvements in cART outcomes. For example, if patients were to present with at least 400 CD4 cells/mm(3), as they do already in some centres, then our model predicts that the mortality in the first three years of cART could be reduced by approximately 20%.	[Smit, Colette; de Wolf, Frank] HIV Monitoring Fdn Amsterdam, Amsterdam, Netherlands; [Hallett, Timothy B.; Garnett, Geoff; de Wolf, Frank] Imperial College London, London, England; [Lange, Joep] Academic Med Ctr Amsterdam, Amsterdam, Netherlands	Imperial College London; University of Amsterdam; Academic Medical Center Amsterdam	Smit, C (corresponding author), HIV Monitoring Fdn Amsterdam, Amsterdam, Netherlands.	Colette.Smit@amc.uva.nl	Garnett, Geoffrey P/A-9312-2008; Hallett, Timothy/A-2390-2011	Hallett, Timothy/0000-0002-9681-0424	Wellcome Trust; UK Medical Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	TBH thanks the Wellcome Trust; GPG thanks the UK Medical Research Council	Adu-Sarkodie Y, 1998, J CLIN VIROL, V11, P173, DOI 10.1016/S0928-0197(98)00062-2; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; DEGRUTTOLA V, 1991, J AM STAT ASSOC, V86, P569, DOI 10.2307/2290384; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; EGGER M, 2007, 14 C RETR OPP INF; Fraser C, 2001, P ROY SOC B-BIOL SCI, V268, P2085, DOI 10.1098/rspb.2001.1777; GRAS L, 2006, MONITORING HUMAN IMM; Hallett TB, 2008, PLOS MED, V5, P403, DOI 10.1371/journal.pmed.0050053; Lepri AC, 1997, J INFECT DIS, V175, P775, DOI 10.1086/513970; MALONE JL, 1990, J ACQ IMMUN DEF SYND, V3, P144; MARGOLICK JB, 1995, NAT MED, V1, P674, DOI 10.1038/nm0795-674; McNeil AJ, 1997, STAT MED, V16, P2555, DOI 10.1002/(SICI)1097-0258(19971130)16:22&lt;2555::AID-SIM690&gt;3.0.CO;2-Y; RABOUD JM, 1995, J ACQ IMMUN DEF SYND, V10, pS67; Sabin CA, 2004, AIDS, V18, P2145, DOI 10.1097/00002030-200411050-00006; van Sighem AI, 2003, AIDS, V17, P2227, DOI 10.1097/00002030-200310170-00011	16	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1949	10.1371/journal.pone.0001949	http://dx.doi.org/10.1371/journal.pone.0001949			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398473	gold, Green Published, Green Submitted			2022-12-27	WOS:000260795500024
J	Hennig, BJ; Fielding, K; Broxholme, J; Diatta, M; Mendy, M; Moore, C; Pollard, AJ; Rayco-Solon, P; Sirugo, G; van der Sande, MA; Waight, P; Whittle, HC; Zaman, SM; Hill, AV; Hall, AJ				Hennig, Branwen J.; Fielding, Katherine; Broxholme, John; Diatta, Mathurin; Mendy, Maimuna; Moore, Catrin; Pollard, Andrew J.; Rayco-Solon, Pura; Sirugo, Giorgio; van der Sande, Marianne A.; Waight, Pauline; Whittle, Hilton C.; Zaman, Syed M.; Hill, Adrian V.; Hall, Andrew J.			Host Genetic Factors and Vaccine-Induced Immunity to Hepatitis B Virus Infection	PLOS ONE			English	Article								Background: Vaccination against hepatitis B virus infection (HBV) is safe and effective; however, vaccine-induced antibody level wanes over time. Peak vaccine-induced anti-HBs level is directly related to antibody decay, as well as risk of infection and persistent carriage despite vaccination. We investigated the role of host genetic factors in long-term immunity against HBV infection based on peak anti-HBs level and seroconversion to anti-HBc. Methods: We analyzed 715 SNP across 133 candidate genes in 662 infant vaccinees from The Gambia, assessing peak vaccine-induced anti-HBs level and core antibody (anti-HBc) status, whilst adjusting for covariates. A replication study comprised 43 SNPs in a further 393 individuals. Results: In our initial screen we found variation in IFNG, MAPK8, and IL10RA to affect peak anti-HBs level (GMTratio of <0.6 or >1.5 and P <= 0.001) and lesser associations in other genes. Odds of core-conversion was associated with variation in CD163. A coding change in ITGAL (R719V) with likely functional relevance showed evidence of association with increased peak anti-HBs level in both screens (1st screen: s595_22 GMTratio 1.71, P = 0.013; 2nd screen: s595_22 GMTratio 2.15, P = 0.011). Conclusion: This is to our knowledge the largest study to date assessing genetic determinants of HBV vaccine-induced immunity. We report on associations with anti-HBs level, which is directly related to durability of antibody level and predictive of vaccine efficacy long-term. A coding change in ITGAL, which plays a central role in immune cell interaction, was shown to exert beneficial effects on induction of peak antibody level in response to HBV vaccination. Variation in this gene does not appear to have been studied in relation to immune responses to viral or vaccine challenges previously. Our findings suggest that genetic variation in loci other than the HLA region affect immunity induced by HBV vaccination.	[Hennig, Branwen J.; Fielding, Katherine; Rayco-Solon, Pura; Hall, Andrew J.] London Sch Hyg & Trop Med, London WC1, England; [Hennig, Branwen J.; Broxholme, John; Hill, Adrian V.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Diatta, Mathurin; Mendy, Maimuna; Rayco-Solon, Pura; Sirugo, Giorgio; van der Sande, Marianne A.; Waight, Pauline; Whittle, Hilton C.; Zaman, Syed M.; Hall, Andrew J.] MRC Labs, Banjul, Gambia; [Moore, Catrin; Pollard, Andrew J.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Wellcome Centre for Human Genetics; MRC Laboratory Molecular Biology; University of Oxford	Hennig, BJ (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	branwen.hennig@lshtm.ac.uk	Sirugo, Giorgio/L-1628-2016; Hennig, Branwen/M-6444-2014; Moore, Catrin/K-1980-2017; Sirugo, Giorgio/N-9056-2019; Mendy, Maimuna/ABD-5038-2021	Moore, Catrin/0000-0002-8639-9846; van der Sande, Marianne AB/0000-0002-4778-6739; Hennig, Branwen J./0000-0003-4127-8386	Wellcome Trust Advanced Training Fellowship; MRC [MC_U190071516, G0700837] Funding Source: UKRI; Medical Research Council [G0700837, MC_U190071516] Funding Source: researchfish	Wellcome Trust Advanced Training Fellowship(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	B.J.H. was supported by a Wellcome Trust Advanced Training Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPER CA, 1995, EXP CLIN IMMUNOGENET, V12, P171; Arbour N, 2002, J EXP MED, V195, P801, DOI 10.1084/jem.20011481; CHOTARD J, 1992, J INFECT DIS, V166, P764, DOI 10.1093/infdis/166.4.764; De Silvestri A, 2001, GENES IMMUN, V2, P367, DOI 10.1038/sj.gene.6363792; DESOMBERE I, 1995, J IMMUNOL, V154, P520; Desombere I, 2005, CLIN EXP IMMUNOL, V140, P126, DOI 10.1111/j.1365-2249.2004.02749.x; FORTUIN M, 1994, J INFECT DIS, V169, P1374, DOI 10.1093/infdis/169.6.1374; FORTUIN M, 1993, LANCET, V341, P1129, DOI 10.1016/0140-6736(93)93137-P; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; HATAE K, 1992, EUR J IMMUNOL, V22, P1899, DOI 10.1002/eji.1830220733; Hiraoka A, 2005, PATHOL RES PRACT, V201, P379, DOI 10.1016/j.prp.2004.10.006; Hohler T, 2005, HEPATOLOGY, V42, P72, DOI 10.1002/hep.20740; Hohler T, 2002, J HEPATOL, V37, P387, DOI 10.1016/S0168-8278(02)00205-2; Hohler T, 2002, LANCET, V360, P991, DOI 10.1016/S0140-6736(02)11083-X; Hohler T, 1998, HUM IMMUNOL, V59, P212, DOI 10.1016/S0198-8859(98)00014-7; INSKIP HM, 1991, INT J EPIDEMIOL, V20, P764, DOI 10.1093/ije/20.3.764; Jack AD, 1999, J INFECT DIS, V179, P489, DOI 10.1086/314578; Kimman TG, 2007, COMMUNITY GENET, V10, P201, DOI 10.1159/000106559; Kruger A, 2005, CLIN EXP IMMUNOL, V140, P325, DOI 10.1111/j.1365-2249.2005.02765.x; LIN TM, 1989, ANTICANCER RES, V9, P737; Lindemann M, 2002, VIROLOGY, V297, P245, DOI 10.1006/viro.2002.1467; Lindemann M, 2001, FEBS LETT, V495, P82, DOI 10.1016/S0014-5793(01)02339-0; LOUAGIE H, 1993, VACCINE, V11, P1188, DOI 10.1016/0264-410X(93)90041-U; Martinetti M, 2000, CLIN IMMUNOL, V97, P234, DOI 10.1006/clim.2000.4933; McDermott AB, 1997, TISSUE ANTIGENS, V50, P8, DOI 10.1111/j.1399-0039.1997.tb02827.x; Milich DR, 2003, AUTOIMMUN REV, V2, P248, DOI 10.1016/S1568-9972(03)00031-4; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051; Ovsyannikova IG, 2004, PHARMACOGENOMICS, V5, P417, DOI 10.1517/14622416.5.4.417; Sleijffers A, 2003, J IMMUNOL, V170, P3423, DOI 10.4049/jimmunol.170.6.3423; Sullivan JS, 1999, J PAEDIATR CHILD H, V35, P412, DOI 10.1046/j.1440-1754.1999.0390k.x; SUN ZT, 1991, CANCER DETECT PREV, V15, P313; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Thursz M, 2001, QJM-MON J ASSOC PHYS, V94, P287, DOI 10.1093/qjmed/94.6.287; van der Sande MAB, 2006, J INFECT DIS, V193, P1528, DOI 10.1086/503433; van der Sande MAB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000753; Vanlandschoot P, 2002, BIOCHEM BIOPH RES CO, V297, P486, DOI 10.1016/S0006-291X(02)02243-X; Vidan-Jeras B, 2000, PFLUG ARCH EUR J PHY, V440, pR188, DOI 10.1007/s004240000059; Viviani S, 1999, VACCINE, V17, P2946, DOI 10.1016/S0264-410X(99)00178-4; Wang CB, 2004, HEPATOLOGY, V39, P978, DOI 10.1002/hep.20142; Weaver LK, 2007, J LEUKOCYTE BIOL, V81, P663, DOI 10.1189/jlb.0706428; Whittle H, 2002, BMJ-BRIT MED J, V325, P569, DOI 10.1136/bmj.325.7364.569; WHITTLE HC, 1991, LANCET, V337, P747, DOI 10.1016/0140-6736(91)91367-4; WHITTLE HC, 1995, LANCET, V345, P1089, DOI 10.1016/S0140-6736(95)90822-6; WHITTLE HC, 1983, LANCET, V1, P1203; *WHO, 2000, HEP B FACT SHEET; Yang SH, 2006, GENE THER, V13, P1110, DOI 10.1038/sj.gt.3302751; Yucesoy B, 2002, VACCINE, V20, P3193, DOI 10.1016/S0264-410X(02)00267-0	48	65	68	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1898	10.1371/journal.pone.0001898	http://dx.doi.org/10.1371/journal.pone.0001898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365030	Green Published, gold, Green Accepted			2022-12-27	WOS:000260762400036
J	Moya-Larano, J; Vinkovic, D; De Mas, E; Corcobado, G; Moreno, E				Moya-Larano, Jordi; Vinkovic, Dejan; De Mas, Eva; Corcobado, Guadalupe; Moreno, Eulalia			Morphological Evolution of Spiders Predicted by Pendulum Mechanics	PLOS ONE			English	Article								Background: Animals have been hypothesized to benefit from pendulum mechanics during suspensory locomotion, in which the potential energy of gravity is converted into kinetic energy according to the energy-conservation principle. However, no convincing evidence has been found so far. Demonstrating that morphological evolution follows pendulum mechanics is important from a biomechanical point of view because during suspensory locomotion some morphological traits could be decoupled from gravity, thus allowing independent adaptive morphological evolution of these two traits when compared to animals that move standing on their legs; i.e., as inverted pendulums. If the evolution of body shape matches simple pendulum mechanics, animals that move suspending their bodies should evolve relatively longer legs which must confer high moving capabilities. Methodology/Principal Findings: We tested this hypothesis in spiders, a group of diverse terrestrial generalist predators in which suspensory locomotion has been lost and gained a few times independently during their evolutionary history. In spiders that hang upside-down from their webs, their legs have evolved disproportionately longer relative to their body sizes when compared to spiders that move standing on their legs. In addition, we show how disproportionately longer legs allow spiders to run faster during suspensory locomotion and how these same spiders run at a slower speed on the ground (i.e., as inverted pendulums). Finally, when suspensory spiders are induced to run on the ground, there is a clear trend in which larger suspensory spiders tend to run much more slowly than similar-size spiders that normally move as inverted pendulums (i.e., wandering spiders). Conclusions/Significance: Several lines of evidence support the hypothesis that spiders have evolved according to the predictions of pendulum mechanics. These findings have potentially important ecological and evolutionary implications since they could partially explain the occurrence of foraging plasticity and dispersal constraints as well as the evolution of sexual size dimorphism and sociality.	[Moya-Larano, Jordi; De Mas, Eva; Corcobado, Guadalupe; Moreno, Eulalia] CSIC, Estac Expt Zonas Aridas, Dept Ecol Func & Evolut, Almeria, Spain; [Vinkovic, Dejan] Univ Split, Phys Dept, Split, Croatia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); University of Split	Moya-Larano, J (corresponding author), CSIC, Estac Expt Zonas Aridas, Dept Ecol Func & Evolut, Almeria, Spain.	jordi@eeza.csic.es	Moreno, Eulalia/D-4230-2014; De Mas, Eva/H-9172-2015; Moya-Laraño, Jordi/K-8596-2014	Moreno, Eulalia/0000-0002-7197-5679; De Mas, Eva/0000-0001-8225-5805; Moya-Laraño, Jordi/0000-0001-7141-3206; Vinkovic, Dejan/0000-0001-9082-3921	Spanish Ministry of Science and Culture (MEC) [CGL2004-03153, CGL2007-60520, CGL2005-01771]; FPI scholarship [BES-2005-9234]	Spanish Ministry of Science and Culture (MEC)(Spanish Government); FPI scholarship	This paper has been written under a Ramon y Cajal research contract from the Spanish Ministry of Science and Culture (MEC) to JML and a FPI scholarship (BES-2005-9234) to GC. This work has been funded by MEC grants CGL2004-03153 and CGL2007-60520 to JML and GC, as well as CGL2005-01771 to EM.	Alderweireldt M., 1994, Bulletin of the British Arachnological Society, V9, P300; Alexander RM., 2003, PRINCIPLES ANIMAL LO; Arnedo MA, 2004, MOL PHYLOGENET EVOL, V31, P225, DOI 10.1016/S1055-7903(03)00261-6; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Aviles Leticia, 1997, P476; BAUWENS D, 1995, EVOLUTION, V49, P848, DOI 10.1111/j.1558-5646.1995.tb02321.x; Bertram JEA, 1999, J EXP BIOL, V202, P2609; Coddington JA, 2005, SPIDERS N AM IDENTIF, P18; Dickinson MH, 2000, SCIENCE, V288, P100, DOI 10.1126/science.288.5463.100; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Foelix R., 2011, BIOL SPIDERS, V3; Foellmer Matthias W., 2007, P71; Framenau VW, 2005, J ARACHNOL, V33, P334, DOI 10.1636/04-57.1; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gomes MW, 2005, J THEOR BIOL, V237, P265, DOI 10.1016/j.jtbi.2005.04.014; HALLGRIMSSON B, 1995, J MORPHOL, V224, P111, DOI 10.1002/jmor.1052240112; Hormiga G., 2000, SMITHSONIAN CONTRIBU, V609, P1, DOI [DOI 10.5479/SI.00810282.609, 10.5479/si.00810282.609]; Jones D., 1985, GUIA CAMPO ARACNIDOS; Kaston B. J., 1981, SPIDERS CONNECTICUT; LUBIN Y, 1993, ECOLOGY, V74, P1915, DOI 10.2307/1940835; Lubin Y, 2007, ADV STUD BEHAV, V37, P83, DOI 10.1016/S0065-3454(07)37003-4; Maddison WP, 2003, INVERTEBR SYST, V17, P529, DOI 10.1071/IS02044; Miller JA, 2004, CLADISTICS, V20, P385, DOI 10.1111/j.1096-0031.2004.00033.x; MORENO E, 1993, ECOLOGY, V74, P2037, DOI 10.2307/1940849; Moya-Larano J, 2002, EVOLUTION, V56, P420, DOI 10.1111/j.0014-3820.2002.tb01351.x; Murphy NP, 2006, MOL PHYLOGENET EVOL, V38, P583, DOI 10.1016/j.ympev.2005.09.004; Peters H. M., 1990, ACTA ZOOL FENN, V190, P309; Powers KS, 2003, ETHOLOGY, V109, P725, DOI 10.1046/j.1439-0310.2003.00918.x; RAMOS M, P NATL ACAD SCI US, V101, P4883; Roberts MJ., 1995, COLLINS FIELD GUIDE; Roberts MJ, 1985, SPIDERS GREAT BRITAI, V2; Roberts MJ, 1985, SPIDERS GREAT BRITAI, V1; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; SWARTZ SM, 1989, INT J PRIMATOL, V10, P387, DOI 10.1007/BF02736368; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Wise DH, 1993, SPIDERS ECOLOGICAL W	36	35	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1841	10.1371/journal.pone.0001841	http://dx.doi.org/10.1371/journal.pone.0001841			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18364999	gold, Green Submitted, Green Published			2022-12-27	WOS:000260762400005
J	Clawson, ML; Richt, JA; Baron, T; Biacabe, AG; Czub, S; Heaton, MP; Smith, TPL; Laegreid, WW				Clawson, Michael L.; Richt, Juergen A.; Baron, Thierry; Biacabe, Anne-Gaelle; Czub, Stefanie; Heaton, Michael P.; Smith, Timothy P. L.; Laegreid, William W.			Association of a Bovine Prion Gene Haplotype with Atypical BSE	PLOS ONE			English	Article								Background: Atypical bovine spongiform encephalopathies (BSEs) are recently recognized prion diseases of cattle. Atypical BSEs are rare; approximately 30 cases have been identified worldwide. We tested prion gene (PRNP) haplotypes for an association with atypical BSE. Methodology/Principle Findings: Haplotype tagging polymorphisms that characterize PRNP haplotypes from the promoter region through the three prime untranslated region of exon 3 (25.2 kb) were used to determine PRNP haplotypes of six available atypical BSE cases from Canada, France and the United States. One or two copies of a distinct PRNP haplotype were identified in five of the six cases (p = 1.3 x 10(-4), two-tailed Fisher's exact test; CI(95%) 0.263-0.901, difference between proportions). The haplotype spans a portion of PRNP that includes part of intron 2, the entire coding region of exon 3 and part of the three prime untranslated region of exon 3 (13 kb). Conclusions/Significance: This result suggests that a genetic determinant in or near PRNP may influence susceptibility of cattle to atypical BSE.	[Clawson, Michael L.; Heaton, Michael P.; Smith, Timothy P. L.; Laegreid, William W.] USDA ARS, US Meat Anim Res Ctr, Agr Res Serv, Clay Ctr, NE 68933 USA; [Richt, Juergen A.] USDA, ARS, Natl Anim Dis Ctr, Ames, IA USA; [Baron, Thierry; Biacabe, Anne-Gaelle] Unite ATNC, AFSSA, Lyon, France; [Czub, Stefanie] Anim Dis Res Inst Canada, Natl & OIE BSE Reference Lab, Food Inspect Agcy, Lethbridge, AB, Canada	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES)	Clawson, ML (corresponding author), USDA ARS, US Meat Anim Res Ctr, Agr Res Serv, Clay Ctr, NE 68933 USA.	mike.clawson@ars.usda.gov	Richt, Juergen/AAL-3632-2020	Laegreid, William/0000-0002-8694-5229; Clawson, Michael/0000-0002-3355-5390; Heaton, Michael/0000-0003-1386-1208	USDA National Research Initiative [2005-35212-15890]; Agricultural Research Service	USDA National Research Initiative(United States Department of Agriculture (USDA)); Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by the USDA National Research Initiative, Competitive Grant No. 2005-35212-15890 and the Agricultural Research Service.	Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6; Baron T, 2007, VACCINE, V25, P5625, DOI 10.1016/j.vaccine.2006.10.058; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Brown P, 2006, EMERG INFECT DIS, V12, P1816; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Brunelle BW, 2007, J ANIM SCI, V85, P3142, DOI 10.2527/jas.2007-0208; Clawson ML, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-51; Haase B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-15; Heaton MP, 2005, JAVMA-J AM VET MED A, V226, P1311, DOI 10.2460/javma.2005.226.1311; Heaton MP, 2003, MAMM GENOME, V14, P765, DOI 10.1007/s00335-003-2283-y; Heaton MP, 2001, MAMM GENOME, V12, P219, DOI 10.1007/s003350010269; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Juling K, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-33; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Richt JA, 2007, J VET DIAGN INVEST, V19, P142, DOI 10.1177/104063870701900202; Sander P, 2004, NEUROGENETICS, V5, P19, DOI 10.1007/s10048-003-0171-y; Smith TPL, 2000, BIOTECHNIQUES, V29, P698, DOI 10.2144/00294bm05; Stephens M, 2006, NAT GENET, V38, P375, DOI 10.1038/ng1746; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501	21	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1830	10.1371/journal.pone.0001830	http://dx.doi.org/10.1371/journal.pone.0001830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350166	Green Submitted, gold, Green Published			2022-12-27	WOS:000260762300032
J	Takeuchi, T; Ohtsuki, G; Yoshida, T; Fukaya, M; Wainai, T; Yamashita, M; Yamazaki, Y; Mori, H; Sakimura, K; Kawamoto, S; Watanabe, M; Hirano, T; Mishina, M				Takeuchi, Tomonori; Ohtsuki, Gen; Yoshida, Takashi; Fukaya, Masahiro; Wainai, Tasuku; Yamashita, Manami; Yamazaki, Yoshito; Mori, Hisashi; Sakimura, Kenji; Kawamoto, Susumu; Watanabe, Masahiko; Hirano, Tomoo; Mishina, Masayoshi			Enhancement of Both Long-Term Depression Induction and Optokinetic Response Adaptation in Mice Lacking Delphilin	PLOS ONE			English	Article								In the cerebellum, Delphilin is expressed selectively in Purkinje cells (PCs) and is localized exclusively at parallel fiber (PF) synapses, where it interacts with glutamate receptor (GluR) delta 2 that is essential for long-term depression (LTD), motor learning and cerebellar wiring. Delphilin ablation exerted little effect on the synaptic localization of GluR delta 2. There were no detectable abnormalities in cerebellar histology, PC cytology and PC synapse formation in contrast to GluR delta 2 mutant mice. However, LTD induction was facilitated at PF-PC synapses in Delphilin mutant mice. Intracellular Ca(2+) required for the induction of LTD appeared to be reduced in the mutant mice, while Ca(2+) influx through voltage-gated Ca(2+) channels and metabotropic GluR1-mediated slow synaptic response were similar between wild-type and mutant mice. We further showed that the gain-increase adaptation of the optokinetic response (OKR) was enhanced in the mutant mice. These findings are compatible with the idea that LTD induction at PF-PC synapses is a crucial rate-limiting step in OKR gain-increase adaptation, a simple form of motor learning. As exemplified in this study, enhancing synaptic plasticity at a specific synaptic site of a neural network is a useful approach to understanding the roles of multiple plasticity mechanisms at various cerebellar synapses in motor control and learning.	[Takeuchi, Tomonori; Wainai, Tasuku; Mori, Hisashi; Mishina, Masayoshi] Univ Tokyo, Grad Sch Med, Dept Mol Neurobiol & Pharmacol, Tokyo, Japan; [Ohtsuki, Gen; Yoshida, Takashi; Yamashita, Manami; Yamazaki, Yoshito; Hirano, Tomoo] Kyoto Univ, CREST, Grad Sch Sci, Japan Sci & Technol Agcy, Kyoto, Japan; [Fukaya, Masahiro; Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido, Japan; [Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata, Japan; [Kawamoto, Susumu] Chiba Univ, Res Ctr Pathogen Fungi & Microbial Toxicoses, Dept Mol Funct, Chiba, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kyoto University; Hokkaido University; Niigata University; Chiba University	Takeuchi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Neurobiol & Pharmacol, Tokyo, Japan.	thirano@neurosci.biophys.kyoto-u.ac.jp; mishina@m.u-tokyo.ac.jp	WATANABE, Masahiko/A-4055-2012; Takeuchi, Tomonori/P-5988-2016; Yoshida, Takashi/GPX-3941-2022; Watanabe, Masahiko/S-3614-2019; Ohtsuki/AAB-4570-2019	WATANABE, Masahiko/0000-0001-5037-7138; Takeuchi, Tomonori/0000-0002-9981-4260; Yoshida, Takashi/0000-0002-7089-4009; Watanabe, Masahiko/0000-0001-5037-7138; Ohtsuki/0000-0003-3004-5886	Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid]; Japan Science and Technology Agency; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-Aid for Scientific Research on Priority Areas-Molecular Brain Science from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Science and Technology Agency. G.O. and T.Y. were supported by Japan Society for the Promotion of Science.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Altman J, 1997, DEV CEREBELLAR SYSTE; ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; Boyden ES, 2006, NEURON, V51, P823, DOI 10.1016/j.neuron.2006.08.026; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; Cesa R, 2003, J NEUROSCI, V23, P2363; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Faulstich M, 2006, J NEUROPHYSIOL, V96, P1187, DOI 10.1152/jn.00045.2006; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Fukaya M, 2000, J COMP NEUROL, V426, P572; Funabiki K, 1995, NEUROREPORT, V7, P189, DOI 10.1097/00001756-199512000-00045; Fuse T, 2004, BIOCHEM BIOPH RES CO, V318, P665, DOI 10.1016/j.bbrc.2004.04.076; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Hashimoto K, 2001, J NEUROSCI, V21, P9701, DOI 10.1523/JNEUROSCI.21-24-09701.2001; HIRANO T, 1995, NEUROREPORT, V6, P524, DOI 10.1097/00001756-199502000-00029; HIRANO T, 1994, NEUROSCI LETT, V182, P172, DOI 10.1016/0304-3940(94)90790-0; Hironaka K, 2000, J BIOL CHEM, V275, P16167, DOI 10.1074/jbc.M909302199; Ichikawa R, 2002, J NEUROSCI, V22, P8487; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Ito M, 1984, CEREBELLUM NEURAL CO; Iwashita M, 2001, NEUROSCI RES, V39, P299, DOI 10.1016/S0168-0102(00)00228-5; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Katoh A, 2000, LEARN MEMORY, V7, P220, DOI 10.1101/lm.7.4.220; Katoh A, 2005, EUR J NEUROSCI, V21, P1315, DOI 10.1111/j.1460-9568.2005.03946.x; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kina S, 2007, EUR J NEUROSCI, V26, P2269, DOI 10.1111/j.1460-9568.2007.05829.x; Kishimoto Y, 2001, EUR J NEUROSCI, V13, P1249, DOI 10.1046/j.0953-816x.2001.01488.x; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Komiyama NH, 2002, J NEUROSCI, V22, P9721; Kurihara H, 1997, J NEUROSCI, V17, P9613; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Mishina M, 2003, INT CONGR SER, V1250, P473, DOI 10.1016/S0531-5131(03)00186-9; Miyagi Y, 2002, J NEUROSCI, V22, P803, DOI 10.1523/JNEUROSCI.22-03-00803.2002; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; NAGAO S, 1988, EXP BRAIN RES, V73, P489, DOI 10.1007/BF00406606; Nakagama S, 1998, J COMP NEUROL, V395, P112, DOI 10.1002/(SICI)1096-9861(19980525)395:1<112::AID-CNE8>3.0.CO;2-3; Nakamura K, 2001, EUR J NEUROSCI, V13, P179, DOI 10.1046/j.0953-816X.2000.01366.x; Pugh JR, 2006, NEURON, V51, P113, DOI 10.1016/j.neuron.2006.05.021; Roche KW, 1999, J NEUROSCI, V19, P3926; SAKIMURA K, 1980, J NEUROCHEM, V34, P687, DOI 10.1111/j.1471-4159.1980.tb11198.x; Shimuta M, 2001, MOL CELL NEUROSCI, V17, P921, DOI 10.1006/mcne.2001.0981; Takahashi T, 1996, J NEUROSCI, V16, P4376; Takayama C, 1996, DEV BRAIN RES, V92, P147, DOI 10.1016/0165-3806(95)00212-X; Takeuchi T, 2005, J NEUROSCI, V25, P2146, DOI 10.1523/JNEUROSCI.4740-04.2005; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Uemura T, 2007, J NEUROSCI, V27, P12096, DOI 10.1523/JNEUROSCI.2680-07.2007; Welsh JP, 2005, P NATL ACAD SCI USA, V102, P17166, DOI 10.1073/pnas.0508191102; YAMAZAKI M, 1992, BIOCHEM BIOPH RES CO, V183, P886, DOI 10.1016/0006-291X(92)90566-4; Yap CC, 2003, BIOCHEM BIOPH RES CO, V301, P1122, DOI 10.1016/S0006-291X(03)00070-6; Yasumura M, 2008, NEUROSCI LETT, V433, P146, DOI 10.1016/j.neulet.2008.01.009; Yawata S, 2006, J NEUROSCI, V26, P3626, DOI 10.1523/JNEUROSCI.4183-05.2006; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9; Zhang W, 2006, J NEUROSCI, V26, P6935, DOI 10.1523/JNEUROSCI.0784-06.2006; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	67	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2297	10.1371/journal.pone.0002297	http://dx.doi.org/10.1371/journal.pone.0002297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509461	Green Published, Green Submitted, gold			2022-12-27	WOS:000262268500036
J	Abu-Raddad, LJ; Magaret, AS; Celum, C; Wald, A; Longini, IM; Self, SG; Corey, L				Abu-Raddad, Laith J.; Magaret, Amalia S.; Celum, Connie; Wald, Anna; Longini, Ira M., Jr.; Self, Steven G.; Corey, Lawrence			Genital Herpes Has Played a More Important Role than Any Other Sexually Transmitted Infection in Driving HIV Prevalence in Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; EMPIRICAL OBSERVATIONS UNDERESTIMATE; SIMPLEX-VIRUS; MALE CIRCUMCISION; TYPE-2 INFECTION; BEHAVIOR-CHANGE; ULCER DISEASE; DEVELOPING-COUNTRIES; TREATMENT TRIALS	Background: Extensive evidence from observational studies suggests a role for genital herpes in the HIV epidemic. A number of herpes vaccines are under development and several trials of the efficacy of HSV-2 treatment with acyclovir in reducing HIV acquisition, transmission, and disease progression have just reported their results or will report their results in the next year. The potential impact of these interventions requires a quantitative assessment of the magnitude of the synergy between HIV and HSV-2 at the population level. Methods and Findings: A deterministic compartmental model of HIV and HSV-2 dynamics and interactions was constructed. The nature of the epidemiologic synergy was explored qualitatively and quantitatively and compared to other sexually transmitted infections (STIs). The results suggest a more substantial role for HSV-2 in fueling HIV spread in sub-Saharan Africa than other STIs. We estimate that in settings of high HSV-2 prevalence, such as Kisumu, Kenya, more than a quarter of incident HIV infections may have been attributed directly to HSV-2. HSV-2 has also contributed considerably to the onward transmission of HIV by increasing the pool of HIV positive persons in the population and may explain one-third of the differential HIV prevalence among the cities of the Four City study. Conversely, we estimate that HIV had only a small net impact on HSV-2 prevalence. Conclusions: HSV-2 role as a biological cofactor in HIV acquisition and transmission may have contributed substantially to HIV particularly by facilitating HIV spread among the low-risk population with stable long-term sexual partnerships. This finding suggests that prevention of HSV-2 infection through a prophylactic vaccine may be an effective intervention both in nascent epidemics with high HIV incidence in the high risk groups, and in established epidemics where a large portion of HIV transmission occurs in stable partnerships.	[Abu-Raddad, Laith J.; Self, Steven G.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Abu-Raddad, Laith J.] Univ Washington, Ctr Stud Demography & Ecol, Seattle, WA USA; [Magaret, Amalia S.] Fred Hutchinson Canc Res Ctr, Program Biostat, Seattle, WA USA; [Celum, Connie; Wald, Anna] Univ Washington, Dept Med, Seattle, WA USA; [Celum, Connie; Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA USA; [Wald, Anna] Univ Washington, Virol Res Clin, Seattle, WA USA; [Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA USA; [Longini, Ira M., Jr.] Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Seattle, WA USA; [Longini, Ira M., Jr.; Self, Steven G.] Univ Washington, Dept Biostat, Seattle, WA USA; [Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Clin Res Div, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Abu-Raddad, LJ (corresponding author), Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, 1124 Columbia St, Seattle, WA 98104 USA.	laith@scharp.org	Abu-Raddad, Laith J/AAY-1441-2020; Corey, Lawrence/AAE-1796-2020; Wald, Anna/B-6272-2012	Abu-Raddad, Laith J/0000-0003-0790-0506; Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438	University of Washington Center for AIDS Research (CFAR); NIH [P30 AI 27757, PO1 AI031448, K24 AI071113, PO1 AI-30731]; Fred Hutchinson Cancer Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031448, P30AI027757, P01AI030731, U01AI031448, K24AI071113] Funding Source: NIH RePORTER	University of Washington Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred Hutchinson Cancer Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This publication resulted from research supported by the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI 27757). Additional funding was provided by the Fred Hutchinson Cancer Research Center, NIH grants PO1 AI031448, K24 AI071113, and PO1 AI-30731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; ALBRECHT MA, 1989, J VIROL, V63, P1861, DOI 10.1128/JVI.63.5.1861-1868.1989; [Anonymous], INFECT DIS HUMANS DY; Artzrouni M, 2002, AIDS, V16, pW1; AUGENBRAUN M, 1995, ANN INTERN MED, V123, P845, DOI 10.7326/0003-4819-123-11-199512010-00006; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2001, AIDS, V15, pS31, DOI 10.1097/00002030-200108004-00004; Bailey R, 2007, SCALING CIRCUMCISION; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BENEDETTI J, 1994, ANN INTERN MED, V121, P847, DOI 10.7326/0003-4819-121-11-199412010-00004; Blower S, 2004, CLIN INFECT DIS, V39, pS240, DOI 10.1086/422361; Boily MC, 1997, CAN J PUBLIC HEALTH, V88, P255, DOI 10.1007/BF03404793; Boily MC, 1996, SEX TRANSM DIS, V23, P312, DOI 10.1097/00007435-199607000-00012; BRUNHAM RC, 1990, MED CLIN N AM, V74, P1339, DOI 10.1016/S0025-7125(16)30484-9; Buve A, 2001, AIDS, V15, pS127, DOI 10.1097/00002030-200108004-00014; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Celum C, 2004, B WORLD HEALTH ORGAN, V82, P447; CELUM C, 2008, 15 C RETR OPP INF BO; Celum Connie L, 2004, Herpes, V11 Suppl 1, p36A; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Corey L, 2004, JAIDS-J ACQ IMM DEF, V35, P435, DOI 10.1097/00126334-200404150-00001; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Corey L, 2000, JAMA-J AM MED ASSOC, V283, P791, DOI 10.1001/jama.283.6.791; COWAN FM, 1994, BRIT MED J, V309, P1325, DOI 10.1136/bmj.309.6965.1325; CUNNINGHAM AL, 1985, J CLIN INVEST, V75, P226, DOI 10.1172/JCI111678; DeJesus E, 2003, J INFECT DIS, V188, P1009, DOI 10.1086/378416; Dickerson MC, 1996, SEX TRANSM DIS, V23, P429, DOI 10.1097/00007435-199609000-00015; Ferry B, 2001, AIDS, V15, pS41, DOI 10.1097/00002030-200108004-00005; FIFE KH, 1994, J INFECT DIS, V169, P1338, DOI 10.1093/infdis/169.6.1338; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Freeman EE, 2007, SEX TRANSM INFECT; GOLDEN MP, 1992, J INFECT DIS, V166, P494, DOI 10.1093/infdis/166.3.494; Gray RH, 1999, AIDS, V13, P2113, DOI 10.1097/00002030-199910220-00015; Gray RH, 2004, J INFECT DIS, V189, P1209, DOI 10.1086/382750; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2007, SEX TRANSM DIS, V34, P61, DOI 10.1097/01.olq.0000253172.20985.9b; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P00281; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; Gupta R, 2004, J INFECT DIS, V190, P1374, DOI 10.1086/424519; Halioua B, 1999, EUR J DERMATOL, V9, P177; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; HENG MCY, 1994, LANCET, V343, P255, DOI 10.1016/S0140-6736(94)91110-X; Hethcote H., 1984, LECT NOTES BIOMATH, V56, P18; Hitti J, 1997, AM J OBSTET GYNECOL, V177, P450, DOI 10.1016/S0002-9378(97)70214-X; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Kamali A, 1999, SEX TRANSM INFECT, V75, P98, DOI 10.1136/sti.75.2.98; Kaul R, 2004, JAMA-J AM MED ASSOC, V291, P2555, DOI 10.1001/jama.291.21.2555; Keou FXM, 1999, AIDS, V13, P536, DOI 10.1097/00002030-199903110-00021; KOOPMAN JS, 1991, AM J EPIDEMIOL, V133, P1199, DOI 10.1093/oxfordjournals.aje.a115832; Korenromp EL, 2000, AIDS, V14, P573, DOI 10.1097/00002030-200003310-00013; Korenromp EL, 2002, SEX TRANSM DIS, V29, P228, DOI 10.1097/00007435-200204000-00008; Korenromp EL, 2002, AIDS, V16, P2209, DOI 10.1097/00002030-200211080-00014; Korenromp EL, 2001, SEX TRANSM DIS, V28, P613, DOI 10.1097/00007435-200111000-00001; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; LATIF AS, 1989, AIDS, V3, P519, DOI 10.1097/00002030-198908000-00006; Law G., 1999, ADM SUBDIVISIONS COU; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; LYCKE E, 1980, SEX TRANSM DIS, V7, P6, DOI 10.1097/00007435-198001000-00002; Mbopi-Keou FX, 2003, CLIN MICROBIOL INFEC, V9, P161, DOI 10.1046/j.1469-0691.2003.00550.x; McFarland W, 1999, J INFECT DIS, V180, P1459, DOI 10.1086/315076; Mole L, 1997, J INFECT DIS, V176, P766, DOI 10.1086/517297; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; Morgan D, 2001, NAT MED, V7, P143, DOI 10.1038/84564; Morison L, 2001, AIDS, V15, pS61, DOI 10.1097/00002030-200108004-00007; MOSCA JD, 1987, NATURE, V325, P67, DOI 10.1038/325067a0; MOSCA JD, 1987, P NATL ACAD SCI USA, V84, P7408, DOI 10.1073/pnas.84.21.7408; Mostad SB, 2000, AM J OBSTET GYNECOL, V183, P948, DOI 10.1067/mob.2000.106589; Mostad SB, 2000, J INFECT DIS, V181, P58, DOI 10.1086/315188; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Nahmias A J, 1990, Scand J Infect Dis Suppl, V69, P19; O'Farrell N, 1999, SEX TRANSM INFECT, V75, P377, DOI 10.1136/sti.75.6.377; Orroth KK, 2006, SEX TRANSM DIS, V33, P536, DOI 10.1097/01.olq.0000204667.11192.71; Orroth KK, 2003, SEX TRANSM INFECT, V79, P98, DOI 10.1136/sti.79.2.98; PLUMMER FA, 1983, LANCET, V2, P1293; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rebbapragada A, 2007, AIDS, V21, P589, DOI 10.1097/QAD.0b013e328012b896; Robinson NJ, 1997, INT J EPIDEMIOL, V26, P180, DOI 10.1093/ije/26.1.180; Rodriguez MDM, 2002, AIDS, V16, P451; Schacker T, 1998, J INFECT DIS, V178, P1616, DOI 10.1086/314486; Schacker T, 2002, J INFECT DIS, V186, P1718, DOI 10.1086/345771; Schacker T, 1998, ANN INTERN MED, V128, P21, DOI 10.7326/0003-4819-128-1-199801010-00004; Schacker T, 1998, JAMA-J AM MED ASSOC, V280, P61, DOI 10.1001/jama.280.1.61; SCHROETER AL, 1971, J AMER MED ASSOC, V218, P711, DOI 10.1001/jama.218.5.711; Serwadda D, 2003, J INFECT DIS, V188, P1492, DOI 10.1086/379333; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; STAMM WE, 1988, JAMA-J AM MED ASSOC, V260, P1429, DOI 10.1001/jama.260.10.1429; Suligoi B, 2002, ANTIVIR THER, V7, P289; *UNAIDS WHO, AIDS EP UPD 2007; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; Wald A, 2006, J INFECT DIS, V194, P42, DOI 10.1086/504717; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; Wald A, 2001, JAMA-J AM MED ASSOC, V285, P3100, DOI 10.1001/jama.285.24.3100; Wald Anna, 2004, Herpes, V11, P70; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; Weiss HA, 2001, AIDS, V15, pS97, DOI 10.1097/00002030-200108004-00011; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; Weiss Helen, 2004, Herpes, V11 Suppl 1, p24A; YORKE JA, 1978, SEX TRANSM DIS, V5, P51, DOI 10.1097/00007435-197804000-00003; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	125	192	197	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2230	10.1371/journal.pone.0002230	http://dx.doi.org/10.1371/journal.pone.0002230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493617	Green Submitted, Green Published, gold			2022-12-27	WOS:000262258700038
J	Giretti, MS; Fu, XD; De Rosa, G; Sarotto, I; Baldacci, C; Garibaldi, S; Mannella, P; Biglia, N; Sismondi, P; Genazzani, AR; Simoncini, T				Giretti, Maria Silvia; Fu, Xiao-Dong; De Rosa, Giovanni; Sarotto, Ivana; Baldacci, Chiara; Garibaldi, Silvia; Mannella, Paolo; Biglia, Nicoletta; Sismondi, Piero; Genazzani, Andrea Riccardo; Simoncini, Tommaso			Extra-Nuclear Signalling of Estrogen Receptor to Breast Cancer Cytoskeletal Remodelling, Migration and Invasion	PLOS ONE			English	Article								Background: Estrogen is an established enhancer of breast cancer development, but less is known on its effect on local progression or metastasis. We studied the effect of estrogen receptor recruitment on actin cytoskeleton remodeling and breast cancer cell movement and invasion. Moreover, we characterized the signaling steps through which these actions are enacted. Methodology/Principal Findings: In estrogen receptor (ER) positive T47-D breast cancer cells ER activation with 17 beta-estradiol induces rapid and dynamic actin cytoskeleton remodeling with the formation of specialized cell membrane structures like ruffles and pseudopodia. These effects depend on the rapid recruitment of the actin-binding protein moesin. Moesin activation by estradiol depends on the interaction of ER alpha with the G protein G alpha(13), which results in the recruitment of the small GTPase RhoA and in the subsequent activation of its downstream effector Rho-associated kinase-2 (ROCK-2). ROCK-2 is responsible for moesin phosphorylation. The G alpha(13)/RhoA/ROCK/moesin cascade is necessary for the cytoskeletal remodeling and for the enhancement of breast cancer cell horizontal migration and invasion of three-dimensional matrices induced by estrogen. In addition, human samples of normal breast tissue, fibroadenomas and invasive ductal carcinomas show that the expression of wild-type moesin as well as of its active form is deranged in cancers, with increased protein amounts and a loss of association with the cell membrane. Conclusions/Significance: These results provide an original mechanism through which estrogen can facilitate breast cancer local and distant progression, identifying the extra-nuclear G alpha(13)/RhoA/ROCK/moes in signaling cascade as a target of ERa in breast cancer cells. This information helps to understand the effects of estrogen on breast cancer metastasis and may provide new targets for therapeutic interventions.	[Giretti, Maria Silvia; Fu, Xiao-Dong; Baldacci, Chiara; Garibaldi, Silvia; Mannella, Paolo; Genazzani, Andrea Riccardo; Simoncini, Tommaso] Univ Pisa, Dept Reprod Med & Child Dev, Pisa, Italy; [De Rosa, Giovanni; Sarotto, Ivana] Univ Turin, Inst Canc Res & Treatment Candiolo, Mauriziano Umberto I Hosp, Pathol Unit, Turin, Italy; [Biglia, Nicoletta; Sismondi, Piero] Univ Turin, Inst Canc Res & Treatment Candiolo, Mauriziano Umberto I Hosp, Dept Gynecol Oncol, Turin, Italy	University of Pisa; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; IRCCS Fondazione del Piemonte per l'Oncologia; Mauritian Umberto I Hospital; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; IRCCS Fondazione del Piemonte per l'Oncologia; Mauritian Umberto I Hospital; University of Turin	Giretti, MS (corresponding author), Univ Pisa, Dept Reprod Med & Child Dev, Pisa, Italy.	t.simoncini@obgyn.med.unipi.it	sarotto, ivana/AAB-7797-2020; Mannella, Paolo/AAB-2045-2019; Simoncini, Tommaso/AAC-1879-2019; Biglia, Nicoletta/F-8801-2013	Mannella, Paolo/0000-0001-8146-6731; Simoncini, Tommaso/0000-0002-2971-0079; Biglia, Nicoletta/0000-0003-1009-5309; Sismondi, Piero/0000-0002-2505-5716	Italian University and Scientific Research Ministry (MIUR) [2004057090_007]	Italian University and Scientific Research Ministry (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work has been supported by the PRIN grant 2004057090_007 by the Italian University and Scientific Research Ministry (MIUR) to TS.	Acconcia F, 2006, ENDOCRINOLOGY, V147, P1203, DOI 10.1210/en.2005-1293; Bretscher A, 1997, J CELL SCI, V110, P3011; Carmeci C, 1998, SURGERY, V124, P211, DOI 10.1016/S0039-6060(98)70122-9; Chen ZC, 2001, CANCER-AM CANCER SOC, V92, P3068, DOI 10.1002/1097-0142(20011215)92:12<3068::AID-CNCR10149>3.0.CO;2-5; Elliott BE, 2005, BREAST CANCER RES, V7, pR365, DOI 10.1186/bcr1006; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Iontcheva I, 2004, INFECT IMMUN, V72, P2312, DOI 10.1128/IAI.72.4.2312-2320.2004; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jeon S, 2002, J BIOL CHEM, V277, P16576, DOI 10.1074/jbc.M110380200; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kraichely DM, 2000, ENDOCRINOLOGY, V141, P3534, DOI 10.1210/en.141.10.3534; Long XH, 2006, J BIOL CHEM, V281, P9607, DOI 10.1074/jbc.M510809200; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; RICKETTS D, 1991, CANCER RES, V51, P1817; SARRIO D, 2006, BREAST CANC RES TREA; Simoncini T, 2003, EUR J ENDOCRINOL, V148, P281, DOI 10.1530/eje.0.1480281; Simoncini T, 2006, MOL ENDOCRINOL, V20, P1756, DOI 10.1210/me.2005-0259; Song J, 2005, CANCER LETT, V220, P57, DOI 10.1016/j.canlet.2004.04.024; Song RXD, 2002, MOL ENDOCRINOL, V16, P116, DOI 10.1210/me.16.1.116; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966	28	93	96	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2238	10.1371/journal.pone.0002238	http://dx.doi.org/10.1371/journal.pone.0002238			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493596	Green Submitted, Green Published, gold			2022-12-27	WOS:000262258700046
J	Peters, JH; Hilbrands, LB; Koenen, HJPM; Joosten, I				Peters, Jorieke H.; Hilbrands, Luuk B.; Koenen, Hans J. P. M.; Joosten, Irma			Ex Vivo Generation of Human Alloantigen-Specific Regulatory T Cells from CD4(pos)CD25(high) T Cells for Immunotherapy	PLOS ONE			English	Article								Background: Regulatory T cell (Treg) based immunotherapy is a potential treatment for several immune disorders. By now, this approach proved successful in preclinical animal transplantation and auto-immunity models. In these models the success of Treg based immunotherapy crucially depends on the antigen-specificity of the infused Treg population. For the human setting, information is lacking on how to generate Treg with direct antigen-specificity ex vivo to be used for immunotherapy. Methodology/Principal Findings: Here, we demonstrate that in as little as two stimulation cycles with HLA mismatched allogeneic stimulator cells and T cell growth factors a very high degree of alloantigen-specificity was reached in magnetic bead isolated human CD4(pos)CD25(high) Treg. Efficient increases in cell numbers were obtained. Primary allogeneic stimulation appeared a prerequisite in the generation of alloantigen-specific Treg, while secondary allogeneic or polyclonal stimulation with anti-CD3 plus anti-CD28 monoclonal antibodies enriched alloantigen-specificity and cell yield to a similar extent. Conclusions/Significance: The ex vivo expansion protocol that we describe will very likely increase the success of clinical Treg-based immunotherapy, and will help to induce tolerance to selected antigens, while minimizing general immune suppression. This approach is of particular interest for recipients of HLA mismatched transplants.	[Peters, Jorieke H.; Koenen, Hans J. P. M.; Joosten, Irma] Radboud Univ Nijmegen, Med Ctr, Dept Bloodtransfus & Transplantat Immunol, NL-6525 ED Nijmegen, Netherlands; [Hilbrands, Luuk B.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Nephrol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Peters, JH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Bloodtransfus & Transplantat Immunol, NL-6525 ED Nijmegen, Netherlands.	I.Joosten@abti.umcn.nl	Koenen, Hans J.P.M./A-2852-2014; Hilbrands, Luuk/B-4921-2011; Joosten, Irma/N-4418-2013	Hilbrands, Luuk/0000-0002-4935-9765; Joosten, Irma/0000-0003-2950-4977	Dutch Kidney Foundation [C05-2106]	Dutch Kidney Foundation	This study was supported by a grant of the Dutch Kidney Foundation (C05-2106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzali B, 2007, TISSUE ANTIGENS, V69, P545, DOI 10.1111/j.1399-0039.2007.00834.x; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Bushell A, 2005, J IMMUNOL, V174, P3290, DOI 10.4049/jimmunol.174.6.3290; Coenen JJA, 2007, TRANSPL IMMUNOL, V17, P237, DOI 10.1016/j.trim.2007.01.004; Cohen JL, 2002, J EXP MED, V196, P401, DOI 10.1084/jem.20020090; Earle KE, 2005, CLIN IMMUNOL, V115, P3, DOI 10.1016/j.clim.2005.02.017; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Fu S, 2004, AM J TRANSPLANT, V4, P65, DOI 10.1046/j.1600-6143.2003.00293.x; Godfrey WR, 2004, BLOOD, V104, P453, DOI 10.1182/blood-2004-01-0151; GOLSHAYAN D, 2006, BLOOD; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Hoffmann P, 2006, BIOL BLOOD MARROW TR, V12, P267, DOI 10.1016/j.bbmt.2006.01.005; Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086; Jiang SP, 2003, BLOOD, V102, P2180, DOI 10.1182/blood-2003-04-1164; Jin LP, 2004, J IMMUNOL, V173, P3612, DOI 10.4049/jimmunol.173.6.3612; Joffre O, 2004, BLOOD, V103, P4216, DOI 10.1182/blood-2004-01-0005; Jones SC, 2003, BIOL BLOOD MARROW TR, V9, P243, DOI 10.1053/bbmt.2003.50027; Karakhanova S, 2006, J IMMUNOTHER, V29, P336, DOI 10.1097/01.cji.0000203080.43235.9e; Koenen HJPM, 2005, J IMMUNOL, V174, P7573, DOI 10.4049/jimmunol.174.12.7573; Koenen HJPM, 2003, J IMMUNOL, V171, P6431, DOI 10.4049/jimmunol.171.12.6431; Koh LP, 2007, BIOL BLOOD MARROW TR, V13, P1249, DOI 10.1016/j.bbmt.2007.08.003; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; KREIJVELD E, 2006, J IMMUNOL METHODS; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Masteller EL, 2005, J IMMUNOL, V175, P3053, DOI 10.4049/jimmunol.175.5.3053; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nishimura E, 2004, INT IMMUNOL, V16, P1189, DOI 10.1093/intimm/dxh122; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Taams LS, 2002, EUR J IMMUNOL, V32, P1621, DOI 10.1002/1521-4141(200206)32:6<1621::AID-IMMU1621>3.0.CO;2-Q; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Trenado A, 2003, J CLIN INVEST, V112, P1688, DOI 10.1172/JCI17702; WICHLAN DG, 2006, J IMMUNOL METHODS; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103	37	71	78	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2233	10.1371/journal.pone.0002233	http://dx.doi.org/10.1371/journal.pone.0002233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493605	Green Submitted, gold, Green Published			2022-12-27	WOS:000262258700041
J	Huguenin, M; Muller, EJ; Trachsel-Rosmann, S; Oneda, B; Ambort, D; Sterchi, EE; Lottaz, D				Huguenin, Maya; Mueller, Eliane J.; Trachsel-Roesmann, Sandra; Oneda, Beatrice; Ambort, Daniel; Sterchi, Erwin E.; Lottaz, Daniel			The Metalloprotease Meprin beta Processes E-Cadherin and Weakens Intercellular Adhesion	PLOS ONE			English	Article								Background: Meprin (EC 3.4.24.18), an astacin-like metalloprotease, is expressed in the epithelium of the intestine and kidney tubules and has been related to cancer, but the mechanistic links are unknown. Methodology/Principal Findings: We used MDCK and Caco-2 cells stably transfected with meprin alpha and or meprin beta to establish models of renal and intestinal epithelial cells expressing this protease at physiological levels. In both models E-cadherin was cleaved, producing a cell-associated 97-kDa E-cadherin fragment, which was enhanced upon activation of the meprin zymogen and reduced in the presence of a meprin inhibitor. The cleavage site was localized in the extracellular domain adjacent to the plasma membrane. In vitro assays with purified components showed that the 97-kDa fragment was specifically generated by meprin beta, but not by ADAM-10 or MMP-7. Concomitantly with E-cadherin cleavage and degradation of the E-cadherin cytoplasmic tail, the plaque proteins beta-catenin and plakoglobin were processed by an intracellular protease, whereas alpha-catenin, which does not bind directly to E-cadherin, remained intact. Using confocal microscopy, we observed a partial colocalization of meprin beta and E-cadherin at lateral membranes of incompletely polarized cells at preconfluent or early confluent stages. Meprin beta-expressing cells displayed a reduced strength of cell-cell contacts and a significantly lower tendency to form multicellular aggregates. Conclusions/Significance: By identifying E-cadherin as a substrate for meprin beta in a cellular context, this study reveals a novel biological role of this protease in epithelial cells. Our results suggest a crucial role for meprin beta in the control of adhesiveness via cleavage of E-cadherin with potential implications in a wide range of biological processes including epithelial barrier function and cancer progression.	[Huguenin, Maya; Trachsel-Roesmann, Sandra; Oneda, Beatrice; Ambort, Daniel; Sterchi, Erwin E.; Lottaz, Daniel] Univ Bern, Inst Biochem & Mol Biol, Bern, Switzerland; [Mueller, Eliane J.] Univ Bern, Inst Animal Pathol, Bern, Switzerland	University of Bern; University of Bern	Huguenin, M (corresponding author), Univ Bern, Inst Biochem & Mol Biol, Bern, Switzerland.	daniel.lottaz@insel.ch			Bernese Cancer League BKL; Swiss National Science Foundation SNF [3100A0-100772]	Bernese Cancer League BKL; Swiss National Science Foundation SNF(Swiss National Science Foundation (SNSF))	This study was supported by the Bernese Cancer League BKL (to D. L.) and the Swiss National Science Foundation SNF (grant #3100A0-100772 to E. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; BOND JS, 1986, BIOMED BIOCHIM ACTA, V45, P1515; Calautti E, 2005, J BIOL CHEM, V280, P32856, DOI 10.1074/jbc.M506119200; Calautti E, 1998, J CELL BIOL, V141, P1449, DOI 10.1083/jcb.141.6.1449; Chestukhin A, 1997, J BIOL CHEM, V272, P3153, DOI 10.1074/jbc.272.6.3153; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; Davies G, 2001, CLIN CANCER RES, V7, P3289; Dietrich JM, 1996, J BIOL CHEM, V271, P2271, DOI 10.1074/jbc.271.4.2271; DUMERMUTH E, 1993, FEBS LETT, V335, P367, DOI 10.1016/0014-5793(93)80421-P; Eldering JA, 1997, EUR J BIOCHEM, V247, P920, DOI 10.1111/j.1432-1033.1997.00920.x; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; GRAFF JR, 1995, CANCER RES, V55, P5195; GRUNBERG J, 1993, FEBS LETT, V335, P376, DOI 10.1016/0014-5793(93)80422-Q; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; Hung CF, 2006, EXP DERMATOL, V15, P315, DOI 10.1111/j.0906-6705.2006.00411.x; Ishmael FT, 2005, J BIOL CHEM, V280, P13895, DOI 10.1074/jbc.M414218200; Keller SH, 2003, BIOCHEM BIOPH RES CO, V307, P215, DOI 10.1016/S0006-291X(03)01143-4; Kohler D, 2000, FEBS LETT, V465, P2, DOI 10.1016/S0014-5793(99)01712-3; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; Lottaz D, 1999, CANCER RES, V59, P1127; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Matters GL, 1999, MOL CARCINOGEN, V25, P169, DOI 10.1002/(SICI)1098-2744(199907)25:3<169::AID-MC3>3.0.CO;2-Y; Matters GL, 2005, CLIN EXP METASTAS, V22, P331, DOI 10.1007/s10585-005-0660-5; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; Noe V, 2001, J CELL SCI, V114, P111; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Pischitzis A, 1999, EUR J BIOCHEM, V261, P421, DOI 10.1046/j.1432-1327.1999.00268.x; Redfield A, 1997, J CELL BIOL, V138, P1323, DOI 10.1083/jcb.138.6.1323; Richmond PJM, 1997, CANCER RES, V57, P3189; Rios-Doria J, 2004, CANCER RES, V64, P7237, DOI 10.1158/0008-5472.CAN-04-1048; Rios-Doria J, 2003, J BIOL CHEM, V278, P1372, DOI 10.1074/jbc.M208772200; Rosmann S, 2002, J BIOL CHEM, V277, P40650, DOI 10.1074/jbc.M206203200; SHIOZAKI H, 1991, AM J PATHOL, V139, P17; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; STERCHI EE, 1988, ARCH BIOCHEM BIOPHYS, V265, P105, DOI 10.1016/0003-9861(88)90376-1; TRACHTMAN H, 1995, BIOCHEM BIOPH RES CO, V208, P498, DOI 10.1006/bbrc.1995.1366; UMBAS R, 1992, CANCER RES, V52, P5104; Weis WI, 2006, J BIOL CHEM, V281, P35593, DOI 10.1074/jbc.R600027200; Wild-Bode C, 2006, J BIOL CHEM, V281, P23824, DOI 10.1074/jbc.M601542200; WOLLNER DA, 1992, J CELL BIOL, V116, P889, DOI 10.1083/jcb.116.4.889; Xie ZJ, 2007, J BIOL CHEM, V282, P8695, DOI 10.1074/jbc.M609135200; Zlobec I, 2007, J PATHOL, V212, P260, DOI 10.1002/path.2164	56	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2153	10.1371/journal.pone.0002153	http://dx.doi.org/10.1371/journal.pone.0002153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478055	Green Published, Green Accepted, gold			2022-12-27	WOS:000262172800018
J	Bate, R; Coticelli, P; Tren, R; Attaran, A				Bate, Roger; Coticelli, Philip; Tren, Richard; Attaran, Amir			Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa - A Six Country Study	PLOS ONE			English	Article								A range of antimalarial drugs were procured from private pharmacies in urban and peri-urban areas in the major cities of six African countries, situated in the part of that continent and the world that is most highly endemic for malaria. Semiquantitative thin-layer chromatography (TLC) and dissolution testing were used to measure active pharmaceutical ingredient content against internationally acceptable standards. 35% of all samples tested failed either or both tests, and were substandard. Further, 33% of treatments collected were artemisinin monotherapies, most of which (78%) were manufactured in disobservance of an appeal by the World Health Organisation (WHO) to withdraw these clinically inappropriate medicines from the market. The high persistence of substandard drugs and clinically inappropriate artemisinin monotherapies in the private sector risks patient safety and, through drug resistance, places the future of malaria treatment at risk globally.	[Bate, Roger; Coticelli, Philip; Tren, Richard] Africa Fighting Malaria, Washington, DC USA; [Bate, Roger] American Enterprise Inst, Washington, DC USA; [Attaran, Amir] Univ Ottawa, Inst Populat Hlth & Fac Law & Med, Ottawa, ON, Canada	University of Ottawa	Bate, R (corresponding author), Africa Fighting Malaria, Washington, DC USA.	pcoticelli@fightingmalaria.org			Africa Fighting Malaria; Ohrstrom Foundation	Africa Fighting Malaria; Ohrstrom Foundation	Funding for this study was provided in full by Africa Fighting Malaria, drawing on a general budgetary support grant made by the Ohrstrom Foundation. The authors' work was entirely independent of the Ohrstrom Foundation.	Amin AA, 2005, J CLIN PHARM THER, V30, P559, DOI 10.1111/j.1365-2710.2005.00685.x; Attaran A, 2004, LANCET, V363, P237, DOI 10.1016/S0140-6736(03)15330-5; Basco LK, 2004, AM J TROP MED HYG, V70, P245, DOI 10.4269/ajtmh.2004.70.245; Dondorp AM, 2004, TROP MED INT HEALTH, V9, P1241, DOI 10.1111/j.1365-3156.2004.01342.x; Gomes M, 1998, Bull World Health Organ, V76 Suppl 1, P9; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Green MD, 2006, J POSTGRAD MED, V52, P288; Hall KA, 2006, AM J TROP MED HYG, V75, P804, DOI 10.4269/ajtmh.2006.75.804; Lon CT, 2006, T ROY SOC TROP MED H, V100, P1019, DOI 10.1016/j.trstmh.2006.01.003; Minzi OMS, 2003, J CLIN PHARM THER, V28, P117, DOI 10.1046/j.1365-2710.2003.00470.x; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; SNOW RW, 1992, T ROY SOC TROP MED H, V86, P237, DOI 10.1016/0035-9203(92)90290-S; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Vijaykadga Saowanit, 2006, Southeast Asian J Trop Med Public Health, V37 Suppl 3, P5	14	101	103	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2132	10.1371/journal.pone.0002132	http://dx.doi.org/10.1371/journal.pone.0002132			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461128	Green Published, gold			2022-12-27	WOS:000261642400053
J	Rab, MA; Afzal, M; Abou-Zeid, A; Silverman, H				Rab, Mohammad Abdur; Afzal, Mohammad; Abou-Zeid, Alaa; Silverman, Henry			Ethical Practices for Health Research in the Eastern Mediterranean Region of the World Health Organization: A Retrospective Data Analysis	PLOS ONE			English	Article								Background: Commentators have expressed concern regarding the existence of proper ethics review systems in developing countries. Our aim is to explore the extent with which investigators from countries in the Eastern Mediterranean (Conclusion/Significance: These results suggest that attention to ethical safeguards is not optimal among investigators in the EM Region. Further guidelines for strengthening ethical review systems, as well as enhanced educational training in concepts of research ethics for investigators are warranted in this region.EM) Region consider several ethical practices in the conduct of their research. Methodology/Principal Findings: Investigators from 12 countries in the EM region submitted 143 proposals involving Public Health and Biotechnology & Genomics to a grant scheme funded by the Eastern Mediterranean Regional Office of the WHO and the Organization of Islamic Conference Standing Committee for Science and Technological Cooperation in 2006. The grant application included a 1-page questionnaire that asked investigators 1) whether ethical clearance was obtained, 2) whether they plan to obtain informed consent, and 3) whether confidentiality of human subject data would be ensured. The methodologies of the submitted researches were categorized as to whether it involved 1) human subject research (e.g., the prospective collection of biological specimens or the performance of qualitative research), 2) research that could be exempt from ongoing ethics review, and 3) research not involving human subjects. A descriptive analysis was used to analyze the investigators' responses and a chi-square analysis was used to analyze categorical variables. Of the 79 submitted proposals determined to involve "human subjects'', ethical clearance was not obtained in 29%; investigators thought that informed consent was not needed in 29%; and investigators did not mention that they would ensure confidentiality of the obtained data in 8% of the studies. The magnitude of these deficiencies was similar regardless of study design type, i.e., prospective collection of biological samples and qualitative research methods. Conclusion/Significance: These results suggest that attention to ethical safeguards is not optimal among investigators in the EM Region. Further guidelines for strengthening ethical review systems, as well as enhanced educational training in concepts of research ethics for investigators are warranted in this region.	[Rab, Mohammad Abdur] WHO, Country Off, Khartoum, Sudan; [Afzal, Mohammad; Abou-Zeid, Alaa] WHO, Res Policy & Cooperat Unit, E Mediterranean Region Off, Cairo, Egypt; [Silverman, Henry] Univ Maryland, Sch Med, Baltimore, MD USA	World Health Organization; Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; University System of Maryland; University of Maryland Baltimore	Rab, MA (corresponding author), WHO, Country Off, Khartoum, Sudan.	hsilverm@medicine.umaryland.edu		AbouZeid, Alaa/0000-0002-7283-3154				Benatar SR, 2002, SOC SCI MED, V54, P1131, DOI 10.1016/S0277-9536(01)00327-6; Bhutta ZA, 2004, B WORLD HEALTH ORGAN, V82, P771; *CIOMS, 2002, INT ETH GUID BIOM RE; Dickens BM, 2003, INT J GYNECOL OBSTET, V80, P79, DOI 10.1016/S0020-7292(02)00349-1; *FOG INT CTR, INT BIOETH ED CAR DE; Hyder AA, 2004, J MED ETHICS, V30, P68, DOI 10.1136/jme.2002.001933; Kirigia JM, 2005, BMC MED ETHICS, V6; Nuffield Council on Bioethics, 2002, ETH RES REL HEALTHC; RAB MA, 2004, GLOBAL FORUM HTLH RE; SUMATHIPALA A, BMC MED ETHICS, V5; *UNESCO, 2007, SOC HUM SCI ET; *WELLC TRUST, 2007, BIOM ETH PROGR ETH B; World Health Organization, 2000, OP GUID ETH COMM REV; World Medical Association, 2001, WORLD MED ASS DECL H; 1981, FED POLICY PROTECTIO	15	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2094	10.1371/journal.pone.0002094	http://dx.doi.org/10.1371/journal.pone.0002094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	382YX	18461183	gold, Green Submitted, Green Published			2022-12-27	WOS:000261642400016
J	Suzawa, M; Ingraham, HA				Suzawa, Miyuki; Ingraham, Holly A.			The Herbicide Atrazine Activates Endocrine Gene Networks via Non-Steroidal NR5A Nuclear Receptors in Fish and Mammalian Cells	PLOS ONE			English	Article								Atrazine (ATR) remains a widely used broadleaf herbicide in the United States despite the fact that this s-chlorotriazine has been linked to reproductive abnormalities in fish and amphibians. Here, using zebrafish we report that environmentally relevant ATR concentrations elevated zcyp19a1 expression encoding aromatase (2.2 mu g/L), and increased the ratio of female to male fish (22 mu g/L). ATR selectively increased zcyp19a1, a known gene target of the nuclear receptor SF-1 (NR5A1), whereas zcyp19a2, which is estrogen responsive, remained unchanged. Remarkably, in mammalian cells ATR functions in a cell-specific manner to upregulate SF-1 targets and other genes critical for steroid synthesis and reproduction, including Cyp19A1, StAR, Cyp11A1, hCG, FSTL3, LH(ss), INH alpha, alpha GSU, and 11(ss)-HSD2. Our data appear to eliminate the possibility that ATR directly affects SF-1 DNA- or ligand-binding. Instead, we suggest that the stimulatory effects of ATR on the NR5A receptor subfamily (SF-1, LRH-1, and zff1d) are likely mediated by receptor phosphorylation, amplification of cAMP and PI3K signaling, and possibly an increase in the cAMP-responsive cellular kinase SGK-1, which is known to be upregulated in infertile women. Taken together, we propose that this pervasive and persistent environmental chemical alters hormone networks via convergence of NR5A activity and cAMP signaling, to potentially disrupt normal endocrine development and function in lower and higher vertebrates.	[Suzawa, Miyuki; Ingraham, Holly A.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; [Suzawa, Miyuki; Ingraham, Holly A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Suzawa, M (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	holly.ingraham@ucsf.edu			Susan B. Komen [postdoctoral fellowship]; NIH-RO1	Susan B. Komen(Susan G. Komen Breast Cancer Foundation); NIH-RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Susan B. Komen postdoctoral fellowship to M.S. and NIH-RO1 support to H.A.I.	Biron-Shental T, 2008, PLACENTA, V29, P51, DOI 10.1016/j.placenta.2007.09.001; Carr JA, 2003, ENVIRON TOXICOL CHEM, V22, P396, DOI [10.1897/1551-5028(2003)022&lt;0396:ROLXLT&gt;2.0.CO;2, 10.1002/etc.5620220222]; Chen WY, 2005, MOL CELL BIOL, V25, P10442, DOI 10.1128/MCB.25.23.10442-10453.2005; Crain DA, 1997, ENVIRON HEALTH PERSP, V105, P528, DOI 10.2307/3433582; Crews D, 2006, ENDOCRINOLOGY, V147, pS4, DOI 10.1210/en.2005-1122; de-Souza Bruno Ferraz, 2006, Pediatr Endocrinol Rev, V3, P359; Eldridge JC, 1999, REPROD TOXICOL, V13, P491, DOI 10.1016/S0890-6238(99)00056-8; Fan WQ, 2007, ENVIRON HEALTH PERSP, V115, P720, DOI 10.1289/ehp.9758; Fan W, 2007, BIOCHEM BIOPH RES CO, V355, P1012, DOI 10.1016/j.bbrc.2007.02.062; Fenske M, 2004, AQUAT TOXICOL, V67, P105, DOI 10.1016/j.aquatox.2003.10.008; FEROZEZAIDI F, 2007, ROLE REGULATION SERU; Filipov NM, 2005, TOXICOL SCI, V86, P324, DOI 10.1093/toxsci/kfi188; Forson D, 2006, ENVIRON TOXICOL CHEM, V25, P168, DOI 10.1897/05-260R.1; Forson DD, 2006, ECOL APPL, V16, P2325, DOI 10.1890/1051-0761(2006)016[2325:AIRSIT]2.0.CO;2; Friedmann AS, 2002, REPROD TOXICOL, V16, P275, DOI 10.1016/S0890-6238(02)00019-9; Gaido KW, 2000, MOL PHARMACOL, V58, P852, DOI 10.1124/mol.58.4.852; Greenlee AR, 2004, ENVIRON HEALTH PERSP, V112, P703, DOI 10.1289/ehp.6774; Hammer GD, 1999, MOL CELL, V3, P521, DOI 10.1016/S1097-2765(00)80480-3; Hayes T, 2002, NATURE, V419, P895, DOI 10.1038/419895a; Hayes T, 2003, ENVIRON HEALTH PERSP, V111, P568, DOI 10.1289/ehp.5932; Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499; He YW, 2002, J LEUKOCYTE BIOL, V72, P440; Hinfray N, 2006, ENVIRON TOXICOL, V21, P332, DOI 10.1002/tox.20203; Kazeto Y, 2004, AQUAT TOXICOL, V69, P25, DOI 10.1016/j.aquatox.2004.04.008; Kazeto YK, 2001, BIOCHEM BIOPH RES CO, V288, P503, DOI 10.1006/bbrc.2001.5796; Keller JM, 2004, MAR ENVIRON RES, V58, P347, DOI 10.1016/j.marenvres.2004.03.080; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Kiesecker JM, 2002, P NATL ACAD SCI USA, V99, P9900, DOI 10.1073/pnas.152098899; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lan HC, 2007, MOL CELL BIOL, V27, P2027, DOI 10.1128/MCB.02253-06; Lee CT, 2006, EUR J NEUROSCI, V23, P1311, DOI 10.1111/j.1460-9568.2006.04650.x; Mehats Celine, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS12, DOI 10.1186/1471-2393-7-S1-S12; MESSNER B, 1979, BIOCHEM PHARMACOL, V28, P207, DOI 10.1016/0006-2952(79)90505-7; Moore A, 1998, PESTIC BIOCHEM PHYS, V62, P41, DOI 10.1006/pest.1998.2366; Oger S, 2005, J IMMUNOL, V174, P8082, DOI 10.4049/jimmunol.174.12.8082; Okamoto A, 2006, PLACENTA, V27, P317, DOI 10.1016/j.placenta.2004.12.007; Orn S, 2003, AQUAT TOXICOL, V65, P397, DOI 10.1016/S0166-445X(03)00177-2; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Perrotti N, 2001, J BIOL CHEM, V276, P9406, DOI 10.1074/jbc.M007052200; Poulin H, 2006, BIOCHEM BIOPH RES CO, V346, P306, DOI 10.1016/j.bbrc.2006.05.134; Rayner JL, 2004, TOXICOL APPL PHARM, V195, P23, DOI 10.1016/j.taap.2003.11.005; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Richards JS, 2001, MOL ENDOCRINOL, V15, P209, DOI 10.1210/me.15.2.209; Roberge M, 2004, TOXICOL LETT, V154, P61, DOI 10.1016/j.toxlet.2004.07.005; Rooney AA, 2003, TOXICOL SCI, V76, P366, DOI 10.1093/toxsci/kfg250; Rowe AM, 2008, BASIC CLIN PHARMACOL, V102, P139, DOI 10.1111/j.1742-7843.2007.00175.x; Safe SH, 2002, ENVIRON HEALTH PERSP, V110, P925, DOI 10.1289/ehp.02110s6925; Safe SH, 2001, REPROD FERT DEVELOP, V13, P307, DOI 10.1071/RD00108; Sanderson JT, 2002, TOXICOL APPL PHARM, V182, P44, DOI 10.1006/taap.2002.9420; Sanderson JT, 2001, ENVIRON HEALTH PERSP, V109, P1027, DOI 10.2307/3454957; Scippo ML, 2004, ANAL BIOANAL CHEM, V378, P664, DOI 10.1007/s00216-003-2251-0; SHEN WH, 1994, CELL, V77, P651, DOI 10.1016/0092-8674(94)90050-7; Singleton DW, 2006, ENVIRON RES, V100, P86, DOI 10.1016/j.envres.2005.05.004; Singleton DW, 2004, MOL CELL ENDOCRINOL, V221, P47, DOI 10.1016/j.mce.2004.04.010; Spalding RF, 2003, J ENVIRON QUAL, V32, P84, DOI 10.2134/jeq2003.0084; Spano L, 2004, AQUAT TOXICOL, V66, P369, DOI 10.1016/j.aquatox.2003.10.009; Stoker TE, 2002, TOXICOL SCI, V67, P198, DOI 10.1093/toxsci/67.2.198; Storrs SI, 2004, ENVIRON HEALTH PERSP, V112, P1054, DOI 10.1289/ehp.6821; Tavera-Mendoza L, 2002, ENVIRON TOXICOL CHEM, V21, P1264, DOI [10.1897/1551-5028(2002)021<1264:ROTATX>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;1264:ROTATX&gt;2.0.CO;2]; Tavera-Mendoza L, 2002, ENVIRON TOXICOL CHEM, V21, P527, DOI 10.1897/1551-5028(2002)021&lt;0527:ROTATX&gt;2.0.CO;2; Tong SK, 2003, J STEROID BIOCHEM, V86, P381, DOI 10.1016/S0960-0760(03)00347-9; Trentacoste SV, 2001, J ANDROL, V22, P142; Uchida D, 2004, COMP BIOCHEM PHYS A, V137, P11, DOI 10.1016/S1095-6433(03)00178-8; von Hofsten J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-63; Weck J, 2006, MOL ENDOCRINOL, V20, P1090, DOI 10.1210/me.2005-0199; Xia Y, 2004, MOL ENDOCRINOL, V18, P979, DOI 10.1210/me.2003-0364; Xue Q, 2007, J CLIN ENDOCR METAB, V92, P3261, DOI 10.1210/jc.2007-0494; Zeitoun KM, 1999, FERTIL STERIL, V72, P961, DOI 10.1016/S0015-0282(99)00393-3	70	124	131	6	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2117	10.1371/journal.pone.0002117	http://dx.doi.org/10.1371/journal.pone.0002117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461179	Green Published, gold, Green Submitted			2022-12-27	WOS:000261642400039
J	Ungar, PS; Grine, FE; Teaford, MF				Ungar, Peter S.; Grine, Frederick E.; Teaford, Mark F.			Dental Microwear and Diet of the Plio-Pleistocene Hominin Paranthropus boisei	PLOS ONE			English	Article							TEXTURE ANALYSIS; HUMAN-EVOLUTION; AUSTRALOPITHECUS; TEETH; VARIABILITY; PATTERNS; FOODS	The Plio-Pleistocene hominin Paranthropus boisei had enormous, flat, thickly enameled cheek teeth, a robust cranium and mandible, and inferred massive, powerful chewing muscles. This specialized morphology, which earned P. boisei the nickname "Nutcracker Man'', suggests that this hominin could have consumed very mechanically challenging foods. It has been recently argued, however, that specialized hominin morphology may indicate adaptations for the consumption of occasional fallback foods rather than preferred resources. Dental microwear offers a potential means by which to test this hypothesis in that it reflects actual use rather than genetic adaptation. High microwear surface texture complexity and anisotropy in extant primates can be associated with the consumption of exceptionally hard and tough foods respectively. Here we present the first quantitative analysis of dental microwear for P. boisei. Seven specimens examined preserved unobscured antemortem molar microwear. These all show relatively low complexity and anisotropy values. This suggests that none of the individuals consumed especially hard or tough foods in the days before they died. The apparent discrepancy between microwear and functional anatomy is consistent with the idea that P. boisei presents a hominin example of Liem's Paradox, wherein a highly derived morphology need not reflect a specialized diet.	[Ungar, Peter S.] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA; [Grine, Frederick E.] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY USA; [Grine, Frederick E.] SUNY Stony Brook, Dept Anatom Sci, Stony Brook, NY USA; [Grine, Frederick E.; Teaford, Mark F.] Univ Cambridge, Leverhulme Ctr Human Evolut Stud, Cambridge, England	University of Arkansas System; University of Arkansas Fayetteville; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Cambridge	Ungar, PS (corresponding author), Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA.	pungar@uark.edu	Self, Casey J/B-6871-2011		US National Science Foundation	US National Science Foundation(National Science Foundation (NSF))	US National Science Foundation	CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Constantino P, 2007, EVOL ANTHROPOL, V16, P49, DOI 10.1002/evan.20130; Cook RJ, 1996, J ROY STAT SOC A STA, V159, P93, DOI 10.2307/2983471; DEMES B, 1988, J HUM EVOL, V17, P657, DOI 10.1016/0047-2484(88)90023-1; Grine F.E., 1988, P3; GRINE FE, 1986, J HUM EVOL, V15, P783, DOI 10.1016/S0047-2484(86)80010-0; Hylander W.L., 1988, P55; JOLLY CJ, 1970, MAN, V5, P5, DOI 10.2307/2798801; KAY RF, 1985, ANNU REV ANTHROPOL, V14, P315, DOI 10.1146/annurev.an.14.100185.001531; King T, 1999, AM J PHYS ANTHROPOL, V108, P359, DOI 10.1002/(SICI)1096-8644(199903)108:3<359::AID-AJPA10>3.0.CO;2-9; Laden G, 2005, J HUM EVOL, V49, P482, DOI 10.1016/j.jhevol.2005.05.007; Lucas P., 2004, DENT FUNCTIONAL MORP; LUCAS P W, 1986, Zeitschrift fuer Morphologie und Anthropologie, V76, P253; MARTIN L, 1991, NATURE, V352, P111, DOI 10.1038/352111a0; Peters CR, 2005, J HUM EVOL, V48, P219, DOI 10.1016/j.jhevol.2004.11.003; Plavcan JM, 2001, EVOL ANTHROPOL, V10, P204, DOI 10.1002/evan.20001; PUECH PF, 1983, J HUM EVOL, V12, P721, DOI 10.1016/S0047-2484(83)80127-4; Rak Y., 1983, AUSTRALOPITHECINE FA, DOI [10.1016/B978-0-12-576280-9.50006-7, DOI 10.1016/B978-0-12-576280-9.50006-7]; Robinson BW, 1998, AM NAT, V151, P223, DOI 10.1086/286113; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Sponheimer M, 2006, SCIENCE, V314, P980, DOI 10.1126/science.1133827; Stanford CB, 2006, PRIMATES, V47, P91, DOI 10.1007/s10329-005-0148-6; TEAFORD MF, 1988, SCANNING MICROSCOPY, V2, P1167; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P447, DOI 10.1002/ajpa.1330800405; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; Teaford MF, 2000, P NATL ACAD SCI USA, V97, P13506, DOI 10.1073/pnas.260368897; Tobias P. V., 1967, CRANIUM MAXILLARY DE; Ungar PS, 2007, VERTEBR PALEOBIOL PA, P321, DOI 10.1007/978-1-4020-5845-5_22; Ungar PS, 2003, SCANNING, V25, P185, DOI 10.1002/sca.4950250405; UNGAR PS, 2007, J MAMMALIAN IN PRESS; WALKER A, 1986, NATURE, V322, P517, DOI 10.1038/322517a0; WALKER A, 1981, PHILOS T ROY SOC B, V292, P57, DOI 10.1098/rstb.1981.0013; WOOD BA, 2000, AM J PHYS ANTHR, V326; Wood B, 2007, YEARB PHYS ANTHROPOL, V50, P106, DOI 10.1002/ajpa.20732; Wrangham R.W., 2007, EVOLUTION HUMAN DIET, P308	36	196	204	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2044	10.1371/journal.pone.0002044	http://dx.doi.org/10.1371/journal.pone.0002044			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	381YR	18446200	gold, Green Published			2022-12-27	WOS:000261572300016
J	Schlaepfer, E; Speck, RF				Schlaepfer, Erika; Speck, Roberto F.			Anti-HIV Activity Mediated by Natural Killer and CD8+Cells after Toll-Like Receptor 7/8 Triggering	PLOS ONE			English	Article								We previously found that triggering TLR7/8 either by single stranded HIV RNA or synthetic compounds induced changes in the lymphoid microenvironment unfavorable to HIV. In this study, we used selective TLR7 and 8 agonists to dissect their contribution to the anti-HIV effects. While triggering TLR7 inhibited efficiently HIV replication in lymphoid suspension cells from tonsillar origin, its effect was inconsistent in peripheral blood mononuclear cells (PBMC). In contrast, triggering TLR8 showed a very prominent and overall very consistent effect in PBMC and tonsillar lymphoid suspension cells. Depletion of dendritic cells (DC), Natural killer cells (NK) and CD8+ T-cells from PBMC resulted in the reversal of TLR8 induced anti-HIV effects. Especially noteworthy, depletion of either NK or CD8+ T-cells alone was only partially effective. We interpret these findings that DC are the initiator of complex changes in the microenvironment that culminates in the anti-HIV active NK and CD8+ effector cells. The near lack of NK and the low number of CD8+ T-cells in tonsillar lymphoid suspension cells may explain the lower TLR8 agonist's anti-HIV effects in that tissue. However, additional cell-type specific differences must exist since the TLR7 agonists had a very strong inhibitory effect in tonsillar lymphoid suspension cells. Separation of effector from the CD4+ target cells did not abolish the anti-HIV effects pointing to the critical role of soluble factors. Triggering TLR7 or 8 were accompanied by major changes in the cytokine milieu; however, it appeared that not a single soluble factor could be assigned for the potent effects. These results delineate the complex effects of triggering TLR7/8 for an efficient antiviral defense. While the ultimate mechanism(s) remains unknown, the potent effects described may have therapeutic value for treating chronic viral diseases. Notably, HIV replication is blocked by TLR triggering before HIV integrates into the host chromosome which would prevent the establishment or maintenance of the latent reservoir.	[Schlaepfer, Erika; Speck, Roberto F.] Univ Zurich Hosp, Dept Internal Med, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital	Schlaepfer, E (corresponding author), Univ Zurich Hosp, Dept Internal Med, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	roberto.speck@usz.ch	Speck, Roberto F/O-2433-2016	Speck, Roberto/0000-0002-8453-1137	Stiftung fur wissenschaftliche Forschung an der Universitat Zurich	Stiftung fur wissenschaftliche Forschung an der Universitat Zurich	This study was supported by the "Stiftung fur wissenschaftliche Forschung an der Universitat Zurich".	Ahonen CL, 1999, CELL IMMUNOL, V197, P62, DOI 10.1006/cimm.1999.1555; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Alter G, 2007, J IMMUNOL, V178, P7658, DOI 10.4049/jimmunol.178.12.7658; Barton GM, 2007, SEMIN IMMUNOL, V19, P33, DOI 10.1016/j.smim.2007.01.003; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Chan SY, 2000, J VIROL, V74, P4933, DOI 10.1128/JVI.74.10.4933-4937.2000; Cox K, 2005, J LEUKOCYTE BIOL, V78, P1142, DOI 10.1189/jlb.1103-532; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Gorski KS, 2006, INT IMMUNOL, V18, P1115, DOI 10.1093/intimm/dxl046; Hardy AW, 2007, P NATL ACAD SCI USA, V104, P17453, DOI 10.1073/pnas.0707244104; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hengel H, 2003, INT IMMUNOPHARMACOL, V3, P1159, DOI 10.1016/S1567-5769(03)00028-6; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kantakamalakul W, 2003, J IMMUNOL METHODS, V272, P189, DOI 10.1016/S0022-1759(02)00505-7; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Klimkait T, 1998, ARCH VIROL, V143, P2109, DOI 10.1007/s007050050447; Levy JA, 2003, TRENDS IMMUNOL, V24, P628, DOI 10.1016/j.it.2003.10.005; Meier A, 2007, J VIROL, V81, P8180, DOI 10.1128/JVI.00421-07; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Piccioli D, 2007, BLOOD, V109, P5371, DOI 10.1182/blood-2006-08-038422; Schlaepfer E, 2006, J IMMUNOL, V176, P2888, DOI 10.4049/jimmunol.176.5.2888; SCHWARTZ O, 1994, VIROLOGY, V198, P360, DOI 10.1006/viro.1994.1042; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; WILD C, 1992, P NATL ACAD SCI USA, V89, P10537, DOI 10.1073/pnas.89.21.10537; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433	36	28	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1999	10.1371/journal.pone.0001999	http://dx.doi.org/10.1371/journal.pone.0001999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431484	Green Published, gold, Green Submitted			2022-12-27	WOS:000261558700019
J	Abdulle, S; Hagberg, L; Svennerholm, B; Fuchs, D; Gisslen, M				Abdulle, Sahra; Hagberg, Lars; Svennerholm, Bo; Fuchs, Dietmar; Gisslen, Magnus			Cerebrospinal Fluid Viral Load and Intrathecal Immune Activation in Individuals Infected with Different HIV-1 Genetic Subtypes	PLOS ONE			English	Article								Background: HIV-1 exhibits a high degree of genetic diversity and is presently divided into 3 distinct HIV-1 genetic groups designated major (M), non-M/non-O (N) and outlier (O). Group M, which currently comprises 9 subtypes (A-D, F-H, J and K), at least 34 circulating recombinant forms (CRFs) and several unique recombinant forms (URFs) is responsible for most of the HIV-1 epidemic. Most of the current knowledge of HIV-1 central nervous system (CNS) infection is based on subtype B. However, subtypes other than subtype B account for the majority of global HIV-1 infections. Therefore, we investigated whether subtypes have any influence on cerebrospinal fluid (CSF) markers of HIV-1 CNS infection. Methodology/Principal Findings: CSF HIV-1 RNA, CSF neopterin and CSF white blood cell (WBC) count were measured in patients infected with different HIV-1 subtypes. Using multivariate regression analysis, no differences in the CSF WBC count, neopterin and viral load were found between various HIV-1 subtypes. Conclusions: We did not find any subtype-dependent differences in the markers evaluated in this study.	[Abdulle, Sahra; Hagberg, Lars; Gisslen, Magnus] Univ Gothenburg, Sahlgrenska Acad, Dept Infect Dis, Gothenburg, Sweden; [Svennerholm, Bo] Gothenburg Univ, Sahlgrenska Acad, Dept Virol, Gothenburg, Sweden; [Fuchs, Dietmar] Innsbruck Med Univ, Ludwig Boltzmann Inst AIDS Res, Div Biol Chem, Innsbruck, Austria	University of Gothenburg; University of Gothenburg; Ludwig Boltzmann Institute; Medical University of Innsbruck	Abdulle, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Infect Dis, Gothenburg, Sweden.	sahra.abdulle@infect.gu.se	Fuchs, Dietmar/AAL-8011-2021; Gisslen, Magnus/D-7454-2015	Fuchs, Dietmar/0000-0003-1627-9563; Gisslen, Magnus/0000-0002-2357-1020	National Institutes of Health [R01 NS43103-01]; Medical Faculty of Goteborg University [ALFGBG-2874]; Goteborg Medical Society; Research Foundation of Swedish Physicians Against AIDS; government of the State of the Austrian Tyrol; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Faculty of Goteborg University; Goteborg Medical Society; Research Foundation of Swedish Physicians Against AIDS; government of the State of the Austrian Tyrol; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from the National Institutes of Health (NINDS R01 NS43103-01), the Medical Faculty of Goteborg University (ALFGBG-2874), the Goteborg Medical Society, the Research Foundation of Swedish Physicians Against AIDS and the government of the State of the Austrian Tyrol.	Alaeus A, 1999, AIDS, V13, P901, DOI 10.1097/00002030-199905280-00005; Albright AV, 2003, J NEUROVIROL, V9, P222, DOI 10.1080/13550280390194073; Amornkul PN, 1999, AIDS, V13, P1963, DOI 10.1097/00002030-199910010-00020; BACELLAR H, 1994, NEUROLOGY, V44, P1892, DOI 10.1212/WNL.44.10.1892; BOGNER JR, 1992, CLIN INVESTIGATOR, V70, P665; Brew BJ, 1996, J INFECT DIS, V174, P294, DOI 10.1093/infdis/174.2.294; Clifford DB, 2007, J NEUROVIROL, V13, P67, DOI 10.1080/13550280601169837; CONRAD AJ, 1995, J ACQ IMMUN DEF SYND, V10, P425, DOI 10.1097/00042560-199512000-00005; Fischer-Smith Tracy, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010239; Gartner S, 2000, SCIENCE, V287, P602, DOI 10.1126/science.287.5453.602; Geretti AM, 2006, CURR OPIN INFECT DIS, V19, P1, DOI 10.1097/01.qco.0000200293.45532.68; Gisslen M, 1999, J ACQ IMMUN DEF SYND, V21, P271, DOI 10.1097/00126334-199908010-00003; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; HAGBERG LAL, 2004, CLIN APPL CEREBROSPI, P102; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; Kaleebu P, 2002, J INFECT DIS, V185, P1244, DOI 10.1086/340130; Kaleebu P, 2001, AIDS, V15, P293, DOI 10.1097/00002030-200102160-00001; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; LAEYENDECKER O, 2006, 13 C RETR OPP INF 20; Liner KJ, 2007, J NEUROVIROL, V13, P291, DOI 10.1080/13550280701422383; Mamidi A, 2002, J NEUROVIROL, V8, P158, DOI 10.1080/13550280290049723; McArthur J H, 1986, J Neurosci Nurs, V18, P242; Neilson JR, 1999, J VIROL, V73, P4393, DOI 10.1128/JVI.73.5.4393-4403.1999; Price RW, 1996, LANCET, V348, P445, DOI 10.1016/S0140-6736(95)11035-6; Sacktor N, 2007, NAT CLIN PRACT NEURO, V3, P436, DOI 10.1038/ncpneuro0559; Shafer RW, 2000, NUCLEIC ACIDS RES, V28, P346, DOI 10.1093/nar/28.1.346; Spudich SS, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-98; Vasan A, 2006, CLIN INFECT DIS, V42, P843, DOI 10.1086/499952; Weisman Z, 1999, J ACQ IMMUN DEF SYND, V21, P157; Wong MH, 2007, NEUROLOGY, V68, P350, DOI 10.1212/01.wnl.0000252811.48891.6d; Yepthomi T, 2006, J INT NEUROPSYCH SOC, V12, P424, DOI 10.1017/S1355617706060516	31	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1971	10.1371/journal.pone.0001971	http://dx.doi.org/10.1371/journal.pone.0001971			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414666	Green Published, gold, Green Submitted			2022-12-27	WOS:000260867300015
J	Hoeft, F; Wu, DA; Hernandez, A; Glover, GH; Shimojo, S				Hoeft, Fumiko; Wu, Daw-An; Hernandez, Arvel; Glover, Gary H.; Shimojo, Shinsuke			Electronically Switchable Sham Transcranial Magnetic Stimulation (TMS) System	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; CURRENT DIRECTIONS; COIL ORIENTATION; WAVE-FORM; BRAIN; THRESHOLDS; ACTIVATION; DISEASE; FIBER; PULSE	Transcranial magnetic stimulation (TMS) is increasingly being used to demonstrate the causal links between brain and behavior in humans. Further, extensive clinical trials are being conducted to investigate the therapeutic role of TMS in disorders such as depression. Because TMS causes strong peripheral effects such as auditory clicks and muscle twitches, experimental artifacts such as subject bias and placebo effect are clear concerns. Several sham TMS methods have been developed, but none of the techniques allows one to intermix real and sham TMS on a trial-by-trial basis in a double-blind manner. We have developed an attachment that allows fast, automated switching between Standard TMS and two types of control TMS (Sham and Reverse) without movement of the coil or reconfiguration of the setup. We validate the setup by performing mathematical modeling, search-coil and physiological measurements. To see if the stimulus conditions can be blinded, we conduct perceptual discrimination and sensory perception studies. We verify that the physical properties of the stimulus are appropriate, and that successive stimuli do not contaminate each other. We find that the threshold for motor activation is significantly higher for Reversed than for Standard stimulation, and that Sham stimulation entirely fails to activate muscle potentials. Subjects and experimenters perform poorly at discriminating between Sham and Standard TMS with a figure-of-eight coil, and between Reverse and Standard TMS with a circular coil. Our results raise the possibility of utilizing this technique for a wide range of applications.	[Hoeft, Fumiko; Hernandez, Arvel] Stanford Univ, Sch Med, Ctr Interdisciplinary Brain Sci Res, Palo Alto, CA 94304 USA; [Hoeft, Fumiko; Wu, Daw-An; Shimojo, Shinsuke] CALTECH, Computat & Neural Syst & Div Biol, Pasadena, CA USA; [Wu, Daw-An] Harvard Univ, Dept Psychol, Cambridge, MA USA; [Glover, Gary H.] Stanford Univ, Sch Med, Dept Radiol, Palo Alto, CA USA	Stanford University; California Institute of Technology; Harvard University; Stanford University	Hoeft, F (corresponding author), Stanford Univ, Sch Med, Ctr Interdisciplinary Brain Sci Res, Palo Alto, CA 94304 USA.			Wu, Daw-An/0000-0003-4296-3369; Hernandez, Arvel/0000-0001-7653-9318	National Science Foundation [BCS-0305276, BCS-0305866]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015891] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was funded by the National Science Foundation under BCS-0305276 and BCS-0305866. The sponsors did not play any role in the study besides providing funding.	AMASSIAN VE, 1992, ELECTROEN CLIN NEURO, V85, P291, DOI 10.1016/0168-5597(92)90105-K; BARKER AT, 1991, ELECTROEN CLIN NEURO, P227; BARKER AT, 1985, LANCET, V1, P1106; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Chen R, 2000, MUSCLE NERVE, pS26; Corthout E, 2001, EXP BRAIN RES, V141, P128, DOI 10.1007/s002210100860; George MS, 2006, TRANSCRANIAL MAGNETI; Green DM, 1966, SIGNAL DETECTION THE; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Hallett M., 2005, MAGNETIC STIMULATION, V2nd; HARRINGTON A, 2002, SCI PLACEBO; Hill AC, 2000, NEUROREPORT, V11, P3257, DOI 10.1097/00001756-200009280-00041; Ilmoniemi RJ, 1999, CRIT REV BIOMED ENG, V27, P241; Jackson J. D, 1998, CLASSICAL ELECTRODYN, VThird; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P51; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P2015, DOI 10.1016/S1388-2457(01)00673-3; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Kaptchuk TJ, 2000, ALTERN THER HEALTH M, V6, P18; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Lisanby Sarah H, 2004, BRAIN STIMULATION PS; Maeda F, 2003, PSYCHOPHARMACOLOGY, V168, P359, DOI 10.1007/s00213-002-1216-x; MILLS KR, 1992, ELECTROEN CLIN NEURO, V85, P17, DOI 10.1016/0168-5597(92)90096-T; Mulleners WM, 2002, EUR J NEUROL, V9, P35, DOI 10.1046/j.1468-1331.2002.00334.x; Okabe S, 2003, MOVEMENT DISORD, V18, P382, DOI 10.1002/mds.10370; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; PASCUALLEONE A, 1994, ELECTROEN CLIN NEURO, V93, P42, DOI 10.1016/0168-5597(94)90090-6; Paus T, 2005, PHILOS T R SOC B, V360, P1109, DOI 10.1098/rstb.2005.1652; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; ROTH BJ, 1990, IEEE T BIO-MED ENG, V37, P588, DOI 10.1109/10.55662; Ruohonen J, 2000, IEEE T BIO-MED ENG, V47, P145, DOI 10.1109/10.821731; Sakai K, 1997, EXP BRAIN RES, V113, P24, DOI 10.1007/BF02454139; Schatzberg AF, 2000, BIOL PSYCHIAT, V47, P736, DOI 10.1016/S0006-3223(00)00846-5; Vucic S, 2006, BRAIN, V129, P2436, DOI 10.1093/brain/awl172; Walsh V, 2005, TRANSCRANIAL MAGNETI; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8	35	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1923	10.1371/journal.pone.0001923	http://dx.doi.org/10.1371/journal.pone.0001923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398456	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000260795500007
J	Stark, K; Reinhard, W; Neureuther, K; Wiedmann, S; Sedlacek, K; Baessler, A; Fischer, M; Weber, S; Kaess, B; Erdmann, J; Schunkert, H; Hengstenberg, C				Stark, Klaus; Reinhard, Wibke; Neureuther, Katharina; Wiedmann, Silke; Sedlacek, Kamil; Baessler, Andrea; Fischer, Marcus; Weber, Stefan; Kaess, Bernhard; Erdmann, Jeanette; Schunkert, Heribert; Hengstenberg, Christian			Association of Common Polymorphisms in GLUT9 Gene with Gout but Not with Coronary Artery Disease in a Large Case-Control Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SERUM URIC-ACID; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; RISK-FACTORS; HYPERURICEMIA; MORTALITY; LOCI; SUSCEPTIBILITY; EPIDEMIOLOGY	Background: Serum uric acid (UA) levels have recently been shown to be genetically influenced by common polymorphisms in the GLUT9 gene in two genome-wide association analyses of Italian and British populations. Elevated serum UA levels are often found in conjunction with the metabolic syndrome. Hyperuricemia is the major risk factor for gout and has been associated with increased cardiovascular morbidity and mortality. The aim of the present study was to further elucidate the association of polymorphisms in GLUT9 with gout and coronary artery disease (CAD) or myocardial infarction (MI). To test our hypotheses, we performed two large case-control association analyses of individuals from the German MI Family Study. Methods and Findings: First, 665 patients with gout and 665 healthy controls, which were carefully matched for age and gender, were genotyped for four single nucleotide polymorphisms (SNPs) within or near the GLUT9 gene. All four SNPs demonstrated highly significant association with gout. SNP rs6855911, located within intron 7 of GLUT9, showed the strongest signal with a protective effect of the minor allele with an allelic odds ratio of 0.62 (95% confidence interval 0.52-0.75; p = 3.2*10(-7)). Importantly, this finding was not influenced by adjustment for components of the metabolic syndrome or intake of diuretics. Secondly, 1,473 cases with severe CAD or MI and 1,241 healthy controls were tested for the same four GLUT9 SNPs. The analyses revealed, however, no significant association with CAD or with MI. Additional screening of genome-wide association data sets showed no signal for CAD or MI within the GLUT9 gene region. Conclusion: Thus, our results provide compelling evidence that common genetic variations within the GLUT9 gene strongly influence the risk for gout but are unlikely to have a major effect on CAD or MI in a German population.	[Stark, Klaus; Reinhard, Wibke; Neureuther, Katharina; Wiedmann, Silke; Sedlacek, Kamil; Baessler, Andrea; Fischer, Marcus; Weber, Stefan; Kaess, Bernhard; Hengstenberg, Christian] Klinikum Univ Regensburg, Klin & Poliklin Innere Med 2, Regensburg, Germany; [Erdmann, Jeanette; Schunkert, Heribert] Univ Schleswig Holstein, Med Klin 2, Lubeck, Germany	University of Regensburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Kiel; Schleswig Holstein University Hospital	Hengstenberg, C (corresponding author), Klinikum Univ Regensburg, Klin & Poliklin Innere Med 2, Regensburg, Germany.	christian.hengstenberg@klinik.uni-regensburg.de	Stark, Klaus/D-3813-2009; Erdmann, Jeanette/P-7513-2014	Stark, Klaus/0000-0002-7832-1942; Erdmann, Jeanette/0000-0002-4486-6231; Wiedmann, Silke/0000-0002-4486-6207; Sedlacek, Kamil/0000-0003-1257-1321	National Genome Network [01GS0417]; Deutsche Forschungsgemeinschaft [He1921/9-1]; Vaillant-Stiftung; Deutsche Stiftung fuer Herzforschung; EU sponsored project Cardiogenics [LSH-2005-037593]	National Genome Network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Vaillant-Stiftung; Deutsche Stiftung fuer Herzforschung; EU sponsored project Cardiogenics	This study was supported by grants from the National Genome Network (NGFN, 01GS0417), Deutsche Forschungsgemeinschaft (He1921/9-1), the Vaillant-Stiftung (C.H., H.S.), the Deutsche Stiftung fuer Herzforschung, and the EU sponsored project Cardiogenics (LSH-2005-037593).	Annemans L, 2008, ANN RHEUM DIS, V67, P960, DOI 10.1136/ard.2007.076232; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Choi HK, 2005, CURR OPIN RHEUMATOL, V17, P341; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; Conen D, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-9; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Cupples LA, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S1; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Fam AG, 2002, J RHEUMATOL, V29, P1350; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hense HW, 1995, J HUM HYPERTENS, V9, P935; Knight JC, 2003, CLIN SCI, V104, P493, DOI 10.1042/CS20020304; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Luk AJ, 2005, AM J MANAG CARE, V11, pS435; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Mayer B, 2007, CLIN RES CARDIOL, V96, P1, DOI 10.1007/s00392-006-0447-y; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Pascual E, 2004, CURR OPIN RHEUMATOL, V16, P282, DOI 10.1097/00002281-200405000-00020; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sedlacek K, 2007, J MOL MED, V85, P997, DOI 10.1007/s00109-007-0211-4; Shoji A, 2004, ARTHRIT RHEUM-ARTHR, V51, P321, DOI 10.1002/art.20405; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Underwood M, 2006, BMJ-BRIT MED J, V332, P1315, DOI 10.1136/bmj.332.7553.1315; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Wallace KL, 2004, J RHEUMATOL, V31, P1582; Xu JF, 2002, HUM GENET, V111, P573, DOI 10.1007/s00439-002-0819-y; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	42	67	76	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1948	10.1371/journal.pone.0001948	http://dx.doi.org/10.1371/journal.pone.0001948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398472	Green Submitted, Green Published			2022-12-27	WOS:000260795500023
J	Grimaldi, A; Bianchi, C; Greco, G; Tettamanti, G; Noonan, DM; Valvassori, R; de Eguileor, M				Grimaldi, Annalisa; Bianchi, Cristiano; Greco, Gabriella; Tettamanti, Gianluca; Noonan, Douglas M.; Valvassori, Roberto; de Eguileor, Magda			In Vivo Isolation and Characterization of Stem Cells with Diverse Phenotypes Using Growth Factor Impregnated Biomatrices	PLOS ONE			English	Article							HIRUDO-MEDICINALIS	Background: The stimulation to differentiate into specific cell types for somatic stem cells is largely due to a series of internal and external signals coming from the microenvironment that surrounds the stem cell. Even though intensive research has been made, the basic mechanisms of plasticity and/or the molecules regulating stem cells proliferation and differentiation are not completely determined. Potential answers concerning the problems could be derived from the studies of stem cells in culture. Methodology/Principle Findings: We combine a new procedure (using the matrigel biopolymer supplemented with a selected cytokine/growth factor) with classic techniques such as light, confocal and electron microscopy, immunohistochemistry and cell culture, to perform an analysis on stem cells involved in the leech (Hirudo medicinalis) repair tissues. The leech has a relative anatomical simplicity and is a reliable model for studying a variety of basic events, such as tissue repair, which has a striking similarity with vertebrate responses. Our data demonstrate that the injection of an appropriate combination of the matrigel biopolymer supplemented with a selected cytokine/growth factor in the leech Hirudo medicinalis is a remarkably effective tool for isolating a specific cell population in vivo. A comparative analysis of biopolymer in vivo sorted stem cells indicates that VEGF recruited cells of a hematopoietic/endothelial phenotype whereas MCP-1/CCL2 isolated cells that were of an early myeloid lineage. Conclusion: Our paper describes, for the first time, a method allowing not only the isolation of a specific cell population in relation to the cytokine utilized but also the possibility to culture a precise cell type whose isolation is otherwise quite difficult. This approach could be broadly applied to isolate stem cells of diverse origins based on the recruitment stimuli employed.	[Grimaldi, Annalisa; Bianchi, Cristiano; Greco, Gabriella; Tettamanti, Gianluca; Valvassori, Roberto; de Eguileor, Magda] Univ Insubria, Dept Struct & Funct Biol, Varese, Italy; [Noonan, Douglas M.] Univ Insubria, Dept Clin & Biol Sci, Varese, Italy; [Noonan, Douglas M.] IRCCS Multimedica, Milan, Italy	University of Insubria; University of Insubria; IRCCS Multimedica	Grimaldi, A (corresponding author), Univ Insubria, Dept Struct & Funct Biol, Varese, Italy.	annalisa.grimaldi@uninsubria.it	Tettamanti, Gianluca/L-8748-2019; Noonan, Douglas M/A-8620-2010; Tettamanti, Gianluca/E-5465-2012	Tettamanti, Gianluca/0000-0002-0665-828X; Noonan, Douglas M/0000-0001-8058-0719; Tettamanti, Gianluca/0000-0002-0665-828X; Grimaldi, Annalisa/0000-0002-9258-7595	(FAR) Fondi dell'Ateneo per la Ricerca; Centro Grandi Attrezzature (CGA) of the University of Insubria; MIUR (Ministero dell'Universita e della Ricerca) PRIN; Associazione Italiana per la Ricerca sul Cancro (AIRC)	(FAR) Fondi dell'Ateneo per la Ricerca; Centro Grandi Attrezzature (CGA) of the University of Insubria; MIUR (Ministero dell'Universita e della Ricerca) PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the FAR (Fondi dell'Ateneo per la Ricerca) and the Centro Grandi Attrezzature (CGA) of the University of Insubria, the MIUR (Ministero dell'Universita e della Ricerca) PRIN, and the Associazione Italiana per la Ricerca sul Cancro (AIRC).	Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Barbero A, 2001, J CELL PHYSIOL, V186, P183, DOI 10.1002/1097-4652(200102)186:2<183::AID-JCP1020>3.3.CO;2-H; Benelli R, 2000, J INFECT DIS, V182, P1643, DOI 10.1086/317597; de Eguileor M, 2004, CURR PHARM DESIGN, V10, P1979, DOI 10.2174/1381612043384358; De Eguileor M., 2001, Angiogenesis, V4, P299, DOI 10.1023/A:1016025803370; Delorme B, 2006, REGEN MED, V1, P497, DOI 10.2217/17460751.1.4.497; FLAMME I, 1992, DEVELOPMENT, V116, P435; Grimaldi A, 2006, CURR PHARM DESIGN, V12, P3033, DOI 10.2174/138161206777947443; Gritti A, 2002, J PHYSIOL-PARIS, V96, P81, DOI 10.1016/S0928-4257(01)00083-3; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Kaushansky K, 2006, NEW ENGL J MED, V354, P2034, DOI 10.1056/NEJMra052706; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; Lagasse E, 2001, IMMUNITY, V14, P425, DOI 10.1016/S1074-7613(01)00123-6; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sreerekha PR, 2006, CELL PROLIFERAT, V39, P301, DOI 10.1111/j.1365-2184.2006.00389.x; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Tettamanti G, 2006, CURR MED CHEM, V13, P2737, DOI 10.2174/092986706778521986; Tettamanti G, 2004, BIOL CELL, V96, P443, DOI 10.1016/j.biolcel.2004.04.008; Tettamanti G, 2003, CYTOKINE, V22, P168, DOI 10.1016/S1043-4666(03)00176-5; Tettamanti G, 2003, TISSUE CELL, V35, P199, DOI 10.1016/S0040-8166(03)00027-2	21	11	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1910	10.1371/journal.pone.0001910	http://dx.doi.org/10.1371/journal.pone.0001910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382683	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795400035
J	Outeiro, TF; Putcha, P; Tetzlaff, JE; Spoelgen, R; Koker, M; Carvalho, F; Hyman, BT; McLean, PJ				Outeiro, Tiago Fleming; Putcha, Preeti; Tetzlaff, Julie E.; Spoelgen, Robert; Koker, Mirjam; Carvalho, Filipe; Hyman, Bradley T.; McLean, Pamela J.			Formation of Toxic Oligomeric alpha-Synuclein Species in Living Cells	PLOS ONE			English	Article								Background: Misfolding, oligomerization, and fibrillization of alpha-synuclein are thought to be central events in the onset and progression of Parkinson's disease (PD) and related disorders. Although fibrillar alpha-synuclein is a major component of Lewy bodies (LBs), recent data implicate prefibrillar, oligomeric intermediates as the toxic species. However, to date, oligomeric species have not been identified in living cells. Methodology/Principal Findings: Here we used bimolecular fluorescence complementation (BiFC) to directly visualize alpha-synuclein oligomerization in living cells, allowing us to study the initial events leading to alpha-synuclein oligomerization, the precursor to aggregate formation. This novel assay provides us with a tool with which to investigate how manipulations affecting alpha-synuclein aggregation affect the process over time. Stabilization of alpha-synuclein oligomers via BiFC results in increased cytotoxicity, which can be rescued by Hsp70 in a process that reduces the formation of alpha-synuclein oligomers. Introduction of PD-associated mutations in alpha-synuclein did not affect oligomer formation but the biochemical properties of the mutant alpha-synuclein oligomers differ from those of wild type alpha-synuclein. Conclusions/Significance: This novel application of the BiFC assay to the study of the molecular basis of neurodegenerative disorders enabled the direct visualization of alpha-synuclein oligomeric species in living cells and its modulation by Hsp70, constituting a novel important tool in the search for therapeutics for synucleinopathies.	[Outeiro, Tiago Fleming; Putcha, Preeti; Tetzlaff, Julie E.; Spoelgen, Robert; Koker, Mirjam; Carvalho, Filipe; Hyman, Bradley T.; McLean, Pamela J.] Harvard Univ, Sch Med, MGH,Alzheimers Res Unit, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; [Outeiro, Tiago Fleming] Univ Lisbon, Fac Med, Inst Fisiol, Inst Med Mol,Cell & Mol Neurosci Unit, Lisbon, Portugal	Harvard University; Universidade de Lisboa	Outeiro, TF (corresponding author), Harvard Univ, Sch Med, MGH,Alzheimers Res Unit, MassGen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA.	touteiro@fm.ul.pt; pmclean@partners.org	Tetzlaff, Julie/ABA-3395-2021; Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/M-8106-2019; Outeiro, Tiago/L-7351-2019	Outeiro, Tiago F/0000-0003-1679-1727; Outeiro, Tiago/0000-0003-1679-1727; McLean, Pamela/0000-0003-4870-5715	American Parkinson's disease association; NIH [5P50-NS38372A-06]; MBRC [Tosteson Award Postdoctoral Fellowship]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063963, P50NS038372] Funding Source: NIH RePORTER	American Parkinson's disease association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MBRC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the American Parkinson's disease association (PJM) and from the NIH 5P50-NS38372A-06 (BTH). T.F.O. was supported by the Tosteson Award Postdoctoral Fellowship from MBRC.	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Goedert M, 2001, CLIN CHEM LAB MED, V39, P308, DOI 10.1515/CCLM.2001.047; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; KLUCKEN J, 2004, J BIOL CHEM; Klucken J, 2006, FASEB J, V20, P2050, DOI 10.1096/fj.05-5422com; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lansbury PT, 2002, CURR OPIN CELL BIOL, V14, P653, DOI 10.1016/S0955-0674(02)00377-0; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	31	322	334	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1867	10.1371/journal.pone.0001867	http://dx.doi.org/10.1371/journal.pone.0001867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382657	Green Submitted, Green Published, gold			2022-12-27	WOS:000260795400007
J	Rocha-Perugini, V; Montpellier, C; Delgrange, D; Wychowski, C; Helle, F; Pillez, A; Drobecq, H; Le Naour, F; Charrin, S; Levy, S; Rubinstein, E; Dubuisson, J; Cocquerel, L				Rocha-Perugini, Vera; Montpellier, Claire; Delgrange, David; Wychowski, Czeslaw; Helle, Francois; Pillez, Andre; Drobecq, Herve; Le Naour, Francois; Charrin, Stephanie; Levy, Shoshana; Rubinstein, Eric; Dubuisson, Jean; Cocquerel, Laurence			The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry	PLOS ONE			English	Article								Two to three percent of the world's population is chronically infected with hepatitis C virus (HCV) and thus at risk of developing liver cancer. Although precise mechanisms regulating HCV entry into hepatic cells are still unknown, several cell surface proteins have been identified as entry factors for this virus. Among these molecules, the tetraspanin CD81 is essential for HCV entry. Here, we have identified a partner of CD81, EWI-2wint, which is expressed in several cell lines but not in hepatocytes. Ectopic expression of EWI-2wint in a hepatoma cell line susceptible to HCV infection blocked viral entry by inhibiting the interaction between the HCV envelope glycoproteins and CD81. This finding suggests that, in addition to the presence of specific entry factors in the hepatocytes, the lack of a specific inhibitor can contribute to the hepatotropism of HCV. This is the first example of a pathogen gaining entry into host cells that lack a specific inhibitory factor.	[Rocha-Perugini, Vera; Montpellier, Claire; Delgrange, David; Wychowski, Czeslaw; Helle, Francois; Pillez, Andre; Drobecq, Herve; Dubuisson, Jean; Cocquerel, Laurence] Univ Lille 1, CNRS, Inst Biol, UMR8161, Lille, France; [Levy, Shoshana; Cocquerel, Laurence] Stanford Univ, Med Ctr, Dept Med, Div Oncol, Stanford, CA USA; [Le Naour, Francois; Charrin, Stephanie; Rubinstein, Eric] Univ Paris 11, Inst Andre Lwoff, INSERM U602, Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Rocha-Perugini, V (corresponding author), Univ Lille 1, CNRS, Inst Biol, UMR8161, Lille, France.	jean.dubuisson@ibl.fr; laurence.cocquerel@ibl.fr	CHARRIN, Stephanie/B-2892-2019; HELLE, Francois/G-7427-2011; Rubinstein, Eric/B-4650-2019; Rocha-Perugini, Vera/D-6977-2014; Cocquerel, Laurence/P-1951-2016; Dubuisson, Jean/E-6813-2016	HELLE, Francois/0000-0001-6884-2456; Rubinstein, Eric/0000-0001-7623-9665; Rocha-Perugini, Vera/0000-0002-1761-9884; Cocquerel, Laurence/0000-0002-2136-5178; MONTPELLIER, Claire/0000-0002-3112-8491; Dubuisson, Jean/0000-0003-1626-7693; Charrin, Stephanie/0000-0002-4942-3990; Drobecq, Herve/0000-0002-4081-1575	Institut Federatif de Recherche-142; CNRS; Agence Nationale de Recherches sur le Sida et les hepatites virales ANRS [fellowship]; Institut Pasteur de Lille/Region Nord Pas-de-Calais [fellowship]; French Ministry of Research; Howard Hughes Medical Institute	Institut Federatif de Recherche-142; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de Recherches sur le Sida et les hepatites virales ANRS(ANRSFrench National Research Agency (ANR)); Institut Pasteur de Lille/Region Nord Pas-de-Calais(Region Hauts-de-France); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by the Institut Federatif de Recherche-142 (IFR142) and by grants from the CNRS and the Agence Nationale de Recherches sur le Sida et les hepatites virales ANRS. V R-P was supported by a fellowship from the Institut Pasteur de Lille/Region Nord Pas-de-Calais . DD was supported by a fellowship from the ANRS. FH was supported by a fellowship from the French Ministry of Research. JD is an international scholar of the Howard Hughes Medical Institute.	Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Bost AG, 2003, J VIROL, V77, P4401, DOI 10.1128/JVI.77.7.4401-4408.2003; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Clark KL, 2001, J IMMUNOL, V167, P5115, DOI 10.4049/jimmunol.167.9.5115; Cocquerel L, 2006, J GEN VIROL, V87, P1075, DOI 10.1099/vir.0.81646-0; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Cocquerel L, 2003, J VIROL, V77, P10677, DOI 10.1128/JVI.77.19.10677-10683.2003; Cocquerel L, 2003, J VIROL, V77, P1604, DOI 10.1128/JVI.77.2.1604-1609.2003; Cocquerel L, 2001, J GEN VIROL, V82, P1629, DOI 10.1099/0022-1317-82-7-1629; COFFEY G, 2006, C FRS TUCS AZ US; Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101; Crotta S, 2006, EUR J IMMUNOL, V36, P919, DOI 10.1002/eji.200535527; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; DUBUISSON J, 2007, CELL MICROB IN PRESS; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Keck ZY, 2004, J VIROL, V78, P9224, DOI 10.1128/JVI.78.17.9224-9232.2004; Kolesnikova TV, 2004, BLOOD, V103, P3013, DOI 10.1182/blood-2003-07-2201; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; LEMON SM, 2007, FIELDS VIROLOGY, P1253; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Maillard P, 2001, J VIROL, V75, P8240, DOI 10.1128/JVI.75.17.8240-8250.2001; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; MEERTENS L, 2008, J VIROL; Molina S, 2008, J VIROL, V82, P569, DOI 10.1128/JVI.01443-07; OREN R, 1990, MOL CELL BIOL, V10, P4007, DOI 10.1128/MCB.10.8.4007; Rubinstein E, 1996, EUR J IMMUNOL, V26, P2657, DOI 10.1002/eji.1830261117; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Sandrin V, 2002, BLOOD, V100, P823, DOI 10.1182/blood-2001-11-0042; Stipp CS, 2003, J CELL BIOL, V163, P1167, DOI 10.1083/jcb.200309113; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; Stipp CS, 2001, J BIOL CHEM, V276, P4853, DOI 10.1074/jbc.M009859200; Tscherne DM, 2006, J VIROL, V80, P1734, DOI 10.1128/JVI.80.4.1734-1741.2006; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; YANG W, 2008, J BIOL CHEM; Yang XH, 2006, J BIOL CHEM, V281, P12976, DOI 10.1074/jbc.M510617200; Zhang XA, 2003, CANCER RES, V63, P2665; Zheng AH, 2007, J VIROL, V81, P12465, DOI 10.1128/JVI.01457-07; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	51	86	89	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1866	10.1371/journal.pone.0001866	http://dx.doi.org/10.1371/journal.pone.0001866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382656	Green Submitted, gold, Green Published			2022-12-27	WOS:000260795400006
J	Tinto, N; Zagari, A; Capuano, M; De Simone, A; Capobianco, V; Daniele, G; Giugliano, M; Spadaro, R; Franzese, A; Sacchetti, L				Tinto, Nadia; Zagari, Adriana; Capuano, Marina; De Simone, Alfonso; Capobianco, Valentina; Daniele, Gerardo; Giugliano, Michela; Spadaro, Raffaella; Franzese, Adriana; Sacchetti, Lucia			Glucokinase Gene Mutations: Structural and Genotype-Phenotype Analyses in MODY Children from South Italy	PLOS ONE			English	Article							YOUNG TYPE-2 MODY-2; INSULIN SENSITIVITY; ONSET; IDENTIFICATION; MECHANISMS; GCK; HYPERINSULINEMIA; HYPERGLYCEMIA; CONSERVATION; NOMENCLATURE	Background: Maturity onset diabetes of the young type 2 (or GCK MODY) is a genetic form of diabetes mellitus provoked by mutations in the glucokinase gene (GCK). Methodology/Principal Findings: We screened the GCK gene by direct sequencing in 30 patients from South Italy with suspected MODY. The mutation-induced structural alterations in the protein were analyzed by molecular modeling. The patients' biochemical, clinical and anamnestic data were obtained. Mutations were detected in 16/30 patients (53%); 9 of the 12 mutations identified were novel (p.Glu70Asp, p.Phe123Leu, p.Asp132Asn, p.His137Asp, p.Gly162Asp, p.Thr168Ala, p.Arg392Ser, p.Glu290X, p.Gln106_Met107delinsLeu) and are in regions involved in structural rearrangements required for catalysis. The prevalence of mutation sites was higher in the small domain (7/12: similar to 59%) than in the large (4/12: 33%) domain or in the connection (1/12: 8%) region of the protein. Mild diabetic phenotypes were detected in almost all patients [mean (SD) OGTT = 7.8 mMol/L (1.8)] and mean triglyceride levels were lower in mutated than in unmutated GCK patients (p = 0.04). Conclusions: The prevalence of GCK MODY is high in southern Italy, and the GCK small domain is a hot spot for MODY mutations. Both the severity of the GCK mutation and the genetic background seem to play a relevant role in the GCK MODY phenotype. Indeed, a partial genotype-phenotype correlation was identified in related patients (3 pairs of siblings) but not in two unrelated children bearing the same mutation. Thus, the molecular approach allows the physician to confirm the diagnosis and to predict severity of the mutation.	[Tinto, Nadia; Capuano, Marina; Capobianco, Valentina; Daniele, Gerardo; Sacchetti, Lucia] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Naples, Italy; [Zagari, Adriana; De Simone, Alfonso] Univ Napoli Federico II, CEINGE Biotecnol Avanzate, Dipartimento Sci Biol, Naples, Italy; [Giugliano, Michela; Spadaro, Raffaella; Franzese, Adriana] Univ Napoli Federico II, Dipartimento Pediat, Naples, Italy	University of Naples Federico II; CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II	Tinto, N (corresponding author), Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Naples, Italy.	sacchetti@dbbm.unina.it	capuano, marina/GLT-0659-2022	Capobianco, Valentina/0000-0002-9161-1581	CEINGE-Regione Campania; MIUR; Ministero Salute [DL 502/92, DL 229/99]	CEINGE-Regione Campania; MIUR(Ministry of Education, Universities and Research (MIUR)); Ministero Salute(Ministry of Health, Italy)	Work supported by grants from CEINGE-Regione Campania (Convenzione del. G. R. 27/12/2002 N. 6276), from MIUR art.5.2. and from Ministero Salute (ricerca finalizzata - progetto ordinario DL 502/92 and DL 229/99 art.12 and 12 bis).	Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; [Anonymous], HUMAN GENE MUTATION; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berger M, 2005, CLIN CHEM, V51, P791, DOI 10.1373/clinchem.2004.045963; Burke CV, 1999, BIOCHEM J, V342, P345, DOI 10.1042/0264-6021:3420345; den Dunnen JT, 2003, HUM MUTAT, V22, P181, DOI 10.1002/humu.10262; den Dunnen JT, 2001, HUM GENET, V109, P121, DOI 10.1007/s004390100505; Ellard S, 2007, DIABETOLOGIA, V50, P2313, DOI 10.1007/s00125-007-0798-6; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fraternali F, 1996, J MOL BIOL, V256, P939, DOI 10.1006/jmbi.1996.0139; Garcia-Herrero CM, 2007, DIABETOLOGIA, V50, P325, DOI 10.1007/s00125-006-0542-7; Glaser F, 2005, PROTEINS, V58, P610, DOI 10.1002/prot.20305; Gloyn AL, 2003, HUM MUTAT, V22, P353, DOI 10.1002/humu.10277; Hattersley AT, 1998, NAT GENET, V19, P268, DOI 10.1038/953; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Mantovani Vilma, 2003, Hum Mutat, V22, P338, DOI 10.1002/humu.9179; Massa O, 2001, DIABETOLOGIA, V44, P898; Miller SP, 1999, DIABETES, V48, P1645, DOI 10.2337/diabetes.48.8.1645; Pinterova D, 2007, CLIN GENET, V71, P95, DOI 10.1111/j.1399-0004.2006.00729.x; Prisco F, 2000, DIABETOLOGIA, V43, P1331; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Rhodes CJ, 2002, EUR J CLIN INVEST, V32, P3, DOI 10.1046/j.1365-2362.32.s3.2.x; Sagen JV, 2006, DIABETES, V55, P1713, DOI 10.2337/db05-1513; Shield JPH, 2004, ARCH DIS CHILD-FETAL, V89, pF341, DOI 10.1136/adc.2003.030502; STOFFEL M, 1992, P NATL ACAD SCI USA, V89, P7698, DOI 10.1073/pnas.89.16.7698; Toaima Dalia, 2005, Hum Mutat, V25, P503, DOI 10.1002/humu.9334; VeigadaCunha M, 1996, J BIOL CHEM, V271, P6292, DOI 10.1074/jbc.271.11.6292; Velho G, 1997, DIABETOLOGIA, V40, P217, DOI 10.1007/s001250050666; Weedon Michael N, 2007, Curr Diab Rep, V7, P131, DOI 10.1007/s11892-007-0022-6; PROTEIN FAMILIES DAT; PRIMER3 INPUT 0 4 0	34	35	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1870	10.1371/journal.pone.0001870	http://dx.doi.org/10.1371/journal.pone.0001870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382660	Green Submitted, gold, Green Published			2022-12-27	WOS:000260795400010
J	Mydlarz, LD; Holthouse, SF; Peters, EC; Harvell, CD				Mydlarz, Laura D.; Holthouse, Sally F.; Peters, Esther C.; Harvell, C. Drew			Cellular Responses in Sea Fan Corals: Granular Amoebocytes React to Pathogen and Climate Stressors	PLOS ONE			English	Article							DISEASE RESISTANCE; TEMPERATURE STRESS; INNATE IMMUNITY; ECOLOGY; PERSPECTIVES; ATTENUATION; RESILIENCE; INFECTION; SURVIVE; MARINE	Background: Climate warming is causing environmental change making both marine and terrestrial organisms, and even humans, more susceptible to emerging diseases. Coral reefs are among the most impacted ecosystems by climate stress, and immunity of corals, the most ancient of metazoans, is poorly known. Although coral mortality due to infectious diseases and temperature-related stress is on the rise, the immune effector mechanisms that contribute to the resistance of corals to such events remain elusive. In the Caribbean sea fan corals (Anthozoa, Alcyonacea: Gorgoniidae), the cell-based immune defenses are granular acidophilic amoebocytes, which are known to be involved in wound repair and histocompatibility. Methodology/Principal Findings: We demonstrate for the first time in corals that these cells are involved in the organismal response to pathogenic and temperature stress. In sea fans with both naturally occurring infections and experimental inoculations with the fungal pathogen Aspergillus sydowii, an inflammatory response, characterized by a massive increase of amoebocytes, was evident near infections. Melanosomes were detected in amoebocytes adjacent to protective melanin bands in infected sea fans; neither was present in uninfected fans. In naturally infected sea fans a concurrent increase in prophenoloxidase activity was detected in infected tissues with dense amoebocytes. Sea fans sampled in the field during the 2005 Caribbean Bleaching Event (a once-in-hundred-year climate event) responded to heat stress with a systemic increase in amoebocytes and amoebocyte densities were also increased by elevated temperature stress in lab experiments. Conclusions/Significance: The observed amoebocyte responses indicate that sea fan corals use cellular defenses to combat fungal infection and temperature stress. The ability to mount an inflammatory response may be a contributing factor that allowed the survival of even infected sea fan corals during a stressful climate event.	[Mydlarz, Laura D.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Holthouse, Sally F.; Harvell, C. Drew] Cornell Univ, Dept Ecol & Evolut Biol, Ithaca, NY USA; [Peters, Esther C.] Tetra Tech Inc, Fairfax, VA USA	University of Texas System; University of Texas Arlington; Cornell University	Mydlarz, LD (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA.	Mydlarz@UTA.edu	Peters, Esther C/ABA-5788-2021; Mydlarz, Laura/B-8132-2011	Peters, Esther C/0000-0001-5404-5309; 	NSF/NIH Ecology of Infectious Disease Program [NSF EF- 0326705]	NSF/NIH Ecology of Infectious Disease Program	We would like to acknowledge funding for this project from NSF/NIH Ecology of Infectious Disease Program (NSF EF- 0326705).	ALKER A, 2006, CORAL REEFS, V23, P397; Blackstone NW, 2005, INTEGR COMP BIOL, V45, P605, DOI 10.1093/icb/45.4.605; Brakhage AA, 2005, CURR DRUG TARGETS, V6, P875, DOI 10.2174/138945005774912717; Brown BE, 2005, MAR ECOL PROG SER, V296, P291, DOI 10.3354/meps296291; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cheng W, 2001, FISH SHELLFISH IMMUN, V11, P53, DOI 10.1006/fsim.2000.0293; Cooper EL, 2002, BIOESSAYS, V24, P319, DOI 10.1002/bies.10077; Ellner SP, 2007, AM NAT, V170, pE143, DOI 10.1086/522841; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Galloway TS, 2001, ECOTOXICOLOGY, V10, P5, DOI 10.1023/A:1008939520263; Griffin SP, 2006, COMP BIOCHEM PHYS A, V144, P155, DOI 10.1016/j.cbpa.2006.02.017; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; HARVELL CD, 2007, OCEANOGRAPHY, V20, P59; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kim K, 2000, MAR BIOL, V136, P259, DOI 10.1007/s002270050684; Kim K, 2004, AM NAT, V164, pS52, DOI 10.1086/424609; Lesser MP, 2007, P NATL ACAD SCI USA, V104, P5259, DOI 10.1073/pnas.0700910104; LEVY JM, 2006, B AM METEOROL SOC, V87, pS21; Levy O, 2006, J EXP MAR BIOL ECOL, V328, P35, DOI 10.1016/j.jembe.2005.06.018; Li WKW, 1998, LIMNOL OCEANOGR, V43, P1746, DOI 10.4319/lo.1998.43.7.1746; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Meszaros A, 1999, J INVERTEBR PATHOL, V73, P321, DOI 10.1006/jipa.1999.4851; Miller J, 2006, CORAL REEFS, V25, P418, DOI 10.1007/s00338-006-0125-6; Monari M, 2007, FISH SHELLFISH IMMUN, V22, P98, DOI 10.1016/j.fsi.2006.03.016; Mullen KM, 2004, CORAL HEALTH AND DISEASE, P377; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Olano CT, 2000, J INVERTEBR PATHOL, V76, P176, DOI 10.1006/jipa.2000.4974; Ouedraogo RM, 2003, J INVERTEBR PATHOL, V82, P103, DOI 10.1016/S0022-2011(02)00185-4; Ouedraogo RM, 2002, J INVERTEBR PATHOL, V81, P19, DOI 10.1016/S0022-2011(02)00117-9; Oxenford HA, 2008, CLIMATIC CHANGE, V87, P435, DOI 10.1007/s10584-007-9311-y; PATTERSON MJ, 1979, J INVERTEBR PATHOL, V33, P189, DOI 10.1016/0022-2011(79)90152-6; Petes LE, 2003, MAR ECOL PROG SER, V264, P167, DOI 10.3354/meps264167; PORCHETHENNERE E, 1992, CELL TISSUE RES, V269, P167, DOI 10.1007/BF00384737; Rinkevich B, 1996, MAR ECOL PROG SER, V143, P297, DOI 10.3354/meps143297; Sadd BM, 2006, P ROY SOC B-BIOL SCI, V273, P2571, DOI 10.1098/rspb.2006.3574; Sheehan D.C., 1980, THEORY PRACTICE HIST; Sigsgaard L, 2000, ENTOMOL EXP APPL, V95, P173, DOI 10.1023/A:1003993719952; Smith GW, 1996, NATURE, V383, P487, DOI 10.1038/383487a0; SPARKS AK, 1985, SYNOPSIS INVERTEBRAT, P1; Thomas MB, 2003, TRENDS ECOL EVOL, V18, P344, DOI 10.1016/S0169-5347(03)00069-7; TRUSCOTT R, 1990, FUNCT ECOL, V4, P455, DOI 10.2307/2389609; Vargas-Angel B, 2007, J INVERTEBR PATHOL, V95, P140, DOI 10.1016/j.jip.2007.01.003; Ward JR, 2007, MAR ECOL PROG SER, V329, P115, DOI 10.3354/meps329115	47	132	134	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1811	10.1371/journal.pone.0001811	http://dx.doi.org/10.1371/journal.pone.0001811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18364996	gold, Green Published			2022-12-27	WOS:000260762400002
J	Park, D; Veenstra, JA; Park, JH; Taghert, PH				Park, Dongkook; Veenstra, Jan A.; Park, Jae H.; Taghert, Paul H.			Mapping Peptidergic Cells in Drosophila: Where DIMM Fits In	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTOR MIST1; IMMUNOREACTIVE NEURONS; NEUROSECRETORY-CELLS; SEROTONERGIC NEURONS; EXPRESSING NEURONS; ECDYSIS BEHAVIOR; FEEDING-BEHAVIOR; GENE-EXPRESSION; INNATE BEHAVIOR	The bHLH transcription factor DIMMED has been associated with the differentiation of peptidergic cells in Drosophila. However, whether all Drosophila peptidergic cells express DIMM, and the extent to which all DIMM cells are peptidergic, have not been determined. To address these issues, we have mapped DIMM expression in the central nervous system (CNS) and periphery in the late larval stage Drosophila. At 100 hr after egg-laying, DIMM immunosignals are largely congruent with a dimm-promoter reporter (c929 GAL4) and they present a stereotyped pattern of 306 CNS cells and 52 peripheral cells. We assigned positional values for all DIMM CNS cells with respect to reference gene expression patterns, or to patterns of secondary neuroblast lineages. We could assign provisional peptide identities to 68% of DIMM-expressing CNS cells (207/306) and to 73% of DIMM-expressing peripheral cells (38/52) using a panel of 24 markers for Drosophila neuropeptide genes. Furthermore, we found that DIMM co-expression was a prevalent feature within single neuropeptide marker expression patterns. Of the 24 CNS neuropeptide gene patterns we studied, six patterns are >90% DIMM-positive, while 16 of 22 patterns are >40% DIMM-positive. Thus most or all DIMM cells in Drosophila appear to be peptidergic, and many but not all peptidergic cells express DIMM. The co-incidence of DIMM-expression among peptidergic cells is best explained by a hypothesis that DIMM promotes a specific neurosecretory phenotype we term LEAP. LEAP denotes Large cells that display Episodic release of Amidated Peptides.	[Park, Dongkook; Taghert, Paul H.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Veenstra, Jan A.] Univ Bordeaux 1, CNIC UMR 5228 CNRS, Talence, France; [Park, Jae H.] Univ Tennessee Knoxville, Dept Biochem & Cell & Mol Biol, Knoxville, TN USA	Washington University (WUSTL); UDICE-French Research Universities; Universite de Bordeaux; University of Tennessee System; University of Tennessee Knoxville	Park, D (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	taghertp@pcg.wustl.edu	Veenstra, Jan/B-4610-2008	Veenstra, Jan Adrianus/0000-0002-2783-0018; Park, Jae/0000-0002-4846-2197	NSF [IBN-0133538]; NIH [NS21749, NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021749, P30NS057105] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by a grant from the NSF (IBN-0133538) to JAP, and the NIH (NS21749) to PHT, and by an NIH Neuroscience Blueprint Core Grant (#NS057105) to Washington University	Acampora D, 1999, GENE DEV, V13, P2787, DOI 10.1101/gad.13.21.2787; Allan DW, 2005, NEURON, V45, P689, DOI 10.1016/j.neuron.2005.01.026; ARCH S, 1989, BRAIN RES REV, V14, P181, DOI 10.1016/0165-0173(89)90014-3; Bader R, 2007, J COMP NEUROL, V502, P848, DOI 10.1002/cne.21342; Baggerman G, 2002, J BIOL CHEM, V277, P40368, DOI 10.1074/jbc.M206257200; Baggerman G, 2005, J MASS SPECTROM, V40, P250, DOI 10.1002/jms.744; Baker JD, 2002, J EXP BIOL, V205, P2555; BARGMANN W, 1951, SITE ORIGIN HORMONE; Baumgardt M, 2007, PLOS BIOL, V5, P295, DOI 10.1371/journal.pbio.0050037; Blitz DM, 1999, J NEUROSCI, V19, P6774, DOI 10.1523/JNEUROSCI.19-16-06774.1999; Boonen K, 2007, GEN COMP ENDOCR, V152, P231, DOI 10.1016/j.ygcen.2007.05.002; BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8; Broeck JV, 2001, PEPTIDES, V22, P241, DOI 10.1016/S0196-9781(00)00376-4; BURBACH JPH, 1986, J NEUROCHEM, V47, P1814, DOI 10.1111/j.1471-4159.1986.tb13093.x; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; Cabrero P, 2002, J EXP BIOL, V205, P3799; Candy DJ, 2002, INSECT BIOCHEM MOLEC, V32, P1361, DOI 10.1016/S0965-1748(02)00056-5; CHEN YT, 1994, CELL TISSUE RES, V278, P493, DOI 10.1007/BF00331367; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; CHIN AC, 1990, DNA CELL BIOL, V9, P263, DOI 10.1089/dna.1990.9.263; Choi YJ, 2005, J COMP NEUROL, V482, P372, DOI 10.1002/cne.20419; Clark AC, 2004, J NEUROSCI, V24, P4283, DOI 10.1523/JNEUROSCI.4938-03.2004; COPENHAVER PF, 1986, J NEUROSCI, V6, P1738; CUI X, 1992, DEVELOPMENT, V116, P943; de Velasco B, 2007, DEV BIOL, V302, P309, DOI 10.1016/j.ydbio.2006.09.035; Dewey EM, 2004, CURR BIOL, V14, P1208, DOI 10.1016/j.cub.2004.06.051; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Ding YQ, 2003, NAT NEUROSCI, V6, P933, DOI 10.1038/nn1104; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; Ewer J, 1996, J COMP NEUROL, V370, P330; Furuya K, 2000, P NATL ACAD SCI USA, V97, P6469, DOI 10.1073/pnas.97.12.6469; Gauthier SA, 2006, J EXP BIOL, V209, P1803, DOI 10.1242/jeb.02202; GORCZYCA MG, 1994, DEVELOPMENT, V120, P2143; Goshu E, 2004, MOL ENDOCRINOL, V18, P1251, DOI 10.1210/me.2003-0372; Hartenstein V, 2006, J ENDOCRINOL, V190, P555, DOI 10.1677/joe.1.06964; Hewes RS, 2006, J NEUROSCI, V26, P7860, DOI 10.1523/JNEUROSCI.1759-06.2006; Hewes RS, 2003, DEVELOPMENT, V130, P1771, DOI 10.1242/dev.00404; HEWES RS, 1994, J NEUROSCI, V14, P1812, DOI 10.1523/JNEUROSCI.14-03-01812.1994; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hosoya T, 2001, GENES CELLS, V6, P361, DOI 10.1046/j.1365-2443.2001.00421.x; ISABEL G, 2004, AM J PHYSL REGUL INT; Jiang N, 2000, DEV BIOL, V226, P118, DOI 10.1006/dbio.2000.9832; Kaneko M, 1997, J NEUROSCI, V17, P6745; Karcavich R, 2005, J COMP NEUROL, V481, P240, DOI 10.1002/cne.20371; Kean L, 2002, AM J PHYSIOL-REG I, V282, pR1297, DOI 10.1152/ajpregu.00584.2001; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Kim YJ, 2006, P NATL ACAD SCI USA, V103, P14211, DOI 10.1073/pnas.0603459103; Kim YJ, 2006, CURR BIOL, V16, P1395, DOI 10.1016/j.cub.2006.06.027; Kolhekar AS, 1997, J NEUROSCI, V17, P1363, DOI 10.1523/jneurosci.17-04-01363.1997; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lemercier C, 1998, EMBO J, V17, P1412, DOI 10.1093/emboj/17.5.1412; Liu F, 2006, MOL CELL PROTEOMICS, V5, P510, DOI 10.1074/mcp.M400114-MCP200; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Lundell MJ, 1998, DEVELOPMENT, V125, P463; LUNDQUIST T, 1990, J COMP NEUROL, V294, P161, DOI 10.1002/cne.902940202; Macins A, 1999, ARCH INSECT BIOCHEM, V40, P107, DOI 10.1002/(SICI)1520-6327(1999)40:2&lt;107::AID-ARCH5&gt;3.0.CO;2-B; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Miguel-Aliaga I, 2004, DEVELOPMENT, V131, P5837, DOI 10.1242/dev.01447; NAKAI S, 1995, GENE DEV, V3121, P2; Nassel DR, 2006, CELL TISSUE RES, V326, P1, DOI 10.1007/s00441-006-0210-8; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; NASSEL DR, 1991, CELL TISSUE RES, V266, P511, DOI 10.1007/BF00318593; Neupert S, 2007, ANAL CHEM, V79, P3690, DOI 10.1021/ac062411p; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; O'Brien MA, 1998, J EXP BIOL, V201, P193; Park DK, 2004, DEV BIOL, V269, P95, DOI 10.1016/j.ydbio.2004.01.015; Park D, 2008, MOL CELL BIOL, V28, P410, DOI 10.1128/MCB.01104-07; Park JH, 2003, DEVELOPMENT, V130, P2645, DOI 10.1242/dev.00503; Park Y, 1999, FEBS LETT, V463, P133, DOI 10.1016/S0014-5793(99)01622-1; Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006; Pin CL, 2000, ANAT REC, V259, P157, DOI 10.1002/(SICI)1097-0185(20000601)259:2<157::AID-AR6>3.0.CO;2-0; Pin CL, 2001, J CELL BIOL, V155, P519, DOI 10.1083/jcb.200105060; Ramsey VG, 2007, DEVELOPMENT, V134, P211, DOI 10.1242/dev.02700; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Roller L, 2003, CELL TISSUE RES, V312, P393, DOI 10.1007/s00441-003-0722-4; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Santos JG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000695; SCHOLNICK SB, 1986, SCIENCE, V234, P998, DOI 10.1126/science.3095924; Schonemann MD, 1995, GENE DEV, V9, P3122, DOI 10.1101/gad.9.24.3122; SCHOOFS L, 1993, PEPTIDES, V14, P409, DOI 10.1016/0196-9781(93)90126-2; Shiga S, 2003, MICROSC RES TECHNIQ, V62, P114, DOI 10.1002/jemt.10366; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; STAY B, 1992, CELL TISSUE RES, V270, P15, DOI 10.1007/BF00381875; SUDHOF TC, 2008, NEUROTRANSMITTER REL, P1; TAGER HS, 1976, ANAL BIOCHEM, V71, P367; TAGHERT PH, 1990, J NEUROSCI, V10, P1929; Taghert PH, 2003, ADV GENET, V49, P1, DOI 10.1016/S0065-2660(03)01001-0; Taghert PH, 2001, J NEUROSCI, V21, P6673, DOI 10.1523/JNEUROSCI.21-17-06673.2001; Taylor CAM, 2004, J NEUROBIOL, V58, P379, DOI 10.1002/neu.10301; Terhzaz S, 2007, BIOCHEM BIOPH RES CO, V352, P305, DOI 10.1016/j.bbrc.2006.11.030; Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533; Verleyen P, 2004, J NEUROCHEM, V88, P311, DOI 10.1046/j.1471-4159.2003.02161.x; VILLAR MJ, 1988, NEUROSCI LETT, V86, P114, DOI 10.1016/0304-3940(88)90193-0; Wang WD, 2000, DEV BIOL, V227, P432, DOI 10.1006/dbio.2000.9902; Wegener C, 2006, J NEUROCHEM, V96, P1362, DOI 10.1111/j.1471-4159.2005.03634.x; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Zitnan D, 1996, SCIENCE, V271, P88, DOI 10.1126/science.271.5245.88; ZITNAN D, 1993, DEV BIOL, V156, P117, DOI 10.1006/dbio.1993.1063	102	135	136	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1896	10.1371/journal.pone.0001896	http://dx.doi.org/10.1371/journal.pone.0001896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365028	Green Submitted, Green Published, gold			2022-12-27	WOS:000260762400034
J	Groenenberg, DSJ; Beintema, AJ; Dekker, RWRJ; Gittenberger, E				Groenenberg, Dick S. J.; Beintema, Albert J.; Dekker, Rene W. R. J.; Gittenberger, Edmund			Ancient DNA Elucidates the Controversy about the Flightless Island Hens (Gallinula sp.) of Tristan da Cunha	PLOS ONE			English	Article								A persistent controversy surrounds the flightless island hen of Tristan da Cunha, Gallinula nesiotis. Some believe that it became extinct by the end of the 19th century. Others suppose that it still inhabits Tristan. There is no consensus about Gallinula comeri, the name introduced for the flightless moorhen from the nearby island of Gough. On the basis of DNA sequencing of both recently collected and historical material, we conclude that G. nesiotis and G. comeri are different taxa, that G. nesiotis indeed became extinct, and that G. comeri now inhabits both islands. This study confirms that among gallinules seemingly radical adaptations (such as the loss of flight) can readily evolve in parallel on different islands, while conspicuous changes in other morphological characters fail to occur.	[Groenenberg, Dick S. J.; Dekker, Rene W. R. J.; Gittenberger, Edmund] Natl Museum Nat Hist Naturalis, Leiden, Netherlands; [Beintema, Albert J.] Biowrite, Gorssel, Netherlands; [Gittenberger, Edmund] Leiden Univ, Inst Biol, Leiden, Netherlands	Naturalis Biodiversity Center; Leiden University; Leiden University - Excl LUMC	Groenenberg, DSJ (corresponding author), Natl Museum Nat Hist Naturalis, Leiden, Netherlands.	groenenberg@naturalis.nl						Allen JA, 1892, B AM MUS NAT HIST, V4, P57; Austin JJ, 2003, MOL ECOL, V12, P1415, DOI 10.1046/j.1365-294X.2003.01842.x; Beintema A.J., 1972, Bulletin Br Orn Club, V92, P106; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Binladen J, 2006, GENETICS, V172, P733, DOI 10.1534/genetics.105.049718; Broekhuysen G. V., 1949, Ardea Leiden, V37, P97; Casane D, 1997, J MOL EVOL, V45, P216, DOI 10.1007/PL00006223; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; Dickinson EC., 2003, HOWARD MOORE COMPLET; Eber G., 1962, Bonner Zoologische Beitraege, V12, P247; Eldridge MDB, 1999, CONSERV BIOL, V13, P531, DOI 10.1046/j.1523-1739.1999.98115.x; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; Knox A.G., 1994, BRIT ORNITHOLOGISTS; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kolokotronis SO, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-67; Maddison WP, 2005, MACCLADE ANAL PHYLOG; MILNER J, 1869, CRUISE HMS GLATEA CA; MUSE SV, 1992, GENETICS, V132, P269; Nicoll MJ, 1908, 3 VOYAGES NATURALIST; NICOLL MJ, 1906, BIRDS COLLECTED OBSE, V8, P666; NYLANDER J.A.A., 2004, MRMODELTEST 2 2 PROG; Orlando L, 2003, MOL PHYLOGENET EVOL, V28, P485, DOI 10.1016/S1055-7903(03)00023-X; Perna NT, 1996, CURR BIOL, V6, P128, DOI 10.1016/S0960-9822(02)00441-4; POND SLK, 2005, HYPHY HYPOTHESIS TES, P676; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quinn TW, 1992, MOL ECOL, V1, P105, DOI 10.1111/j.1365-294X.1992.tb00162.x; Richardson M.E., 1984, Cormorant, V12, P123; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCLATER PL, 1861, P ZOOL SOC LOND, P260; Slikas B, 2002, J AVIAN BIOL, V33, P5, DOI 10.1034/j.1600-048X.2002.330103.x; Sorenson MD, 1998, AUK, V115, P214, DOI 10.2307/4089130; SPERLING RM, 1872, IBIS, V3, P74; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAYLOR B, 1998, RAILS GUIDE RAILS CO	37	9	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1835	10.1371/journal.pone.0001835	http://dx.doi.org/10.1371/journal.pone.0001835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350170	Green Published, gold			2022-12-27	WOS:000260762300036
J	Zen, K; Liu, DQ; Guo, YL; Wang, C; Shan, J; Fang, M; Zhang, CY; Liu, Y				Zen, Ke; Liu, Dan-Qing; Guo, Ya-Lan; Wang, Chen; Shan, Jun; Fang, Ming; Zhang, Chen-Yu; Liu, Yuan			CD44v4 Is a Major E-Selectin Ligand that Mediates Breast Cancer Cell Transendothelial Migration	PLOS ONE			English	Article								Background: Endothelial E-selectin has been shown to play a pivotal role in mediating cell-cell interactions between breast cancer cells and endothelial monolayers during tumor cell metastasis. However, the counterreceptor for E-selectin and its role in mediating breast cancer cell transendothelial migration remain unknown. Methodology/Principal Findings: By assessing migration of various breast cancer cells across TNF-alpha pre-activated human umbilical vein endothelial cells (HUVECs), we found that breast cancer cells migrated across HUVEC monolayers differentially and that transmigration was E-selectin dependent. Cell surface labeling with the E-selectin extracellular domain/Fc chimera (exE-selectin/Fc) showed that the transmigration capacity of breast cancer cells was correlated to both the expression level and localization pattern of E-selectin binding protein(s) on the tumor cell surface. The exE-selectin/Fc strongly bound to metastatic MDA-MB-231, MDA-MB-435 and MDA-MB-468 cells, but not non-metastatic MCF-7 and T47D cells. Binding of exE-selectin/Fc was abolished by removal of tumor cell surface sialyl lewis x (sLe(x)) moieties. Employing an exE-selectin/Fc affinity column, we further purified the counterreceptor of E-selectin from metastatic breast cancer cells. The N-terminal protein sequence and cDNA sequence identified this E-selectin ligand as a similar to 170 kD human CD44 variant 4 (CD44v4). Purified CD44v4 showed a high affinity for E-selectin via sLe(x) moieties and, as expected, MDA-MB-231 cell adhesion to and migration across HUVEC monolayers were significantly reduced by down-regulation of tumor cell CD44v4 via CD44v4-specific siRNA. Conclusions/Significance: We demonstrated, for the first time, that breast cancer cell CD44v4 is a major E-selectin ligand in facilitating tumor cell migration across endothelial monolayers. This finding offers new insights into the molecular basis of E-selectin-dependent adhesive interactions that mediate breast cancer cell transendothelial metastasis.	[Zen, Ke; Liu, Dan-Qing; Guo, Ya-Lan; Wang, Chen; Shan, Jun; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Zen, Ke] Jiangsu CDC Nanjing Univ Joint Inst Virol, Nanjing, Peoples R China; [Fang, Ming; Liu, Yuan] Georgia State Univ, Dept Biol, Program Cell & Mol Biol, Atlanta, GA USA	Nanjing University; University System of Georgia; Georgia State University	Zen, K (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	kzen@nju.edu.cn	wang, chen/GWM-9481-2022		American Heart Association; Nanjing University; China Basic Science 973 program [2006CB503909]	American Heart Association(American Heart Association); Nanjing University(Nanjing University); China Basic Science 973 program(National Basic Research Program of China)	First-aid grant from the American Heart Association (Yuan Liu), Research grant from Nanjing University (111 Project) (Ke Zen), China Basic Science 973 program (2006CB503909)(C.Y. Zhang, and K. Zen)	Bajorath J, 2000, PROTEINS, V39, P103, DOI 10.1002/(SICI)1097-0134(20000501)39:2<103::AID-PROT1>3.3.CO;2-7; Bouker KB, 2005, CARCINOGENESIS, V26, P1527, DOI 10.1093/carcin/bgi113; Diaz LK, 2005, CLIN CANCER RES, V11, P3309, DOI 10.1158/1078-0432.CCR-04-2184; Dimitroff CJ, 2005, CANCER RES, V65, P5750, DOI 10.1158/0008-5472.CAN-04-4653; Dumont N, 2003, CANCER CELL, V3, P531, DOI 10.1016/S1535-6108(03)00135-1; Edberg DD, 2005, J BIOL CHEM, V280, P8961, DOI 10.1074/jbc.M407348200; Edwards DR, 1998, NATURE, V394, P527, DOI 10.1038/28961; Fanning A, 2005, INT IMMUNOL, V17, P449, DOI 10.1093/intimm/dxh225; Fujimoto T, 2001, INT IMMUNOL, V13, P359, DOI 10.1093/intimm/13.3.359; Fujisaki T, 1999, CANCER RES, V59, P4427; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; GUO YJ, 1994, CANCER RES, V54, P1561; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; Herrera-Gayol A, 1999, EXP MOL PATHOL, V66, P99, DOI 10.1006/exmp.1999.2236; HESSION C, 1990, P NATL ACAD SCI USA, V87, P1673, DOI 10.1073/pnas.87.5.1673; Hibino S, 2005, CANCER RES, V65, P10494, DOI 10.1158/0008-5472.CAN-05-0314; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; Jensen PV, 2004, HISTOCHEM CELL BIOL, V121, P361, DOI 10.1007/s00418-004-0648-2; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Koike T, 2004, P NATL ACAD SCI USA, V101, P8132, DOI 10.1073/pnas.0402088101; Krop I, 2005, CANCER RES, V65, P11326, DOI 10.1158/0008-5472.CAN-05-1523; Laferriere J, 2001, J BIOL CHEM, V276, P33762, DOI 10.1074/jbc.M008564200; Laferriere J, 2002, ANN NY ACAD SCI, V973, P562, DOI 10.1111/j.1749-6632.2002.tb04702.x; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P14321, DOI 10.1074/jbc.M212246200; Lechertier T, 2004, ANTICANCER RES, V24, P4011; LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Marhaba R, 2004, J MOL HISTOL, V35, P211; McEver RP, 2002, THROMB HAEMOSTASIS, V87, P364; Mine S, 2003, EXP CELL RES, V288, P189, DOI 10.1016/S0014-4827(03)00184-8; Moss MA, 2000, ANTICANCER RES, V20, P1425; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Nubel T, 2004, FASEB J, V18, P140, DOI 10.1096/fj.03-0261fje; Price EA, 1996, INT J CANCER, V65, P513, DOI 10.1002/(SICI)1097-0215(19960208)65:4<513::AID-IJC20>3.0.CO;2-9; Roetger A, 1998, AM J PATHOL, V153, P1797, DOI 10.1016/S0002-9440(10)65694-5; ROSEN SD, 1994, CURR OPIN CELL BIOL, V6, P663, DOI 10.1016/0955-0674(94)90092-2; Ryu JW, 2004, ARTERIOSCL THROM VAS, V24, P864, DOI 10.1161/01.ATV.0000125705.28058.eb; SEITER S, 1993, J EXP MED, V177, P443, DOI 10.1084/jem.177.2.443; Spessotto P, 2002, J CELL BIOL, V158, P1133, DOI 10.1083/jcb.200202120; Tozawa K, 2005, KIDNEY INT, V67, P1391, DOI 10.1111/j.1523-1755.2005.00216.x; TOZEREN A, 1995, INT J CANCER, V60, P426; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; Tzircotis G, 2006, ONCOGENE, V25, P7401, DOI 10.1038/sj.onc.1209724; Tzircotis G, 2005, J CELL SCI, V118, P5119, DOI 10.1242/jcs.02629; UNDERHILL C, 1992, J CELL SCI, V103, P293; Wallach-Dayan SB, 2001, J CELL SCI, V114, P3463; Wang HS, 2005, EXP CELL RES, V304, P116, DOI 10.1016/j.yexcr.2004.10.015; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; ZAHALKA MA, 1995, J IMMUNOL, V154, P5345; Zen K, 2004, MOL BIOL CELL, V15, P3926, DOI 10.1091/mbc.E04-04-0317; Zen K, 2002, J IMMUNOL, V169, P5270, DOI 10.4049/jimmunol.169.9.5270	53	93	94	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1826	10.1371/journal.pone.0001826	http://dx.doi.org/10.1371/journal.pone.0001826			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350162	gold, Green Published, Green Submitted			2022-12-27	WOS:000260762300028
J	Rentero, C; Zech, T; Quinn, CM; Engelhardt, K; Williamson, D; Grewal, T; Jessup, W; Harder, T; Gaus, K				Rentero, Carles; Zech, Tobias; Quinn, Carmel M.; Engelhardt, Karin; Williamson, David; Grewal, Thomas; Jessup, Wendy; Harder, Thomas; Gaus, Katharina			Functional Implications of Plasma Membrane Condensation for T Cell Activation	PLOS ONE			English	Article								The T lymphocyte plasma membrane condenses at the site of activation but the functional significance of this receptor-mediated membrane reorganization is not yet known. Here we demonstrate that membrane condensation at the T cell activation sites can be inhibited by incorporation of the oxysterol 7-ketocholesterol (7KC), which is known to prevent the formation of raft-like liquid-ordered domains in model membranes. We enriched T cells with 7KC, or cholesterol as control, to assess the importance of membrane condensation for T cell activation. Upon 7KC treatment, T cell antigen receptor (TCR) triggered calcium fluxes and early tyrosine phosphorylation events appear unaltered. However, signaling complexes form less efficiently on the cell surface, fewer phosphorylated signaling proteins are retained in the plasma membrane and actin restructuring at activation sites is impaired in 7KC-enriched cells resulting in compromised downstream activation responses. Our data emphasizes lipids as an important medium for the organization at T cell activation sites and strongly indicates that membrane condensation is an important element of the T cell activation process.	[Rentero, Carles; Quinn, Carmel M.; Williamson, David; Jessup, Wendy; Gaus, Katharina] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Zech, Tobias; Engelhardt, Karin; Harder, Thomas] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Grewal, Thomas] Univ Sydney, Fac Pharm, Sydney, NSW, Australia	University of New South Wales Sydney; University of Oxford; University of Sydney	Rentero, C (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia.	thomas.harder@path.ox.ac.uk; k.gaus@unsw.edu.au	Rentero Alfonso, Carles/L-4430-2017; Williamson, David J/G-2265-2012	Rentero Alfonso, Carles/0000-0003-4684-0278; Williamson, David J/0000-0002-6222-6297; Grewal, Thomas/0000-0002-7937-8887; Gaus, Katharina/0000-0002-8009-9658; Zech, Tobias/0000-0001-8394-088X	EPA [studentship, senior fellow]; Wellcome Trust [082782/2/07/2]; Australian Research Council; National Health & Medical Research Council of Australia	EPA(United States Environmental Protection Agency); Wellcome Trust(Wellcome TrustEuropean Commission); Australian Research Council(Australian Research Council); National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	TZ is recipient of an EPA studentship, TH is an EPA senior fellow. The work in T.H. laboratory was supported by the Wellcome trust project grant 082782/2/07/2. KG acknowledges funding from the Australian Research Council and the National Health & Medical Research Council of Australia.	Antollini SS, 1996, BIOPHYS J, V70, P1275, DOI 10.1016/S0006-3495(96)79684-4; Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143; Berthier A, 2005, FEBS J, V272, P3093, DOI 10.1111/j.1742-4658.2005.04723.x; Blery M, 2006, J EXP MED, V203, P1773, DOI 10.1084/jem.20060552; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Drevot P, 2002, EMBO J, V21, P1899, DOI 10.1093/emboj/21.8.1899; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Flores-Borja F, 2005, ARTHRITIS RHEUM-US, V52, P3955, DOI 10.1002/art.21416; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Gaus K, 2004, FASEB J, V18, P574, DOI 10.1096/fj.03-0486fje; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Glebov OO, 2004, NAT CELL BIOL, V6, P238, DOI 10.1038/ncb1103; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Harder T, 2004, CURR OPIN IMMUNOL, V16, P353, DOI 10.1016/j.coi.2004.03.013; Hartgroves LC, 2003, J BIOL CHEM, V278, P20389, DOI 10.1074/jbc.M301212200; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Jury EC, 2004, J CLIN INVEST, V113, P1176, DOI 10.1172/JCI200420345; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Krawczyk C, 2001, TRENDS CELL BIOL, V11, P212, DOI 10.1016/S0962-8924(01)01981-X; Leonarduzzi G, 2006, ANTIOXID REDOX SIGN, V8, P375, DOI 10.1089/ars.2006.8.375; Li XM, 2003, BIOPHYS J, V85, P3788, DOI 10.1016/S0006-3495(03)74794-8; London E, 2002, CURR OPIN STRUC BIOL, V12, P480, DOI 10.1016/S0959-440X(02)00351-2; Massey JB, 2005, BIOCHEMISTRY-US, V44, P10423, DOI 10.1021/bi0506425; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Neekhra A, 2007, INVEST OPHTH VIS SCI, V48, P1362, DOI 10.1167/iovs.06-0900; PATTEN PA, 1993, J IMMUNOL, V150, P2281; Pizzo P, 2002, EUR J IMMUNOL, V32, P3082, DOI 10.1002/1521-4141(200211)32:11<3082::AID-IMMU3082>3.0.CO;2-2; Prunet C, 2005, J BIOCHEM MOL TOXIC, V19, P311, DOI 10.1002/jbt.20096; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Stentz FB, 2006, BIOCHEM BIOPH RES CO, V346, P721, DOI 10.1016/j.bbrc.2006.05.159; van der Merwe PA, 2002, NAT IMMUNOL, V3, P1122, DOI 10.1038/ni1202-1122; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Wilde JI, 2001, CELL SIGNAL, V13, P691, DOI 10.1016/S0898-6568(01)00191-7	44	88	90	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2262	10.1371/journal.pone.0002262	http://dx.doi.org/10.1371/journal.pone.0002262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509459	Green Published, Green Submitted, gold			2022-12-27	WOS:000262268500010
J	Kawaguchi, M; Hager, HA; Wada, A; Koyama, T; Chang, MS; Bader, DM				Kawaguchi, Michiya; Hager, Hillary A.; Wada, Aya; Koyama, Tatsuki; Chang, Min S.; Bader, David M.			Identification of a Novel Intracellular Interaction Domain Essential for Bves Function	PLOS ONE			English	Article								While Blood vessel epicardial substance (Bves) confers adhesive properties, the molecular mechanism of regulating this activity is unknown. No predicted functional motifs in this highly conserved integral membrane protein, other than the transmembrane domain, have been identified. Here, we report for the first time that Bves interacts with itself through an intracellular interaction domain that is essential for its intercellular adhesion activity. Glutathion-S-transferase (GST) pulldown and SPOTs analyses mapped this domain to amino acids 268-274 in the intracellular C-terminus. Site-directed mutagenesis revealed that lysines 272 and 273 are essential for homodimerization and cell adhesion. Human corneal cells transfected with wild-type Bves trafficked the protein to the cell surface, assembled junction complexes and formed epithelial sheets. In contrast, cells expressing Bves mutated at these positions did not form continuous epithelial sheets or maintain junctional proteins such as ZO-1 and E-cadherin at the membrane. A dramatic reduction in transepithelial electrical resistance was also observed indicating a functional loss of tight junctions. Importantly, expression of mutated Bves in epithelial cells promoted the transformation of cells from an epithelial to a mesenchymal phenotype. This study is the first to demonstrate the essential nature of any domain within Bves for maintenance of epithelial phenotype and function.	[Kawaguchi, Michiya; Hager, Hillary A.; Wada, Aya; Koyama, Tatsuki; Bader, David M.] Vanderbilt Univ, Dept Med, Stahlman Cardiovasc Res Labs, Nashville, TN 37235 USA; [Chang, Min S.] Vanderbilt Univ, Dept Ophthalmol & Visual Sci, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Kawaguchi, M (corresponding author), Vanderbilt Univ, Dept Med, Stahlman Cardiovasc Res Labs, Nashville, TN 37235 USA.	david.bader@Vanderbilt.edu			NIH [HL 79050, EY017185, HL 07411]; RPB-Robert E McCormick Scholar;  [Challenge Grant]; NATIONAL EYE INSTITUTE [R01EY017185] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079050] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RPB-Robert E McCormick Scholar; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	DB is supported by NIH HL 79050; MC is supported by NIH HL 79050, NIH EY017185, RPB-Robert E McCormick Scholar (MSC) and Challenge Grant (VEI); and HH is supported by NIH HL 79050 and NIH HL 07411.	Andree B, 2000, DEV BIOL, V223, P371, DOI 10.1006/dbio.2000.9751; Andree B, 2002, MOL CELL BIOL, V22, P1504, DOI 10.1128/MCB.22.5.1504-1512.2002; ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Brand T, 2005, CELL BIOCHEM BIOPHYS, V43, P95, DOI 10.1385/CBB:43:1:095; Breher SS, 2004, DEV DYNAM, V229, P695, DOI 10.1002/dvdy.20015; DiAngelo JR, 2001, HYBRIDOMA HYBRIDOM, V20, P377, DOI 10.1089/15368590152740789; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Hitz MP, 2002, MECH DEVELOP, V115, P123, DOI 10.1016/S0925-4773(02)00085-0; Hsu J., 1996, MULTIPLE COMP THEORY, DOI DOI 10.1007/978-1-4899-7180-7; Knight RF, 2003, J BIOL CHEM, V278, P32872, DOI 10.1074/jbc.M301961200; Lin S, 2007, INT J DEV BIOL, V51, P37, DOI 10.1387/ijdb.052108sl; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; Nakada MT, 2000, J IMMUNOL, V164, P452, DOI 10.4049/jimmunol.164.1.452; Osler ME, 2006, DEV DYNAM, V235, P586, DOI 10.1002/dvdy.20688; Osler ME, 2005, J CELL SCI, V118, P4667, DOI 10.1242/jcs.02588; Osler ME, 2004, DEV DYNAM, V229, P658, DOI 10.1002/dvdy.10490; Ozawa M, 1998, J BIOL CHEM, V273, P6166, DOI 10.1074/jbc.273.11.6166; Ozawa M, 1998, J CELL BIOL, V142, P1605, DOI 10.1083/jcb.142.6.1605; Reese DE, 2002, CIRC RES, V91, P761, DOI 10.1161/01.RES.0000038961.53759.3C; Reese DE, 1999, MAMM GENOME, V10, P913, DOI 10.1007/s003359901113; Reese DE, 1999, DEV BIOL, V209, P159, DOI 10.1006/dbio.1999.9246; Ripley AN, 2006, P NATL ACAD SCI USA, V103, P614, DOI 10.1073/pnas.0506095103; Ripley AN, 2004, INVEST OPHTH VIS SCI, V45, P2475, DOI 10.1167/iovs.04-0013; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Vasavada TK, 2004, J HISTOCHEM CYTOCHEM, V52, P371, DOI 10.1177/002215540405200308; Wada AM, 2001, DEVELOPMENT, V128, P2085	26	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2261	10.1371/journal.pone.0002261	http://dx.doi.org/10.1371/journal.pone.0002261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493308	gold, Green Published, Green Submitted			2022-12-27	WOS:000262258700060
J	Ryu, JJ; Borrmann, K; Chaudhuri, A				Ryu, Jae-Jin; Borrmann, Karen; Chaudhuri, Avi			Imagine Jane and Identify John: Face Identity Aftereffects Induced by Imagined Faces	PLOS ONE			English	Article							IMPAIRED VISUAL-PERCEPTION; NEURAL SYSTEMS; MENTAL-IMAGERY; HUMAN BRAIN; ADAPTATION; REPRESENTATION; CORTEX; LINES; CONTRAST; NEURONS	It is not known whether prolonged exposure to perceived and imagined complex visual images produces similar shifts in subsequent perception through selective adaptation. This question is important because a positive finding would suggest that perception and imagery of visual stimuli are mediated by shared neural networks. In this study, we used a selective adaptation procedure designed to induce high-level face-identity aftereffects - a phenomenon in which extended exposure to a particular face facilitates recognition of subsequent faces with opposite features while impairing recognition of all other faces. We report here that adaptation to either real or imagined faces produces a similar shift in perception and that identity boundaries represented in real and imagined faces are equivalent. Together, our results show that identity information contained in imagined and real faces produce similar behavioral outcomes. Our findings of high-level visual aftereffects induced by imagined stimuli can be taken as evidence for the involvement of shared neural networks that mediate perception and imagery of complex visual stimuli.	[Ryu, Jae-Jin; Borrmann, Karen; Chaudhuri, Avi] McGill Univ, Dept Psychol, Montreal, PQ, Canada	McGill University	Ryu, JJ (corresponding author), McGill Univ, Dept Psychol, 1205 Dr Penfield Ave, Montreal, PQ, Canada.	jjryu@ego.psych.mcgill.ca			Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by operating grants from the Canadian Institutes of Health Research (CIHR) to AC.	Bartolomeo P, 1998, NEUROPSYCHOLOGIA, V36, P239, DOI 10.1016/S0028-3932(97)00103-6; BEHRMANN M, 1994, J EXP PSYCHOL HUMAN, V20, P1068, DOI 10.1037/0096-1523.20.5.1068; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BROERSE J, 1980, PERCEPT PSYCHOPHYS, V28, P560, DOI 10.3758/BF03198826; FARAH MJ, 1985, J EXP PSYCHOL GEN, V114, P91, DOI 10.1037/0096-3445.114.1.91; FINKE RA, 1977, J EXP PSYCHOL HUMAN, V3, P599, DOI 10.1037/0096-1523.3.4.599; FINKE RA, 1978, PERCEPT PSYCHOPHYS, V23, P515, DOI 10.3758/BF03199528; Frisby J. P., 1980, SEEING ILLUSION BRAI; Furl N, 2007, NEUROIMAGE, V37, P300, DOI 10.1016/j.neuroimage.2007.04.057; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; ISHAI A, 1995, SCIENCE, V268, P1772, DOI 10.1126/science.7792605; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KOEHLER W, 1944, P AM PHILOS SOC, V88, P269; Kosslyn SM, 1997, NEUROIMAGE, V6, P320, DOI 10.1006/nimg.1997.0295; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Michelon P, 2003, NEUROPSYCHOLOGIA, V41, P421, DOI 10.1016/S0028-3932(02)00176-8; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; OVER R, 1972, PSYCHON SCI, V29, P203; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; SINGER G, 1965, AM J PSYCHOL, V78, P96, DOI 10.2307/1421086; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Watson TL, 2003, PERCEPTION, V32, P1109, DOI 10.1068/p5082; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420	29	18	18	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2195	10.1371/journal.pone.0002195	http://dx.doi.org/10.1371/journal.pone.0002195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493304	gold, Green Published, Green Submitted			2022-12-27	WOS:000262258700004
J	Roeber, S; Grasbon-Frodl, EM; Windl, O; Krebs, B; Xiang, W; Vollmert, C; Illig, T; Schroeter, A; Arzberger, T; Weber, P; Zerr, I; Kretzschmar, HA				Roeber, Sigrun; Grasbon-Frodl, Eva-Maria; Windl, Otto; Krebs, Bjarne; Xiang, Wei; Vollmert, Caren; Illig, Thomas; Schroeter, Andreas; Arzberger, Thomas; Weber, Petra; Zerr, Inga; Kretzschmar, Hans A.			Evidence for a Pathogenic Role of Different Mutations at Codon 188 of PRNP	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN GENE; MRI; CLASSIFICATION; DIAGNOSIS; FRAGMENT; KORA	Clinical and pathological changes in familial Creutzfeldt-Jakob disease (CJD) cases may be similar or indistinguishable from sporadic CJD. Therefore determination of novel mutations in PRNP remains of major importance. We identified two different rare mutations in codon 188 of the prion protein gene (PRNP) in four patients suffering from a disease clinically very similar to the major subtype of sporadic CJD. Both mutations result in an exchange of the amino acid residue threonine for a highly basic residue, either arginine (T188R) or lysine (T188K). The T188R mutation was found in one patient and the T188K mutation in three patients. The prevalence of mutations at codon 188 of PRNP was tested in 593 sporadic CJD cases and 735 healthy individuals. Neither mutation was found. The data presented here argue in favor of T188K being a pathogenic mutation causing genetic CJD. Since one individual with this mutation, who is the father of a clinically affected patient with T188K mutation, is now 79 years old and shows no signs of disease, this mutation is likely associated with a penetrance under 100%. Further observations will have to show whether T188R is a pathogenic mutation.	[Roeber, Sigrun; Grasbon-Frodl, Eva-Maria; Windl, Otto; Krebs, Bjarne; Xiang, Wei; Arzberger, Thomas; Weber, Petra; Kretzschmar, Hans A.] Ludwig Maximilians Univ Munchen, Ctr Neuropathol & Prion Res, Munich, Germany; [Vollmert, Caren; Illig, Thomas] Forschungszentrum Umwelt Gesundheit GSF, Inst Epidemiol, Munich, Germany; [Schroeter, Andreas; Zerr, Inga] Univ Gottingen, Dept Neurol, Gottingen, Germany	University of Munich; University of Gottingen	Roeber, S (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Neuropathol & Prion Res, Munich, Germany.	Hans.Kretzschmar@med.uni-muenchen.de	Windl, Otto/C-6760-2011; Xiang, Wei/Y-3171-2019		Federal Ministry of Health; European Commission [TSELAB QLK 2- CT-2002-81523]; Federal Ministry of Education and Research (BMBF) [01GS0166]; German Federal Ministry of Education and Research; State of Bavaria	Federal Ministry of Health; European Commission(European CommissionEuropean Commission Joint Research Centre); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); State of Bavaria	This study was supported by a grant from the Federal Ministry of Health (Bundesgesundheitsministerium) and the European Commission (TSELAB QLK 2- CT-2002-81523). Genotyping in this study was partially supported within the German National Genomic Research Network (01GS0166) by the Federal Ministry of Education and Research (BMBF). The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the GSF-National Research Centre for Environment and Health, which is funded by the German Federal Ministry of Education and Research and of the State of Bavaria.	[Anonymous], 1998, Wkly Epidemiol Rec, V73, P361; Cambier DM, 2003, CLIN NEUROPHYSIOL, V114, P1724, DOI 10.1016/S1388-2457(03)00109-3; CHAPMAN J, 1994, NEUROLOGY, V44, P1683, DOI 10.1212/WNL.44.9.1683; Collins S, 2000, ARCH NEUROL-CHICAGO, V57, P1058, DOI 10.1001/archneur.57.7.1058; Finckh U, 2000, AM J HUM GENET, V66, P110, DOI 10.1086/302702; GOLDFARB LG, 1991, EUR J EPIDEMIOL, V7, P477, DOI 10.1007/BF00143125; GOLDFARB LG, 1994, MOL NEUROBIOL, V8, P89, DOI 10.1007/BF02780658; GOLDGABER D, 1989, EXP NEUROL, V106, P204, DOI 10.1016/0014-4886(89)90095-2; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; Jin K, 2004, NEUROLOGY, V62, P502, DOI 10.1212/01.WNL.0000106954.54011.80; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Kovacs GG, 2002, J NEUROL, V249, P1567, DOI 10.1007/s00415-002-0896-9; Krasnianski A, 2006, BRAIN, V129, P2288, DOI 10.1093/brain/awl123; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; MEDORI R, 1992, NEW ENGL J MED, V326, P444, DOI 10.1056/NEJM199202133260704; Meissner B, 2005, NEUROLOGY, V65, P1544, DOI 10.1212/01.wnl.0000184674.32924.c9; Mollenhauer B, 2002, DEUT MED WOCHENSCHR, V127, P312, DOI 10.1055/s-2002-20150; Nitrini R, 2001, J NEUROL SCI, V184, P163, DOI 10.1016/S0022-510X(01)00432-4; Notari S, 2004, J BIOL CHEM, V279, P16797, DOI 10.1074/jbc.M313220200; Palmer MS, 1996, HUM MUTAT, V7, P280, DOI 10.1002/(SICI)1098-1004(1996)7:3<280::AID-HUMU17>3.0.CO;2-Z; Parchi P, 1998, P NATL ACAD SCI USA, V95, P8322, DOI 10.1073/pnas.95.14.8322; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; POCCHIARI M, 1993, ANN NEUROL, V34, P802, DOI 10.1002/ana.410340608; Roeber S, 2005, ACTA NEUROPATHOL, V109, P443, DOI 10.1007/s00401-004-0978-0; Satoh K, 2003, J GEN VIROL, V84, P2885, DOI 10.1099/vir.0.19236-0; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; Schulz-Schaeffer WJ, 2000, AM J PATHOL, V156, P51, DOI 10.1016/S0002-9440(10)64705-0; Spiegal J, 2002, NERVENARZT, V73, P952, DOI 10.1007/s00115-002-1364-6; SPUDICH S, 1995, MOL MED, V1, P607, DOI 10.1007/BF03401601; Tagliavini F, 2001, J BIOL CHEM, V276, P6009, DOI 10.1074/jbc.M007062200; Tschampa HJ, 2005, BRAIN, V128, P2026, DOI 10.1093/brain/awh575; VOLLMERT C, 2006, J MED GENET, V59, P43; *WHO, 2003, WHO MAN SURV HUM TRA, P71; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Windl O, 1999, HUM GENET, V105, P244, DOI 10.1007/s004390051096; WINDL O, 1995, GENE, V159, P181, DOI 10.1016/0378-1119(95)00064-D; Windl O, 1996, HUM GENET, V98, P259, DOI 10.1007/s004390050204; WINDL O, 1999, CONT NEUROLOGY SERIE, P191; Young GS, 2005, AM J NEURORADIOL, V26, P1551; ZERR I, 1995, LANCET, V345, P1609, DOI 10.1016/S0140-6736(95)90118-3	42	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2147	10.1371/journal.pone.0002147	http://dx.doi.org/10.1371/journal.pone.0002147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478114	Green Submitted, Green Published, gold			2022-12-27	WOS:000262172800012
J	Stotz, SC; Vriens, J; Martyn, D; Clardy, J; Clapham, DE				Stotz, Stephanie C.; Vriens, Joris; Martyn, Derek; Clardy, Jon; Clapham, David E.			Citral Sensing by TRANSient Receptor Potential Channels in Dorsal Root Ganglion Neurons	PLOS ONE			English	Article							CAPSAICIN-RECEPTOR; ION-CHANNEL; TRP CHANNEL; 2-AMINOETHOXYDIPHENYL BORATE; TOPICAL CAPSAICIN; ACTIVATION; HEAT; PAIN; REVEALS; CONSTITUENTS	Transient receptor potential (TRP) ion channels mediate key aspects of taste, smell, pain, temperature sensation, and pheromone detection. To deepen our understanding of TRP channel physiology, we require more diverse pharmacological tools. Citral, a bioactive component of lemongrass, is commonly used as a taste enhancer, as an odorant in perfumes, and as an insect repellent. Here we report that citral activates TRP channels found in sensory neurons (TRPV1 and TRPV3, TRPM8, and TRPA1), and produces long-lasting inhibition of TRPV1 -3 and TRPM8, while transiently blocking TRPV4 and TRPA1. Sustained citral inhibition is independent of internal calcium concentration, but is state-dependent, developing only after TRP channel opening. Citral's actions as a partial agonist are not due to cysteine modification of the channels nor are they a consequence of citral's stereoisoforms. The isolated aldehyde and alcohol cis and trans enantiomers (neral, nerol, geranial, and geraniol) each reproduce citral's actions. In juvenile rat dorsal root ganglion neurons, prolonged citral inhibition of native TRPV1 channels enabled the separation of TRPV2 and TRPV3 currents. We find that TRPV2 and TRPV3 channels are present in a high proportion of these neurons (94% respond to 2-aminoethyldiphenyl borate), consistent with our immunolabeling experiments and previous in situ hybridization studies. The TRPV1 activation requires residues in transmembrane segments two through four of the voltage-sensor domain, a region previously implicated in capsaicin activation of TRPV1 and analogous menthol activation of TRPM8. Citral's broad spectrum and prolonged sensory inhibition may prove more useful than capsaicin for allodynia, itch, or other types of pain involving superficial sensory nerves and skin.	[Stotz, Stephanie C.; Vriens, Joris; Clapham, David E.] Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA; [Stotz, Stephanie C.; Vriens, Joris; Clapham, David E.] Harvard Med Sch, Dept Neurobiol, Boston, MA USA; [Martyn, Derek; Clardy, Jon] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Stotz, SC (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/S-1123-2019; Vriens, Joris/G-9966-2018; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; Vriens, Joris/0000-0002-2502-0409; 	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Howard Hughes Medical Institute provided funding only. Fonds voor Wetenschappelijk Onderzoek, Flanders provided salary support for Joris Vriens.	Araneda RC, 2004, J PHYSIOL-LONDON, V555, P743, DOI 10.1113/jphysiol.2003.058040; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Binzen U, 2006, NEUROSCIENCE, V142, P527, DOI 10.1016/j.neuroscience.2006.06.020; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Colton C. K., 2007, V179, P173; DEAL CL, 1991, CLIN THER, V13, P383; Dudai N, 2005, PLANTA MED, V71, P484, DOI 10.1055/s-2005-864146; EPSTEIN JB, 1994, ORAL SURG ORAL MED O, V77, P135, DOI 10.1016/0030-4220(94)90275-5; FRANCKOWIAK G, 1985, EUR J PHARMACOL, V114, P223, DOI 10.1016/0014-2999(85)90631-4; Frosch PJ, 2005, CONTACT DERMATITIS, V52, P216, DOI 10.1111/j.0105-1873.2005.00563.x; Greffrath W, 2003, NEUROREPORT, V14, P2251, DOI 10.1097/00001756-200312020-00023; Heydorn S, 2003, CONTACT DERMATITIS, V49, P32, DOI 10.1111/j.0105-1873.2003.00144.x; Hille B., 1992, IONIC CHANNELS EXCIT; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Liapi A, 2005, EUR J NEUROSCI, V22, P825, DOI 10.1111/j.1460-9568.2005.04270.x; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; More JD, 2002, ORG LETT, V4, P3001, DOI 10.1021/ol026427n; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Picquet M, 2000, EUR J ORG CHEM, V2000, P2361, DOI 10.1002/1099-0690(200007)2000:13<2361::AID-EJOC2361>3.0.CO;2-S; Price DN, 2006, J INSECT PHYSIOL, V52, P309, DOI 10.1016/j.jinsphys.2005.11.010; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rau KK, 2007, J NEUROPHYSIOL, V97, P2651, DOI 10.1152/jn.00840.2006; Roberts LA, 2002, BRIT J PHARMACOL, V137, P421, DOI 10.1038/sj.bjp.0704904; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Sadraei H, 2003, FITOTERAPIA, V74, P445, DOI 10.1016/S0367-326X(03)00109-6; Salvatore A, 2004, J CHEM ECOL, V30, P323, DOI 10.1023/B:JOEC.0000017980.66124.d1; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; WATSON CPN, 1988, PAIN, V35, P289, DOI 10.1016/0304-3959(88)90139-X; WATSON CPN, 1992, PAIN, V51, P375, DOI 10.1016/0304-3959(92)90223-X; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zgani I, 2004, J MED CHEM, V47, P4600, DOI 10.1021/jm049861z; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755	55	94	101	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2082	10.1371/journal.pone.0002082	http://dx.doi.org/10.1371/journal.pone.0002082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461159	Green Published, Green Submitted, gold			2022-12-27	WOS:000261642400006
J	Delmas, O; Holmes, EC; Talbi, C; Larrous, F; Dacheux, L; Bouchier, C; Bourhy, H				Delmas, Olivier; Holmes, Edward C.; Talbi, Chiraz; Larrous, Florence; Dacheux, Laurent; Bouchier, Christiane; Bourhy, Herve			Genomic Diversity and Evolution of the Lyssaviruses	PLOS ONE			English	Article								Lyssaviruses are RNA viruses with single-strand, negative-sense genomes responsible for rabies-like diseases in mammals. To date, genomic and evolutionary studies have most often utilized partial genome sequences, particularly of the nucleoprotein and glycoprotein genes, with little consideration of genome-scale evolution. Herein, we report the first genomic and evolutionary analysis using complete genome sequences of all recognised lyssavirus genotypes, including 14 new complete genomes of field isolates from 6 genotypes and one genotype that is completely sequenced for the first time. In doing so we significantly increase the extent of genome sequence data available for these important viruses. Our analysis of these genome sequence data reveals that all lyssaviruses have the same genomic organization. A phylogenetic analysis reveals strong geographical structuring, with the greatest genetic diversity in Africa, and an independent origin for the two known genotypes that infect European bats. We also suggest that multiple genotypes may exist within the diversity of viruses currently classified as 'Lagos Bat'. In sum, we show that rigorous phylogenetic techniques based on full length genome sequence provide the best discriminatory power for genotype classification within the lyssaviruses.	[Delmas, Olivier; Talbi, Chiraz; Larrous, Florence; Dacheux, Laurent; Bourhy, Herve] WHO, Collaborating Ctr Reference & Res Rabies, UPRE Lyssavirus Dynam & Host Adaptat, Inst Pasteur, Paris, France; [Holmes, Edward C.] Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, Mueller Lab, University Pk, PA USA; [Bouchier, Christiane] Pasteur Genopole Ile France, Plate forme Genom, Inst Pasteur, Paris, France; [Holmes, Edward C.] NIH, Fogarty Int Ctr, Bethesda, MD USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; World Health Organization; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Delmas, O (corresponding author), WHO, Collaborating Ctr Reference & Res Rabies, UPRE Lyssavirus Dynam & Host Adaptat, Inst Pasteur, Paris, France.	hbourhy@pasteur.fr	Larrous, Florence/AAH-9400-2019; Dacheux, Laurent/AAJ-5372-2020; Holmes, Edward/GVR-9499-2022; Holmes, Edward/Y-2789-2019; Bourhy, Hervé/F-5272-2010	Larrous, Florence/0000-0003-0881-4263; Holmes, Edward/0000-0001-9596-3552; Dacheux, Laurent/0000-0002-4401-3706	European commission through the VIZIER Integrated project [LSHG-CT-2004-511966]; Genomic Platform Ile de France Analyse de la Diversite Genetique des Rhabdoviridae; NIH [GM080533-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080533] Funding Source: NIH RePORTER	European commission through the VIZIER Integrated project; Genomic Platform Ile de France Analyse de la Diversite Genetique des Rhabdoviridae; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	O. Delmas was supported by the European commission through the VIZIER Integrated project (LSHG-CT-2004-511966). This work was also funded by the VIZIER program, and by the grant of Genomic Platform Ile de France Analyse de la Diversite Genetique des Rhabdoviridae 2005 to 2006, and in part by NIH grant number GM080533-01.	Arai YT, 2003, EMERG INFECT DIS, V9, P333, DOI 10.3201/eid0903.020252; Auewarakul P, 2005, VIRUS RES, V109, P33, DOI 10.1016/j.virusres.2004.10.004; Badrane H, 2001, J VIROL, V75, P8096, DOI 10.1128/JVI.75.17.8096-8104.2001; Botvinkin AD, 2003, EMERG INFECT DIS, V9, P1623, DOI 10.3201/eid0912.030374; Bourhy H, 2005, J GEN VIROL, V86, P2849, DOI 10.1099/vir.0.81128-0; BOURHY H, 1989, J GEN VIROL, V70, P2063, DOI 10.1099/0022-1317-70-8-2063; BOURHY H, 1993, VIROLOGY, V194, P70, DOI 10.1006/viro.1993.1236; Bourhy H, 1999, J GEN VIROL, V80, P2545, DOI 10.1099/0022-1317-80-10-2545; Davis PL, 2007, ARCH VIROL, V152, P1251, DOI 10.1007/s00705-007-0962-9; Davis PL, 2006, INFECT GENET EVOL, V6, P464, DOI 10.1016/j.meegid.2006.02.007; Davis PL, 2005, J VIROL, V79, P10487, DOI 10.1128/JVI.79.16.10487-10497.2005; Emonet S, 2006, BIOCHEM BIOPH RES CO, V344, P1080, DOI 10.1016/j.bbrc.2006.04.015; Emonet SF, 2007, NAT PROTOC, V2, P340, DOI 10.1038/nprot.2006.453; Faber M, 2004, P NATL ACAD SCI USA, V101, P16328, DOI 10.1073/pnas.0407289101; Finke S, 1999, J VIROL, V73, P3818, DOI 10.1128/JVI.73.5.3818-3825.1999; Gifford R, 2006, AIDS, V20, P1521, DOI 10.1097/01.aids.0000237368.64488.ae; Gould AR, 2002, VIRUS RES, V89, P1, DOI 10.1016/S0168-1702(02)00056-4; Gould AR, 1998, VIRUS RES, V54, P165, DOI 10.1016/S0168-1702(98)00025-2; Holmes EC, 2002, VIROLOGY, V292, P247, DOI 10.1006/viro.2001.1271; KISSI B, 1995, VIROLOGY, V209, P526, DOI 10.1006/viro.1995.1285; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Kuzmin IV, 2005, VIRUS RES, V111, P28, DOI 10.1016/j.virusres.2005.03.008; Kuzmin IV, 2003, VIRUS RES, V97, P65, DOI 10.1016/S0168-1702(03)00217-X; KUZMIN IV, 2008, J CLIN MICROBIOL; LeMercier P, 1997, J GEN VIROL, V78, P1571, DOI 10.1099/0022-1317-78-7-1571; Marston DA, 2007, J GEN VIROL, V88, P1302, DOI 10.1099/vir.0.82692-0; Nadin-Davis SA, 2002, VIROLOGY, V298, P286, DOI 10.1006/viro.2002.1492; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; SHOPE RE, 1982, YALE J BIOL MED, V55, P271; Steele J.H., 1991, P1; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TORDO N, 1988, VIROLOGY, V165, P565, DOI 10.1016/0042-6822(88)90600-9; TORDO N, 1986, P NATL ACAD SCI USA, V83, P3914, DOI 10.1073/pnas.83.11.3914; Warrell MJ, 2004, LANCET, V363, P959, DOI 10.1016/S0140-6736(04)15792-9; Warrilow D, 2002, VIROLOGY, V297, P109, DOI 10.1006/viro.2002.1417; Wu XF, 2007, VIRUS RES, V129, P91, DOI 10.1016/j.virusres.2007.06.022	38	117	139	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2057	10.1371/journal.pone.0002057	http://dx.doi.org/10.1371/journal.pone.0002057			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446239	Green Published, gold, Green Submitted			2022-12-27	WOS:000261572300026
J	Schulte, R; Talamas, J; Doucet, C; Hetzer, MW				Schulte, Roberta; Talamas, Jessica; Doucet, Christine; Hetzer, Martin W.			Single Bead Affinity Detection (SINBAD) for the Analysis of Protein-Protein Interactions	PLOS ONE			English	Article								We present a miniaturized pull-down method for the detection of protein-protein interactions using standard affinity chromatography reagents. Binding events between different proteins, which are color-coded with quantum dots (QDs), are visualized on single affinity chromatography beads by fluorescence microscopy. The use of QDs for single molecule detection allows the simultaneous analysis of multiple protein-protein binding events and reduces the amount of time and material needed to perform a pull-down experiment.	[Schulte, Roberta; Talamas, Jessica; Doucet, Christine; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Schulte, R (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu		Doucet, Christine/0000-0002-1611-8279	Salk Institute [Innovation Grant]; NIH [R01 GM073994]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073994] Funding Source: NIH RePORTER	Salk Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Innovation Grant, Salk Institute. This work was supported by the Pew Scholar program and NIH R01 GM073994.	Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Burbulis I, 2007, NAT METHODS, V4, P1011, DOI 10.1038/nmeth1127; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Gorlich D, 1997, CURR OPIN CELL BIOL, V9, P412, DOI 10.1016/S0955-0674(97)80015-4; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; HETZER M, 2005, ANN REV CELL DEV BIO; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Oh BK, 2006, SMALL, V2, P103, DOI 10.1002/smll.200500260; Patel SS, 2008, MOL CELL PROTEOMICS, V7, P121, DOI 10.1074/mcp.M700407-MCP200; Patolsky F, 2006, ANAL CHEM, V78, P4260, DOI 10.1021/ac069419j; Stansel RM, 2001, EMBO J, V20, P5532; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Wente SR, 2000, SCIENCE, V288, P1374, DOI 10.1126/science.288.5470.1374; Zhang CY, 2006, ANALYST, V131, P484, DOI 10.1039/b514309h	20	7	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2061	10.1371/journal.pone.0002061	http://dx.doi.org/10.1371/journal.pone.0002061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446240	Green Published, gold, Green Submitted			2022-12-27	WOS:000261572300030
J	Wellens, A; Garofalo, C; Nguyen, H; Van Gerven, N; Slattegard, R; Hernalsteens, JP; Wyns, L; Oscarson, S; De Greve, H; Hultgren, S; Bouckaert, J				Wellens, Adinda; Garofalo, Corinne; Nguyen, Hien; Van Gerven, Nani; Slattegard, Rikard; Hernalsteens, Jean-Pierre; Wyns, Lode; Oscarson, Stefan; De Greve, Henri; Hultgren, Scott; Bouckaert, Julie			Intervening with Urinary Tract Infections Using Anti-Adhesives Based on the Crystal Structure of the FimH-Oligomannose-3 Complex	PLOS ONE			English	Article								Background: Escherichia coli strains adhere to the normally sterile human uroepithelium using type 1 pili, that are long, hairy surface organelles exposing a mannose-binding FimH adhesin at the tip. A small percentage of adhered bacteria can successfully invade bladder cells, presumably via pathways mediated by the high-mannosylated uroplakin-Ia and alpha 3 beta 1 integrins found throughout the uroepithelium. Invaded bacteria replicate and mature into dense, biofilm-like inclusions in preparation of fluxing and of infection of neighbouring cells, being the major cause of the troublesome recurrent urinary tract infections. Methodology/Principal Findings: We demonstrate that alpha-D-mannose based inhibitors of FimH not only block bacterial adhesion on uroepithelial cells but also antagonize invasion and biofilm formation. Heptyl a-D-mannose prevents binding of type 1-piliated E. coli to the human bladder cell line 5637 and reduces both adhesion and invasion of the UTI89 cystitis isolate instilled in mouse bladder via catheterization. Heptyl a-D-mannose also specifically inhibited biofilm formation at micromolar concentrations. The structural basis of the great inhibitory potential of alkyl and aryl alpha-D-mannosides was elucidated in the crystal structure of the FimH receptor-binding domain in complex with oligomannose-3. FimH interacts with Man alpha 1,3Man beta 1,4GlcNAc beta 1,4GlcNAc in an extended binding site. The interactions along the alpha 1,3 glycosidic bond and the first beta 1,4 linkage to the chitobiose unit are conserved with those of FimH with butyl a-D-mannose. The strong stacking of the central mannose with the aromatic ring of Tyr48 is congruent with the high affinity found for synthetic inhibitors in which this mannose is substituted for by an aromatic group. Conclusions/Significance: The potential of ligand-based design of antagonists of urinary tract infections is ruled by the structural mimicry of natural epitopes and extends into blocking of bacterial invasion, intracellular growth and capacity to fluxing and of recurrence of the infection.	[Wellens, Adinda; Nguyen, Hien; Wyns, Lode; De Greve, Henri; Bouckaert, Julie] Free Univ Brussels, Dept Mol & Cellular Interact, Brussels, Belgium; [Wellens, Adinda; Nguyen, Hien; Wyns, Lode; De Greve, Henri; Bouckaert, Julie] Free Univ Brussels, Brussels, Belgium; [Garofalo, Corinne; Hultgren, Scott] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO USA; [Van Gerven, Nani; Hernalsteens, Jean-Pierre] Free Univ Brussels, Viral Genet, Brussels, Belgium; [Slattegard, Rikard] Stockholm Univ, Arrhenius Lab, Dept Organ Chem, Stockholm, Sweden; [Oscarson, Stefan] Univ Coll Dublin, Ctr Synthesis & Chem Biol, Dublin, Ireland	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Washington University (WUSTL); Universite Libre de Bruxelles; Vrije Universiteit Brussel; Stockholm University; University College Dublin	Wellens, A (corresponding author), Free Univ Brussels, Dept Mol & Cellular Interact, Brussels, Belgium.	bouckaej@vub.ac.be		Oscarson, Stefan/0000-0002-8273-4918; Bouckaert, Julie/0000-0001-8112-1442; Van Gerven, Nani/0000-0002-4269-3904; Hernalsteens, Jean-Pierre/0000-0003-2146-0586	FWO-Flanders (FWO) [postdoctoral fellowship]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); EMBL;  [DK51406];  [Scor P50 DK64540];  [AI48689]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051406, P50DK064540] Funding Source: NIH RePORTER	FWO-Flanders (FWO)(FWO); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); EMBL; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	JB received a postdoctoral fellowship from the FWO-Flanders (FWO). NVG is a recipient of a Ph.D grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen). The use of beamline X12 at the DESY synchrotron in Hamburg, Germany for project PX-06-92 was funded by the EMBL. Supported by grants DK51406, Scor P50 DK64540 and AI48689.	ANDERSON BN, J BACTERIOL, V189, P1794; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Apodaca G, 2004, TRAFFIC, V5, P117, DOI 10.1046/j.1600-0854.2003.00156.x; Aprikian P, 2007, J BIOL CHEM, V282, P23437, DOI 10.1074/jbc.M702037200; ARONSON M, 1979, ISRAEL J MED SCI, V15, P88; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Bishop BL, 2007, NAT MED, V13, P625, DOI 10.1038/nm1572; BLOMFIELD IC, 1991, MOL MICROBIOL, V5, P1439, DOI 10.1111/j.1365-2958.1991.tb00790.x; Bouckaert J, 2005, MOL MICROBIOL, V55, P441, DOI 10.1111/j.1365-2958.2004.04415.x; Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMBILLAU C, 1992, IRIS 4D SERIES; Cavallone D, 2004, J BIOL CHEM, V279, P216, DOI 10.1074/jbc.M308821200; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; De Greve H, 2007, CURR OPIN STRUC BIOL, V17, P506, DOI 10.1016/j.sbi.2007.06.011; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Duncan MJ, 2005, J BIOL CHEM, V280, P37707, DOI 10.1074/jbc.M501249200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; Eto DS, 2007, NAT MED, V13, P531, DOI 10.1038/nm0507-531; Eto DS, 2006, CELL MICROBIOL, V8, P704, DOI 10.1111/j.1462-5822.2006.00691.x; FIRON N, 1983, CARBOHYD RES, V120, P235, DOI 10.1016/0008-6215(83)88019-7; Foulquier F, 2004, EUR J BIOCHEM, V271, P398, DOI 10.1046/j.1432-1033.2003.03938.x; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Garofalo CK, 2007, INFECT IMMUN, V75, P52, DOI 10.1128/IAI.01123-06; Geerlings SE, 2002, INT J ANTIMICROB AG, V19, P539, DOI 10.1016/S0924-8579(02)00090-0; Geerlings SE, 2002, DIABETES CARE, V25, P1405, DOI 10.2337/diacare.25.8.1405; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; IMBERTY A, 1993, ADV BIOPH C, V0003; Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104; Justice SS, 2006, INFECT IMMUN, V74, P4793, DOI 10.1128/IAI.00355-06; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langermann S, 2000, J INFECT DIS, V181, P774, DOI 10.1086/315258; Liang FX, 2001, BIOCHEM J, V355, P13, DOI 10.1042/0264-6021:3550013; Litynska A, 2002, ACTA BIOCHIM POL, V49, P491; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Min GW, 2002, J MOL BIOL, V317, P697, DOI 10.1006/jmbi.2002.5442; MINION FC, 1989, J BACTERIOL, V165, P1033; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; NEESER JR, 1986, INFECT IMMUN, V52, P428, DOI 10.1128/IAI.52.2.428-436.1986; Nilsson LM, 2006, J BIOL CHEM, V281, P16656, DOI 10.1074/jbc.M511496200; Nilsson LM, 2006, APPL ENVIRON MICROB, V72, P3005, DOI 10.1128/AEM.72.4.3005-3010.2006; NORDEN NE, 1973, J BIOL CHEM, V248, P6210; Orndorff PE, 2004, INFECT IMMUN, V72, P1929, DOI 10.1128/IAI.72.4.1929-1938.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pak J, 2001, J BIOL CHEM, V276, P9924, DOI 10.1074/jbc.M008610200; Rijavec M, 2006, CURR MICROBIOL, V53, P158, DOI 10.1007/s00284-005-0501-4; ROSENSTEIN IJ, 1988, LANCET, V2, P1327; Schilling JD, 2003, P NATL ACAD SCI USA, V100, P4203, DOI 10.1073/pnas.0736473100; Schilling JD, 2002, INT J ANTIMICROB AG, V19, P457, DOI 10.1016/S0924-8579(02)00098-5; Serafini-Cessi F, 2005, GLYCOCONJUGATE J, V22, P383, DOI 10.1007/s10719-005-2142-z; Sharon N, 2006, BBA-GEN SUBJECTS, V1760, P527, DOI 10.1016/j.bbagen.2005.12.008; SHARON N, 1987, FEBS LETT, V217, P145, DOI 10.1016/0014-5793(87)80654-3; Sokurenko EV, 1997, J BIOL CHEM, V272, P17880, DOI 10.1074/jbc.272.28.17880; Svanborg C, 2006, CURR OPIN MICROBIOL, V9, P33, DOI 10.1016/j.mib.2005.12.012; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Touaibia M, 2007, CHEMMEDCHEM, V2, P1190, DOI 10.1002/cmdc.200700063; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103; WARIN V, 1979, CARBOHYD RES, V76, P11, DOI 10.1016/0008-6215(79)80002-6; Wormald MR, 2002, CHEM REV, V102, P371, DOI 10.1021/cr990368i; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x; Xie B, 2006, J BIOL CHEM, V281, P14644, DOI 10.1074/jbc.M600877200; Zhou G, 2001, J CELL SCI, V114, P4095	72	194	211	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2040	10.1371/journal.pone.0002040	http://dx.doi.org/10.1371/journal.pone.0002040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446213	Green Published, gold			2022-12-27	WOS:000261572300012
J	Zhang, JX; Diehl, GE; Littman, DR				Zhang, Jing-xin; Diehl, Gretchen E.; Littman, Dan R.			Relief of Preintegration Inhibition and Characterization of Additional Blocks for HIV Replication in Primary Mouse T Cells	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CENTRAL-NERVOUS-SYSTEM; QUANTITATIVE ASSAY; VIRAL-DNA; HUMAN CD4; INFECTION; EXPRESSION; LYMPHOCYTES; ENTRY; CCR5	Development of a small animal model to study HIV replication and pathogenesis has been hampered by the failure of the virus to replicate in non- primate cells. Most studies aimed at achieving replication in murine cells have been limited to fibroblast cell lines, but generating an appropriate model requires overcoming blocks to viral replication in primary T cells. We have studied HIV- 1 replication in CD4(+) T cells from human CD4/CCR5/Cyclin T1 transgenic mice. Expression of hCD4 and hCCR5 in mouse CD4(+) T cells enabled efficient entry of R5 strain HIV- 1. In mouse T cells, HIV- 1 underwent reverse transcription and nuclear import as efficiently as in human T cells. In contrast, chromosomal integration of HIV- 1 proviral DNA was inefficient in activated mouse T cells. This process was greatly enhanced by providing a secondary T cell receptor ( TCR) signal after HIV- 1 infection, especially between 12 to 24 h post infection. This effect was specific for primary mouse T cells. The pathways involved in HIV replication appear to be PKC theta-, CARMA1-, and WASp-independent. Treatment with Cyclosporin A (CsA) further relieved the pre-integration block. However, transcription of HIV-1 RNA was still reduced in mouse CD4+ T cells despite expression of the hCyclin T1 transgene. Additional post-transcriptional defects were observed at the levels of Gag expression, Gag processing, Gag release and virus infectivity. Together, these post-integration defects resulted in a dramatically reduced yield of infectious virus (300-500 fold) after a single cycle of HIV-1 replication. This study implies the existence of host factors, in addition to those already identified, that are critical for HIV-1 replication in mouse cells. This study also highlights the differences between primary T cells and cell lines regarding pre-integration steps in the HIV-1 replication cycle.	[Zhang, Jing-xin; Diehl, Gretchen E.; Littman, Dan R.] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10003 USA; [Littman, Dan R.] NYU, Sch Med, Dept Microbiol & Pathol, New York, NY USA; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY USA	New York University; New York University; Howard Hughes Medical Institute; New York University	Zhang, JX (corresponding author), NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med, New York, NY 10003 USA.	littman@saturn.med.nyu.edu		Diehl, Gretchen/0000-0002-1841-2842	National Institutes of Health [AI033856, AI033303]; American Cancer Society; Biogen Idec; Genetech; Ronald Levy Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033303, R37AI033303, R01AI033856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Biogen Idec(Biogen); Genetech; Ronald Levy Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health to DRL (AI033856; AI033303). GED is supported by the American Cancer Society-Biogen Idec/Genetech/Ronald Levy Postdoctoral Fellowship. The sponsors had no role in design or conduct of the study.	Ariumi Y, 2005, J VIROL, V79, P2973, DOI 10.1128/JVI.79.5.2973-2978.2005; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Baumann JG, 2004, J VIROL, V78, P12537, DOI 10.1128/JVI.78.22.12537-12547.2004; Berthoux L, 2004, J VIROL, V78, P11739, DOI 10.1128/JVI.78.21.11739-11750.2004; Bieniasz PD, 2000, J VIROL, V74, P9868, DOI 10.1128/JVI.74.21.9868-9877.2000; Browning J, 1997, P NATL ACAD SCI USA, V94, P14637, DOI 10.1073/pnas.94.26.14637; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Carroll RG, 1997, SCIENCE, V276, P273, DOI 10.1126/science.276.5310.273; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Chen BK, 2001, P NATL ACAD SCI USA, V98, P15239, DOI 10.1073/pnas.261563198; CORBOY JR, 1992, SCIENCE, V258, P1804, DOI 10.1126/science.1465618; Coskun AK, 2006, J VIROL, V80, P3406, DOI 10.1128/JVI.80.7.3406-3415.2006; Cuenda A, 2000, METH MOL B, V99, P161; Daniel R, 2003, P NATL ACAD SCI USA, V100, P4778, DOI 10.1073/pnas.0730887100; Daniel R, 2001, MOL CELL BIOL, V21, P1164, DOI 10.1128/MCB.21.4.1164-1172.2001; De SK, 1997, J CLIN INVEST, V99, P1484, DOI 10.1172/JCI119310; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Francois F, 2003, J VIROL, V77, P2539, DOI 10.1128/JVI.77.4.2539-2549.2003; Garza HH, 1996, J IMMUNOL, V156, P3631; Goffinet C, 2007, P NATL ACAD SCI USA, V104, P1015, DOI 10.1073/pnas.0607414104; Greger JG, 2005, J VIROL, V79, P4610, DOI 10.1128/JVI.79.8.4610-4618.2005; Ha HC, 2001, P NATL ACAD SCI USA, V98, P3364, DOI 10.1073/pnas.051633498; Hatziioannou T, 2005, J VIROL, V79, P15586, DOI 10.1128/JVI.79.24.15586-15589.2005; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Holm GH, 2004, J VIROL, V78, P4541, DOI 10.1128/JVI.78.9.4541-4551.2004; Huang YP, 2007, J CELL SCI, V120, P723, DOI 10.1242/jcs.000786; Hubner W, 2006, VIROLOGY, V352, P27, DOI 10.1016/j.virol.2006.04.024; Jamieson BD, 1997, J VIROL, V71, P8245, DOI 10.1128/JVI.71.11.8245-8253.1997; Julias JG, 2001, J VIROL, V75, P6537, DOI 10.1128/JVI.75.14.6537-6546.2001; Keppler OT, 2002, J EXP MED, V195, P719, DOI 10.1084/jem.20011549; KILLEEN N, 1993, EMBO J, V12, P1547, DOI 10.1002/j.1460-2075.1993.tb05798.x; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; Mariani R, 2000, J VIROL, V74, P3859, DOI 10.1128/JVI.74.8.3859-3870.2000; Mariani R, 2001, J VIROL, V75, P3141, DOI 10.1128/JVI.75.7.3141-3151.2001; McCune JM, 1997, SCIENCE, V278, P2141, DOI 10.1126/science.278.5346.2141; Morner A, 1999, J VIROL, V73, P2343; Noser JA, 2006, J VIROL, V80, P7769, DOI 10.1128/JVI.02427-05; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; Oswald-Richter K, 2004, EUR J IMMUNOL, V34, P1705, DOI 10.1002/eji.200424892; Reed M, 2002, J VIROL, V76, P436, DOI 10.1128/JVI.76.1.436-443.2002; Sastry L, 2004, HUM GENE THER, V15, P221, DOI 10.1089/104303404772680029; Sawada S, 1998, J EXP MED, V187, P1439, DOI 10.1084/jem.187.9.1439; Sokolskaja E, 2006, J VIROL, V80, P2855, DOI 10.1128/JVI.80.6.2855-2862.2006; Sokolskaja E, 2006, CURR OPIN MICROBIOL, V9, P404, DOI 10.1016/j.mib.2006.06.011; Sun JL, 2006, J VIROL, V80, P1850, DOI 10.1128/JVI.80.4.1850-1862.2006; Sundrud MS, 2005, BLOOD, V106, P3440, DOI 10.1182/blood-2005-03-0857; Swanson CM, 2004, EMBO J, V23, P2632, DOI 10.1038/sj.emboj.7600270; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; Triques K, 2004, J VIROL, V78, P5523, DOI 10.1128/JVI.78.10.5523-5527.2004; Tsurutani N, 2007, J VIROL, V81, P677, DOI 10.1128/JVI.00870-06; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; WISKERCHEN M, 1995, J VIROL, V69, P376, DOI 10.1128/JVI.69.1.376-386.1995; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zheng YH, 2003, NAT CELL BIOL, V5, P611, DOI 10.1038/ncb1000; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005	60	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2035	10.1371/journal.pone.0002035	http://dx.doi.org/10.1371/journal.pone.0002035			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446227	Green Published, Green Submitted, gold			2022-12-27	WOS:000261572300008
J	Kerkhoven, RM; Sie, D; Nieuwland, M; Heimerikx, M; De Ronde, J; Brugman, W; Velds, A				Kerkhoven, Ron M.; Sie, Daoud; Nieuwland, Marja; Heimerikx, Mike; De Ronde, Jorma; Brugman, Wim; Velds, Arno			The T7-Primer Is a Source of Experimental Bias and Introduces Variability between Microarray Platforms	PLOS ONE			English	Article								Eberwine(-like) amplification of mRNA adds distinct 6-10 bp nucleotide stretches to the 59 end of amplified RNA transcripts. Analysis of over six thousand microarrays reveals that probes containing motifs complementary to these stretches are associated with aberrantly high signals up to a hundred fold the signal observed in unaffected probes. This is not observed when total RNA is used as target source. Different T7 primer sequences are used in different laboratories and platforms and consequently different T7 primer bias is observed in different datasets. This will hamper efforts to compare data sets across platforms.	[Kerkhoven, Ron M.; Sie, Daoud; Nieuwland, Marja; Heimerikx, Mike; De Ronde, Jorma; Brugman, Wim; Velds, Arno] Netherlands Canc Inst, Cent Microarray Facil, Amsterdam, Netherlands	Netherlands Cancer Institute	Kerkhoven, RM (corresponding author), Netherlands Canc Inst, Cent Microarray Facil, Amsterdam, Netherlands.	r.kerkhoven@nki.nl		Velds, Arno/0000-0003-4333-8872; Sie, Daoud/0000-0001-6762-2582				Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; He ZL, 2005, APPL ENVIRON MICROB, V71, P3753, DOI 10.1128/AEM.71.7.3753-3760.2005; Kuo WP, 2006, NAT BIOTECHNOL, V24, P832, DOI 10.1038/nbt1217; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Nacheva GA, 2003, EUR J BIOCHEM, V270, P1458, DOI 10.1046/j.1432-1033.2003.03510.x; Petalidis L, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng142; Petersen D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-63; *R DEV COR TEAM, 2007, LANG ENV STAT COMP R; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546	12	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1980	10.1371/journal.pone.0001980	http://dx.doi.org/10.1371/journal.pone.0001980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431470	Green Submitted, Green Published, gold			2022-12-27	WOS:000261558700005
J	Jayaram, SA; Senti, KA; Tiklova, K; Tsarouhas, V; Hemphala, J; Samakovlis, C				Jayaram, Satish Arcot; Senti, Kirsten-Andre; Tiklova, Katarina; Tsarouhas, Vasilios; Hemphala, Johanna; Samakovlis, Christos			COPI Vesicle Transport Is a Common Requirement for Tube Expansion in Drosophila	PLOS ONE			English	Article								Background: Tube expansion defects like stenoses and atresias cause devastating human diseases. Luminal expansion during organogenesis begins to be elucidated in several systems but we still lack a mechanistic view of the process in many organs. The Drosophila tracheal respiratory system provides an amenable model to study tube size regulation. In the trachea, COPII anterograde transport of luminal proteins is required for extracellular matrix assembly and the concurrent tube expansion. Principal Findings: We identified and analyzed Drosophila COPI retrograde transport mutants with narrow tracheal tubes. gamma COP mutants fail to efficiently secrete luminal components and assemble the luminal chitinous matrix during tracheal tube expansion. Likewise, tube extension is defective in salivary glands, where it also coincides with a failure in the luminal deposition and assembly of a distinct, transient intraluminal matrix. Drosophila gamma COP colocalizes with cis-Golgi markers and in gamma COP mutant embryos the ER and Golgi structures are severely disrupted. Analysis of gamma COP and Sar1 double mutants suggests that bidirectional ER-Golgi traffic maintains the ER and Golgi compartments and is required for secretion and assembly of luminal matrixes during tube expansion. Conclusions/Significance: Our results demonstrate the function of COPI components in organ morphogenesis and highlight the common role of apical secretion and assembly of transient organotypic matrices in tube expansion. Intraluminal matrices have been detected in the notochord of ascidians and zebrafish COPI mutants show defects in notochord expansion. Thus, the programmed deposition and growth of distinct luminal molds may provide distending forces during tube expansion in diverse organs.	[Jayaram, Satish Arcot; Senti, Kirsten-Andre; Tiklova, Katarina; Tsarouhas, Vasilios; Hemphala, Johanna; Samakovlis, Christos] Stockholm Univ, Dept Dev Biol, Wenner Gren Inst, S-10691 Stockholm, Sweden	Stockholm University	Samakovlis, C (corresponding author), Stockholm Univ, Dept Dev Biol, Wenner Gren Inst, S-10691 Stockholm, Sweden.	christos@devbio.su.se	Tsarouhas, Vasilios/AAG-8226-2020; Senti, Kirsten-Andre/AAB-3036-2020	Tsarouhas, Vasilios/0000-0002-2933-1351; Arcot Jayaram, Satish/0000-0002-2479-2669; Senti, Kirsten-Andre/0000-0002-7208-7593	Swedish Research Council; Cancerfonden, SSF; EMBO postdoctoral fellowship	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfonden, SSF(Swedish Foundation for Strategic ResearchSwedish Cancer Society); EMBO postdoctoral fellowship(European Molecular Biology Organization (EMBO))	Swedish Research Council (VR), Cancerfonden, SSF to CS. EMBO postdoctoral fellowship to KAS. The funding agencies had no role in any part of the manuscript.	Abrams EW, 2006, DEVELOPMENT, V133, P3517, DOI 10.1242/dev.02525; Abrams EW, 2005, DEVELOPMENT, V132, P2743, DOI 10.1242/dev.01863; ADAMS DS, 1990, DEVELOPMENT, V110, P115; Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0; Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031; Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; Bartoszewski S, 2004, MECH DEVELOP, V121, P1259, DOI 10.1016/j.mod.2004.05.006; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Bethune J, 2006, J MEMBRANE BIOL, V211, P65, DOI 10.1007/s00232-006-0859-7; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Coutinho P, 2004, DEV CELL, V7, P547, DOI 10.1016/j.devcel.2004.07.020; Deak P, 1997, GENETICS, V147, P1697; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049; Jiang D, 2007, DEV DYNAM, V236, P1748, DOI 10.1002/dvdy.21184; Kuraishi T, 2007, EXP CELL RES, V313, P500, DOI 10.1016/j.yexcr.2006.10.027; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Moelleken J, 2007, P NATL ACAD SCI USA, V104, P4425, DOI 10.1073/pnas.0611360104; Olver RE, 2004, ANNU REV PHYSIOL, V66, P77, DOI 10.1146/annurev.physiol.66.071702.145229; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Perens EA, 2005, DEV CELL, V8, P893, DOI 10.1016/j.devcel.2005.03.009; Pimpl P, 2000, PLANT CELL, V12, P2219, DOI 10.1105/tpc.12.11.2219; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sabri N, 2007, J CELL BIOL, V178, P557, DOI 10.1083/jcb.200612135; SADLER TW, 1985, LANGMANS MED EMBRYOL; Seshaiah P, 2001, DEV BIOL, V239, P309, DOI 10.1006/dbio.2001.0429; Sisson JC, 2000, J CELL BIOL, V151, P905, DOI 10.1083/jcb.151.4.905; Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; STENBECK G, 1992, FEBS LETT, V314, P195, DOI 10.1016/0014-5793(92)80973-K; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; WADDINGTON CH, 1962, PROC R SOC SER B-BIO, V156, P459, DOI 10.1098/rspb.1962.0050; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Yano H, 2005, P NATL ACAD SCI USA, V102, P13467, DOI 10.1073/pnas.0506681102	46	52	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1964	10.1371/journal.pone.0001964	http://dx.doi.org/10.1371/journal.pone.0001964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398480	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795500033
J	Gehrmann, M; Liebisch, G; Schmitz, G; Anderson, R; Steinem, C; De Maio, A; Pockley, G; Multhoff, G				Gehrmann, Mathias; Liebisch, Gerhard; Schmitz, Gerd; Anderson, Robin; Steinem, Claudia; De Maio, Antonio; Pockley, Graham; Multhoff, Gabriele			Tumor-Specific Hsp70 Plasma Membrane Localization Is Enabled by the Glycosphingolipid Gb3	PLOS ONE			English	Article								Background: Human tumors differ from normal tissues in their capacity to present Hsp70, the major stress-inducible member of the HSP70 family, on their plasma membrane. Membrane Hsp70 has been found to serve as a prognostic indicator of overall patient survival in leukemia, lower rectal and non small cell lung carcinomas. Why tumors, but not normal cells, present Hsp70 on their cell surface and the impact of membrane Hsp70 on cancer progression remains to be elucidated. Methodology/Principal Findings: Although Hsp70 has been reported to be associated with cholesterol rich microdomains (CRMs), the partner in the plasma membrane with which Hsp70 interacts has yet to be identified. Herein, global lipid profiling demonstrates that Hsp70 membrane-positive tumors differ from their membrane-negative counterparts by containing significantly higher amounts of globotriaoslyceramide (Gb3), but not of other lipids such as lactosylceramide (LacCer), dodecasaccharideceramide (DoCer), galactosylceramide (GalCer), ceramide (Cer), or the ganglioside GM1. Apart from germinal center B cells, normal tissues are Gb3 membrane-negative. Co-localization of Hsp70 and Gb3 was selectively determined in Gb3 membrane-positive tumor cells, and these cells were also shown to bind soluble Hsp70-FITC protein from outside in a concentration-dependent manner. Given that the latter interaction can be blocked by a Gb3-specific antibody, and that the depletion of globotriaosides from tumors reduces the amount of membrane-bound Hsp70, we propose that Gb3 is a binding partner for Hsp70. The in vitro finding that Hsp70 predominantly binds to artificial liposomes containing Gb3 (PC/SM/Chol/Gb3, 17/45/33/5) confirms that Gb3 is an interaction partner for Hsp70. Conclusions/Significance: These data indicate that the presence of Gb3 enables anchorage of Hsp70 in the plasma membrane of tumors and thus they might explain tumor-specific membrane localization of Hsp70.	[Gehrmann, Mathias; Multhoff, Gabriele] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiotherapy & Radiooncol, D-8000 Munich, Germany; [Liebisch, Gerhard; Schmitz, Gerd] Univ Hosp Regensburg, Inst Clin Chem, Regensburg, Germany; [Anderson, Robin] Peter MacCallum Canc Inst, East Melbourne, Victoria, Australia; [Steinem, Claudia] Univ Gottingen, Inst Organ & Biomol Chem, Gottingen, Germany; [De Maio, Antonio] Univ Calif San Diego, Dept Surg, La Jolla, CA USA; [Pockley, Graham] Univ Sheffield, Sch Med & Biomed Sci, Sheffield, S Yorkshire, England; [Multhoff, Gabriele] Helmholtz Ctr Munich, German Res Ctr Environm Hlth GmbH, Inst Pathol, Munich, Germany	Technical University of Munich; University of Regensburg; Peter Maccallum Cancer Center; University of Gottingen; University of California System; University of California San Diego; University of Sheffield; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Multhoff, G (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiotherapy & Radiooncol, D-8000 Munich, Germany.	gabriele.multhoff@lrz.tu-muenchen.de	Anderson, Robin/K-6966-2019; Steinem, Claudia/K-7534-2018; Anderson, Robin/I-2306-2013; Steinem, Claudia/O-4801-2019; Pockley, Alan G/I-4704-2015; Liebisch, Gerhard/G-6130-2010; Anderson, Robin/S-1005-2017	Steinem, Claudia/0000-0001-8778-9283; Pockley, Alan G/0000-0001-9593-6431; Liebisch, Gerhard/0000-0003-4886-0811; Anderson, Robin/0000-0002-6841-7422; Multhoff, Gabriele/0000-0002-2616-3137	Deutsche Forschungsgemeinschaft [MU1238 7/2]; Bundesministerium fur Forschung und Technologie [0312338]; EU [2004-512253]; Helmholtz Gemeinschaft; biotech company multimmune GmbH; NIH [GM 50878]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Forschung und Technologie; EU(European Commission); Helmholtz Gemeinschaft(Helmholtz Association); biotech company multimmune GmbH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by grants of the Deutsche Forschungsgemeinschaft (DFG MU1238 7/2 to G.M.), the Bundesministerium fur Forschung und Technologie (BMBF BioChance plus, 0312338), EU (TRANSNET MRTN 2004-512253), by the Helmholtz Gemeinschaft, the biotech company multimmune GmbH and NIH GM 50878 (to A.D.M.). The sponsors/funders had no input into the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Arispe N, 2004, FASEB J, V18, P1636, DOI 10.1096/fj.04-2088com; Arispe N, 2002, CELL STRESS CHAPERON, V7, P330, DOI 10.1379/1466-1268(2002)007<0330:LIDTCA>2.0.CO;2; Asea A, 2001, INT J HYPERTHER, V17, P347, DOI 10.1080/02656730110053146; Barreto A, 2003, CELL IMMUNOL, V222, P97, DOI 10.1016/S0008-8749(03)00115-1; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown G, 2005, VIROLOGY, V338, P69, DOI 10.1016/j.virol.2005.05.004; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Calderwood SK, 2007, FEBS LETT, V581, P3689, DOI 10.1016/j.febslet.2007.04.044; Chen XH, 2002, IMMUNOL LETT, V84, P81, DOI 10.1016/S0165-2478(02)00042-1; FARKASHIMSLEY H, 1995, P NATL ACAD SCI USA, V92, P6996, DOI 10.1073/pnas.92.15.6996; Gastpar R, 2004, J IMMUNOL, V172, P972, DOI 10.4049/jimmunol.172.2.972; Gehrmann M, 2005, CELL DEATH DIFFER, V12, P38, DOI 10.1038/sj.cdd.4401510; GREGORY CD, 1987, J IMMUNOL, V139, P313; Guzhova I, 2001, BRAIN RES, V914, P66, DOI 10.1016/S0006-8993(01)02774-3; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HIGHTOWER LE, 1989, J CELL PHYSIOL, V138, P257, DOI 10.1002/jcp.1041380206; Johansson D, 2006, CANCER BIOL THER, V5, P1211, DOI 10.4161/cbt.5.9.3173; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liebisch G, 1999, J LIPID RES, V40, P1539; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; Maloney MD, 1999, GLYCOCONJUGATE J, V16, P821, DOI 10.1023/A:1007145420116; MALONEY MD, 1994, J EXP MED, V180, P191, DOI 10.1084/jem.180.1.191; Mambula SS, 2006, J IMMUNOL, V177, P7849, DOI 10.4049/jimmunol.177.11.7849; Mamelak D, 2001, J BIOL CHEM, V276, P449, DOI 10.1074/jbc.M006732200; Multhoff G, 1997, J IMMUNOL, V158, P4341; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; MULTHOFF G, 1995, INT J CANCER, V61, P272, DOI 10.1002/ijc.2910610222; NUDELMAN IL, 1987, INT SURG, V72, P104; Nutikka A, 2003, GLYCOCONJUGATE J, V20, P33, DOI 10.1023/B:GLYC.0000016740.69726.fb; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Pockley AG, 1998, IMMUNOL INVEST, V27, P367, DOI 10.3109/08820139809022710; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Theriault JR, 2005, FEBS LETT, V579, P1951, DOI 10.1016/j.febslet.2005.02.046; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Triantafilou M, 2002, J CELL SCI, V115, P2603; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R	44	125	128	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1925	10.1371/journal.pone.0001925	http://dx.doi.org/10.1371/journal.pone.0001925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382692	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000260795400045
J	van Rijn, BB; Franx, A; Steegers, EAP; de Groot, CJM; Bertina, RM; Pasterkamp, G; Voorbij, HAM; Bruinse, HW; Roest, M				van Rijn, Bas B.; Franx, Arie; Steegers, Eric A. P.; de Groot, Christianne J. M.; Bertina, Rogier M.; Pasterkamp, Gerard; Voorbij, Hieronymus A. M.; Bruinse, Hein W.; Roest, Mark			Maternal TLR4 and NOD2 Gene Variants, Pro-Inflammatory Phenotype and Susceptibility to Early-Onset Preeclampsia and HELLP Syndrome	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; ELEVATED LIVER-ENZYMES; INNATE-IMMUNE-SYSTEM; HEART-DISEASE; LOW PLATELETS; RISK; TOLL-LIKE-RECEPTOR-4; ASSOCIATION; PREGNANCY; HEAT-SHOCK-PROTEIN-60	Background: Altered maternal inflammatory responses play a role in the development of preeclampsia and the hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome. We examined whether allelic variants of the innate immune receptors Toll-like receptor 4 (TLR4) and nucleotide-binding oligomerization domain 2 (NOD2), that impair the inflammatory response to endotoxin, are related to preeclampsia and HELLP syndrome. Methods and Findings: We determined five common mutations in TLR4 (D299G and T399I) and NOD2 (R702W, G908R and L1007fs) in 340 primiparous women with a history of early-onset preeclampsia, of whom 177 women developed HELLP syndrome and in 113 women with a history of only uneventful pregnancies as controls. In addition, we assessed plasma levels of pro-inflammatory biomarkers C-reactive protein, interleukin-6, soluble intercellular adhesion molecule-1, fibrinogen and von Willebrand factor in a subset of 214 women included at least six months after delivery. After adjustment for maternal age and chronic hypertension, attenuating allelic variants of TLR4 were more common in women with a history of early-onset preeclampsia than in controls (OR 2.9 [95% CI 1.2-6.7]). Highest frequencies for TLR4 variants were observed in women who developed HELLP syndrome (adjusted OR 4.1 [95% CI 1.7-9.8]). In addition, high levels of interleukin-6 and fibrinogen were associated with a history of early-onset preeclampsia. Combined positivity for any of the TLR4 and NOD2 allelic variants and high levels of interleukin-6 was 6.9-fold more common in women with a history of early-onset preeclampsia (95% CI 2.1-23.2) compared to controls. Conclusions: We observed an association of common TLR4 and NOD2 gene variants, and pro-inflammatory phenotype with a history of early-onset preeclampsia and HELLP syndrome. These findings suggest involvement of the maternal innate immune system in severe hypertensive disorders of pregnancy.	[van Rijn, Bas B.; Bruinse, Hein W.] Univ Med Ctr Utrecht, Div Perinatol & Gynecol, Utrecht, Netherlands; [van Rijn, Bas B.; Voorbij, Hieronymus A. M.; Roest, Mark] Univ Med Ctr Utrecht, Lab Clin Chem & Hematol, Utrecht, Netherlands; [Pasterkamp, Gerard] Univ Med Ctr Utrecht, Dept Expt Cardiol, Utrecht, Netherlands; [Franx, Arie] St Elisabeth Hosp Tilburg, Dept Obstet & Gynecol, Tilburg, Netherlands; [Steegers, Eric A. P.] Erasmus MC, Div Obstet & Prenatal Med, Rotterdam, Netherlands; [de Groot, Christianne J. M.] Med Ctr Haaglanden, Dept Obstet & Gynecol, Hagen, Germany; [Bertina, Rogier M.] Leiden Univ Med Ctr, Dept Hematol, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Elisabeth-TweeSteden Ziekenhuis (ETZ); Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC)	van Rijn, BB (corresponding author), Univ Med Ctr Utrecht, Div Perinatol & Gynecol, Utrecht, Netherlands.	brijn2@umcutrecht.nl	Franx, Arie/AAA-1739-2021; van Rijn, Bas/E-2512-2013; van Rijn, Bas/ABZ-1080-2022; Bertina, Rogier/AGQ-5246-2022	van Rijn, Bas/0000-0003-1305-3825; van Rijn, Bas/0000-0003-1305-3825; 	The Netherlands Organization for Scientific Research [920-03-230]	The Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	BvR is supported by a stipend from The Netherlands Organization for Scientific Research (ZonMW/NWO grant 920-03-230). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Arechavaleta-Velasco F, 2006, AM J PATHOL, V168, P1951, DOI 10.2353/ajpath.2006.050781; Beutler B, 2001, CRIT CARE MED, V29, pS2, DOI 10.1097/00003246-200107001-00002; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Boggess KA, 2003, OBSTET GYNECOL, V101, P227, DOI 10.1016/S0029-7844(02)02314-1; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Bulut Y, 2002, J IMMUNOL, V168, P1435, DOI 10.4049/jimmunol.168.3.1435; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Costello MJ, 2007, AM J REPROD IMMUNOL, V57, P67, DOI 10.1111/j.1600-0897.2006.00447.x; Crider KS, 2005, GENET MED, V7, P593, DOI 10.1097/01.gim.0000187223.69947.db; CUNNINGHAM DS, 1993, J REPROD MED, V38, P459; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; De Groot CJM, 1999, AM J OBSTET GYNECOL, V181, P975, DOI 10.1016/S0002-9378(99)70335-2; FAAS MM, 1994, AM J OBSTET GYNECOL, V171, P158, DOI 10.1016/0002-9378(94)90463-4; Freeman DJ, 2004, HYPERTENSION, V44, P708, DOI 10.1161/01.HYP.0000143849.67254.ca; Gaya DR, 2006, LANCET, V367, P1271, DOI 10.1016/S0140-6736(06)68345-1; Goddard KAB, 2007, HUM HERED, V63, P1, DOI 10.1159/000097926; Goulis DG, 2005, BJOG-INT J OBSTET GY, V112, P299, DOI 10.1111/j.1471-0528.2004.00423.x; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hulstein JJJ, 2006, J THROMB HAEMOST, V4, P2569, DOI 10.1111/j.1538-7836.2006.02205.x; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kim YM, 2005, AM J OBSTET GYNECOL, V193, P921, DOI 10.1016/j.ajog.2005.06.053; Kloosterman G J, 1969, Ned Tijdschr Verloskd Gynaecol, V69, P349; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lafayette RA, 1998, KIDNEY INT, V54, P1240, DOI 10.1046/j.1523-1755.1998.00097.x; Levine RJ, 2004, AM J OBSTET GYNECOL, V190, P707, DOI 10.1016/j.ajog.2003.12.019; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; MARTIN JN, 1991, AM J OBSTET GYNECOL, V164, P1500, DOI 10.1016/0002-9378(91)91429-Z; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; MCMASTER MT, 1994, ANN NY ACAD SCI, V734, P122, DOI 10.1111/j.1749-6632.1994.tb21740.x; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Mockenhaupt FP, 2006, J INFECT DIS, V194, P184, DOI 10.1086/505152; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Ridker PM, 2004, CIRCULATION, V109, P6, DOI 10.1161/01.CIR.0000133444.17867.56; SIBAI BM, 1986, AM J OBSTET GYNECOL, V155, P501, DOI 10.1016/0002-9378(86)90266-8; Sikkema JM, 2002, PLACENTA, V23, P337, DOI 10.1053/plac.2001.0785; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Stepan H, 2006, NEW ENGL J MED, V354, P1857, DOI 10.1056/NEJMc052721; Terrone DA, 2000, SOUTHERN MED J, V93, P768; Ulevitch R, 2001, CRIT CARE MED, V29, pS6; van Heel DA, 2001, LANCET, V357, P1902, DOI 10.1016/S0140-6736(00)05091-1; van Rijn BB, 2006, AM J OBSTET GYNECOL, V195, P723, DOI 10.1016/j.ajog.2006.06.044; van Rijn BB, 2004, J IMMUNOL METHODS, V289, P81, DOI 10.1016/j.jim.2004.03.013; Heimel PJV, 2006, EUR J OBSTET GYN R B, V128, P187, DOI 10.1016/j.ejogrb.2005.11.041; Visser N, 2007, OBSTET GYNECOL SURV, V62, P191, DOI 10.1097/01.ogx.0000256779.06275.c4; von Dadelszen P, 2003, BJOG-INT J OBSTET GY, V110, P725, DOI 10.1111/j.1471-0528.2003.02481.x; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; WHO, 2005, MAK EV MOTH CHILD CO; Yang IA, 2006, CURR OPIN ALLERGY CL, V6, P23, DOI 10.1097/01.all.0000200503.77295.bb	55	63	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1865	10.1371/journal.pone.0001865	http://dx.doi.org/10.1371/journal.pone.0001865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382655	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000260795400005
J	Akbarzadeh, S; Wheldon, LM; Sweet, SMM; Talma, S; Mardakheh, FK; Heath, JK				Akbarzadeh, Shiva; Wheldon, Lee M.; Sweet, Steve M. M.; Talma, Sonia; Mardakheh, Faraz Khosravi; Heath, John K.			The Deleted in Brachydactyly B Domain of ROR2 Is Required for Receptor Activation by Recruitment of Src	PLOS ONE			English	Article								The transmembrane receptor 'ROR2' resembles members of the receptor tyrosine kinase family of signalling receptors in sequence but its' signal transduction mechanisms remain enigmatic. This problem has particular importance because mutations in ROR2 are associated with two human skeletal dysmorphology syndromes, recessive Robinow Syndrome (RS) and dominant acting Brachydactyly type B (BDB). Here we show, using a constitutive dimerisation approach, that ROR2 exhibits dimerisation-induced tyrosine kinase activity and the ROR2 C-terminal domain, which is deleted in BDB, is required for recruitment and activation of the non-receptor tyrosine kinase Src. Native ROR2 phosphorylation is induced by the ligand Wnt5a and is blocked by pharmacological inhibition of Src kinase activity. Eight sites of Src-mediated ROR2 phosphorylation have been identified by mass spectrometry. Activation via tyrosine phosphorylation of ROR2 receptor leads to its internalisation into Rab5 positive endosomes. These findings show that BDB mutant receptors are defective in kinase activation as a result of failure to recruit Src.	[Akbarzadeh, Shiva; Wheldon, Lee M.; Sweet, Steve M. M.; Talma, Sonia; Mardakheh, Faraz Khosravi; Heath, John K.] Univ Birmingham, Sch Biosci, CR UK Growth Factor Grp, Birmingham, W Midlands, England	University of Birmingham	Akbarzadeh, S (corresponding author), Univ Birmingham, Sch Biosci, CR UK Growth Factor Grp, Birmingham, W Midlands, England.	J.K.Heath@bham.ac.uk	Sweet, Steve/B-5528-2008	Sweet, Steve/0000-0002-3962-0421; akbarzadeh, shivaa/0000-0002-2787-3317; Mardakheh, Faraz/0000-0003-3896-0827; Heath, John/0000-0003-4886-4070	Wellcome Trust; Cancer Research UK; Endotrack (EU FP6)	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Endotrack (EU FP6)(European Commission)	This research was funded by the Wellcome Trust (to JKH, Andrew Wilkie and Gillian Morriss-Kay) and Cancer Research UK. SMMS was funded by Endotrack (EU FP6).	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; ALEXANDROPOULOS K, 1995, P NATL ACAD SCI USA, V92, P3110, DOI 10.1073/pnas.92.8.3110; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Forrester WC, 2002, CELL MOL LIFE SCI, V59, P83, DOI 10.1007/s00018-002-8407-9; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Liu J, 2007, MOL BIOL CELL, V18, P1375, DOI 10.1091/mbc.E06-08-0725; Liu Y, 2007, MOL ENDOCRINOL, V21, P3050, DOI 10.1210/me.2007-0323; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; Oishi I, 1999, GENES CELLS, V4, P41, DOI 10.1046/j.1365-2443.1999.00234.x; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Sammar M, 2004, GENES CELLS, V9, P1227, DOI 10.1111/j.1365-2443.2004.00799.x; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084; Stricker S, 2006, DEV DYNAM, V235, P3456, DOI 10.1002/dvdy.20993; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	26	59	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1873	10.1371/journal.pone.0001873	http://dx.doi.org/10.1371/journal.pone.0001873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365018	gold, Green Published, Green Submitted			2022-12-27	WOS:000260762400024
J	Roberts, M; Zimin, AV; Hayes, W; Hunt, BR; Ustun, C; White, JR; Havlak, P; Yorke, J				Roberts, Michael; Zimin, Aleksey V.; Hayes, Wayne; Hunt, Brian R.; Ustun, Cevat; White, James R.; Havlak, Paul; Yorke, James			Improving Phrap-Based Assembly of the Rat Using "Reliable" Overlaps	PLOS ONE			English	Article							GENOME	The assembly methods used for whole-genome shotgun (WGS) data have a major impact on the quality of resulting draft genomes. We present a novel algorithm to generate a set of "reliable'' overlaps based on identifying repeat k-mers. To demonstrate the benefits of using reliable overlaps, we have created a version of the Phrap assembly program that uses only overlaps from a specific list. We call this version PhrapUMD. Integrating PhrapUMD and our "reliable-overlap'' algorithm with the Baylor College of Medicine assembler, Atlas, we assemble the BACs from the Rattus norvegicus genome project. Starting with the same data as the Nov. 2002 Atlas assembly, we compare our results and the Atlas assembly to the 4.3 Mb of rat sequence in the 21 BACs that have been finished. Our version of the draft assembly of the 21 BACs increases the coverage of finished sequence from 93.4% to 96.3%, while simultaneously reducing the base error rate from 4.5 to 1.1 errors per 10,000 bases. There are a number of ways of assessing the relative merits of assemblies when the finished sequence is available. If one views the overall quality of an assembly as proportional to the inverse of the product of the error rate and sequence missed, then the assembly presented here is seven times better. The UMD Overlapper with options for reliable overlaps is available from the authors at http://www.genome.umd.edu. We also provide the changes to the Phrap source code enabling it to use only the reliable overlaps.	[Roberts, Michael; Zimin, Aleksey V.; Hayes, Wayne; Hunt, Brian R.; Ustun, Cevat; White, James R.; Yorke, James] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Havlak, Paul] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX USA	University System of Maryland; University of Maryland College Park; Baylor College of Medicine	Roberts, M (corresponding author), Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA.	alekseyz@ipst.umd.edu	Hunt, Brian/J-6895-2012	Hayes, Wayne B./0000-0002-3310-6042	NSF [DMS0616585]; NIH [1R01HG0294501]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002945] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported under NSF grant DMS0616585 and under NIH grant 1R01HG0294501.	Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Green P, 1996, PHRAP DOCUMENTATION; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Huang XQ, 2003, GENOME RES, V13, P2164, DOI 10.1101/gr.1390403; Mullikin JC, 2003, GENOME RES, V13, P81, DOI 10.1101/gr.731003; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Roberts M, 2004, J COMPUT BIOL, V11, P734; SALZBERG SL, 2005, BIOINFORMATICS, V21, P133; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]	15	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1836	10.1371/journal.pone.0001836	http://dx.doi.org/10.1371/journal.pone.0001836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350171	Green Published, gold, Green Accepted			2022-12-27	WOS:000260762300037
J	Fouchet, D; Regoes, R				Fouchet, David; Regoes, Roland			A Population Dynamics Analysis of the Interaction between Adaptive Regulatory T Cells and Antigen Presenting Cells	PLOS ONE			English	Article								Background: Regulatory T cells are central actors in the maintenance of tolerance of self-antigens or allergens and in the regulation of the intensity of the immune response during infections by pathogens. An understanding of the network of the interaction between regulatory T cells, antigen presenting cells and effector T cells is starting to emerge. Dynamical systems analysis can help to understand the dynamical properties of an interaction network and can shed light on the different tasks that can be accomplished by a network. Methodology and Principal Findings: We used a mathematical model to describe a interaction network of adaptive regulatory T cells, in which mature precursor T cells may differentiate into either adaptive regulatory T cells or effector T cells, depending on the activation state of the cell by which the antigen was presented. Using an equilibrium analysis of the mathematical model we show that, for some parameters, the network has two stable equilibrium states: one in which effector T cells are strongly regulated by regulatory T cells and another in which effector T cells are not regulated because the regulatory T cell population is vanishingly small. We then simulate different types of perturbations, such as the introduction of an antigen into a virgin system, and look at the state into which the system falls. We find that whether or not the interaction network switches from the regulated (tolerant) state to the unregulated state depends on the strength of the antigenic stimulus and the state from which the network has been perturbed. Conclusion/Significance: Our findings suggest that the interaction network studied in this paper plays an essential part in generating and maintaining tolerance against allergens and self-antigens.	[Fouchet, David; Regoes, Roland] ETH, ETH Zentrum, Inst Integrat Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Fouchet, D (corresponding author), ETH, ETH Zentrum, Inst Integrat Biol, Zurich, Switzerland.	david.fouchet@env.ethz.ch	Regoes, Roland R/A-6538-2008	Regoes, Roland R/0000-0001-8319-5293	Swiss National Science Fundation	Swiss National Science Fundation(Swiss National Science Foundation (SNSF))	RRR greatfully acknowledges the financial support of the Swiss National Science Fundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 2003, IMMUNOLOGY, V109, P319, DOI 10.1046/j.1365-2567.2003.01678.x; Asseman C, 2003, J IMMUNOL, V171, P971, DOI 10.4049/jimmunol.171.2.971; Bacchetta R, 2002, EUR J IMMUNOL, V32, P2237, DOI 10.1002/1521-4141(200208)32:8<2237::AID-IMMU2237>3.0.CO;2-2; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barrat FJ, 2002, J EXP MED, V195, P603, DOI 10.1084/jem.20011629; Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Burroughs NJ, 2006, J THEOR BIOL, V241, P134, DOI 10.1016/j.jtbi.2005.11.010; Carneiro J, 2007, IMMUNOL REV, V216, P48; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Dhodapkar MV, 2001, J EXP MED, V193, P233, DOI 10.1084/jem.193.2.233; Dieckmann D, 2002, J EXP MED, V196, P247, DOI 10.1084/jem.20020642; Elston DM, 2006, J AM ACAD DERMATOL, V54, P172, DOI 10.1016/j.jaad.2005.09.020; Fairweather D, 2005, REV MED VIROL, V15, P17, DOI 10.1002/rmv.445; Garza KM, 2000, J IMMUNOL, V164, P3982, DOI 10.4049/jimmunol.164.8.3982; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hawrylowicz CM, 2005, NAT REV IMMUNOL, V5, P271, DOI 10.1038/nri1589; HORAK I, 1995, CLIN IMMUNOL IMMUNOP, V76, P172; Jonuleit H, 2003, J IMMUNOL, V171, P6323, DOI 10.4049/jimmunol.171.12.6323; Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213; Jonuleit H, 2001, TRENDS IMMUNOL, V22, P394, DOI 10.1016/S1471-4906(01)01952-4; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Koya T, 2007, J ALLERGY CLIN IMMUN, V119, P1241, DOI 10.1016/j.jaci.2007.01.039; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Leon K, 2000, J THEOR BIOL, V207, P231, DOI 10.1006/jtbi.2000.2169; Ling EM, 2004, LANCET, V363, P608, DOI 10.1016/S0140-6736(04)15592-X; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; MODIGLIANI Y, 1995, P NATL ACAD SCI USA, V92, P7555, DOI 10.1073/pnas.92.16.7555; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Penna G, 2005, MICROBES INFECT, V7, P1033, DOI 10.1016/j.micinf.2005.03.025; Powrie F, 2003, SCIENCE, V299, P1030, DOI 10.1126/science.1082031; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Rose NR, 2001, J CLIN INVEST, V107, P943, DOI 10.1172/JCI12673; Rovere-Querini P, 2005, AUTOIMMUN REV, V4, P555, DOI 10.1016/j.autrev.2005.04.013; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; SMITH H, 1992, J IMMUNOL, V149, P2212; Steinbrink K, 1997, J IMMUNOL, V159, P4772; Steinbrink K, 2002, BLOOD, V99, P2468, DOI 10.1182/blood.V99.7.2468; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Veldman C, 2006, INT ARCH ALLERGY IMM, V140, P174, DOI 10.1159/000092576; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	46	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2306	10.1371/journal.pone.0002306	http://dx.doi.org/10.1371/journal.pone.0002306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509463	Green Published, Green Submitted, gold			2022-12-27	WOS:000262268500041
J	Bikbaev, A; Neyman, S; Ngomba, RT; Conn, J; Nicoletti, F; Manahan-Vaughan, D				Bikbaev, Arthur; Neyman, Sergey; Ngomba, Richard Teke; Conn, Jeffrey; Nicoletti, Ferdinando; Manahan-Vaughan, Denise			MGluR5 Mediates the Interaction between Late-LTP, Network Activity, and Learning	PLOS ONE			English	Article								Hippocampal synaptic plasticity and learning are strongly regulated by metabotropic glutamate receptors (mGluRs) and particularly by mGluR5. Here, we investigated the mechanisms underlying mGluR5-modulation of these phenomena. Prolonged pharmacological blockade of mGluR5 with MPEP produced a profound impairment of spatial memory. Effects were associated with 1) a reduction of mGluR1a-expression in the dentate gyrus; 2) impaired dentate gyrus LTP; 3) enhanced CA1-LTP and 4) suppressed theta (5-10 Hz) and gamma (30-100 Hz) oscillations in the dentate gyrus. Allosteric potentiation of mGluR1 after mGluR5 blockade significantly ameliorated dentate gyrus LTP, as well as suppression of gamma oscillatory activity. CA3-lesioning prevented MPEP effects on CA1-LTP, suggesting that plasticity levels in CA1 are driven by mGluR5-dependent synaptic and network activity in the dentate gyrus. These data support the hypothesis that prolonged mGluR5-inactivation causes altered hippocampal LTP levels and network activity, which is mediated in part by impaired mGluR1-expression in the dentate gyrus. The consequence is impairment of long-term learning.	[Bikbaev, Arthur; Neyman, Sergey; Manahan-Vaughan, Denise] Ruhr Univ Bochum, Dept Expt Neurophysiol, Fac Med, Bochum, Germany; [Manahan-Vaughan, Denise] Ruhr Univ Bochum, Int Grad Sch Neurosci, Bochum, Germany; [Neyman, Sergey] Humboldt Univ, Inst Physiol Charite, Synaptic Plasticity Res Grp, Berlin, Germany; [Ngomba, Richard Teke; Nicoletti, Ferdinando] Inst Neurol Mediterraneo INM, Pozzilli, Italy; [Conn, Jeffrey] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN USA; [Nicoletti, Ferdinando] Univ Roma La Sapienza, Dept Human Physiol & Pharmacol, Rome, Italy	Ruhr University Bochum; Ruhr University Bochum; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; IRCCS Neuromed; Vanderbilt University; Sapienza University Rome	Bikbaev, A (corresponding author), Ruhr Univ Bochum, Dept Expt Neurophysiol, Fac Med, Bochum, Germany.	dmv-igsn@rub.de	Nicoletti, Ferdinando/K-4410-2016; Nicoletti, Ferdinando/T-4898-2019; Nicoletti, Ferdinando/A-2446-2010	Ngomba, Richard/0000-0003-3825-3970; Manahan-Vaughan, Denise/0000-0002-9283-9609; NICOLETTI, Ferdinando/0000-0003-3366-7269; Nicoletti, Ferdinando/0000-0003-0917-443X	German Research Foundation (Deutsche Forschungsgemeinschaft)(DFG)	German Research Foundation (Deutsche Forschungsgemeinschaft)(DFG)(German Research Foundation (DFG))	This work was supported by a research grant the German Research Foundation (Deutsche Forschungsgemeinschaft)(DFG). The DFG was not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Abraham WC, 2003, PHILOS T R SOC B, V358, P735, DOI 10.1098/rstb.2002.1222; AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Balschun D, 1999, LEARN MEMORY, V6, P138; Balschun D, 2006, NEUROSCIENCE, V142, P691, DOI 10.1016/j.neuroscience.2006.06.043; BARNES CA, 1994, J NEUROSCI, V14, P5793; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; BENARI Y, 1988, J PHYSIOL-LONDON, V404, P365, DOI 10.1113/jphysiol.1988.sp017294; Bordi F, 1997, BRAIN RES, V761, P121, DOI 10.1016/S0006-8993(97)00320-X; BRAGIN A, 1995, J NEUROSCI, V15, P47; Braunewell KH, 2003, NEUROPHARMACOLOGY, V44, P707, DOI 10.1016/S0028-3908(03)00051-0; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CAIN DP, 1993, HIPPOCAMPUS, V3, P153, DOI 10.1002/hipo.450030208; Casabona G, 1997, EUR J NEUROSCI, V9, P12, DOI 10.1111/j.1460-9568.1997.tb01348.x; Chen YL, 2007, MOL PHARMACOL, V71, P1389, DOI 10.1124/mol.106.032425; CHINESTRA P, 1993, J NEUROPHYSIOL, V70, P2684, DOI 10.1152/jn.1993.70.6.2684; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Cobb SR, 2000, NEUROPHARMACOLOGY, V39, P1933, DOI 10.1016/S0028-3908(00)00036-8; Cohen AS, 1998, HIPPOCAMPUS, V8, P160, DOI 10.1002/(SICI)1098-1063(1998)8:2<160::AID-HIPO8>3.3.CO;2-J; Cohen AS, 1996, J NEUROPHYSIOL, V76, P953, DOI 10.1152/jn.1996.76.2.953; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Cozzi A, 2002, NEUROPHARMACOLOGY, V43, P119, DOI 10.1016/S0028-3908(02)00080-1; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; Fitzjohn SM, 2001, J PHYSIOL-LONDON, V537, P421, DOI 10.1111/j.1469-7793.2001.00421.x; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; Gasparini F, 2002, CURR OPIN PHARMACOL, V2, P43, DOI 10.1016/S1471-4892(01)00119-9; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Hemstapat K, 2006, MOL PHARMACOL, V70, P616, DOI 10.1124/mol.105.021857; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Holscher C, 1997, EUR J PHARMACOL, V322, P155, DOI 10.1016/S0014-2999(96)01000-X; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Hughes SW, 2004, NEURON, V42, P253, DOI 10.1016/S0896-6273(04)00191-6; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; KEMP A, 2007, CEREB CORTE IN PRESS; Kemp A, 2007, TRENDS NEUROSCI, V30, P111, DOI 10.1016/j.tins.2007.01.002; Knoflach F, 2001, P NATL ACAD SCI USA, V98, P13402, DOI 10.1073/pnas.231358298; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; Kulla A, 2000, CEREB CORTEX, V10, P614, DOI 10.1093/cercor/10.6.614; Lanneau C, 2002, NEUROPHARMACOLOGY, V43, P131, DOI 10.1016/S0028-3908(02)00086-2; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; Lu YM, 1997, J NEUROSCI, V17, P5196; Manahan-Vaughan D, 2005, CEREB CORTEX, V15, P1703, DOI 10.1093/cercor/bhi047; Manahan-Vaughan D, 2003, NEUROPHARMACOLOGY, V44, P17, DOI 10.1016/S0028-3908(02)00342-8; Manahan-Vaughan D, 1998, NEUROSCIENCE, V86, P709, DOI 10.1016/S0306-4522(98)00111-0; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Manahan-Vaughan D, 2000, J NEUROSCI, V20, P8572, DOI 10.1523/JNEUROSCI.20-22-08572.2000; ManahanVaughan D, 1997, J NEUROSCI, V17, P3303; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; MANZONI OJ, 1994, EUR J NEUROSCI, V6, P1050, DOI 10.1111/j.1460-9568.1994.tb00599.x; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Moser EI, 1999, NEUROSCI BIOBEHAV R, V23, P661, DOI 10.1016/S0149-7634(98)00060-8; Naie K, 2005, EUR J NEUROSCI, V21, P411, DOI 10.1111/j.1460-9568.2005.03864.x; Naie K, 2004, CEREB CORTEX, V14, P189, DOI 10.1093/cercor/bhg118; Nakajima S, 1991, Hippocampus, V1, P67, DOI 10.1002/hipo.450010107; Neyman S, 2008, EUR J NEUROSCI, V27, P1345, DOI 10.1111/j.1460-9568.2008.06109.x; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Queiroz CMT, 2007, EUR J NEUROSCI, V25, P3071, DOI 10.1111/j.1460-9568.2007.05573.x; SELIG DK, 1995, J NEUROPHYSIOL, V74, P1075, DOI 10.1152/jn.1995.74.3.1075; Sourdet V, 2003, J NEUROSCI, V23, P10238; THOMAS MJ, 1995, BRAIN RES, V695, P45, DOI 10.1016/0006-8993(95)00757-H; Thuault SJ, 2002, NEUROPHARMACOLOGY, V43, P141, DOI 10.1016/S0028-3908(02)00095-3; Traub RD, 2005, J NEUROPHYSIOL, V94, P1225, DOI 10.1152/jn.00069.2005; Uzakov S, 2005, LEARN MEMORY, V12, P165, DOI 10.1101/lm.89305; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Wilsch VW, 1998, J NEUROSCI, V18, P6071	70	57	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2155	10.1371/journal.pone.0002155	http://dx.doi.org/10.1371/journal.pone.0002155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478073	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000262172800020
J	Miller, RA; Christoforou, N; Pevsner, J; McCallion, AS; Gearhart, JD				Miller, Ronald A.; Christoforou, Nicolas; Pevsner, Jonathan; McCallion, Andrew S.; Gearhart, John D.			Efficient Array-Based Identification of Novel Cardiac Genes through Differentiation of Mouse ESCs	PLOS ONE			English	Article								Remarkably, although cardiac disease accounts for the largest proportion of adult mortality and morbidity in the industrialized world, the genetic programs controlling early cardiogenesis are largely incompletely understood. To better understand this process, we set out to identify genes whose expression is enriched within early cardiac fated populations, obtaining the transcriptional signatures of mouse embryonic stem cells (mESCs) at defined intervals during their differentiation along a cardiac path. We compared the RNA profiles of cardiac precursors cells (CPCs) with time-matched non-CPCs and undifferentiated mESCs, using a transgenic mESC line harboring an Nkx2-5 cardiac-specific regulatory sequence driving green fluorescent protein (GFP) to facilitate selection of CPCs. We identify 176 transcripts that are significantly elevated in their abundance within CPCs compared with other assayed populations, predicting that they will likely play a role in cardiogenesis. Of note, approximately 24% (43/176) of the cardiogenic candidate transcripts have known roles in cardiac function or development. Importantly, we evaluated the biological relevance of a significant subset 31/133 (23%) of the remaining candidate genes by in situ hybridization at multiple time points during development (embryonic day, E7.5-9.5) and report that all were expressed in key cardiac structures during cardiogenesis. Furthermore 9/31, of which many were previously uncharacterized, were detected as early as the formation of the cardiac crescent. These data demonstrate the potential power of integrating genomic approaches with mESC differentiation to illuminate developmental processes, and provides a valuable resource that may be mined to further elucidate the genetic programs underlying cardiogenesis.	[Miller, Ronald A.; Christoforou, Nicolas; Gearhart, John D.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA; [Miller, Ronald A.; Pevsner, Jonathan; McCallion, Andrew S.; Gearhart, John D.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Pevsner, Jonathan] Kennedy Krieger Inst, Baltimore, MD USA; [Gearhart, John D.] Johns Hopkins Univ, Sch Med, Dept Obstet & Gynecol, Baltimore, MD USA; [McCallion, Andrew S.] Johns Hopkins Univ, Sch Med, Dept Mol & Comparative Pathobiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University	Miller, RA (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.	amccalli@jhmi.edu; gearhart@jhmi.edu			Institute for Cell Engineering of Johns Hopkins Medicine; Armstrong Fellow in Regenerative medicine; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071648] Funding Source: NIH RePORTER	Institute for Cell Engineering of Johns Hopkins Medicine; Armstrong Fellow in Regenerative medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Institute for Cell Engineering of Johns Hopkins Medicine for provided the funding for this research (JDG). NC is an Armstrong Fellow in Regenerative medicine. ASM was additionally supported by grants from NIH.	Abu-Issa R, 2004, DEV BIOL, V272, P281, DOI 10.1016/j.ydbio.2004.05.016; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BODMER R, 1993, DEVELOPMENT, V118, P719; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; CHRISTOFOROU N, 2008, J CLIN INVEST; Eppig JT, 2007, NUCLEIC ACIDS RES, V35, pD630, DOI 10.1093/nar/gkl940; Gibson-Brown JJ, 1998, DEVELOPMENT, V125, P2499; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Hescheler J, 1997, CARDIOVASC RES, V36, P149, DOI 10.1016/S0008-6363(97)00193-4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kasahara H, 1998, CIRC RES, V82, P936, DOI 10.1161/01.RES.82.9.936; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Lien CL, 1999, DEVELOPMENT, V126, P75; LYONS I, 1995, GENE DEV, V9, P1954; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; Masino AM, 2004, CIRC RES, V95, P389, DOI 10.1161/01.RES.0000138302.02691.be; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tam PPL, 1997, DEVELOPMENT, V124, P1631; Thomas T, 1998, DEV BIOL, V196, P228, DOI 10.1006/dbio.1998.8849; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028	26	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2176	10.1371/journal.pone.0002176	http://dx.doi.org/10.1371/journal.pone.0002176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478100	Green Published, Green Submitted, gold			2022-12-27	WOS:000262172800041
J	Wang, BE; Wang, XD; Ernst, JA; Polakis, P; Gao, WQ				Wang, Bu-Er; Wang, Xi-De; Ernst, James A.; Polakis, Paul; Gao, Wei-Qiang			Regulation of Epithelial Branching Morphogenesis and Cancer Cell Growth of the Prostate by Wnt Signaling	PLOS ONE			English	Article								Although Wnt signaling has been shown to be important for embryonic morphogenesis and cancer pathogenesis of several tissues, its role in prostatic development and tumorigenesis is not well understood. Here we show that Wnt signaling regulated prostatic epithelial branching morphogenesis and luminal epithelial cell differentiation in developing rat prostate organ cultures. Specifically, Wnt signaling regulated the proliferation of prostate epithelial progenitor cells. Assessment of the expression levels of a Wnt pathway transcriptional target gene, Axin2, showed that the Wnt pathway was activated in the developing prostate, but was down-regulated in the adult. Castration resulted in an upregulation of Axin2 whereas androgen replacement resulted in a down regulation of Axin2. Such dynamic changes of Wnt activity was also confirmed in a BAT-gal transgenic mouse line in which beta-galactosidase reporter is expressed under the control of beta-catenin/T cell factor responsive elements. Furthermore, we evaluated the role of Wnt signaling in prostate tumorigenesis. Axin2 expression was found upregulated in the majority of human prostate cancer cell lines examined. Moreover, addition of a Wnt pathway inhibitor, Dickkopf 1 (DKK1), into the culture medium significantly inhibited prostate cancer cell growth and migration. These findings suggest that Wnt signaling regulates prostatic epithelial ductal branching morphogenesis by influencing cell proliferation, and highlights a role for Wnt pathway activation in prostatic cancer progression.	[Wang, Bu-Er; Wang, Xi-De; Gao, Wei-Qiang] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Ernst, James A.] Genentech Inc, Dept Protein Chem & Protein Engn, San Francisco, CA USA; [Polakis, Paul] Genentech Inc, Dept Canc Target & Pathways, San Francisco, CA USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Wang, BE (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	gao@gene.com	Gao, Wei/GXH-0380-2022; Thomson, Axel/A-7893-2013					Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bruxvoort KJ, 2007, CANCER RES, V67, P2490, DOI 10.1158/0008-5472.CAN-06-3028; Chen GP, 2004, CANCER-AM CANCER SOC, V101, P1345, DOI 10.1002/cncr.20518; COFFEY DS, 1968, ARCH BIOCHEM BIOPHYS, V124, P184, DOI 10.1016/0003-9861(68)90319-6; Corey E, 2003, PROSTATE, V55, P239, DOI 10.1002/pros.10198; FURUYA Y, 1993, ENDOCRINOLOGY, V133, P2660, DOI 10.1210/en.133.6.2660; Gao H, 2004, P NATL ACAD SCI USA, V101, P17204, DOI 10.1073/pnas.0407693101; Hayward SW, 1996, ACTA ANAT, V155, P81; HAYWARD SW, 1995, IN VITRO CELL DEV-AN, V31, P14; Ilyas M, 2005, J PATHOL, V205, P130, DOI 10.1002/path.1692; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Katoh M, 2001, INT J ONCOL, V19, P1003; Kawano Y, 2006, ONCOGENE, V25, P6528, DOI 10.1038/sj.onc.1209661; Li Y, 2005, J MAMMARY GLAND BIOL, V10, P17, DOI 10.1007/s10911-005-2537-2; Lipschutz JH, 1997, PROSTATE, V32, P35; Lipschutz JH, 1996, J UROLOGY, V155, P1762, DOI 10.1016/S0022-5347(01)66194-9; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Maddison LA, 2004, PROSTATE, V58, P335, DOI 10.1002/pros.10341; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Robinson EJ, 1998, PROSTATE, V37, P149, DOI 10.1002/(SICI)1097-0045(19981101)37:3<149::AID-PROS4>3.0.CO;2-E; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Shidaifat F, 2004, ENDOCR RES, V30, P327, DOI 10.1081/ERC-200033196; Shoemaker AR, 1998, P NATL ACAD SCI USA, V95, P10826, DOI 10.1073/pnas.95.18.10826; Shou JY, 2002, P NATL ACAD SCI USA, V99, P2830, DOI 10.1073/pnas.052705299; Shou JY, 2001, CANCER RES, V61, P7291; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Thomson AA, 1999, DEVELOPMENT, V126, P3693; TIMMS BG, 1994, J UROLOGY, V151, P1427, DOI 10.1016/S0022-5347(17)35273-4; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Verras M, 2004, CANCER RES, V64, P8860, DOI 10.1158/0008-5472.CAN-04-2370; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang BE, 2003, J BIOL CHEM, V278, P18506, DOI 10.1074/jbc.M300968200; Wang XD, 2006, DEV BIOL, V290, P66, DOI 10.1016/j.ydbio.2005.11.009; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Wright AS, 1999, ENDOCRINOLOGY, V140, P4509, DOI 10.1210/en.140.10.4509; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Zhu HN, 2004, CANCER RES, V64, P7918, DOI 10.1158/0008-5472.CAN-04-2704; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	45	51	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2186	10.1371/journal.pone.0002186	http://dx.doi.org/10.1371/journal.pone.0002186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478098	Green Submitted, Green Published, gold			2022-12-27	WOS:000262172800051
J	Akchurin, T; Aissiou, T; Kemeny, N; Prosk, E; Nigam, N; Komarova, SV				Akchurin, Timur; Aissiou, Tayeb; Kemeny, Naomi; Prosk, Erin; Nigam, Nilima; Komarova, Svetlana V.			Complex Dynamics of Osteoclast Formation and Death in Long-Term Cultures	PLOS ONE			English	Article								Background: Osteoclasts, cells responsible for bone resorption, contribute to the development of degenerative, metabolic and neoplastic bone diseases, which are often characterized by persistent changes in bone microenvironment. We aimed to investigate the dynamics of osteoclast formation and death in cultures that considerably exceeded the length of standard protocol and to design a mathematical model describing osteoclastogenesis. Methodology/Principal Findings: RAW 264.7 monocytic cells fuse to form multinucleated osteoclasts upon treatment with pro-resorptive cytokine RANKL. We have found that in long-term experiments (15-26 days), the dynamics of changes in osteoclast numbers was remarkably complex and qualitatively variable in different experiments. Whereas 19 of 46 experiments exhibited single peak of osteoclast formation, in 27 experiments we observed development of successive waves of osteoclast formation and death. Periodic changes in osteoclast numbers were confirmed in long-term cultures of mouse bone marrow cells treated with M-CSF and RANKL. Because the dynamics of changes in osteoclast numbers was found to be largely independent of monocytes, a two-species model of ordinary differential equations describing the changes in osteoclasts and monocytes was ineffective in recapitulating the oscillations in osteoclast numbers. Following experimental observation that medium collected from mature osteoclasts inhibited osteoclastogenesis in fresh cultures, we introduced a third variable, factor f, to describe osteoclast-derived inhibitor. This model allowed us to simulate the oscillatory changes in osteoclasts, which were coupled to oscillatory changes in the factor f, whereas monocytes changed exponentially. Importantly, to achieve the experimentally observed oscillations with increasing amplitude, we also had to assume that osteoclast presence stimulates osteoclast formation. Conclusions/Significance: This study identifies the critical role for osteoclast autocrine regulation in controlling long-term dynamic of osteoclast formation and death and describes the complementary roles for negative and positive feedback mediators in determining the sharp dynamics of activation and inactivation of osteoclasts.	[Akchurin, Timur; Aissiou, Tayeb; Kemeny, Naomi; Komarova, Svetlana V.] McGill Univ, Fac Dent, Montreal, PQ, Canada; [Aissiou, Tayeb; Prosk, Erin; Nigam, Nilima] McGill Univ, Dept Math & Stat, Montreal, PQ, Canada	McGill University; McGill University	Akchurin, T (corresponding author), McGill Univ, Fac Dent, Montreal, PQ, Canada.	svetlana.komarova@mcgill.ca			CIHR/IMHA; NSERC	CIHR/IMHA(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study is supported by operating grants from CIHR/IMHA and NSERC. SVK holds Canada Research Chair in osteoclast biology.	Bharti AC, 2004, J BIOL CHEM, V279, P6065, DOI 10.1074/jbc.M308062200; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Choi SJ, 2001, J BONE MINER RES, V16, P814, DOI 10.1359/jbmr.2001.16.5.814; Choi SJ, 1999, J BIOL CHEM, V274, P27747, DOI 10.1074/jbc.274.39.27747; Colijn C, 2005, J THEOR BIOL, V237, P133, DOI 10.1016/j.jtbi.2005.03.034; Collin-Osdoby P, 2003, METH MOLEC MED, V80, P153; Defranoux NA, 2005, J BONE MINER RES, V20, P1079, DOI 10.1359/JBMR.050401; Espinosa L, 2002, J CELL SCI, V115, P3837, DOI 10.1242/jcs.00062; Go RS, 2005, BLOOD REV, V19, P53, DOI 10.1016/j.blre.2004.05.001; Goya M, 2006, PROSTATE, V66, P1573, DOI 10.1002/pros.20375; Grey A, 2007, EXPERT OPIN EMERG DR, V12, P493, DOI 10.1517/14728214.12.3.493; Horwitz M, 2004, TRENDS MOL MED, V10, P163, DOI 10.1016/j.molmed.2004.02.002; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Komarova SV, 2005, ENDOCRINOLOGY, V146, P3589, DOI 10.1210/en.2004-1642; Komarova SV, 2003, BONE, V33, P206, DOI 10.1016/S8756-3282(03)00157-1; Kroll MH, 2000, B MATH BIOL, V62, P163, DOI 10.1006/bulm.1999.0146; Lawson Jack, 2002, Semin Musculoskelet Radiol, V6, P285, DOI 10.1055/s-2002-36727; Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023; Menaa C, 1999, J CLIN INVEST, V103, P1605, DOI 10.1172/JCI6374; O'Sullivan S, 2007, J BONE MINER RES, V22, P1679, DOI 10.1359/JBMR.070719; PEREVERZEV A, 2007, EXTRACELLULAR ACIDIF; Quinn JMW, 2001, J BONE MINER RES, V16, P1787, DOI 10.1359/jbmr.2001.16.10.1787; Rao HW, 2006, J BONE MINER RES, V21, P1657, DOI 10.1359/JBMR.060718; Reddy S V, 2001, Rev Endocr Metab Disord, V2, P195; REDDY SV, 1994, J BONE MINER RES, V9, P753; Roodman GD, 2006, ANN NY ACAD SCI, V1068, P100, DOI 10.1196/annals.1346.013; Stern PH, 2007, J CELL BIOCHEM, V101, P1087, DOI 10.1002/jcb.21311; Takahashi Naoyuki, 2007, V135, P285; TAKAHASHI S, 1994, J BIOL CHEM, V269, P28696; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wani MR, 1999, ENDOCRINOLOGY, V140, P1927, DOI 10.1210/en.140.4.1927; WISE GE, 1995, J DENT RES, V74, P1551, DOI 10.1177/00220345950740090801; WISE GE, 1989, J DENT RES, V68, P150, DOI 10.1177/00220345890680021001; Xiao ZJ, 2003, LEUKEMIA RES, V27, P89, DOI 10.1016/S0145-2126(02)00097-8; Yao SM, 2007, ARCH ORAL BIOL, V52, P228, DOI 10.1016/j.archoralbio.2006.10.008; Yun JH, 2007, J PERIODONTAL RES, V42, P212, DOI 10.1111/j.1600-0765.2006.00935.x; Zheng H, 2006, J BIOL CHEM, V281, P15809, DOI 10.1074/jbc.M513225200	42	30	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2104	10.1371/journal.pone.0002104	http://dx.doi.org/10.1371/journal.pone.0002104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461134	Green Submitted, Green Published, gold			2022-12-27	WOS:000261642400026
J	Brennan, LJ; Keddie, BA; Braig, HR; Harris, HL				Brennan, Lesley J.; Keddie, B. Andrew; Braig, Henk R.; Harris, Harriet L.			The Endosymbiont Wolbachia pipientis Induces the Expression of Host Antioxidant Proteins in an Aedes albopictus Cell Line	PLOS ONE			English	Article							CU/ZN SUPEROXIDE-DISMUTASE; GENOME-WIDE ANALYSIS; ESCHERICHIA-COLI; IMMUNE-RESPONSE; GLUTATHIONE-PEROXIDASE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; LIFE-SPAN; DROSOPHILA; GENE	Wolbachia are obligate intracellular bacteria which commonly infect arthropods. They are maternally inherited and capable of altering host development, sex determination, and reproduction. Reproductive manipulations include feminization, male-killing, parthenogenesis, and cytoplasmic incompatibility. The mechanism by which Wolbachia avoid destruction by the host immune response is unknown. Generation of antimicrobial peptides (AMPs) and reactive oxygen species (ROS) by the host are among the first lines of traditional antimicrobial defense. Previous work shows no link between a Wolbachia infection and the induction of AMPs. Here we compare the expression of protein in a cell line naturally infected with Wolbachia and an identical cell line cured of the infection through the use of antibiotics. Protein extracts of each cell line were analyzed by two dimensional gel electrophoresis and LC/MS/MS. Our results show the upregulation of host antioxidant proteins, which are active against ROS generated by aerobic cell metabolism and during an immune response. Furthermore, flow cytometric and microscopic analysis demonstrates that ROS production is significantly greater in Wolbachia-infected mosquito cells and is associated with endosymbiont-containing vacuoles located in the host cell cytoplasm. This is the first empirical data supporting an association between Wolbachia and the insect antioxidant system.	[Brennan, Lesley J.; Keddie, B. Andrew; Harris, Harriet L.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Braig, Henk R.] Univ Wales, Sch Biol Sci, Bangor, Gwynedd, Wales; [Brennan, Lesley J.; Harris, Harriet L.] Concordia Univ, Coll Alberta, Dept Biol & Env Sci, Edmonton, AB, Canada	University of Alberta; Bangor University; Concordia University - Canada	Brennan, LJ (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	hharris@concordia.ab.ca	Braig, Henk/I-5477-2013; Keddie, Andrew/A-2654-2014	Braig, Henk/0000-0001-9592-1141; Keddie, Andrew/0000-0002-0131-4306	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work is supported by the Natural Sciences and Engineering Research Council of Canada.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Adrain C, 2004, J BIOL CHEM, V279, P36923, DOI 10.1074/jbc.M402638200; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ANDREWS SC, 1989, J BACTERIOL, V171, P3940, DOI 10.1128/jb.171.7.3940-3947.1989; ARAI K, 1987, J BIOL CHEM, V262, P16969; BENOV LT, 1994, J BIOL CHEM, V269, P25310; Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; CABISCOL E, 2000, INT MICROBIOL, V2, P3; Cao C, 2003, J BIOL CHEM, V278, P29667, DOI 10.1074/jbc.M301292200; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Cha MK, 1996, J BACTERIOL, V178, P5610, DOI 10.1128/jb.178.19.5610-5614.1996; CHAE HZ, 1993, J BIOL CHEM, V268, P16815; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chen CY, 1999, MICROBIOL-SGM, V145, P2967, DOI 10.1099/00221287-145-10-2967; Csar XF, 2001, PROTEOMICS, V1, P435, DOI 10.1002/1615-9861(200103)1:3<435::AID-PROT435>3.3.CO;2-H; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; DeJong RJ, 2007, P NATL ACAD SCI USA, V104, P2121, DOI 10.1073/pnas.0608407104; DEVAMANOHARAN PS, 1994, INFECT IMMUN, V62, P2619, DOI 10.1128/IAI.62.6.2619-2621.1994; Eremeeva ME, 1998, MICROBIOL-SGM, V144, P2037, DOI 10.1099/00221287-144-8-2037; Fares MA, 2004, TRENDS GENET, V20, P413, DOI 10.1016/j.tig.2004.07.001; FRANZON VL, 1990, INFECT IMMUN, V58, P529, DOI 10.1128/IAI.58.2.529-535.1990; Fridell YWC, 2005, CELL METAB, V1, P145, DOI 10.1016/j.cmet.2005.01.005; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Geslin C, 2001, RES MICROBIOL, V152, P901, DOI 10.1016/S0923-2508(01)01273-6; Gort AS, 1999, MOL MICROBIOL, V32, P179, DOI 10.1046/j.1365-2958.1999.01343.x; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Harris HL, 2003, BIOCHEM CELL BIOL, V81, P229, DOI [10.1139/o03-053, 10.1139/O03-053]; HASSAN HM, 1977, J BIOL CHEM, V252, P7667; Hermans PG, 2001, J ANTIMICROB CHEMOTH, V47, P659, DOI 10.1093/jac/47.5.659; Ho YS, 1998, ENVIRON HEALTH PERSP, V106, P1219, DOI 10.2307/3433989; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hurst GDD, 2003, INSECT MOL BIOL, V12, P93, DOI 10.1046/j.1365-2583.2003.00380.x; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; Iiyama K, 2007, APPL ENVIRON MICROB, V73, P1569, DOI 10.1128/AEM.00981-06; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Jeong W, 2000, J BIOL CHEM, V275, P2924, DOI 10.1074/jbc.275.4.2924; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; KEHRER JP, 1994, FREE RADICAL BIO MED, V17, P65, DOI 10.1016/0891-5849(94)90008-6; Khelef N, 1996, FEMS MICROBIOL LETT, V142, P231; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LOEWEN PC, 1985, ARCH BIOCHEM BIOPHYS, V243, P144, DOI 10.1016/0003-9861(85)90782-9; Ma JF, 1999, J BACTERIOL, V181, P3730, DOI 10.1128/JB.181.12.3730-3742.1999; Manduzio H, 2003, AQUAT TOXICOL, V64, P73, DOI 10.1016/S0166-445X(03)00026-2; McGonigle S, 1998, PARASITOL TODAY, V14, P139, DOI 10.1016/S0169-4758(97)01211-8; Missirlis F, 2003, BIOL CHEM, V384, P463, DOI 10.1515/BC.2003.052; Mittapalli O, 2007, P NATL ACAD SCI USA, V104, P1889, DOI 10.1073/pnas.0604722104; Ni DJ, 2007, FISH SHELLFISH IMMUN, V23, P1032, DOI 10.1016/j.fsi.2007.04.008; ONeill SL, 1997, INSECT MOL BIOL, V6, P33, DOI 10.1046/j.1365-2583.1997.00157.x; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Parker JD, 2004, INSECT MOL BIOL, V13, P587, DOI 10.1111/j.0962-1075.2004.00515.x; Parkes TL, 1998, GENOME, V41, P642; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; Roos D, 2003, MICROBES INFECT, V5, P1307, DOI 10.1016/j.micinf.2003.09.009; ROUSSET F, 1992, P ROY SOC B-BIOL SCI, V250, P91, DOI 10.1098/rspb.1992.0135; SANTUCCI LA, 1992, INFECT IMMUN, V60, P5113, DOI 10.1128/IAI.60.12.5113-5118.1992; Sarto C, 1999, ELECTROPHORESIS, V20, P3458, DOI 10.1002/(SICI)1522-2683(19991101)20:17<3458::AID-ELPS3458>3.3.CO;2-X; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; SILVERMAN DJ, 1988, INFECT IMMUN, V56, P3110, DOI 10.1128/IAI.56.12.3110-3115.1988; Singh OP, 2004, AM J TROP MED HYG, V70, P27, DOI 10.4269/ajtmh.2004.70.27; SMITH J, 1979, COMP BIOCHEM PHYS B, V63, P39, DOI 10.1016/0305-0491(79)90231-1; Stothard P, 2005, NUCLEIC ACIDS RES, V33, pD317, DOI 10.1093/nar/gki075; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; URSINI F, 1995, METHOD ENZYMOL, V252, P38; Whitten MMA, 1999, J INSECT PHYSIOL, V45, P667, DOI 10.1016/S0022-1910(99)00039-6; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Woodruff RC, 2004, GENOME, V47, P1029, DOI 10.1139/G04-083; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; XI ZY, 2008, BMC GENOMICS, V9; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	77	112	115	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2083	10.1371/journal.pone.0002083	http://dx.doi.org/10.1371/journal.pone.0002083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461124	gold, Green Published, Green Submitted			2022-12-27	WOS:000261642400007
J	Nayak, S; Salim, S; Luan, D; Zai, M; Varner, JD				Nayak, Satyaprakash; Salim, Saniya; Luan, Deyan; Zai, Michael; Varner, Jeffrey D.			A Test of Highly Optimized Tolerance Reveals Fragile Cell-Cycle Mechanisms Are Molecular Targets in Clinical Cancer Trials	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; SENSITIVITY-ANALYSIS; ROBUSTNESS PROPERTIES; RESTRICTION POINT; KINASE INHIBITOR; IN-VITRO; S-PHASE; PROTEIN; ACTIVATION; EXPRESSION	Robustness, a long-recognized property of living systems, allows function in the face of uncertainty while fragility, i.e., extreme sensitivity, can potentially lead to catastrophic failure following seemingly innocuous perturbations. Carlson and Doyle hypothesized that highly-evolved networks, e. g., those involved in cell-cycle regulation, can be resistant to some perturbations while highly sensitive to others. The "robust yet fragile'' duality of networks has been termed Highly Optimized Tolerance (HOT) and has been the basis of new lines of inquiry in computational and experimental biology. In this study, we tested the working hypothesis that cell-cycle control architectures obey the HOT paradigm. Three cell-cycle models were analyzed using monte-carlo sensitivity analysis. Overall state sensitivity coefficients, which quantify the robustness or fragility of a given mechanism, were calculated using a monte-carlo strategy with three different numerical techniques along with multiple parameter perturbation strategies to control for possible numerical and sampling artifacts. Approximately 65% of the mechanisms in the G1/S restriction point were responsible for 95% of the sensitivity, conversely, the G2-DNA damage checkpoint showed a much stronger dependence on a few mechanisms;,32% or 13 of 40 mechanisms accounted for 95% of the sensitivity. Our analysis predicted that CDC25 and cyclin E mechanisms were strongly implicated in G1/S malfunctions, while fragility in the G2/M checkpoint was predicted to be associated with the regulation of the cyclin B-CDK1 complex. Analysis of a third model containing both G1/S and G2/M checkpoint logic, predicted in addition to mechanisms already mentioned, that translation and programmed proteolysis were also key fragile subsystems. Comparison of the predicted fragile mechanisms with literature and current preclinical and clinical trials suggested a strong correlation between efficacy and fragility. Thus, when taken together, these results support the working hypothesis that cell-cycle control architectures are HOT networks and establish the mathematical estimation and subsequent therapeutic exploitation of fragile mechanisms as a novel strategy for anti-cancer lead generation.	[Nayak, Satyaprakash; Luan, Deyan; Zai, Michael; Varner, Jeffrey D.] Cornell Univ, Dept Chem & Biomol Engn, Ithaca, NY USA; [Salim, Saniya] Cornell Univ, Dept Biol & Env Engn, Ithaca, NY USA	Cornell University; Cornell University	Varner, JD (corresponding author), Cornell Univ, Dept Chem & Biomol Engn, Ithaca, NY USA.	jdv27@cornell.edu			Cornell University Center for Life Science Enterprise; New York State Center for Advanced Technology; Engineering Learning Initiatives Undergraduate Research Awards [ELI-650, ELI-895]	Cornell University Center for Life Science Enterprise; New York State Center for Advanced Technology; Engineering Learning Initiatives Undergraduate Research Awards	The authors acknowledge the gracious financial support of the Cornell University Center for Life Science Enterprise, a New York State Center for Advanced Technology grant (to J.V. for the support of S. N.) and Engineering Learning Initiatives Undergraduate Research Awards ELI-650 and ELI-895 to M.Z. and S.S. The Cornell University Center for Life Science Enterprise and the Engineering Learning Initiatives Undergraduate research program played no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Aguda BD, 1999, ONCOGENE, V18, P2846, DOI 10.1038/sj.onc.1202462; Aguda BD, 1999, CELL PROLIFERAT, V32, P321, DOI 10.1046/j.1365-2184.1999.3250321.x; Aguda BD, 1999, P NATL ACAD SCI USA, V96, P11352, DOI 10.1073/pnas.96.20.11352; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; ASIEDU C, 1995, CANCER RES, V55, P3716; Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Bang S, 2005, CLIN CANCER RES, V11, P1545, DOI 10.1158/1078-0432.CCR-04-1939; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Brezak MC, 2005, MOL CANCER THER, V4, P1378, DOI 10.1158/1535-7163.MCT-05-0168; Cagney G, 2000, METHOD ENZYMOL, V328, P3, DOI 10.1016/S0076-6879(00)28386-9; CARLSON JM, 2002, P NATL ACAD SCI USA, V99, P2358; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Cho KH, 2003, SIMUL-T SOC MOD SIM, V79, P726, DOI 10.1177/0037549703040943; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Cote RJ, 1998, CANCER RES, V58, P1090; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Donnellan R, 1998, J CLIN PATHOL-MOL PA, V51, P1; DOUGHERTY EP, 1979, INT J CHEM KINET, V11, P1237, DOI 10.1002/kin.550111203; Eissing T, 2005, IEE P SYST BIOL, V152, P221, DOI 10.1049/ip-syb:20050046; ENG CP, 1984, J ANTIBIOT, V37, P1231, DOI 10.7164/antibiotics.37.1231; FIELDS S, 1994, TRENDS GENET, V10, P286, DOI 10.1016/0168-9525(90)90012-U; Fredersdorf S, 1997, P NATL ACAD SCI USA, V94, P6380, DOI 10.1073/pnas.94.12.6380; Gadkar KG, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-155; Gadkar KG, 2005, SYSTEMS BIOL, V2, P17, DOI 10.1049/sb:20045029; Garber K, 2005, J NATL CANCER I, V97, P166, DOI 10.1093/jnci/97.3.166; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gunawan R, 2005, BIOPHYS J, V88, P2530, DOI 10.1529/biophysj.104.053405; Gunawan R, 2007, J BIOL RHYTHM, V22, P180, DOI 10.1177/0748730407299194; Gunawan R, 2006, BIOPHYS J, V91, P2131, DOI 10.1529/biophysj.105.078006; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hayun M, 2007, LEUKEMIA, V21, P1504, DOI 10.1038/sj.leu.2404746; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HORNUNG RL, 1992, CANCER RES, V52, P101; HOUCHENS DP, 1983, EUR J CANCER CLIN ON, V19, P799, DOI 10.1016/0277-5379(83)90012-3; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; Kar S, 2006, MOL CANCER THER, V5, P1511, DOI 10.1158/1535-7163.MCT-05-0485; Keenan SM, 2004, J BIOL CHEM, V279, P5387, DOI 10.1074/jbc.M310383200; KEYOMARSI K, 1995, ONCOGENE, V11, P941; Kholodenko BN, 2002, P NATL ACAD SCI USA, V99, P12841, DOI 10.1073/pnas.192442699; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; KRAMER MA, 1984, INT J CHEM KINET, V16, P559, DOI 10.1002/kin.550160506; Kremling A, 2004, GENOME RES, V14, P1773, DOI 10.1101/gr.1226004; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; LEIS JR, 1985, COMPUT CHEM ENG, V9, P93, DOI 10.1016/0098-1354(85)87008-3; Li BDL, 1997, CANCER-AM CANCER SOC, V79, P2385; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Lukas J, 1997, GENE DEV, V11, P1479, DOI 10.1101/gad.11.11.1479; Mahdavi A, 2007, PLOS COMPUT BIOL, V3, P1257, DOI 10.1371/journal.pcbi.0030130; MCCORMICK J, 2003, P AN M AM SOC CLIN, V22, P208; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; *NCI, 2007, NCT00003690 NCI; *NCI, NCT00060567 NCI; *NCI, 2007, NCT00039455 NCI; *NCI, 2007, PHAS 2 STUD FLAV HMR; *NCI, 2007, NCT00002907 NCI; *NCI, 2007, NCT00112723 NCI; NEWSAM GN, 1983, SIAM J ALGEBRA DISCR, V4, P404, DOI 10.1137/0604041; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Porter DC, 2001, MOL CELL BIOL, V21, P6254, DOI 10.1128/MCB.21.18.6254-6269.2001; Qu ZL, 2003, AM J PHYSIOL-CELL PH, V284, pC349, DOI 10.1152/ajpcell.00066.2002; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Senderowicz AM, 1999, INVEST NEW DRUG, V17, P313, DOI 10.1023/A:1006353008903; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Soderlund G, 2004, NEOPLASMA, V51, P1; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Tamura K, 2000, CANCER RES, V60, P1317; van Kesteren C, 2002, ANTI-CANCER DRUG, V13, P989, DOI 10.1097/00001813-200211000-00002; Varterasian ML, 1998, J CLIN ONCOL, V16, P56, DOI 10.1200/JCO.1998.16.1.56; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Venkatasubramanian V, 2004, COMPUT CHEM ENG, V28, P1789, DOI 10.1016/j.compchemeng.2004.02.028; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; You L, 2006, IEE P SYST BIOL, V153, P46, DOI 10.1049/ip-syb:20050026; You X, 2006, P NATL ACAD SCI USA, V103, P18458, DOI 10.1073/pnas.0605422103	90	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2016	10.1371/journal.pone.0002016	http://dx.doi.org/10.1371/journal.pone.0002016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431497	Green Published, gold, Green Submitted			2022-12-27	WOS:000261558700032
J	Wong, CC; Gaspar-Maia, A; Ramalho-Santos, M; Pera, RAR				Wong, Connie C.; Gaspar-Maia, Alexandre; Ramalho-Santos, Miguel; Pera, Renee A. Reijo			High-Efficiency Stem Cell Fusion-Mediated Assay Reveals Sall4 as an Enhancer of Reprogramming	PLOS ONE			English	Article								Several methods allow reprogramming of differentiated somatic cells to embryonic stem cell-like cells. However, the process of reprogramming remains inefficient and the underlying molecular mechanisms are poorly understood. Here, we report the optimization of somatic cell fusion with embryonic stem cells in order to provide an efficient, quantitative assay to screen for factors that facilitate reprogramming. Following optimization, we achieved a reprogramming efficiency 15-590 fold higher than previous protocols. This allowed observation of cellular events during the reprogramming process. Moreover, we demonstrate that overexpression of the Spalt transcription factor, Sall4, which was previously identified as a regulator of embryonic stem cell pluripotency and early mouse development, can enhance reprogramming. The reprogramming activity of Sall4 is independent of an N-terminal domain implicated in recruiting the nucleosome remodeling and deacetylase corepressor complex, a global transcriptional repressor. These results indicate that improvements in reprogramming assays, including fusion assays, may allow the systematic identification and molecular characterization of enhancers of somatic cell reprogramming.	[Wong, Connie C.; Gaspar-Maia, Alexandre; Ramalho-Santos, Miguel; Pera, Renee A. Reijo] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA USA; [Wong, Connie C.; Pera, Renee A. Reijo] Univ Calif San Francisco, Dept Obstet, Gynecol & Reprod Sci, San Francisco, CA USA; [Gaspar-Maia, Alexandre; Ramalho-Santos, Miguel] Univ Calif San Francisco, Diabetes Ctr, San Francisco, CA USA; [Gaspar-Maia, Alexandre] Univ Coimbra, Ctr Neurosci & Cell Biol, Doctoral Program Biomed & Expt Biol, Coimbra, Portugal	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade de Coimbra	Ramalho-Santos, M (corresponding author), Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA USA.	mrsantos@diabetes.ucsf.edu; reneer@stanford.edu	Gaspar-Maia, Alexandre/AAY-5416-2020; Ramalho-Santos, Miguel/L-9092-2018	Gaspar-Maia, Alexandre/0000-0001-8528-5575; Ramalho-Santos, Miguel/0000-0003-0177-5556; Reijo Pera, Renee/0000-0002-6487-1329	UCSF Institute for Regeneration Medicine; Juvenile Diabetes Research Foundation; Stanford University Institute for Stem Cell Biology and Regenerative Medicine; California Institute of Regenerative Medicine	UCSF Institute for Regeneration Medicine; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Stanford University Institute for Stem Cell Biology and Regenerative Medicine; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine)	This research was supported by funds from the UCSF Institute for Regeneration Medicine and Juvenile Diabetes Research Foundation (to MRS) and from the Stanford University Institute for Stem Cell Biology and Regenerative Medicine, and the California Institute of Regenerative Medicine (to RARP). The funders were not directly involved in the study or the preparation of the manuscript.	Alberio R, 2006, REPRODUCTION, V132, P709, DOI 10.1530/rep.1.01077; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Bohm J, 2007, BIOCHEM BIOPH RES CO, V356, P773, DOI 10.1016/j.bbrc.2007.03.050; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; CERVERA RP, 2007, CLIN PHARM THER; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Deans B, 2003, CANCER RES, V63, P8181; Eilertsen KJ, 2007, ANIM REPROD SCI, V98, P129, DOI 10.1016/j.anireprosci.2006.10.019; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; FREI E, 1988, EMBO J, V7, P197, DOI 10.1002/j.1460-2075.1988.tb02800.x; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; Hochedlinger K, 2002, CURR OPIN CELL BIOL, V14, P741, DOI 10.1016/S0955-0674(02)00380-0; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; JURGENS G, 1988, EMBO J, V7, P189, DOI 10.1002/j.1460-2075.1988.tb02799.x; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; OKITA K, 2007, NATURE; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Sweetman D, 2006, DEV BIOL, V293, P285, DOI 10.1016/j.ydbio.2006.02.009; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; WERNIG M, 2007, NATURE; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Xia XF, 2007, STEM CELLS DEV, V16, P167, DOI 10.1089/scd.2006.0057; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Yu JY, 2006, STEM CELLS, V24, P168, DOI 10.1634/stemcells.2005-0292; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	41	55	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1955	10.1371/journal.pone.0001955	http://dx.doi.org/10.1371/journal.pone.0001955			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414659	gold, Green Submitted, Green Published			2022-12-27	WOS:000260867300008
J	Kinjo, AR; Nakamura, H				Kinjo, Akira R.; Nakamura, Haruki			Nature of Protein Family Signatures: Insights from Singular Value Analysis of Position-Specific Scoring Matrices	PLOS ONE			English	Article							ACID SUBSTITUTION MATRICES; SEQUENCE; PREDICTION; GENERATION; RESIDUES; FOLD; IDENTIFICATION; OPTIMIZATION; PARAMETERS; PROFILES	Position-specific scoring matrices (PSSMs) are useful for detecting weak homology in protein sequence analysis, and they are thought to contain some essential signatures of the protein families. In order to elucidate what kind of ingredients constitute such family-specific signatures, we apply singular value decomposition to a set of PSSMs and examine the properties of dominant right and left singular vectors. The first right singular vectors were correlated with various amino acid indices including relative mutability, amino acid composition in protein interior, hydropathy, or turn propensity, depending on proteins. A significant correlation between the first left singular vector and a measure of site conservation was observed. It is shown that the contribution of the first singular component to the PSSMs act to disfavor potentially but falsely functionally important residues at conserved sites. The second right singular vectors were highly correlated with hydrophobicity scales, and the corresponding left singular vectors with contact numbers of protein structures. It is suggested that sequence alignment with a PSSM is essentially equivalent to threading supplemented with functional information. In addition, singular vectors may be useful for analyzing and annotating the characteristics of conserved sites in protein families.	[Kinjo, Akira R.; Nakamura, Haruki] Osaka Univ, Inst Prot Res, Osaka, Japan	Osaka University	Kinjo, AR (corresponding author), Osaka Univ, Inst Prot Res, Osaka, Japan.	akinjo@protein.osaka-u.ac.jp		Kinjo, Akira/0000-0002-4006-8208	Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	Supported by Japan Science and Technology Agency, which played no role in the study but financial support.	ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; BASHFORD D, 1987, J MOL BIOL, V196, P199, DOI 10.1016/0022-2836(87)90521-3; Bastolla U, 2005, PROTEINS, V58, P22, DOI 10.1002/prot.20240; BEGHIN F, 1975, ARCH INT PHYSIOL BIO, V83, P167; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; BOWIE JU, 1990, PROTEINS, V7, P257, DOI 10.1002/prot.340070307; BUNDI A, 1979, BIOPOLYMERS, V18, P285, DOI 10.1002/bip.1979.360180206; Charton M, 1983, J THEOR BIOL, V111, P447; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Doolittle R. F., 1986, URFS ORFS PRIMER ANA; Durbin R., 1999, BIOL SEQUENCE ANAL P; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fukuchi S, 2001, J MOL BIOL, V309, P835, DOI 10.1006/jmbi.2001.4718; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Horn RA., 1985, MATRIX ANAL; Ishida T, 2006, PROTEINS, V64, P940, DOI 10.1002/prot.21047; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Kann M, 2000, PROTEINS, V41, P498, DOI 10.1002/1097-0134(20001201)41:4<498::AID-PROT70>3.0.CO;2-3; Kawashima S, 1999, NUCLEIC ACIDS RES, V27, P368, DOI 10.1093/nar/27.1.368; KIDERA A, 1985, J PROTEIN CHEM, V4, P23, DOI 10.1007/BF01025492; Kinjo AR, 2008, CHEM PHYS LETT, V451, P132, DOI 10.1016/j.cplett.2007.12.005; Kinjo AR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-401; Kinjo Akira R, 2005, Biophysics (Nagoya-shi), V1, P67, DOI 10.2142/biophysics.1.67; Kinjo AR, 2005, BIOINFORMATICS, V21, P2167, DOI 10.1093/bioinformatics/bti330; Kinjo AR, 2005, PROTEINS, V58, P158, DOI 10.1002/prot.20300; Kinjo AR, 2004, BIOINFORMATICS, V20, P2504, DOI 10.1093/bioinformatics/bth297; KLEIN P, 1984, BIOCHIM BIOPHYS ACTA, V787, P221, DOI 10.1016/0167-4838(84)90312-1; Koehl P, 1999, P NATL ACAD SCI USA, V96, P12524, DOI 10.1073/pnas.96.22.12524; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lecomte JTJ, 2005, CURR OPIN STRUC BIOL, V15, P290, DOI 10.1016/j.sbi.2005.05.008; LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8; Miyazawa S, 1999, PROTEINS, V34, P49; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NAKAI K, 1988, PROTEIN ENG, V2, P93, DOI 10.1093/protein/2.2.93; NISHIKAWA K, 1986, J BIOCHEM-TOKYO, V100, P1043, DOI 10.1093/oxfordjournals.jbchem.a121783; NISHIKAWA K, 1980, INT J PEPT PROT RES, V16, P19; OOBATAKE M, 1977, J THEOR BIOL, V67, P567, DOI 10.1016/0022-5193(77)90058-3; Ota M, 1997, PROTEIN ENG, V10, P339, DOI 10.1093/protein/10.4.339; Ota M, 1997, FEBS LETT, V415, P129, DOI 10.1016/S0014-5793(97)01110-1; Pokarowski P, 2007, PROTEINS, V69, P379, DOI 10.1002/prot.21509; Porto M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.218101; Qian B, 2002, PROTEINS, V48, P605, DOI 10.1002/prot.10132; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Rosano C, 2000, J MOL BIOL, V303, P77, DOI 10.1006/jmbi.2000.4106; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; ROYER WE, 1994, J MOL BIOL, V235, P657, DOI 10.1006/jmbi.1994.1019; Rudolph MG, 2003, ACTA CRYSTALLOGR D, V59, P290, DOI 10.1107/S0907444902021704; SNEATH PHA, 1966, J THEOR BIOL, V12, P157, DOI 10.1016/0022-5193(66)90112-3; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; TAYLOR WR, 1986, J MOL BIOL, V188, P233, DOI 10.1016/0022-2836(86)90308-6; Thomas MC, 2006, ELEMENTS INFORM THEO; Tomii K, 1996, PROTEIN ENG, V9, P27, DOI 10.1093/protein/9.1.27; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wrabl JO, 2005, PROTEINS, V61, P523, DOI 10.1002/prot.20648; Yuan Z, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-248	65	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1963	10.1371/journal.pone.0001963	http://dx.doi.org/10.1371/journal.pone.0001963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398479	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795500032
J	Stavrum, R; Valvatne, H; Bo, TH; Jonassen, I; Hinds, J; Butcher, PD; Grewal, HMS				Stavrum, Ruth; Valvatne, Havard; Bo, Trond H.; Jonassen, Inge; Hinds, Jason; Butcher, Philip D.; Grewal, Harleen M. S.			Genomic Diversity among Beijing and non-Beijing Mycobacterium tuberculosis Isolates from Myanmar	PLOS ONE			English	Article							STRAINS; GENE; PREDOMINANCE; DIFFERENCE; VARIANCE; SEQUENCE; LINEAGE; FAMILY; YANGON	Background: The Beijing family of Mycobacterium tuberculosis is dominant in countries in East Asia. Genomic polymorphisms are a source of diversity within the M. tuberculosis genome and may account for the variation of virulence among M. tuberculosis isolates. Till date there are no studies that have examined the genomic composition of M. tuberculosis isolates from the high TB-burden country, Myanmar. Methodology/Principle Findings: Twenty-two M. tuberculosis isolates from Myanmar were screened on whole-genome arrays containing genes from M. tuberculosis H37Rv, M. tuberculosis CDC1551 and M. bovis AF22197. Screening identified 198 deletions or extra regions in the clinical isolates compared to H37Rv. Twenty-two regions differentiated between Beijing and non-Beijing isolates and were verified by PCR on an additional 40 isolates. Six regions (Rv0071-0074 [RD105], Rv1572-1576c [RD149], Rv1585c-1587c [RD149], MT1798-Rv1755c [RD152], Rv1761c [RD152] and Rv0279c) were deleted in Beijing isolates, of which 4 (Rv1572-1576c, Rv1585c-1587c, MT1798-Rv1755c and Rv1761c) were variably deleted among ST42 isolates, indicating a closer relationship between the Beijing and ST42 lineages. The TbD1 region, Mb1582-Mb1583 was deleted in Beijing and ST42 isolates. One M. bovis gene of unknown function, Mb3184c was present in all isolates, except 11 of 13 ST42 isolates. The CDC1551 gene, MT1360 coding for a putative adenylate cyclase, was present in all Beijing and ST42 isolates (except 1). The pks15/1 gene, coding for a putative virulence factor, was intact in all Beijing and non-Beijing isolates, except in ST42 and ST53 isolates. Conclusion: This study describes previously unreported deletions/extra regions in Beijing and non-Beijing M. tuberculosis isolates. The modern and highly frequent ST42 lineage showed a closer relationship to the hypervirulent Beijing lineage than to the ancient non-Beijing lineages. The pks15/1 gene was disrupted only in modern non-Beijing isolates. This is the first report of an in-depth analysis on the genomic diversity of M. tuberculosis isolates from Myanmar.	[Stavrum, Ruth; Valvatne, Havard; Grewal, Harleen M. S.] Univ Bergen, Gade Inst, Microbiol & Immunol Sect, Bergen, Norway; [Stavrum, Ruth; Valvatne, Havard; Grewal, Harleen M. S.] Haukeland Hosp, Dept Microbiol & Immunol, Bergen, Norway; [Bo, Trond H.; Jonassen, Inge] Univ Bergen, Bergen Ctr Computat Sci, Dept Informat, Bergen, Norway; [Hinds, Jason; Butcher, Philip D.] Univ London, Div Cell & Mol Med, Bacterial Microarray Grp, London, England	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of London	Grewal, HMS (corresponding author), Univ Bergen, Gade Inst, Microbiol & Immunol Sect, Bergen, Norway.	Harleen.Grewal@Gades.uib.no	Jonassen, Inge/AAC-7035-2020; Grewal, Harleen/ABC-5831-2020	Butcher, Philip/0000-0003-1223-9097; Jonassen, Inge/0000-0003-4110-0748; Hinds, Jason/0000-0002-2739-1908	Helse Vest; Norwegian Research Council; University of Bergen	Helse Vest; Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Bergen	This study was funded by Helse Vest, the Norwegian Research Council and University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betts JC, 2003, ANTIMICROB AGENTS CH, V47, P2903, DOI 10.1128/AAC.47.9.2903-2913.2003; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Chan MY, 2001, EPIDEMIOL INFECT, V127, P169, DOI 10.1017/S0950268801005659; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; Espitia C, 1999, MICROBIOL-UK, V145, P3487, DOI 10.1099/00221287-145-12-3487; Filliol I, 2002, EMERG INFECT DIS, V8, P1347, DOI 10.3201/eid0811.020125; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gehring AJ, 2003, INFECT IMMUN, V71, P4487, DOI 10.1128/IAI.71.8.4487-4497.2003; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Gutierrez MC, 2006, EMERG INFECT DIS, V12, P1367, DOI 10.3201/eid1209.050017; Hinds J, 2002, METHOD MICROBIOL, V33, P83; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Lillebaek T, 2003, EMERG INFECT DIS, V9, P1553, DOI 10.3201/eid0912.030276; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Malik AN, 2005, LANCET INFECT DIS, V5, P174, DOI 10.1016/S1473-3099(05)01310-1; Mostowy S, 2002, J INFECT DIS, V186, P74, DOI 10.1086/341068; Musser JM, 2000, GENETICS, V155, P7; Phyu S, 2005, SCAND J INFECT DIS, V37, P846, DOI 10.1080/00365540500265065; Phyu S, 2003, J CLIN MICROBIOL, V41, P4907, DOI 10.1128/JCM.41.10.4907-4908.2003; Rao KR, 2005, J CLIN MICROBIOL, V43, P5978, DOI 10.1128/JCM.43.12.5978-5982.2005; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rocke DM, 2003, BIOINFORMATICS, V19, P966, DOI 10.1093/bioinformatics/btg107; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; VANEMBDEN JDA, 1995, MYCOBACTERIUM BOVIS, P15; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; *WHO, WHO REP 2005 GLOB TU	37	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1973	10.1371/journal.pone.0001973	http://dx.doi.org/10.1371/journal.pone.0001973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398483	gold, Green Accepted, Green Published			2022-12-27	WOS:000260795500036
J	van der Krogt, GNM; Ogink, J; Ponsioen, B; Jalink, K				van der Krogt, Gerard N. M.; Ogink, Janneke; Ponsioen, Bas; Jalink, Kees			A Comparison of Donor-Acceptor Pairs for Genetically Encoded FRET Sensors: Application to the Epac cAMP Sensor as an Example	PLOS ONE			English	Article								We recently reported on CFP-Epac-YFP, an Epac-based single polypeptide FRET reporter to resolve cAMP levels in living cells. In this study, we compared and optimized the fluorescent protein donor/acceptor pairs for use in biosensors such as CFP-Epac-YFP. Our strategy was to prepare a wide range of constructs consisting of different donor and acceptor fluorescent proteins separated by a short linker. Constructs were expressed in HEK293 cells and tested for FRET and other relevant properties. The most promising pairs were subsequently used in an attempt to improve the FRET span of the Epac-based cAMP sensor. The results show significant albeit not perfect correlation between performance in the spacer construct and in the Epac sensor. Finally, this strategy enabled us to identify improved sensors both for detection by sensitized emission and by fluorescent lifetime imaging. The present overview should be helpful in guiding development of future FRET sensors.	[van der Krogt, Gerard N. M.; Ogink, Janneke; Ponsioen, Bas; Jalink, Kees] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Ponsioen, Bas] Netherlands Canc Inst, Div Cell Biochem, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Jalink, K (corresponding author), Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.	k.jalink@nki.nl		Jalink, Kees/0000-0001-7019-3440	Dutch Cancer Foundation; NWO; Josephine Nefkens Foundation	Dutch Cancer Foundation(KWF Kankerbestrijding); NWO(Netherlands Organization for Scientific Research (NWO)); Josephine Nefkens Foundation	Supported by the Dutch Cancer Foundation (KWF) and by material grants from NWO and the Josephine Nefkens Foundation. Funding agencies were not involved in any part of the study.	Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Erickson MG, 2003, BIOPHYS J, V85, P599, DOI 10.1016/S0006-3495(03)74504-4; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; Forster T., 1948, ANN PHYS, V437, P57; Fradkov AF, 2002, BIOCHEM J, V368, P17, DOI 10.1042/BJ20021191; Galperin E, 2004, NAT METHODS, V1, P209, DOI 10.1038/NMETH720; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Goedhart J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001011; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; He YY, 2004, J BIOL CHEM, V279, P53867, DOI 10.1074/jbc.M405781200; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Li XQ, 1997, J BIOL CHEM, V272, P28545, DOI 10.1074/jbc.272.45.28545; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mizuno H, 2001, BIOCHEMISTRY-US, V40, P2502, DOI 10.1021/bi002263b; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Pepperkok R, 1999, CURR BIOL, V9, P269, DOI 10.1016/S0960-9822(99)80117-1; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Post JN, 2005, FEBS LETT, V579, P325, DOI 10.1016/j.febslet.2004.11.092; Provost N, 2003, AM J PHYSIOL-CELL PH, V284, pC51, DOI 10.1152/ajpcell.00205.2002; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shimozono S, 2006, BIOCHEMISTRY-US, V45, P6267, DOI 10.1021/bi060093i; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	38	131	134	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1916	10.1371/journal.pone.0001916	http://dx.doi.org/10.1371/journal.pone.0001916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382687	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795400040
J	Lamina, C; Bongardt, F; Kuchenhoff, H; Heid, IM				Lamina, Claudia; Bongardt, Friedhelm; Kuechenhoff, Helmut; Heid, Iris M.			Haplotype Reconstruction Error as a Classical Misclassification Problem: Introducing Sensitivity and Specificity as Error Measures	PLOS ONE			English	Article								Background: Statistically reconstructing haplotypes from single nucleotide polymorphism (SNP) genotypes, can lead to falsely classified haplotypes. This can be an issue when interpreting haplotype association results or when selecting subjects with certain haplotypes for subsequent functional studies. It was our aim to quantify haplotype reconstruction error and to provide tools for it. Methods and Results: By numerous simulation scenarios, we systematically investigated several error measures, including discrepancy, error rate, and R 2, and introduced the sensitivity and specificity to this context. We exemplified several measures in the KORA study, a large population-based study from Southern Germany. We find that the specificity is slightly reduced only for common haplotypes, while the sensitivity was decreased for some, but not all rare haplotypes. The overall error rate was generally increasing with increasing number of loci, increasing minor allele frequency of SNPs, decreasing correlation between the alleles and increasing ambiguity. Conclusions: We conclude that, with the analytical approach presented here, haplotype-specific error measures can be computed to gain insight into the haplotype uncertainty. This method provides the information, if a specific risk haplotype can be expected to be reconstructed with rather no or high misclassification and thus on the magnitude of expected bias in association estimates. We also illustrate that sensitivity and specificity separate two dimensions of the haplotype reconstruction error, which completely describe the misclassification matrix and thus provide the prerequisite for methods accounting for misclassification.	[Lamina, Claudia; Heid, Iris M.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, Neuherberg, Germany; [Bongardt, Friedhelm; Heid, Iris M.] Ludwig Maximilians Univ Munchen, Inst Med Informat Processing, Biometry & Epidemiol, Munich, Germany; [Kuechenhoff, Helmut] Ludwig Maximilians Univ Munchen, Inst Statist, Stablab, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich	Lamina, C (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, Neuherberg, Germany.	heid@helmholtz-muenchen.de	Kuchenhoff, Helmut/A-8291-2010; Lamina, Claudia/F-7608-2010	Lamina, Claudia/0000-0002-5398-5806; Kuchenhoff, Helmut/0000-0002-6372-2487	DFG; NGFN [PDN-S31T10]	DFG(German Research Foundation (DFG)); NGFN	This work was supported by the DFG grant within the SFB-386 (Analysis of discrete structure, project B10 Genetic epidemiological methods: Analysis of haplotype risk structure) and the NGFN grant PDN-S31T10.	Adkins RM, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-22; Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Carroll RJ, 2006, MEASUREMENT ERROR NO; Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Epstein MP, 2003, AM J HUM GENET, V73, P1316, DOI 10.1086/380204; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Illig T, 2004, J CLIN ENDOCR METAB, V89, P5053, DOI 10.1210/jc.2004-0355; Illig T, 2003, DIABETES, V52, P2861, DOI 10.2337/diabetes.52.11.2861; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kraft P, 2005, GENET EPIDEMIOL, V28, P261, DOI 10.1002/gepi.20061; Kuchenhoff' H, 2006, BIOMETRICS, V62, P85, DOI 10.1111/j.1541-0420.2005.00396.x; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Levenstien MA, 2006, PLOS GENET, V2, P1156, DOI 10.1371/journal.pgen.0020127; Lin DY, 2006, J AM STAT ASSOC, V101, P89, DOI 10.1198/016214505000000808; Little R.J.A., 2002, STAT ANAL MISSING DA; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Morrissey MJ, 1999, BIOMETRICS, V55, P338, DOI 10.1111/j.0006-341X.1999.00338.x; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Spinka C, 2005, GENET EPIDEMIOL, V29, P108, DOI 10.1002/gepi.20085; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; THOMAS D, 1993, ANNU REV PUBL HEALTH, V14, P69, DOI 10.1146/annurev.pu.14.050193.000441; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Xu HY, 2004, HUM HERED, V58, P63, DOI 10.1159/000083026; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhao LP, 2003, AM J HUM GENET, V72, P1231, DOI 10.1086/375140	35	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1853	10.1371/journal.pone.0001853	http://dx.doi.org/10.1371/journal.pone.0001853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365008	Green Published, Green Submitted, gold			2022-12-27	WOS:000260762400014
J	Bourret, TJ; Porwollik, S; McClelland, M; Zhao, R; Greco, T; Ischiropoulos, H; Vazquez-Torres, A				Bourret, Travis J.; Porwollik, Steffen; McClelland, Michael; Zhao, Rui; Greco, Todd; Ischiropoulos, Harry; Vazquez-Torres, Andres			Nitric Oxide Antagonizes the Acid Tolerance Response that Protects Salmonella against Innate Gastric Defenses	PLOS ONE			English	Article								Background: Reactive nitrogen species (RNS) derived from dietary and salivary inorganic nitrogen oxides foment innate host defenses associated with the acidity of the stomach. The mechanisms by which these reactive species exert antimicrobial activity in the gastric lumen are, however, poorly understood. Methodology/Principal Findings: The genetically tractable acid tolerance response (ATR) that enables enteropathogens to survive harsh acidity was screened for signaling pathways responsive to RNS. The nitric oxide ( NO) donor spermine NONOate derepressed the Fur regulon that controls secondary lines of resistance against organic acids. Despite inducing a Fur-mediated adaptive response, acidified RNS largely repressed oral virulence as demonstrated by the fact that Salmonella bacteria exposed to NO donors during mildly acidic conditions were shed in low amounts in feces and exhibited ameliorated oral virulence. NO prevented Salmonella from mounting a de novo ATR, but was unable to suppress an already functional protective response, suggesting that RNS target regulatory cascades but not their effectors. Transcriptional and translational analyses revealed that the PhoPQ signaling cascade is a critical ATR target of NO in rapidly growing Salmonella. Inhibition of PhoPQ signaling appears to contribute to most of the NO-mediated abrogation of the ATR in log phase bacteria, because the augmented acid sensitivity of phoQ-deficient Salmonella was not further enhanced after RNS treatment. Conclusions/Significance: Since PhoPQ-regulated acid resistance is widespread in enteric pathogens, the RNS-mediated inhibition of the Salmonella ATR described herein may represent a common component of innate host defenses.	[Bourret, Travis J.; Vazquez-Torres, Andres] Univ Colorado, Hlth Sci Ctr, Dept Microbiol, Aurora, CO USA; [Porwollik, Steffen; McClelland, Michael] Sidney Kimmel Canc Ctr, San Diego, CA USA; [Zhao, Rui] Univ Colorado, Hlth Sci Ctr, Dept Biomol Structure, Aurora, CO USA; [Greco, Todd; Ischiropoulos, Harry] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA USA; [Greco, Todd] Univ Penn, Childrens Hosp Philadelphia, Dept Pharmacol, Philadelphia, PA USA; [Ischiropoulos, Harry] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Bourret, TJ (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Microbiol, Aurora, CO USA.	andres.vazquez-torres@uchsc.edu	McClelland, Michael/A-8583-2011; Bourret, Travis/J-4673-2019	McClelland, Michael/0000-0003-1788-9347; Bourret, Travis/0000-0002-4154-929X	National Institutes of Health [AI54959, T32 AI52066]; Burroughs Wellcome Fund; Schweppe Foundation; NIEHS Center of Excellence in Environmental Toxicology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054959, R56AI054959, T32AI052066] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Schweppe Foundation; NIEHS Center of Excellence in Environmental Toxicology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support of this work was provided by the National Institutes of Health (AI54959 and T32 AI52066), the Burroughs Wellcome Fund, the Schweppe Foundation and the NIEHS Center of Excellence in Environmental Toxicology.	Adams P, 2001, PROTEOMICS, V1, P597, DOI 10.1002/1615-9861(200104)1:4<597::AID-PROT597>3.0.CO;2-P; Aiso T, 2003, GENES CELLS, V8, P179, DOI 10.1046/j.1365-2443.2003.00624.x; Bacon RT, 2003, J FOOD PROTECT, V66, P732, DOI 10.4315/0362-028X-66.5.732; Bang IS, 2000, J BACTERIOL, V182, P2245, DOI 10.1128/JB.182.8.2245-2252.2000; Baumler AJ, 1996, GENE, V183, P207, DOI 10.1016/S0378-1119(96)00560-4; Bearson BL, 1998, J BACTERIOL, V180, P2409, DOI 10.1128/JB.180.9.2409-2417.1998; BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Bjorne H, 2006, FREE RADICAL BIO MED, V41, P1404, DOI 10.1016/j.freeradbiomed.2006.07.020; BUCHIN PJ, 1980, J CLIN GASTROENTEROL, V2, P133, DOI 10.1097/00004836-198006000-00005; Butler CS, 1997, BIOCHEMISTRY-US, V36, P16259, DOI 10.1021/bi971481a; Canani RB, 2006, PEDIATRICS, V117, pE817, DOI 10.1542/peds.2005-1655; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; COOK GC, 1985, SCAND J GASTROENTERO, V20, P17, DOI 10.3109/00365528509093751; Cunningham R, 2003, J HOSP INFECT, V54, P243, DOI 10.1016/S0195-6701(03)00088-4; D'Autreaux B, 2002, P NATL ACAD SCI USA, V99, P16619, DOI 10.1073/pnas.252591299; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; DORMAN CJ, 1989, INFECT IMMUN, V57, P2136, DOI 10.1128/IAI.57.7.2136-2140.1989; DRESSMAN JB, 1990, PHARMACEUT RES, V7, P756, DOI 10.1023/A:1015827908309; DUNCAN C, 1995, NAT MED, V1, P546, DOI 10.1038/nm0695-546; Dykhuizen RS, 1996, ANTIMICROB AGENTS CH, V40, P1422, DOI 10.1128/AAC.40.6.1422; Eichelberg K, 1999, INFECT IMMUN, V67, P4099, DOI 10.1128/IAI.67.8.4099-4105.1999; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; FIELDS PI, 1989, SCIENCE, V243, P1059, DOI 10.1126/science.2646710; Fite A, 2004, ANTIMICROB AGENTS CH, V48, P655, DOI 10.1128/AAC.48.2.655-658.2004; FOSTER JW, 1991, J BACTERIOL, V173, P5129, DOI 10.1128/jb.173.16.5129-5135.1991; FOSTER JW, 1990, J BACTERIOL, V172, P771, DOI 10.1128/jb.172.2.771-778.1990; FOSTER JW, 1993, J BACTERIOL, V175, P1981, DOI 10.1128/JB.175.7.1981-1987.1993; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; GIANNELLA RA, 1972, GUT, V13, P251, DOI 10.1136/gut.13.4.251; Golubeva YA, 2006, J BACTERIOL, V188, P7853, DOI 10.1128/JB.00706-06; GROISMAN EA, 1992, P NATL ACAD SCI USA, V89, P11939, DOI 10.1073/pnas.89.24.11939; Hall HK, 1996, J BACTERIOL, V178, P5683, DOI 10.1128/jb.178.19.5683-5691.1996; HOLT P, 1985, PRACTITIONER, V229, P1027; Hori H, 1996, J BIOL CHEM, V271, P9254, DOI 10.1074/jbc.271.16.9254; Hung CR, 2004, EUR J PHARMACOL, V491, P61, DOI 10.1016/j.ejphar.2004.03.029; HUSAIN M, 2008, J BIOL CHEM IN PRESS; Klose KE, 1997, INFECT IMMUN, V65, P587, DOI 10.1128/IAI.65.2.587-596.1997; LEE IS, 1995, MOL MICROBIOL, V17, P155; Lee YH, 2007, J BACTERIOL, V189, P2417, DOI 10.1128/JB.01277-06; LEYER GJ, 1993, APPL ENVIRON MICROB, V59, P1842, DOI 10.1128/AEM.59.6.1842-1847.1993; Llama-Palacios A, 2003, MOL MICROBIOL, V49, P347, DOI 10.1046/j.1365-2958.2003.03583.x; McCollister BD, 2005, J EXP MED, V202, P625, DOI 10.1084/jem.20050246; McCollister BD, 2007, IMMUNOBIOLOGY, V212, P759, DOI 10.1016/j.imbio.2007.09.019; Miller JH., 1972, EXPT MOL GENETICS; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Monsieurs P, 2005, J MOL EVOL, V60, P462, DOI 10.1007/s00239-004-0212-7; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; Porwollik S, 2003, NUCLEIC ACIDS RES, V31, P1869, DOI 10.1093/nar/gkg298; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Puzniak L, 2004, INFECT CONT HOSP EP, V25, P628, DOI 10.1086/502452; REYNAERT H, 1995, J GASTROENTEROL, V30, P775, DOI 10.1007/BF02349646; SMALL P, 1994, J BACTERIOL, V176, P1729, DOI 10.1128/jb.176.6.1729-1737.1994; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; SPIEGELHALDER B, 1976, FOOD COSMET TOXICOL, V14, P545, DOI 10.1016/S0015-6264(76)80005-3; STOCKBRUEGGER RW, 1985, SCAND J GASTROENTERO, V20, P7, DOI 10.3109/00365528509093749; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; TANNENBAUM SR, 1976, FOOD COSMET TOXICOL, V14, P549, DOI 10.1016/S0015-6264(76)80006-5; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; van der Velden AWM, 1998, INFECT IMMUN, V66, P2803, DOI 10.1128/IAI.66.6.2803-2808.1998; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Worley MJ, 2000, MOL MICROBIOL, V36, P749, DOI 10.1046/j.1365-2958.2000.01902.x; Xu J, 2001, J APPL MICROBIOL, V90, P523, DOI 10.1046/j.1365-2672.2001.01278.x; Zhou DG, 1999, INFECT IMMUN, V67, P1974; Zhou DS, 2005, FEMS MICROBIOL LETT, V250, P85, DOI 10.1016/j.femsle.2005.06.053; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	71	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1833	10.1371/journal.pone.0001833	http://dx.doi.org/10.1371/journal.pone.0001833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350168	gold, Green Published			2022-12-27	WOS:000260762300034
J	Chiara, F; Castellaro, D; Marin, O; Petronilli, V; Brusilow, WS; Juhaszova, M; Sollott, SJ; Forte, M; Bernardi, P; Rasola, A				Chiara, Federica; Castellaro, Diego; Marin, Oriano; Petronilli, Valeria; Brusilow, William S.; Juhaszova, Magdalena; Sollott, Steven J.; Forte, Michael; Bernardi, Paolo; Rasola, Andrea			Hexokinase II Detachment from Mitochondria Triggers Apoptosis through the Permeability Transition Pore Independent of Voltage-Dependent Anion Channels	PLOS ONE			English	Article								Type II hexokinase is overexpressed in most neoplastic cells, and it mainly localizes on the outer mitochondrial membrane. Hexokinase II dissociation from mitochondria triggers apoptosis. The prevailing model postulates that hexokinase II release from its mitochondrial interactor, the voltage-dependent anion channel, prompts outer mitochondrial membrane permeabilization and the ensuing release of apoptogenic proteins, and that these events are inhibited by growth factor signalling. Here we show that a hexokinase II N-terminal peptide selectively detaches hexokinase II from mitochondria and activates apoptosis. These events are abrogated by inhibiting two established permeability transition pore modulators, the adenine nucleotide translocator or cyclophilin D, or in cyclophilin D knock-out cells. Conversely, insulin stimulation or genetic ablation of the voltage-dependent anion channel do not affect cell death induction by the hexokinase II peptide. Therefore, hexokinase II detachment from mitochondria transduces a permeability transition pore opening signal that results in cell death and does not require the voltage-dependent anion channel. These findings have profound implications for our understanding of the pathways of outer mitochondrial membrane permeabilization and their inactivation in tumors.	[Chiara, Federica; Castellaro, Diego; Petronilli, Valeria; Bernardi, Paolo; Rasola, Andrea] Univ Padua, CNR, Inst Neurosci, Dept Biomed Sci, Padua, Italy; [Marin, Oriano] Univ Padua, Venetian Inst Mol Med, Dept Biol Chem, Padua, Italy; [Brusilow, William S.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA; [Juhaszova, Magdalena; Sollott, Steven J.] NIH, Natl Inst Aging, Gerontol Res Ctr, Lab Cardiovascul Sci, Baltimore, MD USA; [Forte, Michael] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR USA	Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua; Veneto Institute Molecular Medicine; Wayne State University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Oregon Health & Science University	Chiara, F (corresponding author), Univ Padua, CNR, Inst Neurosci, Dept Biomed Sci, Padua, Italy.	bernardi@bio.unipd.it; rasola@bio.unipd.it	Bernardi, Paolo/C-3656-2008; Petronilli, Valeria/C-3558-2015	Bernardi, Paolo/0000-0001-9187-3736; Petronilli, Valeria/0000-0003-4026-6404; chiara, federica/0000-0003-2396-3080; Rasola, Andrea/0000-0003-4522-3008	Progetti di Ricerca di Interesse Nazionale del Ministero dell Universita e della Ricerca; USA NIH-PHS [GM69883]; Intramural Research Program, National Institute on Aging, NIH; AIRC; Progetti di Ateneo dell Universita di Padova; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000823] Funding Source: NIH RePORTER	Progetti di Ricerca di Interesse Nazionale del Ministero dell Universita e della Ricerca; USA NIH-PHS; Intramural Research Program, National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AIRC(Fondazione AIRC per la ricerca sul cancro); Progetti di Ateneo dell Universita di Padova; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was made possible by grants from the Progetti di Ricerca di Interesse Nazionale del Ministero dell Universita e della Ricerca (MIUR-PRIN, to P.B.), from the USA NIH-PHS (Grant GM69883 to M.F and P.B.), from the Intramural Research Program, National Institute on Aging, NIH (to M.J. and S.J.S.), from AIRC (to P.B.), and from Progetti di Ateneo dell Universita di Padova (to A.R.).	Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Belzacq AS, 2002, BIOCHIMIE, V84, P167, DOI 10.1016/S0300-9084(02)01366-4; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; BLACHLYDYSON E, 1993, J BIOL CHEM, V268, P1835; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Gramaglia D, 2004, CELL DEATH DIFFER, V11, P342, DOI 10.1038/sj.cdd.4401326; Halestrap AP, 1998, BBA-BIOENERGETICS, V1366, P79, DOI 10.1016/S0005-2728(98)00122-4; Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; JUHASZOVA M, 2008, ANN N Y ACA IN PRESS; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; POSTIC C, 1994, AM J PHYSIOL, V266, pE548, DOI 10.1152/ajpendo.1994.266.4.E548; Rasola A, 2001, CYTOMETRY, V45, P151, DOI 10.1002/1097-0320(20011001)45:2<151::AID-CYTO1157>3.0.CO;2-I; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Vyssokikh M, 2004, MOL CELL BIOCHEM, V256, P117, DOI 10.1023/B:MCBI.0000009863.69249.d9; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wu SL, 1999, BBA-MOL CELL RES, V1452, P68, DOI 10.1016/S0167-4889(99)00120-2; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; Zhou H, 2005, EXP CELL RES, V309, P316, DOI 10.1016/j.yexcr.2005.06.014; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001	42	214	221	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1852	10.1371/journal.pone.0001852	http://dx.doi.org/10.1371/journal.pone.0001852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350175	Green Published, Green Submitted, gold			2022-12-27	WOS:000260762300041
J	Linderholm, A; Malmstrom, H; Liden, K; Holmlund, G; Gotherstrom, A				Linderholm, Anna; Malmstrom, Helena; Liden, Kerstin; Holmlund, Gunilla; Gotherstrom, Anders			Cryptic Contamination and Phylogenetic Nonsense	PLOS ONE			English	Article							ANCIENT DNA; LACTASE-PERSISTENCE; BONES	Ancient human DNA has been treated cautiously ever since the problems related to this type of material were exposed in the early 1990s, but as sequential genetic data from ancient specimens have been key components in several evolutionary and ecological studies, interest in ancient human DNA is on the increase again. It is especially tempting to approach archaeological and anthropological questions through this type of material, but DNA from ancient human tissue is notoriously complicated to work with due to the risk of contamination with modern human DNA. Various ways of authenticating results based on ancient human DNA have been developed to circumvent the problems. One commonly used method is to predict what the contamination is expected to look like and then test whether the ancient human DNA fulfils this prediction. If it does, the results are rejected as contamination, while if it does not, they are often considered authentic. We show here that human contamination in ancient material may well deviate from local allele frequencies or the distributions to be found among the laboratory workers and archaeologists. We conclude that it is not reliable to authenticate ancient human DNA solely by showing that it is different from what would be expected from people who have handled the material.	[Linderholm, Anna; Liden, Kerstin] Stockholm Univ, Archaeol Res Lab, S-10691 Stockholm, Sweden; [Malmstrom, Helena; Gotherstrom, Anders] Uppsala Univ, Dept Evol Biol, Uppsala, Sweden; [Holmlund, Gunilla] Natl Board Forens Med, Dept Forens Genet & Forens Toxicol, Linkoping, Sweden	Stockholm University; Uppsala University; Swedish National Board of Forensic Medicine	Linderholm, A (corresponding author), Stockholm Univ, Archaeol Res Lab, S-10691 Stockholm, Sweden.	anna.linderholm@arklab.su.se	Linderholm, Anna/R-7516-2019; Malmström, Helena/C-2476-2017	Malmström, Helena/0000-0002-6456-8055; Gotherstrom, Anders/0000-0001-8579-1304; Liden, Kerstin/0000-0002-5911-9503; Linderholm, Anna/0000-0002-1613-9926				Abbott A, 2003, NATURE, V423, P468, DOI 10.1038/423468b; Adcock GJ, 2001, P NATL ACAD SCI USA, V98, P537, DOI 10.1073/pnas.98.2.537; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; Caramelli D, 2003, P NATL ACAD SCI USA, V100, P6593, DOI 10.1073/pnas.1130343100; Cooper A, 2000, SCIENCE, V289, P1139; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Kuokkanen M, 2005, INT J CANCER, V117, P90, DOI 10.1002/ijc.21130; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Malmstrom H, 2007, MOL BIOL EVOL, V24, P998, DOI 10.1093/molbev/msm015; PAABO S, 1985, NATURE, V314, P644, DOI 10.1038/314644a0; RICHARDS MB, 1995, J ARCHAEOL SCI, V22, P291, DOI 10.1006/jasc.1995.0031; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Svensson EM, 2007, ANIM GENET, V38, P378, DOI 10.1111/j.1365-2052.2007.01620.x; Wall JD, 2007, PLOS GENET, V3, P1862, DOI 10.1371/journal.pgen.0030175; WOODWARD SR, 1994, SCIENCE, V266, P1229; Xie CZ, 2007, P R SOC B, V274, P1597, DOI 10.1098/rspb.2007.0219; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2; ZISCHLER H, 1995, SCIENCE, V268, P1192, DOI 10.1126/science.7605504	24	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2316	10.1371/journal.pone.0002316	http://dx.doi.org/10.1371/journal.pone.0002316			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391XW	18509458	Green Published, Green Submitted, gold			2022-12-27	WOS:000262268500044
J	Torpey, KE; Kabaso, ME; Mutale, LN; Kamanga, MK; Mwango, AJ; Simpungwe, J; Suzuki, C; Mukadi, YD				Torpey, Kwasi E.; Kabaso, Mushota E.; Mutale, Liya N.; Kamanga, Mpuma K.; Mwango, Albert J.; Simpungwe, James; Suzuki, Chiho; Mukadi, Ya Diul			Adherence Support Workers: A Way to Address Human Resource Constraints in Antiretroviral Treatment Programs in the Public Health Setting in Zambia	PLOS ONE			English	Article							DIRECTLY OBSERVED THERAPY; POOR SETTINGS; HIV TREATMENT; VIRAL LOAD; FEASIBILITY; EFFICACY	Background: In order to address staff shortages and improve adherence counseling for people on antiretroviral therapy (ART), the Zambia Prevention, Care and Treatment Partnership (ZPCT) developed an innovative strategy of training community volunteers to provide adherence support at the health facility and community levels. The objective of this study was to assess the effectiveness of these 'adherence support workers' (ASWs) in adherence counseling, treatment retention and addressing inadequate human resources at health facilities. Methodology/Principal Findings: The study used quantitative and qualitative research techniques at five selected ART sites in four provinces in Zambia. Five hundred patients on ART were interviewed using a structured questionnaire to compare the quality of adherence counseling before and after the ASW scheme was introduced at the selected sites and between ASWs and HCWs after the introduction of ASWs. In addition, 3,903 and 4,972 electronic records of all new patients accessing antiretroviral therapy for the time period of 12 months before and 12 months after the introduction of ASWs respectively, were analyzed to assess loss to follow-up rates. Two focus group discussions with ASWs and health care workers ( HCWs) were conducted in each clinic. Key informant interviews in the ART clinics were also conducted. There was a marked shift of workload from HCWs to ASWs without any compromise in the quality of counseling. Quality of adherence counseling by ASWs was comparable to HCWs after their introduction. The findings suggest that the deployment of ASWs helped reduce waiting times for adherence counseling. Loss to follow-up rates of new clients declined from 15% to 0% after the deployment of ASWs. Conclusion: Adherence counseling tasks can be shifted to lay cadres like ASWs without compromising the quality of counseling. Follow-up of clients by ASWs within the community is necessary to improve retention of clients on ART.	[Torpey, Kwasi E.; Kabaso, Mushota E.; Mutale, Liya N.; Kamanga, Mpuma K.] Family Hlth Int Zambia Prevent Care & Treatment P, Lusaka, Zambia; [Mwango, Albert J.; Simpungwe, James] Ministry Hlth, Lusaka, Zambia; [Suzuki, Chiho; Mukadi, Ya Diul] Family Hlth Int, Arlington, VA USA		Torpey, KE (corresponding author), Family Hlth Int Zambia Prevent Care & Treatment P, Lusaka, Zambia.	KTorpey@zpct.org		Torpey, Kwasi/0000-0003-1628-2922	U.S. Agency for International Development (USAID) [690-A-00-04-00319-00]	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID))	Support for this paper was provided by Family Health International (FHI)/Zambia Prevention Care and Treatment Partnership with funds from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Agency for International Development (USAID) Cooperative Agreement No. 690-A-00-04-00319-00. The views expressed in this publication do not necessarily reflect those of FHI. The sponsor of the study had no role in the design, data collection, analysis, interpretation and writing of the report. The corresponding author had full access to data and had final responsibility to submit this article for publication.	Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; BANGSBERG DR, 2002, J ACQ IMMUN DEF SYND, V15, P1181; Berg KM, 2006, JAIDS-J ACQ IMM DEF, V43, pS79, DOI 10.1097/01.qai.0000248337.97814.66; BROWN S, 2004, ASSESSMENT ADHERENCE; Coetzee D, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406003-00006; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Farmer P, 2001, B WORLD HEALTH ORGAN, V79, P1145; *FHI, 2007, ADH SUPP WORK TRAIN; *GBOH, 2003, NAT HLTH STRAT PLAN; Gifford AL, 2000, J ACQ IMMUN DEF SYND, V23, P386; Gill CJ, 2005, AIDS, V19, P1243, DOI 10.1097/01.aids.0000180094.04652.3b; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Koenig SP, 2004, AIDS, V18, pS21, DOI 10.1097/00002030-200406003-00005; *MIN HLTH, 2006, HLTH SECT JOINT ANN; *MIN HLTH, 2005, ANN HLTH STAT B; *MIN HLTH, 2005, MIN HLTH STRAT PLAN; Mukherjee JS, 2006, JAIDS-J ACQ IMM DEF, V43, pS123, DOI 10.1097/01.qai.0000248348.25630.74; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, pS127, DOI 10.1097/01.qai.0000248349.25630.3d; Orrell C, 2003, AIDS, V17, P1369, DOI 10.1097/00002030-200306130-00011; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pearson CR, 2006, JAIDS-J ACQ IMM DEF, V43, pS134, DOI 10.1097/01.qai.0000248339.82567.17; Person Anna K, 2007, Curr HIV/AIDS Rep, V4, P73, DOI 10.1007/s11904-007-0011-z; ROSEN S, 2007, PLOS MED; Simoni JM, 2006, JAIDS-J ACQ IMM DEF, V43, pS23, DOI 10.1097/01.qai.0000248342.05438.52; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Wainberg MA, 1998, JAMA-J AM MED ASSOC, V279, P1977, DOI 10.1001/jama.279.24.1977; Wohl AR, 2004, CLIN INFECT DIS, V38, pS388, DOI 10.1086/421401	32	81	82	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2204	10.1371/journal.pone.0002204	http://dx.doi.org/10.1371/journal.pone.0002204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493615	Green Published, gold, Green Accepted			2022-12-27	WOS:000262258700013
J	Abaraviciene, SM; Lundquist, I; Galvanovskis, J; Flodgren, E; Olde, B; Salehi, A				Abaraviciene, Sandra Meidute; Lundquist, Ingmar; Galvanovskis, Juris; Flodgren, Erik; Olde, Bjorn; Salehi, Albert			Palmitate-Induced beta-Cell Dysfunction Is Associated with Excessive NO Production and Is Reversed by Thiazolidinedione-Mediated Inhibition of GPR40 Transduction Mechanisms	PLOS ONE			English	Article								Background: Type 2 diabetes often displays hyperlipidemia. We examined palmitate effects on pancreatic islet function in relation to FFA receptor GPR40, NO generation, insulin release, and the PPAR gamma agonistic thiazolidinedione, rosiglitazone. Principal Findings: Rosiglitazone suppressed acute palmitate-stimulated GPR40-transduced PI hydrolysis in HEK293 cells and insulin release from MIN6c cells and mouse islets. Culturing islets 24 h with palmitate at 5 mmol/l glucose induced beta-cell iNOS expression as revealed by confocal microscopy and increased the activities of ncNOS and iNOS associated with suppression of glucose-stimulated insulin response. Rosiglitazone reversed these effects. The expression of iNOS after high-glucose culturing was unaffected by rosiglitazone. Downregulation of GPR40 by antisense treatment abrogated GPR40 expression and suppressed palmitate-induced iNOS activity and insulin release. Conclusion: We conclude that, in addition to mediating acute FFA-stimulated insulin release, GPR40 is an important regulator of iNOS expression and dysfunctional insulin release during long-term exposure to FFA. The adverse effects of palmitate were counteracted by rosiglitazone at GPR40, suggesting that thiazolidinediones are beneficial for beta-cell function in hyperlipidemic type 2 diabetes.	[Abaraviciene, Sandra Meidute; Galvanovskis, Juris; Flodgren, Erik; Salehi, Albert] UMAS, Malmo Univ Hosp, Div Endocrine Pharmacol, Dept Clin Sci, Malmo, Sweden; [Lundquist, Ingmar; Olde, Bjorn] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University; Skane University Hospital; Lund University	Abaraviciene, SM (corresponding author), UMAS, Malmo Univ Hosp, Div Endocrine Pharmacol, Dept Clin Sci, Malmo, Sweden.	S_Albert.Salehi@med.lu.se	Salehi, Albert/F-7768-2018	Salehi, Albert/0000-0001-6120-3539	Swedish Science Council [04X-20029]; Medical faculty (University of Lund); NOVO Nordic; Magnus Bergvall; Crafoord Founda-tions	Swedish Science Council; Medical faculty (University of Lund); NOVO Nordic; Magnus Bergvall; Crafoord Founda-tions	This study was supported by the Swedish Science Council (04X-20029), the Medical faculty (University of Lund), NOVO Nordic, Magnus Bergvall, Albert Pahlsson and Crafoord Founda-tions. The technical assistance of Britt-Marie Nilsson is gratefully acknowledged.	Akesson B, 1999, J ENDOCRINOL, V163, P39, DOI 10.1677/joe.0.1630039; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brunham LR, 2007, NAT MED, V13, P340, DOI 10.1038/nm1546; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cnop M, 2002, BIOCHEM PHARMACOL, V63, P1281, DOI 10.1016/S0006-2952(02)00860-2; Gastaldelli A, 2007, AM J PHYSIOL-ENDOC M, V292, pE871, DOI 10.1152/ajpendo.00551.2006; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; HEDING LG, 1966, SIMPLIFIED INSULIN R, P345; Henningsson R, 2002, AM J PHYSIOL-CELL PH, V283, pC296, DOI 10.1152/ajpcell.00537.2001; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jimenez-Feltstrom J, 2005, CELL TISSUE RES, V319, P221, DOI 10.1007/s00441-004-1013-4; Jimenez-Feltstrom J, 2004, REGUL PEPTIDES, V122, P109, DOI 10.1016/j.regpep.2004.06.004; Kang DS, 2002, MOL PHARMACOL, V62, P281, DOI 10.1124/mol.62.2.281; Kotarsky K, 2003, BIOCHEM BIOPH RES CO, V301, P406, DOI 10.1016/S0006-291X(02)03064-4; Lajoix AD, 2001, DIABETES, V50, P1311, DOI 10.2337/diabetes.50.6.1311; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Lupi R, 2004, AM J PHYSIOL-ENDOC M, V286, pE560, DOI 10.1152/ajpendo.00561.2002; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Olofsson CS, 2004, J PHYSIOL-LONDON, V557, P935, DOI 10.1113/jphysiol.2004.066258; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Qader SS, 2007, AM J PHYSIOL-ENDOC M, V292, pE1447, DOI 10.1152/ajpendo.00172.2006; Salehi A, 1996, AM J PHYSIOL-CELL PH, V270, pC1634, DOI 10.1152/ajpcell.1996.270.6.C1634; Salehi A, 2005, CELL TISSUE RES, V322, P207, DOI 10.1007/s00441-005-0017-z; Salehi A, 2001, ENDOCRINE, V16, P97, DOI 10.1385/ENDO:16:2:097; Salehi A, 2003, HORM METAB RES, V35, P48, DOI 10.1055/s-2003-38391; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shimabukuro M, 1998, J BIOL CHEM, V273, P3547, DOI 10.1074/jbc.273.6.3547; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Takamura T, 1998, J BIOL CHEM, V273, P2493, DOI 10.1074/jbc.273.5.2493; Tsuura Y, 1998, BIOCHEM BIOPH RES CO, V252, P34, DOI 10.1006/bbrc.1998.9601; Wang X, 2007, LIFE SCI, V81, P160, DOI 10.1016/j.lfs.2007.04.034; Yaney GC, 2003, DIABETOLOGIA, V46, P1297, DOI 10.1007/s00125-003-1207-4; Yang C, 2001, DIABETES, V50, P2598, DOI 10.2337/diabetes.50.11.2598; Yoshikawa H, 2004, AM J PHYSIOL-ENDOC M, V287, pE1202, DOI 10.1152/ajpendo.00255.2004	39	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2182	10.1371/journal.pone.0002182	http://dx.doi.org/10.1371/journal.pone.0002182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478115	gold, Green Published, Green Submitted			2022-12-27	WOS:000262172800047
J	Zhu, YN; Hou, HY; Nikolic, WV; Ehrhart, J; Rrapo, E; Bickford, P; Giunta, B; Tan, J				Zhu, Yuyan; Hou, Huayan; Nikolic, William V.; Ehrhart, Jared; Rrapo, Elona; Bickford, Paula; Giunta, Brian; Tan, Jun			CD45RB Is a Novel Molecular Therapeutic Target to Inhibit A beta Peptide-Induced Microglial MAPK Activation	PLOS ONE			English	Article								Background: Microglial activation, characterized by p38 MAPK or p44/42 MAPK pathway signal transduction, occurs in Alzheimer's disease (AD). Our previous studies demonstrated CD45, a membrane-bound protein tyrosine phosphatase (PTP), opposed beta-amyloid (A beta) peptide-induced microglial activation via inhibition of p44/42 MAPK. Additionally we have shown agonism of the RB isoform of CD45 (CD45RB) abrogates lipopolysaccharide (LPS)-induced microglial activation. Methodology and Results: In this study, CD45RB modulation of A beta peptide or LPS-activated primary cultured microglial cells was further investigated. Microglial cells were co-treated with "aged" FITC-A beta(1-42) and multiple CD45 isoform agonist antibodies. Data revealed cross-linking of CD45, particularly the CD45RB isoform, enhances microglial phagocytosis of A beta(1-42) peptide and inhibits LPS-induced activation of p44/42 and p38 pathways. Co-treatment of microglial cells with agonist CD45 antibodies results in significant inhibition of LPS-induced microglial TNF-alpha and IL-6 release through p44/42 and/or p38 pathways. Moreover, inhibition of either of these pathways augmented CD45RB cross-linking induced microglial phagocytosis of A beta(1-42) peptide. To investigate the mechanism(s) involved, microglial cells were co-treated with a PTP inhibitor (potassium bisperoxo [1,10-phenanthroline oxovanadate; Phen]) and A beta(1-42) peptides. Data showed synergistic induction of microglial activation as evidenced by TNF-alpha and IL-6 release; both of which are demonstrated to be dependent on increased p44/42 and/or p38 activation. Finally, it was observed that cross-linking of CD45RB in the presence of A beta(1-42) peptide, inhibits co-localization of microglial MHC class II and A beta peptide; suggesting CD45 activation inhibits the antigen presenting phenotype of microglial cells. Conclusion: In summary, p38 MAPK is another novel signaling pathway, besides p44/42, in which CD45RB cross-linking negatively regulates microglial A beta phagocytosis while increasing potentially neurotoxic inflammation. Therefore, agonism of CD45RB PTP activity may be an effective therapeutic target for novel agents to treat AD due to its A beta lowering, and inflammation reducing, properties that are particularly targeted at microglial cells. Such treatments may be more effective with less potential to produce systemic side-effects than therapeutics which induce non-specific, systemic down-regulation of inflammation.	[Zhu, Yuyan; Hou, Huayan; Nikolic, William V.; Ehrhart, Jared; Rrapo, Elona; Giunta, Brian; Tan, Jun] Univ S Florida, Coll Med, Dept Psychiat & Behav Med, Silver Child Dev Ctr,Rashid Lab Dev Neurobiol, Tampa, FL 33620 USA; [Bickford, Paula; Tan, Jun] Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg, Tampa, FL USA; [Bickford, Paula] Univ S Florida, Coll Med, Veterans Adm Hosp, Res Serv, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Zhu, YN (corresponding author), Univ S Florida, Coll Med, Dept Psychiat & Behav Med, Silver Child Dev Ctr,Rashid Lab Dev Neurobiol, Tampa, FL 33620 USA.	jtan@hsc.usf.edu	Tan, Jun/I-5339-2012; Bickford, Paula C/J-5970-2012; Giunta, Brian/H-3817-2011; Nikolic, William/H-4672-2013	Bickford, Paula C/0000-0001-9657-7725; Nikolic, William/0000-0002-7670-6910	NIH/NIA [AG04418]; NIH/NINDS [NS048335]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH098737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004418] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants to J.T. from the NIH/NIA (AG04418) and the NIH/NINDS (NS048335).	Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Bradt BM, 1998, J EXP MED, V188, P431, DOI 10.1084/jem.188.3.431; Breitner JCS, 1996, ANNU REV MED, V47, P401; Breitner JCS, 1996, NEUROBIOL AGING, V17, P789; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Chung HY, 1999, J BIOL CHEM, V274, P32301, DOI 10.1074/jbc.274.45.32301; Combs CK, 2001, J NEUROSCI, V21, P1179; Combs CK, 1999, J NEUROSCI, V19, P928; Cornet A, 1998, REV NEUROL, V154, P586; Cosenza-Nashat MA, 2006, BRAIN PATHOL, V16, P256, DOI 10.1111/j.1750-3639.2006.00027.x; Dalpke AH, 2002, J IMMUNOL, V168, P4854, DOI 10.4049/jimmunol.168.10.4854; Dickson DW, 1997, NEUROBIOL AGING, V18, pS21, DOI 10.1016/S0197-4580(97)00065-1; Fiala M, 2007, J ALZHEIMERS DIS, V11, P457; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Giunta B, 2004, BRAIN RES BULL, V64, P165, DOI 10.1016/j.brainresbull.2004.06.008; Golde TE, 2000, BBA-MOL BASIS DIS, V1502, P172, DOI 10.1016/S0925-4439(00)00043-0; HAMBLETON J, 1995, J EXP MED, V182, P147, DOI 10.1084/jem.182.1.147; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Higgins J. A., 1994, Insect Molecular Biology, V3, P27, DOI 10.1111/j.1365-2583.1994.tb00147.x; HIGGINS MJ, 1995, ENVIRON MOL MUTAGEN, V26, P37, DOI 10.1002/em.2850260106; Irie-Sasaki J, 2003, CURR TOP MED CHEM, V3, P783, DOI 10.2174/1568026033452339; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; KARP HL, 1994, GLIA, V11, P284, DOI 10.1002/glia.440110310; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Koistinaho M, 2002, GLIA, V40, P175, DOI 10.1002/glia.10151; Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998; Launer LJ, 2003, DRUGS, V63, P731, DOI 10.2165/00003495-200363080-00001; Licastro F, 1998, J NEUROIMMUNOL, V88, P105, DOI 10.1016/S0165-5728(98)00096-4; LIEW SCK, 1994, J NEUROPATH EXP NEUR, V53, P150, DOI 10.1097/00005072-199403000-00006; Mackenzie IRA, 1998, NEUROLOGY, V50, P986, DOI 10.1212/WNL.50.4.986; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; MASLIAH E, 1991, ACTA NEUROPATHOL, V83, P12, DOI 10.1007/BF00294425; MATSUSHIMA GK, 1994, CELL, V78, P645, DOI 10.1016/0092-8674(94)90529-0; McDonald DR, 1998, J NEUROSCI, V18, P4451; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Mitrasinovic OM, 2002, J BIOL CHEM, V277, P29889, DOI 10.1074/jbc.M200868200; OLSSON T, 1995, NEUROLOGY, V45, pS11, DOI 10.1212/WNL.45.6_Suppl_6.S11; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; PERLMUTTER LS, 1992, J NEUROSCI RES, V33, P549, DOI 10.1002/jnr.490330407; Pyo H, 1998, NEUROREPORT, V9, P871, DOI 10.1097/00001756-199803300-00020; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; Sasaki T, 2001, INT J BIOCHEM CELL B, V33, P1041, DOI 10.1016/S1357-2725(01)00075-9; Sastre M, 2006, INT J DEV NEUROSCI, V24, P167, DOI 10.1016/j.ijdevneu.2005.11.014; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Stein VM, 2007, J VET MED A, V54, P314, DOI 10.1111/j.1439-0442.2007.00926.x; STREULI M, 1987, J EXP MED, V166, P1548, DOI 10.1084/jem.166.5.1548; Suttles J, 1999, J BIOL CHEM, V274, P5835, DOI 10.1074/jbc.274.9.5835; SWANBORG RH, 1995, CLIN IMMUNOL IMMUNOP, V77, P4, DOI 10.1016/0090-1229(95)90130-2; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Tan J, 2002, J NEUROIMMUNOL, V132, P164, DOI 10.1016/S0165-5728(02)00309-0; Tan J, 2002, CURR OPIN PHARMACOL, V2, P445, DOI 10.1016/S1471-4892(02)00180-7; Tan J, 2000, J BIOL CHEM, V275, P37224, DOI 10.1074/jbc.M002006200; Tan J, 1999, J IMMUNOL, V163, P6614; Tan J, 2000, J NEUROSCI, V20, P7587; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Townsend KP, 2004, NEUROSCI LETT, V362, P26, DOI 10.1016/j.neulet.2004.01.082; Townsend KP, 2005, EUR J IMMUNOL, V35, P901, DOI 10.1002/eji.200425585; Van Eldik LJ, 2007, INT REV NEUROBIOL, V82, P277, DOI 10.1016/S0074-7742(07)82015-0; von Bernhardi R, 2007, NEUROBIOL DIS, V26, P153, DOI 10.1016/j.nbd.2006.12.006; Yang YP, 1996, SCIENCE, V273, P1862, DOI 10.1126/science.273.5283.1862; Zhang K, 2002, J ALLERGY CLIN IMMUN, V110, P421, DOI 10.1067/mai.2002.126382	63	17	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2135	10.1371/journal.pone.0002135	http://dx.doi.org/10.1371/journal.pone.0002135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478117	Green Published, Green Submitted, gold			2022-12-27	WOS:000262172800001
J	Harkonen, T; Jussi, M; Jussi, I; Verevkin, M; Dmitrieva, L; Helle, E; Sagitov, R; Harding, KC				Harkonen, Tero; Jussi, Mart; Jussi, Ivar; Verevkin, Michail; Dmitrieva, Lilia; Helle, Eero; Sagitov, Roustam; Harding, Karin C.			Seasonal Activity Budget of Adult Baltic Ringed Seals	PLOS ONE			English	Article								Although ringed seals are important components in oceanic and fresh water ecosystems at high latitudes, little is known about how they exploit these harsh environments. Seasonal activity and diving behaviour of 19 adult Baltic ringed seals were studied by satellite telemetry. We elaborated an activity budget for ten months of the year, extending over the period from moult to the breeding season. Seals from three main regions showed explicit site fidelity and the distributions of animals tagged from different areas did not overlap, suggesting separate stocks. Both the mean duration and the mean depth of dives peaked in June and July. Seals spent 70% (females) to 85% (males) of their time diving in June and July which decreased to 50% in late autumn. Less than one percent of dives exceeded 10 min in females, while 10% of male dives lasted longer than 10 min in June to September. Less than one percent of dives lasted for more than 25 min. Both females and males were most active during day time and hauled out predominantly during the night. Activity patterns during the summer are suggested to be correlated to energy accumulation and prey availability. The information on seasonal activity budget is crucial for developing population energetic models where interactions between ringed seals and other trophic levels can be evaluated.	[Harkonen, Tero] Swedish Museum Nat Hist, S-10405 Stockholm, Sweden; [Jussi, Mart] Estonian Fund for Nature, Tartu, Estonia; [Jussi, Ivar] Estonian Marine Institute, Tallinn, Estonia; [Verevkin, Michail; Sagitov, Roustam] St Petersburg State Univ, St Petersburg, Russia; [Dmitrieva, Lilia] St Petersburg Naturalist Soc, St Petersburg, Russia; [Helle, Eero] Finnish Game & Fisheries Res Inst, Helsinki, Finland; [Harding, Karin C.] Gothenburg Univ, Dept Marine Ecol, Gothenburg, Sweden	Swedish Museum of Natural History; University of Tartu; Estonian Marine Institute; Saint Petersburg State University; Natural Resources Institute Finland (Luke); University of Gothenburg	Harkonen, T (corresponding author), Swedish Museum Nat Hist, S-10405 Stockholm, Sweden.	tero.harkonen@nrm.se	Harding, Karin/F-9957-2013	Harding, Karin/0000-0003-1527-0903	Wallenberg foundation; World Wide Fund for Nature (Sweden); Swedish Environment Protection Agency; Finnish Game Research Institute; Estonian Fund for Nature	Wallenberg foundation(European Commission); World Wide Fund for Nature (Sweden); Swedish Environment Protection Agency; Finnish Game Research Institute; Estonian Fund for Nature	This study was supported by the Wallenberg foundation, World Wide Fund for Nature (Sweden), The Swedish Environment Protection Agency, The Finnish Game Research Institute and the Estonian Fund for Nature.	Bergman A., 1985, FINNISH GAME RES, V44, P47; Born EW, 2004, ARCTIC, V57, P129; Born EW, 2002, MAR MAMMAL SCI, V18, P167, DOI 10.1111/j.1748-7692.2002.tb01026.x; Damgaard J, 1998, HYDROBIOLOGIA, V377, P9, DOI 10.1023/A:1003256906580; EBERHARDT LL, 1990, CAN J FISH AQUAT SCI, V47, P122, DOI 10.1139/f90-012; FOWLER CW, 1990, MAR MAMMAL SCI, V6, P171, DOI 10.1111/j.1748-7692.1990.tb00242.x; Gjertz I, 2000, POLAR BIOL, V23, P651, DOI 10.1007/s003000000143; Harding KC, 1999, AMBIO, V28, P619; Harkonen Tero, 1998, NAMMCO Scientific Publications, V1, P167; HEIDEJORGENSEN MP, 1992, ECOGRAPHY, V15, P56, DOI 10.1111/j.1600-0587.1992.tb00008.x; HELLE E, 1980, ANN ZOOL FENN, V17, P147; HELLE E, 1986, FINNISH GAME RES, V44, P28; JEVREJEVA S, 2002, REPORT SERIES GEOPHY, V44, P31; Kapel Finn O., 1998, NAMMCO Scientific Publications, V1, P211; Kelly BP, 1996, CAN J ZOOL, V74, P1547, DOI 10.1139/z96-169; Kunnasranta M., 2001, THESIS U JOENSUU FIN; Ojaveer E, 1988, BALTIC HERRINGS BIOL; Palo J., 2003, THESIS U HELSINKI FI; Ries EH, 1997, CAN J ZOOL, V75, P2063, DOI 10.1139/z97-840; Seina A, 1996, MERI, V27, P79; Soderberg S., 1972, SALENS FODOVAL SKADE; Stewart BS, 1996, MAR MAMMAL SCI, V12, P528; Teilmann J, 1999, CAN J ZOOL, V77, P1934, DOI 10.1139/cjz-77-12-1934; THOMPSON PM, 1989, J APPL ECOL, V26, P521, DOI 10.2307/2404078; Thompson PM, 1996, J APPL ECOL, V33, P1572, DOI 10.2307/2404795; Tollit DJ, 1998, J ZOOL, V244, P209, DOI 10.1111/j.1469-7998.1998.tb00026.x; TORMOSOV DD, 1978, FINN GAME RES, V37, P14; [No title captured]	28	21	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e2006	10.1371/journal.pone.0002006	http://dx.doi.org/10.1371/journal.pone.0002006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414676	Green Submitted, Green Published, gold			2022-12-27	WOS:000260867300025
J	Kuhlman, SJ; Huang, ZJ				Kuhlman, Sandra J.; Huang, Z. Josh			High-Resolution Labeling and Functional Manipulation of Specific Neuron Types in Mouse Brain by Cre-Activated Viral Gene Expression	PLOS ONE			English	Article								We describe a method that combines Cre-recombinase knockin mice and viral-mediated gene transfer to genetically label and functionally manipulate specific neuron types in the mouse brain. We engineered adeno-associated viruses (AAVs) that express GFP, dsRedExpress, or channelrhodopsin (ChR2) upon Cre/loxP recombination-mediated removal of a transcription-translation STOP cassette. Fluorescent labeling was sufficient to visualize neuronal structures with synaptic resolution in vivo, and ChR2 expression allowed light activation of neuronal spiking. The structural dynamics of a specific class of neocortical neuron, the parvalbumin-containing (Pv) fast-spiking GABAergic interneuron, was monitored over the course of a week. We found that although the majority of Pv axonal boutons were stable in young adults, bouton additions and subtractions on axonal shafts were readily observed at a rate of 10.10% and 9.47%, respectively, over 7 days. Our results indicate that Pv inhibitory circuits maintain the potential for structural re-wiring in post-adolescent cortex. With the generation of an increasing number of Cre knockin mice and because viral transfection can be delivered to defined brain regions at defined developmental stages, this strategy represents a general method to systematically visualize the structure and manipulate the function of different cell types in the mouse brain.	[Kuhlman, Sandra J.; Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	huangj@cshl.edu	Kuhlman, Sandra/Q-1211-2015	Kuhlman, Sandra/0000-0003-0450-7282; Huang, Z. Josh/0000-0003-0592-028X	NARSAD; NIH; Mathes Foundation;  [MH070052-05]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070052] Funding Source: NIH RePORTER	NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathes Foundation; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	NARSAD to S.J.K.; NIH and Mathes Foundation to Z.J.H.; supported in part by grant MH070052-05 to Karel Svoboda	Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Awatramani R, 2001, NAT GENET, V29, P257, DOI 10.1038/ng1101-257; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; Chamberlin NL, 1998, BRAIN RES, V793, P169, DOI 10.1016/S0006-8993(98)00169-3; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Daly Thomas M, 2004, Methods Mol Biol, V246, P157; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; Dumitriu D, 2007, CEREB CORTEX, V17, P81, DOI 10.1093/cercor/bhj126; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GONG S, 2003, GENE EXPRESSION ATLA, V425, P917; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guo HL, 2000, BIOCHEM BIOPH RES CO, V273, P661, DOI 10.1006/bbrc.2000.2870; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HOLTMAAT AJ, 2004, IMAGING NEURONS, P624; Jiao YY, 2006, J NEUROSCI, V26, P8691, DOI 10.1523/JNEUROSCI.2478-06.2006; Kawaguchi Y, 2006, CEREB CORTEX, V16, P696, DOI 10.1093/cercor/bhj015; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Osten P, 2007, Handb Exp Pharmacol, P177; Passini Marco A, 2004, Methods Mol Biol, V246, P225; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; Wang JH, 2007, P NATL ACAD SCI USA, V104, P13104, DOI 10.1073/pnas.0702778104; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252	42	137	172	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e2005	10.1371/journal.pone.0002005	http://dx.doi.org/10.1371/journal.pone.0002005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414675	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000260867300024
J	Jimenez-Diaz, L; Geranton, SM; Passmore, GM; Leith, JL; Fisher, AS; Berliocchi, L; Sivasubramaniam, AK; Sheasby, A; Lumb, BM; Hunt, SP				Jimenez-Diaz, Lydia; Geranton, Sandrine M.; Passmore, Gayle M.; Leith, J. Lianne; Fisher, Amy S.; Berliocchi, Laura; Sivasubramaniam, Anantha K.; Sheasby, Anne; Lumb, Bridget M.; Hunt, Stephen P.			Local Translation in Primary Afferent Fibers Regulates Nociception	PLOS ONE			English	Article							PROTEIN S6 PHOSPHORYLATION; MENTAL-RETARDATION PROTEIN; ROOT GANGLION NEURONS; SYNAPTIC PLASTICITY; MAMMALIAN TARGET; CENTRAL SENSITIZATION; MECHANICAL STIMULI; INFLAMMATORY PAIN; SIGNALING PATHWAY; RNA TRANSLATION	Recent studies have demonstrated the importance of local protein synthesis for neuronal plasticity. In particular, local mRNA translation through the mammalian target of rapamycin (mTOR) has been shown to play a key role in regulating dendrite excitability and modulating long-term synaptic plasticity associated with learning and memory. There is also increased evidence to suggest that intact adult mammalian axons have a functional requirement for local protein synthesis in vivo. Here we show that the translational machinery is present in some myelinated sensory fibers and that active mTOR-dependent pathways participate in maintaining the sensitivity of a subpopulation of fast-conducting nociceptors in vivo. Phosphorylated mTOR together with other downstream components of the translational machinery were localized to a subset of myelinated sensory fibers in rat cutaneous tissue. We then showed with electromyographic studies that the mTOR inhibitor rapamycin reduced the sensitivity of a population of myelinated nociceptors known to be important for the increased mechanical sensitivity that follows injury. Behavioural studies confirmed that local treatment with rapamycin significantly attenuated persistent pain that follows tissue injury, but not acute pain. Specifically, we found that rapamycin blunted the heightened response to mechanical stimulation that develops around a site of injury and reduced the long-term mechanical hypersensitivity that follows partial peripheral nerve damage - a widely used model of chronic pain. Our results show that the sensitivity of a subset of sensory fibers is maintained by ongoing mTOR-mediated local protein synthesis and uncover a novel target for the control of long-term pain states.	[Jimenez-Diaz, Lydia; Geranton, Sandrine M.; Berliocchi, Laura; Sivasubramaniam, Anantha K.; Sheasby, Anne; Hunt, Stephen P.] UCL, Dept Anat & Dev Biol, London, England; [Passmore, Gayle M.; Fisher, Amy S.] UCL, Dept Pharmacol, London, England; [Leith, J. Lianne; Lumb, Bridget M.] Dept Physiol, Bristol, Avon, England; [Jimenez-Diaz, Lydia] Univ Salamanca, Inst Neuroci Castilla Leon, Fac Med, Dept Fisiol, Salamanca, Spain; [Berliocchi, Laura] Ctr Expt Neurobiol Mondino Tor Vergata, IRRCS C Mondino, Rome, Italy	University of London; University College London; University of London; University College London; University of Salamanca	Hunt, SP (corresponding author), UCL, Dept Anat & Dev Biol, London, England.	hunt@ucl.ac.uk	Sivasubramaniam, Anantha Krishna/AHB-2476-2022; Jiménez-Diaz, Lydia/R-8383-2019	Sivasubramaniam, Anantha Krishna/0000-0002-2464-0104; Jiménez-Diaz, Lydia/0000-0001-9121-0334; Berliocchi, Laura/0000-0002-3014-1838; Hunt, Stephen/0000-0001-9453-5505; Lumb, Bridget/0000-0002-0268-6419	Wellcome Trust [065374]; Spanish MEC [JCI-2005-1775-25]	Wellcome Trust(Wellcome TrustEuropean Commission); Spanish MEC(Spanish Government)	This work was supported by research grants from the Wellcome Trust to the London Pain Consortium 065374 and JCI-2005-1775-25 from the Spanish MEC.	Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Basbaum AI, 2006, SCI AM, V294, P60, DOI 10.1038/scientificamerican0606-60; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Ben Mamou C, 2006, NAT NEUROSCI, V9, P1237, DOI 10.1038/nn1778; Bester H, 1997, J COMP NEUROL, V383, P439; Carroll P, 1998, NAT NEUROSCI, V1, P42, DOI 10.1038/242; CHAN AW, 1992, J NEUROL NEUROSUR PS, V55, P56, DOI 10.1136/jnnp.55.1.56; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Craner MJ, 2002, ANN NEUROL, V52, P786, DOI 10.1002/ana.10364; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Devor M, 2006, J PAIN, V7, pS3, DOI 10.1016/j.jpain.2005.09.006; Djouhri L, 2004, BRAIN RES REV, V46, P131, DOI 10.1016/j.brainresrev.2004.07.015; Duvarci S, 2006, EUR J NEUROSCI, V24, P249, DOI 10.1111/j.1460-9568.2006.04907.x; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Gilchrist HD, 1996, PAIN, V67, P179, DOI 10.1016/0304-3959(96)03104-1; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001; Klann E, 2004, LEARN MEMORY, V11, P365, DOI 10.1101/lm.79004; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Koenig E, 2000, J NEUROSCI, V20, P8390, DOI 10.1523/JNEUROSCI.20-22-08390.2000; Koltzenburg M, 2001, CURR OPIN NEUROL, V14, P641, DOI 10.1097/00019052-200110000-00014; Koltzenburg M, 1999, EUR J NEUROSCI, V11, P1698, DOI 10.1046/j.1460-9568.1999.00590.x; KRESS M, 1992, J NEUROPHYSIOL, V68, P581, DOI 10.1152/jn.1992.68.2.581; Lawson SN, 2002, J PHYSIOL-LONDON, V540, P989, DOI 10.1113/jphysiol.2001.013086; Lawson SN, 1996, J COMP NEUROL, V365, P355; Lawson SN, 1997, J PHYSIOL-LONDON, V505, P177, DOI 10.1111/j.1469-7793.1997.00177.x; Leith JL, 2007, J NEUROSCI, V27, P11296, DOI 10.1523/JNEUROSCI.2586-07.2007; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Magerl W, 2001, BRAIN, V124, P1754, DOI 10.1093/brain/124.9.1754; Mannion RJ, 1999, P NATL ACAD SCI USA, V96, P9385, DOI 10.1073/pnas.96.16.9385; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; McMullan S, 2004, J NEUROSCI METH, V138, P133, DOI 10.1016/j.jneumeth.2004.03.020; McMullan S, 2006, PAIN, V124, P59, DOI 10.1016/j.pain.2006.03.015; Meyer RA, 2006, WALL MELZACKS TXB PA, V5, P3; Murashov AK, 2007, FASEB J, V21, P656, DOI 10.1096/fj.06-6155com; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Pare M, 2001, J NEUROSCI, V21, P7236, DOI 10.1523/JNEUROSCI.21-18-07236.2001; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Price TJ, 2006, NEUROSCIENCE, V141, P2107, DOI 10.1016/j.neuroscience.2006.05.047; Price TJ, 2007, J NEUROSCI, V27, P13958, DOI 10.1523/JNEUROSCI.4383-07.2007; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; REEH PW, 1986, NEUROSCI LETT, V66, P141, DOI 10.1016/0304-3940(86)90180-1; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Rice FL, 1998, DEV BIOL, V198, P57, DOI 10.1006/dbio.1998.8861; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Sotelo-Silveira JR, 2006, TRAFFIC, V7, P508, DOI 10.1111/j.1600-0854.2006.00405.x; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Suzuki R, 2002, NAT NEUROSCI, V5, P1319, DOI 10.1038/nn966; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; TAL M, 1994, PAIN, V57, P375, DOI 10.1016/0304-3959(94)90013-2; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P753, DOI 10.1113/jphysiol.1995.sp020766; Treede R D, 2000, Prog Brain Res, V129, P331; Tukey JW, 1977, EXPLORATORY DATA ANA; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Weragoda RMS, 2007, J NEUROPHYSIOL, V98, P1231, DOI 10.1152/jn.01189.2006; Weragoda RMS, 2004, J NEUROSCI, V24, P10393, DOI 10.1523/JNEUROSCI.2329-04.2004; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Zeitz KP, 2002, J NEUROSCI, V22, P1010, DOI 10.1523/JNEUROSCI.22-03-01010.2002; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001; Ziegler EA, 1999, BRAIN, V122, P2245, DOI 10.1093/brain/122.12.2245	80	119	125	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1961	10.1371/journal.pone.0001961	http://dx.doi.org/10.1371/journal.pone.0001961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398477	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795500030
J	Thorrez, L; Van Deun, K; Tranchevent, LC; Van Lommel, L; Engelen, K; Marchal, K; Moreau, Y; Van Mechelen, I; Schuit, F				Thorrez, Lieven; Van Deun, Katrijn; Tranchevent, Leon-Charles; Van Lommel, Leentje; Engelen, Kristof; Marchal, Kathleen; Moreau, Yves; Van Mechelen, Iven; Schuit, Frans			Using Ribosomal Protein Genes as Reference: A Tale of Caution	PLOS ONE			English	Article								Background: Housekeeping genes are needed in every tissue as their expression is required for survival, integrity or duplication of every cell. Housekeeping genes commonly have been used as reference genes to normalize gene expression data, the underlying assumption being that they are expressed in every cell type at approximately the same level. Often, the terms "reference genes'' and "housekeeping genes'' are used interchangeably. In this paper, we would like to distinguish between these terms. Consensus is growing that housekeeping genes which have traditionally been used to normalize gene expression data are not good reference genes. Recently, ribosomal protein genes have been suggested as reference genes based on a meta-analysis of publicly available microarray data. Methodology/Principal Findings: We have applied several statistical tools on a dataset of 70 microarrays representing 22 different tissues, to assess and visualize expression stability of ribosomal protein genes. We confirmed the housekeeping status of these genes, but further estimated expression stability across tissues in order to assess their potential as reference genes. One- and two-way ANOVA revealed that all ribosomal protein genes have significant expression variation across tissues and exhibit tissue-dependent expression behavior as a group. Via multidimensional unfolding analysis, we visualized this tissue-dependency. In addition, we explored mechanisms that may cause tissue dependent effects of individual ribosomal protein genes. Conclusions/Significance: Here we provide statistical and biological evidence that ribosomal protein genes exhibit important tissue-dependent variation in mRNA expression. Though these genes are most stably expressed of all investigated genes in a meta-analysis they cannot be considered true reference genes.	[Thorrez, Lieven; Van Lommel, Leentje; Schuit, Frans] Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, Louvain, Belgium; [Thorrez, Lieven; Tranchevent, Leon-Charles; Moreau, Yves] Katholieke Univ Leuven, ESAT SCD, Dept Elect Engn, Louvain, Belgium; [Van Deun, Katrijn; Van Mechelen, Iven] Katholieke Univ Leuven, Dept Psychol, Louvain, Belgium; [Engelen, Kristof; Marchal, Kathleen] Katholieke Univ Leuven, Dept Microb & Mol Syst, Louvain, Belgium; [Thorrez, Lieven; Van Deun, Katrijn; Tranchevent, Leon-Charles; Van Lommel, Leentje; Engelen, Kristof; Marchal, Kathleen; Moreau, Yves; Van Mechelen, Iven; Schuit, Frans] KU Leuven Ctr Computat Syst Biol, SymBioSys, Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven	Thorrez, L (corresponding author), Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, Louvain, Belgium.	frans.schuit@med.kuleuven.be	Marchal, Kathleen/B-5001-2013; Marchal, Kathleen/O-7936-2017; Thorrez, Lieven/A-2583-2011	Marchal, Kathleen/0000-0002-2169-4588; Marchal, Kathleen/0000-0002-2169-4588; Thorrez, Lieven/0000-0002-5896-6823; Tranchevent, Leon-Charles/0000-0002-1257-4824; Engelen, Kristof/0000-0001-6215-1689; Moreau, Yves/0000-0002-4647-6560	Katholieke Universiteit Leuven [GOA/2004/11]; Belgian Federal Science Policy Office; EU-RTD: ERNSI: FP6-MC-EST Bioptrain	Katholieke Universiteit Leuven(KU Leuven); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); EU-RTD: ERNSI: FP6-MC-EST Bioptrain	This research was supported by research grants from the Katholieke Universiteit Leuven (GOA 2004 11 to the FS laboratory, GOA AMBioRICS (2004 2009) and SymBioSys, CoE EF 05 007) and the Belgian Federal Science Policy Office (IUAP P6 25 BioMaGNet, 2007 2011). L. Tranchevent is funded by EU-RTD, ERNSI, FP6 MC EST Bioptrain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman NJ, 1997, GENOMICS, V42, P146, DOI 10.1006/geno.1997.4687; Borg I, 2010, MODERN MULTIDIMENSIO; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Cooper GM, 2000, CELL MOL APPROACH; Cuccurese M, 2005, NUCLEIC ACIDS RES, V33, P5965, DOI 10.1093/nar/gki905; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Maccoux LJ, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-62; Nakao M, 2005, NUCLEIC ACIDS RES, V33, P2355, DOI 10.1093/nar/gki520; Peters IR, 2007, VET IMMUNOL IMMUNOP, V117, P55, DOI 10.1016/j.vetimm.2007.01.011; RUBIN AD, 1968, NATURE, V220, P196, DOI 10.1038/220196a0; Schoonjans L, 2003, STEM CELLS, V21, P90, DOI 10.1634/stemcells.21-1-90; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Van Deun K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-181; VanRaay TJ, 1996, GENOMICS, V37, P172, DOI 10.1006/geno.1996.0538	25	151	154	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1854	10.1371/journal.pone.0001854	http://dx.doi.org/10.1371/journal.pone.0001854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365009	Green Published, gold			2022-12-27	WOS:000260762400015
J	Yu, RX; Liu, J; True, N; Wang, W				Yu, Ron X.; Liu, Jie; True, Nick; Wang, Wei			Identification of Direct Target Genes Using Joint Sequence and Expression Likelihood with Application to DAF-16	PLOS ONE			English	Article								A major challenge in the post-genome era is to reconstruct regulatory networks from the biological knowledge accumulated up to date. The development of tools for identifying direct target genes of transcription factors (TFs) is critical to this endeavor. Given a set of microarray experiments, a probabilistic model called TRANSMODIS has been developed which can infer the direct targets of a TF by integrating sequence motif, gene expression and ChIP-chip data. The performance of TRANSMODIS was first validated on a set of transcription factor perturbation experiments (TFPEs) involving Pho4p, a well studied TF in Saccharomyces cerevisiae. TRANSMODIS removed elements of arbitrariness in manual target gene selection process and produced results that concur with one's intuition. TRANSMODIS was further validated on a genome-wide scale by comparing it with two other methods in Saccharomyces cerevisiae. The usefulness of TRANSMODIS was then demonstrated by applying it to the identification of direct targets of DAF-16, a critical TF regulating ageing in Caenorhabditis elegans. We found that 189 genes were tightly regulated by DAF-16. In addition, DAF-16 has differential preference for motifs when acting as an activator or repressor, which awaits experimental verification. TRANSMODIS is computationally efficient and robust, making it a useful probabilistic framework for finding immediate targets.	[Yu, Ron X.; Liu, Jie; Wang, Wei] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA USA; [Liu, Jie; Wang, Wei] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA USA; [True, Nick] Univ Calif San Diego, Dept Comp Sci, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Yu, RX (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA USA.	wei-wang@ucsd.edu			NIH; Center for Theoretical Biological Physics (CTBP)	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Theoretical Biological Physics (CTBP)	This work is partially funded by NIH and the Center for Theoretical Biological Physics (CTBP).	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Beyer A, 2006, PLOS COMPUT BIOL, V2, P615, DOI 10.1371/journal.pcbi.0020070; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Bussemaker HJ, 2000, P NATL ACAD SCI USA, V97, P10096, DOI 10.1073/pnas.180265397; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Conlon EM, 2003, P NATL ACAD SCI USA, V100, P3339, DOI 10.1073/pnas.0630591100; Das D, 2004, P NATL ACAD SCI USA, V101, P16234, DOI 10.1073/pnas.0407365101; Das D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100067; Flick JS, 1998, GENETICS, V148, P33; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Gordon DB, 2005, BIOINFORMATICS, V21, P3164, DOI 10.1093/bioinformatics/bti481; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HERTZ GZ, 1990, COMPUT APPL BIOSCI, V6, P81; Honda Y, 2002, ANN NY ACAD SCI, V959, P466, DOI 10.1111/j.1749-6632.2002.tb02117.x; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; KANEKO Y, 1987, GENE, V58, P137; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Martinez P, 1998, MOL GEN GENET, V258, P628, DOI 10.1007/s004380050776; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Narlikar L, 2006, BIOINFORMATICS, V22, pE384, DOI 10.1093/bioinformatics/btl251; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schwarz EM, 2006, NUCLEIC ACIDS RES, V34, pD475, DOI 10.1093/nar/gkj061; Segal E, 2003, BIOINFORMATICS, V19, pi273, DOI 10.1093/bioinformatics/btg1038; Segal E, 2001, Bioinformatics, V17 Suppl 1, pS243; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang W, 2005, P NATL ACAD SCI USA, V102, P1998, DOI 10.1073/pnas.0405537102; Wang W, 2002, P NATL ACAD SCI USA, V99, P16893, DOI 10.1073/pnas.252638199; WINGENDER E, 1988, NUCLEIC ACIDS RES, V16, P1879, DOI 10.1093/nar/16.5.1879; WURST H, 1995, J BACTERIOL, V177, P898, DOI 10.1128/jb.177.4.898-906.1995; Yompakdee C, 1996, GENE, V171, P41, DOI 10.1016/0378-1119(96)00079-0	40	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1821	10.1371/journal.pone.0001821	http://dx.doi.org/10.1371/journal.pone.0001821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350157	gold, Green Published, Green Submitted			2022-12-27	WOS:000260762300023
J	Haeberle, H; Bryan, LA; Vadakkan, TJ; Dickinson, ME; Lumpkin, EA				Haeberle, Henry; Bryan, Leigh A.; Vadakkan, Tegy J.; Dickinson, Mary E.; Lumpkin, Ellen A.			Swelling-Activated Ca2+ Channels Trigger Ca2+ Signals in Merkel Cells	PLOS ONE			English	Article								Merkel cell-neurite complexes are highly sensitive touch receptors comprising epidermal Merkel cells and sensory afferents. Based on morphological and molecular studies, Merkel cells are proposed to be mechanosensory cells that signal afferents via neurotransmission; however, functional studies testing this hypothesis in intact skin have produced conflicting results. To test this model in a simplified system, we asked whether purified Merkel cells are directly activated by mechanical stimulation. Cell shape was manipulated with anisotonic solution changes and responses were monitored by Ca2+ imaging with fura-2. We found that hypotonic-induced cell swelling, but not hypertonic solutions, triggered cytoplasmic Ca2+ transients. Several lines of evidence indicate that these signals arise from swelling-activated Ca2+-permeable ion channels. First, transients were reversibly abolished by chelating extracellular Ca2+, demonstrating a requirement for Ca2+ influx across the plasma membrane. Second, Ca2+ transients were initially observed near the plasma membrane in cytoplasmic processes. Third, voltage-activated Ca2+ channel (VACC) antagonists reduced transients by half, suggesting that swelling-activated channels depolarize plasma membranes to activate VACCs. Finally, emptying internal Ca2+ stores attenuated transients by 80%, suggesting Ca2+ release from stores augments swelling-activated Ca2+ signals. To identify candidate mechanotransduction channels, we used RT-PCR to amplify ion-channel transcripts whose pharmacological profiles matched those of hypotonic-evoked Ca2+ signals in Merkel cells. We found 11 amplicons, including PKD1, PKD2, and TRPC1, channels previously implicated in mechanotransduction in other cells. Collectively, these results directly demonstrate that Merkel cells are activated by hypotonic-evoked swelling, identify cellular signaling mechanisms that mediate these responses, and support the hypothesis that Merkel cells contribute to touch reception in the Merkel cell-neurite complex.	[Haeberle, Henry] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Haeberle, Henry; Bryan, Leigh A.; Lumpkin, Ellen A.] Baylor Coll Med, Dept Neurosci, Houston, TX USA; [Vadakkan, Tegy J.; Dickinson, Mary E.; Lumpkin, Ellen A.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX USA; [Lumpkin, Ellen A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX USA	University of California System; University of California San Francisco; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Haeberle, H (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA.	lumpkin@bcm.edu		Lumpkin, Ellen/0000-0002-1166-3374	Gillson Longenbaugh Foundation; Sandler Program in Basic Sciences; NIH [R01AR051219, R01HL077187, P20EB007076]; NSF graduate research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P20EB007076] Funding Source: NIH RePORTER	Gillson Longenbaugh Foundation; Sandler Program in Basic Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF graduate research fellowship(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the Gillson Longenbaugh Foundation (E. A. L.), the Sandler Program in Basic Sciences (E. A. L.), the NIH (NIAMS R01AR051219 to E. A. L., NHLBI R01HL077187 and NIBIB P20EB007076 to M. E. D.) and the NSF (graduate research fellowship to H. H.). The funding agencies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Altamirano J, 1998, J GEN PHYSIOL, V112, P145, DOI 10.1085/jgp.112.2.145; Arnaout MA, 2001, ANNU REV MED, V52, P93, DOI 10.1146/annurev.med.52.1.93; Baumann KI, 1996, NEUROSCI LETT, V213, P1, DOI 10.1016/0304-3940(96)12813-5; Blount P, 1996, BIOL CELL, V87, P1, DOI 10.1016/S0248-4900(97)89832-2; Chen Y, 1996, AM J PHYSIOL-CELL PH, V270, pC1790, DOI 10.1152/ajpcell.1996.270.6.C1790; Cibulsky SM, 1999, J PHARMACOL EXP THER, V289, P1447; Colbert HA, 1997, J NEUROSCI, V17, P8259; CRIST JR, 1993, HEARING RES, V69, P194, DOI 10.1016/0378-5955(93)90107-C; DIETRICH A, 2007, PRESSURE INDUCED STO; Du HP, 1996, NEURON, V16, P183, DOI 10.1016/S0896-6273(00)80035-5; Dumont RA, 2002, JARO-J ASSOC RES OTO, V3, P375, DOI 10.1007/s101620020049; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; GARCIAANOVEROS J, 1995, CURR BIOL, V5, P441, DOI 10.1016/S0960-9822(95)00085-6; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Halata Z, 2003, ANAT REC PART A, V271A, P225, DOI 10.1002/ar.a.10029; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hayashi Y, 1996, BIOPHYS J, V71, P1057, DOI 10.1016/S0006-3495(96)79306-2; Hitchcock IS, 2004, NEUROSCI LETT, V362, P196, DOI 10.1016/j.neulet.2004.02.071; Hudspeth AJ, 2000, CURR OPIN NEUROBIOL, V10, P631, DOI 10.1016/S0959-4388(00)00133-1; IGGO A, 1969, J PHYSIOL-LONDON, V200, P763, DOI 10.1113/jphysiol.1969.sp008721; IGGO A, 1984, SENSORY RECEPTOR MEC, P117; IKEDA I, 1994, J PHYSIOL-LONDON, V479, P247, DOI 10.1113/jphysiol.1994.sp020292; IKEDA K, 1991, ORL J OTO-RHINO-LARY, V53, P78, DOI 10.1159/000276192; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Kinkelin I, 1999, EUR J NEUROSCI, V11, P3963, DOI 10.1046/j.1460-9568.1999.00822.x; Kung C, 2004, MOL MICROBIOL, V53, P373, DOI 10.1111/j.1365-2958.2004.04180.x; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; LUMPKIN EA, 1995, P NATL ACAD SCI USA, V92, P10297, DOI 10.1073/pnas.92.22.10297; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Lumpkin EA, 2007, NATURE, V445, P858, DOI 10.1038/nature05662; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; MILLS LR, 1995, J NEUROCYTOL, V24, P117, DOI 10.1007/BF01181555; NAGASAKI K, 1989, CELL CALCIUM, V10, P63, DOI 10.1016/0143-4160(89)90045-6; Nakafusa J, 2006, BRIT J DERMATOL, V155, P883, DOI 10.1111/j.1365-2133.2006.07441.x; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nunzi MG, 2004, J NEUROCYTOL, V33, P359, DOI 10.1023/B:NEUR.0000044196.45602.92; Ogawa H, 1996, PROG NEUROBIOL, V49, P317, DOI 10.1016/0301-0082(96)00018-4; OIKE M, 1994, P NATL ACAD SCI USA, V91, P2940, DOI 10.1073/pnas.91.8.2940; Pacitti E G, 1988, Prog Brain Res, V74, P37; Piontek KB, 2004, J AM SOC NEPHROL, V15, P3035, DOI 10.1097/01.ASN.0000144204.01352.86; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Tachibana T, 1997, ARCH HISTOL CYTOL, V60, P379, DOI 10.1679/aohc.60.379; Tazaki M, 1998, NEUROSCI LETT, V243, P69, DOI 10.1016/S0304-3940(98)00066-4; Toyoshima K, 1998, J HISTOCHEM CYTOCHEM, V46, P1329, DOI 10.1177/002215549804601113; Viana F, 2001, EUR J NEUROSCI, V13, P722, DOI 10.1046/j.0953-816x.2000.01441.x; Woodbury CJ, 2007, J COMP NEUROL, V505, P547, DOI 10.1002/cne.21517; YAMASHITA Y, 1992, J PHYSIOL-LONDON, V450, P143, DOI 10.1113/jphysiol.1992.sp019120; Zitt C, 1996, NEURON, V16, P1189, DOI 10.1016/S0896-6273(00)80145-2	56	34	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1750	10.1371/journal.pone.0001750	http://dx.doi.org/10.1371/journal.pone.0001750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18454189	gold, Green Published, Green Submitted			2022-12-27	WOS:000260723000004
J	Thaut, MH; Demartin, M; Sanes, JN				Thaut, Michael H.; Demartin, Martina; Sanes, Jerome N.			Brain Networks for Integrative Rhythm Formation	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; SENSORIMOTOR SYNCHRONIZATION; FINGER MOVEMENTS; TEMPORAL INFORMATION; CEREBELLAR LESIONS; PARKINSONS-DISEASE; PREFRONTAL CORTEX; VISUAL-ATTENTION; PARIETAL CORTEX; TIME PERCEPTION	Background: Performance of externally paced rhythmic movements requires brain and behavioral integration of sensory stimuli with motor commands. The underlying brain mechanisms to elaborate beat-synchronized rhythm and polyrhythms that musicians readily perform may differ. Given known roles in perceiving time and repetitive movements, we hypothesized that basal ganglia and cerebellar structures would have greater activation for polyrhythms than for on-the-beat rhythms. Methodology/Principal Findings: Using functional MRI methods, we investigated brain networks for performing rhythmic movements paced by auditory cues. Musically trained participants performed rhythmic movements at 2 and 3 Hz either at a 1: 1 on-the-beat or with a 3: 2 or a 2: 3 stimulus-movement structure. Due to their prior musical experience, participants performed the 3: 2 or 2: 3 rhythmic movements automatically. Both the isorhythmic 1: 1 and the polyrhythmic 3: 2 or 2: 3 movements yielded the expected activation in contralateral primary motor cortex and related motor areas and ipsilateral cerebellum. Direct comparison of functional MRI signals obtained during 3: 2 or 2: 3 and on-the-beat rhythms indicated activation differences bilaterally in the supplementary motor area, ipsilaterally in the supramarginal gyrus and caudate-putamen and contralaterally in the cerebellum. Conclusions/Significance: The activated brain areas suggest the existence of an interconnected brain network specific for complex sensory-motor rhythmic integration that might have specificity for elaboration of musical abilities.	[Thaut, Michael H.] Colorado State Univ, Ctr Biomed Res Mus, Ft Collins, CO 80523 USA; [Thaut, Michael H.] Colorado State Univ, Mol, Cellular, & Integrat Neurosci Program, Ft Collins, CO USA; [Demartin, Martina] Inst Expt Med, Natl Res Council, Rome, Italy; [Sanes, Jerome N.] Brown Univ, Alpert Med Sch, Dept Neurosci, Providence, RI USA; [Sanes, Jerome N.] IRCCS, Fdn Santa Lucia, Lab Funct Neuroimag, Rome, Italy	Colorado State University; Colorado State University; Brown University; IRCCS Santa Lucia	Thaut, MH (corresponding author), Colorado State Univ, Ctr Biomed Res Mus, Ft Collins, CO 80523 USA.	Jerome_Sanes@Brown.edu			Colorado Commission on Higher Education [Center of Excellence Grant]; National Institutes of Health [R01-AG10684, K02-NS35376]; Italian Ministry of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG010684] Funding Source: NIH RePORTER	Colorado Commission on Higher Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of Health(Ministry of Health, Italy); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds granted from a Center of Excellence Grant by the Colorado Commission on Higher Education to Michael H. Thaut, the National Institutes of Health to Jerome N. Sanes (R01-AG10684, K02-NS35376), and the Italian Ministry of Health to Foundation Santa Lucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCHERSLEBEN G, 1995, PERCEPT PSYCHOPHYS, V57, P305, DOI 10.3758/BF03213056; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; BEAUVILLAIN C, 1984, MUSIC PERCEPT, V1, P485; Blacking John, 1973, MUSICAL IS MAN; BOECKER H, 1994, BRAIN, V117, P1231, DOI 10.1093/brain/117.6.1231; Bogacz S, 2005, J MOTOR BEHAV, V37, P21, DOI 10.3200/JMBR.37.1.21-34; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1717, DOI 10.1152/jn.1996.76.3.1717; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1698, DOI 10.1152/jn.1996.76.3.1698; Chen R, 1997, ANN NEUROL, V41, P247, DOI 10.1002/ana.410410216; Clynes, 1982, MUSIC MIND BRAIN, P83, DOI [10.1007/978-1-4684-8917-0_5, DOI 10.1007/978-1-4684-8917-0_5]; Cooper G., 1960, RHYTHMIC STRUCTURE M; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DEUTSCH D, 1983, PERCEPT PSYCHOPHYS, V34, P331, DOI 10.3758/BF03203045; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; EPSTEIN D, 1985, MUSIC THEOR SPECTRUM, V7, P34, DOI 10.1525/mts.1985.7.1.02a00030; Del Olmo MF, 2007, J NEUROPHYSIOL, V98, P145, DOI 10.1152/jn.01088.2006; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; GRACCO VL, 1988, EXP BRAIN RES, V71, P515, DOI 10.1007/BF00248744; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Harrington DL, 1998, J NEUROSCI, V18, P1085; Indovina I, 2001, EXP BRAIN RES, V140, P265, DOI 10.1007/s002210100796; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; JAGACINSKI RJ, 1988, J MOTOR BEHAV, V20, P416; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; Jancke L, 1998, NEUROSCI LETT, V252, P37, DOI 10.1016/S0304-3940(98)00540-0; KELSO JAS, 1990, ATTENTION PERFORM, P139; Kelso JAS, 1998, NATURE, V392, P814, DOI 10.1038/33922; Kim JA, 2005, J NEUROPHYSIOL, V94, P2504, DOI 10.1152/jn.01047.2004; Kimpo RR, 2003, J NEUROSCI, V23, P5750; Klapp ST, 1998, J MOTOR BEHAV, V30, P301, DOI 10.1080/00222899809601346; Krampe RT, 2000, J EXP PSYCHOL HUMAN, V26, P206, DOI 10.1037/0096-1523.26.1.206; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lashley KS, 1930, PSYCHOL REV, V37, P1, DOI 10.1037/h0074134; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; MATES J, 1994, BIOL CYBERN, V70, P463, DOI 10.1007/BF00203239; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; Molinari M, 2005, BRAIN RES BULL, V67, P448, DOI 10.1016/j.brainresbull.2005.07.014; Muller K, 2000, J COGNITIVE NEUROSCI, V12, P546, DOI 10.1162/089892900562282; OBoyle DJ, 1996, BRAIN, V119, P51, DOI 10.1093/brain/119.1.51; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PALMER C, 1990, J EXP PSYCHOL HUMAN, V16, P728, DOI 10.1037/0096-1523.16.4.728; PARNCUTT R, 1994, MUSIC PERCEPT, V11, P409; Parsons L, 2001, NEUROIMAGE, V13, pS925; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; Pressing J, 2002, MUSIC PERCEPT, V19, P285, DOI 10.1525/mp.2002.19.3.285; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Repp BH, 2001, HUM MOVEMENT SCI, V20, P277, DOI 10.1016/S0167-9457(01)00049-5; Rijntjes M, 1999, J NEUROSCI, V19, P8043; Roberts S, 2000, PHYS REV E, V62, P2597, DOI 10.1103/PhysRevE.62.2597; Rounis E, 2007, J COGNITIVE NEUROSCI, V19, P513, DOI 10.1162/jocn.2007.19.3.513; Rushworth MFS, 2001, J NEUROSCI, V21, P5262, DOI 10.1523/JNEUROSCI.21-14-05262.2001; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Rushworth MFS, 2001, J COGNITIVE NEUROSCI, V13, P698, DOI 10.1162/089892901750363244; Schlaug G, 1996, NEUROREPORT, V7, P879, DOI 10.1097/00001756-199603220-00009; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Snyder B, 2000, MUSIC AND MEMORY; Spencer RMC, 2007, NEUROIMAGE, V36, P378, DOI 10.1016/j.neuroimage.2007.03.009; Spencer RMC, 2005, BRAIN COGNITION, V58, P84, DOI 10.1016/j.bandc.2004.09.010; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Stephan KM, 2002, NEUROIMAGE, V15, P345, DOI 10.1006/nimg.2001.0929; STEPHAN KM, 2002, CORTICOCEREBELLAR CI; Summers J, 2002, BRAIN COGNITION, V48, P166, DOI 10.1006/brcg.2001.1311; Tajima M, 1999, PERCEPT MOTOR SKILL, V88, P1160, DOI 10.2466/PMS.88.3.1160-1168; Talairach J., 1988, COPLANAR STEREOTAXIC; Tecchio F, 2000, EXP BRAIN RES, V135, P222, DOI 10.1007/s002210000507; Thaut MH, 2003, HUM MOVEMENT SCI, V22, P321, DOI 10.1016/S0167-9457(03)00048-4; Thaut MH, 1998, BIOL CYBERN, V79, P241, DOI 10.1007/s004220050474; Thaut MH, 1999, IEEE ENG MED BIOL, V18, P101, DOI 10.1109/51.752991; THAUT MH, 2008, CORTEX IN PRESS; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Ullen F, 2003, J NEUROPHYSIOL, V89, P1126, DOI 10.1152/jn.00775.2002; Vorberg D., 1996, HDB PERCEPT ACTION, P181, DOI [10.1016/S1874-5822(06)80007-1, DOI 10.1016/S1874-5822(06)80007-1, 10.1016/S1874-5822(06)80007-1.]; Vuust P, 2006, NEUROIMAGE, V31, P832, DOI 10.1016/j.neuroimage.2005.12.037; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	87	40	41	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2312	10.1371/journal.pone.0002312	http://dx.doi.org/10.1371/journal.pone.0002312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391XW	18509462	gold, Green Submitted, Green Published			2022-12-27	WOS:000262268500042
J	van der Stoop, P; Boutsma, EA; Hulsman, D; Noback, S; Heimerikx, M; Kerkhoven, RM; Voncken, JW; Wessels, LFA; van Lohuizen, M				van der Stoop, Petra; Boutsma, Erwin A.; Hulsman, Danielle; Noback, Sonja; Heimerikx, Mike; Kerkhoven, Ron M.; Voncken, J. Willem; Wessels, Lodewyk F. A.; van Lohuizen, Maarten			Ubiquitin E3 Ligase Ring1b/Rnf2 of Polycomb Repressive Complex 1 Contributes to Stable Maintenance of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							RNA-POLYMERASE-II; HISTONE H2A; DEVELOPMENTAL REGULATORS; POLYHOMEOTIC GENE; X-INACTIVATION; SELF-RENEWAL; TARGET GENES; DIFFERENTIATION; PROTEINS; PLURIPOTENCY	Background: Polycomb repressive complex 1 (PRC1) core member Ring1b/Rnf2, with ubiquitin E3 ligase activity towards histone H2A at lysine 119, is essential for early embryogenesis. To obtain more insight into the role of Ring1b in early development, we studied its function in mouse embryonic stem (ES) cells. Methodology/Principal Findings: We investigated the effects of Ring1b ablation on transcriptional regulation using Ring1b conditional knockout ES cells and large-scale gene expression analysis. The absence of Ring1b results in aberrant expression of key developmental genes and deregulation of specific differentiation-related pathways, including TGFbeta signaling, cell cycle regulation and cellular communication. Moreover, ES cell markers, including Zfp42/Rex-1 and Sox2, are downregulated. Importantly, retained expression of ES cell regulators Oct4, Nanog and alkaline phosphatase indicates that Ring1b-deficient ES cells retain important ES cell specific characteristics. Comparative analysis of our expression profiling data with previously published global binding studies shows that the genes that are bound by Ring1b in ES cells have bivalent histone marks, i.e. both active H3K4me3 and repressive H3K27me3, or the active H3K4me3 histone mark alone and are associated with CpG- rich' promoters. However, deletion of Ring1b results in deregulation, mainly derepression, of only a subset of these genes, suggesting that additional silencing mechanisms are involved in repression of the other Ring1b bound genes in ES cells. Conclusions: Ring1b is essential to stably maintain an undifferentiated state of mouse ES cells by repressing genes with important roles during differentiation and development. These genes are characterized by high CpG content promoters and bivalent histone marks or the active H3K4me3 histone mark alone.	[van der Stoop, Petra; Boutsma, Erwin A.; Hulsman, Danielle; Noback, Sonja; van Lohuizen, Maarten] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Heimerikx, Mike; Kerkhoven, Ron M.] Netherlands Canc Inst, Ctr Biomed Genet, Amsterdam, Netherlands; [Wessels, Lodewyk F. A.] Netherlands Canc Inst, Div Mol Biol, Amsterdam, Netherlands; [Voncken, J. Willem] Maastricht Univ, Med Ctr, Dept Mol Genet, Maastricht, Netherlands; [van Lohuizen, Maarten] Univ Amsterdam, Acad Med Ctr, Dept Neurogenet, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam	van der Stoop, P (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	m.v.lohuizen@nki.nl			Dutch Cancer Foundation; Dutch organization for Scientific Research	Dutch Cancer Foundation(KWF Kankerbestrijding); Dutch organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from the Dutch Cancer Foundation (KWF) and the Dutch organization for Scientific Research (NWO).	Akasaka T, 1996, DEVELOPMENT, V122, P1513; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Breiling A, 2004, EMBO REP, V5, P976, DOI 10.1038/sj.embor.7400260; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; DECAMILLIS M, 1992, GENE DEV, V6, P223, DOI 10.1101/gad.6.2.223; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FAUST C, 1995, DEVELOPMENT, V121, P273; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lorente MD, 2000, DEVELOPMENT, V127, P5093; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minucci S, 1996, EMBO J, V15, P888, DOI 10.1002/j.1460-2075.1996.tb00423.x; Mulholland NM, 2003, GENE DEV, V17, P2741, DOI 10.1101/gad.1143303; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; PEASE S, 1990, DEV BIOL, V141, P344, DOI 10.1016/0012-1606(90)90390-5; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schenke-Layland K, 2007, STEM CELLS, V25, P1529, DOI 10.1634/stemcells.2006-0729; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Takihara Y, 1997, DEVELOPMENT, V124, P3673; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wei JH, 2006, J BIOL CHEM, V281, P22537, DOI 10.1074/jbc.M600826200; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; Wong RCB, 2004, STEM CELLS, V22, P883, DOI 10.1634/stemcells.22-6-883; Yamauchi M, 2007, CANCER SCI, V98, P1491, DOI 10.1111/j.1349-7006.2007.00534.x; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	68	84	84	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2235	10.1371/journal.pone.0002235	http://dx.doi.org/10.1371/journal.pone.0002235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493325	Green Published, gold			2022-12-27	WOS:000262258700043
J	Porto, I; Granados, C; Restrepo, JC; Sanchez, JA				Porto, Isabel; Granados, Camila; Restrepo, Juan C.; Sanchez, Juan A.			Macroalgal-Associated Dinoflagellates Belonging to the Genus Symbiodinium in Caribbean Reefs	PLOS ONE			English	Article							SPARISOMA-VIRIDE; CORAL; DIVERSITY; SPECIFICITY; ZOOXANTHELLAE; PREDATION; OCTOCORAL; SYMBIOSIS; DYNAMICS; PACIFIC	Coral-algal symbiosis has been a subject of great attention during the last two decades in response to global coral reef decline. However, the occurrence and dispersion of free-living dinoflagellates belonging to the genus Symbiodinium are less documented. Here ecological and molecular evidence is presented demonstrating the existence of demersal free-living Symbiodinium populations in Caribbean reefs and the possible role of the stoplight parrotfish (Sparisoma viride) as Symbiodinium spp. dispersers. Communities of free-living Symbiodinium were found within macroalgal beds consisting of Halimeda spp., Lobophora variegata, Amphiroa spp., Caulerpa spp. and Dictyota spp. Viable Symbiodinium spp. cells were isolated and cultured from macroalgal beds and S. viride feces. Further identification of Symbiodinium spp. type was determined by length variation in the Internal Transcribed Spacer 2 (ITS2, nuclear rDNA) and length variation in domain V of the chloroplast large subunit ribosomal DNA (cp23S-rDNA). Determination of free-living Symbiodinium and mechanisms of dispersal is important in understanding the life cycle of Symbiodinium spp.	[Porto, Isabel; Granados, Camila; Restrepo, Juan C.; Sanchez, Juan A.] Univ Los Andes, Dept Ciencias Biol, Fac Ciencias, Lab Biol Mol Marina BIOMMAR, Bogota, DC, Colombia	Universidad de los Andes (Colombia)	Porto, I (corresponding author), Univ Los Andes, Dept Ciencias Biol, Fac Ciencias, Lab Biol Mol Marina BIOMMAR, Bogota, DC, Colombia.	juansanc@uniandes.edu.co	sanchez, juan/GSD-8167-2022	Sanchez, Juan Armando/0000-0001-7149-8369	COLCIENCIAS [120409-16825]; Facultad de Ciencias, Department of Biological Sciences, Universidad de los Andes	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Facultad de Ciencias, Department of Biological Sciences, Universidad de los Andes	This study was funded by COLCIENCIAS (No. 120409-16825), J. Dave Hardy Jr. (Tobago), and Facultad de Ciencias, Department of Biological Sciences, Universidad de los Andes (funding to J.A. Sanchez). These funding agencies granted the money without any commercial or unethical interest, other than providing support for this research. They did not have any role making the manuscript. The Minister of Environment, Household and Territorial Development of Colombia granted access to genetic resources to J.A.S. for the DNA analyses included in this paper (Contract 007, resolution 634, 14 March 2007).	ALLDREDGE AL, 1977, MAR BIOL, V41, P317, DOI 10.1007/BF00389098; BAKER A, 2003, EVOL SYST, V34, P661; Barnes D.J., 1990, P109; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bruckner AW, 2000, CORAL REEFS, V19, P50, DOI 10.1007/s003380050225; BRUGGEMANN JH, 1994, MAR ECOL PROG SER, V106, P41, DOI 10.3354/meps106041; Bruggemann JH, 1996, MAR ECOL PROG SER, V134, P59, DOI 10.3354/meps134059; BURRIS RH, 1983, MAR BIOL, V75, P151, DOI 10.1007/BF00405997; Carlos AA, 1999, J PHYCOL, V35, P1054, DOI 10.1046/j.1529-8817.1999.3551054.x; CHANG FH, 1983, NEW ZEAL J MAR FRESH, V17, P279, DOI 10.1080/00288330.1983.9516003; COFFROTH M, 2006, CURR BIOL, V16; COFFROTH MA, 1992, MAR BIOL, V114, P317, DOI 10.1007/BF00349534; Coffroth MA, 2001, MAR ECOL PROG SER, V222, P85, DOI 10.3354/meps222085; Elbrachter M, 2003, J PHYCOL, V39, P629, DOI 10.1046/j.1529-8817.2003.39041.x; Gomez-Cabrera MD, 2008, CORAL REEFS, V27, P219, DOI 10.1007/s00338-007-0315-x; Gou WL, 2003, J EXP MAR BIOL ECOL, V296, P135, DOI 10.1016/S0022-0981(03)00242-9; Goulet TL, 2003, MAR ECOL PROG SER, V250, P117, DOI 10.3354/meps250117; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hoegh-Guldberg O, 2002, NATURE, V415, P601, DOI 10.1038/415601a; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; Lewis CL, 2004, SCIENCE, V304, P1490, DOI 10.1126/science.1097323; Littler MM, 2007, AQUAT CONSERV, V17, P195, DOI 10.1002/aqc.790; Miller MW, 1998, OECOLOGIA, V113, P231, DOI 10.1007/s004420050373; Muscatine L., 1990, P75; PARKER GM, 1984, BIOL BULL, V167, P159, DOI 10.2307/1541344; Parrow MW, 2004, J PHYCOL, V40, P664, DOI 10.1111/j.1529-8817.2004.03202.x; Pasternak Z, 2006, CORAL REEFS, V25, P201, DOI 10.1007/s00338-005-0085-2; PEARSE VB, 1971, BIOL BULL, V141, P350, DOI 10.2307/1540123; Pochon X, 2001, MAR BIOL, V139, P1069; POSADA D, 1998, BIOINFORMATICS, V17, P754; Rodriguez-Lanetty M, 2003, MAR BIOL, V143, P1193, DOI 10.1007/s00227-003-1165-x; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Sanchez JA, 2004, CORAL REEFS, V23, P578, DOI 10.1007/s00338-004-0419-5; Santos SR, 2003, MAR BIOTECHNOL, V5, P130, DOI 10.1007/s10126-002-0076-9; Santos SR, 2001, J PHYCOL, V37, P900, DOI 10.1046/j.1529-8817.2001.00194.x; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Thornhill DJ, 2006, J EXP MAR BIOL ECOL, V338, P50, DOI 10.1016/j.jembe.2006.06.032; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; Vila M, 2001, AQUAT MICROB ECOL, V26, P51, DOI 10.3354/ame026051; Yacobovitch T, 2004, J EXP MAR BIOL ECOL, V298, P35, DOI 10.1016/j.jembe.2003.08.003; Yahel R, 2005, CORAL REEFS, V24, P75, DOI 10.1007/s00338-004-0449-z; Zhang H, 2005, J PHYCOL, V41, P411, DOI 10.1111/j.1529-8817.2005.04168.x; [No title captured]	48	47	50	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2160	10.1371/journal.pone.0002160	http://dx.doi.org/10.1371/journal.pone.0002160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478069	Green Submitted, gold, Green Published			2022-12-27	WOS:000262172800025
J	Bassett, AR; Cooper, SE; Ragab, A; Travers, AA				Bassett, Andrew R.; Cooper, Sarah E.; Ragab, Anan; Travers, Andrew A.			The Chromatin Remodelling Factor dATRX Is Involved in Heterochromatin Formation	PLOS ONE			English	Article								Despite extensive study of heterochromatin, relatively little is known about the mechanisms by which such a structure forms. We show that the Drosophila homologue of the human alpha-thalassemia and mental retardation X-linked protein (dATRX), is important in the formation or maintenance of heterochromatin through modification of position effect variegation. We further show that there are two isoforms of the dATRX protein, the longer of which interacts directly with heterochromatin protein 1 (dHP-1) through a CxVxL motif both in vitro and in vivo. These two proteins co-localise at heterochromatin in a manner dependent on this motif. Consistent with this observation, the long isoform of the dATRX protein localises primarily to the heterochromatin at the chromocentre on salivary gland polytene chromosomes, whereas the short isoform binds to many sites along the chromosome arms. We suggest that the establishment of a regular nucleosomal organisation may be common to heterochromatin and transcriptionally repressed chromatin in other locations, and may require the action of ATP dependent chromatin remodelling factors.	[Bassett, Andrew R.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Cooper, Sarah E.; Travers, Andrew A.] Med Res Council MRC, Lab Mol Biol, Cambridge, England; [Ragab, Anan] German Canc Res Ctr, Signaling & Funct Genom, Heidelberg, Germany	University of Cambridge; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Helmholtz Association; German Cancer Research Center (DKFZ)	Bassett, AR (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	arb43@cam.ac.uk		Bassett, Andrew/0000-0003-1632-9137	Medical Research Council [Studentship]; MRC [MC_U105184288] Funding Source: UKRI; Medical Research Council [MC_U105184288] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Medical Research Council Studentship	Cardoso C, 2005, DEV BIOL, V278, P49, DOI 10.1016/j.ydbio.2004.10.014; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; de la Cruz X, 2005, BIOESSAYS, V27, P164, DOI 10.1002/bies.20176; EISSENBERG JC, 1992, GENETICS, V131, P345; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; Ishov AM, 2004, J CELL SCI, V117, P3807, DOI 10.1242/jcs.01230; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; LI H, 2006, NATURE; Luciani JJ, 2006, J CELL SCI, V119, P2518, DOI 10.1242/jcs.02965; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; Nan XS, 2007, P NATL ACAD SCI USA, V104, P2709, DOI 10.1073/pnas.0608056104; Nielsen AL, 2002, EMBO J, V21, P5797, DOI 10.1093/emboj/cdf560; Shimono Y, 2003, J BIOL CHEM, V278, P51638, DOI 10.1074/jbc.M309198200; Steensma DP, 2005, BLOOD, V105, P443, DOI 10.1182/blood-2004-07-2792; Stephens GE, 2006, BIOCHEMISTRY-US, V45, P14990, DOI 10.1021/bi060983y; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Sun XT, 2006, GENETICS, V173, P1397, DOI 10.1534/genetics.106.057893; Wallace J, 2005, CHROMOSOMA, V114, P389, DOI 10.1007/s00412-005-0024-6; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Wu CY, 2007, EMBO REP, V8, P1129, DOI 10.1038/sj.embor.7401115; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100	25	28	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2099	10.1371/journal.pone.0002099	http://dx.doi.org/10.1371/journal.pone.0002099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461125	Green Published, gold, Green Submitted			2022-12-27	WOS:000261642400021
J	Smagghe, BJ; Trent, JT; Hargrove, MS				Smagghe, Benoit J.; Trent, James T., III; Hargrove, Mark S.			NO Dioxygenase Activity in Hemoglobins Is Ubiquitous In Vitro, but Limited by Reduction In Vivo	PLOS ONE			English	Article								Genomics has produced hundreds of new hemoglobin sequences with examples in nearly every living organism. Structural and biochemical characterizations of many recombinant proteins reveal reactions, like oxygen binding and NO dioxygenation, that appear general to the hemoglobin superfamily regardless of whether they are related to physiological function. Despite considerable attention to "hexacoordinate'' hemoglobins, which are found in nearly every plant and animal, no clear physiological role(s) has been assigned to them in any species. One popular and relevant hypothesis for their function is protection against NO. Here we have tested a comprehensive representation of hexacoordinate hemoglobins from plants (rice hemoglobin), animals (neuroglobin and cytoglobin), and bacteria (Synechocystis hemoglobin) for their abilities to scavenge NO compared to myoglobin. Our experiments include in vitro comparisons of NO dioxygenation, ferric NO binding, NO-induced reduction, NO scavenging with an artificial reduction system, and the ability to substitute for a known NO scavenger (flavohemoglobin) in E. coli. We conclude that none of these tests reveal any distinguishing predisposition toward a role in NO scavenging for the hxHbs, but that any hemoglobin could likely serve this role in the presence of a mechanism for heme iron re-reduction. Hence, future research to test the role of Hbs in NO scavenging would benefit more from the identification of cognate reductases than from in vitro analysis of NO and O-2 binding.	[Smagghe, Benoit J.; Trent, James T., III; Hargrove, Mark S.] Iowa State Univ, Dept Biochem, Biophys, & Mol Biol, Ames, IA USA	Iowa State University	Smagghe, BJ (corresponding author), Iowa State Univ, Dept Biochem, Biophys, & Mol Biol, Ames, IA USA.	msh@iastate.edu			National Institutes of Health [R01-GM065948]; Iowa State University Plant Sciences Institute; Conseil Regional du Nord-Pas de Calais [doctoral fellowship]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iowa State University Plant Sciences Institute; Conseil Regional du Nord-Pas de Calais(Region Hauts-de-FranceRegion Ile-de-France); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was made possible by the National Institutes of Health Award R01-GM065948, support from the Iowa State University Plant Sciences Institute, by a Contrat Plan-Etat-Region to the Laboratoire Stress abiotiques et differenciation des vegetaux cultives, and by a doctoral fellowship of the Conseil Regional du Nord-Pas de Calais.	ANTONINI E, 1965, PHYSIOL REV, V45, P123, DOI 10.1152/physrev.1965.45.1.123; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; APPLEBY CA, 1992, SCI PROG, V76, P365; Awenius C, 2001, BIOCHEM BIOPH RES CO, V287, P418, DOI 10.1006/bbrc.2001.5614; BROWN WD, 1969, J BIOL CHEM, V244, P6702; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P209, DOI 10.1016/S0968-0004(01)01824-2; Burmester T, 2002, MOL BIOL EVOL, V19, P416, DOI 10.1093/oxfordjournals.molbev.a004096; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Dordas C, 2004, PLANTA, V219, P66, DOI 10.1007/s00425-004-1212-y; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Fago A, 2006, FEBS LETT, V580, P4884, DOI 10.1016/j.febslet.2006.08.003; Fernandez BO, 2004, INORG CHEM, V43, P5393, DOI 10.1021/ic049532x; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Ford PC, 2005, CHEM REV, V105, P2439, DOI 10.1021/cr0307289; Franzen S, 2002, J AM CHEM SOC, V124, P13271, DOI 10.1021/ja017708d; Frey AD, 2002, APPL ENVIRON MICROB, V68, P4835, DOI 10.1128/AEM.68.10.4835-4840.2002; Gardner AM, 2000, J BIOL CHEM, V275, P12581, DOI 10.1074/jbc.275.17.12581; Gardner AM, 2002, J BIOL CHEM, V277, P8166, DOI 10.1074/jbc.M110470200; Gardner PR, 2008, METHOD ENZYMOL, V436, P217, DOI 10.1016/S0076-6879(08)36012-1; Gardner PR, 2006, J INORG BIOCHEM, V100, P542, DOI 10.1016/j.jinorgbio.2005.12.012; Gardner PR, 2000, J BIOL CHEM, V275, P31581, DOI 10.1074/jbc.M004141200; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; Goncalves VL, 2006, FEBS LETT, V580, P1817, DOI 10.1016/j.febslet.2006.02.039; HALDER P, 2006, PROTEINS STRUCTURE F; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Hardison RC, 1996, P NATL ACAD SCI USA, V93, P5675, DOI 10.1073/pnas.93.12.5675; Hargrove MS, 2000, BIOPHYS J, V79, P2733, DOI 10.1016/S0006-3495(00)76512-X; Hargrove MS, 2000, STRUCTURE, V8, P1005, DOI 10.1016/S0969-2126(00)00194-5; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; Helmick RA, 2005, ANTIMICROB AGENTS CH, V49, P1837, DOI 10.1128/AAC.49.5.1837-1843.2005; Hernandez-Urzua E, 2003, J BIOL CHEM, V278, P34975, DOI 10.1074/jbc.M303629200; Herold S, 2005, COMP BIOCHEM PHYS A, V142, P124, DOI 10.1016/j.cbpb.2005.06.009; Herold S, 2005, BIOCHEMISTRY-US, V44, P6223, DOI 10.1021/bi0475929; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Herold S, 2001, BIOCHEMISTRY-US, V40, P3385, DOI 10.1021/bi002407m; Hogg N, 1996, FEBS LETT, V382, P223, DOI 10.1016/0014-5793(96)00086-5; Hoy JA, 2004, J BIOL CHEM, V279, P16535, DOI 10.1074/jbc.M313707200; Hvitved AN, 2001, J BIOL CHEM, V276, P34714, DOI 10.1074/jbc.M105175200; Igamberdiev AU, 2006, PLANTA, V223, P1033, DOI 10.1007/s00425-005-0146-3; Igamberdiev AU, 2004, J EXP BOT, V55, P2473, DOI 10.1093/jxb/erh272; Ilari A, 2002, J BIOL CHEM, V277, P23725, DOI 10.1074/jbc.M202228200; JAKOB W, 1992, ARCH BIOCHEM BIOPHYS, V292, P29, DOI 10.1016/0003-9861(92)90046-Y; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kaur R, 2002, APPL ENVIRON MICROB, V68, P152, DOI 10.1128/AEM.68.1.152-160.2002; Kawada N, 2001, J BIOL CHEM, V276, P25318, DOI 10.1074/jbc.M102630200; Kundu S, 2003, TRENDS PLANT SCI, V8, P387, DOI 10.1016/S1360-1385(03)00163-8; LEDO AFF, 2004, MOL ASPECTS MED, V24, P75; Liu LM, 2000, P NATL ACAD SCI USA, V97, P4672, DOI 10.1073/pnas.090083597; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; Membrillo-Hernandez J, 1998, MOL MICROBIOL, V29, P1101, DOI 10.1046/j.1365-2958.1998.01000.x; Membrillo-Hernandez J, 1999, J BIOL CHEM, V274, P748, DOI 10.1074/jbc.274.2.748; Minning DM, 1999, NATURE, V401, P497, DOI 10.1038/46822; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Olson JS, 2004, FREE RADICAL BIO MED, V36, P685, DOI 10.1016/j.freeradbiomed.2003.11.030; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Perazzolli M, 2006, J EXP BOT, V57, P479, DOI 10.1093/jxb/erj051; Perazzolli M, 2004, PLANT CELL, V16, P2785, DOI 10.1105/tpc.104.025379; Pesce A, 2003, STRUCTURE, V11, P1087, DOI 10.1016/S0969-2126(03)00166-7; Sakamoto A, 2004, FEBS LETT, V572, P27, DOI 10.1016/j.febslet.2004.07.005; Schmidt M, 2003, J BIOL CHEM, V278, P1932, DOI 10.1074/jbc.M209909200; Scott NL, 2002, BIOCHEMISTRY-US, V41, P6902, DOI 10.1021/bi025609m; Singh RJ, 1996, J BIOL CHEM, V271, P18596, DOI 10.1074/jbc.271.31.18596; Smagghe BJ, 2006, BIOCHEMISTRY-US, V45, P561, DOI 10.1021/bi051902l; STAMLER JS, 1992, ANAL CHEM, V64, P779, DOI 10.1021/ac00031a014; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Trandafir F, 2007, GENE, V398, P103, DOI 10.1016/j.gene.2007.02.038; Trent JT, 2001, J BIOL CHEM, V276, P30106, DOI 10.1074/jbc.C100300200; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Trent JT, 2001, BIOCHEMISTRY-US, V40, P6155, DOI 10.1021/bi0100790; Van Doorslaer S, 2003, J BIOL CHEM, V278, P4919, DOI 10.1074/jbc.M210617200; Vidwans AS, 1999, J NEUROCHEM, V72, P1843, DOI 10.1046/j.1471-4159.1999.0721843.x; Weber RE, 2004, RESP PHYSIOL NEUROBI, V144, P141, DOI 10.1016/j.resp.2004.04.018; Weiland TR, 2004, J AM CHEM SOC, V126, P11930, DOI 10.1021/ja046990w; WITTENBERG JB, 1965, J GEN PHYSIOL, V49, P57; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200; ZHU H, 1992, P NATL ACAD SCI USA, V89, P5015, DOI 10.1073/pnas.89.11.5015	86	117	117	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2039	10.1371/journal.pone.0002039	http://dx.doi.org/10.1371/journal.pone.0002039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446211	gold, Green Published, Green Submitted			2022-12-27	WOS:000261572300011
J	Suzuki, T; Kondo, S; Wakayama, T; Cizdziel, PE; Hayashizaki, Y				Suzuki, Takahiro; Kondo, Shinji; Wakayama, Teruhiko; Cizdziel, Paul E.; Hayashizaki, Yoshihide			Genome-Wide Analysis of Abnormal H3K9 Acetylation in Cloned Mice	PLOS ONE			English	Article							GENE-EXPRESSION; NUCLEAR TRANSFER; MOUSE EMBRYOS; TRICHOSTATIN-A; CLONING; LEPTIN; CELL; HUMAN-CHROMOSOME-21; TRANSCRIPTOME; PROMOTERS	Somatic nuclear transfer is a cloning technique that shows great promise in the application to regenerative medicine. Although cloned animals are genetically identical to their donor counterparts, abnormalities in phenotype and gene expression are frequently observed. One hypothesis is that the cause of these abnormalities is due to epigenetic aberration. In this report, we focused our analysis on the acetylation of histone H3 at lysine9 (H3K9Ac). Through the use of whole genome tiling arrays and quantitative PCR, we examined this epigenetic event and directly compared and assessed the differences between a cloned mouse (C1) and its parental nuclear donor (D1) counterpart. We identified 4720 regions of chromosomal DNA that showed notable differences in H3K9Ac and report here many genes identified in these hyper-and hypo-acetylated regions. Analysis of a second clone (C2) and its parental donor counterpart (D2) for H3K9Ac showed a high degree of similarity to the C1/D1 pair. This conservation of aberrant acetylation is suggestive of a reproducible epigenetic phenomenon that may lead to the frequent abnormalities observed in cloned mice, such as obesity. Furthermore, we demonstrated Crp which was identified as a hyper-acetylated gene in this study is related to the body mass, suggesting that Crp is a possible candidate of a cause for the abnormal obesity in cloned mice. In this, one of the first reports describing genome-wide epigenetic abberation between parental and nuclear transfer-cloned mammals, we propose that aberrant acetylation of histones (H3K9Ac) flanking promoter regions highly correlates with gene-expression and may itself be an epigenetic change that accounts for variable expression patterns observed in cloned animals.	[Suzuki, Takahiro; Kondo, Shinji; Cizdziel, Paul E.; Hayashizaki, Yoshihide] RIKEN, Yokohama Inst, Genom Sci Ctr, Genome Explorat Res Grp, Kanagawa, Japan; [Suzuki, Takahiro; Hayashizaki, Yoshihide] Yokohama City Univ, Int Grad Sch Arts & Sci, Div Genom Informat Resources, Supramol Biol, Yokohama, Kanagawa, Japan; [Wakayama, Teruhiko] RIKEN Kobe, Ctr Dev Biol, Lab Genom Reprogramming, Kobe, Hyogo, Japan; [Hayashizaki, Yoshihide] RIKEN, Discovery & Res Inst, Genome Sci Lab, Wako, Saitama, Japan; [Hayashizaki, Yoshihide] RIKEN Frontier Res Syst, Funct RNA Res Program, Wako, Saitama, Japan	RIKEN; Yokohama City University; RIKEN; RIKEN; RIKEN	Suzuki, T (corresponding author), RIKEN, Yokohama Inst, Genom Sci Ctr, Genome Explorat Res Grp, Kanagawa, Japan.	rgscerg@gsc.riken.jp	Suzuki, Takahiro/AAW-8509-2020; Hayashizaki, Yoshihide/N-6590-2015	Suzuki, Takahiro/0000-0002-0972-6911; 	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government; RIKEN [15080211]	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN	This work was supported in part by a Research Grant for the RIKEN Genome Exploration Research Project from the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government to YH; a Grant of the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan; The Strategic Program for R&D of RIKEN; Grant for the RIKEN Frontier Research System, Functional RNA research program and Scientific Research in Priority Areas (15080211) and a project for the realization of regenerative medicine from the Ministry of Education, Culture, Sports, Science and Technology of Japanese Government to TW.	Balbach ST, 2007, DEV BIOL, V308, P309, DOI 10.1016/j.ydbio.2007.05.034; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 2006, NAT CLIN PRACT NEPHR, V2, P700, DOI 10.1038/ncpneph0344; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Chen K, 2006, NAT MED, V12, P425, DOI 10.1038/nm1372; Chen ZX, 2005, BIOCHEM CELL BIOL, V83, P438, DOI 10.1139/O05-138; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Enright BP, 2003, BIOL REPROD, V69, P896, DOI 10.1095/biolreprod.103.017954; Farooqi IS, 2007, NAT MED, V13, P16, DOI 10.1038/nm0107-16; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Gertler A, 2007, NAT MED, V13, P18, DOI 10.1038/nm0107-18; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gura T, 1999, SCIENCE, V286, P881; Hasegawa Y, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl497; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Hutchinson WL, 2007, NAT MED, V13, P17, DOI 10.1038/nm0107-17; Inoue K, 2002, SCIENCE, V295, P297, DOI 10.1126/science.295.5553.297; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Kishigami S, 2007, J REPROD DEVELOP, V53, P165, DOI 10.1262/jrd.18098; Kohda T, 2005, BIOL REPROD, V73, P1302, DOI 10.1095/biolreprod.105.044958; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGregor GP, 1996, ENDOCRINOLOGY, V137, P1501, DOI 10.1210/en.137.4.1501; Nishida H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-108; Nishida H, 2006, CHROMOSOME RES, V14, P203, DOI 10.1007/s10577-006-1036-7; Ohgane J, 2001, GENESIS, V30, P45, DOI 10.1002/gene.1031; Ohgane J, 2004, GENES CELLS, V9, P253, DOI 10.1111/j.1356-9597.2004.00720.x; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; SANDELIN A, 2007, NAT REV GENET; Senda S, 2007, CLONING STEM CELLS, V9, P293, DOI 10.1089/clo.2006.0050; Shimizu H, 1997, INT J OBESITY, V21, P536, DOI 10.1038/sj.ijo.0800437; Szmitko Paul E, 2006, J Cardiometab Syndr, V1, P66, DOI 10.1111/j.0197-3118.2006.05340.x; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262; Tanaka S, 2001, BIOL REPROD, V65, P1813, DOI 10.1095/biolreprod65.6.1813; Tong GQ, 2006, CELL TISSUE RES, V325, P231, DOI 10.1007/s00441-006-0189-1; Wakayama S, 2005, J REPROD DEVELOP, V51, P765, DOI 10.1262/jrd.17061; Wakayama T, 1999, SEMIN CELL DEV BIOL, V10, P253, DOI 10.1006/scdb.1998.0267; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 2007, J REPROD DEVELOP, V53, P13, DOI 10.1262/jrd.18120; Yang FK, 2007, REPRODUCTION, V133, P219, DOI 10.1530/rep.1.01206; Yang JF, 2007, BIOL REPROD, V76, P36, DOI 10.1095/biolreprod.106.051383; Yu Y, 2007, REPRODUCTION, V133, P947, DOI 10.1530/REP-06-0358	52	19	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1905	10.1371/journal.pone.0001905	http://dx.doi.org/10.1371/journal.pone.0001905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398451	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795500001
J	Boutin, C; Diestel, S; Desoeuvre, A; Tiveron, MC; Cremer, H				Boutin, Camille; Diestel, Simone; Desoeuvre, Angelique; Tiveron, Marie-Catherine; Cremer, Harold			Efficient In Vivo Electroporation of the Postnatal Rodent Forebrain	PLOS ONE			English	Article								Functional gene analysis in vivo represents still a major challenge in biomedical research. Here we present a new method for the efficient introduction of nucleic acids into the postnatal mouse forebrain. We show that intraventricular injection of DNA followed by electroporation induces strong expression of transgenes in radial glia, neuronal precursors and neurons of the olfactory system. We present two proof-of-principle experiments to validate our approach. First, we show that expression of a human isoform of the neural cell adhesion molecule (hNCAM-140) in radial glia cells induces their differentiation into cells showing a neural precursor phenotype. Second, we demonstrate that p21 acts as a cell cycle inhibitor for postnatal neural stem cells. This approach will represent an important tool for future studies of postnatal neurogenesis and of neural development in general.	[Boutin, Camille; Diestel, Simone; Desoeuvre, Angelique; Tiveron, Marie-Catherine; Cremer, Harold] Univ Aix Marseille 2, CNRS, IBDML, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Boutin, C (corresponding author), Univ Aix Marseille 2, CNRS, IBDML, Campus Luminy, Marseille, France.	cremer@ibdm.univ-mrs.fr	TIVERON, Marie-Catherine/AAR-1142-2020	Cremer, Harold/0000-0002-8673-5176	Fondation de France; Association Francaise contre les Myopathies; European Union; Agence Nationale de la Recherche	Fondation de France(Fondation de France); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); European Union(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work has been supported by grants from the Fondation de France (FDF), Association Francaise contre les Myopathies (AFM), the European Union through the Network of Excellence NeuroNE and the Agence Nationale de la Recherche (ANR) to HC.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Chazal G, 2000, J NEUROSCI, V20, P1446; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Diestel S, 2007, J CELL SCI, V120, P4035, DOI 10.1242/jcs.019729; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1997, J NEUROSCI, V17, P5046; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Kim JH, 2005, J NEUROCHEM, V94, P417, DOI 10.1111/j.1471-4159.2005.03208.x; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Miller VM, 2005, CELL MOL NEUROBIOL, V25, P1195, DOI 10.1007/s10571-005-8447-4; Mir LM, 2005, ADV GENET, V54, P83, DOI 10.1016/S0065-2660(05)54005-7; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; Morin X, 2007, NAT NEUROSCI, V10, P1440, DOI 10.1038/nn1984; Nakamura H, 2004, MECH DEVELOP, V121, P1137, DOI 10.1016/j.mod.2004.05.013; Nelson SB, 2006, CURR OPIN NEUROBIOL, V16, P571, DOI 10.1016/j.conb.2006.08.006; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439	20	108	108	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1883	10.1371/journal.pone.0001883	http://dx.doi.org/10.1371/journal.pone.0001883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382666	gold, Green Published			2022-12-27	WOS:000260795400017
J	Kyere, SK; Joseph, PRB; Summers, MF				Kyere, Sampson K.; Joseph, Prem Raj B.; Summers, Michael F.			The p12 Domain Is Unstructured in a Murine Leukemia Virus p12-CA(N) Gag Construct	PLOS ONE			English	Article								The Gag polyproteins of gammaretroviruses contain a conserved p12 domain between MA and CA that plays critical roles in virus assembly, reverse transcription and nuclear integration. Here we show using nuclear magnetic resonance, that p12 is unstructured in a Moloney murine leukemia virus (MMLV) Gag fragment that includes the N-terminal domain of CA (p12-CA(N)). Furthermore, no long range interactions were observed between the domains, as has been previously predicted. Flexibility appears to be a common feature of Gag "late'' domains required for virus release during budding. Residues near the N-terminus of CA(N) that form a beta-hairpin in the mature CA protein are unfolded in p12-CA(N), consistent with proposals that hairpin formation helps trigger capsid assembly.	[Kyere, Sampson K.; Joseph, Prem Raj B.; Summers, Michael F.] Univ Maryland, Howard Hughes Med Inst, Dept Chem & Biochem, Baltimore, MD 21201 USA	Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore	Kyere, SK (corresponding author), Univ Maryland, Howard Hughes Med Inst, Dept Chem & Biochem, Baltimore, MD 21201 USA.	summers@hhmi.umbc.edu	Joseph, Prem Raj/E-8553-2010		NIH [AI30917, GM076979]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030917, R37AI030917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM076979] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was received from the NIH (AI30917 to MFS and GM076979 to SKK).	Auerbach MR, 2003, P NATL ACAD SCI USA, V100, P11678, DOI 10.1073/pnas.2034020100; BOWERMAN B, 1989, GENE DEV, V3, P469, DOI 10.1101/gad.3.4.469; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; COLICELLI J, 1988, J MOL BIOL, V199, P47, DOI 10.1016/0022-2836(88)90378-6; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KAY LE, 1990, SCIENCE, V249, P411, DOI 10.1126/science.2377896; Khorasanizadeh S, 1999, J MOL BIOL, V291, P491, DOI 10.1006/jmbi.1999.2986; Le Blanc I, 2002, J VIROL, V76, P10024, DOI 10.1128/JVI.76.19.10024-10029.2002; Lee SK, 2005, J VIROL, V79, P4159, DOI 10.1128/JVI.79.7.4159-4169.2005; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Oshima M, 2004, J VIROL, V78, P1411, DOI 10.1128/JVI.78.3.1411-1420.2004; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Puffer BA, 1998, J VIROL, V72, P10218, DOI 10.1128/JVI.72.12.10218-10221.1998; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wang HT, 2002, J VIROL, V76, P8485, DOI 10.1128/JVI.76.16.8485-8493.2002; WILLS JW, 1994, J VIROL, V68, P6605, DOI 10.1128/JVI.68.10.6605-6618.1994; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yasuda J, 1998, J VIROL, V72, P4095, DOI 10.1128/JVI.72.5.4095-4103.1998; Yeager M, 1998, P NATL ACAD SCI USA, V95, P7299, DOI 10.1073/pnas.95.13.7299; Yuan B, 1999, EMBO J, V18, P4700, DOI 10.1093/emboj/18.17.4700; Yuan B, 2000, J VIROL, V74, P7250, DOI 10.1128/JVI.74.16.7250-7260.2000; Yuan B, 2002, J VIROL, V76, P10801, DOI 10.1128/JVI.76.21.10801-10810.2002; Yueh A, 2003, J VIROL, V77, P1820, DOI 10.1128/JVI.77.3.1820-1829.2003	46	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1902	10.1371/journal.pone.0001902	http://dx.doi.org/10.1371/journal.pone.0001902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382677	Green Submitted, Green Published, gold			2022-12-27	WOS:000260795400029
J	Mao, Y; Kerr, M; Freeman, M				Mao, Yanlan; Kerr, Martin; Freeman, Matthew			Modulation of Drosophila Retinal Epithelial Integrity by the Adhesion Proteins Capricious and Tartan	PLOS ONE			English	Article								Background: The development of the Drosophila eye imaginal disc requires complex epithelial rearrangements. Cells of the morphogenetic furrow are apically constricted and this leads to a physical indentation in the epithelium. Posterior to the furrow, cells start to rearrange into distinct clusters and eventually form a precisely patterned array of ommatidia. These morphogenetic processes include regulated changes of adhesion between cells. Methodology/Principal Findings: Here, we show that two transmembrane adhesion proteins, Capricious and Tartan, have dynamic and complementary expression patterns in the eye imaginal disc. We also describe novel null mutations in capricious and double null mutations in capricious and tartan. We report that they have redundant functions in regulating the architecture of the morphogenetic furrow and ommatidial spacing. Conclusions/Significance: We conclude that Capricious and Tartan contribute to the adhesive properties of the cells in the morphogenetic furrow and that this regulated adhesion participates in the control of spacing ommatidial clusters.	[Mao, Yanlan; Kerr, Martin; Freeman, Matthew] MRC Lab Mol Biol, Cambridge, England	MRC Laboratory Molecular Biology	Mao, Y (corresponding author), MRC Lab Mol Biol, Cambridge, England.	mf1@mrc-lmb.cam.ac.uk		Freeman, Matthew/0000-0003-0410-5451	Core MRC; Medical Research Council [MC_U105178780] Funding Source: researchfish; MRC [MC_U105178780] Funding Source: UKRI	Core MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Core MRC support	BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; Brown KE, 2006, DEV BIOL, V300, P710, DOI 10.1016/j.ydbio.2006.08.003; CHANG Z, 1993, DEV BIOL, V160, P315, DOI 10.1006/dbio.1993.1310; Escudero LM, 2007, DEV CELL, V13, P717, DOI 10.1016/j.devcel.2007.09.002; GAUL U, 1992, CELL, V68, P1007, DOI 10.1016/0092-8674(92)90073-L; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Kauffmann RC, 1996, GENE DEV, V10, P2167, DOI 10.1101/gad.10.17.2167; Milan M, 2005, DEV DYNAM, V233, P804, DOI 10.1002/dvdy.20384; Milan M, 2003, DEVELOPMENT, V130, P553, DOI 10.1242/dev.00276; Milan M, 2002, DEV CELL, V2, P797, DOI 10.1016/S1534-5807(02)00169-7; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Preston CR, 1996, GENETICS, V144, P1623; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Sakurai KT, 2007, DEV BIOL, V309, P126, DOI 10.1016/j.ydbio.2007.07.001; Salzberg A, 1997, GENETICS, V147, P1723; Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013; Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118; Taniguchi H, 2000, J NEUROBIOL, V42, P104, DOI 10.1002/(SICI)1097-4695(200001)42:1<104::AID-NEU10>3.0.CO;2-V; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; XU T, 1993, DEVELOPMENT, V117, P1223	26	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1827	10.1371/journal.pone.0001827	http://dx.doi.org/10.1371/journal.pone.0001827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350163	Green Published, Green Submitted, gold			2022-12-27	WOS:000260762300029
J	Moustafa, A; Reyes-Prieto, A; Bhattacharya, D				Moustafa, Ahmed; Reyes-Prieto, Adrian; Bhattacharya, Debashish			Chlamydiae Has Contributed at Least 55 Genes to Plantae with Predominantly Plastid Functions	PLOS ONE			English	Article								Background: The photosynthetic organelle (plastid) originated via primary endosymbiosis in which a phagotrophic protist captured and harnessed a cyanobacterium. The plastid was inherited by the common ancestor of the red, green (including land plants), and glaucophyte algae (together, the Plantae). Despite the critical importance of primary plastid endosymbiosis, its ancient derivation has left behind very few "footprints" of early key events in organelle genesis. Methodology/Principal Findings: To gain insights into this process, we conducted an in-depth phylogenomic analysis of genomic data (nuclear proteins) from 17 Plantae species to identify genes of a surprising provenance in these taxa, Chlamydiae bacteria. Previous studies show that Chlamydiae contributed many genes (at least 21 in one study) to Plantae that primarily have plastid functions and were postulated to have played a fundamental role in organelle evolution. Using our comprehensive approach, we identify at least 55 Chlamydiae-derived genes in algae and plants, of which 67% (37/55) are putatively plastid targeted and at least 3 have mitochondrial functions. The remainder of the proteins does not contain a bioinformatically predicted organelle import signal although one has an N-terminal extension in comparison to the Chlamydiae homolog. Our data suggest that environmental Chlamydiae were significant contributors to early Plantae genomes that extend beyond plastid metabolism. The chlamydial gene distribution and protein tree topologies provide evidence for both endosymbiotic gene transfer and a horizontal gene transfer ratchet driven by recurrent endoparasitism as explanations for gene origin. Conclusions/Significance: Our findings paint a more complex picture of gene origin than can easily be explained by endosymbiotic gene transfer from an organelle-like point source. These data significantly extend the genomic impact of Chlamydiae on Plantae and show that about one-half (30/55) of the transferred genes are most closely related to sequences emanating from the genome of the only environmental isolate that is currently available. This strain, Candidatus Protochlamydia amoebophila UWE25 is an endosymbiont of Acanthamoeba and likely represents the type of endoparasite that contributed the genes to Plantae.	[Moustafa, Ahmed; Bhattacharya, Debashish] Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA; [Moustafa, Ahmed; Reyes-Prieto, Adrian; Bhattacharya, Debashish] Univ Iowa, Roy J Carver Ctr Comparative Genom, Dept Biol Sci, Iowa City, IA USA	University of Iowa; University of Iowa	Moustafa, A (corresponding author), Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA.	debashi-bhattacharya@uiowa.edu	Moustafa, Ahmed/AAZ-3991-2020; Moustafa, Ahmed/C-5234-2009	Moustafa, Ahmed/0000-0002-0111-3555; Moustafa, Ahmed/0000-0002-0111-3555	National Aeronautics and Space Administration [NNG04GM17G]; National Science Foundation [EF 04-31117]; National Institutes of Health [R01ES013679]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Aeronautics and Space Administration, the National Science Foundation, and the National Institutes of Health in grants awarded to DB (NNG04GM17G, EF 04-31117, R01ES013679, respectively).	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Bhattacharya D, 2004, BIOESSAYS, V26, P50, DOI 10.1002/bies.10376; Bhattacharya D, 2007, BIOESSAYS, V29, P1239, DOI 10.1002/bies.20671; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; BRENNICKE A, 1993, FEBS LETT, V325, P140, DOI 10.1016/0014-5793(93)81430-8; Brinkman FSL, 2002, GENOME RES, V12, P1159, DOI 10.1101/gr.341802; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; CHANG JMM, 2008, PROTEINS; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; Corsarol D, 2006, CLIN MICROBIOL REV, V19, P283, DOI 10.1128/CMR.19.2.283-297.2006; Delwiche CF, 1999, AM NAT, V154, pS164, DOI 10.1086/303291; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; Doolittle WE, 1998, TRENDS GENET, V14, P307; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Everett KDE, 2005, INT J SYST EVOL MICR, V55, P1581, DOI 10.1099/ijs.0.63454-0; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Frickey T, 2004, NUCLEIC ACIDS RES, V32, P5231, DOI 10.1093/nar/gkh867; Greub G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-48; Greub G, 2003, APPL ENVIRON MICROB, V69, P5530, DOI 10.1128/AEM.69.9.5530-5535.2003; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang CY, 2005, PLANT PHYSIOL, V138, P1723, DOI 10.1104/pp.105.060327; Huang JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r99; Leister D, 2005, TRENDS GENET, V21, P655, DOI 10.1016/j.tig.2005.09.004; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Matsuo M, 2005, PLANT CELL, V17, P665, DOI 10.1105/tpc.104.027706; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; McFadden GI, 2004, CURR BIOL, V14, pR514, DOI 10.1016/j.cub.2004.06.041; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Moustafa A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-6; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Nosenko T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-173; Nozaki H, 2007, MOL BIOL EVOL, V24, P1592, DOI 10.1093/molbev/msm091; O'Brien EA, 2007, NUCLEIC ACIDS RES, V35, pD445, DOI 10.1093/nar/gkl770; Parfrey LW, 2006, PLOS GENET, V2, P2062, DOI 10.1371/journal.pgen.0020220; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Reyes-Prieto A, 2006, CURR BIOL, V16, P2320, DOI 10.1016/j.cub.2006.09.063; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Schmitz-Esser S, 2004, J BACTERIOL, V186, P683, DOI 10.1128/JB.186.3.683-691.2004; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stechmann A, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-101; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Thorsness PE, 1996, INT REV CYTOL, V165, P207, DOI 10.1016/S0074-7696(08)62223-8; Tokuhisa JG, 1998, PLANT CELL, V10, P699, DOI 10.1105/tpc.10.5.699; Tyra HM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r212; Watkins RF, 2006, J MOL EVOL, V63, P801, DOI 10.1007/s00239-006-0031-0	52	96	97	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2205	10.1371/journal.pone.0002205	http://dx.doi.org/10.1371/journal.pone.0002205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493612	gold, Green Published, Green Submitted			2022-12-27	WOS:000262258700014
J	Mwangi, TW; Fegan, G; Williams, TN; Kinyanjui, SM; Snow, RW; Marsh, K				Mwangi, Tabitha Wanja; Fegan, Gregory; Williams, Thomas Neil; Kinyanjui, Sam Muchina; Snow, Robert William; Marsh, Kevin			Evidence for Over-Dispersion in the Distribution of Clinical Malaria Episodes in Children	PLOS ONE			English	Article							ENTOMOLOGICAL INOCULATION RATE; COMBATING MALARIA; CHILDHOOD MALARIA; TRANSMISSION; MORBIDITY; PREVALENCE; PROTECTION; INFECTION; MORTALITY; DISEASE	Background: It may be assumed that patterns of clinical malaria in children of similar age under the same level of exposure would follow a Poisson distribution with no over-dispersion. Longitudinal studies that have been conducted over many years suggest that some children may experience more episodes of clinical malaria than would be expected. The aim of this study was to identify this group of children and investigate possible causes for this increased susceptibility. Methodology and Principal Findings: Using Poisson regression, we chose a group of children whom we designated as 'more susceptible' to malaria from 373 children under 10 years of age who were followed up for between 3 to 5 years from 1998-2003. About 21% of the children were categorized as 'more susceptible' and although they contributed only 23% of the person-time of follow-up, they experienced 55% of total clinical malaria episodes. Children that were parasite negative at all cross-sectional survey were less likely to belong to this group [AOR = 0.09, (95% CI: 0.14-0.61), p = 0.001]. Conclusions and Significance: The pattern of clinical malaria episodes follows a negative binomial distribution. Use of lack of a clinical malaria episode in a certain time period as endpoints for intervention or immunological studies may not adequately distinguish groups who are more or less immune. It may be useful in such studies, in addition to the usual endpoint of the time to first episode, to include end points which take into account the total number of clinical episodes experienced per child.	[Mwangi, Tabitha Wanja; Fegan, Gregory; Williams, Thomas Neil; Kinyanjui, Sam Muchina; Marsh, Kevin] Coast Wellcome Trust Collaborat Program, Ctr Geog Med Res, Kenya Med Res Inst, Kilifi, Kenya; [Fegan, Gregory] London Sch Hyg & Trop Med, Dept Populat Hlth, Infect Dis Epidemiol Unit, London, England; [Williams, Thomas Neil; Kinyanjui, Sam Muchina; Snow, Robert William; Marsh, Kevin] John Radcliffe Hosp, Ctr Trop Med, Nuffield Dept Clin Med, Oxford, England; [Snow, Robert William] Kenya Govt Med Res Ctr, Wellcome Trust Collaborative Program, Nairobi, Kenya	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Kenya Medical Research Institute	Mwangi, TW (corresponding author), Coast Wellcome Trust Collaborat Program, Ctr Geog Med Res, Kenya Med Res Inst, Kilifi, Kenya.	tmwangi@kilifi.kemri-wellcome.org	Fegan, Greg W/O-8079-2018; Snow, Robert William/AFR-1436-2022	Fegan, Greg W/0000-0002-2663-2765; Snow, Robert William/0000-0003-3725-6088	Wellcome Trust [631342, 076934, 079080]; European Network 6 BioMalpar Consortium	Wellcome Trust(Wellcome TrustEuropean Commission); European Network 6 BioMalpar Consortium	Kevin Marsh is supported by The Wellcome Trust as Senior Research Fellow (#631342), Thomas Williams is also supported by The Wellcome trust as Senior Research Fellow (#076934) and the European Network 6 BioMalpar Consortium. Robert W. Snow is supported by The Wellcome Trust as a Principal Fellow (#079080). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Berkley JA, 1999, QJM-INT J MED, V92, P151, DOI 10.1093/qjmed/92.3.151; Bonnet S, 2002, TROP MED INT HEALTH, V7, P249, DOI 10.1046/j.1365-3156.2002.00861.x; Contamin H, 1996, AM J TROP MED HYG, V54, P632, DOI 10.4269/ajtmh.1996.54.632; Creasey A, 2004, PARASITOLOGY, V129, P263, DOI 10.1017/S0031182004005724; Deloron P, 1999, AM J TROP MED HYG, V61, P99, DOI 10.4269/ajtmh.1999.61.99; Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Kazembe LN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-93; Lloyd-Smith JO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000180; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Mwangi TW, 2003, T ROY SOC TROP MED H, V97, P369, DOI 10.1016/S0035-9203(03)90056-3; ROGIER C, 1993, T ROY SOC TROP MED H, V87, P245, DOI 10.1016/0035-9203(93)90110-C; Rogier C, 2003, T ROY SOC TROP MED H, V97, P193, DOI 10.1016/S0035-9203(03)90116-7; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; SNOW RW, 1993, T ROY SOC TROP MED H, V87, P386, DOI 10.1016/0035-9203(93)90007-D; Snow RW, 2000, TROP MED INT HEALTH, V5, P377, DOI 10.1046/j.1365-3156.2000.00568.x; Trape JF, 2002, TRENDS PARASITOL, V18, P224, DOI 10.1016/S1471-4922(02)02249-3; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; Wambua S, 2006, PLOS MED, V3, P643, DOI 10.1371/journal.pmed.0030158; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	26	44	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2196	10.1371/journal.pone.0002196	http://dx.doi.org/10.1371/journal.pone.0002196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493319	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000262258700005
J	Oda, S; Oda, T; Nishi, K; Takabuchi, S; Wakamatsu, T; Tanaka, T; Adachi, T; Fukuda, K; Semenza, GL; Hirota, K				Oda, Seiko; Oda, Tomoyuki; Nishi, Kenichiro; Takabuchi, Satoshi; Wakamatsu, Takuhiko; Tanaka, Tomoharu; Adachi, Takehiko; Fukuda, Kazuhiko; Semenza, Gregg L.; Hirota, Kiichi			Macrophage Migration Inhibitory Factor Activates Hypoxia-Inducible Factor in a p53-Dependent Manner	PLOS ONE			English	Article								Background: Macrophage migration inhibitory factor (MIF) is not only a cytokine which has a critical role in several inflammatory conditions but also has endocrine and enzymatic functions. MIF is identified as an intracellular signaling molecule and is implicated in the process of tumor progression, and also strongly enhances neovascularization. Overexpression of MIF has been observed in tumors from various organs. MIF is one of the genes induced by hypoxia in an hypoxia-inducible factor 1 (HIF-1)-dependent manner. Methods/Principal Findings: The effect of MIF on HIF-1 activity was investigated in human breast cancer MCF-7 and MDA-MB-231 cells, and osteosarcoma Saos-2 cells. We demonstrate that intracellular overexpression or extracellular administration of MIF enhances activation of HIF-1 under hypoxic conditions in MCF-7 cells. Mutagenesis analysis of MIF and knockdown of 53 demonstrates that the activation is not dependent on redox activity of MIF but on wild-type p53. We also indicate that the MIF receptor CD74 is involved in HIF-1 activation by MIF at least when MIF is administrated extracellularly. Conclusion/Significance: MIF regulates HIF-1 activity in a p53-dependent manner. In addition to MIF's potent effects on the immune system, MIF is linked to fundamental processes conferring cell proliferation, cell survival, angiogenesis, and tumor invasiveness. This functional interdependence between MIF and HIF-1 alpha protein stabilization and transactivation activity provide a molecular mechanism for promotion of tumorigenesis by MIF.	[Oda, Seiko; Takabuchi, Satoshi; Wakamatsu, Takuhiko; Tanaka, Tomoharu; Fukuda, Kazuhiko; Hirota, Kiichi] Kyoto Univ, Kyoto Univ Hosp, Dept Anesthesia, Kyoto, Japan; [Oda, Seiko; Oda, Tomoyuki; Nishi, Kenichiro; Takabuchi, Satoshi; Adachi, Takehiko; Hirota, Kiichi] Kitano Hosp, Tazuke Kofukai Med Res Inst, Osaka, Japan; [Oda, Tomoyuki] Kyoto Univ, Grad Sch Med, Dept Cardiovascular Med, Kyoto, Japan; [Nishi, Kenichiro] Kansai Med Univ, Dept Anesthesiol, Osaka, Japan; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vascular Biol Program, Baltimore, MD USA	Kyoto University; Kitano Hospital; Kyoto University; Kansai Medical University; Johns Hopkins University	Oda, S (corresponding author), Kyoto Univ, Kyoto Univ Hosp, Dept Anesthesia, Kyoto, Japan.	hif1@mac.com	Hirota, Kiichi/E-9181-2010	Hirota, Kiichi/0000-0003-1110-0827	Ministry of education, culture, sports, science and technology, JAPAN [grant-in-aids]	Ministry of education, culture, sports, science and technology, JAPAN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aids for scientific research from Ministry of education, culture, sports, science and technology, JAPAN (to TA and KH).	Amin MA, 2003, CIRC RES, V93, P321, DOI 10.1161/01.RES.0000087641.56024.DA; Bae MK, 2002, J BIOL CHEM, V277, P9, DOI 10.1074/jbc.C100442200; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Bemis L, 2004, GENE DEV, V18, P739, DOI 10.1101/gad.1180104; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Hardman MJ, 2005, AM J PATHOL, V167, P1561, DOI 10.1016/S0002-9440(10)61241-2; Hirota K, 2005, BIOCHEM BIOPH RES CO, V338, P610, DOI 10.1016/j.bbrc.2005.08.193; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kasuno K, 2004, J BIOL CHEM, V279, P2550, DOI 10.1074/jbc.M308197200; Kleemann R, 1999, EUR J BIOCHEM, V261, P753, DOI 10.1046/j.1432-1327.1999.00327.x; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Koong AC, 2000, CANCER RES, V60, P883; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Leng L, 2005, CRIT CARE MED, V33, pS475, DOI 10.1097/01.CCM.0000191278.04636.D8; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lue HQ, 2006, CELL SIGNAL, V18, P688, DOI 10.1016/j.cellsig.2005.06.013; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Nishihira J, 2000, J INTERF CYTOK RES, V20, P751, DOI 10.1089/10799900050151012; ODA T, 2006, AM J PHYSIOL-CELL PH, V204, pC113; Ravi R, 2000, GENE DEV, V14, P34; Sasada T, 1996, J CLIN INVEST, V97, P2268, DOI 10.1172/JCI118668; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2000, CANCER METAST REV, V19, P59, DOI 10.1023/A:1026544214667; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shimizu T, 1999, BIOCHEM BIOPH RES CO, V264, P751, DOI 10.1006/bbrc.1999.1584; Thiele M, 2005, ANTIOXID REDOX SIGN, V7, P1234, DOI 10.1089/ars.2005.7.1234; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Welsh SJ, 2003, MOL CANCER THER, V2, P235; Welsh SJ, 2002, CANCER RES, V62, P5089; Winner M, 2007, CANCER RES, V67, P186, DOI 10.1158/0008-5472.CAN-06-3292	47	92	97	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2215	10.1371/journal.pone.0002215	http://dx.doi.org/10.1371/journal.pone.0002215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493321	Green Submitted, Green Published, gold			2022-12-27	WOS:000262258700023
J	Yang, LM; Wang, JL; Kang, L; Gao, S; Liu, YH; Hu, TM				Yang, Li-Min; Wang, Jing-Lin; Kang, Lin; Gao, Shan; Liu, Yan-Hua; Hu, Ting-Mao			Construction and Analysis of High-Complexity Ribosome Display Random Peptide Libraries	PLOS ONE			English	Article								Random peptide libraries displayed on the ribosome are becoming a new tool for the in vitro selection of biologically relevant macromolecules, including epitopes, antagonists, enzymes, and cell-surface receptors. Ribosome display is a cell-free system of coupling individual nascent proteins (phenotypes) to their corresponding mRNA (genotypes) by the formation of stable protein-ribosome-mRNA complexes and permitting the selection of a functional nascent protein by iterative cycles of panning and reverse transcription-polymerase chain reaction (RT-PCR) amplification in vitro. The complexity of the random peptide library is critical for the success of a panning experiment; greater the diversity of sequences within the library, the more likely it is that the library comprises sequences that can bind a given target with specific affinity. Here, we have used the cell-free system Escherichia coli S30 lysate to construct high-complexity random peptide libraries (>10(14) independent members) by introducing strategies that are different from the methods described by Mattheakis et al. and Lamla et al. The key step in our method is to produce nanomole (nmol) amounts of DNA elements that are necessary for in vitro transcription/translation by using PCR but not plasmid DNA. Library design strategies and protocols that facilitate rapid identification are also presented.	[Yang, Li-Min; Hu, Ting-Mao] Chinese Acad Sci, Ctr Mol Virol, Inst Microbiol, Beijing, Peoples R China; [Wang, Jing-Lin; Kang, Lin; Gao, Shan; Liu, Yan-Hua] Acad Mil Med Sci, Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecurity, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Academy of Military Medical Sciences - China	Yang, LM (corresponding author), Chinese Acad Sci, Ctr Mol Virol, Inst Microbiol, Beijing, Peoples R China.	wangjlin@bmi.ac.cn			National Natural Sciences Foundation of China [30370081]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This research work was supported by a grant from the National Natural Sciences Foundation of China (No. 30370081). In addition, we thank Dr. Ming-Yue He (chief scientific officer, Discerna Limited, Cambridge,UK) and Dr. Xiang-Bin Wang (Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing) for their comments and suggestions during the preparation of this manuscript.	Amstutz P, 2002, J AM CHEM SOC, V124, P9396, DOI 10.1021/ja025870q; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; CULL MG, 1992, P NATL ACAD SCI USA, V89, P1865, DOI 10.1073/pnas.89.5.1865; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Forrer P, 1998, GENE, V224, P45, DOI 10.1016/S0378-1119(98)00538-1; FRANCISCO JA, 1992, P NATL ACAD SCI USA, V89, P2713, DOI 10.1073/pnas.89.7.2713; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Hanes J, 2000, NAT BIOTECHNOL, V18, P1287, DOI 10.1038/82407; Hanes J, 2000, METHOD ENZYMOL, V328, P404, DOI 10.1016/S0076-6879(00)28409-7; He M, 2007, BIOCHEM SOC T, V35, P962, DOI 10.1042/BST0350962; Kim JM, 2007, MOL BIOTECHNOL, V36, P32, DOI 10.1007/s12033-007-0017-1; Lamla T, 2003, J MOL BIOL, V329, P381, DOI 10.1016/S0022-2836(03)00432-7; LANCET D, 1993, P NATL ACAD SCI USA, V90, P3715, DOI 10.1073/pnas.90.8.3715; MATTHEAKIS LC, 1994, P NATL ACAD SCI USA, V91, P9022, DOI 10.1073/pnas.91.19.9022; Mondon P, 2008, FRONT BIOSCI-LANDMRK, V13, P1117, DOI 10.2741/2749; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Schaffitzel C, 1999, J IMMUNOL METHODS, V231, P119, DOI 10.1016/S0022-1759(99)00149-0; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Yang F, 2000, NAT STRUCT BIOL, V7, P230	19	15	16	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2092	10.1371/journal.pone.0002092	http://dx.doi.org/10.1371/journal.pone.0002092			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493302	gold, Green Published, Green Submitted			2022-12-27	WOS:000262258700001
J	Hodgson, A; Forgor, AA; Chandramohan, D; Reed, Z; Binka, F; Bevilacqua, C; Boutriau, D; Greenwood, B				Hodgson, Abraham; Forgor, Abudulai Adams; Chandramohan, Daniel; Reed, Zarifah; Binka, Fred; Bevilacqua, Cornelia; Boutriau, Dominique; Greenwood, Brian			A Phase II, Randomized Study on an Investigational DTPw-HBV/Hib-MenAC Conjugate Vaccine Administered to Infants in Northern Ghana	PLOS ONE			English	Article								Background: Combining meningococcal vaccination with routine immunization in infancy may reduce the burden of meningococcal meningitis, especially in the meningitis belt of Africa. We have evaluated the immunogenicity, persistence of immune response, immune memory and safety of an investigational DTPw-HBV/Hib-MenAC conjugate vaccine given to infants in Northern Ghana. Methods and Findings: In this phase II, double blind, randomized, controlled study, 280 infants were primed with DTPw-HBV/Hib-MenAC or DTPw-HBV/Hib vaccines at 6, 10 and 14 weeks of age. At 12 months of age, children in each group received a challenge dose of serogroup A+C polysaccharides. Antibody responses were assessed pre, and one month-post dose 3 of the priming schedule and pre and 1 month after administration of the challenge dose. One month post-dose 3, 87.8% and 88.2% of subjects in the study group had bactericidal meningococcal serogroup A (SBA-MenA) and meningococcal serogroup C (SBA-MenC) antibody titres >= 1: 8 respectively. Seroprotection/seropositivity rates to the 5 antigens administered in the routine EPI schedule were non-inferior in children in the study group compared to those in the control group. The percentages of subjects in the study group with persisting SBA-MenA titres >= 1: 8 or SBA-MenC titres >= 1:8 at the age of 12 months prior to challenge were significantly higher than in control group (47.7% vs 25.7% and 56.4% vs 5.1% respectively). The administration of 10 mu g of serogroup A polysaccharide increased the SBA-MenA GMT by 14.0-fold in the DTPW-HBV/HibMenAC-group compared to a 3.8 fold increase in the control-group. Corresponding fold-increases in SBA-MenC titres following challenge with 10 mu g of group C polysaccharide were 18.8 and 1.9 respectively. Reactogenicity following primary vaccination or the administration of the challenge dose was similar in both groups, except for swelling (Grade 3) after primary vaccination which was more frequent in children in the vaccine than in the control group (23.7%; 95% CI [19.6-28.1] of doses vs 14.1%; 95% CI [10.9-17.8] of doses). Fifty-nine SAEs (including 8 deaths), none of them related to vaccination, were reported during the entire study. Conclusions: Three dose primary vaccination with DTPw-HBV/Hib-MenAC was non-inferior to DTPw-HBV/Hib for the 5 common antigens used in the routine EPI schedule and induced bactericidal antibodies against Neisseria meningitidis of serogroups A and C in the majority of infants. Serogroup A and C bactericidal antibody levels had fallen below titres associated with protection in nearly half of the infants by the age of 12 months confirming that a booster dose is required at about that age. An enhanced memory response was shown after polysaccharide challenge. This vaccine could provide protection against 7 important childhood diseases (including meningococcal A and C) and be of particular value in countries of the African meningitis belt.	[Hodgson, Abraham; Forgor, Abudulai Adams] Navrongo Hlth Res Ctr, Minist Hlth, Navrongo, Ghana; [Chandramohan, Daniel; Greenwood, Brian] London Sch Hyg & Trop Med, London, England; [Reed, Zarifah] WHO, Geneva, Switzerland; [Binka, Fred] Univ Ghana, Accra, Ghana; [Bevilacqua, Cornelia] Consultant, Basel, Switzerland; [Boutriau, Dominique] GlaxoSmithKline Biol, Rixensart, Belgium	Navrongo Health Research Center; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; University of Ghana; GlaxoSmithKline	Hodgson, A (corresponding author), Navrongo Hlth Res Ctr, Minist Hlth, Navrongo, Ghana.	Dominique.Boutriau@gskbio.com			GlaxoSmithKline Biologicals; WHO	GlaxoSmithKline Biologicals(GlaxoSmithKline); WHO(World Health Organization)	This study was funded by GlaxoSmithKline Biologicals. Several site visits were financed by WHO to monitor the study's compliance to Good Clinical Practice Guideline. The commercial entity funding the study was involved in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Amir J, 2005, VACCINE, V23, P977, DOI 10.1016/j.vaccine.2004.07.042; Aspinall S, 1998, S AFR MED J, V88, P36; Balmer P, 2002, CURR OPIN INFECT DIS, V15, P275, DOI 10.1097/00001432-200206000-00010; BLAKEBROUGH IS, 1980, J INFECTION, V2, P137, DOI 10.1016/S0163-4453(80)91159-7; Boisier P, 2005, TROP MED INT HEALTH, V10, P435, DOI 10.1111/j.1365-3156.2005.01394.x; Borrow R, 2005, VACCINE, V23, P2222, DOI 10.1016/j.vaccine.2005.01.051; Campagne G, 1999, B WORLD HEALTH ORGAN, V77, P499; Carter JA, 2004, EPILEPSIA, V45, P978, DOI 10.1111/j.0013-9580.2004.65103.x; Chippaux JP, 2004, VACCINE, V22, P3303, DOI 10.1016/j.vaccine.2004.02.028; De Wals P, 2005, CLIN INFECT DIS, V40, P1116, DOI 10.1086/428729; Forgor AA, 2005, TROP MED INT HEALTH, V10, P1229, DOI 10.1111/j.1365-3156.2005.01520.x; GATCHALIAN S, 2007, INT J INFEC IN PRESS; GHEESLING LL, 1994, J CLIN MICROBIOL, V32, P1475, DOI 10.1128/JCM.32.6.1475-1482.1994; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; GREENWOOD BM, 1986, T ROY SOC TROP MED H, V80, P1006, DOI 10.1016/0035-9203(86)90303-2; Kitchin NRE, 2007, ARCH DIS CHILD, V92, P11, DOI 10.1136/adc.2005.076109; LAPEYSONNIE L, 1963, B WORLD HEALTH ORGAN, V28, pS3; Leach A, 1997, J INFECT DIS, V175, P200, DOI 10.1093/infdis/175.1.200; Leimkugel J, 2007, PLOS MED, V4, P535, DOI 10.1371/journal.pmed.0040101; LINGAPPA J, 2001, EMERG INFECT DIS, V9, P665; MacLennan J, 2001, J INFECT DIS, V183, P97, DOI 10.1086/317667; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; MIYAMURA K, 1974, J BIOL STAND, V2, P189, DOI 10.1016/0092-1157(74)90015-8; Mueller JE, 2006, J INFECT DIS, V193, P812, DOI 10.1086/500511; *NAT AIDS STI CONT, 2007, HIV SENT SURV 2006 R, P52; Nathan N, 2005, LANCET, V366, P308, DOI 10.1016/S0140-6736(05)66792-X; Njanpop-Lafourcade BM, 2005, MICROBES INFECT, V7, P645, DOI 10.1016/j.micinf.2005.01.003; NYARKO P, 2001, 45 COMM HLTH FAM PLA; Peltola H, 1998, DRUGS, V55, P347, DOI 10.2165/00003495-199855030-00003; Pichichero ME, 2005, EXPERT OPIN BIOL TH, V5, P1475, DOI 10.1517/14712598.5.11.1475; Richmond P, 1999, J INFECT DIS, V179, P1569, DOI 10.1086/314753; Richmond P, 2001, INFECT IMMUN, V69, P2378, DOI 10.1128/IAI.69.4.2378-2382.2001; Robbins JB, 2003, B WORLD HEALTH ORGAN, V81, P745; Southern J, 2006, VACCINE, V24, P215, DOI 10.1016/j.vaccine.2005.07.060; Tikhomirov Eugene, 1997, World Health Statistics Quarterly, V50, P170; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; TWUMASI PA, 1995, J INFECT DIS, V171, P632, DOI 10.1093/infdis/171.3.632; Usen S, 2000, PEDIATR INFECT DIS J, V19, P444, DOI 10.1097/00006454-200005000-00010; Vergnano Stefania, 2003, Expert Rev Vaccines, V2, P571, DOI 10.1586/14760584.2.4.571; *WHO, 2006, N141 WHO; WHO, 1998, WHO PRACT GUID; *WHO REG OFF AFR, 2006, MDSC MEN WEEKL B; WILLIAMSON WA, 1978, LANCET, V1, P1328; World Health Organization, 1996, WHOMAL961075, P19; Yaro S, 2007, VACCINE, V25, pA42, DOI 10.1016/j.vaccine.2007.04.039; GHANAS EXPANDED PROG; 2005, EPIDEMIOLOGICAL RECO, V80, P113; 2005, WEEKLY EPIDEMIOLOGIC, V80, P313; 2001, WEEKLY EPIDEMIOLOGIC, V76, P282	50	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2159	10.1371/journal.pone.0002159	http://dx.doi.org/10.1371/journal.pone.0002159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478093	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000262172800024
J	Wolfenbarger, LL; Naranjo, SE; Lundgren, JG; Bitzer, RJ; Watrud, LS				Wolfenbarger, L. LaReesa; Naranjo, Steven E.; Lundgren, Jonathan G.; Bitzer, Royce J.; Watrud, Lidia S.			Bt Crop Effects on Functional Guilds of Non-Target Arthropods: A Meta-Analysis	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS CORN; RESISTANT TRANSGENIC PLANTS; LONG-TERM ASSESSMENT; CRY1AB TOXIN; COTTON; ECOLOGY; PREDATORS; IMPACT; NEUROPTERA; ABUNDANCE	Background: Uncertainty persists over the environmental effects of genetically-engineered crops that produce the insecticidal Cry proteins of Bacillus thuringiensis (Bt). We performed meta-analyses on a modified public database to synthesize current knowledge about the effects of Bt cotton, maize and potato on the abundance and interactions of arthropod non-target functional guilds. Methodology/Principal Findings: We compared the abundance of predators, parasitoids, omnivores, detritivores and herbivores under scenarios in which neither, only the non-Bt crops, or both Bt and non-Bt crops received insecticide treatments. Predators were less abundant in Bt cotton compared to unsprayed non-Bt controls. As expected, fewer specialist parasitoids of the target pest occurred in Bt maize fields compared to unsprayed non-Bt controls, but no significant reduction was detected for other parasitoids. Numbers of predators and herbivores were higher in Bt crops compared to sprayed non-Bt controls, and type of insecticide influenced the magnitude of the difference. Omnivores and detritivores were more abundant in insecticide-treated controls and for the latter guild this was associated with reductions of their predators in sprayed non-Bt maize. No differences in abundance were found when both Bt and non-Bt crops were sprayed. Predator-to-prey ratios were unchanged by either Bt crops or the use of insecticides; ratios were higher in Bt maize relative to the sprayed non-Bt control. Conclusions/Significance: Overall, we find no uniform effects of Bt cotton, maize and potato on the functional guilds of non-target arthropods. Use of and type of insecticides influenced the magnitude and direction of effects; insecticde effects were much larger than those of Bt crops. These meta-analyses underscore the importance of using controls not only to isolate the effects of a Bt crop per se but also to reflect the replacement of existing agricultural practices. Results will provide researchers with information to design more robust experiments and will inform the decisions of diverse stakeholders regarding the safety of transgenic insecticidal crops.	[Wolfenbarger, L. LaReesa] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA; [Naranjo, Steven E.] USDA ARS Arid Land Agr Res Ctr, Maricopa, AZ USA; [Lundgren, Jonathan G.] USDA ARS North Cent Agr Res Lab, Brookings, SD USA; [Bitzer, Royce J.] Iowa State Univ, Dept Entomol, Ames, IA USA; [Watrud, Lidia S.] US Env Protect Agcy, W Ecol Div, Natl Hlth & Env Effects Res Lab, Corvallis, OR USA	University of Nebraska System; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Iowa State University; United States Environmental Protection Agency	Wolfenbarger, LL (corresponding author), Univ Nebraska, Dept Biol, Omaha, NE 68182 USA.	Steve.Naranjo@ars.usda.gov			EPA [CR-83214701]	EPA(United States Environmental Protection Agency)	Creation of the full database was funded by EPA grant number CR-83214701 awarded to Michelle Marvier and Peter Karieva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, MANUAL NEARCTIC DIPT; ARNQVIST G, 1995, TRENDS ECOL EVOL, V10, P236, DOI 10.1016/S0169-5347(00)89073-4; Bitzer RJ, 2005, ENVIRON ENTOMOL, V34, P1346, DOI 10.1603/0046-225X(2005)034[1346:BACSOE]2.0.CO;2; Borror D. J., 1989, An introduction to the study of insects.; Brookes G., 2006, AgBioForum, V9, P139; Cannon R. J. C., 2000, Integrated Pest Management Reviews, V5, P151, DOI 10.1023/A:1011347122894; Conner AJ, 2003, PLANT J, V33, P19, DOI 10.1046/j.0960-7412.2002.001607.x; Dively GP, 2005, ENVIRON ENTOMOL, V34, P1267, DOI 10.1603/0046-225X(2005)034[1267:IOTVCL]2.0.CO;2; Gould F, 2000, NAT BIOTECHNOL, V18, P266, DOI 10.1038/73693; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Groot AT, 2002, PLANT J, V31, P387, DOI 10.1046/j.1365-313X.2002.01366.x; GUREVITCH J, 1992, AM NAT, V140, P539, DOI 10.1086/285428; Gurevitch J, 1999, ECOLOGY, V80, P1142, DOI 10.1890/0012-9658(1999)080[1142:SIIEMA]2.0.CO;2; Gutierrez AP, 2006, ECOL MODEL, V191, P360, DOI 10.1016/j.ecolmodel.2005.06.002; Hagler JR, 2005, BIOCONTROL SCI TECHN, V15, P321, DOI 10.1080/09583150500086474; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; HEIMPEL GE, 1992, J AGR ENTOMOL, V9, P137; Hilbeck A, 1999, ENTOMOL EXP APPL, V91, P305, DOI 10.1023/A:1003678630661; Hilbeck A, 1998, ENVIRON ENTOMOL, V27, P480, DOI 10.1093/ee/27.2.480; James C., 2006, PREVIEW GLOBAL STATU; Jesse LCH, 2000, OECOLOGIA, V125, P241, DOI 10.1007/s004420000502; Light R.J., 1984, SUMMING SCI REV RES; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Lovei GL, 2005, ENTOMOL EXP APPL, V114, P1, DOI 10.1111/j.0013-8703.2005.00235.x; Lundgren JG, 2004, ENVIRON ENTOMOL, V33, P958, DOI 10.1603/0046-225X-33.4.958; Lundgren JG, 2006, RENEW AGR FOOD SYST, V21, P227, DOI 10.1079/RAF2006152; Marvier M, 2001, AM SCI, V89, P160; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; Musser FR, 2003, J ECON ENTOMOL, V96, P71, DOI 10.1603/0022-0493-96.1.71; Naranjo SE, 2005, ENVIRON ENTOMOL, V34, P1193, DOI 10.1603/0046-225X(2005)034[1193:LAOTEO]2.0.CO;2; Naranjo SE, 2005, ENVIRON ENTOMOL, V34, P1211, DOI 10.1603/0046-225X(2005)034[1211:LAOTEO]2.0.CO;2; NARANJO SE, INTEGRATED IN PRESS; Norris RF, 2005, ANNU REV ENTOMOL, V50, P479, DOI 10.1146/annurev.ento.49.061802.123218; O'Callaghan M, 2005, ANNU REV ENTOMOL, V50, P271, DOI 10.1146/annurev.ento.50.071803.130352; Obrist LB, 2006, ECOL ENTOMOL, V31, P143, DOI 10.1111/j.0307-6946.2006.00762.x; OSENBERG CW, 1998, INTEGRATIVE BIOL ISS, V1, P43; Pilcher CD, 2005, ENVIRON ENTOMOL, V34, P1302, DOI 10.1603/0046-225X(2005)034[1302:IOTBTC]2.0.CO;2; Pilson D, 2004, ANNU REV ECOL EVOL S, V35, P149, DOI 10.1146/annurev.ecolsys.34.011802.132406; Ponsard S, 2002, ENVIRON ENTOMOL, V31, P1197, DOI 10.1603/0046-225X-31.6.1197; Raybould A, 2007, PLANT SCI, V173, P589, DOI 10.1016/j.plantsci.2007.09.003; Robertson GP, 2005, FRONT ECOL ENVIRON, V3, P38, DOI 10.2307/3868443; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2004, J INSECT PHYSIOL, V50, P175, DOI 10.1016/j.jinsphys.2003.11.004; ROSENBERG MS, 2000, METAWIN VERSION 2 ST; Schuler TH, 1999, TRENDS BIOTECHNOL, V17, P210, DOI 10.1016/S0167-7799(98)01298-0; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Torres JB, 2006, BIOL CONTROL, V39, P47, DOI 10.1016/j.biocontrol.2006.03.006; USDA, 2006, AGR CHEM US 2005 FIE; *USDA, 2007, AGR CHEM US 2006 VEG; Wang MC, 1998, PSYCHOL METHODS, V3, P46, DOI 10.1037/1082-989X.3.1.46; Whitehouse MEA, 2005, ENVIRON ENTOMOL, V34, P1224, DOI 10.1603/0046-225X(2005)034[1224:ACOACI]2.0.CO;2; WILLIAMS MR, 2006, P BELTW COTT C NAT C, P1151; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088; Wu K, 2002, CROP PROT, V21, P997, DOI 10.1016/S0261-2194(02)00080-7	55	232	253	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2118	10.1371/journal.pone.0002118	http://dx.doi.org/10.1371/journal.pone.0002118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461164	Green Submitted, Green Published, gold			2022-12-27	WOS:000261642400040
J	Beekwilder, J; van Leeuwen, W; van Dam, NM; Bertossi, M; Grandi, V; Mizzi, L; Soloviev, M; Szabados, L; Molthoff, JW; Schipper, B; Verbocht, H; de Vos, RCH; Morandini, P; Aarts, MGM; Bovy, A				Beekwilder, Jules; van Leeuwen, Wessel; van Dam, Nicole M.; Bertossi, Monica; Grandi, Valentina; Mizzi, Luca; Soloviev, Mikhail; Szabados, Laszlo; Molthoff, Jos W.; Schipper, Bert; Verbocht, Hans; de Vos, Ric C. H.; Morandini, Piero; Aarts, Mark G. M.; Bovy, Arnaud			The Impact of the Absence of Aliphatic Glucosinolates on Insect Herbivory in Arabidopsis	PLOS ONE			English	Article							THALIANA; DIVERSIFICATION; ISOTHIOCYANATES; IDENTIFICATION; BIOSYNTHESIS; MYROSINASE; RESISTANCE; BIOLOGY; GROWTH	Aliphatic glucosinolates are compounds which occur in high concentrations in Arabidopsis thaliana and other Brassicaceae species. They are important for the resistance of the plant to pest insects. Previously, the biosynthesis of these compounds was shown to be regulated by transcription factors MYB28 and MYB29. We now show that MYB28 and MYB29 are partially redundant, but in the absence of both, the synthesis of all aliphatic glucosinolates is blocked. Untargeted and targeted biochemical analyses of leaf metabolites showed that differences between single and double knock-out mutants and wild type plants were restricted to glucosinolates. Biosynthesis of long-chain aliphatic glucosinolates was blocked by the myb28 mutation, while short-chain aliphatic glucosinolates were reduced by about 50% in both the myb28 and the myb29 single mutants. Most remarkably, all aliphatic glucosinolates were completely absent in the double mutant. Expression of glucosinolate biosynthetic genes was slightly but significantly reduced by the single myb mutations, while the double mutation resulted in a drastic decrease in expression of these genes. Since the myb28myb29 double mutant is the first Arabidopsis genotype without any aliphatic glucosinolates, we used it to establish the relevance of aliphatic glucosinolate biosynthesis to herbivory by larvae of the lepidopteran insect Mamestra brassicae. Plant damage correlated inversely to the levels of aliphatic glucosinolates observed in those plants: Larval weight gain was 2.6 fold higher on the double myb28myb29 mutant completely lacking aliphatic glucosinolates and 1.8 higher on the single mutants with intermediate levels of aliphatic glucosinolates compared to wild type plants.	[Beekwilder, Jules; Molthoff, Jos W.; Schipper, Bert; Verbocht, Hans; de Vos, Ric C. H.; Bovy, Arnaud] Plant Res Int, Wageningen, Netherlands; [van Leeuwen, Wessel; Aarts, Mark G. M.] Wageningen Univ, Lab Genet, Wageningen, Netherlands; [van Dam, Nicole M.] Netherlands Inst Ecol, Heteren, Netherlands; [Bertossi, Monica; Grandi, Valentina; Morandini, Piero] Univ Milan, CNR Biophys Inst, Dept Biol, Milan, Italy; [Mizzi, Luca] Univ Milan, CNR Biophys Inst, Dept Biomol Sci & Biotechnol, Milan, Italy; [Soloviev, Mikhail] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Szabados, Laszlo] Biol Res Ctr, Szeged, Hungary	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Milan; University of Milan; University of London; Royal Holloway University London; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Beekwilder, J (corresponding author), Plant Res Int, Wageningen, Netherlands.	jules.beekwilder@wur.nl	Morandini, Piero A/B-1394-2017; van Dam, Nicole M./B-3281-2008; Aarts, Mark/O-1706-2019; Beekwilder, Jules/A-6802-2011; Aarts, Mark G.M./G-8929-2013; Szabados, Laszlo/F-2078-2010; MORANDINI, PIERO ANGELO/AAZ-1880-2021; De Vos, Ric/F-5012-2017	Morandini, Piero A/0000-0002-7994-6426; van Dam, Nicole M./0000-0003-2622-5446; Aarts, Mark/0000-0001-5257-0740; Beekwilder, Jules/0000-0003-3238-4427; Aarts, Mark G.M./0000-0001-5257-0740; MORANDINI, PIERO ANGELO/0000-0002-7994-6426; Soloviev, Mikhail/0000-0002-3235-1134; Szabados, Laszlo/0000-0002-9163-9875; Bovy, Arnaud/0000-0003-2643-7377				Agrawal AA, 2003, J CHEM ECOL, V29, P1403, DOI 10.1023/A:1024265420375; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Benderoth M, 2006, P NATL ACAD SCI USA, V103, P9118, DOI 10.1073/pnas.0601738103; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Celenza JL, 2005, PLANT PHYSIOL, V137, P253, DOI 10.1104/pp.104.054395; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Gigolashvili T, 2008, NEW PHYTOL, V177, P627, DOI 10.1111/j.1469-8137.2007.02295.x; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Gigolashvili T, 2007, PLANT J, V50, P886, DOI 10.1111/j.1365-313X.2007.03099.x; Gimsing AL, 2006, ENVIRON TOXICOL CHEM, V25, P2038, DOI 10.1897/05-610R.1; Gratwick M., 1992, CROP PESTS UK COLLEC; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hemm MR, 2003, PLANT CELL, V15, P179, DOI 10.1105/tpc.006544; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; HOGGE LR, 1988, J CHROMATOGR SCI, V26, P551, DOI 10.1093/chromsci/26.11.551; Kelly PJ, 1998, PLANTA, V206, P370, DOI 10.1007/s004250050412; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Kliebenstein D, 2002, GENETICS, V161, P325; Kliebenstein DJ, 2004, PLANT CELL ENVIRON, V27, P675, DOI 10.1111/j.1365-3040.2004.01180.x; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Li Q, 2000, J CHEM ECOL, V26, P2401, DOI 10.1023/A:1005535129399; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCCLOSKEY C, 1993, J CHEM ECOL, V19, P249, DOI 10.1007/BF00993693; Popova T. A., 1993, Entomological Review (English Translation of Entomologicheskoye Obozreniye), V72, P125; Reichelt M, 2002, PHYTOCHEMISTRY, V59, P663, DOI 10.1016/S0031-9422(02)00014-6; Rojas JC, 2000, J INSECT BEHAV, V13, P247, DOI 10.1023/A:1007792332046; Sonderby IE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001322; Szabados L, 2002, PLANT J, V32, P233, DOI 10.1046/j.1365-313X.2002.01417.x; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Windsor AJ, 2005, PHYTOCHEMISTRY, V66, P1321, DOI 10.1016/j.phytochem.2005.04.016; Wittstock U, 2003, RECENT ADV PHYTOCHEM, V37, P101	35	190	198	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2068	10.1371/journal.pone.0002068	http://dx.doi.org/10.1371/journal.pone.0002068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446225	Green Published, gold			2022-12-27	WOS:000261572300037
J	Dan, JM; Wang, JP; Lee, CK; Levitz, SM				Dan, Jennifer M.; Wang, Jennifer P.; Lee, Chrono K.; Levitz, Stuart M.			Cooperative Stimulation of Dendritic Cells by Cryptococcus neoformans Mannoproteins and CpG Oligodeoxynucleotides	PLOS ONE			English	Article								While mannosylation targets antigens to mannose receptors on dendritic cells (DC), the resultant immune response is suboptimal. We hypothesized that the addition of toll-like receptor (TLR) ligands would enhance the DC response to mannosylated antigens. Cryptococcus neoformans mannoproteins (MP) synergized with CpG-containing oligodeoxynucleotides to stimulate enhanced production of proinflammatory cytokines and chemokines from murine conventional and plasmacytoid DC. Synergistic stimulation required the interaction of mannose residues on MP with the macrophage mannose receptor (MR), CD206. Moreover, synergy with MP was observed with other TLR ligands, including tripalmitoylated lipopeptide (Pam3CSK4), polyinosine-polycytidylic acid (pI: C), and imiquimod. Finally, CpG enhanced MP-specific MHC II-restricted CD4(+) T-cell responses by a mechanism dependent upon DC expression of CD206 and TLR9. These data suggest a rationale for vaccination strategies that combine mannosylated antigens with TLR ligands and imply that immune responses to naturally mannosylated antigens on pathogens may be greatly augmented if TLR and MR are cooperatively stimulated.	[Dan, Jennifer M.; Levitz, Stuart M.] Boston Univ, Sch Med, Dept Microbiol, Immunol Training Program, Boston, MA 02118 USA; [Dan, Jennifer M.; Wang, Jennifer P.; Lee, Chrono K.; Levitz, Stuart M.] Univ Massachusetts, Med Sch, Dept Med, Div Infect Dis, Worcester, MA USA	Boston University; University of Massachusetts System; University of Massachusetts Worcester	Dan, JM (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Immunol Training Program, Boston, MA 02118 USA.	Stuart.Levitz@umassmed.edu		wang, jennifer/0000-0002-2556-9100	National Institutes of Health [RO1 AI25780, RO1 AI37532, K08 AI 53542]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025780, R01AI037532, R01AI066087, K08AI053542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants RO1 AI25780 and RO1 AI37532 to SML and K08 AI 53542 to JPW. The funding agency had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Bicanic T, 2005, BRIT MED BULL, V72, P99, DOI 10.1093/bmb/ldh043; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; Edwards L, 2005, EUR J IMMUNOL, V35, P273, DOI 10.1002/eji.200425640; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hacker H, 2000, J EXP MED, V192, P595, DOI 10.1084/jem.192.4.595; Hazeki K, 2007, BIOL PHARM BULL, V30, P1617, DOI 10.1248/bpb.30.1617; Herring AC, 2002, INFECT IMMUN, V70, P2959, DOI 10.1128/IAI.70.6.2959-2964.2002; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hochrein H, 2002, HUM IMMUNOL, V63, P1103, DOI 10.1016/S0198-8859(02)00748-6; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kinjo T, 2007, MICROBIOL IMMUNOL, V51, P741, DOI 10.1111/j.1348-0421.2007.tb03963.x; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Levitz SM, 2001, P NATL ACAD SCI USA, V98, P10422, DOI 10.1073/pnas.181331398; Levitz SM, 2006, FEMS YEAST RES, V6, P513, DOI 10.1111/j.1567-1364.2006.00071.x; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mansour MK, 2006, J IMMUNOL, V176, P3053, DOI 10.4049/jimmunol.176.5.3053; Mansour MK, 2004, INFECT IMMUN, V72, P1746, DOI 10.1128/IAI.72.3.1746-1754.2004; Mansour MK, 2002, J IMMUNOL, V168, P2872, DOI 10.4049/jimmunol.168.6.2872; Miyagi K, 2005, CLIN EXP IMMUNOL, V140, P220, DOI 10.1111/j.1365-2249.2005.02772.x; MURPHY JW, 1988, INFECT IMMUN, V56, P424, DOI 10.1128/IAI.56.2.424-431.1988; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Park CG, 2001, INT IMMUNOL, V13, P1283, DOI 10.1093/intimm/13.10.1283; Pietrella D, 2005, INFECT IMMUN, V73, P820, DOI 10.1128/IAI.73.2.820-827.2005; Ramakrishna V, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-5; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Shoham S, 2005, BRIT J HAEMATOL, V129, P569, DOI 10.1111/j.1365-2141.2005.05397.x; Specht CA, 2007, J INFECT DIS, V196, P796, DOI 10.1086/520536; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Zhang JM, 2004, INFECT IMMUN, V72, P3147, DOI 10.1128/IAI.72.6.3147-3160.2004	40	49	50	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2046	10.1371/journal.pone.0002046	http://dx.doi.org/10.1371/journal.pone.0002046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446192	Green Published, gold, Green Submitted			2022-12-27	WOS:000261572300018
J	Gustafsson, C; Mjosberg, J; Matussek, A; Geffers, R; Matthiesen, L; Berg, G; Sharma, S; Buer, J; Ernerudh, J				Gustafsson, Charlotte; Mjoesberg, Jenny; Matussek, Andreas; Geffers, Robert; Matthiesen, Leif; Berg, Goeran; Sharma, Surendra; Buer, Jan; Ernerudh, Jan			Gene Expression Profiling of Human Decidual Macrophages: Evidence for Immunosuppressive Phenotype	PLOS ONE			English	Article								Background: Although uterine macrophages are thought to play an important regulatory role at the maternal-fetal interface, their global gene expression profile is not known. Methodology/Principal Findings: Using micro-array comprising approximately 14,000 genes, the gene expression pattern of human first trimester decidual CD14+ monocytes/macrophages was characterized and compared with the expression profile of the corresponding cells in blood. Some of the key findings were confirmed by real time PCR or by secreted protein. A unique gene expression pattern intrinsic of first trimester decidual CD14+ cells was demonstrated. A large number of regulated genes were functionally related to immunomodulation and tissue remodelling, corroborating polarization patterns of differentiated macrophages mainly of the alternatively activated M2 phenotype. These include known M2 markers such as CCL-18, CD209, insulin-like growth factor (IGF)-1, mannose receptor c type (MRC)-1 and fibronectin-1. Further, the selective up-regulation of triggering receptor expressed on myeloid cells (TREM)-2, alpha-2-macroglobulin (A2M) and prostaglandin D2 synthase (PGDS) provides new insights into the regulatory function of decidual macrophages in pregnancy that may have implications in pregnancy complications. Conclusions/Significance: The molecular characterization of decidual macrophages presents a unique transcriptional profile replete with important components for fetal immunoprotection and provides several clues for further studies of these cells.	[Gustafsson, Charlotte; Mjoesberg, Jenny; Ernerudh, Jan] Linkoping Univ Hosp, Fac Hlth Sci, Dept Clin & Expt Med,Div Clin Immunol, Unit Autoimmunity & Immune Regulat AIR, S-58185 Linkoping, Sweden; [Matussek, Andreas] Cty Hosp Ryhov, Dept Clin Microbiol, Jonkoping, Sweden; [Geffers, Robert] Helmholtz Ctr Infect Res HCI, Braunschweig, Germany; [Matthiesen, Leif; Berg, Goeran] Univ Hosp, Fac Hlth Sci, Div Gynecol & Obstet, Linkoping, Sweden; [Sharma, Surendra] Brown Univ, Women & Infants Hosp Rhode Island, Dept Pediat, Providence, RI USA; [Sharma, Surendra] Brown Univ, Women & Infants Hosp Rhode Island, Dept Pathol, Providence, RI USA; [Buer, Jan] Univ Hosp Essen, Inst Med Microbiol, Essen, Germany	Linkoping University; Brown University; Women & Infants Hospital Rhode Island; Brown University; Women & Infants Hospital Rhode Island; University of Duisburg Essen	Gustafsson, C (corresponding author), Linkoping Univ Hosp, Fac Hlth Sci, Dept Clin & Expt Med,Div Clin Immunol, Unit Autoimmunity & Immune Regulat AIR, S-58185 Linkoping, Sweden.	charlotte.gustafsson@imk.liu.se	Matussek, Andreas/AAB-3629-2021	Gustafsson, Charlotte/0000-0003-4997-6795; Buer, Jan/0000-0002-7602-1698	Swedish Research Council; Medical Research Council of South-east Sweden (FORSS); County Council of Ostergotland; National Institutes of Health, USA [HD-41701]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041701] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Research Council of South-east Sweden (FORSS); County Council of Ostergotland; National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from the Swedish Research Council, the Medical Research Council of South-east Sweden (FORSS), the County Council of Ostergotland and by a grant from the National Institutes of Health, USA (HD-41701).	Aoki S, 1998, HUM REPROD, V13, P2950, DOI 10.1093/humrep/13.10.2950; Baykal C, 2005, FETAL DIAGN THER, V20, P249, DOI 10.1159/000085079; Begum NA, 2004, INFECT IMMUN, V72, P937, DOI 10.1128/IAI.72.2.937-948.2004; Bischof RJ, 2000, CLIN EXP IMMUNOL, V119, P361; Brown M, 2004, HUM IMMUNOL, V65, P1336, DOI 10.1016/j.humimm.2004.08.176; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Burk MR, 2001, PLACENTA, V22, P309, DOI 10.1053/plac.2001.0624; Chaouat G, 1999, AM J REPROD IMMUNOL, V42, P1; CHEUNG DL, 1992, BLOOD, V79, P1972; Clark DA, 2003, AM J REPROD IMMUNOL, V50, P187, DOI 10.1034/j.1600-0897.2003.00086.x; Coolman M, 2007, PLACENTA, V28, P709, DOI 10.1016/j.placenta.2006.06.017; Cupurdija K, 2004, AM J REPROD IMMUNOL, V51, P117, DOI 10.1046/j.8755-8920.2003.00128.x; Daly C, 2003, MICROCIRCULATION, V10, P247, DOI 10.1038/sj.mn.7800190; Dealtry GB, 1998, AM J REPROD IMMUNOL, V40, P283; Furugori K, 1997, J CLIN ENDOCR METAB, V82, P2726, DOI 10.1210/jc.82.8.2726; Gabinskaya T, 1998, AM J REPROD IMMUNOL, V40, P339; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gustafsson C, 2006, J REPROD IMMUNOL, V71, P41, DOI 10.1016/j.jri.2005.12.009; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hanna N, 2000, J IMMUNOL, V164, P5721, DOI 10.4049/jimmunol.164.11.5721; Hashimoto SI, 2003, SCAND J INFECT DIS, V35, P619, DOI 10.1080/00365540310015926; Heikkinen J, 2003, CLIN EXP IMMUNOL, V131, P498, DOI 10.1046/j.1365-2249.2003.02092.x; Hunt J S, 1992, Curr Top Microbiol Immunol, V181, P39; Ip WK, 2006, CLIN EXP IMMUNOL, V145, P162, DOI 10.1111/j.1365-2249.2006.03085.x; Kammerer U, 2005, CHEM IMMUNOL ALLERGY, V89, P96, DOI 10.1159/000087951; Kammerer U, 2003, AM J PATHOL, V162, P887, DOI 10.1016/S0002-9440(10)63884-9; Kodelja V, 1997, IMMUNOBIOLOGY, V197, P478, DOI 10.1016/S0171-2985(97)80080-0; Kodelja V, 1998, J IMMUNOL, V160, P1411; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Larin Sergei S, 2002, Russ J Immunol, V7, P34; Laskarin G, 2005, HUM REPROD, V20, P1057, DOI 10.1093/humrep/deh740; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lidstrom C, 2003, AM J REPROD IMMUNOL, V50, P444, DOI 10.1046/j.8755-8920.2003.00112.x; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Marvin KW, 2002, MOL HUM REPROD, V8, P399, DOI 10.1093/molehr/8.4.399; MIZUNO M, 1994, AM J REPROD IMMUNOL, V31, P180, DOI 10.1111/j.1600-0897.1994.tb00865.x; Mor Gil, 2003, Reprod Biol Endocrinol, V1, P119, DOI 10.1186/1477-7827-1-119; MUES B, 1989, IMMUNOLOGY, V67, P303; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nayak NR, 2003, PLACENTA, V24, P281, DOI 10.1053/plac.2002.0906; PARHAR RS, 1988, CELL IMMUNOL, V116, P392, DOI 10.1016/0008-8749(88)90240-7; Puig-Kroger A, 2004, J BIOL CHEM, V279, P25680, DOI 10.1074/jbc.M311516200; Rieger L, 2002, MOL HUM REPROD, V8, P255, DOI 10.1093/molehr/8.3.255; Roth I, 1996, J EXP MED, V184, P539, DOI 10.1084/jem.184.2.539; Rutella S, 2006, BLOOD, V108, P218, DOI 10.1182/blood-2005-08-3141; Sacks GP, 2001, PLACENTA, V22, P550, DOI 10.1053/plac.2001.0686; Saito S, 2002, AM J REPROD IMMUNOL, V47, P295, DOI 10.1034/j.1600-0897.2002.01113.x; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Takabayshi K, 2006, IMMUNITY, V24, P475, DOI 10.1016/j.immuni.2006.02.008; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tayade C, 2005, MOL CELL ENDOCRINOL, V245, P60, DOI 10.1016/j.mce.2005.10.004; Terness P, 2007, AM J REPROD IMMUNOL, V58, P238, DOI 10.1111/j.1600-0897.2007.00510.x; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; van Lieshout AWT, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-23; Volpe E, 2006, IMMUNOLOGY, V118, P449, DOI 10.1111/j.1365-2567.2006.02378.x; Watkins SK, 2007, J IMMUNOL, V178, P1357, DOI 10.4049/jimmunol.178.3.1357	60	261	274	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2078	10.1371/journal.pone.0002078	http://dx.doi.org/10.1371/journal.pone.0002078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446208	Green Published, gold, Green Submitted			2022-12-27	WOS:000261572300046
J	Hong, SK; Tsang, M; Dawid, IB				Hong, Sung-Kook; Tsang, Michael; Dawid, Igor B.			The Mych Gene Is Required for Neural Crest Survival during Zebrafish Development	PLOS ONE			English	Article								Background: Among Myc family genes, c-Myc is known to have a role in neural crest specification in Xenopus and in craniofacial development in the mouse. There is no information on the function of other Myc genes in neural crest development, or about any developmental role of zebrafish Myc genes. Principal Findings: We isolated the zebrafish mych (myc homologue) gene. Knockdown of mych leads to severe defects in craniofacial development and in certain other tissues including the eye. These phenotypes appear to be caused by cell death in the neural crest and in the eye field in the anterior brain. Significance: Mych is a novel factor required for neural crest cell survival in zebrafish.	[Hong, Sung-Kook; Tsang, Michael; Dawid, Igor B.] NICHHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA; [Tsang, Michael] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hong, SK (corresponding author), NICHHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA.	hongsk@mail.nih.gov	Tsang, Michael/AAG-9338-2020; Tsang, Michael W/I-9305-2014; Tsang, Michael/ABV-0504-2022; TSANG, Michael/E-2758-2013	Tsang, Michael W/0000-0001-7123-0063; Tsang, Michael/0000-0001-7123-0063; TSANG, Michael/0000-0001-6384-2422	National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008809] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008809] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Intramural Research Program of the National Institute of Child Health and Human Development, National Institutes of Health	AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Barembaum M, 2005, SEMIN CELL DEV BIOL, V16, P642, DOI 10.1016/j.semcdb.2005.06.006; Barrallo-Gimeno A, 2004, DEVELOPMENT, V131, P1463, DOI 10.1242/dev.01033; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Chuang JC, 2002, BIOESSAYS, V24, P519, DOI 10.1002/bies.10097; Dang CV, 1999, MOL CELL BIOL, V19, P1; Facchini LM, 1997, MOL CELL BIOL, V17, P100, DOI 10.1128/MCB.17.1.100; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hong SK, 2005, P NATL ACAD SCI USA, V102, P18473, DOI 10.1073/pnas.0509457102; Hukriede NA, 1999, P NATL ACAD SCI USA, V96, P9745, DOI 10.1073/pnas.96.17.9745; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Kawahara A, 2002, DEV BIOL, V248, P107, DOI 10.1006/dbio.2002.0709; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Kudoh T, 2001, MECH DEVELOP, V109, P95, DOI 10.1016/S0925-4773(01)00505-6; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Light W, 2005, DEVELOPMENT, V132, P1831, DOI 10.1242/dev.01734; Loeb-Hennard C, 2005, GENE EXPR PATTERNS, V5, P341, DOI 10.1016/j.modgep.2004.10.003; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; O'Brien EK, 2004, DEV BIOL, V265, P246, DOI 10.1016/j.ydbio.2003.09.029; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Oster SK, 2000, MOL CELL BIOL, V20, P6768, DOI 10.1128/MCB.20.18.6768-6778.2000; Oster SK, 2003, ONCOGENE, V22, P1998, DOI 10.1038/sj.onc.1206228; Phillips BT, 2006, DEV BIOL, V294, P376, DOI 10.1016/j.ydbio.2006.03.001; Piotrowski T, 2003, DEVELOPMENT, V130, P5043, DOI 10.1242/dev.00704; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Ryan KM, 1996, BIOCHEM J, V314, P713, DOI 10.1042/bj3140713; SCHREIBERAGUS N, 1993, MOL CELL BIOL, V13, P2765, DOI 10.1128/MCB.13.5.2765; Secombe J, 2004, CELL, V117, P153, DOI 10.1016/S0092-8674(04)00336-8; THISSE C, 1994, DEV BIOL, V164, P420, DOI 10.1006/dbio.1994.1212; Wei K, 2007, GENESIS, V45, P382, DOI 10.1002/dvg.20304; Westerfield M, 1995, ZEBRAFISH BOOK	32	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2029	10.1371/journal.pone.0002029	http://dx.doi.org/10.1371/journal.pone.0002029			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446220	Green Accepted, gold, Green Published			2022-12-27	WOS:000261572300003
J	Chiaraviglio, L; Brown, DA; Kirby, JE				Chiaraviglio, Lucius; Brown, Daniel A.; Kirby, James E.			Infection of Cultured Human Endothelial Cells by Legionella pneumophila	PLOS ONE			English	Article								Legionella pneumophila is a gram-negative pathogen that causes a severe pneumonia known as Legionnaires' disease. Here, we demonstrate for the first time that L. pneumophila infects and grows within cultured human endothelial cells. Endothelial infection may contribute to lung damage observed during Legionnaires' disease and to systemic spread of this organism.	[Chiaraviglio, Lucius; Brown, Daniel A.; Kirby, James E.] Beth Israel Deaconess Med Ctr, Div Canc Biol & Angiogenesis, Dept Pathol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Chiaraviglio, L (corresponding author), Beth Israel Deaconess Med Ctr, Div Canc Biol & Angiogenesis, Dept Pathol, Boston, MA 02215 USA.	jekirby@bidmc.harvard.edu	Kirby, James/K-4438-2019	Chiaraviglio, Lucius/0000-0002-2613-6614	American Heart Association [Grant-In-Aid award]	American Heart Association(American Heart Association)	Supported in part by a Grant-In-Aid award from the American Heart Association. The sponsor did not have a role in design of studies or preparation of the manuscript	AbuKwaik Y, 1996, APPL ENVIRON MICROB, V62, P2022, DOI 10.1128/AEM.62.6.2022-2028.1996; Andrews HL, 1998, INFECT IMMUN, V66, P950, DOI 10.1128/IAI.66.3.950-958.1998; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; BRIELAND J, 1994, AM J PATHOL, V145, P1537; CHASTRE J, 1987, CHEST, V91, P57, DOI 10.1378/chest.91.1.57; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; CIANCIOTTO NP, 1995, CURR MICROBIOL, V30, P247, DOI 10.1007/BF00293641; EVANS CP, 1981, AM J CLIN PATHOL, V76, P813; Fabbi M, 1998, J CLIN MICROBIOL, V36, P1942, DOI 10.1128/JCM.36.7.1942-1947.1998; Gao LY, 1998, MICROB PATHOGENESIS, V25, P291, DOI 10.1006/mpat.1998.0237; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; HUSMANN LK, 1994, INFECT IMMUN, V62, P2111, DOI 10.1128/IAI.62.5.2111-2114.1994; ISBERG RR, 1991, SCIENCE, V252, P934, DOI 10.1126/science.1674624; Khelef N, 2001, INFECT IMMUN, V69, P5157, DOI 10.1128/IAI.69.8.5157-5161.2001; KING CH, 1991, INFECT IMMUN, V59, P758, DOI 10.1128/IAI.59.3.758-763.1991; Kirby JE, 1998, MOL MICROBIOL, V27, P323, DOI 10.1046/j.1365-2958.1998.00680.x; MARRA A, 1992, P NATL ACAD SCI USA, V89, P9607, DOI 10.1073/pnas.89.20.9607; Marruchella A, 2003, SARCOIDOSIS VASC DIF, V20, P77; Maruta K, 1998, AM J RESP CRIT CARE, V157, P1967, DOI 10.1164/ajrccm.157.6.9710108; Massey R, 2003, HEART, V89, DOI 10.1136/heart.89.5.e16; MCCABE RE, 1984, ANN INTERN MED, V100, P525, DOI 10.7326/0003-4819-100-4-525; MODY CH, 1993, J INFECT DIS, V167, P1138, DOI 10.1093/infdis/167.5.1138; NASH TW, 1984, J CLIN INVEST, V74, P771, DOI 10.1172/JCI111493; NEWSOME AL, 1985, INFECT IMMUN, V50, P449, DOI 10.1128/IAI.50.2.449-452.1985; Roy CR, 2002, J CELL BIOL, V158, P415, DOI 10.1083/jcb.200205011; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Segal G, 1997, INFECT IMMUN, V65, P5057, DOI 10.1128/IAI.65.12.5057-5066.1997; Stout JE, 1997, NEW ENGL J MED, V337, P682, DOI 10.1056/NEJM199709043371006; Sundar KM, 2004, SARCOIDOSIS VASC DIF, V21, P158; Swanson MS, 1996, INFECT IMMUN, V64, P2585, DOI 10.1128/IAI.64.7.2585-2594.1996; TOMPKINS LS, 1988, NEW ENGL J MED, V318, P530, DOI 10.1056/NEJM198803033180902; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Watarai M, 2001, J EXP MED, V194, P1081, DOI 10.1084/jem.194.8.1081	35	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2012	10.1371/journal.pone.0002012	http://dx.doi.org/10.1371/journal.pone.0002012			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431493	Green Published, gold, Green Submitted			2022-12-27	WOS:000261558700028
J	Zybailov, B; Rutschow, H; Friso, G; Rudella, A; Emanuelsson, O; Sun, Q; van Wijk, KJ				Zybailov, Boris; Rutschow, Heidi; Friso, Giulia; Rudella, Andrea; Emanuelsson, Olof; Sun, Qi; van Wijk, Klaas J.			Sorting Signals, N-Terminal Modifications and Abundance of the Chloroplast Proteome	PLOS ONE			English	Article								Characterization of the chloroplast proteome is needed to understand the essential contribution of the chloroplast to plant growth and development. Here we present a large scale analysis by nanoLC-Q-TOF and nanoLC-LTQ-Orbitrap mass spectrometry (MS) of ten independent chloroplast preparations from Arabidopsis thaliana which unambiguously identified 1325 proteins. Novel proteins include various kinases and putative nucleotide binding proteins. Based on repeated and independent MS based protein identifications requiring multiple matched peptide sequences, as well as literature, 916 nuclear-encoded proteins were assigned with high confidence to the plastid, of which 86% had a predicted chloroplast transit peptide (cTP). The protein abundance of soluble stromal proteins was calculated from normalized spectral counts from LTQ-Obitrap analysis and was found to cover four orders of magnitude. Comparison to gel-based quantification demonstrates that 'spectral counting' can provide large scale protein quantification for Arabidopsis. This quantitative information was used to determine possible biases for protein targeting prediction by TargetP and also to understand the significance of protein contaminants. The abundance data for 550 stromal proteins was used to understand abundance of metabolic pathways and chloroplast processes. We highlight the abundance of 48 stromal proteins involved in post-translational proteome homeostasis (including aminopeptidases, proteases, deformylases, chaperones, protein sorting components) and discuss the biological implications. N-terminal modifications were identified for a subset of nuclear- and chloroplast-encoded proteins and a novel N-terminal acetylation motif was discovered. Analysis of cTPs and their cleavage sites of Arabidopsis chloroplast proteins, as well as their predicted rice homologues, identified new species-dependent features, which will facilitate improved subcellular localization prediction. No evidence was found for suggested targeting via the secretory system. This study provides the most comprehensive chloroplast proteome analysis to date and an expanded Plant Proteome Database (PPDB) in which all MS data are projected on identified gene models.	[Zybailov, Boris; Rutschow, Heidi; Friso, Giulia; Rudella, Andrea; van Wijk, Klaas J.] Cornell Univ, Dept Plant Biol, Ithaca, NY USA; [Emanuelsson, Olof] Stockholm Univ, AlbaNova, Stockholm Bioinformat Ctr, Stockholm, Sweden; [Sun, Qi] Cornell Univ, Cornell Theory Ctr, Computat Biol Serv Unit, Ithaca, NY USA	Cornell University; Stockholm University; Cornell University	van Wijk, KJ (corresponding author), Cornell Univ, Dept Plant Biol, Ithaca, NY USA.	kv35@cornell.edu		Zybailov, Boris/0000-0003-2432-9145	National Science Foundation [0343444]; U.S. Department of Energy [DE-FG02-04ER15560]; New York Science, Technology and Academic Research (NYSTAR); Microsoft Corporation; Knut and Alice Wallenberg Foundation	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); New York Science, Technology and Academic Research (NYSTAR); Microsoft Corporation(Microsoft); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This project was supported by a grant from the National Science Foundation (MCB # 0343444), the U.S. Department of Energy (DE-FG02-04ER15560) and New York Science, Technology and Academic Research (NYSTAR) to K.J.v.W. QS was supported by resources of the Computational Biology Service Unit from Cornell University which is partially funded by the Microsoft Corporation. OE was supported by a grant from the Knut and Alice Wallenberg Foundation.	Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Amin P, 1999, PLANT PHYSIOL, V121, P61, DOI 10.1104/pp.121.1.61; Baginsky S, 2006, J EXP BOT, V57, P1485, DOI 10.1093/jxb/erj130; Baginsky S, 2004, J EXP BOT, V55, P1213, DOI 10.1093/jxb/erh104; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; Book AJ, 2005, PLANT PHYSIOL, V138, P1046, DOI 10.1104/pp.104.057406; Chen H, 2006, PLANT MOL BIOL, V61, P567, DOI 10.1007/s11103-006-0031-x; Dirk LMA, 2002, ARCH BIOCHEM BIOPHYS, V406, P135, DOI 10.1016/S0003-9861(02)00426-5; Dirk LMA, 2001, PLANT PHYSIOL, V127, P97, DOI 10.1104/pp.127.1.97; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fernie AR, 2005, CURR OPIN PLANT BIOL, V8, P174, DOI 10.1016/j.pbi.2005.01.008; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Giglione C, 2003, EMBO J, V22, P13, DOI 10.1093/emboj/cdg007; Giglione C, 2001, TRENDS PLANT SCI, V6, P566, DOI 10.1016/S1360-1385(01)02151-3; Giglione C, 2000, EMBO J, V19, P5916, DOI 10.1093/emboj/19.21.5916; Glinski M, 2006, MASS SPECTROM REV, V25, P173, DOI 10.1002/mas.20063; Heazlewood JL, 2004, PLANT CELL, V16, P241, DOI 10.1105/tpc.016055; Heazlewood JL, 2005, PLANT PHYSIOL, V139, P598, DOI 10.1104/pp.105.065532; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hennig L, 2007, TRENDS PLANT SCI, V12, P287, DOI 10.1016/j.tplants.2007.05.002; Hummel J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-216; Jain R, 2007, BIOCHEM BIOPH RES CO, V359, P486, DOI 10.1016/j.bbrc.2007.05.142; Jensen ON, 2006, NAT REV MOL CELL BIO, V7, P391, DOI 10.1038/nrm1939; Kleffmann T, 2007, PLANT PHYSIOL, V143, P912, DOI 10.1104/pp.106.090738; Listgarten J, 2005, MOL CELL PROTEOMICS, V4, P419, DOI 10.1074/mcp.R500005-MCP200; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Mallick P, 2007, NAT BIOTECHNOL, V25, P125, DOI 10.1038/nbt1275; Meinnel T, 2006, BIOL CHEM, V387, P839, DOI 10.1515/BC.2006.107; Mendenhall W, 1995, STAT ENG SCI; MICHEL H, 1988, J BIOL CHEM, V263, P1123; MICHEL H, 1991, J BIOL CHEM, V266, P17584; Millar AH, 2006, CURR OPIN PLANT BIOL, V9, P610, DOI 10.1016/j.pbi.2006.09.002; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Nesvizhskii AI, 2007, NAT METHODS, V4, P787, DOI 10.1038/NMETH1088; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; Peltier JB, 2004, J BIOL CHEM, V279, P49367, DOI 10.1074/jbc.M406763200; Peltier JB, 2004, J BIOL CHEM, V279, P4768, DOI 10.1074/jbc.M309212200; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Pesaresi P, 2003, PLANT CELL, V15, P1817, DOI 10.1105/tpc.012377; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Reumann S, 2004, PLANT PHYSIOL, V136, P2587, DOI 10.1104/pp.104.043695; Richly E, 2004, GENE, V329, P11, DOI 10.1016/j.gene.2004.01.008; Rolland N, 2006, J EXP BOT, V57, P1579, DOI 10.1093/jxb/erj162; Roose JL, 2004, J BIOL CHEM, V279, P45417, DOI 10.1074/jbc.M408458200; Ross S, 2005, PLANT PHYSIOL, V137, P623, DOI 10.1104/pp.104.056861; Rudella A, 2006, PLANT CELL, V18, P1704, DOI 10.1105/tpc.106.042861; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; Scigelova M, 2006, PROTEOMICS, P16, DOI 10.1002/pmic.200600528; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sjogren LLE, 2006, PLANT CELL, V18, P2635, DOI 10.1105/tpc.106.044594; SOKAL R, 2005, BIOMETRY, pCH5; Stahl A, 2005, J MOL BIOL, V349, P847, DOI 10.1016/j.jmb.2005.04.023; Stahl-Zeng J, 2007, MOL CELL PROTEOMICS, V6, P1809, DOI 10.1074/mcp.M700132-MCP200; Sun Q, 2004, PLANT PHYSIOL, V135, P723, DOI 10.1104/pp.104.040717; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; van Wijk KJ, 2004, PLANT PHYSIOL BIOCH, V42, P963, DOI 10.1016/j.plaphy.2004.10.015; van Wijk Klaas J., 2007, V355, P43; VANWIJK KJ, 2007, PHOTOSYNTHESIS COMPR, pCH8; Villarejo A, 2005, NAT CELL BIOL, V7, P1224, DOI 10.1038/ncb1330; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; Wang BC, 2006, PROTEOMICS, V6, P2555, DOI 10.1002/pmic.200500657; Whitelegge JP, 2004, PLANT PHYSIOL BIOCH, V42, P919, DOI 10.1016/j.plaphy.2004.11.005; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Ytterberg AJ, 2006, PLANT PHYSIOL, V140, P984, DOI 10.1104/pp.105.076083; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	80	509	645	3	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1994	10.1371/journal.pone.0001994	http://dx.doi.org/10.1371/journal.pone.0001994			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431481	Green Published, Green Submitted, gold			2022-12-27	WOS:000261558700016
J	Chiang, N; Schwab, JM; Fredman, G; Kasuga, K; Gelman, S; Serhan, CN				Chiang, Nan; Schwab, Jan M.; Fredman, Gabrielle; Kasuga, Kie; Gelman, Simon; Serhan, Charles N.			Anesthetics Impact the Resolution of Inflammation	PLOS ONE			English	Article								Background: Local and volatile anesthetics are widely used for surgery. It is not known whether anesthetics impinge on the orchestrated events in spontaneous resolution of acute inflammation. Here we investigated whether a commonly used local anesthetic (lidocaine) and a widely used inhaled anesthetic (isoflurane) impact the active process of resolution of inflammation. Methods and Findings: Using murine peritonitis induced by zymosan and a systems approach, we report that lidocaine delayed and blocked key events in resolution of inflammation. Lidocaine inhibited both PMN apoptosis and macrophage uptake of apoptotic PMN, events that contributed to impaired PMN removal from exudates and thereby delayed the onset of resolution of acute inflammation and return to homeostasis. Lidocaine did not alter the levels of specific lipid mediators, including pro-inflammatory leukotriene B-4, prostaglandin E-2 and anti-inflammatory lipoxin A(4), in the cell-free peritoneal lavages. Addition of a lipoxin A(4) stable analog, partially rescued lidocaine-delayed resolution of inflammation. To identify protein components underlying lidocaine's actions in resolution, systematic proteomics was carried out using nanospray-liquid chromatography-tandem mass spectrometry. Lidocaine selectively up-regulated pro-inflammatory proteins including S100A8/9 and CRAMP/LL-37, and down-regulated anti-inflammatory and some pro-resolution peptides and proteins including IL-4, IL-13, TGF-(alpha) over cap and Galectin-1. In contrast, the volatile anesthetic isoflurane promoted resolution in this system, diminishing the amplitude of PMN infiltration and shortening the resolution interval (Ri) similar to 50%. In addition, isoflurane down-regulated a panel of pro-inflammatory chemokines and cytokines, as well as proteins known to be active in cell migration and chemotaxis (i.e., CRAMP and cofilin-1). The distinct impact of lidocaine and isoflurane on selective molecules may underlie their opposite actions in resolution of inflammation, namely lidocaine delayed the onset of resoluion (T-max), while isoflurane shortened resolution interval (Ri). Conclusions: Taken together, both local and volatile anesthetics impact endogenous resolution program(s), altering specific resolution indices and selective cellular/molecular components in inflammation-resolution. Isoflurane enhances whereas lidocaine impairs timely resolution of acute inflammation.	[Chiang, Nan; Schwab, Jan M.; Fredman, Gabrielle; Kasuga, Kie; Gelman, Simon; Serhan, Charles N.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Chiang, N (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, 75 Francis St, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Kasuga, Kie/D-2308-2013; Chiang, Nan/ABA-4924-2021	Kasuga, Kie/0000-0003-0489-194X; Chiang, Nan/0000-0003-1963-1585; Schwab, Jan/0000-0001-6784-4919	NIH [GM 38765, P50-DE016191]; German Research Council [Schw 1064/1-1]; Arthritis Foundation Postdoctoral Fellowship; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038765, R01GM038765, R37GM038765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Council(German Research Foundation (DFG)); Arthritis Foundation Postdoctoral Fellowship; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants GM 38765 and P50-DE016191 (CNS) and the German Research Council (DFG, Schw 1064/1-1) (JMS). Kie Kasuga is the recipient of an Arthritis Foundation Postdoctoral Fellowship.	Alam S, 2006, MOL IMMUNOL, V43, P1432, DOI 10.1016/j.molimm.2005.07.025; AZAD SS, 1993, J CLIN ANESTH, V5, P122, DOI 10.1016/0952-8180(93)90139-6; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Biteman B, 2007, FASEB J, V21, P2257, DOI 10.1096/fj.06-7918com; Brandt L, 1967, Scand J Haematol Suppl, V2, P1; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; Cotran RS., 1999, ROBBINS PATHOLOGIC B, P1425; CULLEN BF, 1974, ANESTHESIOLOGY, V40, P142, DOI 10.1097/00000542-197402000-00009; de Klaver MJM, 2003, ANESTH ANALG, V97, P465, DOI 10.1213/01.ANE.0000073162.27208.E9; de Rossi LW, 2002, ANESTH ANALG, V95, P583, DOI 10.1097/00000539-200209000-00017; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; Dias-Baruffi M, 2003, J BIOL CHEM, V278, P41282, DOI 10.1074/jbc.M306624200; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Gallos G, 2004, ANESTHESIOLOGY, V101, P902, DOI 10.1097/00000542-200410000-00015; Gil CD, 2006, INFLAMM RES, V55, P99, DOI 10.1007/s00011-005-0059-4; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; GOLAN DE, 2007, PRINCIPLES PHARM PAT, P985; GOLDSTEIN IM, 1977, J EXP MED, V146, P483, DOI 10.1084/jem.146.2.483; Hawkins J Mel, 2002, Dent Clin North Am, V46, P719, DOI 10.1016/S0011-8532(02)00020-4; Hayes JK, 2004, ANESTH ANALG, V98, P999, DOI 10.1213/01.ANE.0000104584.91385.1D; Kurosaka K, 2005, J IMMUNOL, V174, P6257, DOI 10.4049/jimmunol.174.10.6257; Lee HT, 2004, AM J PHYSIOL-RENAL, V286, pF111, DOI 10.1152/ajprenal.00108.2003; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Maddox JE, 1996, J EXP MED, V183, P137, DOI 10.1084/jem.183.1.137; Mazzocco M, 2002, GENE, V291, P233, DOI 10.1016/S0378-1119(02)00602-9; Nascimento-Silva V, 2005, AM J PHYSIOL-CELL PH, V289, pC557, DOI 10.1152/ajpcell.00045.2005; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Plachinta RV, 2003, ANESTHESIOLOGY, V98, P89, DOI 10.1097/00000542-200301000-00017; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; SALO M, 1992, ACTA ANAESTH SCAND, V36, P201, DOI 10.1111/j.1399-6576.1992.tb03452.x; SASAGAWA S, 1991, IMMUNOPHARM IMMUNOT, V13, P607, DOI 10.3109/08923979109019726; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Sawatzky DA, 2006, AM J PATHOL, V168, P33, DOI 10.2353/ajpath.2006.050058; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, BRIT J PHARMACOL, V153, pS200, DOI 10.1038/sj.bjp.0707489; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Tamaki H, 2006, GASTROENTEROLOGY, V131, P1110, DOI 10.1053/j.gastro.2006.08.023; Taniguchi T, 1999, AM J EMERG MED, V17, P548, DOI 10.1016/S0735-6757(99)90194-8; Underhill DM, 2003, J ENDOTOXIN RES, V9, P176, DOI 10.1179/096805103125001586; Verleye M, 2000, PHARMACOL RES, V41, P539, DOI 10.1006/phrs.1999.0619; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; WINYARD PG, 2003, INFLAMMATION PROTOCO, P378; Yregard L, 2003, BURNS, V29, P335, DOI 10.1016/S0305-4179(03)00006-8	49	97	101	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1879	10.1371/journal.pone.0001879	http://dx.doi.org/10.1371/journal.pone.0001879			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382663	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795400014
J	Lahdesmaki, H; Rust, AG; Shmulevich, I				Lahdesmaki, Harri; Rust, Alistair G.; Shmulevich, Ilya			Probabilistic Inference of Transcription Factor Binding from Multiple Data Sources	PLOS ONE			English	Article							OPEN-ACCESS DATABASE; REGULATORY ELEMENTS; COMPUTATIONAL IDENTIFICATION; GENE-EXPRESSION; STATISTICAL SIGNIFICANCE; SAMPLING METHOD; SEQUENCE; SITES; PREDICTION; MODEL	An important problem in molecular biology is to build a complete understanding of transcriptional regulatory processes in the cell. We have developed a flexible, probabilistic framework to predict TF binding from multiple data sources that differs from the standard hypothesis testing (scanning) methods in several ways. Our probabilistic modeling framework estimates the probability of binding and, thus, naturally reflects our degree of belief in binding. Probabilistic modeling also allows for easy and systematic integration of our binding predictions into other probabilistic modeling methods, such as expression-based gene network inference. The method answers the question of whether the whole analyzed promoter has a binding site, but can also be extended to estimate the binding probability at each nucleotide position. Further, we introduce an extension to model combinatorial regulation by several TFs. Most importantly, the proposed methods can make principled probabilistic inference from multiple evidence sources, such as, multiple statistical models (motifs) of the TFs, evolutionary conservation, regulatory potential, CpG islands, nucleosome positioning, DNase hypersensitive sites, ChIP-chip binding segments and other (prior) sequence-based biological knowledge. We developed both a likelihood and a Bayesian method, where the latter is implemented with a Markov chain Monte Carlo algorithm. Results on a carefully constructed test set from the mouse genome demonstrate that principled data fusion can significantly improve the performance of TF binding prediction methods. We also applied the probabilistic modeling framework to all promoters in the mouse genome and the results indicate a sparse connectivity between transcriptional regulators and their target promoters. To facilitate analysis of other sequences and additional data, we have developed an on-line web tool, ProbTF, which implements our probabilistic TF binding prediction method using multiple data sources. Test data set, a web tool, source codes and supplementary data are available at: http://www.probtf.org.	[Lahdesmaki, Harri; Rust, Alistair G.; Shmulevich, Ilya] Inst Syst Biol, Seattle, WA USA	Institute for Systems Biology (ISB)	Lahdesmaki, H (corresponding author), Inst Syst Biol, Seattle, WA USA.	ishmulevich@systemsbiology.org		Rust, Alistair/0000-0001-7287-192X	NIH/NIGMS [R01 GM072855, P50 GM076547]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547, R01GM072855] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants R01 GM072855 and P50 GM076547 from NIH/NIGMS.	AMBESI I, 2006, BMC NEUROSCIENCE S1, V7, pS8; [Anonymous], 1999, MODELLING GENE EXPRE; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bajic IV, 2006, IEEE T SIGNAL PROCES, V54, P2388, DOI 10.1109/TSP.2006.873739; Barash Y, 2005, BIOINFORMATICS, V21, P596, DOI 10.1093/bioinformatics/bti041; BARASH Y, 2003, P 7 ANN INT C COMP B; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Bernard A, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P459; Beyer A, 2006, PLOS COMPUT BIOL, V2, P615, DOI 10.1371/journal.pcbi.0020070; Blanco E, 2006, NUCLEIC ACIDS RES, V34, pD63, DOI 10.1093/nar/gkj116; Brooks SP, 2003, J COMPUT GRAPH STAT, V12, P1, DOI 10.1198/1061860031347; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r4; CHEN T, 1999, P PAC S BIOC, V4, P29; Claverie JM, 1996, COMPUT APPL BIOSCI, V12, P431; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Davidson E. H., 2001, DEV EVOLUTION; de Hoon MJL, 2004, BIOINFORMATICS, V20, P101, DOI 10.1093/bioinformatics/bth927; Eisenstein M, 2005, NAT METHODS, V2, P5, DOI 10.1038/nmeth0105-5; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878; Gordon DB, 2005, BIOINFORMATICS, V21, P3164, DOI 10.1093/bioinformatics/bti481; GuhaThakurta D, 2006, NUCLEIC ACIDS RES, V34, P3585, DOI 10.1093/nar/gkl372; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Heintzman ND, 2007, CELL MOL LIFE SCI, V64, P386, DOI 10.1007/s00018-006-6295-0; Hertzberg L, 2005, J COMPUT BIOL, V12, P314, DOI 10.1089/cmb.2005.12.314; Holloway DT, 2006, IBM J RES DEV, V50, P631, DOI 10.1147/rd.506.0631; Holloway Dustin T, 2005, Genome Inform, V16, P83; Huang HY, 2004, J COMPUT BIOL, V11, P1, DOI 10.1089/106652704773416858; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Husmeier D, 2003, BIOINFORMATICS, V19, P2271, DOI 10.1093/bioinformatics/btg313; Husmeier D, 2005, ADV INFO KNOW PROC, P17; Jensen ST, 2005, BIOINFORMATICS, V21, P3832, DOI 10.1093/bioinformatics/bti628; Kel-Margoulis OV, 2002, NUCLEIC ACIDS RES, V30, P332, DOI 10.1093/nar/30.1.332; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; LAHDESMAKI H, 2007, P 5 IEEE INT WORKSH; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lehrach WP, 2006, BIOINFORMATICS, V22, P532, DOI 10.1093/bioinformatics/bti804; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Liu X, 2001, Pac Symp Biocomput, P127; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; MacIsaac KD, 2006, PLOS COMPUT BIOL, V2, P201, DOI 10.1371/journal.pcbi.0020036; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; NARLIKAR L, PLOS COMPUTATIONAL B; Narlikar L, 2007, LECT NOTES COMPUT SC, V4453, P107; Narlikar L, 2006, BIOINFORMATICS, V22, pE384, DOI 10.1093/bioinformatics/btl251; Pan W, 2006, BIOINFORMATICS, V22, P795, DOI 10.1093/bioinformatics/btl011; Qi Y, 2006, NAT BIOTECHNOL, V24, P963, DOI 10.1038/nbt1233; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30; REGULY T, 2006, J BIOL, V5; Reiss DJ, 2004, BIOINFORMATICS, V20, P274, DOI 10.1093/bioinformatics/bth922; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robert PC, 2004, MONTE CARLO STAT MET; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Segal E, 2003, BIOINFORMATICS, V19, pi273, DOI 10.1093/bioinformatics/btg1038; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sinha S, 2006, BIOINFORMATICS, V22, pE454, DOI 10.1093/bioinformatics/btl227; Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040; SMIT AFA, 1997, REPEATMASKER COMPUTE; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; Steck H., 2002, ADV NEURAL INFORM PR, P697; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Tamada Y, 2003, BIOINFORMATICS, V19, pII227, DOI 10.1093/bioinformatics/btg1082; Taylor J, 2006, GENOME RES, V16, P1596, DOI 10.1101/gr.4537706; Thijs G, 2002, J COMPUT BIOL, V9, P447, DOI 10.1089/10665270252935566; Thijs G, 2001, BIOINFORMATICS, V17, P1113, DOI 10.1093/bioinformatics/17.12.1113; Thomas K, 2007, MOL CELL ENDOCRINOL, V270, P1, DOI 10.1016/j.mce.2007.03.001; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wilkinso D.J., 2006, STOCHASTIC MODELLING; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wu TD, 2000, BIOINFORMATICS, V16, P233, DOI 10.1093/bioinformatics/16.3.233; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yuh Chiou-Hwa, 2001, P73; Zhang LG, 2007, P NATL ACAD SCI USA, V104, P3061, DOI 10.1073/pnas.0611075104; Zhou Q, 2004, BIOINFORMATICS, V20, P909, DOI 10.1093/bioinformatics/bth006	91	36	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1820	10.1371/journal.pone.0001820	http://dx.doi.org/10.1371/journal.pone.0001820			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18364997	Green Published, Green Submitted, gold			2022-12-27	WOS:000260762400003
J	Warthmann, N; Chen, H; Ossowski, S; Weigel, D; Herve, P				Warthmann, Norman; Chen, Hao; Ossowski, Stephan; Weigel, Detlef; Herve, Philippe			Highly Specific Gene Silencing by Artificial miRNAs in Rice	PLOS ONE			English	Article							CYTOCHROME-P450 MONOOXYGENASE; GREEN-REVOLUTION; MESSENGER-RNAS; MICRORNAS; EXPRESSION; ENCODES; INTERFERENCE; SUPPRESSION; EFFICIENT; CLEAVAGE	Background: Endogenous microRNAs (miRNAs) are potent negative regulators of gene expression in plants and animals. Artificial miRNAs (amiRNAs)-designed to target one or several genes of interest-provide a new and highly specific approach for effective post-transcriptional gene silencing (PTGS) in plants. Methodology: We devised an amiRNA-based strategy for both japonica and indica type strains of cultivated rice, Oryza sativa. Using an endogenous rice miRNA precursor and customized 21mers, we designed amiRNA constructs targeting three different genes (Pds, Spl11, and Eui1/CYP714D1). Upon constitutive expression of these amiRNAs in the varieties Nipponbare (japonica) and IR64 (indica), the targeted genes are down-regulated by amiRNA-guided cleavage of the transcripts, resulting in the expected mutant phenotypes. The effects are highly specific to the target gene, the transgenes are stably inherited and they remain effective in the progeny. Conclusion/Significance: Our results not only show that amiRNAs can efficiently trigger gene silencing in a monocot crop, but also that amiRNAs can effectively modulate agronomically important traits in varieties used in modern breeding programs. We provide all software tools and a protocol for the design of rice amiRNA constructs, which can be easily adapted to other crops. The approach is suited for candidate gene validation, comparative functional genomics between different varieties, and for improvement of agronomic performance and nutritional value.	[Warthmann, Norman; Ossowski, Stephan; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Chen, Hao; Herve, Philippe] Internatl Rice Res Inst IRRI, Manila, Philippines	Max Planck Society; CGIAR; International Rice Research Institute (IRRI)	Warthmann, N (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany.	norman@warthmann.com; p.herve@cgiar.org	Warthmann, Norman/E-1069-2011; Ding, Cheng-Qiang/B-6287-2011; Weigel, Detlef/C-1418-2008; Ossowski, Stephan/E-2139-2011; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/GSJ-0799-2022	Warthmann, Norman/0000-0002-1178-8409; Weigel, Detlef/0000-0002-2114-7963; Ossowski, Stephan/0000-0002-7416-9568; Weigel, Detlef/0000-0002-2114-7963	Max Planck Society; European Community FP6 IP SIROCCO [LSHG-CT-2006-037900]; USAID	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Community FP6 IP SIROCCO(European Commission); USAID(United States Agency for International Development (USAID))	This work was supported by the Max Planck Society, of which D.W. is a director, by European Community FP6 IP SIROCCO (contract LSHG-CT-2006-037900), and by the USAID-funded project entitled Development of rice biotechnology products for Asia: technical and pre-regulatory components at the International Rice Research Institute (IRRI) coordinated by P.H. and Gerard Barry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Asano K, 2007, BREEDING SCI, V57, P53, DOI 10.1270/jsbbs.57.53; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Harushima Y, 2002, GENETICS, V160, P313; Herve P, 2006, METH MOL B, V343, P213; Hiei Y, 2006, PLANT CELL TISS ORG, V85, P271, DOI 10.1007/s11240-005-9069-8; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kusaba M, 2004, CURR OPIN BIOTECH, V15, P139, DOI 10.1016/j.copbio.2004.02.004; Leshem Y, 2006, P NATL ACAD SCI USA, V103, P18008, DOI 10.1073/pnas.0604421103; Liu B, 2005, PLANT PHYSIOL, V139, P296, DOI 10.1104/pp.105.063420; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Luo AD, 2006, PLANT CELL PHYSIOL, V47, P181, DOI 10.1093/pcp/pci233; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Muckstein U, 2006, BIOINFORMATICS, V22, P1177, DOI 10.1093/bioinformatics/btl024; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Ossowski S, 2008, PLANT J, V53, P674, DOI 10.1111/j.1365-313X.2007.03328.x; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu J, 2007, J VIROL, V81, P6690, DOI 10.1128/JVI.02457-06; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rutger JN, 2005, CROP SCI, V45, P433, DOI 10.2135/cropsci2005.0433; Sallaud C, 2004, PLANT J, V39, P450, DOI 10.1111/j.1365-313X.2004.02145.x; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Sen GL, 2006, FASEB J, V20, P1293, DOI 10.1096/fj.06-6014rev; SINGH K, 1995, RICE GENET NEWSL, V12, P192; Small I, 2007, CURR OPIN BIOTECH, V18, P148, DOI 10.1016/j.copbio.2007.01.012; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Tang GL, 2007, METABOLOMICS, V3, P357, DOI 10.1007/s11306-007-0073-3; Watson JM, 2005, FEBS LETT, V579, P5982, DOI 10.1016/j.febslet.2005.08.014; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Xu P, 2006, PLANT PHYSIOL, V142, P429, DOI 10.1104/pp.106.083295; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455	46	235	268	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1829	10.1371/journal.pone.0001829	http://dx.doi.org/10.1371/journal.pone.0001829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350165	gold, Green Published, Green Submitted			2022-12-27	WOS:000260762300031
J	Bryk, J; Hardouin, E; Pugach, I; Hughes, D; Strotmann, R; Stoneking, M; Myles, S				Bryk, Jaroslaw; Hardouin, Emilie; Pugach, Irina; Hughes, David; Strotmann, Rainer; Stoneking, Mark; Myles, Sean			Positive Selection in East Asians for an EDAR Allele that Enhances NF-kappa B Activation	PLOS ONE			English	Article							SKIN PIGMENTATION; POPULATION DIFFERENTIATION; LINKAGE DISEQUILIBRIUM; GENETIC-STRUCTURE; GENOMIC REGIONS; SIGNATURES; RECEPTOR; IDENTIFICATION; MUTATIONS; PATTERNS	Genome-wide scans for positive selection in humans provide a promising approach to establish links between genetic variants and adaptive phenotypes. From this approach, lists of hundreds of candidate genomic regions for positive selection have been assembled. These candidate regions are expected to contain variants that contribute to adaptive phenotypes, but few of these regions have been associated with phenotypic effects. Here we present evidence that a derived nonsynonymous substitution (370A) in EDAR, a gene involved in ectodermal development, was driven to high frequency in East Asia by positive selection prior to 10,000 years ago. With an in vitro transfection assay, we demonstrate that 370A enhances NF-kappa B activity. Our results suggest that 370A is a positively selected functional genetic variant that underlies an adaptive human phenotype.	[Bryk, Jaroslaw; Hardouin, Emilie; Pugach, Irina; Hughes, David; Stoneking, Mark; Myles, Sean] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Strotmann, Rainer] Univ Leipzig, Med Fac, Inst Biochem, Leipzig, Germany	Max Planck Society; Leipzig University	Bryk, J (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany.	smm367@cornell.edu	Bryk, Jarosław/C-4883-2009; Hughes, David/E-7190-2015	Bryk, Jarosław/0000-0002-2791-9709; Hughes, David/0000-0002-9644-8998; Myles, Sean/0000-0001-9754-5987	German Bundesministerium fur Bildung und Forschung; Max Planck Society	German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the German Bundesministerium fur Bildung und Forschung (BMBF: NGFN2) and the Max Planck Society.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Botchkarev VA, 2005, J INVEST DERM SYMP P, V10, P247, DOI 10.1111/j.1087-0024.2005.10129.x; Cann HM, 2002, SCIENCE, V296, P261; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Chassaing N, 2006, HUM MUTAT, V27, P255, DOI 10.1002/humu.20295; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Franbourg A, 2003, J AM ACAD DERMATOL, V48, pS115, DOI 10.1067/mjd.2003.277; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Izagirre N, 2006, MOL BIOL EVOL, V23, P1697, DOI 10.1093/molbev/msl030; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; Koppinen P, 2001, EXP CELL RES, V269, P180, DOI 10.1006/excr.2001.5331; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lao O, 2007, ANN HUM GENET, V71, P354, DOI 10.1111/j.1469-1809.2006.00341.x; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Myles S, 2008, ANN HUM GENET, V72, P99, DOI 10.1111/j.1469-1809.2007.00390.x; MYLES S, 2008, RECENT ADV MOL BIOL; Myles S, 2007, HUM GENET, V120, P613, DOI 10.1007/s00439-006-0256-4; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Pollinger JP, 2005, GENOME RES, V15, P1809, DOI 10.1101/gr.4374505; Przeworski M, 2003, GENETICS, V164, P1667; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Shimomura Y, 2004, J INVEST DERMATOL, V123, P649, DOI 10.1111/j.0022-202X.2004.23405.x; Soejima M, 2006, MOL BIOL EVOL, V23, P179, DOI 10.1093/molbev/msj018; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Thesleff Irma, 2002, Sci STKE, V2002, ppe22, DOI 10.1126/stke.2002.131.pe22; Thornton KR, 2007, GENETICS, V175, P737, DOI 10.1534/genetics.106.064642; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Wright S., 1969, THEORY GENE FREQUENC; Yan MH, 2002, CURR BIOL, V12, P409, DOI 10.1016/S0960-9822(02)00687-5	49	72	75	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2209	10.1371/journal.pone.0002209	http://dx.doi.org/10.1371/journal.pone.0002209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493316	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000262258700018
J	Jiang, LQ; Wang, MY; Zhang, J; Monticone, RE; Telljohann, R; Spinetti, G; Pintus, G; Lakatta, EG				Jiang, Liqun; Wang, Mingyi; Zhang, Jing; Monticone, Robert E.; Telljohann, Richard; Spinetti, Gaia; Pintus, Gianfranco; Lakatta, Edward G.			Increased Aortic Calpain-1 Activity Mediates Age-Associated Angiotensin II Signaling of Vascular Smooth Muscle Cells	PLOS ONE			English	Article								Background: Angiotensin II (Ang II) signaling, including matrix metalloproteinase type II (MMP2) activation, has been linked to an age-associated increase in migration capacity of vascular smooth muscle cells (VSMC), and to other proinflammatory features of arterial aging. Calpain-1 activation is required for MMP2 expression in fibroblasts and is induced in cardiomyocytes by Ang II. The consequences of engagement of calpain-1 with its substrates, however, in governing the age-associated proinflammatory status within the arterial wall, remains unknown. Methodology/Principal Findings: The present findings demonstrate that transcription, translation, and activity of calpain-1 are significantly up-regulated in rat aortae or early-passage aortic VSMC from old (30-mo) rats compared to young (8-mo). Dual immunolabeling of the arterial wall indicates that colocalization of calpain-1 and Ang II increases within the aged arterial wall. To further explore the relationship of calpain-1 to Ang II, we chronically infused Ang II into young rats, and treated cultured aortic rings or VSMC with Ang II. We also constructed adenoviruses harboring calpain-1 (CANP1) or its endogenous inhibitor calpastatin (CAST) and infected these into VSMC. Ang II induces calpain-1 expression in the aortic walls in vivo and ex vivo and VSMC in vitro. The Ang II mediated, age-associated increased MMP2 activity and migration in VSMC are both blocked by calpain inhibitor 1 or CAST. Over-expression of calpain-1 in young VSMC results in cleavage of intact vimentin, and an increased migratory capacity mimicking that of old VSMC, which is blocked by the MMP inhibitor, GM6001. Conclusions/Significance: Calpain-1 activation is a pivotal molecular event in the age-associated arterial Ang II/MMP2 signaling cascade that is linked to cytoskeleton protein restructuring, and VSMC migration. Therefore, targeting calpain-1 has the potential to delay or reverse the arterial remodeling that underlies age-associated diseases i.e. atherosclerosis.	[Jiang, Liqun; Wang, Mingyi; Zhang, Jing; Monticone, Robert E.; Telljohann, Richard; Spinetti, Gaia; Pintus, Gianfranco; Lakatta, Edward G.] NIA, Cardiovasc Sci Lab, Natl Inst Hlth, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Jiang, LQ (corresponding author), NIA, Cardiovasc Sci Lab, Natl Inst Hlth, Baltimore, MD 21224 USA.	mingyiw@grc.nia.nih.gov	Pintus, Gianfranco/C-2975-2009; Wang, Mingyi/L-8370-2017; Spinetti, Gaia/T-8245-2018; Lakatta, Edward G/AAL-1447-2020	Pintus, Gianfranco/0000-0002-3031-7733; Wang, Mingyi/0000-0001-6412-369X; Spinetti, Gaia/0000-0001-7996-6809; Lakatta, Edward/0000-0002-4772-0035	Intramural Research Program of the NIH, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000236, Z01AG000236] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the NIH, National Institute on Aging.	Abe M, 1998, J CELL PHYSIOL, V174, P186, DOI 10.1002/(SICI)1097-4652(199802)174:2<186::AID-JCP6>3.0.CO;2-K; Bennett BJ, 2006, ARTERIOSCL THROM VAS, V26, P2117, DOI 10.1161/01.ATV.0000236428.91125.e6; Bialkowska K, 2005, J CELL SCI, V118, P381, DOI 10.1242/jcs.01625; Burkard N, 2005, CIRCULATION, V111, P1045, DOI 10.1161/01.CIR.0000156458.80515.F7; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; Croall DE, 2002, ANAL BIOCHEM, V304, P129, DOI 10.1006/abio.2001.5606; Csiszar A, 2002, CIRC RES, V90, P1159, DOI 10.1161/01.RES.0000020401.61826.EA; Droge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x; EGGENA P, 1988, CLIN EXP HYPERTENS A, V10, P597, DOI 10.3109/10641968809033912; Escobales N, 1996, J HYPERTENS, V14, P115; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Harris F, 2006, ANN NY ACAD SCI, V1084, P452, DOI 10.1196/annals.1372.011; HATA A, 1992, FEBS LETT, V304, P241, DOI 10.1016/0014-5793(92)80628-T; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hood JL, 2006, BIOESSAYS, V28, P850, DOI 10.1002/bies.20440; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Ishihata A, 2006, ANN NY ACAD SCI, V1067, P173, DOI 10.1196/annals.1354.021; ISHII H, 1992, BIOCHEM J, V284, P755, DOI 10.1042/bj2840755; Jiang LQ, 2002, HYPERTENS RES, V25, P647; KAPPRELL HP, 1989, J BIOL CHEM, V264, P17888; Kieffer P, 2000, LIFE SCI, V66, P2371, DOI 10.1016/S0024-3205(00)00567-1; Korzick DH, 2005, CARDIOVASC RES, V66, P384, DOI 10.1016/j.cardiores.2005.01.015; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Li ZH, 1997, EXP MOL PATHOL, V64, P1, DOI 10.1006/exmp.1997.2204; Manya H, 2002, J BIOL CHEM, V277, P35503, DOI 10.1074/jbc.M206033200; Matsubara H, 2000, MOL CELL BIOCHEM, V212, P187, DOI 10.1023/A:1007189828584; MICHEL JB, 1994, AM J PHYSIOL, V267, pR214; Nagai Y, 1998, CIRCULATION, V98, P1504, DOI 10.1161/01.CIR.98.15.1504; Newcomb JK, 2000, METH MOL B, V144, P219; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; PAULY RR, 1994, CIRC RES, V75, P41, DOI 10.1161/01.RES.75.1.41; Popp O, 2003, BIOL CHEM, V384, P951, DOI 10.1515/BC.2003.107; Postovit LM, 2002, BIOCHEM BIOPH RES CO, V297, P294, DOI 10.1016/S0006-291X(02)02187-3; Sahar S, 2005, CIRC RES, V96, P1064, DOI 10.1161/01.RES.0000168210.10358.f4; Sandmann S, 2001, BRIT J PHARMACOL, V132, P767, DOI 10.1038/sj.bjp.0703860; Schaub FJ, 2003, CIRC RES, V93, P515, DOI 10.1161/01.RES.0000093205.42313.7C; Scherberich A, 2000, J CELL SCI, V113, P653; Spinetti G, 2004, ARTERIOSCL THROM VAS, V24, P1397, DOI 10.1161/01.ATV.0000134529.65173.08; STARY HC, 1990, EUR HEART J, V11, P3, DOI 10.1093/eurheartj/11.suppl_E.3; Tabet F, 2004, J CARDIOVASC PHARM, V44, P200, DOI 10.1097/00005344-200408000-00009; Takahashi M, 2006, J CARDIOVASC PHARM, V47, P413; van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731; Viedt C, 2004, J MOL MED, V82, P31, DOI 10.1007/s00109-003-0500-5; VIRMANI R, 1991, AM J PATHOL, V139, P1119; Wang M, 2002, HYPERTENSION, V39, P865, DOI 10.1161/01.HYP.0000014506.13322.66; Wang M, 2006, HDB HYPERTENSION ART, P137; Wang M, 2007, HYPERTENSION, V50, P219, DOI 10.1161/HYPERTENSIONAHA.107.089409; Wang M, 2006, CIRCULATION, V114, P335; Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2; Wang MY, 2005, AM J PATHOL, V167, P1429, DOI 10.1016/S0002-9440(10)61229-1; Wang MY, 2003, HYPERTENSION, V41, P1308, DOI 10.1161/01.HYP.0000073843.56046.45; Yildiz G, 2007, ANN NY ACAD SCI, V1100, P353, DOI 10.1196/annals.1395.038; ZAWASKI K, 1993, BIOCHEM BIOPH RES CO, V197, P585, DOI 10.1006/bbrc.1993.2519; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403	56	78	81	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2231	10.1371/journal.pone.0002231	http://dx.doi.org/10.1371/journal.pone.0002231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493299	gold, Green Published, Green Submitted			2022-12-27	WOS:000262258700039
J	Marchesi, C; Belicchi, M; Meregalli, M; Farini, A; Cattaneo, A; Parolini, D; Gavina, M; Porretti, L; D'Angelo, MG; Bresolin, N; Cossu, G; Torrente, Y				Marchesi, Chiara; Belicchi, Marzia; Meregalli, Mirella; Farini, Andrea; Cattaneo, Alessandra; Parolini, Daniele; Gavina, Manuela; Porretti, Laura; D'Angelo, Maria Grazia; Bresolin, Nereo; Cossu, Giulio; Torrente, Yvan			Correlation of Circulating CD133+Progenitor Subclasses with a Mild Phenotype in Duchenne Muscular Dystrophy Patients	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; STEM-CELLS; EXPRESSION; MARKER; BLOOD; GLUCOCORTICOIDS; PROGRESSION; THICKNESS; DISEASE; HEART	Background: Various prognostic serum and cellular markers have been identified for many diseases, such as cardiovascular diseases and tumor pathologies. Here we assessed whether the levels of certain stem cells may predict the progression of Duchenne muscular dystrophy (DMD). Methods and Findings: The levels of several subpopulations of circulating stem cells expressing the CD133 antigen were determined by flow cytometry in 70 DMD patients. The correlation between the levels and clinical status was assessed by statistical analysis. The median (+/- SD) age of the population was 10.66 +/- 3.81 (range 3 to 20 years). The levels of CD133+CXCR4+CD34- stem cells were significantly higher in DMD patients compared to healthy controls (mean +/- standard deviation: 17.38 +/- 1.38 vs. 11.0 +/- 1.70; P = 0.03) with a tendency towards decreased levels in older patients. Moreover, the levels of this subpopulation of cells correlated with the clinical condition. In a subgroup of 19 DMD patients after 24 months of follow-up, increased levels of CD133+CXCR4+CD34- cells was shown to be associated with a phenotype characterised by slower disease progression. The circulating CD133+CXCR4+CD34- cells in patients from different ages did not exhibit significant differences in their myogenic and endothelial in vitro differentiation capacity. Conclusions: Our results suggest that levels of CD133+CXCR4+CD34- could function as a new prognostic clinical marker for the progression of DMD.	[Marchesi, Chiara; Belicchi, Marzia; Meregalli, Mirella; Farini, Andrea; Parolini, Daniele; Gavina, Manuela; Bresolin, Nereo; Torrente, Yvan] Univ Milan, Ctr Dino Ferrari, IRCCS Osped Maggiore Policliln, Dept Neurol Sci,Stem Cell Lab, Milan, Italy; [Cattaneo, Alessandra; Porretti, Laura] Univ Milan, IRCCS Osped Maggiore Policlin, Centro Trasfusionale Immunol Trapianti, Milan, Italy; [D'Angelo, Maria Grazia] IRCCS E Medea, Bosisio Parini, Italy; [Cossu, Giulio] Osped San Raffaele, Stem Cell Res Inst, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Eugenio Medea; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Marchesi, C (corresponding author), Univ Milan, Ctr Dino Ferrari, IRCCS Osped Maggiore Policliln, Dept Neurol Sci,Stem Cell Lab, Milan, Italy.	torrenteyvan@hotmail.com	Porretti, Laura/J-6748-2015; Cattaneo, Alessandra/K-5049-2012; D'Angelo, Maria Grazia/K-4685-2016; TORRENTE, YVAN/A-2964-2015	Porretti, Laura/0000-0001-8100-4262; Cattaneo, Alessandra/0000-0002-4500-6540; D'Angelo, Maria Grazia/0000-0003-1241-4350; Bresolin, Nereo/0000-0001-6694-3595; Meregalli, Mirella/0000-0002-5151-607X; Farini, Andrea/0000-0002-8514-4921; TORRENTE, YVAN/0000-0002-2705-3984	European Union [LSH-2005-037479]; Association Monegasque contre les Myopathies; Duchenne Parent Project de France; Associazione La Nostra Famiglia Fondo DMD Gli Amici di Emanuele; Ricerca Corrente and Progetto a Concorso 2006 Fondazione IRCCS Policlinico Hospital of Milan; Associazione Amici Centro Dino Ferrari, Department of Neurological Science, University of Milan, Italy	European Union(European Commission); Association Monegasque contre les Myopathies; Duchenne Parent Project de France; Associazione La Nostra Famiglia Fondo DMD Gli Amici di Emanuele; Ricerca Corrente and Progetto a Concorso 2006 Fondazione IRCCS Policlinico Hospital of Milan; Associazione Amici Centro Dino Ferrari, Department of Neurological Science, University of Milan, Italy	This work was founded by the European Union under the 6th Framework Programme (Contract no.: LSH-2005-037479; Project acronym: MYOAMP) and supported by the Association Monegasque contre les Myopathies (AMM; ICE project), the Duchenne Parent Project de France (DPP France), the Associazione La Nostra Famiglia Fondo DMD Gli Amici di Emanuele, the Ricerca Corrente and Progetto a Concorso 2006 Fondazione IRCCS Policlinico Hospital of Milan and by the Associazione Amici Centro Dino Ferrari, Department of Neurological Science, University of Milan, Italy.	Angelini C, 1996, J NEUROL SCI, V142, P70, DOI 10.1016/0022-510X(96)00144-X; BAUMBACH LL, 1989, NEUROLOGY, V39, P465, DOI 10.1212/WNL.39.4.465; Boos CJ, 2006, J AM COLL CARDIOL, V48, P1538, DOI 10.1016/j.jacc.2006.02.078; BROOKE MH, 1989, NEUROLOGY, V39, P475, DOI 10.1212/WNL.39.4.475; de Groot E, 2004, CIRCULATION, V109, P33, DOI 10.1161/01.CIR.0000131516.65699.ba; Del Papa N, 2004, ARTHRITIS RHEUM-US, V50, P1296, DOI 10.1002/art.20116; Derfoul A, 2006, STEM CELLS, V24, P1487, DOI 10.1634/stemcells.2005-0415; Dome B, 2006, CANCER RES, V66, P7341, DOI 10.1158/0008-5472.CAN-05-4654; Duda DG, 2006, J CLIN ONCOL, V24, P1449, DOI 10.1200/JCO.2005.04.2861; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Fadini GP, 2006, STEM CELLS, V24, P1806, DOI 10.1634/stemcells.2005-0440; Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446; Gallacher L, 2000, BLOOD, V95, P2813, DOI 10.1182/blood.V95.9.2813.009k20_2813_2820; Gavina M, 2006, BLOOD, V108, P2857, DOI 10.1182/blood-2006-04-018564; Grafte-Faure S, 1999, AM J HEMATOL, V62, P65, DOI 10.1002/(SICI)1096-8652(199910)62:2<65::AID-AJH1>3.0.CO;2-G; Guven H, 2006, J AM COLL CARDIOL, V48, P1579, DOI 10.1016/j.jacc.2006.04.101; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; Hyde SA, 2001, NEUROMUSCULAR DISORD, V11, P165, DOI 10.1016/S0960-8966(00)00175-9; Infante JP, 1999, MOL CELL BIOCHEM, V195, P155, DOI 10.1023/A:1006972315739; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Makita S, 2005, STROKE, V36, P2138, DOI 10.1161/01.STR.0000181740.74005.ee; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Phillips MF, 2001, AM J RESP CRIT CARE, V164, P2191, DOI 10.1164/ajrccm.164.12.2103052; Sabolek M, 2006, NEUROREPORT, V17, P1719, DOI 10.1097/01.wnr.0000236862.08834.50; Scott E, 2006, DEV MED CHILD NEUROL, V48, P540, DOI 10.1017/S0012162206001137; SCOTT OM, 1982, MUSCLE NERVE, V5, P291, DOI 10.1002/mus.880050405; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	31	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2218	10.1371/journal.pone.0002218	http://dx.doi.org/10.1371/journal.pone.0002218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493616	Green Published, Green Submitted, gold			2022-12-27	WOS:000262258700026
J	Raymond, SB; Treat, LH; Dewey, JD; McDannold, NJ; Hynynen, K; Bacskai, BJ				Raymond, Scott B.; Treat, Lisa H.; Dewey, Jonathan D.; McDannold, Nathan J.; Hynynen, Kullervo; Bacskai, Brian J.			Ultrasound Enhanced Delivery of Molecular Imaging and Therapeutic Agents in Alzheimer's Disease Mouse Models	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; FOCUSED ULTRASOUND; TARGETED DELIVERY; NERVOUS-SYSTEM; ADULT-MOUSE; ANTIBODIES; PEPTIDE; IMMUNOTHERAPY; PERMEABILITY; DISRUPTION	Alzheimer's disease is a neurodegenerative disorder typified by the accumulation of a small protein, beta-amyloid, which aggregates and is the primary component of amyloid plaques. Many new therapeutic and diagnostic agents for reducing amyloid plaques have limited efficacy in vivo because of poor transport across the blood-brain barrier. Here we demonstrate that low-intensity focused ultrasound with a microbubble contrast agent may be used to transiently disrupt the blood-brain barrier, allowing non-invasive, localized delivery of imaging fluorophores and immunotherapeutics directly to amyloid plaques. We administered intravenous Trypan blue, an amyloid staining red fluorophore, and anti-amyloid antibodies, concurrently with focused ultrasound therapy in plaque-bearing, transgenic mouse models of Alzheimer's disease with amyloid pathology. MRI guidance permitted selective treatment and monitoring of plaque-heavy anatomical regions, such as the hippocampus. Treated brain regions exhibited 16.5 +/- 5.4-fold increase in Trypan blue fluorescence and 2.7 +/- 1.2-fold increase in anti-amyloid antibodies that localized to amyloid plaques. Ultrasound-enhanced delivery was consistently reproduced in two different transgenic strains (APPswe:PSEN1dE9, PDAPP), across a large age range (9-26 months), with and without MR guidance, and with little or no tissue damage. Ultrasound-mediated, transient blood-brain barrier disruption allows the delivery of both therapeutic and molecular imaging agents in Alzheimer's mouse models, which should aid pre-clinical drug screening and imaging probe development. Furthermore, this technique may be used to deliver a wide variety of small and large molecules to the brain for imaging and therapy in other neurodegenerative diseases.	[Raymond, Scott B.; Treat, Lisa H.] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Raymond, Scott B.; Bacskai, Brian J.] Harvard Med Sch, Massachusetts General Hosp, Dept Neurol, Boston, MA USA; [Treat, Lisa H.; McDannold, Nathan J.] Harvard Med Sch, Brigham and Womens Hosp, Dept Radiol, Boston, MA USA; [Dewey, Jonathan D.] Duke Univ, Sch Med, Durham, NC USA; [Hynynen, Kullervo] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Duke University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Raymond, SB (corresponding author), Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.	bbacskai@partners.org	Bacskai, Brian/AAE-9583-2021; Raymond, Scott/AGV-0585-2022	Raymond, Scott/0000-0001-7008-8974	NIH [EB000768, EB000705, AG026240, U41RR019703, T32 EB001680]; NDSEG [fellowship]; Harvard University [Ashford fellowship]; MIT Whitaker Health Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [U41RR019703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001680, R33EB000705, R21EB000705, R01EB003268, R01EB000768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026240] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NDSEG; Harvard University; MIT Whitaker Health Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Our work was supported by NIH EB000768, EB000705, AG026240, and U41RR019703. S. B. Raymond is supported by T32 EB001680, an NDSEG fellowship, and a Harvard University Ashford fellowship. L. H. Treat is supported by the MIT Whitaker Health Sciences Fund.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Choi JJ, 2007, ULTRASOUND MED BIOL, V33, P95, DOI 10.1016/j.ultrasmedbio.2006.07.018; Dickstein DL, 2006, FASEB J, V20, P426, DOI 10.1096/fj.05-3956com; Fryer JD, 2003, J NEUROSCI, V23, P7889; Furumoto S, 2007, CURR TOP MED CHEM, V7, P1773, DOI 10.2174/156802607782507402; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; Gardberg AS, 2007, P NATL ACAD SCI USA, V104, P15659, DOI 10.1073/pnas.0705888104; Hawkes Cheryl A, 2007, Expert Rev Neurother, V7, P1535, DOI 10.1586/14737175.7.11.1535; Hull M, 2006, DRUGS, V66, P2075; Hynynen K, 2005, NEUROIMAGE, V24, P12, DOI 10.1016/j.neuroimage.2004.06.046; Hynynen K, 2004, MAGN RESON MED, V52, P100, DOI 10.1002/mrm.20118; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Hynynen K, 2006, EUR J RADIOL, V59, P149, DOI 10.1016/j.ejrad.2006.04.007; Ingelsson M, 2002, ANN MED, V34, P259, DOI 10.1080/078538902320322529; Kinoshita M, 2006, BIOCHEM BIOPH RES CO, V340, P1085, DOI 10.1016/j.bbrc.2005.12.112; Kinoshita M, 2006, P NATL ACAD SCI USA, V103, P11719, DOI 10.1073/pnas.0604318103; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Macklin CC, 1920, ARCH NEURO PSYCHIATR, V3, P353, DOI 10.1001/archneurpsyc.1920.02180160002001; McDannold N, 2005, ULTRASOUND MED BIOL, V31, P1527, DOI 10.1016/j.ultrasmedbio.2005.07.010; McDannold N J, 2000, Top Magn Reson Imaging, V11, P191, DOI 10.1097/00002142-200006000-00005; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Nikolic WV, 2007, P NATL ACAD SCI USA, V104, P2507, DOI 10.1073/pnas.0609377104; Pike KE, 2007, BRAIN, V130, P2837, DOI 10.1093/brain/awm238; Poduslo JF, 2001, NEUROBIOL DIS, V8, P555, DOI 10.1006/nbdi.2001.0402; Poduslo JF, 2007, J NEUROCHEM, V102, P420, DOI 10.1111/j.1471-4159.2007.04591.x; Raymond SB, 2007, J CEREBR BLOOD F MET, V27, P393, DOI 10.1038/sj.jcbfm.9600336; Senechal Y, 2007, J NEUROCHEM, V102, P1928, DOI 10.1111/j.1471-4159.2007.04672.x; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; Sheikov N, 2006, ULTRASOUND MED BIOL, V32, P1399, DOI 10.1016/j.ultrasmedbio.2006.05.015; Shi NY, 2000, P NATL ACAD SCI USA, V97, P7567, DOI 10.1073/pnas.130187497; SIGURDSSON EM, 2007, NEUROBIOL AGING; Skowronek M, 2000, COMPUT CHEM, V24, P429, DOI 10.1016/S0097-8485(99)00089-3; Thakker DR, 2004, P NATL ACAD SCI USA, V101, P17270, DOI 10.1073/pnas.0406214101; Treat LH, 2007, INT J CANCER, V121, P901, DOI 10.1002/ijc.22732; Ujiie M, 2003, MICROCIRCULATION, V10, P463, DOI 10.1038/sj.mn.7800212; Wu DF, 1999, P NATL ACAD SCI USA, V96, P254, DOI 10.1073/pnas.96.1.254; Yang FY, 2007, ULTRASOUND MED BIOL, V33, P1421, DOI 10.1016/j.ultrasmedbio.2007.04.006	39	168	183	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2175	10.1371/journal.pone.0002175	http://dx.doi.org/10.1371/journal.pone.0002175			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478109	Green Submitted, Green Published, gold			2022-12-27	WOS:000262172800040
J	Farhana, A; Kumar, S; Rathore, SS; Ghosh, PC; Ehtesham, NZ; Tyagi, AK; Hasnain, SE				Farhana, Aisha; Kumar, Sandeep; Rathore, Shailendra S.; Ghosh, Prahlad C.; Ehtesham, Nasreen Z.; Tyagi, Anil K.; Hasnain, Seyed E.			Mechanistic Insights into a Novel Exporter-Importer System of Mycobacterium tuberculosis Unravel Its Role in Trafficking of Iron	PLOS ONE			English	Article								Background: Elucidation of the basic mechanistic and biochemical principles underlying siderophore mediated iron uptake in mycobacteria is crucial for targeting this principal survival strategy vis-a-vis virulence determinants of the pathogen. Although, an understanding of siderophore biosynthesis is known, the mechanism of their secretion and uptake still remains elusive. Methodology/Principal Findings: Here, we demonstrate an interplay among three iron regulated Mycobacterium tuberculosis (M. tb) proteins, namely, Rv1348 (IrtA), Rv1349 (IrtB) and Rv2895c in export and import of M. tb siderophores across the membrane and the consequent iron uptake. IrtA, interestingly, has a fused N-terminal substrate binding domain (SBD), representing an atypical subset of ABC transporters, unlike IrtB that harbors only the permease and ATPase domain. SBD selectively binds to non-ferrated siderophores whereas Rv2895c exhibits relatively higher affinity towards ferrated siderophores. An interaction between the permease domain of IrtB and Rv2895c is evident from GST pull-down assay. In vitro liposome reconstitution experiments further demonstrate that IrtA is indeed a siderophore exporter and the two-component IrtB-Rv2895c system is an importer of ferrated siderophores. Knockout of msmeg_6554, the irtA homologue in Mycobacterium smegmatis, resulted in an impaired M. tb siderophore export that is restored upon complementation with M. tb irtA. Conclusion: Our data suggest the interplay of three proteins, namely IrtA, IrtB and Rv2895c in synergizing the balance of siderophores and thus iron inside the mycobacterial cell.	[Farhana, Aisha; Kumar, Sandeep] Ctr DNA Fingerprinting & Diagnost, Mol & Cellular Biol Lab, Hyderabad, Andhra Pradesh, India; [Rathore, Shailendra S.; Ghosh, Prahlad C.; Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India; [Ehtesham, Nasreen Z.] Natl Inst Nutrit, Mol Biol Unit, Hyderabad, Andhra Pradesh, India; [Hasnain, Seyed E.] Univ Hyderabad, Dept Biochem, Hyderabad, Andhra Pradesh, India; [Hasnain, Seyed E.] Hyderabad Univ Campus, Inst Life Sci, Hyderabad, Andhra Pradesh, India; [Hasnain, Seyed E.] Jawaharlal Nehru Ctr Advanced Sci Res, Bangalore, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); University of Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); University of Hyderabad; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Farhana, A (corresponding author), Ctr DNA Fingerprinting & Diagnost, Mol & Cellular Biol Lab, Hyderabad, Andhra Pradesh, India.	seh@uohyd.ernet.in	EHTESHAM, NASREEN ZAFAR/AAI-3169-2020; Farhana, Aisha/AAR-7356-2020	Hasnain, Seyed/0000-0002-2967-0791; Kumar, Sandeep/0000-0003-1249-1743; Farhana, Aisha/0000-0002-4631-2769	Council of Scientific and Industrial Research (CSIR), India [Senior Research Fellowship]; CDFD	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); CDFD	Senior Research Fellowship of Council of Scientific and Industrial Research (CSIR), India to Aisha Farhana. Financial support from CDFD core grants is acknowledged.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bairoch A, 1999, NUCLEIC ACIDS RES, V27, P49, DOI 10.1093/nar/27.1.49; Banerjee S, 2007, J BACTERIOL, V189, P4046, DOI 10.1128/JB.00026-07; BEISEL WR, 1977, AM J CLIN NUTR, V30, P1236, DOI 10.1093/ajcn/30.8.1236; Braibant M, 2000, FEMS MICROBIOL REV, V24, P449, DOI 10.1111/j.1574-6976.2000.tb00550.x; Brickman TJ, 2005, J BACTERIOL, V187, P3650, DOI 10.1128/JB.187.11.3650-3661.2005; Cronje L, 2005, FEMS IMMUNOL MED MIC, V45, P103, DOI 10.1016/j.femsim.2005.02.007; Crosa JH, 1997, MICROBIOL MOL BIOL R, V61, P319, DOI 10.1128/.61.3.319-336.1997; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; De Voss JJ, 1999, J BACTERIOL, V181, P4443, DOI 10.1128/JB.181.15.4443-4451.1999; Dhar N, 2000, FEMS MICROBIOL LETT, V190, P309, DOI 10.1111/j.1574-6968.2000.tb09304.x; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fiske CH, 1925, J BIOL CHEM, V66, P375; Furrer JL, 2002, MOL MICROBIOL, V44, P1225, DOI 10.1046/j.1365-2958.2002.02885.x; Gobin J, 1996, J EXP MED, V183, P1527, DOI 10.1084/jem.183.4.1527; Hoegy FO, 2005, J BIOL CHEM, V280, P20222, DOI 10.1074/jbc.M500776200; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Krithika R, 2006, P NATL ACAD SCI USA, V103, P2069, DOI 10.1073/pnas.0507924103; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LEVY D, 1990, BIOCHIM BIOPHYS ACTA, V1025, P179, DOI 10.1016/0005-2736(90)90096-7; LI XZ, 1995, ANTIMICROB AGENTS CH, V39, P1948, DOI 10.1128/AAC.39.9.1948; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Neilands J.B., 1991, CRC HDB MICROBIAL IR, P1; PARISH T, 1998, ELECTROPORATION MYCO, P129; Prakash P, 2005, J BIOL CHEM, V280, P19641, DOI 10.1074/jbc.M413026200; Prakash P, 2005, BIOINFORMATICS, V21, P2161, DOI 10.1093/bioinformatics/bti375; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Ratledge C, 1996, MICROBIOL-UK, V142, P2207, DOI 10.1099/13500872-142-8-2207; Rindi L, 1999, BIOCHEM BIOPH RES CO, V258, P94, DOI 10.1006/bbrc.1999.0591; Rodriguez GM, 2006, J BACTERIOL, V188, P424, DOI 10.1128/JB.188.2.424-430.2006; Rodriguez GM, 2003, MOL MICROBIOL, V47, P1485, DOI 10.1046/j.1365-2958.2003.03384.x; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; SAMBROOK J, 2000, MOL CLONING LAB MANU; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schubert S, 1999, J BACTERIOL, V181, P6387, DOI 10.1128/JB.181.20.6387-6395.1999; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10691, DOI 10.1073/pnas.200318797; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEINBERG ED, 1978, MICROBIOL REV, V42, P45, DOI 10.1128/MMBR.42.1.45-66.1978; Zhu WM, 1998, MOL MICROBIOL, V29, P629, DOI 10.1046/j.1365-2958.1998.00961.x	44	44	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2087	10.1371/journal.pone.0002087	http://dx.doi.org/10.1371/journal.pone.0002087			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461140	gold, Green Published			2022-12-27	WOS:000261642400010
J	Alonso-Magdalena, P; Ropero, AB; Carrera, MP; Cederroth, CR; Baquie, M; Gauthier, BR; Nef, S; Stefani, E; Nadal, A				Alonso-Magdalena, Paloma; Ropero, Ana B.; Carrera, M. Pilar; Cederroth, Christopher R.; Baquie, Mathurin; Gauthier, Benoit R.; Nef, Serge; Stefani, Enrico; Nadal, Angel			Pancreatic Insulin Content Regulation by the Estrogen Receptor ER alpha	PLOS ONE			English	Article								The function of pancreatic beta-cells is the synthesis and release of insulin, the main hormone involved in blood glucose homeostasis. Estrogen receptors, ER alpha and ER beta, are important molecules involved in glucose metabolism, yet their role in pancreatic beta-cell physiology is still greatly unknown. In this report we show that both ER alpha and ER beta are present in pancreatic beta-cells. Long term exposure to physiological concentrations of 17 beta-estradiol (E2) increased beta-cell insulin content, insulin gene expression and insulin release, yet pancreatic beta-cell mass was unaltered. The up-regulation of pancreatic beta-cell insulin content was imitated by environmentally relevant doses of the widespread endocrine disruptor Bisphenol-A (BPA). The use of ER alpha and ER beta agonists as well as ER alpha KO and ER beta KO mice suggests that the estrogen receptor involved is ER alpha. The up-regulation of pancreatic insulin content by ER alpha activation involves ERK1/2. These data may be important to explain the actions of E2 and environmental estrogens in endocrine pancreatic function and blood glucose homeostasis.	[Alonso-Magdalena, Paloma; Ropero, Ana B.; Carrera, M. Pilar; Nadal, Angel] Univ Miguel Hernandez Elche, Inst Bioingen, Alicante, Spain; [Ropero, Ana B.; Nadal, Angel] Inst Salud Carlos III, CIBERDEM, Alicante, Spain; [Cederroth, Christopher R.; Nef, Serge] Univ Geneva, Med Sch, Dept Genet Med & Development, Geneva, Switzerland; [Baquie, Mathurin; Gauthier, Benoit R.] Univ Geneva, Med Sch, Dept Cell Physiol & Metabolism, Geneva, Switzerland; [Stefani, Enrico] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Div Mol Med, Los Angeles, CA USA; [Stefani, Enrico] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA USA	Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; University of Geneva; University of Geneva; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Alonso-Magdalena, P (corresponding author), Univ Miguel Hernandez Elche, Inst Bioingen, Alicante, Spain.	nadal@umh.es	del Pilar Carrera González, María/K-2580-2018; Gauthier, Benoit R/C-3138-2017; Cederroth, Christopher R./AAO-9501-2020; Alonso-Magdalena, Paloma/AAH-2076-2021; Nef, Serge/AAV-6445-2020; ROPERO, ANA B./AAK-8342-2021; Cederroth, Christopher/B-9932-2011; B, Ana/AAN-9680-2021; Nadal, Angel/G-6721-2014	del Pilar Carrera González, María/0000-0001-6575-8240; Gauthier, Benoit R/0000-0001-8146-7486; Nef, Serge/0000-0001-5462-0676; ROPERO, ANA B./0000-0002-6503-7598; Nadal, Angel/0000-0003-4178-2152; ALONSO MAGDALENA, PALOMA/0000-0003-1065-5388; Cederroth, Christopher/0000-0001-7267-5136	Spanish Ministry of Education and Science [BFU2005-01052]; Instituto de Salud Carlos III-RETIC RD06; Ministry of Education and Science [studentship, SB2004-0044]; Swiss National Science Foundation [NRP50, 4050-104375]; The Sir Jules Thorn Charitable Overseas Trust Reg; Swiss National Research Foundation [3100A0-107682/1]	Spanish Ministry of Education and Science(Spanish Government); Instituto de Salud Carlos III-RETIC RD06(Instituto de Salud Carlos III); Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); The Sir Jules Thorn Charitable Overseas Trust Reg; Swiss National Research Foundation(Swiss National Science Foundation (SNSF))	This study was supported by the Spanish Ministry of Education and Science, grant BFU2005-01052 and Instituto de Salud Carlos III-RETIC RD06 to AN. PA-M had a studentship from the Ministry of Education and Science. ABR had a postdoctoral fellowship from the Ministry of Education and Science (SB2004-0044). CRC and SN were funded by a grant from the Swiss National Science Foundation (NRP50, 4050-104375) and The Sir Jules Thorn Charitable Overseas Trust Reg., Schaan. MB and BRG are subsidized by a Swiss National Research Foundation Grant (#3100A0-107682/1 to BRG).	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Alonso-Magdalena P, 2005, ENVIRON HEALTH PERSP, V113, P969, DOI 10.1289/ehp.8002; BARKLEY MS, 1979, BIOL REPROD, V20, P733, DOI 10.1095/biolreprod20.4.733; Barros RPA, 2006, P NATL ACAD SCI USA, V103, P1605, DOI 10.1073/pnas.0510391103; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; Benes C, 1999, BIOCHEM J, V340, P219, DOI 10.1042/0264-6021:3400219; Biles JE, 1997, J AGR FOOD CHEM, V45, P4697, DOI 10.1021/jf970518v; BONE AJ, 1976, NATURE, V262, P501, DOI 10.1038/262501a0; BROTONS JA, 1995, ENVIRON HEALTH PERSP, V103, P608, DOI 10.2307/3432439; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Cook R, 2006, ENVIRON HEALTH PERSP, V114, P1631, DOI 10.1289/ehp.8606; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; Dupont S, 2000, DEVELOPMENT, V127, P4277; Gauthier BR, 2004, J BIOL CHEM, V279, P31121, DOI 10.1074/jbc.M405030200; Godsland IF, 2005, DIABETOLOGIA, V48, P2213, DOI 10.1007/s00125-005-1930-0; GREEN IC, 1973, BIOCHEM J, V134, P481, DOI 10.1042/bj1340481; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Khoo S, 2003, J BIOL CHEM, V278, P32969, DOI 10.1074/jbc.M301198200; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Migliaccio A, 2007, INT J BIOCHEM CELL B, V39, P1343, DOI 10.1016/j.biocel.2006.12.009; Monje P, 2001, J CELL BIOCHEM, V82, P467, DOI 10.1002/jcb.1182; Morimoto S, 2001, LIFE SCI, V68, P2979, DOI 10.1016/S0024-3205(01)01100-6; Nadal A, 2005, PFLUG ARCH EUR J PHY, V449, P335, DOI 10.1007/s00424-004-1343-9; Nadal A, 2001, NEWS PHYSIOL SCI, V16, P251; Nadal A, 1998, FASEB J, V12, P1341, DOI 10.1096/fasebj.12.13.1341; Olea N, 1996, ENVIRON HEALTH PERSP, V104, P298, DOI 10.2307/3432888; PAPPAS TC, 1995, FASEB J, V9, P404, DOI 10.1096/fasebj.9.5.7896011; Pedram A, 2006, MOL BIOL CELL, V17, P2125, DOI 10.1091/mbc.E05-11-1013; Rochira V, 2002, MOL CELL ENDOCRINOL, V193, P19, DOI 10.1016/S0303-7207(02)00092-8; Ropero AB, 2002, MOL ENDOCRINOL, V16, P497, DOI 10.1210/me.16.3.497; Ropero AB, 2008, STEROIDS, V73, P874, DOI 10.1016/j.steroids.2007.12.018; Ropero AB, 2006, J STEROID BIOCHEM, V102, P163, DOI 10.1016/j.jsbmb.2006.09.019; Ropero AB, 2006, J MOL CELL CARDIOL, V41, P496, DOI 10.1016/j.yjmcc.2006.05.022; Rubin BS, 2006, ENDOCRINOLOGY, V147, P3681, DOI 10.1210/en.2006-0189; Sajiki J, 1999, J CHROMATOGR B, V736, P255, DOI 10.1016/S0378-4347(99)00471-5; Sheeler CQ, 2000, ENVIRON HEALTH PERSP, V108, P97, DOI 10.2307/3454506; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Takeuchi T, 2002, BIOCHEM BIOPH RES CO, V291, P76, DOI 10.1006/bbrc.2002.6407; Vandenberg LN, 2006, J STEROID BIOCHEM, V101, P263, DOI 10.1016/j.jsbmb.2006.06.028; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713; WAKELING AE, 1991, CANCER RES, V51, P3867; Watson CS, 2007, STEROIDS, V72, P124, DOI 10.1016/j.steroids.2006.11.002; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Zsarnovszky A, 2005, ENDOCRINOLOGY, V146, P5388, DOI 10.1210/en.2005-0565	55	289	301	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2069	10.1371/journal.pone.0002069	http://dx.doi.org/10.1371/journal.pone.0002069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446233	Green Published, gold, Green Submitted			2022-12-27	WOS:000261572300038
J	Keller, DX; Franks, KM; Bartol, TM; Sejnowski, TJ				Keller, Daniel X.; Franks, Kevin M.; Bartol, Thomas M., Jr.; Sejnowski, Terrence J.			Calmodulin Activation by Calcium Transients in the Postsynaptic Density of Dendritic Spines	PLOS ONE			English	Article							NMDA RECEPTORS; HIPPOCAMPAL SPINES; SINGLE SPINES; CHANNELS; DYNAMICS; INFLUX; AMPA; MECHANISMS; NUCLEUS; SIGNAL	The entry of calcium into dendritic spines can trigger a sequence of biochemical reactions that begins with the activation of calmodulin (CaM) and ends with long-term changes to synaptic strengths. The degree of activation of CaM can depend on highly local elevations in the concentration of calcium and the duration of transient increases in calcium concentration. Accurate measurement of these local changes in calcium is difficult because the spaces are so small and the numbers of molecules are so low. We have therefore developed a Monte Carlo model of intracellular calcium dynamics within the spine that included calcium binding proteins, calcium transporters and ion channels activated by voltage and glutamate binding. The model reproduced optical recordings using calcium indicator dyes and showed that without the dye the free intracellular calcium concentration transient was much higher than predicted from the fluorescent signal. Excitatory postsynaptic potentials induced large, long-lasting calcium gradients across the postsynaptic density, which activated CaM. When glutamate was released at the synapse 10 ms before an action potential occurred, simulating activity patterns that strengthen hippocampal synapses, the calcium gradient and activation of CaM in the postsynaptic density were much greater than when the order was reversed, a condition that decreases synaptic strengths, suggesting a possible mechanism underlying the induction of long-term changes in synaptic strength. The spatial and temporal mechanisms for selectivity in CaM activation demonstrated here could be used in other signaling pathways.	[Keller, Daniel X.; Franks, Kevin M.; Bartol, Thomas M., Jr.; Sejnowski, Terrence J.] Salk Inst Biol Studies, Computat Neurobiol Lab, Howard Hughes Med Inst, La Jolla, CA USA; [Keller, Daniel X.; Franks, Kevin M.; Bartol, Thomas M., Jr.; Sejnowski, Terrence J.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA USA; [Keller, Daniel X.; Franks, Kevin M.; Bartol, Thomas M., Jr.; Sejnowski, Terrence J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA USA; [Keller, Daniel X.] Univ Calif San Diego, Neurosci Grad Program, La Jolla, CA USA	Howard Hughes Medical Institute; Salk Institute; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Keller, DX (corresponding author), Salk Inst Biol Studies, Computat Neurobiol Lab, Howard Hughes Med Inst, La Jolla, CA USA.	dkeller@salk.edu	Sejnowski, Terrence/AAV-5558-2021		Howard Hughes Medical Institute [GM068630, P01-NS044306]; National Institutes of Health [GM068630, P01-NS044306]; National Science Foundation's Center for Theoretical Biological Physics [PHY0225630]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044306] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation's Center for Theoretical Biological Physics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Howard Hughes Medical Institute and the National Institutes of Health (GM068630, P01-NS044306) and the National Science Foundation's Center for Theoretical Biological Physics (PHY0225630).	ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; Bischofberger J, 2002, J NEUROSCI, V22, P10593; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Buldakova SL, 2007, NEUROSCIENCE, V144, P88, DOI 10.1016/j.neuroscience.2006.09.005; BURNASHEV N, 2005, J PHYSL, V485, P403; CARAFOLI E, 1992, J BIOL CHEM, V267, P2115; Church PJ, 1996, J PHYSIOL-LONDON, V496, P59, DOI 10.1113/jphysiol.1996.sp021665; Cohen P, 1988, CALMODULIN; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; EBERHARD M, 1991, BIOCHEM BIOPH RES CO, V180, P209, DOI 10.1016/S0006-291X(05)81278-1; Franks KM, 2003, J NEUROSCI, V23, P3186; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; FRANKS KM, 2002, THESIS U CALIFORNIA; Garaschuk O, 1996, J PHYSIOL-LONDON, V491, P757, DOI 10.1113/jphysiol.1996.sp021255; Graupner M, 2007, PLOS COMPUT BIOL, V3, P2299, DOI 10.1371/journal.pcbi.0030221; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; HAUGLAND RP, 1996, HDB BIOL FLUORESCENT; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Holcman D, 2004, BIOPHYS J, V87, P81, DOI 10.1529/biophysj.103.035972; Holthoff K, 2002, NEURON, V33, P425, DOI 10.1016/S0896-6273(02)00576-7; JAHR CE, 1993, P NATL ACAD SCI USA, V90, P11573, DOI 10.1073/pnas.90.24.11573; JAHR CE, 1990, J NEUROSCI, V10, P3178; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KENNEDY MB, 1989, TRENDS NEUROSCI, V12, P417, DOI 10.1016/0166-2236(89)90089-1; KERR RA, 2008, SIAM J SCI COMPUTING; Kharazia VN, 1996, NEUROSCI LETT, V210, P37, DOI 10.1016/0304-3940(96)12658-6; KOCH C, 1993, J NEUROSCI, V13, P413; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; LLINAS R, 1995, NEUROPHARMACOLOGY, V34, P1443, DOI 10.1016/0028-3908(95)00150-5; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Majewska A, 2000, J NEUROSCI, V20, P1722; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MIHALAS S, 2006, THESIS CALTECH; MIHALAS S, 2005, QUANTITATIVE MODEL C; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Muller A, 2005, J NEUROSCI, V25, P558, DOI 10.1523/JNEUROSCI.3799-04.2005; Nagerl UV, 2000, BIOPHYS J, V79, P3009, DOI 10.1016/S0006-3495(00)76537-4; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Sakmann B., 1995, SINGLE CHANNEL RECOR; Scheuss V, 2006, J NEUROSCI, V26, P8183, DOI 10.1523/JNEUROSCI.1962-06.2006; Schneggenburger R, 1996, BIOPHYS J, V70, P2165, DOI 10.1016/S0006-3495(96)79782-5; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Stiles JR, 2001, METH NE FRO NEUROSCI, P87; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yeung LC, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.011907; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976	75	62	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2045	10.1371/journal.pone.0002045	http://dx.doi.org/10.1371/journal.pone.0002045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446197	Green Published, gold, Green Submitted			2022-12-27	WOS:000261572300017
J	Wanchu, A; Dong, YX; Sethi, S; Myneedu, VP; Nadas, A; Liu, ZT; Belisle, J; Laal, S				Wanchu, Ajay; Dong, Yuxin; Sethi, Sunil; Myneedu, V. P.; Nadas, Arthur; Liu, Zhentong; Belisle, John; Laal, Suman			Biomarkers for Clinical and Incipient Tuberculosis: Performance in a TB-Endemic Country	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CULTURE FILTRATE ANTIGENS; MYCOBACTERIUM-TUBERCULOSIS; UNDIAGNOSED TUBERCULOSIS; PRECLINICAL TUBERCULOSIS; PULMONARY TUBERCULOSIS; ANTIBODY-RESPONSES; MALATE SYNTHASE; HIV-INFECTION; DIAGNOSIS	Background: Simple biomarkers are required to identify TB in both HIV-TB+ and HIV+TB+ patients. Earlier studies have identified the M. tuberculosis Malate Synthase (MS) and MPT51 as immunodominant antigens in TB patients. One goal of these investigations was to evaluate the sensitivity and specificity of anti-MS and -MPT51 antibodies as biomarkers for TB in HIV-TB+ and HIV+TB+ patients from a TB-endemic setting. Earlier studies also demonstrated the presence of these biomarkers during incipient subclinical TB. If these biomarkers correlate with incipient TB, their prevalence should be higher in asymptomatic HIV+ subjects who are at a high-risk for TB. The second goal was to compare the prevalence of these biomarkers in asymptomatic, CD4(+) T cell-matched HIV+ TB 2 subjects from India who are at high-risk for TB with similar subjects from US who are at low-risk for TB. Methods and Results: Anti-MS and - MPT51 antibodies were assessed in sera from 480 subjects including PPD+ or PPD- healthy subjects, healthy community members, and HIV-TB+ and HIV+TB+ patients from India. Results demonstrate high sensitivity (similar to 80%) of detection of smear-positive HIV-TB+ and HIV+TB+ patients, and high specificity (>97%) with PPD+ subjects and endemic controls. While similar to 45% of the asymptomatic HIV+ TB 2 patients at high-risk for TB tested biomarker-positive, >97% of the HIV+TB- subjects at low risk for TB tested negative. Although the current studies are hampered by lack of knowledge of the outcome, these results provide strong support for the potential of these biomarkers to detect incipient, subclinical TB in HIV+ subjects. Conclusions: These biomarkers provide high sensitivity and specificity for TB diagnosis in a TB endemic setting. Their performance is not compromised by concurrent HIV infection, site of TB and absence of pulmonary manifestations in HIV+TB+ patients. Results also demonstrate the potential of these biomarkers for identifying incipient subclinical TB in HIV+TB- subjects at high-risk for TB.	[Wanchu, Ajay] Post Grad Inst Med Educ & Res, Dept Internal Med, Chandigarh, India; [Sethi, Sunil] Post Grad Inst Med Educ & Res, Dept Med Microbiol, Chandigarh, India; [Myneedu, V. P.] Lala Ram Sarup Inst Tuberculosis & Respiratory Dis, Dept Microbiol, New Delhi, India; [Liu, Zhentong; Belisle, John] Colorado State Univ, Dept Microbiol, Immunol & Pathol, Ft Collins, CO USA; [Dong, Yuxin; Laal, Suman] NYU, Sch Med, Dept Pathol, New York, NY USA; [Laal, Suman] NYU, Sch Med, Dept Microbiol, New York, NY USA; [Nadas, Arthur] NYU, Sch Med, Inst Env Med, New York, NY USA; [Laal, Suman] Veterans Affairs Med Ctr, New York, NY USA	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Colorado State University; New York University; New York University; New York University	Wanchu, A (corresponding author), Post Grad Inst Med Educ & Res, Dept Internal Med, Chandigarh, India.	suman.laal@med.nyu.edu	Belisle, John T/B-8944-2017	Belisle, John T/0000-0002-2539-2798	AIDS International Training and Research Program (AITRP) [TW001409]; National Institutes of Health (NIH) [R01 AI056257]; VA Merit Review Award; NIH/NIAID [N01 AI75320]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI075320, R01AI056257] Funding Source: NIH RePORTER	AIDS International Training and Research Program (AITRP); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review Award(US Department of Veterans Affairs); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	A. Wanchu, S. Sethi, V.P. Myneedu and S. Laal are supported by the AIDS International Training and Research Program (AITRP) Grant TW001409. These studies were also supported by the National Institutes of Health (NIH) Grant R01 AI056257, by the VA Merit Review Award and by the NIH/NIAID Contract N01 AI75320 entitled TB Research Materials and Vaccine Testing. The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2007, SCAND J IMMUNOL, V66, P176, DOI 10.1111/j.1365-3083.2007.01978.x; Achkar JM, 2006, CLIN VACCINE IMMUNOL, V13, P1291, DOI 10.1128/CVI.00158-06; Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; BARRERA L, 1992, TUBERCLE LUNG DIS, V73, P187, DOI 10.1016/0962-8479(92)90084-W; Cohen J, 2004, SCIENCE, V304, P504, DOI 10.1126/science.304.5670.504; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; DANIEL TM, 1996, TUBERCULOSIS, P223; Foulds J, 1998, INT J TUBERC LUNG D, V2, P778; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Hendrickson RC, 2000, J CLIN MICROBIOL, V38, P2354; Houghton RL, 2002, CLIN DIAGN LAB IMMUN, V9, P883, DOI 10.1128/CDLI.9.4.883-891.2002; HUEBNER RE, 1994, CLIN INFECT DIS, V19, P26, DOI 10.1093/clinids/19.1.26; JANOFF EN, 1991, J IMMUNOL, V147, P2130; Kinhikar AG, 2006, MOL MICROBIOL, V60, P999, DOI 10.1111/j.1365-2958.2006.05151.x; Laal S, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P71; Laal S, 1997, J INFECT DIS, V176, P133, DOI 10.1086/514015; Laal S, 1997, CLIN DIAGN LAB IMMUN, V4, P49, DOI 10.1128/CDLI.4.1.49-56.1997; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Moore DAJ, 2006, NEW ENGL J MED, V355, P1539, DOI 10.1056/NEJMoa055524; Mukherjee S, 2004, CLIN DIAGN LAB IMMUN, V11, P280, DOI 10.1128/CDLI.11.2.280-286.2004; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Perkins MD, 2007, J INFECT DIS, V196, pS15, DOI 10.1086/518656; Perkins MD, 2000, INT J TUBERC LUNG D, V4, pS182; Ramalingam B, 2003, SCAND J INFECT DIS, V35, P234, DOI 10.1080/00365540310000292; RAVIGLIONE MC, 1992, B WORLD HEALTH ORGAN, V70, P515; SALTINI C, 1992, American Review of Respiratory Disease, V145, pA686; Samanich K, 2001, INFECT IMMUN, V69, P4600, DOI 10.1128/IAI.69.7.4600-4609.2001; Samanich KM, 1998, J INFECT DIS, V178, P1534, DOI 10.1086/314438; Samanich KM, 2000, CLIN DIAGN LAB IMMUN, V7, P662, DOI 10.1128/CDLI.7.4.662-668.2000; Sartain MJ, 2006, MOL CELL PROTEOMICS, V5, P2102, DOI 10.1074/mcp.M600089-MCP200; Singh KK, 2005, INFECT IMMUN, V73, P5004, DOI 10.1128/IAI.73.8.5004-5014.2005; Singh KK, 2005, CLIN DIAGN LAB IMMUN, V12, P354, DOI 10.1128/CDLI.12.2.354-358.2005; Singh KK, 2003, J INFECT DIS, V188, P371, DOI 10.1086/376532; Singh KK, 2001, INFECT IMMUN, V69, P4185, DOI 10.1128/IAI.69.6.4185-4191.2001; Steingart KR, 2007, PLOS MED, V4, P1; *UNICEF UNDP WORLD, 2006, DIAGN TUB GLOB DEM M; VANDERWERF TS, 1992, MED MICROBIOL IMMUN, V181, P71, DOI 10.1007/BF00189425; Weldingh K, 2005, J CLIN MICROBIOL, V43, P57, DOI 10.1128/JCM.43.1.57-65.2005; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC	43	31	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2071	10.1371/journal.pone.0002071	http://dx.doi.org/10.1371/journal.pone.0002071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446210	gold, Green Published, Green Submitted			2022-12-27	WOS:000261572300040
J	Sakuntabhai, A; Ndiaye, R; Casademont, I; Peerapittayamonkol, C; Rogier, C; Tortevoye, P; Tall, A; Paul, R; Turbpaiboon, C; Phimpraphi, W; Trape, JF; Spiegel, A; Heath, S; Mercereau-Puijalon, O; Dieye, A; Julier, C				Sakuntabhai, Anavaj; Ndiaye, Rokhaya; Casademont, Isabelle; Peerapittayamonkol, Chayanon; Rogier, Christophe; Tortevoye, Patricia; Tall, Adama; Paul, Richard; Turbpaiboon, Chairat; Phimpraphi, Waraphon; Trape, Jean-Francois; Spiegel, Andre; Heath, Simon; Mercereau-Puijalon, Odile; Dieye, Alioune; Julier, Cecile			Genetic Determination and Linkage Mapping of Plasmodium falciparum Malaria Related Traits in Senegal	PLOS ONE			English	Article							BLOOD INFECTION LEVELS; INTERLEUKIN-7 RECEPTOR; PROMOTER POLYMORPHISM; SUSCEPTIBILITY LOCUS; SEGREGATION ANALYSIS; SCHISTOSOMA-MANSONI; GENOMEWIDE SCREEN; HOLOENDEMIC AREA; CHROMOSOME 13Q14; CLINICAL MALARIA	Plasmodium falciparum malaria episodes may vary considerably in their severity and clinical manifestations. There is good evidence that host genetic factors contribute to this variability. To date, most genetic studies aiming at the identification of these genes have used a case/control study design for severe malaria, exploring specific candidate genes. Here, we performed a family-based genetic study of falciparum malaria related phenotypes in two independent longitudinal survey cohorts, as a first step towards the identification of genes and mechanisms involved in the outcome of infection. We studied two Senegalese villages, Dielmo and Ndiop that differ in ethnicity, malaria transmission and endemicity. We performed genome-scan linkage analysis of several malaria-related phenotypes both during clinical attacks and asymptomatic infection. We show evidence for a strong genetic contribution to both the number of clinical falciparum malaria attacks and the asymptomatic parasite density. The asymptomatic parasite density showed linkage to chromosome 5q31 (LOD = 2.26, empirical p = 0.0014, Dielmo), confirming previous findings in other studies. Suggestive linkage values were also obtained at three additional chromosome regions: the number of clinical malaria attacks on chromosome 5p15 (LOD = 2.57, empirical p = 0.001, Dielmo) and 13q13 (LOD = 2.37, empirical p = 0.0014 Dielmo), and the maximum parasite density during asymptomatic infection on chromosome 12q21 (LOD = 3.1, empirical p, 10 24, Ndiop). While regions of linkage show little overlap with genes known to be involved in severe malaria, the four regions appear to overlap with regions linked to asthma or atopy related traits, suggesting that common immune related pathways may be involved.	[Sakuntabhai, Anavaj; Ndiaye, Rokhaya; Casademont, Isabelle; Peerapittayamonkol, Chayanon; Turbpaiboon, Chairat; Phimpraphi, Waraphon; Julier, Cecile] Inst Pasteur, Unite Genet Malad Infect & Autoimmunes, Paris, France; [Sakuntabhai, Anavaj; Ndiaye, Rokhaya; Casademont, Isabelle; Peerapittayamonkol, Chayanon; Turbpaiboon, Chairat; Phimpraphi, Waraphon; Julier, Cecile] INSERM U730, Paris, France; [Sakuntabhai, Anavaj; Casademont, Isabelle; Paul, Richard] Inst Pasteur, Lab Genet Reponse Infect homme, Paris, France; [Ndiaye, Rokhaya; Dieye, Alioune] Inst Pasteur, Unite Immunogenet, Dakar, Senegal; [Rogier, Christophe; Tall, Adama; Spiegel, Andre] Inst Pasteur, Unite Epidemiol, Dakar, Senegal; [Rogier, Christophe] Inst Med Trop Serv Sante Armees, Unite Rech Biol Epidemiol Parasit, IFR48, Marseille, France; [Tortevoye, Patricia] Inst Pasteur, Unite Epidemiol Physiopathol Virus Oncogenes, Paris, France; [Trape, Jean-Francois] Inst Rech Dev, Lab Paludol, BP 1386, Dakar, Senegal; [Spiegel, Andre] Ecole Val Grace, Dept Epidemiol Sante Publ, Paris, France; [Heath, Simon] Ctr Natl Genotypage, Evry, France; [Mercereau-Puijalon, Odile] Inst Pasteur, Unite Immunol Mol Parasites, CNRS URA 2581, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut de Recherche pour le Developpement (IRD); CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Sakuntabhai, A (corresponding author), Inst Pasteur, Unite Genet Malad Infect & Autoimmunes, Paris, France.	anavaj@pasteur.fr	Peerapittayamongkol, Chayanon/B-4920-2010; Mercereau-Puijalon, Odile/AAA-2242-2020; Heath, Simon C/J-4138-2012; JULIER, Cécile/M-9824-2017	Heath, Simon C/0000-0002-9550-0897; JULIER, Cécile/0000-0002-1538-0240	French Ministry of Research and Technology; Institut national de la sante et de la recherche medicale (INSERM) [post-doctoral fellowship]; BioMalPar European Network of Excellence [LSHP-CT-2004-503578]; Institut Pasteur de Dakar [studentship]; Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand [post-doctoral fellowship]; Royal Golden Jubilee Program; Thailand Research Fund; French Embassy in Thailand	French Ministry of Research and Technology; Institut national de la sante et de la recherche medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); BioMalPar European Network of Excellence; Institut Pasteur de Dakar; Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand; Royal Golden Jubilee Program; Thailand Research Fund(Thailand Research Fund (TRF)); French Embassy in Thailand	This work was funded in part by grants from the French Ministry of Research and Technology, the Institut Pasteur and Institut national de la sante et de la recherche medicale (INSERM) to C.J. Research in the laboratory of OMP is partly supported by the BioMalPar European Network of Excellence supported by a European grant (LSHP-CT-2004-503578) from the Priority 1 Life Sciences, Genomics and Biotechnology for Health in the 6th Framework Programme. We thank the Centre National de Genotypage for providing access to their genotyping facility. R.N. was supported by a studentship from the Institut Pasteur de Dakar. C.P. was supported by post-doctoral fellowships from Inserm and from the Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand. C.T. and W.P. were supported by the Royal Golden Jubilee Program, the Thailand Research Fund and the French Embassy in Thailand.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BEGHDADI W, 2008, J EXP MED IN PRESS; Bereczky S, 2004, INT J PARASITOL, V34, P935, DOI 10.1016/j.ijpara.2004.04.007; Blangero J, 2001, ADV GENET, V42, P151, DOI 10.1016/S0065-2660(01)42021-9; Blangero J, 2000, GENET EPIDEMIOL, V19, pS8, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI2>3.0.CO;2-Y; Booth DR, 2005, J MOL MED, V83, P822, DOI 10.1007/s00109-005-0684-y; Cancre N, 2000, AM J EPIDEMIOL, V152, P760, DOI 10.1093/aje/152.8.760; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; Concannon P, 2005, DIABETES, V54, P2995, DOI 10.2337/diabetes.54.10.2995; Elghazali G, 1997, CLIN EXP IMMUNOL, V109, P84, DOI 10.1046/j.1365-2249.1997.4401337.x; Falchi M, 2006, HUM MOL GENET, V15, P2975, DOI 10.1093/hmg/ddl227; Flori L, 2003, GENES IMMUN, V4, P265, DOI 10.1038/sj.gene.6363960; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; Fontenille D, 1997, AM J TROP MED HYG, V56, P247, DOI 10.4269/ajtmh.1997.56.247; Friberg C, 2006, J INVEST DERMATOL, V126, P998, DOI 10.1038/sj.jid.5700194; Garcia A, 1998, AM J TROP MED HYG, V58, P705, DOI 10.4269/ajtmh.1998.58.705; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Haileamlak A, 2005, J ALLERGY CLIN IMMUN, V115, P370, DOI 10.1016/j.jaci.2004.10.024; HALDANE JBS, 1950, ANN EUGENIC, V15, P15, DOI 10.1111/j.1469-1809.1949.tb02418.x; Hernandez-Valladares M, 2004, IMMUNOGENETICS, V56, P115, DOI 10.1007/s00251-004-0667-0; Iyengar SK, 2001, GENET EPIDEMIOL, V21, pS130, DOI 10.1002/gepi.2001.21.s1.s130; JAKOBSEN PH, 1995, PARASITE IMMUNOL, V17, P223, DOI 10.1111/j.1365-3024.1995.tb01019.x; Jang N, 2005, GENES IMMUN, V6, P262, DOI 10.1038/sj.gene.6364169; JEPSON AP, 1995, J INFECT DIS, V172, P316, DOI 10.1093/infdis/172.1.316; Jeronimo SMB, 2007, GENES IMMUN, V8, P539, DOI 10.1038/sj.gene.6364422; Kohara Y, 2001, IMMUNOGENETICS, V53, P15, DOI 10.1007/s002510000286; Kun JF, 2001, J INFECT DIS, V184, P330, DOI 10.1086/322037; Kurz T, 2006, J ALLERGY CLIN IMMUN, V118, P396, DOI 10.1016/j.jaci.2006.04.036; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Latiano A, 2007, J PEDIATR GASTR NUTR, V45, P180, DOI 10.1097/MPG.0b013e3180616bd2; Lee JK, 2002, BIOCHEM BIOPH RES CO, V295, P771, DOI 10.1016/S0006-291X(02)00679-4; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; Modiano D, 1996, P NATL ACAD SCI USA, V93, P13206, DOI 10.1073/pnas.93.23.13206; Mombo LE, 2003, AM J TROP MED HYG, V68, P186, DOI 10.4269/ajtmh.2003.68.186; Morahan G, 2002, GENES IMMUN, V3, P414, DOI 10.1038/sj.gene.6363909; Morahan G, 2002, LANCET, V360, P455, DOI 10.1016/S0140-6736(02)09676-9; Morrot A, 2006, INFECT IMMUN, V74, P2495, DOI 10.1128/IAI.74.4.2495-2497.2006; Nacher M, 2000, PARASITE IMMUNOL, V22, P107, DOI 10.1046/j.1365-3024.2000.00284.x; Nacher M, 2001, AM J TROP MED HYG, V65, P834, DOI 10.4269/ajtmh.2001.65.834; Ndiaye R, 2005, TISSUE ANTIGENS, V65, P474, DOI 10.1111/j.1399-0039.2005.00388.x; Noranate N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000139; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ohno T, 2001, IMMUNOGENETICS, V53, P736, DOI 10.1007/s00251-001-0390-z; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Perlmann P, 1999, IMMUNOL LETT, V65, P29, DOI 10.1016/S0165-2478(98)00120-5; Perlmann P, 1997, INFECT IMMUN, V65, P116, DOI 10.1128/IAI.65.1.116-121.1997; Philippi A, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-74; Randolph AG, 2004, AM J HUM GENET, V75, P709, DOI 10.1086/424886; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Rihet P, 1998, GENET EPIDEMIOL, V15, P435, DOI 10.1002/(SICI)1098-2272(1998)15:5<435::AID-GEPI1>3.0.CO;2-#; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Rogier C, 1996, T ROY SOC TROP MED H, V90, P175, DOI 10.1016/S0035-9203(96)90128-5; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; SCHOFIELD L, 1993, ANN TROP MED PARASIT, V87, P617, DOI 10.1080/00034983.1993.11812820; SCHORK NJ, 1993, HUM HERED, V43, P1, DOI 10.1159/000154106; Sergent Ed., 1935, Arch Inst Pasteur Alger, V13, P279; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Sklar P, 2004, MOL PSYCHIATR, V9, P213, DOI 10.1038/sj.mp.4001418; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; Sokhna CS, 2000, AM J TROP MED HYG, V62, P266, DOI 10.4269/ajtmh.2000.62.266; Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9; Stirnadel HA, 1999, GENET EPIDEMIOL, V17, P16, DOI 10.1002/(SICI)1098-2272(1999)17:1<16::AID-GEPI2>3.0.CO;2-7; Sunyer J, 2001, THORAX, V56, P290, DOI [10.1136/thorax.56.4.290, 10.1136/thorax.56.11.897a]; Timmann C, 2007, PLOS GENET, V3, P393, DOI 10.1371/journal.pgen.0030048; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; Walley AJ, 2004, EUR J HUM GENET, V12, P132, DOI 10.1038/sj.ejhg.5201084; WEATHERALL DJ, 1987, ANN TROP MED PARASIT, V81, P539, DOI 10.1080/00034983.1987.11812155; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Williams TN, 1996, NATURE, V383, P522, DOI 10.1038/383522a0; Xu JF, 2001, AM J HUM GENET, V68, P1437, DOI 10.1086/320589; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; Zhang YM, 2003, NAT GENET, V34, P181, DOI 10.1038/ng1166; Zhang Z, 2005, GENES IMMUN, V6, P145, DOI 10.1038/sj.gene.6364171	87	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2000	10.1371/journal.pone.0002000	http://dx.doi.org/10.1371/journal.pone.0002000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431485	Green Published, gold, Green Submitted			2022-12-27	WOS:000261558700020
J	Wu, RQ; Dong, WF; Ji, YX; Zhou, M; Marini, CP; Ravikumar, TS; Wang, P				Wu, Rongqian; Dong, Weifeng; Ji, Youxin; Zhou, Mian; Marini, Corrado P.; Ravikumar, Thanjavur S.; Wang, Ping			Orexigenic Hormone Ghrelin Attenuates Local and Remote Organ Injury after Intestinal Ischemia-Reperfusion	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; GUT BARRIER DYSFUNCTION; SECRETAGOGUE RECEPTOR; ACYLATED PEPTIDE; PROGNOSTIC VALUE; STIMULATES GH; VAGAL NERVE; SECRETION; EXPRESSION; STOMACH	Background: Gut ischemia/reperfusion (I/R) injury is a serious condition in intensive care patients. Activation of immune cells adjacent to the huge endothelial cell surface area of the intestinal microvasculature produces initially local and then systemic inflammatory responses. Stimulation of the vagus nerve can rapidly attenuate systemic inflammatory responses through inhibiting the activation of macrophages and endothelial cells. Ghrelin, a novel orexigenic hormone, is produced predominately in the gastrointestinal system. Ghrelin receptors are expressed at a high density in the dorsal vagal complex of the brain stem. In this study, we investigated the regulation of the cholinergic anti-inflammatory pathway by the novel gastrointestinal hormone, ghrelin, after gut I/R. Methods and Findings: Gut ischemia was induced by placing a microvascular clip across the superior mesenteric artery for 90 min in male adult rats. Our results showed that ghrelin levels were significantly reduced after gut I/R and that ghrelin administration inhibited pro-inflammatory cytokine release, reduced neutrophil infiltration, ameliorated intestinal barrier dysfunction, attenuated organ injury, and improved survival after gut I/R. Administration of a specific ghrelin receptor antagonist worsened gut I/R-induced organ injury and mortality. To determine whether ghrelin's beneficial effects after gut I/R require the intact vagus nerve, vagotomy was performed in sham and gut I/R animals immediately prior to the induction of gut ischemia. Our result showed that vagotomy completely eliminated ghrelin's beneficial effect after gut I/R. To further confirm that ghrelin's beneficial effects after gut I/R are mediated through the central nervous system, intracerebroventricular administration of ghrelin was performed at the beginning of reperfusion after 90-min gut ischemia. Our result showed that intracerebroventricular injection of ghrelin also protected the rats from gut I/R injury. Conclusions: These findings suggest that ghrelin attenuates excessive inflammation and reduces organ injury after gut I/R through activation of the cholinergic anti-inflammatory pathway.	[Wu, Rongqian; Zhou, Mian; Ravikumar, Thanjavur S.; Wang, Ping] Feinstein Inst Med Res, Manhasset, NY USA; [Wu, Rongqian; Dong, Weifeng; Ji, Youxin; Zhou, Mian; Marini, Corrado P.; Ravikumar, Thanjavur S.; Wang, Ping] N Shore Univ Hosp, Long Island Jewish Med Ctr, Dept Surg, Manhasset, NY USA	Northwell Health; Northwell Health; North Shore University Hospital	Wu, RQ (corresponding author), Feinstein Inst Med Res, Manhasset, NY USA.	pwang@nshs.edu	Wu, Rongqian/I-3614-2012; ji, youxin/F-3802-2014; ji, youxin/F-3802-2014	Wu, Rongqian/0000-0003-0993-4531; ji, youxin/0000-0003-2895-4730; ji, youxin/0000-0003-2303-8784; Wang, Ping/0000-0002-1557-0394; Marini, Corrado Paolo/0000-0002-4155-8292	National Institutes of Health [R01 GM053008, R01 AG028352]; American Heart Association [0325802T]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028352] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health grants R01 GM053008 and R01 AG028352 (PW). Dr. Rongqian Wu was supported by a Postdoctoral Fellowship from the American Heart Association (the Heritage Affiliate) #0325802T.	Arvat E, 2000, J ENDOCRINOL INVEST, V23, P493, DOI 10.1007/BF03343763; Asakawa A, 2003, GUT, V52, P947, DOI 10.1136/gut.52.7.947; Balanescu S, 2004, MED SCI MONITOR, V10, pCR307; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Berlanga J, 2002, AM J PATHOL, V161, P373, DOI 10.1016/S0002-9440(10)64192-2; Bilchick KC, 2002, AM J CARDIOL, V90, P24, DOI 10.1016/S0002-9149(02)02380-9; Borovikova LV, 2000, AUTON NEUROSCI-BASIC, V85, P141, DOI 10.1016/S1566-0702(00)00233-2; Chang L, 2004, J CARDIOVASC PHARM, V43, P165, DOI 10.1097/00005344-200402000-00001; Chavez AM, 1999, CRIT CARE MED, V27, P2246, DOI 10.1097/00003246-199910000-00030; Chen WL, 2007, ACAD EMERG MED, V14, P392, DOI 10.1197/j.aem.2006.12.015; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2004, ENDOCRINOLOGY, V145, P2604, DOI 10.1210/en.2004-0346; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Date Y, 2000, BIOCHEM BIOPH RES CO, V275, P477, DOI 10.1006/bbrc.2000.3342; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Dwivedi AJ, 2007, J AM COLL SURGEONS, V205, P284, DOI 10.1016/j.jamcollsurg.2007.03.012; Evrengul H, 2004, RHEUMATOL INT, V24, P198, DOI 10.1007/s00296-003-0357-5; Fink M P, 1994, Semin Respir Infect, V9, P256; Hattori N, 2001, J CLIN ENDOCR METAB, V86, P4284, DOI 10.1210/jc.86.9.4284; Higuchi S, 2007, J SURG RES, V137, P46, DOI 10.1016/j.jss.2006.04.019; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Kong SE, 1998, AUST NZ J SURG, V68, P554, DOI 10.1111/j.1445-2197.1998.tb02099.x; Lanza GA, 1998, AM J CARDIOL, V82, P1323, DOI 10.1016/S0002-9149(98)00635-3; Laversuch CJ, 1997, J RHEUMATOL, V24, P1540; LINDGREN S, 1993, SCAND J GASTROENTERO, V28, P638, DOI 10.3109/00365529309096103; Nagaya N, 2001, CIRCULATION, V104, P1430, DOI 10.1161/hc3601.095575; Nass R, 2000, J NEUROENDOCRINOL, V12, P1194, DOI 10.1046/j.1365-2826.2000.00586.x; Oldenburg WA, 2004, ARCH INTERN MED, V164, P1054, DOI 10.1001/archinte.164.10.1054; Papotti M, 2000, J CLIN ENDOCR METAB, V85, P3803, DOI 10.1210/jc.85.10.3803; Sakata I, 2003, NEUROSCI LETT, V342, P183, DOI 10.1016/S0304-3940(03)00294-5; Sakata I, 2002, J ENDOCRINOL, V174, P463, DOI 10.1677/joe.0.1740463; Sato N, 2003, JPN J PHYSIOL, V53, P443, DOI 10.2170/jjphysiol.53.443; Shuto YJ, 2001, LIFE SCI, V68, P991, DOI 10.1016/S0024-3205(00)01001-8; Soejima K, 2000, JPN CIRC J, V64, P32, DOI 10.1253/jcj.64.32; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2005, J EXP MED, V202, P1017, DOI 10.1084/jem.20051760; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Villareal Rollo P, 2002, Curr Atheroscler Rep, V4, P120, DOI 10.1007/s11883-002-0035-1; Wang GY, 2002, REGUL PEPTIDES, V105, P75, DOI 10.1016/S0167-0115(02)00012-5; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wu JT, 2004, ANN SURG, V239, P464, DOI 10.1097/01.sla.0000118561.54919.61; Wu R, 2007, AM J PHYSIOL-ENDOC M, V293, pE1697, DOI 10.1152/ajpendo.00098.2007; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed; Wu RQ, 2003, INT J MOL MED, V12, P777; Yang RK, 2003, AM J PHYSIOL-GASTR L, V285, pG621, DOI 10.1152/ajpgi.00177.2003; Yang RK, 2006, MOL MED, V12, P105, DOI 10.2119/2006-00010.Yang	49	80	84	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2026	10.1371/journal.pone.0002026	http://dx.doi.org/10.1371/journal.pone.0002026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431503	gold, Green Published, Green Submitted			2022-12-27	WOS:000261558700038
J	Shenje, LT; Field, LJ; Pritchard, CA; Guerin, CJ; Rubart, M; Soonpaa, MH; Ang, KL; Galinanes, M				Shenje, Lincoln T.; Field, Loren J.; Pritchard, Catrin A.; Guerin, Christopher J.; Rubart, Michael; Soonpaa, Mark H.; Ang, Keng-Leong; Galinanes, Manuel			Lineage Tracing of Cardiac Explant Derived Cells	PLOS ONE			English	Article								Aims: Cultured cardiac explants produce a heterogeneous population of cells including a distinctive population of refractile cells described here as small round cardiac explant derived cells (EDCs). The aim of this study was to explore the source, morphology and cardiogenic potential of EDCs. Methods: Transgenic MLC2v-Cre/ZEG, and actin-eGFP mice were used for lineage-tracing of EDCs in vitro and in vivo. C57B16 mice were used as cell transplant recipients of EDCs from transgenic hearts, as well as for the general characterisation of EDCs. The activation of cardiac-specific markers were analysed by: immunohistochemistry with bright field and immunofluorescent microscopy, electron microscopy, PCR and RT-PCR. Functional engraftment of transplanted cells was further investigated with calcium transient studies. Results: Production of EDCs was highly dependent on the retention of blood-derived cells or factors in the cultured explants. These cells shared some characteristics of cardiac myocytes in vitro and survived engraftment in the adult heart in vivo. However, EDCs failed to differentiate into functional cardiac myocytes in vivo as demonstrated by the absence of stimulation-evoked intracellular calcium transients following transplantation into the peri-infarct zone. Conclusions: This study highlights that positive identification based upon one parameter alone such as morphology or immunofluorescene is not adequate to identify the source, fate and function of adult cardiac explant derived cells.	[Shenje, Lincoln T.; Ang, Keng-Leong; Galinanes, Manuel] Univ Leicester, Dept Cardiovasc Sci, Cardiac Surg Unit, Leicester, Leics, England; [Field, Loren J.; Rubart, Michael; Soonpaa, Mark H.] Indiana Univ, Sch Med, Krannert Inst Cardiol, Div Pediat Cardiol, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA; [Pritchard, Catrin A.] Univ Leicester, Dept Biochem, Leicester, Leics, England; [Guerin, Christopher J.] Univ Leicester, MRC Toxicol Unit, Leicester, Leics, England	University of Leicester; Indiana University System; Indiana University-Purdue University Indianapolis; University of Leicester; University of Leicester	Shenje, LT (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Cardiac Surg Unit, Leicester, Leics, England.	mg50@le.ac.uk	Guerin, Christopher/AAM-3233-2020; Galiñanes, Manuel/H-8195-2012	Pritchard, Catrin/0000-0003-1859-4487	Bristol Myer Squib Cardiovascular Prize Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075165, R01HL083126] Funding Source: NIH RePORTER	Bristol Myer Squib Cardiovascular Prize Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Bristol Myer Squib Cardiovascular Prize Fellowship 2003 (LTS)	Bedada FB, 2005, MOL CELL BIOL, V25, P9509, DOI 10.1128/MCB.25.21.9509-9519.2005; Chen J, 1998, J BIOL CHEM, V273, P1252, DOI 10.1074/jbc.273.2.1252; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; Koyanagi M, 2005, CIRC RES, V96, P1039, DOI 10.1161/01.RES.0000168650.23479.0c; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Rubart M, 2004, J CLIN INVEST, V114, P775, DOI 10.1172/JCI200421589; Rubart M, 2003, CIRC RES, V92, P1217, DOI 10.1161/01.RES.0000075089.39335.8C; Rubart M, 2003, AM J PHYSIOL-CELL PH, V284, pC1654, DOI 10.1152/ajpcell.00469.2002; Schulze M, 2005, GENE DEV, V19, P1787, DOI 10.1101/gad.339305; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Steele A, 2005, J HEART LUNG TRANSPL, V24, P1930, DOI 10.1016/j.healun.2005.02.001	16	35	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1929	10.1371/journal.pone.0001929	http://dx.doi.org/10.1371/journal.pone.0001929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414652	gold, Green Published, Green Submitted			2022-12-27	WOS:000260867300001
J	Paul, F; Waiczies, S; Wuerfel, J; Bellmann-Strobl, J; Dorr, J; Waiczies, H; Haertle, M; Wernecke, KD; Volk, HD; Aktas, O; Zipp, F				Paul, Friedemann; Waiczies, Sonia; Wuerfel, Jens; Bellmann-Strobl, Judith; Doerr, Jan; Waiczies, Helmar; Haertle, Mareile; Wernecke, Klaus D.; Volk, Hans-Dieter; Aktas, Orhan; Zipp, Frauke			Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis	PLOS ONE			English	Article							DOUBLE-BLIND; CELLS; COMBINATION; PARALYSIS; STATINS; LESIONS; TRIAL	Background: Recent data from animal models of multiple sclerosis (MS) and from a pilot study indicated a possible beneficial impact of statins on MS. Methodology/Principal Findings: Safety, tolerability and effects on disease activity of atorvastatin given alone or in combination with interferon-beta (IFN-beta) were assessed in a phase II open-label baseline-to-treatment trial in relapsing-remitting MS (RRMS). Patients with at least one gadolinium-enhancing lesion (CEL) at screening by magnetic resonance imaging (MRI) were eligible for the study. After a baseline period of 3 monthly MRI scans (months 22 to 0), patients followed a 9-month treatment period on 80 mg atorvastatin daily. The number of CEL in treatment months 6 to 9 compared to baseline served as the primary endpoint. Other MRI-based parameters as well as changes in clinical scores and immune responses served as secondary endpoints. Of 80 RRMS patients screened, 41 were included, among them 16 with IFN-beta comedication. The high dose of 80 mg atorvastatin was well tolerated in the majority of patients, regardless of IFN-beta comedication. Atorvastatin treatment led to a substantial reduction in the number and volume of CEL in two-sided multivariate analysis (p = 0.003 and p = 0.008). A trend towards a significant decrease in number and volume of CEL was also detected in patients with IFN-beta comedication (p = 0.060 and p = 0.062), in contrast to patients without IFN-beta comedication (p = 0.170 and p = 0.140). Immunological investigations showed no suppression in T cell response but a significant increase in IL-10 production. Conclusions/Significance: Our data suggest that high-dose atorvastatin treatment in RRMS is safe and well tolerated. Moreover, MRI analysis indicates a possible beneficial effect of atorvastatin, alone or in combination with IFN-beta, on the development of new CEL. Thus, our findings provide a rationale for phase II/III trials, including combination of atorvastatin with already approved immunomodulatory therapy regimens. Trial Registration: ClinicalTrials.gov NCT00616187	[Paul, Friedemann; Waiczies, Sonia; Wuerfel, Jens; Bellmann-Strobl, Judith; Doerr, Jan; Waiczies, Helmar; Haertle, Mareile; Aktas, Orhan; Zipp, Frauke] Charite, Cecilie Vogt Clin Neurol, HELIOS Clin Berlin Buch, D-13353 Berlin, Germany; [Doerr, Jan] HELIOS Clin Berlin Buch, Dept Neurol, Berlin, Germany; [Wernecke, Klaus D.] Dept Med Stat, Berlin, Germany; [Volk, Hans-Dieter] Univ Med Berlin Charite, Inst Immunol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Paul, F (corresponding author), Charite, Cecilie Vogt Clin Neurol, HELIOS Clin Berlin Buch, D-13353 Berlin, Germany.	frauke.zipp@charite.de	Paul, Friedemann/ABF-9415-2020; volk, hans-dieter/AAV-8053-2021; Waiczies, Sonia/H-4181-2012; Aktas, Orhan/B-7623-2009; Zipp, Frauke/C-9968-2015	volk, hans-dieter/0000-0002-7743-6668; Waiczies, Sonia/0000-0002-9916-9572; Aktas, Orhan/0000-0002-2020-9210; Zipp, Frauke/0000-0002-1231-1928; Bellmann-Strobl, Judith/0000-0003-2615-1643; Wuerfel, Jens/0000-0002-0034-8053; Waiczies, Helmar/0000-0001-6651-4790; paul, friedemann/0000-0002-6378-0070	German Research Council (DFG) [SFB 650]; Federal Ministry of Education and Research (BMBF); Pfizer GmbH Germany	German Research Council (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Pfizer GmbH Germany	This work was supported by a grant from the German Research Council (DFG) to FZ (SFB 650), the Federal Ministry of Education and Research (BMBF), and by a limited grant from Pfizer GmbH Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all the data in the study and was responsible for the decision to submit for publication.	Aktas O, 2003, J EXP MED, V197, P725, DOI 10.1084/jem.20021425; Bergh FT, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-19; Bielekova B, 2004, P NATL ACAD SCI USA, V101, P8705, DOI 10.1073/pnas.0402653101; Birnbaum G, 2007, NEUROLOGY, V68, pA206; Brunner E, 2002, NONPARAMETRIC ANAL L; Dunn SE, 2006, J EXP MED, V203, P401, DOI 10.1084/jem.20051129; KANO Y, 1988, CANCER RES, V48, P351; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207; Massacesi L, 2005, ARCH NEUROL-CHICAGO, V62, P1843, DOI 10.1001/archneur.62.12.1843; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Neuhaus O, 2002, NEUROLOGY, V59, P990, DOI 10.1212/WNL.59.7.990; Richert ND, 1998, AM J NEURORADIOL, V19, P1705; Stanislaus R, 2001, J NEUROSCI RES, V66, P155, DOI 10.1002/jnr.1207; TROIANO R, 1984, ANN NEUROL, V15, P257, DOI 10.1002/ana.410150309; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Waiczies S, 2005, J IMMUNOL, V174, P5630, DOI 10.4049/jimmunol.174.9.5630; Wandinger KP, 2003, LANCET, V361, P2036, DOI 10.1016/S0140-6736(03)13641-0; Wuerfel J, 2004, BRAIN, V127, P111, DOI 10.1093/brain/awh007; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Zipp F, 2007, TRENDS PHARMACOL SCI, V28, P342, DOI 10.1016/j.tips.2007.05.001	22	93	96	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1928	10.1371/journal.pone.0001928	http://dx.doi.org/10.1371/journal.pone.0001928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398457	Green Accepted, Green Published, gold			2022-12-27	WOS:000260795500008
J	Gisselsson, D; Hakanson, U; Stoller, P; Marti, D; Jin, Y; Rosengren, AH; Stewenius, Y; Kahl, F; Panagopoulos, I				Gisselsson, David; Hakanson, Ulf; Stoller, Patrick; Marti, Dominik; Jin, Yuesheng; Rosengren, Anders H.; Stewenius, Ylva; Kahl, Fredrik; Panagopoulos, Ioannis			When the Genome Plays Dice: Circumvention of the Spindle Assembly Checkpoint and Near-Random Chromosome Segregation in Multipolar Cancer Cell Mitoses	PLOS ONE			English	Article							CENTROSOME AMPLIFICATION; GENETIC INSTABILITY; TELOMERE DYSFUNCTION; MITOTIC CHECKPOINT; ANEUPLOIDY; COMPLEX; KINASE; OVEREXPRESSION; TUMORIGENESIS; DUPLICATION	Background: Normal cell division is coordinated by a bipolar mitotic spindle, ensuring symmetrical segregation of chromosomes. Cancer cells, however, occasionally divide into three or more directions. Such multipolar mitoses have been proposed to generate genetic diversity and thereby contribute to clonal evolution. However, this notion has been little validated experimentally. Principal Findings: Chromosome segregation and DNA content in daughter cells from multipolar mitoses were assessed by multiphoton cross sectioning and fluorescence in situ hybridization in cancer cells and non-neoplastic transformed cells. The DNA distribution resulting from multipolar cell division was found to be highly variable, with frequent nullisomies in the daughter cells. Time-lapse imaging of H2B/GFP-labelled multipolar mitoses revealed that the time from the initiation of metaphase to the beginning of anaphase was prolonged and that the metaphase plates often switched polarity several times before metaphase-anaphase transition. The multipolar metaphase-anaphase transition was accompanied by a normal reduction of cellular cyclin B levels, but typically occurred before completion of the normal separase activity cycle. Centromeric AURKB and MAD2 foci were observed frequently to remain on the centromeres of multipolar ana-telophase chromosomes, indicating that multipolar mitoses were able to circumvent the spindle assembly checkpoint with some sister chromatids remaining unseparated after anaphase. Accordingly, scoring the distribution of individual chromosomes in multipolar daughter nuclei revealed a high frequency of nondisjunction events, resulting in a near-binomial allotment of sister chromatids to the daughter cells. Conclusion: The capability of multipolar mitoses to circumvent the spindle assembly checkpoint system typically results in a near-random distribution of chromosomes to daughter cells. Spindle multipolarity could thus be a highly efficient generator of genetically diverse minority clones in transformed cell populations.	[Gisselsson, David; Jin, Yuesheng; Stewenius, Ylva; Panagopoulos, Ioannis] Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden; [Gisselsson, David] Lund Univ Hosp, Dept Pathol, Lund, Sweden; [Hakanson, Ulf] Lund Univ, Div Solid State Phys, Nanometer Structure Consortium, Lund, Sweden; [Stoller, Patrick; Marti, Dominik] Univ Bern, Inst Appl Phys, Bern, Switzerland; [Rosengren, Anders H.] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden; [Kahl, Fredrik] Lund Univ, Dept Math, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; University of Bern; Lund University; Lund University	Gisselsson, D (corresponding author), Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden.	david.gisselsson@med.lu.se	Rosengren, Anders/E-8371-2012; Marti, Dominik/B-4856-2008; Hakanson, Ulf/A-1862-2009	Rosengren, Anders/0000-0002-9333-5736; Marti, Dominik/0000-0002-1745-3116; Stoller, Patrick/0000-0002-6620-1249; Panagopoulos, Ioannis/0000-0003-2159-5341	Swedish Children's Cancer Foundation; Swedish Cancer Society; Swedish Research Council; Swedish Medical Society; Swiss National Science Foundation [3152A0-100431]; Lund University Hospital Donation Funds; Gunnar Nilsson Cancer Foundation; Medical Faculty of Lund University; Crafoord Foundation; Erik-Philip Sorensen Foundation; Lundgren Foundation; Sward Foundation	Swedish Children's Cancer Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Medical Society; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Lund University Hospital Donation Funds; Gunnar Nilsson Cancer Foundation; Medical Faculty of Lund University; Crafoord Foundation; Erik-Philip Sorensen Foundation; Lundgren Foundation; Sward Foundation	This study was supported by the Swedish Children's Cancer Foundation, the Swedish Cancer Society, the Swedish Research Council, the Swedish Medical Society, the Swiss National Science Foundation (Grant 3152A0-100431), the Lund University Hospital Donation Funds, the Gunnar Nilsson Cancer Foundation, the Medical Faculty of Lund University, the Crafoord Foundation, the Erik-Philip Sorensen Foundation, the Lundgren Foundation, and the Sward Foundation. The funders had no role in the conduct of the study, or in the collection, analysis, interpretation of the data, or in the preparation, review, or approval of the manuscript.	Alami J, 2003, INT J CANCER, V107, P365, DOI 10.1002/ijc.11429; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Bylund L, 2004, CYTOGENET GENOME RES, V106, P28, DOI 10.1159/000078556; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chestukhin A, 2003, P NATL ACAD SCI USA, V100, P4574, DOI 10.1073/pnas.0730733100; CHNG WJ, 2007, BLOOD; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; D'Assoro AB, 2002, BREAST CANCER RES TR, V75, P25, DOI 10.1023/A:1016550619925; Deng CX, 2001, MUTAT RES-FUND MOL M, V477, P183, DOI 10.1016/S0027-5107(01)00119-1; Duensing A, 2007, ONCOGENE, V26, P6280, DOI 10.1038/sj.onc.1210456; Duensing A, 2006, CELL CYCLE, V5, P2899, DOI 10.4161/cc.5.24.3567; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; DUENSING S, 2001, BIOCHIM BIOPHYS ACTA, V1471, P81; Emdad L, 2005, FRONT BIOSCI-LANDMRK, V10, P728; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; Giet R, 2005, TRENDS CELL BIOL, V15, P241, DOI 10.1016/j.tcb.2005.03.004; Gisselsson D, 2001, P NATL ACAD SCI USA, V98, P12683, DOI 10.1073/pnas.211357798; Hansemann D., 1890, ARCH PATHOL ANAT PH, V119, P299, DOI DOI 10.1007/BF01882039; Iovino F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-38; Jensen S, 2001, J CELL BIOL, V152, P27, DOI 10.1083/jcb.152.1.27; Jin YS, 2007, CLIN CANCER RES, V13, P1703, DOI 10.1158/1078-0432.CCR-06-2705; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kaneko Y, 2000, GENE CHROMOSOME CANC, V29, P89, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1021>3.0.CO;2-Y; Klisch K, 2005, CELLS TISSUES ORGANS, V181, P103, DOI 10.1159/000091099; Landen CN, 2007, CLIN CANCER RES, V13, P4098, DOI 10.1158/1078-0432.CCR-07-0431; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Mattsson G, 2007, J MOL DIAGN, V9, P479, DOI 10.2353/jmoldx.2007.070041; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003; PALITTI F, 1972, GENETICA, V43, P130; PERA F, 1969, CHROMOSOMA, V26, P337, DOI 10.1007/BF00326527; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Reiter R, 2006, CLIN CANCER RES, V12, P5136, DOI 10.1158/1078-0432.CCR-05-1650; RIZZONI M, 1974, CHROMOSOMA, V45, P151, DOI 10.1007/BF00362308; Saunders W, 2005, SEMIN CANCER BIOL, V15, P25, DOI 10.1016/j.semcancer.2004.09.003; Saunders WS, 2000, P NATL ACAD SCI USA, V97, P303, DOI 10.1073/pnas.97.1.303; Shinmura K, 2007, ONCOGENE, V26, P2939, DOI 10.1038/sj.onc.1210085; Steinbeck RG, 1998, BRIT J CANCER, V77, P1027, DOI 10.1038/bjc.1998.171; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Stewenius Y, 2007, CLIN CANCER RES, V13, P6593, DOI 10.1158/1078-0432.CCR-07-1081; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; TEPLITZ RL, 1968, EXP CELL RES, V52, P379, DOI 10.1016/0014-4827(68)90479-5; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yamamoto Y, 2006, CLIN CANCER RES, V12, P2752, DOI 10.1158/1078-0432.CCR-05-0805; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	53	41	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1871	10.1371/journal.pone.0001871	http://dx.doi.org/10.1371/journal.pone.0001871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18392149	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795400011
J	Meadows, SK; Dressman, HK; Muramoto, GG; Himburg, H; Salter, A; Wei, ZZ; Ginsburg, G; Chao, NJ; Nevins, JR; Chute, JP				Meadows, Sarah K.; Dressman, Holly K.; Muramoto, Garrett G.; Himburg, Heather; Salter, Alice; Wei, ZhengZheng; Ginsburg, Geoff; Chao, Nelson J.; Nevins, Joseph R.; Chute, John P.			Gene Expression Signatures of Radiation Response Are Specific, Durable and Accurate in Mice and Humans	PLOS ONE			English	Article							RETRACTED ARTICLE. SEE; EXPOSURE; CELLS; LIPOPOLYSACCHARIDE; LYMPHOCYTES; BIOMARKERS; FREQUENCY; PATTERNS; P53	Background: Previous work has demonstrated the potential for peripheral blood (PB) gene expression profiling for the detection of disease or environmental exposures. Methods and Findings: We have sought to determine the impact of several variables on the PB gene expression profile of an environmental exposure, ionizing radiation, and to determine the specificity of the PB signature of radiation versus other genotoxic stresses. Neither genotype differences nor the time of PB sampling caused any lessening of the accuracy of PB signatures to predict radiation exposure, but sex difference did influence the accuracy of the prediction of radiation exposure at the lowest level (50 cGy). A PB signature of sepsis was also generated and both the PB signature of radiation and the PB signature of sepsis were found to be 100% specific at distinguishing irradiated from septic animals. We also identified human PB signatures of radiation exposure and chemotherapy treatment which distinguished irradiated patients and chemotherapy-treated individuals within a heterogeneous population with accuracies of 90% and 81%, respectively. Conclusions: We conclude that PB gene expression profiles can be identified in mice and humans that are accurate in predicting medical conditions, are specific to each condition and remain highly accurate over time.	[Meadows, Sarah K.; Muramoto, Garrett G.; Himburg, Heather; Salter, Alice; Chao, Nelson J.; Chute, John P.] Duke Univ, Med Ctr, Div Cell Therapy, Durham, NC 27706 USA; [Dressman, Holly K.; Wei, ZhengZheng; Nevins, Joseph R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Dressman, Holly K.; Ginsburg, Geoff; Nevins, Joseph R.; Chute, John P.] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC USA	Duke University; Duke University; Duke University	Meadows, SK (corresponding author), Duke Univ, Med Ctr, Div Cell Therapy, Durham, NC 27706 USA.	john.chute@duke.edu			National Institutes of Allergy and Infectious Diseases [AI-067798-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded, in part, by grant AI-067798-01 from the National Institutes of Allergy and Infectious Diseases (JRN and JPC).	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2; Amundson SA, 2004, CANCER RES, V64, P6368, DOI 10.1158/0008-5472.CAN-04-1883; Amundson SA, 2001, RADIAT RES, V156, P657, DOI 10.1667/0033-7587(2001)156[0657:IOGEAA]2.0.CO;2; Baird AE, 2007, STROKE, V38, P694, DOI 10.1161/01.STR.0000250431.99687.7b; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Boolchand V, 2006, ANN INTERN MED, V145, P654, DOI 10.7326/0003-4819-145-9-200611070-00007; Cheng SH, 2006, J CLIN ONCOL, V24, P4594, DOI 10.1200/JCO.2005.02.5676; Dainiak N, 2002, EXP HEMATOL, V30, P513, DOI 10.1016/S0301-472X(02)00802-0; DAMLE R, 2007, BLOOD; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Edwards CJ, 2007, MOL MED, V13, P40, DOI 10.2119/2006-000056.Edwards; Einstein AJ, 2007, CIRCULATION, V116, P1290, DOI 10.1161/CIRCULATIONAHA.107.688101; Falt S, 2003, CARCINOGENESIS, V24, P1837, DOI 10.1093/carcin/bgg134; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; Hick RW, 2006, J IMMUNOL, V177, P169, DOI 10.4049/jimmunol.177.1.169; HIRAI Y, 1995, MUTAT RES-FUND MOL M, V329, P183, DOI 10.1016/0027-5107(95)00044-J; Horwitz PA, 2004, CIRCULATION, V110, P3815, DOI 10.1161/01.CIR.0000150539.72783.BF; Hsieh SC, 2002, ONCOGENE, V21, P3050, DOI 10.1038/sj.onc.1205417; Inoue K, 2005, FASEB J, V19, P533, DOI 10.1096/fj.05-3864fje; Iwamoto KS, 1998, J NATL CANCER I, V90, P1167, DOI 10.1093/jnci/90.15.1167; Jen KY, 2003, GENOME RES, V13, P2092, DOI 10.1101/gr.1240103; Kaiser J, 2003, SCIENCE, V302, P378, DOI 10.1126/science.302.5644.378; Lampe JW, 2004, CANCER EPIDEM BIOMAR, V13, P445; Lin BC, 2003, CLIN CHEM, V49, P1045, DOI 10.1373/49.7.1045; Mandel M, 2006, LUPUS, V15, P451, DOI 10.1191/0961203306lu2332oa; Martin KJ, 2001, P NATL ACAD SCI USA, V98, P2646, DOI 10.1073/pnas.041622398; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; Moore DH, 1997, RADIAT RES, V148, P463, DOI 10.2307/3579324; NEEL JV, 1990, ANNU REV GENET, V24, P327; Nevins JR, 2007, NAT REV GENET, V8, P601, DOI 10.1038/nrg2137; Patino WD, 2005, P NATL ACAD SCI USA, V102, P3423, DOI 10.1073/pnas.0408032102; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; POURNARA I, 2007, BMC BIOINFORMATICS, V23, P1; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rubins KH, 2004, P NATL ACAD SCI USA, V101, P15190, DOI 10.1073/pnas.0405759101; Seierstad T, 2007, RADIAT PROT DOSIM, V123, P246, DOI 10.1093/rpd/ncl141; TAKESHIMA Y, 1993, LANCET, V342, P1520, DOI 10.1016/S0140-6736(05)80087-X; Valenzuela HF, 2007, CANCER RES, V67, P6155, DOI 10.1158/0008-5472.CAN-05-4431; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	43	80	89	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1912	10.1371/journal.pone.0001912	http://dx.doi.org/10.1371/journal.pone.0001912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382685	Green Published, gold			2022-12-27	WOS:000260795400037
J	Salter, KH; Acharya, CR; Walters, KS; Redman, R; Anguiano, A; Garman, KS; Anders, CK; Mukherjee, S; Dressman, HK; Barry, WT; Marcom, KP; Olson, J; Nevins, JR; Potti, A				Salter, Kelly H.; Acharya, Chaitanya R.; Walters, Kelli S.; Redman, Richard; Anguiano, Ariel; Garman, Katherine S.; Anders, Carey K.; Mukherjee, Sayan; Dressman, Holly K.; Barry, William T.; Marcom, Kelly P.; Olson, John; Nevins, Joseph R.; Potti, Anil			An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer	PLOS ONE			English	Article								Background: A major challenge in oncology is the selection of the most effective chemotherapeutic agents for individual patients, while the administration of ineffective chemotherapy increases mortality and decreases quality of life in cancer patients. This emphasizes the need to evaluate every patient's probability of responding to each chemotherapeutic agent and limiting the agents used to those most likely to be effective. Methods and Results: Using gene expression data on the NCI-60 and corresponding drug sensitivity, mRNA and microRNA profiles were developed representing sensitivity to individual chemotherapeutic agents. The mRNA signatures were tested in an independent cohort of 133 breast cancer patients treated with the TFAC (paclitaxel, 5-fluorouracil, adriamycin, and cyclophosphamide) chemotherapy regimen. To further dissect the biology of resistance, we applied signatures of oncogenic pathway activation and performed hierarchical clustering. We then used mRNA signatures of chemotherapy sensitivity to identify alternative therapeutics for patients resistant to TFAC. Profiles from mRNA and microRNA expression data represent distinct biologic mechanisms of resistance to common cytotoxic agents. The individual mRNA signatures were validated in an independent dataset of breast tumors (P = 0.002, NPV = 82%). When the accuracy of the signatures was analyzed based on molecular variables, the predictive ability was found to be greater in basal-like than non basal-like patients (P = 0.03 and P = 0.06). Samples from patients with co-activated Myc and E2F represented the cohort with the lowest percentage (8%) of responders. Using mRNA signatures of sensitivity to other cytotoxic agents, we predict that TFAC non-responders are more likely to be sensitive to docetaxel (P = 0.04), representing a viable alternative therapy. Conclusions: Our results suggest that the optimal strategy for chemotherapy sensitivity prediction integrates molecular variables such as ER and HER2 status with corresponding microRNA and mRNA expression profiles. Importantly, we also present evidence to support the concept that analysis of molecular variables can present a rational strategy to identifying alternative therapeutic opportunities.	[Salter, Kelly H.; Acharya, Chaitanya R.; Walters, Kelli S.; Redman, Richard; Anguiano, Ariel; Garman, Katherine S.; Anders, Carey K.; Mukherjee, Sayan; Dressman, Holly K.; Barry, William T.; Olson, John; Nevins, Joseph R.; Potti, Anil] Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27706 USA; [Redman, Richard; Anguiano, Ariel; Garman, Katherine S.; Anders, Carey K.; Marcom, Kelly P.; Potti, Anil] Duke Univ, Med Ctr, Dept Med, Durham, NC USA; [Mukherjee, Sayan; Barry, William T.] Duke Univ, Inst Stat & Decision Sci, Durham, NC USA; [Olson, John] Duke Univ, Med Ctr, Dept Surg, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Salter, KH (corresponding author), Duke Univ, Duke Inst Genome Sci & Policy, Durham, NC 27706 USA.	anil.potti@duke.edu	Acharya, Chaitanya/T-3510-2019	Mukherjee, Sayan/0000-0002-6715-3920	Department of Defense (CDMRP); Jimmy V. Foundation	Department of Defense (CDMRP)(United States Department of Defense); Jimmy V. Foundation	The current work is supported by research grants from the Department of Defense (CDMRP) and the Jimmy V. Foundation.	Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; BONNEFOI H, 2007, LANCET ONCOL; Breathnach OS, 2001, J CLIN ONCOL, V19, P1734, DOI 10.1200/JCO.2001.19.6.1734; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chang JC, 2003, LANCET, V362, P362, DOI 10.1016/S0140-6736(03)14023-8; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Dumontet C, 1999, J CLIN ONCOL, V17, P1061, DOI 10.1200/JCO.1999.17.3.1061; Gyorffy B, 2006, INT J CANCER, V118, P1699, DOI 10.1002/ijc.21570; Hayes DF, 2007, NEW ENGL J MED, V357, P1496, DOI 10.1056/NEJMoa071167; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Herbst RS, 2006, J CLIN ONCOL, V24, P190, DOI 10.1200/JCO.2005.04.8678; Hsu DS, 2007, J CLIN ONCOL, V25, P4350, DOI 10.1200/JCO.2007.11.0593; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Mano MS, 2007, CANCER TREAT REV, V33, P64, DOI 10.1016/j.ctrv.2006.10.001; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Nevins JR, 2007, NAT REV GENET, V8, P601, DOI 10.1038/nrg2137; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Pusztai L, 2007, CLIN CANCER RES, V13, P6080, DOI 10.1158/1078-0432.CCR-07-0809; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Tagawa H, 2007, CANCER SCI, V98, P1482, DOI 10.1111/j.1349-7006.2007.00531.x; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yoo GH, 2002, CLIN CANCER RES, V8, P3910	28	65	73	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1908	10.1371/journal.pone.0001908	http://dx.doi.org/10.1371/journal.pone.0001908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382681	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795400033
J	Wagner, S; Storbeck, CJ; Roovers, K; Chaar, ZY; Kolodziej, P; Mckay, M; Sabourin, LA				Wagner, Simona; Storbeck, Chris J.; Roovers, Kristin; Chaar, Ziad Y.; Kolodziej, Piotr; Mckay, Marlene; Sabourin, Luc A.			FAK/src-Family Dependent Activation of the Ste20-Like Kinase SLK Is Required for Microtubule-Dependent Focal Adhesion Turnover and Cell Migration	PLOS ONE			English	Article								Cell migration involves a multitude of signals that converge on cytoskeletal reorganization, essential for development, immune responses and tissue repair. Using knockdown and dominant negative approaches, we show that the microtubule-associated Ste20-like kinase SLK is required for focal adhesion turnover and cell migration downstream of the FAK/c-src complex. Our results show that SLK co-localizes with paxillin, Rac1 and the microtubules at the leading edge of migrating cells and is activated by scratch wounding. SLK activation is dependent on FAK/c-src/MAPK signaling, whereas SLK recruitment to the leading edge is src-dependent but FAK independent. Our results show that SLK represents a novel focal adhesion disassembly signal.	[Wagner, Simona; Chaar, Ziad Y.; Sabourin, Luc A.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Storbeck, Chris J.; Roovers, Kristin; Kolodziej, Piotr; Mckay, Marlene; Sabourin, Luc A.] Ottawa Hlth Res Inst, Canc Therapeut, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Wagner, S (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.	lsabourin@ohri.ca			Canadian Institute for Health Research; MDAUSA; Premier's Research for Excellence Award; Canadian Heart and Stroke Foundation Fellowship; Canadian Breast Cancer Foundation; CIHR scholar award; OGSST; NSERC [studentship]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); MDAUSA(Muscular Dystrophy Association); Premier's Research for Excellence Award; Canadian Heart and Stroke Foundation Fellowship(Heart & Stroke Foundation of Canada); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); CIHR scholar award(Canadian Institutes of Health Research (CIHR)); OGSST; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Institute for Health Research, MDAUSA and a Premier's Research for Excellence Award. CJS is the recipient of a Canadian Heart and Stroke Foundation Fellowship. KR is supported by the Canadian Breast Cancer Foundation. LAS is the recipient of a CIHR scholar award. SW is supported by OGSST and NSERC studentship.	Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010; Chaar Z, 2006, J BIOL CHEM, V281, P28193, DOI 10.1074/jbc.M605665200; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Enomoto T, 1996, CELL STRUCT FUNCT, V21, P317, DOI 10.1247/csf.21.317; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hao W, 2006, J BIOL CHEM, V281, P3075, DOI 10.1074/jbc.M511744200; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Laurent CE, 2004, MOL CELL BIOL, V24, P9351, DOI 10.1128/MCB.24.21.9351-9358.2004; McGarrigle D, 2006, J BIOL CHEM, V281, P10583, DOI 10.1074/jbc.M513002200; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; O'Reilly PG, 2005, J BIOL CHEM, V280, P42383, DOI 10.1074/jbc.M510763200; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Ren XD, 2000, J CELL SCI, V113, P3673; Rengifo-Cam W, 2004, ONCOGENE, V23, P289, DOI 10.1038/sj.onc.1207041; Sabourin LA, 2000, MOL CELL BIOL, V20, P684, DOI 10.1128/MCB.20.2.684-696.2000; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; Schaar DG, 1996, BRAIN RES, V721, P217, DOI 10.1016/0006-8993(96)00176-X; Schaller MD, 1999, MOL BIOL CELL, V10, P3489, DOI 10.1091/mbc.10.10.3489; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Schwartz MA, 2006, CELL, V125, P1223, DOI 10.1016/j.cell.2006.06.015; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Simon JR, 1998, J NEUROCYTOL, V27, P119, DOI 10.1023/A:1006999306413; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Storbeck CJ, 2004, MUSCLE NERVE, V29, P553, DOI 10.1002/mus.20000; Sulimenko V, 2006, J IMMUNOL, V176, P7243, DOI 10.4049/jimmunol.176.12.7243; Wagner S, 2002, J BIOL CHEM, V277, P37685, DOI 10.1074/jbc.M205899200; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082	50	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1868	10.1371/journal.pone.0001868	http://dx.doi.org/10.1371/journal.pone.0001868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382658	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795400008
J	Li, ZY; Yi, YZ; Yin, XP; Zhang, ZF; Liu, JX				Li, Zhiyong; Yi, Yongzhu; Yin, Xiangping; Zhang, Zhifang; Liu, Jixing			Expression of Foot-and-Mouth Disease Virus Capsid Proteins in Silkworm-Baculovirus Expression System and Its Utilization as a Subunit Vaccine	PLOS ONE			English	Article								Background: Foot-and-mouth disease (FMD) is a highly contagious disease of livestock that causes severe economic loss in susceptible cloven-hoofed animals. Although the traditional inactivated vaccine has been proved effective, it may lead to a new outbreak of FMD because of either incomplete inactivation of FMDV or the escape of live virus from vaccine production workshop. Thus, it is urgent to develop a novel FMDV vaccine that is safer, more effective and more economical than traditional vaccines. Methodology and Principal Findings: A recombinant silkworm baculovirus Bm-P12A3C which contained the intact P1-2A and 3C protease coding regions of FMDV Asia 1/HNK/CHA/05 was developed. Indirect immunofluorescence test and sandwich-ELISA were used to verify that Bm-P12A3C could express the target cassette. Expression products from silkworm were diluted to 30 folds and used as antigen to immunize cattle. Specific antibody was induced in all vaccinated animals. After challenge with virulent homologous virus, four of the five animals were completely protected, and clinical symptoms were alleviated and delayed in the remaining one. Furthermore, a PD50 (50% bovine protective dose) test was performed to assess the bovine potency of the subunit vaccine. The result showed the subunit vaccine could achieve 6.34 PD50 per dose. Conclusion: The results suggest that this strategy might be used to develop the new subunit FMDV vaccine.	[Li, Zhiyong; Yin, Xiangping; Liu, Jixing] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Key Lab Anim Virol,Minist Agr, Lanzhou, Gansu, Peoples R China; [Yi, Yongzhu; Zhang, Zhifang] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Li, ZY (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Key Lab Anim Virol,Minist Agr, Lanzhou, Gansu, Peoples R China.	zhifangzhang@yahoo.com; liuxing@hotmail.com			National 863 Project of China [2006AA02Z440]; Chinese Funding for Social Public Interests [2005DIB4J041]	National 863 Project of China; Chinese Funding for Social Public Interests	This work was supported by grants from National 863 Project of China (No. 2006AA02Z440) and Chinese Funding for Social Public Interests (No. 2005DIB4J041). The funders had no role in the study design and conduct, data collection and analysis, decision to publish, or in the preparation of the manuscript.	ABRAMS CC, 1995, J GEN VIROL, V76, P3089, DOI 10.1099/0022-1317-76-12-3089; Balamurugan V, 2005, ARCH VIROL, V150, P967, DOI 10.1007/s00705-004-0460-2; Belliot G, 2001, J CLIN MICROBIOL, V39, P4288, DOI 10.1128/JCM.39.12.4288-4295.2001; BELSHAM GJ, 1991, J GEN VIROL, V72, P747, DOI 10.1099/0022-1317-72-3-747; Brown F, 2003, VIRUS RES, V91, P3, DOI 10.1016/S0168-1702(02)00268-X; CHOUDARY PV, 1995, BACULOVIRUS EXPRESSI, P243; Doel TR, 2003, VIRUS RES, V91, P81, DOI 10.1016/S0168-1702(02)00261-7; GRUBMAN MJ, 1993, VACCINE, V11, P825, DOI 10.1016/0264-410X(93)90357-4; Guo H., 2006, Journal of Veterinary Medicine. Series B, V53, P29, DOI 10.1111/j.1439-0450.2006.01018.x; Guo HC, 2005, VACCINE, V23, P3236, DOI 10.1016/j.vaccine.2004.03.074; KLEID DG, 1981, SCIENCE, V214, P1125, DOI 10.1126/science.6272395; KRAUSSLICH HG, 1990, J VIROL, V64, P2433; LAURENT S, 1994, J VIROL, V68, P6794, DOI 10.1128/JVI.68.10.6794-6798.1994; LEWIS SA, 1991, J VIROL, V65, P6572, DOI 10.1128/JVI.65.12.6572-6580.1991; Li D, 2007, VIRUS GENES, V35, P273, DOI 10.1007/s11262-006-0073-9; Lin XA, 2006, Z NATURFORSCH C, V61, P595; Maranga Luis, 2002, Adv Biochem Eng Biotechnol, V74, P183; Mayr GA, 2001, VACCINE, V19, P2152, DOI 10.1016/S0264-410X(00)00384-4; Mayr GA, 1999, VIROLOGY, V263, P496, DOI 10.1006/viro.1999.9940; Moraes MP, 2003, VACCINE, V22, P268, DOI 10.1016/S0264-410X(03)00560-7; Moraes MP, 2002, VACCINE, V20, P1631, DOI 10.1016/S0264-410X(01)00483-2; Mortola E, 2004, FEBS LETT, V576, P174, DOI 10.1016/j.febslet.2004.09.009; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Pacheco JM, 2005, VIROLOGY, V337, P205, DOI 10.1016/j.virol.2005.04.014; Perry BD, 2003, FOOT-AND-MOUTH DISEASE: CONTROL STRATEGIES, P23; Pluimers FH, 2002, REV SCI TECH OIE, V21, P711, DOI 10.20506/rst.21.3.1371; ROOSIEN J, 1990, J GEN VIROL, V71, P1703, DOI 10.1099/0022-1317-71-8-1703; Santos MJD, 2005, VACCINE, V23, P1838, DOI 10.1016/j.vaccine.2004.11.014; Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353; Wu XF, 2001, GENE EXPRESSION TECH, P135	30	56	66	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2273	10.1371/journal.pone.0002273	http://dx.doi.org/10.1371/journal.pone.0002273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509464	Green Submitted, gold, Green Published			2022-12-27	WOS:000262268500018
J	Leclerc, P; Biarc, J; St-Onge, M; Gilbert, C; Dussault, AA; Laflamme, C; Pouliot, M				Leclerc, Patrick; Biarc, Jordane; St-Onge, Mireille; Gilbert, Caroline; Dussault, Andree-Anne; Laflamme, Cynthia; Pouliot, Marc			Nucleobindin Co-Localizes and Associates with Cyclooxygenase (COX)-2 in Human Neutrophils	PLOS ONE			English	Article								The inducible cyclooxygenase isoform (COX-2) is associated with inflammation, tumorigenesis, as well as with physiological events. Despite efforts deployed in order to understand the biology of this multi-faceted enzyme, much remains to be understood. Nucleobindin (Nuc), a ubiquitous Ca2+-binding protein, possesses a putative COX-binding domain. In this study, we investigated its expression and subcellular localization in human neutrophils, its affinity for COX-2 as well as its possible impact on PGE(2) biosynthesis. Complementary subcellular localization approaches including nitrogen cavitation coupled to Percoll fractionation, immunofluorescence, confocal and electron microscopy collectively placed Nuc, COX-2, and all of the main enzymes involved in prostanoid synthesis, in the Golgi apparatus and endoplasmic reticulum of human neutrophils. Immunoprecipitation experiments indicated a high affinity between Nuc and COX-2. Addition of human recombinant (hr) Nuc to purified hrCOX-2 dose-dependently caused an increase in PGE(2) biosynthesis in response to arachidonic acid. Co-incubation of Nuc with COX-2-expressing neutrophil lysates also increased their capacity to produce PGE(2). Moreover, neutrophil transfection with hrNuc specifically enhanced PGE(2) biosynthesis. Together, these results identify a COX-2-associated protein which may have an impact in prostanoid biosynthesis.	[Leclerc, Patrick; Biarc, Jordane; St-Onge, Mireille; Gilbert, Caroline; Dussault, Andree-Anne; Laflamme, Cynthia; Pouliot, Marc] Univ Laval, Fac Med, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1K 7P4, Canada	Laval University	Leclerc, P (corresponding author), Univ Laval, Fac Med, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1K 7P4, Canada.	Marc.Pouliot@crchul.ulaval.ca	Biarc, Jordane/AAP-4958-2020; Pouliot, Marc/G-4103-2016	Pouliot, Marc/0000-0002-2466-5424; Gilbert, Caroline/0000-0003-2722-1180	Canadian Institutes of Health Research [MOP-64315]; The Arthritis Society [04/0079]; Fonds de la Recherche en Sante du Quebec (FRSQ) [Senior Investigator Scholarship]; Canadian Arthritis Network [fellowship, studentship]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); The Arthritis Society; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Arthritis Network	This work is supported by grants from the Canadian Institutes of Health Research (CIHR, grant no. MOP-64315) and The Arthritis Society (TAS, grant no. 04/0079 to MP). MP is the recipient of a Senior Investigator Scholarship from the Fonds de la Recherche en Sante du Quebec (FRSQ). JB and MSO are respectively recipients of a fellowship and studentship from the Canadian Arthritis Network.	Ballif BA, 1996, P NATL ACAD SCI USA, V93, P5544, DOI 10.1073/pnas.93.11.5544; Bertagnolli M M, 1999, Curr Oncol Rep, V1, P173, DOI 10.1007/s11912-999-0030-6; Bornfeldt KE, 1997, J CLIN INVEST, V100, P875, DOI 10.1172/JCI119603; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; BREDEROO P, 1983, CELL TISSUE RES, V234, P469, DOI 10.1007/BF00218646; Cadieux JS, 2005, J CELL SCI, V118, P1437, DOI 10.1242/jcs.01737; CHANDRA S, 1991, J CELL SCI, V100, P747; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; DuBois RN, 1996, CANCER RES, V56, P733; FANTONE JC, 1981, PROSTAG LEUKOTR ESS, V7, P195, DOI 10.1016/0161-4630(81)90062-8; FANTONE JC, 1983, J IMMUNOL, V130, P1495; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; HAM EA, 1983, P NATL ACAD SCI-BIOL, V80, P4349, DOI 10.1073/pnas.80.14.4349; Higashi Y, 2000, INT J CANCER, V86, P667, DOI 10.1002/(SICI)1097-0215(20000601)86:5<667::AID-IJC10>3.3.CO;2-P; Howe LR, 2001, ENDOCR-RELAT CANCER, V8, P97, DOI 10.1677/erc.0.0080097; KANAI Y, 1992, IMMUNOL LETT, V32, P43; Kjeldsen L, 1999, J IMMUNOL METHODS, V232, P131, DOI 10.1016/S0022-1759(99)00171-4; Lachance G, 2002, J BIOL CHEM, V277, P21537, DOI 10.1074/jbc.M201903200; Lavoie C, 2002, MOL ENDOCRINOL, V16, P2462, DOI 10.1210/me.2002-0079; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; Lin P, 1998, J CELL BIOL, V141, P1515, DOI 10.1083/jcb.141.7.1515; Lin P, 2000, P NATL ACAD SCI USA, V97, P674, DOI 10.1073/pnas.97.2.674; Maloney CG, 1998, J IMMUNOL, V160, P1402; Marshall J, 2000, J IMMUNOL, V164, P2084, DOI 10.4049/jimmunol.164.4.2084; MIURA K, 1992, BIOCHEM BIOPH RES CO, V187, P375, DOI 10.1016/S0006-291X(05)81503-7; Miura K, 1996, GENOMICS, V34, P181, DOI 10.1006/geno.1996.0263; MIURA K, 1994, BIOCHEM BIOPH RES CO, V199, P1388, DOI 10.1006/bbrc.1994.1384; MOCHIZUKI N, 1995, FEBS LETT, V373, P155, DOI 10.1016/0014-5793(95)01031-9; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; Petersson U, 2004, BONE, V34, P949, DOI 10.1016/j.bone.2004.01.019; Pouliot M, 2002, J IMMUNOL, V169, P5279, DOI 10.4049/jimmunol.169.9.5279; Pouliot M, 1998, FASEB J, V12, P1109, DOI 10.1096/fasebj.12.12.1109; Pouliot M, 1996, EUR J BIOCHEM, V238, P250, DOI 10.1111/j.1432-1033.1996.0250q.x; Pouliot M, 1997, J IMMUNOL, V158, P4930; RIVKIN I, 1975, J IMMUNOL, V115, P1126; Somogyi E, 2004, CALCIFIED TISSUE INT, V74, P366, DOI 10.1007/s00223-003-0146-x; St-Onge M, 2007, BBA-MOL CELL BIOL L, V1771, P1235, DOI 10.1016/j.bbalip.2007.06.002; WANG SN, 1994, PATHOL INT, V44, P844, DOI 10.1111/j.1440-1827.1994.tb01682.x; WENDEL M, 1995, J BIOL CHEM, V270, P6125, DOI 10.1074/jbc.270.11.6125; Zimmermann KC, 1999, CANCER RES, V59, P198; ZURIER RB, 1974, J CLIN INVEST, V53, P297, DOI 10.1172/JCI107550	47	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2229	10.1371/journal.pone.0002229	http://dx.doi.org/10.1371/journal.pone.0002229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493301	Green Submitted, Green Published, gold			2022-12-27	WOS:000262258700037
J	McGuigan, AP; Bruzewicz, DA; Glavan, A; Butte, M; Whitesides, GM				McGuigan, Alison P.; Bruzewicz, Derek A.; Glavan, Ana; Butte, Manish; Whitesides, George M.			Cell Encapsulation in Sub-mm Sized Gel Modules Using Replica Molding	PLOS ONE			English	Article							3-DIMENSIONAL CULTURES; COLLAGEN GEL; HEPATOCYTES; FIBROBLASTS; CONTRACTION; FABRICATION; MICROARRAY; SPHEROIDS; PHENOTYPE; HYDROGEL	For many types of cells, behavior in two-dimensional (2D) culture differs from that in three-dimensional (3D) culture. Among biologists, 2D culture on treated plastic surfaces is currently the most popular method for cell culture. In 3D, no analogous standard method-one that is similarly convenient, flexible, and reproducible-exists. This paper describes a soft-lithographic method to encapsulate cells in 3D gel objects (modules) in a variety of simple shapes (cylinders, crosses, rectangular prisms) with lateral dimensions between 40 and 1000 mu m, cell densities of 10(5) - 10(8) cells/cm(3), and total volumes between 1x10(-7) and 8x10(-4) cm(3). By varying (i) the initial density of cells at seeding, and (ii) the dimensions of the modules, the number of cells per module ranged from 1 to 2500 cells. Modules were formed from a range of standard biopolymers, including collagen, Matrigel (TM), and agarose, without the complex equipment often used in encapsulation. The small dimensions of the modules allowed rapid transport of nutrients by diffusion to cells at any location in the module, and therefore allowed generation of modules with cell densities near to those of dense tissues (10(8) - 10(9) cells/cm(3)). This modular method is based on soft lithography and requires little special equipment; the method is therefore accessible, flexible, and well suited to (i) understanding the behavior of cells in 3D environments at high densities of cells, as in dense tissues, and (ii) developing applications in tissue engineering.	[McGuigan, Alison P.; Bruzewicz, Derek A.; Glavan, Ana; Butte, Manish; Whitesides, George M.] Harvard Univ, Cambridge, MA 02138 USA	Harvard University	McGuigan, AP (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	gwhitesides@gmwgroup.harvard.edu	Butte, Manish/AAM-8604-2020; McGuigan, Alison/B-4744-2010; Butte, Manish/T-8860-2019	Butte, Manish/0000-0002-4490-5595; Butte, Manish/0000-0002-4490-5595; McGuigan, Alison/0000-0003-2803-0917	NIH EHS [GM 065364]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065364] Funding Source: NIH RePORTER	NIH EHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH EHS grant GM 065364	Abu-Absi SF, 2002, EXP CELL RES, V274, P56, DOI 10.1006/excr.2001.5467; AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f; [Anonymous], PRINCIPLES TISSUE EN; Barralet JE, 2005, J MATER SCI-MATER M, V16, P515, DOI 10.1007/s10856-005-0526-z; BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274; Berthiaume F, 1996, FASEB J, V10, P1471, DOI 10.1096/fasebj.10.13.8940293; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022; Cygan ZT, 2005, LANGMUIR, V21, P3629, DOI 10.1021/la0471137; Ehrlich HP, 2000, J CELL PHYSIOL, V185, P432, DOI 10.1002/1097-4652(200012)185:3<432::AID-JCP14>3.0.CO;2-R; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; FINESMITH TH, 1990, J CELL PHYSIOL, V144, P99, DOI 10.1002/jcp.1041440113; Fukuda J, 2006, BIOMATERIALS, V27, P5259, DOI 10.1016/j.biomaterials.2006.05.044; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Humphreys P, 1996, J NEUROSCI METH, V66, P23, DOI 10.1016/0165-0270(95)00142-5; Kamamoto F, 2003, ARTIF ORGANS, V27, P701, DOI 10.1046/j.1525-1594.2003.07277.x; Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m; Kono Y, 1996, BIOCHEM BIOPH RES CO, V220, P628, DOI 10.1006/bbrc.1996.0454; LAZAR A, 1995, IN VITRO CELL DEV-AN, V31, P340, DOI 10.1007/BF02634282; LAZAR A, 1995, CELL TRANSPLANT, V4, P259, DOI 10.1016/0963-6897(94)00058-R; Li GN, 2007, TISSUE ENG, V13, P1035, DOI 10.1089/ten.2006.0251; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319; McGuigan AP, 2006, NAT PROTOC, V1, P2963, DOI 10.1038/nprot.2006.443; Mcguigan AP, 2007, TISSUE ENG, V13, P1069, DOI 10.1089/ten.2006.0253; McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103; MORRA M, 1990, Clinical Materials, V5, P147, DOI 10.1016/0267-6605(90)90014-M; Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0; PHILLIPS HJ, 1957, EXP CELL RES, V13, P341, DOI 10.1016/0014-4827(57)90013-7; Powers MJ, 2002, TISSUE ENG, V8, P499, DOI 10.1089/107632702760184745; Puri S, 2007, DEV BIOL, V306, P82, DOI 10.1016/j.ydbio.2007.03.003; Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077; SORANZO C, 1986, TUMORI, V72, P459, DOI 10.1177/030089168607200502; Tan W, 2005, J BIOMED MATER RES A, V72A, P146, DOI 10.1002/jbm.a.30182; Tan W, 2004, BIOMATERIALS, V25, P1355, DOI 10.1016/j.biomaterials.2003.08.021; Tan W, 2003, BIOMED MICRODEVICES, V5, P235, DOI 10.1023/A:1025764310391; Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Yeh J, 2006, BIOMATERIALS, V27, P5391, DOI 10.1016/j.biomaterials.2006.06.005	41	75	76	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2258	10.1371/journal.pone.0002258	http://dx.doi.org/10.1371/journal.pone.0002258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493609	Green Published, gold			2022-12-27	WOS:000262258700058
J	Nakashima, A; Maruki, Y; Imamura, Y; Kondo, C; Kawamata, T; Kawanishi, I; Takata, H; Matsuura, A; Lee, KS; Kikkawa, U; Ohsumi, Y; Yonezawa, K; Kamada, Y				Nakashima, Akio; Maruki, Yoshiko; Imamura, Yuko; Kondo, Chika; Kawamata, Tomoko; Kawanishi, Ippei; Takata, Hideki; Matsuura, Akira; Lee, Kyung S.; Kikkawa, Ushio; Ohsumi, Yoshinori; Yonezawa, Kazuyoshi; Kamada, Yoshiaki			The Yeast Tor Signaling Pathway Is Involved in G2/M Transition via Polo-Kinase	PLOS ONE			English	Article							CELL-CYCLE; NUCLEAR-LOCALIZATION; BINDING-PROTEIN; HIGH OSMOLARITY; MESSENGER-RNA; FISSION YEAST; RAPAMYCIN; GROWTH; TRANSCRIPTION; PHOSPHATASE	The target of rapamycin (Tor) protein plays central roles in cell growth. Rapamycin inhibits cell growth and promotes cell cycle arrest at G1 (G0). However, little is known about whether Tor is involved in other stages of the cell division cycle. Here we report that the rapamycin-sensitive Tor complex 1 (TORC1) is involved in G2/M transition in S. cerevisiae. Strains carrying a temperature-sensitive allele of KOG1 (kog1-105) encoding an essential component of TORC1, as well as yeast cell treated with rapamycin show mitotic delay with prolonged G2. Overexpression of Cdc5, the yeast polo-like kinase, rescues the growth defect of kog1-105, and in turn, Cdc5 activity is attenuated in kog1-105 cells. The TORC1-Type2A phosphatase pathway mediates nucleocytoplasmic transport of Cdc5, which is prerequisite for its proper localization and function. The C-terminal polo-box domain of Cdc5 has an inhibitory role in nuclear translocation. Taken together, our results indicate a novel function of Tor in the regulation of cell cycle and proliferation.	[Nakashima, Akio; Maruki, Yoshiko; Kawanishi, Ippei; Kikkawa, Ushio; Ohsumi, Yoshinori; Yonezawa, Kazuyoshi] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo, Japan; [Nakashima, Akio; Yonezawa, Kazuyoshi; Kamada, Yoshiaki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Japan; [Imamura, Yuko; Kondo, Chika; Kawamata, Tomoko; Kamada, Yoshiaki] Natl Inst Basic Biol, Div Mol Cell Biol, Okazaki, Aichi, Japan; [Takata, Hideki; Matsuura, Akira] Natl Inst Longevity Sci, Dept Geriat Res, Obu Aichi, Japan; [Lee, Kyung S.] Natl Inst Hlth, Natl Canc Inst, Ctr Canc Res, Lab Metabolism, Bethesda, MD USA	Kobe University; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nakashima, A (corresponding author), Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo, Japan.	yoshikam@nibb.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Kawamata-HORIE, Tomoko/B-1699-2017; Matsuura, Akira/AAO-1572-2021; Matsuura, Akira/J-3864-2017	Ohsumi, Yoshinori/0000-0003-2384-2166; Kawamata-HORIE, Tomoko/0000-0002-3990-1194; Matsuura, Akira/0000-0002-2300-7227; Matsuura, Akira/0000-0002-2300-7227; Kamada, Yoshiaki/0000-0001-7395-660X				Asano S, 2005, EMBO J, V24, P2194, DOI 10.1038/sj.emboj.7600683; Barbe E., 1996, MEDITERR POLIT, V1, P25; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; BRENNER C, 1988, MOL CELL BIOL, V8, P3556, DOI 10.1128/MCB.8.8.3556; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burke D., 2000, METHODS YEAST GENETI, pxvii; Cheng L, 1998, MOL CELL BIOL, V18, P7360, DOI 10.1128/MCB.18.12.7360; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Cid VJ, 2002, MICROBIOL-SGM, V148, P2647, DOI 10.1099/00221287-148-9-2647; Darieva Z, 2006, NATURE, V444, P494, DOI 10.1038/nature05339; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harwood FC, 2008, J BIOL CHEM, V283, P2575, DOI 10.1074/jbc.M706173200; Honma Y, 2006, EMBO J, V25, P3832, DOI 10.1038/sj.emboj.7601262; Hosoi H, 1998, MOL PHARMACOL, V54, P815, DOI 10.1124/mol.54.5.815; Huang S, 2001, CANCER METAST REV, V20, P69, DOI 10.1023/A:1013167315885; IIDA H, 1984, J CELL BIOL, V98, P1185, DOI 10.1083/jcb.98.4.1185; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Jiang Y, 2006, MICROBIOL MOL BIOL R, V70, P440, DOI 10.1128/MMBR.00049-05; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Kawai M, 2001, CURR GENET, V39, P166; Kelm O, 2002, J BIOL CHEM, V277, P25247, DOI 10.1074/jbc.M202855200; Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863; Kubota H, 2003, J BIOL CHEM, V278, P20457, DOI 10.1074/jbc.C300133200; Lee KS, 2005, CELL CYCLE, V4, P1346, DOI 10.4161/cc.4.10.2049; Leslie DM, 2002, MOL CELL BIOL, V22, P2544, DOI 10.1128/MCB.22.8.2544-2555.2002; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; LIN FC, 1995, EMBO J, V14, P2745, DOI 10.1002/j.1460-2075.1995.tb07275.x; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; MITSUZAWA H, 1989, GENETICS, V123, P739; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Park JE, 2004, MOL CELL BIOL, V24, P9873, DOI 10.1128/MCB.24.22.9873-9886.2004; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Pyhtila B, 2003, J BIOL CHEM, V278, P42699, DOI 10.1074/jbc.M307135200; SACHS AB, 1989, CELL, V58, P857, DOI 10.1016/0092-8674(89)90938-0; Shitamukai A, 2004, J BIOL CHEM, V279, P3651, DOI 10.1074/jbc.M306098200; Song S, 2000, MOL CELL BIOL, V20, P286, DOI 10.1128/MCB.20.1.286-298.2000; Taniguchi E, 2002, J BIOL CHEM, V277, P48884, DOI 10.1074/jbc.M206307200; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Wang HM, 2003, MOL BIOL CELL, V14, P4342, DOI 10.1091/mbc.E03-02-0072; Weisman R, 2003, CURR TOP MICROBIOL, V279, P85; Weisman R, 1997, J BACTERIOL, V179, P6325, DOI 10.1128/jb.179.20.6325-6334.1997; Yang HF, 2000, MOL CELL BIOL, V20, P8143, DOI 10.1128/MCB.20.21.8143-8156.2000; Yoshida S, 2006, SCIENCE, V313, P108, DOI 10.1126/science.1126747; Zheng Y, 2005, MOL BIOL CELL, V16, P2119, DOI 10.1091/mbc.e04-09-0797	51	50	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2223	10.1371/journal.pone.0002223	http://dx.doi.org/10.1371/journal.pone.0002223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493323	gold, Green Submitted, Green Published			2022-12-27	WOS:000262258700031
J	Rencus-Lazar, S; Amir, Y; Wu, JT; Chien, CT; Chamovitz, DA; Segal, D				Rencus-Lazar, Sigal; Amir, Yaniv; Wu, Junetai; Chien, Cheng-Ting; Chamovitz, Daniel A.; Segal, Daniel			The Proto-Oncogene Int6 Is Essential for Neddylation of Cul1 and Cul3 in Drosophila	PLOS ONE			English	Article								Int6 is a proto-oncogene implicated in various types of cancer, but the mechanisms underlying its activity are not clear. Int6 encodes a subunit of the eukaryotic translation initiation factor 3, and interacts with two related complexes, the proteasome, whose activity is regulated by Int6 in S. pombe, and the COP9 signalosome. The COP9 signalosome regulates the activity of Cullin-Ring Ubiquitin Ligases via deneddylation of their cullin subunit. We report here the generation and analysis of two Drosophila mutants in Int6. The mutants are lethal demonstrating that Int6 is an essential gene. The mutant larvae accumulate high levels of non-neddylated Cul1, suggesting that Int6 is a positive regulator of cullin neddylation. Overexpression in Int6 in cell culture leads to accumulation of neddylated cullins, further supporting a positive role for Int6 in regulating neddylation. Thus Int6 and the COP9 signalosome play opposing roles in regulation of cullin neddylation.	[Rencus-Lazar, Sigal; Amir, Yaniv; Segal, Daniel] Tel Aviv Univ, Dept Mol Microbiol, IL-69978 Tel Aviv, Israel; [Rencus-Lazar, Sigal; Amir, Yaniv; Segal, Daniel] Tel Aviv Univ, Dept Biotechnol, Tel Aviv, Israel; [Wu, Junetai; Chien, Cheng-Ting] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Chamovitz, Daniel A.] Tel Aviv Univ, Dept Plant Sci, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Academia Sinica - Taiwan; Tel Aviv University	Rencus-Lazar, S (corresponding author), Tel Aviv Univ, Dept Mol Microbiol, IL-69978 Tel Aviv, Israel.	dannyc@ex.tau.ac.il; dsegal@post.tau.ac.il	Chien, Cheng-Ting/AAA-5200-2021; Chamovitz, Daniel/S-5021-2019	Chien, Cheng-Ting/0000-0002-7906-7173; Chamovitz, Daniel/0000-0002-2815-2909; Segal, Daniel/0000-0002-6777-505X; WU, JUNE-TAI/0000-0002-4023-7315; Rencus-Lazar, Sigal/0000-0001-5076-1949	Israel Academy of Sciences	Israel Academy of Sciences	This work was supported by a grant from the Israel Academy of Sciences (to DAC).	Akiyoshi Y, 2001, J BIOL CHEM, V276, P10056, DOI 10.1074/jbc.M010188200; Alves KH, 2002, FEBS LETT, V527, P15, DOI 10.1016/S0014-5793(02)03147-2; Asano K, 1997, J BIOL CHEM, V272, P23477, DOI 10.1074/jbc.272.38.23477; Bandyopadhyay A, 2000, MOL BIOL CELL, V11, P4005, DOI 10.1091/mbc.11.11.4005; Chou TB, 1996, GENETICS, V144, P1673; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Freilich S, 1999, CURR BIOL, V9, P1187, DOI 10.1016/S0960-9822(00)80023-8; Grumbling G, 2006, NUCLEIC ACIDS RES, V34, pD484, DOI 10.1093/nar/gkj068; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; He Q, 2005, GENE DEV, V19, P1518, DOI 10.1101/gad.1322205; Karniol B, 1999, PLANT CELL, V11, P839, DOI 10.1105/tpc.11.5.839; Mack DL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1742; MARCHETTI A, 1995, J VIROL, V69, P1932, DOI 10.1128/JVI.69.3.1932-1938.1995; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Mayeur GL, 2002, FEBS LETT, V514, P49, DOI 10.1016/S0014-5793(02)02307-4; Mistry H, 2004, MECH DEVELOP, V121, P1495, DOI 10.1016/j.mod.2004.07.007; Miyazaki S, 1999, GENE, V233, P241, DOI 10.1016/S0378-1119(99)00130-4; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Morris C, 2005, ONCOGENE, V24, P1203, DOI 10.1038/sj.onc.1208268; Oron E, 2002, DEVELOPMENT, V129, P4399; Oron E, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100150; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Rasmussen SB, 2001, ONCOGENE, V20, P5291, DOI 10.1038/sj.onc.1204624; REICHHART JM, 1998, DROS INFO SERV, V81, P201; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Szlanka T, 2003, J CELL SCI, V116, P1023, DOI 10.1242/jcs.00332; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; WHITFIELD WGF, 1990, EMBO J, V9, P2563, DOI 10.1002/j.1460-2075.1990.tb07437.x; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Yahalom A, 2001, J BIOL CHEM, V276, P334, DOI 10.1074/jbc.M006721200; YAHALOM A, 2007, PLANT J IN PRESS; Yen HCS, 2003, CELL, V112, P207, DOI 10.1016/S0092-8674(03)00043-6	33	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2239	10.1371/journal.pone.0002239	http://dx.doi.org/10.1371/journal.pone.0002239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493598	Green Submitted, Green Published, gold			2022-12-27	WOS:000262258700047
J	Xing, JH; Chen, J				Xing, Jianhua; Chen, Jing			The Goldbeter-Koshland Switch in the First-Order Region and Its Response to Dynamic Disorder	PLOS ONE			English	Article								In their classical work (Proc. Natl. Acad. Sci. USA, 1981, 78: 6840-6844), Goldbeter and Koshland mathematically analyzed a reversible covalent modification system which is highly sensitive to the concentration of effectors. Its signal-response curve appears sigmoidal, constituting a biochemical switch. However, the switch behavior only emerges in the 'zero-order region', i.e. when the signal molecule concentration is much lower than that of the substrate it modifies. In this work we showed that the switching behavior can also occur under comparable concentrations of signals and substrates, provided that the signal molecules catalyze the modification reaction in cooperation. We also studied the effect of dynamic disorders on the proposed biochemical switch, in which the enzymatic reaction rates, instead of constant, appear as stochastic functions of time. We showed that the system is robust to dynamic disorder at bulk concentration. But if the dynamic disorder is quasi-static, large fluctuations of the switch response behavior may be observed at low concentrations. Such fluctuation is relevant to many biological functions. It can be reduced by either increasing the conformation interconversion rate of the protein, or correlating the enzymatic reaction rates in the network.	[Xing, Jianhua] Lawrence Livermore Natl Lab, Chem Mat & Life Sci Directorate, Lawrence Livermore Natl Lab, Livermore, CA USA; [Xing, Jianhua] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA USA; [Chen, Jing] Univ Calif, Biophys Grad Program, Berkeley, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Virginia Polytechnic Institute & State University; University of California System; University of California Berkeley	Xing, JH (corresponding author), Lawrence Livermore Natl Lab, Chem Mat & Life Sci Directorate, Lawrence Livermore Natl Lab, Livermore, CA USA.	jxing@vt.edu	Xing, Jianhua/A-8101-2012; Chen, Jing/D-4845-2016	Xing, Jianhua/0000-0002-3700-8765; Chen, Jing/0000-0001-6321-0505	Lawrence Livermore National Laboratory; U.S. Department of Energy by the University of California, Lawrence Livermore National Laboratory [W-7405-Eng-48]	Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); U.S. Department of Energy by the University of California, Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	JX is partly supported by a Lawrence Livermore National Laboratory Directed Research and Development grant. This work was performed under the auspices of the U.S. Department of Energy by the University of California, Lawrence Livermore National Laboratory under Contract No. W-7405-Eng-48.	ASTUMIAN RD, 1994, PHYS REV LETT, V72, P1766, DOI 10.1103/PhysRevLett.72.1766; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Bustamante C, 2001, ACCOUNTS CHEM RES, V34, P412, DOI 10.1021/ar0001719; CHOCK PB, 1977, P NATL ACAD SCI USA, V74, P2766, DOI 10.1073/pnas.74.7.2766; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759; FEINBERG M, 1998, CHEM REACTION NETWOR; Frauenfelder H, 1999, REV MOD PHYS, V71, pS419, DOI 10.1103/RevModPhys.71.S419; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Karplus M, 2000, J PHYS CHEM B, V104, P11, DOI 10.1021/jp993555t; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kou SC, 2005, J PHYS CHEM B, V109, P19068, DOI 10.1021/jp051490q; Levine J, 2007, BIOPHYS J, V92, P4473, DOI 10.1529/biophysj.106.088856; Li GP, 2003, CELL BIOCHEM BIOPHYS, V39, P45, DOI 10.1385/CBB:39:1:45; MAGNASCO MO, 1993, PHYS REV LETT, V71, P1477, DOI 10.1103/PhysRevLett.71.1477; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Min W, 2005, ACCOUNTS CHEM RES, V38, P923, DOI 10.1021/ar040133f; Min W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198302; Min W, 2008, J PHYS CHEM B, V112, P454, DOI 10.1021/jp076533c; Morishita Y, 2006, BIOPHYS J, V91, P2072, DOI 10.1529/biophysj.105.070797; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; PRESS WH, 1997, NUMERICAL RECIPES C, pR26; PRESS WH, 1997, NUMERICAL RECIPES C, P994; Qian H, 2002, J PHYS CHEM B, V106, P2065, DOI 10.1021/jp013143w; Qian H, 2008, BIOCHEMISTRY-US, V47, P2211, DOI 10.1021/bi702125s; Qian H, 2007, ANNU REV PHYS CHEM, V58, P113, DOI 10.1146/annurev.physchem.58.032806.104550; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Reimann P, 2002, PHYS REP, V361, P57, DOI 10.1016/S0370-1573(01)00081-3; RICARD J, 1987, EUR J BIOCHEM, V166, P255, DOI 10.1111/j.1432-1033.1987.tb13510.x; Sabouri-Ghomi M, 2008, J THEOR BIOL, V250, P209, DOI 10.1016/j.jtbi.2007.09.001; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Samoilov MS, 2006, NAT BIOTECHNOL, V24, P1235, DOI 10.1038/nbt1253; Shibata T, 2005, P NATL ACAD SCI USA, V102, P331, DOI 10.1073/pnas.0403350102; STADTMAN ER, 1977, P NATL ACAD SCI USA, V74, P2761, DOI 10.1073/pnas.74.7.2761; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tanase-Nicola S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.068102; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wang J, 2006, PLOS COMPUT BIOL, V2, P1385, DOI 10.1371/journal.pcbi.0020147; Xie XS, 1999, J BIOL CHEM, V274, P15967, DOI 10.1074/jbc.274.23.15967; Xing JH, 2005, BIOPHYS J, V89, P1551, DOI 10.1529/biophysj.104.055178; Xing JH, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.168103; Xing JH, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061911; ZWANZIG R, 1992, J CHEM PHYS, V97, P3587, DOI 10.1063/1.462993; ZWANZIG R, 1990, ACCOUNTS CHEM RES, V23, P148, DOI 10.1021/ar00173a005	49	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2140	10.1371/journal.pone.0002140	http://dx.doi.org/10.1371/journal.pone.0002140			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478088	Green Published, gold, Green Submitted			2022-12-27	WOS:000262172800005
J	Hendrickson, DG; Hogan, DJ; Herschlag, D; Ferrell, JE; Brown, PO				Hendrickson, David G.; Hogan, Daniel J.; Herschlag, Daniel; Ferrell, James E.; Brown, Patrick O.			Systematic Identification of mRNAs Recruited to Argonaute 2 by Specific microRNAs and Corresponding Changes in Transcript Abundance	PLOS ONE			English	Article							ANIMAL DEVELOPMENT; GENE-REGULATION; LET-7 MICRORNA; BINDING-SITES; IN-VIVO; MIRNAS; EXPRESSION; PROTEINS; DISCOVERY; CLEAVAGE	microRNAs (miRNAs) are small non-coding RNAs that regulate mRNA stability and translation through the action of the RNAi-induced silencing complex (RISC). Our current understanding of miRNA function is inferred largely from studies of the effects of miRNAs on steady-state mRNA levels and from seed match conservation and context in putative targets. Here we have taken a more direct approach to these issues by comprehensively assessing the miRNAs and mRNAs that are physically associated with Argonaute 2 (Ago2), which is a core RISC component. We transfected HEK293T cells with epitope-tagged Ago2, immunopurified Ago2 together with any associated miRNAs and mRNAs, and quantitatively determined the levels of these RNAs by microarray analyses. We found that Ago2 immunopurified samples contained a representative repertoire of the cell's miRNAs and a select subset of the cell's total mRNAs. Transfection of the miRNAs miR-1 and miR-124 caused significant changes in the association of scores of mRNAs with Ago2. The mRNAs whose association with Ago2 increased upon miRNA expression were much more likely to contain specific miRNA seed matches and to have their overall mRNA levels decrease in response to the miRNA transfection than expected by chance. Hundreds of mRNAs were recruited to Ago2 by each miRNA via seed sequences in 3'-untranslated regions and coding sequences and a few mRNAs appear to be targeted via seed sequences in 5'-untranslated regions. Microarray analysis of Ago2 immunopurified samples provides a simple, direct method for experimentally identifying the targets of miRNAs and for elucidating roles of miRNAs in cellular regulation.	[Hendrickson, David G.; Ferrell, James E.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Hogan, Daniel J.; Herschlag, Daniel; Ferrell, James E.; Brown, Patrick O.] Stanford Univ, Sch Med, Dept Biochem, Palo Alto, CA USA; [Hogan, Daniel J.; Brown, Patrick O.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Palo Alto, CA USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Hendrickson, DG (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	herschla@stanford.edu; pbrown@pmgm2.stanford.edu			Howard Hughes Medical Institute; National Cancer Institute; National Institutes of Health [GM61276]; NSF [predoctoral fellowship]; AHA [predoctoral fellowship]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061276] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); AHA(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute, by a grant from the National Cancer Institute to POB, and by a grant from the National Institutes of Health (GM61276) to JEF. POB is an investigator of the Howard Hughes Medical Institute. DGH was partially supported by an NSF predoctoral fellowship and DJH was partially supported by NSF and AHA predoctoral fellowships.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; *AMB, 2008, MIRVANA MIRNA PROB S; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Chen PY, 2005, BIOL CHEM, V386, P1205, DOI 10.1515/BC.2005.139; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enright AJ, 2004, GENOME BIOL, V5; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Fare TL, 2003, ANAL CHEM, V75, P4672, DOI 10.1021/ac034241b; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Ferea TL, 1999, CURR OPIN GENET DEV, V9, P715, DOI 10.1016/S0959-437X(99)00033-7; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hall TMT, 2005, STRUCTURE, V13, P1403, DOI 10.1016/j.str.2005.08.005; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Myers JW, 2005, METH MOL B, V309, P93; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; *SFGF, 2008, HUM EX EV BAS OL HEE; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wu LG, 2005, MOL CELL BIOL, V25, P9198, DOI 10.1128/MCB.25.21.9198-9208.2005; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014	76	148	153	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2126	10.1371/journal.pone.0002126	http://dx.doi.org/10.1371/journal.pone.0002126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461144	Green Submitted, Green Published, gold			2022-12-27	WOS:000261642400047
J	Kim, JW; Roberts, CD; Berg, SA; Caicedo, A; Roper, SD; Chaudhari, N				Kim, Joung Woul; Roberts, Craig D.; Berg, Stephanie A.; Caicedo, Alejandro; Roper, Stephen D.; Chaudhari, Nirupa			Imaging Cyclic AMP Changes in Pancreatic Islets of Transgenic Reporter Mice	PLOS ONE			English	Article								Cyclic AMP (cAMP) and Ca(2+) are two ubiquitous second messengers in transduction pathways downstream of receptors for hormones, neurotransmitters and local signals. The availability of fluorescent Ca(2+) reporter dyes that are easily introduced into cells and tissues has facilitated analysis of the dynamics and spatial patterns for Ca(2+) signaling pathways. A similar dissection of the role of cAMP has lagged because indicator dyes do not exist. Genetically encoded reporters for cAMP are available but they must be introduced by transient transfection in cell culture, which limits their utility. We report here that we have produced a strain of transgenic mice in which an enhanced cAMP reporter is integrated in the genome and can be expressed in any targeted tissue and with tetracycline induction. We have expressed the cAMP reporter in beta-cells of pancreatic islets and conducted an analysis of intracellular cAMP levels in relation to glucose stimulation, Ca(2+) levels, and membrane depolarization. Pancreatic function in transgenic mice was normal. In induced transgenic islets, glucose evoked an increase in cAMP in beta-cells in a dose-dependent manner. The cAMP response is independent of (in fact, precedes) the Ca(2+) influx that results from glucose stimulation of islets. Glucose-evoked cAMP responses are synchronous in cells throughout the islet and occur in 2 phases suggestive of the time course of insulin secretion. Insofar as cAMP in islets is known to potentiate insulin secretion, the novel transgenic mouse model will for the first time permit detailed analyses of cAMP signals in beta-cells within islets, i.e. in their native physiological context. Reporter expression in other tissues (such as the heart) where cAMP plays a critical regulatory role, will permit novel biomedical approaches.	[Kim, Joung Woul; Berg, Stephanie A.; Roper, Stephen D.; Chaudhari, Nirupa] Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33152 USA; [Roberts, Craig D.; Caicedo, Alejandro; Roper, Stephen D.; Chaudhari, Nirupa] Univ Miami, Sch Med, Program Neurosci, Miami, FL USA; [Caicedo, Alejandro] Univ Miami, Sch Med, Diabetes Res Inst, Miami, FL USA	University of Miami; University of Miami; University of Miami	Kim, JW (corresponding author), Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33152 USA.	NChaudhari@med.miami.edu	Caicedo, Alejandro/F-1202-2010; Caicedo, Alejandro/AAC-8544-2020	Kim, Joung Woul/0000-0001-5456-8820; Roper, Stephen/0000-0001-6049-8320; Berg, Stephanie/0000-0001-6193-5350; Tilahin, Shimelis/0000-0001-8975-8026	National Institutes of Health [F31DC007591, R03DK075487, R01DC000374, R01DC006021, R01DC006308]; The Diabetes Research Institute, University of Miami; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK075487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006308, R01DC006021, F31DC007591, R01DC000374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Diabetes Research Institute, University of Miami; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the National Institutes of Health: F31DC007591 (C.D.R.), R03DK075487 (A.C.), R01DC000374 (S.D.R.), R01DC006021 and R01DC006308 (N.C). The Diabetes Research Institute, University of Miami, also provided support for this project. The study sponsors were not involved in study design, data analysis, or manuscript preparation.	ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; Beauvois MC, 2006, AM J PHYSIOL-CELL PH, V290, pC1503, DOI 10.1152/ajpcell.00400.2005; BERGGREN PO, 1994, BIOCHEM SOC T, V22, P12, DOI 10.1042/bst0220012; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; CHARLES MA, 1975, J BIOL CHEM, V250, P6134; Dachicourt N, 1996, AM J PHYSIOL-ENDOC M, V271, pE725, DOI 10.1152/ajpendo.1996.271.4.E725; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; El-Kholy W, 2007, MOL ENDOCRINOL, V21, P753, DOI 10.1210/me.2006-0258; Ghil S, 2006, P NATL ACAD SCI USA, V103, P19158, DOI 10.1073/pnas.0609392103; GILON P, 1993, J BIOL CHEM, V268, P22265; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gray PC, 1998, NEURON, V20, P1017, DOI 10.1016/S0896-6273(00)80482-1; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Hatakeyama H, 2007, J PHYSIOL-LONDON, V582, P1087, DOI 10.1113/jphysiol.2007.135228; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; Henquin JC, 2006, DIABETES, V55, P441, DOI 10.2337/diabetes.55.02.06.db05-1051; Hisatomi M, 1996, ENDOCRINOLOGY, V137, P4644, DOI 10.1210/en.137.11.4644; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; Kang GX, 2006, J PHYSIOL-LONDON, V573, P595, DOI 10.1113/jphysiol.2006.107391; Kim JW, 2006, CHEM SENSES, V31, P213, DOI 10.1093/chemse/bjj021; Klopotowska D, 2008, NEUROCHEM INT, V52, P221, DOI 10.1016/j.neuint.2007.05.014; LACY PE, 1975, LAB INVEST, V33, P570; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Neary CL, 2001, ONCOGENE, V20, P8019, DOI 10.1038/sj.onc.1204992; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Nunemaker CS, 2006, AM J PHYSIOL-ENDOC M, V290, pE523, DOI 10.1152/ajpendo.00392.2005; PIPELEERS D, 1982, P NATL ACAD SCI-BIOL, V79, P7322, DOI 10.1073/pnas.79.23.7322; Schonig Kai, 2003, Methods Mol Biol, V209, P69; VALDEOLMILLOS M, 1989, FEBS LETT, V259, P19, DOI 10.1016/0014-5793(89)81484-X; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345	35	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2127	10.1371/journal.pone.0002127	http://dx.doi.org/10.1371/journal.pone.0002127			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461145	Green Submitted, Green Published, gold			2022-12-27	WOS:000261642400048
J	Mori, I; Parizot, C; Dorgham, K; Demeret, S; Amoura, Z; Bolgert, F; Gorochov, G				Mori, Izumi; Parizot, Christophe; Dorgham, Karim; Demeret, Sophie; Amoura, Zahir; Bolgert, Francis; Gorochov, Guy			Prominent Plasmacytosis Following Intravenous Immunoglobulin Correlates with Clinical Improvement in Guillain-Barre Syndrome	PLOS ONE			English	Article								Background: High doses of pooled polyclonal IgG are commonly used to treat numerous autoimmune diseases. Their mode of action nevertheless remains only partially explained. At the same time, until now, no early biological marker has been able to predict their efficacy. Methodology/Principal Findings: In a first pilot retrospective analysis, we reviewed white blood cell counts and blood smears in consecutive patients with autoimmune disease (n = 202) and non-autoimmune disease (n = 104). Autoimmune patients received either intravenous immunoglobulin (IVIg, n = 103), plasma exchange (n = 78) or no specific treatment (n = 21). We then prospectively monitored consecutive autoimmune patients with IVIg injection (n = 67), or without any specific treatment (n = 10) using the same routine laboratory tests, as well as flow cytometry. Both retrospective and prospective analyses identified large plasma-cell mobilization exclusively in IVIg-treated autoimmune patients 7 days after initiation of treatment. The majority of IVIg-mobilized plasma cells were immature HLA-DR(high)/CD138(low)/CXCR4(low) plasma cells expressing intracellular immunoglobulin G which were neither IVIg- nor human IgG-specific. Importantly, we found a strong negative correlation between the absolute number of IVIg- mobilized plasma cells and time to improve neurological function in both retrospective and prospective studies of Guillain-Barre syndrome (GBS), (r = -0.52, p = 0.0031, n = 30, r = 20.47, p = 0.0028, n = 40, respectively). Conclusions/Significance: IVIg promotes immature plasma-cell mobilization in patients with GBS, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis and inflammatory myopathy. Prominent day 7 plasma-cell mobilization is a favourable prognostic marker in patients with GBS receiving IVIg treatment.	[Mori, Izumi; Dorgham, Karim; Gorochov, Guy] INSERM, U543, Paris, France; [Parizot, Christophe; Gorochov, Guy] Assistance Publ Hop Paris AP HP, Hop Pitie Salpetriere, Lab Immunol Cellulaire Tissulaire, Paris, France; [Demeret, Sophie; Bolgert, Francis] Assistance Publ Hop Paris AP HP, Hop Pitie Salpetriere, Dept Neurol, Paris, France; [Amoura, Zahir] Assistance Publ Hop Paris AP HP, Hop Pitie Salpetriere, Dept Internal Med, Paris, France; [Mori, Izumi; Amoura, Zahir; Gorochov, Guy] Univ Pierre Marie Curie Paris 6 UPMC, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Mori, I (corresponding author), INSERM, U543, Paris, France.	guy.gorochov@psl.aphp.fr	AMOURA, Zahir/P-5324-2017; Dorgham, karim/A-2241-2016; Gorochov, Guy/P-2911-2017; Amoura, Zahir/P-5325-2017	AMOURA, Zahir/0000-0003-0292-9043; Dorgham, karim/0000-0001-9539-3203; PARIZOT, Christophe/0000-0001-5723-4471; Gorochov, Guy/0000-0003-2097-9677	Assistance Publique - Hopitaux de Paris (CIB Pitie-Salpetriere); INSERM; Laboratoire francais du Fractionnement et des Biotechnologies (LFB-Biomedicaments)	Assistance Publique - Hopitaux de Paris (CIB Pitie-Salpetriere); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Laboratoire francais du Fractionnement et des Biotechnologies (LFB-Biomedicaments)	This study was financially supported by Assistance Publique - Hopitaux de Paris (CIB Pitie-Salpetriere) and by grants from INSERM and Laboratoire francais du Fractionnement et des Biotechnologies (LFB-Biomedicaments).	Ahmed AR, 2004, EXPERT OPIN INV DRUG, V13, P1019, DOI 10.1517/13543784.13.8.1019; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; BOHAN A, 1977, MEDICINE, V56, P255, DOI 10.1097/00005792-197707000-00001; Cepok S, 2005, BRAIN, V128, P1667, DOI 10.1093/brain/awh486; CORNBLATH DR, 1991, NEUROLOGY, V41, P617; de Grandmont MJ, 2003, BLOOD, V101, P3065, DOI 10.1182/blood-2002-06-1684; Gold R, 2007, NAT CLIN PRACT NEURO, V3, P36, DOI 10.1038/ncpneuro0376; Govoni V, 2001, CURR OPIN NEUROL, V14, P605, DOI 10.1097/00019052-200110000-00009; Gurcan HM, 2007, ANN PHARMACOTHER, V41, P812, DOI 10.1345/aph.1K037; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Hughes RAC, 1997, LANCET, V349, P225; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; HUGHES RAC, 1993, LANCET, V341, P586; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Medina F, 2002, BLOOD, V99, P2154, DOI 10.1182/blood.V99.6.2154; Muehlinghaus G, 2005, BLOOD, V105, P3965, DOI 10.1182/blood-2004-08-2992; Nakayama T, 2003, J IMMUNOL, V170, P1136, DOI 10.4049/jimmunol.170.3.1136; Nimmerjahn F, 2007, J EXP MED, V204, P11, DOI 10.1084/jem.20061788; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Ravetch JV, 2007, NAT IMMUNOL, V8, P337, DOI 10.1038/ni0407-337; Siragam V, 2006, NAT MED, V12, P688, DOI 10.1038/nm1416; STEVENS RH, 1979, J IMMUNOL, V122, P2498; THOMSON PD, 1977, J IMMUNOL, V118, P1480; van Koningsveld R, 2004, LANCET, V363, P192, DOI 10.1016/S0140-6736(03)15324-X; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8; VANDERMECHE EF, 1992, NEW ENGL J MED, V326, P1123; Vassilev T, 1999, EUR J IMMUNOL, V29, P2436, DOI 10.1002/(SICI)1521-4141(199908)29:08<2436::AID-IMMU2436>3.3.CO;2-0; Victor M, 2001, ADAMS VICTORS PRINCI, P1536; Visser LH, 1999, NEUROLOGY, V53, P598, DOI 10.1212/WNL.53.3.598; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101	35	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2109	10.1371/journal.pone.0002109	http://dx.doi.org/10.1371/journal.pone.0002109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461177	Green Published, gold			2022-12-27	WOS:000261642400031
J	Bogdanik, L; Framery, B; Froelich, A; Franco, B; Mornet, D; Bockaert, J; Sigrist, SJ; Grau, Y; Parmentier, ML				Bogdanik, Laurent; Framery, Berenice; Froelich, Andreas; Franco, Benedicte; Mornet, Dominique; Bockaert, Joel; Sigrist, Stephan J.; Grau, Yves; Parmentier, Marie-Laure			Muscle Dystroglycan Organizes the Postsynapse and Regulates Presynaptic Neurotransmitter Release at the Drosophila Neuromuscular Junction	PLOS ONE			English	Article								Background: The Dystrophin-glycoprotein complex (DGC) comprises dystrophin, dystroglycan, sarcoglycan, dystrobrevin and syntrophin subunits. In muscle fibers, it is thought to provide an essential mechanical link between the intracellular cytoskeleton and the extracellular matrix and to protect the sarcolemma during muscle contraction. Mutations affecting the DGC cause muscular dystrophies. Most members of the DGC are also concentrated at the neuromuscular junction (NMJ), where their deficiency is often associated with NMJ structural defects. Hence, synaptic dysfunction may also intervene in the pathology of dystrophic muscles. Dystroglycan is a central component of the DGC because it establishes a link between the extracellular matrix and Dystrophin. In this study, we focused on the synaptic role of Dystroglycan (Dg) in Drosophila. Methodology/Principal Findings: We show that Dg was concentrated postsynaptically at the glutamatergic NMJ, where, like in vertebrates, it controls the concentration of synaptic Laminin and Dystrophin homologues. We also found that synaptic Dg controlled the amount of postsynaptic 4.1 protein Coracle and alpha-Spectrin, as well as the relative subunit composition of glutamate receptors. In addition, both Dystrophin and Coracle were required for normal Dg concentration at the synapse. In electrophysiological recordings, loss of postsynaptic Dg did not affect postsynaptic response, but, surprisingly, led to a decrease in glutamate release from the presynaptic site. Conclusion/Significance: Altogether, our study illustrates a conservation of DGC composition and interactions between Drosophila and vertebrates at the synapse, highlights new proteins associated with this complex and suggests an unsuspected trans-synaptic function of Dg.	[Bogdanik, Laurent; Framery, Berenice; Franco, Benedicte; Bockaert, Joel; Grau, Yves; Parmentier, Marie-Laure] CNRS, Inst Genom Fonct, UMR 5203, Montpellier, France; [Bogdanik, Laurent; Framery, Berenice; Franco, Benedicte; Bockaert, Joel; Grau, Yves; Parmentier, Marie-Laure] INSERM, U661, Montpellier, France; [Bogdanik, Laurent; Framery, Berenice; Franco, Benedicte; Bockaert, Joel; Grau, Yves; Parmentier, Marie-Laure] Univ Montpellier, Montpellier, France; [Froelich, Andreas; Sigrist, Stephan J.] European Neurosci Inst Gottingen, Gottingen, Germany; [Sigrist, Stephan J.] Univ Wurzburg, Rudolf Virchow Zentrum, Inst Klin Neurobiol, Wurzburg, Germany; [Mornet, Dominique] Univ Montpellier 1, INSERM, ERI 25, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; University of Wurzburg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Bogdanik, L (corresponding author), CNRS, Inst Genom Fonct, UMR 5203, Montpellier, France.	Marie-Laure.Parmentier@igf.cnrs.fr	Parmentier, Marie-Laure/N-9915-2017	Parmentier, Marie-Laure/0000-0001-6133-3413; Bogdanik, Laurent/0000-0001-7015-6631	AFM [10808]; ANR [JC05_56382]	AFM(Association Francaise contre les Myopathies); ANR(French National Research Agency (ANR))	This work was supported by AFM fellowships to L. Bogdanik and B. Franco, the AFM grant 10808 MNM2 2004 Subvention Groupe C and the ANR grant JC05_56382 to M.-L. Parmentier. Sponsors and funders played no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; Balci B, 2005, NEUROMUSCULAR DISORD, V15, P271, DOI 10.1016/j.nmd.2005.01.013; Bartoli M, 2001, J BIOL CHEM, V276, P24911, DOI 10.1074/jbc.M103258200; Batchelor CL, 2007, CELL CYCLE, V6, P353, DOI 10.4161/cc.6.3.3819; Blake DJ, 2000, TRENDS NEUROSCI, V23, P92, DOI 10.1016/S0166-2236(99)01510-6; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen K, 2005, J NEUROSCI, V25, P6667, DOI 10.1523/JNEUROSCI.1527-05.2005; Collins CA, 2007, CURR OPIN NEUROBIOL, V17, P35, DOI 10.1016/j.conb.2007.01.001; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Deconinck AE, 1997, J CELL BIOL, V136, P883, DOI 10.1083/jcb.136.4.883; Delhommeau F, 2005, CR BIOL, V328, P43, DOI 10.1016/j.crvi.2004.11.003; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; DiAntonio A, 1999, J NEUROSCI, V19, P3023; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Featherstone DE, 2005, J NEUROSCI, V25, P3199, DOI 10.1523/JNEUROSCI.4201-04.2005; FEHON RG, 1994, DEVELOPMENT, V120, P545; FESSLER LI, 1987, J CELL BIOL, V105, P2383, DOI 10.1083/jcb.105.5.2383; Gimm JA, 2002, BIOCHEMISTRY-US, V41, P7275, DOI 10.1021/bi0256330; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Grady RM, 1997, J CELL BIOL, V136, P871, DOI 10.1083/jcb.136.4.871; Greener MJ, 2000, FEBS LETT, V482, P13, DOI 10.1016/S0014-5793(00)02018-4; HAINES N, 2007, MOL BIOL CELL; Hosaka Y, 2002, J CELL BIOL, V158, P1097, DOI 10.1083/jcb.200204076; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Kueh SLL, 2008, CLIN EXP PHARMACOL P, V35, P207, DOI 10.1111/j.1440-1681.2007.04816.x; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Lisi MT, 2007, BBA-MOL BASIS DIS, V1772, P159, DOI 10.1016/j.bbadis.2006.09.006; LYONS PR, 1991, J NEUROCYTOL, V20, P969, DOI 10.1007/BF01187915; Macleod GT, 2006, NEURON, V52, P569, DOI 10.1016/j.neuron.2006.11.006; Marchand S, 2001, EUR J NEUROSCI, V13, P221, DOI 10.1046/j.1460-9568.2001.01373.x; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Montanaro F, 2003, NEURON, V37, P193, DOI 10.1016/S0896-6273(03)00032-1; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; NAGEL A, 1990, MUSCLE NERVE, V13, P742, DOI 10.1002/mus.880130813; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; PASTERNAK C, 1995, J CELL BIOL, V128, P355, DOI 10.1083/jcb.128.3.355; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; PONS F, 1994, CIRCULATION, V90, P369, DOI 10.1161/01.CIR.90.1.369; Prokop A, 1998, DEV BIOL, V196, P58, DOI 10.1006/dbio.1997.8830; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Schmid A, 2006, J NEUROSCI, V26, P11267, DOI 10.1523/JNEUROSCI.2722-06.2006; Schneider M, 2006, DEVELOPMENT, V133, P3805, DOI 10.1242/dev.02549; Sciandra F, 2007, TRENDS BIOTECHNOL, V25, P262, DOI 10.1016/j.tibtech.2007.04.002; Shcherbata HR, 2007, EMBO J, V26, P481, DOI 10.1038/sj.emboj.7601503; Son YJ, 2000, J BIOL CHEM, V275, P451, DOI 10.1074/jbc.275.1.451; Spence HJ, 2004, HUM MOL GENET, V13, P1657, DOI 10.1093/hmg/ddh170; Taniguchi M, 2006, HUM MOL GENET, V15, P1279, DOI 10.1093/hmg/ddl045; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tremblay MR, 2006, J BIOL CHEM, V281, P13365, DOI 10.1074/jbc.M600912200; van der Plas MC, 2006, J NEUROSCI, V26, P333, DOI 10.1523/JNEUROSCI.4069-05.2006; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Winder SJ, 2001, TRENDS BIOCHEM SCI, V26, P118, DOI 10.1016/S0968-0004(00)01731-X	62	44	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2084	10.1371/journal.pone.0002084	http://dx.doi.org/10.1371/journal.pone.0002084			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446215	Green Published, Green Submitted, gold			2022-12-27	WOS:000261572300048
J	van den Heuvel, M; Mandl, R; Pol, HH				van den Heuvel, Martijn; Mandl, Rene; Pol, Hilleke Hulshoff			Normalized Cut Group Clustering of Resting-State fMRI Data	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; FUNCTIONAL CONNECTIVITY; DEFAULT-MODE; ALZHEIMERS-DISEASE; BOLD SIGNAL; BRAIN; NETWORKS; FLUCTUATIONS; CORTEX; SCHIZOPHRENIA	Background: Functional brain imaging studies have indicated that distinct anatomical brain regions can show coherent spontaneous neuronal activity during rest. Regions that show such correlated behavior are said to form resting-state networks (RSNs). RSNs have been investigated using seed-dependent functional connectivity maps and by using a number of model-free methods. However, examining RSNs across a group of subjects is still a complex task and often involves human input in selecting meaningful networks. Methodology/Principal Findings: We report on a voxel based model-free normalized cut graph clustering approach with whole brain coverage for group analysis of resting-state data, in which the number of RSNs is computed as an optimal clustering fit of the data. Inter-voxel correlations of time-series are grouped at the individual level and the consistency of the resulting networks across subjects is clustered at the group level, defining the group RSNs. We scanned a group of 26 subjects at rest with a fast BOLD sensitive fMRI scanning protocol on a 3 Tesla MR scanner. Conclusions/Significance: An optimal group clustering fit revealed 7 RSNs. The 7 RSNs included motor/visual, auditory and attention networks and the frequently reported default mode network. The found RSNs showed large overlap with recently reported resting-state results and support the idea of the formation of spatially distinct RSNs during rest in the human brain.	[van den Heuvel, Martijn; Mandl, Rene; Pol, Hilleke Hulshoff] Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	van den Heuvel, M (corresponding author), Univ Med Ctr Utrecht, Dept Psychiat, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	M.P.vandenheuvel@umcutrecht.nl	Hulshoff Pol, Hilleke Evertje/B-4795-2014; Mandl, René C.W./AAU-7037-2020; van den Heuvel, Martijn/AFR-3213-2022	Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; van den Heuvel, Martijn/0000-0003-1570-1195	Dutch Science Organization for Medical Research NWO ZON-MW VIDI Program [917.46.370]	Dutch Science Organization for Medical Research NWO ZON-MW VIDI Program	This work was supported in part by a grant from the Dutch Science Organization for Medical Research NWO ZON-MW VIDI Program (H.E.H.,917.46.370).	Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cordes D, 2002, MAGN RESON IMAGING, V20, P305, DOI 10.1016/S0730-725X(02)00503-9; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; DAMOISEAUX JS, 2007, CEREB CORTEX; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; DUDU RO, 2001, PATTERN RECOGNITION; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Golay X, 2000, MAGNET RESON MED, V43, P779, DOI 10.1002/1522-2594(200006)43:6<779::AID-MRM1>3.0.CO;2-4; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Kiviniemi V, 2003, NEUROIMAGE, V19, P253, DOI 10.1016/S1053-8119(03)00097-1; Knight RT, 2007, SCIENCE, V316, P1578, DOI 10.1126/science.1144677; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ramsey NF, 1998, NEUROIMAGE, V8, P240, DOI 10.1006/nimg.1998.0358; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Salvador R, 2007, NEUROIMAGE, V35, P83, DOI 10.1016/j.neuroimage.2006.12.001; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; SHI J, 2000, IEEE T PATTERN ANAL, V22, P17; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Thirion B, 2006, NEUROIMAGE, V29, P321, DOI 10.1016/j.neuroimage.2005.06.054; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; Williamson P, 2007, SCHIZOPHRENIA BULL, V33, P994, DOI 10.1093/schbul/sbm043; Ylipavalniemi J, 2008, NEUROIMAGE, V39, P169, DOI 10.1016/j.neuroimage.2007.08.027; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081	48	289	291	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2001	10.1371/journal.pone.0002001	http://dx.doi.org/10.1371/journal.pone.0002001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431486	Green Published, gold			2022-12-27	WOS:000261558700021
J	Whitaker, D; Levi, DM; Kennedy, GJ				Whitaker, David; Levi, Dennis M.; Kennedy, Graeme J.			Integration across Time Determines Path Deviation Discrimination for Moving Objects	PLOS ONE			English	Article							MOTION; DIRECTION; ORIENTATION; PERCEPTION; MECHANISMS; SCALE; SPEED	Background: Human vision is vital in determining our interaction with the outside world. In this study we characterize our ability to judge changes in the direction of motion of objects-a common task which can allow us either to intercept moving objects, or else avoid them if they pose a threat. Methodology/Principal Findings: Observers were presented with objects which moved across a computer monitor on a linear path until the midline, at which point they changed their direction of motion, and observers were required to judge the direction of change. In keeping with the variety of objects we encounter in the real world, we varied characteristics of the moving stimuli such as velocity, extent of motion path and the object size. Furthermore, we compared performance for moving objects with the ability of observers to detect a deviation in a line which formed the static trace of the motion path, since it has been suggested that a form of static memory trace may form the basis for these types of judgment. The static line judgments were well described by a 'scale invariant' model in which any two stimuli which possess the same two-dimensional geometry (length/width) result in the same level of performance. Performance for the moving objects was entirely different. Irrespective of the path length, object size or velocity of motion, path deviation thresholds depended simply upon the duration of the motion path in seconds. Conclusions/Significance: Human vision has long been known to integrate information across space in order to solve spatial tasks such as judgment of orientation or position. Here we demonstrate an intriguing mechanism which integrates direction information across time in order to optimize the judgment of path deviation for moving objects.	[Whitaker, David; Kennedy, Graeme J.] Univ Bradford, Dept Optometry, Bradford BD7 1DP, W Yorkshire, England; [Levi, Dennis M.] Univ Calif, Sch Optometry, Helen Wills Neurosci Inst, Berkeley, CA USA	University of Bradford; University of California System; University of California Berkeley	Whitaker, D (corresponding author), Univ Bradford, Dept Optometry, Bradford BD7 1DP, W Yorkshire, England.	D.J.Whitaker@bradford.ac.uk			Research Fellowship from The Leverhulme Trust; National Eye Institute, NIH [R01EY01728, RO1 EY04776]; NATIONAL EYE INSTITUTE [R01EY004776, R01EY001728] Funding Source: NIH RePORTER	Research Fellowship from The Leverhulme Trust; National Eye Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	DW was supported by a Research Fellowship from The Leverhulme Trust. DL was supported by Research grants R01EY01728 and RO1 EY04776 from the National Eye Institute, NIH.	ANDREWS DP, 1967, VISION RES, V7, P999, DOI 10.1016/0042-6989(67)90015-6; ANDREWS DP, 1973, VISION RES, V13, P599, DOI 10.1016/0042-6989(73)90026-6; BURR D, 1980, NATURE, V284, P164, DOI 10.1038/284164a0; Burr D, 2000, CURR BIOL, V10, pR440, DOI 10.1016/S0960-9822(00)00545-5; Burr DC, 2002, J NEUROSCI, V22, P8661; DZHAFAROV EN, 1993, PERCEPT PSYCHOPHYS, V54, P733, DOI 10.3758/BF03211798; Geisler WS, 1999, NATURE, V400, P65, DOI 10.1038/21886; Genova B, 2000, VISION RES, V40, P3049, DOI 10.1016/S0042-6989(00)00158-9; GRZYWACZ NM, 1995, VISION RES, V35, P3183, DOI 10.1016/0042-6989(95)00102-6; Heeley DW, 1998, EXP BRAIN RES, V120, P217, DOI 10.1007/s002210050395; Hohnsbein J, 1998, VISION RES, V38, P2569, DOI 10.1016/S0042-6989(98)00014-5; Joseph JS, 1997, VISION RES, V37, P3097, DOI 10.1016/S0042-6989(97)00068-0; KINGDOM FAA, 1995, VISION RES, V35, P79, DOI 10.1016/0042-6989(94)E0079-Z; Kingdom FAA, 1999, VISION RES, V39, P1477, DOI 10.1016/S0042-6989(98)00217-X; KLEIN SA, 1985, J OPT SOC AM A, V2, P1170, DOI 10.1364/JOSAA.2.001170; KOENDERINK JJ, 1988, J OPT SOC AM A, V5, P1136, DOI 10.1364/JOSAA.5.001136; KOOI FL, 1993, VISION RES, V33, P2347, DOI 10.1016/0042-6989(93)90112-A; Krekelberg B, 1999, VISION RES, V39, P2669, DOI 10.1016/S0042-6989(98)00287-9; SEKULER AB, 1990, PERCEPTION, V19, P181, DOI 10.1068/p190181; Skillen J, 2002, VISION RES, V42, P2447, DOI 10.1016/S0042-6989(02)00261-4; TOET A, 1987, VISION RES, V27, P441, DOI 10.1016/0042-6989(87)90092-7; Tong JL, 2007, PERCEPT PSYCHOPHYS, V69, P48, DOI 10.3758/BF03194452; Tripathy SP, 2004, J VISION, V4, P1020, DOI 10.1167/4.12.4; Tripathy SP, 2003, PERCEPTION, V32, P1403, DOI 10.1068/p5161; Vakrou C, 2007, J VISION, V7, DOI 10.1167/7.14.13; Watamaniuk SNJ, 2005, VISION RES, V45, P2993, DOI 10.1016/j.visres.2005.07.027; WATAMANIUK SNJ, 1995, VISION RES, V35, P65, DOI 10.1016/0042-6989(94)E0047-O; WESTHEIMER G, 1994, J NEUROPHYSIOL, V71, P33, DOI 10.1152/jn.1994.71.1.33; Whitaker D, 1998, VISION RES, V38, P3843, DOI 10.1016/S0042-6989(98)00104-7; Whitaker D, 2002, VISION RES, V42, P1137, DOI 10.1016/S0042-6989(02)00030-5; WILSON HR, 1986, VISION RES, V26, P453, DOI 10.1016/0042-6989(86)90188-4	31	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1930	10.1371/journal.pone.0001930	http://dx.doi.org/10.1371/journal.pone.0001930			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414653	Green Published, gold			2022-12-27	WOS:000260867300002
J	Li, ZJ; Zhang, SC; Liu, QH				Li, Zhaojie; Zhang, Shicui; Liu, Qinghui			Vitellogenin Functions as a Multivalent Pattern Recognition Receptor with an Opsonic Activity	PLOS ONE			English	Article								Background: Vitellogenin (Vg), a major reproductive protein, has been associated with infection-resistant response in fish. However, the underlying mechanisms by which Vg is involved in anti-infectious response are not understood. Methodology/Results: By both protein-microbe interaction analysis and enzyme-linked immunosorbent assay as well as phagocytosis test, we demonstrate for the first time that fish Vg acts as a pattern recognition molecule with multiple specificities that can recognize bacteria as well as fungus rather than self components from fish, and functions as an opsonin that can enhance macrophage phagocytosis. Conclusions: This study shows that fish Vg plays an integrative function in regulating immunity via its pleiotropic effects on both recognizing pathogen-associated molecular patterns and promoting macrophage phagocytosis. It also supports the notion that factors normally involved in control of female reproduction are associated with immunity in organisms that rely on Vg for oocyte development.	[Li, Zhaojie; Zhang, Shicui] Ocean Univ China, Dept Marine Biol, Qingdao, Peoples R China; [Liu, Qinghui] Chinese Acad Fisheries, Yellow Sea Fishery Res Inst, Qingdao, Peoples R China	Ocean University of China; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS	Li, ZJ (corresponding author), Ocean Univ China, Dept Marine Biol, Qingdao, Peoples R China.	sczhang@ouc.edu.cn			Ministry of Science and Technology (MOST) [2006CB101805, 30730072]; Natural Science Foundation of China (NSFC)	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants (2006CB101805; 30730072) of Ministry of Science and Technology (MOST) and Natural Science Foundation of China (NSFC).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ALONSODEVELASCO E, 1994, VACCINE, V12, P1419, DOI 10.1016/0264-410X(94)90151-1; Amdam GV, 2006, BEHAV BRAIN RES, V169, P201, DOI 10.1016/j.bbr.2006.01.006; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; ARUKWE A, 2003, COMP HEPATOL, V2, pE4; Avarre JC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-3; Brown GD, 2003, IMMUNITY, V19, P311, DOI 10.1016/S1074-7613(03)00233-4; BYRNE BM, 1989, PROG BIOPHYS MOL BIO, V53, P33, DOI 10.1016/0079-6107(89)90005-9; Chen X, 2001, J BIOL CHEM, V276, P34617, DOI 10.1074/jbc.M103995200; CUTTING JA, 1973, ANAL BIOCHEM, V54, P386, DOI 10.1016/0003-2697(73)90367-9; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; de Vlaming V L, 1977, Life Sci, V20, P1945, DOI 10.1016/0024-3205(77)90172-2; DELLACIOPPA G, 1987, INSECT BIOCHEM, V17, P401, DOI 10.1016/0020-1790(87)90002-3; DHADIALLA TS, 1990, J BIOL CHEM, V265, P9924; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P1092; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; Hiramatsu N, 2005, BIOCH MOLEC, V6, P431; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang HB, 2004, INSECT BIOCHEM MOLEC, V34, P89, DOI 10.1016/j.ibmb.2003.09.006; JOMORI T, 1992, FEBS LETT, V296, P283, DOI 10.1016/0014-5793(92)80305-Z; Kurata S, 2006, IMMUNOBIOLOGY, V211, P237, DOI 10.1016/j.imbio.2005.10.016; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Nakamura A, 1999, BIOCHEM BIOPH RES CO, V264, P580, DOI 10.1006/bbrc.1999.1549; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; RABINOVITCH M, 1995, TRENDS CELL BIOL, V5, P85, DOI 10.1016/S0962-8924(00)88955-2; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Roos A, 2004, EUR J IMMUNOL, V34, P921, DOI 10.1002/eji.200424904; Roque ACA, 2004, J MOL RECOGNIT, V17, P262, DOI 10.1002/jmr.661; Royet J, 2004, MOL IMMUNOL, V41, P1063, DOI 10.1016/j.molimm.2004.06.009; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Shi XD, 2006, FISH SHELLFISH IMMUN, V20, P769, DOI 10.1016/j.fsi.2005.09.005; SHYU AB, 1986, P NATL ACAD SCI USA, V83, P3865, DOI 10.1073/pnas.83.11.3865; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Sun XT, 2001, COMP BIOCHEM PHYS B, V129, P121, DOI 10.1016/S1096-4959(01)00310-4; Tyler CR, 1996, REV FISH BIOL FISHER, V6, P287, DOI 10.1007/BF00122584; Yu XQ, 2003, DEV COMP IMMUNOL, V27, P189, DOI 10.1016/S0145-305X(02)00099-X; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; ZAPATA A, 1979, DEV COMP IMMUNOL, V3, P55, DOI 10.1016/S0145-305X(79)80006-3; ZAPATA A, 1981, DEV COMP IMMUNOL, V5, P685, DOI 10.1016/S0145-305X(81)80043-2; Zhang SC, 2005, FISH SHELLFISH IMMUN, V19, P93, DOI 10.1016/j.fsi.2004.10.008; Zou YM, 2006, BIOCHEM BIOPH RES CO, V351, P625, DOI 10.1016/j.bbrc.2006.10.091	48	124	133	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1940	10.1371/journal.pone.0001940	http://dx.doi.org/10.1371/journal.pone.0001940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398466	Green Submitted, Green Published, gold			2022-12-27	WOS:000260795500017
J	Matsuzawa, D; Obata, T; Shirayama, Y; Nonaka, H; Kanazawa, Y; Yoshitome, E; Takanashi, J; Matsuda, T; Shimizu, E; Ikehira, H; Iyo, M; Hashimoto, K				Matsuzawa, Daisuke; Obata, Takayuki; Shirayama, Yukihiko; Nonaka, Hiroi; Kanazawa, Yoko; Yoshitome, Eiji; Takanashi, Junichi; Matsuda, Tsuyoshi; Shimizu, Eiji; Ikehira, Hiroo; Iyo, Masaomi; Hashimoto, Kenji			Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T H-1-MRS Study	PLOS ONE			English	Article								Background: Glutathione (GSH), a major intracellular antioxidant, plays a role in NMDA receptor-mediated neurotransmission, which is involved in the pathophysiology of schizophrenia. In the present study, we aimed to investigate whether GSH levels are altered in the posterior medial frontal cortex of schizophrenic patients. Furthermore, we examined correlations between GSH levels and clinical variables in patients. Methods and Findings: Twenty schizophrenia patients and 16 age-and gender-matched normal controls were enrolled to examine the levels of GSH in the posterior medial frontal cortex by using 3T SIGNA EXCITE H-1-MRS with the spectral editing technique, MEGA-PRESS. Clinical variables of patients were assessed by the Global Assessment of Functioning (GAF), Scale for the Assessment of Negative Symptoms (SANS), Brief Psychiatric Rating Scale (BPRS), Drug-Induced Extra-Pyramidal Symptoms Scale (DIEPSS), and five cognitive performance tests (Word Fluency Test, Stroop Test, Trail Making Test, Wisconsin Card Sorting Test and Digit Span Distractibility Test). Levels of GSH in the posterior medial frontal cortex of schizophrenic patients were not different from those of normal controls. However, we found a significant negative correlation between GSH levels and the severity of negative symptoms (SANS total score and negative symptom subscore on BPRS) in patients. There were no correlations between brain GSH levels and scores on any cognitive performance test except Trail Making Test part A. Conclusion: These results suggest that GSH levels in the posterior medial frontal cortex may be related to negative symptoms in schizophrenic patients. Therefore, agents that increase GSH levels in the brain could be potential therapeutic drugs for negative symptoms in schizophrenia.	[Hashimoto, Kenji] Chiba Univ, Ctr Forensic Mental Hlth, Div Clin Neurosci, Chiba, Japan; [Matsuzawa, Daisuke; Shirayama, Yukihiko; Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan; [Matsuzawa, Daisuke; Obata, Takayuki; Nonaka, Hiroi; Kanazawa, Yoko; Yoshitome, Eiji; Ikehira, Hiroo] Natl Inst Radiol Sci, Mol Imaging Ctr, Dept Biophys, Chiba, Japan; [Matsuzawa, Daisuke; Shimizu, Eiji] Chiba Univ, Grad Sch Med, Dept Integrative Neurophysiol, Chiba, Japan; [Takanashi, Junichi] Kameda Med Ctr, Div Pediat, Chiba, Japan; [Matsuda, Tsuyoshi] GE Yokogawa Med Syst Ltd, Imaging Appl Tech Ctr, Tokyo, Japan	Chiba University; Chiba University; National Institutes for Quantum Science & Technology; Chiba University; General Electric	Hashimoto, K (corresponding author), Chiba Univ, Ctr Forensic Mental Hlth, Div Clin Neurosci, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Shimizu, Eiji/K-4637-2017; Obata, Takayuki/AAR-9820-2020; Hashimoto, Kenji/I-5800-2015	Shimizu, Eiji/0000-0002-6741-9338; Obata, Takayuki/0000-0001-7678-5033; Matsuzawa, Daisuke/0000-0003-0408-2608; Takanashi, Jun-ichi/0000-0002-1147-1938; Hashimoto, Kenji/0000-0002-8892-0439	Minister of Education, Culture, Sports, Science, and Technology of Japan	Minister of Education, Culture, Sports, Science, and Technology of Japan	This study was supported in part by grants from the Minister of Education, Culture, Sports, Science, and Technology of Japan (to K.H.).	ABDALLA DSP, 1986, CLIN CHEM, V32, P805; Akyol O, 2002, PROG NEURO-PSYCHOPH, V26, P995, DOI 10.1016/S0278-5846(02)00220-8; American Psychiatric Association, DIAGN STAT MAN MENT; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Ben Othmen L, 2008, PROG NEURO-PSYCHOPH, V32, P155, DOI 10.1016/j.pnpbp.2007.08.003; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; Do KQ, 2000, EUR J NEUROSCI, V12, P3721, DOI 10.1046/j.1460-9568.2000.00229.x; Fukami G, 2004, BRAIN RES, V1016, P90, DOI 10.1016/j.brainres.2004.04.072; Goff DC, 2001, AM J PSYCHIAT, V158, P1367, DOI 10.1176/appi.ajp.158.9.1367; Gysin R, 2007, P NATL ACAD SCI USA, V104, P16621, DOI 10.1073/pnas.0706778104; Harada S, 2001, BIOCHEM BIOPH RES CO, V281, P267, DOI 10.1006/bbrc.2001.4347; Hashimoto K, 2003, ARCH GEN PSYCHIAT, V60, P572, DOI 10.1001/archpsyc.60.6.572; Hashimoto K, 2004, NEUROPSYCHOPHARMACOL, V29, P2018, DOI 10.1038/sj.npp.1300512; HASHIMOTO K, 2003, CURR MED CHEMCNS AGE, V60, P572; Hashimoto T, 2005, AM J MED GENET B, V135B, P5, DOI 10.1002/ajmg.b.30164; HASHIMOTO T, 2008, AM J MED B IN PRESS; Jacobsen JPR, 2005, NEUROSCIENCE, V132, P1055, DOI 10.1016/j.neuroscience.2005.01.059; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; KOHR G, 1994, NEURON, V12, P1031, DOI 10.1016/0896-6273(94)90311-5; LAVOIE S, 2007, NEUROPSYCHO IN PRESS; Mahadik SP, 1996, SCHIZOPHR RES, V19, P1, DOI 10.1016/0920-9964(95)00049-6; Matsuzawa D, 2005, NEUROPSYCHOBIOLOGY, V52, P68, DOI 10.1159/000086607; Pae CU, 2004, PSYCHIAT GENET, V14, P147, DOI 10.1097/00041444-200409000-00005; REDDY R, 1991, BIOL PSYCHIAT, V30, P409, DOI 10.1016/0006-3223(91)90298-Z; Reitan RM, 1985, HALSTEAD REITAN NEUR; Satoh T, 2006, NEUROSCI RES, V55, P34, DOI 10.1016/j.neures.2006.01.002; Shad MU, 2006, SCHIZOPHR RES, V86, P54, DOI 10.1016/j.schres.2006.06.006; SUCHER NJ, 1991, J NEUROSCI RES, V30, P582, DOI 10.1002/jnr.490300316; Sumiyoshi C, 2005, SCHIZOPHR RES, V74, P91, DOI 10.1016/j.schres.2004.05.011; Tamminga CA, 1998, CRIT REV NEUROBIOL, V12, P21, DOI 10.1615/CritRevNeurobiol.v12.i1-2.20; Terpstra M, 2005, MAGN RESON MATER PHY, V18, P276, DOI 10.1007/s10334-005-0012-0; Terpstra M, 2003, MAGN RESON MED, V50, P19, DOI 10.1002/mrm.10499; Tosic M, 2006, AM J HUM GENET, V79, P586, DOI 10.1086/507566; Varga V, 1997, NEUROCHEM RES, V22, P1165, DOI 10.1023/A:1027377605054; Wilder-Willis KE, 2001, BIPOLAR DISORD, V3, P58, DOI 10.1034/j.1399-5618.2001.030202.x; Yao JK, 2006, DIS MARKERS, V22, P83, DOI 10.1155/2006/248387; Yao JK, 1999, BIOL PSYCHIAT, V45, P1512, DOI 10.1016/S0006-3223(98)00184-X; Yao JK, 2001, CNS DRUGS, V15, P287, DOI 10.2165/00023210-200115040-00004; Zhang XY, 2007, J CLIN PSYCHIAT, V68, P754, DOI 10.4088/JCP.v68n0513	40	150	154	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1944	10.1371/journal.pone.0001944	http://dx.doi.org/10.1371/journal.pone.0001944			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398470	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795500021
J	Madeira, L; Galante, PAF; Budu, A; Azevedo, MF; Malnic, B; Garcia, CRS				Madeira, Luciana; Galante, Pedro A. F.; Budu, Alexandre; Azevedo, Mauro F.; Malnic, Bettina; Garcia, Celia R. S.			Genome-Wide Detection of Serpentine Receptor-Like Proteins in Malaria Parasites	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; TOPOLOGY PREDICTION; COUPLED RECEPTORS; XANTHURENIC ACID; CALCIUM; PROTEOME; IDENTIFICATION; TRANSCRIPTOME; DISCOVERY; MELATONIN	Serpentine receptors comprise a large family of membrane receptors distributed over diverse organisms, such as bacteria, fungi, plants and all metazoans. However, the presence of serpentine receptors in protozoan parasites is largely unknown so far. In the present study we performed a genome-wide search for proteins containing seven transmembrane domains (7TM) in the human malaria parasite Plasmodium falciparum and identified four serpentine receptor-like proteins. These proteins, denoted PfSR1, PfSR10, PfSR12 and PfSR25, show membrane topologies that resemble those exhibited by members belonging to different families of serpentine receptors. Expression of the pfsrs genes was detected by Real Time PCR in P. falciparum intraerythrocytic stages, indicating that they potentially code for functional proteins. We also found corresponding homologues for the PfSRs in five other Plasmodium species, two primate and three rodent parasites. PfSR10 and 25 are the most conserved receptors among the different species, while PfSR1 and 12 are more divergent. Interestingly, we found that PfSR10 and PfSR12 possess similarity to orphan serpentine receptors of other organisms. The identification of potential parasite membrane receptors raises a new perspective for essential aspects of malaria parasite host cell infection.	[Budu, Alexandre; Azevedo, Mauro F.; Garcia, Celia R. S.] Univ Sao Paulo, Inst Bioci, Dept Fisiol, BR-05508 Sao Paulo, Brazil; [Madeira, Luciana] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, Sao Paulo, Brazil; [Galante, Pedro A. F.; Malnic, Bettina] Univ Sao Paulo, Inst Quimi, Dept Bioquim, Sao Paulo, Brazil; [Galante, Pedro A. F.] Ludwig Inst Canc Res, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Ludwig Institute for Cancer Research	Garcia, CRS (corresponding author), Univ Sao Paulo, Inst Bioci, Dept Fisiol, BR-05508 Sao Paulo, Brazil.	cgarcia@usp.br	4, INCT/H-4499-2013; Inbeqmedi, Inct/I-1929-2013; Galante, Pedro/U-8594-2019; Garcia, Celia R. S./A-4093-2011; Budu, Alexandre/F-6498-2013; Malnic, Bettina/A-4905-2008; Galante, Pedro A. F./C-6564-2012; Azevedo, Mauro/H-6180-2012	Galante, Pedro/0000-0002-4820-4155; Garcia, Celia R. S./0000-0003-2825-1701; Budu, Alexandre/0000-0002-7110-9754; Malnic, Bettina/0000-0002-5877-4784; Galante, Pedro A. F./0000-0002-4820-4155; Azevedo, Mauro/0000-0002-5233-2037	FAPESP [fellowship]; CNPq/Ministerio da Saude	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq/Ministerio da Saude(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	FAPESP; CNPq/Ministerio da Saude (Neglected Tropical Diseases Grant) to CRSG LM, PAFG, AB and MF received fellowship from FAPESP.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Bannister L, 2003, TRENDS PARASITOL, V19, P209, DOI 10.1016/S1471-4922(03)00086-2; Beraldo FH, 2005, J CELL BIOL, V170, P551, DOI 10.1083/jcb.200505117; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bozdech Z, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-17; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brzostowski JA, 2001, TRENDS BIOCHEM SCI, V26, P291, DOI 10.1016/S0968-0004(01)01804-7; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Daily JP, 2005, J INFECT DIS, V191, P1196, DOI 10.1086/428289; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; Farias SL, 2005, MOL BIOCHEM PARASIT, V141, P71, DOI 10.1016/j.molbiopara.2005.01.015; FINN RD, 2007, NUCL ACIDS RES; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Garcia GE, 1998, J BIOL CHEM, V273, P12003, DOI 10.1074/jbc.273.20.12003; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; Goodstadt L, 2001, BIOINFORMATICS, V17, P845, DOI 10.1093/bioinformatics/17.9.845; Gunasekera AM, 2004, MOL BIOCHEM PARASIT, V136, P35, DOI 10.1016/j.molbiopara.2004.02.007; Hall RA, 1999, J CELL BIOL, V145, P927, DOI 10.1083/jcb.145.5.927; Hotta CT, 2000, NAT CELL BIOL, V2, P466, DOI 10.1038/35017112; Inoue Y, 2004, COMPUT BIOL CHEM, V28, P39, DOI 10.1016/j.compbiolchem.2003.11.003; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; McConkey GA, 2004, TRENDS PARASITOL, V20, P60, DOI 10.1016/j.pt.2003.11.001; Melen K, 2003, J MOL BIOL, V327, P735, DOI 10.1016/S0022-2836(03)00182-7; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; Otaki JM, 2001, J THEOR BIOL, V211, P77, DOI 10.1006/jtbi.2001.2272; Persson B, 1996, PROTEIN SCI, V5, P363; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Quevillon E, 2003, GENE, V306, P13, DOI 10.1016/S0378-1119(03)00381-0; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; WALLIN E, 1995, PROTEIN ENG, V8, P693, DOI 10.1093/protein/8.7.693; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Yao H, 2005, PLANT MOL BIOL, V57, P445, DOI 10.1007/s11103-005-0271-1	48	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1889	10.1371/journal.pone.0001889	http://dx.doi.org/10.1371/journal.pone.0001889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365025	gold, Green Published, Green Submitted			2022-12-27	WOS:000260762400031
J	Kim, W; Yoo, TK; Shin, DJ; Rho, HW; Jin, HJ; Kim, ET; Bae, YS				Kim, Wook; Yoo, Tag-Keun; Shin, Dong-Jik; Rho, Hyun-Wook; Jin, Han-Jun; Kim, Eun-Tak; Bae, Yoon-Sun			Mitochondrial DNA Haplogroup Analysis Reveals no Association between the Common Genetic Lineages and Prostate Cancer in the Korean Population	PLOS ONE			English	Article								Mitochondrial DNA (mtDNA) variation has recently been suggested to have an association with various cancers, including prostate cancer risk, in human populations. Since mtDNA is haploid and lacks recombination, specific mutations in the mtDNA genome associated with human diseases arise and remain in particular genetic backgrounds referred to as haplogroups. To assess the possible contribution of mtDNA haplogroup-specific mutations to the occurrence of prostate cancer, we have therefore performed a population-based study of a prostate cancer cases and corresponding controls from the Korean population. No statistically significant difference in the distribution of mtDNA haplogroup frequencies was observed between the case and control groups of Koreans. Thus, our data imply that specific mtDNA mutations/lineages did not appear to have a significant effect on a predisposition to prostate cancer in the Korean population, although larger sample sizes are necessary to validate our results.	[Kim, Wook; Rho, Hyun-Wook; Jin, Han-Jun] Dankook Univ, Dept Biol Sci, Cheonan, South Korea; [Yoo, Tag-Keun] Eulji Univ, Sch Med, Eulji Med Ctr, Dept Urol, Seoul, South Korea; [Shin, Dong-Jik; Bae, Yoon-Sun] Yonsei Univ, Coll Med, Cardiovascular Genome Ctr, Seoul, South Korea; [Kim, Eun-Tak] Eulji Univ, Sch Med, Dept Urol, Seoul, South Korea	Dankook University; Eulji University; Yonsei University; Yonsei University Health System; Eulji University	Kim, W (corresponding author), Dankook Univ, Dept Biol Sci, Cheonan, South Korea.	wookkim@dankook.ac.kr	Yoo, Tag/M-8852-2019		Korean Science and Engineering Foundation;  [KOSEF R01-2005-000-10534-0]	Korean Science and Engineering Foundation(Korea Science and Engineering Foundation); 	WK is supported by grants from the Korean Science and Engineering Foundation (KOSEF R01-2005-000-10534-0), Republic of Korea.	[Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Booker LM, 2006, J UROLOGY, V175, P468, DOI 10.1016/S0022-5347(05)00163-1; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Brothman AR, 1999, PROSTATE, V38, P303; Dagnelie PC, 2004, BJU INT, V93, P1139, DOI 10.1111/j.1464-410X.2004.04795.x; Derenko M. V., 2004, Genetika, V40, P1562; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Hsing AW, 2000, CANCER EPIDEM BIOMAR, V9, P1335; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jessie BC, 2001, EXP GERONTOL, V37, P169, DOI 10.1016/S0531-5565(01)00153-X; Jin HJ, 2003, HUM GENET, V114, P27, DOI 10.1007/s00439-003-1019-0; Kim W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000172; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Paracchini S, 2003, J MED GENET, V40, P815, DOI 10.1136/jmg.40.11.815; Parr RL, 2006, J MOL DIAGN, V8, P312, DOI 10.2353/jmoldx.2006.050112; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Sambrook J., 2002, MOL CLONING LAB MANU; Sim HG, 2005, EUR J CANCER, V41, P834, DOI 10.1016/j.ejca.2004.12.033; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Torroni A, 1996, GENETICS, V144, P1835; Umetsu K, 2005, ELECTROPHORESIS, V26, P91, DOI 10.1002/elps.200406129; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751	26	24	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2211	10.1371/journal.pone.0002211	http://dx.doi.org/10.1371/journal.pone.0002211			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493608	Green Published, gold, Green Submitted			2022-12-27	WOS:000262258700020
J	Crasta, OR; Folkerts, O; Fei, ZJ; Mane, SP; Evans, C; Martino-Catt, S; Bricker, B; Yu, GX; Du, L; Sobral, BW				Crasta, Oswald R.; Folkerts, Otto; Fei, Zhangjun; Mane, Shrinivasrao P.; Evans, Clive; Martino-Catt, Susan; Bricker, Betsy; Yu, GongXin; Du, Lei; Sobral, Bruno W.			Genome Sequence of Brucella abortus Vaccine Strain S19 Compared to Virulent Strains Yields Candidate Virulence Genes	PLOS ONE			English	Article							WILD-TYPE VIRULENCE; ACYL-COA CARBOXYLASE; ERYTHRITOL CATABOLISM; ACID BIOSYNTHESIS; IDENTIFICATION; MACROPHAGES; RESISTANCE; EFFICACY; MUTANTS; PRODUCT	The Brucella abortus strain S19, a spontaneously attenuated strain, has been used as a vaccine strain in vaccination of cattle against brucellosis for six decades. Despite many studies, the physiological and molecular mechanisms causing the attenuation are not known. We have applied pyrosequencing technology together with conventional sequencing to rapidly and comprehensively determine the complete genome sequence of the attenuated Brucella abortus vaccine strain S19. The main goal of this study is to identify candidate virulence genes by systematic comparative analysis of the attenuated strain with the published genome sequences of two virulent and closely related strains of B. abortus, 9-941 and 2308. The two S19 chromosomes are 2,122,487 and 1,161,449 bp in length. A total of 3062 genes were identified and annotated. Pairwise and reciprocal genome comparisons resulted in a total of 263 genes that were non-identical between the S19 genome and any of the two virulent strains. Amongst these, 45 genes were consistently different between the attenuated strain and the two virulent strains but were identical amongst the virulent strains, which included only two of the 236 genes that have been implicated as virulence factors in literature. The functional analyses of the differences have revealed a total of 24 genes that may be associated with the loss of virulence in S19. Of particular relevance are four genes with more than 60bp consistent difference in S19 compared to both the virulent strains, which, in the virulent strains, encode an outer membrane protein and three proteins involved in erythritol uptake or metabolism.	[Crasta, Oswald R.; Folkerts, Otto; Fei, Zhangjun; Mane, Shrinivasrao P.; Evans, Clive; Martino-Catt, Susan; Yu, GongXin; Sobral, Bruno W.] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Bricker, Betsy] Natl Anim Dis Ctr, Ames, IA USA; [Du, Lei] Life Sciences 454, Branford, CT USA	Virginia Polytechnic Institute & State University; United States Department of Agriculture (USDA)	Crasta, OR (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	ocrasta@vbi.vt.edu	Sobral, Bruno/GVU-7637-2022; Fei, Zhangjun/H-5152-2012	Sobral, Bruno/0000-0003-3908-577X; Mane, Shrinivasrao/0000-0003-4123-624X; Fei, Zhangjun/0000-0001-9684-1450	Virginia Bioinformatics Institute; National Science Foundation [OCI-0537461]; NIAID [HHSN26620040035C]	Virginia Bioinformatics Institute; National Science Foundation(National Science Foundation (NSF)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was funded by the Virginia Bioinformatics Institute to Bruno Sobral. The data analysis was also funded through the National Science Foundation (NSF grant # OCI-0537461 to O. Crasta). Preparation and submission of genomic sequences to GenBank and annotation were funded by NIAID Contract HHSN26620040035C to Bruno Sobral and are available at PATRIC's site (http://patric.vbi.vt.edu/).	Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Bandara AB, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-57; Bellaire BH, 2003, INFECT IMMUN, V71, P1794, DOI 10.1128/IAI.71.4.1794-1803.2003; Celli J, 2004, CURR OPIN MICROBIOL, V7, P93, DOI 10.1016/j.mib.2003.11.001; Chain PSG, 2005, INFECT IMMUN, V73, P8353, DOI 10.1128/IAI.73.12.8353-8361.2005; *COMP PROGRAMLOWE, 1997, TRNASCAN SE; Corbel M. J., 1989, Brucellosis: clinical and laboratory aspects., P25; Cutler SJ, 2005, J APPL MICROBIOL, V98, P1270, DOI 10.1111/j.1365-2672.2005.02622.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delrue RM, 2004, FEMS MICROBIOL LETT, V231, P1, DOI 10.1016/S0378-1097(03)00963-7; DelVecchio VG, 2002, P NATL ACAD SCI USA, V99, P443, DOI 10.1073/pnas.221575398; DIAZ R, 1968, J BACTERIOL, V96, P893, DOI 10.1128/JB.96.4.893-901.1968; Endley S, 2001, J BACTERIOL, V183, P2454, DOI 10.1128/JB.183.8.2454-2462.2001; Forestier C, 2000, J IMMUNOL, V165, P5202, DOI 10.4049/jimmunol.165.9.5202; Gago G, 2006, J BACTERIOL, V188, P477, DOI 10.1128/JB.188.2.477-486.2006; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; GARCIALOBO JM, 2004, BRUCELLA MOL CELLULA, P232; Gee JM, 2005, INFECT IMMUN, V73, P2873, DOI 10.1128/IAI.73.5.2873-2880.2005; Gee JM, 2004, VET MICROBIOL, V102, P111, DOI 10.1016/j.vetmic.2004.05.009; GRAVES RR, 1943, J AM VET MED ASSOC, V102, P193; Halling SM, 2005, J BACTERIOL, V187, P2715, DOI 10.1128/JB.187.8.2715-2726.2005; Hornback ML, 2006, J BACTERIOL, V188, P1295, DOI 10.1128/JB.188.4.1295-1300.2006; Kim S, 2003, INFECT IMMUN, V71, P3020, DOI 10.1128/IAI.71.6.3020-3027.2003; Langford M J, 2002, Dev Biol (Basel), V110, P107; Lavigne JP, 2005, INFECT IMMUN, V73, P5524, DOI 10.1128/IAI.73.9.5524-5529.2005; Lestrate P, 2000, MOL MICROBIOL, V38, P543, DOI 10.1046/j.1365-2958.2000.02150.x; Lin TW, 2006, P NATL ACAD SCI USA, V103, P3072, DOI 10.1073/pnas.0510580103; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; NICOLETTI P, 1990, ANIMAL BRUCELLOSIS, P284; Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100; Paulsen IT, 2002, P NATL ACAD SCI USA, V99, P13148, DOI 10.1073/pnas.192319099; Poester FP, 2006, VACCINE, V24, P5327, DOI 10.1016/j.vaccine.2006.04.020; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; SANGARI FJ, 1994, FEMS MICROBIOL LETT, V121, P337, DOI 10.1111/j.1574-6968.1994.tb07123.x; Sangari FJ, 1998, VACCINE, V16, P1640, DOI 10.1016/S0264-410X(98)00063-2; Sangari FJ, 2000, MICROBIOL-UK, V146, P487, DOI 10.1099/00221287-146-2-487; Seleem MN, 2008, VET MICROBIOL, V129, P1, DOI 10.1016/j.vetmic.2007.11.023; SMITH H, 1962, NATURE, V193, P47, DOI 10.1038/193047a0; Snyder EE, 2007, NUCLEIC ACIDS RES, V35, pD401, DOI 10.1093/nar/gkl858; SPERRY JF, 1975, J BACTERIOL, V121, P619, DOI 10.1128/JB.121.2.619-630.1975; Tech M, 2005, BIOINFORMATICS, V21, P3568, DOI 10.1093/bioinformatics/bti563; Vemulapalli R, 2000, INFECT IMMUN, V68, P3286, DOI 10.1128/IAI.68.6.3286-3289.2000; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065; Yost CK, 2006, MICROBIOL-SGM, V152, P2061, DOI 10.1099/mic.0.28938-0; Young EJ, 2000, PRINCIPLES PRACTICE, P2386; Yu GX, 2007, NUCLEIC ACIDS RES, V35, P3953, DOI 10.1093/nar/gkm377; Zhang RG, 2002, J BIOL CHEM, V277, P19183, DOI 10.1074/jbc.M112171200	49	85	418	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2193	10.1371/journal.pone.0002193	http://dx.doi.org/10.1371/journal.pone.0002193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478107	Green Published, gold, Green Submitted			2022-12-27	WOS:000262172800057
J	Faivre, O; Juusola, M				Faivre, Olivier; Juusola, Mikko			Visual Coding in Locust Photoreceptors	PLOS ONE			English	Article							ADAPTING-BUMP MODEL; LIGHT ADAPTATION; SPECTRAL SENSITIVITY; FLY PHOTORECEPTORS; 2ND-ORDER NEURONS; RESPONSE DYNAMICS; PUPIL MECHANISM; COMPOUND EYE; SIGNAL; NOISE	Information capture by photoreceptors ultimately limits the quality of visual processing in the brain. Using conventional sharp microelectrodes, we studied how locust photoreceptors encode random (white-noise, WN) and naturalistic (1/f stimuli, NS) light patterns in vivo and how this coding changes with mean illumination and ambient temperature. We also examined the role of their plasma membrane in shaping voltage responses. We found that brightening or warming increase and accelerate voltage responses, but reduce noise, enabling photoreceptors to encode more information. For WN stimuli, this was accompanied by broadening of the linear frequency range. On the contrary, with NS the signaling took place within a constant bandwidth, possibly revealing a 'preference' for inputs with 1/f statistics. The faster signaling was caused by acceleration of the elementary phototransduction current - leading to bumps - and their distribution. The membrane linearly translated phototransduction currents into voltage responses without limiting the throughput of these messages. As the bumps reflected fast changes in membrane resistance, the data suggest that their shape is predominantly driven by fast changes in the light-gated conductance. On the other hand, the slower bump latency distribution is likely to represent slower enzymatic intracellular reactions. Furthermore, the Q(10)s of bump duration and latency distribution depended on light intensity. Altogether, this study suggests that biochemical constraints imposed upon signaling change continuously as locust photoreceptors adapt to environmental light and temperature conditions.	[Faivre, Olivier] Univ Cambridge, Dept Zool, Cambridge, England; [Juusola, Mikko] Univ Sheffield, Dept Biomed Sci, Sheffield, S Yorkshire, England	University of Cambridge; University of Sheffield	Faivre, O (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	m.juusola@sheffield.ac.uk	Juusola, Mikko/E-6948-2011	Juusola, Mikko/0000-0002-4428-5330	Royal Society; Gatsby Charitable Trust; BBSRC; Cambridge European trust; Isaac Newton Trust; Ecole Normale Superieure, Paris	Royal Society(Royal Society of London); Gatsby Charitable Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge European trust; Isaac Newton Trust; Ecole Normale Superieure, Paris	This work was supported by grants from the Royal Society (MJ), the Gatsby Charitable Trust (MJ) and the BBSRC (MJ). OF was supported by the Cambridge European trust, the Isaac Newton Trust and the Ecole Normale Superieure, Paris. These sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arganda S, 2007, NAT NEUROSCI, V10, P1467, DOI 10.1038/nn1982; ATICK JJ, 1992, COULD INFORM THEORY, P213; Atick JJ, 1990, NEURAL COMPUT, V2, P308, DOI 10.1162/neco.1990.2.3.308; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Baker R. R., 1978, EVOLUTIONARY ECOLOGY; Barlow H. B., 1961, P331; BARLOW HB, 1996, INTRANEURONAL INFORM, P251; BENDAT JS, 1971, RANDOM DATA ANAL MEA, P566; BENNETT RR, 1967, Z VERGL PHYSIOL, V55, P195, DOI 10.1007/BF00342254; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Burton BG, 2006, VISION RES, V46, P622, DOI 10.1016/j.visres.2005.09.020; Burton BG, 2001, J NEUROPHYSIOL, V86, P950, DOI 10.1152/jn.2001.86.2.950; CUTTLE MF, 1995, J COMP PHYSIOL A, V176, P307, DOI 10.1007/BF00219056; Dan Y, 1996, J NEUROSCI, V16, P3351; de Polavieja GG, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.061910; EVANS PD, 1984, J EXP BIOL, V110, P231; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; FRENCH AS, 1980, NATURE, V283, P200, DOI 10.1038/283200a0; Gu YC, 2005, CURR BIOL, V15, P1228, DOI 10.1016/j.cub.2005.05.058; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; HOWARD J, 1987, PROC R SOC SER B-BIO, V231, P415, DOI 10.1098/rspb.1987.0053; HOWARD J, 1981, J COMP PHYSIOL, V144, P61, DOI 10.1007/BF00612798; James AC, 1996, J COMP PHYSIOL A, V178, P183, DOI 10.1007/BF00188161; JARVILEHTO M, 1973, Z ZELLFORSCH MIK ANA, V136, P291, DOI 10.1007/BF00307446; JUUSOLA M, 1993, J COMP PHYSIOL A, V172, P511, DOI 10.1007/BF00213533; Juusola M, 1997, J NEUROPHYSIOL, V77, P1487, DOI 10.1152/jn.1997.77.3.1487; Juusola M, 2003, J NEUROPHYSIOL, V90, P2014, DOI 10.1152/jn.00395.2003; JUUSOLA M, 1994, J NEUROSCI METH, V53, P1, DOI 10.1016/0165-0270(94)90137-6; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; JUUSOLA M, 1993, NEUROSCI LETT, V154, P84, DOI 10.1016/0304-3940(93)90177-M; JUUSOLA M, 1995, J GEN PHYSIOL, V105, P117, DOI 10.1085/jgp.105.1.117; Krapp HG, 2005, J NEUROPHYSIOL, V93, P2240, DOI 10.1152/jn.00965.2004; Laughlin SB, 1996, VISION RES, V36, P1529, DOI 10.1016/0042-6989(95)00242-1; LAUGHLIN SB, 1978, J COMP PHYSIOL, V128, P319, DOI 10.1007/BF00657606; LILLYWHITE PG, 1977, J COMP PHYSIOL, V122, P189, DOI 10.1007/BF00611889; LILLYWHITE PG, 1979, NATURE, V277, P569, DOI 10.1038/277569a0; MARR D, 1976, SCIENCE, V194, P283, DOI 10.1126/science.968482; MEINERTZHAGEN IA, 1976, PHILOS T ROY SOC B, V274, P555, DOI 10.1098/rstb.1976.0064; Oberwinkler J, 2000, J NEUROSCI, V20, P1701; PAYNE R, 1981, NATURE, V290, P415, DOI 10.1038/290415a0; PECE AEC, 1990, BIOPHYS J, V57, P733, DOI 10.1016/S0006-3495(90)82594-7; ROEBROEK JGH, 1990, J INSECT PHYSIOL, V36, P499, DOI 10.1016/0022-1910(90)90101-K; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SHAPLEY RJ, 1984, PROG RETIN RES, V2, P263; Shaw S. R., 1968, Symposia of the Zoological Society of London, VNo. 23, P135; Simmons PJ, 2005, J NEUROSCI, V25, P7529, DOI 10.1523/JNEUROSCI.1119-05.2005; SNYDER AW, 1977, J COMP PHYSIOL, V116, P161, DOI 10.1007/BF00605401; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; SPEKREIJ.H, 1970, KYBERNETIK, V7, P22, DOI 10.1007/BF00270331; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; SRINIVASAN MV, 1975, VISION RES, V15, P515, DOI 10.1016/0042-6989(75)90029-2; Stavenga DG, 2004, J EXP BIOL, V207, P1703, DOI 10.1242/jeb.00949; Stavenga DG, 2004, J COMP PHYSIOL A, V190, P115, DOI 10.1007/s00359-003-0477-0; VANHATEREN JH, 1992, NATURE, V360, P68, DOI 10.1038/360068a0; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; VanSteveninck RRD, 1996, INT J NEURAL SYST, V7, P437, DOI 10.1142/S0129065796000415; VANSTEVENNICK RD, 1996, RATE INFORM TRANSFER, P642; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; WARRANT EJ, 1993, PROG NEUROBIOL, V40, P413, DOI 10.1016/0301-0082(93)90017-M; Warrant EJ, 2006, ARTHROPOD STRUCT DEV, V35, P293, DOI 10.1016/j.asd.2006.08.012; WECKSTROM M, 1992, PFLUG ARCH EUR J PHY, V421, P469, DOI 10.1007/BF00370258; WECKSTROM M, 1991, J PHYSIOL-LONDON, V440, P635, DOI 10.1113/jphysiol.1991.sp018729; WECKSTROM M, 1994, J COMP PHYSIOL A, V174, P795, DOI 10.1007/BF00192729; WECKSTROM M, 1992, P R SOC B, P83; WILLIAMS DS, 1982, SCIENCE, V218, P898, DOI 10.1126/science.7134980; WILLIAMS DS, 1983, J COMP PHYSIOL, V150, P509, DOI 10.1007/BF00609577; Yu YG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108103	79	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2173	10.1371/journal.pone.0002173	http://dx.doi.org/10.1371/journal.pone.0002173			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478123	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000262172800038
J	Konigshoff, M; Balsara, N; Pfaff, EM; Kramer, M; Chrobak, I; Seeger, W; Eickelberg, O				Koenigshoff, Melanie; Balsara, Nisha; Pfaff, Eva-Maria; Kramer, Monika; Chrobak, Izabella; Seeger, Werner; Eickelberg, Oliver			Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							KEY REGULATOR; BETA-CATENIN; PATHWAY; PATHOGENESIS; DISEASE; CELLS	Background: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease, characterized by distorted lung architecture and loss of respiratory function. Alveolar epithelial cell injury and hyperplasia, enhanced extracellular matrix deposition, and (myo) fibroblast activation are features of IPF. Wnt/beta-catenin signaling has been shown to determine epithelial cell fate during development. As aberrant reactivation of developmental signaling pathways has been suggested to contribute to IPF pathogenesis, we hypothesized that Wnt/beta-catenin signaling is activated in epithelial cells in IPF. Thus, we quantified and localized the expression and activity of the Wnt/beta-catenin pathway in IPF. Methodology/Principal Findings: The expression of Wnt1, 3a, 7b, and 10b, the Wnt receptors Fzd1-4, Lrp5-6, as well as the intracellular signal transducers Gsk-3 beta, beta-catenin, Tcf1, 3, 4, and Lef1 was analyzed in IPF and transplant donor lungs by quantitative real-time (q) RT-PCR. Wnt1, 7b and 10b, Fzd2 and 3, beta-catenin, and Lef1 expression was significantly increased in IPF. Immunohistochemical analysis localized Wnt1, Wnt3a, beta-catenin, and Gsk-3 beta expression largely to alveolar and bronchial epithelium. This was confirmed by qRT-PCR of primary alveolar epithelial type II (ATII) cells, demonstrating a significant increase of Wnt signaling in ATII cells derived from IPF patients. In addition, Western blot analysis of phospho-Gsk-3 beta, phospho-Lrp6, and beta-catenin, and qRT-PCR of the Wnt target genes cyclin D1, Mmp 7, or Fibronectin 1 demonstrated increased functional Wnt/beta-catenin signaling in IPF compared with controls. Functional in vitro studies further revealed that Wnt ligands induced lung epithelial cell proliferation and (myo) fibroblast activation and collagen synthesis. Conclusions/Significance: Our study demonstrates that the Wnt/beta-catenin pathway is expressed and operative in adult lung epithelium. Increased Wnt/beta-catenin signaling may be involved in epithelial cell injury and hyperplasia, as well as impaired epithelial-mesenchymal cross-talk in IPF. Thus, modification of Wnt signaling may represent a therapeutic option in IPF.	[Koenigshoff, Melanie; Balsara, Nisha; Pfaff, Eva-Maria; Kramer, Monika; Chrobak, Izabella; Seeger, Werner; Eickelberg, Oliver] Univ Giessen, Dept Med, Lung Ctr, Giessen, Germany	Justus Liebig University Giessen	Konigshoff, M (corresponding author), Univ Giessen, Dept Med, Lung Ctr, Giessen, Germany.	oliver.eickelberg@innere.med.uni-giessen.de	Eickelberg, Oliver/A-5461-2013	Eickelberg, Oliver/0000-0001-7170-0360; Seeger, Werner/0000-0003-1946-0894	The German Research Foundation's (DFG); Excellence Cluster Cardiopulmonary System (ECCPS); Clinical Research Group 118 Lung Fibrosis; Signalling Mechanisms of Lung Physiology and Disease (SMLPD) [IGRK1062]; Alexander von Humboldt-Foundation [Sofja Kovalevskaja Award]	The German Research Foundation's (DFG)(German Research Foundation (DFG)); Excellence Cluster Cardiopulmonary System (ECCPS)(German Research Foundation (DFG)); Clinical Research Group 118 Lung Fibrosis; Signalling Mechanisms of Lung Physiology and Disease (SMLPD); Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation)	The German Research Foundation's (DFG) Excellence Cluster Cardiopulmonary System (ECCPS) (W.S., O.E.), Clinical Research Group 118 Lung Fibrosis (W.S., O.E.), the International Graduate Program IGRK1062 Signalling Mechanisms of Lung Physiology and Disease (SMLPD) (M.K., W.S., O.E.), and the Sofja Kovalevskaja Award by the Alexander von Humboldt-Foundation to O.E.	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Chua F, 2005, AM J RESP CELL MOL, V33, P9, DOI 10.1165/rcmb.2005-0062TR; Fang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL242, DOI 10.1152/ajplung.00178.2005; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Johnson ML, 2006, REV ENDOCR METAB DIS, V7, P41, DOI 10.1007/s1154-006-9003-3; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kim Dong Soon, 2006, Proc Am Thorac Soc, V3, P285, DOI 10.1513/pats.200601-005TK; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; Kitowska K, 2008, AM J PHYSIOL-LUNG C, V294, pL34, DOI 10.1152/ajplung.00007.2007; Konigshoff M, 2007, AM J RESP CELL MOL, V37, P640, DOI 10.1165/rcmb.2006-0379TR; Lewis CC, 2008, AM J RESP CRIT CARE, V177, P376, DOI 10.1164/rccm.200702-333OC; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morrisey EE, 2003, AM J PATHOL, V162, P1393, DOI 10.1016/S0002-9440(10)64271-X; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Noble PW, 2005, AM J RESP CELL MOL, V33, P113, DOI 10.1165/rcmb.F301; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Rulifson EJ, 2000, MOL CELL, V6, P117, DOI 10.1016/S1097-2765(00)00013-7; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Shu WG, 2002, DEVELOPMENT, V129, P4831; Szeto W, 2001, CANCER RES, V61, P4197; Taneyhill Lisa, 2004, BMC Developmental Biology, V4; Taskar Varsha S, 2006, Proc Am Thorac Soc, V3, P293, DOI 10.1513/pats.200512-131TK; Visscher Daniel W, 2006, Proc Am Thorac Soc, V3, P322, DOI 10.1513/pats.200602-019TK; Walter Nicholas, 2006, Proc Am Thorac Soc, V3, P330, DOI 10.1513/pats.200602-016TK; White ES, 2003, J PATHOL, V201, P343, DOI 10.1002/path.1446; Yang IV, 2007, AM J RESP CRIT CARE, V175, P45, DOI 10.1164/rccm.200601-062OC; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099; 1998, AM J RESP CRIT CARE, V157, P1301	45	351	381	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2142	10.1371/journal.pone.0002142	http://dx.doi.org/10.1371/journal.pone.0002142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478089	Green Submitted, gold, Green Published			2022-12-27	WOS:000262172800007
J	Srikakulam, R; Liu, L; Winkelmann, DA				Srikakulam, Rajani; Liu, Li; Winkelmann, Donald A.			Unc45b Forms a Cytosolic Complex with Hsp90 and Targets the Unfolded Myosin Motor Domain	PLOS ONE			English	Article								Myosin folding and assembly in striated muscle is mediated by the general chaperones Hsc70 and Hsp90 and a myosin specific co-chaperone, UNC45. Two UNC45 genes are found in vertebrates, including a striated muscle specific form, Unc45b. We have investigated the role of Unc45b in myosin folding. Epitope tagged murine Unc45b (Unc45b(Flag)) was expressed in muscle and non-muscle cells and bacteria, isolated and characterized. The protein is a soluble monomer in solution with a compact folded rod-shaped structure of similar to 19 nm length by electron microscopy. When over-expressed in striated muscle cells, Unc45b(Flag) fractionates as a cytosolic protein and isolates as a stable complex with Hsp90. Purified Unc45b(Flag) re-binds Hsp90 and forms a stable complex in solution. The endogenous Unc45b in muscle cell lysates is also found associated with Hsp90. The Unc45b(Flag)/Hsp90 complex binds the partially folded myosin motor domain when incubated with myosin subfragments synthesized in a reticulocyte lysate. This binding is independent of the myosin rod or light chains. Unc45b(Flag) does not bind native myosin subfragments consistent with a chaperone function. More importantly, Unc45b(Flag) enhances myosin motor domain folding during de novo motor domain synthesis indicating that it has a direct role in myosin maturation. Thus, mammalian Unc45b is a cytosolic protein that forms a stable complex with Hsp90, selectively binds the unfolded conformation of the myosin motor domain, and promotes motor domain folding.	[Srikakulam, Rajani; Liu, Li; Winkelmann, Donald A.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Srikakulam, R (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA.	daw@pleiad.umdnj.edu			NIAMS [AR38454]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038454, R29AR038454] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a grant number AR38454 from NIAMS to DAW. NIAMS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Berteaux-Lecellier V, 1998, EMBO J, V17, P1248, DOI 10.1093/emboj/17.5.1248; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Chow D, 2002, J BIOL CHEM, V277, P36799, DOI 10.1074/jbc.M204101200; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Kachur T, 2004, J CELL SCI, V117, P5313, DOI 10.1242/jcs.01389; Kinose F, 1996, J CELL BIOL, V134, P895, DOI 10.1083/jcb.134.4.895; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; LIU L, 2008, J BIOL CHEM IN PRESS; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Maruya M, 1999, J MOL BIOL, V285, P903, DOI 10.1006/jmbi.1998.2349; Murphy PJM, 2001, J BIOL CHEM, V276, P30092, DOI 10.1074/jbc.M103773200; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Srikakulam R, 2004, J CELL SCI, V117, P641, DOI 10.1242/jcs.00899; Srikakulam R, 1999, J BIOL CHEM, V274, P27265, DOI 10.1074/jbc.274.38.27265; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; VENOLIA L, 1990, GENETICS, V126, P345; Wang Q, 2003, J CELL SCI, V116, P4227, DOI 10.1242/jcs.00709; Wesche S, 2003, CURR BIOL, V13, P715, DOI 10.1016/S0960-9822(03)00264-1; WINKELMANN DA, 1986, J MOL BIOL, V188, P595, DOI 10.1016/S0022-2836(86)80009-2; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Wong KCY, 2000, J CELL SCI, V113, P2421; Yu Q, 2003, CURR BIOL, V13, pR525, DOI 10.1016/S0960-9822(03)00447-0	32	61	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2137	10.1371/journal.pone.0002137	http://dx.doi.org/10.1371/journal.pone.0002137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478096	Green Published, gold, Green Submitted			2022-12-27	WOS:000262172800002
J	Hansen, DM; Kaiser, CN; Muller, CB				Hansen, Dennis M.; Kaiser, Christopher N.; Mueller, Christine B.			Seed Dispersal and Establishment of Endangered Plants on Oceanic Islands: The Janzen-Connell Model, and the Use of Ecological Analogues	PLOS ONE			English	Article							TROPICAL FORESTS; INSECT HERBIVORES; PLEISTOCENE PARK; GIANT TORTOISE; RAIN-FOREST; CONSERVATION; TREE; ANIMALS; ANACHRONISMS; GERMINATION	Background: The Janzen-Connell model states that plant-specific natural enemies may have a disproportionately large negative effect on progeny close to maternal trees. The majority of experimental and theoretical studies addressing the Janzen-Connell model have explored how it can explain existing patterns of species diversity in tropical mainland areas. Very few studies have investigated how the model's predictions apply to isolated oceanic islands, or to the conservation management of endangered plants. Here, we provide the first experimental investigation of the predictions of the Janzen-Connell model on an oceanic island, in a conservation context. In addition, we experimentally evaluate the use of ecological analogue animals to resurrect the functional component of extinct frugivores that could have dispersed seeds away from maternal trees. Methodology/Principal Findings: In Mauritius, we investigated seed germination and seedling survival patterns of the critically endangered endemic plant Syzygium mamillatum (Myrtaceae) in relation to proximity to maternal trees. We found strong negative effects of proximity to maternal trees on growth and survival of seedlings. We successfully used giant Aldabran tortoises as ecological analogues for extinct Mauritian frugivores. Effects of gut-passage were negative at the seed germination stage, but seedlings from gut-passed seeds grew taller, had more leaves, and suffered less damage from natural enemies than any of the other seedlings. Conclusions/Significance: We provide the first experimental evidence of a distance-dependent Janzen-Connell effect on an oceanic island. Our results potentially have serious implications for the conservation management of rare plant species on oceanic islands, which harbour a disproportionately large fraction of the world's endemic and endangered plants. Furthermore, in contrast to recent controversy about the use of non-indigenous extant megafauna for re-wilding projects in North America and elsewhere, we argue that Mauritius and other oceanic islands are ideal study systems in which to empirically explore the use of ecological analogue species in restoration ecology.	[Hansen, Dennis M.; Kaiser, Christopher N.; Mueller, Christine B.] Univ Zurich, Inst Env Sci, Zurich, Switzerland	University of Zurich	Hansen, DM (corresponding author), Univ Zurich, Inst Env Sci, Zurich, Switzerland.	dmhansen@stanford.edu	Hansen, Dennis M/A-3307-2008; Kaiser-Bunbury, Christopher/C-5038-2012	Hansen, Dennis M/0000-0002-9584-2766; Kaiser-Bunbury, Christopher/0000-0001-7254-3491	NSF [631-065950]; University of Zurich	NSF(National Science Foundation (NSF)); University of Zurich	Swiss NSF grant #631-065950 to CBM. Research Fund of the University of Zurich to DMH during analysis and write-up	Arevalo JR, 2003, PLANT ECOL, V165, P1, DOI 10.1023/A:1021490715660; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; BEARDSELL DV, 1993, AUST J BOT, V41, P511, DOI 10.1071/BT9930511; Bevill RL, 1999, CONSERV BIOL, V13, P1323, DOI 10.1046/j.1523-1739.1999.98450.x; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; Borges PAV, 1999, BIOL J LINN SOC, V66, P373, DOI 10.1111/j.1095-8312.1999.tb01897.x; BOSSER J, 1987, ADANSONIA, V9, P29; Caro T, 2007, TRENDS ECOL EVOL, V22, P281, DOI 10.1016/j.tree.2007.03.001; Cheke A.S., 1987, P5, DOI 10.1017/CBO9780511735769.003; CHEKE AS, LOST LAND D IN PRESS; CLARK DA, 1981, OECOLOGIA, V49, P73, DOI 10.1007/BF00376900; CLARK DA, 1984, AM NAT, V124, P769, DOI 10.1086/284316; Clout M., 2002, TURNING TIDE ERADICA; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; CONNELL J H, 1971, P298; Cordeiro NJ, 2001, CONSERV BIOL, V15, P1733, DOI 10.1046/j.1523-1739.2001.99579.x; COX PA, 1991, CONSERV BIOL, V5, P448, DOI 10.1111/j.1523-1739.1991.tb00351.x; Donlan CJ, 2006, AM NAT, V168, P660, DOI 10.1086/508027; Donlan J, 2005, NATURE, V436, P913, DOI 10.1038/436913a; Galetti M, 2006, BOT J LINN SOC, V151, P141, DOI 10.1111/j.1095-8339.2006.00529.x; Galetti M., 2004, NAT CONSERV, V2, P93; Garcia-Guzman G, 2001, AM J BOT, V88, P634, DOI 10.2307/2657063; Gilbert GS, 1996, BIOSCIENCE, V46, P98, DOI 10.2307/1312812; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; Grant PR, 1998, EVOLUTION ISLANDS; Guimaraes Paulo R. Jr, 2008, PLoS ONE, V3, pUnpaginated, DOI 10.1371/journal.pone.0001745; HACHISUKA M, 1953, DODO KINDRED BIRDS E, P250; HAMBLER C, 1994, BIOL CONSERV, V69, P293, DOI 10.1016/0006-3207(94)90429-4; HAMILTON J, 1982, J ARID ENVIRON, V5, P127, DOI 10.1016/S0140-1963(18)31545-3; HNATIUK SH, 1978, OECOLOGIA, V36, P345, DOI 10.1007/BF00348060; Howe HF, 2000, TRENDS ECOL EVOL, V15, P434, DOI 10.1016/S0169-5347(00)01965-0; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Hutton I, 2007, ANIM CONSERV, V10, P22, DOI 10.1111/j.1469-1795.2006.00077.x; IVERSON JB, 1987, J HERPETOL, V21, P229, DOI 10.2307/1564487; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jones CG, 2002, HANDBOOK OF ECOLOGICAL RESTORATION, VOL 1, P355; Kaiser CN, 2008, BIOTROPICA, V40, P86, DOI 10.1111/j.1744-7429.2007.00345.x; LAWTON JH, 1995, OIKOS, V73, P145, DOI 10.2307/3545902; LEE MAB, 1985, OIKOS, V45, P169, DOI 10.2307/3565702; LORENCE D H, 1986, Journal of Tropical Ecology, V2, P147; MARTIN PS, 2005, TWILIGHT MAMMOTHS IC, P250; Maunder M, 2002, ORYX, V36, P56, DOI 10.1017/S0030605302000091; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Nyhagen DF, 2005, BIOL CONSERV, V122, P491, DOI 10.1016/j.biocon.2004.08.012; Oliveira PS, 1995, BIOTROPICA, V27, P518, DOI 10.2307/2388966; Pinheiro J, 2000, MIXED EFFECTS MODELS; Pretorius JC, 2002, ANN APPL BIOL, V141, P117, DOI 10.1111/j.1744-7348.2002.tb00203.x; R Development Core Team, 2006, R LANG ENV STAT COMP; Ribeiro SP, 2005, ECOGRAPHY, V28, P315, DOI 10.1111/j.0906-7590.2005.04104.x; RICK CM, 1961, EVOLUTION, V15, P407, DOI 10.2307/2406309; Rodriguez-Perez J, 2005, FUNCT ECOL, V19, P699, DOI 10.1111/j.0269-8463.2005.00971.x; Rubenstein DR, 2006, BIOL CONSERV, V132, P232, DOI 10.1016/j.biocon.2006.04.003; Samuels IA, 2005, FUNCT ECOL, V19, P365, DOI 10.1111/j.1365-2435.2005.00973.x; Steadman DW, 2003, EARTH-SCI REV, V61, P133, DOI 10.1016/S0012-8252(02)00116-2; TEMPLE SA, 1977, SCIENCE, V197, P885, DOI 10.1126/science.197.4306.885; Traveset A, 2005, CONSERV BIOL, V19, P421, DOI 10.1111/j.1523-1739.2005.00019.x; VENABLES WN, 2002, MODERN APPL STAT S, P548; VITOUSEK PM, 1995, ISLANDS BIOL DIVERSI, V115, P238; Wiles GJ, 1996, BIOL CONSERV, V76, P229, DOI 10.1016/0006-3207(95)00078-X; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252; WITMER MC, 1991, OIKOS, V61, P133, DOI 10.2307/3545415; Wright SJ, 2007, BIOTROPICA, V39, P289, DOI 10.1111/j.1744-7429.2007.00293.x; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; WYSEJACKSON PS, 1988, TROP ECOL, V29, P98; Zimov SA, 2005, SCIENCE, V308, P796, DOI 10.1126/science.1113442	66	43	45	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2111	10.1371/journal.pone.0002111	http://dx.doi.org/10.1371/journal.pone.0002111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461169	Green Published, Green Submitted, gold			2022-12-27	WOS:000261642400033
J	Li, M; Wang, CJ; Feng, YJ; Pan, XZ; Cheng, G; Wang, J; Ge, JC; Zheng, F; Cao, M; Dong, YQ; Liu, D; Wang, JF; Lin, Y; Du, HL; Gao, GF; Wang, XN; Hu, FQ; Tang, JQ				Li, Ming; Wang, Changjun; Feng, Youjun; Pan, Xiuzhen; Cheng, Gong; Wang, Jing; Ge, Junchao; Zheng, Feng; Cao, Min; Dong, Yaqing; Liu, Di; Wang, Jufang; Lin, Ying; Du, Hongli; Gao, George F.; Wang, Xiaoning; Hu, Fuquan; Tang, Jiaqi			SalK/SalR, a Two-Component Signal Transduction System, Is Essential for Full Virulence of Highly Invasive Streptococcus suis Serotype 2	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; MURAMIDASE-RELEASED PROTEIN; GROUP-A STREPTOCOCCUS; SURFACE PROTEIN; PATHOGENICITY ISLANDS; BACTERIAL VIRULENCE; REGULATORY SYSTEM; ABC TRANSPORTERS; RESPONSE-REGULATOR; DRUG-RESISTANCE	Background: Streptococcus suis serotype 2 (S. suis 2, SS2) has evolved into a highly infectious entity, which caused the two recent large-scale outbreaks of human SS2 epidemic in China, and is characterized by a toxic shock-like syndrome. However, the molecular pathogenesis of this new emerging pathogen is still poorly understood. Methodology/Principal Findings: 89K is a newly predicted pathogenicity island (PAI) which is specific to Chinese epidemic strains isolated from these two SS2 outbreaks. Further bioinformatics analysis revealed a unique two-component signal transduction system (TCSTS) located in the candidate 89K PAI, which is orthologous to the SalK/SalR regulatory system of Streptococcus salivarius. Knockout of salKR eliminated the lethality of SS2 in experimental infection of piglets. Functional complementation of salKR into the isogenic mutant DsalKR restored its soaring pathogenicity. Colonization experiments showed that the DsalKR mutant could not colonize any susceptible tissue of piglets when administered alone. Bactericidal assays demonstrated that resistance of the mutant to polymorphonuclear leukocyte (PMN)-mediated killing was greatly decreased. Expression microarray analysis exhibited a transcription profile alteration of 26 various genes down-regulated in the DsalKR mutant. Conclusions/Significance: These findings suggest that SalK/SalR is requisite for the full virulence of ethnic Chinese isolates of highly pathogenic SS2, thus providing experimental evidence for the validity of this bioinformatically predicted PAI.	[Li, Ming; Hu, Fuquan; Tang, Jiaqi] Third Mil Med Univ, Dept Microbiol, Chongqing, Peoples R China; [Li, Ming; Wang, Changjun; Pan, Xiuzhen; Cheng, Gong; Wang, Jing; Ge, Junchao; Zheng, Feng; Cao, Min; Dong, Yaqing; Hu, Fuquan; Tang, Jiaqi] Res Inst Med Nanjing Command, Dept Epidemiol, Nanjing, Peoples R China; [Feng, Youjun; Liu, Di; Gao, George F.] Chinese Acad Sci, Inst Microbiol, Ctr Mol Immunol, Beijing, Peoples R China; [Wang, Jufang; Lin, Ying; Du, Hongli; Wang, Xiaoning] S China Univ Technol, Sch Biosci & Bioengn, Provincial Key Lab Biotechnol, Guangzhou, Peoples R China; [Feng, Youjun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Army Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS; South China University of Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, M (corresponding author), Third Mil Med Univ, Dept Microbiol, Chongqing, Peoples R China.	xnwang@21.net; hufuquan@yahoo.com; tjq85@hotmail.com	Feng, Youjun/I-4134-2012; Feng, Youjun/E-8386-2010; Liu, Di/ABD-2729-2021; Gao, George Fu/ABD-5229-2021; Liu, Di/G-6135-2014	Liu, Di/0000-0003-3693-2726; Liu, Di/0000-0003-3693-2726	National High-Tech Research & Development Project 863 [2006AA0Z455]; National Natural Science Foundation of China [30670105, 30600533]; National Key Technologies R&D Programs [2006BAD06A01]; National Basic Research Program (973) of China [2005CB523001, 2007CB512402]; Natural Science Foundation of Jiangsu Province, China [BK2006014, BK2007013]	National High-Tech Research & Development Project 863(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Programs(National Key Technology R&D Program); National Basic Research Program (973) of China(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	The work was supported by National High-Tech Research & Development Project 863 (2006AA0Z455), National Natural Science Foundation of China (30670105 & 30600533), National Key Technologies R&D Programs (2006BAD06A01) and National Basic Research Program (973) of China (2005CB523001 & 2007CB512402), and Natural Science Foundation of Jiangsu Province, China (BK2006014 & BK2007013).	BALTIMORE RS, 1977, J IMMUNOL, V118, P673; Banu S, 2000, MOL MICROBIOL, V35, P854, DOI 10.1046/j.1365-2958.2000.01760.x; BaThein W, 1996, J BACTERIOL, V178, P2514, DOI 10.1128/jb.178.9.2514-2520.1996; Beier D, 2006, CURR OPIN MICROBIOL, V9, P143, DOI 10.1016/j.mib.2006.01.005; Berthelot-Herault F, 2000, VET RES, V31, P473, DOI 10.1051/vetres:2000133; Berthelot-Herault F, 2005, CAN J VET RES, V69, P236; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; DAIGLE F, 1995, INFECT IMMUN, V63, P4924, DOI 10.1128/IAI.63.12.4924-4927.1995; de Greeff A, 2002, MICROB PATHOGENESIS, V33, P185, DOI 10.1006/mpat.2002.0526; de Greeff A, 2002, INFECT IMMUN, V70, P1319, DOI 10.1128/IAI.70.3.1319-1325.2002; de Saizieu A, 2000, J BACTERIOL, V182, P4696, DOI 10.1128/JB.182.17.4696-4703.2000; Feng YJ, 2007, FEMS MICROBIOL LETT, V275, P80, DOI 10.1111/j.1574-6968.2007.00859.x; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; Gottschalk M, 1998, CAN J VET RES, V62, P75; Gottschalk M, 1999, J CLIN MICROBIOL, V37, P4202, DOI 10.1128/JCM.37.12.4202-4203.1999; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Jain R, 2002, THEOR POPUL BIOL, V61, P489, DOI 10.1006/tpbi.2002.1596; Jones PM, 2005, INT J PARASITOL, V35, P555, DOI 10.1016/j.ijpara.2005.01.012; Jonsson IM, 2002, J INFECT DIS, V185, P1417, DOI 10.1086/340503; Kehoe MA, 1996, TRENDS MICROBIOL, V4, P436, DOI 10.1016/0966-842X(96)10058-5; Kobayashi SD, 2003, P NATL ACAD SCI USA, V100, P10948, DOI 10.1073/pnas.1833375100; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Lee CA, 1996, INFECT AGENT DIS, V5, P1; Li YY, 2006, INFECT IMMUN, V74, P305, DOI 10.1128/IAI.74.1.305-312.2006; Liang XD, 2005, J BACTERIOL, V187, P5486, DOI 10.1128/JB.187.15.5486-5492.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lun SC, 2003, MICROB PATHOGENESIS, V34, P27, DOI 10.1016/S0882-4010(02)00192-4; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; MAHAN MJ, 1993, SCIENCE, V259, P686, DOI 10.1126/science.8430319; McCluskey J, 2004, MOL MICROBIOL, V51, P1661, DOI 10.1111/j.1365-2958.2003.03917.x; Miller AA, 2001, MOL MICROBIOL, V40, P976, DOI 10.1046/j.1365-2958.2001.02441.x; Ng WL, 2005, J BACTERIOL, V187, P7444, DOI 10.1128/JB.187.21.7444-7459.2005; Normile D, 2005, SCIENCE, V309, P1308; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Roberts AP, 2006, PERIODONTOL 2000, V42, P36, DOI 10.1111/j.1600-0757.2006.00149.x; Sanders IR, 2006, TRENDS ECOL EVOL, V21, P656, DOI 10.1016/j.tree.2006.10.006; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Shimizu T, 2002, J BACTERIOL, V184, P2587, DOI 10.1128/JB.184.10.2587-2594.2002; SHIMIZU T, 1994, J BACTERIOL, V176, P1616, DOI 10.1128/jb.176.6.1616-1623.1994; Shin NR, 2007, FEMS IMMUNOL MED MIC, V50, P94, DOI 10.1111/j.1574-695X.2007.00236.x; Sipos G, 2006, CURR DRUG TARGETS, V7, P471, DOI 10.2174/138945006776359403; Smith HE, 2000, MICROB PATHOGENESIS, V29, P127, DOI 10.1006/mpat.2000.0372; Smith HE, 1996, INFECT IMMUN, V64, P4409, DOI 10.1128/IAI.64.10.4409-4412.1996; SMITH HE, 1995, MICROBIOL-UK, V141, P181, DOI 10.1099/00221287-141-1-181; SMITH HE, 1992, INFECT IMMUN, V60, P2361, DOI 10.1128/IAI.60.6.2361-2367.1992; Sriskandan S, 2006, PLOS MED, V3, P595, DOI 10.1371/journal.pmed.0030187; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Staats JJ, 1999, VET MICROBIOL, V70, P201, DOI 10.1016/S0378-1135(99)00147-9; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Takamatsu D, 2002, J BACTERIOL, V184, P2050, DOI 10.1128/JB.184.7.2050-2057.2002; Takamatsu D, 2001, PLASMID, V45, P101, DOI 10.1006/plas.2000.1510; TANG J, 2006, PLOS MED, V151, P2; Tarradas C, 2001, VET REC, V148, P183, DOI 10.1136/vr.148.6.183; Throup JP, 2000, MOL MICROBIOL, V35, P566, DOI 10.1046/j.1365-2958.2000.01725.x; Upton M, 2001, J BACTERIOL, V183, P3931, DOI 10.1128/JB.183.13.3931-3938.2001; VECHT U, 1992, INFECT IMMUN, V60, P550, DOI 10.1128/IAI.60.2.550-556.1992; Voyich JM, 2003, P NATL ACAD SCI USA, V100, P1996, DOI 10.1073/pnas.0337370100; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Wolfger H, 2001, RES MICROBIOL, V152, P375, DOI 10.1016/S0923-2508(01)01209-8; Yazaki K, 2006, FEBS LETT, V580, P1183, DOI 10.1016/j.febslet.2005.12.009	65	114	138	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2080	10.1371/journal.pone.0002080	http://dx.doi.org/10.1371/journal.pone.0002080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461172	Green Submitted, gold, Green Published			2022-12-27	WOS:000261642400004
J	Shalchian-Tabrizi, K; Minge, MA; Espelund, M; Orr, R; Ruden, T; Jakobsen, KS; Cavalier-Smith, T				Shalchian-Tabrizi, Kamran; Minge, Marianne A.; Espelund, Mari; Orr, Russell; Ruden, Torgeir; Jakobsen, Kjetill S.; Cavalier-Smith, Thomas			Multigene Phylogeny of Choanozoa and the Origin of Animals	PLOS ONE			English	Article							CAPSASPORA-OWCZARZAKI; EVOLUTIONARY ORIGIN; PROTEIN; SEQUENCE; GENE	Animals are evolutionarily related to fungi and to the predominantly unicellular protozoan phylum Choanozoa, together known as opisthokonts. To establish the sequence of events when animals evolved from unicellular ancestors, and understand those key evolutionary transitions, we need to establish which choanozoans are most closely related to animals and also the evolutionary position of each choanozoan group within the opisthokont phylogenetic tree. Here we focus on Ministeria vibrans, a minute bacteria-eating cell with slender radiating tentacles. Single-gene trees suggested that it is either the closest unicellular relative of animals or else sister to choanoflagellates, traditionally considered likely animal ancestors. Sequencing thousands of Ministeria protein genes now reveals about 14 with domains of key significance for animal cell biology, including several previously unknown from deeply diverging Choanozoa, e. g. domains involved in hedgehog, Notch and tyrosine kinase signaling or cell adhesion (cadherin). Phylogenetic trees using 78 proteins show that Ministeria is not sister to animals or choanoflagellates (themselves sisters to animals), but to Capsaspora, another protozoan with threadlike (filose) tentacles. The Ministeria/Capsaspora clade (new class Filasterea) is sister to animals and choanoflagellates, these three groups forming a novel clade (filozoa) whose ancestor presumably evolved filose tentacles well before they aggregated as a periciliary collar in the choanoflagellate/sponge common ancestor. Our trees show ichthyosporean choanozoans as sisters to filozoa; a fusion between ubiquitin and ribosomal small subunit S30 protein genes unifies all holozoa (filozoa plus Ichthyosporea), being absent in earlier branching eukaryotes. Thus, several successive evolutionary innovations occurred among their unicellular closest relatives prior to the origin of the multicellular body-plan of animals.	[Shalchian-Tabrizi, Kamran; Orr, Russell] Univ Oslo, Dept Biol, Microbial Evolut Res Grp, Oslo, Norway; [Minge, Marianne A.; Espelund, Mari; Jakobsen, Kjetill S.] Univ Oslo, Ctr Ecol & Evolut Synthesis, Oslo, Norway; [Ruden, Torgeir] Univ Oslo, Ctr Informat Technol Serv, Sci Comp Grp, Oslo, Norway; [Cavalier-Smith, Thomas] Univ Oxford, Dept Zool, Oxford, England	University of Oslo; University of Oslo; University of Oslo; University of Oxford	Shalchian-Tabrizi, K (corresponding author), Univ Oslo, Dept Biol, Microbial Evolut Res Grp, Oslo, Norway.	Kamran@bio.uio.no			NERC; Canadian Institute for Advanced Research Evolutionary Biology Program; Norwegian Research Council	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Canadian Institute for Advanced Research Evolutionary Biology Program(Canadian Institute for Advanced Research (CIFAR)); Norwegian Research Council(Research Council of NorwayEuropean Commission)	TC-S thanks NERC and the Canadian Institute for Advanced Research Evolutionary Biology Program for fellowship support and NERC for research grants, and KSJ the Norwegian Research Council for a research project and scholarships to KS, MAM and ME.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adamska M, 2007, CURR BIOL, V17, pR836, DOI 10.1016/j.cub.2007.08.010; Baker RT, 1996, J BIOL CHEM, V271, P13549, DOI 10.1074/jbc.271.23.13549; Bayly RD, 2007, DEVELOPMENT, V134, P2115, DOI 10.1242/dev.02850; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 2003, EUR J PROTISTOL, V39, P338, DOI 10.1078/0932-4739-00002; Cavalier-Smith T, 2003, J MOL EVOL, V56, P540, DOI 10.1007/s00239-002-2424-z; Cavalier-Smith T, 1998, SYST ASSOC SPEC VOL, V56, P375; Cavalier-Smith T, 2001, MYCOTA, V7, P3; Cavalier-Smith T., 1987, EVOLUTIONARY BIOL FU, P339; Dykova I, 2003, FOLIA PARASIT, V50, P161, DOI 10.14411/fp.2003.030; Gromov BV, 2000, ZOOL ZH, V79, P517; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hertel LA, 2002, INT J PARASITOL, V32, P1183, DOI 10.1016/S0020-7519(02)00066-8; Jimenez-Guri E, 2007, SCIENCE, V317, P116, DOI 10.1126/science.1142024; Karpov SA, 1998, J EUKARYOT MICROBIOL, V45, P361, DOI 10.1111/j.1550-7408.1998.tb04550.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Medina M, 2003, INT J ASTROBIOL, V2, P203, DOI [DOI 10.1017/S1473550403001551), 10.1017/S1473550403001551, DOI 10.1017/S1473550403001551]; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Ruiz-Trillo I, 2008, MOL BIOL EVOL, V25, P664, DOI 10.1093/molbev/msn006; Ruiz-Trillo I, 2007, TRENDS GENET, V23, P113, DOI 10.1016/j.tig.2007.01.005; Ruiz-Trillo I, 2006, J EUKARYOT MICROBIOL, V53, P379, DOI 10.1111/j.1550-7408.2006.00118.x; Segawa Y, 2006, P NATL ACAD SCI USA, V103, P12021, DOI 10.1073/pnas.0600021103; Snell EA, 2006, P ROY SOC B-BIOL SCI, V273, P401, DOI 10.1098/rspb.2005.3263; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; Tong SM, 1997, OPHELIA, V47, P71, DOI 10.1080/00785236.1997.10427291; [No title captured]	38	165	171	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2098	10.1371/journal.pone.0002098	http://dx.doi.org/10.1371/journal.pone.0002098			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461162	Green Submitted, gold, Green Published			2022-12-27	WOS:000261642400020
J	Thomas, SH; Wagner, RD; Arakaki, AK; Skolnick, J; Kirby, JR; Shimkets, LJ; Sanford, RA; Loffler, FE				Thomas, Sara H.; Wagner, Ryan D.; Arakaki, Adrian K.; Skolnick, Jeffrey; Kirby, John R.; Shimkets, Lawrence J.; Sanford, Robert A.; Loeffler, Frank E.			The Mosaic Genome of Anaeromyxobacter dehalogenans Strain 2CP-C Suggests an Aerobic Common Ancestor to the Delta- Proteobacteria	PLOS ONE			English	Article							FRUITING BODY DEVELOPMENT; GEOBACTER-SULFURREDUCENS; MYXOCOCCUS-XANTHUS; ESCHERICHIA-COLI; REDUCTIVE DEHALOGENASE; DESULFOVIBRIO-VULGARIS; PHYLOGENETIC ANALYSIS; FE(III) REDUCTION; ELECTRON-TRANSFER; ACETYL-COENZYME	Anaeromyxobacter dehalogenans strain 2CP-C is a versaphilic delta-Proteobacterium distributed throughout many diverse soil and sediment environments. 16S rRNA gene phylogenetic analysis groups A. dehalogenans together with the myxobacteria, which have distinguishing characteristics including strictly aerobic metabolism, sporulation, fruiting body formation, and surface motility. Analysis of the 5.01 Mb strain 2CP-C genome substantiated that this organism is a myxobacterium but shares genotypic traits with the anaerobic majority of the delta-Proteobacteria (i.e., the Desulfuromonadales). Reflective of its respiratory versatility, strain 2CP-C possesses 68 genes coding for putative c-type cytochromes, including one gene with 40 heme binding motifs. Consistent with its relatedness to the myxobacteria, surface motility was observed in strain 2CP-C and multiple types of motility genes are present, including 28 genes for gliding, adventurous (A-) motility and 17 genes for type IV pilus-based motility (i.e., social (S-) motility) that all have homologs in Myxococcus xanthus. Although A. dehalogenans shares many metabolic traits with the anaerobic majority of the delta-Proteobacteria, strain 2CP-C grows under microaerophilic conditions and possesses detoxification systems for reactive oxygen species. Accordingly, two gene clusters coding for NADH dehydrogenase subunits and two cytochrome oxidase gene clusters in strain 2CP-C are similar to those in M. xanthus. Remarkably, strain 2CP-C possesses a third NADH dehydrogenase gene cluster and a cytochrome cbb3 oxidase gene cluster, apparently acquired through ancient horizontal gene transfer from a strictly anaerobic green sulfur bacterium. The mosaic nature of the A. dehalogenans strain 2CP-C genome suggests that the metabolically versatile, anaerobic members of the delta-Proteobacteria may have descended from aerobic ancestors with complex lifestyles.	[Thomas, Sara H.; Loeffler, Frank E.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA; [Wagner, Ryan D.; Arakaki, Adrian K.; Skolnick, Jeffrey; Loeffler, Frank E.] Georgia Inst Technol, Sch Biol, Atlanta, GA USA; [Kirby, John R.] Univ Iowa, Dept Microbiol, Iowa City, IA USA; [Shimkets, Lawrence J.] Univ Georgia, Dept Microbiol, Athens, GA USA; [Sanford, Robert A.] Univ Illinois, Dept Geol, Urbana, IL USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of Iowa; University System of Georgia; University of Georgia; University of Illinois System; University of Illinois Urbana-Champaign	Thomas, SH (corresponding author), Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA.	frank.loeffler@ce.gatech.edu	Sanford, Robert/C-1720-2019; Loeffler, Frank E/M-8216-2013	Sanford, Robert/0000-0002-9607-9897; 	Environmental Remediation Science Division (ERSD), Biological and Environmental Research (BER), U.S. Department of Energy; NSF IGERT [DGE 0114400]; NSF GK-12 [0338261]	Environmental Remediation Science Division (ERSD), Biological and Environmental Research (BER), U.S. Department of Energy(United States Department of Energy (DOE)); NSF IGERT(National Science Foundation (NSF)); NSF GK-12(National Science Foundation (NSF))	This research was supported by the Environmental Remediation Science Division (ERSD), Biological and Environmental Research (BER), U.S. Department of Energy and by NSF IGERT (Grant No. DGE 0114400) and NSF GK-12 (Grant No. 0338261) fellowships. The sponsoring agencies were not involved in the design and conduct of the study. The sponsoring agencies have not reviewed this manuscript, and therefore, agency approval of the views expressed herein should not be inferred.	Abdel-Hamid AM, 2007, J BACTERIOL, V189, P369, DOI 10.1128/JB.01373-06; Afkar E, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-41; Aguilar D, 2004, J MOL BIOL, V340, P491, DOI 10.1016/j.jmb.2004.04.059; Akiyama T, 2003, J BACTERIOL, V185, P3317, DOI 10.1128/JB.185.11.3317-3324.2003; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arakaki AK, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-315; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Bellenger K, 2002, J BACTERIOL, V184, P5654, DOI 10.1128/JB.184.20.5654-5660.2002; Bergey DH., 2001, BERGEYS MANUAL SYSTE; Berleman JE, 2006, J BACTERIOL, V188, P5888, DOI 10.1128/JB.00559-06; Blaisdell BE, 1996, P NATL ACAD SCI USA, V93, P5854, DOI 10.1073/pnas.93.12.5854; Bohlendorf B, 1999, EUR J ORG CHEM, V1999, P2601; Bonner PJ, 2005, MOL MICROBIOL, V57, P1499, DOI 10.1111/j.1365-2958.2005.04785.x; Brioukhanov AL, 2002, MICROBIOLOGY+, V71, P281, DOI 10.1023/A:1015846409735; Brown JR, 2003, NAT REV GENET, V4, P121, DOI 10.1038/nrg1000; CASTRESANA J, 1994, EMBO J, V13, P2516, DOI 10.1002/j.1460-2075.1994.tb06541.x; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; COLE JR, 1994, APPL ENVIRON MICROB, V60, P3536, DOI 10.1128/AEM.60.10.3536-3542.1994; Dagan T, 2007, P NATL ACAD SCI USA, V104, P870, DOI 10.1073/pnas.0606318104; de Bok FAM, 2002, ANTON LEEUW INT J G, V81, P283, DOI 10.1023/A:1020539323190; Dedysh SN, 2006, APPL ENVIRON MICROB, V72, P2110, DOI 10.1128/AEM.72.3.2110-2117.2006; Dolla A, 2006, J BIOTECHNOL, V126, P87, DOI 10.1016/j.jbiotec.2006.03.041; Dworkin M, 1996, MICROBIOL REV, V60, P70, DOI 10.1128/MMBR.60.1.70-102.1996; Esteve-Nunez A, 2008, ENVIRON MICROBIOL, V10, P497, DOI 10.1111/j.1462-2920.2007.01470.x; Evans KJ, 2007, J BACTERIOL, V189, P4850, DOI 10.1128/JB.01942-06; Fung JM, 2007, APPL ENVIRON MICROB, V73, P4439, DOI 10.1128/AEM.00215-07; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Gorlenko VM, 2004, MICROBIOLOGY+, V73, P541, DOI 10.1023/B:MICI.0000044245.67298.9f; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Guiral M, 2005, BBA-GEN SUBJECTS, V1723, P45, DOI 10.1016/j.bbagen.2005.01.015; Haywood-Farmer E, 2003, EVOLUTION, V57, P1783; He JZ, 2003, NATURE, V424, P62, DOI 10.1038/nature01717; He Q, 2003, APPL ENVIRON MICROB, V69, P2712, DOI 10.1128/AEM.69.5.2712-2718.2003; *INT UN BIOCH MOL, 1992, ENZ NOM 1992 REC NOM, P862; Jelsbak L, 2000, CURR OPIN MICROBIOL, V3, P637, DOI 10.1016/S1369-5274(00)00153-3; Jelsbak L, 2005, J BACTERIOL, V187, P2105, DOI 10.1128/JB.187.6.2105-2112.2005; Jovanovic T, 2000, J BIOL CHEM, V275, P28439, DOI 10.1074/jbc.M003314200; Kaiser D, 2004, ANNU REV MICROBIOL, V58, P75, DOI 10.1146/annurev.micro.58.030603.123620; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; Karlin S, 2006, P NATL ACAD SCI USA, V103, P11352, DOI 10.1073/pnas.0604311103; Kimura Y, 2000, J BACTERIOL, V182, P5462, DOI 10.1128/JB.182.19.5462-5469.2000; Kimura Y, 2004, MICROBIOL-SGM, V150, P631, DOI 10.1099/mic.0.26786-0; Kirby JR, 2003, P NATL ACAD SCI USA, V100, P2008, DOI 10.1073/pnas.0330944100; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Krajmalnik-Brown R, 2004, APPL ENVIRON MICROB, V70, P6347, DOI 10.1128/AEM.70.10.6347-6351.2004; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Lin WC, 2004, APPL ENVIRON MICROB, V70, P2525, DOI 10.1128/AEM.70.4.2525-2528.2004; Loffler FE, 2006, CURR OPIN BIOTECH, V17, P274, DOI 10.1016/j.copbio.2006.05.001; Lombard M, 2000, J BIOL CHEM, V275, P27021; LOVLEY DR, 1993, APPL ENVIRON MICROB, V59, P3572, DOI 10.1128/AEM.59.11.3572-3576.1993; LOVLEY DR, 1993, ARCH MICROBIOL, V159, P336, DOI 10.1007/BF00290916; Lowe KL, 2000, GEOMICROBIOL J, V17, P163, DOI 10.1080/01490450050023836; Lumppio HL, 2001, J BACTERIOL, V183, P101, DOI 10.1128/JB.183.1.101-108.2001; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Madigan M.T., 2006, BROCK BIOL MICROORGA; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; Mignot T, 2007, SCIENCE, V315, P853, DOI 10.1126/science.1137223; Mrazek J, 1998, P NATL ACAD SCI USA, V95, P3720, DOI 10.1073/pnas.95.7.3720; Pett-Ridge J, 2005, APPL ENVIRON MICROB, V71, P6998, DOI 10.1128/AEM.71.11.6998-7007.2005; PFENNIG N, 1967, ANNU REV MICROBIOL, V21, P285, DOI 10.1146/annurev.mi.21.100167.001441; Pfennig N, 1989, BERGEYS MANUAL SYSTE, P1635; Pham VD, 2005, MICROBIOL-SGM, V151, P1865, DOI 10.1099/mic.0.27824-0; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Pradella S, 2002, ARCH MICROBIOL, V178, P484, DOI 10.1007/s00203-002-0479-2; Rahm BG, 2006, APPL ENVIRON MICROB, V72, P5486, DOI 10.1128/AEM.00855-06; Rao CV, 2004, PLOS BIOL, V2, P239, DOI 10.1371/journal.pbio.0020049; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Reguera G, 2007, J BACTERIOL, V189, P2125, DOI 10.1128/JB.01284-06; REICHENB.H, 1969, J GEN MICROBIOL, V58, P3, DOI 10.1099/00221287-58-1-3; Reichenbach H, 1999, ENVIRON MICROBIOL, V1, P15, DOI 10.1046/j.1462-2920.1999.00016.x; Reichenbach H, 2001, J IND MICROBIOL BIOT, V27, P149, DOI 10.1038/sj.jim.7000025; Rodrigues ML, 2006, EMBO J, V25, P5951, DOI 10.1038/sj.emboj.7601439; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sait M, 2006, APPL ENVIRON MICROB, V72, P1852, DOI 10.1128/AEM.72.3.1852-1857.2006; Sanford RA, 2002, APPL ENVIRON MICROB, V68, P893, DOI 10.1128/AEM.68.2.893-900.2002; Sanford RA, 2007, ENVIRON MICROBIOL, V9, P2885, DOI 10.1111/j.1462-2920.2007.01405.x; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shi L, 2007, MOL MICROBIOL, V65, P12, DOI 10.1111/j.1365-2958.2007.05783.x; Shi SY, 2005, ACTA BIOCH BIOPH SIN, V37, P561, DOI 10.1111/j.1745-7270.2005.00075.x; SHIMKETS L, 1992, P NATL ACAD SCI USA, V89, P9459, DOI 10.1073/pnas.89.20.9459; STIEFEL EI, 1979, NATURE, V279, P81, DOI 10.1038/279081a0; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; Suyama A, 2002, J BACTERIOL, V184, P3419, DOI 10.1128/JB.184.13.3419-3425.2002; THONYMEYER L, 1993, J BACTERIOL, V175, P7450; Tian WD, 2004, NUCLEIC ACIDS RES, V32, P6226, DOI 10.1093/nar/gkh956; Todorova SG, 2006, ENVIRON MICROBIOL, V8, P426, DOI 10.1111/j.1462-2920.2005.00908.x; Treude N, 2003, FEMS MICROBIOL ECOL, V44, P261, DOI 10.1016/S0168-6496(03)00048-5; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; van Eerde A, 2006, ACTA CRYSTALLOGR F, V62, P1061, DOI 10.1107/S1744309106039583; Velicer GJ, 2002, ANTON LEEUW INT J G, V81, P155, DOI 10.1023/A:1020546130033; Wu Q, 2006, APPL ENVIRON MICROB, V72, P3608, DOI 10.1128/AEM.72.5.3608-3614.2006; Zhou JP, 2007, J MICROBIOL, V45, P105	101	106	113	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2103	10.1371/journal.pone.0002103	http://dx.doi.org/10.1371/journal.pone.0002103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461135	Green Published, Green Submitted, gold			2022-12-27	WOS:000261642400025
J	Lombaert, IMA; Brunsting, JF; Wierenga, PK; Faber, H; Stokman, MA; Kok, T; Visser, WH; Kampinga, HH; de Haan, G; Coppes, RP				Lombaert, Isabelle M. A.; Brunsting, Jeanette F.; Wierenga, Pieter K.; Faber, Hette; Stokman, Monique A.; Kok, Tineke; Visser, Willy H.; Kampinga, Harm H.; de Haan, Gerald; Coppes, Robert P.			Rescue of Salivary Gland Function after Stem Cell Transplantation in Irradiated Glands	PLOS ONE			English	Article								Head and neck cancer is the fifth most common malignancy and accounts for 3% of all new cancer cases each year. Despite relatively high survival rates, the quality of life of these patients is severely compromised because of radiation-induced impairment of salivary gland function and consequential xerostomia (dry mouth syndrome). In this study, a clinically applicable method for the restoration of radiation-impaired salivary gland function using salivary gland stem cell transplantation was developed. Salivary gland cells were isolated from murine submandibular glands and cultured in vitro as salispheres, which contained cells expressing the stem cell markers Sca-1, c-Kit and Musashi-1. In vitro, the cells differentiated into salivary gland duct cells and mucin and amylase producing acinar cells. Stem cell enrichment was performed by flow cytrometric selection using c-Kit as a marker. In vitro, the cells differentiated into amylase producing acinar cells. In vivo, intra-glandular transplantation of a small number of c-Kit(+) cells resulted in long-term restoration of salivary gland morphology and function. Moreover, donor-derived stem cells could be isolated from primary recipients, cultured as secondary spheres and after re-transplantation ameliorate radiation damage. Our approach is the first proof for the potential use of stem cell transplantation to functionally rescue salivary gland deficiency.	[Lombaert, Isabelle M. A.; Brunsting, Jeanette F.; Faber, Hette; Kok, Tineke; Visser, Willy H.; Kampinga, Harm H.; Coppes, Robert P.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Radiat & Stress Cell Biol, Groningen, Netherlands; [Lombaert, Isabelle M. A.; Wierenga, Pieter K.; Visser, Willy H.; de Haan, Gerald] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Stem Cell Biol, Groningen, Netherlands; [Faber, Hette; Coppes, Robert P.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands; [Stokman, Monique A.] Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Lombaert, IMA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Radiat & Stress Cell Biol, Groningen, Netherlands.	r.p.coppes@med.umcg.nl	Coppes, Robert P/B-4089-2008; de Haan, Gerald/AAF-8963-2019; de Haan, Gerald/D-2081-2015	Coppes, Robert P/0000-0001-5503-1064; de Haan, Gerald/0000-0001-9706-0138; de Haan, Gerald/0000-0001-9706-0138; Kampinga, Harm/0000-0002-8966-8466	Dutch Society for Cancer Research [RUG2003-2909]; European Union [503436]	Dutch Society for Cancer Research; European Union(European Commission)	This study was financially supported by grants of the Dutch Society for Cancer Research (RUG2003-2909) and the European Union (FP-6, contract 503436).	Baum BJ, 2006, PERIODONTOL 2000, V41, P218, DOI 10.1111/j.1600-0757.2006.00160.x; BURFORDMASON AP, 1993, J ORAL PATHOL MED, V22, P440, DOI 10.1111/j.1600-0714.1993.tb00122.x; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Chen JH, 2005, ENDOCRINOLOGY, V146, P3985, DOI 10.1210/en.2005-0185; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Couzin J, 2006, SCIENCE, V313, P1715; Denny PC, 1999, ANAT REC, V254, P408, DOI 10.1002/(SICI)1097-0185(19990301)254:3<408::AID-AR12>3.0.CO;2-G; Denny PC, 1997, CRIT REV ORAL BIOL M, V8, P51, DOI 10.1177/10454411970080010301; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; GRESIK EW, 1994, MICROSC RES TECHNIQ, V27, P1, DOI 10.1002/jemt.1070270102; Hisatomi Y, 2004, HEPATOLOGY, V39, P667, DOI 10.1002/hep.20063; Kawase Y, 2004, EXP CELL RES, V295, P194, DOI 10.1016/j.yexcr.2003.12.027; Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6; Kishi T, 2006, BIOCHEM BIOPH RES CO, V340, P544, DOI 10.1016/j.bbrc.2005.12.031; Konings AWT, 2005, INT J RADIAT ONCOL, V62, P1187, DOI 10.1016/j.ijrobp.2004.12.051; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Lin AL, 2001, ARCH ORAL BIOL, V46, P1085, DOI 10.1016/S0003-9969(01)00063-2; Lombaert IMA, 2006, CLIN CANCER RES, V12, P1804, DOI 10.1158/1078-0432.CCR-05-2381; Ma XQ, 2002, STEM CELLS, V20, P514, DOI 10.1634/stemcells.20-6-514; Man YG, 2001, ANAT REC, V263, P202, DOI 10.1002/ar.1098; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Medina RJ, 2006, J CELL BIOCHEM, V98, P174, DOI 10.1002/jcb.20757; Nishida M, 2004, BIOCHEM BIOPH RES CO, V324, P341, DOI 10.1016/j.bbrc.2004.09.051; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Takahashi S, 2004, J ORAL PATHOL MED, V33, P23, DOI 10.1111/j.1600-0714.2004.00191.x; Takahashi S, 2000, TISSUE CELL, V32, P457, DOI 10.1016/S0040-8166(00)80002-6; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P213, DOI 10.1177/154411130301400306; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532	38	308	325	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2063	10.1371/journal.pone.0002063	http://dx.doi.org/10.1371/journal.pone.0002063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446241	Green Published, Green Submitted, gold			2022-12-27	WOS:000261572300032
J	Ao, ZJ; Yu, Z; Wang, LN; Zheng, YF; Yao, XJ				Ao, Zhujun; Yu, Zhe; Wang, Lina; Zheng, Yingfeng; Yao, Xiaojian			Vpr14-88-Apobec3G Fusion Protein Is Efficiently Incorporated into Vif-Positive HIV-1 Particles and Inhibits Viral Infection	PLOS ONE			English	Article								Background: APOBEC3G (A3G), a deoxycytidine deaminase, is a potent host antiviral factor that can restrict HIV-1 infection. During Vif-negative HIV-1 replication, A3G is incorporated into HIV-1 particles, induces mutations in reverse transcribed viral DNA and inhibits reverse transcription. However, HIV-1 Vif counteracts A3G's activities by inducing its degradation and by blocking its incorporation into HIV-1 particles. Thus, it is interesting to elucidate a mechanism that would allow A3G to escape the effects of Vif in order to rescue its potent antiviral activity and to provide a possible novel therapeutic strategy for treating HIV-1 infection. Methods and Findings: In this study, we generated an R88-A3G fusion protein by fusing A3G to a virion-targeting polypeptide (R14-88) derived from HIV-1 Vpr protein and compared its antiviral effects relative to those of HA-tagged native A3G (HA-A3G). Our study showed that transient expression of the R88-A3G fusion protein in both Vif 2 and Vif(+) HIV-1 producing cells drastically inhibited viral infection in HeLa-CD4-CCR5-cells, CD4(+) C8166 T cells and human primary PBMCs. Moreover, we established CD4(+) C8166 T cell lines that stably express either R88-A3G or HA-A3G by transduction with VSV-G-pseudotyped lentiviral vector that harbor expression cassettes for R88-A3G or HA-A3G, respectively, and tested their susceptibility to Vif(+) HIV-1 infection. Our results clearly reveal that expression of R88-A3G in transduced CD4(+) C8166 cells significantly blocked Vif(+) HIV-1 infection. In an attempt to understand the mechanism underlying the antiviral activity of R88-A3G, we demonstrated that R88-A3G was efficiently incorporated into viral particles in the presence of Vif. Moreover, PCR analysis revealed that R88-A3G significantly inhibited viral cDNA synthesis during the early stage of Vif(+) virus infection. Conclusions: Our results clearly indicate that R88 delivers A3G into Vif(+) HIV-1 particles and inhibits infectivity and spread of the virions among CD4(+) T cells. This study provides evidence for an effective strategy to modify a host protein with innate anti-HIV-1 activity and rescue its potent anti-HIV potential in the presence of Vif. Further characterization and optimization of this system may lead to the development of an effective therapeutic approach against HIV-1 infection.	[Ao, Zhujun; Yu, Zhe; Wang, Lina; Zheng, Yingfeng; Yao, Xiaojian] Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Mol Human Retrovirol, Winnipeg, MB, Canada	University of Manitoba	Ao, ZJ (corresponding author), Univ Manitoba, Fac Med, Dept Med Microbiol, Lab Mol Human Retrovirol, Winnipeg, MB, Canada.	yao2@cc.umanitoba.ca	Zheng, Yingfeng/AAE-2983-2022; Zheng, Yingfeng/CAE-9225-2022	Zheng, Yingfeng/0000-0002-0914-7864; Yao, Xiaojian/0000-0002-5022-1309	The Manitoba Medical Service Foundation [Basic Science Career Development Research Award]; CIHR [HPR85525]; CFI Leaders Opportunity Fund; University of Manitoba	The Manitoba Medical Service Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); CFI Leaders Opportunity Fund(Canada Foundation for Innovation); University of Manitoba	X-J. Yao is the recipient of the Basic Science Career Development Research Award from The Manitoba Medical Service Foundation. This work was supported by CIHR HIV preventing grant (HPR85525), CFI Leaders Opportunity Fund, University Research Grants Program (URGP) from University of Manitoba, and the grant from The Manitoba Medical Service Foundation to X-J. Yao.	AGUIAR RS, 2007, J BIOL CHEM; Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Ao Z, 2004, J VIROL, V78, P3170, DOI 10.1128/JVI.78.6.3170-3177.2004; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Ao ZJ, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-62; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Coker HA, 2007, DNA REPAIR, V6, P235, DOI 10.1016/j.dnarep.2006.10.001; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Doehle BP, 2005, J VIROL, V79, P8201, DOI 10.1128/JVI.79.13.8201-8207.2005; Fletcher TM, 1997, EMBO J, V16, P5123, DOI 10.1093/emboj/16.16.5123; Goncalves J, 1996, J VIROL, V70, P8701, DOI 10.1128/JVI.70.12.8701-8709.1996; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; KAO S, 2004, RETROVIROLOGY, V1, P1; Kao S, 2007, VIROLOGY, V369, P329, DOI 10.1016/j.virol.2007.08.005; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kobinger GP, 2001, NAT BIOTECHNOL, V19, P225, DOI 10.1038/85664; Kobinger GP, 1998, J VIROL, V72, P5441, DOI 10.1128/JVI.72.7.5441-5448.1998; KONDO E, 1995, J VIROL, V69, P2759, DOI 10.1128/JVI.69.5.2759-2764.1995; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; LAVALLEE C, 1994, J VIROL, V68, P1926; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; LEVY DN, 1993, CELL, V72, P541, DOI 10.1016/0092-8674(93)90073-Y; Li JL, 2004, J CELL BIOCHEM, V92, P560, DOI 10.1002/jcb.20082; LU YL, 1993, J VIROL, V67, P6542, DOI 10.1128/JVI.67.11.6542-6550.1993; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Opi S, 2007, J VIROL, V81, P8236, DOI 10.1128/JVI.02694-06; Park IW, 1996, J ACQ IMMUN DEF SYND, V11, P341, DOI 10.1097/00042560-199604010-00004; PAXTON W, 1993, J VIROL, V67, P7229, DOI 10.1128/JVI.67.12.7229-7237.1993; Petersen-Mahrt S, 2005, IMMUNOL REV, V203, P80, DOI 10.1111/j.0105-2896.2005.00232.x; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; RE F, 1995, J VIROL, V69, P6859, DOI 10.1128/JVI.69.11.6859-6864.1995; ROGEL ME, 1995, J VIROL, V69, P882, DOI 10.1128/JVI.69.2.882-888.1995; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1996, J VIROL, V70, P5297, DOI 10.1128/JVI.70.8.5297-5305.1996; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Wu XY, 1996, VIROLOGY, V219, P307, DOI 10.1006/viro.1996.0253; Wu XY, 1997, EMBO J, V16, P5113, DOI 10.1093/emboj/16.16.5113; WU XY, 1995, J VIROL, V69, P3389, DOI 10.1128/JVI.69.6.3389-3398.1995; Xu HZ, 2004, P NATL ACAD SCI USA, V101, P5652, DOI 10.1073/pnas.0400830101; Yang Y, 2007, VIROLOGY; YAO XJ, 1995, VIROLOGY, V209, P615, DOI 10.1006/viro.1995.1293; Yao XJ, 1999, GENE THER, V6, P1590, DOI 10.1038/sj.gt.3300988; Yao XJ, 1998, J VIROL, V72, P4686, DOI 10.1128/JVI.72.6.4686-4693.1998; YAO XJ, 1995, J VIROL, V69, P7032, DOI 10.1128/JVI.69.11.7032-7044.1995; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	70	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1995	10.1371/journal.pone.0001995	http://dx.doi.org/10.1371/journal.pone.0001995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414671	Green Published, Green Submitted, gold			2022-12-27	WOS:000260867300020
J	Lamaziere, A; Wolf, C; Lambert, O; Chassaing, G; Trugnan, G; Ayala-Sanmartin, J				Lamaziere, Antonin; Wolf, Claude; Lambert, Olivier; Chassaing, Gerard; Trugnan, Germain; Ayala-Sanmartin, Jesus			The Homeodomain Derived Peptide Penetratin Induces Curvature of Fluid Membrane Domains	PLOS ONE			English	Article								Background: Protein membrane transduction domains that are able to cross the plasma membrane are present in several transcription factors, such as the homeodomain proteins and the viral proteins such as Tat of HIV-1. Their discovery resulted in both new concepts on the cell communication during development, and the conception of cell penetrating peptide vectors for internalisation of active molecules into cells. A promising cell penetrating peptide is Penetratin, which crosses the cell membranes by a receptor and metabolic energy-independent mechanism. Recent works have claimed that Penetratin and similar peptides are internalized by endocytosis, but other endocytosis-independent mechanisms have been proposed. Endosomes or plasma membranes crossing mechanisms are not well understood. Previously, we have shown that basic peptides induce membrane invaginations suggesting a new mechanism for uptake, "physical endocytosis''. Methodology/Principal Findings: Herein, we investigate the role of membrane lipid phases on Penetratin induced membrane deformations (liquid ordered such as in "raft'' microdomains versus disordered fluid "non-raft'' domains) in membrane models. Experimental data show that zwitterionic lipid headgroups take part in the interaction with Penetratin suggesting that the external leaflet lipids of cells plasma membrane are competent for peptide interaction in the absence of net negative charges. NMR and X-ray diffraction data show that the membrane perturbations (tubulation and vesiculation) are associated with an increase in membrane negative curvature. These effects on curvature were observed in the liquid disordered but not in the liquid ordered (raft-like) membrane domains. Conclusions/Significance: The better understanding of the internalisation mechanisms of protein transduction domains will help both the understanding of the mechanisms of cell communication and the development of potential therapeutic molecular vectors. Here we showed that the membrane targets for these molecules are preferentially the fluid membrane domains and that the mechanism involves the induction of membrane negative curvature. Consequences on cellular uptake are discussed.	[Lamaziere, Antonin; Wolf, Claude; Trugnan, Germain; Ayala-Sanmartin, Jesus] CHU St Antoine, UMR538, INSERM, Paris, France; [Lamaziere, Antonin; Wolf, Claude; Trugnan, Germain; Ayala-Sanmartin, Jesus] CHU St Antoine, Univ Pierre Marie Curie, Paris, France; [Lambert, Olivier] Univ Bordeaux 1, CNRS, CBMN, UMR 5248, Pessac, France; [Chassaing, Gerard] Univ Pierre Marie Curie, UMR CNRS 7613, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Lamaziere, A (corresponding author), CHU St Antoine, UMR538, INSERM, Paris, France.	jayala@chusa.jussieu.fr	Lamaziere, Antonin/AFM-0000-2022; Lamaziere, Antonin/AAH-2285-2022	Lambert, Olivier/0000-0002-5651-8082	ANR-PCV [06 139187]	ANR-PCV(French National Research Agency (ANR))	This work was supported by an ANR-PCV grant (06 139187)France.	Afonin S, 2006, CHEMPHYSCHEM, V7, P2134, DOI 10.1002/cphc.200600306; Andersson A, 2004, BBA-BIOMEMBRANES, V1661, P18, DOI 10.1016/j.bbamem.2003.11.014; Ayala-Sanmartin J, 2001, BBA-BIOMEMBRANES, V1510, P18, DOI 10.1016/S0005-2736(00)00262-5; Ayala-Sanmartin J, 2000, BIOCHEMISTRY-US, V39, P15190, DOI 10.1021/bi000764r; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Bellet-Amalric E, 2000, BBA-BIOMEMBRANES, V1467, P131, DOI 10.1016/S0005-2736(00)00218-2; Berlose JP, 1996, EUR J BIOCHEM, V242, P372, DOI 10.1111/j.1432-1033.1996.0372r.x; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Bruston F, 2007, BIOPOLYMERS, V86, P42, DOI 10.1002/bip.20703; Caesar CEB, 2006, BIOCHEMISTRY-US, V45, P7682, DOI 10.1021/bi052095t; Cedric T, 2004, EUR BIOPHYS J BIOPHY, V33, P513, DOI 10.1007/s00249-004-0392-5; Christiaens B, 2002, EUR J BIOCHEM, V269, P2918, DOI 10.1046/j.1432-1033.2002.02963.x; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Dietz GPH, 2004, MOL CELL NEUROSCI, V27, P85, DOI 10.1016/j.mcn.2004.03.005; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Fischer R, 2005, CHEMBIOCHEM, V6, P2126, DOI 10.1002/cbic.200500044; Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Lamaziere Antonin, 2006, Journal de la Societe de Biologie, V200, P229, DOI 10.1051/jbio:2006026; Lambert O, 2004, J BIOL CHEM, V279, P10872, DOI 10.1074/jbc.M313657200; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; Magzoub M, 2002, BBA-BIOMEMBRANES, V1563, P53, DOI 10.1016/S0005-2736(02)00373-5; Mangavel C, 1998, BBA-BIOMEMBRANES, V1371, P265, DOI 10.1016/S0005-2736(98)00026-1; Menger FM, 2003, J AM CHEM SOC, V125, P2846, DOI 10.1021/ja021337z; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Murriel Christopher L, 2006, Expert Opin Drug Deliv, V3, P739, DOI 10.1517/17425247.3.6.739; PEREZ F, 1994, MOL ENDOCRINOL, V8, P1278, DOI 10.1210/me.8.9.1278; Persson D, 2003, BIOCHEMISTRY-US, V42, P421, DOI 10.1021/bi026453t; Prochiantz A, 2000, CURR OPIN CELL BIOL, V12, P400, DOI 10.1016/S0955-0674(00)00108-3; Prochiantz A, 2003, NAT REV MOL CELL BIO, V4, P814, DOI 10.1038/nrm1227; Rothbard JB, 2005, ADV DRUG DELIVER REV, V57, P495, DOI 10.1016/j.addr.2004.10.003; Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Terrone D, 2003, BIOCHEMISTRY-US, V42, P13787, DOI 10.1021/bi035293y; Thoren PEG, 2005, BIOPHYS CHEM, V114, P169, DOI 10.1016/j.bpc.2004.11.016; Veatch SL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.268101; Volynsky PE, 2005, BIOCHEMISTRY-US, V44, P14626, DOI 10.1021/bi0514562	38	60	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1938	10.1371/journal.pone.0001938	http://dx.doi.org/10.1371/journal.pone.0001938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398464	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795500015
J	Rai, M; Soragni, E; Jenssen, K; Burnett, R; Herman, D; Coppola, G; Geschwind, DH; Gottesfeld, JM; Pandolfo, M				Rai, Myriam; Soragni, Elisabetta; Jenssen, Kai; Burnett, Ryan; Herman, David; Coppola, Giovanni; Geschwind, Daniel H.; Gottesfeld, Joel M.; Pandolfo, Massimo			HDAC Inhibitors Correct Frataxin Deficiency in a Friedreich Ataxia Mouse Model	PLOS ONE			English	Article								Background: Friedreich ataxia, an autosomal recessive neurodegenerative and cardiac disease, is caused by abnormally low levels of frataxin, an essential mitochondrial protein. All Friedreich ataxia patients carry a GAA.TTC repeat expansion in the first intron of the frataxin gene, either in the homozygous state or in compound heterozygosity with other loss-of-function mutations. The GAA expansion inhibits frataxin expression through a heterochromatin-mediated repression mechanism. Histone modifications that are characteristic of silenced genes in heterochromatic regions occur at expanded alleles in cells from Friedreich ataxia patients, including increased trimethylation of histone H3 at lysine 9 and hypoacetylation of histones H3 and H4. Methodology/Principal Findings: By chromatin immunoprecipitation, we detected the same heterochromatin marks in homozygous mice carrying a (GAA)(230) repeat in the first intron of the mouse frataxin gene (KIKI mice). These animals have decreased frataxin levels and, by microarray analysis, show significant gene expression changes in several tissues. We treated KIKI mice with a novel histone deacetylase inhibitor, compound 106, which substantially increases frataxin mRNA levels in cells from Friedreich ataxia individuals. Treatment increased histone H3 and H4 acetylation in chromatin near the GAA repeat and restored wild-type frataxin levels in the nervous system and heart, as determined by quantitative RT-PCR and semiquantitative western blot analysis. No toxicity was observed. Furthermore, most of the differentially expressed genes in KIKI mice reverted towards wild-type levels. Conclusions/Significance: Lack of acute toxicity, normalization of frataxin levels and of the transcription profile changes resulting from frataxin deficiency provide strong support to a possible efficacy of this or related compounds in reverting the pathological process in Friedreich ataxia, a so far incurable neurodegenerative disease.	[Rai, Myriam; Pandolfo, Massimo] Free Univ Brussels, Hop Erasme, Lab Neurol Expt, Brussels, Belgium; [Soragni, Elisabetta; Jenssen, Kai; Burnett, Ryan; Herman, David; Gottesfeld, Joel M.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA USA; [Coppola, Giovanni; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA USA	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Scripps Research Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Rai, M (corresponding author), Free Univ Brussels, Hop Erasme, Lab Neurol Expt, Brussels, Belgium.	massimo.pandolfo@ulb.ac.be	Pandolfo, Massimo/B-2853-2010	Gottesfeld, Joel/0000-0002-4643-5777	GOFAR Foundation (Italy); Friedreich Ataxia Research Alliance (USA); Ataxia UK; Ataxia Ireland; Fondazione CRT (Italy); Belgian National Scientific Research Funds (FNRS); Belgian Ministry of Scientific Policy (Program IAP6); FARA; National Ataxia Foundation (NAF); National Institutes of Neurological Disorders and Stroke (NINDS)	GOFAR Foundation (Italy); Friedreich Ataxia Research Alliance (USA); Ataxia UK; Ataxia Ireland; Fondazione CRT (Italy); Belgian National Scientific Research Funds (FNRS)(Fonds de la Recherche Scientifique - FNRS); Belgian Ministry of Scientific Policy (Program IAP6); FARA; National Ataxia Foundation (NAF); National Institutes of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the GOFAR Foundation (Italy), the Friedreich Ataxia Research Alliance (USA), Ataxia UK, Ataxia Ireland, Fondazione CRT (Italy), the Belgian National Scientific Research Funds (FNRS), the Belgian Ministry of Scientific Policy (Program IAP6) to MP; from FARA, the National Ataxia Foundation (NAF), the National Institutes of Neurological Disorders and Stroke (NINDS) to JMG; and from NINDS to DG.	Anderson PR, 2005, HUM MOL GENET, V14, P3397, DOI 10.1093/hmg/ddi367; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chen OS, 2002, P NATL ACAD SCI USA, V99, P12321, DOI 10.1073/pnas.192449599; COPPOLA G, 2007, ANN NEUROLOGY, V62, pS24; Cossee M, 2000, HUM MOL GENET, V9, P1219, DOI 10.1093/hmg/9.8.1219; Di Prospero NA, 2005, NAT REV GENET, V6, P756, DOI 10.1038/nrg1690; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Miranda CJ, 2002, FEBS LETT, V512, P291, DOI 10.1016/S0014-5793(02)02251-2; Montermini L, 1997, ANN NEUROL, V41, P675, DOI 10.1002/ana.410410518; O'Neill HA, 2005, BIOCHEMISTRY-US, V44, P537, DOI 10.1021/bi048459j; O'Neill HA, 2005, J MOL BIOL, V345, P433, DOI 10.1016/j.jmb.2004.10.074; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Ohshima K, 1996, J BIOL CHEM, V271, P16773, DOI 10.1074/jbc.271.28.16773; Pandolfo M, 2002, MITOCHONDRION, V2, P87, DOI 10.1016/S1567-7249(02)00039-9; PANDOLFO M, 2007, MOL NEUROLOGY, pCH18; Pandolfo M., 2006, GENETIC INSTABILITIE, P277; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Simon D, 2004, J NEUROSCI, V24, P1987, DOI 10.1523/JNEUROSCI.4549-03.2004; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Vazzola V, 2007, FEBS LETT, V581, P667, DOI 10.1016/j.febslet.2007.01.030; Ventura N, 2006, FASEB J, V20, P1029, DOI 10.1096/fj.06-0505ufm; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200	29	170	174	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1958	10.1371/journal.pone.0001958	http://dx.doi.org/10.1371/journal.pone.0001958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18463734	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795500028
J	Forstmann, BU; Wolfensteller, U; Derrfuss, J; Neumann, J; Brass, M; Ridderinkhof, KR; von Cramon, DY				Forstmann, Birte U.; Wolfensteller, Uta; Derrfuss, Jan; Neumann, Jane; Brass, Marcel; Ridderinkhof, K. Richard; von Cramon, D. Yves			When the Choice Is Ours: Context and Agency Modulate the Neural Bases of Decision-Making	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; EVENT-RELATED FMRI; PREFRONTAL CORTEX; SOCIAL COGNITION; METAANALYSIS; BRAIN; SELF	The option to choose between several courses of action is often associated with the feeling of being in control. Yet, in certain situations, one may prefer to decline such agency and instead leave the choice to others. In the present functional magnetic resonance imaging (fMRI) study, we provide evidence that the neural processes involved in decision-making are modulated not only by who controls our choice options (agency), but also by whether we have a say in who is in control (context). The fMRI results are noteworthy in that they reveal specific contributions of the anterior frontomedian cortex (viz. BA 10) and the rostral cingulate zone (RCZ) in decision-making processes. The RCZ is engaged when conditions clearly present us with the most choice options. BA 10 is engaged in particular when the choice is completely ours, as well as when it is completely up to others to choose for us which in turn gives rise to an attribution of control to oneself or someone else, respectively. After all, it does not only matter whether we have any options to choose from, but also who decides on that.	[Forstmann, Birte U.; Ridderinkhof, K. Richard] Univ Amsterdam, Amsterdam Ctr Study Adapt Control Brain & Behav, Amsterdam, Netherlands; [Wolfensteller, Uta; Derrfuss, Jan; Neumann, Jane; Brass, Marcel; von Cramon, D. Yves] Max Planck Inst Human Cognitive & Brain Sci, Dept Cognitive Neurol, Leipzig, Germany; [Derrfuss, Jan] Inst Med, Res Ctr Juelich, Julich, Germany	University of Amsterdam; Max Planck Society; Helmholtz Association; Research Center Julich	Forstmann, BU (corresponding author), Univ Amsterdam, Amsterdam Ctr Study Adapt Control Brain & Behav, Amsterdam, Netherlands.	b.u.forstmann@uva.nl	Brass, Marcel/J-7082-2012; Forstmann, Birte/AAS-8515-2020; Wolfensteller, Uta/AAG-8921-2019; Derrfuss, Jan/J-3038-2012	Brass, Marcel/0000-0002-3364-4019; Derrfuss, Jan/0000-0002-8212-487X	NIH [R01 MH74457]; Netherlands Organization for Scientific Research [VICI grant]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074457] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	J.N.'s work is supported by the NIH (Grant Number: R01 MH74457). The work of B.U.F. and K.R.R. was afforded by a VICI grant from the Netherlands Organization for Scientific Research (NWO) to K.R.R.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Forstmann BU, 2006, J COGNITIVE NEUROSCI, V18, P388, DOI 10.1162/089892906775990589; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Talairach J, 1988, CO PLANAR STEREOTAXI; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339	18	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1899	10.1371/journal.pone.0001899	http://dx.doi.org/10.1371/journal.pone.0001899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370XC	18398450	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795400026
J	Rollins, SM; Peppercorn, A; Young, JS; Drysdale, M; Baresch, A; Bikowski, MV; Ashford, DA; Quinn, CP; Handfield, M; Hillman, JD; Lyons, CR; Koehler, TM; Calderwood, SB; Ryan, ET				Rollins, Sean M.; Peppercorn, Amanda; Young, John S.; Drysdale, Melissa; Baresch, Andrea; Bikowski, Margaret V.; Ashford, David A.; Quinn, Conrad P.; Handfield, Martin; Hillman, Jeffrey D.; Lyons, C. Rick; Koehler, Theresa M.; Calderwood, Stephen B.; Ryan, Edward T.			Application of In Vivo Induced Antigen Technology (IVIAT) to Bacillus anthracis	PLOS ONE			English	Article								In vivo induced antigen technology (IVIAT) is an immuno-screening technique that identifies bacterial antigens expressed during infection and not during standard in vitro culturing conditions. We applied IVIAT to Bacillus anthracis and identified PagA, seven members of a N-acetylmuramoyl-L-alanine amidase autolysin family, three P60 family lipoproteins, two transporters, spore cortex lytic protein SleB, a penicillin binding protein, a putative prophage holin, respiratory nitrate reductase NarG, and three proteins of unknown function. Using quantitative real-time PCR comparing RNA isolated from in vitro cultured B. anthracis to RNA isolated from BALB/c mice infected with virulent Ames strain B. anthracis, we confirmed induced expression in vivo for a subset of B. anthracis genes identified by IVIAT, including L-alanine amidases BA3767, BA4073, and amiA (pXO2-42); the bacteriophage holin gene BA4074; and pagA (pXO1-110). The exogenous addition of two purified putative autolysins identified by IVIAT, N-acetylmuramoyl-L-alanine amidases BA0485 and BA2446, to vegetative B. anthracis cell suspensions induced a species-specific change in bacterial morphology and reduction in viable bacterial cells. Many of the proteins identified in our screen are predicted to affect peptidoglycan re-modeling, and our results support significant cell wall structural remodeling activity during B. anthracis infection. Identification of L-alanine amidases with B. anthracis specificity may suggest new potential therapeutic targets.	[Rollins, Sean M.; Peppercorn, Amanda; Young, John S.; Baresch, Andrea; Bikowski, Margaret V.; Calderwood, Stephen B.; Ryan, Edward T.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Drysdale, Melissa; Lyons, C. Rick] Univ New Mexico Hlth Sci Ctr, Albuquerque, NM USA; [Drysdale, Melissa; Koehler, Theresa M.] Univ Texas Med Sch Houston, Dept Microbiol & Mol Genet, Houston, TX USA; [Ashford, David A.] USDA, APHIS, Sao Paulo, Brazil; [Quinn, Conrad P.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Handfield, Martin] Univ Florida, Coll Dentist, Ctr Mol Microbiol, Dept Oral Biol, Gainesville, FL USA; [Hillman, Jeffrey D.] Oragenics Inc, Alachua, FL USA; [Calderwood, Stephen B.] Harvard Med Sch, Dept Microbiol & Mol Genet, Boston, MA USA; [Calderwood, Stephen B.; Ryan, Edward T.] Harvard Med Sch, Dept Med, Boston, MA USA; [Ryan, Edward T.] Harvard Sch Public Hlth, Dept Immunol & Infect Dis, Boston, MA USA	Harvard University; Massachusetts General Hospital; University of New Mexico; University of New Mexico's Health Sciences Center; University of Texas System; University of Texas Health Science Center Houston; Centers for Disease Control & Prevention - USA; State University System of Florida; University of Florida; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Rollins, SM (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	srollins1@partners.org	Young, John/ABG-2132-2020	Young, John/0000-0001-7801-9017; Rollins, Sean/0000-0002-3724-1989	New England Regional Center of Excellence/Biodefense and Emerging Infectious Disease Career Development Award [U54 AI057159];  [AI053442];  [N01-A1-40053];  [T32 AI07061];  [DE13523];  [U54 AI057156];  [AI33537]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033537, U54AI057156, R29AI033537, U54AI057159, T32AI007061, R21AI053442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013523] Funding Source: NIH RePORTER	New England Regional Center of Excellence/Biodefense and Emerging Infectious Disease Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by AI053442 and N01-A1-40053 (ETR); U54 AI057159 (SBC); T32 AI07061 (AP), a New England Regional Center of Excellence/Biodefense and Emerging Infectious Disease Career Development Award U54 AI057159 (SMR), DE13523 (MH), U54 AI057156 (TMK and CRL) and AI33537 (TMK).	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Antelmann H, 2005, PROTEOMICS, V5, P3684, DOI 10.1002/pmic.200401218; Bourgogne A, 2003, INFECT IMMUN, V71, P2736, DOI 10.1128/IAI.71.5.2736-2743.2003; Chirakkal H, 2002, MICROBIOL-SGM, V148, P2383, DOI 10.1099/00221287-148-8-2383; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Chitlaru T, 2006, J BACTERIOL, V188, P3551, DOI 10.1128/JB.188.10.3551-3571.2006; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Deb DK, 2002, TUBERCULOSIS, V82, P175, DOI 10.1054/tube.2002.0337; Drysdale M, 2004, J BACTERIOL, V186, P307, DOI 10.1128/JB.186.2.307-315.2004; DRYSDALE M, 2007, INFECT IMMUN; ETIENNETOUMELIN I, 1995, J BACTERIOL, V177, P614, DOI 10.1128/jb.177.3.614-620.1995; Fisher N, 2006, J BACTERIOL, V188, P1301, DOI 10.1128/JB.188.4.1301-1309.2006; FOSTER SJ, 1992, J BACTERIOL, V174, P464, DOI 10.1128/jb.174.2.464-470.1992; Fouet A, 1999, J APPL MICROBIOL, V87, P251, DOI 10.1046/j.1365-2672.1999.00882.x; Friedlander AM, 2002, CURR TOP MICROBIOL, V271, P33; Gao LY, 2006, INFECT IMMUN, V74, P1757, DOI 10.1128/IAI.74.3.1757-1767.2006; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gat O, 2006, INFECT IMMUN, V74, P3987, DOI 10.1128/IAI.00174-06; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Handfield M, 2000, TRENDS MICROBIOL, V8, P336, DOI 10.1016/S0966-842X(00)01775-3; Handfield Martin, 2006, Infectious Disorders - Drug Targets, V6, P327, DOI 10.2174/187152606778249908; Hang L, 2003, P NATL ACAD SCI USA, V100, P8508, DOI 10.1073/pnas.1431769100; Harris JB, 2006, INFECT IMMUN, V74, P5161, DOI 10.1128/IAI.00488-06; Ishikawa S, 1998, J BACTERIOL, V180, P2549, DOI 10.1128/JB.180.9.2549-2555.1998; John M, 2005, INFECT IMMUN, V73, P2665, DOI 10.1128/IAI.73.5.2665-2679.2005; Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003; Koehler TM, 2002, CURR TOP MICROBIOL, V271, P143; KOEHLER TM, 1994, J BACTERIOL, V176, P586, DOI 10.1128/jb.176.3.586-595.1994; LaRocque RC, 2005, INFECT IMMUN, V73, P4488, DOI 10.1128/IAI.73.8.4488-4493.2005; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; MAKINO S, 1989, J BACTERIOL, V171, P722, DOI 10.1128/jb.171.2.722-730.1989; Merrell DS, 2002, MOL MICROBIOL, V43, P1471, DOI 10.1046/j.1365-2958.2002.02857.x; Mesnage S, 2002, J BACTERIOL, V184, P331, DOI 10.1128/JB.184.1.331-334.2002; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Moriyama R, 1996, J BACTERIOL, V178, P5330, DOI 10.1128/jb.178.17.5330-5332.1996; Moriyama R, 1996, J BACTERIOL, V178, P6059, DOI 10.1128/jb.178.20.6059-6063.1996; PEZARD C, 1993, J GEN MICROBIOL, V139, P2459, DOI 10.1099/00221287-139-10-2459; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Rollins SM, 2005, CELL MICROBIOL, V7, P1, DOI 10.1111/j.1462-5822.2004.00477.x; Saile E, 2002, J BACTERIOL, V184, P370, DOI 10.1128/JB.184.2.370-380.2002; Salim KY, 2005, INFECT IMMUN, V73, P6026, DOI 10.1128/IAI.73.9.6026-6038.2005; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; STERNE M, 1939, J VET SCI ANIM IND, V13, P307; Tinsley E, 2004, J BACTERIOL, V186, P2717, DOI 10.1128/JB.186.9.2717-2723.2004; Weber I, 2000, MOL MICROBIOL, V35, P1017, DOI 10.1046/j.1365-2958.2000.01794.x; Wei YP, 2004, J BACTERIOL, V186, P258, DOI 10.1128/JB.186.1.258-261.2004; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; WUENSCHER MD, 1993, J BACTERIOL, V175, P3491, DOI 10.1128/jb.175.11.3491-3501.1993; Yoong P, 2006, J BACTERIOL, V188, P2711, DOI 10.1128/JB.188.7.2711-2714.2006; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; YOUNG R, 1995, FEMS MICROBIOL REV, V17, P191, DOI 10.1016/0168-6445(94)00079-4	54	25	29	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1824	10.1371/journal.pone.0001824	http://dx.doi.org/10.1371/journal.pone.0001824			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350160	gold, Green Submitted, Green Published			2022-12-27	WOS:000260762300026
J	Wilmes, P; Wexler, M; Bond, PL				Wilmes, Paul; Wexler, Margaret; Bond, Philip L.			Metaproteomics Provides Functional Insight into Activated Sludge Wastewater Treatment	PLOS ONE			English	Article								Background: Through identification of highly expressed proteins from a mixed culture activated sludge system this study provides functional evidence of microbial transformations important for enhanced biological phosphorus removal (EBPR). Methodology/Principal Findings: A laboratory-scale sequencing batch reactor was successfully operated for different levels of EBPR, removing around 25, 40 and 55 mg/l P. The microbial communities were dominated by the uncultured polyphosphate-accumulating organism "Candidatus Accumulibacter phosphatis''. When EBPR failed, the sludge was dominated by tetrad-forming alpha-Proteobacteria. Representative and reproducible 2D gel protein separations were obtained for all sludge samples. 638 protein spots were matched across gels generated from the phosphate removing sludges. 111 of these were excised and 46 proteins were identified using recently available sludge metagenomic sequences. Many of these closely match proteins from "Candidatus Accumulibacter phosphatis'' and could be directly linked to the EBPR process. They included enzymes involved in energy generation, polyhydroxyalkanoate synthesis, glycolysis, gluconeogenesis, glycogen synthesis, glyoxylate/TCA cycle, fatty acid beta oxidation, fatty acid synthesis and phosphate transport. Several proteins involved in cellular stress response were detected. Conclusions/Significance: Importantly, this study provides direct evidence linking the metabolic activities of "Accumulibacter'' to the chemical transformations observed in EBPR. Finally, the results are discussed in relation to current EBPR metabolic models.	[Wilmes, Paul; Bond, Philip L.] Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England; [Wexler, Margaret; Bond, Philip L.] Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England	University of East Anglia; University of East Anglia	Wilmes, P (corresponding author), Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England.	phil.bond@uq.edu.au	Wilmes, Paul/B-1707-2017; Wexler, Margaret/G-3423-2011; Bond, Philip/C-6046-2009; Bond, Philip/N-6649-2017	Wilmes, Paul/0000-0002-6478-2924; Bond, Philip/0000-0002-9025-4797	Anglian Water; School of Environmental Sciences Studentship; British Council Chevening Scholarship; short-term research scholarship from the German Academic Exchange Service; research scholarship from the Luxembourg Ministry of Culture, Higher Education and Research; Biotechnology and Biological Sciences Research Council [BB/D013348/1]; BBSRC [BB/D013348/1] Funding Source: UKRI	Anglian Water; School of Environmental Sciences Studentship; British Council Chevening Scholarship; short-term research scholarship from the German Academic Exchange Service; research scholarship from the Luxembourg Ministry of Culture, Higher Education and Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project received financial support from Anglian Water. PW was supported by a School of Environmental Sciences Studentship, a British Council Chevening Scholarship, a short-term research scholarship from the German Academic Exchange Service and a research scholarship from the Luxembourg Ministry of Culture, Higher Education and Research. PLB and MW received support from the Biotechnology and Biological Sciences Research Council, grant reference no. BB/D013348/1.	Aldor AS, 2003, CURR OPIN BIOTECH, V14, P475, DOI 10.1016/j.copbio.2003.09.002; Baker-Austin C, 2005, MICROBIOL-SGM, V151, P2637, DOI 10.1099/mic.0.28076-0; Beer M, 2004, MICROBIOL-SGM, V150, P2267, DOI 10.1099/mic.0.26825-0; Benndorf D, 2007, ISME J, V1, P224, DOI 10.1038/ismej.2007.39; Blackall LL, 2002, ANTON LEEUW INT J G, V81, P681, DOI 10.1023/A:1020538429009; Bond PL, 1999, APPL ENVIRON MICROB, V65, P4077; BOND PL, 1995, APPL ENVIRON MICROB, V61, P1910, DOI 10.1128/AEM.61.5.1910-1916.1995; COMEAU Y, 1986, WATER RES, V20, P1511, DOI 10.1016/0043-1354(86)90115-6; Crocetti GR, 2000, APPL ENVIRON MICROB, V66, P1175, DOI 10.1128/AEM.66.3.1175-1182.2000; Crocetti GR, 2002, MICROBIOL-SGM, V148, P3353, DOI 10.1099/00221287-148-11-3353; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Falkentoft CM, 2002, WATER RES, V36, P491, DOI 10.1016/S0043-1354(01)00231-7; Filipe CDM, 2001, BIOTECHNOL BIOENG, V76, P32, DOI 10.1002/bit.1023; Gessesse A, 2003, WATER RES, V37, P3652, DOI 10.1016/S0043-1354(03)00241-0; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; He S, 2006, WATER SCI TECHNOL, V54, P111, DOI 10.2166/wst.2006.378; Hesketh AR, 2002, MOL MICROBIOL, V46, P917, DOI 10.1046/j.1365-2958.2002.03219.x; Hesselmann RPX, 2000, WATER RES, V34, P3487, DOI 10.1016/S0043-1354(00)00092-0; Hesselmann RPX, 1999, SYST APPL MICROBIOL, V22, P454, DOI 10.1016/S0723-2020(99)80055-1; Hu QZ, 2005, J MASS SPECTROM, V40, P430, DOI 10.1002/jms.856; Hugenholtz P, 1998, J BACTERIOL, V180, P6793, DOI 10.1128/JB.180.24.6793-6793.1998; Kan Jinjun, 2005, Saline Syst, V1, P7, DOI 10.1186/1746-1448-1-7; Klaassens ES, 2007, APPL ENVIRON MICROB, V73, P1388, DOI 10.1128/AEM.01921-06; Lacerda CMR, 2007, J PROTEOME RES, V6, P1145, DOI 10.1021/pr060477v; Lee N, 2003, SYST APPL MICROBIOL, V26, P211, DOI 10.1078/072320203322346065; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; Louie TM, 2000, WATER RES, V34, P1507, DOI 10.1016/S0043-1354(99)00302-4; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Maron PA, 2007, MICROB ECOL, V53, P486, DOI 10.1007/s00248-006-9196-8; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; McMahon KD, 2002, APPL ENVIRON MICROB, V68, P4971, DOI 10.1128/AEM.68.10.4971-4978.2002; Mino T., 1987, BIOLOGICAL PHOSPHATE, P27; Oehmen A, 2005, BIOTECHNOL BIOENG, V91, P162, DOI 10.1002/bit.20500; Pereira H, 1996, WATER RES, V30, P2128, DOI 10.1016/0043-1354(96)00035-8; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Rehm BHA, 2006, BIOTECHNOL LETT, V28, P207, DOI 10.1007/s10529-005-5521-4; ROLLER C, 1994, MICROBIOL-UK, V140, P2849, DOI 10.1099/00221287-140-10-2849; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sato S, 2007, J BIOSCI BIOENG, V103, P38, DOI 10.1263/jbb.103.38; Schulze WX, 2005, OECOLOGIA, V142, P335, DOI 10.1007/s00442-004-1698-9; Seviour RJ, 2003, FEMS MICROBIOL REV, V27, P99, DOI 10.1016/S0168-6445(03)00021-4; Seviour RJ, 2000, ENVIRON MICROBIOL, V2, P581, DOI 10.1046/j.1462-2920.2000.00153.x; van Veen HW, 1997, ANTON LEEUW INT J G, V72, P299, DOI 10.1023/A:1000530927928; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Waltermann M, 2005, J BACTERIOL, V187, P3607, DOI 10.1128/JB.187.11.3607-3619.2005; WENTZEL MC, 1991, WATER SCI TECHNOL, V23, P567, DOI 10.2166/wst.1991.0506; Wilmes P, 2006, WATER SCI TECHNOL, V54, P217, DOI 10.2166/wst.2006.390; Wilmes P, 2006, TRENDS MICROBIOL, V14, P92, DOI 10.1016/j.tim.2005.12.006; Wilmes P, 2004, ENVIRON MICROBIOL, V6, P911, DOI 10.1111/j.1462-2920.2004.00687.x; Wong MT, 2004, MICROBIOL-SGM, V150, P3741, DOI 10.1099/mic.0.27291-0; Yagci N, 2003, BIOTECHNOL BIOENG, V84, P359, DOI 10.1002/bit.10765	53	123	132	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2008	3	3							e1778	10.1371/journal.pone.0001778	http://dx.doi.org/10.1371/journal.pone.0001778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369VW	18392150	gold, Green Published			2022-12-27	WOS:000260723000031
J	Berrebi, D; Leclerc, J; Schleiermacher, G; Zaccaria, I; Boccon-Gibod, L; Fabre, M; Jaubert, F; El Ghoneimi, A; Jeanpierre, C; Peuchmaur, M				Berrebi, Dominique; Leclerc, Julie; Schleiermacher, Gudrun; Zaccaria, Isabelle; Boccon-Gibod, Liliane; Fabre, Monique; Jaubert, Francis; El Ghoneimi, Alaa; Jeanpierre, Cecile; Peuchmaur, Michel			High Cyclin E Staining Index in Blastemal, Stromal or Epithelial Cells Is Correlated with Tumor Aggressiveness in Patients with Nephroblastoma	PLOS ONE			English	Article								Purpose: Identifying among nephroblastoma those with a high propensity for distant metastases using cell cycle markers: cyclin E as a regulator of progression through the cell cycle and Ki-67 as a tumor proliferation marker, since both are often deregulated in many human malignancies. Methodology/Principal Findings: A staining index (SI) was obtained by immunohistochemistry using anti-cyclin E and anti-Ki-67 antibodies in paraffin sections of 54 postchemotherapy nephroblastoma including 42 nephroblastoma without metastasis and 12 with metastases. Median cyclin E and Ki-67 SI were 46% and 33% in blastemal cells, 30% and 10% in stromal cells, 37% and 29.5% in epithelial cells. The highest values were found for anaplastic nephroblastoma. A correlation between cyclin E and Ki-67 SI was found for the blastemal component and for the epithelial component. Univariate analysis showed prognostic significance for metastases with cyclin E SI in stromal cells, epithelial cells and blastemal cells (p = 0.03, p = 0.01 and p = 0.002, respectively) as well as with Ki-67 SI in blastema (p, 10 24). The most striking data were that both cyclin E SI and blastemal Ki-67 SI discriminated between patients with metastases and patients without metastasis among intermediate-risk nephroblastoma. Conclusions: Our findings show that a high cyclin E SI in all components of nephroblastoma is correlated with tumor aggressiveness and metastases, and that assessment of its expression may have prognostic value in the categorization of nephroblastoma.	[Berrebi, Dominique; Peuchmaur, Michel] Hop Robert Debre, AP HP, Serv Anat & Cytol Pathol, F-75019 Paris, France; [Berrebi, Dominique; Leclerc, Julie; El Ghoneimi, Alaa; Peuchmaur, Michel] Univ Paris 07, UFR Med EA3102, Paris, France; [Leclerc, Julie; Jeanpierre, Cecile] Univ Paris 05, Fac Med, Hop Necker Enfants Malades, Inserm U574, Paris, France; [Schleiermacher, Gudrun] Inst Curie, Serv Oncol Pediat, Paris, France; [Zaccaria, Isabelle] Assistance Publ Hop Paris AP HP, Hop Robert Debre, Unite Epidemiol Clin, Paris, France; [Zaccaria, Isabelle] Hop Robert Debre, CIE5, Inserm, Paris, France; [Boccon-Gibod, Liliane] Assistance Publ Hop Paris AP HP, Hop Armand Trousseau, Serv Anatom Cytol Pathol, Paris, France; [Fabre, Monique] Assistance Publ Hop Paris AP HP, Hop Bicetre, Serv Anatom Cytol Pathol, Paris, France; [Jaubert, Francis] Assistance Publ Hop Paris AP HP, Hop Necker Enfants Malades, Serv Anatom Cytol Pathol, Paris, France; [El Ghoneimi, Alaa] Assistance Publ Hop Paris AP HP, Hop Robert Debre, Serv Chirurg Infantile, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Berrebi, D (corresponding author), Hop Robert Debre, AP HP, Serv Anat & Cytol Pathol, F-75019 Paris, France.	dominique.berrebi@rdb.ap-hop-paris.fr	Schleiermacher, Gudrun/AAN-4711-2021; berrebi, dominique/B-1419-2014; Jeanpierre, cecile/H-3770-2017	Schleiermacher, Gudrun/0000-0002-0133-5879; Jeanpierre, cecile/0000-0002-3463-5907; El Ghoneimi, Alaa/0000-0001-8133-2979				Dome JS, 2005, J CLIN ONCOL, V23, P9138, DOI 10.1200/JCO.2005.00.562; DUTTA A, 1995, P NATL ACAD SCI USA, V92, P5386, DOI 10.1073/pnas.92.12.5386; Eggert A, 2001, J CLIN ONCOL, V19, P689, DOI 10.1200/JCO.2001.19.3.689; FAUSSILLON M, 2005, CANC LETT, V67, pD2; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Ghanem MA, 2005, UROLOGY, V65, P1047, DOI 10.1016/j.urology.2004.12.005; Ghanem MA, 2004, CLIN CANCER RES, V10, P591, DOI 10.1158/1078-0432.CCR-0884-02; Ghanem MA, 2003, J CLIN PATHOL, V56, P107, DOI 10.1136/jcp.56.2.107; Ghanem MA, 2001, CANCER-AM CANCER SOC, V92, P3120, DOI 10.1002/1097-0142(20011215)92:12<3120::AID-CNCR10173>3.0.CO;2-2; Ghanems MA, 2001, BRIT J CANCER, V85, P1557, DOI 10.1054/bjoc.2001.2146; Grundy PE, 2005, J CLIN ONCOL, V23, P7312, DOI 10.1200/JCO.2005.01.2799; Harwell RM, 2000, CANCER RES, V60, P481; Hunt KK, 2005, SEMIN CANCER BIOL, V15, P319, DOI 10.1016/j.semcancer.2005.04.007; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Juszkiewicz Piotr, 1997, Polish Journal of Pathology, V48, P113; Loeb DM, 2002, J BIOL CHEM, V277, P19627, DOI 10.1074/jbc.M201336200; Marshall RJ, 2001, J CLIN EPIDEMIOL, V54, P603, DOI 10.1016/S0895-4356(00)00344-9; NAGOSHI M, 1994, J SURG ONCOL, V55, P114, DOI 10.1002/jso.2930550211; Natrajan R, 2006, CLIN CANCER RES, V12, P7284, DOI 10.1158/1078-0432.CCR-06-1567; Natrajan R, 2006, CANCER RES, V66, P11148, DOI 10.1158/0008-5472.CAN-06-1931; Perlman E, 2004, ANN PATHOL, V24, P516, DOI 10.1016/S0242-6498(04)94016-3; Pollack A, 2004, J CLIN ONCOL, V22, P2133, DOI 10.1200/JCO.2004.09.150; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Rosen DG, 2006, CANCER-AM CANCER SOC, V106, P1925, DOI 10.1002/cncr.21767; Singhal S, 2005, CLIN CANCER RES, V11, P3974, DOI 10.1158/1078-0432.CCR-04-2661; Takahashi M, 2002, CANCER RES, V62, P6598; Tissier F, 2004, EUR J ENDOCRINOL, V150, P809, DOI 10.1530/eje.0.1500809; Vujanic GM, 2002, MED PEDIATR ONCOL, V38, P79, DOI 10.1002/mpo.1276; Wingate H, 2005, J BIOL CHEM, V280, P15148, DOI 10.1074/jbc.M409789200; Wittmann S, 2008, GENE CHROMOSOME CANC, V47, P386, DOI 10.1002/gcc.20544	30	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2216	10.1371/journal.pone.0002216	http://dx.doi.org/10.1371/journal.pone.0002216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493303	Green Submitted, Green Published, gold			2022-12-27	WOS:000262258700024
J	Colomb, S; Joly, W; Bonneaud, N; Maschat, F				Colomb, Sophie; Joly, Willy; Bonneaud, Nathalie; Maschat, Florence			A Concerted Action of Engrailed and Gooseberry-Neuro in Neuroblast 6-4 Is Triggering the Formation of Embryonic Posterior Commissure Bundles	PLOS ONE			English	Article								One challenging question in neurogenesis concerns the identification of cues that trigger axonal growth and pathfinding to form stereotypic neuronal networks during the construction of a nervous system. Here, we show that in Drosophila, Engrailed (EN) and Gooseberry-Neuro (GsbN) act together as cofactors to build the posterior commissures (PCs), which shapes the ventral nerve cord. Indeed, we show that these two proteins are acting together in axon growth and midline crossing, and that this concerted action occurs at early development, in neuroblasts. More precisely, we identified that their expressions in NB 6-4 are necessary and sufficient to trigger the formation of the PCs, demonstrating that segmentation genes such as EN and GsbN play a crucial role in the determination of NB 6-4 in a way that will later influence growth and guidance of all the axons that form the PCs. We also demonstrate a more specific function of GsbN in differentiated neurons, leading to fasciculations between axons, which might be required to obtain PC mature axon bundles.	[Colomb, Sophie; Joly, Willy; Bonneaud, Nathalie; Maschat, Florence] Inst Human Genet, Montpellier, France	Universite de Montpellier	Colomb, S (corresponding author), Inst Human Genet, Montpellier, France.	fmaschat@igh.cnrs.fr		Colomb, Sophie/0000-0001-6948-120X	CNRS [ACI-BCMS270]; ARC [3595]	CNRS(Centre National de la Recherche Scientifique (CNRS)); ARC(Australian Research Council)	Financial support for FM was CNRS, ACI-BCMS270 and ARC 3595.	Alexandre C, 2003, DEVELOPMENT, V130, P729, DOI 10.1242/dev.00286; BATE CM, 1976, NATURE, V260, P54, DOI 10.1038/260054a0; Baumgardt M, 2007, PLOS BIOL, V5, P295, DOI 10.1371/journal.pbio.0050037; BAUMGARTNER S, 1987, GENE DEV, V1, P1247, DOI 10.1101/gad.1.10.1247; Bhat KM, 1999, BIOESSAYS, V21, P472, DOI 10.1002/(SICI)1521-1878(199906)21:6<472::AID-BIES4>3.0.CO;2-W; Bhat KM, 1997, DEVELOPMENT, V124, P1675; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8; Brunet I, 2007, TRENDS NEUROSCI, V30, P260, DOI 10.1016/j.tins.2007.03.010; Butler SJ, 2007, DEVELOPMENT, V134, P439, DOI 10.1242/dev.02762; Casso D, 2000, MECH DEVELOP, V91, P449; Chanas G, 2004, DEV BIOL, V272, P522, DOI 10.1016/j.ydbio.2004.05.020; Deshpande N, 2001, DEVELOPMENT, V128, P3253; Dittrich R, 1997, DEVELOPMENT, V124, P2515; DOE CQ, 1992, DEVELOPMENT, V116, P855; Dubois L, 2007, DEVELOPMENT, V134, P4347, DOI 10.1242/dev.008409; DumanScheel M, 1997, DEVELOPMENT, V124, P2855; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Garbe DS, 2007, J NEUROSCI, V27, P3584, DOI 10.1523/JNEUROSCI.0301-07.2007; Girard F, 2006, DEV BIOL, V299, P530, DOI 10.1016/j.ydbio.2006.08.014; Gustavson E, 1996, GENETICS, V142, P893; GUTJAHR T, 1993, DEVELOPMENT, V118, P21; Hidalgo A, 1997, DEVELOPMENT, V124, P3253; HIDALGO A, 1995, DEVELOPMENT, V121, P3703; Hidalgo A, 2000, DEVELOPMENT, V127, P393; Higashijima S, 1996, DEVELOPMENT, V122, P527; Hummel T, 1999, DEV BIOL, V209, P381, DOI 10.1006/dbio.1999.9235; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; JACOBS JR, 1989, J NEUROSCI, V9, P2412; Joly W, 2007, DEV BIOL, V301, P542, DOI 10.1016/j.ydbio.2006.10.019; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; Klein T, 1997, DEVELOPMENT, V124, P3123; Kuzin A, 2005, DEV BIOL, V277, P347, DOI 10.1016/j.ydbio.2004.09.027; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LI XL, 1994, NATURE, V367, P83, DOI 10.1038/367083a0; LIN DM, 1995, NEURON, V14, P707, DOI 10.1016/0896-6273(95)90215-5; Liu AM, 2001, DEVELOPMENT, V128, P181; Louvi A, 2000, DEVELOPMENT, V127, P4061; Lundell MJ, 1998, DEVELOPMENT, V125, P463; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Matsuzaki M, 1996, DEVELOPMENT, V122, P3567; Milan M, 2000, DEVELOPMENT, V127, P3069; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Plachez C, 2005, CURR TOP DEV BIOL, V69, P267, DOI 10.1016/S0070-2153(05)69010-2; Ragone G, 2003, DEV BIOL, V255, P138, DOI 10.1016/S0012-1606(02)00081-7; SAENZROBLES MT, 1995, MECH DEVELOP, V53, P185, DOI 10.1016/0925-4773(95)00433-2; Sanchez-Soriano N, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-9; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; SERRANO N, 1995, DEVELOPMENT, V121, P1691; Serrano N, 1997, DEVELOPMENT, V124, P2527; Simon HH, 2003, ANN NY ACAD SCI, V991, P36; Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2; Solano PJ, 2003, DEVELOPMENT, V130, P1243, DOI 10.1242/dev.00348; TABATA T, 1995, DEVELOPMENT, V121, P3359; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Yang XH, 1997, GENE DEV, V11, P1396, DOI 10.1101/gad.11.11.1396; ZHANG Y, 1994, DEVELOPMENT, V120, P1151	60	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2197	10.1371/journal.pone.0002197	http://dx.doi.org/10.1371/journal.pone.0002197			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493305	Green Published, Green Submitted, gold			2022-12-27	WOS:000262258700006
J	Fontana, L; Fiori, ME; Albini, S; Cifaldi, L; Giovinazzi, S; Forloni, M; Boldrini, R; Donfrancesco, A; Federici, V; Giacomini, P; Peschle, C; Fruci, D				Fontana, Laura; Fiori, Micol E.; Albini, Sonia; Cifaldi, Loredana; Giovinazzi, Serena; Forloni, Matteo; Boldrini, Renata; Donfrancesco, Alberto; Federici, Valentina; Giacomini, Patrizio; Peschle, Cesare; Fruci, Doriana			Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM	PLOS ONE			English	Article							N-MYC; MICRORNAS; EXPRESSION; APOPTOSIS; PROLIFERATION; SUPPRESSION; BIOGENESIS; INHIBITOR; MUTATIONS; INDUCTION	We identified a key oncogenic pathway underlying neuroblastoma progression: specifically, MYCN, expressed at elevated level, transactivates the miRNA 17-5p-92 cluster, which inhibits p21 and BIM translation by interaction with their mRNA 39 UTRs. Overexpression of miRNA 17-5p-92 cluster in MYCN-not-amplified neuroblastoma cells strongly augments their in vitro and in vivo tumorigenesis. In vitro or in vivo treatment with antagomir-17-5p abolishes the growth of MYCN-amplified and therapy-resistant neuroblastoma through p21 and BIM upmodulation, leading to cell cycling blockade and activation of apoptosis, respectively. In primary neuroblastoma, the majority of cases show a rise of miR-17-5p level leading to p21 downmodulation, which is particularly severe in patients with MYCN amplification and poor prognosis. Altogether, our studies demonstrate for the first time that antagomir treatment can abolish tumor growth in vivo, specifically in therapy-resistant neuroblastoma.	[Fontana, Laura; Fiori, Micol E.; Giovinazzi, Serena; Peschle, Cesare] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Albini, Sonia; Cifaldi, Loredana; Forloni, Matteo; Fruci, Doriana] Osped Pediat Bambino Gesu, Res Ctr, Rome, Italy; [Boldrini, Renata] Osped Pediat Bambino Gesu, Div Pathol, Rome, Italy; [Donfrancesco, Alberto] Osped Pediat Bambino Gesu, Div Pediat Oncol, Rome, Italy; [Federici, Valentina] Regina Elena Inst Canc Res, Pathol Lab, Rome, Italy; [Giacomini, Patrizio] Regina Elena Inst Canc Res, Lab Immunol, Rome, Italy; [Peschle, Cesare] IRCCS MultiMedica, Milan, Italy	Istituto Superiore di Sanita (ISS); IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Multimedica	Fontana, L (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	lfontana@iss.it	Fiori, Micol E/J-4043-2014; Giacomini, Patrizio/K-5217-2016; Cifaldi, Loredana/AAI-1972-2019; Fiori, Micol Eleonora/J-7295-2016; Fruci, Doriana/AAA-8218-2019	Fiori, Micol E/0000-0002-1813-7035; Giacomini, Patrizio/0000-0001-6109-1709; Fiori, Micol Eleonora/0000-0002-1813-7035; Fruci, Doriana/0000-0003-3388-7296; Cifaldi, Loredana/0000-0001-5014-430X; Forloni, Matteo/0000-0003-4858-8491; albini, sonia/0000-0001-9502-1004	Italy-USA Oncology Program, Istituto Superiore di Sanita, Rome, Italy; AIRC, Milan, Italy	Italy-USA Oncology Program, Istituto Superiore di Sanita, Rome, Italy; AIRC, Milan, Italy(Fondazione AIRC per la ricerca sul cancro)	Supported by Italy-USA Oncology Program, Istituto Superiore di Sanita, Rome, Italy to CP and AIRC, Milan, Italy to DF.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Fulda S, 1999, ONCOGENE, V18, P1479, DOI 10.1038/sj.onc.1202435; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Goldschneider D, 2006, NUCLEIC ACIDS RES, V34, P5603, DOI 10.1093/nar/gkl619; HARPER JW, 1993, CELL, V75, P805; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; IVANOVSKA I, 2008, MOL CELL BIOL; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Laneve P, 2007, P NATL ACAD SCI USA, V104, P7957, DOI 10.1073/pnas.0700071104; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Leonetti C, 1999, CLIN CANCER RES, V5, P2588; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Lutz W, 1996, ONCOGENE, V13, P803; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Martin-Caballero J, 2001, CANCER RES, V61, P6234; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Santamaria D, 2006, FRONT BIOSCI-LANDMRK, V11, P1164, DOI 10.2741/1871; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; SHIOHARA M, 1994, BLOOD, V84, P3781, DOI 10.1182/blood.V84.11.3781.bloodjournal84113781; Tan TT, 2005, CANCER CELL, V7, P227, DOI 10.1016/j.ccr.2005.02.008; Tweddle DA, 2001, AM J PATHOL, V158, P2067, DOI 10.1016/S0002-9440(10)64678-0; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van Golen CM, 2003, ONCOGENE, V22, P2664, DOI 10.1038/sj.onc.1206362; VOGAN K, 1993, CANCER RES, V53, P5269; Wang Q, 2003, CANCER RES, V63, P1631; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang WY, 2007, AM J PATHOL, V171, P728, DOI 10.2353/ajpath.2007.070070; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	50	305	327	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2236	10.1371/journal.pone.0002236	http://dx.doi.org/10.1371/journal.pone.0002236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493594	gold, Green Submitted, Green Published			2022-12-27	WOS:000262258700044
J	Souza, GR; Yonel-Gumruk, E; Fan, D; Easley, J; Rangel, R; Guzman-Rojas, L; Miller, JH; Arap, W; Pasqualini, R				Souza, Glauco R.; Yonel-Gumruk, Esra; Fan, Davin; Easley, Jeffrey; Rangel, Roberto; Guzman-Rojas, Liliana; Miller, J. Houston; Arap, Wadih; Pasqualini, Renata			Bottom-Up Assembly of Hydrogels from Bacteriophage and Au Nanoparticles: The Effect of Cis- and Trans-Acting Factors	PLOS ONE			English	Article								Hydrogels have become a promising research focus because of their potential for biomedical application. Here we explore the long-range, electrostatic interactions by following the effect of trans-acting (pH) and cis-acting factors (peptide mutation) on the formation of Au-phage hydrogels. These bioinorganic hydrogels can be generated from the bottom-up assembly of Au nanoparticles (Au NP) with either native or mutant bacteriophage (phage) through electrostatic interaction of the phage pVIII major capsid proteins (pVIII). The cis-acting factor consists of a peptide extension displayed on the pVIII that mutates the phage. Our results show that pH can dictate the direct-assembly and stability of Au-phage hydrogels in spite of the differences between the native and the mutant pVIII. The first step in characterizing the interactions of Au NP with phage was to generate a molecular model that identified the charge distribution and structure of the native and mutant pVIII. This model indicated that the mutant peptide extension carried a higher positive charge relative to the native pVIII at all pHs. Next, by monitoring the Au-phage interaction by means of optical microscopy, elastic light scattering, fractal dimension analysis as well as Uv-vis and surface plasmon resonance spectroscopy, we show that the positive charge of the mutant peptide extension favors the opposite charge affinity between the phage and Au NP as the pH is decreased. These results show the versatility of this assembly method, where the stability of these hydrogels can be achieved by either adjusting the pH or by changing the composition of the phage pVIII without the need of phage display libraries.	[Souza, Glauco R.; Rangel, Roberto; Guzman-Rojas, Liliana; Arap, Wadih; Pasqualini, Renata] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Souza, Glauco R.; Rangel, Roberto; Guzman-Rojas, Liliana; Arap, Wadih; Pasqualini, Renata] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX USA; [Fan, Davin; Easley, Jeffrey; Miller, J. Houston] Massachusetts Inst Technol, Dept Chem Engn, Boston, MA USA; [Yonel-Gumruk, Esra] George Washington Univ, Dept Chem, Washington, DC USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Massachusetts Institute of Technology (MIT); George Washington University	Souza, GR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.	rpasqual@mdanderson.org	Rangel, Roberto/AHE-6583-2022; Miller, John Houston/B-7324-2009	Rangel, Roberto/0000-0002-9088-7957; Miller, John Houston/0000-0002-6686-1976	Odyssey Program at The University of Texas M.D. Anderson Cancer Center; Department of Defense [Breast Cancer Concept Award]; Gillson-Longenbaugh Foundation	Odyssey Program at The University of Texas M.D. Anderson Cancer Center; Department of Defense(United States Department of Defense); Gillson-Longenbaugh Foundation	G.S. is a Scholar from the Odyssey Program at The University of Texas M.D. Anderson Cancer Center and a recipient of the Breast Cancer Concept Award from DOD. R.R. is also a Scholar from the Odyssey Program at The University of Texas M.D. Anderson Cancer Center. This work was supported by a grant from the Department of Defense and by an award from the Gillson-Longenbaugh Foundation (to W.A. and R.P.). Besides funding the work, the sponsors did not have any role in designing or conducting these studies.	Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Chen C, 2006, NANO LETT, V6, P611, DOI 10.1021/nl0600878; Chen LM, 2004, CHEM BIOL, V11, P1081, DOI 10.1016/j.chembiol.2004.05.019; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; HANDLEY D A, 1989, P23; Huang Y, 2005, NANO LETT, V5, P1429, DOI 10.1021/nl050795d; LEITE ER, 2004, ENCY NANOSCIENCE NAN, P537; Lin Y, 2003, LANGMUIR, V19, P10000, DOI 10.1021/la0350251; Peterson AW, 2002, J AM CHEM SOC, V124, P14601, DOI 10.1021/ja0279996; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; Shipway AN, 2000, LANGMUIR, V16, P8789, DOI [10.1021/la000316k, 10.1021/1a000316k]; Sigal GB, 1996, ANAL CHEM, V68, P490, DOI 10.1021/ac9504023; Souza GR, 2006, ANAL CHEM, V78, P6232, DOI 10.1021/ac060483a; Souza GR, 2006, P NATL ACAD SCI USA, V103, P1215, DOI 10.1073/pnas.0509739103; Souza GR, 2001, J AM CHEM SOC, V123, P6734, DOI 10.1021/ja005919x; SOUZA GR, 2006, ANN REV PLASMONICS; Weisbecker CS, 1996, LANGMUIR, V12, P3763, DOI 10.1021/la950776r; ZACHER AN, 1980, GENE, V9, P127, DOI 10.1016/0378-1119(80)90171-7; Zhong ZY, 2004, J PHYS CHEM B, V108, P4046, DOI 10.1021/jp037056a	20	39	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2242	10.1371/journal.pone.0002242	http://dx.doi.org/10.1371/journal.pone.0002242			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493583	Green Published, Green Submitted, gold			2022-12-27	WOS:000262258700050
J	Steinbeis, N; Koelsch, S				Steinbeis, Nikolaus; Koelsch, Stefan			Comparing the Processing of Music and Language Meaning Using EEG and fMRI Provides Evidence for Similar and Distinct Neural Representations	PLOS ONE			English	Article								Recent demonstrations that music is capable of conveying semantically meaningful information has raised several questions as to what the underlying mechanisms of establishing meaning in music are, and if the meaning of music is represented in comparable fashion to language meaning. This paper presents evidence showing that expressed affect is a primary pathway to music meaning and that meaning in music is represented in a very similar fashion to language meaning. In two experiments using EEG and fMRI, it was shown that single chords varying in harmonic roughness (consonance/dissonance) and thus perceived affect could prime the processing of subsequently presented affective target words, as indicated by an increased N400 and activation of the right middle temporal gyrus (MTG). Most importantly, however, when primed by affective words, single chords incongruous to the preceding affect also elicited an N400 and activated the right posterior STS, an area implicated in processing meaning of a variety of signals (e.g. prosody, voices, motion). This provides an important piece of evidence in support of music meaning being represented in a very similar but also distinct fashion to language meaning: Both elicit an N400, but activate different portions of the right temporal lobe.	[Steinbeis, Nikolaus] Max Planck Inst Human Cognit & Brain Res, Leipzig, Germany; [Koelsch, Stefan] Univ Sussex, Dept Psychol, Brighton, E Sussex, England	Max Planck Society; University of Sussex	Steinbeis, N (corresponding author), Max Planck Inst Human Cognit & Brain Res, Leipzig, Germany.	steinb@cbs.mpg.de	Koelsch, Stefan/AAV-1556-2020					Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Grandjean D, 2005, NAT NEUROSCI, V8, P145, DOI 10.1038/nn1392; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2005, TRENDS COGN SCI, V9, P578, DOI 10.1016/j.tics.2005.10.001; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Maess B, 2006, BRAIN RES, V1096, P163, DOI 10.1016/j.brainres.2006.04.037; Miranda RA, 2007, NEUROIMAGE, V38, P331, DOI 10.1016/j.neuroimage.2007.07.034; Schirmer A, 2003, J COGNITIVE NEUROSCI, V15, P1135, DOI 10.1162/089892903322598102; Sloboda J. A., 1986, MUSICAL MIND; Swain J., 1997, MUSICAL LANGUAGES; Talairach J., 1988, COPLANAR STEREOTAXIC; VANDEGEER JP, 1962, ACTA PSYCHOL, V20, P308, DOI 10.1016/0001-6918(62)90028-8; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	21	77	82	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2226	10.1371/journal.pone.0002226	http://dx.doi.org/10.1371/journal.pone.0002226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493611	Green Published, gold, Green Submitted			2022-12-27	WOS:000262258700034
J	Bettencourt, LMA; Ribeiro, RM				Bettencourt, Luis M. A.; Ribeiro, Ruy M.			Real Time Bayesian Estimation of the Epidemic Potential of Emerging Infectious Diseases	PLOS ONE			English	Article							TO-HUMAN TRANSMISSION; H5N1 INFLUENZA-VIRUS; PANDEMIC INFLUENZA; POPULATION; STRATEGIES; EVOLUTION; DYNAMICS; OUTBREAK; RISK	Background: Fast changes in human demographics worldwide, coupled with increased mobility, and modified land uses make the threat of emerging infectious diseases increasingly important. Currently there is worldwide alert for H5N1 avian influenza becoming as transmissible in humans as seasonal influenza, and potentially causing a pandemic of unprecedented proportions. Here we show how epidemiological surveillance data for emerging infectious diseases can be interpreted in real time to assess changes in transmissibility with quantified uncertainty, and to perform running time predictions of new cases and guide logistics allocations. Methodology/Principal Findings: We develop an extension of standard epidemiological models, appropriate for emerging infectious diseases, that describes the probabilistic progression of case numbers due to the concurrent effects of (incipient) human transmission and multiple introductions from a reservoir. The model is cast in terms of surveillance observables and immediately suggests a simple graphical estimation procedure for the effective reproductive number R (mean number of cases generated by an infectious individual) of standard epidemics. For emerging infectious diseases, which typically show large relative case number fluctuations over time, we develop a Bayesian scheme for real time estimation of the probability distribution of the effective reproduction number and show how to use such inferences to formulate significance tests on future epidemiological observations. Conclusions/Significance: Violations of these significance tests define statistical anomalies that may signal changes in the epidemiology of emerging diseases and should trigger further field investigation. We apply the methodology to case data from World Health Organization reports to place bounds on the current transmissibility of H5N1 influenza in humans and establish a statistical basis for monitoring its evolution in real time.	[Bettencourt, Luis M. A.; Ribeiro, Ruy M.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; [Bettencourt, Luis M. A.] Santa Fe Inst, Santa Fe, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute	Bettencourt, LMA (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.	lmbett@lanl.gov	Bettencourt, Luis/R-9861-2019	Ribeiro, Ruy/0000-0002-3988-8241	U.S. Department of Energy	U.S. Department of Energy(United States Department of Energy (DOE))	We gratefully acknowledge the support of the U.S. Department of Energy through the LANL/LDRD Program for this work.	Abbott A, 2004, NATURE, V427, P472, DOI 10.1038/427472a; ANDERSON RA, 1995, INFECT DIS HUMANS; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Bettencourt LMA, 2007, LECT NOTES COMPUT SC, V4506, P79; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Brauer F., 2012, MATH MODELS POPULATI, V2; Cauchemez S, 2006, EMERG INFECT DIS, V12, P110; Cauchemez S, 2006, AM J EPIDEMIOL, V164, P591, DOI 10.1093/aje/kwj274; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Fauci AS, 2005, NATURE, V435, P423, DOI 10.1038/435423a; Ferguson NM, 2004, SCIENCE, V304, P968, DOI 10.1126/science.1096898; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferrari MJ, 2005, MATH BIOSCI, V198, P14, DOI 10.1016/j.mbs.2005.08.002; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Gog JR, 2003, P NATL ACAD SCI USA, V100, P11143, DOI 10.1073/pnas.1830296100; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; LAWSON AB, SPATIAL SYNDROMIC SU; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Matthews L, 2005, NAT REV MICROBIOL, V3, P529, DOI 10.1038/nrmicro1178; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Mills CE, 2006, PLOS MED, V3, P769, DOI 10.1371/journal.pmed.0030135; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Olsen SJ, 2005, EMERG INFECT DIS, V11, P1799; Ortiz JR, 2007, J INFECT DIS, V196, P1685, DOI 10.1086/522158; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Sedyaningsih ER, 2007, J INFECT DIS, V196, P522, DOI 10.1086/519692; SPICER CC, 1984, J HYG-CAMBRIDGE, V93, P105, DOI 10.1017/S0022172400060988; Tiensin T, 2007, J INFECT DIS, V196, P1679, DOI 10.1086/522007; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; van Boven M, 2007, PLOS COMPUT BIOL, V3, P1394, DOI 10.1371/journal.pcbi.0030145; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; Yang Y, 2007, EMERG INFECT DIS, V13, P1348, DOI 10.3201/eid1309.070111; 2005, AVIAN INFLUENZA ASSE	44	135	140	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2185	10.1371/journal.pone.0002185	http://dx.doi.org/10.1371/journal.pone.0002185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478118	Green Submitted, gold, Green Published			2022-12-27	WOS:000262172800050
J	Lanier, W; Moustafa, A; Bhattacharya, D; Comeron, JM				Lanier, William; Moustafa, Ahmed; Bhattacharya, Debashish; Comeron, Josep M.			EST Analysis of Ostreococcus lucimarinus, the Most Compact Eukaryotic Genome, Shows an Excess of Introns in Highly Expressed Genes	PLOS ONE			English	Article								Background: The genome of the pico-eukaryotic (bacterial-sized) prasinophyte green alga Ostreococcus lucimarinus has one of the highest gene densities known in eukaryotes, yet it contains many introns. Phylogenetic studies suggest this unusually compact genome (13.2 Mb) is an evolutionarily derived state among prasinophytes. The presence of introns in the highly reduced O. lucimarinus genome appears to be in opposition to simple explanations of genome evolution based on unidirectional tendencies, either neutral or selective. Therefore, patterns of intron retention in this species can potentially provide insights into the forces governing intron evolution. Methodology/Principal Findings: Here we studied intron features and levels of expression in O. lucimarinus using expressed sequence tags (ESTs) to annotate the current genome assembly. ESTs were assembled into unigene clusters that were mapped back to the O. lucimarinus Build 2.0 assembly using BLAST and the level of gene expression was inferred from the number of ESTs in each cluster. We find a positive correlation between expression levels and both intron number (R = +0.0893, p = <0.0005) and intron density (number of introns/kb of CDS; R = +0.0753, p = <0.005). Conclusions/Significance: In a species with a genome that has been recently subjected to a great reduction of non-coding DNA, these results imply the existence of selective/functional roles for introns that are principally detectable in highly expressed genes. In these cases, introns are likely maintained by balancing the selective forces favoring their maintenance with other mutational and/or selective forces acting on genome size.	[Lanier, William; Moustafa, Ahmed; Bhattacharya, Debashish; Comeron, Josep M.] Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA; [Bhattacharya, Debashish; Comeron, Josep M.] Univ Iowa, Roy J Carver Ctr Comparative Genom, Dept Biol Sci, Iowa City, IA USA	University of Iowa; University of Iowa	Lanier, W (corresponding author), Univ Iowa, Interdisciplinary Program Genet, Iowa City, IA 52242 USA.	josep-comeron@uiowa.edu	Moustafa, Ahmed/C-5234-2009; Comeron, Josep/G-6630-2012; Moustafa, Ahmed/AAZ-3991-2020	Moustafa, Ahmed/0000-0002-0111-3555; Moustafa, Ahmed/0000-0002-0111-3555	National Science Foundation [DEB-03-44209, EF 04-31117, EF 06-25440]; National Institutes of Health [T 32 GM98629]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629, R01GM098629] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Science Foundation awarded to JMC (DEB-03-44209) and to DB (EF 04-31117, EF 06-25440). WL was supported by an Institutional NRSA (T 32 GM98629) from the National Institutes of Health.	Ares M, 1999, RNA, V5, P1138, DOI 10.1017/S1355838299991379; Blumenstiel JP, 2002, MOL BIOL EVOL, V19, P2211, DOI 10.1093/oxfordjournals.molbev.a004045; Carvalho AB, 1999, NATURE, V401, P344, DOI 10.1038/43827; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; CHRETIENNOTDINET MJ, 1995, PHYCOLOGIA, V34, P285, DOI 10.2216/i0031-8884-34-4-285.1; Comeron JM, 2004, GENETICS, V167, P1293, DOI 10.1534/genetics.104.026351; Comeron JM, 2002, GENETICS, V161, P389; Comeron JM, 2001, CURR OPIN GENET DEV, V11, P652, DOI 10.1016/S0959-437X(00)00249-5; Comeron JM, 2000, GENETICS, V156, P1175; COURTIES C, 1994, NATURE, V370, P255, DOI 10.1038/370255a0; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Fahey ME, 2007, J MOL EVOL, V65, P349, DOI 10.1007/s00239-007-9015-y; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Gregory TR, 2004, GENE, V324, P15, DOI 10.1016/j.gene.2003.09.030; Gregory TR, 2005, ANN BOT-LONDON, V95, P133, DOI 10.1093/aob/mci009; Gregory TR, 2003, TRENDS GENET, V19, P485, DOI 10.1016/S0168-9525(03)00192-6; Henderson GP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000749; Kapraun DF, 2007, ANN BOT-LONDON, V99, P677, DOI 10.1093/aob/mcl294; Keeling Patrick J, 2007, Trends Genet, V23, P151, DOI 10.1016/j.tig.2007.02.008; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lynch M, 2003, MOL BIOL EVOL, V20, P563, DOI 10.1093/molbev/msg068; Munoz ET, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-30; Ophir R, 1997, GENE, V205, P191, DOI 10.1016/S0378-1119(97)00398-3; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Pendle AF, 2005, MOL BIOL CELL, V16, P260, DOI 10.1091/mbc.E04-09-0791; Petrov DA, 1997, GENE, V205, P279, DOI 10.1016/S0378-1119(97)00516-7; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Petrov DA, 2002, THEOR POPUL BIOL, V61, P531, DOI 10.1006/tpbi.2002.1605; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; Petrov DA, 2000, SCIENCE, V287, P1060, DOI 10.1126/science.287.5455.1060; Presgraves DC, 2006, MOL BIOL EVOL, V23, P2203, DOI 10.1093/molbev/msl094; Ren XY, 2006, TRENDS GENET, V22, P528, DOI 10.1016/j.tig.2006.08.008; Robbens S, 2007, MOL BIOL EVOL, V24, P956, DOI 10.1093/molbev/msm012; Scofield DG, 2007, MOL BIOL EVOL, V24, P896, DOI 10.1093/molbev/msm010; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; STEINKOTTER J, 1994, J PHYCOL, V30, P340, DOI 10.1111/j.0022-3646.1994.00340.x; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Vinogradov AE, 1999, J MOL EVOL, V49, P376, DOI 10.1007/PL00006561; Williams BAP, 2005, P NATL ACAD SCI USA, V102, P10936, DOI 10.1073/pnas.0501321102; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	42	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2171	10.1371/journal.pone.0002171	http://dx.doi.org/10.1371/journal.pone.0002171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478122	Green Published, gold			2022-12-27	WOS:000262172800036
J	Doherty, CP; Cox, SE; Fulford, AJ; Austin, S; Hilmers, DC; Abrams, SA; Prentice, AM				Doherty, Conor P.; Cox, Sharon E.; Fulford, Antony J.; Austin, Steven; Hilmers, David C.; Abrams, Steven A.; Prentice, Andrew M.			Iron Incorporation and Post-Malaria Anaemia	PLOS ONE			English	Article								Background: Iron supplementation is employed to treat post-malarial anaemia in environments where iron deficiency is common. Malaria induces an intense inflammatory reaction that stalls reticulo-endothelial macrophagal iron recycling from haemolysed red blood cells and inhibits oral iron absorption, but the magnitude and duration of these effects are unclear. Methodology/Principal Findings: We examined the red blood cell incorporation of oral administered stable isotopes of iron and compared incorporation between age matched 18 to 36 months old children with either anaemia post-malaria (n = 37) or presumed iron deficiency anaemia alone (n = 36). All children were supplemented for 30 days with 2 mg/kg elemental iron as liquid iron sulphate and administered (57)Fe and (58)Fe on days 1 and 15 of supplementation respectively. (57)Fe and (58)Fe incorporation were significantly reduced (8% vs. 28%: p<0.001 and 14% vs. 26%: p=0.045) in the malaria vs. non-malaria groups. There was a significantly greater haemoglobin response in the malaria group at both day 15 (p = 0.001) and 30 (p<0.000) with a regression analysis estimated greater change in haemoglobin of 7.2 g/l (s.e. 2.0) and 10.1 g/l (s.e. 2.5) respectively. Conclusion/Significance: Post-malaria anaemia is associated with a better haemoglobin recovery despite a significant depressant effect on oral iron incorporation which may indicate that early erythropoetic iron need is met by iron recycling rather than oral iron. Supplemental iron administration is of questionable utility within 2 weeks of clinical malaria in children with mild or moderate anaemia.	[Doherty, Conor P.] MRC, Nutr Program, Keneba Field Stn, Fajara, Gambia; [Cox, Sharon E.; Fulford, Antony J.; Prentice, Andrew M.] London Sch Hyg & Trop Med, Nutr & Publ Hlth Intervent Res Unit, Med Res Council Int Nutr Grp, London, England; [Austin, Steven] Elsie Widdowson Lab, Med Res Council Human Nutr Res, Cambridge, England; [Hilmers, David C.; Abrams, Steven A.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Houston, TX USA	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Cambridge; Baylor College of Medicine	Doherty, CP (corresponding author), MRC, Nutr Program, Keneba Field Stn, Fajara, Gambia.	conor.doherty@yorkhill.scot.nhs.uk	Prentice, Andrew/AAG-1961-2019; Cox, Sharon E/ABA-7986-2020	Cox, Sharon E/0000-0002-9908-2936; Abrams, Steven/0000-0003-4972-9233	Medical Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Medical Research Council	Abrams S. A., 2002, Food and Nutrition Bulletin, V23, P158; Ames SK, 1999, AM J CLIN NUTR, V70, P44; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Asobayire FS, 2001, AM J CLIN NUTR, V74, P776; Beesley R, 2000, T ROY SOC TROP MED H, V94, P295, DOI 10.1016/S0035-9203(00)90329-8; Brock JH, 2000, P NUTR SOC, V59, P537, DOI 10.1017/S002966510000077X; Chen ZS, 2005, J NUTR, V135, P1790, DOI 10.1093/jn/135.7.1790; COOK JD, 1993, ANNU REV MED, V44, P63, DOI 10.1146/annurev.med.44.1.63; Das BS, 1997, BRIT J NUTR, V78, P751, DOI 10.1079/BJN19970192; Das BS, 1999, T ROY SOC TROP MED H, V93, P58, DOI 10.1016/S0035-9203(99)90180-3; Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Garibay EV, 2001, J AM COLL NUTR, V20, P286, DOI 10.1080/07315724.2001.10719049; Griffiths MJ, 2001, BRIT J HAEMATOL, V113, P486, DOI 10.1046/j.1365-2141.2001.02758.x; GUBLER CJ, 1950, J BIOL CHEM, V184, P563; Kurtzhals JAL, 1997, BRIT J HAEMATOL, V97, P169, DOI 10.1046/j.1365-2141.1997.82654.x; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; MASSA E, 1978, J PEDIATR-US, V93, P1045, DOI 10.1016/S0022-3476(78)81257-8; Menendez C, 2004, AM J TROP MED HYG, V71, P434, DOI 10.4269/ajtmh.2004.71.434; *NAT NUTR AG, 2001, GAMB; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; PHILLIPS RE, 1986, Q J MED, V58, P305; vanHensbroek MB, 1995, T ROY SOC TROP MED H, V89, P672, DOI 10.1016/0035-9203(95)90438-7; WHO, 2001, IRON DEFICIENCY ANAE; Williams TN, 1999, AM J TROP MED HYG, V60, P875, DOI 10.4269/ajtmh.1999.60.875; World Health Organization, 1999, MAN SEV MALN MAN PHY	26	44	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2133	10.1371/journal.pone.0002133	http://dx.doi.org/10.1371/journal.pone.0002133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461143	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000261642400054
J	Behar, DM; Metspalu, E; Kivisild, T; Rosset, S; Tzur, S; Hadid, Y; Yudkovsky, G; Rosengarten, D; Pereira, L; Amorim, A; Kutuev, I; Gurwitz, D; Bonne-Tamir, B; Villems, R; Skorecki, K				Behar, Doron M.; Metspalu, Ene; Kivisild, Toomas; Rosset, Saharon; Tzur, Shay; Hadid, Yarin; Yudkovsky, Guennady; Rosengarten, Dror; Pereira, Luisa; Amorim, Antonio; Kutuev, Ildus; Gurwitz, David; Bonne-Tamir, Batsheva; Villems, Richard; Skorecki, Karl			Counting the Founders: The Matrilineal Genetic Ancestry of the Jewish Diaspora	PLOS ONE			English	Article								The history of the Jewish Diaspora dates back to the Assyrian and Babylonian conquests in the Levant, followed by complex demographic and migratory trajectories over the ensuing millennia which pose a serious challenge to unraveling population genetic patterns. Here we ask whether phylogenetic analysis, based on highly resolved mitochondrial DNA ( mtDNA) phylogenies can discern among maternal ancestries of the Diaspora. Accordingly, 1,142 samples from 14 different non-Ashkenazi Jewish communities were analyzed. A list of complete mtDNA sequences was established for all variants present at high frequency in the communities studied, along with high-resolution genotyping of all samples. Unlike the previously reported pattern observed among Ashkenazi Jews, the numerically major portion of the non-Ashkenazi Jews, currently estimated at 5 million people and comprised of the Moroccan, Iraqi, Iranian and Iberian Exile Jewish communities showed no evidence for a narrow founder effect, which did however characterize the smaller and more remote Belmonte, Indian and the two Caucasus communities. The Indian and Ethiopian Jewish sample sets suggested local female introgression, while mtDNAs in all other communities studied belong to a well-characterized West Eurasian pool of maternal lineages. Absence of sub-Saharan African mtDNA lineages among the North African Jewish communities suggests negligible or low level of admixture with females of the host populations among whom the African haplogroup (Hg) L0-L3 sub-clades variants are common. In contrast, the North African and Iberian Exile Jewish communities show influence of putative Iberian admixture as documented by mtDNA Hg HV0 variants. These findings highlight striking differences in the demographic history of the widespread Jewish Diaspora.	[Behar, Doron M.; Tzur, Shay; Hadid, Yarin; Skorecki, Karl] Mol Med Lab, Haifa, Israel; [Metspalu, Ene; Kivisild, Toomas; Kutuev, Ildus; Villems, Richard] Univ Tartu, Estonian Bioctr, Dept Evolut Biol, Tartu, Estonia; [Kivisild, Toomas] Univ Cambridge, Leverhulme Ctr Human Evolut Stud, Cambridge, England; [Rosset, Saharon] IBM TJ Watson Res Ctr, Data Analytics Res Grp, Yorktown Hts, NY USA; [Tzur, Shay; Hadid, Yarin; Yudkovsky, Guennady; Rosengarten, Dror; Skorecki, Karl] Israel Inst Technol, Res Inst, Rappaport Fac Med, Haifa, Israel; [Pereira, Luisa; Amorim, Antonio] IPATIMUP, Oporto, Portugal; [Pereira, Luisa] Univ Porto, Fac Med, Oporto, Portugal; [Amorim, Antonio] Univ Porto, Fac Ciencias, Oporto, Portugal; [Kutuev, Ildus] Russian Acad Sci, Ufa Res Ctr, Inst Biochem & Genet, Ufa, Russia; [Gurwitz, David; Bonne-Tamir, Batsheva] Sackler Sch Med, Dept Human Genet, Ramat Aviv, Israel	Rambam Health Care Campus; Estonian Biocentre; University of Tartu; University of Cambridge; International Business Machines (IBM); Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Universidade do Porto; Universidade do Porto; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Tel Aviv University; Sackler Faculty of Medicine	Behar, DM (corresponding author), Mol Med Lab, Rambam Hlth Care Campus, Haifa, Israel.	rvillems@ebc.ee	Amorim, Antonio/A-7938-2008; Pereira, Luisa/H-3050-2011; Gurwitz, David/E-7642-2013; Kivisild, Toomas/P-5889-2017	Amorim, Antonio/0000-0002-7518-6247; Pereira, Luisa/0000-0002-4271-1527; Gurwitz, David/0000-0002-9363-1869; Kivisild, Toomas/0000-0002-6297-7808	Israel Science Foundation; Legacy Heritage Fund; Annie Chutick Endowment; Canadian Technion Society; Milin Charitable Foundation; Estonian Science Foundation [5807]; Fundacao para a Ciencia e a Tecnologia through O Programa Operacional Ciencia, e Inovacao 2010	Israel Science Foundation(Israel Science Foundation); Legacy Heritage Fund; Annie Chutick Endowment; Canadian Technion Society; Milin Charitable Foundation; Estonian Science Foundation; Fundacao para a Ciencia e a Tecnologia through O Programa Operacional Ciencia, e Inovacao 2010	This research was supported in part by grants from the Israel Science Foundation and the Legacy Heritage Fund (to K.L.S.), by the Annie Chutick Endowment and the Canadian Technion Society (to K.L.S.), by a donation from the Milin Charitable Foundation (to D.M.B), by the Estonian Science Foundation grant 5807 (to E.M.), and by Fundacao para a Ciencia e a Tecnologia through O Programa Operacional Ciencia, e Inovacao 2010 (POCI 2010), VI Programa-Quadro (2002 to 2006) (to IPATIMUP).	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Behar DM, 2004, EUR J HUM GENET, V12, P355, DOI 10.1038/sj.ejhg.5201156; Behar DM, 2004, HUM GENET, V114, P354, DOI 10.1007/s00439-003-1073-7; Casella G, 2001, STAT INFERENCE, V2nd; Chaubey G, 2007, BIOESSAYS, V29, P91, DOI 10.1002/bies.20525; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; DellaPergola S., 2001, PAPERS JEWISH DEMOGR, V11, P11; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Forster P, 1996, AM J HUM GENET, V59, P935; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Johnson NL, 1969, DISTRIBUTIONS STAT D; Kivisild T, 1999, GENOMIC DIVERSITY, P135; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Kivisild T, 2003, EXAMINING FARMING LA, P215; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Shen PD, 2004, HUM MUTAT, V24, P248, DOI 10.1002/humu.20077; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74; Thomas MG, 2002, AM J HUM GENET, V70, P1411, DOI 10.1086/340609; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001	39	81	81	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2062	10.1371/journal.pone.0002062	http://dx.doi.org/10.1371/journal.pone.0002062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446216	Green Published, Green Submitted, gold			2022-12-27	WOS:000261572300031
J	Cahill, H; Nathans, J				Cahill, Hugh; Nathans, Jeremy			The Optokinetic Reflex as a Tool for Quantitative Analyses of Nervous System Function in Mice: Application to Genetic and Drug-Induced Variation	PLOS ONE			English	Article								The optokinetic reflex (OKR), which serves to stabilize a moving image on the retina, is a behavioral response that has many favorable attributes as a test of CNS function. The OKR requires no training, assesses the function of diverse CNS circuits, can be induced repeatedly with minimal fatigue or adaptation, and produces an electronic record that is readily and objectively quantifiable. We describe a new type of OKR test apparatus in which computer-controlled visual stimuli and streamlined data analysis facilitate a relatively high throughput behavioral assay. We used this apparatus, in conjunction with infrared imaging, to quantify basic OKR stimulus-response characteristics for C57BL/6J and 129/SvEv mouse strains and for genetically engineered lines lacking one or more photoreceptor systems or with an alteration in cone spectral sensitivity. A second generation (F2) cross shows that the characteristic difference in OKR frequency between C57BL/6J and 129/SvEv is inherited as a polygenic trait. Finally, we demonstrate the sensitivity and high temporal resolution of the OKR for quantitative analysis of CNS drug action. These experiments show that the mouse OKR is well suited for neurologic testing in the context of drug discovery and large-scale phenotyping programs.	[Cahill, Hugh; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Cahill, Hugh; Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD USA; [Nathans, Jeremy] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Cahill, H (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	jnathans@jhmi.edu		Nathans, Jeremy/0000-0001-8106-5460	NIH; Howard Hughes Medical Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	H.C. and J.N. are funded by NIH Visual Neuroscience Training Grant and Howard Hughes Medical Institute.	ALPERN M, 1969, EYE, P1; BALKEMA GW, 1984, INVEST OPHTH VIS SCI, V25, P795; BALKEMA GW, 1982, J NEUROPHYSIOL, V48, P968, DOI 10.1152/jn.1982.48.4.968; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Brunner D, 2002, DRUG DISCOV TODAY, V7, pS107, DOI 10.1016/S1359-6446(02)02423-6; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; CAVALLI S, 1971, GENETICS HUMAN POPUL, P508; COLLEWIJN H, 1969, VISION RES, V9, P117, DOI 10.1016/0042-6989(69)90035-2; Crabbe JC, 2004, NAT NEUROSCI, V7, P1175, DOI 10.1038/nn1343; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Visser L, 2006, GENES BRAIN BEHAV, V5, P458, DOI 10.1111/j.1601-183X.2005.00181.x; De Zeeuw CI, 1998, OTOLARYNG HEAD NECK, V119, P193, DOI 10.1016/S0194-5998(98)70054-3; Dodge R, 1903, AM J PHYSIOL, V8, P307, DOI 10.1152/ajplegacy.1903.8.4.307; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Faulstich BM, 2004, VISION RES, V44, P3419, DOI 10.1016/j.visres.2004.09.006; GODAUX E, 1990, NEUROSCI LETT, V116, P162, DOI 10.1016/0304-3940(90)90403-V; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; HESS BJM, 1985, NEUROSCIENCE, V15, P97, DOI 10.1016/0306-4522(85)90126-5; Iwakabe H, 1997, NEUROPHARMACOLOGY, V36, P135, DOI 10.1016/S0028-3908(96)00167-0; Iwashita M, 2001, NEUROSCI RES, V39, P299, DOI 10.1016/S0168-0102(00)00228-5; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; Katoh A, 1998, P NATL ACAD SCI USA, V95, P7705, DOI 10.1073/pnas.95.13.7705; Kitazawa H, 2000, NEUROSCI LETT, V280, P179, DOI 10.1016/S0304-3940(00)00779-5; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lipp HP, 1998, CURR OPIN NEUROBIOL, V8, P272, DOI 10.1016/S0959-4388(98)80151-7; Long JM, 2006, METHOD ENZYMOL, V417, P66, DOI 10.1016/S0076-6879(06)17006-8; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; MANCALL EM, 1982, ESSENTIALS NEUROLOGI, P228; MANGINI NJ, 1985, J COMP NEUROL, V241, P191, DOI 10.1002/cne.902410207; MARSHALL BE, 1996, GOODMAN GILMANS PHAR, P326; Moldin SO, 2001, MAMM GENOME, V12, P575, DOI 10.1007/s00335-001-4005-7; Picciotto MR, 1998, PHYSIOL REV, V78, P1131, DOI 10.1152/physrev.1998.78.4.1131; Pinto LH, 2007, DOC OPHTHALMOL, V115, P127, DOI 10.1007/s10633-007-9064-y; Pinto LH, 2000, MAMM GENOME, V11, P531, DOI 10.1007/s003350010102; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Sakatani T, 2004, NEUROSCI RES, V49, P123, DOI 10.1016/j.neures.2004.02.002; Sakatani T, 2007, NEUROSCI RES, V58, P324, DOI 10.1016/j.neures.2007.04.003; Schmucker C, 2005, INVEST OPHTH VIS SCI, V46, P398, DOI 10.1167/iovs.04-0959; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; SIMPSON JI, 1984, ANNU REV NEUROSCI, V7, P13, DOI 10.1146/annurev.ne.07.030184.000305; Smallwood PM, 2003, P NATL ACAD SCI USA, V100, P11706, DOI 10.1073/pnas.1934712100; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; Stahl JS, 2006, J NEUROPHYSIOL, V95, P1588, DOI 10.1152/jn.00318.2005; Stahl JS, 2004, VISION RES, V44, P3401, DOI 10.1016/j.visres.2004.09.011; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; Teller DY, 1996, VISION RES, V36, P955, DOI 10.1016/0042-6989(95)00170-0; Thaung C, 2002, NEUROSCI LETT, V325, P21, DOI 10.1016/S0304-3940(02)00223-9; van Alphen AM, 2001, BRAIN RES, V890, P296, DOI 10.1016/S0006-8993(00)03180-2; Vitaterna MH, 2006, TRENDS NEUROSCI, V29, P233, DOI 10.1016/j.tins.2006.02.006; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6	53	93	96	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2055	10.1371/journal.pone.0002055	http://dx.doi.org/10.1371/journal.pone.0002055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446207	Green Published, Green Submitted, gold			2022-12-27	WOS:000261572300024
J	Doublet, B; Golding, GR; Mulvey, MR; Cloeckaert, A				Doublet, Benoit; Golding, George R.; Mulvey, Michael R.; Cloeckaert, Axel			Secondary Chromosomal Attachment Site and Tandem Integration of the Mobilizable Salmonella Genomic Island 1	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM DT104; RESISTANCE GENE-CLUSTER; PROTEUS-MIRABILIS; SXT ELEMENT; VARIANT; SALMONELLA-GENOMIC-ISLAND-1; RECOMBINATION; SPECIFICITY; INSERTION; SEQUENCE	Background: The Salmonella genomic island 1 is an integrative mobilizable element (IME) originally identified in epidemic multidrug-resistant Salmonella enterica serovar Typhimurium (S. Typhimurium) DT104. SGI1 contains a complex integron, which confers various multidrug resistance phenotypes due to its genetic plasticity. Previous studies have shown that SGI1 integrates site-specifically into the S. enterica, Escherichia coli, or Proteus mirabilis chromosome at the 39 end of thdF gene (attB site). Methodology/Principal Findings: Here, we report the transfer of SGI1 to a Delta thdF mutant of S. Typhimurium LT2. In the absence of thdF, the frequency of transconjugant formation was reduced by around thirty times of magnitude. Through DNA sequencing SGI1 was shown to integrate specifically into a secondary attachment site (2(nd) attB), which is located in the intergenic region between the chromosomal sodB and purR genes. At this 2(nd) attB site, we found that a significant fraction of SGI1 transconjugants (43% of wild type and 100% of Delta thdF mutant) contained tandem SGI1 arrays. Moreover, in wild type S. Typhimurium LT2 transconjugants, SGI1 integrated into both attachment sites, i.e., thdF and sodB-purR. The formation of SGI1 tandem arrays occurred in both specific attB sites. There was heterogeneity in the size of the SGI1 tandem arrays detected in single transconjugant colonies. Some arrays consisted as far as six SGI1s arranged in tandem. These tandem arrays were shown to persist during serial passages with or without antibiotic selection pressure. Conclusions/Significance: The ability of integration into two distinct chromosomal sites and tandem array formation of SGI1 could contribute to its spread and persistence. The existence of a secondary attachment site in the Salmonella chromosome has potential implications for the mobility of SGI1, which may integrate in other attachment sites of other bacterial pathogens that do not possess the 1(st) or 2(nd) specific SGI1 attB sites of Salmonella.	[Doublet, Benoit; Cloeckaert, Axel] INRA, UR1282, F-37380 Nouzilly, France; [Golding, George R.; Mulvey, Michael R.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	INRAE; Public Health Agency of Canada	Doublet, B (corresponding author), INRA, UR1282, F-37380 Nouzilly, France.	Benoit.Doublet@tours.inra.fr		Doublet, Benoit/0000-0003-0531-0967	French National Institute of Agronomic Research	French National Institute of Agronomic Research	This research was supported by public funds from the French National Institute of Agronomic Research.	Ahmed AM, 2007, J ANTIMICROB CHEMOTH, V59, P184, DOI 10.1093/jac/dkl471; Azaro MA., 2002, MOBILE DNA-UK, P118, DOI DOI 10.1128/9781555817954.CH7; BAUER CE, 1989, GENETICS, V122, P727; Boyd D, 2002, ANTIMICROB AGENTS CH, V46, P1714, DOI 10.1128/AAC.46.6.1714-1722.2002; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Boyd DA, 2008, ANTIMICROB AGENTS CH, V52, P340, DOI 10.1128/AAC.00902-07; BURGIN AB, 1995, CURR BIOL, V5, P1312, DOI 10.1016/S0960-9822(95)00258-2; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Burrus V, 2004, J BACTERIOL, V186, P2636, DOI 10.1128/JB.186.9.2636-2645.2004; Burrus V, 2003, J BACTERIOL, V185, P5045, DOI 10.1128/JB.185.17.5045-5054.2003; Burrus V, 2002, PLASMID, V48, P77, DOI 10.1016/S0147-619X(02)00102-6; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; Cloeckaert A, 2006, ANTIMICROB AGENTS CH, V50, P3944, DOI 10.1128/AAC.00697-06; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Doublet B, 2005, MOL MICROBIOL, V55, P1911, DOI 10.1111/j.1365-2958.2005.04520.x; Doublet B, 2003, EMERG INFECT DIS, V9, P585, DOI 10.3201/eid0905.020609; Doublet B, 2007, J ANTIMICROB CHEMOTH, V59, P801, DOI 10.1093/jac/dkl540; GAFFNEY DF, 1981, J GEN MICROBIOL, V125, P113; Golding GR, 2007, MICROBES INFECT, V9, P21, DOI 10.1016/j.micinf.2006.10.004; Hochhut B, 1999, MOL MICROBIOL, V32, P99, DOI 10.1046/j.1365-2958.1999.01330.x; Hochhut B, 2001, J BACTERIOL, V183, P1124, DOI 10.1128/JB.183.4.1124-1132.2001; Levings RS, 2005, J BACTERIOL, V187, P4401, DOI 10.1128/JB.187.13.4401-4409.2005; Malanowska K, 2006, MOL MICROBIOL, V60, P1228, DOI 10.1111/j.1365-2958.2006.05164.x; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Members of the SFM Antibiogram Committee, 2003, Int J Antimicrob Agents, V21, P364; Mulvey MR, 2006, MICROBES INFECT, V8, P1915, DOI 10.1016/j.micinf.2005.12.028; Ravatn R, 1998, J BACTERIOL, V180, P4360, DOI 10.1128/JB.180.17.4360-4369.1998; Rutkai E, 2006, J BACTERIOL, V188, P3409, DOI 10.1128/JB.188.9.3409-3411.2006; Rutkai E, 2003, J MOL BIOL, V329, P983, DOI 10.1016/S0022-2836(03)00442-X; Serra-Moreno R, 2007, J BACTERIOL, V189, P6645, DOI 10.1128/JB.00466-07; Song B, 2007, J BACTERIOL, V189, P6594, DOI 10.1128/JB.00668-07; Turner SA, 2004, ANTIMICROB AGENTS CH, V48, P1028, DOI 10.1128/AAC.48.3.1028-1031.2004; Turner SA, 2003, ANTIMICROB AGENTS CH, V47, P727, DOI 10.1128/AAC.47.2.727-734.2003; Vo ATT, 2007, J ANTIMICROB CHEMOTH, V59, P594, DOI 10.1093/jac/dkl531; Wesslund NA, 2007, J BACTERIOL, V189, P1072, DOI 10.1128/JB.01064-06; Wilkins B, 1993, BACTERIAL CONJUGATIO, P105; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	38	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2060	10.1371/journal.pone.0002060	http://dx.doi.org/10.1371/journal.pone.0002060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446190	Green Submitted, Green Published, gold			2022-12-27	WOS:000261572300029
J	Mahanta, S; Fessler, SP; Park, J; Bamdad, C				Mahanta, Sanjeev; Fessler, Shawn P.; Park, Jaehong; Bamdad, Cynthia			A Minimal Fragment of MUC1 Mediates Growth of Cancer Cells	PLOS ONE			English	Article								The MUC1 protein is aberrantly expressed on many solid tumor cancers. In contrast to its apical clustering on healthy epithelial cells, it is uniformly distributed over cancer cells. However, a mechanistic link between aberrant expression and cancer has remained elusive. Herein, we report that a membrane-bound MUC1 cleavage product, that we call MUC1*, is the predominant form of the protein on cultured cancer cells and on cancerous tissues. Further, we demonstrate that transfection of a minimal fragment of MUC1, MUC1* 1110, containing a mere forty-five (45) amino acids of the extracellular domain, is sufficient to confer the oncogenic activities that were previously attributed to the full-length protein. By comparison of molecular weight and function, it appears that MUC1* and MUC1* 1110 are approximately equivalent. Evidence is presented that strongly supports a mechanism whereby dimerization of the extracellular domain of MUC1* activates the MAP kinase signaling cascade and stimulates cell growth. These findings suggest methods to manipulate this growth mechanism for therapeutic interventions in cancer treatments.	[Mahanta, Sanjeev; Fessler, Shawn P.; Park, Jaehong; Bamdad, Cynthia] Minerva Biotechnol, Waltham, MA USA		Mahanta, S (corresponding author), Minerva Biotechnol, Waltham, MA USA.	cbamdad@minervabio.com						ABE M, 1989, CANCER RES, V49, P2834; Andren O, 2007, BRIT J CANCER, V97, P730, DOI 10.1038/sj.bjc.6603944; Bamdad C, 1998, BIOPHYS J, V75, P1989, DOI 10.1016/S0006-3495(98)77640-4; BAMDAD C, 2001, Patent No. 2001020232; BAMDAD C, 2005, Patent No. 20050112607; Baruch A, 1999, CANCER RES, V59, P1552; BORK P, 1995, PROTEIN SCI, V4, P1421, DOI 10.1002/pro.5560040716; Fosang AJ, 1998, FEBS LETT, V430, P186, DOI 10.1016/S0014-5793(98)00667-X; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; GIRLING A, 1989, INT J CANCER, V43, P1072, DOI 10.1002/ijc.2910430620; HAYES DF, 1986, J CLIN ONCOL, V4, P1542, DOI 10.1200/JCO.1986.4.10.1542; Kim YI, 2003, BIOCHEM BIOPH RES CO, V307, P281, DOI 10.1016/S0006-291X(03)01195-1; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; LAN MS, 1990, J BIOL CHEM, V265, P15294; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P227, DOI 10.1023/A:1005580828141; LEARY JA, 1995, INT J CANCER, V64, P189, DOI 10.1002/ijc.2910640308; LEUVERING J H W, 1980, Journal of Immunoassay, V1, P77, DOI 10.1080/01971528008055777; Levitin F, 2005, J BIOL CHEM, V280, P33374, DOI 10.1074/jbc.M506047200; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Meerzaman D, 2001, AM J PHYSIOL-LUNG C, V281, pL86, DOI 10.1152/ajplung.2001.281.1.L86; MERLO GR, 1989, CANCER RES, V49, P6966; Okabe-Kado J, 2002, LEUKEMIA LYMPHOMA, V43, P859, DOI 10.1080/10428190290017006; Parry S, 2001, BIOCHEM BIOPH RES CO, V283, P715, DOI 10.1006/bbrc.2001.4775; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; RUI H, 1994, ENDOCRINOLOGY, V135, P1299, DOI 10.1210/en.135.4.1299; Schneider H, 1997, BLOOD, V89, P473, DOI 10.1182/blood.V89.2.473; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Thathiah A, 2004, BIOCHEM J, V382, P363, DOI 10.1042/BJ20040513; Thathiah A, 2003, J BIOL CHEM, V278, P3386, DOI 10.1074/jbc.M208326200; Tsutsumida H, 2006, CLIN CANCER RES, V12, P2976, DOI 10.1158/1078-0432.CCR-05-1197; WRESCHNER DH, 1990, EUR J BIOCHEM, V189, P463, DOI 10.1111/j.1432-1033.1990.tb15511.x	38	57	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2054	10.1371/journal.pone.0002054	http://dx.doi.org/10.1371/journal.pone.0002054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446242	gold, Green Submitted, Green Published			2022-12-27	WOS:000261572300023
J	Reed, KD; Meece, JK; Archer, JR; Peterson, AT				Reed, Kurt D.; Meece, Jennifer K.; Archer, John R.; Peterson, A. Townsend			Ecologic Niche Modeling of Blastomyces dermatitidis in Wisconsin	PLOS ONE			English	Article							NORTH CENTRAL WISCONSIN; GEOGRAPHIC-DISTRIBUTION; PULMONARY BLASTOMYCOSIS; SPECIES DISTRIBUTIONS; EPIDEMIC; SOIL; DISEASE	Background: Blastomycosis is a potentially fatal mycosis that is acquired by inhaling infectious spores of Blastomyces dermatitidis present in the environment. The ecology of this pathogen is poorly understood, in part because it has been extremely difficult to identify the niche(s) it occupies based on culture isolation of the organism from environmental samples. Methodology/Principal Findings: We investigated the ecology of blastomycosis by performing maximum entropy modeling of exposure sites from 156 cases of human and canine blastomycosis to provide a regional-scale perspective of the geographic and ecologic distribution of B. dermatitidis in Wisconsin. Based on analysis with climatic, topographic, surface reflectance and other environmental variables, we predicted that ecologic conditions favorable for maintaining the fungus in nature occur predominantly within northern counties and counties along the western shoreline of Lake Michigan. Areas of highest predicted occurrence were often in proximity to waterways, especially in northcentral Wisconsin, where incidence of infection is highest. Ecologic conditions suitable for B. dermatitidis are present in urban and rural environments, and may differ at the extremes of distribution of the species in the state. Conclusions/Significance: Our results provide a framework for a more informed search for specific environmental factors modulating B. dermatitidis occurrence and transmission and will be useful for improving public health awareness of relative exposure risks.	[Reed, Kurt D.; Meece, Jennifer K.] Marshfield Clin Res Fdn, Marshfield, WI USA; [Archer, John R.] Wisconsin Dept Hlth & Family Serv, Madison, WI USA; [Peterson, A. Townsend] Univ Kansas, Biodivers Res Ctr, Natural History Museum, Lawrence, KS USA	University of Kansas	Reed, KD (corresponding author), Marshfield Clin Res Fdn, Marshfield, WI USA.	reed.kurt@northwestern.edu	Peterson, A. Townsend/I-5697-2013	Peterson, A. Townsend/0000-0003-0243-2379	Marshfield Clinic Research Foundation	Marshfield Clinic Research Foundation	This research was supported in part by grants from the Marshfield Clinic Research Foundation.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], P 21 INT C MACH LEAR; BAKERSPIGEL A, 1986, J CLIN MICROBIOL, V24, P890, DOI 10.1128/JCM.24.5.890-891.1986; BAUMGARDNER DJ, 1995, J MED VET MYCOL, V33, P171; Baumgardner DJ, 2006, MYCOPATHOLOGIA, V161, P275, DOI 10.1007/s11046-006-0018-9; Baumgardner DJ, 1999, MED MYCOL, V37, P163, DOI 10.1046/j.1365-280X.1999.00214.x; Bradsher RW, 2003, INFECT DIS CLIN N AM, V17, P21, DOI 10.1016/S0891-5520(02)00038-7; Burgess JW, 2006, MED MYCOL, V44, P741, DOI 10.1080/13693780600954749; *CDCP, 1996, MMWR-MORBID MORTAL W, V45, P601; COCKERILL FR, 1984, CHEST, V86, P688, DOI 10.1378/chest.86.5.688; Curtis JT, 1959, VEGETATION WISCONSIN; DENTON JF, 1961, SCIENCE, V133, P1126, DOI 10.1126/science.133.3459.1126; DENTON JF, 1979, AM J TROP MED HYG, V28, P697, DOI 10.4269/ajtmh.1979.28.697; Disalvo Arthur F., 1992, P43; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; KITCHEN MS, 1977, AM REV RESPIR DIS, V115, P1063; KLEIN BS, 1987, AM REV RESPIR DIS, V136, P1333, DOI 10.1164/ajrccm/136.6.1333; KLEIN BS, 1986, NEW ENGL J MED, V314, P529, DOI 10.1056/NEJM198602273140901; Levine RS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000176; Levine RS, 2004, AM J TROP MED HYG, V70, P105, DOI 10.4269/ajtmh.2004.70.105; MacEachren AM, 2004, P NATL ACAD SCI USA, V101, P5279, DOI 10.1073/pnas.0307755101; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Peterson AT, 2002, EMERG INFECT DIS, V8, P662, DOI 10.3201/eid0807.010454; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Proctor ME, 2002, MYCOPATHOLOGIA, V153, P113, DOI 10.1023/A:1014515230994; RIPPON JW, 1988, MED MYCOLOGY PATHOGE, P474; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; TOSH FE, 1974, AM REV RESPIR DIS, V109, P525; Watts B, 2007, NEW ENGL J MED, V356, P1456, DOI 10.1056/NEJMcps055322; *WI DEP NAT RES, EC LANDSC WISC	33	56	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2034	10.1371/journal.pone.0002034	http://dx.doi.org/10.1371/journal.pone.0002034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446224	gold, Green Published			2022-12-27	WOS:000261572300007
J	Voigt, CC; Capps, KA; Dechmann, DKN; Michener, RH; Kunz, TH				Voigt, Christian C.; Capps, Krista A.; Dechmann, Dina K. N.; Michener, Robert H.; Kunz, Thomas H.			Nutrition or Detoxification: Why Bats Visit Mineral Licks of the Amazonian Rainforest	PLOS ONE			English	Article								Many animals in the tropics of Africa, Asia and South America regularly visit so-called salt or mineral licks to consume clay or drink clay-saturated water. Whether this behavior is used to supplement diets with locally limited nutrients or to buffer the effects of toxic secondary plant compounds remains unclear. In the Amazonian rainforest, pregnant and lactating bats are frequently observed and captured at mineral licks. We measured the nitrogen isotope ratio in wing tissue of omnivorous short-tailed fruit bats, Carollia perspicillata, and in an obligate fruit-eating bat, Artibeus obscurus, captured at mineral licks and at control sites in the rainforest. Carollia perspicillata with a plant-dominated diet were more often captured at mineral licks than individuals with an insect-dominated diet, although insects were more mineral depleted than fruits. In contrast, nitrogen isotope ratios of A. obscurus did not differ between individuals captured at mineral lick versus control sites. We conclude that pregnant and lactating fruit-eating bats do not visit mineral licks principally for minerals, but instead to buffer the effects of secondary plant compounds that they ingest in large quantities during periods of high energy demand. These findings have potential implications for the role of mineral licks for mammals in general, including humans.	[Voigt, Christian C.; Dechmann, Dina K. N.] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Capps, Krista A.] Cornell Univ, Dept Ecol & Evolut Biol, Ithaca, NY USA; [Dechmann, Dina K. N.] Smithsonian Trop Res Inst, Balboa, Panama; [Michener, Robert H.] Boston Univ, Dept Biol, Stable Isotope Lab, Boston, MA USA; [Kunz, Thomas H.] Boston Univ, Dept Biol, Ctr Ecol & Conserv Biol, Boston, MA USA	Leibniz Institut fur Zoo und Wildtierforschung; Cornell University; Smithsonian Institution; Smithsonian Tropical Research Institute; Boston University; Boston University	Voigt, CC (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	voigt@izw-berlin.de	Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Dechmann, Dina/A-1827-2010	Dechmann, Dina/0000-0003-0043-8267	Leibniz Institute for Zoo and Wildlife Research (Berlin, Germany); Department of Biology at Boston University (Boston, USA)	Leibniz Institute for Zoo and Wildlife Research (Berlin, Germany); Department of Biology at Boston University (Boston, USA)	Leibniz Institute for Zoo and Wildlife Research (Berlin, Germany) and Department of Biology at Boston University (Boston, USA). Both institutions played no role in any stage of the project.	Adams RA, 2003, J ZOOL, V260, P189, DOI 10.1017/S0952836903003613; Atwood TC, 2003, NORTHEAST NAT, V10, P409, DOI 10.1656/1092-6194(2003)010[0409:SPOMLP]2.0.CO;2; Atwood TC, 2002, AM MIDL NAT, V148, P289, DOI 10.1674/0003-0031(2002)148[0289:SAASPO]2.0.CO;2; Barclay RMR, 2002, BIOTROPICA, V34, P168, DOI 10.1111/j.1744-7429.2002.tb00252.x; BARCLAY RMR, 1994, AM NAT, V144, P1021, DOI 10.1086/285723; Bernard RTF, 1996, S AFR J ZOOL, V31, P218; Booher CM, 2008, J ZOOL, V274, P38, DOI 10.1111/j.1469-7998.2007.00354.x; Bravo A, 2008, BIOTROPICA, V40, P203, DOI 10.1111/j.1744-7429.2007.00362.x; Brightsmith DJ, 2004, BIOTROPICA, V36, P534, DOI 10.1646/1602; Diamond JM, 1999, NATURE, V400, P120, DOI 10.1038/22014; Dominy NJ, 2004, J EXP BIOL, V207, P319, DOI 10.1242/jeb.00758; EMMONS LH, 1979, BIOTROPICA, V4; Gilardi JD, 1999, J CHEM ECOL, V25, P897, DOI 10.1023/A:1020857120217; Haynes Michelle A., 2004, Mammalian Species, P1; Herrera LG, 2001, J MAMMAL, V82, P352, DOI 10.1644/1545-1542(2001)082&lt;0352:SOPITS&gt;2.0.CO;2; Houston DC, 2001, MAMMAL REV, V31, P249, DOI 10.1046/j.1365-2907.2001.00091.x; JOHNS T, 1991, AM J CLIN NUTR, V53, P448, DOI 10.1093/ajcn/53.2.448; JONES RC, 1985, MINERAL LIKCS GEOPHA; KEELER JO, 1992, J MAMMAL, V73, P426, DOI 10.2307/1382079; KENNEDY JF, 1995, AM MIDL NAT, V134, P324, DOI 10.2307/2426301; Ketch LA, 2001, SOIL BIOL BIOCHEM, V33, P199, DOI 10.1016/S0038-0717(00)00129-2; Klaus G, 1998, J TROP ECOL, V14, P829, DOI 10.1017/S0266467498000595; Korine C, 2004, ECOLOGY, V85, P220, DOI 10.1890/02-0632; KUNZ TH, 1995, OECOLOGIA, V101, P407, DOI 10.1007/BF00329419; KWIECINSKI GG, 1987, AM J ANAT, V178, P410, DOI 10.1002/aja.1001780410; Mahaney WC, 1997, PRIMATES, V38, P159, DOI 10.1007/BF02382006; Mahaney WC, 2005, INT J PRIMATOL, V26, P1375, DOI 10.1007/s10764-005-8857-7; Mahaney WC, 2003, J CHEM ECOL, V29, P1503, DOI 10.1023/A:1024263627606; Mclean JA, 1999, FUNCT ECOL, V13, P360, DOI 10.1046/j.1365-2435.1999.00321.x; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; REX K, 2005, BIOL J LINN IN PRESS; RISENHOOVER KL, 1986, OECOLOGIA, V71, P121, DOI 10.1007/BF00377330; Speakman J. R., 1987, RECENT ADV STUDY BAT; STUDIER EH, 1995, J MAMMAL, V76, P32, DOI 10.2307/1382312; STUDIER EH, 1992, COMP BIOCHEM PHYS A, V103, P579, DOI 10.1016/0300-9629(92)90293-Y; STUDIER EH, 1991, COMP BIOCHEM PHYS A, V100, P1035, DOI 10.1016/0300-9629(91)90333-8; TANKERSLEY NG, 1983, CAN J ZOOL, V61, P2242, DOI 10.1139/z83-296; TUTTLE M D, 1974, Mammalia, V38, P141; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; Voigt CC, 2004, J EXP BIOL, V207, P1741, DOI 10.1242/jeb.00929; Voigt CC, 2003, J EXP BIOL, V206, P1419, DOI 10.1242/jeb.00274; Voigt CC, 2003, J COMP PHYSIOL B, V173, P79, DOI 10.1007/s00360-002-0316-6; Voigt Christian C., 2007, Research Letters in Ecology, V2007, P1, DOI 10.1155/2007/34212; Wakibara JV, 2001, INT J PRIMATOL, V22, P495, DOI 10.1023/A:1010763930475; Wendeln MC, 2000, BIOTROPICA, V32, P489, DOI 10.1111/j.1744-7429.2000.tb00495.x; Wiley AS, 1998, CURR ANTHROPOL, V39, P532; Wilson MJ, 2003, J CHEM ECOL, V29, P1525, DOI 10.1023/A:1024262411676; Yanai RD, 2005, WATER AIR SOIL POLL, V160, P109, DOI 10.1007/s11270-005-3940-4	48	46	48	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2011	10.1371/journal.pone.0002011	http://dx.doi.org/10.1371/journal.pone.0002011			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431492	Green Published, Green Submitted, gold			2022-12-27	WOS:000261558700027
J	Volkow, ND; Fowler, JS; Wang, GJ; Telang, F; Logan, J; Wong, C; Ma, J; Pradhan, K; Benveniste, H; Swanson, JM				Volkow, Nora D.; Fowler, Joanna S.; Wang, Gene-Jack; Telang, Frank; Logan, Jean; Wong, Christopher; Ma, Jim; Pradhan, Kith; Benveniste, Helene; Swanson, James M.			Methylphenidate Decreased the Amount of Glucose Needed by the Brain to Perform a Cognitive Task	PLOS ONE			English	Article								The use of stimulants (methylphenidate and amphetamine) as cognitive enhancers by the general public is increasing and is controversial. It is still unclear how they work or why they improve performance in some individuals but impair it in others. To test the hypothesis that stimulants enhance signal to noise ratio of neuronal activity and thereby reduce cerebral activity by increasing efficiency, we measured the effects of methylphenidate on brain glucose utilization in healthy adults. We measured brain glucose metabolism (using Positron Emission Tomography and 2-deoxy-2[18F] fluoro-D-glucose) in 23 healthy adults who were tested at baseline and while performing an accuracy-controlled cognitive task (numerical calculations) given with and without methylphenidate (20 mg, oral). Sixteen subjects underwent a fourth scan with methylphenidate but without cognitive stimulation. Compared to placebo methylphenidate significantly reduced the amount of glucose utilized by the brain when performing the cognitive task but methylphenidate did not affect brain metabolism when given without cognitive stimulation. Whole brain metabolism when the cognitive task was given with placebo increased 21% whereas with methylphenidate it increased 11% (50% less). This reflected both a decrease in magnitude of activation and in the regions activated by the task. Methylphenidate's reduction of the metabolic increases in regions from the default network (implicated in mind-wandering) was associated with improvement in performance only in subjects who activated these regions when the cognitive task was given with placebo. These results corroborate prior findings that stimulant medications reduced the magnitude of regional activation to a task and in addition document a "focusing'' of the activation. This effect may be beneficial when neuronal resources are diverted (i.e., mind-wandering) or impaired (i.e., attention deficit hyperactivity disorder), but it could be detrimental when brain activity is already optimally focused. This would explain why methylphenidate has beneficial effects in some individuals and contexts and detrimental effects in others.	[Volkow, Nora D.] Natl Inst Drug Abuse, Bethesda, MD 20892 USA; [Volkow, Nora D.; Telang, Frank; Ma, Jim] Natl Inst Alcohol Abuse & Alcoholism, Bethesda, MD USA; [Fowler, Joanna S.; Wang, Gene-Jack; Logan, Jean; Wong, Christopher; Pradhan, Kith; Benveniste, Helene] Brookhaven Natl Lab, Med Dept, Upton, NY USA; [Swanson, James M.] Univ Calif Irvine, Child Dev Ctr, Irvine, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); United States Department of Energy (DOE); Brookhaven National Laboratory; University of California System; University of California Irvine	Volkow, ND (corresponding author), Natl Inst Drug Abuse, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov		Logan, Jean/0000-0002-6993-9994	Intramural Research Program of the NIH (National Institutes on Alcoholism and Alcohol Abuse); Department of Energy Office of Biological and Environmental Research [DE-AC01-76CH00016]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000550, ZIAAA000550] Funding Source: NIH RePORTER	Intramural Research Program of the NIH (National Institutes on Alcoholism and Alcohol Abuse)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported in part by the Intramural Research Program of the NIH (National Institutes on Alcoholism and Alcohol Abuse) and by the Department of Energy (Office of Biological and Environmental Research, contract DE-AC01-76CH00016).	Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Conners C K, 2002, J Atten Disord, V6 Suppl 1, pS17; CONNERS CK, 1966, J NERV MENT DIS, V142, P429, DOI 10.1097/00005053-196605000-00005; Elliott R, 1997, PSYCHOPHARMACOLOGY, V131, P196, DOI 10.1007/s002130050284; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; GINSBERG MD, 1988, ANN NEUROL, V23, P152, DOI 10.1002/ana.410230208; Gjedde A, 2002, J CEREBR BLOOD F MET, V22, P1, DOI 10.1097/00004647-200201000-00001; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hirata A, 2006, J NEUROSCI, V26, P4426, DOI 10.1523/JNEUROSCI.5298-05.2006; KEELER JD, 1989, P NATL ACAD SCI USA, V86, P1712, DOI 10.1073/pnas.86.5.1712; Kiyatkin EA, 1996, J NEUROPHYSIOL, V75, P142, DOI 10.1152/jn.1996.75.1.142; Kiyatkin EA, 2002, BEHAV BRAIN RES, V137, P27, DOI 10.1016/S0166-4328(02)00283-8; Kuczenski R, 1997, J NEUROCHEM, V68, P2032; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; MATOCHIK JA, 1994, AM J PSYCHIAT, V151, P658; Mattay VS, 2000, NEUROIMAGE, V12, P268, DOI 10.1006/nimg.2000.0610; Mehta MA, 2000, J NEUROSCI, V20; PORRINO LJ, 1983, ARCH GEN PSYCHIAT, V40, P688; Rapoport J L, 2002, J Atten Disord, V6 Suppl 1, pS57; ROLLS ET, 1984, NEUROSCIENCE, V12, P1201, DOI 10.1016/0306-4522(84)90014-9; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Schweitzer JB, 2004, BIOL PSYCHIAT, V56, P597, DOI 10.1016/j.biopsych.2004.07.011; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; SRINIVAS NR, 1991, PROG NEURO-PSYCHOPH, V15, P213, DOI 10.1016/0278-5846(91)90083-D; Talairach J., 1988, COPLANAR STEREOTAXIC; Teicher MH, 2003, J CHILD ADOL PSYCHOP, V13, P41, DOI 10.1089/104454603321666180; Volkow ND, 2004, AM J PSYCHIAT, V161, P1173, DOI 10.1176/appi.ajp.161.7.1173; Volkow ND, 2008, NATURE, V451, P520, DOI 10.1038/451520a; WANG GJ, 1993, RADIOLOGY, V186, P59, DOI 10.1148/radiology.186.1.8416587; WEBER K, 1985, PSYCHOPHARMACOLOGY, V85, P231, DOI 10.1007/BF00428421; WOODWARD DJ, 1979, FED PROC, V38, P2109	35	85	86	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e2017	10.1371/journal.pone.0002017	http://dx.doi.org/10.1371/journal.pone.0002017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414677	Green Published, Green Submitted, gold			2022-12-27	WOS:000260867300026
J	Millen, SJ; Uys, PW; Hargrove, J; van Helden, PD; Williams, BG				Millen, Stephen J.; Uys, Pieter W.; Hargrove, John; van Helden, Paul D.; Williams, Brian G.			The Effect of Diagnostic Delays on the Drop-Out Rate and the Total Delay to Diagnosis of Tuberculosis	PLOS ONE			English	Article								Background: Numerous patient and healthcare system-related delays contribute to the overall delay experienced by patients from onset of TB symptoms to diagnosis and treatment. Such delays are critical as infected individuals remain untreated in the community, providing more opportunities for transmission of the disease and adversely affecting the epidemic. Methodology/Principal Findings: We present an analysis of the factors that contribute to the overall delay in TB diagnosis and treatment, in a resource-poor setting. Impact on the distribution of diagnostic delay times was assessed for various factors, the sensitivity of the diagnostic method being found to be the most significant. A linear relationship was found between the sensitivity of the test and the predicted mean delay time, with an increase in test sensitivity resulting in a reduced mean delay time and a reduction in the drop-out rate. Conclusions/Significance: The results show that in a developing country a number of delay factors, particularly the low sensitivity of the initial sputum smear microscopy test, potentially increase total diagnostic delay times experienced by TB patients significantly. The results reinforce the urgent need for novel diagnostic methods, both for smear positive and negative TB, that are highly sensitive, accessible and point of care, in order to reduce mean delay times.	[Millen, Stephen J.; Uys, Pieter W.; Hargrove, John] Univ Stellenbosch, DST NRF Ctr Excellence Epidemiol Modelling & Anal, Western Cape, South Africa; [Uys, Pieter W.; van Helden, Paul D.] Stellenbosch Univ, Fac Hlth Sci, DST/NRF Ctr Excellence Biomed TB Res, MRC Ctr Mol & Cell Biol, Western Cape, South Africa; [Williams, Brian G.] WHO, Stop TB, Geneva, Switzerland	National Research Foundation - South Africa; Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University; World Health Organization	Millen, SJ (corresponding author), Univ Stellenbosch, DST NRF Ctr Excellence Epidemiol Modelling & Anal, Western Cape, South Africa.	edserve@iafrica.com		Williams, Brian/0000-0002-3174-4876	Stellenbosch University; MRC; NRF	Stellenbosch University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NRF	Funding was provided by Stellenbosch University, MRC and NRF for this work.	Asch S, 1998, AM J RESP CRIT CARE, V157, P1244, DOI 10.1164/ajrccm.157.4.9709071; Auer C, 2000, TROP MED INT HEALTH, V5, P648, DOI 10.1046/j.1365-3156.2000.00615.x; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Crampin AC, 2001, INT J TUBERC LUNG D, V5, P994; El-Sony A, 2002, INT J TUBERC LUNG D, V6, P91; GEBRE N, 1995, T ROY SOC TROP MED H, V89, P191, DOI 10.1016/0035-9203(95)90491-3; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; Harries AD, 2000, INT J TUBERC LUNG D, V4, P36; Hudson CP, 2000, INT J TUBERC LUNG D, V4, P240; Lambert ML, 2005, TROP MED INT HEALTH, V10, P945, DOI 10.1111/j.1365-3156.2005.01485.x; Phillips L, 2004, PEDIATRICS, V113, pE514, DOI 10.1542/peds.113.6.e514; Selvakumar N, 2002, J CLIN MICROBIOL, V40, P3017, DOI 10.1128/JCM.40.8.3017-3020.2002; Sherman LF, 1999, INT J TUBERC LUNG D, V3, P1088; Verver S, 2004, INT J EPIDEMIOL, V33, P351, DOI 10.1093/ije/dyh021; Wandwalo ER, 2000, INT J TUBERC LUNG D, V4, P133; WHO, 2006, GLOB TUB CONTR; Wilkinson D, 1997, T ROY SOC TROP MED H, V91, P420, DOI 10.1016/S0035-9203(97)90263-7	17	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1933	10.1371/journal.pone.0001933	http://dx.doi.org/10.1371/journal.pone.0001933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398459	Green Published, gold			2022-12-27	WOS:000260795500010
J	Muftuoglu, M; Kusumoto, R; Speina, E; Beck, G; Cheng, WH; Bohr, VA				Muftuoglu, Meltem; Kusumoto, Rika; Speina, Elzbieta; Beck, Gad; Cheng, Wen-Hsing; Bohr, Vilhelm A.			Acetylation Regulates WRN Catalytic Activities and Affects Base Excision DNA Repair	PLOS ONE			English	Article								Background: The Werner protein (WRN), defective in the premature aging disorder Werner syndrome, participates in a number of DNA metabolic processes, and we have been interested in the possible regulation of its function in DNA repair by post-translational modifications. Acetylation mediated by histone acetyltransferases is of key interest because of its potential importance in aging, DNA repair and transcription. Methodology/Principal Findings: Here, we have investigated the p300 acetylation mediated changes on the function of WRN in base excision DNA repair (BER). We show that acetylation of WRN increases in cells treated with methyl methanesulfonate (MMS), suggesting that acetylation of WRN may play a role in response to DNA damage. This hypothesis is consistent with our findings that acetylation of WRN stimulates its catalytic activities in vitro and in vivo, and that acetylated WRN enhances pol beta-mediated strand displacement DNA synthesis more than unacetylated WRN. Furthermore, we show that cellular exposure to the histone deacetylase inhibitor sodium butyrate stimulates long patch BER in wild type cells but not in WRN depleted cells, suggesting that acetylated WRN participates significantly in this process. Conclusion/Significance: Collectively, these results provide the first evidence for a specific role of p300 mediated WRN acetylation in regulating its function during BER.	[Muftuoglu, Meltem; Kusumoto, Rika; Speina, Elzbieta; Beck, Gad; Cheng, Wen-Hsing; Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Speina, Elzbieta] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Bohr, VA (corresponding author), NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.	vbohr@nih.gov	Bohr, Vilhelm/AAP-5931-2020; Speina, Elzbieta/ABB-3371-2021; Muftuoglu, Meltem/AAG-5004-2019	Muftuoglu, Meltem/0000-0001-5372-4780	NATIONAL INSTITUTE ON AGING [Z01AG000721, ZIAAG000727, ZIAAG000726, Z01AG000727, ZIAAG000721, Z01AG000726] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahn B, 2004, J BIOL CHEM, V279, P53465, DOI 10.1074/jbc.M409624200; Ataian Y, 2006, BIOCHEM CELL BIOL, V84, P490, DOI 10.1139/O06-075; Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006; Bhakat KK, 2004, NUCLEIC ACIDS RES, V32, P3033, DOI 10.1093/nar/gkh632; Bhakat KK, 2003, EMBO J, V22, P6299, DOI 10.1093/emboj/cdg595; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Blander G, 2002, J BIOL CHEM, V277, P50934, DOI 10.1074/jbc.M210479200; Blank A, 2004, DNA REPAIR, V3, P629, DOI 10.1016/j.dnarep.2004.02.003; Bohr VA, 2005, MUTAT RES-FUND MOL M, V577, P252, DOI 10.1016/j.mrfmmm.2005.03.021; Brosh RM, 2001, EMBO J, V20, P5791; Chafin DR, 2000, EMBO J, V19, P5492, DOI 10.1093/emboj/19.20.5492; Cheng WH, 2003, MOL CELL BIOL, V23, P6385, DOI 10.1128/MCB.23.18.6385-6395.2003; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; DI GE, 2004, AMINO ACIDS, V26, P435; DRESLER SL, 1985, BIOCHEMISTRY-US, V24, P6861, DOI 10.1021/bi00345a019; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Ehrenhofer-Murray AE, 2004, EUR J BIOCHEM, V271, P2335, DOI 10.1111/j.1432-1033.2004.04162.x; Harrigan JA, 2006, NUCLEIC ACIDS RES, V34, P745, DOI 10.1093/nar/gkj475; Harrigan JA, 2003, J BIOL CHEM, V278, P22686, DOI 10.1074/jbc.M213103200; Hasan S, 2002, J MOL MED, V80, P463, DOI 10.1007/s00109-002-0341-7; Hasan S, 2002, MOL CELL, V10, P1213, DOI 10.1016/S1097-2765(02)00745-1; Hasan S, 2001, MOL CELL, V7, P1221, DOI 10.1016/S1097-2765(01)00272-6; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Huang SR, 2000, NUCLEIC ACIDS RES, V28, P2396, DOI 10.1093/nar/28.12.2396; Huggins CF, 2002, MOL CELL, V10, P1201, DOI 10.1016/S1097-2765(02)00736-0; Imamura O, 2002, ONCOGENE, V21, P954, DOI 10.1038/sj.onc.1205143; Kamath-Loeb AS, 1998, J BIOL CHEM, V273, P34145, DOI 10.1074/jbc.273.51.34145; Karmakar P, 2002, J BIOL CHEM, V277, P18291, DOI 10.1074/jbc.M111523200; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Laine JP, 2003, CANCER RES, V63, P7136; Lindahl T, 2000, MUTAT RES-REV MUTAT, V462, P129, DOI 10.1016/S1383-5742(00)00024-7; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; Martin GM, 1999, J AM GERIATR SOC, V47, P1136, DOI 10.1111/j.1532-5415.1999.tb05240.x; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Munshi A, 2005, CLIN CANCER RES, V11, P4912, DOI 10.1158/1078-0432.CCR-04-2088; Nakatani Y, 2001, GENES CELLS, V6, P79, DOI 10.1046/j.1365-2443.2001.00411.x; Nilsen H, 2002, EMBO J, V21, P5943, DOI 10.1093/emboj/cdf581; Opresko PL, 2003, CARCINOGENESIS, V24, P791, DOI 10.1093/carcin/bgg034; Orren DK, 1999, NUCLEIC ACIDS RES, V27, P3557, DOI 10.1093/nar/27.17.3557; Poot M, 2002, FASEB J, V16, P757, DOI 10.1096/fj.01-0906fje; Porcu M, 2005, TRENDS PHARMACOL SCI, V26, P94, DOI 10.1016/j.tips.2004.12.009; RAMANATHAN B, 1989, J BIOL CHEM, V264, P11026; Saha RN, 2006, CELL DEATH DIFFER, V13, P539, DOI 10.1038/sj.cdd.4401769; SHARMA A, 2007, J BIOL CHEM; Sharma S, 2003, J BIOL CHEM, V278, P23487, DOI 10.1074/jbc.M212798200; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; SMERDON MJ, 1983, BIOCHEMISTRY-US, V22, P3516, DOI 10.1021/bi00283a033; SMERDON MJ, 1982, J BIOL CHEM, V257, P13441; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Stoilov L, 2000, INT J RADIAT BIOL, V76, P1485, DOI 10.1080/09553000050176243; Szekely AM, 2005, MOL CELL BIOL, V25, P10492, DOI 10.1128/MCB.25.23.10492-10506.2005; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; von Kobbe C, 2004, FASEB J, V18, P1970, DOI 10.1096/fj.04-1895fje; von Kobbe C, 2004, NUCLEIC ACIDS RES, V32, P4003, DOI 10.1093/nar/gkh721; von Kobbe C, 2003, J BIOL CHEM, V278, P52997, DOI 10.1074/jbc.M308338200; White NR, 2006, J PEDIATR GASTR NUTR, V42, P134, DOI 10.1097/01.mpg.0000189345.31010.89	57	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1918	10.1371/journal.pone.0001918	http://dx.doi.org/10.1371/journal.pone.0001918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398454	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795500005
J	Chen, LW; Tredget, EE; Wu, PYG; Wu, YJ				Chen, Liwen; Tredget, Edward E.; Wu, Philip Y. G.; Wu, Yaojiong			Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing	PLOS ONE			English	Article								Bone marrow derived mesenchymal stem cells (BM-MSCs) have been shown to enhance wound healing; however, the mechanisms involved are barely understood. In this study, we examined paracrine factors released by BM-MSCs and their effects on the cells participating in wound healing compared to those released by dermal fibroblasts. Analyses of BM-MSCs with Real-Time PCR and of BM-MSC-conditioned medium by antibody-based protein array and ELISA indicated that BM-MSCs secreted distinctively different cytokines and chemokines, such as greater amounts of VEGF-alpha, IGF-1, EGF, keratinocyte growth factor, angiopoietin-1, stromal derived factor-1, macrophage inflammatory protein-1alpha and beta and erythropoietin, compared to dermal fibroblasts. These molecules are known to be important in normal wound healing. BM-MSC-conditioned medium significantly enhanced migration of macrophages, keratinocytes and endothelial cells and proliferation of keratinocytes and endothelial cells compared to fibroblast-conditioned medium. Moreover, in a mouse model of excisional wound healing, where concentrated BM-MSC-conditioned medium was applied, accelerated wound healing occurred compared to administration of pre-conditioned or fibroblast-conditioned medium. Analysis of cell suspensions derived from the wound by FACS showed that wounds treated with BM-MSC-conditioned medium had increased proportions of CD4/80-postive macrophages and Flk-1-, CD34- or c-kit-positive endothelial (progenitor) cells compared to wounds treated with pre-conditioned medium or fibroblast-conditioned medium. Consistent with the above findings, immunohistochemical analysis of wound sections showed that wounds treated with BM-MSC-conditioned medium had increased abundance of macrophages. Our results suggest that factors released by BM-MSCs recruit macrophages and endothelial lineage cells into the wound thus enhancing wound healing.	[Chen, Liwen; Tredget, Edward E.; Wu, Yaojiong] Univ Alberta, Dept Surg, Fac Med & Dent, Edmonton, AB, Canada; [Wu, Philip Y. G.] Univ Hong Kong, Li Ka Shing Fac Med, Hong Kong, Peoples R China; [Wu, Yaojiong] Shenzhen Univ, Sch Med, Shenzhen, Peoples R China	University of Alberta; University of Hong Kong; Shenzhen University	Chen, LW (corresponding author), Univ Alberta, Dept Surg, Fac Med & Dent, Edmonton, AB, Canada.	yjwu2005@yahoo.com			Firefighters Burn Trust Fund; University of Alberta Hospital Foundation; SZU R/D Fund of Shenzhen University	Firefighters Burn Trust Fund; University of Alberta Hospital Foundation(University of Alberta); SZU R/D Fund of Shenzhen University	Firefighters Burn Trust Fund, the University of Alberta Hospital Foundation and the SZU R/D Fund of Shenzhen University supported the study.	Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Amirbekian V, 2007, P NATL ACAD SCI USA, V104, P961, DOI 10.1073/pnas.0606281104; ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Caldelari R, 2000, J INVEST DERMATOL, V114, P1064, DOI 10.1046/j.1523-1747.2000.00960-4.x; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; DANON D, 1989, P NATL ACAD SCI USA, V86, P2018, DOI 10.1073/pnas.86.6.2018; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; DiPietro LA, 1998, J CLIN INVEST, V101, P1693, DOI 10.1172/JCI1020; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dupasquier M, 2004, J INVEST DERMATOL, V123, P876, DOI 10.1111/j.0022-202X.2004.23427.x; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Fathke C, 2004, STEM CELLS, V22, P812, DOI 10.1634/stemcells.22-5-812; Galeano M, 2004, DIABETES, V53, P2509, DOI 10.2337/diabetes.53.9.2509; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Ghahary A, 2005, J INVEST DERMATOL, V124, P170, DOI 10.1111/j.0022-202X.2004.23521.x; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Hasegawa T, 2005, J DERMATOL, V32, P715, DOI 10.1111/j.1346-8138.2005.tb00831.x; Hintermann E, 2001, J CELL BIOL, V153, P465, DOI 10.1083/jcb.153.3.465; Keating A, 2006, CURR OPIN HEMATOL, V13, P419, DOI 10.1097/01.moh.0000245697.54887.6f; Keller Evan T., 1996, Frontiers in Bioscience (online), V1, pD340; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lamme EN, 2002, WOUND REPAIR REGEN, V10, P152, DOI 10.1046/j.1524-475X.2002.10901.x; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462; Miller GE, 2006, P NATL ACAD SCI USA, V103, P5496, DOI 10.1073/pnas.0506312103; Park IW, 2001, BLOOD, V97, P352, DOI 10.1182/blood.V97.2.352; PIERCE GF, 1989, P NATL ACAD SCI USA, V86, P2229, DOI 10.1073/pnas.86.7.2229; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; SBOISMOUTHON C, 2006, FASEB J; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Welch S, 2002, CIRC RES, V90, P641, DOI 10.1161/01.RES.0000013780.77774.75; WU Y, 2007, MESENCHYMAL STEM CEL, P2007; Xing LP, 2005, IMMUNOL REV, V208, P19, DOI 10.1111/j.0105-2896.2005.00336.x; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126	39	1142	1218	11	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1886	10.1371/journal.pone.0001886	http://dx.doi.org/10.1371/journal.pone.0001886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382669	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795400020
J	Figueroa, ME; Reimers, M; Thompson, RF; Ye, K; Li, YS; Selzer, RR; Fridriksson, J; Paietta, E; Wiernik, P; Green, RD; Greally, JM; Melnick, A				Figueroa, Maria E.; Reimers, Mark; Thompson, Reid F.; Ye, Kenny; Li, Yushan; Selzer, Rebecca R.; Fridriksson, Jakob; Paietta, Elisabeth; Wiernik, Peter; Green, Roland D.; Greally, John M.; Melnick, Ari			An Integrative Genomic and Epigenomic Approach for the Study of Transcriptional Regulation	PLOS ONE			English	Article							DNA METHYLATION PATTERNS; GENE-EXPRESSION; PROMOTER HYPERMETHYLATION; HISTONE MODIFICATIONS; CANCER; CHROMATIN; METHYLTRANSFERASE; DEMETHYLATION	The molecular heterogeneity of acute leukemias and other tumors constitutes a major obstacle towards understanding disease pathogenesis and developing new targeted- therapies. Aberrant gene regulation is a hallmark of cancer and plays a central role in determining tumor phenotype. We predicted that integration of different genome-wide epigenetic regulatory marks along with gene expression levels would provide greater power in capturing biological differences between leukemia subtypes. Gene expression, cytosine methylation and histone H3 lysine 9 (H3K9) acetylation were measured using high-density oligonucleotide microarrays in primary human acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL) specimens. We found that DNA methylation and H3K9 acetylation distinguished these leukemias of distinct cell lineage, as expected, but that an integrative analysis combining the information from each platform revealed hundreds of additional differentially expressed genes that were missed by gene expression arrays alone. This integrated analysis also enhanced the detection and statistical significance of biological pathways dysregulated in AML and ALL. Integrative epigenomic studies are thus feasible using clinical samples and provide superior detection of aberrant transcriptional programming than single-platform microarray studies.	[Figueroa, Maria E.; Li, Yushan; Melnick, Ari] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Reimers, Mark] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [Thompson, Reid F.; Greally, John M.] Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY USA; [Ye, Kenny] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY USA; [Selzer, Rebecca R.; Fridriksson, Jakob; Green, Roland D.] Roche NimbleGen Inc, Madison, WI USA; [Paietta, Elisabeth; Wiernik, Peter] Our Lady of Mercy Comprehensive Canc Ctr, Bronx, NY USA; [Greally, John M.] Albert Einstein Coll Med, Dept Med, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; Virginia Commonwealth University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Roche Holding; Yeshiva University; Albert Einstein College of Medicine	Figueroa, ME (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA.	jgreally@aecom.yu.edu; amelnick@aecom.yu.edu	Greally, John/AAF-9540-2019; Figueroa, Maria/AAE-8662-2019; Ye, Kenny/GSM-7731-2022; Ye, Kenny/U-2341-2019; Melnick, Ari/AAA-5763-2020	Greally, John/0000-0001-6069-7960; Ye, Kenny/0000-0002-1466-855X; Thompson, Reid/0000-0003-3661-5296; Figueroa, Maria Eugenia/0000-0003-4887-4981	ASH Fellow Scholar Award; NCI [R01 CA104348]; Chemotherapy Foundation; Sam Waxman Cancer Research Foundation; G&P Foundation; Leukemia and Lymphoma Society Scholar; National Institutes of Health [R01 HD044078]; NIH MSTP [GM007288]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044078] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA104348] Funding Source: NIH RePORTER	ASH Fellow Scholar Award; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chemotherapy Foundation; Sam Waxman Cancer Research Foundation; G&P Foundation; Leukemia and Lymphoma Society Scholar(Leukemia and Lymphoma Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Maria E. Figueroa is supported by an ASH Fellow Scholar Award. Ari M. Melnick is supported by NCI R01 CA104348, the Chemotherapy Foundation, the Sam Waxman Cancer Research Foundation, and the G&P Foundation and is a Leukemia and Lymphoma Society Scholar. John M. Greally is supported by a grant from the National Institutes of Health (NIH) (R01 HD044078). Reid F. Thompson is supported by NIH MSTP Training Grant GM007288.	Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brell M, 2005, CLIN CANCER RES, V11, P5167, DOI 10.1158/1078-0432.CCR-05-0230; BRINKMAN AB, 2007, NUCL ACIDS RES; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esteller M, 1999, CANCER RES, V59, P793; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; Gebhard C, 2006, CANCER RES, V66, P6118, DOI 10.1158/0008-5472.CAN-06-0376; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Melki JR, 1999, CANCER RES, V59, P3730; Melki JR, 2002, SEMIN CANCER BIOL, V12, P347, DOI 10.1016/S1044-579X(02)00055-X; Misra J, 2002, GENOME RES, V12, P1112, DOI 10.1101/gr.225302; Oberley MJ, 2004, METHOD ENZYMOL, V376, P315; Paz MF, 2004, CLIN CANCER RES, V10, P4933, DOI 10.1158/1078-0432.CCR-04-0392; Reimers M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-166; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Shi HD, 2003, CANCER RES, V63, P2164; Taylor KH, 2007, CANCER RES, V67, P2617, DOI 10.1158/0008-5472.CAN-06-3993; Team. RDC, 2007, R LANG ENV STAT COMP; Tessema M, 2003, LEUKEMIA, V17, P910, DOI 10.1038/sj.leu.2402891; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Wu JJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-131; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	40	69	72	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1882	10.1371/journal.pone.0001882	http://dx.doi.org/10.1371/journal.pone.0001882			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365023	gold, Green Published, Green Submitted			2022-12-27	WOS:000260762400029
J	Goncalves, LA; Almeida, P; Mota, MM; Penha-Goncalves, C				Goncalves, Ligia Antunes; Almeida, Paulo; Mota, Maria Manuel; Penha-Goncalves, Carlos			Malaria Liver Stage Susceptibility Locus Identified on Mouse Chromosome 17 by Congenic Mapping	PLOS ONE			English	Article								Host genetic variants are known to confer resistance to Plasmodium blood stage infection and to control malaria severity both in humans and mice. This work describes the genetic mapping of a locus for resistance to liver stage parasite in the mouse. First, we show that decreased susceptibility to the liver stage of Plasmodium berghei in the BALB/c mouse strain is attributable to intra-hepatic factors and impacts on the initial phase of blood stage infection. We used QTL mapping techniques to identify a locus controlling this susceptibility phenotype (LOD score 4.2) on mouse chromosome 17 (belr1 locus). Furthermore, analysis of congenic mouse strains delimited the belr1 locus boundaries distally to the H2 region. Quantification of parasites in the liver of infected congenic mice strongly suggested that the belr1 locus represents a genetic factor controlling the expansion of P. berghei in the hepatic tissue. The mapping of belr1 locus raises the hypothesis that host gene variation is able to control the progression of Plasmodium liver stage infection and opens the possibility that the human genomic region orthologue to belr1 may contain genes that confer resistance to the human malaria liver stage.	[Goncalves, Ligia Antunes; Almeida, Paulo; Mota, Maria Manuel; Penha-Goncalves, Carlos] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Mota, Maria Manuel] Univ Lisbon, Inst Med Mol, Unidade Malaria, Lisbon, Portugal	Instituto Gulbenkian de Ciencia; Universidade de Lisboa	Goncalves, LA (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	cpenha@igc.gulbenkian.pt	Gonçalves, Lígia Antunes/F-6242-2014; Mota, Maria/AAF-2048-2019; Penha-Goncalves, Carlos/F-4640-2012	Gonçalves, Lígia Antunes/0000-0001-9804-6899; Penha-Goncalves, Carlos/0000-0001-7225-1907; Mota, Maria Manuel/0000-0002-2858-1041; Almeida, Paulo/0000-0002-9279-2353	Fundacao para a Ciencia e Tecnologia	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Financial support through grant from Fundacao para a Ciencia e Tecnologia. The funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Bagot S, 2002, P NATL ACAD SCI USA, V99, P9919, DOI 10.1073/pnas.152215199; BENNETT S, 1993, T ROY SOC TROP MED H, V87, P286, DOI 10.1016/0035-9203(93)90130-I; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Burt RA, 2002, INFECT IMMUN, V70, P4750, DOI 10.1128/IAI.70.8.4750-4753.2002; Burt RA, 1999, IMMUNOGENETICS, V50, P278, DOI 10.1007/s002510050603; Campino S, 2005, GENES IMMUN, V6, P416, DOI 10.1038/sj.gene.6364219; Carrolo M, 2003, NAT MED, V9, P1363, DOI 10.1038/nm947; Flori L, 2005, GENES IMMUN, V6, P472, DOI 10.1038/sj.gene.6364231; Foote SJ, 1997, NAT GENET, V17, P380, DOI 10.1038/ng1297-380; Fortin A, 1997, NAT GENET, V17, P382, DOI 10.1038/ng1297-382; Fortin A, 2002, HUM MOL GENET, V11, P2469, DOI 10.1093/hmg/11.20.2469; Fortin A, 2001, P NATL ACAD SCI USA, V98, P10793, DOI 10.1073/pnas.191288998; Hernandez-Valladares M, 2005, TRENDS PARASITOL, V21, P352, DOI 10.1016/j.pt.2005.06.010; Hernandez-Valladares M, 2004, MAMM GENOME, V15, P390, DOI 10.1007/s00335-004-3042-4; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; KHAN ZM, 1991, INFECT IMMUN, V59, P2529, DOI 10.1128/IAI.59.8.2529-2534.1991; Lederberg J, 1999, GENETICS, V153, P1; Leiriao P, 2005, CELL MICROBIOL, V7, P603, DOI 10.1111/j.1462-5822.2004.00490.x; Lin E, 2006, INFECT IMMUN, V74, P5814, DOI 10.1128/IAI.01690-05; McGuire W, 1999, J INFECT DIS, V179, P287, DOI 10.1086/314533; Min-Oo G, 2003, NAT GENET, V35, P357, DOI 10.1038/ng1260; Min-Oo G, 2007, J EXP MED, V204, P511, DOI 10.1084/jem.20061252; Min-Oo G, 2007, BLOOD CELL MOL DIS, V39, P63, DOI 10.1016/j.bcmd.2007.03.003; Nagayasu E, 2002, INFECT IMMUN, V70, P512, DOI 10.1128/IAI.70.2.512-516.2002; Ngonseu E, 1998, PARASITOLOGY, V117, P419, DOI 10.1017/S0031182098003333; Ohno T, 2004, IMMUNOGENETICS, V56, P675, DOI 10.1007/s00251-004-0739-1; Sepulveda N, 2007, HEREDITY, V99, P173, DOI 10.1038/sj.hdy.6800979; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; WEISS WR, 1989, J IMMUNOL, V143, P4263	32	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1874	10.1371/journal.pone.0001874	http://dx.doi.org/10.1371/journal.pone.0001874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365019	Green Submitted, gold, Green Published			2022-12-27	WOS:000260762400025
J	Guessous, I; Periard, D; Lorenzetti, D; Cornuz, J; Ghali, WA				Guessous, Idris; Periard, Daniel; Lorenzetti, Diane; Cornuz, Jacques; Ghali, William A.			The Efficacy of Pharmacotherapy for Decreasing the Expansion Rate of Abdominal Aortic Aneurysms: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							PROSTAGLANDIN E-2 SYNTHESIS; CHLAMYDIA-PNEUMONIAE; DOUBLE-BLIND; GROWTH-RATE; INHIBITION; STATINS; HETEROGENEITY; DEGENERATION; SUPPRESSION; DOXYCYCLINE	Background: Pharmacotherapy may represent a potential means to limit the expansion rate of abdominal aortic aneurysms (AAAs). Studies evaluating the efficacy of different pharmacological agents to slow down human AAA-expansion rates have been performed, but they have never been systematically reviewed or summarized. Methods and Findings: Two independent reviewers identified studies and selected randomized trials and prospective cohort studies comparing the growth rate of AAA in patients with pharmacotherapy vs. no pharmacotherapy. We extracted information on study interventions, baseline characteristics, methodological quality, and AAA growth rate differences (in mm/year). Fourteen prospective studies met eligibility criteria. Five cohort studies raised the possibility of benefit of beta-blockers [pooled growth rate difference: -0.62 mm/year, (95% CI, -1.00 to -0.24)], but this was not confirmed in three beta- blocker RCTs [pooled RCT growth rate difference: -0.05 mm/year (-0.16 to 0.05)]. Statins have been evaluated in two cohort studies that yield a pooled growth rate difference of -2.97 (-5.83 to -0.11). Doxycycline and roxithromycin have been evaluated in two RCTs that suggest possible benefit [pooled RCT growth rate difference: -1.32 mm/year (-2.89 to 0.25)]. Studies assessing NSAIDs, diuretics, calcium channel blockers and ACE inhibitors, meanwhile, did not find statistically significant differences. Conclusions: Beta-blockers do not appear to significantly reduce the growth rate of AAAs. Statins and other anti-inflammatory agents appear to hold promise for decreasing the expansion rate of AAA, but need further evaluation before definitive recommendations can be made.	[Guessous, Idris; Cornuz, Jacques] Univ Lausanne Hosp, Dept Internal Med, Lausanne, Switzerland; [Periard, Daniel] Lausanne Univ Hosp, Serv Angiol, Lausanne, Switzerland; [Lorenzetti, Diane; Ghali, William A.] Univ Calgary, Fac Med, Ctr Hlth & Policy Studies, Calgary, AB, Canada; [Lorenzetti, Diane] Inst Hlth Ec, Edmonton, AB, Canada; [Cornuz, Jacques] Lausanne Univ Hosp, Dept Community Med & Public Hlth, Lausanne, Switzerland; [Ghali, William A.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Ghali, William A.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Calgary; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Calgary; University of Calgary	Guessous, I (corresponding author), Univ Lausanne Hosp, Dept Internal Med, Lausanne, Switzerland.	idris.guessous@chuv.ch		Lorenzetti, Diane L./0000-0001-8423-3458	Alberta Heritage Foundation for Medical Research [Canada Research Chair, Senior Health Scholar Award]	Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	The study was not externally funded. Dr. Ghali is funded by a Canada Research Chair, and by a Senior Health Scholar Award from the Alberta Heritage Foundation for Medical Research.	Bellosta S, 1998, ARTERIOSCL THROM VAS, V18, P1671, DOI 10.1161/01.ATV.18.11.1671; Berger VW, 2004, STAT MED, V23, P1571, DOI 10.1002/sim.1780; Bergoeing MP, 2006, EXPERT OPIN THER TAR, V10, P547, DOI 10.1517/14728222.10.4.547; Biancari F, 2002, AM J SURG, V183, P53, DOI 10.1016/S0002-9610(01)00828-5; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Cronenwett JL, 1996, ANN NY ACAD SCI, V800, P56, DOI 10.1111/j.1749-6632.1996.tb33298.x; Dear K.B.G., 1992, STAT SCI, V7, P237, DOI DOI 10.1214/SS/1177011363; Deeks JJ, 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Englund R, 1998, AUST NZ J SURG, V68, P21, DOI 10.1111/j.1445-2197.1998.tb04630.x; Fleming C, 2005, ANN INTERN MED, V142, P203, DOI 10.7326/0003-4819-142-3-200502010-00012; Fletcher RH, 1988, CLIN EPIDEMIOLOGY ES; GADOWSKI GR, 1994, J VASC SURG, V19, P727, DOI 10.1016/S0741-5214(94)70048-6; Grange J J, 1997, Cardiovasc Surg, V5, P256, DOI 10.1016/S0967-2109(97)00018-5; Guessous Idris, 2006, Expert Rev Pharmacoecon Outcomes Res, V6, P555, DOI 10.1586/14737167.6.5.555; Halme S, 1999, EUR J CLIN INVEST, V29, P546, DOI 10.1046/j.1365-2362.1999.00463.x; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Holmes DR, 1996, J SURG RES, V63, P305, DOI 10.1006/jsre.1996.0265; Holmes DR, 1997, J VASC SURG, V25, P810, DOI 10.1016/S0741-5214(97)70210-6; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Juvonen JJ, 1997, J VASC SURG, V25, P499, DOI 10.1016/S0741-5214(97)70260-X; Kramer BS, 2006, PLOS MED, V3, P756, DOI 10.1371/journal.pmed.0030144; Laupacis A, 2002, J VASC SURG, V35, P72, DOI 10.1067/mva.2002.121308; LEACH SD, 1988, ARCH SURG-CHICAGO, V123, P606; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Lefebvre C, 2001, SYSTEMATIC REV HLTH, P69; Liao SX, 2001, J VASC SURG, V33, P1057, DOI 10.1067/mva.2001.112810; LIMET R, 1991, J VASC SURG, V14, P540, DOI 10.1016/0741-5214(91)90249-T; Lindholt JS, 2001, EUR J VASC ENDOVASC, V21, P51, DOI 10.1053/ejvs.2000.1262; Lindholt JS, 1999, INT ANGIOL, V18, P52; Luan ZX, 2003, ARTERIOSCL THROM VAS, V23, P769, DOI 10.1161/01.ATV.0000068646.76823.AE; McMillan WD, 1999, J VASC SURG, V29, P122, DOI 10.1016/S0741-5214(99)70363-0; Mosorin M, 2001, J VASC SURG, V34, P606, DOI 10.1067/mva.2001.117891; Nagashima H, 2002, J VASC SURG, V36, P158, DOI 10.1067/mva.2002.123680; Petrinec D, 1996, ANN NY ACAD SCI, V800, P263, DOI 10.1111/j.1749-6632.1996.tb33326.x; Petrinec D, 1996, J VASC SURG, V23, P336, DOI 10.1016/S0741-5214(96)70279-3; Powell JT, 1998, LANCET, V352, P1649; Schouten O, 2006, EUR J VASC ENDOVASC, V32, P21, DOI 10.1016/j.ejvs.2005.12.024; Scott RAP, 2005, J MED SCREEN, V12, P57, DOI 10.1258/0969141053908339; Shah PK, 1997, CIRCULATION, V96, P2115; Sterne JAC, 2001, SYSTEMATIC REV HLTH, P347, DOI [DOI 10.1002/9780470693926.CH18, 10.1002/9780470693926.ch18]; Sukhija R, 2006, AM J CARDIOL, V97, P279, DOI 10.1016/j.amjcard.2005.08.033; Thompson RW, 1999, ANN NY ACAD SCI, V878, P159, DOI 10.1111/j.1749-6632.1999.tb07682.x; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Vammen S, 2001, BRIT J SURG, V88, P1066, DOI 10.1046/j.0007-1323.2001.01845.x; Walton LJ, 1999, CIRCULATION, V100, P48, DOI 10.1161/01.CIR.100.1.48; Wassef M, 2001, J VASC SURG, V34, P730, DOI 10.1067/mva.2001.116966; Wilmink A.B.M., 2002, BRIT J SURG, V87, P499, DOI [10.1046/j.1365-2168.2000.01420-23.x, DOI 10.1046/J.1365-2168.2000.01420-23.X]; Wilmink ABM, 2002, J VASC SURG, V36, P751, DOI 10.1067/mva.2002.126550; Wilson KA, 1997, EUR J VASC ENDOVASC, V13, P521, DOI 10.1016/S1078-5884(97)80059-7; Wilson WRW, 2005, EUR J VASC ENDOVASC, V30, P259, DOI 10.1016/j.ejvs.2005.02.044	52	64	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1895	10.1371/journal.pone.0001895	http://dx.doi.org/10.1371/journal.pone.0001895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365027	Green Submitted, gold, Green Published			2022-12-27	WOS:000260762400033
J	Wang, B; Xiao, ZF; Chen, B; Han, J; Gao, Y; Zhang, J; Zhao, WX; Wang, X; Dai, JW				Wang, Bin; Xiao, Zhifeng; Chen, Bing; Han, Jin; Gao, Yuan; Zhang, Jing; Zhao, Wenxue; Wang, Xia; Dai, Jianwu			Nogo-66 Promotes the Differentiation of Neural Progenitors into Astroglial Lineage Cells through mTOR-STAT3 Pathway	PLOS ONE			English	Article								Background: Neural stem/progenitor cells (NPCs) can differentiate into neurons, astrocytes and oligodendrocytes. NPCs are considered valuable for the cell therapy of injuries in the central nervous system (CNS). However, when NPCs are transplanted into the adult mammalian spinal cord, they mostly differentiate into glial lineage. The same results have been observed for endogenous NPCs during spinal cord injury. However, little is known about the mechanism of such fate decision of NPCs. Methodology/Principal Findings: In the present study, we have found that myelin protein and Nogo-66 promoted the differentiation of NPCs into glial lineage. NgR and mTOR-Stat3 pathway were involved in this process. Releasing NgR from cell membranes or blocking mTOR-STAT3 could rescue the enhanced glial differentiation by Nogo-66. Conclusions/Significance: These results revealed a novel function of Nogo-66 in the fate decision of NPCs. This discovery could have profound impact on the understanding of CNS development and could improve the therapy of CNS injuries.	[Wang, Bin; Xiao, Zhifeng; Chen, Bing; Han, Jin; Gao, Yuan; Zhang, Jing; Zhao, Wenxue; Wang, Xia; Dai, Jianwu] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol Dev Biol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Wang, B (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol Dev Biol, Beijing, Peoples R China.	jwdai@genetics.ac.cn	Zhao, Wenxue/I-7721-2013		NSFC [30688002]; Chinese Academy of Sciences [KSCX2-YW-R-133]; Ministry of Science and Technology of China [2006CB943601]	NSFC(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from NSFC (30688002), Chinese Academy of Sciences (KSCX2-YW-R-133), and the Ministry of Science and Technology of China (2006CB943601)	Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Chen HH, 2007, NEUROBIOL AGING, V28, P1148, DOI 10.1016/j.neurobiolaging.2006.05.036; Craig CG, 1996, J NEUROSCI, V16, P2649; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; DELOULME JC, 1991, J NEUROSCI RES, V29, P499, DOI 10.1002/jnr.490290410; Dergham P, 2002, J NEUROSCI, V22, P6570; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gossrau G, 2007, STEM CELLS, V25, P939, DOI 10.1634/stemcells.2006-0299; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hamilton GS, 1998, J MED CHEM, V41, P5119, DOI 10.1021/jm980307x; Hapner SJ, 2006, DEV BIOL, V297, P182, DOI 10.1016/j.ydbio.2006.05.007; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kuhn HG, 1997, J NEUROSCI, V17, P5820; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Rajan P, 1998, J NEUROSCI, V18, P3620; Spencer T, 2003, CURR OPIN NEUROBIOL, V13, P133, DOI 10.1016/S0959-4388(03)00012-6; Weible MW, 2007, GLIA, V55, P1156, DOI 10.1002/glia.20539; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005	24	81	98	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1856	10.1371/journal.pone.0001856	http://dx.doi.org/10.1371/journal.pone.0001856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365011	Green Published, Green Submitted, gold			2022-12-27	WOS:000260762400017
J	Cameron, N; Del Corpo, A; Diorio, J; McAllister, K; Sharma, S; Meaney, MJ				Cameron, Nicole; Del Corpo, Adina; Diorio, Josie; McAllister, Kelli; Sharma, Shakti; Meaney, Michael J.			Maternal Programming of Sexual Behavior and Hypothalamic-Pituitary-Gonadal Function in the Female Rat	PLOS ONE			English	Article							HORMONE-RELEASING HORMONE; ESTROGEN-RECEPTOR-ALPHA; CENTRAL-NERVOUS-SYSTEM; MESSENGER-RNA LEVELS; INDIVIDUAL-DIFFERENCES; GENE-EXPRESSION; REPRODUCTIVE STRATEGIES; CHILDHOOD EXPERIENCE; PUBERTAL MATURATION; CARE	Variations in parental care predict the age of puberty, sexual activity in adolescence and the age at first pregnancy in humans. These findings parallel descriptions of maternal effects on phenotypic variation in reproductive function in other species. Despite the prevalence of such reports, little is known about potential biological mechanisms and this especially true for effects on female reproductive development. We examined the hypothesis that parental care might alter hypothalamic-pituitary-ovarian function and thus reproductive function in the female offspring of rat mothers that vary pup licking/grooming (LG) over the first week postpartum. As adults, the female offspring of Low LG mothers showed 1) increased sexual receptivity; 2) increased plasma levels of luteinizing hormone (LH) and progesterone at proestrus; 3) an increased positive-feedback effect of estradiol on both plasma LH levels and gonadotropin releasing-hormone (GnRH) expression in the medial preoptic region; and 4) increased estrogen receptor alpha (ER alpha) expression in the anterioventral paraventricular nucleus, a system that regulates GnRH. The results of a cross-fostering study provide evidence for a direct effect of postnatal maternal care as well as a possible prenatal influence. Indeed, we found evidence for increased fetal testosterone levels at embryonic day 20 in the female fetuses of High compared to Low LG mothers. Finally, the female offspring of Low LG mothers showed accelerated puberty compared to those of High LG mothers. These data suggest maternal effects in the rat on the development of neuroendocrine systems that regulate female sexual behaviour. Together with studies revealing a maternal effect on the maternal behavior of the female offspring, these findings suggest that maternal care can program alternative reproductive phenotypes in the rat through regionally-specific effects on ER alpha expression.	[Cameron, Nicole; Del Corpo, Adina; Diorio, Josie; McAllister, Kelli; Sharma, Shakti; Meaney, Michael J.] McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada	McGill University	Cameron, N (corresponding author), McGill Univ, Sackler Program Epigenet & Psychobiol, Montreal, PQ, Canada.	michael.meaney@mcgill.ca	Meaney, Michael/N-5931-2019	Cameron, Nicole/0000-0002-5372-3902; Reis, AlessanRSS/0000-0001-8486-7469	Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by a grant from the Canadian Institutes for Health Research to MJM.	AnderssonEllstrom A, 1996, ACTA OBSTET GYN SCAN, V75, P484, DOI 10.3109/00016349609033359; [Anonymous], 1986, DEV ANTISOCIAL PROSO; Arnold AP, 2004, NAT REV NEUROSCI, V5, P701, DOI 10.1038/nrn1494; Belsky J, 1997, CHILD DEV, V68, P598, DOI 10.2307/1132110; BELSKY J, 1991, CHILD DEV, V62, P647, DOI 10.1111/j.1467-8624.1991.tb01558.x; Bingham C R, 1990, J Adolesc Res, V5, P18, DOI 10.1177/074355489051004; Blaustein J. D., 2002, HORMONES BRAIN BEHAV, P139; BREEDLOVE SM, 2002, BEHAV ENDOCRINOLOGY, P75; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; CAMERON N, HORMONES BE IN PRESS; Cameron NM, 2005, NEUROSCI BIOBEHAV R, V29, P843, DOI 10.1016/j.neubiorev.2005.03.022; Champagne F, 2001, P NATL ACAD SCI USA, V98, P12736, DOI 10.1073/pnas.221224598; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Champagne FA, 2003, ENDOCRINOLOGY, V144, P4720, DOI 10.1210/en.2003-0564; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; Charnov Eric L., 1993, P1; CHISHOLM JS, 1993, CURR ANTHROPOL, V34, P1, DOI 10.1086/204131; Coall DA, 2003, SOC SCI MED, V57, P1771, DOI 10.1016/S0277-9536(03)00022-4; Ellis BJ, 1999, J PERS SOC PSYCHOL, V77, P387, DOI 10.1037/0022-3514.77.2.387; Ellis BJ, 2004, PSYCHOL BULL, V130, P920, DOI 10.1037/0033-2909.130.6.920; Ellis BJ, 2000, CHILD DEV, V71, P485, DOI 10.1111/1467-8624.00159; Erskine MS, 2004, BEHAV BRAIN RES, V153, P295, DOI 10.1016/j.bbr.2004.01.026; ERSKINE MS, 1989, HORM BEHAV, V23, P473, DOI 10.1016/0018-506X(89)90037-8; ERSKINE MS, 1992, BEHAV NEUROSCI, V106, P690, DOI 10.1037/0735-7044.106.4.690; Fairbanks LA., 1996, ADV STUDY BEHAV VOL, V25, P579, DOI [10.1016/S0065-3454(08)60343-5, DOI 10.1016/S0065-3454(08)60343-5]; Fleming AS, 1999, NEUROSCI BIOBEHAV R, V23, P673, DOI 10.1016/S0149-7634(99)00011-1; Foecking EM, 2005, BIOL REPROD, V72, P1475, DOI 10.1095/biolreprod.105.039800; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Freeman Marc E., 1994, P613; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; GANS SE, 1993, HORM BEHAV, V27, P403, DOI 10.1006/hbeh.1993.1030; Gomes CM, 2005, J ENDOCRINOL, V184, P435, DOI 10.1677/joe.1.05907; GOODMAN RL, 1978, ENDOCRINOLOGY, V102, P151, DOI 10.1210/endo-102-1-151; GORE AC, 1995, ENDOCRINOLOGY, V136, P889, DOI 10.1210/en.136.3.889; GOSDEN RG, 1976, ENDOCRINOLOGY, V99, P1046, DOI 10.1210/endo-99-4-1046; Goy R. W., 1980, SEXUAL DIFFERENTIATI; GRABER JA, 1995, CHILD DEV, V66, P346, DOI 10.1111/j.1467-8624.1995.tb00875.x; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Gu GB, 1997, J COMP NEUROL, V384, P142; HARDY DF, 1972, J COMP PHYSIOL PSYCH, V78, P400, DOI 10.1037/h0032536; HENNESSY MB, 1980, DEV PSYCHOBIOL, V13, P573, DOI 10.1002/dev.420130603; Herbison AE, 1998, ENDOCR REV, V19, P302, DOI 10.1210/edrv.19.3.0332; HERBISON AE, 1992, NEUROSCIENCE, V50, P283, DOI 10.1016/0306-4522(92)90423-Y; Herbison AE, 2008, ENDOCRINOLOGY, V149, P597, DOI 10.1210/en.2007-1139; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; KALRA PS, 1975, NEUROENDOCRINOLOGY, V19, P289, DOI 10.1159/000122450; Karsch FJ, 1997, BIOL REPROD, V56, P303, DOI 10.1095/biolreprod56.2.303; Kim K, 1997, EVOL HUM BEHAV, V18, P109, DOI 10.1016/S1090-5138(96)00114-6; Laflamme N, 1998, J NEUROBIOL, V36, P357, DOI 10.1002/(SICI)1097-4695(19980905)36:3<357::AID-NEU5>3.0.CO;2-V; Lannigan DA, 2003, STEROIDS, V68, P1, DOI 10.1016/S0039-128X(02)00110-1; LEE MHS, 1975, DEV PSYCHOBIOL, V8, P91, DOI 10.1002/dev.420080113; LEE WS, 1990, P NATL ACAD SCI USA, V87, P5163, DOI 10.1073/pnas.87.13.5163; LEVINE JE, 1991, RECENT PROG HORM RES, V47, P97; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Maestripieri D, 1999, NEUROSCI BIOBEHAV R, V23, P411, DOI 10.1016/S0149-7634(98)00042-6; MARLOWE FW, 2003, J COMP SOC SCI, V37, P282; MCCARTHY MM, 1994, PSYCHONEUROENDOCRINO, V19, P415, DOI 10.1016/0306-4530(94)90029-9; MCCLINTOCK MK, 1982, ANIM BEHAV, V30, P410, DOI 10.1016/S0003-3472(82)80052-3; MCLOYD VC, 1990, CHILD DEV, V61, P311, DOI 10.1111/j.1467-8624.1990.tb02781.x; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Miller L, 1997, J AM ACAD CHILD PSY, V36, P1134, DOI 10.1097/00004583-199708000-00022; MOFFITT TE, 1992, CHILD DEV, V63, P47, DOI 10.1111/j.1467-8624.1992.tb03594.x; MYERS MM, 1989, DEV PSYCHOBIOL, V22, P55, DOI 10.1002/dev.420220105; Ojeda S.R., 1988, PHYSL REPROD, P1699; Padoin MJ, 2001, BEHAV NEUROSCI, V115, P1332, DOI 10.1037//0735-7044.115.6.1332; PETERSEN SL, 1989, BRAIN RES, V484, P279, DOI 10.1016/0006-8993(89)90371-5; PETERSEN SL, 1993, AM ZOOL, V33, P255; PETERSEN SL, 1989, J NEUROENDOCRINOL, V1, P279, DOI 10.1111/j.1365-2826.1989.tb00116.x; PFAFF D, 1973, J COMP NEUROL, V151, P121, DOI 10.1002/cne.901510204; Pfaff Donald W., 1994, P107; PHINNEY VG, 1990, ADOLESCENCE, V25, P321; Quinlan RJ, 2003, EVOL HUM BEHAV, V24, P376, DOI 10.1016/S1090-5138(03)00039-4; Qvarnstrom A, 2001, TRENDS ECOL EVOL, V16, P95, DOI 10.1016/S0169-5347(00)02063-2; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Rhen T, 2002, J NEUROENDOCRINOL, V14, P517, DOI 10.1046/j.1365-2826.2002.00820.x; Roff Derek A., 1992; Roosa MW, 1997, J MARRIAGE FAM, V59, P119, DOI 10.2307/353666; Rossiter M, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P112; Ryder N. B., 1971, REPROD US 1965; SAAL FSV, 1983, SCIENCE, V220, P1306, DOI 10.1126/science.6857252; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; Stearns S.C., 1992, pi; STEINBERG L, 1988, DEV PSYCHOL, V24, P122, DOI 10.1037/0012-1649.24.1.122; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; UDRY JR, 1982, DEMOGRAPHY, V19, P53, DOI 10.2307/2061128; VIAU V, 1991, ENDOCRINOLOGY, V129, P2503, DOI 10.1210/endo-129-5-2503; VOMACHKA AJ, 1986, HORM BEHAV, V20, P181, DOI 10.1016/0018-506X(86)90016-4; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; WIEGAND SJ, 1982, NEUROENDOCRINOLOGY, V34, P395, DOI 10.1159/000123335; Wilson M, 1997, BRIT MED J, V314, P1271, DOI 10.1136/bmj.314.7089.1271; Worthman CM, 1999, EVOLUTIONARY MEDICI NE, P135	94	127	128	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2210	10.1371/journal.pone.0002210	http://dx.doi.org/10.1371/journal.pone.0002210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493313	gold, Green Published, Green Submitted			2022-12-27	WOS:000262258700019
J	Josefsson, E; Higgins, J; Foster, TJ; Tarkowski, A				Josefsson, Elisabet; Higgins, Judy; Foster, Timothy J.; Tarkowski, Andrej			Fibrinogen Binding Sites P-336 and Y-338 of Clumping Factor A Are Crucial for Staphylococcus aureus Virulence	PLOS ONE			English	Article							FACTOR-A; ARTHRITIS; ROLES; IMMUNOGLOBULIN; PHAGOCYTOSIS; COMPLEMENT; SEPTICEMIA; ACTIVATION; PROTEINS; RECEPTOR	We have earlier shown that clumping factor A (ClfA), a fibrinogen binding surface protein of Staphylococcus aureus, is an important virulence factor in septic arthritis. When two amino acids in the ClfA molecule, P-336 and Y-338, were changed to serine and alanine, respectively, the fibrinogen binding property was lost. ClfAP(336)Y(338) mutants have been constructed in two virulent S. aureus strains Newman and LS-1. The aim of this study was to analyze if these two amino acids which are vital for the fibrinogen binding of ClfA are of importance for the ability of S. aureus to generate disease. Septic arthritis or sepsis were induced in mice by intravenous inoculation of bacteria. The clfAP(336)Y(338) mutant induced significantly less arthritis than the wild type strain, both with respect to severity and frequency. The mutant infected mice developed also a much milder systemic inflammation, measured as lower mortality, weight loss, bacterial growth in kidneys and lower IL-6 levels. The data were verified with a second mutant where clfAP(336) and Y-338 were changed to alanine and serine respectively. When sepsis was induced by a larger bacterial inoculum, the clfAP(336)Y(338) mutants induced significantly less septic death. Importantly, immunization with the recombinant A domain of ClfAP(336)SY(338)A mutant but not with recombinant ClfA, protected against septic death. Our data strongly suggest that the fibrinogen binding activity of ClfA is crucial for the ability of S. aureus to provoke disease manifestations, and that the vaccine potential of recombinant ClfA is improved by removing its ability to bind fibrinogen.	[Josefsson, Elisabet; Tarkowski, Andrej] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Higgins, Judy; Foster, Timothy J.] Trinity Coll Dublin, Moyne Inst Prevent Med, Microbiol Dept, Dublin, Ireland	University of Gothenburg; Trinity College Dublin	Josefsson, E (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	elisabet.josefsson@rheuma.gu.se			Goteborg Medical Society; Goteborg Rheumatism Association; King Gustaf V's 80 Years Foundation; LUA/ALF; Rune and Ulla Amlovs Foundation; Swedish Medical Society; Swedish Research Council; Swedish Rheumatism Association; The Sigurd and Elsa Golje Memorial Foundation; The Family Tholens and Kristlers Foundation; Science Foundation Ireland	Goteborg Medical Society; Goteborg Rheumatism Association; King Gustaf V's 80 Years Foundation; LUA/ALF; Rune and Ulla Amlovs Foundation; Swedish Medical Society; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Rheumatism Association; The Sigurd and Elsa Golje Memorial Foundation; The Family Tholens and Kristlers Foundation; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Goteborg Medical Society, Goteborg Rheumatism Association, King Gustaf V's 80 Years Foundation, LUA/ALF, Rune and Ulla Amlovs Foundation, Swedish Medical Society, Swedish Research Council, Swedish Rheumatism Association, The Sigurd and Elsa Golje Memorial Foundation, The Family Tholens and Kristlers Foundation and Science Foundation Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREMELL T, 1991, INFECT IMMUN, V59, P2615, DOI 10.1128/IAI.59.8.2615-2623.1991; BREMELL T, 1992, INFECT IMMUN, V60, P2976, DOI 10.1128/IAI.60.7.2976-2985.1992; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Foster TJ, 1998, METHOD MICROBIOL, V27, P433; Higgins J, 2006, FEMS MICROBIOL LETT, V258, P290, DOI 10.1111/j.1574-6968.2006.00229.x; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Loughman A, 2005, MOL MICROBIOL, V57, P804, DOI 10.1111/j.1365-2958.2005.04731.x; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; McDevitt D, 1997, EUR J BIOCHEM, V247, P416, DOI 10.1111/j.1432-1033.1997.00416.x; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; OBrien L, 2002, MOL MICROBIOL, V44, P1033, DOI 10.1046/j.1365-2958.2002.02935.x; Palmqvist N, 2005, J INFECT DIS, V191, P791, DOI 10.1086/427663; Palmqvist N, 2004, MICROBES INFECT, V6, P188, DOI 10.1016/j.micinf.2003.11.005; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Sakiniene E, 1996, ARTHRITIS RHEUM, V39, P1596, DOI 10.1002/art.1780390921; Sakiniene E, 1999, CLIN EXP IMMUNOL, V115, P95; Sandin C, 2006, MOL MICROBIOL, V59, P20, DOI 10.1111/j.1365-2958.2005.04913.x; Verdrengh M, 1997, INFECT IMMUN, V65, P2517, DOI 10.1128/IAI.65.7.2517-2521.1997; Weineisen M, 2004, J IMMUNOL, V172, P3798, DOI 10.4049/jimmunol.172.6.3798	22	57	68	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2206	10.1371/journal.pone.0002206	http://dx.doi.org/10.1371/journal.pone.0002206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493318	Green Published, gold, Green Submitted			2022-12-27	WOS:000262258700015
J	Ramot, D; Johnson, BE; Berry, TL; Carnell, L; Goodman, MB				Ramot, Daniel; Johnson, Brandon E.; Berry, Tommie L., Jr.; Carnell, Lucinda; Goodman, Miriam B.			The Parallel Worm Tracker: A Platform for Measuring Average Speed and Drug-Induced Paralysis in Nematodes	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; LOCOMOTORY BEHAVIOR; MACHINE VISION; MUTANTS; SEROTONIN; SYSTEM; SENSITIVITY	Background: Caenorhabditis elegans locomotion is a simple behavior that has been widely used to dissect genetic components of behavior, synaptic transmission, and muscle function. Many of the paradigms that have been created to study C. elegans locomotion rely on qualitative experimenter observation. Here we report the implementation of an automated tracking system developed to quantify the locomotion of multiple individual worms in parallel. Methodology/Principal Findings: Our tracking system generates a consistent measurement of locomotion that allows direct comparison of results across experiments and experimenters and provides a standard method to share data between laboratories. The tracker utilizes a video camera attached to a zoom lens and a software package implemented in MATLAB (R). We demonstrate several proof-of-principle applications for the tracker including measuring speed in the absence and presence of food and in the presence of serotonin. We further use the tracker to automatically quantify the time course of paralysis of worms exposed to aldicarb and levamisole and show that tracker performance compares favorably to data generated using a hand-scored metric. Conclusions/Signficance: Although this is not the first automated tracking system developed to measure C. elegans locomotion, our tracking software package is freely available and provides a simple interface that includes tools for rapid data collection and analysis. By contrast with other tools, it is not dependent on a specific set of hardware. We propose that the tracker may be used for a broad range of additional worm locomotion applications including genetic and chemical screening.	[Ramot, Daniel; Goodman, Miriam B.] Stanford Univ, Program Neurosci, Stanford, CA USA; [Johnson, Brandon E.; Berry, Tommie L., Jr.; Goodman, Miriam B.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA USA; [Carnell, Lucinda] Cent Washington Univ, Dept Biol Sci, Ellensburg, WA USA	Stanford University; Stanford University; Central Washington University	Ramot, D (corresponding author), Stanford Univ, Program Neurosci, Stanford, CA USA.	mbgoodman@stanford.edu	Goodman, Miriam B./H-3036-2019	Goodman, Miriam B./0000-0002-5810-1272	Muscular Dystrophy Association [MDA4206]; National Institutes of Health [RO1NS047715, R21NS061147]; National Science Foundation [NSF0725079]; A. P. Sloan Foundation; Klingenstein Fund; McKnight Endowment Fund for Neuroscience; Donald B. and Delia E. Baxter Foundation; Dan David Foundation; Albion Walter Hewlett Stanford Graduate Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS061147, R01NS047715] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); A. P. Sloan Foundation(Alfred P. Sloan Foundation); Klingenstein Fund(Klingenstein Philanthropies); McKnight Endowment Fund for Neuroscience; Donald B. and Delia E. Baxter Foundation; Dan David Foundation; Albion Walter Hewlett Stanford Graduate Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work funded by grants to MBG from the Muscular Dystrophy Association (MDA4206), National Institutes of Health (RO1NS047715, R21NS061147) and the National Science Foundation (NSF0725079), fellowships to MBG from the A. P. Sloan Foundation, Klingenstein Fund, McKnight Endowment Fund for Neuroscience, and the Donald B. and Delia E. Baxter Foundation, a scholarship from the Dan David Foundation (DR), and an Albion Walter Hewlett Stanford Graduate Fellowship (DR). None of the sponsors or funders had a role in the design or conduct of the study, data collection, analysis, interpretation, or in the preparation, review or approval of the manuscript.	Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Baek JH, 2002, J NEUROSCI METH, V118, P9, DOI 10.1016/S0165-0270(02)00117-6; BRENNER S, 1974, GENETICS, V77, P71; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cole RD, 2004, TOXICOL APPL PHARM, V194, P248, DOI 10.1016/j.taap.2003.09.013; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Dernovici S, 2007, DEV NEUROBIOL, V67, P189, DOI 10.1002/dneu.20340; Doi M, 2002, NEURON, V33, P249, DOI 10.1016/S0896-6273(01)00587-6; DUSENBERY DB, 1985, COMPUT BIOL MED, V15, P169, DOI 10.1016/0010-4825(85)90058-7; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Fontaine Ebraheem, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3716; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Geng W, 2003, GENETICS, V165, P1117; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Graves AL, 2005, ARCH ENVIRON CON TOX, V48, P490, DOI 10.1007/s00244-004-0031-2; Hardaker LA, 2001, J NEUROBIOL, V49, P303, DOI 10.1002/neu.10014; Hawasli AH, 2004, GENETICS, V168, P831, DOI 10.1534/genetics.104.030502; Hiley E, 2006, EMBO J, V25, P5884, DOI 10.1038/sj.emboj.7601458; HOSONO R, 1991, NEUROSCI LETT, V128, P243, DOI 10.1016/0304-3940(91)90270-4; HUANG KM, 2007, AUTOMATED TRACKING M, P1240; Huang KM, 2006, J NEUROSCI METH, V158, P323, DOI 10.1016/j.jneumeth.2006.06.007; Jacob TC, 2003, J NEUROSCI, V23, P2122; Karbowski J, 2006, J THEOR BIOL, V242, P652, DOI 10.1016/j.jtbi.2006.04.012; Lesa GM, 2003, J CELL SCI, V116, P4965, DOI 10.1242/jcs.00918; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1987, J NEUROSCI, V7, P3059; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; McMullan R, 2006, GENE DEV, V20, P65, DOI 10.1101/gad.359706; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; NGUYEN M, 1995, GENETICS, V140, P527; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Pierce-Shimomura JT, 2005, J EXP BIOL, V208, P4727, DOI 10.1242/jeb.01933; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Reynolds NK, 2005, GENETICS, V169, P651, DOI 10.1534/genetics.104.031286; Richards J. P., 2005, SUPER PORPHYRY COPPE, V1, P7; Robatzek M, 2000, GENETICS, V156, P1069; Roussel N, 2007, IEEE T BIO-MED ENG, V54, P1786, DOI 10.1109/TBME.2007.894981; Ryu WS, 2002, J NEUROSCI, V22, P5727; Sambongi Y, 1999, NEUROREPORT, V10, P753, DOI 10.1097/00001756-199903170-00017; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Segalat L, 2007, ACS CHEM BIOL, V2, P231, DOI 10.1021/cb700009m; Shingai R, 2000, NEUROSCI RES, V38, P71, DOI 10.1016/S0168-0102(00)00148-6; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Simonetta SH, 2007, J NEUROSCI METH, V161, P273, DOI 10.1016/j.jneumeth.2006.11.015; Stiernagle Theresa, 2006, WormBook, P1; Tsibidis GD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-86; Van Buskirk C, 2007, NAT NEUROSCI, V10, P1300, DOI 10.1038/nn1981; van der Linden AM, 2001, GENETICS, V158, P221; Waggoner LE, 1998, NEURON, V21, P203, DOI 10.1016/S0896-6273(00)80527-9; Wang Q, 2002, J NEUROSCI, V22, P2274, DOI 10.1523/JNEUROSCI.22-06-02274.2002; WANG W, 2007, MICROPOSITIONING SYS, P243; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Wei G, 2004, IEEE T BIO-MED ENG, V51, P1811, DOI 10.1109/TBME.2004.831532; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	59	195	197	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2208	10.1371/journal.pone.0002208	http://dx.doi.org/10.1371/journal.pone.0002208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493300	Green Published, Green Submitted, gold			2022-12-27	WOS:000262258700017
J	Raymond, J; Thiberge, JM; Kalach, N; Bergeret, M; Dupont, C; Labigne, A; Dauga, C				Raymond, Josette; Thiberge, Jean-Michel; Kalach, Nicolas; Bergeret, Michel; Dupont, Christophe; Labigne, Agnes; Dauga, Catherine			Using Macro-Arrays to Study Routes of Infection of Helicobacter pylori in Three Families	PLOS ONE			English	Article								Background: Analysis of the evolutionary dynamics of Helicobacter pylori allowed tracing the spread of infection through populations on different continents but transmission pathways between individual humans have not been clearly described. Materials and Methods: To investigate person-to-person transmission, we studied three families each including one child with persistence of symptoms after antibiotic treatment. Ten isolates from the antrum and corpus of stomach of each family member were analyzed both by sequencing of two housekeeping genes and macroarray tests. Results: A total of 134 (8.4%) out of the 1590 coding sequences (CDSs) tested, including cag PAI and insertion sequences, were present in some but not all isolates (and are therefore defined as variable CDSs). Most of the variable CDSs encoded proteins of unknown function (76/134) or were selfish DNA including that encoding restriction/modification enzymes (13/134). Isolates colonizing the stomach of one individual can vary by point mutations, as seen in hspA, or by the gain or loss of one to five CDSs. They were considered as (genetic) variants. The phylogenetic clustering of gene profiles obtained on macro-arrays allowed identifying the different strains infecting families. Two to five strains circulated within a family. Identical strains were present in at least two members of all three families supporting the accepted model of intrafamilial transmission. Surprisingly, the mother was not implicated in the transmission of H. pylori in the two French families. Sibling-to-sibling transmission and acquisition of H. pylori from outside the family appeared to be probable in the transmission pathways. Conclusion: Macroarray analysis based on previously selected CDSs gives a comprehensive view of the genome diversity of a pathogen. This approach combined with information on the origin of the hspA and glmM alleles revealed that Helicobacter pylori infection may be acquired by more diverse routes than previously expected.	[Raymond, Josette; Bergeret, Michel] Univ Paris 05, Hop Cochin, Serv Bacteriol, Paris, France; [Thiberge, Jean-Michel; Labigne, Agnes] Dept Pathogen Microbienne, Unite Pathogen Bacterienne Muqueuses, Paris, France; [Kalach, Nicolas] Hop St Antoine, Serv Pediat, Lille, France; [Dupont, Christophe] Hop Cochin St Vincent Paul, Dept Pediat, Paris, France; [Dauga, Catherine] Inst Pasteur, Dept Genet Genom, Plateforme 4 Genopole, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Raymond, J (corresponding author), Univ Paris 05, Hop Cochin, Serv Bacteriol, Paris, France.	j.raymond@svp.aphp.fr	Catherine, Dauga/AAA-1379-2019					Achtman M, 1999, MOL MICROBIOL, V32, P459, DOI 10.1046/j.1365-2958.1999.01382.x; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Ando T, 2000, MOL MICROBIOL, V37, P1052, DOI 10.1046/j.1365-2958.2000.02049.x; Berg DE, 1997, CLIN INFECT DIS, V25, P996, DOI 10.1086/516081; BLASER MJ, 1995, CANCER RES, V55, P2111; Carroll IM, 2004, J MED MICROBIOL, V53, P669, DOI 10.1099/jmm.0.05440-0; DRUMM B, 1990, NEW ENGL J MED, V322, P359, DOI 10.1056/NEJM199002083220603; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Georgopoulos SD, 1996, GUT, V39, P634, DOI 10.1136/gut.39.5.634; Ghose C, 2005, J CLIN MICROBIOL, V43, P2635, DOI 10.1128/JCM.43.6.2635-2641.2005; Goodman KJ, 2000, LANCET, V355, P358, DOI 10.1016/S0140-6736(99)05273-3; Gressmann H, 2005, PLOS GENET, V1, P419, DOI 10.1371/journal.pgen.0010043; Han SR, 2000, J CLIN MICROBIOL, V38, P3646, DOI 10.1128/JCM.38.10.3646-3651.2000; Hook-Nikanne J, 1998, HELICOBACTER, V3, P79, DOI 10.1111/j.1523-5378.1998.08011.x; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Jorgensen M, 1996, J INFECT DIS, V174, P631, DOI 10.1093/infdis/174.3.631; Joyce EA, 2002, NAT REV GENET, V3, P462, DOI 10.1038/nrg820; Kauser F, 2004, J CLIN MICROBIOL, V42, P5302, DOI 10.1128/JCM.42.11.5302-5308.2004; Kim Jeong Wook, 2004, Korean Journal of Internal Medicine, V19, P1; Kivi M, 2003, J CLIN MICROBIOL, V41, P5604, DOI 10.1128/JCM.41.12.5604-5608.2003; Knippig C, 2002, Z GASTROENTEROL, V40, P383, DOI 10.1055/s-2002-32128; Kraft C, 2006, J BACTERIOL, V188, P249, DOI 10.1128/JB.188.1.249-254.2006; Marshall DG, 1998, MICROBIOL-SGM, V144, P2925, DOI 10.1099/00221287-144-11-2925; NWOKOLO CU, 1992, GUT, V33, P1323, DOI 10.1136/gut.33.10.1323; Owen RJ, 2003, J MED MICROBIOL, V52, P515, DOI 10.1099/jmm.0.04988-0; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; Raymond J, 2004, EMERG INFECT DIS, V10, P1816, DOI 10.3201/eid1010.040042; Rothenbacher D, 2000, LANCET, V355, P1998, DOI 10.1016/S0140-6736(05)72939-1; Rothenbacher D, 1999, J INFECT DIS, V179, P398, DOI 10.1086/314595; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; Saunders NJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-9; Solca NM, 2001, MICROBIOL-SGM, V147, P1693, DOI 10.1099/00221287-147-6-1693; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tindberg Y, 2001, GASTROENTEROLOGY, V121, P310, DOI 10.1053/gast.2001.26282; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Vulic M, 1999, P NATL ACAD SCI USA, V96, P7348, DOI 10.1073/pnas.96.13.7348; Xu Q, 2000, P NATL ACAD SCI USA, V97, P9671, DOI 10.1073/pnas.97.17.9671	40	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2259	10.1371/journal.pone.0002259	http://dx.doi.org/10.1371/journal.pone.0002259			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493595	gold, Green Published, Green Submitted			2022-12-27	WOS:000262258700059
J	Reiss, AL; Hoeft, F; Tenforde, AS; Chen, W; Mobbs, D; Mignot, EJ				Reiss, Allan L.; Hoeft, Fumiko; Tenforde, Adam S.; Chen, Wynne; Mobbs, Dean; Mignot, Emmanuel J.			Anomalous Hypothalamic Responses to Humor in Cataplexy	PLOS ONE			English	Article								Background: Cataplexy is observed in a subset of patients with narcolepsy and affects approximately 1 in 2,000 persons. Cataplexy is most often triggered by strong emotions such as laughter, which can result in transient, yet debilitating, muscle atonia. The objective of this study was to examine the neural systems underlying humor processing in individuals with cataplexy. Methodology/Principal Findings: While undergoing functional Magnetic Resonance Imaging (fMRI), we showed ten narcolepsy-cataplexy patients and ten healthy controls humorous cartoons. In addition, we examined the brain activity of one subject while in a full-blown cataplectic attack. Behavioral results showed that participants with cataplexy rated significantly fewer humorous cartoons as funny compared to controls. Concurrent fMRI showed that patients, when compared to controls and in the absence of overt cataplexy symptoms, showed pronounced activity in the emotional network including the ventral striatum and hypothalamus while viewing humorous versus non-humorous cartoons. Increased activity was also observed in the right inferior frontal gyri -a core component of the inhibitory circuitry. In comparison, the one subject who experienced a cataplectic attack showed dramatic reductions in hypothalamic activity. Conclusions: These findings suggest an overdrive of the emotional circuitry and possible compensatory suppression by cortical inhibitory regions in cataplexy. Moreover, during cataplectic attacks, the hypothalamus is characterized by a marked decrease in activity similar to that observed during sleep. One possible explanation for these findings is an initial overdrive and compensatory shutdown of the hypothalamus resulting in full cataplectic symptoms.	[Reiss, Allan L.; Hoeft, Fumiko; Tenforde, Adam S.; Mobbs, Dean] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Interdisciplinary Brain Sci Res, Stanford, CA 94305 USA; [Chen, Wynne; Mignot, Emmanuel J.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctrr Narcolepsy, Stanford, CA USA; [Mobbs, Dean] MRC Cognition & Brain Sci Unit, Cambridge, England	Stanford University; Stanford University	Reiss, AL (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Ctr Interdisciplinary Brain Sci Res, Stanford, CA 94305 USA.	reiss@stanford.edu			NIH [23724]; Howard Hughes Medical Institute; Medical Research Council; Medical Research Council [MC_U105579215] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS023724] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by NIH 23724 and the Howard Hughes Medical Institute. DM is funded by the Medical Research Council.	*AASM, 2005, INT CLASS SLEEP DIS; Anic-Labat S, 1999, SLEEP, V22, P77; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Azim E, 2005, P NATL ACAD SCI USA, V102, P16496, DOI 10.1073/pnas.0408456102; Bartolo A, 2006, J COGNITIVE NEUROSCI, V18, P1789, DOI 10.1162/jocn.2006.18.11.1789; Chabas D, 2007, SLEEP, V30, P153, DOI 10.1093/sleep/30.2.153; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; GELB M, 1994, SLEEP, V17, P265, DOI 10.1093/sleep/17.3.265; Hare TA, 2005, BIOL PSYCHIAT, V57, P624, DOI 10.1016/j.biopsych.2004.12.038; Hong SB, 2006, NEUROLOGY, V66, P1747, DOI 10.1212/01.wnl.0000218205.72668.ab; Kerrigan John F, 2005, Semin Pediatr Neurol, V12, P119, DOI 10.1016/j.spen.2005.04.002; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P1162, DOI 10.1164/ajrccm/147.5.1162; Lammers GJ, 2000, CLIN NEUROPHYSIOL, V111, P1276, DOI 10.1016/S1388-2457(00)00306-0; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maquet P, 1996, NATURE, V383, P163, DOI 10.1038/383163a0; MARCADET A, 1985, IMMUNOGENETICS, V22, P679, DOI 10.1007/BF00430317; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Mignot E, 2004, SLEEP MED, V5, pS2, DOI 10.1016/S1389-9457(04)90001-9; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mignot E, 2001, ARCH ITAL BIOL, V139, P207; Mobbs D, 2005, P NATL ACAD SCI USA, V102, P16502, DOI 10.1073/pnas.0408457102; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Moran JM, 2004, NEUROIMAGE, V21, P1055, DOI 10.1016/j.neuroimage.2003.10.017; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Okun MS, 2004, NEUROCASE, V10, P271, DOI 10.1080/13554790490507632; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Schwartz S, 2008, BRAIN, V131, P514, DOI 10.1093/brain/awm292; Talairach J., 1988, COPLANAR STEREOTAXIC; WATSON KK, 2006, BRAIN ACTIVATION SIG; Wild B, 2006, NEUROLOGY, V66, P887, DOI 10.1212/01.wnl.0000203123.68747.02	32	50	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2225	10.1371/journal.pone.0002225	http://dx.doi.org/10.1371/journal.pone.0002225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493621	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000262258700033
J	van der Veen, R; Koehl, M; Abrous, DN; de Kloet, ER; Piazza, PV; Deroche-Gamonet, V				van der Veen, Rixt; Koehl, Muriel; Abrous, D. Nora; de Kloet, E. Ronald; Piazza, Pier-Vincenzo; Deroche-Gamonet, Veronique			Maternal Environment Influences Cocaine Intake in Adulthood in a Genotype-Dependent Manner	PLOS ONE			English	Article							SELF-MEDICATION HYPOTHESIS; SUBSTANCE USE DISORDERS; ANXIETY-LIKE BEHAVIOR; OLFACTORY BULBECTOMY; ANIMAL-MODELS; MOUSE STRAINS; C57BL/6 MICE; LIFE STRESS; DRUG-ABUSE; RAT MODEL	Background: Accumulating epidemiological evidence points to the role of genetic background as a modulator of the capacity of adverse early experiences to give rise to mental illness. However, direct evidence of such gene-environment interaction in the context of substance abuse is scarce. In the present study we investigated whether the impact of early life experiences on cocaine intake in adulthood depends on genetic background. In addition, we studied other behavioral dimensions associated with drug abuse, i.e. anxiety- and depression-related behaviors. Methodology/Principal Findings: For this purpose, we manipulated the maternal environment of two inbred mouse strains, the C57BL/6J and DBA/2J by fostering them with non-related mothers, i.e. the C3H/HeN and AKR strains. These mother strains show respectively high and low pup-oriented behavior. As adults, C57BL/6J and DBA/2J were tested either for cocaine intravenous self-administration or in the elevated plus-maze and forced swim test (FST). We found that the impact of maternal environment on cocaine use and a depression-related behavior depends upon genotype, as cocaine self-administration and behavior in the FST were influenced by maternal environment in DBA/2J, but not in C57BL/6J mice. Anxiety was not influenced by maternal environment in either strain. Conclusions/Significance: Our experimental approach could contribute to the identification of the psychobiological factors determining the susceptibility or the resilience of certain individuals to develop psychopathologies.	[van der Veen, Rixt; Koehl, Muriel; Abrous, D. Nora; Piazza, Pier-Vincenzo; Deroche-Gamonet, Veronique] INSERM, U862, Bordeaux, France; [van der Veen, Rixt; de Kloet, E. Ronald] Leiden Univ, Med Ctr, Amsterdam Ctr Drug Res, Div Med Pharmacol, Leiden, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Veen, R (corresponding author), INSERM, U862, Bordeaux, France.	deroche@bordeaux.inserm.fr	Koehl, Muriel/ABI-2043-2020; Koehl, Muriel/C-3698-2011; Deroche-Gamonet, Véronique/E-5728-2010; van der Veen, Rixt/F-1673-2018; de Kloet, Edo Ronald/H-3278-2011; Abrous, Nora-Djoher/N-6977-2017	Koehl, Muriel/0000-0002-7601-1422; Koehl, Muriel/0000-0002-7601-1422; de Kloet, Ron/0000-0001-9176-1830; van der Veen, Rixt/0000-0002-0808-7396; abrous, nora/0000-0002-8589-305X; Deroche-Gamonet, Veronique/0000-0002-9704-6624	NWO/INSERM/ZON [AH002G, 985-10-014]; University of Bordeaux 2	NWO/INSERM/ZON(Institut National de la Sante et de la Recherche Medicale (Inserm)Netherlands Organization for Scientific Research (NWO)); University of Bordeaux 2	This research was supported by the NWO/INSERM/ZON grants AH002G and 985-10-014 and the university of Bordeaux 2. Funders had no role in design and conduct of the study, they had no role in collection, analysis and interpretation of the data, in the preparation, review or approval of the manuscript.	Anisman H, 1998, INT J DEV NEUROSCI, V16, P149, DOI 10.1016/S0736-5748(98)00025-2; Ator NA, 2003, DRUG ALCOHOL DEPEN, V70, pS55, DOI 10.1016/S0376-8716(03)00099-1; Brady Kathleen T, 2007, Curr Psychiatry Rep, V9, P374, DOI 10.1007/s11920-007-0048-0; CADORET RJ, 1995, ARCH GEN PSYCHIAT, V52, P916; Calcagnetti DJ, 1996, PHYSIOL BEHAV, V59, P597, DOI 10.1016/0031-9384(95)02119-1; CALDJI C, 2004, MAT BEHAV REGULATES; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; CUTRONA CE, 1994, COMPR PSYCHIAT, V35, P171, DOI 10.1016/0010-440X(94)90188-0; De Bellis MD, 2002, PSYCHONEUROENDOCRINO, V27, P155, DOI 10.1016/S0306-4530(01)00042-7; Deroche-Gamonet V, 2003, J NEUROSCI, V23, P4785; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Foley DL, 2004, ARCH GEN PSYCHIAT, V61, P738, DOI 10.1001/archpsyc.61.7.738; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; Friedman E, 2006, DEV PSYCHOBIOL, V48, P169, DOI 10.1002/dev.20119; GAWIN FH, 1991, SCIENCE, V251, P1580, DOI 10.1126/science.2011738; Gordon HW, 2002, PSYCHONEUROENDOCRINO, V27, P115, DOI 10.1016/S0306-4530(01)00039-7; Heim C, 2004, NEUROPSYCHOPHARMACOL, V29, P641, DOI 10.1038/sj.npp.1300397; Jaffee SR, 2005, DEV PSYCHOPATHOL, V17, P67, DOI 10.1017/S0954579405050042; Kendler KS, 2005, AM J PSYCHIAT, V162, P1243, DOI 10.1176/appi.ajp.162.7.1243; Khantzian EJ, 1997, HARVARD REV PSYCHIAT, V4, P231, DOI 10.3109/10673229709030550; KHANTZIAN EJ, 1985, AM J PSYCHIAT, V142, P1259; LUMIA AR, 1992, BRAIN RES, V587, P181, DOI 10.1016/0006-8993(92)90995-L; MARKOU A, 1992, NEUROPSYCHOPHARMACOL, V7, P213; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Millstein RA, 2006, GENES BRAIN BEHAV, V5, P346, DOI 10.1111/j.1601-183X.2005.00172.x; Millstein RA, 2007, NEUROSCI BIOBEHAV R, V31, P3, DOI 10.1016/j.neubiorev.2006.05.003; Moffitt TE, 2006, PERSPECT PSYCHOL SCI, V1, P5, DOI 10.1111/j.1745-6916.2006.00002.x; Newport DJ, 2002, AM J PSYCHIAT, V159, P1265, DOI 10.1176/appi.ajp.159.8.1265; OAKLEYBROWNE MA, 1995, J AFFECT DISORDERS, V34, P13, DOI 10.1016/0165-0327(94)00099-U; Parfitt DB, 2007, HORM BEHAV, V52, P417, DOI 10.1016/j.yhbeh.2007.06.002; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; RANDALL CL, 1975, J STUD ALCOHOL, V36, P973, DOI 10.15288/jsa.1975.36.973; Roman E, 2005, ALCOHOL CLIN EXP RES, V29, P591, DOI 10.1097/01.ALC.0000158933.70242.FC; Romeo RD, 2003, HORM BEHAV, V43, P561, DOI 10.1016/S0018-506X(03)00063-1; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Sameroff AJ, 2000, DEV PSYCHOPATHOL, V12, P297, DOI 10.1017/S0954579400003035; Sigvardsson S, 1996, ARCH GEN PSYCHIAT, V53, P681; Silberg J, 2001, BRIT J PSYCHIAT, V179, P116, DOI 10.1192/bjp.179.2.116; Slattery DA, 2007, PSYCHOPHARMACOLOGY, V190, P555, DOI 10.1007/s00213-006-0630-x; Tienari P, 2004, BRIT J PSYCHIAT, V184, P216, DOI 10.1192/bjp.184.3.216; van der Kam EL, 2005, NEUROPHARMACOLOGY, V48, P685, DOI 10.1016/j.neuropharm.2004.12.014; van der Veen R, 2008, GENES BRAIN BEHAV, V7, P184, DOI 10.1111/j.1601-183X.2007.00337.x; van der Veen R, 2007, PSYCHOPHARMACOLOGY, V193, P179, DOI 10.1007/s00213-007-0777-0; Veenema AH, 2007, PSYCHONEUROENDOCRINO, V32, P437, DOI 10.1016/j.psyneuen.2007.02.008; Weiss RD, 2004, J SUBST ABUSE TREAT, V27, P307, DOI 10.1016/j.jsat.2004.10.001; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Willner P, 2002, BEHAV PHARMACOL, V13, P169, DOI 10.1097/00008877-200205000-00001	52	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2245	10.1371/journal.pone.0002245	http://dx.doi.org/10.1371/journal.pone.0002245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493309	Green Published, gold			2022-12-27	WOS:000262258700053
J	Chae, YK; Woo, J; Kim, MJ; Kang, SK; Kim, MS; Lee, J; Lee, SK; Gong, G; Kim, YH; Soria, JC; Jang, SJ; Sidransky, D; Moon, C				Chae, Young Kwang; Woo, Janghee; Kim, Mi-Jung; Kang, Sung Koo; Kim, Myoung Sook; Lee, Juna; Lee, Seung Koo; Gong, Gyungyub; Kim, Yong Hee; Soria, Jean Charles; Jang, Se Jin; Sidransky, David; Moon, Chulso			Expression of Aquaporin 5 (AQP5) Promotes Tumor Invasion in Human Non Small Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; WATER; SRC; ANGIOGENESIS; LOCALIZATION; INVOLVEMENT; MIGRATION; PATHWAYS; GENES	The aquaporins (AQP) are water channel proteins playing a major role in transcellular and transepithelial water movement. Recently, the role of AQPs in human carcinogenesis has become an area of great interest. Here, by immunohistochemistry (IHC), we have found an expression of AQP5 protein in 35.3% (IHC-score: >= 1, 144/408) of the resected NSCLC tissue samples. Cases with AQP5-positive status (IHC-score: >= 2) displayed a higher rate of tumor recurrence than negative ones in NSCLC (54.7% vs. 35.1%, p = 0.005) and worse disease-free survival (p = 0.033; OR = 1.52; 95% CI: 1.04-2.23). Further in vitro invasion assay using BEAS-2B and NIH3T3 cells stably transfected with overexpression constructs for full length wild-type AQP5 (AQP5) and its two mutants, N185D which blocks membrane trafficking and S156A which blocks phosphorylation on Ser156, showed that AQP5 induced cell invasions while both mutants did not. In BEAS-2B cells, the expression of AQP5 caused a spindle-like and fibroblastic morphologic change and losses of cell-cell contacts and cell polarity. Only cells with AQP5, not either of two mutants, exhibited a loss of epithelial cell markers and a gain of mesenchymal cell markers. In a human SH3-domains protein array, cellular extracts from BEAS-2B with AQP5 showed a robust binding activity to SH3-domains of the c-Src, Lyn, and Grap2 C-terminal. Furthermore, in immunoprecipitation assay, activated c-Src, phosphorylated on Tyr416, showed a stronger binding activity to cellular extracts from BEAS-2B with AQP5 compared with N185D or S156A mutant. Fluorescence in situ hybridization (FISH) analysis failed to show evidence of genomic amplification, suggesting AQP5 expression as a secondary event. Based on these clinical and molecular observations, we conclude that AQP5, through its phosphorylation on Ser156 and subsequent interaction with c-Src, plays an important role in NSCLC invasion and, therefore, may provide a unique opportunity for developing a novel therapeutic target as well as a prognostic marker in NSCLC.	[Chae, Young Kwang; Woo, Janghee; Kang, Sung Koo; Kim, Myoung Sook; Lee, Juna; Gong, Gyungyub; Sidransky, David; Moon, Chulso] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Mi-Jung; Lee, Seung Koo; Gong, Gyungyub; Kim, Yong Hee; Jang, Se Jin] Ulsan Univ, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Lee, Juna; Moon, Chulso] Johns Hopkins Univ, Grad Program Human Genet, Baltimore, MD USA; [Moon, Chulso] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Soria, Jean Charles] Gustave Roussy Inst, Dept Med, Villejuif, France	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Johns Hopkins University; Johns Hopkins University; UNICANCER; Gustave Roussy	Chae, YK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	jangsejin@amc.seoul.kr; cmoon5@jhmi.edu	Soria, Jean-Charles/F-3619-2014; woo, janghee/CAG-2114-2022		SPORE [P50 CA96784-01]; Pyung-Ya Foundation; KOSEF [R01-2004-000-10670-0]; Korea Research Foundation [KFR-2004-041-E00064]; NATIONAL CANCER INSTITUTE [P50CA096784] Funding Source: NIH RePORTER	SPORE; Pyung-Ya Foundation; KOSEF(Korea Science and Engineering Foundation); Korea Research Foundation(National Research Foundation of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the SPORE grant P50 CA96784-01 (to C.M.), Cancer Research Grant from Pyung-Ya Foundation (to C.M.), and KOSEF research grant R01-2004-000-10670-0 and Korea Research Foundation grant KFR-2004-041-E00064 (to S.J.J).	Avizienyte E, 2005, CELLS TISSUES ORGANS, V179, P73, DOI 10.1159/000084511; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Boyer B, 1997, EMBO J, V16, P5904, DOI 10.1093/emboj/16.19.5904; Boyer B, 2002, ONCOGENE, V21, P2347, DOI 10.1038/sj.onc.1205298; Burghardt B, 2003, GUT, V52, P1008, DOI 10.1136/gut.52.7.1008; D'Amico TA, 1999, J THORAC CARDIOV SUR, V117, P736, DOI 10.1016/S0022-5223(99)70294-1; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Herbst RS, 2003, CLIN CANCER RES, V9, P5813; Hoque MO, 2006, AM J PATHOL, V168, P1345, DOI 10.2353/ajpath.2006.050596; Kageyama Y, 1996, J UROLOGY, V156, P291, DOI 10.1016/S0022-5347(01)66019-1; KANG SK, 2008, AM J PATHOL IN PRESS; KE Y, 1988, DIFFERENTIATION, V38, P60, DOI 10.1111/j.1432-0436.1988.tb00592.x; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Kreda SM, 2001, AM J RESP CELL MOL, V24, P224, DOI 10.1165/ajrcmb.24.3.4367; Mayer BJ, 2001, J CELL SCI, V114, P1253; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Moon C, 2004, AM J HEMATOL, V75, P128, DOI 10.1002/ajh.10476; MOON C, 1995, GENOMICS, V30, P354, DOI 10.1006/geno.1995.0029; Pastorino U, 1997, J CLIN ONCOL, V15, P2858, DOI 10.1200/JCO.1997.15.8.2858; RAINA S, 1995, J BIOL CHEM, V270, P1908, DOI 10.1074/jbc.270.4.1908; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Saadoun S, 2002, BRIT J CANCER, V87, P621, DOI 10.1038/sj.bjc.6600512; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Singhal S, 2005, CLIN CANCER RES, V11, P3974, DOI 10.1158/1078-0432.CCR-04-2661; Vacca A, 2001, BRIT J HAEMATOL, V113, P415, DOI 10.1046/j.1365-2141.2001.02738.x; Verkman AS, 1996, AM J PHYSIOL-CELL PH, V270, pC12, DOI 10.1152/ajpcell.1996.270.1.C12; Vielh P, 2005, CRIT REV ONCOL HEMAT, V53, P193, DOI 10.1016/j.critrevonc.2004.10.007; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WOO J, 2008, CANC LETT IN PRESS; Woo J, 2008, BIOCHEM BIOPH RES CO, V367, P291, DOI 10.1016/j.bbrc.2007.12.073; Woo J, 2008, BIOCHEM BIOPH RES CO, V366, P321, DOI 10.1016/j.bbrc.2007.11.078; Yang BX, 1997, J BIOL CHEM, V272, P16140, DOI 10.1074/jbc.272.26.16140; Yang JH, 2006, GYNECOL ONCOL, V100, P294, DOI 10.1016/j.ygyno.2005.08.054; Zhang J, 2007, AM J PATHOL, V170, P366, DOI 10.2353/ajpath.2007.060706	34	101	109	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2162	10.1371/journal.pone.0002162	http://dx.doi.org/10.1371/journal.pone.0002162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478076	gold, Green Published, Green Submitted			2022-12-27	WOS:000262172800027
J	Kleinlogel, S; White, AG				Kleinlogel, Sonja; White, Andrew G.			The Secret World of Shrimps: Polarisation Vision at Its Best	PLOS ONE			English	Article							CIRCULAR-POLARIZATION; COMPOUND EYES; E-VECTOR; LIGHT; SENSITIVITY; NAVIGATION; PATTERN; COLOR	Background: Animal vision spans a great range of complexity, with systems evolving to detect variations in light intensity, distribution, colour, and polarisation. Polarisation vision systems studied to date detect one to four channels of linear polarisation, combining them in opponent pairs to provide intensity-independent operation. Circular polarisation vision has never been seen, and is widely believed to play no part in animal vision. Methodology/Principal Findings: Polarisation is fully measured via Stokes' parameters-obtained by combined linear and circular polarisation measurements. Optimal polarisation vision is the ability to see Stokes' parameters: here we show that the crustacean Gonodactylus smithii measures the exact components required. Conclusions/Significance: This vision provides optimal contrast-enhancement and precise determination of polarisation with no confusion states or neutral points-significant advantages. Linear and circular polarisation each give partial information about the polarisation of light-but the combination of the two, as we will show here, results in optimal polarisation vision. We suggest that linear and circular polarisation vision not be regarded as different modalities, since both are necessary for optimal polarisation vision; their combination renders polarisation vision independent of strongly linearly or circularly polarised features in the animal's environment.	[Kleinlogel, Sonja] Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany; [Kleinlogel, Sonja] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [White, Andrew G.] Univ Queensland, Ctr Quantum Comp Technol, Dept Phys, Brisbane, Qld, Australia	Max Planck Society; University of Queensland; University of Queensland	Kleinlogel, S (corresponding author), Max Planck Inst Biophys, Dept Biophys Chem, Frankfurt, Germany.	Sonja.Kleinlogel@mpibp-frankfurt.mpg.de	White, Andrew G./AAI-1062-2020; White, Andrew G/A-1088-2009	White, Andrew G/0000-0001-9639-5200	Australian Research Council; American Air Force; Swiss National Science Foundation	Australian Research Council(Australian Research Council); American Air Force; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Australian Research Council Federation Fellow program; American Air Force; Swiss National Science Foundation	BERNARD GD, 1977, VISION RES, V17, P1019, DOI 10.1016/0042-6989(77)90005-0; Born M., 1999, PRINCIPLES OPTICS; Cronin TW, 2001, J EXP BIOL, V204, P2461; Cronin TW, 2003, INTEGR COMP BIOL, V43, P549, DOI 10.1093/icb/43.4.549; GAFNI A, 1975, BIOCHIM BIOPHYS ACTA, V387, P256, DOI 10.1016/0005-2728(75)90108-5; Glantz RM, 2001, J EXP BIOL, V204, P2383; GODDARD SM, 1991, J COMP PHYSIOL A, V169, P479; Hecht E., 2001, OPTICS, V4th, P680; Hegedus R, 2007, P ROY SOC A-MATH PHY, V463, P1081, DOI 10.1098/rspa.2007.1811; Hegedus R, 2006, VISION RES, V46, P2786, DOI 10.1016/j.visres.2006.02.007; Horvath G, 2003, POLARIZED LIGHT ANIM; IVANOFF A, 1958, J MAR RES, V16, P255; James D.F.V., 2001, PHYS REV A; Kleinlogel S, 2005, CELL TISSUE RES, V321, P273, DOI 10.1007/s00441-005-1118-4; Kleinlogel S, 2006, J EXP BIOL, V209, P4262, DOI 10.1242/jeb.02499; Laughlin SB, 1975, PHOTORECEPTOR OPTICS, P479; Marshall J, 1999, NATURE, V401, P873, DOI 10.1038/44751; Marshall J, 1999, CURR BIOL, V9, P755, DOI 10.1016/S0960-9822(99)80336-4; MARSHALL NJ, 1988, NATURE, V333, P557, DOI 10.1038/333557a0; MENZEL R, 1986, J COMP PHYSIOL A, V158, P165, DOI 10.1007/BF01338560; NEVILLE AC, 1971, J INSECT PHYSIOL, V17, P519, DOI 10.1016/0022-1910(71)90030-8; Sabbah S, 2006, VISION RES, V46, P444, DOI 10.1016/j.visres.2005.05.017; Schechner YY, 2004, PROC CVPR IEEE, P536; Schwind R, 1999, J EXP BIOL, V202, P3631; SHAPIRO DB, 1991, P SOC PHOTO-OPT INS, V1537, P30, DOI 10.1117/12.49258; Shashar N, 2000, VISION RES, V40, P71, DOI 10.1016/S0042-6989(99)00158-3; Shashar N, 1998, NATURE, V393, P222, DOI 10.1038/30380; SHAW SR, 1966, NATURE, V211, P92, DOI 10.1038/211092a0; STOKES G G, 1851, CAMBRIDGE PHILOS SOC, V9, P399; WATERMAN TH, 1970, Z VERGL PHYSIOL, V68, P154, DOI 10.1007/BF00297692; WEHNER R, 1981, NATURE, V293, P731, DOI 10.1038/293731a0; Wehner R, 2001, J EXP BIOL, V204, P2589; WYNBERG H, 1980, NATURE, V286, P641, DOI 10.1038/286641a0; [No title captured]	34	30	33	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2190	10.1371/journal.pone.0002190	http://dx.doi.org/10.1371/journal.pone.0002190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478095	Green Published, gold, Green Submitted			2022-12-27	WOS:000262172800054
J	Li, L; Norrelykke, SF; Cox, EC				Li, Liang; Norrelykke, Simon F.; Cox, Edward C.			Persistent Cell Motion in the Absence of External Signals: A Search Strategy for Eukaryotic Cells	PLOS ONE			English	Article								Background: Eukaryotic cells are large enough to detect signals and then orient to them by differentiating the signal strength across the length and breadth of the cell. Amoebae, fibroblasts, neutrophils and growth cones all behave in this way. Little is known however about cell motion and searching behavior in the absence of a signal. Is individual cell motion best characterized as a random walk? Do individual cells have a search strategy when they are beyond the range of the signal they would otherwise move toward? Here we ask if single, isolated, Dictyostelium and Polysphondylium amoebae bias their motion in the absence of external cues. Methodology: We placed single well-isolated Dictyostelium and Polysphondylium cells on a nutrient-free agar surface and followed them at 10 sec intervals for similar to 10 hr, then analyzed their motion with respect to velocity, turning angle, persistence length, and persistence time, comparing the results to the expectation for a variety of different types of random motion. Conclusions: We find that amoeboid behavior is well described by a special kind of random motion: Amoebae show a long persistence time (similar to 10 min) beyond which they start to lose their direction; they move forward in a zig-zag manner; and they make turns every 1-2 min on average. They bias their motion by remembering the last turn and turning away from it. Interpreting the motion as consisting of runs and turns, the duration of a run and the amplitude of a turn are both found to be exponentially distributed. We show that this behavior greatly improves their chances of finding a target relative to performing a random walk. We believe that other eukaryotic cells may employ a strategy similar to Dictyostelium when seeking conditions or signal sources not yet within range of their detection system.	[Li, Liang] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Norrelykke, Simon F.; Cox, Edward C.] Princeton Univ, Dept Mol Biol, Princeton, NJ USA	Princeton University; Princeton University	Li, L (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	ecox@princeton.edu	Nørrelykke, Simon F/M-4722-2014; Nørrelykke, Simon/C-9405-2009	Nørrelykke, Simon F/0000-0001-8302-526X; 	NIH; Burroughs Welcome [Fellowship]; NIH/NIGMS [P50 071508]; Carlsberg Foundation; Lundbeck Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Welcome(Burroughs Wellcome Fund); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden)	This work was supported by the NIH, a Burroughs Welcome Fellowship and a stipend from the NIH/NIGMS (P50 071508) to L.L., and support from the Carlsberg Foundation and the Lundbeck Foundation to S.F.N. There is no participation by funding agencies.	Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Benichou O, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.020102; Benichou O, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198101; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; Boyer D, 2008, ARXIV08021762V1; Colby R.H., 2003, POLYM PHYS; COX EC, 1990, P NATL ACAD SCI USA, V87, P8247, DOI 10.1073/pnas.87.21.8247; Czirok A, 1998, PHYS REV LETT, V81, P3038, DOI 10.1103/PhysRevLett.81.3038; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Erdmann U, 2000, EUR PHYS J B, V15, P105, DOI 10.1007/s100510051104; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Garcia R, 2007, MATH BIOSCI, V207, P165, DOI 10.1016/j.mbs.2006.11.014; HARTMAN RS, 1994, BIOPHYS J, V67, P2535, DOI 10.1016/S0006-3495(94)80743-X; Kramer DL, 2001, AM ZOOL, V41, P137, DOI 10.1668/0003-1569(2001)041[0137:TBEOIL]2.0.CO;2; OBRIEN WJ, 1990, AM SCI, V78, P152; POTEL MJ, 1979, J CELL SCI, V36, P281; Raposo EP, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.240601; Santos MC, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046143; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; Shlesinger MF, 2006, NATURE, V443, P281, DOI 10.1038/443281a; UHLENBECK GE, 1930, PHYS REV, V36; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Willard SS, 2006, EUR J CELL BIOL, V85, P897, DOI 10.1016/j.ejcb.2006.06.003; Xu JS, 2007, P NATL ACAD SCI USA, V104, P9296, DOI 10.1073/pnas.0703153104	26	187	188	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2093	10.1371/journal.pone.0002093	http://dx.doi.org/10.1371/journal.pone.0002093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461173	Green Published, Green Submitted, gold			2022-12-27	WOS:000261642400015
J	Ward, RM; Erdin, S; Tran, TA; Kristensen, DM; Lisewski, AM; Lichtarge, O				Ward, R. Matthew; Erdin, Serkan; Tran, Tuan A.; Kristensen, David M.; Lisewski, Andreas Martin; Lichtarge, Olivier			De-Orphaning the Structural Proteome through Reciprocal Comparison of Evolutionarily Important Structural Features	PLOS ONE			English	Article							3D COORDINATE TEMPLATES; FUNCTIONAL SITES; FUNCTION PREDICTION; SECONDARY-STRUCTURE; FAMILY RESOURCE; GENOMICS; SEQUENCE; DATABASE; ANNOTATION; PROTEINS	Function prediction frequently relies on comparing genes or gene products to search for relevant similarities. Because the number of protein structures with unknown function is mushrooming, however, we asked here whether such comparisons could be improved by focusing narrowly on the key functional features of protein structures, as defined by the Evolutionary Trace (ET). Therefore a series of algorithms was built to (a) extract local motifs (3D templates) from protein structures based on ET ranking of residue importance; (b) to assess their geometric and evolutionary similarity to other structures; and (c) to transfer enzyme annotation whenever a plurality was reached across matches. Whereas a prototype had only been 80% accurate and was not scalable, here a speedy new matching algorithm enabled large-scale searches for reciprocal matches and thus raised annotation specificity to 100% in both positive and negative controls of 49 enzymes and 50 non-enzymes, respectively-in one case even identifying an annotation error-while maintaining sensitivity (similar to 60%). Critically, this Evolutionary Trace Annotation (ETA) pipeline requires no prior knowledge of functional mechanisms. It could thus be applied in a large-scale retrospective study of 1218 structural genomics enzymes and reached 92% accuracy. Likewise, it was applied to all 2935 unannotated structural genomics proteins and predicted enzymatic functions in 320 cases: 258 on first pass and 62 more on second pass. Controls and initial analyses suggest that these predictions are reliable. Thus the large-scale evolutionary integration of sequence-structure-function data, here through reciprocal identification of local, functionally important structural features, may contribute significantly to de-orphaning the structural proteome.	[Ward, R. Matthew; Erdin, Serkan; Tran, Tuan A.; Kristensen, David M.; Lisewski, Andreas Martin; Lichtarge, Olivier] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Ward, R. Matthew; Kristensen, David M.; Lichtarge, Olivier] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine	Ward, RM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	lichtarge@bcm.edu	Erdin, Serkan/B-4988-2008; Erdin, Serkan/AAE-4288-2019	Erdin, Serkan/0000-0001-6587-2625; Tran, Tuan/0000-0003-3137-5035	NSF [DBI-0547695]; NIH [R01-GM066099, R01-GM079656, 5 T32 GM07526-29]; March of Dimes [1-FY06-371]; Keck Center for Interdisciplinary Bioscience Training [5T15LM07093]; W.M. Keck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066099, R01GM079656, T32GM007526] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Keck Center for Interdisciplinary Bioscience Training; W.M. Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We wish to gratefully acknowledge partial support from NSF DBI-0547695 (OL), NIH R01-GM066099 and R01-GM079656, as well as from March of Dimes (1-FY06-371). This work was also supported by training fellowships from the Keck Center for Interdisciplinary Bioscience Training NLM Grant No. 5T15LM07093 (RMW and DMK) and from the W.M. Keck Foundation (AML). SE was supported by the NIH institutional postdoctoral fellowship program in a medical genetics training program NIH 5 T32 GM07526-29.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; ARTYMIUK PJ, 1994, J MOL BIOL, V243, P327, DOI 10.1006/jmbi.1994.1657; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attwood TK, 2000, NUCLEIC ACIDS RES, V28, P225, DOI 10.1093/nar/28.1.225; Ausiello G, 2005, NUCLEIC ACIDS RES, V33, pW133, DOI 10.1093/nar/gki499; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Barker JA, 2003, BIOINFORMATICS, V19, P1644, DOI 10.1093/bioinformatics/btg226; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Binkowski TA, 2004, NUCLEIC ACIDS RES, V32, pW555, DOI 10.1093/nar/gkh390; Brenner SE, 2001, NAT REV GENET, V2, P801, DOI 10.1038/35093574; Burley SK, 2000, NAT STRUCT BIOL, V7, P932, DOI 10.1038/80697; Cammer SA, 2003, J MOL BIOL, V334, P387, DOI 10.1016/j.jmb.2003.09.062; Chance MR, 2002, PROTEIN SCI, V11, P723, DOI 10.1110/ps.4570102; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Cokus S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S7; Copley SD, 2004, BIOCHEMISTRY-US, V43, P13981, DOI 10.1021/bi048947r; de Rinaldis M, 1998, J MOL BIOL, V284, P1211, DOI 10.1006/jmbi.1998.2248; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Devos D, 2001, TRENDS GENET, V17, P429, DOI 10.1016/S0168-9525(01)02348-4; Ferre F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-194; FISCHER D, 1993, PROTEINS, V16, P278, DOI 10.1002/prot.340160306; Friedberg I, 2006, NUCLEIC ACIDS RES, V34, pW379, DOI 10.1093/nar/gkl045; Galperin M Y, 1998, In Silico Biol, V1, P55; Gilbert D, 1999, BIOINFORMATICS, V15, P317, DOI 10.1093/bioinformatics/15.4.317; Glaser F, 2006, PROTEINS, V62, P479, DOI 10.1002/prot.20769; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; Harrison A, 2003, BIOINFORMATICS, V19, P1748, DOI 10.1093/bioinformatics/btg240; HOBOHM U, 1992, PROTEIN SCI, V1, P409; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Ivanisenko VA, 2005, NUCLEIC ACIDS RES, V33, pD183, DOI 10.1093/nar/gki105; Ivanisenko VA, 2004, NUCLEIC ACIDS RES, V32, pW549, DOI 10.1093/nar/gkh439; Jambon M, 2005, BIOINFORMATICS, V21, P3929, DOI 10.1093/bioinformatics/bti645; Jambon M, 2003, PROTEINS, V52, P137, DOI 10.1002/prot.10339; Jensen LJ, 2002, J MOL BIOL, V319, P1257, DOI 10.1016/S0022-2836(02)00379-0; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kinoshita Kengo, 2002, Journal of Structural and Functional Genomics, V2, P9, DOI 10.1023/A:1011318527094; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kristensen DM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-17; Kristensen DM, 2006, PROTEIN SCI, V15, P1530, DOI 10.1110/ps.062152706; Kuznetsova E, 2005, FEMS MICROBIOL REV, V29, P263, DOI 10.1016/j.femsre.2004.12.006; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Laskowski RA, 2005, J MOL BIOL, V351, P614, DOI 10.1016/j.jmb.2005.05.067; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Laskowski RA, 1995, J MOL GRAPHICS, V13, P328; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Lee Y, 2002, GENOME RES, V12, P493, DOI 10.1101/gr.212002; Leulliot N, 2005, ACTA CRYSTALLOGR D, V61, P664, DOI 10.1107/S0907444905000028; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lisewski AM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl788; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Madabushi S, 2002, J MOL BIOL, V316, P139, DOI 10.1006/jmbi.2001.5327; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Morgan DH, 2006, BIOINFORMATICS, V22, P2049, DOI 10.1093/bioinformatics/btl285; Nevill-Manning CG, 1998, P NATL ACAD SCI USA, V95, P5865, DOI 10.1073/pnas.95.11.5865; Nocek B, 2005, J MOL BIOL, V354, P91, DOI 10.1016/j.jmb.2005.08.036; NUSSINOV R, 1991, P NATL ACAD SCI USA, V88, P10495, DOI 10.1073/pnas.88.23.10495; O'Handley SF, 1998, J BIOL CHEM, V273, P3192, DOI 10.1074/jbc.273.6.3192; O'Toole N, 2004, PROTEINS, V56, P201, DOI 10.1002/prot.20060; Overbeek R, 1999, In Silico Biol, V1, P93; Pearl FMG, 2003, NUCLEIC ACIDS RES, V31, P452, DOI 10.1093/nar/gkg062; Polacco BJ, 2006, BIOINFORMATICS, V22, P723, DOI 10.1093/bioinformatics/btk038; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Quan XJ, 2004, DEVELOPMENT, V131, P1679, DOI 10.1242/dev.01055; Rajagopalan L, 2006, J NEUROSCI, V26, P12727, DOI 10.1523/JNEUROSCI.2734-06.2006; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; Rosen M, 1998, PROTEIN ENG, V11, P263, DOI 10.1093/protein/11.4.263; Schmitt S, 2002, J MOL BIOL, V323, P387, DOI 10.1016/S0022-2836(02)00811-2; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shima S, 2000, J MOL BIOL, V300, P935, DOI 10.1006/jmbi.2000.3909; SHIN D, 2007, J STRUCT FUNCT GENOM; Shin HJ, 2007, BIOINFORMATICS, V23, P3217, DOI 10.1093/bioinformatics/btm511; Shulman-Peleg A, 2004, J MOL BIOL, V339, P607, DOI 10.1016/j.jmb.2004.04.012; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Sjolander K, 2004, BIOINFORMATICS, V20, P170, DOI 10.1093/bioinformatics/bth021; Skolnick J, 2000, TRENDS BIOTECHNOL, V18, P34, DOI 10.1016/S0167-7799(99)01398-0; Sowa ME, 2001, NAT STRUCT BIOL, V8, P234, DOI 10.1038/84974; Stark A, 2003, NUCLEIC ACIDS RES, V31, P3341, DOI 10.1093/nar/gkg506; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Todd AE, 2005, J MOL BIOL, V348, P1235, DOI 10.1016/j.jmb.2005.03.037; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Vitkup D, 2001, NAT STRUCT BIOL, V8, P559, DOI 10.1038/88640; von Grotthuss M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-53; Wallace AC, 1996, PROTEIN SCI, V5, P1001; Wallace AC, 1997, PROTEIN SCI, V6, P2308; Wangikar PP, 2003, J MOL BIOL, V326, P955, DOI 10.1016/S0022-2836(02)01384-0; Watson JD, 2007, J MOL BIOL, V367, P1511, DOI 10.1016/j.jmb.2007.01.063; Watson JD, 2005, CURR OPIN STRUC BIOL, V15, P275, DOI 10.1016/j.sbi.2005.04.003; Webb E. C., 1992, Enzyme nomenclature 1992. Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes.; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550; Xie L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S4-S9; Yao H, 2003, J MOL BIOL, V326, P255, DOI 10.1016/S0022-2836(02)01336-0; Zhang BH, 1999, PROTEIN SCI, V8, P1104, DOI 10.1110/ps.8.5.1104	107	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2136	10.1371/journal.pone.0002136	http://dx.doi.org/10.1371/journal.pone.0002136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461181	Green Published, gold, Green Submitted			2022-12-27	WOS:000261642400056
J	Wong, CM; Lai, HK; Ou, CQ; Ho, SY; Chan, KP; Thach, TQ; Yang, L; Chau, YK; Lam, TH; Hedley, AJ; Peiris, JSM				Wong, Chit-Ming; Lai, Hak-Kan; Ou, Chun-Quan; Ho, Sai-Yin; Chan, King-Pan; Thach, Thuan-Quoc; Yang, Lin; Chau, Yuen-Kwan; Lam, Tai-Hing; Hedley, Anthony Johnson; Peiris, Joseph Sriyal Malik			Is Exercise Protective Against Influenza-Associated Mortality?	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MODERATE EXERCISE; HONG-KONG; IMMUNE-SYSTEM; ADULT DEATHS; ANTIBODY-RESPONSE; VACCINE; PREVENTION; SUSCEPTIBILITY; INFECTION	Background: Little is known about the effect of physical exercise on influenza-associated mortality. Methods and Findings: We collected information about exercise habits and other lifestyles, and socioeconomic and demographic status, the underlying cause of death of 24,656 adults (21% aged 30-64, 79% aged 65 or above) who died in 1998 in Hong Kong, and the weekly proportion of specimens positive for influenza A (H3N1 and H1N1) and B isolations during the same period. We assessed the excess risks (ER) of influenza-associated mortality due to all-natural causes, cardiovascular diseases, or respiratory disease among different levels of exercise: never/seldom (less than once per month), low/moderate (once per month to three times per week), and frequent (four times or more per week) by Poisson regression. We also assessed the differences in ER between exercise groups by case-only logistic regression. For all the mortality outcomes under study in relation to each 10% increase in weekly proportion of specimens positive for influenza A+B, never/seldom exercise (as reference) was associated with 5.8% to 8.5% excess risks (ER) of mortality (P < 0.0001), while low/moderate exercise was associated with ER which were 4.2% to 6.4% lower than those of the reference (P < 0.001 for all-natural causes; P = 0.001 for cardiovascular; and P = 0.07 for respiratory mortality). Frequent exercise was not different from the reference (change in ER -0.8% to 1.7%, P = 0.30 to 0.73). Conclusion: When compared with never or seldom exercise, exercising at low to moderate frequency is beneficial with lower influenza-associated mortality.	[Wong, Chit-Ming; Lai, Hak-Kan; Ou, Chun-Quan; Ho, Sai-Yin; Chan, King-Pan; Thach, Thuan-Quoc; Yang, Lin; Chau, Yuen-Kwan; Lam, Tai-Hing; Hedley, Anthony Johnson] Univ Hong Kong, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; [Peiris, Joseph Sriyal Malik] Univ Hong Kong, Dept Microbiol, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wong, CM (corresponding author), Univ Hong Kong, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	commed@hkucc.hku.hk	Thach, Thuan-Quoc/C-4416-2009; Hedley, Anthony J/A-9113-2013; YANG, Lin/F-9601-2014; Yang, Lin/E-5183-2011; Lam, Tai Hing/C-4317-2009; Ho, Daniel Sai Yin/C-4307-2009	Thach, Thuan-Quoc/0000-0003-3404-3888; YANG, Lin/0000-0002-5964-3233; Lam, Tai Hing/0000-0002-2033-9971; Ou, Chun-Quan/0000-0001-6866-7213; Ho, Daniel Sai Yin/0000-0001-9485-0273	Health and Health Services Research Fund [631012]; Research Fund for the Control of Infectious Diseases [HKU-AA-008]	Health and Health Services Research Fund; Research Fund for the Control of Infectious Diseases	This study was funded by the Health and Health Services Research Fund (#631012), who provided the Lifestyle and Mortality Study (LIMOR), and the Research Fund for the Control of Infectious Diseases (#HKU-AA-008) funding.	Armstrong BG, 2003, EPIDEMIOLOGY, V14, P467, DOI 10.1097/01.ede.0000071408.39011.99; Brown AS, 2004, MED SCI SPORT EXER, V36, P1290, DOI 10.1249/01.MSS.0000135798.72735.B3; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; Davis JM, 1997, J APPL PHYSIOL, V83, P1461, DOI 10.1152/jappl.1997.83.5.1461; Davis JM, 2004, AM J PHYSIOL-REG I, V286, pR366, DOI 10.1152/ajpregu.00304.2003; Demicheli V, 2000, VACCINE, V18, P957, DOI 10.1016/S0264-410X(99)00332-1; EDWARDS KM, 1994, J INFECT DIS, V169, P68, DOI 10.1093/infdis/169.1.68; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; HEATH GW, 1991, MED SCI SPORT EXER, V23, P152; *HKSAR GOV, 2006, HONG KONG FACTS POP; Ho SY, 2006, PREV MED, V43, P20, DOI 10.1016/j.ypmed.2006.03.007; HOFFMANGOETZ L, 1994, IMMUNOL TODAY, V15, P382, DOI 10.1016/0167-5699(94)90177-5; Kapasi ZF, 2001, PHYS THER, V81, P1801, DOI 10.1093/ptj/81.11.1801; Kohut ML, 2004, VACCINE, V22, P2298, DOI 10.1016/j.vaccine.2003.11.023; Kohut ML, 2002, J GERONTOL A-BIOL, V57, pM557, DOI 10.1093/gerona/57.9.M557; Lam TH, 2004, ANN EPIDEMIOL, V14, P391, DOI 10.1016/j.annepidem.2003.09.005; Lam TH, 2001, BRIT MED J, V323, P361, DOI 10.1136/bmj.323.7309.361; MACNEIL B, 1991, J APPL PHYSIOL, V70, P179, DOI 10.1152/jappl.1991.70.1.179; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1242, DOI 10.1097/00005768-200208000-00003; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; Nieman DC, 2000, IMMUNOL CELL BIOL, V78, P496, DOI 10.1046/j.1440-1711.2000.00950.x; NIEMAN DC, 1990, J SPORT MED PHYS FIT, V30, P316; NIEMAN DC, 1990, INT J SPORTS MED, V11, P467, DOI 10.1055/s-2007-1024839; NIEMAN DC, 1993, MED SCI SPORT EXER, V25, P823, DOI 10.1249/00005768-199307000-00011; NIEMAN DC, 1994, SEMIN HEMATOL, V31, P166; NIEMAN DC, 1994, INT J SPORTS MED, V15, pS131, DOI 10.1055/s-2007-1021128; NIEMAN DC, 1991, SPORTS MED, V11, P183, DOI 10.2165/00007256-199111030-00003; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; PEDERSEN BK, 1995, SPORTS MED, V19, P393, DOI 10.2165/00007256-199519060-00003; Pedersen BK, 1998, ACTA PHYSIOL SCAND, V162, P325, DOI 10.1046/j.1365-201X.1998.0325e.x; Rockhill B, 2001, AM J PUBLIC HEALTH, V91, P578, DOI 10.2105/AJPH.91.4.578; Roubenoff R, 2007, NUTR REV, V65, pS208, DOI 10.1111/j.1753-4887.2007.tb00364.x; Schooling CM, 2006, INT J EPIDEMIOL, V35, P418, DOI 10.1093/ije/dyi296; Schuler PB, 2003, J SPORT MED PHYS FIT, V43, P404; Schwartz J, 2005, EPIDEMIOLOGY, V16, P67, DOI 10.1097/01.ede.0000147114.25957.71; SHINKAI S, 1995, MED SCI SPORT EXER, V27, P1516; Stephenson I, 2001, EUR RESPIR J, V17, P1282, DOI 10.1183/09031936.01.00084301; Thomas LA, 2005, BRAIN BEHAV IMMUN, V19, P377, DOI 10.1016/j.bbi.2005.04.002; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; U.S. Department of Health and Human Services, 2002, PHYS ACT OLD AM BEN; *UK DEP HLTH, 2004, PHYS ACT HLTH IMPR P; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; Wong CM, 2007, PREV MED, V44, P386, DOI 10.1016/j.ypmed.2006.12.012; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315	49	49	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2108	10.1371/journal.pone.0002108	http://dx.doi.org/10.1371/journal.pone.0002108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461130	Green Published, gold, Green Submitted			2022-12-27	WOS:000261642400030
J	Yaghmur, A; Laggner, P; Sartori, B; Rappolt, M				Yaghmur, Anan; Laggner, Peter; Sartori, Barbara; Rappolt, Michael			Calcium Triggered L-alpha-H-2 Phase Transition Monitored by Combined Rapid Mixing and Time-Resolved Synchrotron SAXS	PLOS ONE			English	Article							X-RAY-SCATTERING; LIQUID-CRYSTALLINE PHASES; ALKALINE-EARTH CATIONS; MEMBRANE-FUSION; CUBIC PHASES; DIVALENT-CATIONS; LIPID-BILAYERS; BINDING; LAMELLAR; SYSTEMS	Background: Awad et al. [1] reported on the Ca2+-induced transitions of dioleoyl-phosphatidylglycerol (DOPG)/monoolein (MO) vesicles to bicontinuous cubic phases at equilibrium conditions. In the present study, the combination of rapid mixing and time-resolved synchrotron small-angle X-ray scattering (SAXS) was applied for the in-situ investigations of fast structural transitions of diluted DOPG/MO vesicles into well-ordered nanostructures by the addition of low concentrated Ca2+ solutions. Methodology/Principal Findings: Under static conditions and the in absence of the divalent cations, the DOPG/MO system forms large vesicles composed of weakly correlated bilayers with a d-spacing of similar to 140 angstrom (L-alpha-phase). The utilization of a stopped-flow apparatus allowed mixing these DOPG/MO vesicles with a solution of Ca2+ ions within 10 milliseconds (ms). In such a way the dynamics of negatively charged PG to divalent cation interactions, and the kinetics of the induced structural transitions were studied. Ca2+ ions have a very strong impact on the lipidic nanostructures. Intriguingly, already at low salt concentrations (DOPG/Ca2+ >2), Ca2+ ions trigger the transformation from bilayers to monolayer nanotubes (inverted hexagonal phase, H-2). Our results reveal that a binding ratio of 1 Ca2+ per 8 DOPG is sufficient for the formation of the H-2 phase. At 50 degrees C a direct transition from the vesicles to the H-2 phase was observed, whereas at ambient temperature (20 degrees C) a short lived intermediate phase (possibly the cubic Pn3m phase) coexisting with the H-2 phase was detected. Conclusions/Significance: The strong binding of the divalent cations to the negatively charged DOPG molecules enhances the negative spontaneous curvature of the monolayers and causes a rapid collapsing of the vesicles. The rapid loss of the bilayer stability and the reorganization of the lipid molecules within ms support the argument that the transition mechanism is based on a leaky fusion of the vesicles.	[Yaghmur, Anan; Laggner, Peter; Sartori, Barbara; Rappolt, Michael] Austrian Acad Sci, Inst Biophys & Nanosyst Res IBN, Graz, Austria	Austrian Academy of Sciences	Yaghmur, A (corresponding author), Austrian Acad Sci, Inst Biophys & Nanosyst Res IBN, Graz, Austria.	anan.yaghmur@oeaw.ac.at	Yaghmur, Anan/AGU-9381-2022	Yaghmur, Anan/0000-0003-1608-773X; Rappolt, Michael/0000-0001-9942-3035				Allen SJ, 2004, J MOL BIOL, V342, P1279, DOI 10.1016/j.jmb.2004.07.040; Almsherqi ZA, 2006, J CELL BIOL, V173, P839, DOI 10.1083/jcb.200603055; Amenitsch H, 2004, LANGMUIR, V20, P4621, DOI 10.1021/la036319p; Amenitsch H, 1998, J SYNCHROTRON RADIAT, V5, P506, DOI 10.1107/S090904959800137X; Andersson AS, 1998, BIOPHYS J, V75, P2877, DOI 10.1016/S0006-3495(98)77730-6; Angelova A, 2005, J PHYS CHEM B, V109, P3089, DOI 10.1021/jp044216p; Arseneault M, 2006, CHEM PHYS LIPIDS, V142, P84, DOI 10.1016/j.chemphyslip.2006.03.003; Awad TS, 2005, LANGMUIR, V21, P11556, DOI 10.1021/la051782i; Bernstorff S, 1998, J SYNCHROTRON RADIAT, V5, P1215, DOI 10.1107/S0909049597019110; Bockmann RA, 2004, ANGEW CHEM INT EDIT, V43, P1021, DOI 10.1002/anie.200352784; BOGGS JM, 1983, BIOCHEMISTRY-US, V22, P5425, DOI 10.1021/bi00292a026; Bolze J, 2004, J COLLOID INTERF SCI, V277, P84, DOI 10.1016/j.jcis.2004.04.029; BOYD BJ, 2005, DRUG DELIV REP   AUT, P63; Briggs J, 1996, J PHYS II, V6, P723, DOI 10.1051/jp2:1996208; CAFFREY M, 1985, BIOCHEMISTRY-US, V24, P4826, DOI 10.1021/bi00339a017; CAILLE A, 1972, CR ACAD SCI B PHYS, V274, P891; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; Chernik GG, 1999, CURR OPIN COLLOID IN, V4, P381, DOI 10.1016/S1359-0294(00)00023-6; Colotto A, 1997, BIOCHEMISTRY-US, V36, P7644, DOI 10.1021/bi970382u; Couvreur P, 2006, PHARM RES-DORDR, V23, P1417, DOI 10.1007/s11095-006-0284-8; Crossthwaite AJ, 2005, J BIOL CHEM, V280, P6380, DOI 10.1074/jbc.M411987200; de Campo L, 2004, LANGMUIR, V20, P5254, DOI 10.1021/la0499416; deKruijff B, 1997, CURR TOP MEMBR, V44, P477; deKruijff B, 1997, NATURE, V386, P129, DOI 10.1038/386129a0; DEKRUIJFF B, 1982, BIOCHIM BIOPHYS ACTA, V693, P1, DOI 10.1016/0005-2736(82)90464-3; ELLENS H, 1989, BIOCHEMISTRY-US, V28, P3692, DOI 10.1021/bi00435a011; Epand RM, 1997, CURR TOP MEMBR, V44, P237; Faraudo J, 2007, BIOPHYS J, V92, P2806, DOI 10.1529/biophysj.106.092015; Garidel P, 2000, BBA-BIOMEMBRANES, V1466, P245, DOI 10.1016/S0005-2736(00)00166-8; Garidel P, 1999, LANGMUIR, V15, P5526, DOI 10.1021/la990217a; Garidel P, 2000, LANGMUIR, V16, P1662, DOI 10.1021/la990922j; Garidel P, 2000, PHYS CHEM CHEM PHYS, V2, P4537, DOI 10.1039/b003276j; GOODSELL DS, 2004, BIONANOTECHNOLOGY LE, P227; Gradzielski M, 2004, PROG COLL POL SCI S, V129, P32, DOI 10.1007/b100300; Gradzielski M, 2000, J PHYS CHEM B, V104, P11594, DOI 10.1021/jp0028913; GRADZIELSKI M, 2004, CURR OPIN COLLOID IN, V4, P381; Grillo I, 2003, LANGMUIR, V19, P4573, DOI 10.1021/la0208732; Gustafsson J, 1996, LANGMUIR, V12, P4611, DOI 10.1021/la960318y; HONG K, 1982, BIOPHYS J, V37, P297, DOI 10.1016/S0006-3495(82)84678-X; Hu MZC, 2000, J MATER SCI, V35, P1957, DOI 10.1023/A:1004722603945; HUANG TC, 1993, J APPL CRYSTALLOGR, V26, P180, DOI 10.1107/S0021889892009762; HUI SW, 1981, SCIENCE, V212, P921, DOI 10.1126/science.7233185; HUI SW, 1983, CHEM PHYS LIPIDS, V33, P113, DOI 10.1016/0009-3084(83)90015-4; HYDE S, 1997, ELSEVIER BOOK SERIES; ISRAELACHVILI JN, 1976, J CHEM SOC FARAD T 2, V72, P1525, DOI 10.1039/f29767201525; Kamo T, 2003, LANGMUIR, V19, P9191, DOI 10.1021/la035313x; Kharakoz DP, 2003, MEMBR SCI T, V7, P239, DOI 10.1016/S0927-5193(03)80031-1; KILLIAN JA, 1994, BBA-BIOMEMBRANES, V1189, P225; Krebs J, 1995, ENCY MOL BIOL MOL ME, V1, P237; Kriechbaum M, 1996, PROG SURF SCI, V51, P233, DOI 10.1016/0079-6816(96)00003-2; LAGGNER P, 1991, CHEM PHYS LIPIDS, V57, P121, DOI 10.1016/0009-3084(91)90072-J; Laggner P, 1998, FARADAY DISCUSS, V111, P31; Larsson K, 2000, CURR OPIN COLLOID IN, V5, P64, DOI 10.1016/S1359-0294(00)00040-6; LARSSON K, 1983, NATURE, V304, P664, DOI 10.1038/304664c0; LEHRMANN R, 1994, BBA-BIOMEMBRANES, V1189, P89, DOI 10.1016/0005-2736(94)90284-4; Li SJ, 2001, BIOPHYS J, V81, P983, DOI 10.1016/S0006-3495(01)75756-6; LINDBLOM G, 1989, BIOCHIM BIOPHYS ACTA, V988, P221, DOI 10.1016/0304-4157(89)90020-8; LUTTON ES, 1965, J AM OIL CHEM SOC, V42, P1068, DOI 10.1007/BF02636909; Luzzati V, 1997, CURR OPIN STRUC BIOL, V7, P661, DOI 10.1016/S0959-440X(97)80075-9; Masum SM, 2003, LANGMUIR, V19, P4745, DOI 10.1021/la026847l; Moitzi C, 2007, ADV MATER, V19, P1352, DOI 10.1002/adma.200601679; Nakano M, 2005, J PHYS CHEM B, V109, P4754, DOI 10.1021/jp046181z; NILSSON A, 1994, CHEM PHYS LIPIDS, V71, P119, DOI 10.1016/0009-3084(94)90065-5; Ortiz A, 1999, BIOPHYS J, V77, P2003, DOI 10.1016/S0006-3495(99)77041-4; Pabst G, 2000, PHYS REV E, V62, P4000, DOI 10.1103/PhysRevE.62.4000; Pabst G, 2003, J APPL CRYSTALLOGR, V36, P1378, DOI 10.1107/S0021889803017527; Pabst G, 2007, BIOPHYS J, V93, P2688, DOI 10.1529/biophysj.107.112615; Pabst Georg, 2006, Biophysical Reviews and Letters, V1, P57, DOI 10.1142/S1793048006000069; Panine P, 2006, ADV COLLOID INTERFAC, V127, P9, DOI 10.1016/j.cis.2006.06.003; PAPAHADJOPOULOS D, 1975, BIOPHYS J, V15, P945, DOI 10.1016/S0006-3495(75)85872-3; PATTON JS, 1979, SCIENCE, V204, P145, DOI 10.1126/science.432636; Pedersen UR, 2006, BBA-BIOMEMBRANES, V1758, P573, DOI 10.1016/j.bbamem.2006.03.035; Pitzalis P, 2000, LANGMUIR, V16, P6358, DOI 10.1021/la0002031; Qiu H, 2000, BIOMATERIALS, V21, P223, DOI 10.1016/S0142-9612(99)00126-X; Rappolt M, 2006, EUROPHYS LETT, V75, P267, DOI 10.1209/epl/i2006-10104-y; Rappolt M, 2001, COLLOID SURFACE A, V183, P171, DOI 10.1016/S0927-7757(01)00568-4; Rappolt M, 1998, BBA-BIOMEMBRANES, V1372, P389, DOI 10.1016/S0005-2736(98)00079-0; RAPPOLT M, 2008, CHEM PHYS L IN PRESS; RAPPOLT M, 2007, ELSEVIER BOOK SERIES, V5, P253; ROUX M, 1990, BIOCHEMISTRY-US, V29, P7077, DOI 10.1021/bi00482a019; SEDDON JM, 1990, BIOCHIM BIOPHYS ACTA, V1031, P1, DOI 10.1016/0304-4157(90)90002-T; Shearman GC, 2006, J PHYS-CONDENS MAT, V18, pS1105, DOI 10.1088/0953-8984/18/28/S01; Siegel DP, 1999, BIOPHYS J, V76, P291, DOI 10.1016/S0006-3495(99)77197-3; SIEGEL DP, 1986, BIOPHYS J, V49, P1155, DOI 10.1016/S0006-3495(86)83744-4; Simidjiev I, 2000, P NATL ACAD SCI USA, V97, P1473, DOI 10.1073/pnas.97.4.1473; Sinn CG, 2006, COLLOID SURFACE A, V282, P410, DOI 10.1016/j.colsurfa.2005.10.014; Spicer PT., 2004, DEKKER ENCY NANOSCIE, P881; Szule JA, 2003, J BIOL CHEM, V278, P24251, DOI 10.1074/jbc.C300197200; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; VERKLEIJ AJ, 1982, BIOCHIM BIOPHYS ACTA, V684, P255, DOI 10.1016/0005-2736(82)90014-1; VERKLEIJ AJ, 1980, BIOCHIM BIOPHYS ACTA, V600, P620, DOI 10.1016/0005-2736(80)90465-4; Vest RS, 2004, BIOPHYS J, V86, P2251, DOI 10.1016/S0006-3495(04)74283-6; Weiss TM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.038303; Yaghmur A, 2006, LANGMUIR, V22, P517, DOI 10.1021/la052109w; Yaghmur A, 2002, COLLOID SURFACE A, V209, P71, DOI 10.1016/S0927-7757(02)00168-1; Yaghmur A, 2005, LANGMUIR, V21, P569, DOI 10.1021/la0482711; Yaghmur A, 2006, LANGMUIR, V22, P9919, DOI 10.1021/la061303v; Yaghmur A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000479; ZHANG J, 2002, NANOSTRUCTURE SCI TE; Zhang RT, 1996, BIOPHYS J, V70, P349, DOI 10.1016/S0006-3495(96)79576-0; Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i	102	62	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2072	10.1371/journal.pone.0002072	http://dx.doi.org/10.1371/journal.pone.0002072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446202	Green Accepted, gold, Green Published			2022-12-27	WOS:000261572300041
J	Tribouillard-Tanvier, D; Beringue, V; Desban, N; Gug, F; Bach, S; Voisset, C; Galons, H; Laude, H; Vilette, D; Blondel, M				Tribouillard-Tanvier, Deborah; Beringue, Vincent; Desban, Nathalie; Gug, Fabienne; Bach, Stephane; Voisset, Cecile; Galons, Herve; Laude, Hubert; Vilette, Didier; Blondel, Marc			Antihypertensive Drug Guanabenz Is Active In Vivo against both Yeast and Mammalian Prions	PLOS ONE			English	Article								Background: Prion-based diseases are incurable transmissible neurodegenerative disorders affecting animals and humans. Methodology/Principal Findings: Here we report the discovery of the in vivo antiprion activity of Guanabenz (GA), an agonist of alpha 2-adrenergic receptors routinely used in human medicine as an antihypertensive drug. We isolated GA in a screen for drugs active in vivo against two different yeast prions using a previously described yeast-based two steps assay. GA was then shown to promote ovine PrPSc clearance in a cell-based assay. These effects are very specific as evidenced by the lack of activity of some GA analogues that we generated. GA antiprion activity does not involve its agonist activity on alpha 2-adrenergic receptors as other chemically close anti-hypertensive agents possessing related mechanism of action were found inactive against prions. Finally, GA showed activity in a transgenic mouse-based in vivo assay for ovine prion propagation, prolonging slightly but significantly the survival of treated animals. Conclusion/Significance: GA thus adds to the short list of compounds active in vivo in animal models for the treatment of prion-based diseases. Because it has been administrated for many years to treat hypertension on a daily basis, without major side-effects, our results suggest that it could be evaluated in human as a potential treatment for prion-based diseases.	[Tribouillard-Tanvier, Deborah; Voisset, Cecile; Blondel, Marc] INSERM, U613, Brest, France; [Tribouillard-Tanvier, Deborah; Voisset, Cecile; Blondel, Marc] Univ Brest, Fac Med Sci Sante, UMR S613, Brest, France; [Tribouillard-Tanvier, Deborah; Voisset, Cecile; Blondel, Marc] Etab Francais Sang EFS Bretagne, Brest, France; [Tribouillard-Tanvier, Deborah; Voisset, Cecile; Blondel, Marc] Lab Genet Mol, Hop Morvan, CHU Brest, Brest, France; [Tribouillard-Tanvier, Deborah; Desban, Nathalie; Bach, Stephane] Place Georges Teissier, Protein Phosphorylat & Dis Lab, Stn Biol, CNRS UPS2682, Roscoff, France; [Beringue, Vincent; Laude, Hubert; Vilette, Didier] Virol Immunol Mol, UR892, Inst Natl Rech Agronom INRA, Jouy En Josas, France; [Gug, Fabienne; Galons, Herve] Univ Paris 05, Lab Chim Organ 2, INSERM U648, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; UDICE-French Research Universities; Sorbonne Universite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Blondel, M (corresponding author), INSERM, U613, Brest, France.	marc.blondel@univ-brest.fr	BACH, Stéphane/ABD-5865-2020; Voisset, Cecile/AAK-1636-2020; Blondel, Marc/AAJ-9049-2020	Blondel, Marc/0000-0003-4897-2995; Tribouillard-Tanvier, Deborah/0000-0002-2290-5375; Voisset, Cecile/0000-0001-7505-1927	GIS Infections a prion; ACI Jeune Chercheur from the French government; CRITT Sante Bretagne; Ministere de la Recherche; FRM; CNRS [Ingenieur de valorisation fellowship]; ANR blanche from the French government; INSERM	GIS Infections a prion; ACI Jeune Chercheur from the French government; CRITT Sante Bretagne; Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); FRM(Fondation pour la Recherche Medicale); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR blanche from the French government(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by the following grants: GIS Infections a prion, ACI Jeune Chercheur from the French government, CRITT Sante Bretagne to MB, Ministere de la Recherche and FRM grants (to DTT), Ingenieur de valorisation fellowship from the CNRS, ANR blanche from the French government to MB, CV, VB, HL, DV and HG and INSERM junior contract to CV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer F, 2004, J VIROL, V78, P482, DOI 10.1128/JVI.78.1.482-490.2004; Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855; Bach S, 2006, METHODS, V39, P72, DOI 10.1016/j.ymeth.2006.04.005; Barret A, 2003, J VIROL, V77, P8462, DOI 10.1128/JVI.77.15.8462-8469.2003; BENKEMOUN L, 2006, FUNGAL GENET BIOL; Beringue V, 2000, J VIROL, V74, P5432, DOI 10.1128/JVI.74.12.5432-5440.2000; Bertsch U, 2005, J VIROL, V79, P7785, DOI 10.1128/JVI.79.12.7785-7791.2005; Collins SJ, 2002, ANN NEUROL, V52, P503, DOI 10.1002/ana.10336; Cordeiro Y, 2004, J BIOL CHEM, V279, P5346, DOI 10.1074/jbc.M312262200; Cronier S, 2007, J VIROL, V81, P13794, DOI 10.1128/JVI.01502-07; Dirikoc S, 2007, J NEUROSCI, V27, P9537, DOI 10.1523/JNEUROSCI.1942-07.2007; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; EHLERS B, 1984, J GEN VIROL, V65, P1325, DOI 10.1099/0022-1317-65-8-1325; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Forloni G, 2002, P NATL ACAD SCI USA, V99, P10849, DOI 10.1073/pnas.162195499; GABIZON R, 1988, P NATL ACAD SCI USA, V85, P6617, DOI 10.1073/pnas.85.18.6617; Gilch S, 2007, J MOL BIOL, V371, P362, DOI 10.1016/j.jmb.2007.05.052; HOLMES B, 1983, DRUGS, V26, P212, DOI 10.2165/00003495-198326030-00003; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; HOUSTON MC, 1982, SOUTH MED J, V75, P713, DOI 10.1097/00007611-198206000-00022; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; LEVY R, 1989, LANCET, V2, P329; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Schafer S G, 1995, Ann N Y Acad Sci, V763, P659, DOI 10.1111/j.1749-6632.1995.tb32460.x; Sica Domenic A, 2007, J Clin Hypertens (Greenwich), V9, P399, DOI 10.1111/j.1524-6175.2007.07161.x; Soto C, 2000, LANCET, V355, P192, DOI 10.1016/S0140-6736(99)11419-3; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Tagliavini F, 1997, SCIENCE, V276, P1119, DOI 10.1126/science.276.5315.1119; Taguchi Y, 2003, AM J PATHOL, V163, P2585, DOI 10.1016/S0002-9440(10)63613-9; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; TELLING GC, 1994, P NATL ACAD SCI USA, V91, P9936, DOI 10.1073/pnas.91.21.9936; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Tribouillard Deborah, 2006, Biotechnology Journal, V1, P58, DOI 10.1002/biot.200500001; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vilette D, 2008, VET RES, V39, DOI 10.1051/vetres:2007049; Vilotte JL, 2001, J VIROL, V75, P5977, DOI 10.1128/JVI.75.13.5977-5984.2001; Wermuth CG, 2004, J MED CHEM, V47, P1303, DOI 10.1021/jm030480f; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	41	63	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1981	10.1371/journal.pone.0001981	http://dx.doi.org/10.1371/journal.pone.0001981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431471	Green Submitted, gold, Green Published			2022-12-27	WOS:000261558700006
J	Fung, SY; Yang, H; Chen, P				Fung, Shan Yu; Yang, Hong; Chen, P.			Sequence Effect of Self-Assembling Peptides on the Complexation and In Vitro Delivery of the Hydrophobic Anticancer Drug Ellipticine	PLOS ONE			English	Article								A special class of self-assembling peptides has been found to be capable of stabilizing the hydrophobic anticancer agent ellipticine in aqueous solution. Here we study the effect of peptide sequence on the complex formation and its anticancer activity in vitro. Three peptides, EAK16-II, EAK16-IV and EFK16-II, were selected to have either a different charge distribution (EAK16-II vs. EAK16-IV) or a varying hydrophobicity (EAK16-II vs. EFK16-II). Results on their complexation with ellipticine revealed that EAK16-II and EAK16-IV were able to stabilize protonated ellipticine or ellipticine microcrystals depending on the peptide concentration; EFK16-II could stabilize neutral ellipticine molecules and ellipticine microcrystals. These different molecular states of ellipticine were expected to affect ellipticine delivery. The anticancer activity of these complexes was tested against two cancer cell lines: A549 and MCF-7, and related to the cell viability. The viability results showed that the complexes with protonated ellipticine were effective in eradicating both cancer cells (viability<0.05), but their dilutions in water were not stable, leading to a fast decrease in their toxicity. In contrast, the complexes formulated with EFK16-II were relatively stable upon dilution, but their original toxicity was relatively low compared to that with protonated ellipticine. Overall, the charge distribution of the peptides seemed not to affect the complex formation and its therapeutic efficacy in vitro; however, the increase in hydrophobicity of the peptides significantly altered the state of stabilized ellipticine and increased the stability of the complexes. This work provides essential information for peptide sequence design in the development of self-assembling peptide-based delivery of hydrophobic anticancer drugs.	[Fung, Shan Yu; Yang, Hong; Chen, P.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Chen, P (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.	p4chen@cape.uwaterloo.ca	Fung, Shan-Yu/E-3477-2014; Yang, Hong/AAZ-1061-2020; Yang, Hong/E-3478-2014	Fung, Shan-Yu/0000-0002-4547-8740; Yang, Hong/0000-0002-6707-8481	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); Canada Research Chairs (CRC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canada Research Chairs (CRC)(Canada Research Chairs)	Support for this research has been provided by the Natural Sciences and Engineering Research Council of Canada (NSERC), Canada Foundation for Innovation (CFI) and the Canada Research Chairs (CRC) Program for one of the coauthors (PC).	Aggeli Amalia, 1999, Molecular Medicine Today, V5, P512, DOI 10.1016/S1357-4310(99)01610-X; Biswas ME, 2005, J COLLOID INTERF SCI, V286, P14, DOI 10.1016/j.jcis.2005.01.011; Bokhari MA, 2005, BIOMATERIALS, V26, P5198, DOI 10.1016/j.biomaterials.2005.01.040; Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80; Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103; Eastoe J, 2000, ADV COLLOID INTERFAC, V85, P103, DOI 10.1016/S0001-8686(99)00017-2; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Ellis-Behnke RG, 2006, NANOMED-NANOTECHNOL, V2, P207, DOI 10.1016/j.nano.2006.08.001; Fung SY, 2007, COLLOID SURFACE B, V55, P200, DOI 10.1016/j.colsurfb.2006.12.002; Fung SY, 2006, J PHYS CHEM A, V110, P11446, DOI 10.1021/jp062778y; FUNG SY, 2005, HDB NANOSTRUCTURED B, P1; FUNG SY, 2008, ACS NANO UNPUB; Garbett Nichola C., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P149, DOI 10.2174/1568011043482070; Gu FX, 2007, NANO TODAY, V2, P14, DOI 10.1016/S1748-0132(07)70083-X; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374; Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONAHA.106.639831; Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878; Jun S, 2004, BIOPHYS J, V87, P1249, DOI 10.1529/biophysj.103.038166; Keyes-Baig C, 2004, J AM CHEM SOC, V126, P7522, DOI 10.1021/ja0381297; Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lindgren M, 2005, BIOPHYS J, V88, P4200, DOI 10.1529/biophysj.104.049700; Liu JB, 2004, J PHARM SCI-US, V93, P132, DOI 10.1002/jps.10533; Lundberg P, 2003, J MOL RECOGNIT, V16, P227, DOI 10.1002/jmr.630; Nagai Y, 2006, J CONTROL RELEASE, V115, P18, DOI 10.1016/j.jconrel.2006.06.031; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Schwartz JJ, 2000, CURR OPIN MOL THER, V2, P162; Segers VF, 2007, CIRCULATION, V116, P69; SLAVIK J, 1982, BIOCHIM BIOPHYS ACTA, V694, P1, DOI 10.1016/0304-4157(82)90012-0; Temsamani J, 2004, DRUG DISCOV TODAY, V9, P1012, DOI 10.1016/S1359-6446(04)03279-9; Torrent J, 2004, BIOCHEMISTRY-US, V43, P7162, DOI 10.1021/bi049939d; Yang H, 2006, LANGMUIR, V22, P8553, DOI 10.1021/la061238p; Yang H, 2007, J AM CHEM SOC, V129, P12200, DOI 10.1021/ja073168u; ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	40	44	47	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1956	10.1371/journal.pone.0001956	http://dx.doi.org/10.1371/journal.pone.0001956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398476	gold, Green Submitted, Green Published			2022-12-27	WOS:000260795500027
J	Beck, RMD; Godthelp, H; Weisbecker, V; Archer, M; Hand, SJ				Beck, Robin M. D.; Godthelp, Henk; Weisbecker, Vera; Archer, Michael; Hand, Suzanne J.			Australia's Oldest Marsupial Fossils and their Biogeographical Implications	PLOS ONE			English	Article							PLACENTAL MAMMALS; PHYLOGENETIC IMPLICATIONS; CLADISTIC-ANALYSIS; PETROSAL BONES; LATE PALEOCENE; SEQUENCES; METATHERIANS; ITABORAI; FEATURES; BOLIVIA	Background: We describe new cranial and post-cranial marsupial fossils from the early Eocene Tingamarra Local Fauna in Australia and refer them to Djarthia murgonensis, which was previously known only from fragmentary dental remains. Methodology/Principal Findings: The new material indicates that Djarthia is a member of Australidelphia, a pan-Gondwanan clade comprising all extant Australian marsupials together with the South American microbiotheres. Djarthia is therefore the oldest known crown-group marsupial anywhere in the world that is represented by dental, cranial and post-cranial remains, and the oldest known Australian marsupial by 30 million years. It is also the most plesiomorphic known australidelphian, and phylogenetic analyses place it outside all other Australian marsupials. Conclusions/Significance: As the most plesiomorphic and oldest unequivocal australidelphian, Djarthia may approximate the ancestral morphotype of the Australian marsupial radiation and suggests that the South American microbiotheres may be the result of back-dispersal from eastern Gondwana, which is the reverse of prevailing hypotheses.	[Beck, Robin M. D.; Godthelp, Henk; Weisbecker, Vera; Archer, Michael; Hand, Suzanne J.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Beck, RMD (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	robin.beck@student.unsw.edu.au	Weisbecker, Vera/P-7088-2015; Weisbecker, Vera/AAC-4374-2022; Hand, Suzanne J/C-3853-2008	Weisbecker, Vera/0000-0003-2370-4046; Weisbecker, Vera/0000-0003-2370-4046; Hand, Suzanne/0000-0002-4940-3391; Beck, Robin/0000-0002-7050-7072; Archer, Michael/0000-0002-0304-4039	Leverhulme Trust [SAS/30110]; Australian Research Council; Queensland Parks and Wildlife Service; University of New South Wales; Queensland Museum; Australian Museum; UNSW [CREATE scholarship]	Leverhulme Trust(Leverhulme Trust); Australian Research Council(Australian Research Council); Queensland Parks and Wildlife Service; University of New South Wales; Queensland Museum; Australian Museum; UNSW	This work was supported by the Leverhulme Trust (Study Abroad Studentship SAS/30110 to R. Beck), the Australian Research Council, Queensland Parks and Wildlife Service, the University of New South Wales, the Queensland Museum, the Australian Museum, and Phil Creaser and the CREATE fund at UNSW (CREATE scholarship to R. Beck).	Amrine-Madsen H, 2003, MOL PHYLOGENET EVOL, V28, P186, DOI 10.1016/S1055-7903(03)00122-2; Archer Michael, 1999, Australian Mammalogy, V21, P1; Archer Michael, 1993, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V3, P193; Beck RMD, 2008, J MAMMAL, V89, P175, DOI 10.1644/06-MAMM-A-437.1; Boles Walter E., 1999, Records of the Western Australian Museum Supplement, V57, P229; Couto C. de P., 1952, American Museum Novitates, VNo. 1567, P1; de Muizon C, 1999, GEOBIOS-LYON, V32, P483; Drummond AJ, 2007, ROUGH GUIDE BEAST 1; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ekdale EG, 2004, ACTA PALAEONTOL POL, V49, P161; GODTHELP H, 1992, NATURE, V356, P514, DOI 10.1038/356514a0; Godthelp Henk, 1999, Journal of Mammalian Evolution, V6, P289, DOI 10.1023/A:1020517808869; Goin Francisco J., 1999, Journal of Mammalian Evolution, V6, P335, DOI 10.1023/A:1027357927460; HAND S, 1994, J VERTEBR PALEONTOL, V14, P375, DOI 10.1080/02724634.1994.10011565; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kitazoe Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000384; Ladeveze S, 2004, J VERTEBR PALEONTOL, V24, P202, DOI 10.1671/16; Ladeveze S, 2007, PALAEONTOLOGY, V50, P1123, DOI 10.1111/j.1475-4983.2007.00703.x; Ladeveze S, 2007, ZOOL J LINN SOC-LOND, V150, P85, DOI 10.1111/j.1096-3642.2007.00282.x; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; MARSHALL LG, 1988, NATL GEOGR RES, V4, P23; McKenna MC, 1997, CLASSIFICATION MAMMA; Nylander J. A. A., 2004, MRMODELTEST V2; Phillips MJ, 2008, MOL PHYLOGENET EVOL, V46, P594, DOI 10.1016/j.ympev.2007.09.008; Phillips MJ, 2006, SYST BIOL, V55, P122, DOI 10.1080/10635150500481614; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rougier GW, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)507[1:NJMFPA]2.0.CO;2; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; Salisbury SW, 1996, ALCHERINGA, V20, P179, DOI 10.1080/03115519608619189; Sanchez-Villagra M, 2007, BIOL LETTERS, V3, P318, DOI 10.1098/rsbl.2007.0090; Sanchez-Villagra MR, 2002, J ZOOL SYST EVOL RES, V40, P26, DOI 10.1046/j.1439-0469.2002.00173.x; SANCHEZVILLAGRA MR, 1998, THESIS DUKE U DURHAM; Scanlon John D., 2005, Memoirs of the Queensland Museum, V51, P215; SEGALL W, 1969, ACTA ANAT, V72, P489; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Szalay F.S., 1982, P621; Szalay F. S., 1994, EVOLUTIONARY HIST MA; Szalay Frederick S., 2001, Geodiversitas, V23, P139; van Rheede T, 2006, MOL BIOL EVOL, V23, P587, DOI 10.1093/molbev/msj064; Voss RS, 2003, B AM MUS NAT HIST, P1; Wible JR, 2007, NATURE, V447, P1003, DOI 10.1038/nature05854; Wible J.R., 1990, Journal of Vertebrate Paleontology, V10, P183; Wible John R., 2001, American Museum Novitates, V3322, P1, DOI 10.1206/0003-0082(2001)322<0001:EEERAP>2.0.CO;2; Woodburne Michael O., 1996, Journal of Mammalian Evolution, V3, P121, DOI 10.1007/BF01454359; Worthy TH, 2006, P NATL ACAD SCI USA, V103, P19419, DOI 10.1073/pnas.0605684103; Wroe S, 2000, J MAMMAL, V81, P1008, DOI 10.1644/1545-1542(2000)081<1008:CAODMP>2.0.CO;2	48	80	85	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1858	10.1371/journal.pone.0001858	http://dx.doi.org/10.1371/journal.pone.0001858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365013	Green Submitted, Green Published, gold			2022-12-27	WOS:000260762400019
J	Vomel, M; Wegener, C				Voemel, Matthias; Wegener, Christian			Neuroarchitecture of Aminergic Systems in the Larval Ventral Ganglion of Drosophila melanogaster	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CRUSTACEAN CARDIOACTIVE PEPTIDE; SEROTONIN-CONTAINING NEURONS; TARGETED GENE-EXPRESSION; TYROSINE-HYDROXYLASE; FRUIT-FLY; DOPA DECARBOXYLASE; LOCOMOTOR-ACTIVITY; MUSHROOM BODIES; IMMUNOCYTOCHEMICAL LOCALIZATION	Biogenic amines are important signaling molecules in the central nervous system of both vertebrates and invertebrates. In the fruit fly Drosophila melanogaster, biogenic amines take part in the regulation of various vital physiological processes such as feeding, learning/memory, locomotion, sexual behavior, and sleep/arousal. Consequently, several morphological studies have analyzed the distribution of aminergic neurons in the CNS. Previous descriptions, however, did not determine the exact spatial location of aminergic neurite arborizations within the neuropil. The release sites and pre-/postsynaptic compartments of aminergic neurons also remained largely unidentified. We here used gal4-driven marker gene expression and immunocytochemistry to map presumed serotonergic (5-HT), dopaminergic, and tyraminergic/octopaminergic neurons in the thoracic and abdominal neuromeres of the Drosophila larval ventral ganglion relying on Fasciclin2-immunoreactive tracts as three-dimensional landmarks. With tyrosine hydroxylase-(TH) or tyrosine decarboxylase 2 (TDC2)-specific gal4-drivers, we also analyzed the distribution of ectopically expressed neuronal compartment markers in presumptive dopaminergic TH and tyraminergic/octopaminergic TDC2 neurons, respectively. Our results suggest that thoracic and abdominal 5-HT and TH neurons are exclusively interneurons whereas most TDC2 neurons are efferent. 5-HT and TH neurons are ideally positioned to integrate sensory information and to modulate neuronal transmission within the ventral ganglion, while most TDC2 neurons appear to act peripherally. In contrast to 5-HT neurons, TH and TDC2 neurons each comprise morphologically different neuron subsets with separated in- and output compartments in specific neuropil regions. The three-dimensional mapping of aminergic neurons now facilitates the identification of neuronal network contacts and co-localized signaling molecules, as exemplified for DOPA decarboxylase-synthesizing neurons that co-express crustacean cardioactive peptide and myoinhibiting peptides.	[Voemel, Matthias; Wegener, Christian] Univ Marburg, Dept Biol, Emmy Noether Neuropeptide Grp, Marburg, Germany	Philipps University Marburg	Vomel, M (corresponding author), Univ Marburg, Dept Biol, Emmy Noether Neuropeptide Grp, Marburg, Germany.	wegener@staff.uni-marburg.de		Wegener, Christian/0000-0003-4481-3567	Deutsche Forschungsgemeinschaft [We 2652/2-2,3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG We 2652/2-2,3) to CW.	Adolfsen B, 2004, J CELL BIOL, V166, P249, DOI 10.1083/jcb.200312054; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Bader R, 2007, FLY, V1, P228, DOI 10.4161/fly.4749; Bate Michael, 1993, P1013; BIRMAN S, 1994, J BIOL CHEM, V269, P26559; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; Blumenthal EM, 2005, AM J PHYSIOL-CELL PH, V289, pC1261, DOI 10.1152/ajpcell.00026.2005; Blumenthal EM, 2003, AM J PHYSIOL-CELL PH, V284, pC718, DOI 10.1152/ajpcell.00359.2002; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRAUNIG P, 1988, J COMP PHYSIOL A, V163, P835, DOI 10.1007/BF00604060; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; BUDNIK V, 1987, J NEUROGENET, V4, P309, DOI 10.3109/01677068709102351; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Carr CM, 2007, EMBO REP, V8, P834, DOI 10.1038/sj.embor.7401051; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; CLARK WC, 1978, MOL GEN GENET, V162, P287, DOI 10.1007/BF00268854; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Coleman CM, 2004, INVERTEBR NEUROSCI, V5, P85, DOI 10.1007/s10158-004-0031-y; Coleman CM, 2005, ARCH INSECT BIOCHEM, V59, P12, DOI 10.1002/arch.20050; Cooper RL, 1999, COMP BIOCHEM PHYS B, V122, P199, DOI 10.1016/S0305-0491(98)10160-8; Dasari S, 2006, J COMP PHYSIOL B, V176, P349, DOI 10.1007/s00360-005-0058-3; Davis MM, 2007, DEVELOPMENT, V134, P4395, DOI 10.1242/dev.009902; DIRCKSEN H, 1988, CELL TISSUE RES, V254, P347; Draper I, 2007, DEV NEUROBIOL, V67, P378, DOI 10.1002/dneu.20355; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Ewer J, 2005, HORM BEHAV, V48, P418, DOI 10.1016/j.yhbeh.2005.05.018; Ewer J, 1996, J COMP NEUROL, V370, P330; Farooqui T, 2007, NEUROCHEM RES, V32, P1511, DOI 10.1007/s11064-007-9344-7; Fox LE, 2006, J NEUROSCI, V26, P1486, DOI 10.1523/JNEUROSCI.4749-05.2006; Friggi-Grelin F, 2003, GENESIS, V35, P260, DOI 10.1002/gene.1082; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Greer CL, 2005, J NEUROBIOL, V64, P239, DOI 10.1002/neu.20146; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Hamasaka Y, 2005, J NEUROBIOL, V65, P225, DOI 10.1002/neu.20184; Han KA, 1998, J NEUROSCI, V18, P3650; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; Hardie SL, 2007, DEV NEUROBIOL, V67, P1396, DOI 10.1002/dneu.20459; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Hiesinger PR, 2001, J COMP NEUROL, V429, P277, DOI 10.1002/1096-9861(20000108)429:2<277::AID-CNE8>3.0.CO;2-8; Hodgetts RB, 2006, ANNU REV ENTOMOL, V51, P259, DOI 10.1146/annurev.ento.51.110104.151143; Hoffman BJ, 1998, FRONT NEUROENDOCRIN, V19, P187, DOI 10.1006/frne.1998.0168; Ito K, 1998, LEARN MEMORY, V5, P52; Iyengar BG, 2006, J COMP NEUROL, V499, P583, DOI 10.1002/cne.21133; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; KONRAD KD, 1987, DEV BIOL, V122, P172, DOI 10.1016/0012-1606(87)90343-5; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Kutsukake M, 2000, GENE, V245, P31, DOI 10.1016/S0378-1119(99)00569-7; Landgraf M, 2003, DEV BIOL, V260, P207, DOI 10.1016/S0012-1606(03)00215-X; Landgraf M, 2006, SEMIN CELL DEV BIOL, V17, P3, DOI 10.1016/j.semcdb.2005.11.007; Langley K, 1997, NEUROCHEM INT, V31, P739, DOI 10.1016/S0197-0186(97)00040-5; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Lohr R, 2002, J NEUROSCI, V22, P10357; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Meldolesi J, 2004, TRENDS CELL BIOL, V14, P13, DOI 10.1016/j.tcb.2003.11.006; Meng JH, 2007, J CELL SCI, V120, P2864, DOI 10.1242/jcs.012211; Middleton CA, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-17; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Monastirioti M, 2003, DEV BIOL, V264, P38, DOI 10.1016/j.ydbio.2003.07.019; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Mustard JA, 2005, ARCH INSECT BIOCHEM, V59, P103, DOI 10.1002/arch.20065; Nagaya Y, 2002, NEUROSCI LETT, V329, P324, DOI 10.1016/S0304-3940(02)00596-7; NASSEL DR, 1992, CELL TISSUE RES, V267, P147, DOI 10.1007/BF00318701; Nassel DR, 1996, PROG NEUROBIOL, V48, P325, DOI 10.1016/0301-0082(95)00048-8; Nassel DR, 1996, J NEUROSCI METH, V69, P3, DOI 10.1016/S0165-0270(96)00016-7; Neckameyer WS, 2007, GENES BRAIN BEHAV, V6, P756, DOI 10.1111/j.1601-183X.2007.00307.x; NECKAMEYER WS, 1993, J NEUROGENET, V8, P189, DOI 10.3109/01677069309083448; Neckameyer WS, 2005, STRESS, V8, P117, DOI 10.1080/10253890500147381; Nichols CD, 2007, DEV NEUROBIOL, V67, P752, DOI 10.1002/dneu.20370; NIRENBERG MJ, 1995, P NATL ACAD SCI USA, V92, P8773, DOI 10.1073/pnas.92.19.8773; Nishikawa K, 1999, BRAIN RES, V837, P67, DOI 10.1016/S0006-8993(99)01676-5; O'Donnell MJ, 2006, ARCH INSECT BIOCHEM, V63, P123, DOI 10.1002/arch.20148; Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015; Park JH, 2003, DEVELOPMENT, V130, P2645, DOI 10.1242/dev.00503; Pendleton RG, 2005, PHARMACOL BIOCHEM BE, V81, P849, DOI 10.1016/j.pbb.2005.06.008; Pendleton RG, 2002, BEHAV GENET, V32, P89, DOI 10.1023/A:1015279221600; Pfluger HJ, 2005, ARTHROPOD STRUCT DEV, V34, P379, DOI 10.1016/j.asd.2005.04.004; Predel R, 2001, PEPTIDES, V22, P199, DOI 10.1016/S0196-9781(00)00383-1; Raghu SV, 2007, J COMP NEUROL, V502, P598, DOI 10.1002/cne.21319; Rauschenbach IY, 2007, ARCH INSECT BIOCHEM, V65, P95, DOI 10.1002/arch.20183; Roeder T, 2003, ARCH INSECT BIOCHEM, V54, P1, DOI 10.1002/arch.10102; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Santos JG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000695; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; Schrader S, 2000, J COMP NEUROL, V425, P34; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Soller M, 2006, CURR BIOL, V16, P1771, DOI 10.1016/j.cub.2006.07.055; SPORHASEEICHMANN U, 1992, CELL TISSUE RES, V268, P287, DOI 10.1007/BF00318798; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; STEVENSON PA, 1992, J COMP NEUROL, V315, P382, DOI 10.1002/cne.903150403; STEVENSON PA, 1995, COMP BIOCHEM PHYS A, V110, P203, DOI 10.1016/0300-9629(94)00152-J; SUGAMORI KS, 1995, FEBS LETT, V362, P131, DOI 10.1016/0014-5793(95)00224-W; Sykes PA, 2005, DEV BIOL, V286, P207, DOI 10.1016/j.ydbio.2005.07.025; Tsuboi T, 2004, J BIOL CHEM, V279, P47115, DOI 10.1074/jbc.M408179200; VALLES AM, 1986, J NEUROSCI, V6, P1482; VALLES AM, 1988, J COMP NEUROL, V268, P414, DOI 10.1002/cne.902680310; Vie A, 1999, J BIOL CHEM, V274, P16788, DOI 10.1074/jbc.274.24.16788; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Ye YZ, 2004, EUR J NEUROSCI, V20, P1001, DOI 10.1111/j.1460-9568.2004.03575.x; Yoshihara M, 2003, CURR OPIN NEUROBIOL, V13, P315, DOI 10.1016/S0959-4388(03)00063-1; Yoshihara M, 2002, NEURON, V36, P897, DOI 10.1016/S0896-6273(02)01065-6; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Zhang K, 2007, SCIENCE, V316, P1901, DOI 10.1126/science.1137357; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144; Zitnan D, 2007, GEN COMP ENDOCR, V153, P88, DOI 10.1016/j.ygcen.2007.04.002; Zlatic M, 2003, NEURON, V37, P41, DOI 10.1016/S0896-6273(02)01131-5	115	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1848	10.1371/journal.pone.0001848	http://dx.doi.org/10.1371/journal.pone.0001848			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365004	Green Submitted, Green Published, gold			2022-12-27	WOS:000260762400010
J	Lin, CY; Fang, J; Xu, XL; Zhao, T; Cheng, JA; Tu, JM; Ye, GY; Shen, ZC				Lin, Chaoyang; Fang, Jun; Xu, Xiaoli; Zhao, Te; Cheng, Jiaan; Tu, Juming; Ye, Gongyin; Shen, Zhicheng			A Built-In Strategy for Containment of Transgenic Plants: Creation of Selectively Terminable Transgenic Rice	PLOS ONE			English	Article							MATERNAL INHERITANCE; CYTOCHROMES P450; ORYZA-SATIVA; RED RICE; GENE; TRANSFORMATION; RESISTANCE; EXPRESSION; PROTEINS; FLOW	Plant transgenic technology has been widely utilized for engineering crops for trait improvements and for production of high value proteins such as pharmaceuticals. However, the unintended spreading of commercial transgenic crops by pollination and seed dispersal is a major concern for environmental and food safety. Simple and reliable containment strategies for transgenes are highly desirable. Here we report a novel method for creating selectively terminable transgenic rice. In this method, the gene(s) of interest is tagged with a RNA interference cassette, which specifically suppresses the expression of the bentazon detoxification enzyme CYP81A6 and thus renders transgenic rice to be sensitive to bentazon, a herbicide used for rice weed control. We generated transgenic rice plants by this method using a new glyphosate resistant 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) gene from Pesudomonas putida as the gene of interest, and demonstrated that these transgenic rice plants were highly sensitive to bentazon but tolerant to glyphosate, which is exactly the opposite of conventional rice. Field trial of these transgenic rice plants further confirmed that they can be selectively killed at 100% by one spray of bentazon at a regular dose used for conventional rice weed control. Furthermore, we found that the terminable transgenic rice created in this study shows no difference in growth, development and yield compared to its non-transgenic control. Therefore, this method of creating transgenic rice constitutes a novel strategy of transgene containment, which appears simple, reliable and inexpensive for implementation.	[Lin, Chaoyang; Fang, Jun; Xu, Xiaoli; Zhao, Te; Cheng, Jiaan; Ye, Gongyin; Shen, Zhicheng] Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310027, Peoples R China; [Tu, Juming] Zhejiang Univ, Inst Crop Sci, Hangzhou, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang University	Shen, ZC (corresponding author), Zhejiang Univ, Inst Insect Sci, State Key Lab Rice Biol, Hangzhou 310027, Peoples R China.	zcshen@zju.edu.cn			National Basic Research and Development Program of China [2007CB109202]; Department of Science and Technology of Zhejiang Province [2006C12092]; IRT Program of the Ministry of Education of China [IRT 0535]	National Basic Research and Development Program of China(National Basic Research Program of China); Department of Science and Technology of Zhejiang Province; IRT Program of the Ministry of Education of China(Ministry of Education, China)	This study was supported by the National Basic Research and Development Program of China (2007CB109202), the Department of Science and Technology of Zhejiang Province (2006C12092) and by the IRT Program of the Ministry of Education of China (IRT 0535).	CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Daniell H, 2002, NAT BIOTECHNOL, V20, P581, DOI 10.1038/nbt0602-581; Daniell H, 2001, TRENDS PLANT SCI, V6, P219, DOI 10.1016/S1360-1385(01)01922-7; Daniell H, 2007, P NATL ACAD SCI USA, V104, P6879, DOI 10.1073/pnas.0702219104; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Forthoffer N, 2001, EUR J DRUG METAB PH, V26, P9, DOI 10.1007/BF03190370; Fox JL, 2003, NAT BIOTECHNOL, V21, P3, DOI 10.1038/nbt0103-3b; Gealy DR, 2003, WEED TECHNOL, V17, P627, DOI 10.1614/WT02-100; Gealy DR, 2002, WEED SCI, V50, P333, DOI 10.1614/0043-1745(2002)050[0333:IORRRA]2.0.CO;2; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hood EE, 1999, ADV EXP MED BIOL, V464, P127; Khan MS, 1999, NAT BIOTECHNOL, V17, P910, DOI 10.1038/12907; Kumar S, 2004, PLANT MOL BIOL, V56, P203, DOI 10.1007/s11103-004-2907-y; Kumar S, 2004, PLANT PHYSIOL, V136, P2843, DOI 10.1104/pp.104.045187; Kuvshinov V, 2004, PLANT SCI, V167, P173, DOI 10.1016/j.plantsci.2004.03.018; Kuvshinov V, 2001, PLANT SCI, V160, P517, DOI 10.1016/S0168-9452(00)00414-3; Lamb SB, 1998, FEBS LETT, V431, P343, DOI 10.1016/S0014-5793(98)00771-6; Larrick JW, 2001, CURR OPIN BIOTECH, V12, P411, DOI 10.1016/S0958-1669(00)00236-6; Lee D, 2006, TRENDS BIOTECHNOL, V24, P109, DOI 10.1016/j.tibtech.2006.01.006; MARIANI C, 1990, NATURE, V347, P737, DOI 10.1038/347737a0; MEDGYESY P, 1986, MOL GEN GENET, V204, P195, DOI 10.1007/BF00425497; Morant M, 2003, CURR OPIN BIOTECH, V14, P151, DOI 10.1016/S0958-1669(03)00024-7; Pan G, 2006, PLANT MOL BIOL, V61, P933, DOI 10.1007/s11103-006-0058-z; Pedroncelli R, 2007, NATURE, V445, P132; Siminszky B, 1999, P NATL ACAD SCI USA, V96, P1750, DOI 10.1073/pnas.96.4.1750; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Werck-Reichhart D, 2000, TRENDS PLANT SCI, V5, P116, DOI 10.1016/S1360-1385(00)01567-3; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61	28	40	51	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1818	10.1371/journal.pone.0001818	http://dx.doi.org/10.1371/journal.pone.0001818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350155	gold, Green Published, Green Submitted			2022-12-27	WOS:000260762300021
J	Zhao, Z; Taylor, WD; Styner, M; Steffens, DC; Krishnan, KRR; MacFall, JR				Zhao, Zheen; Taylor, Warren D.; Styner, Martin; Steffens, David C.; Krishnan, K. Ranga R.; MacFall, James R.			Hippocampus Shape Analysis and Late-Life Depression	PLOS ONE			English	Article							GERIATRIC DEPRESSION; ALZHEIMERS-DISEASE; RISK-FACTOR; VOLUME; DEMENTIA; HISTORY; ABNORMALITIES; AMYGDALA; ILLNESS; ONSET	Major depression in the elderly is associated with brain structural changes and vascular lesions. Changes in the subcortical regions of the limbic system have also been noted. Studies examining hippocampus volumetric differences in depression have shown variable results, possibly due to any volume differences being secondary to local shape changes rather than differences in the overall volume. Shape analysis offers the potential to detect such changes. The present study applied spherical harmonic (SPHARM) shape analysis to the left and right hippocampi of 61 elderly subjects with major depression and 43 non-depressed elderly subjects. Statistical models controlling for age, sex, and total cerebral volume showed a significant reduction in depressed compared with control subjects in the left hippocampus (F-1,F-103 = 5.26; p = 0.0240) but not right hippocampus volume (F-1,F-103 = 0.41; p = 0.5213). Shape analysis showed significant differences in the mid-body of the left (but not the right) hippocampus between depressed and controls. When the depressed group was dichotomized into those whose depression was remitted at time of imaging and those who were unremitted, the shape comparison showed remitted subjects to be indistinguishable from controls (both sides) while the unremitted subjects differed in the midbody and the lateral side near the head. Hippocampal volume showed no difference between controls and remitted subjects but nonremitted subjects had significantly smaller left hippocampal volumes with no significant group differences in the right hippocampus. These findings may provide support to other reports of neurogenic effects of antidepressants and their relation to successful treatment for depressive symptoms.	[Zhao, Zheen; Taylor, Warren D.; MacFall, James R.] Duke Univ, Med Ctr, Neuropsychiat Imaging Res Lab, Durham, NC 27706 USA; [MacFall, James R.] Duke Univ, Dept Biomed Engn, Durham, NC USA; [MacFall, James R.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC USA; [Zhao, Zheen; Taylor, Warren D.; Steffens, David C.; Krishnan, K. Ranga R.] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC USA; [Styner, Martin] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC USA; [Krishnan, K. Ranga R.] Duke NUS Grad Med Sch Singapore, Singapore, Singapore	Duke University; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; National University of Singapore	Zhao, Z (corresponding author), Duke Univ, Med Ctr, Neuropsychiat Imaging Res Lab, Durham, NC 27706 USA.	kurt.zhao@duke.edu	Styner, Martin/AAS-9949-2020; Taylor, Warren D/J-3687-2014	Styner, Martin/0000-0002-8747-5118; 	NIMH [K23 MH65939, RR-00030-S42, P50 MH60451, 5U24RR021382]; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382, M01RR000030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH065939, P50MH060451] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by NIMH grants K23 MH65939, RR-00030-S42, P50 MH60451 and 5U24RR021382 (Biomedical Informatics Research Network).	Ashtari M, 1999, PSYCHOL MED, V29, P629, DOI 10.1017/S0033291799008405; AXELSON DA, 1993, PSYCHIAT RES, V47, P163, DOI 10.1016/0165-1781(93)90046-J; Bell-McGinty S, 2002, AM J PSYCHIAT, V159, P1424, DOI 10.1176/appi.ajp.159.8.1424; Beyer JL, 2004, AM J GERIAT PSYCHIAT, V12, P613, DOI 10.1176/appi.ajgp.12.6.613; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Caetano SC, 2004, PSYCHIAT RES-NEUROIM, V132, P141, DOI 10.1016/j.psychresns.2004.08.002; Chen PJ, 1999, ARCH GEN PSYCHIAT, V56, P261, DOI 10.1001/archpsyc.56.3.261; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frodl T, 2002, AM J PSYCHIAT, V159, P1112, DOI 10.1176/appi.ajp.159.7.1112; Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753; Hawley CJ, 2002, J AFFECT DISORDERS, V72, P177, DOI 10.1016/S0165-0327(01)00451-7; Hickie I, 2005, BRIT J PSYCHIAT, V186, P197, DOI 10.1192/bjp.186.3.197; Hickie IB, 2007, J AFFECT DISORDERS, V98, P137, DOI 10.1016/j.jad.2006.07.010; Hsieh MH, 2002, INT J GERIATR PSYCH, V17, P519, DOI 10.1002/gps.611; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Janssen J, 2007, J NEUROL NEUROSUR PS, V78, P638, DOI 10.1136/jnnp.2006.098087; JORM AF, 1991, INT J EPIDEMIOL, V20, pS43, DOI 10.1093/ije/20.Supplement_2.S43; KRISHNAN KRR, 1993, J GERIATR PSYCH NEUR, V6, P39, DOI 10.1177/002383099300600107; KRISHNAN KRR, 1991, J NEUROPSYCH CLIN N, V3, P387; Lee JM, 2004, NEUROIMAGE, V22, P831, DOI 10.1016/j.neuroimage.2004.02.004; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; McHugh TL, 2007, CLIN NEUROPSYCHOL, V21, P130, DOI 10.1080/13854040601064534; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; O'Brien JT, 2004, AM J PSYCHIAT, V161, P2081, DOI 10.1176/appi.ajp.161.11.2081; Olin JT, 2002, AM J GERIAT PSYCHIAT, V10, P125; Pantel J, 1997, J AFFECT DISORDERS, V42, P69, DOI 10.1016/S0165-0327(96)00105-X; Posener JA, 2003, AM J PSYCHIAT, V160, P83, DOI 10.1176/appi.ajp.160.1.83; Rapp MA, 2006, ARCH GEN PSYCHIAT, V63, P161, DOI 10.1001/archpsyc.63.2.161; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Scher AI, 2007, NEUROIMAGE, V36, P8, DOI 10.1016/j.neuroimage.2006.12.036; Shah PJ, 1998, BRIT J PSYCHIAT, V172, P527, DOI 10.1192/bjp.172.6.527; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; SPECK CE, 1995, EPIDEMIOLOGY, V6, P366, DOI 10.1097/00001648-199507000-00006; Steffens David C, 2002, Psychopharmacol Bull, V36, P58; Steffens DC, 2000, BIOL PSYCHIAT, V48, P301, DOI 10.1016/S0006-3223(00)00829-5; Steffens DC, 2002, AM J GERIAT PSYCHIAT, V10, P62, DOI 10.1176/appi.ajgp.10.1.62; Styner M, 2003, MED IMAGE ANAL, V7, P207, DOI 10.1016/S1361-8415(02)00110-X; Styner M., 2006, INSIGHT J; Taki Y, 2005, J AFFECT DISORDERS, V88, P313, DOI 10.1016/j.jad.2005.08.003; Taylor WD, 2005, ARCH GEN PSYCHIAT, V62, P537, DOI 10.1001/archpsyc.62.5.537; Vakili K, 2000, BIOL PSYCHIAT, V47, P1087, DOI 10.1016/S0006-3223(99)00296-6; Vythilingam M, 2003, BIOL PSYCHIAT, V54, P744, DOI 10.1016/S0006-3223(02)01908-X; Wang L, 2003, NEUROIMAGE, V20, P667, DOI 10.1016/S1053-8119(03)00361-6; Wang L, 2001, NEUROIMAGE, V14, P531, DOI 10.1006/nimg.2001.0830; Wang L, 2007, IEEE T MED IMAGING, V26, P462, DOI 10.1109/TMI.2006.887380	46	68	73	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1837	10.1371/journal.pone.0001837	http://dx.doi.org/10.1371/journal.pone.0001837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370KY	18350172	Green Published, gold			2022-12-27	WOS:000260762300038
J	George, I; Cousillas, H; Richard, JP; Hausberger, M				George, Isabelle; Cousillas, Hugo; Richard, Jean-Pierre; Hausberger, Martine			A Potential Neural Substrate for Processing Functional Classes of Complex Acoustic Signals	PLOS ONE			English	Article							EUROPEAN STARLINGS; GENE-EXPRESSION; STURNUS-VULGARIS; CATEGORICAL PERCEPTION; COMMUNICATION SOUNDS; AUDITORY RESPONSES; CONSPECIFIC SONG; HUMAN SPEECH; ORGANIZATION; BIRDSONG	Categorization is essential to all cognitive processes, but identifying the neural substrates underlying categorization processes is a real challenge. Among animals that have been shown to be able of categorization, songbirds are particularly interesting because they provide researchers with clear examples of categories of acoustic signals allowing different levels of recognition, and they possess a system of specialized brain structures found only in birds that learn to sing: the song system. Moreover, an avian brain nucleus that is analogous to the mammalian secondary auditory cortex ( the caudo-medial nidopallium, or NCM) has recently emerged as a plausible site for sensory representation of birdsong, and appears as a well positioned brain region for categorization of songs. Hence, we tested responses in this non-primary, associative area to clear and distinct classes of songs with different functions and social values, and for a possible correspondence between these responses and the functional aspects of songs, in a highly social songbird species: the European starling. Our results clearly show differential neuronal responses to the ethologically defined classes of songs, both in the number of neurons responding, and in the response magnitude of these neurons. Most importantly, these differential responses corresponded to the functional classes of songs, with increasing activation from non-specific to species-specific and from species-specific to individual-specific sounds. These data therefore suggest a potential neural substrate for sorting natural communication signals into categories, and for individual vocal recognition of same-species members. Given the many parallels that exist between birdsong and speech, these results may contribute to a better understanding of the neural bases of speech.	[George, Isabelle; Cousillas, Hugo; Richard, Jean-Pierre; Hausberger, Martine] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	George, I (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	isabelle.george@univ-rennes1.fr	George, Isabelle/A-7770-2008	George, Isabelle/0000-0002-4842-4959	French Ministry of Research	French Ministry of Research(Ministry of Research, FranceEuropean Commission)	Funding for the research was provided by grants of the French Ministry of Research (to IG and MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRET-HAUSBERGER M, 1989, Bioacoustics, V2, P137; ADRETHAUSBERGER M, 1984, Z TIERPSYCHOL, V66, P309; ADRETHAUSBERGER M, 1982, BEHAV ECOL SOCIOBIOL, V11, P241, DOI 10.1007/BF00299300; ADRETHAUSBERGER M, 1984, IBIS, V126, P372, DOI 10.1111/j.1474-919X.1984.tb00258.x; ADRETHAUSBERGER M, 1990, ETHOLOGY, V84, P265; ADRETHAUSBERGER M, 1988, BEHAVIOUR, V107, P138, DOI 10.1163/156853988X00322; Amin N, 2004, J COMP PHYSIOL A, V190, P469, DOI 10.1007/s00359-004-0511-x; Ball GF, 1998, NEURON, V21, P271, DOI 10.1016/S0896-6273(00)80535-8; Bertin A, 2007, DEV PSYCHOBIOL, V49, P362, DOI 10.1002/dev.20223; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Bolhuis JJ, 2001, EUR J NEUROSCI, V13, P2165, DOI 10.1046/j.0953-816x.2001.01588.x; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; CHAIKEN M, 1993, ANIM BEHAV, V46, P1079, DOI 10.1006/anbe.1993.1298; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; Cousillas H, 2004, EUR J NEUROSCI, V19, P3343, DOI 10.1111/j.0953-816X.2004.03376.x; Cousillas H, 2006, NATURWISSENSCHAFTEN, V93, P588, DOI 10.1007/s00114-006-0148-4; DOOLING RJ, 1987, J COMP PSYCHOL, V101, P367, DOI 10.1037/0735-7036.101.4.367; Doupe AJ, 1997, J NEUROBIOL, V33, P694; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Duffy DL, 1999, BRAIN RES, V844, P78, DOI 10.1016/S0006-8993(99)01915-0; EENS M, 1989, ARDEA, V77, P75; Geissler DB, 2004, EUR J NEUROSCI, V19, P1027, DOI 10.1111/j.1460-9568.2004.03205.x; Gentner TQ, 2004, ANN NY ACAD SCI, V1016, P282, DOI 10.1196/annals.1298.008; Gentner TQ, 1998, ANIM BEHAV, V56, P579, DOI 10.1006/anbe.1998.0810; Gentner TQ, 2001, J NEUROBIOL, V46, P48, DOI 10.1002/1097-4695(200101)46:1<48::AID-NEU5>3.0.CO;2-3; Gentner TQ, 2000, J ACOUST SOC AM, V107, P3369, DOI 10.1121/1.429408; George I, 2005, NEUROSCIENCE, V136, P1, DOI 10.1016/j.neuroscience.2005.08.001; George I, 2005, BRAIN RES, V1047, P245, DOI 10.1016/j.brainres.2005.04.047; George I, 2003, J NEUROSCI METH, V125, P65, DOI 10.1016/S0165-0270(03)00025-6; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Hausberger M, 2000, BEHAV BRAIN RES, V114, P89, DOI 10.1016/S0166-4328(00)00191-1; HAUSBERGER M, 1991, BIRD BEHAV, V9, P81, DOI 10.3727/015613890791749127; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; HAUSBERGER M, 1981, BIOL BEHAV, V6, P79; Hausberger Martine, 1997, P128, DOI 10.1017/CBO9780511758843.008; Henry L., 1994, Bioacoustics, V5, P261; Henry L, 1998, REV ECOL-TERRE VIE, V53, P347; HERRNSTEIN RJ, 1985, PHILOS T ROY SOC B, V308, P129, DOI 10.1098/rstb.1985.0015; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Kuhl P. K., 1987, CATEGORICAL PERCEPTI, P355; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9645, DOI 10.1073/pnas.1733998100; Lewicki MS, 1996, J NEUROSCI, V16, P6987; LIBERMAN AM, 1957, J EXP PSYCHOL, V54, P358, DOI 10.1037/h0044417; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; Marler P, 2000, P NATL ACAD SCI USA, V97, P2965, DOI 10.1073/pnas.97.7.2965; MARLER P, 1970, AM SCI, V58, P669; MAY B, 1989, J ACOUST SOC AM, V85, P837, DOI 10.1121/1.397555; MCCASLAND JS, 1987, J NEUROSCI, V7, P23; MELLO C, 1995, J NEUROSCI, V15, P6919; Mello CV, 2002, J COMP PHYSIOL A, V188, P943, DOI 10.1007/s00359-002-0347-1; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; NELSON DA, 1989, SCIENCE, V244, P976, DOI 10.1126/science.2727689; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Park KHJ, 2002, BEHAV BRAIN RES, V136, P185, DOI 10.1016/S0166-4328(02)00129-8; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Poirier C, 2004, J COMP PSYCHOL, V118, P179, DOI 10.1037/0735-7036.118.2.179; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; ROITBLAT HL, 1992, ANNU REV PSYCHOL, V43, P671, DOI 10.1146/annurev.ps.43.020192.003323; Stripling R, 1997, J NEUROSCI, V17, P3883; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; Terleph TA, 2006, J NEUROBIOL, V66, P281, DOI 10.1002/neu.20219; Theunissen FE, 1998, J NEUROSCI, V18, P3786; Theunissen FE, 2006, CURR OPIN NEUROBIOL, V16, P400, DOI 10.1016/j.conb.2006.07.003; Vignal C, 2004, BEHAV BRAIN RES, V153, P241, DOI 10.1016/j.bbr.2003.12.006; Volman SF, 1996, J COMP PHYSIOL A, V178, P849; WHEELER BC, 1999, CRC METH NEUROSCI S, P61; ZEIGLER HP, 2004, ANN NY ACAD SCI, V1016, P786	72	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2203	10.1371/journal.pone.0002203	http://dx.doi.org/10.1371/journal.pone.0002203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493610	Green Published, gold, Green Submitted			2022-12-27	WOS:000262258700012
J	Kim, SC; McGowen, MR; Lubinsky, P; Barber, JC; Mort, ME; Santos-Guerra, A				Kim, Seung-Chul; McGowen, Michael R.; Lubinsky, Pesach; Barber, Janet C.; Mort, Mark E.; Santos-Guerra, Arnoldo			Timing and Tempo of Early and Successive Adaptive Radiations in Macaronesia	PLOS ONE			English	Article								The flora of Macaronesia, which encompasses five Atlantic archipelagos (Azores, Canaries, Madeira, Cape Verde, and Salvage), is exceptionally rich and diverse. Spectacular radiation of numerous endemic plant groups has made the Macaronesian islands an outstanding area for studies of evolution and speciation. Despite intensive investigation in the last 15 years, absolute age and rate of diversification are poorly known for the flora of Macaronesia. Here we report molecular divergence estimates and rates of diversification for five representative, putative rapid radiations of monophyletic endemic plant lineages across the core eudicot clade of flowering plants. Three discrete windows of colonization during the Miocene and early Pliocene are suggested for these lineages, all of which are inferred to have had a single colonization event followed by rapid radiation. Subsequent inter-archipelago dispersal events into Madeira and the Cape Verdes took place very recently during the late Pliocene and Pleistocene after initial diversification on the Canary Islands. The tempo of adaptive radiations differs among the groups, but is relatively rapid compared to continental and other island radiations. Our results demonstrate that opportunity for island colonization and successful radiation may have been constrained to discrete time periods of profound climatic and geological changes in northern African and the Mediterranean.	[Kim, Seung-Chul; Lubinsky, Pesach] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [McGowen, Michael R.] Univ Calif Riverside, Dept Biol, Riverside, CA USA; [Barber, Janet C.] St Louis Univ, Dept Biol, St Louis, MO USA; [Mort, Mark E.] Univ Kansas, Nat Hist Museum & Biodivers Res Ctr, Dept Ecol & Evolut Biol, Lawrence, KS USA; [Santos-Guerra, Arnoldo] Jardin Aclimatacion Orotava, Tenerife, Spain	University of California System; University of California Riverside; University of California System; University of California Riverside; Saint Louis University; University of Kansas	Kim, SC (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	sckim@ucr.edu	Kim, Seung-Chul/AAR-6157-2020	Kim, Seung-Chul/0000-0003-0559-6782	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	The National Science Foundation generously supported earlier molecular phylogenetic studies.	A Aldridge, 1979, PLANTS ISLANDS, P279; Allan GJ, 2004, MOL PHYLOGENET EVOL, V32, P123, DOI 10.1016/j.ympev.2003.11.018; Baldwin BG, 1998, P NATL ACAD SCI USA, V95, P9402, DOI 10.1073/pnas.95.16.9402; Barber JC, 2007, TAXON, V56, P74, DOI 10.2307/25065737; Bohle UR, 1996, P NATL ACAD SCI USA, V93, P11740, DOI 10.1073/pnas.93.21.11740; BORGEN L, 1984, PLANT BIOSYSTEMATICS, P477; Bramwell D., 1972, Taxonomy, phytogeography and evolution., P141; Bromham L, 2004, SYST BIOL, V53, P758, DOI 10.1080/10635150490522278; Carine MA, 2005, TAXON, V54, P895, DOI 10.2307/25065476; Carine MA, 2004, AM J BOT, V91, P1070, DOI 10.3732/ajb.91.7.1070; Carracedo J. C., 2002, GEOLOGY SPAIN, P439, DOI DOI 10.1144/GOSPP; Cronquist A., 1981, INTEGRATED SYSTEM CL; De Jong H, 1998, BIOL J LINN SOC, V65, P99, DOI 10.1006/bijl.1998.0239; Emerson BC, 2005, NATURE, V434, P1015, DOI 10.1038/nature03450; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; ERIKSSON O, 1992, EVOLUTION, V46, P258, DOI [10.2307/2409820, 10.1111/j.1558-5646.1992.tb02000.x]; Frahm JP, 2004, REV PALAEOBOT PALYNO, V129, P81, DOI 10.1016/j.revpalbo.2003.11.004; Francisco-Ortega J, 2002, AM J BOT, V89, P1984, DOI 10.3732/ajb.89.12.1984; Francisco-Ortega J, 2001, AM J BOT, V88, P161, DOI 10.2307/2657136; Francisco-Ortega J, 2000, AM J BOT, V87, P909, DOI 10.2307/2656988; Francisco-Ortega Javier, 1997, P407; FRANCISCOORTEGA J, 1995, AM J BOT, V82, P1321, DOI 10.2307/2446254; FranciscoOrtega J, 1996, P NATL ACAD SCI USA, V93, P4085, DOI 10.1073/pnas.93.9.4085; Fuertes-Aguilar J, 2002, SYST BOT, V27, P74; Garcia-Talavera F, 1995, REV ACAD CANARIA CIE, V7, P77; Geldmacher J, 2001, J VOLCANOL GEOTH RES, V111, P55, DOI 10.1016/S0377-0273(01)00220-7; Goertzen LR, 2002, SYST BOT, V27, P815; Good-Avila SV, 2006, P NATL ACAD SCI USA, V103, P9124, DOI 10.1073/pnas.0603312103; Graham A., 1996, COMPOSITAE SYSTEMATI, V1, P123; Helfgott DM, 2000, SYST BOT, V25, P82, DOI 10.2307/2666675; HSU KJ, 1977, NATURE, V267, P399, DOI 10.1038/267399a0; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; HULBERT RC, 1993, PALEOBIOLOGY, V19, P216, DOI 10.1017/S0094837300015888; Humphries CJ, 1979, PLANTS ISLANDS, P171; Jolivet L, 2006, SEDIMENT GEOL, V188, P9, DOI 10.1016/j.sedgeo.2006.02.004; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Kim SC, 1996, P NATL ACAD SCI USA, V93, P7743, DOI 10.1073/pnas.93.15.7743; Kim SC, 1999, PLANT SYST EVOL, V215, P101, DOI 10.1007/BF00984650; Kim SC, 2007, MOL PHYLOGENET EVOL, V44, P578, DOI 10.1016/j.ympev.2007.03.014; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Klak C, 2004, NATURE, V427, P63, DOI 10.1038/nature02243; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Lee C, 2005, AM J BOT, V92, P2072, DOI 10.3732/ajb.92.12.2072; Lledo MD, 2005, AM J BOT, V92, P1189, DOI 10.3732/ajb.92.7.1189; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Magallon S, 1999, ANN MO BOT GARD, V86, P297, DOI 10.2307/2666180; McCune Amy R., 1997, P585; Molero J, 2002, PLANT SYST EVOL, V231, P109, DOI 10.1007/s006060200014; Moore MJ, 2006, MOL PHYLOGENET EVOL, V39, P668, DOI 10.1016/j.ympev.2006.01.020; Mort ME, 2002, SYST BOT, V27, P271; Mort ME, 2001, AM J BOT, V88, P76, DOI 10.2307/2657129; Percy DM, 2002, AM J BOT, V89, P854, DOI 10.3732/ajb.89.5.854; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; ROSENZWEIG ML, 1992, EVOL ECOL, V6, P90, DOI 10.1007/BF02285336; SANTOSGUERRA A, 1999, ECOLOGIA CULTURA CAN, P107; Schuster M, 2006, SCIENCE, V311, P821, DOI 10.1126/science.1120161; Silvertown J, 2004, J ECOL, V92, P168, DOI 10.1111/j.1365-2745.2004.00853.x; STANLEY ES, 1979, MACROEVOLUTION; Sunding P., 1973, MONOGR BIOL CANARIEN, V4, P112; Sunding P., 1979, PLANTS ISLANDS, P13; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Trusty JL, 2005, MOL ECOL, V14, P1177, DOI 10.1111/j.1365-294X.2005.02487.x; Vanderpoorten A, 2007, AM J BOT, V94, P625, DOI 10.3732/ajb.94.4.625; Vargas P, 1999, AM J BOT, V86, P724, DOI 10.2307/2656582; Vargas P, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P297, DOI 10.1007/1-4020-4904-8_11; Veith M, 2004, J BIOGEOGR, V31, P159, DOI 10.1111/j.1365-2699.2004.00957.x; Vrba ES, 1987, EVOL ECOL, V1, P283, DOI 10.1007/BF02071554; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	71	110	115	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2139	10.1371/journal.pone.0002139	http://dx.doi.org/10.1371/journal.pone.0002139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478126	Green Published, gold			2022-12-27	WOS:000262172800004
J	Bren, GD; Whitman, J; Cummins, N; Shepard, B; Rizza, SA; Trushin, SA; Badley, AD				Bren, Gary D.; Whitman, Joe; Cummins, Nathan; Shepard, Brett; Rizza, Stacey A.; Trushin, Sergey A.; Badley, Andrew D.			Infected Cell Killing by HIV-1 Protease Promotes NF-kappa B Dependent HIV-1 Replication	PLOS ONE			English	Article								Acute HIV-1 infection of CD4 T cells often results in apoptotic death of infected cells, yet it is unclear what evolutionary advantage this offers to HIV-1. Given the independent observations that acute T cell HIV-1 infection results in (1) NF-kappa B activation, (2) caspase 8 dependent apoptosis, and that (3) caspase 8 directly activates NF-kappa B, we questioned whether these three events might be interrelated. We first show that HIV-1 infected T cell apoptosis, NF-kappa B activation, and caspase 8 cleavage by HIV-1 protease are coincident. Next we show that HIV-1 protease not only cleaves procaspase 8, producing Casp8p41, but also independently stimulates NF-kappa B activity. Finally, we demonstrate that the HIV protease cleavage of caspase 8 is necessary for optimal NF-kappa B activation and that the HIV-1 protease specific cleavage fragment Casp8p41 is sufficient to stimulate HIV-1 replication through NF-kappa B dependent HIV-LTR activation both in vitro as well as in cells from HIV infected donors. Consequently, the molecular events which promote death of HIV-1 infected T cells function dually to promote HIV-1 replication, thereby favoring the propagation and survival of HIV-1.	[Bren, Gary D.; Whitman, Joe; Cummins, Nathan; Shepard, Brett; Rizza, Stacey A.; Trushin, Sergey A.; Badley, Andrew D.] Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA; [Rizza, Stacey A.; Badley, Andrew D.] Mayo Clin, Program Translat Immunovirol & Biodefense, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Bren, GD (corresponding author), Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA.	badley.andrew@mayo.edu	badley, andrew d/O-9022-2014	Badley, Andrew/0000-0001-7796-7680	National Institutes of Health [R01 AI62261, R01 AI40384, R21DK 77575-1]; Burroughs Wellcome Fund's Clinical Scientist Award in Translational Research [1005160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062261, R01AI040384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund's Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Andrew Badley is supported by grants from the National Institutes of Health (R01 AI62261 and R01 AI40384), and the Burroughs Wellcome Fund's Clinical Scientist Award in Translational Research (ID#1005160). Dr. Stacey Rizza is supported by a grant from the National Institute of Health (R21DK 77575-1).	Bidere N, 2006, CURR BIOL, V16, P1666, DOI 10.1016/j.cub.2006.06.062; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Gil J, 2004, PROG MOL SUBCELL BIO, V36, P117; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Lemmers B, 2007, J BIOL CHEM, V282, P7416, DOI 10.1074/jbc.M606721200; MCELHINNY JA, 1995, J VIROL, V69, P1500, DOI 10.1128/JVI.69.3.1500-1509.1995; Nie Z, 2002, CELL DEATH DIFFER, V9, P1172, DOI 10.1038/sj.cdd.4401094; NIE Z, 2006, CELL DEATH HIV INFEC, P421; Nie Z, 2007, J VIROL, V81, P6947, DOI 10.1128/JVI.02798-06; Nie Zilin, 2008, Open Virol J, V2, P1, DOI 10.2174/1874357900802010001; PEREZ VL, 1991, J IMMUNOL, V147, P3145; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134	16	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2112	10.1371/journal.pone.0002112	http://dx.doi.org/10.1371/journal.pone.0002112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461165	gold, Green Submitted, Green Published			2022-12-27	WOS:000261642400034
J	Cauchi, S; Meyre, D; Durand, E; Proenca, C; Marre, M; Hadjadj, S; Choquet, H; De Graeve, F; Gaget, S; Allegaert, F; Delplanque, J; Permutt, MA; Wasson, J; Blech, I; Charpentier, G; Balkau, B; Vergnaud, AC; Czernichow, S; Patsch, W; Chikri, M; Glaser, B; Sladek, R; Froguel, P				Cauchi, Stephane; Meyre, David; Durand, Emmanuelle; Proenca, Christine; Marre, Michel; Hadjadj, Samy; Choquet, Helene; De Graeve, Franck; Gaget, Stefan; Allegaert, Frederic; Delplanque, Jerome; Permutt, Marshall Alan; Wasson, Jon; Blech, Ilana; Charpentier, Guillaume; Balkau, Beverley; Vergnaud, Anne-Claire; Czernichow, Sebastien; Patsch, Wolfgang; Chikri, Mohamed; Glaser, Benjamin; Sladek, Robert; Froguel, Philippe			Post Genome-Wide Association Studies of Novel Genes Associated with Type 2 Diabetes Show Gene-Gene Interaction and High Predictive Value	PLOS ONE			English	Article							ANTIOXIDANT VITAMINS; COMPLEX DISEASES; RISK LOCI; OBESITY; POPULATION; SU.VI.MAX; TRIAL	Background: Recently, several Genome Wide Association (GWA) studies in populations of European descent have identified and validated novel single nucleotide polymorphisms (SNPs), highly associated with type 2 diabetes (T2D). Our aims were to validate these markers in other European and non-European populations, then to assess their combined effect in a large French study comparing T2D and normal glucose tolerant (NGT) individuals. Methodology/Principal Findings: In the same French population analyzed in our previous GWA study (3,295 T2D and 3,595 NGT), strong associations with T2D were found for CDKAL1 (ORrs7756992 = 1.30[1.19-1.42], P = 2.3 x 10(-9)), CDKN2A/2B (ORrs10811661 = 0.74[0.66-0.82], P = 3.5 x 10(-8)) and more modestly for IGFBP2 (ORrs1470579 = 1.17[1.07-1.27], P = 0.0003) SNPs. These results were replicated in both Israeli Ashkenazi (577 T2D and 552 NGT) and Austrian (504 T2D and 753 NGT) populations (except for CDKAL1) but not in the Moroccan population (521 T2D and 423 NGT). In the overall group of French subjects (4,232 T2D and 4,595 NGT), IGFBP2 and CXCR4 synergistically interacted with (LOC38776, SLC30A8, HHEX) and (NGN3, CDKN2A/2B), respectively, encoding for proteins presumably regulating pancreatic endocrine cell development and function. The T2D risk increased strongly when risk alleles, including the previously discovered T2D-associated TCF7L2 rs7903146 SNP, were combined (8.68-fold for the 14% of French individuals carrying 18 to 30 risk alleles with an allelic OR of 1.24). With an area under the ROC curve of 0.86, only 15 novel loci were necessary to discriminate French individuals susceptible to develop T2D. Conclusions/Significance: In addition to TCF7L2, SLC30A8 and HHEX, initially identified by the French GWA scan, CDKAL1, IGFBP2 and CDKN2A/2B strongly associate with T2D in French individuals, and mostly in populations of Central European descent but not in Moroccan subjects. Genes expressed in the pancreas interact together and their combined effect dramatically increases the risk for T2D, opening avenues for the development of genetic prediction tests.	[Cauchi, Stephane; Meyre, David; Durand, Emmanuelle; Proenca, Christine; Choquet, Helene; De Graeve, Franck; Gaget, Stefan; Allegaert, Frederic; Delplanque, Jerome; Froguel, Philippe] Inst Pasteur, Inst Biol, CNRS 8090, F-59019 Lille, France; [Marre, Michel] INSERM U695, Paris, France; [Marre, Michel] Rene Diderot Paris 7 Univ, Paris, France; [Marre, Michel] Bichat Claude Bernard Hosp, Dept Endocrinol Diabetol & Nutrit, Paris, France; [Hadjadj, Samy] UFR Med Pharm, Univ Poitiers, INSERM U927, CIC INSERM 0801,CHU Poitiers, Poitiers, France; [Permutt, Marshall Alan; Wasson, Jon] Washington Univ, Sch Med, St Louis, MO USA; [Blech, Ilana; Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Dept Internal Med, Endocrinol & Metabolism Serv, Jerusalem, Israel; [Charpentier, Guillaume] Corbeil Essonnes Hosp, Endocrinol Diabetol Unit, Corbeil Essonnes, France; [Balkau, Beverley] INSERM U780 IFR69, Villejuif, France; [Balkau, Beverley] Univ Paris Sud, Paris, France; [Vergnaud, Anne-Claire; Czernichow, Sebastien] PARIS 13 CRNH IdF, CNAM, U1125 INRA, UMR U557 INSERM, Bobigny, France; [Czernichow, Sebastien] Assistance Publ Hop Paris AP HP, Dept Sante Publ, Hop Avicenne, Bobigny, France; [Patsch, Wolfgang] Paracelsus Med Univ, Landeskrankenhaus Salzburg, Dept Lab Med, Salzburg, Austria; [Chikri, Mohamed] Route Sidi Harazem, Pharm Fez, Fac Med, Lab Biochem, Fes, Morocco; [Sladek, Robert] McGill Univ, Fac Med, Dept Human Genet, Montreal, PQ, Canada; [Sladek, Robert] McGill Univ, Fac Med, Dept Med, Montreal, PQ, Canada; [Sladek, Robert] McGill Univ, Fac Med, Dept Pediat, Montreal, PQ, Canada; [Froguel, Philippe] Imperial Coll London, Hammersmith Hosp, Genom Med, London, England	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Washington University (WUSTL); Hebrew University of Jerusalem; Hadassah University Medical Center; Centre Hospitalier Sud Francilien; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Paracelsus Private Medical University; Mohammed First University of Oujda; Sidi Mohamed Ben Abdellah University of Fez; McGill University; McGill University; McGill University; Imperial College London	Cauchi, S (corresponding author), Inst Pasteur, Inst Biol, CNRS 8090, F-59019 Lille, France.	p.froguel@imperial.ac.uk	Glaser, Benjamin/F-8411-2017; Sladek, Robert/R-2391-2019; FROGUEL, Philippe/O-6799-2017; Meyre, David/D-7315-2011	Glaser, Benjamin/0000-0003-4711-5000; Sladek, Robert/0000-0002-2730-1204; FROGUEL, Philippe/0000-0003-2972-0784; Meyre, David/0000-0003-4850-7444; Gueranger, Anne-Claire/0000-0003-0728-9313; Marre, Michel/0000-0002-3071-1837; Choquet, Helene/0000-0001-9839-8667	French Governmental Agence Nationale de la Recherche; European Union [LSHM-CT-2006-518153]; Association Francaise des Diabetiques; Programme National de Recherche sur le Diabete; Medical Research Council [G0600331] Funding Source: researchfish; MRC [G0600331] Funding Source: UKRI	French Governmental Agence Nationale de la Recherche(French National Research Agency (ANR)); European Union(European Commission); Association Francaise des Diabetiques; Programme National de Recherche sur le Diabete; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the French Governmental Agence Nationale de la Recherche, the European Union (Integrated Project EuroDia LSHM-CT-2006-518153 in the Framework Programme 6 [FP6] of the European-Community, to PF), and the charities Association Francaise des Diabetiques and Programme National de Recherche sur le Diabete.	Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Chimienti F, 2005, BIOMETALS, V18, P313, DOI 10.1007/s10534-005-3687-9; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Esterbauer H, 2001, NAT GENET, V28, P178, DOI 10.1038/88911; FLOREZ JC, 2007, DIABETES, DOI DOI 10.2337/DB07-0451; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Furukawa Y, 2008, J CLIN ENDOCR METAB, V93, P310, DOI 10.1210/jc.2007-1029; GRARUP N, 2007, DIABETES; HADJADJ S, PROGNOSTIC VAL UNPUB; HANSON RL, 2007, DIABETES; HAYES MG, 2007, DIABETES; HELGASON A, 2007, NAT GENET; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hercberg S, 1998, CONTROL CLIN TRIALS, V19, P336, DOI 10.1016/S0197-2456(98)00015-4; HORIKOSHI M, 2007, DIABETOLOGIA; Janssens ACJW, 2004, AM J HUM GENET, V74, P585, DOI 10.1086/382052; Koblas T, 2007, FOLIA BIOL-PRAGUE, V53, P13; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Oberkofler H, 2004, DIABETES, V53, P1385, DOI 10.2337/diabetes.53.5.1385; Omori S, 2007, DIABETES; RAMPERSAUD E, 2007, DIABETES; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schulze MB, 2007, DIABETOLOGIA, V50, P2405, DOI 10.1007/s00125-007-0766-1; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Yang QH, 2005, INT J EPIDEMIOL, V34, P1129, DOI 10.1093/ije/dyi130; Yang QH, 2003, AM J HUM GENET, V72, P636, DOI 10.1086/367923; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	33	123	130	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2031	10.1371/journal.pone.0002031	http://dx.doi.org/10.1371/journal.pone.0002031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461161	gold, Green Published			2022-12-27	WOS:000261642400001
J	Jayapal, KP; Philp, RJ; Kok, YJ; Yap, MGS; Sherman, DH; Griffin, TJ; Hu, WS				Jayapal, Karthik P.; Philp, Robin J.; Kok, Yee-Jiun; Yap, Miranda G. S.; Sherman, David H.; Griffin, Timothy J.; Hu, Wei-Shou			Uncovering Genes with Divergent mRNA-Protein Dynamics in Streptomyces coelicolor	PLOS ONE			English	Article							ABSOLUTE PROTEIN; GLOBAL ANALYSIS; EXPRESSION; ABUNDANCE; SEQUENCE; CODON; TRANSCRIPTOME; QUANTITATION; PEPTIDES; PATHWAY	Many biological processes are intrinsically dynamic, incurring profound changes at both molecular and physiological levels. Systems analyses of such processes incorporating large-scale transcriptome or proteome profiling can be quite revealing. Although consistency between mRNA and proteins is often implicitly assumed in many studies, examples of divergent trends are frequently observed. Here, we present a comparative transcriptome and proteome analysis of growth and stationary phase adaptation in Streptomyces coelicolor, taking the time-dynamics of process into consideration. These processes are of immense interest in microbiology as they pertain to the physiological transformations eliciting biosynthesis of many naturally occurring therapeutic agents. A shotgun proteomics approach based on mass spectrometric analysis of isobaric stable isotope labeled peptides (iTRAQ (TM)) enabled identification and rapid quantification of approximately 14% of the theoretical proteome of S. coelicolor. Independent principal component analyses of this and DNA microarray-derived transcriptome data revealed that the prominent patterns in both protein and mRNA domains are surprisingly well correlated. Despite this overall correlation, by employing a systematic concordance analysis, we estimated that over 30% of the analyzed genes likely exhibited significantly divergent patterns, of which nearly one-third displayed even opposing trends. Integrating this data with biological information, we discovered that certain groups of functionally related genes exhibit mRNA-protein discordance in a similar fashion. Our observations suggest that differences between mRNA and protein synthesis/degradation mechanisms are prominent in microbes while reaffirming the plausibility of such mechanisms acting in a concerted fashion at a protein complex or sub-pathway level.	[Jayapal, Karthik P.; Hu, Wei-Shou] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; [Philp, Robin J.; Kok, Yee-Jiun; Yap, Miranda G. S.] Agcy Sci Technol & Res, Bioprocessing Technol Inst, Singapore, Singapore; [Sherman, David H.] Univ Michigan, Dept Med Chem, Life Sci Inst, Ann Arbor, MI USA; [Sherman, David H.] Univ Michigan, Dept Chem, Life Sci Inst, Ann Arbor, MI USA; [Sherman, David H.] Univ Michigan, Dept Microbiol & Immunol, Life Sci Inst, Ann Arbor, MI USA; [Griffin, Timothy J.] Univ Minnesota, Dept Biochem, Mol Biol & Biophys, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities	Jayapal, KP (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	acre@cems.umn.edu	Kok, Yee Jiun/HCH-9659-2022	Kok, Yee Jiun/0000-0001-6875-8262; Griffin, Timothy/0000-0001-6801-2559	National Institutes of Health [GM55850]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded in part by a grant from the National Institutes of Health (GM55850). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Charaniya S, 2007, NUCLEIC ACIDS RES, V35, P7222, DOI 10.1093/nar/gkm501; Chong PK, 2006, J PROTEOME RES, V5, P1232, DOI 10.1021/pr060018u; de Crecy-Lagard V, 1999, MOL MICROBIOL, V32, P505, DOI 10.1046/j.1365-2958.1999.01364.x; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hesketh AR, 2002, MOL MICROBIOL, V46, P917, DOI 10.1046/j.1365-2958.2002.03219.x; Huang JQ, 2001, GENE DEV, V15, P3183, DOI 10.1101/gad.943401; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jansen R, 2003, NUCLEIC ACIDS RES, V31, P2242, DOI 10.1093/nar/gkg306; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; LI W, 2006, FEMS MICROBIOL LETT; Lithwick G, 2003, GENOME RES, V13, P2665, DOI 10.1101/gr.1485203; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Martin-Galiano AJ, 2004, MICROBIOL-SGM, V150, P2313, DOI 10.1099/mic.0.27097-0; Mehra S, 2006, J IND MICROBIOL BIOT, V33, P159, DOI 10.1007/s10295-005-0034-7; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Molloy MP, 2003, PROTEOMICS, V3, P1912, DOI 10.1002/pmic.200300534; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Price B, 1999, J BACTERIOL, V181, P6142, DOI 10.1128/JB.181.19.6142-6151.1999; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; STROHL WR, 1992, NUCLEIC ACIDS RES, V20, P961, DOI 10.1093/nar/20.5.961; Takano E, 2003, MOL MICROBIOL, V50, P475, DOI 10.1046/j.1365-2958.2003.03728.x; Vohradsky J, 2007, PROTEOMICS, V7, P3853, DOI 10.1002/pmic.200700005; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100; Wu G, 2005, MICROBIOL-SGM, V151, P2175, DOI 10.1099/mic.0.27833-0	34	75	76	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2097	10.1371/journal.pone.0002097	http://dx.doi.org/10.1371/journal.pone.0002097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461186	Green Submitted, gold, Green Published			2022-12-27	WOS:000261642400019
J	Sun, T; McMinn, P; Holcombe, M; Smallwood, R; MacNeil, S				Sun, Tao; McMinn, Phil; Holcombe, Mike; Smallwood, Rod; MacNeil, Sheila			Agent Based Modelling Helps in Understanding the Rules by Which Fibroblasts Support Keratinocyte Colony Formation	PLOS ONE			English	Article							CELL-CELL INTERACTIONS; GROWTH-FACTOR; EXTRACELLULAR-MATRIX; IN-VITRO; EPIDERMAL INTERACTION; INDUCED APOPTOSIS; FEEDER CELLS; STEM-CELLS; SKIN; PROLIFERATION	Background: Autologous keratincoytes are routinely expanded using irradiated mouse fibroblasts and bovine serum for clinical use. With growing concerns about the safety of these xenobiotic materials, it is desirable to culture keratinocytes in media without animal derived products. An improved understanding of epithelial/mesenchymal interactions could assist in this. Methodology/Principal Findings: A keratincyte/fibroblast o-culture model was developed by extending an agent-based keratinocyte colony formation model to include the response of keratinocytes to both fibroblasts and serum. The model was validated by comparison of the in virtuo and in vitro multicellular behaviour of keratinocytes and fibroblasts in single and co-culture in Greens medium. To test the robustness of the model, several properties of the fibroblasts were changed to investigate their influence on the multicellular morphogenesis of keratinocyes and fibroblasts. The model was then used to generate hypotheses to explore the interactions of both proliferative and growth arrested fibroblasts with keratinocytes. The key predictions arising from the model which were confirmed by in vitro experiments were that 1) the ratio of fibroblasts to keratinocytes would critically influence keratinocyte colony expansion, 2) this ratio needed to be optimum at the beginning of the co-culture, 3) proliferative fibroblasts would be more effective than irradiated cells in expanding keratinocytes and 4) in the presence of an adequate number of fibroblasts, keratinocyte expansion would be independent of serum. Conclusions: A closely associated computational and biological approach is a powerful tool for understanding complex biological systems such as the interactions between keratinocytes and fibroblasts. The key outcome of this study is the finding that the early addition of a critical ratio of proliferative fibroblasts can give rapid keratinocyte expansion without the use of irradiated mouse fibroblasts and bovine serum.	[Sun, Tao; MacNeil, Sheila] Univ Sheffield, Dept Mat Engn, Sheffield, S Yorkshire, England; [McMinn, Phil; Holcombe, Mike; Smallwood, Rod] Univ Sheffield, Dept Comp Sci, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield	Sun, T (corresponding author), Univ Sheffield, Dept Mat Engn, Sheffield, S Yorkshire, England.	tao@sheffield.ac.uk; s.macneil@sheffield.ac.uk	Smallwood, Rod/C-5583-2011	Smallwood, Rod/0000-0003-0134-0632	EPSRC(UK)	EPSRC(UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding from EPSRC(UK). The funder did not play a role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation of the manuscript.	ABSHER M, 1981, ENVIRON RES, V26, P438, DOI 10.1016/0013-9351(81)90219-X; ADAMS JC, 1990, CELL, V63, P425, DOI 10.1016/0092-8674(90)90175-E; Angel P, 2002, BIOCHEM PHARMACOL, V64, P949, DOI 10.1016/S0006-2952(02)01158-9; Ashkenas J, 1996, DEV BIOL, V180, P433, DOI 10.1006/dbio.1996.0317; Assoian RK, 1997, J CELL BIOL, V136, P1, DOI 10.1083/jcb.136.1.1; Beyer TA, 2003, EXP CELL RES, V287, P228, DOI 10.1016/S0014-4827(03)00139-3; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; BHORA FY, 1995, J SURG RES, V59, P236, DOI 10.1006/jsre.1995.1160; Blomme EAG, 1999, MOL CELL ENDOCRINOL, V152, P189, DOI 10.1016/S0303-7207(98)00252-4; BOGAERDT AJ, 2004, BIOCHEM BIOPH RES CO, V315, P428, DOI DOI 10.1016/J.BBRC.2004.01.069; Bowers W, 1999, J DERMATOL SCI, V20, P172, DOI 10.1016/S0923-1811(98)00079-6; Bullock AJ, 2006, TISSUE ENG, V12, P245, DOI 10.1089/ten.2006.12.245; Casella GTB, 2000, GLIA, V30, P165, DOI 10.1002/(SICI)1098-1136(200004)30:2<165::AID-GLIA6>3.0.CO;2-L; Chang CC, 1995, J SURG RES, V59, P705, DOI 10.1006/jsre.1995.1227; CLAVEL C, 2005, IL FARMACO, V60, P721; COAKLEY S, 2006, P AG DIR SIM ADS 06; Dai NT, 2004, BIOMATERIALS, V25, P4263, DOI 10.1016/j.biomaterials.2003.11.022; Dawson RA, 1996, BURNS, V22, P93, DOI 10.1016/0305-4179(95)00092-5; Dilley TK, 2003, EXP CELL RES, V290, P38, DOI 10.1016/S0014-4827(03)00308-2; Drasdo D, 2005, PHYS BIOL, V2, P133, DOI 10.1088/1478-3975/2/3/001; Fleischmajer R, 2000, MATRIX BIOL, V19, P637, DOI 10.1016/S0945-053X(00)00092-5; GAILIT J, 1994, CURR OPIN CELL BIOL, V6, P717, DOI 10.1016/0955-0674(94)90099-X; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; GIZELDA TB, 2000, GLIA, V30, P165; GORELIK JV, 1995, CELL BIOL INT, V19, P59, DOI 10.1006/cbir.1995.1008; Goulet F, 1996, BURNS, V22, P107, DOI 10.1016/0305-4179(95)00098-4; Grabe N, 2005, BIOINFORMATICS, V21, P3541, DOI 10.1093/bioinformatics/bti585; Grossmann J, 2001, CELL GROWTH DIFFER, V12, P147; Harrison CA, 2005, WOUND REPAIR REGEN, V13, P543, DOI 10.1111/j.1524-475X.2005.00076.x; Higham MC, 2003, TISSUE ENG, V9, P919, DOI 10.1089/107632703322495565; Hubner G, 1996, EXP CELL RES, V228, P106, DOI 10.1006/excr.1996.0305; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Kansra S, 2004, MOL BIOL CELL, V15, P4299, DOI 10.1091/mbc.E04-03-0233; Kanzaki Y, 2002, EXP CELL RES, V279, P321, DOI 10.1006/excr.2002.5607; Keller UAD, 2004, EUR J CELL BIOL, V83, P607; Kim BM, 1999, BRIT J PLAST SURG, V52, P573, DOI 10.1054/bjps.1999.3162; Kolettas E, 2006, ARCH BIOCHEM BIOPHYS, V445, P184, DOI 10.1016/j.abb.2005.10.006; Kopp J, 2004, MOL THER, V10, P86, DOI 10.1016/j.ymthe.2004.04.016; MACIEIRACOELHO A, 1982, EXP CELL RES, V141, P325, DOI 10.1016/0014-4827(82)90220-8; MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664; Matsuyoshi N, 1997, BIOCHEM BIOPH RES CO, V235, P355, DOI 10.1006/bbrc.1997.6707; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Mirastschijski U, 2004, EXP CELL RES, V299, P465, DOI 10.1016/j.yexcr.2004.06.007; Mishra L, 2005, SCIENCE, V310, P68, DOI 10.1126/science.1118389; Morel D, 2001, ACTA BIOTHEOR, V49, P219, DOI 10.1023/A:1014201805222; Nelson CM, 2002, FEBS LETT, V514, P238, DOI 10.1016/S0014-5793(02)02370-0; Okazaki M, 2002, J DERMATOL SCI, V30, P108, DOI 10.1016/S0923-1811(02)00066-X; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Osborne CS, 1999, BIOMATERIALS, V20, P283, DOI 10.1016/S0142-9612(98)00179-3; Owen MR, 1998, MATH BIOSCI, V153, P125, DOI 10.1016/S0025-5564(98)10034-2; Ponciano JM, 2005, APPL ENVIRON MICROB, V71, P2355, DOI 10.1128/AEM.71.5.2355-2364.2005; Rashbass J, 1996, TRENDS CELL BIOL, V6, P280, DOI 10.1016/0962-8924(96)60028-2; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Roguet R, 1997, TOXICOL IN VITRO, V11, P591, DOI 10.1016/S0887-2333(97)00062-3; RUBIN JS, 1995, CELL BIOL INT, V19, P399, DOI 10.1006/cbir.1995.1085; Sakaguchi M, 2003, J CELL BIOL, V163, P825, DOI 10.1083/jcb.200304017; Santini MT, 2000, CRIT REV ONCOL HEMAT, V36, P75, DOI 10.1016/S1040-8428(00)00078-0; Scheffrahn I, 2005, EXP CELL RES, V307, P427, DOI 10.1016/j.yexcr.2005.03.030; Sher I, 2003, FEBS LETT, V552, P150, DOI 10.1016/S0014-5793(03)00909-8; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Smola H, 1998, EXP CELL RES, V239, P399, DOI 10.1006/excr.1997.3910; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; St Croix B, 1998, J CELL BIOL, V142, P557, DOI 10.1083/jcb.142.2.557; Stark HJ, 2004, EUR J CELL BIOL, V83, P631, DOI 10.1078/0171-9335-00435; Sun T, 2007, J MATER SCI-MATER M, V18, P321, DOI 10.1007/s10856-006-0696-3; Sun T, 2005, TISSUE ENG, V11, P1023, DOI 10.1089/ten.2005.11.1023; Sun T, 2004, WOUND REPAIR REGEN, V12, P626, DOI 10.1111/j.1067-1927.2004.12609.x; Sun T, 2007, J R SOC INTERFACE, V4, P1077, DOI 10.1098/rsif.2007.0227; Suzuki K, 2003, PROG RETIN EYE RES, V22, P113, DOI 10.1016/S1350-9462(02)00042-3; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; SZABOWSKI MN, 1999, J CELL SCI, V112, P1843; Tagashira S, 1997, GENE, V197, P399, DOI 10.1016/S0378-1119(97)00187-X; TAKEUCHI F, 1982, EXP GERONTOL, V17, P473, DOI 10.1016/S0531-5565(82)80009-0; Tepper CG, 2000, EXP CELL RES, V260, P9, DOI 10.1006/excr.2000.4990; Uchi H, 2000, J DERMATOL SCI, V24, pS29, DOI 10.1016/S0923-1811(00)00138-9; WAELTI ER, 1992, J INVEST DERMATOL, V98, P805, DOI 10.1111/1523-1747.ep12499961; Walker JL, 2005, CYTOKINE GROWTH F R, V16, P395, DOI 10.1016/j.cytogfr.2005.03.003; Wearing HJ, 2000, MATH BIOSCI, V165, P41, DOI 10.1016/S0025-5564(00)00008-0; Werner S, 2001, TRENDS CELL BIOL, V11, P143, DOI 10.1016/S0962-8924(01)01955-9; Werner S, 1998, CYTOKINE GROWTH F R, V9, P153, DOI 10.1016/S1359-6101(98)00010-0; Williams IR, 1996, LIFE SCI, V58, P1485, DOI 10.1016/0024-3205(96)00042-2; Witte RP, 2005, BIOMATERIALS, V26, P3673, DOI 10.1016/j.biomaterials.2004.09.054; Yamaguchi Y, 2005, J DERMATOL SCI, V40, P1, DOI 10.1016/j.jdermsci.2005.04.006; Zhang LY, 1999, J DERMATOL SCI, V20, P191, DOI 10.1016/S0923-1811(98)00081-4	85	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2129	10.1371/journal.pone.0002129	http://dx.doi.org/10.1371/journal.pone.0002129			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461132	Green Published, Green Accepted, gold			2022-12-27	WOS:000261642400050
J	Garforth, SJ; Parniak, MA; Prasad, VR				Garforth, Scott J.; Parniak, Michael A.; Prasad, Vinayaka R.			Utilization of a Deoxynucleoside Diphosphate Substrate by HIV Reverse Transcriptase	PLOS ONE			English	Article								Background: Deoxynucleoside triphosphates (dNTPs) are the normal substrates for DNA synthesis catalyzed by polymerases such as HIV-1 reverse transcriptase (RT). However, substantial amounts of deoxynucleoside diphosphates (dNDPs) are also present in the cell. Use of dNDPs in HIV-1 DNA synthesis could have significant implications for the efficacy of nucleoside RT inhibitors such as AZT which are first line therapeutics for treatment of HIV infection. Our earlier work on HIV-1 reverse transcriptase (RT) suggested that the interaction between the gamma-phosphate of the incoming dNTP and RT residue K65 in the active site is not essential for dNTP insertion, implying that this polymerase may be able to insert dNDPs in addition to dNTPs. Methodology/Principal Findings: We examined the ability of recombinant wild type (wt) and mutant RTs with substitutions at residue K65 to utilize a dNDP substrate in primer extension reactions. We found that wild type HIV-1 RT indeed catalyzes incorporation of dNDP substrates whereas RT with mutations of residue K65 were unable to catalyze this reaction. Wild type HIV-1 RT also catalyzed the reverse reaction, inorganic phosphate-dependent phosphorolysis. Nucleotide-mediated phosphorolytic removal of chain-terminating 3'-terminal nucleoside inhibitors such as AZT forms the basis for HIV-1 resistance to such drugs, and this removal is enhanced by thymidine analog mutations (TAMs). We found that both wt and TAM-containing RTs were able to catalyze Pi-mediated phosphorolysis of 3'-terminal AZT at physiological levels of Pi with an efficacy similar to that for ATP-dependent AZT-excision. Conclusions: We have identified two new catalytic functions of HIV-1 RT, the use of dNDPs as substrates for DNA synthesis, and the use of Pi as substrate for phosphorolytic removal of primer 3'-terminal nucleotides. The ability to insert dNDPs has been documented for only one other DNA polymerase, the RB69 DNA polymerase and the reverse reaction employing inorganic phosphate has not been documented for any DNA polymerase. Importantly, our results show that Pi-mediated phosphorolysis can contribute to AZT resistance and indicates that factors that influence HIV resistance to AZT are more complex than previously appreciated.	[Garforth, Scott J.; Prasad, Vinayaka R.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Parniak, Michael A.] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA USA	Yeshiva University; Albert Einstein College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Garforth, SJ (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	prasad@aecom.yu.edu	Prasad, Vinayaka R./A-1029-2011; Garforth, Scott/B-5701-2011	Prasad, Vinayaka/0000-0002-9461-0189	National Institute of Allergy and Infectious Diseases, NIH [R37AI030861]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030861] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research described here was supported by grant number R37AI030861 from the National Institute of Allergy and Infectious Diseases. The funder of this study, the National Institutes of Health have played no part in the conduct of the study, in the collection, analysis and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Bagnis CI, 2006, NEPHRON PHYSIOL, V103, P131, DOI 10.1159/000092247; BARSHOP BA, 1991, ANAL BIOCHEM, V197, P266, DOI 10.1016/0003-2697(91)90387-9; BEBENEK K, 1989, J BIOL CHEM, V264, P16948; BESSMAN MJ, 1958, J BIOL CHEM, V233, P171; BEVINGTON A, 1986, CLIN SCI, V71, P729, DOI 10.1042/cs0710729; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Boyer PL, 2001, J VIROL, V75, P4832, DOI 10.1128/JVI.75.10.4832-4842.2001; BURGERS PMJ, 1979, J BIOL CHEM, V254, P6889; BURGERS PMJ, 1980, J BIOL CHEM, V255, P8229; Cruchaga C, 2006, J BIOL CHEM, V281, P27744, DOI 10.1074/jbc.M603360200; Dharmasena S, 2007, BIOCHEMISTRY-US, V46, P828, DOI 10.1021/bi061364s; DORONIN SV, 1989, FEBS LETT, V259, P83, DOI 10.1016/0014-5793(89)81500-5; DORONIN SV, 1987, FEBS LETT, V216, P221, DOI 10.1016/0014-5793(87)80693-2; Fletcher RS, 1996, PROTEIN EXPRES PURIF, V7, P27, DOI 10.1006/prep.1996.0004; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Garforth SJ, 2007, J MOL BIOL, V365, P38, DOI 10.1016/j.jmb.2006.09.057; GU ZX, 1994, ANTIMICROB AGENTS CH, V38, P275, DOI 10.1128/AAC.38.2.275; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; KEMP GJ, 1993, J THEOR BIOL, V161, P77, DOI 10.1006/jtbi.1993.1041; KORNBERG, 1992, DNA REPLICATION; Kukhanova MK, 2005, BIOCHEM BIOPH RES CO, V338, P1335, DOI 10.1016/j.bbrc.2005.10.092; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Mas A, 2002, J MOL BIOL, V323, P181, DOI 10.1016/S0022-2836(02)00911-7; Meyer PR, 2006, ANTIMICROB AGENTS CH, V50, P3607, DOI 10.1128/AAC.00537-06; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 2003, J VIROL, V77, P6127, DOI 10.1128/JVI.77.11.6127-6137.2003; Meyer PR, 2000, ANTIMICROB AGENTS CH, V44, P3465, DOI 10.1128/AAC.44.12.3465-3472.2000; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Mulder BA, 2005, NUCLEIC ACIDS RES, V33, P4865, DOI 10.1093/nar/gki779; NAZARENKO IA, 1979, NUCLEIC ACIDS RES, V6, P2545, DOI 10.1093/nar/6.7.2545; Parikh UM, 2007, AIDS, V21, P1405, DOI 10.1097/QAD.0b013e3281ac229b; Pelletier H, 1996, BIOCHEMISTRY-US, V35, P12762, DOI 10.1021/bi9529566; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Rigourd M, 2000, J BIOL CHEM, V275, P26944; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; ROZOVSKAYA TA, 1984, BIOCHEM J, V224, P645, DOI 10.1042/bj2240645; SCHACHMAN HK, 1960, J BIOL CHEM, V235, P3242; Selmi B, 2001, J BIOL CHEM, V276, P48466, DOI 10.1074/jbc.M107003200; Sluis-Cremer N, 2000, BIOCHEM J, V348, P77, DOI 10.1042/0264-6021:3480077; Smith AJ, 2005, ANTIMICROB AGENTS CH, V49, P1761, DOI 10.1128/AAC.49.5.1761-1769.2005; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; TAN CK, 1991, BIOCHEMISTRY-US, V30, P2651, DOI 10.1021/bi00224a013; White KL, 2006, ANTIVIR THER, V11, P155; Yang GW, 2002, BIOCHEMISTRY-US, V41, P2526, DOI 10.1021/bi0119924; Yang GW, 1999, BIOCHEMISTRY-US, V38, P8094, DOI 10.1021/bi990653w	50	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2074	10.1371/journal.pone.0002074	http://dx.doi.org/10.1371/journal.pone.0002074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446195	Green Published, Green Accepted, gold			2022-12-27	WOS:000261572300043
J	Surlykke, A; Kalko, EKV				Surlykke, Annemarie; Kalko, Elisabeth K. V.			Echolocating Bats Cry Out Loud to Detect Their Prey	PLOS ONE			English	Article								Echolocating bats have successfully exploited a broad range of habitats and prey. Much research has demonstrated how time-frequency structure of echolocation calls of different species is adapted to acoustic constraints of habitats and foraging behaviors. However, the intensity of bat calls has been largely neglected although intensity is a key factor determining echolocation range and interactions with other bats and prey. Differences in detection range, in turn, are thought to constitute a mechanism promoting resource partitioning among bats, which might be particularly important for the species-rich bat assemblages in the tropics. Here we present data on emitted intensities for 11 species from 5 families of insectivorous bats from Panama hunting in open or background cluttered space or over water. We recorded all bats in their natural habitat in the field using a multi-microphone array coupled with photographic methods to assess the bats' position in space to estimate emitted call intensities. All species emitted intense search signals. Output intensity was reduced when closing in on background by 4-7 dB per halving of distance. Source levels of open space and edge space foragers (Emballonuridae, Mormoopidae, Molossidae, and Vespertilionidae) ranged between 122-134 dB SPL. The two Noctilionidae species hunting over water emitted the loudest signals recorded so far for any bat with average source levels of ca. 137 dB SPL and maximum levels above 140 dB SPL. In spite of this ten-fold variation in emitted intensity, estimates indicated, surprisingly, that detection distances for prey varied far less; bats emitting the highest intensities also emitted the highest frequencies, which are severely attenuated in air. Thus, our results suggest that bats within a local assemblage compensate for frequency dependent attenuation by adjusting the emitted intensity to achieve comparable detection distances for prey across species. We conclude that for bats with similar hunting habits, prey detection range represents a unifying constraint on the emitted intensity largely independent of call shape, body size, and close phylogenetic relationships.	[Surlykke, Annemarie] Univ So Denmark, Inst Biol, Odense, Denmark; [Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama	University of Southern Denmark; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute	Surlykke, A (corresponding author), Univ So Denmark, Inst Biol, Odense, Denmark.	ams@biology.sdu.dk			Danish National Research Foundation; Danish Natural Science Research Foundation; Smithsonian Tropical Research Institute (STRI); German Science Foundation (DFG)	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Natural Science Research Foundation(Danish Natural Science Research Council); Smithsonian Tropical Research Institute (STRI)(Smithsonian InstitutionSmithsonian Tropical Research Institute); German Science Foundation (DFG)(German Research Foundation (DFG))	The research was funded by the Danish National Research Foundation and the Danish Natural Science Research Foundation (to AS) and Smithsonian Tropical Research Institute (STRI) and the German Science Foundation (DFG) (to EKVK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ANSI, 1978, 261978 ANSI SI; Au WWL, 2003, NATURE, V423, P861, DOI 10.1038/nature01727; Boonman A, 2002, J EXP BIOL, V205, P2865; Fenton MB, 2001, J TROP ECOL, V17, P511, DOI 10.1017/S0266467401001389; Fullard JH, 1997, J COMP PHYSIOL A, V181, P477, DOI 10.1007/s003590050131; Ghose K, 2003, J ACOUST SOC AM, V114, P1120, DOI 10.1121/1.1589754; Griffin D.R., 1986, LISTENING DARK; HARTLEY DJ, 1992, J ACOUST SOC AM, V91, P1120, DOI 10.1121/1.402639; HARTLEY DJ, 1992, J ACOUST SOC AM, V91, P1133, DOI 10.1121/1.402640; HARTLEY DJ, 1989, J ACOUST SOC AM, V85, P1348, DOI 10.1121/1.397466; HELLER KG, 1989, OECOLOGIA, V80, P178, DOI 10.1007/BF00380148; Holderied MW, 2005, J EXP BIOL, V208, P1321, DOI 10.1242/jeb.01528; Holderied MW, 2003, P ROY SOC B-BIOL SCI, V270, P2293, DOI 10.1098/rspb.2003.2487; Jensen ME, 1999, BEHAV ECOL SOCIOBIOL, V47, P60, DOI 10.1007/s002650050650; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jung K, 2007, J ZOOL, V272, P125, DOI 10.1111/j.1469-7998.2006.00250.x; KALKO E K V, 1989, Journal of the Acoustical Society of America, V85, P961, DOI 10.1121/1.397569; Kalko EKV, 1998, BEHAV ECOL SOCIOBIOL, V42, P305, DOI 10.1007/s002650050443; Kalko Elisabeth K.V., 1998, P197; Kalko Elisabeth K. V., 1997, P13; KICK SA, 1984, J NEUROSCI, V4, P2725; Leigh EG, 1999, TROPICAL FOREST ECOL; Madsen PT, 2007, DEEP-SEA RES PT I, V54, P1421, DOI 10.1016/j.dsr.2007.04.020; Moss CF, 2006, PLOS BIOL, V4, P615, DOI 10.1371/journal.pbio.0040079; O'Farrell MJ, 1999, BIOTROPICA, V31, P507, DOI 10.1111/j.1744-7429.1999.tb00394.x; Rasmussen MH, 2002, J ACOUST SOC AM, V111, P1122, DOI 10.1121/1.1433814; ROEDER KD, 1966, J INSECT PHYSIOL, V12, P843, DOI 10.1016/0022-1910(66)90035-7; Rydell J, 2002, J ZOOL, V257, P27, DOI 10.1017/S0952836902000626; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SCHNITZLER HU, 1994, BEHAV ECOL SOCIOBIOL, V35, P327, DOI 10.1007/BF00184422; Siemers BM, 2001, J EXP BIOL, V204, P3843; Siemers BM, 2001, BEHAV ECOL SOCIOBIOL, V50, P317, DOI 10.1007/s002650100379; SIMMONS JA, 1980, J COMP PHYSIOL, V135, P61, DOI 10.1007/BF00660182; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; SURLYKKE A, 1993, BEHAV ECOL SOCIOBIOL, V33, P1, DOI 10.1007/BF00164341; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; Surlykke A, 1999, NATURWISSENSCHAFTEN, V86, P238, DOI 10.1007/s001140050607; VONSTAADEN MJ, 1997, J EXP BIOL, V200, P2597; Zar JH., 1999, BIOSTAT ANAL	41	167	174	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2036	10.1371/journal.pone.0002036	http://dx.doi.org/10.1371/journal.pone.0002036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446226	gold, Green Published, Green Submitted			2022-12-27	WOS:000261572300009
J	Jovani, R; Serrano, D; Ursua, E; Tella, JL				Jovani, Roger; Serrano, David; Ursua, Esperanza; Tella, Jose L.			Truncated Power Laws Reveal a Link between Low-Level Behavioral Processes and Grouping Patterns in a Colonial Bird	PLOS ONE			English	Article							LESSER KESTREL; DISPERSAL; SIZE; AVAILABILITY; POPULATION; COMPLEXITY; SELECTION; DYNAMICS; SUCCESS	Background: Departures from power law group size frequency distributions have been proposed as a useful tool to link individual behavior with population patterns and dynamics, although examples are scarce for wild animal populations. Methodology/Principal Findings: We studied a population of Lesser kestrels (Falco naumanni) breeding in groups (colonies) from one to ca. 40 breeding pairs in 10,000 km(2) in NE Spain. A 3.5 fold steady population increase occurred during the eight-year study period, accompanied by a geographical expansion from an initial subpopulation which in turn remained stable in numbers. This population instability was mainly driven by first-breeders, which are less competitive at breeding sites, being relegated to breed solitarily or in small colony sizes, and disperse farther than adults. Colony size frequency distributions shifted from an initial power law to a truncated power law mirroring population increase. Thus, we hypothesized that population instability was behind the truncation of the power law. Accordingly, we found a power law distribution through years in the initial subpopulation, and a match between the power law breakpoint ( at ca. ten pairs) and those colony sizes from which the despotic behavior of colony owners started to impair the settlement of newcomers. Moreover, the instability hypothesis was further supported by snapshot data from another population of Lesser kestrels in SW Spain suffering a population decline. Conclusions/Significance: Appropriate analysis of the scaling properties of grouping patterns has unraveled the link between local agonistic processes and large-scale (population) grouping patterns in a wild bird population.	[Jovani, Roger; Serrano, David; Ursua, Esperanza; Tella, Jose L.] Pabellon Peru, Consejo Superior Investigaciones Cient CSIC, Estac Biol Donana, Dept Conservat Biol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Jovani, R (corresponding author), Pabellon Peru, Consejo Superior Investigaciones Cient CSIC, Estac Biol Donana, Dept Conservat Biol, Seville, Spain.	jovani@ebd.csic.es	Serrano, David/B-5352-2013; Jovani, Roger/C-7080-2013; Tella, José L/I-3707-2015	Serrano, David/0000-0001-6205-386X; Jovani, Roger/0000-0002-8693-9742; Tella, José L/0000-0002-3038-7424	Consejo Superior de Investigaciones Cientificas; Gobierno de Aragon; SEO/BirdLife; DGICYT; DGES [PB93-0040, PB96-0834, BOS2003-01960]	Consejo Superior de Investigaciones Cientificas; Gobierno de Aragon(Gobierno de Aragon); SEO/BirdLife; DGICYT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); DGES	D. Serrano was supported by a I3P postdoctoral contract from the Consejo Superior de Investigaciones Cientificas. Financial support was partially provided by collaborative projects with Gobierno de Aragon (1994-95 and 2000), SEO/BirdLife (1998-99) and DGICYT and DGES Projects PB93-0040, PB96-0834 and BOS2003-01960.	Ainley DG, 2002, ADELIE PENGUIN; Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; Arroyo B, 2001, BEHAV ECOL SOCIOBIOL, V50, P109, DOI 10.1007/s002650100342; Batty M., 1994, FRACTAL CITIES GEOME; BERG A, 1992, J ANIM ECOL, V61, P469, DOI 10.2307/5337; Bonabeau E, 1999, P NATL ACAD SCI USA, V96, P4472, DOI 10.1073/pnas.96.8.4472; Brown C. R., 1996, COLONIALITY CLIFF SW; BROWN CR, 1990, TRENDS ECOL EVOL, V5, P398, DOI 10.1016/0169-5347(90)90023-7; Brown J. H., 1995, MACROECOLOGY; Brown JH, 2002, PHILOS T R SOC B, V357, P619, DOI 10.1098/rstb.2001.0993; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Buldyrev SV, 2003, PHYSICA A, V330, P653, DOI 10.1016/j.physa.2003.09.041; Collett M, 1998, P NATL ACAD SCI USA, V95, P13052, DOI 10.1073/pnas.95.22.13052; Forero MG, 1996, BIOL CONSERV, V78, P289, DOI 10.1016/S0006-3207(96)00011-0; GOUMARK F, 1982, ORNIS SCAND, V13, P211; Halley JM, 2004, ECOL LETT, V7, P254, DOI 10.1111/j.1461-0248.2004.00568.x; Hiraldo F, 1996, J APPL ECOL, V33, P1085, DOI 10.2307/2404688; HIRALDO F, 1995, COLONIAS NIDIFICACIO; Jovani R, 2007, P ROY SOC B-BIOL SCI, V274, P2465, DOI 10.1098/rspb.2007.0527; Krause J., 2002, LIVING GROUPS OXFORD; Lenth R., 2019, Journal of Statistical Software, V60, P1; Lusseau D, 2004, ECOL LETT, V7, P1068, DOI 10.1111/j.1461-0248.2004.00669.x; Manrubia SC, 1999, FRACTALS, V7, P1, DOI 10.1142/S0218348X99000025; May R, 1999, PHILOS T R SOC B, V354, P1951, DOI 10.1098/rstb.1999.0534; Parrish J., 1997, ANIMAL GROUPS 3 DIME; Pascual M, 2002, PHILOS T ROY SOC B, V357, P657, DOI 10.1098/rstb.2001.0983; Pueyo S, 2006, OIKOS, V112, P392, DOI 10.1111/j.0030-1299.2006.14188.x; PUEYO S, 2003, THESIS U BARCELONA S; Pueyo S, 2006, SCIENCE, V313, DOI 10.1126/science.1129595; Rodriguez C, 2006, J APPL ECOL, V43, P587, DOI 10.1111/j.1365-2664.2006.01152.x; Schneider DC, 2002, ECOSYSTEMS, V5, P736, DOI 10.1007/s10021-002-0156-y; Serrano D, 2005, AM NAT, V166, pE22, DOI 10.1086/431255; Serrano D, 2004, ECOLOGY, V85, P3438, DOI 10.1890/04-0463; Serrano D, 2003, ECOLOGY, V84, P3044, DOI 10.1890/02-0231; Serrano D, 2003, J ANIM ECOL, V72, P400, DOI 10.1046/j.1365-2656.2003.00707.x; Serrano D, 2001, J ANIM ECOL, V70, P568, DOI 10.1046/j.1365-2656.2001.00512.x; Serrano D, 2007, AM NAT, V169, pE53, DOI 10.1086/510598; Sjoberg M, 2000, ECOL LETT, V3, P90, DOI 10.1046/j.1461-0248.2000.00113.x; Sole R.V., 2001, SIGNS LIFE COMPLEXIT; Sutherland W.J., 1996, INDIVIDUAL BEHAV POP; Tella JL, 1998, CONSERV BIOL, V12, P593, DOI 10.1046/j.1523-1739.1998.96288.x; TELLA JL, 1996, THESIS U BARCELONA S; Theraulaz G, 2002, P NATL ACAD SCI USA, V99, P9645, DOI 10.1073/pnas.152302199; Vandermeer J, 2006, SCIENCE, V311, P1000, DOI 10.1126/science.1121432	45	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1992	10.1371/journal.pone.0001992	http://dx.doi.org/10.1371/journal.pone.0001992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431479	Green Published, Green Submitted, gold			2022-12-27	WOS:000261558700014
J	Toth, C; Shim, SY; Wang, J; Jiang, Y; Neumayer, G; Belzil, C; Liu, WQ; Martinez, J; Zochodne, D; Nguyen, MD				Toth, Cory; Shim, Su Yeon; Wang, Jian; Jiang, Yulan; Neumayer, Gernot; Belzil, Camille; Liu, Wei-Qiao; Martinez, Jose; Zochodne, Douglas; Nguyen, Minh Dang			Ndel1 Promotes Axon Regeneration via Intermediate Filaments	PLOS ONE			English	Article								Failure of axons to regenerate following acute or chronic neuronal injury is attributed to both the inhibitory glial environment and deficient intrinsic ability to re-grow. However, the underlying mechanisms of the latter remain unclear. In this study, we have investigated the role of the mammalian homologue of aspergillus nidulans NudE, Ndel1, emergently viewed as an integrator of the cytoskeleton, in axon regeneration. Ndel1 was synthesized de novo and upregulated in crushed and transected sciatic nerve axons, and, upon injury, was strongly associated with neuronal form of the intermediate filament (IF) Vimentin while dissociating from the mature neuronal IF (Neurofilament) light chain NF-L. Consistent with a role for Ndel1 in the conditioning lesion-induced neurite outgrowth of Dorsal Root Ganglion (DRG) neurons, the long lasting in vivo formation of the neuronal Ndel1/Vimentin complex was associated with robust axon regeneration. Furthermore, local silencing of Ndel1 in transected axons by siRNA severely reduced the extent of regeneration in vivo. Thus, Ndel1 promotes axonal regeneration; activating this endogenous repair mechanism may enhance neuroregeneration during acute and chronic axonal degeneration.	[Toth, Cory; Shim, Su Yeon; Wang, Jian; Neumayer, Gernot; Belzil, Camille; Liu, Wei-Qiao; Martinez, Jose; Zochodne, Douglas; Nguyen, Minh Dang] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada; [Shim, Su Yeon; Wang, Jian; Neumayer, Gernot; Belzil, Camille; Nguyen, Minh Dang] Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol & Anat, Calgary, AB, Canada; [Shim, Su Yeon; Wang, Jian; Jiang, Yulan; Neumayer, Gernot; Belzil, Camille; Nguyen, Minh Dang] Univ Calgary, Hotchkiss Brain Inst, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Nguyen, MD (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada.	mdnguyen@ucalgary.ca			Amyotrophic Lateral Sclerosis Societies of Canada/USA; Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research (CIHR) [New Investigator Award]; Human Frontier Science Program Organization (HFSPO) [Career Development Award]; Alberta Heritage Foundation for Medical Research (AHFMR) [Scholarship]; Brenda Strafford Foundation Chair in Alzheimer research	Amyotrophic Lateral Sclerosis Societies of Canada/USA; Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Brenda Strafford Foundation Chair in Alzheimer research	This work was supported by the Amyotrophic Lateral Sclerosis Societies of Canada/USA, the Multiple Sclerosis Society of Canada, the Canadian Institutes of Health Research (CIHR) (MDN). M.D.N. holds a Career Development Award from the Human Frontier Science Program Organization (HFSPO), a New Investigator Award from the CIHR, a Scholarship from the Alberta Heritage Foundation for Medical Research (AHFMR) and the Brenda Strafford Foundation Chair in Alzheimer research.	Boyne LJ, 1996, INT J DEV NEUROSCI, V14, P739, DOI 10.1016/S0736-5748(96)00053-6; Chang L, 2006, J CELL BIOL, V172, P747, DOI 10.1083/jcb.200511033; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; DELEON M, 1991, J NEUROSCI RES, V29, P437; DENECHAUD B, 1986, J NEUROCHEM, V46, P708; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dubey M, 2004, J NEUROSCI RES, V78, P245, DOI 10.1002/jnr.20146; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; GILLEN C, 1995, J NEUROSCI RES, V42, P159, DOI 10.1002/jnr.490420203; Guzik BW, 2004, CURR OPIN CELL BIOL, V16, P443, DOI 10.1016/j.ceb.2004.06.002; Hanz S, 2006, J NEUROCHEM, V99, P13, DOI 10.1111/j.1471-4159.2006.04089.x; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2006, HUM MOL GENET, V15, P3313, DOI 10.1093/hmg/ddl407; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; Mackie S, 2007, CURR OPIN NEUROBIOL, V17, P95, DOI 10.1016/j.conb.2007.01.007; Maier IC, 2006, PHILOS T R SOC B, V361, P1611, DOI 10.1098/rstb.2006.1890; McDonald DS, 2003, J NEUROSCI METH, V122, P171, DOI 10.1016/S0165-0270(02)00319-9; Menet V, 2003, P NATL ACAD SCI USA, V100, P8999, DOI 10.1073/pnas.1533187100; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Nguyen MD, 2004, NAT CELL BIOL, V6, P595, DOI 10.1038/ncb1139; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; OBLINGER MM, 1989, J NEUROSCI, V9, P2645; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Pekny M, 2001, Prog Brain Res, V132, P23; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; SHEA TB, 1993, J NEUROSCI RES, V36, P66, DOI 10.1002/jnr.490360108; SHIM SY, 2008, J BIOL CHEM; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Teng FYH, 2006, J NEUROCHEM, V96, P1501, DOI 10.1111/j.1471-4159.2006.03663.x; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; TROY CM, 1990, BRAIN RES, V529, P232, DOI 10.1016/0006-8993(90)90832-V; Vita G, 1998, NEUROREPORT, V9, P697, DOI 10.1097/00001756-199803090-00025; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Wynshaw-Boris A, 2001, GENE DEV, V15, P639, DOI 10.1101/gad.886801; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	47	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2014	10.1371/journal.pone.0002014	http://dx.doi.org/10.1371/journal.pone.0002014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431495	Green Submitted, Green Published, gold			2022-12-27	WOS:000261558700030
J	Aoun, E; Chang, CCH; Greer, JB; Papachristou, GI; Barmada, MM; Whitcomb, DC				Aoun, Elie; Chang, Chung-Chou H.; Greer, Julia B.; Papachristou, Georgios I.; Barmada, M. Michael; Whitcomb, David C.			Pathways to Injury in Chronic Pancreatitis: Decoding the Role of the High-Risk SPINK1 N34S Haplotype Using Meta-Analysis	PLOS ONE			English	Article							SECRETORY TRYPSIN-INHIBITOR; SERINE-PROTEASE INHIBITOR; CYSTIC-FIBROSIS GENE; KAZAL TYPE-1; CATHEPSIN-B; PSTI GENE; CFTR GENE; HEREDITARY PANCREATITIS; TROPICAL PANCREATITIS; JAPANESE PATIENTS	Background: The complex interactions between recurrent trypsin-mediated pancreatic injury, alcohol-associated pancreatic injury and SPINK1 polymorphisms in chronic pancreatitis (CP) are undefined. We hypothesize that CP occurs as a result of multiple pathological mechanisms (pathways) that are initiated by different metabolic or environmental factors (etiologies) and may be influenced differentially by downstream genetic risk factors. We tested this hypothesis by evaluating the differences in effect size of the high risk SPINK1 N34S haplotype on CP from multiple etiologies after combining clinical reports of SPINK1 N34S frequency using meta-analysis. Methods and Findings: The Pubmed and the Embase databases were reviewed. We studied 24 reports of SPINK1 N34S in CP (2,421 cases, 4,857 controls) using reported etiological factors as surrogates for pathways and multiple meta-analyses to determine the differential effects of SPINK1 N34S between alcoholic and non-alcoholic etiologies. Using estimates of between-study heterogeneity, we sub-classified our 24 studies into four specific clusters. We found that SPINK1 N34S is strongly associated with CP overall (OR 11.00; 95% CI: 7.59-15.93), but the effect of SPINK1 N34S in alcoholic CP (OR 4.98, 95% CI: 3.16-7.85) was significantly smaller than in idiopathic CP (OR 14.97, 95% C.I. = 9.09-24.67) or tropical CP (OR 19.15, 95% C. I. = 8.83-41.56). Studies analyzing familial CP showed very high heterogeneity suggestive of a complex etiology with an I 2 = 80.95%. Conclusion: The small effect of SPINK1 N34S in alcoholic subjects suggests that CP is driven through a different pathway that is largely trypsin-independent. The results also suggest that large effect sizes of SPINK1 N34S in small candidate gene studies in CP may be related to a mixture of multiple etiologic pathways leading to the same clinical endpoint.	[Aoun, Elie; Greer, Julia B.; Papachristou, Georgios I.; Whitcomb, David C.] Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15260 USA; [Chang, Chung-Chou H.] Univ Pittsburgh, Dept Gen Internal Med, Pittsburgh, PA USA; [Chang, Chung-Chou H.] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA USA; [Barmada, M. Michael; Whitcomb, David C.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Whitcomb, DC (corresponding author), Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15260 USA.	whitcomb@pitt.edu	Papachristou, Georgios/AAN-7619-2021	Barmada, M Michael/0000-0002-3604-6460	NIH [R01 DK61451, T32-DK063922]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061451, T32DK063922] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH R01 DK61451 (DCW) and T32-DK063922 (JBG).	Apte MV, 2000, GASTROENTEROLOGY, V118, P780, DOI 10.1016/S0016-5085(00)70148-X; Audrezet MP, 2002, EUR J HUM GENET, V10, P100, DOI 10.1038/sj.ejhg.5200786; Bachem MG, 2006, J GASTROEN HEPATOL, V21, pS92, DOI 10.1111/j.1440-1746.2006.04592.x; Bernardino Andrea L Ferreira, 2003, JOP, V4, P169; Bhatia E, 2002, GASTROENTEROLOGY, V123, P1020, DOI 10.1053/gast.2002.36028; Chandak GR, 2004, GUT, V53, P723, DOI 10.1136/gut.2003.026526; Chandak GR, 2002, J MED GENET, V39, P347, DOI 10.1136/jmg.39.5.347; Chen JM, 2001, GASTROENTEROLOGY, V120, P1061, DOI 10.1053/gast.2001.23094; Chen JM, 2000, J MED GENET, V37, P67, DOI 10.1136/jmg.37.1.67; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Deng XY, 2004, DIGEST DIS SCI, V49, P805, DOI 10.1023/B:DDAS.0000030093.25897.61; Drenth JPH, 2002, GUT, V50, P687, DOI 10.1136/gut.50.5.687; Etemad B, 2001, GASTROENTEROLOGY, V120, P682, DOI 10.1053/gast.2001.22586; Fortunato F, 2006, AM J PHYSIOL-GASTR L, V290, pG232, DOI 10.1152/ajpgi.00040.2005; Gomez-Lira M, 2003, EUR J HUM GENET, V11, P543, DOI 10.1038/sj.ejhg.5200989; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Hassan Z, 2002, AM J HUM GENET, V71, P964, DOI 10.1086/342731; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kaneko K, 2001, J HUM GENET, V46, P293, DOI 10.1007/s100380170082; Katz M, 1996, AM J PHYSIOL-GASTR L, V270, pG171, DOI 10.1152/ajpgi.1996.270.1.G171; Keiles S, 2006, PANCREAS, V33, P221, DOI 10.1097/01.mpa.0000232014.94974.75; Khalid A, 2006, GUT, V55, P728, DOI 10.1136/gut.2005.067959; Kume K, 2005, PANCREATOLOGY, V5, P354, DOI 10.1159/000086535; Lankisch PG, 2002, PANCREAS, V25, P411, DOI 10.1097/00006676-200211000-00015; LASSON A, 1986, SCAND J GASTROENTERO, V21, P1275, DOI 10.3109/00365528608996455; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; Lee KH, 2005, DIGEST DIS SCI, V50, P1852, DOI 10.1007/s10620-005-2950-9; Lempinen M, 2005, SCAND J GASTROENTERO, V40, P225, DOI 10.1080/00365520510011560; Mahurkar S, 2006, GUT, V55, P1270, DOI 10.1136/gut.2005.087403; Masamune A, 2007, J GASTROENTEROL, V42, P135, DOI 10.1007/s00535-006-1921-z; Matsubayashi H, 2003, CANCER BIOL THER, V2, P652; Noone PG, 2001, GASTROENTEROLOGY, V121, P1310, DOI 10.1053/gast.2001.29673; OGAWA M, 1988, CLIN BIOCHEM, V21, P19, DOI 10.1016/S0009-9120(88)80107-3; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Perri F, 2003, EUR J HUM GENET, V11, P687, DOI 10.1038/sj.ejhg.5201035; Pfutzer RH, 2000, GASTROENTEROLOGY, V119, P615, DOI 10.1053/gast.2000.18017; Plendl H, 2001, AM J MED GENET, V100, P252, DOI 10.1002/ajmg.1287; Rossi L, 2001, PANCREATOLOGY, V1, P242, DOI 10.1159/000055818; SARLES H, 1989, SCAND J GASTROENTERO, V24, P641; Schneider A, 2003, DIGEST DIS SCI, V48, P1110, DOI 10.1023/A:1023768829772; Schneider A, 2002, BEST PRACT RES CL GA, V16, P347, DOI 10.1053/bega.2002.0311; Schneider A, 2002, GASTROENTEROLOGY, V123, P1026, DOI 10.1053/gast.2002.36059; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Shimosegawa T, 2006, J GASTROEN HEPATOL, V21, pS47, DOI 10.1111/j.1440-1746.2006.04594.x; Sobczynska-Tomaszewska A, 2006, J PEDIATR GASTR NUTR, V43, P299, DOI 10.1097/01.mpg.0000232570.48773.df; STEER ML, 1995, NEW ENGL J MED, V332, P1482, DOI 10.1056/NEJM199506013322206; Szilagyi L, 2001, J BIOL CHEM, V276, P24574, DOI 10.1074/jbc.M011374200; Threadgold J, 2002, GUT, V50, P675, DOI 10.1136/gut.50.5.675; Trikalinos TA, 2004, EUR J HUM GENET, V12, P762, DOI 10.1038/sj.ejhg.5201227; Truninger K, 2002, AM J GASTROENTEROL, V97, P1133; Tzetis M, 2007, CLIN GENET, V71, P451, DOI 10.1111/j.1399-0004.2007.00788.x; Wang YL, 2006, PANCREAS, V32, P351, DOI 10.1097/01.mpa.0000220859.93496.e1; Warshaw AL, 1998, GASTROENTEROLOGY, V115, P765, DOI 10.1016/S0016-5085(98)70157-X; Whitcomb DC, 2004, NAT CLIN PRACT GASTR, V1, P46, DOI 10.1038/ncpgasthep0025; Whitcomb DC, 2004, GUT, V53, P1710, DOI 10.1136/gut.2003.015511; Whitcomb DC, 2006, NEW ENGL J MED, V354, P2142, DOI 10.1056/NEJMcp054958; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Whitcomb DC, 2005, DIGEST DIS SCI, V50, P2195, DOI 10.1007/s10620-005-3033-7; Whitcomb DC, 2002, AM J GASTROENTEROL, V97, P1085; WHITCOMB DC, 2007, CELL MOL LIFE SCI; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2001, JAMA-J AM MED ASSOC, V285, P2716, DOI 10.1001/jama.285.21.2716-a; Yadav D, 2007, GASTROENTEROL CLIN N, V36, P219, DOI 10.1016/j.gtc.2007.03.005	67	93	96	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e2003	10.1371/journal.pone.0002003	http://dx.doi.org/10.1371/journal.pone.0002003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414673	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000260867300022
J	Lanternier, F; Cohen-Akenine, A; Palmerini, F; Feger, F; Yang, Y; Zermati, Y; Barete, S; Sans, B; Baude, C; Ghez, D; Suarez, F; Delarue, R; Casassus, P; Bodemer, C; Catteau, A; Soppelsa, F; Hanssens, K; Arock, M; Sobol, H; Fraitag, S; Canioni, D; Moussy, A; Launay, JM; Dubreuil, P; Hermine, O; Lortholary, O				Lanternier, Fanny; Cohen-Akenine, Annick; Palmerini, Fabienne; Feger, Frederic; Yang, Ying; Zermati, Yael; Barete, Stephane; Sans, Beatrix; Baude, Cedric; Ghez, David; Suarez, Felipe; Delarue, Richard; Casassus, Philippe; Bodemer, Christine; Catteau, Adeline; Soppelsa, Frederique; Hanssens, Katia; Arock, Michel; Sobol, Hagay; Fraitag, Sylvie; Canioni, Daniele; Moussy, Alain; Launay, Jean Marie; Dubreuil, Patrice; Hermine, Olivier; Lortholary, Olivier		AFIRMM Network	Phenotypic and Genotypic Characteristics of Mastocytosis According to the Age of Onset	PLOS ONE			English	Article								Adult's mastocytosis is usually associated with persistent systemic involvement and c-kit 816 mutation, while pediatrics disease is mostly limited to the skin and often resolves spontaneously. We prospectively included 142 adult patients with histologically proven mastocytosis. We compared phenotypic and genotypic features of adults patients whose disease started during childhood (Group 1, n = 28) with those of patients whose disease started at adult's age (Group 2, n = 114). Genotypic analysis was performed on skin biopsy by sequencing of c-kit exons 17 and 8 to 13. According to WHO classification, the percentage of systemic disease was similar (75 vs. 73%) in 2 groups. C-kit 816 mutation was found in 42% and 77% of patients in groups 1 and 2, respectively (p < 0.001). 816 c-kit mutation was associated with systemic mastocytosis in group 2 (87% of patients with systemic mastocytosis vs. 45% with cutaneous mastocytosis, p = 0.0001). Other c-kit activating mutations were found in 23% of patients with mastocytosis' onset before the age of 5, 0% between 6 and 15 years and 2% at adults' age (p < 0.001). In conclusion, pathogenesis of mastocytosis significantly differs according to the age of disease's onset. Our data may have major therapeutic relevance when considering c-kit-targeted therapy.	[Lanternier, Fanny; Lortholary, Olivier] Univ Paris 05, Serv Malad Infect & Trop, Ctr Reference Mastocytoses, Hop Necker Enfants Malad,Ctr Infectol Necker Past, Paris, France; [Cohen-Akenine, Annick; Baude, Cedric; Catteau, Adeline; Soppelsa, Frederique; Hanssens, Katia; Moussy, Alain] AFIRMM Network, Paris, France; [Palmerini, Fabienne; Yang, Ying; Dubreuil, Patrice] Hematopoiise Mol Fonct, U599, Inserm, Ctr Rech Cancerol Marseille, Marseille, France; [Palmerini, Fabienne; Yang, Ying; Sobol, Hagay; Dubreuil, Patrice] Inst Paoli Calmettes, Dept Biopathol, Marseille, France; [Palmerini, Fabienne; Yang, Ying; Dubreuil, Patrice] Univ Aix Marseille 2, Marseille, France; [Feger, Frederic; Arock, Michel] Ecole Normale Superieure Cachan, CNRS UMR8113, Lab Biotechnol Pharmacol Genet Appl, Cachan, France; [Barete, Stephane] Hop Tenon, Ctr reference mastocytoses, Serv Dermatol, Paris, France; [Sans, Beatrix] Hop Purpan, Serv Dermatol, Toulouse, France; [Ghez, David; Suarez, Felipe; Delarue, Richard; Hermine, Olivier] Univ Paris 05, Hop Necker Enfants malades, Ctr reference mastocytoses, IFR Necker, Serv Hematol, Paris, France; [Casassus, Philippe] Hop Avicenne, Serv Hematol, Bobigny, France; [Bodemer, Christine] Univ Paris 05, Hop Necker Enfants malades, Ctr reference mastocytoses, IFR Necker, Serv Dermatol, Paris, France; [Fraitag, Sylvie; Canioni, Daniele] Hop Necker Enfants Malad, Serv Anatomopathol, Paris, France; [Zermati, Yael; Launay, Jean Marie] Hop Lariboisiere, Serv Biochim, Paris, France; [Hermine, Olivier] CNRS, UMR 8147, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Lanternier, F (corresponding author), Univ Paris 05, Serv Malad Infect & Trop, Ctr Reference Mastocytoses, Hop Necker Enfants Malad,Ctr Infectol Necker Past, Paris, France.	hermine@necker.fr; olivier.lortholary@nck.aphp.fr	Hermine, Olivier/Q-7072-2018; dubreuil, patrice/F-5346-2011; Lanternier, Fanny/AAQ-2815-2021; Dubreuil, Patrice/V-4816-2019	dubreuil, patrice/0000-0003-1155-1150; Dubreuil, Patrice/0000-0003-1155-1150; Hermine, Olivier/0000-0003-2574-3874				AZANA JM, 1994, PEDIATR DERMATOL, V11, P102, DOI 10.1111/j.1525-1470.1994.tb00560.x; Buttner C, 1998, J INVEST DERMATOL, V111, P1227, DOI 10.1046/j.1523-1747.1998.00414.x; CZARNETZKI BM, 1988, J AM ACAD DERMATOL, V18, P45, DOI 10.1016/S0190-9622(88)70007-9; Escribano L, 1998, BLOOD, V91, P2731, DOI 10.1182/blood.V91.8.2731.2731_2731_2736; Fearfield LA, 2001, BRIT J DERMATOL, V144, P561, DOI 10.1046/j.1365-2133.2001.04084.x; Fraitag-Spinner S, 2007, ANN DERMATOL VENER, V134, P589, DOI 10.1016/S0151-9638(07)89281-7; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; GARCIAMONTERO AC, 2006, BLOOD, P2006; Hartmann K, 2000, HEMATOL ONCOL CLIN N, V14, P625, DOI 10.1016/S0889-8588(05)70299-9; Hartmann K, 2005, GASTROENTEROLOGY, V129, P1042, DOI 10.1053/j.gastro.2005.06.060; Horny HP, 2001, LEUKEMIA RES, V25, P543, DOI 10.1016/S0145-2126(01)00021-2; Hup MMA, 2002, J EUR ACAD DERMATOL, V16, P115, DOI 10.1046/j.1468-3083.2002.00370.x; IEMURA A, 1994, AM J PATHOL, V144, P321; Longley BJ, 1999, P NATL ACAD SCI USA, V96, P1609, DOI 10.1073/pnas.96.4.1609; MEKORI YA, 1993, J IMMUNOL, V151, P3775; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; RODERMUND OE, 1978, DERMATOL MONATSSCHR, V164, P493; Valent P, 2003, BRIT J HAEMATOL, V122, P695, DOI 10.1046/j.1365-2141.2003.04575.x; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Worobec AS, 1998, CANCER, V83, P2120, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2120::AID-CNCR10>3.0.CO;2-C; Yanagihori H, 2005, J MOL DIAGN, V7, P252, DOI 10.1016/S1525-1578(10)60552-1; Zhang LY, 2006, LEUKEMIA RES, V30, P373, DOI 10.1016/j.leukres.2005.08.015	22	69	70	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1906	10.1371/journal.pone.0001906	http://dx.doi.org/10.1371/journal.pone.0001906			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18404201	Green Published, gold			2022-12-27	WOS:000260795500002
J	Ma, XT; Tarone, AM; Li, WY				Ma, Xiaotu; Tarone, Aaron M.; Li, Wenyuan			Mapping Genetically Compensatory Pathways from Synthetic Lethal Interactions in Yeast	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CHITIN SYNTHESIS; DELETION; NETWORK	Background: Synthetic lethal genetic interaction analysis has been successfully applied to predicting the functions of genes and their pathway identities. In the context of synthetic lethal interaction data alone, the global similarity of synthetic lethal interaction patterns between two genes is used to predict gene function. With physical interaction data, such as protein-protein interactions, the enrichment of physical interactions within subsets of genes and the enrichment of synthetic lethal interactions between those subsets of genes are used as an indication of compensatory pathways. Result: In this paper, we propose a method of mapping genetically compensatory pathways from synthetic lethal interactions. Our method is designed to discover pairs of gene-sets in which synthetic lethal interactions are depleted among the genes in an individual set and where such gene-set pairs are connected by many synthetic lethal interactions. By its nature, our method could select compensatory pathway pairs that buffer the deleterious effect of the failure of either one, without the need of physical interaction data. By focusing on compensatory pathway pairs where genes in each individual pathway have a highly homogenous cellular function, we show that many cellular functions have genetically compensatory properties. Conclusion: We conclude that synthetic lethal interaction data are a powerful source to map genetically compensatory pathways, especially in systems lacking physical interaction information, and that the cellular function network contains abundant compensatory properties.	[Ma, Xiaotu; Tarone, Aaron M.; Li, Wenyuan] Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA	University of Southern California	Ma, XT (corresponding author), Univ So Calif, Dept Biol Sci, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.	xma@usc.edu	Tarone, Aaron/I-6483-2012	Tarone, Aaron/0000-0003-0965-7634	NIH [P50 HG 002790]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is partly supported by NIH grant P50 HG 002790	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KARP G, 1999, CELL MOL BIOL, P292; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Lesage G, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-8; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Munro S, 2001, FEBS LETT, V498, P223, DOI 10.1016/S0014-5793(01)02488-7; Nash R, 2007, NUCLEIC ACIDS RES, V35, pD468, DOI 10.1093/nar/gkl931; Osmond BC, 1999, P NATL ACAD SCI USA, V96, P11206, DOI 10.1073/pnas.96.20.11206; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Ulitsky I, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100144; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Ye P, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100034; Yoko-o T, 2003, GLYCOBIOLOGY, V13, P581, DOI 10.1093/glycob/cwg063	25	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1922	10.1371/journal.pone.0001922	http://dx.doi.org/10.1371/journal.pone.0001922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398455	gold, Green Published, Green Submitted			2022-12-27	WOS:000260795500006
J	Stensmyr, MC; Stieber, R; Hansson, BS				Stensmyr, Marcus C.; Stieber, Regina; Hansson, Bill S.			The Cayman Crab Fly Revisited - Phylogeny and Biology of Drosophila endobranchia	PLOS ONE			English	Article							POPULATION; EVOLUTION; SOFTWARE; DIPTERA; DDC	Background: The majority of all known drosophilid flies feed on microbes. The wide spread of microorganisms consequently mean that drosophilids also can be found on a broad range of substrates. One of the more peculiar types of habitat is shown by three species of flies that have colonized land crabs. In spite of their intriguing lifestyle, the crab flies have remained poorly studied. Perhaps the least investigated of the three crab flies is the Cayman Island endemic Drosophila endobranchia. Apart from its life cycle very little is known about this species, including its phylogenetic position, which has remained unresolved due to a cryptic set of characteristics. Principal Findings: Based on molecular data, corroborated by a re-analysis of the morphological make up, we have resolved the phylogenetic position of D. endobranchia and show that it somewhat surprisingly belongs to the large Neotropical repleta radiation, and should be considered as an aberrant member of the canalinea species group. Furthermore we also provide additional data on the behavior of these remarkable flies. Conclusion: Our findings reveal that the two Caribbean crab flies are not as distantly related as first thought, as both species are members of the derived repleta radiation. That this lineage has given rise to two species with the same odd type of breeding substrate is curious and prompts the question of what aspects of their shared ancestry has made these flies suitable for a life on (and inside) land crabs. Knowledge of the phylogenetic position of D. endobranchia will allow for comparative explorations and will aid in efforts aimed at understanding processes involved in drastic host shifts and extreme specialization.	[Stensmyr, Marcus C.; Stieber, Regina; Hansson, Bill S.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany	Max Planck Society	Stensmyr, MC (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany.	mstensmyr@ice.mpg.de	Hansson, Bill S/G-2774-2013	Hansson, Bill S/0000-0002-4811-1223; Stensmyr, Marcus/0000-0003-4009-9212	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Max Planck Society	Bonacum J, 2005, MOL PHYLOGENET EVOL, V37, P73, DOI 10.1016/j.ympev.2005.03.008; CARSON HL, 1974, P NATL ACAD SCI USA, V71, P3517, DOI 10.1073/pnas.71.9.3517; CARSON HL, 1968, ANN ENTOMOL SOC AM, V61, P675, DOI 10.1093/aesa/61.3.675; Clayton F.E., 1957, U TEXAS PUBLS, V5721, P125; Duda O., 1927, Archiv fuer Naturgeschichte Berlin, V91, P1; Gershenson S, 1928, GENETICS, V13, P488; Grimaldi D.A., 1988, P183; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAMPTON L, CARSON PAPERS AM PHI; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaenike J, 1996, AM NAT, V148, P237, DOI 10.1086/285923; Klaus AV, 2003, J MICROSC-OXFORD, V212, P107, DOI 10.1046/j.1365-2818.2003.01235.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Liu H, 1992, MOL PHYLOGENET EVOL, V1, P41, DOI 10.1016/1055-7903(92)90034-E; Malloch J. R., 1926, Proceedings of the United States National Museum, V68, P1; Medeiros Hermes Fonsêca de, 2004, Biota Neotrop., V4, P01, DOI 10.1590/S1676-06032004000100005; PIPKIN SB, 1965, AM MIDL NAT, V74, P1, DOI 10.2307/2423115; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ratcov V, 2007, IHERINGIA SER ZOOL, V97, P336, DOI 10.1590/S0073-47212007000300019; Remsen J, 2002, MOL PHYLOGENET EVOL, V24, P249, DOI 10.1016/S1055-7903(02)00226-9; Rudolfs W., 1922, B NEW JERSEY AGR EXP, V367, P1; Stensmyr MC, 2007, CURR BIOL, V17, pR743, DOI 10.1016/j.cub.2007.06.015; Sturtevant AH., 1921, CARNEGIE I WASH YR B, V301, P1; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tatarenkov A, 1999, J MOL EVOL, V48, P445, DOI 10.1007/PL00006489; Tatarenkov A, 2001, MOL PHYLOGENET EVOL, V20, P321, DOI 10.1006/mpev.2001.0967; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Throckmorton L.H., 1975, P421; Throckmorton LH, 1962, U TEXAS PUBL, V6205, P207, DOI DOI 10.1016/J.YMPEV.2011.04.012; VILELA C R, 1990, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V63, P1; Wheeler M.R., 1957, U TEXAS PUBL, V5721, P79; Wheeler M.R., 1970, CATALOGUE DIPTERA AM; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	34	8	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1942	10.1371/journal.pone.0001942	http://dx.doi.org/10.1371/journal.pone.0001942			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398468	Green Submitted, Green Published, gold			2022-12-27	WOS:000260795500019
J	Wang, HR; Liang, SY; Burgdorf, J; Wess, J; Yeomans, J				Wang, Haoran; Liang, Shuyin; Burgdorf, Jeffrey; Wess, Jurgen; Yeomans, John			Ultrasonic Vocalizations Induced by Sex and Amphetamine in M2, M4, M5 Muscarinic and D2 Dopamine Receptor Knockout Mice	PLOS ONE			English	Article								Adult mice communicate by emitting ultrasonic vocalizations (USVs) during the appetitive phases of sexual behavior. However, little is known about the genes important in controlling call production. Here, we study the induction and regulation of USVs in muscarinic and dopaminergic receptor knockout (KO) mice as well as wild-type controls during sexual behavior. Female mouse urine, but not female rat or human urine, induced USVs in male mice, whereas male urine did not induce USVs in females. Direct contact of males with females is required for eliciting high level of USVs in males. USVs (25 to 120 kHz) were emitted only by males, suggesting positive state; however human-audible squeaks were produced only by females, implying negative state during male-female pairing. USVs were divided into flat and frequency-modulated calls. Male USVs often changed from continuous to broken frequency-modulated calls after initiation of mounting. In M2 KO mice, USVs were lost in about 70-80% of the mice, correlating with a loss of sexual interaction. In M5 KO mice, mean USVs were reduced by almost 80% even though sexual interaction was vigorous. In D2 KOs, the duration of USVs was extended by 20%. In M4 KOs, no significant differences were observed. Amphetamine dose-dependently induced USVs in wild-type males (most at 0.5 mg/kg i.p.), but did not elicit USVs in M5 KO or female mice. These studies suggest that M2 and M5 muscarinic receptors are needed for male USV production during male-female interactions, likely via their roles in dopamine activation. These findings are important for the understanding of the neural substrates for positive affect.	[Wang, Haoran; Liang, Shuyin; Yeomans, John] Univ Toronto, Dept Psychol, CTBC, Toronto, ON M5S 1A1, Canada; [Burgdorf, Jeffrey] Northwestern Univ, Falk Ctr Mol Therapeut, Evanston, IL USA; [Wess, Jurgen] NIH, NIDDK, Lab Bioorgan Chem, Bethesda, MD USA	University of Toronto; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wang, HR (corresponding author), Univ Toronto, Dept Psychol, CTBC, Toronto, ON M5S 1A1, Canada.	haoranw@psych.toronto.edu; yeomans@psych.toronto.edu	Burgdorf, Jeffrey S/G-9552-2012		CIHR; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK031133] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	CIHR grants to JY	Adell A, 2004, NEUROSCI BIOBEHAV R, V28, P415, DOI 10.1016/j.neubiorev.2004.05.001; Basile AS, 2002, P NATL ACAD SCI USA, V99, P11452, DOI 10.1073/pnas.162371899; Blanchard DC, 2001, NEUROSCI BIOBEHAV R, V25, P205, DOI 10.1016/S0149-7634(01)00009-4; Brennan PA, 2004, HORM BEHAV, V46, P231, DOI 10.1016/j.yhbeh.2004.01.010; Brudzynski SM, 2007, BEHAV BRAIN RES, V182, P261, DOI 10.1016/j.bbr.2007.03.004; Burgdorf J, 2005, BEHAV GENET, V35, P67, DOI 10.1007/s10519-004-0856-5; BYATT S, 1986, HORM BEHAV, V20, P60, DOI 10.1016/0018-506X(86)90029-2; Ciucci MR, 2007, BEHAV BRAIN RES, V182, P284, DOI 10.1016/j.bbr.2007.02.020; D'Amato FR, 2001, BEHAV NEUROSCI, V115, P834, DOI 10.1037//0735-7044.115.4.834; Dockstader CL, 2001, EUR J NEUROSCI, V13, P995, DOI 10.1046/j.1460-9568.2001.01455.x; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; El-Khodor BF, 2004, INT J DEV NEUROSCI, V22, P405, DOI 10.1016/j.ijdevneu.2004.06.001; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Fallon S, 2007, NEUROCHEM RES, V32, P1772, DOI 10.1007/s11064-007-9343-8; FLYNN DD, 1995, J NEUROCHEM, V64, P1888; Forster GL, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0001.2002; Fride E, 2005, BEHAV PHARMACOL, V16, P431, DOI 10.1097/00008877-200509000-00016; Garcia-Alloza M, 2005, NEUROPSYCHOLOGIA, V43, P442, DOI 10.1016/j.neuropsychologia.2004.06.007; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P10483, DOI 10.1073/pnas.96.18.10483; Guo ZS, 2007, CHEM SENSES, V32, P463, DOI 10.1093/chemse/bjm015; Hahn ME, 2002, BEHAV GENET, V32, P267, DOI 10.1023/A:1019728813891; Hahn ME, 1998, BEHAV GENET, V28, P315, DOI 10.1023/A:1021679615792; Hahn ME, 1997, BEHAV GENET, V27, P133, DOI 10.1023/A:1025637408900; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Hull EM, 2007, HORM BEHAV, V52, P45, DOI 10.1016/j.yhbeh.2007.03.030; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Ikemoto S, 1997, J NEUROSCI, V17, P8580; Jarskog LF, 2007, ANNU REV MED, V58, P49, DOI 10.1146/annurev.med.58.060904.084114; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961; Ko SW, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-10; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; MCINTOSH TK, 1978, NATURE, V272, P163, DOI 10.1038/272163a0; Miller AD, 2005, NEUROSCIENCE, V136, P531, DOI 10.1016/j.neuroscience.2005.08.035; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Moles A, 2000, ANIM BEHAV, V60, P689, DOI 10.1006/anbe.2000.1504; Moles A, 2007, BEHAV BRAIN RES, V182, P223, DOI 10.1016/j.bbr.2007.01.020; Niva Y, 2007, ANN NY ACAD SCI, V1104, P357, DOI 10.1196/annals.1390.018; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Petrulis A, 2005, NEUROSCIENCE, V130, P259, DOI 10.1016/j.neuroscience.2004.09.001; Picker JD, 2006, NEUROREPORT, V17, P541, DOI 10.1097/01.wnr.0000208995.38695.2f; POMERANTZ SM, 1983, PHYSIOL BEHAV, V31, P91, DOI 10.1016/0031-9384(83)90101-4; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Raedler TJ, 2007, MOL PSYCHIATR, V12, P232, DOI 10.1038/sj.mp.4001924; ROBERTS LH, 1975, ULTRASONICS, V13, P83, DOI 10.1016/0041-624X(75)90052-9; Roubertoux PL, 1996, BEHAV GENET, V26, P427, DOI 10.1007/BF02359487; SALES GD, 1972, ANIM BEHAV, V20, P88, DOI 10.1016/S0003-3472(72)80177-5; Sanjuan J, 2006, PSYCHIAT GENET, V16, P67, DOI 10.1097/01.ypg.0000185029.35558.bb; SCATTONI ML, 2007, BEHAV BRAIN RES; Schehka S, 2007, J COMP PHYSIOL A, V193, P845, DOI 10.1007/s00359-007-0236-8; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; SIPOS ML, 1995, PHYSIOL BEHAV, V58, P529, DOI 10.1016/0031-9384(95)00089-2; SIPOS ML, 1992, BEHAV NEURAL BIOL, V58, P138, DOI 10.1016/0163-1047(92)90375-E; Takeuchi J, 2002, PHARMACOL BIOCHEM BE, V72, P117, DOI 10.1016/S0091-3057(01)00725-0; Thompson RN, 2007, J EXP BIOL, V210, P1406, DOI 10.1242/jeb.02753; Thornton LM, 2005, BEHAV GENET, V35, P73, DOI 10.1007/s10519-004-0857-4; Tzavaral ET, 2003, MOL PSYCHIATR, V8, P673, DOI 10.1038/sj.mp.4001270; VILARO MT, 1990, NEUROSCI LETT, V114, P154, DOI 10.1016/0304-3940(90)90064-G; Wang HR, 2007, GENOMICS, V89, P59, DOI 10.1016/j.ygeno.2006.07.009; Wang HR, 2004, NEUROPSYCHOPHARMACOL, V29, P2126, DOI 10.1038/sj.npp.1300502; Wess J, 2003, RECEPTOR CHANNEL, V9, P279, DOI 10.3109/10606820308262; White NR, 1998, PHYSIOL BEHAV, V63, P467, DOI 10.1016/S0031-9384(97)00484-8; Winslow JT, 2000, HORM BEHAV, V37, P145, DOI 10.1006/hbeh.1999.1566; Wintink AJ, 2001, PHARMACOL BIOCHEM BE, V70, P317, DOI 10.1016/S0091-3057(01)00615-3; Wohr M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001365; Yeomans J, 2001, LIFE SCI, V68, P2449, DOI 10.1016/S0024-3205(01)01038-4; Yeomans JS, 2000, J NEUROSCI, V20, P8861; Zeesman S, 2006, AM J MED GENET A, V140A, P509, DOI 10.1002/ajmg.a.31110; Zhang WL, 2002, J NEUROSCI, V22, P6347; ZIPPELIUS HM, 1956, NATURWISSENSCHAFTEN, V43, P501	73	94	96	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1893	10.1371/journal.pone.0001893	http://dx.doi.org/10.1371/journal.pone.0001893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382674	gold, Green Submitted, Green Published			2022-12-27	WOS:000260795400025
J	Wee, KB; Pramono, ZAD; Wang, JL; MacDorman, KF; Lai, PS; Yee, WC				Wee, Keng Boon; Pramono, Zacharias Aloysius Dwi; Wang, Jian Li; MacDorman, Karl F.; Lai, Poh San; Yee, Woon Chee			Dynamics of Co-Transcriptional Pre-mRNA Folding Influences the Induction of Dystrophin Exon Skipping by Antisense Oligonucleotides	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SECONDARY STRUCTURE; SPLICING ENHANCERS; NONSENSE MUTATION; SYSTEMIC DELIVERY; GENE-EXPRESSION; IN-VITRO; RESTORATION; PREDICTION; DIAGNOSIS	Antisense oligonucleotides (AONs) mediated exon skipping offers potential therapy for Duchenne muscular dystrophy. However, the identification of effective AON target sites remains unsatisfactory for lack of a precise method to predict their binding accessibility. This study demonstrates the importance of co-transcriptional pre-mRNA folding in determining the accessibility of AON target sites for AON induction of selective exon skipping in DMD. Because transcription and splicing occur in tandem, AONs must bind to their target sites before splicing factors. Furthermore, co-transcriptional pre-mRNA folding forms transient secondary structures, which redistributes accessible binding sites. In our analysis, to approximate transcription elongation, a "window of analysis'' that included the entire targeted exon was shifted one nucleotide at a time along the pre-mRNA. Possible co-transcriptional secondary structures were predicted using the sequence in each step of transcriptional analysis. A nucleotide was considered "engaged'' if it formed a complementary base pairing in all predicted secondary structures of a particular step. Correlation of frequency and localisation of engaged nucleotides in AON target sites accounted for the performance (efficacy and efficiency) of 94% of 176 previously reported AONs. Four novel insights are inferred: (1) the lowest frequencies of engaged nucleotides are associated with the most efficient AONs; (2) engaged nucleotides at 39 or 59 ends of the target site attenuate AON performance more than at other sites; (3) the performance of longer AONs is less attenuated by engaged nucleotides at 39 or 59 ends of the target site compared to shorter AONs; (4) engaged nucleotides at 39 end of a short target site attenuates AON efficiency more than at 59 end.	[Wee, Keng Boon] Bioinformat Inst, Singapore, Singapore; [Pramono, Zacharias Aloysius Dwi; Wang, Jian Li; Yee, Woon Chee] Natl Neurosci Inst, Neuromuscul Res Lab, Singapore, Singapore; [Yee, Woon Chee] Natl Neurosci Inst, Dept Neurol, Singapore, Singapore; [MacDorman, Karl F.] Indiana Univ, Sch Informat, Indianapolis, IN USA; [Lai, Poh San] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore; [Wee, Keng Boon] Natl Univ Singapore, Ctr Life Sci, Grad Sch Integrat Sci & Engn, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National Neuroscience Institute (NNI); National Neuroscience Institute (NNI); Indiana University System; Indiana University-Purdue University Indianapolis; National University of Singapore; National University of Singapore	Wee, KB (corresponding author), Bioinformat Inst, Singapore, Singapore.	dwi_pramono@nni.com.sg	MacDorman, Karl/AAH-4483-2020; wang, jian/GVS-0711-2022	MacDorman, Karl/0000-0003-1093-4184; 	National Medical Research Council of Singapore [NMRC/0938/2005]; SingHealth [NHGA-STP/04022]; A*STAR Graduate Scholarship	National Medical Research Council of Singapore(National Medical Research Council, Singapore); SingHealth(SingHealth); A*STAR Graduate Scholarship(Agency for Science Technology & Research (A*STAR))	Grants from the National Medical Research Council of Singapore (NMRC/0938/2005) and SingHealth (NHGA-STP/04022) supported this study. K.B. Wee is a recipient of an A*STAR Graduate Scholarship. There is no financial interest in this manuscript from any of the above funding organizations.	Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Aartsma-Rus A, 2005, OLIGONUCLEOTIDES, V15, P284, DOI 10.1089/oli.2005.15.284; Aartsma-Rus A, 2004, AM J HUM GENET, V74, P83, DOI 10.1086/381039; Aartsma-Rus A, 2006, MOL THER, V14, P401, DOI 10.1016/j.ymthe.2006.02.022; ALBERTS B, 2002, MOL BIOL CELL, P317; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2; BEYER AL, 1988, GENE DEV, V2, P754, DOI 10.1101/gad.2.6.754; Blencowe BJ, 2000, TRENDS BIOCHEM SCI, V25, P106, DOI 10.1016/S0968-0004(00)01549-8; BOYLE J, 1980, J MOL BIOL, V139, P601, DOI 10.1016/0022-2836(80)90051-0; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chalk AM, 2002, BIOINFORMATICS, V18, P1567, DOI 10.1093/bioinformatics/18.12.1567; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Ding Y, 2003, NUCLEIC ACIDS RES, V31, P7280, DOI 10.1093/nar/gkg938; DOMINSKI Z, 1993, P NATL ACAD SCI USA, V90, P8673, DOI 10.1073/pnas.90.18.8673; EPERON LP, 1988, CELL, V54, P393, DOI 10.1016/0092-8674(88)90202-4; Errington SJ, 2003, J GENE MED, V5, P518, DOI 10.1002/jgm.361; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fall Abbie M, 2006, Genet Vaccines Ther, V4, P3, DOI 10.1186/1479-0556-4-3; Far RKK, 2003, NUCLEIC ACIDS RES, V31, P4417, DOI 10.1093/nar/gkg649; Flamm C, 2000, RNA, V6, P325, DOI 10.1017/S1355838200992161; Goldstrohm AC, 2001, GENE, V277, P31, DOI 10.1016/S0378-1119(01)00695-3; Gorman L, 2000, J BIOL CHEM, V275, P35914, DOI 10.1074/jbc.M006259200; Graveley BR, 1999, CURR BIOL, V9, pR6, DOI 10.1016/S0960-9822(99)80032-3; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Harding PL, 2007, MOL THER, V15, P157, DOI 10.1038/sj.mt.6300006; Harlepp S, 2003, EUR PHYS J E, V12, P605, DOI 10.1140/epje/e2004-00033-4; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; KRAMER FR, 1981, NUCLEIC ACIDS RES, V9, P5109, DOI 10.1093/nar/9.19.5109; Lam BJ, 2002, RNA, V8, P1233, DOI 10.1017/S1355838202028030; Lehmann MJ, 2000, NUCLEIC ACIDS RES, V28, P2597, DOI 10.1093/nar/28.13.2597; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Matsuo M, 1996, BRAIN DEV-JPN, V18, P167, DOI 10.1016/0387-7604(96)00007-1; Matsuo M, 2005, Acta Myol, V24, P110; Matsuo M, 2002, IUBMB LIFE, V53, P147, DOI 10.1080/15216540212333; McClorey G, 2006, NEUROMUSCULAR DISORD, V16, P583, DOI 10.1016/j.nmd.2006.05.017; McClorey G, 2006, GENE THER, V13, P1373, DOI 10.1038/sj.gt.3302800; Mercatante DR, 2001, CURR CANCER DRUG TAR, V1, P211, DOI 10.2174/1568009013334124; Meyer IM, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-10; Muntoni Francesco, 2005, Neuromuscul Disord, V15, P450, DOI 10.1016/j.nmd.2005.02.007; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Nowakowski J., 1999, OXFORD HDB NUCL ACID, P567; OSHEIM YN, 1985, CELL, V43, P143, DOI 10.1016/0092-8674(85)90019-4; Pramono ZAD, 1996, BIOCHEM BIOPH RES CO, V226, P445, DOI 10.1006/bbrc.1996.1375; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Repsilber D, 1999, RNA, V5, P574, DOI 10.1017/S1355838299982018; Sazani P, 2003, J CLIN INVEST, V112, P481, DOI 10.1172/JCI200319547; Sczakiel G, 2000, FRONT BIOSCI, V5, pD194, DOI 10.2741/Sczakiel; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Surono A, 2004, HUM GENE THER, V15, P749, DOI 10.1089/1043034041648444; Suwanmanee T, 2002, MOL THER, V6, P718, DOI 10.1006/mthe.2002.0805; Takeshima Y, 2006, PEDIATR RES, V59, P690, DOI 10.1203/01.pdr.0000215047.51278.7c; TENNYSON CN, 1995, NAT GENET, V9, P184, DOI 10.1038/ng0295-184; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; van Deutekom JCT, 2001, HUM MOL GENET, V10, P1547, DOI 10.1093/hmg/10.15.1547; Vetrini F, 2006, HUM MUTAT, V27, P420, DOI 10.1002/humu.20303; Vickers TA, 2000, NUCLEIC ACIDS RES, V28, P1340, DOI 10.1093/nar/28.6.1340; Wang JH, 2005, NUCLEIC ACIDS RES, V33, P5053, DOI 10.1093/nar/gki810; Wells DJ, 2006, J MUSCLE RES CELL M, V27, P387, DOI 10.1007/s10974-006-9081-6; Wilton SD, 2005, CURR GENE THER, V5, P467, DOI 10.2174/156652305774329249; Wilton SD, 2005, NEUROMUSCULAR DISORD, V15, P399, DOI 10.1016/j.nmd.2005.03.003; Wilton SD, 1999, NEUROMUSCULAR DISORD, V9, P330, DOI 10.1016/S0960-8966(99)00010-3; Wilton SD, 2007, MOL THER, V15, P1288, DOI 10.1038/sj.mt.6300095; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	70	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1844	10.1371/journal.pone.0001844	http://dx.doi.org/10.1371/journal.pone.0001844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365002	Green Published, Green Submitted, gold			2022-12-27	WOS:000260762400008
J	Kliebenstein, DJ				Kliebenstein, Daniel J.			A Role for Gene Duplication and Natural Variation of Gene Expression in the Evolution of Metabolism	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; GLUCOSINOLATE BIOSYNTHESIS; SECONDARY METABOLITES; INSECT RESISTANCE; GIBBERELLIC-ACID; DIVERSITY; PATHWAY; DIVERSIFICATION; DIVERGENCE; HYDROLYSIS	Background: Most eukaryotic genomes have undergone whole genome duplications during their evolutionary history. Recent studies have shown that the function of these duplicated genes can diverge from the ancestral gene via neo-or sub-functionalization within single genotypes. An additional possibility is that gene duplicates may also undergo partitioning of function among different genotypes of a species leading to genetic differentiation. Finally, the ability of gene duplicates to diverge may be limited by their biological function. Methodology/Principal Findings: To test these hypotheses, I estimated the impact of gene duplication and metabolic function upon intraspecific gene expression variation of segmental and tandem duplicated genes within Arabidopsis thaliana. In all instances, the younger tandem duplicated genes showed higher intraspecific gene expression variation than the average Arabidopsis gene. Surprisingly, the older segmental duplicates also showed evidence of elevated intraspecific gene expression variation albeit typically lower than for the tandem duplicates. The specific biological function of the gene as defined by metabolic pathway also modulated the level of intraspecific gene expression variation. The major energy metabolism and biosynthetic pathways showed decreased variation, suggesting that they are constrained in their ability to accumulate gene expression variation. In contrast, a major herbivory defense pathway showed significantly elevated intraspecific variation suggesting that it may be under pressure to maintain and/or generate diversity in response to fluctuating insect herbivory pressures. Conclusion: These data show that intraspecific variation in gene expression is facilitated by an interaction of gene duplication and biological activity. Further, this plays a role in controlling diversity of plant metabolism.	[Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Kliebenstein, DJ (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	Kliebenstein@ucdavis.edu		Kliebenstein, Daniel/0000-0001-5759-3175	NSF [0642481]	NSF(National Science Foundation (NSF))	Funding for this project was obtained by NSF grant DBI#0642481 to DJK.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Barth C, 2006, PLANT J, V46, P549, DOI 10.1111/j.1365-313X.2006.02716.x; Benderoth M, 2006, P NATL ACAD SCI USA, V103, P9118, DOI 10.1073/pnas.0601738103; BENEDETTI CE, 1995, PLANT PHYSIOL, V109, P567, DOI 10.1104/pp.109.2.567; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Burow M, 2006, FEBS J, V273, P2432, DOI 10.1111/j.1742-4658.2006.05252.x; CASNEUF T, 2006, GENOME BIOL, V7; Chen SX, 2003, PLANT J, V33, P923, DOI 10.1046/j.1365-313X.2003.01679.x; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; D'Auria JC, 2005, CURR OPIN PLANT BIOL, V8, P308, DOI 10.1016/j.pbi.2005.03.012; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Ehrenreich IM, 2006, AM J BOT, V93, P953, DOI 10.3732/ajb.93.7.953; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Espiritu DJD, 2001, TOXICON, V39, P1899, DOI 10.1016/S0041-0101(01)00175-1; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; GANKO EW, 2007, MOL BIOL EVOL, DOI DOI 10.1093/MOLBEV/MSM1158; Grubb CD, 2004, PLANT J, V40, P893, DOI 10.1111/j.1365-313X.2004.02261.x; Grun S, 2005, PHYTOCHEMISTRY, V66, P1264, DOI 10.1016/j.phytochem.2005.01.024; Gu ZL, 2004, NAT GENET, V36, P577, DOI 10.1038/ng1355; Ha M, 2007, TRENDS GENET, V23, P162, DOI 10.1016/j.tig.2007.02.005; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen BG, 2007, PLANT J, V50, P902, DOI 10.1111/j.1365-313X.2007.03101.x; Hansen CH, 2001, J BIOL CHEM, V276, P24790, DOI 10.1074/jbc.M102637200; Hansen CH, 2001, J BIOL CHEM, V276, P11078, DOI 10.1074/jbc.M010123200; Hemm MR, 2003, PLANT CELL, V15, P179, DOI 10.1105/tpc.006544; KALISZ S, 2007, VARIATION CONSTRAINT; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim SY, 2007, J PLANT BIOL, V50, P117, DOI 10.1007/BF03030619; Klein M, 2006, FEBS J, V273, P122, DOI 10.1111/j.1742-4658.2005.05048.x; Kliebenstein DJ, 2006, GENETICS, V172, P1179, DOI 10.1534/genetics.105.049353; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kliebenstein DJ, 2004, PLANT CELL ENVIRON, V27, P675, DOI 10.1111/j.1365-3040.2004.01180.x; Kliebenstein DJ, 2002, GENETICS, V161, P1685; Kliebenstein DJ, 2001, GENETICS, V159, P359; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; KORVES TM, 2007, FIELD AM NATURALIST, V169, pE141; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; LANGRIDGE J, 1957, NATURE, V180, P36, DOI 10.1038/180036a0; Lankau RA, 2007, SCIENCE, V317, P1561, DOI 10.1126/science.1147455; Lankau RA, 2007, NEW PHYTOL, V175, P176, DOI 10.1111/j.1469-8137.2007.02090.x; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Mauricio R, 1998, AM NAT, V151, P20, DOI 10.1086/286099; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; Micheals SD, 1999, DEV GENET, V25, P194, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;194::AID-DVG2&gt;3.0.CO;2-2; Mikkelsen MD, 2004, PLANT J, V37, P770, DOI 10.1111/j.1365-313X.2004.02002.x; Mikkelsen MD, 2003, PLANT PHYSIOL, V131, P298, DOI 10.1104/pp.011015; Mithen R, 1996, ENTOMOL EXP APPL, V80, P202, DOI 10.1007/BF00194757; MITHEN R, 1995, SOC EXP BIOL SEMIN S, V56, P261; Mueller LA, 2003, PLANT PHYSIOL, V132, P453, DOI 10.1104/pp.102.017236; Nafisi M, 2007, PLANT CELL, V19, P2039, DOI 10.1105/tpc.107.051383; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Noel L, 1999, PLANT CELL, V11, P2099, DOI 10.1105/tpc.11.11.2099; Ober D, 2005, TRENDS PLANT SCI, V10, P444, DOI 10.1016/j.tplants.2005.07.007; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Scarcelli N, 2007, P NATL ACAD SCI USA, V104, P16986, DOI 10.1073/pnas.0708209104; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schuster J, 2006, PLANT CELL, V18, P2664, DOI 10.1105/tpc.105.039339; Schwenk K, 2003, KEYWORDS CONCEPTS EV, P52; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Textor S, 2004, PLANTA, V218, P1026, DOI 10.1007/s00425-003-1184-3; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Tierens KFMJ, 2001, PLANT PHYSIOL, V125, P1688, DOI 10.1104/pp.125.4.1688; van Leeuwen H, 2007, PLANT CELL, V19, P2099, DOI 10.1105/tpc.107.050641; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; WALSH JB, 1995, GENETICS, V139, P421; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Zhang JM, 2002, PHYSIOL PLANTARUM, V115, P25, DOI 10.1034/j.1399-3054.2002.1150103.x; Zhang PF, 2005, PLANT PHYSIOL, V138, P27, DOI 10.1104/pp.105.060376; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602; Zhou N, 1999, PLANT CELL, V11, P2419, DOI 10.1105/tpc.11.12.2419	86	80	80	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1838	10.1371/journal.pone.0001838	http://dx.doi.org/10.1371/journal.pone.0001838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350173	gold, Green Submitted, Green Published			2022-12-27	WOS:000260762300039
J	Hoekert, M; Bais, L; Kahn, RS; Aleman, A				Hoekert, Marjolijn; Bais, Leonie; Kahn, Rene S.; Aleman, Andre			Time Course of the Involvement of the Right Anterior Superior Temporal Gyrus and the Right Fronto-Parietal Operculum in Emotional Prosody Perception	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; RIGHT-HEMISPHERE; ACOUSTIC PARAMETERS; NEURAL RESPONSES; AUDITORY-CORTEX; SPEECH; FMRI; LANGUAGE; REGIONS; INTONATION	In verbal communication, not only the meaning of the words convey information, but also the tone of voice (prosody) conveys crucial information about the emotional state and intentions of others. In various studies right frontal and right temporal regions have been found to play a role in emotional prosody perception. Here, we used triple-pulse repetitive transcranial magnetic stimulation (rTMS) to shed light on the precise time course of involvement of the right anterior superior temporal gyrus and the right fronto-parietal operculum. We hypothesized that information would be processed in the right anterior superior temporal gyrus before being processed in the right fronto-parietal operculum. Right-handed healthy subjects performed an emotional prosody task. During listening to each sentence a triplet of TMS pulses was applied to one of the regions at one of six time points (400-1900 ms). Results showed a significant main effect of Time for right anterior superior temporal gyrus and right fronto-parietal operculum. The largest interference was observed half-way through the sentence. This effect was stronger for withdrawal emotions than for the approach emotion. A further experiment with the inclusion of an active control condition, TMS over the EEG site POz (midline parietal-occipital junction), revealed stronger effects at the fronto-parietal operculum and anterior superior temporal gyrus relative to the active control condition. No evidence was found for sequential processing of emotional prosodic information from right anterior superior temporal gyrus to the right fronto-parietal operculum, but the results revealed more parallel processing. Our results suggest that both right fronto-parietal operculum and right anterior superior temporal gyrus are critical for emotional prosody perception at a relatively late time period after sentence onset. This may reflect that emotional cues can still be ambiguous at the beginning of sentences, but become more apparent half-way through the sentence.	[Hoekert, Marjolijn; Bais, Leonie; Aleman, Andre] Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [Kahn, Rene S.] Univ Med Ctr Utrecht, Dept Psychiat, Utrecht, Netherlands	University of Groningen; Utrecht University; Utrecht University Medical Center	Hoekert, M (corresponding author), Univ Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands.	L.m.hoekert@med.umcg.nl	Aleman, Andre/E-1341-2012		Netherlands organization for Scientific Research [400 04333, 016.026.027]	Netherlands organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	M.H. was supported by a research grant from the Netherlands organization for Scientific Research (400 04333). A.A. was also supported by a grant from the Netherlands organization for Scientific Research (016.026.027). This organization did not have any influence on the design and the conduct of the study.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2002, EMOTION, V2, P23, DOI 10.1037/1528-3542.2.1.23; Anderson AK, 2000, CURR BIOL, V10, pR551, DOI 10.1016/S0960-9822(00)00612-6; Beaucousin V, 2007, CEREB CORTEX, V17, P339, DOI 10.1093/cercor/bhj151; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Bos EH, 2005, J AFFECT DISORDERS, V87, P221, DOI 10.1016/j.jad.2005.04.001; Buchanan TW, 2000, COGNITIVE BRAIN RES, V9, P227, DOI 10.1016/S0926-6410(99)00060-9; Callan DE, 2006, NEUROIMAGE, V31, P1327, DOI 10.1016/j.neuroimage.2006.01.036; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio A.R., 2000, FEELING WHAT HAPPENS; Ethofer T, 2006, NEUROIMAGE, V30, P580, DOI 10.1016/j.neuroimage.2005.09.059; Ethofer T, 2006, NEUROREPORT, V17, P249, DOI 10.1097/01.wnr.0000199466.32036.5d; George MS, 1996, ARCH NEUROL-CHICAGO, V53, P665, DOI 10.1001/archneur.1996.00550070103017; GORELICK PB, 1987, J NEUROL NEUROSUR PS, V50, P553, DOI 10.1136/jnnp.50.5.553; HEILMAN KM, 1975, J NEUROL NEUROSUR PS, V38, P69, DOI 10.1136/jnnp.38.1.69; Hornak J, 2003, BRAIN, V126, P1691, DOI 10.1093/brain/awg168; JOHNSTONE T, 2006, SOCIAL COGNITIVE AFF; Kotz SA, 2003, BRAIN LANG, V86, P366, DOI 10.1016/S0093-934X(02)00532-1; Kriegstein KV, 2004, NEUROIMAGE, V22, P948, DOI 10.1016/j.neuroimage.2004.02.020; Meyer M, 2002, HUM BRAIN MAPP, V17, P73, DOI 10.1002/hbm.10042; Mitchell RLC, 2003, NEUROPSYCHOLOGIA, V41, P1410, DOI 10.1016/S0028-3932(03)00017-4; Mitchell RLC, 2005, BRAIN, V128, P963, DOI 10.1093/brain/awh466; Morris JS, 1999, NEUROPSYCHOLOGIA, V37, P1155, DOI 10.1016/S0028-3932(99)00015-9; Neggers SFW, 2004, NEUROIMAGE, V21, P1805, DOI 10.1016/j.neuroimage.2003.12.006; Paulmann S, 2008, NEUROREPORT, V19, P209, DOI 10.1097/WNR.0b013e3282f454db; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Pourtois G, 2004, EUR J NEUROSCI, V20, P3507, DOI 10.1111/j.1460-9568.2004.03794.x; Pridmore S, 1998, J ECT, V14, P25; Roelfsema PR, 2002, J COGNITIVE NEUROSCI, V14, P525, DOI 10.1162/08989290260045756; Sack AT, 2005, SCIENCE, V308, P702, DOI 10.1126/science.1107784; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Schneider W., 2002, E PRIME USERS GUIDE; Talairach J., 1988, COPLANAR STEREOTAXIC; TUCKER DM, 1977, NEUROLOGY, V27, P947, DOI 10.1212/WNL.27.10.947; van Rijn S, 2005, EUR J NEUROSCI, V21, P3195, DOI 10.1111/j.1460-9568.2005.04130.x; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Vingerhoets G, 2003, NEUROPSYCHOLOGY, V17, P93, DOI 10.1037/0894-4105.17.1.93; VROOMEN J, 1993, P 3 EUR C SPEECH COM, P577; Walsh V, 2003, BRADFORD BOOKS, P1; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Wambacq IJA, 2004, NEUROREPORT, V15, P555, DOI 10.1097/00001756-200403010-00034; Warren JE, 2006, J NEUROSCI, V26, P13067, DOI 10.1523/JNEUROSCI.3907-06.2006; Wassermann EM, 1996, NEUROIMAGE, V3, P1, DOI 10.1006/nimg.1996.0001; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wiethoff S, 2008, NEUROIMAGE, V39, P885, DOI 10.1016/j.neuroimage.2007.09.028; Wildgruber D, 2005, NEUROIMAGE, V24, P1233, DOI 10.1016/j.neuroimage.2004.10.034; Wildgruber D, 2004, CEREB CORTEX, V14, P1384, DOI 10.1093/cercor/bhh099; Wildgruber D, 2002, NEUROIMAGE, V15, P856, DOI 10.1006/nimg.2001.0998	49	31	31	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2244	10.1371/journal.pone.0002244	http://dx.doi.org/10.1371/journal.pone.0002244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493307	Green Published, Green Submitted, gold			2022-12-27	WOS:000262258700052
J	Pask, AJ; Behringer, RR; Renfree, MB				Pask, Andrew J.; Behringer, Richard R.; Renfree, Marilyn B.			Resurrection of DNA Function In Vivo from an Extinct Genome	PLOS ONE			English	Article								There is a burgeoning repository of information available from ancient DNA that can be used to understand how genomes have evolved and to determine the genetic features that defined a particular species. To assess the functional consequences of changes to a genome, a variety of methods are needed to examine extinct DNA function. We isolated a transcriptional enhancer element from the genome of an extinct marsupial, the Tasmanian tiger (Thylacinus cynocephalus or thylacine), obtained from 100 year-old ethanol-fixed tissues from museum collections. We then examined the function of the enhancer in vivo. Using a transgenic approach, it was possible to resurrect DNA function in transgenic mice. The results demonstrate that the thylacine Col2A1 enhancer directed chondrocyte-specific expression in this extinct mammalian species in the same way as its orthologue does in mice. While other studies have examined extinct coding DNA function in vitro, this is the first example of the restoration of extinct non-coding DNA and examination of its function in vivo. Our method using transgenesis can be used to explore the function of regulatory and protein-coding sequences obtained from any extinct species in an in vivo model system, providing important insights into gene evolution and diversity.	[Pask, Andrew J.; Behringer, Richard R.] Univ Texas MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA; [Pask, Andrew J.; Renfree, Marilyn B.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia	University of Texas System; UTMD Anderson Cancer Center; University of Melbourne	Pask, AJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA.	rrb@mdanderson.org		Renfree, Marilyn/0000-0002-4589-0436; Pask, Andrew/0000-0002-1900-2263	NSF [IBN 0220458]; Ben F. Love Endowment; NHMRC CJ Martin; RD Wright Research Fellowships; ARC Federation Fellowship; NIH [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Ben F. Love Endowment; NHMRC CJ Martin(National Health and Medical Research Council (NHMRC) of Australia); RD Wright Research Fellowships; ARC Federation Fellowship(Australian Research Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by NSF grant IBN 0220458 and the Ben F. Love Endowment to RRB, NHMRC CJ Martin and RD Wright Research Fellowships to AJP, and an ARC Federation Fellowship to MBR. DNA sequencing and veterinary animal care was supported by the NIH Cancer Center Support Grant CA16672.	Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Coyne JA, 2007, CURR BIOL, V17, pR1014, DOI 10.1016/j.cub.2007.10.009; Green RE, 2006, NATURE, V444, P330, DOI 10.1038/nature05336; Hilton-Taylor C., 2000, 2000 IUCN RED LIST T; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lalueza-Fox C, 2007, SCIENCE, V318, P1453, DOI 10.1126/science.1147417; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Leung KKH, 1998, J CELL BIOL, V141, P1291, DOI 10.1083/jcb.141.6.1291; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Nagy A., 2002, MANIPULATING MOUSE E; Novacek MJ, 2001, P NATL ACAD SCI USA, V98, P5466, DOI 10.1073/pnas.091093698; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Paddle R., 2000, LAST TASMANIAN TIGER; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Rompler H, 2006, SCIENCE, V313, P62, DOI 10.1126/science.1128994; Wible JR, 2007, NATURE, V447, P1003, DOI 10.1038/nature05854; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; ZHOU G, 1995, J CELL SCI, V108, P3677	24	17	18	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2240	10.1371/journal.pone.0002240	http://dx.doi.org/10.1371/journal.pone.0002240			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493600	gold, Green Published, Green Submitted			2022-12-27	WOS:000262258700048
J	Arnon, TI; Markel, G; Bar-Ilan, A; Hanna, J; Fima, E; Benchetrit, F; Galili, R; Cerwenka, A; Benharroch, D; Sion-Vardy, N; Porgador, A; Mandelboim, O				Arnon, Tal I.; Markel, Gal; Bar-Ilan, Ahuva; Hanna, Jacob; Fima, Eyal; Benchetrit, Fabrice; Galili, Ruth; Cerwenka, Adelheid; Benharroch, Daniel; Sion-Vardy, Netta; Porgador, Angel; Mandelboim, Ofer			Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy	PLOS ONE			English	Article								The natural cytotoxic receptors (NCRs) are a unique set of activating proteins expressed mainly on the surface of natural killer (NK) cells. The NCRs, which include three members; NKp46, NKp44 and NKp30, are critically involved in NK cytotoxicity against different targets, including a wide range of tumor cells derived from various origins. Even though the tumor ligands of the NCRs have not been identified yet, the selective manner by which these receptors target tumor cells may provide an excellent basis for the development of novel anti-tumor therapies. To test the potential use of the NCRs as anti-tumor agents, we generated soluble NCR-Ig fusion proteins in which the constant region of human IgG1 was fused to the extracellular portion of the receptor. We demonstrate, using two different human prostate cancer cell lines, that treatment with NKp30-Ig, dramatically inhibits tumor growth in vivo. Activated macrophages were shown to mediate an ADCC response against the NKp30-Ig coated prostate cell lines. Finally, the Ig fusion proteins were also demonstrated to discriminate between benign prostate hyperplasia and prostate cancer. This may provide a novel diagnostic modality in the difficult task of differentiating between these highly common pathological conditions.	[Arnon, Tal I.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Markel, Gal] Sheba Med Ctr, Sheba Canc Res Ctr, Tel Hashomer, Israel; [Bar-Ilan, Ahuva; Fima, Eyal; Benchetrit, Fabrice; Porgador, Angel] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Shraga Segal Dept Microbiol & Immunol, Beer Sheva, Israel; [Hanna, Jacob] Whitehead Inst Biomed Res, Cambridge, MA USA; [Galili, Ruth; Mandelboim, Ofer] Hebrew Univ Hadassah Med Sch, Lautenberg Ctr General & Tumor Immunol, Jerusalem, Israel; [Cerwenka, Adelheid] German Canc Res Ctr, Div Innate Immun, Heidelberg, Germany; [Benharroch, Daniel; Sion-Vardy, Netta] Soroka Hosp, Pathol Dept, Beer Sheva, Israel	California Institute of Technology; Chaim Sheba Medical Center; Ben Gurion University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Hebrew University of Jerusalem; Helmholtz Association; German Cancer Research Center (DKFZ); Ben Gurion University; Soroka Medical Center	Arnon, TI (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	angel@bgu.ac.il; oferman@md2.huji.ac.il	Hanna, Jacob/K-1339-2012	Hanna, Jacob/0000-0003-2042-9974; Mandelboim, Ofer/0000-0002-9354-1855; Porgador, Angel/0000-0003-1540-4449; Cerwenka, Adelheid/0000-0001-6977-3536				Adams JY, 2002, NAT MED, V8, P891, DOI 10.1038/nm743; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Bloushtain N, 2004, J IMMUNOL, V173, P2392, DOI 10.4049/jimmunol.173.4.2392; Caplan Aaron, 2002, Am J Clin Pathol, V117 Suppl, pS104; Carter P, 2001, NAT REV CANCER, V1, P118, DOI 10.1038/35101072; Clynes R, 1998, P NATL ACAD SCI USA, V95, P652, DOI 10.1073/pnas.95.2.652; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Coiffier B, 2003, BLOOD REV, V17, P25, DOI 10.1016/S0268-960X(02)00059-0; Costello RT, 2004, TRENDS IMMUNOL, V25, P328, DOI 10.1016/j.it.2004.04.005; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Glennie MJ, 2003, DRUG DISCOV TODAY, V8, P503, DOI 10.1016/S1359-6446(03)02714-4; HERSHKOVITZ O, 2007, GLYCOBIOLOGY    1115; Hershkovitz O, 2007, BIOCHEMISTRY-US, V46, P7426, DOI 10.1021/bi7000455; Iannello A, 2005, CANCER METAST REV, V24, P487, DOI 10.1007/s10555-005-6192-2; Liossis SNC, 2005, J ALLERGY CLIN IMMUN, V116, P721, DOI 10.1016/j.jaci.2005.06.035; Lodoen MB, 2005, NAT REV MICROBIOL, V3, P59, DOI 10.1038/nrmicro1066; Lowe FC, 2005, DRUG TODAY, V41, P179, DOI 10.1358/dot.2005.41.3.892523; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Milas L, 2000, CLIN CANCER RES, V6, P701; Moretta L, 2002, SCAND J IMMUNOL, V55, P229, DOI 10.1046/j.1365-3083.2002.01055.x; Moretta L, 2002, EUR J IMMUNOL, V32, P1205, DOI 10.1002/1521-4141(200205)32:5<1205::AID-IMMU1205>3.0.CO;2-Y; Moretta Lorenzo, 2001, Current Opinion in Pharmacology, V1, P387, DOI 10.1016/S1471-4892(01)00067-4; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Porgador A, 2005, THESCIENTIFICWORLDJO, V5, P151, DOI 10.1100/tsw.2005.22; PRESS OW, 2001, IMMUNOTHERAPY NONHOD, P221; Prewett MC, 2002, CLIN CANCER RES, V8, P994; Shaffer DR, 2003, LANCET ONCOL, V4, P407, DOI 10.1016/S1470-2045(03)01138-0; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Swindle P, 2003, RADIOLOGY, V228, P144, DOI 10.1148/radiol.2281011808; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Yokoyama WM, 2005, ADV EXP MED BIOL, V560, P57; Zilka A, 2005, BIOCHEMISTRY-US, V44, P14477, DOI 10.1021/bi051241s	42	27	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2150	10.1371/journal.pone.0002150	http://dx.doi.org/10.1371/journal.pone.0002150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478075	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000262172800015
J	Barthel, KKB; Liu, XD				Barthel, Kristen K. B.; Liu, Xuedong			A Transcriptional Enhancer from the Coding Region of ADAMTS5	PLOS ONE			English	Article								Background: The revelation that the human genome encodes only similar to 25,000 genes and thus cannot account for phenotypic complexity has been one of the biggest surprises in the post-genomic era. However, accumulating evidence suggests that transcriptional regulation may be in large part responsible for this observed mammalian complexity. Consequently, there has been a strong drive to locate cis-regulatory regions in mammalian genomes in order to understand the unifying principles governing these regions, including their genomic distribution. Although a number of systematic approaches have been developed, these all discount coding sequence. Methodology/Principal Findings: Using the computational tool PRI (Pattern-defined Regulatory Islands), which does not mask coding sequence, we identified a regulatory region associated with the gene ADAMTS5 that encompasses the entirety of the essential coding exon 2. We demonstrate through a combination of chromatin immunoprecipitation and reporter gene studies that this region can not only bind the myogenic transcription factors MYOD and myogenin and the E-protein HEB but can also function as a very strong myogenic transcriptional enhancer. Conclusions/Significance: Thus, we report the identification and detailed characterization of an exonic enhancer. Ultimately, this leads to the interesting question of why evolution would be so parsimonious in the functional assignment of sequence.	[Barthel, Kristen K. B.; Liu, Xuedong] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Barthel, KKB (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	liux@colorado.edu		BJORKMAN, KRISTEN/0000-0002-9540-6657; LIU, XUEDONG/0000-0001-7209-4964	NIH [CA107098, T32GM08759]; NATIONAL CANCER INSTITUTE [R01CA107098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is support by a NIH grant CA107098 to XL and a NIH predoctoral training grant T32GM08759 to KKB.	BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Chen IHB, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-38; Cheung TH, 2007, P NATL ACAD SCI USA, V104, P10116, DOI 10.1073/pnas.0704028104; Chiquet M, 1998, EUR J BIOCHEM, V257, P362, DOI 10.1046/j.1432-1327.1998.2570362.x; DAHLMANWRIGHT K, 1990, J BIOL CHEM, V265, P14030; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hill RE, 2003, J ANAT, V202, P13, DOI 10.1046/j.1469-7580.2003.00148.x; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; MAJELLO B, 1990, EMBO J, V9, P457, DOI 10.1002/j.1460-2075.1990.tb08131.x; McLellan AS, 2006, AM J PHYSIOL-CELL PH, V291, pC300, DOI 10.1152/ajpcell.00345.2005; Neznanov N, 1997, J BIOL CHEM, V272, P27549, DOI 10.1074/jbc.272.44.27549; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; Parker MH, 2006, MOL CELL BIOL, V26, P5771, DOI 10.1128/MCB.02404-05; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623	25	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2184	10.1371/journal.pone.0002184	http://dx.doi.org/10.1371/journal.pone.0002184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478108	gold, Green Published, Green Submitted			2022-12-27	WOS:000262172800049
J	Heisel, SM; Ketter, R; Keller, A; Klein, V; Pallasch, CP; Lenhof, HP; Meese, E				Heisel, Sabrina M.; Ketter, Ralf; Keller, Andreas; Klein, Veronika; Pallasch, Christian P.; Lenhof, Hans-Peter; Meese, Eckart			Increased Seroreactivity to Glioma-Expressed Antigen 2 in Brain Tumor Patients under Radiation	PLOS ONE			English	Article								Background: Surgery and radiation are the mainstays of therapy for human gliomas that are the most common primary brain tumors. Most recently, cell culture and animal studies provided the first convincing evidence that radiation not only eliminates tumor cells, but also modulates the immune response and likely improves anti-tumor immunotherapy. Methology/Pricipal Findings: We present an in vivo study that analyzes the effects of radiation on the immune response in tumor patients. As readout system, we utilized the reactivity of glioma patients' sera against antigen GLEA2 as the most frequent antigen immunogenic in glioblastoma patients. We established an ELISA assay to analyze reactivity of 24 glioblastoma patients over a period of several months. As control we used 30 sera from healthy donors as well as 30 sera from lung cancer patients. We compared the course of GLEA2 seroreactivity at different times prior, during and after radiation. The GLEA2 seroreactivity was increased by the time of surgery, decreased after surgery, increased again under radiation, and slightly decreased after radiation. Conclusions/Significance: Our results provide in vivo evidence for an increased antibody response against tumor antigens under radiation. Antigens that become immunogenic with an increased antibody response as result of radiation can serve as ideal targets for immunotherapy of human tumors.	[Heisel, Sabrina M.; Klein, Veronika; Meese, Eckart] Univ Saarland, Sch Med, Dept Human Genet, D-6650 Homburg, Germany; [Ketter, Ralf] Saarland Univ, Med Sch, Neurosurg Clin, Homburg, Germany; [Keller, Andreas; Lenhof, Hans-Peter] Saarland Univ, Ctr Bioinformat, Saarbrucken, Germany; [Pallasch, Christian P.] Univ Cologne, Med Sch, Internal Med Clin I, Cologne, Germany	Saarland University; Universitatsklinikum des Saarlandes; Saarland University; University of Cologne	Heisel, SM (corresponding author), Univ Saarland, Sch Med, Dept Human Genet, D-6650 Homburg, Germany.	hgemee@uniklinik-saarland.de	Pallasch, Christian Philipp/T-3088-2018; Meese, Eckart Ulrich/ABD-1983-2021; Keller, Andreas/ABB-6412-2021	Keller, Andreas/0000-0002-5361-0895; Pallasch, Christian P./0000-0001-5675-6905	Forschungsforderungsprogramm HOMFOR	Forschungsforderungsprogramm HOMFOR	This study was funded by Forschungsforderungsprogramm HOMFOR 2007. The sponsors were not involved in the study design, in the collection, analysis and interpretation of data, and in the preparation, review, or approval of the manuscript.	Afra D, 2002, LANCET, V359, P1011; Behrends U, 2003, INT J CANCER, V106, P244, DOI 10.1002/ijc.11208; Burnet NG, 2006, CLIN ONCOL-UK, V18, P93, DOI 10.1016/j.clon.2005.08.017; Fischer U, 2001, CLIN EXP IMMUNOL, V126, P206, DOI 10.1046/j.1365-2249.2001.01635.x; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; OHGAKI HKP, 2005, ACTA NEUROPATHOL BER, V109, P479; Pallasch CP, 2005, INT J CANCER, V117, P456, DOI 10.1002/ijc.20929; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Sahin U, 2000, CLIN CANCER RES, V6, P3916; SCHAICH KM, 1980, CRC CR REV FOOD SCI, V13, P89, DOI 10.1080/10408398009527286; Schmits R, 2002, INT J CANCER, V98, P73, DOI 10.1002/ijc.10170; Schneider JP, 2005, NEURORADIOLOGY, V47, P489, DOI 10.1007/s00234-005-1397-1; Smorodin E. P., 2007, Experimental Oncology, V29, P61; Struss AK, 2001, ONCOGENE, V20, P4107, DOI 10.1038/sj.onc.1204552; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taniwaki M, 2006, INT J ONCOL, V29, P567	17	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2164	10.1371/journal.pone.0002164	http://dx.doi.org/10.1371/journal.pone.0002164			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478111	Green Submitted, gold, Green Published			2022-12-27	WOS:000262172800029
J	Winnen, B; Schlumberger, MC; Sturm, A; Schupbach, K; Siebenmann, S; Jenny, P; Hardt, WD				Winnen, Brit; Schlumberger, Markus C.; Sturm, Alexander; Schuepbach, Kaspar; Siebenmann, Stefan; Jenny, Patrick; Hardt, Wolf-Dietrich			Hierarchical Effector Protein Transport by the Salmonella Typhimurium SPI-1 Type III Secretion System	PLOS ONE			English	Article								Background: Type III secretion systems (TTSS) are employed by numerous pathogenic and symbiotic bacteria to inject a cocktail of different "effector proteins'' into host cells. These effectors subvert host cell signaling to establish symbiosis or disease. Methodology/Principal Findings: We have studied the injection of SipA and SptP, two effector proteins of the invasion-associated Salmonella type III secretion system (TTSS-1). SipA and SptP trigger different host cell responses. SipA contributes to triggering actin rearrangements and invasion while SptP reverses the actin rearrangements after the invasion has been completed. Nevertheless, SipA and SptP were both pre-formed and stored in the bacterial cytosol before host cell encounter. By time lapse microscopy, we observed that SipA was injected earlier than SptP. Computer modeling revealed that two assumptions were sufficient to explain this injection hierarchy: a large number of SipA and SptP molecules compete for transport via a limiting number of TTSS; and the TTSS recognize SipA more efficiently than SptP. Conclusions/Significance: This novel mechanism of hierarchical effector protein injection may serve to avoid functional interference between SipA and SptP. An injection hierarchy of this type may be of general importance, allowing bacteria to precisely time the host cell manipulation by type III effectors.	[Winnen, Brit; Schlumberger, Markus C.; Sturm, Alexander; Hardt, Wolf-Dietrich] ETH, Inst Mikrobiol, CH-8092 Zurich, Switzerland; [Schuepbach, Kaspar; Siebenmann, Stefan; Jenny, Patrick] Swiss Fed Inst Technol, Inst Fluid Dynam, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Winnen, B (corresponding author), ETH, Inst Mikrobiol, Schmelzbergstr 7, CH-8092 Zurich, Switzerland.	hardt@micro.biol.ethz.ch		Sturm, Alexander/0000-0002-3818-0428; Winnen, Brit/0000-0003-1958-335X; Hardt, Wolf-Dietrich/0000-0002-9892-6420	Boehringer Ingelheim Foundation; ETH research foundation [TH-10 06-1]	Boehringer Ingelheim Foundation(Boehringer Ingelheim); ETH research foundation	This work was funded by a scholarship from the Boehringer Ingelheim Foundation to BW and a grant from the ETH research foundation (TH-10 06-1) to WDH.	Bakshi CS, 2000, J BACTERIOL, V182, P2341, DOI 10.1128/JB.182.8.2341-2344.2000; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ehrbar K, 2006, MOL MICROBIOL, V59, P248, DOI 10.1111/j.1365-2958.2005.04931.x; Ehrbar K, 2004, J BACTERIOL, V186, P1215, DOI 10.1128/JB.186.4.1215-1219.2004; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; Enninga J, 2005, NAT METHODS, V2, P959, DOI 10.1038/NMETH804; Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x; Fu YX, 1999, NATURE, V401, P293, DOI 10.1038/45829; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Higashide W, 2002, CELL MICROBIOL, V4, P357, DOI 10.1046/j.1462-5822.2002.00196.x; Jepson MA, 2001, CELL MICROBIOL, V3, P417, DOI 10.1046/j.1462-5822.2001.00124.x; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Kaniga K, 1996, MOL MICROBIOL, V21, P633, DOI 10.1111/j.1365-2958.1996.tb02571.x; Karlinsey JE, 2000, MOL MICROBIOL, V37, P1220, DOI 10.1046/j.1365-2958.2000.02081.x; Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lavander M, 2002, J BACTERIOL, V184, P4500, DOI 10.1128/JB.184.16.4500-4509.2002; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Lostroh CP, 2000, MOL MICROBIOL, V37, P300, DOI 10.1046/j.1365-2958.2000.01991.x; MACBETH KJ, 1993, INFECT IMMUN, V61, P1544, DOI 10.1128/IAI.61.4.1544-1546.1993; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; McGhie EJ, 2004, MOL CELL, V13, P497, DOI 10.1016/S1097-2765(04)00053-X; McGhie EJ, 2001, EMBO J, V20, P2131, DOI 10.1093/emboj/20.9.2131; MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Mirold S, 2001, J BACTERIOL, V183, P2348, DOI 10.1128/JB.183.7.2348-2358.2001; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; Sorg JA, 2006, P NATL ACAD SCI USA, V103, P16490, DOI 10.1073/pnas.0605974103; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x; STOCKER BAD, 1982, DEV BIOLOGICALS, V53, P47; Thomas NA, 2007, J BIOL CHEM, V282, P29634, DOI 10.1074/jbc.M706019200; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092; Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176	41	61	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2178	10.1371/journal.pone.0002178	http://dx.doi.org/10.1371/journal.pone.0002178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478101	Green Published, gold, Green Submitted			2022-12-27	WOS:000262172800043
J	Movsesyan, N; Ghochikyan, A; Mkrtichyan, M; Petrushina, I; Davtyan, H; Olkhanud, PB; Head, E; Biragyn, A; Cribbs, DH; Agadjanyan, MG				Movsesyan, Nina; Ghochikyan, Anahit; Mkrtichyan, Mikayel; Petrushina, Irina; Davtyan, Hayk; Olkhanud, Purevdorj B.; Head, Elizabeth; Biragyn, Arya; Cribbs, David H.; Agadjanyan, Michael G.			Reducing AD-Like Pathology in 3xTg-AD Mouse Model by DNA Epitope Vaccine - A Novel Immunotherapeutic Strategy	PLOS ONE			English	Article								Background: The development of a safe and effective AD vaccine requires a delicate balance between providing an adequate anti-A beta antibody response sufficient to provide therapeutic benefit, while eliminating an adverse T cell-mediated proinflammatory autoimmune response. To achieve this goal we have designed a prototype chemokine-based DNA epitope vaccine expressing a fusion protein that consists of 3 copies of the self-B cell epitope of A beta(42) (A beta(1-11)), a non-self T helper cell epitope (PADRE), and macrophage-derived chemokine (MDC/CCL22) as a molecular adjuvant to promote a strong anti-inflammatory Th2 phenotype. Methods and Findings: We generated pMDC-3A beta(1-11)-PADRE construct and immunized 3xTg-AD mouse model starting at age of 3-4 months old. We demonstrated that prophylactic immunizations with the DNA epitope vaccine generated a robust Th2 immune response that induced high titers of anti-A beta antibody, which in turn inhibited accumulation of A beta pathology in the brains of older mice. Importantly, vaccination reduced glial activation and prevented the development of behavioral deficits in aged animals without increasing the incidence of microhemorrhages. Conclusions: Data from this transitional pre-clinical study suggest that our DNA epitope vaccine could be used as a safe and effective strategy for AD therapy. Future safety and immunology studies in large animals with the goal to achieve effective humoral immunity without adverse effects should help to translate this study to human clinical trials.	[Movsesyan, Nina; Ghochikyan, Anahit; Mkrtichyan, Mikayel; Davtyan, Hayk; Agadjanyan, Michael G.] Inst Mol Med, Dept Mol Immunol, Huntington Beach, CA USA; [Movsesyan, Nina; Petrushina, Irina; Head, Elizabeth; Cribbs, David H.; Agadjanyan, Michael G.] Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA USA; [Olkhanud, Purevdorj B.; Biragyn, Arya] NIA, Lab Immunol, Immunotherapeut Unit, Baltimore, MD USA; [Head, Elizabeth; Cribbs, David H.] Univ Calif Irvine, Dept Neurol, Irvine, CA USA	University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California Irvine	Movsesyan, N (corresponding author), Inst Mol Med, Dept Mol Immunol, Huntington Beach, CA USA.	magadjanyan@immed.org		Ghochikyan, Anahit/0000-0001-5436-0616	NIH [AG20241, NS50895, NS057395, AG00538, AG00096, P50 AG16573]; Alzheimers Association [IIRG036279, IIRG0728314]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057395, R01NS050895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG000538, R01AG020241, P50AG016573, ZIAAG000770] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimers Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funding from the NIH: AG20241 (DHC & MGA), NS50895 (DHC & MGA), NS057395 (MGA), AG00538(DHC) and from the Alzheimers Association IIRG036279 (MGA & DHC), IIRG0728314 (AG). NM was supported by NIA training grant AG00096. The 3xTg-AD homozygous mice and amyloid peptides were provided by UCI-Alzheimers Disease Research Center (ADRC) under the NIH/NIA P50 AG16573 grant.	Agadjanyan MG, 2005, J IMMUNOL, V174, P1580, DOI 10.4049/jimmunol.174.3.1580; ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Bayer AJ, 2005, NEUROLOGY, V64, P94, DOI 10.1212/01.WNL.0000148604.77591.67; Berzofsky JA, 2001, NAT REV IMMUNOL, V1, P209, DOI 10.1038/35105075; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Biragyn A, 2004, BLOOD, V104, P1961, DOI 10.1182/blood-2004-02-0637; Biragyn A, 2002, BLOOD, V100, P1153, DOI 10.1182/blood-2002-01-0086; Biragyn A, 2001, J IMMUNOL, V167, P6644, DOI 10.4049/jimmunol.167.11.6644; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Chen GQ, 2007, J NEUROSCI, V27, P2654, DOI 10.1523/JNEUROSCI.3710-06.2007; Cribbs DH, 2003, INT IMMUNOL, V15, P505, DOI 10.1093/intimm/dxg049; CRIBBS DH, 2005, CURR IMMUNOL REV, V1, P139; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; Ghochikyan A, 2006, VACCINE, V24, P2275, DOI 10.1016/j.vaccine.2005.11.039; Ghochikyan A, 2003, EUR J IMMUNOL, V33, P3232, DOI 10.1002/eji.200324000; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hock C, 2003, NEURON, V38, P547, DOI 10.1016/S0896-6273(03)00294-0; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kim HD, 2007, IMMUNOL LETT, V112, P30, DOI 10.1016/j.imlet.2007.06.006; Kutzler MA, 2006, VACCINE, V24, P4630, DOI 10.1016/j.vaccine.2005.08.036; Lemere CA, 2006, REJUV RES, V9, P77, DOI 10.1089/rej.2006.9.77; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li QY, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-22; Mamikonyan G, 2007, J BIOL CHEM, V282, P22376, DOI 10.1074/jbc.M700088200; Masliah E, 2005, NEUROLOGY, V64, P129, DOI 10.1212/01.WNL.0000148590.39911.DF; Monsonego A, 2003, J CLIN INVEST, V112, P415, DOI 10.1172/JCI200318104; Monsonego A, 2001, P NATL ACAD SCI USA, V98, P10273, DOI 10.1073/pnas.191118298; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Nicoll JAR, 2006, J NEUROPATH EXP NEUR, V65, P1040, DOI 10.1097/01.jnen.0000240466.10758.ce; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Oddo S., 2006, J BIOL CHEM; Okura Y, 2006, P NATL ACAD SCI USA, V103, P9619, DOI 10.1073/pnas.0600966103; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Pasquali JL, 2007, J AUTOIMMUN, V29, P250, DOI 10.1016/j.jaut.2007.07.006; Patton RL, 2006, AM J PATHOL, V169, P1048, DOI 10.2353/ajpath.2006.060269; Petrushina I, 2003, NEUROSCI LETT, V338, P5, DOI 10.1016/S0304-3940(02)01357-5; Petrushina I, 2007, J NEUROSCI, V27, P12721, DOI 10.1523/JNEUROSCI.3201-07.2007; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; Qu BX, 2004, ARCH NEUROL-CHICAGO, V61, P1859, DOI 10.1001/archneur.61.12.1859; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schenk D, 2002, NAT REV NEUROSCI, V3, P824, DOI 10.1038/nrn938; Schiavo R, 2006, BLOOD, V107, P4597, DOI 10.1182/blood-2005-08-3207; Schultz JG, 2004, J MOL MED, V82, P706, DOI 10.1007/s00109-004-0570-z; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; WILCOCK DM, 2007, NEUROSCIENC IN PRESS; Zaliauskiene L, 2002, J IMMUNOL, V169, P2337, DOI 10.4049/jimmunol.169.5.2337	53	97	111	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2124	10.1371/journal.pone.0002124	http://dx.doi.org/10.1371/journal.pone.0002124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461171	gold, Green Published			2022-12-27	WOS:000261642400045
J	Opatowski, L; Temime, L; Varon, E; Leclerc, R; Drugeon, H; Boelle, PY; Guillemot, D				Opatowski, Lulla; Temime, Laura; Varon, Emmanuelle; Leclerc, Roland; Drugeon, Henri; Boelle, Pierre-Yves; Guillemot, Didier			Antibiotic Innovation May Contribute to Slowing the Dissemination of Multiresistant Streptococcus pneumoniae: The Example of Ketolides	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; PENICILLIN-BINDING PROTEINS; BETA-LACTAM RESISTANCE; NASOPHARYNGEAL CARRIAGE; ANTIMICROBIAL RESISTANCE; BACTERIAL-RESISTANCE; INFECTIOUS-DISEASES; ANTIBACTERIAL; TRANSMISSION; CHILDREN	Background: Despite increasingly frequent bacterial resistance to antibiotics, antibacterial innovation is rare. Ketolides constitute one of the very few new antibiotic classes active against Streptococcus pneumoniae developed during the last 25 years. Their mechanism of action resembles that of macrolides, but they are unaffected by common resistance mechanisms. However, cross-resistance to ketolides has been observed in some macrolide-resistant strains. We examined how new antibiotic exposure may affect overall pneumococcal resistance patterns in the population. The aims of this study were to assess the potential dissemination of newly emerged resistances and to control the selection of strains already multiresistant to existing antimicrobials. Methodology/Principal Findings: We developed an age-structured population model for S. pneumoniae transmission in a human community exposed to heptavalent vaccine, and beta-lactams, macrolides and ketolides. The dynamics of intraindividual selection of resistant strains under antibiotic exposure and interindividual transmission were simulated, with antibiotic-specific resistance mechanisms defining the path to co-resistances and cross-resistances, and parameters concerning the French situation. Results of this simulation study suggest that new antibiotic consumption could markedly slow the diffusion of multiresistant strains. Wider use was associated with slower progression of multiresistance. When ketolides were prescribed to all ages, resistance to them reached 10% after > 15 years, while it took > 40 years when they were prescribed only to adults. In the scenario according to which new antibiotics totally replaced former antimicrobials, the beta-lactam resistance rate was limited at 70%. Conclusions: In a context of widespread vaccination and rational use of antibiotics, innovative antibiotic, prescribed to all age groups, may have an added impact on multiresistant-strain dissemination in the population.	[Opatowski, Lulla; Guillemot, Didier] Inst Pasteur, Unite Pharmacoepidemiol & Malad Infect, Paris, France; [Opatowski, Lulla; Guillemot, Didier] INSERM, U657, Paris, France; [Temime, Laura] Conserv Natl Arts Metiers, Chaire Hygi & Secur, Paris, France; [Varon, Emmanuelle] Hop Europeen Georges Pompidou, Assistance Publs Hop Paris, Ctr Natl Reference Pneumocoques, Paris, France; [Leclerc, Roland] CHU Cote Nacre, Univ Caen, Serv Microbiol, Interactions hote microorganismes epitheliums, Caen, France; [Drugeon, Henri] Hop G&R Laennec, Hyg Hosp, Lab Bacteriol, Nantes, France; [Boelle, Pierre-Yves] INSERM, U707, Paris, France; [Boelle, Pierre-Yves] UPMC Paris6, UMR S 707, Paris, France; [Boelle, Pierre-Yves] Assistance Publ Hop Paris, Hop Saint Antoine, Paris, France; [Guillemot, Didier] Univ Versailles St Quentin, Versailles, France; [Guillemot, Didier] Assistance Publ Hop Paris, Hop Raymond Poincare, Unite Sant Publ, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); heSam Universite; Conservatoire National Arts & Metiers (CNAM); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Caen NORMANDIE; Universite de Caen Normandie; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Opatowski, L (corresponding author), Inst Pasteur, Unite Pharmacoepidemiol & Malad Infect, Paris, France.	lopatows@pasteur.fr	Guillemot, Didier/AAN-3051-2020; Temime, Laura/G-7010-2011; Opatowski, Lulla/I-3143-2015	Opatowski, Lulla/0000-0001-8348-700X; Guillemot, Didier/0000-0002-8497-1765; Boelle, Pierre-Yves/0000-0002-5367-8232; Temime, Laura/0000-0002-8850-5403	Sanofi-Aventis	Sanofi-Aventis(Sanofi-Aventis)	Sanofi-Aventis accorded funding for this study. The funders had no role in model and simulations design and analysis, decision to publish or preparation of the manuscript.	Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Cassell GH, 2001, JAMA-J AM MED ASSOC, V285, P601, DOI 10.1001/jama.285.5.601; Cauchemez S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-14; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P177; Davis SR, 2000, MIL MED, V165, P35, DOI 10.1093/milmed/165.suppl_2.35; Decousser JW, 2004, EUR J CLIN MICROBIOL, V23, P27, DOI 10.1007/s10096-003-1032-1; Desenclos JC, 2004, EMERG INFECT DIS, V10, P759, DOI 10.3201/eid1004.030754; *EARSS, 2006, ANN REP 2005; Ekdahl K, 1997, CLIN INFECT DIS, V25, P1113, DOI 10.1086/516103; Farrell DJ, 2007, J CLIN MICROBIOL, V45, P290, DOI 10.1128/JCM.01653-06; Farrell DJ, 2005, EMERG INFECT DIS, V11, P851, DOI 10.3201/eid1106.050222; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; *FRENCH NAT HLTH I, FRENCH SURV ANT CONS; GESLIN P, 1992, CTR NAT REF PNEUM; Goldstein F, 2005, EMERG INFECT DIS, V11, P1489, DOI 10.3201/eid1109.050415; Hakenbeck R, 1999, MOL MICROBIOL, V33, P673, DOI 10.1046/j.1365-2958.1999.01521.x; HENDLEY JO, 1975, J INFECT DIS, V132, P55, DOI 10.1093/infdis/132.1.55; Hogberg L, 2007, J CLIN MICROBIOL, V45, P948, DOI 10.1128/JCM.01913-06; *INSEE, 2007, IND SER STAT INSEE; *INVS, 2006, B EP HEBD INVS, V2930, P212; Jorgensen JH, 2004, ANTIMICROB AGENTS CH, V48, P605, DOI 10.1128/AAC.48.2.605-607.2004; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Leclercq R, 2002, J INFECTION, V44, P11, DOI 10.1053/jinf.2001.0940; Leclercq R, 2001, J ANTIMICROB CHEMOTH, V48, P9, DOI 10.1093/jac/48.suppl_2.9; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; Lipsitch M, 2001, CLIN INFECT DIS, V32, P1044, DOI 10.1086/319604; Malley R, 2006, INFECT IMMUN, V74, P2187, DOI 10.1128/IAI.74.4.2187-2195.2006; McGowan JE, 2001, EMERG INFECT DIS, V7, P286, DOI 10.3201/eid0702.010228; Melegaro A, 2004, EPIDEMIOL INFECT, V132, P433, DOI 10.1017/S0950268804001980; Moroney JF, 2001, CLIN INFECT DIS, V33, P797, DOI 10.1086/322623; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; Pichichero ME, 2007, JAMA-J AM MED ASSOC, V298, P1772, DOI 10.1001/jama.298.15.1772; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Riedel S, 2007, EUR J CLIN MICROBIOL, V26, P485, DOI 10.1007/s10096-007-0321-5; Ross DB, 2007, NEW ENGL J MED, V356, P1601, DOI 10.1056/NEJMp078032; Rozen DE, 2007, ANTIMICROB AGENTS CH, V51, P412, DOI 10.1128/AAC.01161-06; Sommet A, 2004, J ANTIMICROB CHEMOTH, V54, P524, DOI 10.1093/jac/dkh342; Soreth J, 2007, NEW ENGL J MED, V356, P1675, DOI 10.1056/NEJMc076135; Stephens DS, 2005, LANCET, V365, P855, DOI 10.1016/S0140-6736(05)71043-6; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; Temime L, 2006, PEDIATR INFECT DIS J, V25, P382, DOI 10.1097/01.inf.0000210460.21966.f1; Temime L, 2004, ANTIMICROB AGENTS CH, V48, P2206, DOI 10.1128/AAC.48.6.2206-2213.2004; Temime L, 2003, EMERG INFECT DIS, V9, P411, DOI 10.3201/eid0904.020213; Tomasz A, 1997, CLIN INFECT DIS, V24, pS85, DOI 10.1093/clinids/24.Supplement_1.S85; Trzcinski K, 2006, J INFECT DIS, V193, P1296, DOI 10.1086/501367; *US FDA, 2007, UPD LAB KET; VARON E, 2005, CTR NAT REF PNEUM RA; VARON E, 2003, CTR NATL REFERENCE P; Wang YC, 2006, P NATL ACAD SCI USA, V103, P9655, DOI 10.1073/pnas.0600636103; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Wierzbowski AK, 2005, ANTIMICROB AGENTS CH, V49, P4635, DOI 10.1128/AAC.49.11.4635-4640.2005; 2002, ARCH PEDIAT, V9, P862	55	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2089	10.1371/journal.pone.0002089	http://dx.doi.org/10.1371/journal.pone.0002089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461139	gold, Green Published, Green Submitted			2022-12-27	WOS:000261642400012
J	Tran, PT; Fan, AC; Bendapudi, PK; Koh, S; Komatsubara, K; Chen, J; Horng, G; Bellovin, DI; Giuriato, S; Wang, CS; Whitsett, JA; Felsher, DW				Tran, Phuoc T.; Fan, Alice C.; Bendapudi, Pavan K.; Koh, Shan; Komatsubara, Kim; Chen, Joy; Horng, George; Bellovin, David I.; Giuriato, Sylvie; Wang, Craig S.; Whitsett, Jeffrey A.; Felsher, Dean W.			Combined Inactivation of MYC and K-Ras Oncogenes Reverses Tumorigenesis in Lung Adenocarcinomas and Lymphomas	PLOS ONE			English	Article							KINASE DOMAIN MUTATION; C-MYC; TYROSINE KINASE; TRANSGENIC MICE; NEOPLASTIC PHENOTYPE; SOMATIC MUTATIONS; STAT3 ACTIVATION; MUTANT EGFR; BCR-ABL; IN-VIVO	Background: Conditional transgenic models have established that tumors require sustained oncogene activation for tumor maintenance, exhibiting the phenomenon known as "oncogene-addiction.'' However, most cancers are caused by multiple genetic events making it difficult to determine which oncogenes or combination of oncogenes will be the most effective targets for their treatment. Methodology/Principal Findings: To examine how the MYC and K-ras(G12D) oncogenes cooperate for the initiation and maintenance of tumorigenesis, we generated double conditional transgenic tumor models of lung adenocarcinoma and lymphoma. The ability of MYC and K-ras(G12D) to cooperate for tumorigenesis and the ability of the inactivation of these oncogenes to result in tumor regression depended upon the specific tissue context. MYC-, K-ras(G12D)- or MYC/K-ras(G12D)-induced lymphomas exhibited sustained regression upon the inactivation of either or both oncogenes. However, in marked contrast, MYC-induced lung tumors failed to regress completely upon oncogene inactivation; whereas K-ras(G12D)-induced lung tumors regressed completely. Importantly, the combined inactivation of both MYC and K-ras(G12D) resulted more frequently in complete lung tumor regression. To account for the different roles of MYC and K-ras(G12D) in maintenance of lung tumors, we found that the down-stream mediators of K-ras(G12D) signaling, Stat3 and Stat5, are dephosphorylated following conditional K-ras(G12D) but not MYC inactivation. In contrast, Stat3 becomes dephosphorylated in lymphoma cells upon inactivation of MYC and/or K-ras(G12D). Interestingly, MYC-induced lung tumors that failed to regress upon MYC inactivation were found to have persistent Stat3 and Stat5 phosphorylation. Conclusions/Significance: Taken together, our findings point to the importance of the K-Ras and associated down-stream Stat effector pathways in the initiation and maintenance of lymphomas and lung tumors. We suggest that combined targeting of oncogenic pathways is more likely to be effective in the treatment of lung cancers and lymphomas.	[Tran, Phuoc T.] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA; [Tran, Phuoc T.; Fan, Alice C.; Bendapudi, Pavan K.; Koh, Shan; Komatsubara, Kim; Chen, Joy; Horng, George; Bellovin, David I.; Wang, Craig S.; Felsher, Dean W.] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA USA; [Tran, Phuoc T.; Fan, Alice C.; Bendapudi, Pavan K.; Koh, Shan; Komatsubara, Kim; Chen, Joy; Horng, George; Bellovin, David I.; Wang, Craig S.; Felsher, Dean W.] Stanford Univ, Sch Med, Dept Pathol, Div Oncol, Stanford, CA USA; [Giuriato, Sylvie] INSERM U563, Ctr Physiopathol Toulouse Purpan, Toulouse, France; [Giuriato, Sylvie] Univ Paul Sabatier, Toulouse, France; [Whitsett, Jeffrey A.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Pulmonary Biol, Cincinnati, OH USA	Stanford University; Stanford University; Stanford University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Tran, PT (corresponding author), Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA.	dfelsher@stanford.edu	Tran, Phuoc/W-2084-2019; Giuriato, Sylvie/A-9113-2010	Tran, Phuoc/0000-0002-0147-0376; Giuriato, Sylvie/0000-0003-3274-3397; Horng, George/0000-0003-0896-2557	RSNA [RR0601]; Henry S. Kaplan Research Fellow award [1046297-100-KAVWO]; Leukemia and Lymphoma Society Career Development Special Fellow in Clinical Research Award; Howard Hughes Medical Institute Medical Student Research Fellowship; NIH, NCI [R01-CA85610, R01-CA105102, 3R01CA089305-03S1, P50, 1P20 CA112973]; Burroughs Wellcome Fund; Damon Runyon Lilly Clinical Investigator Award; NATIONAL CANCER INSTITUTE [U56CA112973, R01CA105102, R01CA085610, R01CA089305] Funding Source: NIH RePORTER	RSNA; Henry S. Kaplan Research Fellow award; Leukemia and Lymphoma Society Career Development Special Fellow in Clinical Research Award; Howard Hughes Medical Institute Medical Student Research Fellowship(Howard Hughes Medical Institute); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Lilly Clinical Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an RSNA Resident Research grant (RR0601) and the Henry S. Kaplan Research Fellow award (SUMC grant 1046297-100-KAVWO) (to P.T.T.); the Leukemia and Lymphoma Society Career Development Special Fellow in Clinical Research Award (to A.C.F.); the Howard Hughes Medical Institute Medical Student Research Fellowship (to P.K.B.); and National Cancer Institute (NCI) Grants R01-CA85610, R01-CA105102, 3R01CA089305-03S1; National Institutes of Health (NIH)_NCI In Vivo Cellular and Molecular Imaging Center Grant P50; NIH_NCI Grant 1P20 CA112973; the Leukemia and Lymphoma Society; the Burroughs Wellcome Fund; and the Damon Runyon Lilly Clinical Investigator Award (to D.W.F.). None of the above funding sources were involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Alvarez JV, 2006, CANCER RES, V66, P3162, DOI 10.1158/0008-5472.CAN-05-3757; Arteaga CL, 2007, NAT MED, V13, P675, DOI 10.1038/nm0607-675; Arvanitis C, 2006, SEMIN CANCER BIOL, V16, P313, DOI 10.1016/j.semcancer.2006.07.012; Bachireddy P, 2005, CLIN CANCER RES, V11, P4278, DOI 10.1158/1078-0432.CCR-05-0534; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Brose MS, 2002, CANCER RES, V62, P6997; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; FRITSCH TME, 1982, MOL CLONING COLD SPR; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Giuriato S, 2004, SEMIN CANCER BIOL, V14, P3, DOI 10.1016/j.semcancer.2003.11.002; GREAVES MF, 1986, SCIENCE, V234, P697, DOI 10.1126/science.3535067; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Haura EB, 2005, CLIN CANCER RES, V11, P8288, DOI 10.1158/1078-0432.CCR-05-0827; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jang JW, 2006, MOL CELL BIOL; Ji HB, 2006, P NATL ACAD SCI USA, V103, P7817, DOI 10.1073/pnas.0510284103; Ji HB, 2007, CANCER RES, V67, P4933, DOI 10.1158/0008-5472.CAN-06-4592; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; Lee JW, 2006, CANCER LETT, V237, P89, DOI 10.1016/j.canlet.2005.05.026; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; Milton DT, 2006, J CLIN ONCOL, V24, P4940, DOI 10.1200/JCO.2006.06.4410; Mo L, 2007, J CLIN INVEST, V117, P314, DOI 10.1172/JCI30062; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Naoki K, 2002, CANCER RES, V62, P7001; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Regales L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000810; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Riely GJ, 2006, CLIN CANCER RES, V12, P7232, DOI 10.1158/1078-0432.CCR-06-0658; Sasaki H, 2006, INT J CANCER, V118, P180, DOI 10.1002/ijc.21301; Sasaki H, 2006, J SURG RES, V133, P203, DOI 10.1016/j.jss.2005.10.022; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Sharma SV, 2006, CLIN CANCER RES, V12, p4392S, DOI 10.1158/1078-0432.CCR-06-0096; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Sun S, 2002, J GEN VIROL, V83, P1651, DOI 10.1099/0022-1317-83-7-1651; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wittig Ilka, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P449, DOI 10.2174/156800805774912999; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	67	61	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2125	10.1371/journal.pone.0002125	http://dx.doi.org/10.1371/journal.pone.0002125			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461184	Green Published, gold, Green Submitted			2022-12-27	WOS:000261642400046
J	Granot, Y; Ivorra, A; Rubinsky, B				Granot, Yair; Ivorra, Antoni; Rubinsky, Boris			A New Concept for Medical Imaging Centered on Cellular Phone Technology	PLOS ONE			English	Article							TOMOGRAPHY	According to World Health Organization reports, some three quarters of the world population does not have access to medical imaging. In addition, in developing countries over 50% of medical equipment that is available is not being used because it is too sophisticated or in disrepair or because the health personnel are not trained to use it. The goal of this study is to introduce and demonstrate the feasibility of a new concept in medical imaging that is centered on cellular phone technology and which may provide a solution to medical imaging in underserved areas. The new system replaces the conventional stand-alone medical imaging device with a new medical imaging system made of two independent components connected through cellular phone technology. The independent units are: a) a data acquisition device (DAD) at a remote patient site that is simple, with limited controls and no image display capability and b) an advanced image reconstruction and hardware control multiserver unit at a central site. The cellular phone technology transmits unprocessed raw data from the patient site DAD and receives and displays the processed image from the central site. (This is different from conventional telemedicine where the image reconstruction and control is at the patient site and telecommunication is used to transmit processed images from the patient site). The primary goal of this study is to demonstrate that the cellular phone technology can function in the proposed mode. The feasibility of the concept is demonstrated using a new frequency division multiplexing electrical impedance tomography system, which we have developed for dynamic medical imaging, as the medical imaging modality. The system is used to image through a cellular phone a simulation of breast cancer tumors in a medical imaging diagnostic mode and to image minimally invasive tissue ablation with irreversible electroporation in a medical imaging interventional mode.	[Granot, Yair; Ivorra, Antoni; Rubinsky, Boris] Univ Calif Berkeley, Biophys Grad Grp, Dept Bioengn, Berkeley, CA 94720 USA; [Rubinsky, Boris] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, Res Ctr Bioengn Serv Human & Soc, Jerusalem, Israel	University of California System; University of California Berkeley; Hebrew University of Jerusalem	Granot, Y (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Dept Bioengn, Berkeley, CA 94720 USA.	rubinsky@me.berkeley.edu	Rubinsky, Boris/B-4439-2010; Ivorra, Antoni/A-3155-2008	Rubinsky, Boris/0000-0002-2794-1543; Ivorra, Antoni/0000-0001-7718-8767	U.S. National Institutes of Health (NIH) [R01 RR018961]; Israel Science Foundation [403/06]; Florida Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR018961] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Florida Hospital; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the U.S. National Institutes of Health (NIH) under Grant NIH R01 RR018961, the Israel Science Foundation (grant no 403/06) and Florida Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSENHEIMER M, 2001, PHYSIOL MEAS, P1; Bayford RH, 2006, ANNU REV BIOMED ENG, V8, P63, DOI 10.1146/annurev.bioeng.8.061505.095716; Brown B. H., 2003, Journal of Medical Engineering & Technology, V27, P97, DOI 10.1080/0309190021000059687; Cherepenin VA, 2002, IEEE T MED IMAGING, V21, P662, DOI 10.1109/TMI.2002.800602; Davalos RV, 2004, IEEE T BIO-MED ENG, V51, P761, DOI 10.1109/TBME.2004.824148; GILBERT J, 1984, USE ULTRASOUND IMAGI, P107; GILBERT JC, 1984, IEEE T BIO-MED ENG, V31, P565; Granot Y, 2007, INT J BIOMED IMAGING, V2007, DOI 10.1155/2007/54798; IN OT, 2007, PHYSIOL MEAS, pS71; Ivorra A, 2007, BIOELECTROCHEMISTRY, V70, P287, DOI 10.1016/j.bioelechem.2006.10.005; Kao TJ, 2006, PHYSIOL MEAS, V27, pS1, DOI 10.1088/0967-3334/27/5/S01; Kim DK, 2005, J TELEMED TELECARE, V11, P58, DOI 10.1258/135763305775124786; ONIK G, 1984, CRYOBIOLOGY, V21, P321, DOI 10.1016/0011-2240(84)90327-4; Otten DM, 2004, TECHNOL CANCER RES T, V3, P125, DOI 10.1177/153303460400300205; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; SUROWIEC AJ, 1988, IEEE T BIO-MED ENG, V35, P257, DOI 10.1109/10.1374; Vauhkonen M, 2001, PHYSIOL MEAS, V22, P107, DOI 10.1088/0967-3334/22/1/314; *WHO, WHO REP DIAGN IM; *WHO, WHO REP ESS DIAGN IM; WHO, WHO REP HLTH TECHN B; World Health Organization-WHO, 2003, ESS HLTH TECHN STRAT	21	57	59	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2075	10.1371/journal.pone.0002075	http://dx.doi.org/10.1371/journal.pone.0002075			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446199	Green Published, gold			2022-12-27	WOS:000261572300044
J	Dahl, L; Richter, K; Hagglund, AC; Carlsson, L				Dahl, Lina; Richter, Karin; Haegglund, Anna-Carin; Carlsson, Leif			Lhx2 Expression Promotes Self-Renewal of a Distinct Multipotential Hematopoietic Progenitor Cell in Embryonic Stem Cell-Derived Embryoid Bodies	PLOS ONE			English	Article							LIM HOMEOBOX GENE; W-MUTANT MICE; C-KIT; YOLK-SAC; IN-VITRO; DEVELOPMENTAL REGULATORS; PRIMITIVE STREAK; COLONY FORMATION; PROTEIN RBTN2; ANEMIC MICE	The molecular mechanisms regulating the expansion of the hematopoietic system including hematopoietic stem cells (HSCs) in the fetal liver during embryonic development are largely unknown. The LIM-homeobox gene Lhx2 is a candidate regulator of fetal hematopoiesis since it is expressed in the fetal liver and Lhx2(-/-) mice die in utero due to severe anemia. Moreover, expression of Lhx2 in embryonic stem (ES) cell-derived embryoid bodies (EBs) can lead to the generation of HSC-like cell lines. To further define the role of this transcription factor in hematopoietic regulation, we generated ES cell lines that enabled tet-inducible expression of Lhx2. Using this approach we observed that Lhx2 expression synergises with specific signalling pathways, resulting in increased frequency of colony forming cells in developing EB cells. The increase in growth factor-responsive progenitor cells directly correlates to the efficiency in generating HSC-like cell lines, suggesting that Lhx2 expression induce self-renewal of a distinct multipotential hematopoietic progenitor cell in EBs. Signalling via the c-kit tyrosine kinase receptor and the gp130 signal transducer by IL-6 is necessary and sufficient for the Lhx2 induced self-renewal. While inducing self-renewal of multipotential progenitor cells, expression of Lhx2 inhibited proliferation of primitive erythroid precursor cells and interfered with early ES cell commitment, indicating striking lineage specificity of this effect.	[Dahl, Lina; Richter, Karin; Haegglund, Anna-Carin; Carlsson, Leif] Umea Univ, Umea Ctr Mol Med, Umea, Sweden	Umea University	Dahl, L (corresponding author), Umea Univ, Umea Ctr Mol Med, Umea, Sweden.	leif.carlsson@ucmm.umu.se			Swedish Cancer Society; Swedish Medical Research Council; Vasterbotten County; Swedish Foundation for Strategic Research; Tobias Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Vasterbotten County; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Tobias Foundation	This work was supported by the Swedish Cancer Society, in part by the Swedish Medical Research Council and a grant from the Vasterbotten County. KR was supported by the Swedish Foundation for Strategic Research. LC was supported by the Tobias Foundation.	Audet J, 2001, P NATL ACAD SCI USA, V98, P1757, DOI 10.1073/pnas.98.4.1757; Baba Y, 2006, J IMMUNOL, V177, P2294, DOI 10.4049/jimmunol.177.4.2294; BARKER JE, 1968, DEV BIOL, V18, P14, DOI 10.1016/0012-1606(68)90020-1; BERNAD A, 1994, IMMUNITY, V1, P725, DOI 10.1016/S1074-7613(94)80014-6; Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; BROTHERTON TW, 1979, P NATL ACAD SCI USA, V76, P2853, DOI 10.1073/pnas.76.6.2853; BROXMEYER HE, 1991, EXP HEMATOL, V19, P143; Carlsson L, 2003, METHOD ENZYMOL, V365, P202; Choi K, 1998, DEVELOPMENT, V125, P725; DOPINTO OP, 2001, EXP HEMATOL, V29, P1019; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; Fleischman RA, 1996, EXP HEMATOL, V24, P209; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; HARRISON DE, 1988, P NATL ACAD SCI USA, V85, P822, DOI 10.1073/pnas.85.3.822; HARRISON DE, 1991, EXP HEMATOL, V19, P374; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Helgason CD, 1996, BLOOD, V87, P2740, DOI 10.1182/blood.V87.7.2740.bloodjournal8772740; Hirota J, 2004, P NATL ACAD SCI USA, V101, P8751, DOI 10.1073/pnas.0400940101; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; JOHNSON GR, 1985, EXP HEMATOL, V13, P200; JOHNSON GR, 1975, NATURE, V258, P726, DOI 10.1038/258726a0; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Keller G, 1998, BLOOD, V92, P877, DOI 10.1182/blood.V92.3.877.415k11_877_887; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; KELLER G, 1990, J EXP MED, V171, P1407, DOI 10.1084/jem.171.5.1407; Kolterud A, 2004, DEVELOPMENT, V131, P5319, DOI 10.1242/dev.01416; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Kyba M, 2003, P NATL ACAD SCI USA, V100, P11904, DOI 10.1073/pnas.1734140100; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Laker C, 1998, J VIROL, V72, P339, DOI 10.1128/JVI.72.1.339-348.1998; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; MCCLANAHAN T, 1993, BLOOD, V81, P2903; MCCULLOCH EA, 1964, SCIENCE, V144, P844, DOI 10.1126/science.144.3620.844; METCALF D, 1991, P NATL ACAD SCI USA, V88, P6239, DOI 10.1073/pnas.88.14.6239; MIGLIACCIO G, 1991, P NATL ACAD SCI USA, V88, P7420, DOI 10.1073/pnas.88.16.7420; Miller CL, 1996, EXP HEMATOL, V24, P185; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; NOCKA K, 1989, GENE DEV, V3, P816, DOI 10.1101/gad.3.6.816; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; OGAWA M, 1993, DEVELOPMENT, V117, P1089; Palis J, 1999, DEVELOPMENT, V126, P5073; Perlingeiro RCR, 2001, DEVELOPMENT, V128, P4597; Peters DG, 2001, ONCOGENE, V20, P2636, DOI 10.1038/sj.onc.1204374; Peters M, 1997, J EXP MED, V185, P755, DOI 10.1084/jem.185.4.755; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Pilat S, 2005, P NATL ACAD SCI USA, V102, P12101, DOI 10.1073/pnas.0505624102; Pinto do O P, 1998, EMBO J, V17, P5744, DOI 10.1093/emboj/17.19.5744; Porter FD, 1997, DEVELOPMENT, V124, P2935; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Richter K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-75; Richter K, 2003, HAEMATOLOGICA, V88, P1336; Richter K., 2002, BLOOD, V99, P3939; Rodriguez-Esteban C, 1998, DEVELOPMENT, V125, P3925; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; Sabin FR, 1920, CONTRIB EMBRYOL, V9, P215; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; SCHMITT RM, 1991, GENE DEV, V5, P728, DOI 10.1101/gad.5.5.728; Sui XW, 1999, BLOOD, V93, P2525, DOI 10.1182/blood.V93.8.2525.408k11_2525_2532; SUI XW, 1995, P NATL ACAD SCI USA, V92, P2859, DOI 10.1073/pnas.92.7.2859; Sui XW, 1996, J EXP MED, V183, P837, DOI 10.1084/jem.183.3.837; Takizawa M, 2003, EXP HEMATOL, V31, P283, DOI 10.1016/S0301-472X(03)00025-0; VALGEARCHER VE, 1994, P NATL ACAD SCI USA, V91, P8617, DOI 10.1073/pnas.91.18.8617; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Visvader JE, 1997, P NATL ACAD SCI USA, V94, P13707, DOI 10.1073/pnas.94.25.13707; Wandzioch E, 2004, P NATL ACAD SCI USA, V101, P16549, DOI 10.1073/pnas.0404678101; Wang Y, 2005, P NATL ACAD SCI USA, V102, P19081, DOI 10.1073/pnas.0506127102; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Willey S, 2006, BLOOD, V107, P3122, DOI 10.1182/blood-2005-10-4120; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; YOSHIDA K, 1994, MECH DEVELOP, V45, P163, DOI 10.1016/0925-4773(94)90030-2; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407; Zafonte BT, 2007, BLOOD, V109, P516, DOI 10.1182/blood-2006-02-004564	81	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2025	10.1371/journal.pone.0002025	http://dx.doi.org/10.1371/journal.pone.0002025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431502	gold, Green Published, Green Submitted			2022-12-27	WOS:000261558700037
J	Quinones, B; Guilhabert, MR; Miller, WG; Mandrell, RE; Lastovica, AJ; Parker, CT				Quinones, Beatriz; Guilhabert, Magalie R.; Miller, William G.; Mandrell, Robert E.; Lastovica, Albert J.; Parker, Craig T.			Comparative Genomic Analysis of Clinical Strains of Campylobacter jejuni from South Africa	PLOS ONE			English	Article								Background: Campylobacter jejuni is a common cause of acute gastroenteritis and is also associated with the post-infectious neuropathies, Guillain-Barre and Miller Fisher syndromes. In the Cape Town area of South Africa, C. jejuni strains with Penner heat-stable (HS) serotype HS: 41 have been observed to be overrepresented among cases of Guillain-Barre syndrome. The present study examined the genetic content of a collection of 32 South African C. jejuni strains with different serotypes, including 13 HS: 41 strains, that were recovered from patients with enteritis, Guillain-Barre or Miller Fisher syndromes. The sequence-based typing methods, multilocus sequence typing and DNA microarrays, were employed to potentially identify distinguishing features within the genomes of these C. jejuni strains with various disease outcomes. Methodology/ Principal Findings: Comparative genomic analyses demonstrated that the HS: 41 South African strains were clearly distinct from the other South African strains. Further DNA microarray analysis demonstrated that the HS: 41 strains from South African patients with the Guillain-Barre syndrome or enteritis were highly similar in gene content. Interestingly, the South African HS: 41 strains were distinct in gene content when compared to HS: 41 strains from other geographical locations due to the presence of genomic islands, referred to as Campylobacter jejuni integrated elements (CJIEs). Only the integrated element CJIE1, a Campylobacter Mu-like prophage, was present in the South African HS: 41 strains whereas this element was absent in two closely-related HS: 41 strains from Mexico. A more distantly-related HS: 41 strain from Canada possessed both integrated elements CJIE1 and CJIE2. Conclusion/Significance: These findings demonstrate that CJIEs may contribute to the differentiation of closely-related C. jejuni strains. In addition, the presence of bacteriophage-related genes in CJIE1 may contribute to the genomic diversity of C. jejuni strains. This comparative genomic analysis of C. jejuni provides fundamental information that potentially could lead to improved methods for analyzing the epidemiology of disease outbreaks.	[Quinones, Beatriz; Miller, William G.; Mandrell, Robert E.; Parker, Craig T.] ARS, USDA, Produce Safety & Microbiol Res Unit, Albany, CA USA; [Guilhabert, Magalie R.] AgraQuest Inc, Davis, CA USA; [Lastovica, Albert J.] Univ Western Cape, Dept Biotechnol, Bellville, South Africa	United States Department of Agriculture (USDA); University of the Western Cape	Quinones, B (corresponding author), ARS, USDA, Produce Safety & Microbiol Res Unit, Albany, CA USA.	bquinones@pw.usda.gov; parker@pw.usda.gov	Mandrell, Robert E/O-9814-2018	Quinones, Beatriz/0000-0001-5010-9889; Parker, Craig/0000-0002-7719-8882	United States Department of Agriculture; Agricultural Research Service CRIS [5325-42000-045]; South African Medical Research Council	United States Department of Agriculture(United States Department of Agriculture (USDA)); Agricultural Research Service CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the United States Department of Agriculture, Agricultural Research Service CRIS project number 5325-42000-045 and the South African Medical Research Council.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Ang CW, 2002, INFECT IMMUN, V70, P1202, DOI 10.1128/IAI.70.3.1202-1208.2002; ANGSTROM J, 1994, P NATL ACAD SCI USA, V91, P11859, DOI 10.1073/pnas.91.25.11859; Anjum MF, 2003, INFECT IMMUN, V71, P4674, DOI 10.1128/IAI.71.8.4674-4683.2003; Barton C, 2007, J CLIN MICROBIOL, V45, P386, DOI 10.1128/JCM.01513-06; BLASER MJ, 1979, ANN INTERN MED, V91, P179, DOI 10.7326/0003-4819-91-2-179; Caporale CM, 2006, J NEUROIMMUNOL, V177, P112, DOI 10.1016/j.jneuroim.2006.05.018; Champion OL, 2005, P NATL ACAD SCI USA, V102, P16043, DOI 10.1073/pnas.0503252102; Colles FM, 2003, APPL ENVIRON MICROB, V69, P7409, DOI 10.1128/AEM.69.12.7409-7413.2003; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2001, J CLIN MICROBIOL, V39, P3346, DOI 10.1128/JCM.39.9.3346-3349.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; Duim B, 2003, J CLIN MICROBIOL, V41, P5593, DOI 10.1128/JCM.41.12.5593-5597.2003; Endtz HP, 2000, J CLIN MICROBIOL, V38, P2297; Engberg J, 2001, J INFECT DIS, V184, P215, DOI 10.1086/322010; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Gilbert M, 2000, J BIOL CHEM, V275, P3896, DOI 10.1074/jbc.275.6.3896; Goddard EA, 1997, ARCH DIS CHILD, V76, P526, DOI 10.1136/adc.76.6.526; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Godschalk PCR, 2007, J CLIN MICROBIOL, V45, P2316, DOI 10.1128/JCM.00203-07; Godschalk PCR, 2007, INFECT IMMUN, V75, P1245, DOI 10.1128/IAI.00872-06; Godschalk PCR, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-32; Gutacker MM, 2002, GENETICS, V162, P1533; Hasenstein JR, 2006, INFECT IMMUN, V74, P3375, DOI 10.1128/IAI.00027-06; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; Karlyshev AV, 2000, MOL MICROBIOL, V35, P529, DOI 10.1046/j.1365-2958.2000.01717.x; Koga M, 2006, J INFECT DIS, V193, P547, DOI 10.1086/499969; KUROKI S, 1993, ANN NEUROL, V33, P243, DOI 10.1002/ana.410330304; Lastovica AJ, 1997, J INFECT DIS, V176, pS139, DOI 10.1086/513796; Leonard EE, 2004, INFECT IMMUN, V72, P1199, DOI 10.1128/IAI.72.2.1199-1203.2004; Leonard EE, 2003, J INFECT DIS, V187, P691, DOI 10.1086/368268; Magira EE, 2003, J IMMUNOL, V170, P3074, DOI 10.4049/jimmunol.170.6.3074; Manning G, 2003, APPL ENVIRON MICROB, V69, P6370, DOI 10.1128/AEM.69.11.6370-6379.2003; Miller WG, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P101; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Nachamkin I, 2002, INFECT IMMUN, V70, P5299, DOI 10.1128/IAI.70.9.5299-5303.2002; Nachamkin I, 2001, J INFECT DIS, V184, P221, DOI 10.1086/322008; Overell JR, 2005, CURR OPIN NEUROL, V18, P562, DOI 10.1097/01.wco.0000173284.25581.2f; Parker CT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-50; Parker CT, 2006, J CLIN MICROBIOL, V44, P4125, DOI 10.1128/JCM.01231-06; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; Pearson BM, 2003, FEBS LETT, V554, P224, DOI 10.1016/S0014-5793(03)01164-5; Perera VN, 2007, FEMS IMMUNOL MED MIC, V50, P27, DOI 10.1111/j.1574-695X.2007.00225.x; Pin C, 2006, APPL MICROBIOL BIOT, V72, P852, DOI 10.1007/s00253-006-0536-x; Sails AD, 2003, J CLIN MICROBIOL, V41, P4733, DOI 10.1128/JCM.41.10.4733-4739.2003; Snelling WJ, 2005, LETT APPL MICROBIOL, V41, P297, DOI 10.1111/j.1472-765X.2005.01788.x; Stoddard RA, 2007, APPL ENVIRON MICROB, V73, P1729, DOI 10.1128/AEM.01816-06; Taboada EN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-359; Taboada EN, 2004, J CLIN MICROBIOL, V42, P4566, DOI 10.1128/JCM.42.10.4566-4576.2004; Takahashi M, 2005, J CLIN MICROBIOL, V43, P335, DOI 10.1128/JCM.43.1.335-339.2005; Tatsumoto M, 2006, J NEUROIMMUNOL, V177, P201, DOI 10.1016/j.jneuroim.2006.04.005; van Belkum A, 2001, NAT MED, V7, P752, DOI 10.1038/89831; VANDERMECHE FG, 1997, J INFECT DIS S, V2, pS99; Wassenaar TM, 2000, J CLIN MICROBIOL, V38, P874, DOI 10.1128/JCM.38.2.874-876.2000; YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771; Yuki N, 2006, CURR OPIN NEUROL, V19, P451, DOI 10.1097/01.wco.0000245367.36576.e9; Zhang W, 2006, GENOME RES, V16, P757, DOI 10.1101/gr.4759706	62	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2015	10.1371/journal.pone.0002015	http://dx.doi.org/10.1371/journal.pone.0002015			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431496	gold, Green Published, Green Submitted			2022-12-27	WOS:000261558700031
J	Ageta, H; Murayama, A; Migishima, R; Kida, S; Tsuchida, K; Yokoyama, M; Inokuchi, K				Ageta, Hiroshi; Murayama, Akiko; Migishima, Rika; Kida, Satoshi; Tsuchida, Kunihiro; Yokoyama, Minesuke; Inokuchi, Kaoru			Activin in the Brain Modulates Anxiety-Related Behavior and Adult Neurogenesis	PLOS ONE			English	Article								Activin, a member of the transforming growth factor-beta superfamily, is an endocrine hormone that regulates differentiation and proliferation of a wide variety of cells. In the brain, activin protects neurons from ischemic damage. In this study, we demonstrate that activin modulates anxiety-related behavior by analyzing ACM4 and FSM transgenic mice in which activin and follistatin (which antagonizes the activin signal), respectively, were overexpressed in a forebrain-specific manner under the control of the alpha CaMKII promoter. Behavioral analyses revealed that FSM mice exhibited enhanced anxiety compared to wild-type littermates, while ACM4 mice showed reduced anxiety. Importantly, survival of newly formed neurons in the subgranular zone of adult hippocampus was significantly decreased in FSM mice, which was partially rescued in ACM4/FSM double transgenic mice. Our findings demonstrate that the level of activin in the adult brain bi-directionally influences anxiety-related behavior. These results further suggest that decreases in postnatal neurogenesis caused by activin inhibition affect an anxiety-related behavior in adulthood. Activin and its signaling pathway may represent novel therapeutic targets for anxiety disorder as well as ischemic brain injury.	[Ageta, Hiroshi; Murayama, Akiko; Migishima, Rika; Yokoyama, Minesuke; Inokuchi, Kaoru] Mitsubishi Kagaku Inst Life Sci, Tokyo, Japan; [Ageta, Hiroshi; Murayama, Akiko; Kida, Satoshi; Inokuchi, Kaoru] CREST, Japan Sci & Technol Corp, Kawaguchi, Japan; [Kida, Satoshi; Inokuchi, Kaoru] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa, Japan; Tokyo Univ Agr, Dept Biosci, Tokyo, Japan; [Tsuchida, Kunihiro] Fujita Hlth Univ, Inst Comprehensive Med Sci, Div Therapies Against Intractable Dis, Aichi, Japan; [Yokoyama, Minesuke] Niigata Univ, Brain Res Inst, Niigata, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); Japan Science & Technology Agency (JST); Yokohama National University; Tokyo University of Agriculture; Fujita Health University; Niigata University	Ageta, H (corresponding author), Mitsubishi Kagaku Inst Life Sci, Tokyo, Japan.	kaoru@mitils.jp	Inokuchi, Kaoru/AAI-9693-2020; Tsuchida, Kunihiro/A-4501-2012	Inokuchi, Kaoru/0000-0002-5393-3133; Tsuchida, Kunihiro/0000-0002-3983-5756	MEXT of the Japanese Government [Grant-in-Aid]	MEXT of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Special Coordinate Funds for Promoting Science and Technology from MEXT of the Japanese Government (K.I.), and in part by a Grant-in-Aid for Scientific Research on Priority Areas Neural Circuit Project, Advanced Brain Science Project, and Molecular Brain Science, from MEXT of the Japanese Government (K.I.).	ANDREASSON K, 1995, NEUROSCIENCE, V69, P781, DOI 10.1016/0306-4522(95)00245-E; Bilezikjian LM, 2006, REPRODUCTION, V132, P207, DOI 10.1530/rep.1.01073; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; CAMERON VA, 1994, ENDOCRINOLOGY, V134, P799, DOI 10.1210/en.134.2.799; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Dow AL, 2005, J NEUROSCI, V25, P4908, DOI 10.1523/JNEUROSCI.5155-04.2005; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Funaba M, 1997, J NEUROENDOCRINOL, V9, P105, DOI 10.1046/j.1365-2826.1997.00558.x; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Guo QX, 1998, MOL ENDOCRINOL, V12, P96, DOI 10.1210/mend.12.1.0053; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hogan B, 1994, MANIPULATING MOUSE E; Ikegami S, 2000, NEUROSCIENCE, V98, P637, DOI 10.1016/S0306-4522(00)00161-5; Inokuchi K, 1996, FEBS LETT, V382, P48, DOI 10.1016/0014-5793(96)00135-4; Kalueff AV, 2007, BEHAV BRAIN RES, V179, P1, DOI 10.1016/j.bbr.2007.01.023; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kokaia Z, 2003, CURR OPIN NEUROBIOL, V13, P127, DOI 10.1016/S0959-4388(03)00017-5; Matsuo R, 2001, BIOCHEM BIOPH RES CO, V289, P479, DOI 10.1006/bbrc.2001.5975; MATZUK MM, 1995, NATURE, V374, P354, DOI 10.1038/374354a0; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Munz B, 1999, EMBO J, V18, P5205, DOI 10.1093/emboj/18.19.5205; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Shoji H, 2000, J BIOL CHEM, V275, P5485, DOI 10.1074/jbc.275.8.5485; Shoji-Kasai Y, 2007, J CELL SCI, V120, P3830, DOI 10.1242/jcs.012450; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stansfield KH, 2007, PHARMACOL BIOCHEM BE, V86, P637, DOI 10.1016/j.pbb.2007.02.008; Sugino Hiromu, 1997, Journal of Medical Investigation, V44, P1; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tretter YP, 2000, NAT MED, V6, P812, DOI 10.1038/77548; Wankell M, 2001, EMBO J, V20, P5361, DOI 10.1093/emboj/20.19.5361; Wong ML, 2004, NAT REV DRUG DISCOV, V3, P136, DOI 10.1038/nrd1303	39	85	86	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1869	10.1371/journal.pone.0001869	http://dx.doi.org/10.1371/journal.pone.0001869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382659	gold, Green Published, Green Submitted			2022-12-27	WOS:000260795400009
J	Alphonse, MP; Saffar, AS; Shan, L; HayGlass, KT; Simons, FER; Gounni, AS				Alphonse, Martin P.; Saffar, Arash S.; Shan, Lianyu; HayGlass, Kent T.; Simons, F. Estelle R.; Gounni, Abdelilah S.			Regulation of the High Affinity IgE Receptor (Fc epsilon RI) in Human Neutrophils: Role of Seasonal Allergen Exposure and Th-2 Cytokines	PLOS ONE			English	Article								The high affinity IgE receptor, Fc epsilon RI, plays a key role in the immunological pathways involved in allergic asthma. Previously we have demonstrated that human neutrophils isolated from allergic asthmatics express a functional Fc epsilon RI, and therefore it was of importance to examine the factors regulating its expression. In this study, we found that neutrophils from allergic asthmatics showed increased expression of Fc epsilon RI-alpha chain surface protein, total protein and mRNA compared with those from allergic non asthmatics and healthy donors (p<0.001). Interestingly, in neutrophils isolated from allergic asthmatics, Fc epsilon RI-alpha chain surface protein and mRNA expression were significantly greater during the pollen season than outside the pollen season (n = 9, P = 0.001), an effect which was not observed either in the allergic non asthmatic group or the healthy donors (p>0.05). Allergen exposure did not affect other surface markers of neutrophils such as CD16/Fc gamma RIII or IL-17R. In contrast to stimulation with IgE, neutrophils incubated with TH2 cytokines IL-9, GM-CSF, and IL-4, showed enhanced Fc epsilon RI-alpha chain surface expression. In conclusion, these results suggest that enhanced Fc epsilon RI expression in human neutrophils from allergic asthmatics during the pollen season can make them more susceptible to the biological effects of IgE, providing a possible new mechanism by which neutrophils contribute to allergic asthma.	[Alphonse, Martin P.; Saffar, Arash S.; Shan, Lianyu; HayGlass, Kent T.; Simons, F. Estelle R.; Gounni, Abdelilah S.] Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0W3, Canada; [HayGlass, Kent T.; Simons, F. Estelle R.] Univ Manitoba, Fac Med, Dept Pediat & Child Hlth, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	Gounni, AS (corresponding author), Univ Manitoba, Fac Med, Dept Immunol, Winnipeg, MB R3E 0W3, Canada.	gounni@cc.umanitoba.ca	Gounni, Abdelilah Soussi/AAH-3456-2020; Alphonse, Martin/AAP-4397-2021	Alphonse, Martin/0000-0003-3447-1284; HayGlass, Kent/0000-0002-4621-7737; Gounni, Abdelilah/0000-0003-1265-6560; Soussi Gounni, Abdelilah/0000-0002-7282-0388	Canadian Institutes of Health Research (CIHR); CIHR sponsored National Training Program in Allergy and Asthma (NTPAA) [studentships]; Manitoba Health Research Council; HSCF Olenick award for excellence in immunology research	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR sponsored National Training Program in Allergy and Asthma (NTPAA)(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council; HSCF Olenick award for excellence in immunology research	This work was supported by grants from the Canadian Institutes of Health Research (CIHR). ASS is supported by studentships from CIHR sponsored National Training Program in Allergy and Asthma (NTPAA), Manitoba Health Research Council and the HSCF Olenick award for excellence in immunology research. The sponsors of the study had no role in study design, collection, analysis or interpretation of data, writing of the report, or in the final decision to submit this report for publication.	BRADLEY BL, 1991, J ALLERGY CLIN IMMUN, V88, P661, DOI 10.1016/0091-6749(91)90160-P; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Campbell AM, 1998, AM J RESP CELL MOL, V19, P92, DOI 10.1165/ajrcmb.19.1.2648; Ennis M, 2003, CURR ALLERGY ASTHM R, V3, P159, DOI 10.1007/s11882-003-0029-2; FAHY JV, 1995, J ALLERGY CLIN IMMUN, V95, P843, DOI 10.1016/S0091-6749(95)70128-1; FURUICHI K, 1985, P NATL ACAD SCI USA, V82, P1522, DOI 10.1073/pnas.82.5.1522; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; Gounni AS, 2001, FASEB J, V15, P940, DOI 10.1096/fj.00-0378com; Holgate ST, 2006, LANCET, V368, P780, DOI 10.1016/S0140-6736(06)69288-X; Kelly EAB, 2000, AM J RESP CRIT CARE, V162, P1157; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kraft S, 1998, J IMMUNOL, V161, P1000; Lantz CS, 1997, J IMMUNOL, V158, P2517; LAVABREBERTRAND T, 1994, LEUKEMIA, V8, P1557; MacGlashan D, 1998, BLOOD, V91, P1633, DOI 10.1182/blood.V91.5.1633.1633_1633_1643; MacGlashan D, 2001, J LEUKOCYTE BIOL, V70, P207; MALVEAUX FJ, 1978, J CLIN INVEST, V62, P176, DOI 10.1172/JCI109103; Maurer D, 1996, J IMMUNOL, V157, P607; MAURER D, 1994, J EXP MED, V179, P745, DOI 10.1084/jem.179.2.745; Monteseirin J, 2003, INT ARCH ALLERGY IMM, V131, P174, DOI 10.1159/000071483; Monteseirin J, 2001, CLIN EXP ALLERGY, V31, P889, DOI 10.1046/j.1365-2222.2001.01083.x; Monteseirin J, 2004, J LEUKOCYTE BIOL, V76, P692, DOI 10.1189/jlb.0903441; Nechansky A, 1997, HYBRIDOMA, V16, P441, DOI 10.1089/hyb.1997.16.441; Nguyen LT, 2005, RESP MED, V99, P200, DOI 10.1016/j.rmed.2004.06.007; Nocker RET, 1999, INT ARCH ALLERGY IMM, V119, P45, DOI 10.1159/000024174; Novak N, 2001, J IMMUNOL, V167, P797, DOI 10.4049/jimmunol.167.2.797; O'Byrne PM, 2003, CHEST, V123, p411S, DOI 10.1378/chest.123.3_suppl.411S; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; Peebles RS, 1998, J ALLERGY CLIN IMMUN, V101, P265, DOI 10.1016/S0091-6749(98)70392-6; Peebles RS, 2001, CLIN EXP ALLERGY, V31, P239; Qian X, 2003, DIAGN MOL PATHOL, V12, P1, DOI 10.1097/00019606-200303000-00001; QUARTO R, 1985, MOL IMMUNOL, V22, P1045, DOI 10.1016/0161-5890(85)90107-5; Saffar AS, 2007, J IMMUNOL, V178, P2535, DOI 10.4049/jimmunol.178.4.2535; Terada N, 1995, J ALLERGY CLIN IMMUN, V96, P1161, DOI 10.1016/S0091-6749(95)70201-6; Xia HZ, 1997, J IMMUNOL, V159, P2911; Yamaguchi M, 1997, J EXP MED, V185, P663, DOI 10.1084/jem.185.4.663; Yamaguchi M, 1999, J IMMUNOL, V162, P5455; Yamaoka KA, 1996, INT IMMUNOL, V8, P479, DOI 10.1093/intimm/8.4.479; Yano K, 1997, LAB INVEST, V77, P185	39	21	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1921	10.1371/journal.pone.0001921	http://dx.doi.org/10.1371/journal.pone.0001921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382690	gold, Green Submitted, Green Published			2022-12-27	WOS:000260795400043
J	Helgason, CM; Jobe, TH				Helgason, Cathy M.; Jobe, Thomas H.			Measurable Prediction for the Single Patient and the Results of Large Double Blind Controlled Randomized Trials	PLOS ONE			English	Article								Background: It has been shown that the clinical state of one patient can be represented by known measured variables of interest, each of which then form the element of a fuzzy set as point in the unit hypercube. We hypothesized that precise comparison of a single patient with the average patient of a large double blind controlled randomized study is possible using fuzzy theory. Methods/Principle Findings: The sets as points unit hypercube geometry allows fuzzy subsethood to define in measures of fuzzy cardinality different conditions, similarity and comparison between fuzzy sets. A fuzzy measure of prediction is defined from fuzzy measures of similarity and comparison. It is a measure of the degree to which fuzzy set A is similar to fuzzy set B when different conditions are taken into account and removed from the comparison. When represented as a fuzzy set as point in the unit hypercube, a clinical patient can be compared to an average patient of a large group study in a precise manner. This comparison is expressed by the fuzzy prediction measure. This measure in itself is not a probability. Once thus precisely matched to the average patient of a large group study, risk reduction is calculated by multiplying the measured similarity of the clinical patient to the risk of the average trial patient. Conclusion/Significance: Otherwise not precisely translatable to the single case, the result of group statistics can be applied to the single case through the use of fuzzy subsethood and measured in fuzzy cardinality. This measure is an alternative to a Bayesian or other probability based statistical approach.	[Helgason, Cathy M.] Univ Illinois, Coll Med, Dept Neurol, Chicago, IL 60680 USA; [Jobe, Thomas H.] Univ Illinois Chicago, Coll Med, Dept Psychiat, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago	Helgason, CM (corresponding author), Univ Illinois, Coll Med, Dept Neurol, Chicago, IL 60680 USA.	helgason@uic.edu						Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; Gorelick PB, 2003, JAMA-J AM MED ASSOC, V289, P2947, DOI 10.1001/jama.289.22.2947; Helgason Cathy M, 2005, Curr Treat Options Cardiovasc Med, V7, P211, DOI 10.1007/s11936-005-0049-4; HELGASON CM, 2007, OPEN ACCESS CYBERNET, V2, P11; HELGASON CM, 2007, IC MED, V1, P5; HELGASON CM, 2003, INT J COMPUTATIONAL, V1, P74; KOSKO B, 1993, NEURAL NETWORKS FUZZ, P263; Nickman NA, 2007, AM J HEALTH-SYST PH, V64, P2250, DOI 10.2146/ajhp060632; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zadeh LA, 2006, COMPUT STAT DATA AN, V51, P15, DOI 10.1016/j.csda.2006.04.029	10	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1909	10.1371/journal.pone.0001909	http://dx.doi.org/10.1371/journal.pone.0001909			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382682	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795400034
J	Lozano, S; Arenas, A; Sanchez, A				Lozano, Sergi; Arenas, Alex; Sanchez, Angel			Mesoscopic Structure Conditions the Emergence of Cooperation on Social Networks	PLOS ONE			English	Article							EVOLUTIONARY GAMES; DILEMMAS; DYNAMICS	Background: We study the evolutionary Prisoner's Dilemma on two social networks substrates obtained from actual relational data. Methodology/Principal Findings: We find very different cooperation levels on each of them that cannot be easily understood in terms of global statistical properties of both networks. We claim that the result can be understood at the mesoscopic scale, by studying the community structure of the networks. We explain the dependence of the cooperation level on the temptation parameter in terms of the internal structure of the communities and their interconnections. We then test our results on community-structured, specifically designed artificial networks, finding a good agreement with the observations in both real substrates. Conclusion: Our results support the conclusion that studies of evolutionary games on model networks and their interpretation in terms of global properties may not be sufficient to study specific, real social systems. Further, the study allows us to define new quantitative parameters that summarize the mesoscopic structure of any network. In addition, the community perspective may be helpful to interpret the origin and behavior of existing networks as well as to design structures that show resilient cooperative behavior.	[Lozano, Sergi] ETH, Swiss Fed Inst Technol, Zurich, Switzerland; [Arenas, Alex] Univ Rovira Virgili, Tarragona, Spain; [Arenas, Alex; Sanchez, Angel] Univ Zaragoza, Inst Biocomput Fisica Sistemas Complejos BIFI, Zaragoza, Spain; [Sanchez, Angel] Univ Carlos Madrid 3, Dept Matematicas, Grupo Interdisciplinar Sistemas Complejos GISC, Leganes, Spain; [Sanchez, Angel] IMDEA Matematicas, Campus Univ Autonoma Madrid, Madrid, Spain	Swiss Federal Institutes of Technology Domain; ETH Zurich; Universitat Rovira i Virgili; University of Zaragoza; Universidad Carlos III de Madrid	Lozano, S (corresponding author), ETH, Swiss Fed Inst Technol, Zurich, Switzerland.	slozano@ethz.ch	Arenas, Alex/A-5216-2009; Lozano, Sergi/B-5974-2015; Sánchez, Angel/A-9229-2008	Arenas, Alex/0000-0003-0937-0334; Lozano, Sergi/0000-0003-1895-9327; Sánchez, Angel/0000-0003-1874-2881	Ministerio de Educacion y Ciencia (Spain) [FIS2006-13321, MOSAICO, NAN2004-9087-C03-03]; Comunidad de Madrid (Spain) [UC3M-FI-05-007, SIMUMAT-CM]; SIMUMAT-CM; URV [FPU grant]	Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Comunidad de Madrid (Spain)(Comunidad de Madrid); SIMUMAT-CM; URV	This work was supported by Ministerio de Educacion y Ciencia (Spain) under grants FIS2006-13321, MOSAICO and NAN2004-9087-C03-03 and by Comunidad de Madrid (Spain) under grants UC3M-FI-05-007 and SIMUMAT-CM. S.L. was supported by URV through a FPU grant.	Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; Apesteguia J, 2007, J ECON THEORY, V136, P217, DOI 10.1016/j.jet.2006.07.006; Arenas A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.114102; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boettcher S, 2001, PHYS REV LETT, V86, P5211, DOI 10.1103/PhysRevLett.86.5211; Boguna M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056122; Bollobas B., 2001, RANDOM GRAPHS; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Dugatkin L.A., 1997, COOPERATION ANIMALS; Eguiluz VM, 2005, AM J SOCIOL, V110, P977, DOI 10.1086/428716; Eshel I, 1998, AM ECON REV, V88, P157; Gintis H., 2005, MORAL SENTIMENTS MAT, P3; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; HAMERSTEIN P, 2003, GENETIC CULTURAL EVO; Hauert C, 2002, INT J BIFURCAT CHAOS, V12, P1531, DOI 10.1142/S0218127402005273; Holme P, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.030901; HUBERMAN BA, 1993, P NATL ACAD SCI USA, V90, P7716, DOI 10.1073/pnas.90.16.7716; Kirchkamp O, 2000, J ECON BEHAV ORGAN, V43, P239, DOI 10.1016/S0167-2681(00)00118-9; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Kosfeld M., 2004, REV NETW ECON, V3, P20; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pringle M, 1996, J ECON BEHAV ORGAN, V29, P191, DOI 10.1016/0167-2681(95)00059-3; Roberts JM, 2000, SOC NETWORKS, V22, P273, DOI 10.1016/S0378-8733(00)00026-5; Roca CP, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.158701; ROCA CP, 2007, IN PRESS; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, J EVOLUTION BIOL, V19, P726, DOI 10.1111/j.1420-9101.2005.01063.x; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Selten R, 2005, GAME ECON BEHAV, V51, P171, DOI 10.1016/j.geb.2004.03.005; Strang D, 2001, AM J SOCIOL, V107, P147, DOI 10.1086/323039; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; VegaRedondo F, 1997, ECONOMETRICA, V65, P375, DOI 10.2307/2171898; Wasserman S., 1999, SOCIAL NETWORK ANAL; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118	42	92	92	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1892	10.1371/journal.pone.0001892	http://dx.doi.org/10.1371/journal.pone.0001892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370XC	18382673	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795400024
J	Ma, XL; Hibbert, B; White, D; Seymour, R; Whitman, SC; O'Brien, ER				Ma, Xiaoli; Hibbert, Benjamin; White, Dawn; Seymour, Richard; Whitman, Stewart C.; O'Brien, Edward R.			Contribution of Recipient-Derived Cells in Allograft Neointima Formation and the Response to Stent Implantation	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ENDOTHELIAL PROGENITOR CELLS; GROWTH-FACTOR; MONONUCLEAR-CELLS; VASA VASORUM; BLOOD-CELLS; ORIGIN; ATHEROSCLEROSIS; VASCULOPATHY; ANGIOPLASTY	Allograft coronary disease is the dominant cause of increased risk of death after cardiac transplantation. While the percutaneous insertion of stents is the most efficacious revascularization strategy for allograft coronary disease there is a high incidence of stent renarrowing. We developed a novel rabbit model of sex-mismatched allograft vascular disease as well as the response to stent implantation. In situ hybridization for the Y-chromosome was employed to detect male cells in the neointima of stented allograft, and the population of recipient derived neointimal cells was measured by quantitative polymerase chain reaction and characterized by immunohistochemistry. To demonstrate the participation of circulatory derived cells in stent neointima formation we infused ex vivo labeled peripheral blood mononuclear cells into native rabbit carotid arteries immediately after stenting. Fourteen days after stenting the neointima area was 58% greater in the stented vs. non-stented allograft segments (p = 0.02). Male cells were detected in the neointima of stented female-to-male allografts. Recipient-derived cells constituted 72.1 +/- 5.7% and 81.5 +/- 4.2% of neointimal cell population in the non-stented and stented segments, respectively and the corresponding proliferation rates were only 2.7 +/- 0.5% and 2.3 +/- 0.2%. Some of the recipient-derived neointimal cells were of endothelial lineage. The ex vivo tagged cells constituted 9.0 +/- 0.4% of the cells per high power field in the stent neointima 14 days after stenting. These experiments provide important quantitative data regarding the degree to which host-derived blood-borne cells contribute to neointima formation in allograft vasculopathy and the early response to stent implantation.	[Ma, Xiaoli; Hibbert, Benjamin; White, Dawn; Seymour, Richard; Whitman, Stewart C.; O'Brien, Edward R.] Univ Ottawa, Inst Heart, Vasc Biol Lab, Ottawa, ON, Canada	University of Ottawa; University of Ottawa Heart Institute	Ma, XL (corresponding author), Univ Ottawa, Inst Heart, Vasc Biol Lab, Ottawa, ON, Canada.	eobrien@ottawaheart.ca	O'Brien, Edward R/J-6621-2013	O'Brien, Edward R/0000-0003-1039-9425	Canadian Institutes of Health Research (CIHR) [36383]; Medtronic [36383]; Heart and Stroke Foundation of Ontario [New Investigator]; Great-West Life and London Life Research salary award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Medtronic(Medtronic); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Great-West Life and London Life Research salary award	This work is supported by an operating grant to EOB (UOP #36383) that is jointly funded by the Canadian Institutes of Health Research (CIHR) and Medtronic. SCW is a New Investigator of the Heart and Stroke Foundation of Ontario and the recipient of the Great-West Life and London Life Research salary award. EOB holds a Research Chair that is jointly funded by the CIHR and Medtronic.	Aranda JM, 2002, J HEART LUNG TRANSPL, V21, P860, DOI 10.1016/S1053-2498(02)00413-8; ASAHARA T, 1995, CIRCULATION, V91, P2793, DOI 10.1161/01.CIR.91.11.2793; Bentzon JF, 2006, ARTERIOSCL THROM VAS, V26, P2696, DOI 10.1161/01.ATV.0000247243.48542.9d; Benza RL, 2004, J AM COLL CARDIOL, V43, P1973, DOI 10.1016/j.jacc.2004.02.045; Byrne P, 2002, BIOTECHNIQUES, V32, P279; Caplice NM, 2003, P NATL ACAD SCI USA, V100, P4754, DOI 10.1073/pnas.0730743100; CLARKE JA, 1965, J ANAT, V99, P877; De Leon H, 2001, CIRCULATION, V104, P1591, DOI 10.1161/circ.104.14.1591; FEIGL W, 1985, VIRCHOWS ARCH A, V406, P133, DOI 10.1007/BF00737081; Froeschl M, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P103, DOI 10.2174/1568006043481293; Glaser R, 2002, CIRCULATION, V106, P17, DOI 10.1161/01.CIR.0000021923.58307.8F; Hibbert B, 2003, TRENDS CARDIOVAS MED, V13, P322, DOI 10.1016/j.tcm.2003.09.002; Hillebrands JL, 2005, TRENDS CARDIOVAS MED, V15, P1, DOI 10.1016/j.tcm.2004.10.002; Hillebrands JL, 2003, ARTERIOSCL THROM VAS, V23, P380, DOI 10.1161/01.ATV.0000059337.60393.64; Hillebrands JL, 2001, J CLIN INVEST, V107, P1411, DOI 10.1172/JCI10233; Hoofnagle MH, 2006, ARTERIOSCL THROM VAS, V26, P2579, DOI 10.1161/01.ATV.0000249623.79871.bc; Hristov M, 2003, TRENDS CARDIOVAS MED, V13, P201, DOI 10.1016/S1050-1738(03)00077-X; Jabs A, 2005, J VASC RES, V42, P174, DOI 10.1159/000084406; Jimenez DF, 2005, TRANSPLANTATION, V79, P142, DOI 10.1097/01.TP.0000144468.71962.AA; Jonas M, 2006, J AM COLL CARDIOL, V48, P453, DOI 10.1016/j.jacc.2006.01.081; KENNEDY LJ, 1971, NEW ENGL J MED, V285, P884, DOI 10.1056/NEJM197110142851603; Lowe HC, 2003, CATHETER CARDIO INTE, V60, P515, DOI 10.1002/ccd.10705; Ma XL, 2004, J LEUKOCYTE BIOL, V75, P1016, DOI 10.1189/jlb.1203618; MARTIN JF, 1991, EUR J CLIN INVEST, V21, P355, DOI 10.1111/j.1365-2362.1991.tb01382.x; McBride C, 2003, CYTOTHERAPY, V5, P7, DOI 10.1080/14653240310000038; Minami E, 2005, CIRCULATION, V112, P2951, DOI 10.1161/CIRCULATIONAHA.105.576017; Nowak G, 2004, CIRCULATION, V110, P3699, DOI 10.1161/01.CIR.0000143626.16576.51; OBRIEN ER, 1994, AM J PATHOL, V145, P883; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Religa P, 2005, CARDIOVASC RES, V65, P535, DOI 10.1016/j.cardiores.2004.10.011; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Schnetzler B, 2000, J HEART LUNG TRANSPL, V19, P557, DOI 10.1016/S1053-2498(00)00115-7; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Simper D, 2003, CIRCULATION, V108, P143, DOI 10.1161/01.CIR.0000081703.34526.5D; Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8; Simpson L, 2005, J HEART LUNG TRANSPL, V24, P1211, DOI 10.1016/j.healun.2004.10.005; TAKESHITA S, 1995, AM J PATHOL, V147, P1649; Wang LJ, 2002, LIVER TRANSPLANT, V8, P822, DOI 10.1053/jlts.2002.34891; Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74; WU MHD, 1995, J VASC SURG, V21, P862, DOI 10.1016/S0741-5214(05)80019-9; Yan BPY, 2005, CARDIOVASC REVASCULA, V6, P38, DOI 10.1016/j.carrev.2005.04.003; Yeh ETH, 2003, CIRCULATION, V108, P2070, DOI 10.1161/01.CIR.0000099501.52718.70	43	9	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1894	10.1371/journal.pone.0001894	http://dx.doi.org/10.1371/journal.pone.0001894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365026	Green Submitted, Green Published, gold			2022-12-27	WOS:000260762400032
J	Buchinsky, FJ; Donfack, J; Derkay, CS; Choi, SS; Conley, SF; Myer, CM; McClay, JE; Campisi, P; Wiatrak, BJ; Sobol, SE; Schweinfurth, JM; Tsuji, DH; Hu, FZ; Rockette, HE; Ehrlich, GD; Post, JC				Buchinsky, Farrel J.; Donfack, Joseph; Derkay, Craig S.; Choi, Sukgi S.; Conley, Stephen F.; Myer, Charles M., III; McClay, John E.; Campisi, Paolo; Wiatrak, Brian J.; Sobol, Steven E.; Schweinfurth, John M.; Tsuji, Domingos H.; Hu, Fen Z.; Rockette, Howard E.; Ehrlich, Garth D.; Post, J. Christopher			Age of Child, More than HPV Type, Is Associated with Clinical Course in Recurrent Respiratory Papillomatosis	PLOS ONE			English	Article								Background: RRP is a devastating disease in which papillomas in the airway cause hoarseness and breathing difficulty. The disease is caused by human papillomavirus (HPV) 6 or 11 and is very variable. Patients undergo multiple surgeries to maintain a patent airway and in order to communicate vocally. Several small studies have been published in which most have noted that HPV 11 is associated with a more aggressive course. Methodology/Principal Findings: Papilloma biopsies were taken from patients undergoing surgical treatment of RRP and were subjected to HPV typing. 118 patients with juvenile-onset RRP with at least 1 year of clinical data and infected with a single HPV type were analyzed. HPV 11 was encountered in 40% of the patients. By our definition, most of the patients in the sample (81%) had run an aggressive course. The odds of a patient with HPV 11 running an aggressive course were 3.9 times higher than that of patients with HPV 6 (Fisher's exact p = 0.017). However, clinical course was more closely associated with age of the patient (at diagnosis and at the time of the current surgery) than with HPV type. Patients with HPV 11 were diagnosed at a younger age (2.4y) than were those with HPV 6 (3.4y) (p = 0.014). Both by multiple linear regression and by multiple logistic regression HPV type was only weakly associated with metrics of disease course when simultaneously accounting for age. Conclusions/Significance Abstract: The course of RRP is variable and a quarter of the variability can be accounted for by the age of the patient. HPV 11 is more closely associated with a younger age at diagnosis than it is associated with an aggressive clinical course. These data suggest that there are factors other than HPV type and age of the patient that determine disease course.	[Buchinsky, Farrel J.; Donfack, Joseph; Hu, Fen Z.; Ehrlich, Garth D.; Post, J. Christopher] Allegheny Gen Hosp, Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA; [Derkay, Craig S.] E Virginia Med Sch, Norfolk, VA USA; [Choi, Sukgi S.] Childrens Natl Med Ctr, Washington, DC USA; [Conley, Stephen F.] Childrens Hosp Wisconsin, Milwaukee, WI USA; [Myer, Charles M., III] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA; [McClay, John E.] Childrens Med Ctr Dallas, Dallas, TX USA; [Campisi, Paolo] Hosp Sick Children, Toronto, ON, Canada; [Hu, Fen Z.; Ehrlich, Garth D.; Post, J. Christopher] Drexel Univ, Coll Med, Dept Human Genet, Microbiol & Immunol, Pittsburgh, PA USA; [Wiatrak, Brian J.] Childrens Hosp Alabama, Birmingham, AL USA; [Sobol, Steven E.] Emory Univ, Sch Med, Atlanta, GA USA; [Schweinfurth, John M.] Univ Mississippi, Med Ctr, Jackson, MS USA; [Tsuji, Domingos H.] Univ Sao Paulo, Med Sch, Hosp Clin, Sao Paulo, Brazil; [Rockette, Howard E.] Univ Pittsburgh, Biostat Dept, Pittsburgh, PA USA	Allegheny General Hospital; Eastern Virginia Medical School; Children's National Health System; Children's Hospital of Wisconsin; Cincinnati Children's Hospital Medical Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Drexel University; Emory University; University of Mississippi; University of Mississippi Medical Center; Universidade de Sao Paulo; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Buchinsky, FJ (corresponding author), Allegheny Gen Hosp, Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA.	fjbuch@gmail.com	Buchinsky, Farrel/AAC-2080-2020; Choi, Sukgi/AAF-6482-2019	Buchinsky, Farrel/0000-0002-2830-6023; Choi, Sukgi/0000-0002-5448-1546; Ehrlich, Garth/0000-0003-1140-6594; Tsuji, Domingos/0000-0002-8219-7550	National Institute on Deafness and Other Communication Disorders [K08DC005819, R01DC008841]; American Laryngological, Rhinological and Otological Society; Inc-Triological Society Research Career Development Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC005819, R01DC008841] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); American Laryngological, Rhinological and Otological Society; Inc-Triological Society Research Career Development Award; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The National Institute on Deafness and Other Communication Disorders-K08DC005819, R01DC008841. The American Laryngological, Rhinological and Otological Society, Inc-Triological Society Research Career Development Award.	Armstrong LR, 1999, ARCH OTOLARYNGOL, V125, P743, DOI 10.1001/archotol.125.7.743; Buchinsky FJ, 2004, LARYNGOSCOPE, V114, P349, DOI 10.1097/00005537-200402000-00032; DERKAY CS, 1995, ARCH OTOLARYNGOL, V121, P1386; Donfack J, 2006, INT J PEDIATR OTORHI, V70, P1235, DOI 10.1016/j.ijporl.2006.01.001; DOYLE DJ, 1994, LARYNGOSCOPE, V104, P523, DOI 10.1002/lary.5541040503; Draganov P, 2006, INT J PEDIATR OTORHI, V70, P469, DOI 10.1016/j.ijporl.2005.07.018; Gabbott M, 1997, J CLIN MICROBIOL, V35, P3098, DOI 10.1128/JCM.35.12.3098-3103.1997; Gerein V, 2005, ANN OTO RHINOL LARYN, V114, P463, DOI 10.1177/000348940511400608; GISSMANN L, 1982, J VIROL, V44, P393, DOI 10.1128/JVI.44.1.393-400.1982; GOMEZ MA, 1995, MEDICINA-BUENOS AIRE, V55, P213; HARTLEY C, 1994, J LARYNGOL OTOL, V108, P226, DOI 10.1017/S0022215100126350; KASHIMA HK, 1991, OTOLARYNG HEAD NECK, V104, P191, DOI 10.1177/019459989110400206; Maloney EM, 2006, ARCH OTOLARYNGOL, V132, P711, DOI 10.1001/archotol.132.7.711; MOUNTS P, 1984, LARYNGOSCOPE, V94, P28, DOI 10.1002/lary.5540940106; MYER CM, 1994, ANN OTO RHINOL LARYN, V103, P319, DOI 10.1177/000348949410300410; PADAYACHEE A, 1993, INT J PEDIATR OTORHI, V26, P141, DOI 10.1016/0165-5876(93)90019-Y; Penaloza-Plascencia M, 2000, ARCH OTOLARYNGOL, V126, P1119, DOI 10.1001/archotol.126.9.1119; POU AM, 1995, ANN OTO RHINOL LARYN, V104, P758, DOI 10.1177/000348949510401002; Pou AM, 2004, ANN OTO RHINOL LARYN, V113, P180, DOI 10.1177/000348940411300302; Rabah R, 2001, PEDIATR DEVEL PATHOL, V4, P68, DOI 10.1007/s100240010105; Reeves WC, 2003, ARCH OTOLARYNGOL, V129, P976, DOI 10.1001/archotol.129.9.976; Reidy PM, 2004, LARYNGOSCOPE, V114, P1906, DOI 10.1097/01.mlg.0000147918.81733.49; RESNICK RM, 1990, JNCI-J NATL CANCER I, V82, P1477, DOI 10.1093/jnci/82.18.1477; Rimell FL, 1997, LARYNGOSCOPE, V107, P915, DOI 10.1097/00005537-199707000-00015; Schraff S, 2004, ARCH OTOLARYNGOL, V130, P1039, DOI 10.1001/archotol.130.9.1039; Sherwood ML, 2006, OTOLARYNG HEAD NECK, V135, P189, DOI 10.1016/j.otohns.2006.03.028; Silverberg MJ, 2004, ARCH OTOLARYNGOL, V130, P711, DOI 10.1001/archotol.130.6.711; Szeps M, 2005, J GEN VIROL, V86, P1695, DOI 10.1099/vir.0.80849-0; Wiatrak BJ, 2004, LARYNGOSCOPE, V114, P1, DOI 10.1097/01.mlg.000148224.83491.0f	29	52	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2263	10.1371/journal.pone.0002263	http://dx.doi.org/10.1371/journal.pone.0002263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509465	Green Published, Green Accepted, gold			2022-12-27	WOS:000262268500011
J	Andrew, MK; Mitnitski, AB; Rockwood, K				Andrew, Melissa K.; Mitnitski, Arnold B.; Rockwood, Kenneth			Social Vulnerability, Frailty and Mortality in Elderly People	PLOS ONE			English	Article							DEFICIT ACCUMULATION; COMMUNITY POPULATION; OLDER-ADULTS; HEALTH; DEMENTIA; ENGAGEMENT; NETWORK; COUNTY; TIES	Background: Social vulnerability is related to the health of elderly people, but its measurement and relationship to frailty are controversial. The aims of the present study were to operationalize social vulnerability according to a deficit accumulation approach, to compare social vulnerability and frailty, and to study social vulnerability in relation to mortality. Methods and Findings: This is a secondary analysis of community-dwelling elderly people in two cohort studies, the Canadian Study of Health and Aging (CSHA, 1996/7-2001/2; N = 3707) and the National Population Health Survey (NPHS, 1994-2002; N = 2648). Social vulnerability index measures that used self-reported items (23 in NPHS, 40 in CSHA) were constructed. Each measure ranges from 0 (no vulnerability) to 1 (maximum vulnerability). The primary outcome measure was mortality over five (CHSA) or eight (NPHS) years. Associations with age, sex, and frailty (as measured by an analogously constructed frailty index) were also studied. All individuals had some degree of social vulnerability. Women had higher social vulnerability than men, and vulnerability increased with age. Frailty and social vulnerability were moderately correlated. Adjusting for age, sex, and frailty, each additional social 'deficit' was associated with an increased odds of mortality (5 years in CSHA, odds ratio = 1.05, 95% confidence interval: 1.02-1.07; 8 years in the NPHS, odds ratio = 1.08, 95% confidence interval: 1.03-1.14). We identified a meaningful survival gradient across quartiles of social vulnerability, and although women had better survival than men, survival for women with high social vulnerability was equivalent to that of men with low vulnerability. Conclusions: Social vulnerability is reproducibly related to individual frailty/fitness, but distinct from it. Greater social vulnerability is associated with mortality in older adults. Further study on the measurement and operationalization of social vulnerability, and of its relationships to other important health outcomes, is warranted.	[Andrew, Melissa K.; Rockwood, Kenneth] Dalhousie Univ, Div Geriatr Med, Halifax, NS, Canada; [Mitnitski, Arnold B.] Dalhousie Univ, Dept Med, Halifax, NS, Canada; [Mitnitski, Arnold B.] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Andrew, MK (corresponding author), Dalhousie Univ, Div Geriatr Med, Halifax, NS, Canada.	kenneth.rockwood@dal.ca	Mitnitski, Arnold/C-7543-2012; Rockwood, Kenneth/AAD-8951-2019; Andrew, Melissa/AAR-7052-2021	Andrew, Melissa/0000-0001-7514-8972	Canadian Institutes for Health Research (CIHR) [MOP- 64169, post-doctoral research fellowship];  [Killam Scholarship]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); 	The analyses were supported by a Canadian Institutes for Health Research (CIHR) operating grant (MOP- 64169) held by Arnold Mitnitski and Kenneth Rockwood. All analyses were conducted by the authors. The CSHA data are held in house. The NPHS data are accessed through an agreement with the Statistics Canada Atlantic Regional Data Centre, which obliges us to operate, for these purposes only, as deemed employees of Statistics Canada. Statistics Canada officials reviewed the analyses to ensure that confidentiality had not been breached. In no other way did any sponsor have influence over the data analyses. Melissa Andrew is supported by a post-doctoral research fellowship from the CIHR and by a Killam Scholarship. Kenneth Rockwood receives career support from the Dalhousie Medical Research Foundation as Kathryn Allen Weldon Professor of Alzheimer Research.	Ahmed N, 2007, AM J MED, V120, P748, DOI 10.1016/j.amjmed.2006.10.018; Andrew MK, 2008, AM J MED, V121, pE21, DOI 10.1016/j.amjmed.2007.09.017; Andrew Melissa K, 2005, Eur J Ageing, V2, P137, DOI 10.1007/s10433-005-0031-8; Andrew MK, 2005, RETRAITE SOC, V46, P129; ARMITAGE P, 2002, STAT METHODS MED RES, P298; Bassuk SS, 1999, ANN INTERN MED, V131, P165, DOI 10.7326/0003-4819-131-3-199908030-00002; BLAZER DG, 1982, AM J EPIDEMIOL, V115, P684, DOI 10.1093/oxfordjournals.aje.a113351; de Leon CFM, 2003, AM J EPIDEMIOL, V157, P633, DOI 10.1093/aje/kwg028; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Grundy E, 2003, SOC SCI MED, V56, P935, DOI 10.1016/S0277-9536(02)00093-X; Grundy E, 2001, J EPIDEMIOL COMMUN H, V55, P895, DOI 10.1136/jech.55.12.895; HEPBURN KW, 2003, BROCKLEHURSTS TXB GE, P183; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY, V174, P290; KULMINSKI A, 2006, MECH AGEING DEV; Lochner KA, 2003, SOC SCI MED, V56, P1797, DOI 10.1016/S0277-9536(02)00177-6; Marmot M., 2004, STATUS SYNDROME YOUR; McCulloch A, 2001, BRIT MED J, V323, P208, DOI 10.1136/bmj.323.7306.208; McDowell I, 2001, INT PSYCHOGERIATR, V13, P5, DOI 10.1017/S1041610202007937; Mitnitski A, 2006, MECH AGEING DEV, V127, P490, DOI 10.1016/j.mad.2006.01.007; Mitnitski A, 2005, J AM GERIATR SOC, V53, P2184, DOI 10.1111/j.1532-5415.2005.00506.x; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Mitnitski AB, 2004, J GERONTOL A-BIOL, V59, P627, DOI 10.1093/gerona/59.6.M627; Rockwood K, 2006, MECH AGEING DEV, V127, P494, DOI 10.1016/j.mad.2006.01.002; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P738, DOI 10.1093/gerona/62.7.738; Rockwood K, 2007, J AM MED DIR ASSOC, V8, P595, DOI 10.1016/j.jamda.2007.07.012; Rockwood K, 2006, J AM GERIATR SOC, V54, P975, DOI 10.1111/j.1532-5415.2006.00738.x; SCHOENBACH VJ, 1986, AM J EPIDEMIOL, V123, P577, DOI 10.1093/oxfordjournals.aje.a114278; Seeman T E, 1993, Ann Epidemiol, V3, P325; SEEMAN TE, 1987, AM J EPIDEMIOL, V126, P714, DOI 10.1093/oxfordjournals.aje.a114711; Singh MP, 1994, NATL POPULATION HLTH; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081; Wilkinson R., 1996, UNHEALTHY SOC AFFLIC; Woo J, 2006, DISABIL REHABIL, V28, P515, DOI 10.1080/09638280500215867	35	212	226	7	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2232	10.1371/journal.pone.0002232	http://dx.doi.org/10.1371/journal.pone.0002232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493324	Green Submitted, gold, Green Published			2022-12-27	WOS:000262258700040
J	Vandepoele, K; Andries, V; Van Roy, N; Staes, K; Vandesompele, J; Laureys, G; De Smet, E; Berx, G; Speleman, F; van Roy, F				Vandepoele, Karl; Andries, Vanessa; Van Roy, Nadine; Staes, Katrien; Vandesompele, Jo; Laureys, Genevieve; De Smet, Els; Berx, Geert; Speleman, Frank; van Roy, Frans			A Constitutional Translocation t(1;17)(p36.2;q11.2) in a Neuroblastoma Patient Disrupts the Human NBPF1 and ACCN1 Genes	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; EXPRESSION PROFILES; HUMAN GENOME; COPY NUMBER; CELL-LINES; BREAKPOINTS; 17Q; INSERTION; FAMILY; REGION	The human 1p36 region is deleted in many different types of tumors, and so it probably harbors one or more tumor suppressor genes. In a Belgian neuroblastoma patient, a constitutional balanced translocation t(1;17)(p36.2;q11.2) may have led to the development of the tumor by disrupting or activating a gene. Here, we report the cloning of both translocation breakpoints and the identification of a novel gene that is disrupted by this translocation. This gene, named NBPF1 for Neuroblastoma BreakPoint Family member 1, belongs to a recently described gene family encoding highly similar proteins, the functions of which are unknown. The translocation truncates NBPF1 and gives rise to two chimeric transcripts of NBPF1 sequences fused to sequences derived from chromosome 17. On chromosome 17, the translocation disrupts one of the isoforms of ACCN1, a potential glioma tumor suppressor gene. Expression of the NBPF family in neuroblastoma cell lines is highly variable, but it is decreased in cell lines that have a deletion of chromosome 1p. More importantly, expression profiling of the NBPF1 gene showed that its expression is significantly lower in cell lines with heterozygous NBPF1 loss than in cell lines with a normal 1p chromosome. Meta-analysis of the expression of NBPF and ACCN1 in neuroblastoma tumors indicates a role for the NBPF genes and for ACCN1 in tumor aggressiveness. Additionally, DLD1 cells with inducible NBPF1 expression showed a marked decrease of clonal growth in a soft agar assay. The disruption of both NBPF1 and ACCN1 genes in this neuroblastoma patient indicates that these genes might suppress development of neuroblastoma and possibly other tumor types.	[Vandepoele, Karl; Andries, Vanessa; Staes, Katrien; Berx, Geert; van Roy, Frans] VIB, Dept Mol Biomed Res, Ghent, Belgium; [Vandepoele, Karl; Andries, Vanessa; Berx, Geert; van Roy, Frans] Univ Ghent, Dept Mol Biol, Ghent, Belgium; [Van Roy, Nadine; Vandesompele, Jo; De Smet, Els; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Laureys, Genevieve] Ghent Univ Hosp, Dept Pediat Hematol & Oncol, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	Vandepoele, K (corresponding author), VIB, Dept Mol Biomed Res, Ghent, Belgium.	F.VanRoy@DMBR.UGent.be	van Roy, Frans M/C-6123-2009; Vandepoele, Karl/C-1197-2009; laureys, genevieve/AAG-2390-2021; speleman, frank/AAR-5184-2020; Vandesompele, Jo/W-3411-2018	van Roy, Frans M/0000-0003-4358-1039; Vandepoele, Karl/0000-0002-0025-5594; speleman, frank/0000-0002-6628-8559; Vandesompele, Jo/0000-0001-6274-0184; Berx, Geert/0000-0001-5770-2458	Foundation against Cancer, Belgium; Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen (IWT); Fund for Scientific Research (FWO), Flanders; Ghent University [BOF, GOA]	Foundation against Cancer, Belgium; Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fund for Scientific Research (FWO), Flanders(FWO); Ghent University(Ghent University)	Karl Vandepoele is supported by the Foundation against Cancer, Belgium. Vanessa Andries is supported by the Instituut voor de Aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen (IWT). Nadine Van Roy and Jo Vandesompele are postdoctoral researchers of the Fund for Scientific Research (FWO), Flanders. This work was supported by several FWO grants, by BOF and GOA grants of Ghent University, and by the Foundation against Cancer, Belgium. This text presents research results of the Belgian Program of Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming and the European 6th framework programme EET pipeline.	Asgharzadeh S, 2006, JNCI-J NATL CANCER I, V98, P1193, DOI 10.1093/jnci/djj330; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; BADER SA, 1991, CELL GROWTH DIFFER, V2, P245; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Bieche I, 1998, ONCOL REP, V5, P267; BIEGEL JA, 1993, AM J HUM GENET, V52, P176; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Ettaiche M, 2004, J NEUROSCI, V24, P1005, DOI 10.1523/JNEUROSCI.4698-03.2004; Fransson S, 2007, GENE CHROMOSOME CANC, V46, P45, DOI 10.1002/gcc.20387; Hiyama E, 2003, J PEDIATR SURG, V38, P1730, DOI 10.1016/j.jpedsurg.2003.08.042; Janoueix-Lerosey I, 2004, ONCOGENE, V23, P5912, DOI 10.1038/sj.onc.1207784; Lastowska M, 2002, GENE CHROMOSOME CANC, V34, P428, DOI 10.1002/gcc.10089; LAUREYS G, 1995, ONCOGENE, V10, P1087; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Okawa ER, 2008, ONCOGENE, V27, P803, DOI 10.1038/sj.onc.1210675; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Roberts T, 1998, HUM MOL GENET, V7, P1169, DOI 10.1093/hmg/7.7.1169; Saugstad JA, 2004, J BIOL CHEM, V279, P55514, DOI 10.1074/jbc.M411849200; SAVELYEVA L, 1994, AM J HUM GENET, V55, P334; Schleiermacher G, 2005, ONCOGENE, V24, P3377, DOI 10.1038/sj.onc.1208486; Schwab M, 1996, GENE CHROMOSOME CANC, V16, P211, DOI 10.1002/(SICI)1098-2264(199608)16:4<211::AID-GCC1>3.0.CO;2-0; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Stallings RL, 2006, CANCER RES, V66, P3673, DOI 10.1158/0008-5472.CAN-05-4154; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Roy N, 2002, GENE CHROMOSOME CANC, V35, P113, DOI 10.1002/gcc.10034; Van Roy N, 1997, EUR J CANCER, V33, P1974, DOI 10.1016/S0959-8049(97)00319-5; Vandepoele K, 2005, MOL BIOL EVOL, V22, P2265, DOI 10.1093/molbev/msi222; Vandepoele K, 2007, VIROLOGY, V362, P1, DOI 10.1016/j.virol.2007.01.044; Vandesompele J, 2005, J CLIN ONCOL, V23, P2280, DOI 10.1200/JCO.2005.06.104; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANROY N, 1994, GENE CHROMOSOME CANC, V10, P103, DOI 10.1002/gcc.2870100205; Vila-Carriles WH, 2006, J BIOL CHEM, V281, P19220, DOI 10.1074/jbc.M603100200; Vinogradova TV, 2002, RUSS J BIOORG CHEM+, V28, P312, DOI 10.1023/A:1019595925333; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; White PS, 2005, ONCOGENE, V24, P2684, DOI 10.1038/sj.onc.1208306; White PS, 1997, EUR J CANCER, V33, P1957, DOI 10.1016/S0959-8049(97)00311-0; Willett-Brozick JE, 2001, HUM GENET, V109, P216, DOI 10.1007/s004390100564	45	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2207	10.1371/journal.pone.0002207	http://dx.doi.org/10.1371/journal.pone.0002207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493581	Green Published, gold, Green Submitted			2022-12-27	WOS:000262258700016
J	Ying, E; Li, D; Guo, S; Dong, S; Wang, J				Ying, Erbo; Li, Dan; Guo, Shaojun; Dong, Shaojun; Wang, Jin			Synthesis and Bio-Imaging Application of Highly Luminescent Mercaptosuccinic Acid-Coated CdTe Nanocrystals	PLOS ONE			English	Article							HIGH-QUALITY CDTE; ONE-POT SYNTHESIS; STABILIZED CDSE; PHOTOLUMINESCENCE; ENHANCEMENT	Here we present a facile one-pot method to prepare high-quality CdTe nanocrystals in aqueous phase. In contrast to the use of oxygen-sensitive NaHTe or H2Te as Te source in the current synthetic methods, we employ more stable sodium tellurite as the Te source for preparing highly luminescent CdTe nanocrystals in aqueous solution. By selecting mercaptosuccinic acid (MSA) as capping agent and providing the borate-citrate acid buffering solution, CdTe nanocrystals with high quantum yield (QY > 70% at pH range 5.0-8.0) can be conveniently prepared by this method. The influence of parameters such as the pH value of the precursor solution and the molar ratio of Cd2+ to Na2TeO3 on the QY of CdTe nanocrystals was systematically investigated in our experiments. Under optimal conditions, the QY of CdTe nanocrystals is even high up to 83%. The biological application of luminescent MSA-CdTe to HEK 293 cell imaging was also illustrated.	[Ying, Erbo; Li, Dan; Guo, Shaojun; Dong, Shaojun] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Elect Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem, Stony Brook, NY USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ying, E (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Elect Chem, Changchun 130022, Jilin, Peoples R China.	dongsj@ciac.jl.cn; jin.wang.1@stonybrook.edu	李, 丹/O-1545-2017; Guo, Shaojun/A-8449-2011	李, 丹/0000-0001-5904-871X; Guo, Shaojun/0000-0002-5941-414X	National Natural Science Foundation of China [20575064, 20475076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (No. 20575064, 20475076).	Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Bao HB, 2004, CHEM MATER, V16, P3853, DOI 10.1021/cm049172b; Bao HF, 2006, SMALL, V2, P476, DOI 10.1002/smll.200500346; Barnham K, 2000, APPL PHYS LETT, V76, P1197, DOI 10.1063/1.125981; BOWENKATARI JE, 1994, J PHYS CHEM-US, V98, P4109, DOI DOI 10.1021/J100066A034); Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Byrne SJ, 2006, J MATER CHEM, V16, P2896, DOI 10.1039/b605333e; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Coe S, 2002, NATURE, V420, P800, DOI 10.1038/nature01217; DEMAS JN, 1971, J PHYS CHEM-US, V75, P991, DOI 10.1021/j100678a001; Gao MY, 1998, J PHYS CHEM B, V102, P8360, DOI 10.1021/jp9823603; Gaponik N, 2002, J PHYS CHEM B, V106, P7177, DOI 10.1021/jp025541k; Gerion D, 2002, J AM CHEM SOC, V124, P7070, DOI 10.1021/ja017822w; Gong YJ, 2005, CHEM MATER, V17, P2648, DOI 10.1021/cm047932c; Guo J, 2005, J PHYS CHEM B, V109, P17467, DOI 10.1021/jp044770z; He Y, 2007, CHEM MATER, V19, P359, DOI 10.1021/cm061863f; Ho YP, 2005, NANO LETT, V5, P1693, DOI 10.1021/nl050888v; JAILSWAIL JK, 2003, NAT BIOTECHNOL, V21, P47; Jiang W, 2006, CHEM MATER, V18, P872, DOI 10.1021/cm051393+; Li CL, 2005, CHEM LETT, V34, P92, DOI 10.1246/cl.2005.92; Li L, 2006, J LUMIN, V116, P59, DOI 10.1016/j.jlumin.2005.03.001; Li L, 2005, CHEM COMMUN, P528, DOI 10.1039/b412686f; MURRAY CB, 1993, J AM CHEM SOC, V115, P8706, DOI 10.1021/ja00072a025; Nirmal M, 1999, ACCOUNTS CHEM RES, V32, P407, DOI 10.1021/ar9700320; Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m; Qian HF, 2006, SMALL, V2, P747, DOI 10.1002/smll.200500530; Qu LH, 2002, J AM CHEM SOC, V124, P2049, DOI 10.1021/ja017002j; Rogach AL, 1996, BER BUNSEN PHYS CHEM, V100, P1772, DOI 10.1002/bbpc.19961001104; Rogach AL, 1999, J PHYS CHEM B, V103, P3065, DOI 10.1021/jp984833b; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Shavel A, 2006, J PHYS CHEM B, V110, P19280, DOI 10.1021/jp063351u; Stephens DJ, 2003, SCIENCE, V300, P82, DOI 10.1126/science.1082160; SWAYAMBUNATHAN V, 1990, J AM CHEM SOC, V112, P3831, DOI 10.1021/ja00166a017; Talapin DV, 2002, COLLOID SURFACE A, V202, P145, DOI 10.1016/S0927-7757(01)01078-0; VOSSMEYER T, 1994, J PHYS CHEM-US, V98, P7665, DOI 10.1021/j100082a044; Wang CL, 2007, J PHYS CHEM C, V111, P2465, DOI 10.1021/jp066601f; Wang Y, 2004, J PHYS CHEM B, V108, P15461, DOI 10.1021/jp048948t; Weijer CJ, 2003, SCIENCE, V300, P96, DOI 10.1126/science.1082830; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764; Wuister SF, 2003, NANO LETT, V3, P503, DOI 10.1021/nl034054t; Yu WW, 2003, CHEM MATER, V15, P4300, DOI 10.1021/cm034729t; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; Zhang H, 2003, ADV MATER, V15, P1712, DOI 10.1002/adma.200305653; Zhang H, 2003, J PHYS CHEM B, V107, P8, DOI 10.1021/jp025910c; Zheng R, 2007, INORG CHEM, V46, P6920, DOI 10.1021/ic700502v; Zheng YG, 2007, ADV MATER, V19, P376, DOI 10.1002/adma.200600342	46	83	85	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2222	10.1371/journal.pone.0002222	http://dx.doi.org/10.1371/journal.pone.0002222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493618	Green Submitted, Green Published, gold			2022-12-27	WOS:000262258700030
J	Brodersen, J; Nilsson, PA; Ammitzboll, J; Hansson, LA; Skov, C; Bronmark, C				Brodersen, Jakob; Nilsson, P. Anders; Ammitzboll, Jeppe; Hansson, Lars-Anders; Skov, Christian; Bronmark, Christer			Optimal Swimming Speed in Head Currents and Effects on Distance Movement of Winter-Migrating Fish	PLOS ONE			English	Article							TIDAL-STREAM TRANSPORT; PLEURONECTES-PLATESSA L; GAIT TRANSITION; PREDATION RISK; ENERGETICS; BIRDS; CONSEQUENCES; METABOLISM; BEHAVIOR; REFUGES	Migration is a commonly described phenomenon in nature that is often caused by spatial and temporal differences in habitat quality. However, as migration requires energy, the timing of migration may depend not only on differences in habitat quality, but also on temporal variation in migration costs. Such variation can, for instance, arise from changes in wind or current velocity for migrating birds and fish, respectively. Whereas behavioural responses of birds to such changing environmental conditions have been relatively well described, this is not the case for fish, although fish migrations are both ecologically and economically important. We here use passive and active telemetry to study how winter migrating roach regulate swimming speed and distance travelled per day in response to variations in head current velocity. Furthermore, we provide theoretical predictions on optimal swimming speeds in head currents and relate these to our empirical results. We show that fish migrate farther on days with low current velocity, but travel at a greater ground speed on days with high current velocity. The latter result agrees with our predictions on optimal swimming speed in head currents, but disagrees with previously reported predictions suggesting that fish ground speed should not change with head current velocity. We suggest that this difference is due to different assumptions on fish swimming energetics. We conclude that fish are able to adjust both swimming speed and timing of swimming activity during migration to changes in head current velocity in order to minimize energy use.	[Brodersen, Jakob; Nilsson, P. Anders; Ammitzboll, Jeppe; Hansson, Lars-Anders; Bronmark, Christer] Lund Univ, Dept Ecol Limnol, Lund, Sweden; [Skov, Christian] Natl Inst Aquat Resources, DTU Aqua, Silkeborg, Denmark	Lund University; Technical University of Denmark	Brodersen, J (corresponding author), Lund Univ, Dept Ecol Limnol, Lund, Sweden.	jakob.brodersen@limnol.lu.se	Hansson, Lars-Anders/HCI-2735-2022; Nilsson, Anders/H-6836-2014; Skov, Christian/X-6511-2019	Nilsson, Anders/0000-0002-3541-9835; Skov, Christian/0000-0002-8547-6520; Hansson, Lars-Anders/0000-0002-3035-1317	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas)	The study was supported by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T., 1990, P331; Alerstam T, 1999, ARCTIC, V52, P346; BERNATCHEZ L, 1987, CAN J FISH AQUAT SCI, V44, P399, DOI 10.1139/f87-049; Borcherding J, 2002, J FISH BIOL, V61, P1154, DOI 10.1006/jfbi.2002.2129; BRODERSEN J, 2008, ECOLOGY IN PRESS; BRONMARK C, 2008, PLOS ONE IN PRESS; Castro-Santos T, 2006, T AM FISH SOC, V135, P1230, DOI 10.1577/T05-262.1; Clough S, 1998, J FISH BIOL, V53, P1060, DOI 10.1111/j.1095-8649.1998.tb00463.x; Copp GH, 1997, REGUL RIVER, V13, P303, DOI 10.1002/(SICI)1099-1646(199705)13:3<303::AID-RRR458>3.0.CO;2-E; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Forward RB, 2001, OCEANOGR MAR BIOL, V39, P305; Hansson LA, 1996, P ROY SOC B-BIOL SCI, V263, P1241, DOI 10.1098/rspb.1996.0182; Hansson LA, 2007, LIMNOL OCEANOGR, V52, P696, DOI 10.4319/lo.2007.52.2.0696; HEDENSTROM A, 1995, PHILOS T ROY SOC B, V348, P471, DOI 10.1098/rstb.1995.0082; Hedenstrom A, 2002, BEHAV ECOL SOCIOBIOL, V52, P308, DOI 10.1007/s00265-002-0504-0; Hedenstrom A, 1996, BEHAV ECOL, V7, P121, DOI 10.1093/beheco/7.2.121; Hinch Scott G., 2006, Fish Physiology, V24, P239; Hinch SG, 2000, CAN J FISH AQUAT SCI, V57, P2470, DOI 10.1139/cjfas-57-12-2470; Holker F, 2003, J FISH BIOL, V62, P565, DOI 10.1046/j.1095-8649.2003.00048.x; Jepsen N, 2002, HYDROBIOLOGIA, V483, P239, DOI 10.1023/A:1021356302311; Jepsen N, 2002, HYDROBIOLOGIA, V483, P167, DOI 10.1023/A:1021379528719; JONES FRH, 1979, J CONSEIL, V38, P331; JONSSON B, 1993, REV FISH BIOL FISHER, V3, P348, DOI 10.1007/BF00043384; Korsmeyer KE, 2002, J EXP BIOL, V205, P1253; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; McNamara JM, 1998, J AVIAN BIOL, V29, P416, DOI 10.2307/3677160; METCALFE JD, 1990, J MAR BIOL ASSOC UK, V70, P149, DOI 10.1017/S0025315400034275; Ohlberger J, 2006, J COMP PHYSIOL B, V176, P17, DOI 10.1007/s00360-005-0024-0; Ohlberger J, 2005, J EXP ZOOL PART A, V303A, P657, DOI 10.1002/jez.a.181; Peake SJ, 2004, J EXP BIOL, V207, P1563, DOI 10.1242/jeb.00927; Pettersson LB, 2000, P ROY SOC B-BIOL SCI, V267, P759, DOI 10.1098/rspb.2000.1068; Salinger DH, 2006, T AM FISH SOC, V135, P188, DOI 10.1577/T04-181.1; Skov C, 2005, J FISH BIOL, V67, P1195, DOI 10.1111/j.1095-8649.2005.00814.x; SKOV C, 2008, ECOL FRESHW IN PRESS; TRUMP CL, 1980, CAN J FISH AQUAT SCI, V37, P1086, DOI 10.1139/f80-141; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; WALKER MG, 1978, J CONSEIL, V38, P58; Wardle CS, 1996, J FISH BIOL, V49, P854, DOI 10.1111/j.1095-8649.1996.tb00084.x; Weber TP, 2000, J THEOR BIOL, V205, P95, DOI 10.1006/jtbi.2000.2047; WEIHS D, 1978, J CONSEIL, V38, P92; WERNER EE, 1988, ECOLOGY, V69, P1352, DOI 10.2307/1941633; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508	42	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2156	10.1371/journal.pone.0002156	http://dx.doi.org/10.1371/journal.pone.0002156			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478053	Green Published, Green Submitted, gold			2022-12-27	WOS:000262172800021
J	Dinur-Mills, M; Tal, M; Pines, O				Dinur-Mills, Maya; Tal, Merav; Pines, Ophry			Dual Targeted Mitochondrial Proteins Are Characterized by Lower MTS Parameters and Total Net Charge	PLOS ONE			English	Article								Background: In eukaryotic cells, identical proteins can be located in different subcellular compartments (termed dual-targeted proteins). Methodology/Principal Findings: We divided a reference set of mitochondrial proteins (published single gene studies) into two groups: i) Dual targeted mitochondrial proteins and ii) Exclusive mitochondrial proteins. Mitochondrial proteins were considered dual-targeted if they were also found or predicted to be localized to the cytosol, the nucleus, the endoplasmic reticulum (ER) or the peroxisome. We found that dual localized mitochondrial proteins have i) A weaker mitochondrial targeting sequence (MitoProtII score, hydrophobic moment and number of basic residues) and ii) a lower whole-protein net charge, when compared to exclusive mitochondrial proteins. We have also generated an annotation list of dual-targeted proteins within the predicted yeast mitochondrial proteome. This considerably large group of dual-localized proteins comprises approximately one quarter of the predicted mitochondrial proteome. We supported this prediction by experimental verification of a subgroup of the predicted dual targeted proteins. Conclusions/Significance: Taken together, these results establish dual targeting as a widely abundant phenomenon that should affect our concepts of gene expression and protein function. Possible relationships between the MTS/mature sequence traits and protein dual targeting are discussed.	[Dinur-Mills, Maya; Tal, Merav; Pines, Ophry] Hebrew Univ Jerusalem, Sch Med, Dept Mol Biol, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Dinur-Mills, M (corresponding author), Hebrew Univ Jerusalem, Sch Med, Dept Mol Biol, IL-91010 Jerusalem, Israel.	ophryp@ekmd.huji.ac.il	pines, ophry/C-4086-2011	pines, ophry/0000-0001-7126-2575	Israel Science Foundation (ISF); German Israeli Foundation (GIF); German Israeli Project Cooperation	Israel Science Foundation (ISF)(Israel Science Foundation); German Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); German Israeli Project Cooperation	This research was supported by the Israel Science Foundation (ISF) and the German Israeli Foundation (GIF) and the German Israeli Project Cooperation (DIP).F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas-Terki T, 1999, EUR J BIOCHEM, V266, P517, DOI 10.1046/j.1432-1327.1999.00881.x; Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; Bandlow W, 1998, BIOCHEM J, V329, P359, DOI 10.1042/bj3290359; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DANPURE CJ, 1995, TRENDS CELL BIOL, V5, P230, DOI 10.1016/S0962-8924(00)89016-9; HARTMANN C, 1991, NATURE, V352, P762, DOI 10.1038/352762b0; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; JAUSSI R, 1995, EUR J BIOCHEM, V228, P551, DOI 10.1111/j.1432-1033.1995.tb20294.x; Karniely S, 2005, EMBO REP, V6, P420, DOI 10.1038/sj.embor.7400394; Karniely S, 2006, EXP CELL RES, V312, P3835, DOI 10.1016/j.yexcr.2006.08.021; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; MAGDOLEN V, 1992, FEBS LETT, V299, P267, DOI 10.1016/0014-5793(92)80129-5; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Prokisch H, 2006, NUCLEIC ACIDS RES, V34, pD705, DOI 10.1093/nar/gkj127; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; Schricker R, 2002, J BIOL CHEM, V277, P28757, DOI 10.1074/jbc.M201561200; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Small I, 1998, PLANT MOL BIOL, V38, P265, DOI 10.1023/A:1006081903354; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012	23	48	48	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2161	10.1371/journal.pone.0002161	http://dx.doi.org/10.1371/journal.pone.0002161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478128	gold, Green Published, Green Submitted			2022-12-27	WOS:000262172800026
J	Dixon-McIver, A; East, P; Mein, CA; Cazier, JB; Molloy, G; Chaplin, T; Lister, TA; Young, BD; Debernardi, S				Dixon-McIver, Amanda; East, Phil; Mein, Charles A.; Cazier, Jean-Baptiste; Molloy, Gael; Chaplin, Tracy; Lister, T. Andrew; Young, Bryan D.; Debernardi, Silvana			Distinctive Patterns of MicroRNA Expression Associated with Karyotype in Acute Myeloid Leukaemia	PLOS ONE			English	Article								Acute myeloid leukaemia (AML) is the most common acute leukaemia in adults; however, the genetic aetiology of the disease is not yet fully understood. A quantitative expression profile analysis of 157 mature miRNAs was performed on 100 AML patients representing the spectrum of known karyotypes common in AML. The principle observation reported here is that AMLs bearing a t(15; 17) translocation had a distinctive signature throughout the whole set of genes, including the up regulation of a subset of miRNAs located in the human 14q32 imprinted domain. The set included miR-127, miR-154, miR-154*, miR-299, miR-323, miR-368, and miR-370. Furthermore, specific subsets of miRNAs were identified that provided molecular signatures characteristic of the major translocation-mediated gene fusion events in AML. Analysis of variance showed the significant deregulation of 33 miRNAs across the leukaemic set with respect to bone marrow from healthy donors. Fluorescent in situ hybridisation analysis using miRNA-specific locked nucleic acid (LNA) probes on cryopreserved patient cells confirmed the results obtained by real-time PCR. This study, conducted on about a fifth of the miRNAs currently reported in the Sanger database (microrna.sanger.ac.uk), demonstrates the potential for using miRNA expression to sub-classify cancer and suggests a role in the aetiology of leukaemia.	[Dixon-McIver, Amanda; Cazier, Jean-Baptiste; Molloy, Gael; Chaplin, Tracy; Lister, T. Andrew; Young, Bryan D.; Debernardi, Silvana] Med Oncol Ctr, Sch Med, Inst Canc, London, England; [East, Phil; Cazier, Jean-Baptiste] Canc Res UK, Bioinformat & Biostat Serv, London, England; [Mein, Charles A.] Barts & The London, Sch Med, Genome Ctr, London, England	Cancer Research UK; University of London; Queen Mary University London	Dixon-McIver, A (corresponding author), Med Oncol Ctr, Sch Med, Inst Canc, London, England.	silvana.debernardi@cancer.org.uk	Cazier, Jean-Baptiste/F-2369-2010; Cazier, Jean-Baptiste/GLR-2949-2022	Cazier, Jean-Baptiste/0000-0001-7581-9051; Cazier, Jean-Baptiste/0000-0001-7581-9051; Mein, Charles/0000-0003-0811-9658; East, Philip/0000-0001-5801-5713	Cancer Research UK [C6277/A6789]; Barts and The London, Research Advisory Board Studentship [ONA100P]	Cancer Research UK(Cancer Research UK); Barts and The London, Research Advisory Board Studentship	This work was supported by funds from Cancer Research UK, Project Grant (C6277/A6789) to BDY and SD, Barts and The London, Research Advisory Board Studentship (ONA100P) to AD-M.	Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; Brueckner B, 2007, CANCER RES, V67, P1419, DOI 10.1158/0008-5472.CAN-06-4074; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Debernardi S, 2007, LEUKEMIA, V21, P912, DOI 10.1038/sj.leu.2404605; Debernardi S, 2003, GENE CHROMOSOME CANC, V37, P149, DOI 10.1002/gcc.10198; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Haferlach T, 2005, BLOOD, V106, P1189, DOI 10.1182/blood-2004-12-4938; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Isken F, 2008, BRIT J HAEMATOL, V140, P153, DOI 10.1111/j.1365-2141.2007.06915.x; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Meng F, 2008, ONCOGENE, V27, P378, DOI 10.1038/sj.onc.1210648; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Michael MZ, 2003, MOL CANCER RES, V1, P882; MITELMAN F, 2007, MITELMAN DATABASE CH; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; OZEN M, 2007, ONCOGENE ADV ONLINE; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Rarnkissoon SH, 2006, MOL CELL PROBE, V20, P1, DOI 10.1016/j.mcp.2005.07.004; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Schoch C, 2002, P NATL ACAD SCI USA, V99, P10008, DOI 10.1073/pnas.142103599; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yin D, 2004, INT J ONCOL, V24, P1011; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207	54	206	223	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2141	10.1371/journal.pone.0002141	http://dx.doi.org/10.1371/journal.pone.0002141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478077	Green Published, Green Submitted, gold			2022-12-27	WOS:000262172800006
J	Pfenninger, M; Nowak, C				Pfenninger, Markus; Nowak, Carsten			Reproductive Isolation and Ecological Niche Partition among Larvae of the Morphologically Cryptic Sister Species Chironomus riparius and C. piger	PLOS ONE			English	Article							GENE FLOW; DNA; DIPTERA; THUMMI; COEXISTENCE; HAPLOTYPES; SETTLEMENT; EVOLUTION; SEQUENCES	Background: One of the central issues in ecology is the question what allows sympatric occurrence of closely related species in the same general area? The non-biting midges Chironomus riparius and C. piger, interbreeding in the laboratory, have been shown to coexist frequently despite of their close relatedness, similar ecology and high morphological similarity. Methodology/Principal Findings: In order to investigate factors shaping niche partitioning of these cryptic sister species, we explored the actual degree of reproductive isolation in the field. Congruent results from nuclear microsatellite and mitochondrial haplotype analyses indicated complete absence of interspecific gene-flow. Autocorrelation analysis showed a non-random spatial distribution of the two species. Though not dispersal limited at the scale of the study area, the sister species occurred less often than expected at the same site, indicating past or present competition. Correlation and multiple regression analyses suggested the repartition of the available habitat along water chemistry gradients (nitrite, conductivity, CaCO3), ultimately governed by differences in summer precipitation regime. Conclusions: We show that these morphologically cryptic sister species partition their niches due to a certain degree of ecological distinctness and total reproductive isolation in the field. The coexistence of these species provides a suitable model system for the investigation of factors shaping the distribution of closely related, cryptic species.	Goethe Univ Frankfurt, Abt Okol & Evolut, Frankfurt, Germany	Goethe University Frankfurt	Pfenninger, M (corresponding author), Goethe Univ Frankfurt, Abt Okol & Evolut, Frankfurt, Germany.	Pfenninger@bio.uni-frankfurt.de	Nowak, Carsten/A-4466-2014; Pfenninger, Markus/A-8230-2012	Nowak, Carsten/0000-0002-3139-1951; 	programme Environmental Quality and its Security and Sustainment (BW-Plus); Baden-Wurttemberg [BWR 22018]	programme Environmental Quality and its Security and Sustainment (BW-Plus); Baden-Wurttemberg	This research has been supported by the programme Environmental Quality and its Security and Sustainment (BW-Plus) with funding of the state Baden-Wurttemberg (project number BWR 22018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Armitage P.D., 1995, P194; ARNOLD ML, 1992, ANNU REV ECOL SYST, V23, P237, DOI 10.1146/annurev.es.23.110192.001321; Belkhir K, 1996, GENETIX 4 04 LOGICIE; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; CAREW ME, 2003, B ENTEMOLOGICAL RES, V8, P287; CHESSON P, 1991, TRENDS ECOL EVOL, V6, P26, DOI 10.1016/0169-5347(91)90144-M; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Crandall KA, 1996, MOL BIOL EVOL, V13, P115, DOI 10.1093/oxfordjournals.molbev.a025550; Darwin C., 1859, ORIGINS SPECIES MEAN; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; EXCOFFIER L, 1992, GENETICS, V131, P479; Gunderina LI, 2005, RUSS J GENET+, V41, P130, DOI 10.1007/s11177-005-0107-8; Guryev V, 2001, MOL PHYLOGENET EVOL, V19, P9, DOI 10.1006/mpev.2001.0898; Haas H., 1957, Biologisches Zentralblatt Leipzig, V76, P513; Hagele K, 1999, J ZOOL SYST EVOL RES, V37, P161; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; HILSENHOFF WL, 1968, ANN ENTOMOL SOC AM, V61, P1173, DOI 10.1093/aesa/61.5.1173; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; JOHNSON RK, 1987, ENTOMOL SCAND, P233; Kelly A, 2004, J N AM BENTHOL SOC, V23, P287, DOI 10.1899/0887-3593(2004)023&lt;0287:SIAPFI&gt;2.0.CO;2; Keyl H. G., 1959, Archiv fuer Hydrobiologie Stuttgart, V56, P43; KEYL HG, 1956, Z NATURFORSCH PT B, V11, P727; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; MCLACHLAN A, 1993, HYDROBIOLOGIA, V259, P1, DOI 10.1007/BF00005959; Meszena G, 2006, THEOR POPUL BIOL, V69, P68, DOI 10.1016/j.tpb.2005.07.001; MIEHLBRADT J, 1976, BEHAVIOUR, V58, P272, DOI 10.1163/156853976X00190; Neumann D, 2001, ARCH HYDROBIOL, V153, P103; NOWAK C, 2006, MOL ECOLOGY IN PRESS; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pfenninger M, 2007, MOL ECOL, V16, P1957, DOI 10.1111/j.1365-294X.2006.03136.x; Ross R, 1997, J MOL EVOL, V44, P321, DOI 10.1007/PL00006149; Sawada M, 1999, B ECOL SOC AM, V80, P231, DOI DOI 10.1890/0012-9623(1999)080[0231:TT]2.0.CO;2; SCHARF BW, 1973, ARCH HYDROBIOL, V72, P225; Servia MJ, 2004, HYDROBIOLOGIA, V523, P137, DOI 10.1023/B:HYDR.0000033101.78277.8b; Stevens MM, 2003, J CHEM ECOL, V29, P911, DOI 10.1023/A:1022983800421; STRENZKE K, 1957, ANALLES ENTOMOL FENN, V26, P111; Suemoto T, 2004, HYDROBIOLOGIA, V515, P107, DOI 10.1023/B:HYDR.0000027322.11005.20; Templeton AR, 1998, MOL ECOL, V7, P381, DOI 10.1046/j.1365-294x.1998.00308.x; TEMPLETON AR, 1992, GENETICS, V132, P619; Tokeshi M., 1995, P225; Tokeshi M., 1995, P297; TOKESHI M, 1995, FRESHWATER BIOL, V33, P567, DOI 10.1111/j.1365-2427.1995.tb00414.x; Vos JH, 2002, ARCH HYDROBIOL, V154, P103; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Zhang DY, 2004, ECOL LETT, V7, P165, DOI 10.1111/j.1461-0248.2004.00569.x	50	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2157	10.1371/journal.pone.0002157	http://dx.doi.org/10.1371/journal.pone.0002157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478074	Green Submitted, Green Published, gold			2022-12-27	WOS:000262172800022
J	Yu, Z; Li, P; Zhang, M; Hannink, M; Stamler, JS; Yan, Z				Yu, Zengli; Li, Ping; Zhang, Mei; Hannink, Mark; Stamler, Jonathan S.; Yan, Zhen			Fiber Type-Specific Nitric Oxide Protects Oxidative Myofibers against Cachectic Stimuli	PLOS ONE			English	Article								Oxidative skeletal muscles are more resistant than glycolytic muscles to cachexia caused by chronic heart failure and other chronic diseases. The molecular mechanism for the protection associated with oxidative phenotype remains elusive. We hypothesized that differences in reactive oxygen species (ROS) and nitric oxide (NO) determine the fiber type susceptibility. Here, we show that intraperitoneal injection of endotoxin (lipopolysaccharide, LPS) in mice resulted in higher level of ROS and greater expression of muscle-specific E3 ubiqitin ligases, muscle atrophy F-box (MAFbx)/atrogin-1 and muscle RING finger-1 (MuRF1), in glycolytic white vastus lateralis muscle than in oxidative soleus muscle. By contrast, NO production, inducible NO synthase (iNos) and antioxidant gene expression were greatly enhanced in oxidative, but not in glycolytic muscles, suggesting that NO mediates protection against muscle wasting. NO donors enhanced iNos and antioxidant gene expression and blocked cytokine/endotoxin-induced MAFbx/atrogin-1 expression in cultured myoblasts and in skeletal muscle in vivo. Our studies reveal a novel protective mechanism in oxidative myofibers mediated by enhanced iNos and antioxidant gene expression and suggest a significant value of enhanced NO signaling as a new therapeutic strategy for cachexia.	[Yu, Zengli; Li, Ping; Stamler, Jonathan S.; Yan, Zhen] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Stamler, Jonathan S.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC USA; [Zhang, Mei; Yan, Zhen] Duke NUS Grad Med Sch, Singapore, Singapore; [Hannink, Mark] Univ Missouri Columbia, Life Sci Ctr, Dept Biochem, Columbia, MO USA	Duke University; Duke University; National University of Singapore; University of Missouri System; University of Missouri Columbia	Yu, Z (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	zhen.yan@duke.edu		Li, Ping/0000-0002-4549-9517; Stamler, Jonathan/0000-0002-6866-1572; Yan, Zhen/0000-0002-4826-9813	American Heart Association-Mid-Atlantic Affiliate Post-doctoral Fellowship [0625518]; National Institutes of Health [R01-HLO59130]; Grant-in-Aid [0555426U]	American Heart Association-Mid-Atlantic Affiliate Post-doctoral Fellowship(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grant-in-Aid	This study is supported by the American Heart Association-Mid-Atlantic Affiliate Post-doctoral Fellowship 0625518 (to P.L.), National Institutes of Health R01-HLO59130 (to J.S.S), and Grant-in-Aid 0555426U (to Z.Y.).	Abraham RZ, 1998, COMP BIOCHEM PHYS A, V119, P177, DOI 10.1016/S1095-6433(97)00421-2; Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Adams V, 1997, BIOCHEM MOL MED, V61, P152, DOI 10.1006/bmme.1997.2598; Agusti A, 2004, THORAX, V59, P483, DOI 10.1136/thx.2003.017640; Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; Appell HJ, 1997, INT J SPORTS MED, V18, P157; AriasDiaz J, 1997, EUR J SURG, V163, P619; Barreiro E, 2005, FEBS LETT, V579, P1646, DOI 10.1016/j.febslet.2005.02.017; BIANCA R, 2002, MED SCI MONITOR, V8, P1; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje; Boveris A, 2002, FREE RADICAL BIO MED, V33, P1186, DOI 10.1016/S0891-5849(02)01009-2; Butori C, 1995, ANN PATHOL, V15, P424; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Chang WJ, 1996, P NATL ACAD SCI USA, V93, P9142, DOI 10.1073/pnas.93.17.9142; Comtois AS, 2001, AM J RESP CRIT CARE, V163, P977, DOI 10.1164/ajrccm.163.4.9912057; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Davila HH, 2004, BIOL REPROD, V71, P1568, DOI 10.1095/biolreprod.104.030833; Escames G, 2006, J PINEAL RES, V40, P71, DOI 10.1111/j.1600-079X.2005.00281.x; Escames G, 2007, FEBS J, V274, P2135, DOI 10.1111/j.1742-4658.2007.05755.x; Fagan JM, 1996, ARCH SURG-CHICAGO, V131, P1326; FAGAN JM, 1996, ARCH SURG-CHICAGO, V131, P1331; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Grozdanovic Z, 1999, HISTOL HISTOPATHOL, V14, P243, DOI 10.14670/HH-14.243; Hollander J, 1999, AM J PHYSIOL-REG I, V277, pR856, DOI 10.1152/ajpregu.1999.277.3.R856; JI LL, 1992, J APPL PHYSIOL, V73, P1854, DOI 10.1152/jappl.1992.73.5.1854; KAWANO T, 2007, J CEREB BLOOD FLOW M; Krolick KA, 2006, CLIN IMMUNOL, V121, P286, DOI 10.1016/j.clim.2006.07.005; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Li P, 2007, AM J PATHOL, V170, P599, DOI 10.2353/ajpath.2007.060505; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Linke A, 2005, CIRCULATION, V111, P1763, DOI 10.1161/01.CIR.0000165503.08661.E5; LOWENSTEIN CJ, 1992, P NATL ACAD SCI USA, V89, P6711, DOI 10.1073/pnas.89.15.6711; Minnaard R, 2005, MUSCLE NERVE, V31, P339, DOI 10.1002/mus.20268; MULLER FL, 2007, AM J PHYSL REGUL INT; Nin N, 2004, INTENS CARE MED, V30, P2271, DOI 10.1007/s00134-004-2427-x; Obasanjo-Blackshire K, 2006, CARDIOVASC RES, V71, P672, DOI 10.1016/j.cardiores.2006.05.026; Ockaili R, 2002, AM J PHYSIOL-HEART C, V283, pH1263, DOI 10.1152/ajpheart.00324.2002; Reid MB, 1998, COMP BIOCHEM PHYS A, V119, P211, DOI 10.1016/S1095-6433(97)00417-0; Salloum F, 2003, CIRC RES, V92, P595, DOI 10.1161/01.RES.0000066853.09821.98; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; SHAH AJ, 1983, CLIN NEUROPATHOL, V2, P83; Wang MX, 2001, NITRIC OXIDE-BIOL CH, V5, P219, DOI 10.1006/niox.2001.0348; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	46	63	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2086	10.1371/journal.pone.0002086	http://dx.doi.org/10.1371/journal.pone.0002086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461174	Green Published, gold			2022-12-27	WOS:000261642400009
J	Buhimschi, IA; Zhao, G; Rosenberg, VA; Abdel-Razeq, S; Thung, S; Buhimschi, CS				Buhimschi, Irina A.; Zhao, Guomao; Rosenberg, Victor A.; Abdel-Razeq, Sonya; Thung, Stephen; Buhimschi, Catalin S.			Multidimensional Proteomics Analysis of Amniotic Fluid to Provide Insight into the Mechanisms of Idiopathic Preterm Birth	PLOS ONE			English	Article							URINARY TRYPSIN-INHIBITOR; PREMATURE RUPTURE; FETAL-GROWTH; A-II; BIKUNIN; APOLIPOPROTEINS; INFLAMMATION; CONTRACTION; EXPRESSION; BIOMARKERS	Background: Though recent advancement in proteomics has provided a novel perspective on several distinct pathogenetic mechanisms leading to preterm birth (inflammation, bleeding), the etiology of most preterm births still remains elusive. We conducted a multidimensional proteomic analysis of the amniotic fluid to identify pathways related to preterm birth in the absence of inflammation or bleeding. Methodology/Principal Findings: A proteomic fingerprint was generated from fresh amniotic fluid using surface-enhanced laser desorbtion ionization time of flight (SELDI-TOF) mass spectrometry in a total of 286 consecutive samples retrieved from women who presented with signs or symptoms of preterm labor or preterm premature rupture of the membranes. Inflammation and/or bleeding proteomic patterns were detected in 32% (92/286) of the SELDI tracings. In the remaining tracings, a hierarchical algorithm was applied based on descriptors quantifying similarity/dissimilarity among proteomic fingerprints. This allowed identification of a novel profile (Q-profile) based on the presence of 5 SELDI peaks in the 10-12.5 kDa mass area. Women displaying the Q-profile(mean +/- SD, gestational age: 25 +/- 4 weeks, n = 40) were more likely to deliver preterm despite expectant management in the context of intact membranes and normal amniotic fluid clinical results. Utilizing identification-centered proteomics techniques (fluorescence two-dimensional differential gel electrophoresis, robotic tryptic digestion and mass spectrometry) coupled with Protein ANalysis THrough Evolutionary Relationships (PANTHER) ontological classifications, we determined that in amniotic fluids with Q-profile the differentially expressed proteins are primarily involved in non-inflammatory biological processes such as protein metabolism, signal transduction and transport. Conclusion/Significance: Proteomic profiling of amniotic fluid coupled with non-hierarchical bioinformatics algorithms identified a subgroup of patients at risk for preterm birth in the absence of intra-amniotic inflammation or bleeding, suggesting a novel pathogenetic pathway leading to preterm birth. The altered proteins may offer opportunities for therapeutical intervention and future drug development to prevent prematurity.	[Buhimschi, Irina A.; Zhao, Guomao; Rosenberg, Victor A.; Abdel-Razeq, Sonya; Thung, Stephen; Buhimschi, Catalin S.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA	Yale University	Buhimschi, IA (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.	irina.buhimschi@yale.edu	Buhimschi, Irina/AAY-6619-2021	Buhimschi, Irina/0000-0002-1701-1326	National Institutes of Child Health and Development [RO1 HD 047321 IAB]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047321] Funding Source: NIH RePORTER	National Institutes of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The study was funded by a grant from the National Institutes of Child Health and Development (RO1 HD 047321 IAB). The funding source had no involvement in study design, interpretation of data, writing of the report or decision to submit the paper for publication.	ACOG Committee on Practice Bulletins-Obstetrics, 2007, OBSTET GYNECOL, V109, P1007, DOI DOI 10.1097/01.AOG.0000263888.69178.1F; BREWER MT, 1988, BIOCHEM BIOPH RES CO, V152, P1289, DOI 10.1016/S0006-291X(88)80425-X; Buhimschi CS, 2007, PLOS MED, V4, P84, DOI 10.1371/journal.pmed.0040018; Buhimschi CS, 2007, PEDIATR RES, V61, P318, DOI 10.1203/01.pdr.0000252439.48564.37; Buhimsehi CS, 2006, OBSTET GYNECOL SURV, V61, P481, DOI 10.1097/01.ogx.0000224617.11789.ab; Buhimschi IA, 2005, BJOG-INT J OBSTET GY, V112, P173, DOI 10.1111/j.1471-0528.2004.00340.x; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chevallier B, 1998, BIOL NEONATE, V73, P404, DOI 10.1159/000014003; ElMaradny E, 1996, GYNECOL OBSTET INVES, V41, P96, DOI 10.1159/000292051; Fries E, 2000, INT J BIOCHEM CELL B, V32, P125, DOI 10.1016/S1357-2725(99)00125-9; Gettins PGW, 2002, BIOL CHEM, V383, P1677, DOI 10.1515/BC.2002.188; Heffner LJ, 1998, GROWTH HORM IGF RES, V8, P33, DOI 10.1016/S1096-6374(98)80319-5; Kaga N, 1996, OBSTET GYNECOL, V88, P872, DOI 10.1016/0029-7844(96)00268-2; Kalopissis AD, 2000, INT J TISSUE REACT, V22, P67; KANAYAMA N, 1986, AM J OBSTET GYNECOL, V155, P1043, DOI 10.1016/0002-9378(86)90343-1; KANAYAMA N, 1995, AM J OBSTET GYNECOL, V173, P192, DOI 10.1016/0002-9378(95)90189-2; KANAYAMA N, 1995, EUR J OBSTET GYN R B, V60, P181, DOI 10.1016/0028-2243(95)02087-9; Kobayashi H, 2003, BIOL CHEM, V384, P749, DOI 10.1515/BC.2003.083; Kobayashi H, 1999, MOL HUM REPROD, V5, P662, DOI 10.1093/molehr/5.7.662; LEBOEUF RC, 1994, J LIPID RES, V35, P121; Lockwood CJ, 2003, CLIN LAB MED, V23, P345, DOI 10.1016/S0272-2712(03)00029-5; Marko-Varga G, 2007, J PROTEOME RES, V6, P2925, DOI 10.1021/pr070046s; Matsuzaki H, 2004, CLIN DIAGN LAB IMMUN, V11, P1140, DOI 10.1128/CDLI.11.6.1140-1147.2004; MCKEEHAN WL, 1986, J BIOL CHEM, V261, P5378; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Michaels JEA, 2007, J PROTEOME RES, V6, P1277, DOI 10.1021/pr060543t; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; Moutquin JM, 2003, BJOG-INT J OBSTET GY, V110, P30, DOI 10.1016/S1470-0328(03)00021-1; Naef RW, 1998, AM J OBSTET GYNECOL, V178, P126, DOI 10.1016/S0002-9378(98)70638-6; Naeye RL., 1992, DISORDERS PLACENTA F, P118; Nesvizhskii A.I., 2007, METHODS MOL BIOL, V367, P87, DOI DOI 10.1385/1-59745-275-0:87; Ngoc NTN, 2006, B WORLD HEALTH ORGAN, V84, P699, DOI 10.2471/BLT.05.027300; OBRIEN WF, 1990, AM J OBSTET GYNECOL, V162, P756, DOI 10.1016/0002-9378(90)91002-T; Petricoin EF, 2002, J MAMMARY GLAND BIOL, V7, P433, DOI 10.1023/A:1024042200521; Popovici RM, 2001, J CLIN ENDOCR METAB, V86, P2653, DOI 10.1210/jc.86.6.2653; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; Sherer DM, 2000, GYNECOL OBSTET INVES, V50, P92, DOI 10.1159/000010289; STEINMETZ A, 1989, GYNECOL OBSTET INVES, V28, P127, DOI 10.1159/000293547; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Vij N, 2004, EXP EYE RES, V78, P957, DOI 10.1016/j.exer.2003.12.006; WACHTER E, 1981, H-S Z PHYSIOL CHEM, V362, P1351, DOI 10.1515/bchm2.1981.362.2.1351; Weiner CP, 2005, AM J OBSTET GYNECOL, V192, P710, DOI 10.1016/j.ajog.2004.10.588	42	42	44	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2049	10.1371/journal.pone.0002049	http://dx.doi.org/10.1371/journal.pone.0002049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431506	Green Published, Green Submitted, gold			2022-12-27	WOS:000261558700041
J	Martins, PM; Rocha, F; Damas, AM				Martins, Pedro M.; Rocha, Fernando; Damas, Ana M.			Understanding Water Equilibration Fundamentals as a Step for Rational Protein Crystallization	PLOS ONE			English	Article								Background: Vapor diffusion is the most widely used technique for protein crystallization and the rate of water evaporation plays a key role on the quality of the crystals. Attempts have been made in the past to solve the mass transfer problem governing the evaporation process, either analytically or by employing numerical methods. Despite these efforts, the methods used for protein crystallization remain based on trial and error techniques rather than on fundamental principles. Methodology/Principal Findings: Here we present a new theoretical model which describes the hanging drop method as a function of the different variables that are known to influence the evaporation process. The model is extensively tested against experimental data published by other authors and considering different crystallizing conditions. Aspects responsible for the discrepancies between the existing theories and the measured evaporation kinetics are especially discussed; they include the characterization of vapor-liquid equilibrium, the role of mass transfer within the evaporating droplet, and the influence of the droplet-reservoir distance. Conclusions/Significance: The validation tests show that the proposed model can be used to predict the water evaporation rates under a wide range of experimental conditions used in the hanging drop vapor-diffusion method, with no parameter fitting or computational requirements. This model combined with protein solubility data is expected to become a useful tool for a priori screening of crystallization conditions.	[Martins, Pedro M.; Damas, Ana M.] Univ Porto, IBMC, Grp Estrutura Mol, P-4100 Oporto, Portugal; [Martins, Pedro M.; Rocha, Fernando] Univ Porto, Fac Engenharia, Dept Engenharia Quim, Oporto, Portugal; [Damas, Ana M.] Univ Porto, ICBAS, Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Martins, PM (corresponding author), Univ Porto, IBMC, Grp Estrutura Mol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	amdamas@ibmc.up.pt	Martins, Pedro/GWC-7702-2022; Martins, Pedro M/J-3765-2013; Rocha, Fernando A/D-4324-2014	Rocha, Fernando A/0000-0002-2778-8374; Martins, Pedro Miguel/0000-0002-6908-1828	Fundacao para a Ciencia e a Tecnologia, Portugal [FEDER FCT POCI/SAU-NEU/69123/2006, PTDC/EQU-FTT/81496/2006]; EU [EURAMY(FP6-LIFESCIHEALTH-6)]; FCT [SFRH/BPD/34556/2007]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); EU(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the projects FEDER FCT POCI/SAU-NEU/69123/2006 and PTDC/EQU-FTT/81496/2006 from Fundacao para a Ciencia e a Tecnologia, Portugal, and project EURAMY(FP6-LIFESCIHEALTH-6) from EU. PMM is funded by a FCT grant with reference SFRH/BPD/34556/2007. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Asherie N, 2004, METHODS, V34, P266, DOI 10.1016/j.ymeth.2004.03.028; Baird JK, 1999, J CRYST GROWTH, V204, P553, DOI 10.1016/S0022-0248(99)00134-7; Capuano F, 2006, J SOLUTION CHEM, V35, P1525, DOI 10.1007/s10953-006-9077-2; Chayen NE, 2004, CURR OPIN STRUC BIOL, V14, P577, DOI 10.1016/j.sbi.2004.08.002; Chayen NE, 1997, STRUCTURE, V5, P1269, DOI 10.1016/S0969-2126(97)00279-7; Diller DJ, 1999, ACTA CRYSTALLOGR D, V55, P656, DOI 10.1107/S0907444998014589; DUCRUIX A, 1999, CRYSTALLISATION NUCL; Falini G, 2002, ACTA CRYSTALLOGR D, V58, P1649, DOI 10.1107/S0907444902012763; Fernandez-Serra MV, 2004, J CHEM PHYS, V121, P11136, DOI 10.1063/1.1813431; FOWLIS WW, 1988, J CRYST GROWTH, V90, P117, DOI 10.1016/0022-0248(88)90306-5; Luft JR, 1996, ACTA CRYSTALLOGR D, V52, P1098, DOI 10.1107/S0907444996006932; MIKOL V, 1990, ANAL BIOCHEM, V186, P332, DOI 10.1016/0003-2697(90)90091-M; Nakamura H, 2003, J CRYST GROWTH, V259, P149, DOI 10.1016/S0022-0248(03)01571-9; Saridakis E, 2000, PROTEIN SCI, V9, P755; SIBILLE L, 1991, J CRYST GROWTH, V110, P72, DOI 10.1016/0022-0248(91)90868-6; SIBILLE L, 1991, J CRYST GROWTH, V110, P80, DOI 10.1016/0022-0248(91)90869-7; Talreja S, 2007, LANGMUIR, V23, P4516, DOI 10.1021/la063734j; Tang L, 2005, ACTA CRYSTALLOGR D, V61, P53, DOI 10.1107/S0907444904026009	18	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1998	10.1371/journal.pone.0001998	http://dx.doi.org/10.1371/journal.pone.0001998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431483	Green Published, gold, Green Submitted			2022-12-27	WOS:000261558700018
J	Ali, GS; Prasad, KVSK; Hanumappa, M; Reddy, ASN				Ali, Gul Shad; Prasad, K. V. S. K.; Hanumappa, M.; Reddy, A. S. N.			Analyses of In Vivo Interaction and Mobility of Two Spliceosomal Proteins Using FRAP and BiFC	PLOS ONE			English	Article								U1-70K, a U1 snRNP-specific protein, and serine/arginine-rich (SR) proteins are components of the spliceosome and play critical roles in both constitutive and alternative pre-mRNA splicing. However, the mobility properties of U1-70K, its in vivo interaction with SR proteins, and the mobility of the U1-70K-SR protein complex have not been studied in any system. Here, we studied the in vivo interaction of U1-70K with an SR protein (SR45) and the mobility of the U1-70K/SR protein complex using bimolecular fluorescence complementation (BiFC) and fluorescence recovery after photobleaching (FRAP). Our results show that U1-70K exchanges between speckles and the nucleoplasmic pool very rapidly and that this exchange is sensitive to ongoing transcription and phosphorylation. BiFC analyses showed that U1-70K and SR45 interacted primarily in speckles and that this interaction is mediated by the RS1 or RS2 domain of SR45. FRAP analyses showed considerably slower recovery of the SR45/U1-70K complex than either protein alone indicating that SR45/U1-70K complexes remain in the speckles for a longer duration. Furthermore, FRAP analyses with SR45/U1-70K complex in the presence of inhibitors of phosphorylation did not reveal any significant change compared to control cells, suggesting that the mobility of the complex is not affected by the status of protein phosphorylation. These results indicate that U1-70K, like SR splicing factors, moves rapidly in the nucleus ensuring its availability at various sites of splicing. Furthermore, although it appears that U1-70K moves by diffusion its mobility is regulated by phosphorylation and transcription.	[Ali, Gul Shad; Prasad, K. V. S. K.; Hanumappa, M.; Reddy, A. S. N.] Colorado State Univ, Dept Biol, Program Mol Plant Biol, Ft Collins, CO 80523 USA	Colorado State University	Ali, GS (corresponding author), Colorado State Univ, Dept Biol, Program Mol Plant Biol, Ft Collins, CO 80523 USA.	reddy@colostate.edu		Reddy, Anireddy/0000-0002-4038-4091	Department of Energy [DE-FG02-04ER15556]; National Science Foundation	Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the Department of Energy (DE-FG02-04ER15556) and the National Science Foundation to ASNR.	ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Ali GS, 2003, PLANT J, V36, P883, DOI 10.1046/j.1365-313X.2003.01932.x; Ali GS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000471; Ali GS, 2006, J CELL SCI, V119, P3527, DOI 10.1242/jcs.03144; Anderie I, 2007, CELL BIOL INT, V31, P1131, DOI 10.1016/j.cellbi.2007.03.025; Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Cao WH, 1998, J BIOL CHEM, V273, P20629, DOI 10.1074/jbc.273.32.20629; Dye BT, 2001, EXP CELL RES, V263, P131, DOI 10.1006/excr.2000.5097; EPERON IC, 1993, EMBO J, V12, P3607, DOI 10.1002/j.1460-2075.1993.tb06034.x; Fang YD, 2004, MOL BIOL CELL, V15, P2664, DOI 10.1091/mbc.E04-02-0100; Golovkin M, 1996, PLANT CELL, V8, P1421, DOI 10.1105/tpc.8.8.1421; Golovkin M, 1998, PLANT CELL, V10, P1637, DOI 10.1105/tpc.10.10.1637; Golovkin M, 1999, J BIOL CHEM, V274, P36428, DOI 10.1074/jbc.274.51.36428; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Guo YJ, 2005, J BIOL CHEM, V280, P1438, DOI 10.1074/jbc.M407593200; HEDLEY ML, 1995, P NATL ACAD SCI USA, V92, P11524, DOI 10.1073/pnas.92.25.11524; JAMISON SF, 1995, NUCLEIC ACIDS RES, V23, P3260, DOI 10.1093/nar/23.16.3260; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; Lorkovic ZJ, 2004, J BIOL CHEM, V279, P33890, DOI 10.1074/jbc.M400270200; Lorkovic ZJ, 2004, MOL BIOL CELL, V15, P3233, DOI 10.1091/mbc.E04-01-0055; Lorkovic ZJ, 2004, TRENDS PLANT SCI, V9, P565, DOI 10.1016/j.tplants.2004.10.003; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; MERMOUD JE, 1992, NUCLEIC ACIDS RES, V20, P5263, DOI 10.1093/nar/20.20.5263; Misteli T, 1999, CURR BIOL, V9, pR198, DOI 10.1016/S0960-9822(99)80128-6; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Reddy ASN, 2004, TRENDS PLANT SCI, V9, P541, DOI 10.1016/j.tplants.2004.09.007; Reddy ASN, 2001, CRIT REV PLANT SCI, V20, P523, DOI 10.1016/S0735-2689(01)80004-6; ROMAC JMJ, 1994, MOL CELL BIOL, V14, P4662, DOI 10.1128/MCB.14.7.4662; Schmidt C, 2003, MOL CELL, V12, P1287, DOI 10.1016/S1097-2765(03)00390-3; Schmidt U, 2006, J CELL BIOL, V172, P373, DOI 10.1083/jcb.200503061; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; TAZI J, 1992, J BIOL CHEM, V267, P4322; TAZI J, 1993, NATURE, V363, P283, DOI 10.1038/363283a0; Tillemans V, 2005, PLANT J, V41, P567, DOI 10.1111/j.1365-313X.2004.02321.x; Tillemans V, 2006, PLANT CELL, V18, P3218, DOI 10.1105/tpc.106.044529; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wei XY, 1999, J CELL BIOL, V146, P543, DOI 10.1083/jcb.146.3.543; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; WOPPMANN A, 1993, NUCLEIC ACIDS RES, V21, P2815, DOI 10.1093/nar/21.12.2815; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; ZAHLER AM, 1995, P NATL ACAD SCI USA, V92, P2642, DOI 10.1073/pnas.92.7.2642	53	25	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1953	10.1371/journal.pone.0001953	http://dx.doi.org/10.1371/journal.pone.0001953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414657	Green Published, gold, Green Submitted			2022-12-27	WOS:000260867300006
J	Esnault, C; Boulesteix, M; Duchemin, JB; Koffi, AA; Chandre, F; Dabire, R; Robert, V; Simard, F; Tripet, F; Donnelly, MJ; Fontenille, D; Biemont, C				Esnault, Caroline; Boulesteix, Matthieu; Duchemin, Jean Bernard; Koffi, Alphonsine A.; Chandre, Fabrice; Dabire, Roch; Robert, Vincent; Simard, Frederic; Tripet, Frederic; Donnelly, Martin J.; Fontenille, Didier; Biemont, Christian			High Genetic Differentiation between the M and S Molecular Forms of Anopheles gambiae in Africa	PLOS ONE			English	Article								Background: Anopheles gambiae, a major vector of malaria, is widely distributed throughout sub-Saharan Africa. In an attempt to eliminate infective mosquitoes, researchers are trying to develop transgenic strains that are refractory to the Plasmodium parasite. Before any release of transgenic mosquitoes can be envisaged, we need an accurate picture of the differentiation between the two molecular forms of An. gambiae, termed M and S, which are of uncertain taxonomic status. Methodology/Principal Findings: Insertion patterns of three transposable elements (TEs) were determined in populations from Benin, Burkina Faso, Cameroon, Ghana, Ivory Coast, Madagascar, Mali, Mozambique, Niger, and Tanzania, using Transposon Display, a TE-anchored strategy based on Amplified Fragment Length Polymorphism. The results reveal a clear differentiation between the M and S forms, whatever their geographical origin, suggesting an incipient speciation process. Conclusions/Significance: Any attempt to control the transmission of malaria by An. gambiae using either conventional or novel technologies must take the M/S genetic differentiation into account. In addition, we localized three TE insertion sites that were present either in every individual or at a high frequency in the M molecular form. These sites were found to be located outside the chromosomal regions that are suspected of involvement in the speciation event between the two forms. This suggests that these chromosomal regions are either larger than previously thought, or there are additional differentiated genomic regions interspersed with undifferentiated regions.	[Esnault, Caroline; Boulesteix, Matthieu; Biemont, Christian] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR 5558, F-69622 Villeurbanne, France; [Duchemin, Jean Bernard] Reseau Int Inst Pasteur, Ctr Rech Med Sanitaire, Niamey, Niger; [Koffi, Alphonsine A.] Inst Natl Sante Publique, Inst Pierre Richet, Abidjan, Cote Ivoire; [Chandre, Fabrice] CREC, Inst Rech Dev, Unite Rech, Cotonou, Benin; [Dabire, Roch] Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Robert, Vincent] Museum Natl Histoire Naturelle, Unite Sci Museum, Inst Rech Dev, Unite Rech, Paris, France; [Robert, Vincent] Inst Pasteur, Antananarivo, Madagascar; [Simard, Frederic] Org Coordinat Endemies Afrique Centrale, Lab Rech Paludisme, Yaounde, Cameroon; [Simard, Frederic; Fontenille, Didier] Inst Rech Dev, Unite Rech, Montpellier, France; [Tripet, Frederic] Keele Univ, Sch Life Sci, Ctr Appl Entomol & Parasitol, Staffordshire, England; [Donnelly, Martin J.] Pembroke Place, Liverpool Sch Trop Med, Vector Grp, Liverpool, Merseyside, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Entomological Research Center of Cotonou (CREC); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Institut de Recherche pour le Developpement (IRD); Keele University; Liverpool School of Tropical Medicine; University of Liverpool	Esnault, C (corresponding author), Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR 5558, F-69622 Villeurbanne, France.	biemont@biomserv.univ-lyon1.fr	Frederic, SIMARD/AFV-5001-2022; Chandre, Fabrice/Q-3429-2019; Tripet, Frederic/M-6693-2015; FONTENILLE, didier/G-4091-2013; Esnault, Caroline/C-7221-2015; Duchemin, Jean-Bernard/D-7000-2011; Dabire, Roch Kounbobr/ABF-3525-2020; SIMARD, Frederic/J-9489-2016; Duchemin, Jean-Bernard/AAE-8077-2020	Frederic, SIMARD/0000-0002-2871-5329; Chandre, Fabrice/0000-0002-1994-9705; Tripet, Frederic/0000-0002-7939-0712; Duchemin, Jean-Bernard/0000-0001-5044-4855; SIMARD, Frederic/0000-0002-2871-5329; Duchemin, Jean-Bernard/0000-0001-5044-4855; ROBERT, Vincent/0000-0003-1738-1842; Donnelly, Martin/0000-0001-5218-1497; FONTENILLE, didier/0000-0002-0544-3885	PAL+ program of the French Ministry of Research; CNRS	PAL+ program of the French Ministry of Research; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the PAL+ program of the French Ministry of Research and CNRS.	Amorosa LF, 2005, HEALTH PLACE, V11, P67, DOI 10.1016/j.healthplace.2004.06.003; Barnes MJ, 2005, INSECT MOL BIOL, V14, P353, DOI 10.1111/j.1365-2583.2005.00566.x; BOETE C, 2006, GENETICALLY MODIFIED, P174; Boulesteix M, 2007, MOL ECOL, V16, P441, DOI 10.1111/j.1365-294X.2006.03150.x; Casa AM, 2000, P NATL ACAD SCI USA, V97, P10083, DOI 10.1073/pnas.97.18.10083; Chandre F, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P319; Chessel D., 2004, R NEWS, V4, P5; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; EXCOFFIER L, 1992, GENETICS, V131, P479; Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Favia G, 2001, INSECT MOL BIOL, V10, P19, DOI 10.1046/j.1365-2583.2001.00236.x; Gentile G, 2001, INSECT MOL BIOL, V10, P25, DOI 10.1046/j.1365-2583.2001.00237.x; Guerreiro MPG, 2007, GENETICS, V175, P301, DOI 10.1534/genetics.106.064378; Johnson L, 2008, HEREDITY, V100, P5, DOI 10.1038/sj.hdy.6801064; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; MACPHERSON JM, 2008, MOL BIOL EV IN PRESS; Melayah D, 2001, PLANT J, V28, P159, DOI 10.1046/j.1365-313X.2001.01141.x; Mukabayire O, 2001, INSECT MOL BIOL, V10, P33, DOI 10.1046/j.1365-2583.2001.00238.x; PEAKALL R, 1995, MOL ECOL, V4, P135, DOI 10.1111/j.1365-294X.1995.tb00203.x; Slotman MA, 2007, MOL ECOL, V16, P639, DOI 10.1111/j.1365-294X.2006.03172.x; Slotman MA, 2006, GENETICS, V174, P2081, DOI 10.1534/genetics.106.059949; Stump AD, 2005, P NATL ACAD SCI USA, V102, P15930, DOI 10.1073/pnas.0508161102; Turner TL, 2007, MOL BIOL EVOL, V24, P2132, DOI 10.1093/molbev/msm143; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Van den Broeck D, 1998, PLANT J, V13, P121, DOI 10.1046/j.1365-313X.1998.00004.x; Wang R, 2001, P NATL ACAD SCI USA, V98, P10769, DOI 10.1073/pnas.191003598; Wondji C, 2002, INSECT MOL BIOL, V11, P11, DOI 10.1046/j.0962-1075.2001.00306.x; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269; Yawson AE, 2007, GENETICS, V175, P751, DOI 10.1534/genetics.106.065888; Zampicinini G, 2004, GENOME, V47, P1154, DOI [10.1139/g04-066, 10.1139/G04-066]	34	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1968	10.1371/journal.pone.0001968	http://dx.doi.org/10.1371/journal.pone.0001968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414665	Green Published, Green Accepted, gold			2022-12-27	WOS:000260867300014
J	Paaby, AB; Schmidt, PS				Paaby, Annalise B.; Schmidt, Paul S.			Functional Significance of Allelic Variation at methuselah, an Aging Gene in Drosophila	PLOS ONE			English	Article							EXTENDED LIFE-SPAN; QUANTITATIVE TRAIT GENE; ADAPTIVE EVOLUTION; MUTANT; MELANOGASTER; LONGEVITY; EXTENSION; DIAPAUSE; HISTORY; EXPRESSION	Background: Longevity and age-specific patterns of mortality are complex traits that vary within and among taxa. Multiple candidate genes for aging have been identified in model systems by extended longevity mutant phenotypes, including the G-protein coupled receptor methuselah (mth) in D. melanogaster. These genes offer important insights into the mechanisms of lifespan determination and have been major targets of interest in the biology of aging. However, it is largely unknown whether these genes contribute to genetic variance for lifespan in natural populations, and consequently contribute to lifespan evolution. Methodology/Principle Findings: For a gene to contribute to genetic variance for a particular trait, it must meet two criteria: natural allelic variation and functional differences among variants. Previous work showed that mth varies significantly among wild populations; here we assess the functional significance of wild-derived mth alleles on lifespan, fecundity and stress resistance using a quantitative complementation scheme. Our results demonstrate that mth alleles segregating in nature have a functional effect on all three traits. Conclusions/Significance: These results suggest that allelic variation at mth contributes to observed differences in lifespan and correlated phenotypes in natural populations, and that evaluation of genetic diversity at candidate genes for aging can be a fruitful approach to identifying loci contributing to lifespan evolution.	[Paaby, Annalise B.; Schmidt, Paul S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Paaby, AB (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	paaby@sas.upenn.edu		Paaby, Annalise/0000-0003-1422-047X	Binns-Williams Scholarship; NSF	Binns-Williams Scholarship; NSF(National Science Foundation (NSF))	Funding for this work was provided by a Binns-Williams Scholarship to ABP and by an NSF grant to PSS. These sources played no other role in the study.	Baldal EA, 2006, EXP GERONTOL, V41, P1126, DOI 10.1016/j.exger.2006.08.014; Carbone MA, 2006, CURR BIOL, V16, P912, DOI 10.1016/j.cub.2006.03.051; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Cvejic S, 2004, NAT CELL BIOL, V6, P540, DOI 10.1038/ncb1133; De Luca M, 2003, NAT GENET, V34, P429, DOI 10.1038/ng1218; Duvernell DD, 2003, MOL ECOL, V12, P1277, DOI 10.1046/j.1365-294X.2003.01841.x; Geiger-Thornsberry GL, 2004, MECH AGEING DEV, V125, P179, DOI 10.1016/j.mad.2003.12.008; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ja WW, 2007, NAT CHEM BIOL, V3, P415, DOI 10.1038/nchembio.2007.2; Jenkins NL, 2004, P ROY SOC B-BIOL SCI, V271, P2523, DOI 10.1098/rspb.2004.2897; Landry CR, 2005, GENETICS, V171, P1813, DOI 10.1534/genetics.105.047449; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Mackay TFC, 2002, MECH AGEING DEV, V123, P95, DOI 10.1016/S0047-6374(01)00330-X; Marden JH, 2003, P NATL ACAD SCI USA, V100, P3369, DOI 10.1073/pnas.0634985100; Mockett RJ, 2006, EXP GERONTOL, V41, P566, DOI 10.1016/j.exger.2006.03.015; Nuzhdin SV, 2005, GENETICS, V170, P719, DOI 10.1534/genetics.104.038331; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Pasyukova EG, 2004, AGING CELL, V3, P297, DOI 10.1111/j.1474-9728.2004.00114.x; Pasyukova EG, 2000, GENETICS, V156, P1129; Petrosyan A, 2007, BEHAV GENET, V37, P585, DOI 10.1007/s10519-007-9159-y; Promislow DEL, 1996, GENETICS, V143, P839; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; ROSE MR, 1981, GENETICS, V97, P187; Schmidt PS, 2006, EVOLUTION, V60, P1602, DOI 10.1111/j.0014-3820.2006.tb00505.x; Schmidt PS, 2005, EVOLUTION, V59, P2616, DOI 10.1111/j.0014-3820.2005.tb00974.x; Schmidt PS, 2005, EVOLUTION, V59, P1721, DOI 10.1111/j.0014-3820.2005.tb01821.x; Schmidt PS, 2000, P NATL ACAD SCI USA, V97, P10861, DOI 10.1073/pnas.190338897; SCHMIDT PS, 2008, EVOLUTION IN PRESS; Song W, 2002, NEURON, V36, P105, DOI 10.1016/S0896-6273(02)00932-7; Spencer CC, 2005, J HERED, V96, P513, DOI 10.1093/jhered/esi071; Spencer CC, 2003, AGING CELL, V2, P123, DOI 10.1046/j.1474-9728.2003.00044.x; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Trotta V, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-67; Vermeulen CJ, 2007, EXP GERONTOL, V42, P153, DOI 10.1016/j.exger.2006.09.014; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; West AP, 2001, P NATL ACAD SCI USA, V98, P3744, DOI 10.1073/pnas.051625298; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wilson RH, 2006, GENETICS, V173, P1455, DOI 10.1534/genetics.105.055111	40	40	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1987	10.1371/journal.pone.0001987	http://dx.doi.org/10.1371/journal.pone.0001987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414670	Green Submitted, Green Published, gold			2022-12-27	WOS:000260867300019
J	Bharti, N; Xia, YC; Bjornstad, ON; Grenfell, BT				Bharti, Nita; Xia, Yingcun; Bjornstad, Ottar N.; Grenfell, Bryan T.			Measles on the Edge: Coastal Heterogeneities and Infection Dynamics	PLOS ONE			English	Article							SPATIAL HIERARCHIES; GRAVITY MODEL; SPREAD; WAVES; RATES	Mathematical models can help elucidate the spatio-temporal dynamics of epidemics as well as the impact of control measures. The gravity model for directly transmitted diseases is currently one of the most parsimonious models for spatial epidemic spread. This model uses distance-weighted, population size-dependent coupling to estimate host movement and disease incidence in metapopulations. The model captures overall measles dynamics in terms of underlying human movement in pre-vaccination England and Wales (previously established). In spatial models, edges often present a special challenge. Therefore, to test the model's robustness, we analyzed gravity model incidence predictions for coastal cities in England and Wales. Results show that, although predictions are accurate for inland towns, they significantly underestimate coastal persistence. We examine incidence, outbreak seasonality, and public transportation records, to show that the model's inaccuracies stem from an underestimation of total contacts per individual along the coast. We rescue this predicted 'edge effect' by increasing coastal contacts to approximate the number of per capita inland contacts. These results illustrate the impact of 'edge effects' on epidemic metapopulations in general and illustrate directions for the refinement of spatiotemporal epidemic models.	[Bharti, Nita; Bjornstad, Ottar N.; Grenfell, Bryan T.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Xia, Yingcun] Natl Univ Singapore, Dept Stat & Appl Probability, Singapore, Singapore; [Bjornstad, Ottar N.] Penn State Univ, Dept Entomol, University Pk, PA USA; [Bjornstad, Ottar N.; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD USA; [Bharti, Nita; Bjornstad, Ottar N.; Grenfell, Bryan T.] Penn State Univ, Ctr Infect Dis Dynamics, University Pk, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bharti, N (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	nita@psu.edu	Bjornstad, Ottar N/I-4518-2012	Xia, Yingcun/0000-0002-0309-8635; Bharti, Nita/0000-0003-1940-7794	department of biology at Penn State; Center for Infectious Disease Dynamics	department of biology at Penn State; Center for Infectious Disease Dynamics	Funding was provided by the department of biology at Penn State and the Center for Infectious Disease Dynamics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ANDERSON R M, 1991; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Bolker BM, 1996, P NATL ACAD SCI USA, V93, P12648, DOI 10.1073/pnas.93.22.12648; British Railways Board, 1963, RESH BRIT RAILW; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; CLIFF AD, 1993, MEASLES HIST GEOGRAP, pR20; CREIGHTON C, 1965, HIST EPIDEMICS BRIT; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Ferrari MJ, 2006, AM NAT, V168, P294, DOI 10.1086/506917; Glass K, 2002, EPIDEMIOL INFECT, V128, P491, DOI 10.1017/S0950268802006829; GRENFELL BT, 1995, P ROY SOC B-BIOL SCI, V259, P97, DOI 10.1098/rspb.1995.0015; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Real LA, 2005, J HERED, V96, P253, DOI 10.1093/jhered/esi031; SAVILL NJ, 2006, BMC VET RES, V2; SHEAIL J, 1976, GEOGR J, V142, P257, DOI 10.2307/1796600; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; WALTON JK, 1981, ECON HIST REV, V34, P249; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	22	20	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1941	10.1371/journal.pone.0001941	http://dx.doi.org/10.1371/journal.pone.0001941			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398467	Green Submitted, Green Published, gold			2022-12-27	WOS:000260795500018
J	Lozier, J; McCright, B; Gridley, T				Lozier, Julie; McCright, Brent; Gridley, Thomas			Notch Signaling Regulates Bile Duct Morphogenesis in Mice	PLOS ONE			English	Article							ALAGILLE-SYNDROME; LIVER DEVELOPMENT; HUMAN JAGGED1; MUTATIONS; DIFFERENTIATION; DEFECTS; GENE; HEPATOCYTE; MODELS; LIGAND	Background: Alagille syndrome is a developmental disorder caused predominantly by mutations in the Jagged1 (JAG1) gene, which encodes a ligand for Notch family receptors. A characteristic feature of Alagille syndrome is intrahepatic bile duct paucity. We described previously that mice doubly heterozygous for Jag1 and Notch2 mutations are an excellent model for Alagille syndrome. However, our previous study did not establish whether bile duct paucity in Jag1/Notch2 double heterozygous mice resulted from impaired differentiation of bile duct precursor cells, or from defects in bile duct morphogenesis. Methodology/Principal Findings: Here we characterize embryonic biliary tract formation in our previously described Jag1/Notch2 double heterozygous Alagille syndrome model, and describe another mouse model of bile duct paucity resulting from liver-specific deletion of the Notch2 gene. Conclusions/Significance: Our data support a model in which bile duct paucity in Notch pathway loss of function mutant mice results from defects in bile duct morphogenesis rather than cell fate specification.	[Lozier, Julie; McCright, Brent; Gridley, Thomas] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Lozier, J (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	tom.gridley@jax.org			National Institute of Diabetes and Digestive and Kidney Diseases [DK066387]; National Institute of Neurological Disorders and Stroke [NS036437]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036437] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grants for the National Institute of Diabetes and Digestive and Kidney Diseases (DK066387; TG) and the National Institute of Neurological Disorders and Stroke (NS036437; TG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAGILLE D, 1987, J PEDIATR-US, V110, P195, DOI 10.1016/S0022-3476(87)80153-1; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Carlton VEH, 2004, ANN MED, V36, P606, DOI 10.1080/07853890410018916; Clotman F, 2006, CELL CYCLE, V5, P168, DOI 10.4161/cc.5.2.2341; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Clotman F, 2002, DEVELOPMENT, V129, P1819; Coffinier C, 2002, DEVELOPMENT, V129, P1829; Duncan SA, 2003, MECH DEVELOP, V120, P19, DOI 10.1016/S0925-4773(02)00328-3; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Emerick KM, 1999, HEPATOLOGY, V29, P822, DOI 10.1002/hep.510290331; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Kodama Y, 2004, GASTROENTEROLOGY, V127, P1775, DOI 10.1053/j.gastro.2004.09.004; Lazaridis KN, 2004, GASTROENTEROLOGY, V127, P1565, DOI 10.1053/j.gastro.2004.08.006; Lemaigre F, 2004, CURR OPIN GENET DEV, V14, P582, DOI 10.1016/j.gde.2004.08.004; Lemaigre FP, 2003, MECH DEVELOP, V120, P81; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Loomes KM, 2007, HEPATOLOGY, V45, P323, DOI 10.1002/hep.21460; McCright B, 2001, DEVELOPMENT, V128, P491; McCright B, 2006, GENESIS, V44, P29, DOI 10.1002/gene.20181; McCright B, 2002, DEVELOPMENT, V129, P1075; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; SHIOJIRI N, 1992, ANAT EMBRYOL, V185, P17, DOI 10.1007/BF00213597; Spinner Nancy B., 2004, P461; Strick-Marchand H, 2003, MECH DEVELOP, V120, P89, DOI 10.1016/S0925-4773(02)00335-0; Sund NJ, 2000, MOL CELL BIOL, V20, P5175, DOI 10.1128/MCB.20.14.5175-5183.2000; Tanimizu N, 2004, J CELL SCI, V117, P3165, DOI 10.1242/jcs.01169; Warthen DM, 2006, HUM MUTAT, V27, P436, DOI 10.1002/humu.20310; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	32	98	107	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1851	10.1371/journal.pone.0001851	http://dx.doi.org/10.1371/journal.pone.0001851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365007	Green Published, gold, Green Submitted			2022-12-27	WOS:000260762400013
J	Fournier, PE; Belghazi, L; Robert, C; Elkarkouri, K; Richards, AL; Greub, G; Collyn, F; Ogawa, M; Portillo, A; Oteo, JA; Psaroulaki, A; Bitam, I; Raoult, D				Fournier, Pierre-Edouard; Belghazi, Lokmane; Robert, Catherine; Elkarkouri, Khalid; Richards, Allen L.; Greub, Gilbert; Collyn, Francois; Ogawa, Motohiko; Portillo, Arantxa; Oteo, Jose A.; Psaroulaki, Anna; Bitam, Idir; Raoult, Didier			Variations of Plasmid Content in Rickettsia felis	PLOS ONE			English	Article								Background: Since its first detection, characterization of R. felis has been a matter of debate, mostly due to the contamination of an initial R. felis culture by R. typhi. However, the first stable culture of R. felis allowed its precise phenotypic and genotypic characterization, and demonstrated that this species belonged to the spotted fever group rickettsiae. Later, its genome sequence revealed the presence of two forms of the same plasmid, physically confirmed by biological data. In a recent article, Gillespie et al. (PLoS One. 2007; 2(3): e266.) used a bioinformatic approach to refute the presence of the second plasmid form, and proposed the creation of a specific phylogenetic group for R. felis. Methodology/Principal Findings: In the present report, we, and five independent international laboratories confirmed unambiguously by PCR the presence of two plasmid forms in R. felis strain URRWXCal(2)(T), but observed that the plasmid content of this species, from none to 2 plasmid forms, may depend on the culture passage history of the studied strain. We also demonstrated that R. felis does not cultivate in Vero cells at 37 degrees C but generates plaques at 30 degrees C. Finally, using a phylogenetic study based on 667 concatenated core genes, we demonstrated the position of R. felis within the spotted fever group. Significance: We demonstrated that R. felis, which unambiguously belongs to the spotted fever group rickettsiae, may contain up to two plasmid forms but this plasmid content is unstable.	[Fournier, Pierre-Edouard; Belghazi, Lokmane; Robert, Catherine; Elkarkouri, Khalid; Raoult, Didier] Univ Aix Marseille 2, Fac Med, CNRS, Unite Rickettsies,IFR 48,IRD UMR 6236, Marseille, France; [Richards, Allen L.] Naval Med Res Ctr, Silver Spring, MD USA; [Greub, Gilbert; Collyn, Francois] Univ Lausanne, Univ Hosp Ctr, Inst Microbiol, Ctr Res Intracellular Bacteria, Lausanne, Switzerland; [Ogawa, Motohiko] Natl Inst Infect Dis, Dept Virol 1, Tokyo, Japan; [Portillo, Arantxa; Oteo, Jose A.] Hosp San Pedro, CIBIR, Logrono, Spain; [Psaroulaki, Anna] Univ Crete, Labo Clin Bacteriol, Parasitol, Zoonoses, Iraklion, Greece; [Bitam, Idir] Inst Pasteur, Serv Eco Epidemiol Parasitaire, Unite Entomol Med, Algiers, Algeria	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Naval Medical Research Center (NMRC); University of Lausanne; National Institute of Infectious Diseases (NIID); University of Crete	Fournier, PE (corresponding author), Univ Aix Marseille 2, Fac Med, CNRS, Unite Rickettsies,IFR 48,IRD UMR 6236, Marseille, France.	Didier.Raoult@gmail.com	Fournier, Pierre-Edouard/AAC-6155-2021; Greub, Gilbert GG/K-5804-2017; RAOULT, Didier/A-8434-2008; Oteo, Jose A./AAB-3134-2020; Portillo, Arantza/ABH-7807-2020	Fournier, Pierre-Edouard/0000-0001-8463-8885; Greub, Gilbert GG/0000-0001-9529-3317; RAOULT, Didier/0000-0002-0633-5974; Oteo, Jose A./0000-0001-7080-6542; Portillo, Arantza/0000-0002-2055-1825				Abergel C, 2006, MOL BIOL EVOL, V23, P2112, DOI 10.1093/molbev/msl082; ADAMS JR, 1990, AM J TROP MED HYG, V43, P400, DOI 10.4269/ajtmh.1990.43.400; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AZAD AF, 1992, P NATL ACAD SCI USA, V89, P43, DOI 10.1073/pnas.89.1.43; Azad AF, 1997, EMERG INFECT DIS, V3, P319, DOI 10.3201/eid0303.970308; BALDRIDGE GD, 2007, APPL ENV MICROBIOL; Bitam I, 2006, AM J TROP MED HYG, V74, P532, DOI 10.4269/ajtmh.2006.74.532; Blanc G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030014; Bouyer DH, 2001, INT J SYST EVOL MICR, V51, P339, DOI 10.1099/00207713-51-2-339; BOZEMAN FM, 1975, NATURE, V255, P545, DOI 10.1038/255545a0; BOZEMAN FM, 1970, J INFECT DIS, V121, P367, DOI 10.1093/infdis/121.4.367; Choi YJ, 2007, MICROBIOL IMMUNOL, V51, P307, DOI 10.1111/j.1348-0421.2007.tb03912.x; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Fang R, 2003, CLIN DIAGN LAB IMMUN, V10, P221, DOI 10.1128/CDLI.10.2.221-228.2003; FOURNIER PE, 2007, RICKETTSIAL DIS, P1, DOI DOI 10.3109/9781420019971.001; Gillespie JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000266; HEBERT GA, 1980, ANN INTERN MED, V92, P45, DOI 10.7326/0003-4819-92-1-45; HENDERSON G, 1993, J MED ENTOMOL, V30, P619, DOI 10.1093/jmedent/30.3.619; Higgins J. A., 1994, Insect Molecular Biology, V3, P27, DOI 10.1111/j.1365-2583.1994.tb00147.x; Higgins JA, 1996, J CLIN MICROBIOL, V34, P671, DOI 10.1128/JCM.34.3.671-674.1996; Horta MC, 2006, APPL ENVIRON MICROB, V72, P1705, DOI 10.1128/AEM.72.2.1705-1707.2006; Houhamdi L, 2006, AM J TROP MED HYG, V74, P521, DOI 10.4269/ajtmh.2006.74.521; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; La Scola B, 2002, INT J SYST EVOL MICR, V52, P2035, DOI [10.1099/ijs.0.02070-0, 10.1099/00207713-52-6-2035]; Medina-Sancheza A, 2005, ANN NY ACAD SCI, V1063, P327, DOI 10.1196/annals.1355.052; Ngwamidiba M, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-12; Noden BH, 1998, J MED ENTOMOL, V35, P410, DOI 10.1093/jmedent/35.4.410; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Paddock CD, 2004, CLIN INFECT DIS, V38, P805, DOI 10.1086/381894; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Parola P, 2003, EMERG INFECT DIS, V9, P592, DOI 10.3201/eid0905.020511; Pornwiroon W, 2006, APPL ENVIRON MICROB, V72, P5589, DOI 10.1128/AEM.00532-06; Radulovic S, 1996, ANTIMICROB AGENTS CH, V40, P2912; RADULOVIC S, 1995, ANTIMICROB AGENTS CH, V39, P2564, DOI 10.1128/AAC.39.11.2564; RADULOVIC S, 1995, INFECT IMMUN, V63, P4826, DOI 10.1128/IAI.63.12.4826-4829.1995; Raoult D, 2001, EMERG INFECT DIS, V7, P73, DOI 10.3201/eid0701.010112; REISSGUTFREUND RJ, 1966, AM J TROP MED HYG, V15, P943, DOI 10.4269/ajtmh.1966.15.943; Richter J, 2002, EMERG INFECT DIS, V8, P207, DOI 10.3201/eid0802.010293; Rolain JM, 2002, ANTIMICROB AGENTS CH, V46, P2747, DOI 10.1128/AAC.46.9.2747-2751.2002; Rolain JM, 1998, ANTIMICROB AGENTS CH, V42, P1537, DOI 10.1128/AAC.42.7.1537; Roux V, 1999, RICKETTSIAE RICKETTS, P52; SCHRIEFER ME, 1994, J CLIN MICROBIOL, V32, P949, DOI 10.1128/JCM.32.4.949-954.1994; Sekeyova Z, 2001, INT J SYST EVOL MICR, V51, P1353, DOI 10.1099/00207713-51-4-1353; Stenos J, 2000, INT J SYST EVOL MICR, V50, P1775, DOI 10.1099/00207713-50-5-1775; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wolf YI, 1999, TRENDS GENET, V15, P173, DOI 10.1016/S0168-9525(99)01704-7; Zavala-Velazquez JE, 2000, LANCET, V356, P1079, DOI 10.1016/S0140-6736(00)02735-5	51	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2008	3	5							e2289	10.1371/journal.pone.0002289	http://dx.doi.org/10.1371/journal.pone.0002289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391XW	18509454	Green Submitted, Green Published, gold			2022-12-27	WOS:000262268500030
J	Busso, N; Karababa, M; Nobile, M; Rolaz, A; Van Gool, F; Galli, M; Leo, O; So, A; De Smedt, T				Busso, Nathalie; Karababa, Mahir; Nobile, Massimo; Rolaz, Aline; Van Gool, Frederic; Galli, Mara; Leo, Oberdan; So, Alexander; De Smedt, Thibaut			Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase/Visfatin Enzymatic Activity Identifies a New Inflammatory Pathway Linked to NAD	PLOS ONE			English	Article								Nicotinamide phosphoribosyltransferase (NAMPT), also known as visfatin, is the rate-limiting enzyme in the salvage pathway of NAD biosynthesis from nicotinamide. Since its expression is upregulated during inflammation, NAMPT represents a novel clinical biomarker in acute lung injury, rheumatoid arthritis, and Crohn's disease. However, its role in disease progression remains unknown. We report here that NAMPT is a key player in inflammatory arthritis. Increased expression of NAMPT was confirmed in mice with collagen-induced arthritis, both in serum and in the arthritic paw. Importantly, a specific competitive inhibitor of NAMPT effectively reduced arthritis severity with comparable activity to etanercept, and decreased proinflammatory cytokine secretion in affected joints. Moreover, NAMPT inhibition reduced intracellular NAD concentration in inflammatory cells and circulating TNF alpha levels during endotoxemia in mice. In vitro pharmacological inhibition of NAMPT reduced the intracellular concentration of NAD and pro-inflammatory cytokine secretion by inflammatory cells. Thus, NAMPT links NAD metabolism to inflammatory cytokine secretion by leukocytes, and its inhibition might therefore have therapeutic efficacy in immune-mediated inflammatory disorders.	[Busso, Nathalie; Karababa, Mahir; So, Alexander] CHU Vaudois, Dept Med, Serv Rheumatol, CH-1011 Lausanne, Switzerland; [Nobile, Massimo; Rolaz, Aline; De Smedt, Thibaut] TopoTarget Switzerland SA, Lausanne, Switzerland; [Van Gool, Frederic; Galli, Mara; Leo, Oberdan] Free Univ Brussels, Lab Physiol Anim, Brussels, Belgium	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universite Libre de Bruxelles; Vrije Universiteit Brussel	Busso, N (corresponding author), CHU Vaudois, Dept Med, Serv Rheumatol, CH-1011 Lausanne, Switzerland.	desmedtt@mac.com	Van Gool, Frederic/V-4638-2019		Swiss National Scientific Research Funds [3200-067231.01, K-32K1-116460]; TopoTarget Switzerland SA	Swiss National Scientific Research Funds; TopoTarget Switzerland SA	This work was supported by the Swiss National Scientific Research Funds (grant 3200-067231.01 and K-32K1-116460 to N.B.) and by TopoTarget Switzerland SA. Thibaut De Smedt, Massimo Nobile and Aline Rolaz are TopoTarget Switzerland SA employees.	Andreakos ET, 2002, CYTOKINE GROWTH F R, V13, P299, DOI 10.1016/S1359-6101(02)00018-7; Bae SK, 2006, FEBS LETT, V580, P4105, DOI 10.1016/j.febslet.2006.06.052; Brentano F, 2007, ARTHRITIS RHEUM, V56, P2829, DOI 10.1002/art.22833; Drevs J, 2003, ANTICANCER RES, V23, P4853; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Fukuhara A, 2007, SCIENCE, V318, P565, DOI 10.1126/science.318.5850.565b; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Hasmann M, 2003, CANCER RES, V63, P7436; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Iqbal J, 2006, BIOCHEM BIOPH RES CO, V342, P1312, DOI 10.1016/j.bbrc.2006.02.109; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Khan JA, 2006, NAT STRUCT MOL BIOL, V13, P582, DOI 10.1038/nsmb1105; Kim MK, 2006, J MOL BIOL, V362, P66, DOI 10.1016/j.jmb.2006.06.082; Kim SR, 2007, BIOCHEM BIOPH RES CO, V357, P150, DOI 10.1016/j.bbrc.2007.03.105; LeClaire RD, 1996, TOXICOLOGY, V107, P69, DOI 10.1016/0300-483X(95)03202-Q; LEE YA, 2007, CLIN RHEUMATOL; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Moller B, 2006, SPRINGER SEMIN IMMUN, V27, P391, DOI 10.1007/s00281-006-0012-9; Mohammed FF, 2003, ANN RHEUM DIS, V62, P43; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Muruganandham M, 2005, CLIN CANCER RES, V11, P3503, DOI 10.1158/1078-0432.CCR-04-1399; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Nowell MA, 2006, ARTHRITIS RHEUM-US, V54, P2084, DOI 10.1002/art.21942; Ognjanovic S, 2001, J MOL ENDOCRINOL, V26, P107, DOI 10.1677/jme.0.0260107; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; PEACOCK DJ, 1992, J EXP MED, V175, P1135, DOI 10.1084/jem.175.4.1135; Pero RW, 1999, MOL CELL BIOCHEM, V193, P119, DOI 10.1023/A:1006932714982; Pogrebniak A, 2006, EUR J MED RES, V11, P313; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2007, CURR OPIN GASTROEN, V23, P164, DOI 10.1097/MOG.0b013e32801b3c8f; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Segawa K, 2006, BIOCHEM BIOPH RES CO, V349, P875, DOI 10.1016/j.bbrc.2006.07.083; Swierkot J, 2006, PHARMACOL REP, V58, P473; Tanaka M, 2007, BIOCHEM BIOPH RES CO, V359, P194, DOI 10.1016/j.bbrc.2007.05.096; Taylor PC, 2005, CURR OPIN RHEUMATOL, V17, P293, DOI 10.1097/01.bor.0000155361.83990.5b; Veale DJ, 2006, BEST PRACT RES CL RH, V20, P941, DOI 10.1016/j.berh.2006.05.004; WAGNER TC, 1994, ANAL BIOCHEM, V222, P417, DOI 10.1006/abio.1994.1511; Wosikowski K, 2002, CANCER RES, V62, P1057; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Ziegler M, 2000, EUR J BIOCHEM, V267, P1550, DOI 10.1046/j.1432-1327.2000.01187.x	45	190	216	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2267	10.1371/journal.pone.0002267	http://dx.doi.org/10.1371/journal.pone.0002267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493620	Green Published, Green Submitted, gold			2022-12-27	WOS:000262258700061
J	Takashima, A; Takahata, M				Takashima, Akira; Takahata, Masakazu			Effects of Active Conductance Distribution over Dendrites on the Synaptic Integration in an Identified Nonspiking Interneuron	PLOS ONE			English	Article							LOCAL INTERNEURONS; PURKINJE-CELLS; CRAYFISH; MEMBRANE; NEURONS; ULTRASTRUCTURE; INPUT; SYNAPSES; CHANNELS; CURRENTS	The synaptic integration in individual central neuron is critically affected by how active conductances are distributed over dendrites. It has been well known that the dendrites of central neurons are richly endowed with voltage- and ligand-regulated ion conductances. Nonspiking interneurons (NSIs), almost exclusively characteristic to arthropod central nervous systems, do not generate action potentials and hence lack voltage- regulated sodium channels, yet having a variety of voltage- regulated potassium conductances on their dendritic membrane including the one similar to the delayed-rectifier type potassium conductance. It remains unknown, however, how the active conductances are distributed over dendrites and how the synaptic integration is affected by those conductances in NSIs and other invertebrate neurons where the cell body is not included in the signal pathway from input synapses to output sites. In the present study, we quantitatively investigated the functional significance of active conductance distribution pattern in the spatio-temporal spread of synaptic potentials over dendrites of an identified NSI in the crayfish central nervous system by computer simulation. We systematically changed the distribution pattern of active conductances in the neuron's multicompartment model and examined how the synaptic potential waveform was affected by each distribution pattern. It was revealed that specific patterns of nonuniform distribution of potassium conductances were consistent, while other patterns were not, with the waveform of compound synaptic potentials recorded physiologically in the major input-output pathway of the cell, suggesting that the possibility of nonuniform distribution of potassium conductances over the dendrite cannot be excluded as well as the possibility of uniform distribution. Local synaptic circuits involving input and output synapses on the same branch or on the same side were found to be potentially affected under the condition of nonuniform distribution while operation of the major input-output pathway from the soma side to the one on the opposite side remained the same under both conditions of uniform and nonuniform distribution of potassium conductances over the NSI dendrite.	[Takashima, Akira; Takahata, Masakazu] Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 060, Japan	Hokkaido University	Takashima, A (corresponding author), Hokkaido Univ, Fac Sci, Dept Biol Sci, Sapporo, Hokkaido 060, Japan.	takashim@sci.hokudai.ac.jp	Takashima, Akira/B-8295-2015	Takashima, Akira/0000-0003-1422-6820	Japan Society for the Promotion of Science [17370024, 18657025]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the Research Fellowship for Young Scientists (AT) and Grants-in-Aid (MT) from the Japan Society for the Promotion of Science (17370024, 18657025).	Achard P, 2006, PLOS COMPUT BIOL, V2, P794, DOI 10.1371/journal.pcbi.0020094; BHALLA US, 1992, TRENDS NEUROSCI, V15, P453, DOI 10.1016/0166-2236(92)90009-W; Chen XX, 2006, PFLUG ARCH EUR J PHY, V453, P397, DOI 10.1007/s00424-006-0097-y; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P401, DOI 10.1152/jn.1994.71.1.401; DiCaprio RA, 2004, J NEUROPHYSIOL, V92, P302, DOI 10.1152/jn.01176.2003; EDWARDS DH, 1987, J NEUROPHYSIOL, V57, P1425, DOI 10.1152/jn.1987.57.5.1425; EVOY WH, 1977, IDENTIFIED NEURONS B, P67; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Gurkiewicz M, 2006, PFLUG ARCH EUR J PHY, V453, P283, DOI 10.1007/s00424-006-0076-3; GWILLIAM GF, 1980, J EXP BIOL, V86, P49; Hama N, 2005, J COMP PHYSIOL A, V191, P747, DOI 10.1007/s00359-005-0630-z; Hikosaka R, 1996, ZOOL SCI, V13, P69, DOI 10.2108/zsj.13.69; Hikosaka R, 1998, J COMP NEUROL, V392, P373, DOI 10.1002/(SICI)1096-9861(19980316)392:3<373::AID-CNE7>3.0.CO;2-Z; HINES M, 1984, INT J BIOMED COMPUT, V15, P69, DOI 10.1016/0020-7101(84)90008-4; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Keren N, 2005, J NEUROPHYSIOL, V94, P3730, DOI 10.1152/jn.00408.2005; Koch Christof, 1999, P1; KONDOH Y, 1986, J COMP NEUROL, V254, P259, DOI 10.1002/cne.902540209; KONDOH Y, 1986, J COMP NEUROL, V251, P334, DOI 10.1002/cne.902510305; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; KRENZ WD, 1985, J COMP PHYSIOL A, V157, P499, DOI 10.1007/BF00615151; LLINAS R, 1971, J NEUROPHYSIOL, V34, P532, DOI 10.1152/jn.1971.34.4.532; Llinas R.R., 2004, SYNAPTIC ORG BRAIN, DOI [10.1093/acprof:oso/9780195159561.003.0007, DOI 10.1093/ACPR0F:0S0/9780195159561.003.0007, DOI 10.1093/ACPROF:OSO/9780195159561.003.0007]; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Magee J. C., 1999, DENDRITES, P139; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Martina M, 2003, J NEUROSCI, V23, P5698; NADIM F, 1995, J COMPUT NEUROSCI, V2, P215, DOI 10.1007/BF00961435; NELSON M, 1997, BOOK GENESIS, P29; OKADA Y, 1988, J COMP PHYSIOL A, V162, P705, DOI 10.1007/BF00610960; PERKEL DH, 1981, NEUROSCIENCE, V6, P823, DOI 10.1016/0306-4522(81)90165-2; RALL W, 1992, PHYSIOL REV, V72, pS159, DOI 10.1152/physrev.1992.72.suppl_4.S159; RALL W, 1969, BIOPHYS J, V9, P1483, DOI 10.1016/S0006-3495(69)86467-2; RALL W, 1981, NEURONES IMPULSES, P223; REICHERT H, 1983, J COMP PHYSIOL, V151, P261, DOI 10.1007/BF00623903; ROSS WN, 1987, J PHYSIOL-LONDON, V389, P319, DOI 10.1113/jphysiol.1987.sp016659; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; Segev I., 1998, BOOK GENESIS EXPLORI, P51, DOI [10.1007/978-1-4612-1634-6_5, DOI 10.1007/978-1-4612-1634-6_5]; Segev I, 1998, METHODS NEURONAL MOD, P93; SEGEV I, 1999, DENDRITES, P205; SPRUSTON N, 1994, TRENDS NEUROSCI, V17, P161, DOI 10.1016/0166-2236(94)90094-9; Takahashi M, 1995, J NEUROPHYSIOL, V74, P2242, DOI 10.1152/jn.1995.74.6.2242; Takashima A, 1996, J COMP PHYSIOL A, V179, P447; Takashima A, 2000, J COMPUT NEUROSCI, V9, P187, DOI 10.1023/A:1008924025488; Takashima A, 2006, J NEUROPHYSIOL, V96, P3157, DOI 10.1152/jn.00680.2006; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; WATSON AHD, 1982, J COMP NEUROL, V205, P383, DOI 10.1002/cne.902050407; WATSON AHD, 1983, J COMP NEUROL, V214, P154, DOI 10.1002/cne.902140205; Wilson MA, 1989, ADV NEURAL INFORMATI, V1989, P485	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2217	10.1371/journal.pone.0002217	http://dx.doi.org/10.1371/journal.pone.0002217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493322	Green Published, gold			2022-12-27	WOS:000262258700025
J	Bowlin, MS; Wikelski, M				Bowlin, Melissa S.; Wikelski, Martin			Pointed Wings, Low Wingloading and Calm Air Reduce Migratory Flight Costs in Songbirds	PLOS ONE			English	Article							METABOLIC-RATE; BIRDS; SHAPE; PERFORMANCE; FIELD	Migratory bird, bat and insect species tend to have more pointed wings than non-migrants. Pointed wings and low wingloading, or body mass divided by wing area, are thought to reduce energy consumption during long-distance flight, but these hypotheses have never been directly tested. Furthermore, it is not clear how the atmospheric conditions migrants encounter while aloft affect their energy use; without such information, we cannot accurately predict migratory species' response(s) to climate change. Here, we measured the heart rates of 15 free-flying Swainson's Thrushes (Catharus ustulatus) during migratory flight. Heart rate, and therefore rate of energy expenditure, was positively associated with individual variation in wingtip roundedness and wingloading throughout the flights. During the cruise phase of the flights, heart rate was also positively associated with wind speed but not wind direction, and negatively but not significantly associated with large-scale atmospheric stability. High winds and low atmospheric stability are both indicative of the presence of turbulent eddies, suggesting that birds may be using more energy when atmospheric turbulence is high. We therefore suggest that pointed wingtips, low wingloading and avoidance of high winds and turbulence reduce flight costs for small birds during migration, and that climate change may have the strongest effects on migrants' in-flight energy use if it affects the frequency and/or severity of high winds and atmospheric instability.	[Bowlin, Melissa S.; Wikelski, Martin] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ USA	Princeton University	Bowlin, MS (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ USA.	melissa.bowlin@mso.umt.edu			Society for Integrative and Comparative Biology; Cooper Ornithological Society; American Ornithologists' Union; Princeton University's Department of Ecology and Evolutionary Biology; National Geographic Society; NSF DDIG [IOB-0608252]	Society for Integrative and Comparative Biology; Cooper Ornithological Society; American Ornithologists' Union; Princeton University's Department of Ecology and Evolutionary Biology(Princeton University); National Geographic Society(National Geographic Society); NSF DDIG(National Science Foundation (NSF))	Financial assistance was provided by the Society for Integrative and Comparative Biology, the Cooper Ornithological Society, the American Ornithologists' Union, Princeton University's Department of Ecology and Evolutionary Biology, the National Geographic Society, and an NSF DDIG (#IOB-0608252). None of these funding organizations played any role in designing, carrying out, or writing up the study.	BIEBACH H, 1992, IBIS, V134, P47; Bowlin MS, 2007, AUK, V124, P1388, DOI 10.1642/0004-8038(2007)124[1388:SWSAWP]2.0.CO;2; Bowlin MS, 2005, INTEGR COMP BIOL, V45, P295, DOI 10.1093/icb/45.2.295; Burns JG, 2002, BEHAV ECOL SOCIOBIOL, V52, P128, DOI 10.1007/s00265-002-0494-y; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Cochran W.W., 1985, Illinois Natural History Survey Bulletin, V33, P297; Cochran William W., 2005, P274; Cohen J.E., 1988, STAT POWER ANAL BEHA; Hedenstrom A, 2002, BEHAV ECOL SOCIOBIOL, V52, P308, DOI 10.1007/s00265-002-0504-0; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Keller LF, 2001, HEREDITY, V87, P325, DOI 10.1046/j.1365-2540.2001.00900.x; Kerlinger P., 1989, Current Ornithology, V6, P109; Klaassen M, 2000, CONDOR, V102, P444, DOI 10.1650/0010-5422(2000)102[0444:FCAFCO]2.0.CO;2; Klaassen M, 2004, J AVIAN BIOL, V35, P4; Klaassen M, 1996, J EXP BIOL, V199, P57; Kvist A, 2001, NATURE, V413, P730, DOI 10.1038/35099556; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; LINCOLN FC, 1952, MIGRATION BIRDS; Lindstrom A, 1999, FUNCT ECOL, V13, P352, DOI 10.1046/j.1365-2435.1999.00320.x; Lockwood R, 1998, J AVIAN BIOL, V29, P273, DOI 10.2307/3677110; Lutgens F. K., 1998, ATMOSPHERE INTRO MET; Mesinger F, 2006, B AM METEOROL SOC, V87, P343, DOI 10.1175/BAMS-87-3-343; Nisbet I. C. T., 1955, British Birds, V48, P557; Norberg UML, 1990, VERTEBRATE FLIGHT; PENNYCUICK CJ, 1978, OIKOS, V30, P165, DOI 10.2307/3543476; Pennycuick CJ, 1997, J EXP BIOL, V200, P2355; PENNYCUICK CJ, 1972, ANIMAL FLIGHT; Richardson W.J., 1990, P78; Schmaljohann H, 2007, P R SOC B, V274, P735, DOI 10.1098/rspb.2006.0011; SCHMIDTWELLENBU.CA, 2007, THESIS U GRONINGEN N; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Stull R.B, 1988, INTRO BOUNDARY LAYER; Swaddle JP, 2003, IBIS, V145, P457, DOI 10.1046/j.1474-919X.2003.00189.x; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Winkler Hans, 2005, P79; YONG W, 1994, AUK, V111, P683	38	127	134	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2154	10.1371/journal.pone.0002154	http://dx.doi.org/10.1371/journal.pone.0002154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478072	gold, Green Submitted, Green Published			2022-12-27	WOS:000262172800019
J	Jaing, C; Gardner, S; McLoughlin, K; Mulakken, N; Alegria-Hartman, M; Banda, P; Williams, P; Gu, P; Wagner, M; Manohar, C; Slezak, T				Jaing, Crystal; Gardner, Shea; McLoughlin, Kevin; Mulakken, Nisha; Alegria-Hartman, Michelle; Banda, Phillip; Williams, Peter; Gu, Pauline; Wagner, Mark; Manohar, Chitra; Slezak, Tom			A Functional Gene Array for Detection of Bacterial Virulence Elements	PLOS ONE			English	Article							MICROARRAY	Emerging known and unknown pathogens create profound threats to public health. Platforms for rapid detection and characterization of microbial agents are critically needed to prevent and respond to disease outbreaks. Available detection technologies cannot provide broad functional information about known or novel organisms. As a step toward developing such a system, we have produced and tested a series of high-density functional gene arrays to detect elements of virulence and antibiotic resistance mechanisms. Our first generation array targets genes from Escherichia coli strains K12 and CFT073, Enterococcus faecalis and Staphylococcus aureus. We determined optimal probe design parameters for gene family detection and discrimination. When tested with organisms at varying phylogenetic distances from the four target strains, the array detected orthologs for the majority of targeted gene families present in bacteria belonging to the same taxonomic family. In combination with whole-genome amplification, the array detects femtogram concentrations of purified DNA, either spiked in to an aerosol sample background, or in combinations from one or more of the four target organisms. This is the first report of a high density NimbleGen microarray system targeting microbial antibiotic resistance and virulence mechanisms. By targeting virulence gene families as well as genes unique to specific biothreat agents, these arrays will provide important data about the pathogenic potential and drug resistance profiles of unknown organisms in environmental samples.	[Jaing, Crystal; Alegria-Hartman, Michelle; Banda, Phillip; Manohar, Chitra] Lawrence Livermore Natl Lab, Chem, Mat, Earth & Life Sci, Livermore, CA 94550 USA; [Gardner, Shea; McLoughlin, Kevin; Mulakken, Nisha; Williams, Peter; Gu, Pauline; Wagner, Mark; Slezak, Tom] Lawrence Livermore Natl Lab, Comp, Livermore, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Jaing, C (corresponding author), Lawrence Livermore Natl Lab, Chem, Mat, Earth & Life Sci, Livermore, CA 94550 USA.	jaing2@llnl.gov		Jaing, Crystal/0000-0001-9933-3005; McLoughlin, Kevin/0000-0001-9651-4951	Department of Homeland Security; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]	Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	The funding was provided by the Department of Homeland Security. The funding agency was not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript. This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344.	Arriola E, 2007, LAB INVEST, V87, P75, DOI 10.1038/labinvest.3700495; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Burden C.J., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1095, DOI 10.2202/1544-6115.1095]; Gentry TJ, 2006, MICROB ECOL, V52, P159, DOI 10.1007/s00248-006-9072-6; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; He ZL, 2005, APPL ENVIRON MICROB, V71, P3753, DOI 10.1128/AEM.71.7.3753-3760.2005; Jackson SA, 2007, FORENSIC SCI INT, V168, P183, DOI 10.1016/j.forsciint.2006.06.079; Kane MD, 2000, NUCLEIC ACIDS RES, V28, P4552, DOI 10.1093/nar/28.22.4552; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; MAURELLI AT, 2007, MICROBE, V2, P388; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Radosevich JL, 2002, LETT APPL MICROBIOL, V34, P162, DOI 10.1046/j.1472-765x.2002.01048.x; Rhee SK, 2004, APPL ENVIRON MICROB, V70, P4303, DOI 10.1128/AEM.70.7.4303-4317.2004; Rozen S, 2000, Methods Mol Biol, V132, P365; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; SWAN KA, 2005, ANN IC POSTD RES FEL; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05	19	30	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2163	10.1371/journal.pone.0002163	http://dx.doi.org/10.1371/journal.pone.0002163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478124	Green Submitted, gold, Green Published			2022-12-27	WOS:000262172800028
J	Salim, O; Clarke, IN; Lambden, PR				Salim, Omar; Clarke, Ian N.; Lambden, Paul R.			Functional Analysis of the 5 ' Genomic Sequence of a Bovine Norovirus	PLOS ONE			English	Article								Background: Jena Virus (JV), a bovine Norovirus, causes enteric disease in cattle and represents a potential model for the study of enteric norovirus infection and pathogenesis. The positive sense RNA genome of JV is organised into ORF1 (nonstructural proteins), ORF2 (major capsid protein) and ORF3 (minor capsid protein). The lack of a cell culture system for studying JV replication has meant that work to date has relied upon in vitro systems to study non-structural protein synthesis and processing. Principal Findings: Only two of the three major ORF1 proteins were identified (p110 and 2C) following in vitro translation of JV RNA, the N-term protein was not detected. The N-term encoding genomic sequence (5'GS) was tested for IRES-like function in a bi-cistronic system and displayed no evidence of IRES-like activity. The site of translation initiation in JV was determined to be at the predicted nucleotide 22. Following the insertion of an epitope within the 59GS the JV N-term protein was identified in vitro and within RNA transfected cells. Conclusions: The in vitro transcription/translation system is currently the best system for analysing protein synthesis and processing in JV. Unlike similarly studied human noroviruses JV initially did not appear to express the N-terminal protein, presenting the possibility that the encoding RNA sequence had a regulatory function, most likely involved in translation initiation in an IRES-like manner. This was not the case and, following determination of the site of translation initiation the N-term protein was detected using an epitope tag, both in vitro and in vivo. Although slightly larger than predicted the N-term protein was detected in a processed form in vivo, thus not only demonstrating initial translation of the ORF1 polyprotein but also activity of the viral protease. These findings indicate that the block to noroviral replication in cultured cells lies elsewhere.	[Salim, Omar; Clarke, Ian N.; Lambden, Paul R.] Univ Southampton, Southampton Gen Hosp, Sch Med, Mol Mikrobiol Grp, Southampton, Hants, England	University of Southampton	Salim, O (corresponding author), Univ Southampton, Southampton Gen Hosp, Sch Med, Mol Mikrobiol Grp, Southampton, Hants, England.	O.Salim@soton.ac.uk		Clarke, Ian/0000-0002-4938-1620; Salim, Omar/0000-0002-2562-4827	Medical Research Council; Wellcome Trust [069233]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)	OS would like to thank the Medical Research Council for providing a studentship to support this work, which was also supported by Wellcome Trust Grant 069233.	Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; BRIDGER JC, 1984, INFECT IMMUN, V43, P133, DOI 10.1128/IAI.43.1.133-138.1984; Clarke IN, 2000, J INFECT DIS, V181, pS309, DOI 10.1086/315575; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; DAUGHENBAUGH KF, 2006, VIROLOGY J, V23; Ettayebi K, 2003, J VIROL, V77, P11790, DOI 10.1128/JVI.77.21.11790-11797.2003; Fernandez-Vega V, 2004, J VIROL, V78, P4827, DOI 10.1128/JVI.78.9.4827-4837.2004; Glass PJ, 2003, J VIROL, V77, P3569, DOI 10.1128/JVI.77.6.3569-3577.2003; GUNTHER H, 1984, ARCH EXP VET MED, V38, P781; GUNTHER H, 1987, LEIPZIG, V41, P934; Gutierrez-Escolano AL, 2003, BIOCHEM BIOPH RES CO, V311, P759, DOI 10.1016/j.bbrc.2003.10.066; Gutierrez-Escolano AL, 2000, J VIROL, V74, P8558, DOI 10.1128/JVI.74.18.8558-8562.2000; HALLER AA, 1995, VIROLOGY, V206, P923, DOI 10.1006/viro.1995.1015; Hardy ME, 2005, FEMS MICROBIOL LETT, V253, P1, DOI 10.1016/j.femsle.2005.08.031; JIANG X, 1993, VIROLOGY, V195, P51, DOI 10.1006/viro.1993.1345; Kaminski A, 1995, RNA, V1, P924; Kozak M, 2001, MOL CELL BIOL, V21, P1899, DOI 10.1128/MCB.21.6.1899-1907.2001; Liu BL, 1999, J VIROL, V73, P819, DOI 10.1128/JVI.73.1.819-825.1999; LIU BL, 1997, POLYPROTEIN PROCESSI, P66; Lopmam BA, 2003, EMERG INFECT DIS, V9, P90; LOVE DN, 1975, ARCH VIROL, V48, P213, DOI 10.1007/BF01317964; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; Meyers G, 2000, VIROLOGY, V276, P349, DOI 10.1006/viro.2000.0545; Oliver SL, 2007, ARCH VIROL, V152, P257, DOI 10.1007/s00705-006-0856-2; Oliver SL, 2006, J CLIN MICROBIOL, V44, P992, DOI 10.1128/JCM.44.3.992-998.2006; Pelosi E, 1999, J MED VIROL, V58, P93, DOI 10.1002/(SICI)1096-9071(199905)58:1&lt;93::AID-JMV15&gt;3.0.CO;2-P; Seah EEL, 1999, J VIROL, V73, P10531, DOI 10.1128/JVI.73.12.10531-10535.1999; Seah EL, 2003, J VIROL, V77, P7150, DOI 10.1128/JVI.77.12.7150-7155.2003; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Sosnovtsev SV, 2002, J VIROL, V76, P7060, DOI 10.1128/JVI.76.14.7060-7072.2002; SOUTHERN JA, 1991, J GEN VIROL, V72, P1551, DOI 10.1099/0022-1317-72-7-1551	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2169	10.1371/journal.pone.0002169	http://dx.doi.org/10.1371/journal.pone.0002169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478070	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000262172800034
J	Shiraiwa, T				Shiraiwa, Takashi			Multimodal Chemosensory Integration through the Maxillary Palp in Drosophila	PLOS ONE			English	Article							MUSHROOM BODIES; MOLECULAR-BASIS; INTRAPOPULATIONAL VARIATION; OLFACTORY PHYSIOLOGY; RECEPTOR EXPRESSION; COURTSHIP BEHAVIOR; FEEDING-BEHAVIOR; GENETIC-ANALYSIS; ANTENNAL LOBE; MELANOGASTER	Drosophila melanogaster has an olfactory organ called the maxillary palp. It is smaller and numerically simpler than the antenna, and its specific role in behavior has long been unclear. Because of its proximity to the mouthparts, I explored the possibility of a role in taste behavior. Maxillary palp was tuned to mediate odor-induced taste enhancement: a sucrose solution was more appealing when simultaneously presented with the odorant 4-methylphenol. The same result was observed with other odors that stimulate other types of olfactory receptor neuron in the maxillary palp. When an antennal olfactory receptor was genetically introduced in the maxillary palp, the fly interpreted a new odor as a sweet-enhancing smell. These results all point to taste enhancement as a function of the maxillary palp. It also opens the door for studying integration of multiple senses in a model organism.	[Shiraiwa, Takashi] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Shiraiwa, T (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	takashi.shiraiwa@yale.edu			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was funded by the the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCORTA E, 1989, BEHAV GENET, V19, P285, DOI 10.1007/BF01065911; ALCORTA E, 1988, HEREDITY, V60, P7, DOI 10.1038/hdy.1988.2; Armstrong JD, 1998, LEARN MEMORY, V5, P102; AYER RK, 1991, P NATL ACAD SCI USA, V88, P5467, DOI 10.1073/pnas.88.12.5467; AYER RK, 1992, J NEUROBIOL, V23, P965, DOI 10.1002/neu.480230804; Bagley KR, 2006, ANIM BEHAV, V71, P1439, DOI 10.1016/j.anbehav.2006.01.003; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Cayirlioglu P, 2008, SCIENCE, V319, P1256, DOI 10.1126/science.1149483; CHARRO MJ, 1994, J COMP PHYSIOL A, V175, P761; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Couri M. S., 2003, Braz. J. Biol., V63, P223, DOI 10.1590/S1519-69842003000200007; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cytowic R. E., 2002, SYNESTHESIA UNION SE; D'Haese CA, 2003, ZOOL SCR, V32, P563, DOI 10.1046/j.1463-6409.2003.00134.x; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Dalton P, 2000, NAT NEUROSCI, V3, P431, DOI 10.1038/74797; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; de Carvalho C. J. B., 2003, PERSPECTIVA LATINOAM, P263; de Gelder B, 2003, SCHIZOPHR RES, V59, P211, DOI 10.1016/S0920-9964(01)00344-9; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; FRANK RA, 1988, CHEM SENSES, V13, P445, DOI 10.1093/chemse/13.3.445; FUYAMA Y, 1978, BEHAV GENET, V8, P399, DOI 10.1007/BF01067937; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; HERSHBERGER WA, 1967, ANIM BEHAV, V15, P259, DOI 10.1016/0003-3472(67)90008-5; HEY J, 1993, MOL BIOL EVOL, V10, P804; HIGA I, 1993, GENETICA, V88, P129, DOI 10.1007/BF02424469; HULTIN HO, 1961, FOOD TECHNOL-CHICAGO, V15, P440; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; KENT KS, 1986, CELL TISSUE RES, V245, P237; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; LILLY M, 1990, GENETICS, V124, P293; MCKENZIE JA, 1972, OECOLOGIA, V10, P373, DOI 10.1007/BF00345738; MCKENZIE JA, 1974, OECOLOGIA, V15, P1, DOI 10.1007/BF00345225; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; MONTE P, 1989, BEHAV GENET, V19, P267, DOI 10.1007/BF01065910; Nisimura T, 2005, J NEUROSCI, V25, P7507, DOI 10.1523/JNEUROSCI.1862-05.2005; PROKOP A, 1994, DEV BIOL, V161, P321, DOI 10.1006/dbio.1994.1034; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; ROZIN P, 1982, PERCEPT PSYCHOPHYS, V31, P397, DOI 10.3758/BF03202667; Schifferstein HNJ, 1996, ACTA PSYCHOL, V94, P87, DOI 10.1016/0001-6918(95)00040-2; Schroter U, 2003, J COMP NEUROL, V465, P168, DOI 10.1002/cne.10843; Schulte BA, 1999, ANIM BEHAV, V57, P1265, DOI 10.1006/anbe.1999.1092; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; SHIRAIWA T, 2007, PROBOSCIS EXTENSION, DOI DOI 10.3791/193; Snodgrass RE, 1935, PRINCIPLES INSECT MO; Stein BE, 2002, NEUROSCIENTIST, V8, P306, DOI 10.1177/107385840200800406; STOCKER RF, 1983, CELL TISSUE RES, V232, P237, DOI 10.1007/BF00213783; STOCKER RF, 1989, BEHAV GENET, V19, P371, DOI 10.1007/BF01066165; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Thum AS, 2007, J NEUROSCI, V27, P11132, DOI 10.1523/JNEUROSCI.2712-07.2007; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; *VCF, 2000, VOL COMP FOOD DATABA; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; WOODARD C, 1989, GENETICS, V123, P315; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005	71	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2191	10.1371/journal.pone.0002191	http://dx.doi.org/10.1371/journal.pone.0002191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	390OE	18478104	Green Published, Green Submitted, gold			2022-12-27	WOS:000262172800055
J	Cheng, YW; Lee, PL; Yang, CY; Lin, CP; Hung, D; Decety, J				Cheng, Yawei; Lee, Po-Lei; Yang, Chia-Yen; Lin, Ching-Po; Hung, Daisy; Decety, Jean			Gender Differences in the Mu Rhythm of the Human Mirror-Neuron System	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; AUTISM SPECTRUM DISORDERS; HIGH-FUNCTIONING AUTISM; NORMAL SEX-DIFFERENCES; SOCIAL NEUROSCIENCE; FACIAL EXPRESSIONS; ASPERGER-SYNDROME; PREMOTOR CORTEX; HUMAN EMPATHY; ACTIVATION	Background: Psychologically, females are usually thought to be superior in interpersonal sensitivity than males. The human mirror-neuron system is considered to provide the basic mechanism for social cognition. However, whether the human mirror-neuron system exhibits gender differences is not yet clear. Methodology/Principal Findings: We measured the electroencephalographic mu rhythm, as a reliable indicator of the human mirror-neuron system activity, when female (N = 20) and male (N = 20) participants watched either hand actions or a moving dot. The display of the hand actions included androgynous, male, and female characteristics. The results demonstrate that females displayed significantly stronger mu suppression than males when watching hand actions. Instead, mu suppression was similar across genders when participants observed the moving dot and between the perceived sex differences (same-sex vs. opposite-sex). In addition, the mu suppressions during the observation of hand actions positively correlated with the personal distress subscale of the interpersonal reactivity index and negatively correlated with the systemizing quotient. Conclusions/Significance: The present findings indirectly lend support to the extreme male brain theory put forward by Baron-Cohen (2005), and may cast some light on the mirror-neuron dysfunction in autism spectrum disorders. The mu rhythm in the human mirror-neuron system can be a potential biomarker of empathic mimicry.	[Cheng, Yawei; Lin, Ching-Po] Natl Yang Ming Univ, Sch Life Sci, Inst Neurosci, Taipei 112, Taiwan; [Cheng, Yawei] Natl Yang Ming Univ Hosp, Dept Rehabil, Yilan, Taiwan; [Lee, Po-Lei] Natl Cent Univ, Dept Elect Engn, Taoyuan, Taiwan; [Yang, Chia-Yen] Ching Yun Univ, Inst Comp, Commun & Syst Engn, Chungli, Taiwan; [Hung, Daisy] Natl Cent Univ, Coll Sci, Inst Cognitive Neurosci, Taoyuan, Taiwan; [Decety, Jean] Univ Chicago, Ctr Cognitive & Social Neurosci, Dept Psychiat, Chicago, IL USA; [Decety, Jean] Univ Chicago, Ctr Cognitive & Social Neurosci, Dept Psychol, Chicago, IL USA	National Yang Ming Chiao Tung University; National Central University; Chien Hsin University of Science & Technology; National Central University; University of Chicago; University of Chicago	Cheng, YW (corresponding author), Natl Yang Ming Univ, Sch Life Sci, Inst Neurosci, Taipei 112, Taiwan.	decety@uchicago.edu			National Science Council [95-2752-H-010-004-PAE, 96-2314-B-532-001, 96-2221-E-008-122-MY3]; Department of Health, Taipei City Government [96001-62-044]; Ministry of Education, Taiwan [96-2752-B-010-008-PAE]; NSF [BCS- 0718480]	National Science Council(Ministry of Science and Technology, Taiwan); Department of Health, Taipei City Government; Ministry of Education, Taiwan(Ministry of Education, Taiwan); NSF(National Science Foundation (NSF))	This study was sponsored by the National Science Council (95-2752-H-010-004-PAE; 96-2314-B-532-001; 96-2221-E-008-122-MY3), the Department of Health, Taipei City Government (96001-62-044), and Ministry of Education (96-2752-B-010-008-PAE), Taiwan. Dr. Jean Decety was supported by an NSF grant (BCS- 0718480).	Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; CHENG Y, 2008, NEUROIMAGE IN PRESS; Cheng YW, 2006, NEUROREPORT, V17, P1115, DOI 10.1097/01.wnr.0000223393.59328.21; Cheng YW, 2007, CURR BIOL, V17, P1708, DOI 10.1016/j.cub.2007.09.020; Cheng YW, 2007, NEUROREPORT, V18, P887, DOI 10.1097/WNR.0b013e3280ebb486; CIALDINI RB, 1987, J PERS SOC PSYCHOL, V52, P749, DOI 10.1037/0022-3514.52.4.749; Cochin S, 1998, ELECTROEN CLIN NEURO, V107, P287, DOI 10.1016/S0013-4694(98)00071-6; Cochin S, 1999, EUR J NEUROSCI, V11, P1839, DOI 10.1046/j.1460-9568.1999.00598.x; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Davis M., 1996, EMPATHY SOCIAL PSYCH; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Decety J, 2007, SOC NEUROSCI, V2, P151, DOI 10.1080/17470910701506060; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; DIMBERG U, 1990, BIOL PSYCHOL, V30, P151, DOI 10.1016/0301-0511(90)90024-Q; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Doherty RW, 1997, J NONVERBAL BEHAV, V21, P131, DOI 10.1023/A:1024956003661; EISENBERG N, 1990, MOTIV EMOTION, V14, P131, DOI 10.1007/BF00991640; Fadiga L, 2004, J CLIN NEUROPHYSIOL, V21, P157, DOI 10.1097/00004691-200405000-00004; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GASTAUT HJ, 1954, ELECTROEN CLIN NEURO, V6, P433, DOI 10.1016/0013-4694(54)90058-9; GASTAUT MH, 1952, REV NEUROL, V87, P176; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Geary DC, 2021, MALE, FEMALE, 3 EDITION, P1, DOI 10.1037/0000181-000; Hadjikhani N, 2007, HUM BRAIN MAPP, V28, P441, DOI 10.1002/hbm.20283; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Hall J. A., 1984, NONVERBAL SEX DIFFER; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Jarvelainen J, 2004, NEUROIMAGE, V23, P187, DOI 10.1016/j.neuroimage.2004.06.010; Jarvelainen J, 2001, NEUROREPORT, V12, P3493; Kemp AH, 2004, NEUROIMAGE, V21, P632, DOI 10.1016/j.neuroimage.2003.09.055; Klimesch W, 1998, NEUROSCI LETT, V244, P73, DOI 10.1016/S0304-3940(98)00122-0; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; McIntosh DN, 2006, DEVELOPMENTAL SCI, V9, P295, DOI 10.1111/j.1467-7687.2006.00492.x; Muthukumaraswamy SD, 2004, CLIN NEUROPHYSIOL, V115, P1760, DOI 10.1016/j.clinph.2004.03.004; Muthukumaraswamy SD, 2004, COGNITIVE BRAIN RES, V19, P195, DOI 10.1016/j.cogbrainres.2003.12.001; Nishitani N, 2004, ANN NEUROL, V55, P558, DOI 10.1002/ana.20031; Oberman LM, 2007, SOC COGN AFFECT NEUR, V2, P62, DOI 10.1093/scan/nsl022; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; Pfurtscheller G, 1997, INT J PSYCHOPHYSIOL, V26, P121, DOI 10.1016/S0167-8760(97)00760-5; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Seifritz E, 2003, BIOL PSYCHIAT, V54, P1367, DOI 10.1016/S0006-3223(03)00697-8; Siu AMH, 2005, RES SOCIAL WORK PRAC, V15, P118, DOI 10.1177/1049731504270384; Theoret H, 2005, CURR BIOL, V15, pR84, DOI 10.1016/j.cub.2005.01.022; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8	56	101	105	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2113	10.1371/journal.pone.0002113	http://dx.doi.org/10.1371/journal.pone.0002113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	382YX	18461176	Green Published, Green Submitted, gold			2022-12-27	WOS:000261642400035
J	Legrand, J; Sanchez, A; Le Pont, F; Camacho, L; Larouze, B				Legrand, Judith; Sanchez, Alexandra; Le Pont, Francoise; Camacho, Luiz; Larouze, Bernard			Modeling the Impact of Tuberculosis Control Strategies in Highly Endemic Overcrowded Prisons	PLOS ONE			English	Article								Background: Tuberculosis (TB) in prisons is a major health problem in countries of high and intermediate TB endemicity such as Brazil. For operational reasons, TB control strategies in prisons cannot be compared through population based intervention studies. Methodology/Principal Findings: A mathematical model is proposed to simulate the TB dynamics in prison and evaluate the potential impact on active TB prevalence of several intervention strategies. The TB dynamics with the ongoing program was simulated over a 10 year period in a Rio de Janeiro prison (TB prevalence 4.6 %). Then, a simulation of the DOTS strategy reaching the objective of 70 % of bacteriologically-positive cases detected and 85 % of detected cases cured was performed; this strategy reduced only to 2.8% the average predicted TB prevalence after 5 years. Adding TB detection at entry point to DOTS strategy had no major effect on the predicted active TB prevalence. But, adding further a yearly X-ray mass screening of inmates reduced the predicted active TB prevalence below 1%. Furthermore, according to this model, after applying this strategy during 2 years (three annual screenings), the TB burden would be reduced and the active TB prevalence could be kept at a low level by associating X-ray screening at entry point and DOTS. Conclusions/Significance: We have shown that X-ray mass screenings should be considered to control TB in highly endemic prison. Prisons with different levels of TB prevalence could be examined thanks to this model which provides a rational tool for public health deciders.	[Legrand, Judith; Le Pont, Francoise; Larouze, Bernard] INSERM, U707, Paris, France; [Legrand, Judith; Le Pont, Francoise; Larouze, Bernard] Univ Pierre Marie Curie Paris 6, UMR S 707, Paris, France; [Legrand, Judith] Imperial Coll, Dept Infect Dis Epidemiol, London, England; [Sanchez, Alexandra] Secretaria Estado Adm Penitenciaria Rio de Janeiro, Coordenacso Gestao Saude, Rio De Janeiro, Brazil; [Camacho, Luiz] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Dept Epidemiol Metodos Quantit, Rio De Janeiro, Brazil	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Imperial College London; Fundacao Oswaldo Cruz	Legrand, J (corresponding author), INSERM, U707, Paris, France.	j.legrand@imperial.ac.uk			Institut National de la Sante et de la Recherche Medicale, France; Fondation Oswaldo Cruz, Brazil	Institut National de la Sante et de la Recherche Medicale, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation Oswaldo Cruz, Brazil	This work was partially supported by the joined program Institut National de la Sante et de la Recherche Medicale, France/Fondation Oswaldo Cruz, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts A, 2000, INT J TUBERC LUNG D, V4, P1104; Aerts A, 2006, INT J TUBERC LUNG D, V10, P1215; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Blower SM, 1998, J MOL MED, V76, P624, DOI 10.1007/s001090050260; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Blower SM, 1996, SCIENCE, V273, P497, DOI 10.1126/science.273.5274.497; BLOWER SM, 1991, PHILOS T R SOC B, V331, P171, DOI 10.1098/rstb.1991.0006; Bone A., 2000, TUBERCULOSIS CONTROL; Chaves F, 1997, AM J RESP CRIT CARE, V155, P719, DOI 10.1164/ajrccm.155.2.9032218; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; Coninx R, 2000, BRIT MED J, V320, P440, DOI 10.1136/bmj.320.7232.440; den Boon S, 2006, INT J TUBERC LUNG D, V10, P876; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2001, P ROY SOC B-BIOL SCI, V268, P45, DOI 10.1098/rspb.2000.1328; Fournet N, 2006, PUBLIC HEALTH, V120, P976, DOI 10.1016/j.puhe.2006.06.004; GILLEPSIE DT, 1976, J COMPUTATIONAL PHYS, V22; Jones TF, 2001, AM J RESP CRIT CARE, V164, P77, DOI 10.1164/ajrccm.164.1.2010108; Kimerling ME, 2005, INT J TUBERC LUNG D, V9, P589; Layton MC, 1997, AM J PUBLIC HEALTH, V87, P1335, DOI 10.2105/AJPH.87.8.1335; Leung CC, 2005, INT J TUBERC LUNG D, V9, P627; MacIntyre CR, 1997, CLIN INFECT DIS, V24, P1060, DOI 10.1086/513632; Nyangulu DS, 1997, LANCET, V350, P1284, DOI 10.1016/S0140-6736(97)05023-X; Porco TC, 1998, THEOR POPUL BIOL, V54, P117, DOI 10.1006/tpbi.1998.1366; Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC, 2006, MMWR RECOMM REP, V55, P1; Sanchez A, 2005, INT J TUBERC LUNG D, V9, P633; Sanchez AR, 2007, CAD SAUDE PUBLICA, V23, P545, DOI 10.1590/S0102-311X2007000300013; Sanchez MA, 1997, AM J EPIDEMIOL, V145, P1127; *SECR EST AD PEN R, 2006, REL TECN AN PROGR CO; *SECR EST AD PEN R, 2006, REL TECN AN PROGR PN; STANSELL J, 1994, TXB RESP MED, P2333; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; 2001, INT J TUBERC LUNG DI, V5, P213; 2003, MMWR MORB MORTAL WKL, V52, P250	34	45	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2100	10.1371/journal.pone.0002100	http://dx.doi.org/10.1371/journal.pone.0002100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461123	Green Published, gold			2022-12-27	WOS:000261642400022
J	Vissers, DCJ; Voeten, HACM; Nagelkerke, NJD; Habbema, JDF; de Vlas, SJ				Vissers, Debby C. J.; Voeten, Helene A. C. M.; Nagelkerke, Nico J. D.; Habbema, J. Dik F.; de Vlas, Sake J.			The Impact of Pre-Exposure Prophylaxis (PrEP) on HIV Epidemics in Africa and India: A Simulation Study	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; ACTIVE ANTIRETROVIRAL THERAPY; RISK BEHAVIOR; SOUTH-INDIA; PREVENTION; INFECTION; CHEMOPROPHYLAXIS; TRANSMISSION; INTERVENTIONS; PREVALENCE	Background: Pre-exposure prophylaxis (PrEP) is a promising new HIV prevention method, especially for women. An urgent demand for implementation of PrEP is expected at the moment efficacy has been demonstrated in clinical trials. We explored the long-term impact of PrEP on HIV transmission in different HIV epidemics. Methodology/Principal Findings: We used a mathematical model that distinguishes the general population, sex workers and their clients. PrEP scenarios varying in effectiveness, coverage and target group were modeled in the epidemiological settings of Botswana, Nyanza Province in Kenya, and Southern India. We also studied the effect of condom addition or condom substitution during PrEP use. Main outcome was number of HIV infections averted over ten years of PrEP use. PrEP strategies with high effectiveness and high coverage can have a substantial impact in African settings. In Southern India, by contrast, the number of averted HIV infections in different PrEP scenarios would be much lower. The impact of PrEP may be strongly diminished or even reversed by behavioral disinhibition, especially in scenarios with low coverage and low effectiveness. However, additional condom use during low coverage and low effective PrEP doubled the amount of averted HIV infections. Conclusions/Significance: The public health impact of PrEP can be substantial. However, this impact may be diminished, or even reversed, by changes in risk behavior. Implementation of PrEP strategies should therefore come on top of current condom campaigns, not as a substitution.	[Vissers, Debby C. J.; Voeten, Helene A. C. M.; Habbema, J. Dik F.; de Vlas, Sake J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Nagelkerke, Nico J. D.] United Arab Emirates Univ, Dept Community Med, Al Ain, U Arab Emirates	Erasmus University Rotterdam; Erasmus MC; United Arab Emirates University	Vissers, DCJ (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	d.vissers@erasmusmc.nl		Voeten, Helene/0000-0003-1358-6752; de Vlas, Sake J./0000-0002-1830-5668				ABBAS UL, 2007, PLOS ONE, V875, P1; [Anonymous], 2007, MANUAL ESTIMATING NA; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; Becker ML, 2007, AIDS, V21, P739, DOI 10.1097/QAD.0b013e328012b885; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Cardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Castilla J, 2005, JAIDS-J ACQ IMM DEF, V40, P96, DOI 10.1097/01.qai.0000157389.78374.45; Cohen J, 2007, SCIENCE, V318, P1048, DOI 10.1126/science.318.5853.1048; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; EISELE TP, 2007, AIDS BEHAV; Grant RM, 2005, SCIENCE, V309, P2170, DOI 10.1126/science.1116204; Grant RM, 2006, J INFECT DIS, V194, P874, DOI 10.1086/507314; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Kumar R, 2006, LANCET, V367, P1164, DOI 10.1016/S0140-6736(06)68435-3; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Liu AY, 2006, JAMA-J AM MED ASSOC, V296, P863, DOI 10.1001/jama.296.7.863; Martin JN, 2004, AIDS, V18, P787, DOI 10.1097/00002030-200403260-00010; MARUM L, 2003, KENYA DEMOGRAPHIC HL, pCH13; *NACO, 2005, NAT AIDS CONTR ORG F; *NACO, 2005, BEH SURV SURV REP; Nagelkerke NJD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-16; Nagelkerke NJD, 2002, B WORLD HEALTH ORGAN, V80, P89; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Paxton LA, 2007, LANCET, V370, P89, DOI 10.1016/S0140-6736(07)61053-8; Peterson Leigh, 2007, PLoS Clin Trials, V2, pe27, DOI 10.1371/journal.pctr.0020027; *PREP WATCH, 2007, CLEAR AV PREP WATCH; Ramjee G, 2007, PLOS MED, V4, P1167, DOI 10.1371/journal.pmed.0040235; Schechter M, 2004, JAIDS-J ACQ IMM DEF, V35, P519, DOI 10.1097/00126334-200404150-00010; Smith Stephen M, 2004, Retrovirology, V1, P16, DOI 10.1186/1742-4690-1-16; Stephenson J, 2004, JAMA-J AM MED ASSOC, V292, P1163, DOI 10.1001/jama.292.10.1163; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; UNAIDS, 2006, REP GLOB AIDS EP; *UNAIDS WHO, 2004, IND EP FACT SHEET HI; Voeten HACM, 2002, SEX TRANSM DIS, V29, P444, DOI 10.1097/00007435-200208000-00003; Youle M, 2003, AIDS, V17, P937, DOI 10.1097/00002030-200304110-00027; Youle Mike, 2003, J Int Assoc Physicians AIDS Care (Chic), V2, P102, DOI 10.1177/154510970300200302; 2007, NATURE, V446, P1	41	85	93	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2077	10.1371/journal.pone.0002077	http://dx.doi.org/10.1371/journal.pone.0002077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461185	gold, Green Published, Green Submitted			2022-12-27	WOS:000261642400003
J	Kondo, Y; Shen, L; Ahmed, S; Boumber, Y; Sekido, Y; Haddad, BR; Issa, JPJ				Kondo, Yutaka; Shen, Lanlan; Ahmed, Saira; Boumber, Yanis; Sekido, Yoshitaka; Haddad, Bassem R.; Issa, Jean-Pierre J.			Downregulation of Histone H3 Lysine 9 Methyltransferase G9a Induces Centrosome Disruption and Chromosome Instability in Cancer Cells	PLOS ONE			English	Article								Background: Modifications of the histone amino-terminal tails affect access of regulatory factors and complexes to chromatin and thereby influence biological processes. Cancer cells are characterized by prominent epigenetic dysregulation, including histone modifications. However, the functional roles of the histone methyltransferases (HMT) in cancer remain unclear. Methodology/Principal Findings: We studied RNAi-based inhibition (knockdown, KD) of 2 different H3K9 HMTs, SUV39H1 and G9a. Knockdown of the 2 HMTs in PC3 cancer cell line markedly inhibited cell growth and caused profound morphological changes with loss of telomerase activity and shortened telomeres. SUV39H1 KD cells showed substantial increase in G2/M fraction. G9a KD cells showed increased DNA content (1.7-fold in 2 independent clones) compared with FACS analyses to control. Karyotype analyses showed that this was due to an increased number of chromosomes (from 61 to 102) in G9a KD cells compared to parental PC3. Intriguingly, we found abnormal centrosome morphology and number in about 25% of the G9a KD cells, while centrosomes were morphologically normal in control cells. Microarray analyses after KD of SUV39H1 or G9a showed very few genes up-regulated among the 39,000 genes. The silenced tumor-suppressor genes p16 and RASSF1A were not activated in KD cells. Conclusions/Significance: These data suggest that the 2 HMTs, SUV39H1 and G9a are required to perpetuate the malignant phenotype. Furthermore, G9a plays a critical role in regulating centrosome duplication presumably through chromatin structure rather than through affecting gene expression in cancer cells. Targeting these histone methyltransferases may be of therapeutic benefit in cancers.	[Kondo, Yutaka; Sekido, Yoshitaka] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Nagoya, Aichi 464, Japan; [Kondo, Yutaka; Shen, Lanlan; Ahmed, Saira; Boumber, Yanis; Issa, Jean-Pierre J.] Univ Texas, MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA; [Haddad, Bassem R.] Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehensive Canc Ctr, Washington, DC USA; [Haddad, Bassem R.] Georgetown Univ, Med Ctr, Dept Obstet & Gynecol, Lombardi Comprehensive Canc Ctr, Washington, DC USA	Aichi Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Georgetown University; Georgetown University	Kondo, Y (corresponding author), Aichi Canc Ctr, Res Inst, Div Mol Oncol, Nagoya, Aichi 464, Japan.	ykondo@aichi-cc.jp	Sekido, Yoshitaka/P-9756-2015; Boumber, Yanis/AAP-8901-2021	Sekido, Yoshitaka/0000-0002-2428-3848; Boumber, Yanis/0000-0001-5003-248X; Issa, Jean-Pierre/0000-0003-2258-5030	NIH [CA098006, CA100632]; Japan Society for the Promotion of Science; NATIONAL CANCER INSTITUTE [P50CA100632, R01CA098006] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants CA098006 and CA100632 from the NIH (JPJI) and a grant from the Japan Society for the Promotion of Science (YK).	Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bernard P, 2002, TRENDS CELL BIOL, V12, P419, DOI 10.1016/S0962-8924(02)02344-9; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi Judith, 2003, Methods Mol Biol, V223, P155; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Fahrner JA, 2002, CANCER RES, V62, P7213; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; Gilson Eric, 1993, Trends in Cell Biology, V3, P128, DOI 10.1016/0962-8924(93)90175-Z; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Kondo Y, 2004, P NATL ACAD SCI USA, V101, P7398, DOI 10.1073/pnas.0306641101; Kondo Y, 2007, HEPATOL RES, V37, P974, DOI 10.1111/j.1872-034X.2007.00141.x; Nguyen CT, 2002, CANCER RES, V62, P6456; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Zhang XQ, 2003, CANCER RES, V63, P760	27	192	196	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2037	10.1371/journal.pone.0002037	http://dx.doi.org/10.1371/journal.pone.0002037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446223	Green Published, gold, Green Submitted			2022-12-27	WOS:000261572300010
J	Cothros, N; Wong, J; Gribble, PL				Cothros, Nicholas; Wong, Jeremy; Gribble, Paul L.			Distinct Haptic Cues Do Not Reduce Interference when Learning to Reach in Multiple Force Fields	PLOS ONE			English	Article							INTERNAL-MODELS; NEURAL REPRESENTATIONS; MOTOR MEMORIES; ADAPTATION; CONSOLIDATION; MOVEMENTS; DYNAMICS; LOADS; HAND; TRANSFORMATIONS	Background: Previous studies of learning to adapt reaching movements in the presence of novel forces show that learning multiple force fields is prone to interference. Recently it has been suggested that force field learning may reflect learning to manipulate a novel object. Within this theoretical framework, interference in force field learning may be the result of static tactile or haptic cues associated with grasp, which fail to indicate changing dynamic conditions. The idea that different haptic cues (e.g. those associated with different grasped objects) signal motor requirements and promote the learning and retention of multiple motor skills has previously been unexplored in the context of force field learning. Methodology/Principle Findings: The present study tested the possibility that interference can be reduced when two different force fields are associated with differently shaped objects grasped in the hand. Human subjects were instructed to guide a cursor to targets while grasping a robotic manipulandum, which applied two opposing velocity-dependent curl fields to the hand. For one group of subjects the manipulandum was fitted with two different handles, one for each force field. No attenuation in interference was observed in these subjects relative to controls who used the same handle for both force fields. Conclusions/Significance: These results suggest that in the context of the present learning paradigm, haptic cues on their own are not sufficient to reduce interference and promote learning multiple force fields.	[Cothros, Nicholas; Wong, Jeremy; Gribble, Paul L.] Univ Western Ontario, Dept Psychol, London, ON, Canada; [Cothros, Nicholas; Wong, Jeremy] Univ Western Ontario, Grad Program Neurosci, London, ON, Canada; [Gribble, Paul L.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Gribble, PL (corresponding author), Univ Western Ontario, Dept Psychol, London, ON, Canada.	pgribble@uwo.ca		Gribble, Paul/0000-0002-1368-032X; Wong, Jeremy/0000-0001-5564-1794	NSERC (Canada); CIHR (Canada); NIH (USA)	NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR (Canada)(Canadian Institutes of Health Research (CIHR)); NIH (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from NSERC (Canada), CIHR (Canada) and NIH (USA).	BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; Cothros N, 2006, EXP BRAIN RES, V173, P689, DOI 10.1007/s00221-006-0411-0; Cothros N, 2006, J COGNITIVE NEUROSCI, V18, P2167, DOI 10.1162/jocn.2006.18.12.2167; Davidson PR, 2005, J NEUROSCI, V25, P5425, DOI 10.1523/JNEUROSCI.0429-05.2005; Davidson PR, 2004, NEUROSCI LETT, V370, P102, DOI 10.1016/j.neulet.2004.08.003; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; Ghahramani Z, 1996, J NEUROSCI, V16, P7085; Goodbody SJ, 1998, J NEUROPHYSIOL, V79, P1825, DOI 10.1152/jn.1998.79.4.1825; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; Hwang EJ, 2006, EXP BRAIN RES, V173, P425, DOI 10.1007/s00221-006-0391-0; Imamizu H, 2007, EXP BRAIN RES, V181, P395, DOI 10.1007/s00221-007-0940-1; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Krakauer JW, 2006, PLOS BIOL, V4, P1798, DOI 10.1371/journal.pbio.0040316; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Lackner JR, 2005, CURR OPIN NEUROBIOL, V15, P653, DOI 10.1016/j.conb.2005.10.012; LEDERMAN SJ, 1990, COGNITIVE PSYCHOL, V22, P421, DOI 10.1016/0010-0285(90)90009-S; Malfait N, 2005, J NEUROPHYSIOL, V93, P3327, DOI 10.1152/jn.00883.2004; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; Mattar AAG, 2007, J NEUROPHYSIOL, V97, P220, DOI 10.1152/jn.00736.2006; Osu R, 2004, NAT NEUROSCI, V7, P111, DOI 10.1038/nn1184; Overduin SA, 2006, J NEUROSCI, V26, P11888, DOI 10.1523/JNEUROSCI.1320-06.2006; Pine ZM, 1996, NEUROREPORT, V7, P2357, DOI 10.1097/00001756-199610020-00016; ROBYBRAMI A, 1995, COGNITIVE BRAIN RES, V2, P229, DOI 10.1016/0926-6410(95)90014-4; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Tong C, 2003, J NEUROPHYSIOL, V90, P578, DOI 10.1152/jn.01087.2002; Wada Y, 2003, NEUROSCI RES, V46, P319, DOI 10.1016/S0168-0102(03)00094-4; Witney AG, 2003, J NEUROPHYSIOL, V89, P1837, DOI 10.1152/jn.00929.2002; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555	35	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1990	10.1371/journal.pone.0001990	http://dx.doi.org/10.1371/journal.pone.0001990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	381TL	18431477	Green Submitted, Green Published, gold			2022-12-27	WOS:000261558700012
J	Peirce, JL; Broman, KW; Lu, L; Chesler, EJ; Zhou, G; Airey, DC; Birmingham, AE; Williams, RW				Peirce, Jeremy L.; Broman, Karl W.; Lu, Lu; Chesler, Elissa J.; Zhou, Guomin; Airey, David C.; Birmingham, Amanda E.; Williams, Robert W.			Genome Reshuffling for Advanced Intercross Permutation (GRAIP): Simulation and Permutation for Advanced Intercross Population Analysis	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; INBRED MOUSE STRAINS; GENE LOCI; MARKER LOCI; IDENTIFICATION; LINES; MICE; HIPPOCAMPUS; EXPRESSION; RESOURCE	Background: Advanced intercross lines (AIL) are segregating populations created using a multi-generation breeding protocol for fine mapping complex trait loci (QTL) in mice and other organisms. Applying QTL mapping methods for intercross and backcross populations, often followed by naive permutation of individuals and phenotypes, does not account for the effect of AIL family structure in which final generations have been expanded and leads to inappropriately low significance thresholds. The critical problem with naive mapping approaches in AIL populations is that the individual is not an exchangeable unit. Methodology/Principal Findings: The effect of family structure has immediate implications for the optimal AIL creation (many crosses, few animals per cross, and population expansion before the final generation) and we discuss these and the utility of AIL populations for QTL fine mapping. We also describe Genome Reshuffling for Advanced Intercross Permutation, (GRAIP) a method for analyzing AIL data that accounts for family structure. GRAIP permutes a more interchangeable unit in the final generation crosses - the parental genome - and simulating regeneration of a permuted AIL population based on exchanged parental identities. GRAIP determines appropriate genome-wide significance thresholds and locus-specific P-values for AILs and other populations with similar family structures. We contrast GRAIP with naive permutation using a large densely genotyped mouse AIL population (1333 individuals from 32 crosses). A naive permutation using coat color as a model phenotype demonstrates high false-positive locus identification and uncertain significance levels, which are corrected using GRAIP. GRAIP also detects an established hippocampus weight locus and a new locus, Hipp9a. Conclusions and Significance: GRAIP determines appropriate genome-wide significance thresholds and locus-specific P-values for AILs and other populations with similar family structures. The effect of family structure has immediate implications for the optimal AIL creation and we discuss these and the utility of AIL populations.	[Peirce, Jeremy L.; Lu, Lu; Chesler, Elissa J.; Zhou, Guomin; Airey, David C.; Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Ctr Neurosci, Memphis, TN 38163 USA; [Peirce, Jeremy L.; Lu, Lu; Chesler, Elissa J.; Williams, Robert W.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Ctr Genom & Bioinformat, Memphis, TN USA; [Broman, Karl W.] Johns Hopkins Univ, Dept Biostat, Baltimore, MD USA; [Birmingham, Amanda E.] Dharmacon Inc, Lafayette, CO USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Johns Hopkins University	Peirce, JL (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Ctr Neurosci, Memphis, TN 38163 USA.	jpeirce@utmem.edu	Chesler, Elissa/K-4641-2019; zhou, guomin/M-2871-2016; Williams, Robert W./H-8789-2016	Chesler, Elissa/0000-0002-5642-5062; Williams, Robert W./0000-0001-8924-4447; Broman, Karl/0000-0002-4914-6671	The Informatics Center for Mouse Neurogenetics; NIMH [P20-MH62009]; NIDA [P20-MH62009]; NSF [P20-MH62009]; NIAAA [U01AA13499, U24AA135B, U01AA01442501]; National Heart, Lung, and Blood Institute (NHLBI) [HV48141]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV048141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH062009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA013499] Funding Source: NIH RePORTER	The Informatics Center for Mouse Neurogenetics; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NSF(National Science Foundation (NSF)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Our thanks for financial support from (1) The Informatics Center for Mouse Neurogenetics; (2) P20-MH62009 from NIMH, NIDA, and NSF to RWW. (2) INIA grants U01AA13499 and U24AA135B from NIAAA to RWW, and INIA grant U01AA01442501 from NIAAA to LL. As mentioned in the text, genotypes were provided for 1333 AIL mice by the Mammalian Genotyping Service (MGS; National Heart, Lung, and Blood Institute (NHLBI) Contract Number HV48141), for which we would like to express our gratitude to Dr. James Weber and colleagues. Except for MGS contribution of genotypes, no funding agency had a role in design, conduct, data collection, analysis, or interpretation or in preparation of the manuscript.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Broman KW, 2005, GENETICS, V169, P1133, DOI 10.1534/genetics.104.035212; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Broman KW, 2002, GENETICS, V160, P1123; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chesler EJ, 2003, NEUROINFORMATICS, V1, P343, DOI 10.1385/NI:1:4:343; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; CHURCHILL GA, 1994, GENETICS, V138, P963; DARVASI A, 1995, GENETICS, V141, P1199; Iakoubova OA, 2001, GENOMICS, V74, P89, DOI 10.1006/geno.2000.6497; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Iraqi F, 2000, MAMM GENOME, V11, P645, DOI 10.1007/s003350010133; Iraqi F, 2000, EXP LUNG RES, V26, P641, DOI 10.1080/01902140150216729; Jagodic M, 2004, J IMMUNOL, V173, P1366, DOI 10.4049/jimmunol.173.2.1366; Korstanje R, 2002, NAT GENET, V31, P235, DOI 10.1038/ng0702-235; Lu L, 2001, J NEUROSCI, V21, P3503, DOI 10.1523/JNEUROSCI.21-10-03503.2001; Lyon ML, 1989, GENETIC VARIANTS STR, P773; Palmer AA, 2003, NEUROPSYCHOPHARMACOL, V28, P818, DOI 10.1038/sj.npp.1300064; Peirce JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001036; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Peirce JL, 2003, GENES BRAIN BEHAV, V2, P238, DOI 10.1034/j.1601-183X.2003.00030.x; Sen S, 2001, GENETICS, V159, P371; SHENG J, 2005, GENETICS; Silver L. M., 1995, MOUSE GENETICS; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Tsaih SW, 2005, MAMM GENOME, V16, P344, DOI 10.1007/s00335-004-2466-1; Wang M, 2003, CANCER RES, V63, P3317; Wang XS, 2003, GENOME RES, V13, P1654, DOI 10.1101/gr.1185803; WELLER JI, 1990, J DAIRY SCI, V73, P2525, DOI 10.3168/jds.S0022-0302(90)78938-2; Williams RW, 2004, MAMM GENOME, V15, P637, DOI 10.1007/s00335-004-2380-6; Williams RW, 2001, GENOME BIOL, V2; Zhou G, 1999, INVEST OPHTH VIS SCI, V40, P817; ZOU F, QUANTITATIVE TRAIT L; ZOU F, 2005, GENETICS	37	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e1977	10.1371/journal.pone.0001977	http://dx.doi.org/10.1371/journal.pone.0001977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431467	Green Submitted, Green Published, gold			2022-12-27	WOS:000261558700002
J	Li, W; Liu, Y; Mukhtar, MM; Gong, R; Pan, Y; Rasool, ST; Gao, YC; Kang, L; Hao, Q; Peng, GQ; Chen, YN; Chen, X; Wu, JG; Zhu, Y				Li, Wei; Liu, Yan; Mukhtar, Muhammad Mahmood; Gong, Rui; Pan, Ying; Rasool, Sahibzada T.; Gao, Yecheng; Kang, Lei; Hao, Qian; Peng, Guiqing; Chen, Yanni; Chen, Xin; Wu, Jianguo; Zhu, Ying			Activation of Interleukin-32 Pro-Inflammatory Pathway in Response to Influenza A Virus Infection	PLOS ONE			English	Article								Background: Interleukin (IL)-32 is a recently described pro-inflammatory cytokine that has been reported to be induced by bacteria treatment in culture cells. Little is known about IL-32 production by exogenous pathogens infection in human individuals. Methods and Findings: In this study, we found that IL-32 level was increased by 58.2% in the serum samples from a cohort of 108 patients infected by influenza A virus comparing to that of 115 healthy individuals. Another pro-inflammatory factor cyclooxygenase (COX)-2-associated prostaglandin E2 was also upregulated by 2.7-fold. Expression of IL-32 in influenza A virus infected A549 human lung epithelial cells was blocked by either selective COX-2 inhibitor NS398 or Aspirin, a known anti-inflammatory drug, indicating IL-32 was induced through COX-2 in the inflammatory cascade. Interestingly, we found that COX-2-associate PGE2 production activated by influenza virus infection was significantly suppressed by over-expression of IL-32 but increased by IL-32-specific siRNA, suggesting there was a feedback mechanism between IL-32 and COX-2. Conclusions: IL-32 is induced by influenza A virus infection via COX- 2 in the inflammatory cascade. Our results provide that IL-32 is a potential target for anti-inflammatory medicine screening.	[Li, Wei; Liu, Yan; Mukhtar, Muhammad Mahmood; Gong, Rui; Pan, Ying; Rasool, Sahibzada T.; Gao, Yecheng; Kang, Lei; Hao, Qian; Peng, Guiqing; Chen, Yanni; Chen, Xin; Wu, Jianguo; Zhu, Ying] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Li, W (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	wu9988@vip.sina.com; yingzhu@whu.edu.cn	Rasool, Sahibzada/M-4508-2016	Rasool, Sahibzada/0000-0002-6115-8499; Wu, Jianguo/0000-0002-8326-2895	National Natural Science Foundation of China [30570066]; Major State Basic Research Development Program of China [2007CB512803, 2005CB523010]; National High-Tech Research and Development Program of China [2006AA02A306]; Hubei Provincial Science Foundation for Distinguished Youth Scholar; Ph.D. Program Foundation of Ministry of Education of China [20050486012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Hubei Provincial Science Foundation for Distinguished Youth Scholar; Ph.D. Program Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by research grants from the National Natural Science Foundation of China (No. 30570066), the Major State Basic Research Development Program of China (973 project No. 2007CB512803 and No. 2005CB523010), the National High-Tech Research and Development Program of China (863 project No. 2006AA02A306), Hubei Provincial Science Foundation for Distinguished Youth Scholar to Zhu Y, and the Ph.D. Program Foundation of Ministry of Education of China (No. 20050486012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carey MA, 2005, J IMMUNOL, V175, P6878, DOI 10.4049/jimmunol.175.10.6878; Ciencewicki J, 2006, AM J PHYSIOL-LUNG C, V290, pL1154, DOI 10.1152/ajplung.00318.2005; COPELAND RA, 1994, P NATL ACAD SCI USA, V91, P11202, DOI 10.1073/pnas.91.23.11202; Coruzzi Gabriella, 2007, Acta Biomed, V78, P96; Deng WG, 2003, J BIOL CHEM, V278, P4770, DOI 10.1074/jbc.M209286200; Eliopoulos AG, 1999, J BIOL CHEM, V274, P16085, DOI 10.1074/jbc.274.23.16085; Gilroy DW, 2001, AM J PHYSIOL-CELL PH, V281, pC188, DOI 10.1152/ajpcell.2001.281.1.C188; Goodwin DC, 1999, FASEB J, V13, P1121, DOI 10.1096/fasebj.13.10.1121; Guillot L, 2005, J BIOL CHEM, V280, P5571, DOI 10.1074/jbc.M410592200; Heitmeier MR, 1998, J BIOL CHEM, V273, P15301, DOI 10.1074/jbc.273.24.15301; Hinz B, 2002, J PHARMACOL EXP THER, V300, P367, DOI 10.1124/jpet.300.2.367; Iniguez MA, 2000, J BIOL CHEM, V275, P23627, DOI 10.1074/jbc.M001381200; Jacobs BL, 1996, VIROLOGY, V219, P339, DOI 10.1006/viro.1996.0259; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kundu M, 2006, PLOS MED, V3, P1210, DOI 10.1371/journal.pmed.0030274; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; Lara-Pezzi E, 2002, J CLIN INVEST, V110, P1831, DOI 10.1172/JCI200215887; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Liu M, 2007, FASEB J, V21, P1586, DOI 10.1096/fj.06-6589com; Maggi LB, 2000, EMBO J, V19, P3630, DOI 10.1093/emboj/19.14.3630; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; Mizumura K, 2003, CLIN EXP ALLERGY, V33, P1244, DOI 10.1046/j.1365-2222.2003.01750.x; Naesdall J, 2006, DRUG SAFETY, V29, P119; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Novick D, 2006, P NATL ACAD SCI USA, V103, P3316, DOI 10.1073/pnas.0511206103; SAMUELSSON B, 1987, DRUGS, V33, P2, DOI 10.2165/00003495-198700331-00003; Shoda H, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2074; Steer SA, 2003, J IMMUNOL, V170, P1070, DOI 10.4049/jimmunol.170.2.1070; Steer SA, 2006, J IMMUNOL, V177, P3413, DOI 10.4049/jimmunol.177.5.3413; Subbaramaiah K, 1996, CANCER RES, V56, P4424; Traynor TR, 2004, LIFE SCI, V74, P2563, DOI 10.1016/j.lfs.2003.10.010; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; White William B, 2007, Subcell Biochem, V42, P145; Wu Kenneth K, 2003, Semin Vasc Med, V3, P107; Yan XH, 2006, INT J BIOCHEM CELL B, V38, P1417, DOI 10.1016/j.biocel.2006.02.003; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200	39	84	93	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2008	3	4							e1985	10.1371/journal.pone.0001985	http://dx.doi.org/10.1371/journal.pone.0001985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371XZ	18414668	Green Submitted, Green Published, gold			2022-12-27	WOS:000260867300017
J	Novikova, SI; He, F; Bai, J; Cutrufello, NJ; Lidow, MS; Undieh, AS				Novikova, Svetlana I.; He, Fang; Bai, Jie; Cutrufello, Nicholas J.; Lidow, Michael S.; Undieh, Ashiwel S.			Maternal Cocaine Administration in Mice Alters DNA Methylation and Gene Expression in Hippocampal Neurons of Neonatal and Prepubertal Offspring	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; EMBRYONIC STEM-CELLS; CPG ISLANDS; IMPRINTED GENES; IN-UTERO; METHYLTRANSFERASE GENE; MAMMALIAN DEVELOPMENT; CHROMATIN-STRUCTURE; CEREBRAL-CORTEX; NERVOUS-SYSTEM	Previous studies documented significant behavioral changes in the offspring of cocaine-exposed mothers. We now explore the hypothesis that maternal cocaine exposure could alter the fetal epigenetic machinery sufficiently to cause lasting neurochemical and functional changes in the offspring. Pregnant CD1 mice were administered either saline or 20 mg/kg cocaine twice daily on gestational days 8-19. Male pups from each of ten litters of the cocaine and control groups were analyzed at 3 (P3) or 30 (P30) days postnatum. Global DNA methylation, methylated DNA immunoprecipitation followed by CGI(2) microarray profiling and bisulfite sequencing, as well as quantitative real-time RT-PCR gene expression analysis, were evaluated in hippocampal pyramidal neurons excised by laser capture microdissection. Following maternal cocaine exposure, global DNA methylation was significantly decreased at P3 and increased at P30. Among the 492 CGIs whose methylation was significantly altered by cocaine at P3, 34% were hypermethylated while 66% were hypomethylated. Several of these CGIs contained promoter regions for genes implicated in crucial cellular functions. Endogenous expression of selected genes linked to the abnormally methylated CGIs was correspondingly decreased or increased by as much as 4-19-fold. By P30, some of the cocaine-associated effects at P3 endured, reversed to opposite directions, or disappeared. Further, additional sets of abnormally methylated targets emerged at P30 that were not observed at P3. Taken together, these observations indicate that maternal cocaine exposure during the second and third trimesters of gestation could produce potentially profound structural and functional modifications in the epigenomic programs of neonatal and prepubertal mice.	[Novikova, Svetlana I.; He, Fang; Bai, Jie; Cutrufello, Nicholas J.; Lidow, Michael S.] Univ Maryland, Dept Biomed Sci, Lab Neurogenom & Prote, Baltimore, MD 21201 USA; [Novikova, Svetlana I.; Undieh, Ashiwel S.] Thomas Jefferson Univ, Sch Pharm, Dept Pharmaceut Sci, Lab Integrat Neuropharmacol, Philadelphia, PA USA	University System of Maryland; University of Maryland Baltimore; Jefferson University	Undieh, AS (corresponding author), Univ Maryland, Dept Biomed Sci, Lab Neurogenom & Prote, Baltimore, MD 21201 USA.	ashiwel.undieh@jefferson.edu	Undieh, Ashiwel/ABG-4004-2020	Undieh, Ashiwel/0000-0003-1823-5230	United States National Institutes of Health/National Institute on Drug Abuse [R01DA08057, R01DA17614]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017614, R01DA008057] Funding Source: NIH RePORTER	United States National Institutes of Health/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by United States National Institutes of Health/National Institute on Drug Abuse Grants R01DA08057 and R01DA17614.	ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Antequera F, 1999, CURR BIOL, V9, pR661, DOI 10.1016/S0960-9822(99)80418-7; ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z; Baraban SC, 1999, DEV BRAIN RES, V117, P213, DOI 10.1016/S0165-3806(99)00106-6; Baraban SC, 1997, J NEUROPHYSIOL, V77, P126, DOI 10.1152/jn.1997.77.1.126; Bashkatova V, 2005, NEUROREPORT, V16, P1217, DOI 10.1097/00001756-200508010-00017; BECK S, 2003, EPIGENOME MOL HIDE S; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bonthius DJ, 2004, BRAIN RES PROTOC, V14, P45, DOI 10.1016/j.brainresprot.2004.09.003; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; Brown CJ, 2001, SEMIN REPROD MED, V19, P125, DOI 10.1055/s-2001-15392; Capo-chichi CD, 2005, DEV BIOL, V286, P574, DOI 10.1016/j.ydbio.2005.07.037; Chang SC, 2006, FRONT BIOSCI-LANDMRK, V11, P852, DOI 10.2741/1842; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Cone-Wesson B, 2005, J COMMUN DISORD, V38, P279, DOI 10.1016/j.jcomdis.2005.02.004; Costello JF, 2001, J MED GENET, V38, P285, DOI 10.1136/jmg.38.5.285; Crandall JE, 2004, CEREB CORTEX, V14, P665, DOI 10.1093/cercor/bhh027; Cross SH, 1997, GENOMICS, V40, P454, DOI 10.1006/geno.1996.4598; Cunliffe VT, 2003, GENE, V305, P141, DOI 10.1016/S0378-1119(03)00386-X; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Doerfler W, 2005, BIOCHEMISTRY-MOSCOW+, V70, P505, DOI 10.1007/s10541-005-0145-9; Ehrlich M, 2003, J CELL BIOCHEM, V88, P899, DOI 10.1002/jcb.10464; Faherty CJ, 2003, DEV BRAIN RES, V141, P55, DOI 10.1016/S0165-3806(02)00642-9; Fan GP, 2001, ADV EXP MED BIOL, V499, P195; Fernandez-Gonzalez R, 2004, P NATL ACAD SCI USA, V101, P5880, DOI 10.1073/pnas.0308560101; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GARMAISE D, 2005, HIV AIDS POLICY LAW, V10, P16; GARRO AJ, 1991, ALCOHOL CLIN EXP RES, V15, P395, DOI 10.1111/j.1530-0277.1991.tb00536.x; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; GOTO K, 1994, DIFFERENTIATION, V56, P39, DOI 10.1046/j.1432-0436.1994.56120039.x; Goto T, 1998, MICROBIOL MOL BIOL R, V62, P362, DOI 10.1128/MMBR.62.2.362-378.1998; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Guerrero-Bosagna C, 2005, EVOL DEV, V7, P341, DOI 10.1111/j.1525-142X.2005.05033.x; Harvey JA, 2004, NEUROSCI BIOBEHAV R, V27, P751, DOI 10.1016/j.neubiorev.2003.11.006; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; He F, 2006, NEUROTOXICOL TERATOL, V28, P198, DOI 10.1016/j.ntt.2005.12.003; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Holliday R, 2002, METHODS, V27, P179, DOI 10.1016/S1046-2023(02)00072-5; Hope VD, 2005, ADDICTION, V100, P1701, DOI 10.1111/j.1360-0443.2005.01244.x; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Hu JF, 1998, MOL ENDOCRINOL, V12, P220, DOI 10.1210/me.12.2.220; JOHANSON CE, 1989, PHARMACOL REV, V41, P3; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Ke ZJ, 2003, J NEUROPATH EXP NEUR, V62, P195, DOI 10.1093/jnen/62.2.195; Keller RW, 2000, ANN NY ACAD SCI, V909, P217; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li K, 2002, J BIOL CHEM, V277, P47052, DOI 10.1074/jbc.M205374200; Lidow MS, 2003, DEV BRAIN RES, V147, P23, DOI 10.1016/j.devbrainres.2003.09.001; Little JZ, 1998, DEV BRAIN RES, V110, P115, DOI 10.1016/S0165-3806(98)00100-X; Ma S, 2003, MOL CELL BIOL, V23, P6936, DOI 10.1128/MCB.23.19.6936-6943.2003; March JC, 2006, EUR ADDICT RES, V12, P33, DOI 10.1159/000088581; McCabe MT, 2005, CANCER RES, V65, P3624, DOI 10.1158/0008-5472.CAN-04-2158; McLachlan JA, 2001, TOXICOL LETT, V120, P161, DOI 10.1016/S0378-4274(01)00295-8; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Meehan RR, 2003, SEMIN CELL DEV BIOL, V14, P53, DOI 10.1016/S1084-9521(02)00137-4; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; MONK M, 1987, NATURE, V328, P203, DOI 10.1038/328203a0; Nakahira E, 2005, J COMP NEUROL, V483, P329, DOI 10.1002/cne.20441; Nakai D, 2004, AGING CELL, V3, P273, DOI 10.1111/j.1474-9728.2004.00116.x; Nakai D, 2001, BIOCHEM BIOPH RES CO, V289, P463, DOI 10.1006/bbrc.2001.5977; Niculescu MD, 2004, J NEUROCHEM, V89, P1252, DOI 10.1111/j.1471-4159.2004.02414.x; Novikova SI, 2005, SYNAPSE, V56, P105, DOI 10.1002/syn.20134; Novikova SI, 2005, NEUROTOXICOL TERATOL, V27, P3, DOI 10.1016/j.ntt.2004.08.004; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Paoloni-Giacobino A, 2006, CYTOGENET GENOME RES, V113, P116, DOI 10.1159/000090822; Paul S, 2003, CELL MOL LIFE SCI, V60, P2465, DOI 10.1007/s00018-003-3123-7; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; RAZIN A, 1984, P NATL ACAD SCI-BIOL, V81, P2275, DOI 10.1073/pnas.81.8.2275; Reed MG, 2001, J MICROSC-OXFORD, V202, P473, DOI 10.1046/j.1365-2818.2001.00830.x; Reik W, 2003, THERIOGENOLOGY, V59, P21, DOI 10.1016/S0093-691X(02)01269-4; Reinhart B, 2002, MOL CELL BIOL, V22, P2089, DOI 10.1128/MCB.22.7.2089-2098.2002; Reinhart B, 2006, MOL CELL BIOL, V26, P8347, DOI 10.1128/MCB.00981-06; Reinoso BS, 1996, J NEUROSCI RES, V43, P439, DOI 10.1002/(SICI)1097-4547(19960215)43:4<439::AID-JNR5>3.0.CO;2-G; Ren JQ, 2004, INT J DEV NEUROSCI, V22, P309, DOI 10.1016/j.ijdevneu.2004.05.003; REZNIKOV KY, 1991, ADV ANAT EMBRYOL CEL, V122, P1; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Schiller Cassandra, 2005, Pediatr Nurs, V31, P427; Seeburg DP, 2005, ONCOGENE, V24, P292, DOI 10.1038/sj.onc.1208277; Shimozaki K, 2005, J NEUROCHEM, V93, P432, DOI 10.1111/j.1471-4159.2005.03031.x; Siegfried Z, 1999, NAT GENET, V22, P203, DOI 10.1038/9727; Sjoholt G, 2004, MOL PSYCHIATR, V9, P621, DOI 10.1038/sj.mp.4001460; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Smith SS, 2000, J MOL BIOL, V302, P1, DOI 10.1006/jmbi.2000.4046; Soga T, 2002, BBA-GENE STRUCT EXPR, V1579, P173, DOI 10.1016/S0167-4781(02)00546-8; *SUBST AB MENT HLT, 2005, NAT SURV DRUG US HLT, P1; Sugden PH, 2003, J MOL CELL CARDIOL, V35, P871, DOI 10.1016/S0022-2828(03)00153-6; Teter B, 1996, GLIA, V17, P195; Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Vercelli D, 2004, J ALLERGY CLIN IMMUN, V113, P381, DOI 10.1016/j.jaci.2004.01.752; Vickaryous N, 2005, REPROD FERT DEVELOP, V17, P335, DOI 10.1071/RD04133; Warnecke PM, 1997, NUCLEIC ACIDS RES, V25, P4422, DOI 10.1093/nar/25.21.4422; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Williams J, 2006, SUBST USE MISUSE, V41, P489, DOI 10.1080/10826080500521755; Wilson IM, 2006, CELL CYCLE, V5, P155, DOI 10.4161/cc.5.2.2367; Yan QS, 2004, BRAIN RES, V1009, P228, DOI 10.1016/j.brainres.2004.02.052; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	101	91	96	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1919	10.1371/journal.pone.0001919	http://dx.doi.org/10.1371/journal.pone.0001919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382688	Green Published, gold			2022-12-27	WOS:000260795400041
J	Yuan, RR; Maeda, Y; Li, WP; Lu, W; Cook, S; Dowling, P				Yuan, RuiRong; Maeda, Yasuhiro; Li, Weiping; Lu, Wei; Cook, Stuart; Dowling, Peter			Erythropoietin: A Potent Inducer of Peripheral Immuno/Inflammatory Modulation in Autoimmune EAE	PLOS ONE			English	Article							REGULATORY T-CELLS; CUTTING EDGE; CD4 CELLS; CYTOKINE; IL-17; INFLAMMATION; TOLERANCE; RESPONSES; SELECTION; PEPTIDES	Background: Beneficial effects of short-term erythropoietin (EPO) therapy have been demonstrated in several animal models of acute neurologic injury, including experimental autoimmune encephalomyelitis (EAE)-the animal model of multiple sclerosis. We have found that EPO treatment substantially reduces the acute clinical paralysis seen in EAE mice and this improvement is accompanied by a large reduction in the mononuclear cell infiltration and downregulation of glial MHC class II expression within the inflamed CNS. Other reports have recently indicated that peripherally generated anti-inflammatory CD4(+)Foxp3(+) regulatory T cells (Tregs) and the IL17-producing CD4+ T helper cell (Th17) subpopulations play key antagonistic roles in EAE pathogenesis. However, no information regarding the effects of EPO therapy on the behavior of the general mononuclear-lymphocyte population, Tregs or Th17 cells in EAE has emerged. Methods and Findings: We first determined in vivo that EPO therapy markedly suppressed MOG specific T cell proliferation and sharply reduced the number of reactive dendritic cells (CD11c positive) in EAE lymph nodes during both inductive and later symptomatic phases of MOG(35-55) induced EAE. We then determined the effect in vivo of EPO on numbers of peripheral Treg cells and Th17 cells. We found that EPO treatment modulated immune balance in both the periphery and the inflamed spinal cord by promoting a large expansion in Treg cells, inhibiting Th17 polarization and abrogating proliferation of the antigen presenting dendritic cell population. Finally we utilized tissue culture assays to show that exposure to EPO in vitro similarly downregulated MOG-specific T cell proliferation and also greatly suppressed T cell production of pro-inflammatory cytokines. Conclusions: Taken together, our findings reveal an important new locus whereby EPO induces substantial long-term tissue protection in the host through signaling to several critical subsets of immune cells that reside in the peripheral lymphatic system.	[Yuan, RuiRong; Maeda, Yasuhiro; Li, Weiping; Lu, Wei; Cook, Stuart; Dowling, Peter] New Jersey Hlth Care Syst, Dept Vet Affairs, E Orange, NJ USA; [Yuan, RuiRong; Maeda, Yasuhiro; Cook, Stuart; Dowling, Peter] UMDNJ New Jersey Med Sch, Dept Neurosci & Neurol, Newark, NJ USA	New Jersey Department of Health & Senior Services; Rutgers State University New Brunswick; Rutgers State University Medical Center	Yuan, RR (corresponding author), New Jersey Hlth Care Syst, Dept Vet Affairs, E Orange, NJ USA.	dowlinpc@umdnj.edu	黎, 伟/GXM-4040-2022; li, wj/HGD-7322-2022		VA Merit Review; Segal Foundation; New Jersey State Commission on Cancer Research; National MS Society	VA Merit Review(US Department of Veterans Affairs); Segal Foundation; New Jersey State Commission on Cancer Research; National MS Society(National Multiple Sclerosis Society)	This work was supported by a VA Merit Review, the Segal Foundation, New Jersey State Commission on Cancer Research and the National MS Society.	Adembri C, 2008, CRIT CARE MED, V36, P975, DOI 10.1097/CCM.0B013E3181644343; Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Baldwin KK, 1999, J IMMUNOL, V163, P689; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Bynoe MS, 2003, IMMUNITY, V19, P317, DOI 10.1016/S1074-7613(03)00239-5; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Chitnis T, 2003, IMMUNOL RES, V28, P223, DOI 10.1385/IR:28:3:223; Crawford J, 2007, J CLIN ONCOL, V25, P1021, DOI 10.1200/JCO.2006.08.8153; Cuzzocrea S, 2005, ARTHRITIS RHEUM, V52, P940, DOI 10.1002/art.20875; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; Fernandez-Martin A, 2006, EUR J IMMUNOL, V36, P318, DOI 10.1002/eji.200535430; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Ford ML, 2005, EUR J IMMUNOL, V35, P76, DOI 10.1002/eji.200425660; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; Govermant Joan, 2005, Current Drug Targets - Inflammation and Allergy, V4, P239, DOI 10.2174/1568010053586264; Grasso G, 2005, NEUROSURGERY, V56, P821, DOI 10.1227/01.NEU.0000156493.00904.7E; Henke M, 2006, J CLIN ONCOL, V24, P4708, DOI 10.1200/JCO.2006.06.2737; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Hofstetter HH, 2007, J IMMUNOL, V178, P1372, DOI 10.4049/jimmunol.178.3.1372; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Hofstetter HH, 2005, J NEUROIMMUNOL, V170, P105, DOI 10.1016/j.jneuroim.2005.09.004; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Johnson AJ, 2007, INT REV NEUROBIOL, V79, P73, DOI 10.1016/S0074-7742(07)79004-9; Kassiotis G, 2003, J EXP MED, V197, P1007, DOI 10.1084/jem.20021812; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Leist M, 2004, SCIENCE, V305, P239, DOI 10.1126/science.1098313; Leyland-Jones B, 2005, J CLIN ONCOL, V23, P5960, DOI 10.1200/JCO.2005.06.150; Li WP, 2004, ANN NEUROL, V56, P767, DOI 10.1002/ana.20274; McDole J, 2006, NEUROL RES, V28, P256, DOI 10.1179/016164106X98125; Ponomarev ED, 2004, J IMMUNOL, V173, P1587, DOI 10.4049/jimmunol.173.3.1587; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Reddy J, 2005, J IMMUNOL, V175, P5591, DOI 10.4049/jimmunol.175.9.5591; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Steinman L, 2001, J EXP MED, V194, pF27, DOI 10.1084/jem.194.5.F27; Stockinger B, 1999, Adv Immunol, V71, P229; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Sun DM, 2003, INT IMMUNOL, V15, P261, DOI 10.1093/intimm/dxg023; Sun DM, 2001, J IMMUNOL, V166, P7579, DOI 10.4049/jimmunol.166.12.7579; Suryani S, 2007, J NEUROIMMUNOL, V183, P96, DOI 10.1016/j.jneuroim.2006.11.023; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; WEKERLE H, 1994, ANN NEUROL, V36, pS47, DOI 10.1002/ana.410360714; YUAN R, 2005, ANN NEUROL, V58, pA20; Yuan RR, 2004, BLOOD, V104, P2397, DOI 10.1182/blood-2004-01-0324; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	55	77	83	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1924	10.1371/journal.pone.0001924	http://dx.doi.org/10.1371/journal.pone.0001924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382691	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795400044
J	Frankild, S; de Boer, RJ; Lund, O; Nielsen, M; Kesmir, C				Frankild, Sune; de Boer, Rob J.; Lund, Ole; Nielsen, Morten; Kesmir, Can			Amino Acid Similarity Accounts for T Cell Cross-Reactivity and for "Holes" in the T Cell Repertoire	PLOS ONE			English	Article								Background: Cytotoxic T cell (CTL) cross-reactivity is believed to play a pivotal role in generating immune responses but the extent and mechanisms of CTL cross-reactivity remain largely unknown. Several studies suggest that CTL clones can recognize highly diverse peptides, some sharing no obvious sequence identity. The emerging realization in the field is that T cell receptors (TcR) recognize multiple distinct ligands. Principal Findings: First, we analyzed peptide scans of the HIV epitope SLFNTVATL (SFL9) and found that TCR specificity is position dependent and that biochemically similar amino acid substitutions do not drastically affect recognition. Inspired by this, we developed a general model of TCR peptide recognition using amino acid similarity matrices and found that such a model was able to predict the cross-reactivity of a diverse set of CTL epitopes. With this model, we were able to demonstrate that seemingly distinct T cell epitopes, i.e., ones with low sequence identity, are in fact more biochemically similar than expected. Additionally, an analysis of HIV immunogenicity data with our model showed that CTLs have the tendency to respond mostly to peptides that do not resemble self-antigens. Conclusions: T cell cross-reactivity can thus, to an extent greater than earlier appreciated, be explained by amino acid similarity. The results presented in this paper will help resolving some of the long-lasting discussions in the field of T cell cross-reactivity.	[Frankild, Sune; Lund, Ole; Nielsen, Morten] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [de Boer, Rob J.; Kesmir, Can] Univ Utrecht, Theoret Biol Bioinformat, Utrecht, Netherlands; [Kesmir, Can] Univ Utrecht, Academ Biomed Ctr, Utrecht, Netherlands	Technical University of Denmark; Utrecht University; Utrecht University	Frankild, S (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	mniel@cbs.dtu.dk	Kesmir, Can/B-9410-2011; Nielsen, Morten/E-7754-2011; de Boer, Rob/B-6050-2011; Nielsen, Morten/AAL-8700-2020; Lund, Ole/F-4437-2014	Nielsen, Morten/0000-0001-7885-4311; de Boer, Rob/0000-0002-2130-691X; Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Pletscher-Frankild, Sune/0000-0002-7745-193X	NIAID [HHSN266200400083C]	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID Contract no. HHSN266200400083C. The principal funding recipient was Prof. Ole Lund (Technical University of Denmark).	Arden B, 1998, CURR OPIN IMMUNOL, V10, P74, DOI 10.1016/S0952-7915(98)80035-6; Assarsson E, 2007, J IMMUNOL, V178, P7890, DOI 10.4049/jimmunol.178.12.7890; Brehm MA, 2002, NAT IMMUNOL, V3, P627, DOI 10.1038/ni806; CASANOVA JL, 1993, IMMUNOL TODAY, V14, P391, DOI 10.1016/0167-5699(93)90140-G; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Felix NJ, 2007, NAT IMMUNOL, V8, P388, DOI 10.1038/ni1446; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Hemmer B, 1998, J IMMUNOL, V160, P3631; Hohn H, 2003, EUR J IMMUNOL, V33, P1613, DOI 10.1002/eji.200323480; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; Kim SK, 2005, J EXP MED, V201, P523, DOI 10.1084/jem.20041337; KULKARNI AB, 1993, J VIROL, V67, P4086, DOI 10.1128/JVI.67.7.4086-4092.1993; La Rosa C, 2001, BLOOD, V97, P1776; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; Lauemoller S L, 2000, Rev Immunogenet, V2, P477; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Nilges K, 2003, J VIROL, V77, P5464, DOI 10.1128/JVI.77.9.5464-5474.2003; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rolland M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000823; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Selin LK, 2006, IMMUNOL REV, V211, P164, DOI 10.1111/j.0105-2896.2006.00394.x; SHANNON CE, 1948, BELL SYSTEM TECH J, V27; Spaulding AC, 1999, J VIROL, V73, P398, DOI 10.1128/JVI.73.1.398-403.1999; Tangri S, 2001, J EXP MED, V194, P833, DOI 10.1084/jem.194.6.833; Van Epps HL, 1999, J VIROL, V73, P5301, DOI 10.1128/JVI.73.7.5301-5308.1999; Wedemeyer H, 2001, J VIROL, V75, P11392, DOI 10.1128/JVI.75.23.11392-11400.2001; Welsh RM, 2004, ANNU REV IMMUNOL, V22, P711, DOI 10.1146/annurev.immunol.22.012703.104527; Wong CP, 2006, J IMMUNOL, V176, P1637, DOI 10.4049/jimmunol.176.3.1637; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zivny J, 1999, J IMMUNOL, V163, P2754	38	80	82	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1831	10.1371/journal.pone.0001831	http://dx.doi.org/10.1371/journal.pone.0001831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350167	Green Submitted, gold, Green Published			2022-12-27	WOS:000260762300033
J	Rosado, A; Zanella, F; Garcia, B; Carnero, A; Link, WG				Rosado, Aranzazu; Zanella, Fabian; Garcia, Beatriz; Carnero, Amancio; Link, Wolfgang			A Dual-Color Fluorescence-Based Platform to Identify Selective Inhibitors of Akt Signaling	PLOS ONE			English	Article								Background: Inhibition of Akt signaling is considered one of the most promising therapeutic strategies for many cancers. However, rational target-orientated approaches to cell based drug screens for anti-cancer agents have historically been compromised by the notorious absence of suitable control cells. Methodology/Principal Findings: In order to address this fundamental problem, we have developed BaFiso, a live-cell screening platform to identify specific inhibitors of this pathway. BaFiso relies on the co-culture of isogenic cell lines that have been engineered to sustain interleukin-3 independent survival of the parental Ba/F3 cells, and that are individually tagged with different fluorescent proteins. Whilst in the first of these two lines cell survival in the absence of IL-3 is dependent on the expression of activated Akt, the cells expressing constitutively-activated Stat5 signaling display IL-3 independent growth and survival in an Akt-independent manner. Small molecules can then be screened in these lines to identify inhibitors that rescue IL-3 dependence. Conclusions/Significance: BaFiso measures differential cell survival using multiparametric live cell imaging and permits selective inhibitors of Akt signaling to be identified. BaFiso is a platform technology suitable for the identification of small molecule inhibitors of IL-3 mediated survival signaling.	[Rosado, Aranzazu; Zanella, Fabian; Garcia, Beatriz; Carnero, Amancio; Link, Wolfgang] Ctr Nacl Investigaciones Oncol CNIO, Expt Therapeut Program, Madrid, Spain		Rosado, A (corresponding author), Ctr Nacl Investigaciones Oncol CNIO, Expt Therapeut Program, Madrid, Spain.	wlink@cnio.es	IBIS, CANCER/P-3323-2015; Link, Wolfgang/F-4435-2012	Link, Wolfgang/0000-0002-3340-5165; Carnero, Amancio/0000-0003-4357-3979; Rosado Diez, Aranzazu/0000-0002-3362-2450	Spanish MCyT [BIO2002-00197]; Spanish MEC [BIO2006-02432]; Marie Curie Fellowship	Spanish MCyT(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Spanish MEC(Spanish Government); Marie Curie Fellowship(European Commission)	This work was supported by a grant from the Spanish MCyT (BIO2002-00197) and the Spanish MEC (project BIO2006-02432). F.Z. is the recipient of a Marie Curie Fellowship.	Balis FM, 2002, J NATL CANCER I, V94, P78, DOI 10.1093/jnci/94.2.78; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Carnero A, 2000, NUCLEIC ACIDS RES, V28, P2234, DOI 10.1093/nar/28.11.2234; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; delPeso L, 1997, SCIENCE, V278, P687; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Gibbs JB, 2000, SCIENCE, V287, P1969, DOI 10.1126/science.287.5460.1969; Hoover RR, 2001, ONCOGENE, V20, P5826, DOI 10.1038/sj.onc.1204549; Komander D, 2003, BIOCHEM J, V375, P255, DOI 10.1042/BJ20031119; Leverrier Y, 1999, CELL DEATH DIFFER, V6, P290, DOI 10.1038/sj.cdd.4400492; Link W, 2005, J CELL BIOCHEM, V95, P979, DOI 10.1002/jcb.20479; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; SATO N, 1993, EMBO J, V12, P4181, DOI 10.1002/j.1460-2075.1993.tb06102.x; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Torrance CJ, 2001, NAT BIOTECHNOL, V19, P940, DOI 10.1038/nbt1001-940; Zanella F, 2007, ASSAY DRUG DEV TECHN, V5, P333, DOI 10.1089/adt.2007.058; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	23	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2008	3	3							e1823	10.1371/journal.pone.0001823	http://dx.doi.org/10.1371/journal.pone.0001823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KY	18350159	Green Published, gold			2022-12-27	WOS:000260762300025
J	Hallett, TB; Singh, K; Smith, JA; White, RG; Abu-Raddad, LJ; Garnett, GP				Hallett, Timothy B.; Singh, Kanwarjit; Smith, Jennifer A.; White, Richard G.; Abu-Raddad, Laith J.; Garnett, Geoff P.			Understanding the Impact of Male Circumcision Interventions on the Spread of HIV in Southern Africa	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; COMMUNITY RANDOMIZED-TRIALS; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; MATHEMATICAL-MODELS; BEHAVIOR-CHANGE; PREVENTION; INFECTION; TRANSMISSION; RAKAI	Background: Three randomised controlled trials have clearly shown that circumcision of adult men reduces the chance that they acquire HIV infection. However, the potential impact of circumcision programmes - either alone or in combination with other established approaches - is not known and no further field trials are planned. We have used a mathematical model, parameterised using existing trial findings, to understand and predict the impact of circumcision programmes at the population level. Findings: Our results indicate that circumcision will lead to reductions in incidence for women and uncircumcised men, as well as those circumcised, but that even the most effective intervention is unlikely to completely stem the spread of the virus. Without additional interventions, HIV incidence could eventually be reduced by 25-35%, depending on the level of coverage achieved and whether onward transmission from circumcised men is also reduced. However, circumcision interventions can act synergistically with other types of prevention programmes, and if efforts to change behaviour are increased in parallel with the scale-up of circumcision services, then dramatic reductions in HIV incidence could be achieved. In the long-term, this could lead to reduced AIDS deaths and less need for anti-retroviral therapy. Any increases in risk behaviours following circumcision, i.e. 'risk compensation', could offset some of the potential benefit of the intervention, especially for women, but only very large increases would lead to more infections overall. Conclusions: Circumcision will not be the silver bullet to prevent HIV transmission, but interventions could help to substantially protect men and women from infection, especially in combination with other approaches.	[Hallett, Timothy B.; Smith, Jennifer A.; Garnett, Geoff P.] Imperial Coll London, Dept Infect Dis Epidemiol, London, England; [Singh, Kanwarjit] Bill & Melinda Gates Fdn, Seattle, WA USA; [White, Richard G.] London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London, England; [Abu-Raddad, Laith J.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA USA	Imperial College London; Bill & Melinda Gates Foundation; University of London; London School of Hygiene & Tropical Medicine; Fred Hutchinson Cancer Center	Hallett, TB (corresponding author), Imperial Coll London, Dept Infect Dis Epidemiol, London, England.	timothy.hallett@imperial.ac.uk	Abu-Raddad, Laith J/AAY-1441-2020; White, Richard G/D-5407-2009; Hallett, Timothy/A-2390-2011; Garnett, Geoffrey P/A-9312-2008	Abu-Raddad, Laith J/0000-0003-0790-0506; White, Richard G/0000-0003-4410-6635; Hallett, Timothy/0000-0002-9681-0424; Smith, Jennifer/0000-0002-8809-8553	Wellcome Trust; UK Medical Research Council; Puget Sound Partners for Global Healt; UNAIDS; Medical Research Council [G0600719B] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Puget Sound Partners for Global Healt; UNAIDS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	For funding support TBH thanks the Wellcome Trust; RGW thanks the UK Medical Research Council and the Wellcome Trust; LJA-R thanks the Puget Sound Partners for Global Health; and, GPG thanks UNAIDS, the Wellcome Trust and the UK Medical Research Council.	Agot KE, 2007, JAIDS-J ACQ IMM DEF, V44, P66, DOI 10.1097/01.qai.0000242455.05274.20; *AIDSM, 2007, WOM MAY BE NEIGHT HI; Alary M, 2003, AIDS, V17, P2661, DOI 10.1097/00002030-200312050-00014; ANDERSON R M, 1991; ANDERSON RM, 1992, PHILOS T R SOC B, V336, P135, DOI 10.1098/rstb.1992.0052; ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0; Autier P, 1998, JNCI-J NATL CANCER I, V90, P1873, DOI 10.1093/jnci/90.24.1873; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Baggaley RF, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-9; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Boerma JT, 2003, SEX TRANSM DIS, V30, P779, DOI 10.1097/01.OLQ.0000078820.62897.A6; deGourville EM, 1998, INT J STD AIDS, V9, P151, DOI 10.1258/0956462981921918; Ferry B, 2001, AIDS, V15, pS41, DOI 10.1097/00002030-200108004-00005; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; Garnett GP, 2002, NAT MED, V8, P651, DOI 10.1038/nm0702-651; Garnett GP, 2002, SEX TRANSM INFECT, V78, P7, DOI 10.1136/sti.78.1.7; Ghani AC, 2000, SEX TRANSM DIS, V27, P579, DOI 10.1097/00007435-200011000-00006; Grassly NC, 2001, B WORLD HEALTH ORGAN, V79, P1121; Gray RH, 2000, AIDS, V14, P2371, DOI 10.1097/00002030-200010200-00019; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Gregson S, 2002, AIDS, V16, P643, DOI 10.1097/00002030-200203080-00017; Gregson S, 2007, PLOS MED, V4, P545, DOI 10.1371/journal.pmed.0040102; Grosskurth H, 2000, LANCET, V355, P1981, DOI 10.1016/S0140-6736(00)02336-9; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Hallett TB, 2008, INT J EPIDEMIOL, V37, P77, DOI 10.1093/ije/dym232; Hallett TB, 2006, LANCET, V368, P116, DOI 10.1016/S0140-6736(06)68997-6; Hallett TB, 2006, SEX TRANSM INFECT, V82, pI1, DOI 10.1136/sti.2005.016014; Hallett TB, 2007, SEX TRANSM INFECT, V83, pI55, DOI 10.1136/sti.2006.023663; Halperin DT, 2004, LANCET, V364, P1913, DOI 10.1016/S0140-6736(04)17487-4; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Kapiga SH, 1998, AIDS, V12, P75, DOI 10.1097/00002030-199801000-00009; Kilian AHD, 1999, AIDS, V13, P391, DOI 10.1097/00002030-199902250-00012; Lagarde E, 2001, AIDS, V15, pS71, DOI 10.1097/00002030-200108004-00008; MCNEIL DG, 2007, TIME RETHINK AIDSS G; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Nagelkerke NJD, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-16; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Stover J, 2006, SCIENCE, V311, P1474, DOI 10.1126/science.1121176; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; Susser M, 1996, AM J PUBLIC HEALTH, V86, P1713, DOI 10.2105/AJPH.86.12.1713; Tshehlo R, 2007, COSTING MALE CIRCUMC; Turner AN, 2007, AIDS, V21, P1779, DOI 10.1097/QAD.0b013e32827b144c; UNAIDS, 1999, TRENDS HIV INC PREV; *UNAIDS, 2007, SAF VOL INF MAL CIRC; *UNAIDS, 2007, WHO UNAIDS ANN REC E; *UNAIDS WHO, 2007, AIDS EP UPD; *UNAIDS WHO LOND S, 2007, MAL CIRC GLOB TRENDS; WATSONJONES D, 2007, IMPACT HSV 2 SUPPRES; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; WEISS H, PERSISTING IN PRESS; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; White RG, 2004, JAIDS-J ACQ IMM DEF, V37, P1500, DOI 10.1097/01.qai.0000127062.94627.31; WHITE RG, J ACQUIR IM IN PRESS; WHITE RG, 2007, MALE CIRCUMCISION HI; *WHO UNAIDS, 2007, NW DAT MAL CIRC HIV; *WHO UNAIDS UNICEF, 2007, U ACC SCAL PRIOR HIV; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262	70	104	104	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2212	10.1371/journal.pone.0002212	http://dx.doi.org/10.1371/journal.pone.0002212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	391UK	18493593	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000262258700021
J	Antezana, MA; Jordan, IK				Antezana, Marcos A.; Jordan, I. King			Highly Conserved Regimes of Neighbor-Base-Dependent Mutation Generated the Background Primary-Structural Heterogeneities along Vertebrate Chromosomes	PLOS ONE			English	Article							TRANSCRIPTION-COUPLED REPAIR; SPECIALIZED DNA-POLYMERASES; DOUBLE-STRAND BREAKS; GC-CONTENT; HOMOLOGOUS RECOMBINATION; MOLECULAR EVOLUTION; DIFFERENT RATES; REPLICATION; GENE; GENOME	The content of guanine+cytosine varies markedly along the chromosomes of homeotherms and great effort has been devoted to studying this heterogeneity and its biological implications. Already before the DNA-sequencing era, however, it was established that the dinucleotides in the DNA of mammals in particular, and of most organisms in general, show striking over- and under-representations that cannot be explained by the base composition. Here we show that in the coding regions of vertebrates both GC content and codon occurrences are strongly correlated with such "motif preferences" even though we quantify the latter using an index that is not affected by the base composition, codon usage, and protein-sequence encoding. These correlations are likely to be the result of the long-term shaping of the primary structure of genic and non-genic DNA by a regime of mutation of which central features have been maintained by natural selection. We find indeed that these preferences are conserved in vertebrates even more rigidly than codon occurrences and we show that the occurrence-preference correlations are stronger in intronic and non-genic DNA, with the R(2)s reaching 99% when GC content is similar to 0.5. The mutation regime appears to be characterized by rates that depend markedly on the bases present at the site preceding and at that following each mutating site, because when we estimate such rates of neighbor-base-dependent mutation (NBDM) from substitutions retrieved from alignments of coding, intronic, and non-genic mammalian DNA sorted and grouped by GC content, they suffice to simulate DNA sequences in which motif occurrences and preferences as well as the correlations of motif preferences with GC content and with motif occurrences, are very similar to the mammalian ones. The best fit, however, is obtained with NBDM regimes lacking strand effects, which indicates that over the long term NBDM switches strands in the germline as one would expect for effects due to loosely contained background transcription. Finally, we show that human coding regions are less mutable under the estimated NBDM regimes than under matched context-independent mutation and that this entails marked differences between the spectra of amino-acid mutations that either mutation regime should generate. In the Discussion we examine the mechanisms likely to underlie NBDM heterogeneity along chromosomes and propose that it reflects how the diversity and activity of lesion-bypass polymerases (LBPs) track the landscapes of scheduled and non-scheduled genome repair, replication, and transcription during the cell cycle. We conclude that the primary structure of vertebrate genic DNA at and below the trinucleotide level has been governed over the long term by highly conserved regimes of NBDM which should be under direct natural selection because they alter drastically missense-mutation rates and hence the somatic and the germline mutational loads. Therefore, the non-coding DNA of vertebrates may have been shaped by NBDM only epiphenomenally, with non-genic DNA being affected mainly when found in the proximity of genes.	[Antezana, Marcos A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Jordan, I. King] Georgia Inst Technol, Atlanta, GA USA	University of Chicago; University System of Georgia; Georgia Institute of Technology	Antezana, MA (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	marcos.antezana@gmail.com		Antezana, marcos/0000-0001-5052-2219				Aboussekhra A, 2005, EMBO J, V24, P1999, DOI 10.1038/sj.emboj.7600665; AGUILERA A, 2006, NATURE STRUCTURAL MO, V12, P737; Antezana M, 2003, J MOL EVOL, V56, P198, DOI 10.1007/s00239-002-2394-1; Antezana MA, 1999, J MOL EVOL, V49, P36, DOI 10.1007/PL00006532; ANTEZANA MA, 2005, J MOL EVOL, V61, P1; BARRAI I, 1995, INT J PEPT PROT RES, V45, P326; Bernardi G, 2000, GENE, V259, P31, DOI 10.1016/S0378-1119(00)00441-8; Bernardi G., 2005, STRUCTURAL EVOLUTION; Bielas JH, 2000, P NATL ACAD SCI USA, V97, P11391, DOI 10.1073/pnas.190330997; Bielas JH, 2003, P NATL ACAD SCI USA, V100, P12853, DOI 10.1073/pnas.2235595100; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; CACCIO S, 1994, J MOL EVOL, V39, P331, DOI 10.1007/BF00160265; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Drake JW, 2006, GENETICS, V173, P1; Duan JB, 2003, J MOL EVOL, V57, P694, DOI 10.1007/s00239-003-2519-1; Dufton MJ, 1997, J THEOR BIOL, V187, P165, DOI 10.1006/jtbi.1997.0443; Duret L, 2006, J MOL EVOL, V62, P803, DOI 10.1007/s00239-005-0228-7; DYKHUIZEN D, 1978, EVOLUTION, V32, P125, DOI 10.1111/j.1558-5646.1978.tb01103.x; ESPOSITO MS, 1993, CURR GENET, V23, P430, DOI 10.1007/BF00312630; Farah JA, 2005, GENETICS, V169, P1261, DOI 10.1534/genetics.104.037515; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Fujii S, 2007, J MOL BIOL, V372, P883, DOI 10.1016/j.jmb.2007.07.036; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Gowrishankar J, 2004, MOL MICROBIOL, V54, P598, DOI 10.1111/j.1365-2958.2004.04289.x; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; Hanawalt PC, 2001, ENVIRON MOL MUTAGEN, V38, P89, DOI 10.1002/em.1057; HAND R, 1978, CELL, V15, P317, DOI 10.1016/0092-8674(78)90001-6; Heddle JA, 2005, ENVIRON MOL MUTAGEN, V45, P143, DOI 10.1002/em.20112; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HOLMQUIST G, 1982, CELL, V31, P121, DOI 10.1016/0092-8674(82)90411-1; Holmquist GP, 2006, CYTOGENET GENOME RES, V114, P96, DOI 10.1159/000093326; Holmquist GP, 2002, MUTAT RES-FUND MOL M, V510, P1, DOI 10.1016/S0027-5107(02)00247-6; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Janoueix-Lerosey I, 2005, CELL CYCLE, V4, P1842, DOI 10.4161/cc.4.12.2257; Jaroudi S, 2007, MUTAT RES-REV MUTAT, V635, P53, DOI 10.1016/j.mrrev.2006.09.002; Jeon Y, 2005, P NATL ACAD SCI USA, V102, P6419, DOI 10.1073/pnas.0405088102; Jiricny J, 2004, MOL CELL, V13, P768, DOI 10.1016/S1097-2765(04)00149-2; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; Jordan IK, 2001, GENOME BIOL, V2; Jordan IK, 2005, GENE, V345, P119, DOI 10.1016/j.gene.2004.11.034; Karlin S, 1996, J MOL BIOL, V262, P459, DOI 10.1006/jmbi.1996.0528; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Keeney S, 2006, BIOCHEM SOC T, V34, P523, DOI 10.1042/BST0340523; KING JL, 1969, SCIENCE, V164, P788, DOI 10.1126/science.164.3881.788; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; KONDRASHOV FA, 2005, J THEOR BIOL; Langston LD, 2006, MOL CELL, V23, P155, DOI 10.1016/j.molcel.2006.05.034; Lehmann AR, 2006, MOL CELL, V24, P493, DOI 10.1016/j.molcel.2006.10.021; Lehmann AR, 2006, DNA REPAIR, V5, P1495, DOI 10.1016/j.dnarep.2006.07.002; Lettier G, 2006, PLOS GENET, V2, P1773, DOI 10.1371/journal.pgen.0020194; Li WH, 2002, CURR OPIN GENET DEV, V12, P650, DOI 10.1016/S0959-437X(02)00354-4; Li XL, 2006, GENE DEV, V20, P1838, DOI 10.1101/gad.1438306; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; MAGNI GE, 1962, GENETICS, V47, P1097; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Mellon I, 2005, MUTAT RES-FUND MOL M, V577, P155, DOI 10.1016/j.mrfmmm.2005.03.016; MELLON I, 1986, P NATL ACAD SCI USA, V83, P8878, DOI 10.1073/pnas.83.23.8878; Meunier J, 2004, MOL BIOL EVOL, V21, P984, DOI 10.1093/molbev/msh070; MINDEN JS, 1989, J CELL BIOL, V109, P505, DOI 10.1083/jcb.109.2.505; MIYATA T, 1987, P JPN ACAD B-PHYS, V63, P327, DOI 10.2183/pjab.63.327; Monroe JJ, 2001, MUTAT RES-FUND MOL M, V476, P1, DOI 10.1016/S0027-5107(01)00081-1; Nouspikel T, 2000, MOL CELL BIOL, V20, P1562, DOI 10.1128/MCB.20.5.1562-1570.2000; NUSSINOV R, 1981, J MOL BIOL, V149, P125, DOI 10.1016/0022-2836(81)90264-3; NUSSINOV R, 1984, NUCLEIC ACIDS RES, V12, P1749, DOI 10.1093/nar/12.3.1749; NUSSINOV R, 1981, J BIOL CHEM, V256, P8458; Pavlov YI, 2003, CURR BIOL, V13, P744, DOI 10.1016/S0960-9822(03)00284-7; Pavlov YI, 2002, MOL CELL, V10, P207, DOI 10.1016/S1097-2765(02)00567-1; Prado F, 2005, MOL CELL BIOL, V25, P1526, DOI 10.1128/MCB.25.4.1526-1536.2005; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rattray AJ, 2003, ANNU REV GENET, V37, P31, DOI 10.1146/annurev.genet.37.042203.132748; Rattray AJ, 2005, MOL CELL, V20, P658, DOI 10.1016/j.molcel.2005.11.018; Rattray AJ, 2001, GENETICS, V158, P109; Schleiermacher G, 2003, CANCER GENET CYTOGEN, V141, P32, DOI 10.1016/S0165-4608(02)00644-1; Schmegner C, 2005, GENOMICS, V86, P439, DOI 10.1016/j.ygeno.2005.06.011; SETLOW P, 1976, HDB BIOCH MOL BIOL N, V2, P312; Stoltzfus A, 2006, EVOL DEV, V8, P304, DOI 10.1111/j.1525-142X.2006.00101.x; Symington LS, 2005, EMBO REP, V6, P512, DOI 10.1038/sj.embor.7400438; Tang H, 2006, MOL BIOL EVOL, V23, P372, DOI 10.1093/molbev/msj043; Tang H, 2004, MOL BIOL EVOL, V21, P1548, DOI 10.1093/molbev/msh158; VANHOFFEN A, 1995, EMBO J, V14, P360, DOI 10.1002/j.1460-2075.1995.tb07010.x; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Walter CA, 1998, P NATL ACAD SCI USA, V95, P10015, DOI 10.1073/pnas.95.17.10015; Willingham AT, 2006, CELL, V125, P1215, DOI 10.1016/j.cell.2006.06.009; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Wright S, 1931, GENETICS, V16, P0097; Xu GG, 2005, BIOL REPROD, V73, P123, DOI 10.1095/biolreprod.104.039123; Yampolsky LY, 2005, GENETICS, V170, P1459, DOI 10.1534/genetics.104.039107; Yi SJ, 2005, MOL BIOL EVOL, V22, P1223, DOI 10.1093/molbev/msi106; Zink D, 2006, CHROMOSOMA, V115, P273, DOI 10.1007/s00412-006-0062-8	94	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2145	10.1371/journal.pone.0002145	http://dx.doi.org/10.1371/journal.pone.0002145			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478116	Green Published, gold, Green Submitted			2022-12-27	WOS:000262172800010
J	Loyola, RD; Becker, CG; Kubota, U; Haddad, CFB; Fonseca, CR; Lewinsohn, TM				Loyola, Rafael Dias; Becker, Carlos Guilherme; Kubota, Umberto; Baptista Haddad, Celio Fernando; Fonseca, Carlos Roberto; Lewinsohn, Thomas Michael			Hung Out to Dry: Choice of Priority Ecoregions for Conserving Threatened Neotropical Anurans Depends on Life-History Traits	PLOS ONE			English	Article							IDENTIFYING CONSERVATION PRIORITIES; RESERVE SELECTION ALGORITHMS; POPULATION DECLINES; ECOLOGICAL TRAITS; SPECIES RICHNESS; INDICATOR GROUPS; BIODIVERSITY; DIVERSITY; LANDSCAPE; HABITAT	Background: In the Neotropics, nearly 35% of amphibian species are threatened by habitat loss, habitat fragmentation, and habitat split; anuran species with different developmental modes respond to habitat disturbance in different ways. This entails broad-scale strategies for conserving biodiversity and advocates for the identification of high conservation-value regions that are significant in a global or continental context and that could underpin more detailed conservation assessments towards such areas. Methodology/Principal Findings: We identified key ecoregion sets for anuran conservation using an algorithm that favors complementarity (beta-diversity) among ecoregions. Using the WWF's Wildfinder database, which encompasses 700 threatened anuran species in 119 Neotropical ecoregions, we separated species into those with aquatic larvae (AL) or terrestrial development (TD), as this life-history trait affects their response to habitat disturbance. The conservation target of 100% of species representation was attained with a set of 66 ecoregions. Among these, 30 were classified as priority both for species with AL and TD, 26 were priority exclusively for species with AL, and 10 for species with TD only. Priority ecoregions for both developmental modes are concentrated in the Andes and in Mesoamerica. Ecoregions important for conserving species with AL are widely distributed across the Neotropics. When anuran life histories were ignored, species with AL were always underrepresented in priority sets. Conclusions/Significance: The inclusion of anuran developmental modes in prioritization analyses resulted in more comprehensive coverage of priority ecoregions-especially those essential for species that require an aquatic habitat for their reproduction-when compared to usual analyses that do not consider this life-history trait. This is the first appraisal of the most important regions for conservation of threatened Neotropical anurans. It is also a first endeavor including anuran life-history traits in priority area-selection for conservation, with a clear gain in comprehensiveness of the selection process.	[Loyola, Rafael Dias] Univ Estadual Campinas, Inst Biol, Programa Posgrad Ecol, Sao Paulo, Brazil; [Loyola, Rafael Dias; Becker, Carlos Guilherme; Kubota, Umberto; Lewinsohn, Thomas Michael] Univ Estadual Campinas, Inst Biol, Dept Zool, Sao Paulo, Brazil; [Baptista Haddad, Celio Fernando] Univ Estadual Paulista, Dept Zool, Sao Paulo, Brazil; [Fonseca, Carlos Roberto] Univ Vale Rio dos Sinos, Sao Leopoldo, Sao Leopoldo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade do Vale do Rio dos Sinos (Unisinos)	Loyola, RD (corresponding author), Univ Estadual Campinas, Inst Biol, Programa Posgrad Ecol, Sao Paulo, Brazil.	avispa@gmail.com	Lewinsohn, Thomas M/D-5880-2012; Loyola, Rafael/A-4425-2008; Fonseca, Carlos Roberto/V-5869-2017; Fonseca, Carlos Roberto/A-9273-2013; Becker, C. Guilherme/B-9887-2014; Loyola, Rafael/S-3978-2019; Haddad, Célio F. B./C-4267-2012	Lewinsohn, Thomas M/0000-0001-5950-5343; Loyola, Rafael/0000-0001-5323-2735; Fonseca, Carlos Roberto/0000-0003-0292-0399; Loyola, Rafael/0000-0001-5323-2735; Haddad, Célio F. B./0000-0002-7044-5764	CNPq [140267/2005-0, 302512/2005-5, 305428/2005-5, 306049/2004-0]; FAPESP [04/13132-3]; CAPES;  [04/15482-1]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); 	RDL, CGB and UK were supported by CNPq (140267/2005-0), FAPESP (04/13132-3) and CAPES, respectively. CFBH thanks FAPESP and CNPq (302512/2005-5) for financial support. CRF is supported by CNPq (305428/2005-5). TML was funded by FAPESP (04/15482-1) and CNPq (306049/2004-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDELMAN S, 1999, SITES V 1 0 AN TOOLB; [Anonymous], 2004, HOTSPOTS REVISITED E; Becker CG, 2008, BIODIVERS CONSERV, V17, P2297, DOI 10.1007/s10531-007-9298-8; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Bell KE, 2006, CONSERV BIOL, V20, P1750, DOI 10.1111/j.1523-1739.2006.00522.x; Bini LM, 2006, DIVERS DISTRIB, V12, P475, DOI 10.1111/j.1366-9516.2006.00286.x; BOJORQUEZTAPIA LA, 1995, ECOL APPL, V5, P215, DOI 10.2307/1942065; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Cabeza M, 2001, TRENDS ECOL EVOL, V16, P242, DOI 10.1016/S0169-5347(01)02125-5; CALDERON R, 2004, NATURE CONSERVANCY; Csuti B, 1997, BIOL CONSERV, V80, P83, DOI 10.1016/S0006-3207(96)00068-7; Diniz JAF, 2006, ACTA OECOL, V29, P9, DOI 10.1016/j.actao.2005.07.004; Duellman W.E., 1979, MONOGR MUS NAT HIST, P371, DOI 10.5962/bhl.title.3207; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ferrier S, 2000, BIOL CONSERV, V93, P303, DOI 10.1016/S0006-3207(99)00149-4; Frost DR, 2007, AMPHIBIAN SPECIES WO; Garcia A, 2006, BIOL CONSERV, V130, P25, DOI 10.1016/j.biocon.2005.11.030; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Guerry AD, 2002, CONSERV BIOL, V16, P745, DOI 10.1046/j.1523-1739.2002.00557.x; Haddad CFB, 2005, BIOSCIENCE, V55, P724, DOI 10.1641/0006-3568(2005)055[0724:RMIFC]2.0.CO;2; Hero JM, 2005, J ZOOL, V267, P221, DOI 10.1017/S0952836905007296; Howard PC, 1998, NATURE, V394, P472, DOI 10.1038/28843; *IUCN CONS INT NAT, 2006, GLOB AMPH ASS; KIRKPATRICK JB, 1983, BIOL CONSERV, V25, P127, DOI 10.1016/0006-3207(83)90056-3; Kress WJ, 1998, BIODIVERS CONSERV, V7, P1577, DOI 10.1023/A:1008889803319; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Loyola RD, 2007, DIVERS DISTRIB, V13, P389, DOI 10.1111/j.1472-4642.2007.00345.x; LOYOLA RD, 2008, DIVERS DIST IN PRESS; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Moore JL, 2003, CONSERV BIOL, V17, P207, DOI 10.1046/j.1523-1739.2003.01126.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pearman PB, 1997, CONSERV BIOL, V11, P1211, DOI 10.1046/j.1523-1739.1997.96202.x; Pimenta BVS, 2005, SCIENCE, V309, DOI 10.1126/science.1112996; Pineda E, 2004, BIOL CONSERV, V117, P499, DOI 10.1016/j.biocon.2003.08.009; Pope SE, 2000, ECOLOGY, V81, P2498; Possingham H, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P291; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Pressey RL, 1996, BIOL CONSERV, V76, P259, DOI 10.1016/0006-3207(95)00120-4; Pressey RL, 1997, BIOL CONSERV, V80, P207, DOI 10.1016/S0006-3207(96)00045-6; Reyers B, 2000, P ROY SOC B-BIOL SCI, V267, P505, DOI 10.1098/rspb.2000.1029; Rittenhouse TAG, 2006, BIOL CONSERV, V131, P14, DOI 10.1016/j.biocon.2006.01.024; Sarkar S, 2002, J BIOSCIENCES, V27, P299, DOI 10.1007/BF02704961; Sierra R, 2002, LANDSCAPE URBAN PLAN, V59, P95, DOI 10.1016/S0169-2046(02)00006-3; Silvano RAM, 2005, ECOL ECON, V53, P369, DOI 10.1016/j.ecolecon.2004.12.003; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tocher Mandy D., 2001, P235; Urbina-Cardona JN, 2006, BIOL CONSERV, V132, P61, DOI 10.1016/j.biocon.2006.03.014; VIANA V.M., 1997, TROPICAL FOREST REMN, P347; *WORLD WILDL FUND, 2006, WILDFINDER ONL DAT S; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	56	55	61	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2120	10.1371/journal.pone.0002120	http://dx.doi.org/10.1371/journal.pone.0002120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461175	Green Published, Green Submitted, gold			2022-12-27	WOS:000261642400041
J	Kinkhabwala, A; Guet, CC				Kinkhabwala, Ali; Guet, Calin C.			Uncovering cis Regulatory Codes Using Synthetic Promoter Shuffling	PLOS ONE			English	Article								Revealing the spectrum of combinatorial regulation of transcription at individual promoters is essential for understanding the complex structure of biological networks. However, the computations represented by the integration of various molecular signals at complex promoters are difficult to decipher in the absence of simple cis regulatory codes. Here we synthetically shuffle the regulatory architecture-operator sequences binding activators and repressors-of a canonical bacterial promoter. The resulting library of complex promoters allows for rapid exploration of promoter encoded logic regulation. Among all possible logic functions, NOR and ANDN promoter encoded logics predominate. A simple transcriptional cis regulatory code determines both logics, establishing a straightforward map between promoter structure and logic phenotype. The regulatory code is determined solely by the type of transcriptional regulation combinations: two repressors generate a NOR: NOT (a OR b) whereas a repressor and an activator generate an ANDN: a AND NOT b. Three-input versions of both logics, having an additional repressor as an input, are also present in the library. The resulting complex promoters cover a wide dynamic range of transcriptional strengths. Synthetic promoter shuffling represents a fast and efficient method for exploring the spectrum of complex regulatory functions that can be encoded by complex promoters. From an engineering point of view, synthetic promoter shuffling enables the experimental testing of the functional properties of complex promoters that cannot necessarily be inferred ab initio from the known properties of the individual genetic components. Synthetic promoter shuffling may provide a useful experimental tool for studying naturally occurring promoter shuffling.	[Kinkhabwala, Ali; Guet, Calin C.] Rockefeller Univ, Lab Living Matter, New York, NY 10021 USA; [Kinkhabwala, Ali] Max Planck Inst Mol Physiol, Syst Cell Biol, Dortmund, Germany; [Guet, Calin C.] Univ Chicago, Inst Biophys Dynam, Chicago, IL USA	Rockefeller University; Max Planck Society; University of Chicago	Kinkhabwala, A (corresponding author), Rockefeller Univ, Lab Living Matter, 1230 York Ave, New York, NY 10021 USA.	kinkhabw@mpi-dortmund.mpg.de; calin@uchicago.edu			NIH [Ruth L. Kirschstein NRSA fellowship]; Yen Fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yen Fellowship	A.K. was supported by an NIH Ruth L. Kirschstein NRSA fellowship, C.C.G. was supported by a Yen Fellowship.	Babu MM, 2003, TRENDS GENET, V19, P75, DOI 10.1016/S0168-9525(02)00039-2; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Brinig MM, 2006, J BACTERIOL, V188, P2375, DOI 10.1128/JB.188.7.2375-2382.2006; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chuzhanova NA, 2000, GENE, V254, P9, DOI 10.1016/S0378-1119(00)00308-5; Chuzhanova NA, 2002, EVOLUTION, V56, P224; Davidson E. H., 2001, DEV EVOLUTION; DIEDERICH L, 1992, PLASMID, V28, P14, DOI 10.1016/0147-619X(92)90032-6; Gralla JD, 1996, ESCHERICHIA COLI SAL, P1232; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; GUET CC, 2004, THESIS PRINCETON U P; Hermsen R, 2006, PLOS COMPUT BIOL, V2, P1552, DOI 10.1371/journal.pcbi.0020164; Kauffman S. A., 1993, ORIGINS ORDER; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; LANZER M, 1988, P NATL ACAD SCI USA, V85, P8973, DOI 10.1073/pnas.85.23.8973; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Morgan-Kiss RM, 2002, P NATL ACAD SCI USA, V99, P7373, DOI 10.1073/pnas.122227599; REEDER T, 1993, J MOL BIOL, V231, P205, DOI 10.1006/jmbi.1993.1276; Sanges R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r56; Schleif R, 2003, BIOESSAYS, V25, P274, DOI 10.1002/bies.10237; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Stone JR, 2001, MOL BIOL EVOL, V18, P1764, DOI 10.1093/oxfordjournals.molbev.a003964; SUGITA M, 1961, J PHYS SOC JPN, V16, P737, DOI 10.1143/JPSJ.16.737; Surguchov A, 1991, Biomed Sci, V2, P22; Tan K, 2005, GENOME RES, V15, P312, DOI 10.1101/gr.3069205; Walser JC, 2006, PLOS GENET, V2, P1541, DOI 10.1371/journal.pgen.0020165; Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhang X, 1996, J MOL BIOL, V258, P14, DOI 10.1006/jmbi.1996.0230	30	33	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2030	10.1371/journal.pone.0002030	http://dx.doi.org/10.1371/journal.pone.0002030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446205	Green Published, gold, Green Submitted			2022-12-27	WOS:000261572300004
J	Michael, JB; Nigel, JB; Edward, MS; Clokie, MRJ; Mann, NH; Bryan, SJ				Bryan, Michael J.; Burroughs, Nigel J.; Spence, Edward M.; Clokie, Martha R. J.; Mann, Nicholas H.; Bryan, Samantha J.			Evidence for the Intense Exchange of MazG in Marine Cyanophages by Horizontal Gene Transfer	PLOS ONE			English	Article								Background: S-PM2 is a phage capable of infecting strains of unicellular cyanobacteria belonging to the genus Synechococcus. S-PM2, like other myoviruses infecting marine cyanobacteria, encodes a number of bacterial-like genes. Amongst these genes is one encoding a MazG homologue that is hypothesized to be involved in the adaption of the infected host for production of progeny phage. Methodology/Principal Findings: This study focuses on establishing the occurrence of mazG homologues in other cyanophages isolated from different oceanic locations. Degenerate PCR primers were designed using the mazG gene of S-PM2. The mazG gene was found to be widely distributed and highly conserved among Synechococcus myoviruses and podoviruses from diverse oceanic provinces. Conclusions/Significance: This study provides evidence of a globally connected cyanophage gene pool, the cyanophage mazG gene having a small effective population size indicative of rapid lateral gene transfer despite being present in a substantial fraction of cyanophage. The Prochlorococcus and Synechococcus phage mazG genes do not cluster with the host mazG gene, suggesting that their primary hosts are not the source of the mazG gene.	[Bryan, Michael J.; Spence, Edward M.; Mann, Nicholas H.; Bryan, Samantha J.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Burroughs, Nigel J.] Univ Warwick, Warwick Syst Biol Ctr, Coventry, W Midlands, England; [Clokie, Martha R. J.] Univ Leicester, Dept Infect, Immun & Inflammat, Leicester, Leics, England	University of Warwick; University of Warwick; University of Leicester	Michael, JB (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	Samantha_bryan@hotmail.co.uk		Clokie, Martha/0000-0002-6069-8936	Warick University	Warick University	Funding was provided by the Warick University. They had no role in the design or conduct of the study.	Bailey S, 2004, RES MICROBIOL, V155, P720, DOI 10.1016/j.resmic.2004.06.002; BORBELY G, 1980, J BACTERIOL, V144, P859; Breitbart M, 2006, FEMS MICROBIOL LETT, V254, P332; Clokie MRJ, 2006, ENVIRON MICROBIOL, V8, P2074, DOI 10.1111/j.1462-2920.2006.01171.x; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; FRIGA GM, 1981, ARCH MICROBIOL, V129, P341, DOI 10.1007/BF00406458; Fuller NJ, 1998, APPL ENVIRON MICROB, V64, P2051; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gross M, 2006, MOL MICROBIOL, V59, P590, DOI 10.1111/j.1365-2958.2005.04956.x; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; MANN N, 1975, BIOCHIM BIOPHYS ACTA, V402, P41, DOI 10.1016/0005-2787(75)90368-8; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Mann NH, 2003, FEMS MICROBIOL REV, V27, P17, DOI 10.1016/S0168-6445(03)00016-0; Morris RM, 2004, APPL ENVIRON MICROB, V70, P2836, DOI 10.1128/AEM.70.5.2836-2842.2004; Short CM, 2005, APPL ENVIRON MICROB, V71, P480, DOI 10.1128/AEM.71.1.480-486.2005; SPRAGUE SG, 1981, J BACTERIOL, V147, P1021, DOI 10.1128/JB.147.3.1021-1031.1981; Wang JD, 2007, CELL, V128, P865, DOI 10.1016/j.cell.2006.12.043	19	45	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2008	3	4							e2048	10.1371/journal.pone.0002048	http://dx.doi.org/10.1371/journal.pone.0002048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381TL	18431505	gold, Green Published, Green Submitted			2022-12-27	WOS:000261558700040
J	Hu, JH; Chen, ZH; Gu, J; Wan, MB; Shen, Q; Kieny, MP; He, J; Li, Z; Zhang, QF; Reed, ZH; Zhu, YM; Li, WJ; Cao, Y; Qu, L; Cao, ZF; Wang, Q; Liu, HT; Pan, XG; Huang, XD; Zhang, DM; Xue, XY; Pan, WQ				Hu, Jinhong; Chen, Zhihui; Gu, Jun; Wan, Mobin; Shen, Qian; Kieny, Marie-Paule; He, Jia; Li, Zhen; Zhang, Qingfeng; Reed, Zarifah Hussain; Zhu, Yongmei; Li, Wenjie; Cao, Yang; Qu, Li; Cao, Zhifang; Wang, Qiang; Liu, Haitao; Pan, Xuegong; Huang, Xiudong; Zhang, Dongmei; Xue, Xiangyang; Pan, Weiqing			Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein Formulated in Montanide ISA 720 in Healthy Adults	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; BLOOD-STAGE VACCINE; MEROZOITE SURFACE PROTEIN-1; INHIBIT PARASITE GROWTH; CASE-DEFINITION; INJECTION SITE; IN-VITRO; COMBINATION VACCINE; DOMAIN-III; ANTIBODIES	Background: The P. falciparum chimeric protein 2.9 (PfCP-2.9) consisting of the sequences of MSP1-19 and AMA-1 (III) is a malaria vaccine candidate that was found to induce inhibitory antibodies in rabbits and monkeys. This was a phase I randomized, single-blind, placebo-controlled, dose-escalation study to evaluate the safety and immunogenicity of the PfCP-2.9 formulated with a novel adjuvant Montanide ISA720. Fifty-two subjects were randomly assigned to 4 dose groups of 10 participants, each receiving the test vaccine of 20, 50, 100, or 200 mu g respectively, and 1 placebo group of 12 participants receiving the adjuvant only. Methods and Findings: The vaccine formulation was shown to be safe and well-tolerated, and none of the participants withdrew. The total incidence of local adverse events (AEs) was 75%, distributed among 58% of the placebo group and 80% of those vaccinated. Among the vaccinated, 65% had events that were mild and 15% experienced moderate AEs. Almost all systemic adverse reactions observed in this study were graded as mild and required no therapy. The participants receiving the test vaccine developed detectable antibody responses which were boosted by the repeated vaccinations. Sixty percent of the vaccinated participants had high ELISA titers (>1:10,000) of antigen-specific antibodies which could also recognize native parasite proteins in an immunofluorescence assay (IFA). Conclusion: This study is the first clinical trial for this candidate and builds on previous investigations supporting PfCP-2.9/ISA720 as a promising blood-stage malaria vaccine. Results demonstrate safety, tolerability (particularly at the lower doses tested) and immunogenicity of the formulation. Further clinical development is ongoing to explore optimizing the dose and schedule of the formulation to decrease reactogenicity without compromising immunogenicity.	[Zhang, Qingfeng; Qu, Li; Zhang, Dongmei; Xue, Xiangyang; Pan, Weiqing] Second Mil Med Univ, Dept Pathogen Biol, State Key Lab Med Immunol, Shanghai, Peoples R China; [Hu, Jinhong; Chen, Zhihui; Gu, Jun; Wan, Mobin; Shen, Qian; Li, Zhen; Zhu, Yongmei; Li, Wenjie] Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China; [He, Jia; Cao, Yang] Second Mil Med Univ, Dept Stat, Shanghai, Peoples R China; [Cao, Zhifang; Wang, Qiang; Liu, Haitao; Pan, Xuegong; Huang, Xiudong] Shanghai Wanxing Biopharmaceut Co Ltd, Shanghai, Peoples R China; [Kieny, Marie-Paule; Reed, Zarifah Hussain] WHO, Initiat Vaccine Res, Geneva, Switzerland	Naval Medical University; Naval Medical University; Naval Medical University; World Health Organization	Pan, WQ (corresponding author), Second Mil Med Univ, Dept Pathogen Biol, State Key Lab Med Immunol, Shanghai, Peoples R China.	wqpan0912@yahoo.com.cn	Kieny, Marie-Paule/Q-1238-2019; Cao, Yang/C-6185-2008; Kieny, Marie-Paule/N-3914-2017; Cao, Yang/HGD-6463-2022	Cao, Yang/0000-0002-3552-9153; Kieny, Marie-Paule/0000-0002-5943-6488; He, Jia/0000-0002-2338-9501	UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases [A30090]; National Natural Science Foundation of China [30430610]; National 863 project	UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 project(National High Technology Research and Development Program of China)	This investigation received financial support from the UNDP/World Bank/WHO Special Program for Research and Training in Tropical Diseases (TDR)(ID No.A30090) and the National Natural Science Foundation of China (No.30430610) and the National 863 project.	Anders RF, 2000, PARASITOL TODAY, V16, P444, DOI 10.1016/S0169-4758(00)01784-1; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Burns JM, 2004, INFECT IMMUN, V72, P5605, DOI 10.1128/IAI.72.10.5605-5612.2004; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; COOPER JA, 1993, PARASITOL TODAY, V9, P50, DOI 10.1016/0169-4758(93)90031-A; Cot M, 2003, AM J EPIDEMIOL, V157, P203, DOI 10.1093/aje/kwf192; CREWTHER PE, 1990, EXP PARASITOL, V70, P193, DOI 10.1016/0014-4894(90)90100-Q; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Druilhe P, 1997, ANN TROP MED PARASIT, V91, pS37, DOI 10.1080/00034989761292; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Gelb MH, 2007, CURR OPIN CHEM BIOL, V11, P440, DOI 10.1016/j.cbpa.2007.05.038; Good MF, 1998, ANNU REV IMMUNOL, V16, P57, DOI 10.1146/annurev.immunol.16.1.57; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Holder AA, 1981, NATURE, V294, P361, DOI 10.1038/294361a0; Hu J, 2006, AM J TROP MED HYG, V75, P317; Kato K, 2005, P NATL ACAD SCI USA, V102, P5552, DOI 10.1073/pnas.0501594102; Kohl KS, 2007, VACCINE, V25, P5858, DOI 10.1016/j.vaccine.2007.04.056; Kohl KS, 2007, VACCINE, V25, P5839, DOI 10.1016/j.vaccine.2007.04.062; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; McGregor I. A., 1986, Clinics in Tropical Medicine and Communicable Diseases, V1, P29; Nair M, 2002, J MOL BIOL, V322, P741, DOI 10.1016/S0022-2836(02)00806-9; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Ockenhouse CF, 2006, VACCINE, V24, P3009, DOI 10.1016/j.vaccine.2005.11.028; Pan WQ, 2004, J IMMUNOL, V172, P6167, DOI 10.4049/jimmunol.172.10.6167; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Ramasamy R, 2001, TRENDS PARASITOL, V17, P194, DOI 10.1016/S1471-4922(00)01946-2; Rothstein E, 2004, VACCINE, V22, P575, DOI 10.1016/j.vaccine.2003.09.005; Saul A, 1999, VACCINE, V17, P3145, DOI 10.1016/S0264-410X(99)00175-9; SIDDIQUI WA, 1987, P NATL ACAD SCI USA, V84, P3014, DOI 10.1073/pnas.84.9.3014; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Zhang DM, 2005, INFECT IMMUN, V73, P6530, DOI 10.1128/IAI.73.10.6530-6536.2005; Zhang QF, 2007, VACCINE, V25, P2112, DOI 10.1016/j.vaccine.2006.11.015	35	50	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1952	10.1371/journal.pone.0001952	http://dx.doi.org/10.1371/journal.pone.0001952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398475	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795500026
J	Volgushev, M; Malyshev, A; Balaban, P; Chistiakova, M; Volgushev, S; Wolf, F				Volgushev, Maxim; Malyshev, Aleksey; Balaban, Pavel; Chistiakova, Marina; Volgushev, Stanislav; Wolf, Fred			Onset Dynamics of Action Potentials in Rat Neocortical Neurons and Identified Snail Neurons: Quantification of the Difference	PLOS ONE			English	Article								The generation of action potentials (APs) is a key process in the operation of nerve cells and the communication between neurons. Action potentials in mammalian central neurons are characterized by an exceptionally fast onset dynamics, which differs from the typically slow and gradual onset dynamics seen in identified snail neurons. Here we describe a novel method of analysis which provides a quantitative measure of the onset dynamics of action potentials. This method captures the difference between the fast, step-like onset of APs in rat neocortical neurons and the gradual, exponential-like AP onset in identified snail neurons. The quantitative measure of the AP onset dynamics, provided by the method, allows us to perform quantitative analyses of factors influencing the dynamics.	[Volgushev, Maxim; Malyshev, Aleksey; Chistiakova, Marina] Univ Connecticut, Dept Phychol, Storrs, CT 06269 USA; [Volgushev, Maxim; Chistiakova, Marina] Ruhr Univ Bochum, Fac Med, Dept Neurophysiol, Bochum, Germany; [Volgushev, Stanislav] Ruhr Univ Bochum, Fac Math 3, Bochum, Germany; [Volgushev, Maxim; Malyshev, Aleksey; Balaban, Pavel] Russian Acad Sci, Inst Higher Nervous Activity & Neurophysiol, Moscow, Russia; [Wolf, Fred] Univ Gottingen, Bernstein Ctr Computat Neurosci, Fac Phys, MPI Dynam & Self Org, Gottingen, Germany	University of Connecticut; Ruhr University Bochum; Ruhr University Bochum; Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences; Max Planck Society; University of Gottingen	Volgushev, M (corresponding author), Univ Connecticut, Dept Phychol, Storrs, CT 06269 USA.	maxim.volgushev@uconn.edu	Balaban, Pavel M/I-5811-2014; Volgushev, Maxim/AAO-6793-2020; Wolf, Fred/D-5771-2011; Malyshev, Alexey/P-2775-2015; Malyshev, Aleksey/R-8471-2018	Balaban, Pavel M/0000-0001-9248-8207; Volgushev, Maxim/0000-0002-8080-1136; Wolf, Fred/0000-0002-7068-3762; Malyshev, Aleksey/0000-0002-4633-7691	Deutsche Forschungsgemeinschaft; SFB 509 TPA5; FoRUM-Programm F475-2005; BMBF; Human Frontier Science Program [RGP0063/2003-C102]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SFB 509 TPA5; FoRUM-Programm F475-2005; BMBF(Federal Ministry of Education & Research (BMBF)); Human Frontier Science Program(Human Frontier Science Program)	The work preformed in author's labs is supported by the grants from Deutsche Forschungsgemeinschaft, SFB 509 TPA5, FoRUM-Programm F475-2005 and the BMBF to MV, and from the Human Frontier Science Program, RGP0063/2003-C102 and the BMBF to FW.	Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Antic S, 2000, J PHYSIOL-LONDON, V527, P55, DOI 10.1111/j.1469-7793.2000.00055.x; Balaban PM, 2002, NEUROSCI BIOBEHAV R, V26, P597, DOI 10.1016/S0149-7634(02)00022-2; Baranauskas G, 2006, J NEUROSCI, V26, P671, DOI 10.1523/JNEUROSCI.2283-05.2006; Beck O, 2005, J NEUROPHYSIOL, V94, P363, DOI 10.1152/jn.01287.2004; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; Dayan P., 2001, THEORETICAL NEUROSCI, P460; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; DODT HU, 1990, BRAIN RES, V537, P333, DOI 10.1016/0006-8993(90)90380-T; FATT P, 1957, J NEUROPHYSIOL, V20, P61, DOI 10.1152/jn.1957.20.1.61; FUORTES MGF, 1957, J GEN PHYSIOL, V40, P735, DOI 10.1085/jgp.40.5.735; Hille B., 2001, ION CHANNELS EXCITAB, P813; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P424, DOI 10.1113/jphysiol.1952.sp004716; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; Khaliq ZM, 2006, J NEUROSCI, V26, P1935, DOI 10.1523/JNEUROSCI.4664-05.2006; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Meeks JP, 2005, J PHYSIOL-LONDON, V566, P425, DOI 10.1113/jphysiol.2005.089086; NAUNDORF B, 2006, UNIQUE FEATURES ACTI, P1060; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; TAUC L, 1962, J GEN PHYSIOL, V45, P1099, DOI 10.1085/jgp.45.6.1099; TAUC L, 1962, J GEN PHYSIOL, V45, P1077, DOI 10.1085/jgp.45.6.1077; Volgushev M, 2000, J PHYSIOL-LONDON, V522, P59, DOI 10.1111/j.1469-7793.2000.0059m.x; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003; Zecevic D, 1996, NATURE, V381, P322, DOI 10.1038/381322a0	30	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1962	10.1371/journal.pone.0001962	http://dx.doi.org/10.1371/journal.pone.0001962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398478	Green Published, gold			2022-12-27	WOS:000260795500031
J	Wang, SJ; Szalay, MS; Zhang, CS; Csermely, P				Wang, Shijun; Szalay, Mate S.; Zhang, Changshui; Csermely, Peter			Learning and Innovative Elements of Strategy Adoption Rules Expand Cooperative Network Topologies	PLOS ONE			English	Article							PRISONERS-DILEMMA GAME; SOCIAL DILEMMAS; EVOLUTIONARY GAMES; MAINTENANCE; TRANSITIONS; DYNAMICS; GRAPHS	Cooperation plays a key role in the evolution of complex systems. However, the level of cooperation extensively varies with the topology of agent networks in the widely used models of repeated games. Here we show that cooperation remains rather stable by applying the reinforcement learning strategy adoption rule, Q-learning on a variety of random, regular, small-word, scale-free and modular network models in repeated, multi-agent Prisoner's Dilemma and Hawk-Dove games. Furthermore, we found that using the above model systems other long-term learning strategy adoption rules also promote cooperation, while introducing a low level of noise (as a model of innovation) to the strategy adoption rules makes the level of cooperation less dependent on the actual network topology. Our results demonstrate that long-term learning and random elements in the strategy adoption rules, when acting together, extend the range of network topologies enabling the development of cooperation at a wider range of costs and temptations. These results suggest that a balanced duo of learning and innovation may help to preserve cooperation during the re-organization of real-world networks, and may play a prominent role in the evolution of self-organizing, complex systems.	[Szalay, Mate S.; Csermely, Peter] Semmelweis Univ, Dept Med Chem, Budapest, Hungary; [Wang, Shijun; Zhang, Changshui] Tsinghua Univ, Dept Automat, Beijing, Peoples R China	Semmelweis University; Tsinghua University	Csermely, P (corresponding author), Semmelweis Univ, Dept Med Chem, Budapest, Hungary.	csermely@puskin.sote.hu	Wang, Shijun/E-5005-2010; Csermely, Peter/J-2067-2017	Csermely, Peter/0000-0001-9234-0659	EU [FP6-518230]; Hungarian Science Foundation [OTKA- K69105]; Hungarian National Research Initiative [NKFP-1A/056/2004, KKK-0015/3.0]	EU(European Commission); Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National Research Initiative	Work in the authors' laboratory was supported by research grants from the EU (FP6-518230), Hungarian Science Foundation (OTKA- K69105) and the Hungarian National Research Initiative (NKFP-1A/056/2004 and KKK-0015/3.0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumann RJ, 2006, P NATL ACAD SCI USA, V103, P17075, DOI 10.1073/pnas.0608329103; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Cohen MD, 2001, RATION SOC, V13, P5, DOI 10.1177/104346301013001001; Csermely P, 2006, WEAK LINKS STABILIZE; Derenyi I, 2004, PHYSICA A, V334, P583, DOI 10.1016/j.physa.2003.10.083; Durrett R, 2006, RANDOM GRAPH DYNAMIC; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056118; FEIGEL A, 2006, EVOLUTION COOPERATIO; Fu F, 2007, PHYS LETT A, V371, P58, DOI 10.1016/j.physleta.2007.05.116; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goyal S, 2005, GAME ECON BEHAV, V50, P178, DOI 10.1016/j.geb.2004.01.005; GRANOVETTER M, 1985, AM J SOCIOL, V91, P481, DOI 10.1086/228311; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Holme P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.098701; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kovacs IA, 2005, FEBS LETT, V579, P2254, DOI 10.1016/j.febslet.2005.03.056; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Luthi L, 2007, LECT NOTES ARTIF INT, V4648, P545; Macy MW, 2002, P NATL ACAD SCI USA, V99, P7214, DOI 10.1073/pnas.082097399; Macy MW, 2002, P NATL ACAD SCI USA, V99, P7229, DOI 10.1073/pnas.092080099; Masuda N, 2007, P R SOC B, V274, P1815, DOI 10.1098/rspb.2007.0294; McNamara JM, 2004, NATURE, V428, P745, DOI 10.1038/nature02432; Michod RE, 2006, P NATL ACAD SCI USA, V103, P9113, DOI 10.1073/pnas.0601080103; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2006, PLOS COMPUT BIOL, V2, P1634, DOI 10.1371/journal.pcbi.0020178; Rong ZH, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.027101; Sandholm TW, 1996, BIOSYSTEMS, V37, P147, DOI 10.1016/0303-2647(95)01551-5; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Skyrms B., 2004, STAG HUNT EVOLUTION, DOI DOI 10.1017/CBO9781139165228; Sutton R. S., 1999, REINFORCEMENT LEARNI; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Tang CL, 2006, EUR PHYS J B, V53, P411, DOI 10.1140/epjb/e2006-00395-2; Tomassini M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016132; Tomassini M, 2007, INT J MOD PHYS C, V18, P1173, DOI 10.1142/S0129183107011212; Traulsen A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000270; Vukov J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026109; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	46	58	59	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1917	10.1371/journal.pone.0001917	http://dx.doi.org/10.1371/journal.pone.0001917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370XD	18398453	Green Published, Green Submitted, gold			2022-12-27	WOS:000260795500004
J	Cheng, N; de Wetering, CIV; Knudson, CM				Cheng, Ningli; van de Wetering, Christopher I.; Knudson, C. Michael			p27 Deficiency Cooperates with Bcl-2 but Not Bax to Promote T-Cell Lymphoma	PLOS ONE			English	Article								The effect of Bcl-2 on oncogenesis is complex and expression may either delay or accelerate oncogenesis. The pro-oncogenic activity is attributed to its well characterized anti-apoptotic function while the anti-oncogenic function has been attributed to its inhibition of cellular proliferation. Recent studies demonstrate that p27 may mediate the effects of Bcl-2 on cellular proliferation. We hypothesized that p27 may suppress tumor formation by Bcl-2 family members. To test this hypothesis, cell cycle inhibition and lymphoma development were examined in Lck-Bcl-2 and Lck-Bax38/1 transgenic mice deficient in p27. Strikingly, p27 deficiency synergistically cooperates with Bcl-2 to increase T cell hyperplasia and development of spontaneous T cell lymphomas. Within 1 year, >90% of these mice had developed thymic T cell lymphomas. This high penetrance contrasts with a one year incidence of <5% of thymic lymphoma in Lck-Bcl-2 or p27 -/- mice alone. In contrast, p27 deficiency had no effect on tumor formation in Lck-Bax38/1 transgenic mice, another model of T cell lymphoma. Histologically the lymphomas in p27 -/- Lck-Bcl-2 mice are lymphoblastic and frequently involve multiple organs suggesting an aggressive phenotype. Interestingly, in mature splenic T cells, Bcl-2 largely retains its anti-proliferative function even in the absence of p27. T cells from p27 -/- Lck-Bcl-2 mice show delayed kinetics of CDK2 Thr-160 phosphorylation. This delay is associated with a delay in the up regulation of both Cyclin D2 and D3. These data demonstrate a complex relationship between the Bcl-2 family, cellular proliferation, and oncogenesis and demonstrate that p27 up-regulation is not singularly important in the proliferative delay observed in T cells expressing Bcl-2 family members. Nonetheless, the results indicate that p27 is a critical tumor suppressor in the context of Bcl-2 expression.	[Cheng, Ningli; van de Wetering, Christopher I.; Knudson, C. Michael] Univ Iowa, Roy J & Lucille P Carver Coll Med, Dept Pathol, Program Mol & Cell Biol, Iowa City, IA USA	University of Iowa	Cheng, N (corresponding author), Univ Iowa, Roy J & Lucille P Carver Coll Med, Dept Pathol, Program Mol & Cell Biol, Iowa City, IA USA.	c-knudson@uiowa.edu		Knudson, Charles Michael/0000-0003-3964-5466	National Research Service Award (NRSA) predoctoral fellowship [F31CA103363]; NIH [1RO1CA104695, 1RO1CA88967]; NATIONAL CANCER INSTITUTE [R01CA104695, R01CA088967, F31CA103363] Funding Source: NIH RePORTER	National Research Service Award (NRSA) predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CIvdW was supported in part by a National Research Service Award (NRSA) predoctoral fellowship grant #F31CA103363. This work was supported by NIH grants 1RO1CA104695 and 1RO1CA88967 (C.M.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Breckenridge DG, 2004, CURR OPIN CELL BIOL, V16, P647, DOI 10.1016/j.ceb.2004.09.009; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Buglioni S, 1999, INT J CANCER, V84, P545, DOI 10.1002/(SICI)1097-0215(19991222)84:6<545::AID-IJC1>3.0.CO;2-2; Callagy GM, 2006, CLIN CANCER RES, V12, P2468, DOI 10.1158/1078-0432.CCR-05-2719; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Cheng NL, 2004, ONCOGENE, V23, P3770, DOI 10.1038/sj.onc.1207478; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; de la Coste A, 1999, CANCER RES, V59, P5017; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Emerson DK, 2005, J BIOL CHEM, V280, P3233, DOI 10.1074/jbc.M411672200; Engedal N, 2006, J IMMUNOL, V177, P2851, DOI 10.4049/jimmunol.177.5.2851; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Geisen C, 2003, ONCOGENE, V22, P1724, DOI 10.1038/sj.onc.1206340; Greider C, 2002, ONCOGENE, V21, P7765, DOI 10.1038/sj.onc.1205928; Gurova KV, 2002, CANCER BIOL THER, V1, P39, DOI 10.4161/cbt.1.1.39; Hadzic T, 2005, J IMMUNOL, V175, P7965, DOI 10.4049/jimmunol.175.12.7965; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Holmes JK, 2001, EUR J BIOCHEM, V268, P4647, DOI 10.1046/j.1432-1327.2001.02392.x; Huang DCS, 1997, EMBO J, V16, P4628, DOI 10.1093/emboj/16.15.4628; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Kaklamanis L, 1998, BRIT J CANCER, V77, P1864, DOI 10.1038/bjc.1998.310; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Knudson CM, 2001, CANCER RES, V61, P659; Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; LINETTE GP, 1995, BLOOD, V86, P1255, DOI 10.1182/blood.V86.4.1255.bloodjournal8641255; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; Luke JJ, 2003, CELL DEATH DIFFER, V10, P740, DOI 10.1038/sj.cdd.4401233; MacCarthy-Morrogh L, 1999, BIOCHEM SOC T, V27, P785, DOI 10.1042/bst0270785; Manne U, 1997, INT J CANCER, V74, P346, DOI 10.1002/(SICI)1097-0215(19970620)74:3<346::AID-IJC19>3.0.CO;2-9; Martin-Caballero J, 2004, ONCOGENE, V23, P8231, DOI 10.1038/sj.onc.1207863; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; MARVEL J, 1994, ONCOGENE, V9, P1117; Meterissian SH, 2001, ANN SURG ONCOL, V8, P533, DOI 10.1245/aso.2001.8.6.533; Murphy KL, 1999, ONCOGENE, V18, P6597, DOI 10.1038/sj.onc.1203099; Nakayama K, 1998, BIOESSAYS, V20, P1020, DOI 10.1002/(SICI)1521-1878(199812)20:12<1020::AID-BIES8>3.0.CO;2-D; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; OFNER D, 1995, BRIT J CANCER, V72, P981, DOI 10.1038/bjc.1995.446; OReilly LA, 1997, J IMMUNOL, V159, P2301; OReilly LA, 1997, INT IMMUNOL, V9, P1291, DOI 10.1093/intimm/9.9.1291; OReilly LA, 1996, EMBO J, V15, P6979, DOI 10.1002/j.1460-2075.1996.tb01090.x; Philipp-Staheli J, 2004, ONCOGENE, V23, P905, DOI 10.1038/sj.onc.1207220; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Rossiter H, 2001, CANCER RES, V61, P3619; Roussel MF, 1999, ONCOGENE, V18, P5311, DOI 10.1038/sj.onc.1202998; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SILVESTRINI R, 1994, J NATL CANCER I, V86, P499, DOI 10.1093/jnci/86.7.499; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; Vairo G, 2000, MOL CELL BIOL, V20, P4745, DOI 10.1128/MCB.20.13.4745-4753.2000; Vairo G, 1996, ONCOGENE, V13, P1511; van de Wetering CI, 2007, CANCER RES, V67, P8081, DOI 10.1158/0008-5472.CAN-07-1666	57	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1911	10.1371/journal.pone.0001911	http://dx.doi.org/10.1371/journal.pone.0001911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382684	Green Submitted, Green Published, gold			2022-12-27	WOS:000260795400036
J	Nosil, P; Sandoval, CP				Nosil, Patrik; Sandoval, Cristina P.			Ecological Niche Dimensionality and the Evolutionary Diversification of Stick Insects	PLOS ONE			English	Article							HOST-PLANT ADAPTATION; REPRODUCTIVE ISOLATION; HABITAT PREFERENCE; SPECIES BOUNDARY; SYMPATRIC SPECIATION; DISRUPTIVE SELECTION; ADAPTIVE DIVERGENCE; NATURAL-SELECTION; VISUAL PREDATION; SANTA-ROSALIA	The degree of phenotypic divergence and reproductive isolation between taxon pairs can vary quantitatively, and often increases as evolutionary divergence proceeds through various stages, from polymorphism to population differentiation, ecotype and race formation, speciation, and post-speciational divergence. Although divergent natural selection promotes divergence, it does not always result in strong differentiation. For example, divergent selection can fail to complete speciation, and distinct species pairs sometimes collapse ('speciation in reverse'). Widely-discussed explanations for this variability concern genetic architecture, and the geographic arrangement of populations. A less-explored possibility is that the degree of phenotypic and reproductive divergence between taxon pairs is positively related to the number of ecological niche dimensions (i.e., traits) subject to divergent selection. Some data supporting this idea stem from laboratory experimental evolution studies using Drosophila, but tests from nature are lacking. Here we report results from manipulative field experiments in natural populations of herbivorous Timema stick insects that are consistent with this 'niche dimensionality' hypothesis. In such insects, divergent selection between host plants might occur for cryptic colouration (camouflage to evade visual predation), physiology (to detoxify plant chemicals), or both of these niche dimensions. We show that divergent selection on the single niche dimension of cryptic colouration can result in ecotype formation and intermediate levels of phenotypic and reproductive divergence between populations feeding on different hosts. However, greater divergence between a species pair involved divergent selection on both niche dimensions. Although further replication of the trends reported here is required, the results suggest that dimensionality of selection may complement genetic and geographic explanations for the degree of diversification in nature.	[Nosil, Patrik] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Sandoval, Cristina P.] Univ Calif Santa Barbara, Marine Sci Inst, Santa Barbara, CA USA	University of British Columbia; University of California System; University of California Santa Barbara	Nosil, P (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	pnosil@zoology.ubc.ca			Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support was provided by the Natural Science and Engineering Research Council of Canada.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Beltran M, 2002, MOL BIOL EVOL, V19, P2176, DOI 10.1093/oxfordjournals.molbev.a004042; Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Bolnick DI, 2007, EVOLUTION, V61, P2229, DOI 10.1111/j.1558-5646.2007.00179.x; Bond AB, 2002, NATURE, V415, P609, DOI 10.1038/415609a; BOUGHMAN JW, 2002, TRENDS ECOL EVOL, V10, P1; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Bull V, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-11; Carleton KL, 2005, MOL ECOL, V14, P4341, DOI 10.1111/j.1365-294X.2005.02735.x; Chase J.M., 2009, ECOLOGICAL NICHES LI; Coyne J.A., 2004, SPECIATION; COYNE JA, 1989, EVOLUTION, V43, P362, DOI [10.2307/2409213, 10.1111/j.1558-5646.1989.tb04233.x]; Crespi BJ, 2000, J EVOLUTION BIOL, V13, P249, DOI 10.1046/j.1420-9101.2000.00164.x; Dambroski HR, 2007, J EVOLUTION BIOL, V20, P2101, DOI 10.1111/j.1420-9101.2007.01435.x; de Queiroz K, 2005, P NATL ACAD SCI USA, V102, P6600, DOI 10.1073/pnas.0502030102; Dijkstra PD, 2007, J EVOLUTION BIOL, V20, P496, DOI 10.1111/j.1420-9101.2006.01266.x; Dijkstra PD, 2005, BEHAV ECOL SOCIOBIOL, V58, P136, DOI 10.1007/s00265-005-0919-5; Dopman EB, 2005, P NATL ACAD SCI USA, V102, P14706, DOI 10.1073/pnas.0502054102; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Elton C., 1927, ANIMAL ECOLOGY; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Forister ML, 2007, J EVOLUTION BIOL, V20, P985, DOI 10.1111/j.1420-9101.2007.01310.x; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Funk DJ, 2002, GENETICA, V116, P251, DOI 10.1023/A:1021236510453; Funk DJ, 1998, EVOLUTION, V52, P1744, DOI [10.2307/2411347, 10.1111/j.1558-5646.1998.tb02254.x]; FUTUYMA DJ, 1995, EVOLUTION, V49, P797, DOI 10.1111/j.1558-5646.1995.tb02316.x; Gavrilets S, 2004, FITNESS LANDSCAPES O; Geraldes A, 2006, GENETICS, V173, P919, DOI 10.1534/genetics.105.054106; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Grinnell J., 1917, Auk Cambridge Mass, V34; Harmon LJ, 2005, EVOLUTION, V59, P409; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; Hendry AP, 2004, EVOLUTION, V58, P2319; Hendry AP, 2001, EVOLUTION, V55, P459, DOI 10.1554/0014-3820(2001)055[0459:PMATAD]2.0.CO;2; HUBBS CL, 1955, SYST ZOOL, V4, P1, DOI 10.2307/2411933; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; Law JH, 2002, MOL ECOL, V11, P1471, DOI 10.1046/j.1365-294X.2002.01547.x; Mallet J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-28; MAYR E, 1947, EVOLUTION, V1, P263, DOI 10.2307/2405327; Muller HJ, 1942, BIOL S, V6, P71; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Nosil P, 2002, NATURE, V417, P440, DOI 10.1038/417440a; Nosil P, 2006, J EVOLUTION BIOL, V19, P929, DOI 10.1111/j.1420-9101.2005.01035.x; Nosil P, 2006, AM NAT, V167, pE66, DOI 10.1086/499383; Nosil P, 2004, P ROY SOC B-BIOL SCI, V271, P1521, DOI 10.1098/rspb.2004.2751; Nosil P, 2004, EVOLUTION, V58, P102, DOI 10.1111/j.0014-3820.2004.tb01577.x; Nosil P, 2003, P ROY SOC B-BIOL SCI, V270, P1911, DOI 10.1098/rspb.2003.2457; Nosil P, 2005, EVOLUTION, V59, P705; NOSIL P, 2008, ECOLOGY SPECIATION, P20; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Nosil P, 2007, AM NAT, V169, P151, DOI 10.1086/510634; Nosil P, 2006, CURR BIOL, V16, pR806, DOI 10.1016/j.cub.2006.08.038; Nosil P, 2006, P NATL ACAD SCI USA, V103, P9090, DOI 10.1073/pnas.0601575103; Olendorf R, 2006, NATURE, V441, P633, DOI 10.1038/nature04646; Ortiz-Barrientos D, 2005, SCIENCE, V310, P1467, DOI 10.1126/science.1121260; Ortiz-Barrientos D, 2002, GENETICA, V116, P167, DOI 10.1023/A:1021296829109; Pianka ER, 1978, EVOL ECOL, V2nd; Putnam AS, 2007, EVOLUTION, V61, P912, DOI 10.1111/j.1558-5646.2007.00076.x; Rice WR, 1987, EVOL ECOL, V1, P301, DOI 10.1007/BF02071555; RICE WR, 1988, AM NAT, V131, P911, DOI 10.1086/284831; RICE WR, 1990, EVOLUTION, V44, P1140, DOI 10.1111/j.1558-5646.1990.tb05221.x; RICE WR, 1985, EVOLUTION, V39, P645, DOI 10.1111/j.1558-5646.1985.tb00401.x; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Richmond JQ, 2007, P ROY SOC B-BIOL SCI, V274, P1701, DOI 10.1098/rspb.2007.0364; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Roe AD, 2007, MOL ECOL, V16, P3617, DOI 10.1111/j.1365-294X.2007.03412.x; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; SANDOVAL CP, 1994, BIOL J LINN SOC, V52, P341; Sandoval CP, 2005, EVOLUTION, V59, P2405; SANDOVAL CP, 1994, EVOLUTION, V48, P1866, DOI 10.1111/j.1558-5646.1994.tb02220.x; SANDOVAL CP, 2000, SW NAT, V45, P19; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schoener T.W., 1989, P79; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; SEEHAUSEN O, 2008, MOL ECOL IN PRESS; SEEHAUSEN O, 2008, ECOLOGY SPECIATION, P20; Sinervo B, 2002, HEREDITY, V89, P329, DOI 10.1038/sj.hdy.6800148; Svensson EI, 2005, AM NAT, V165, P567, DOI 10.1086/429278; SVENSSON EI, 2008, EVOL ECOL IN PRESS; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; VICKERY VR, 1993, CAN ENTOMOL, V125, P657, DOI 10.4039/Ent125657-4; Vines TH, 2003, EVOLUTION, V57, P1876; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	93	69	72	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1907	10.1371/journal.pone.0001907	http://dx.doi.org/10.1371/journal.pone.0001907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382680	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000260795400032
J	Ndam, NT; Bischoff, E; Proux, C; Lavstsen, T; Salanti, A; Guitard, J; Nielsen, MA; Coppee, JY; Gaye, A; Theander, T; David, PH; Deloron, P				Ndam, Nicaise Tuikue; Bischoff, Emmanuel; Proux, Caroline; Lavstsen, Thomas; Salanti, Ali; Guitard, Juliette; Nielsen, Morten A.; Coppee, Jean-Yves; Gaye, Alioune; Theander, Thor; David, Peter H.; Deloron, Philippe			Plasmodium falciparum Transcriptome Analysis Reveals Pregnancy Malaria Associated Gene Expression	PLOS ONE			English	Article							VARIANT SURFACE-ANTIGENS; CHONDROITIN SULFATE; INFECTED ERYTHROCYTES; PLACENTAL MALARIA; ANTIBODIES; CHILDREN; ADHERENCE; PARASITES; DYNAMICS; ADHESIVE	Background: Pregnancy-associated malaria (PAM) causing maternal anemia and low birth weight is among the multiple manifestations of Plasmodium falciparum malaria. Infected erythrocytes (iEs) can acquire various adhesive properties that mediate the clinical severity of malaria. Recent advances on the molecular basis of virulence and immune evasion have helped identify var2csa as a PAM-specific var gene. Methodology/Principal Findings: The present study presents a genome-wide microarray transcript analysis of 18 P. falciparum parasite isolates freshly collected from the placenta. The proportion of PAM over-expressed genes located in subtelomeric regions as well as that of PAM over-expressed genes predicted to be exported were higher than expected compared to the whole genome. The identification of novel parasite molecules with specificity to PAM and which are likely involved in host-pathogen interactions and placental tropism is described. One of these proteins, PFI1785w, was further characterized as the product of a two-exon PHIST gene, and was more often recognized by serum samples from P. falciparum-exposed women than from men. Conclusions/Significance: These findings suggest that other parasite proteins, such as PFI1785w, may contribute beside VAR2CSA to the pathogenesis of PAM. These data may be very valuable for future vaccine development.	[Ndam, Nicaise Tuikue; Guitard, Juliette; Deloron, Philippe] Univ Paris 05, UR010, Fac Pharm, IRD, Paris, France; [Bischoff, Emmanuel; Proux, Caroline; Coppee, Jean-Yves] Inst Pasteur, Plate Forme 2, Paris, France; [Lavstsen, Thomas; Salanti, Ali; Nielsen, Morten A.; Theander, Thor] Univ Copenhagen, Ctr Med Parasitol, Copenhagen, Denmark; [Gaye, Alioune] Ctr Sante Roi Baudoin Guediawaye, Dakar, Senegal; [David, Peter H.] Inst Pasteur, URA CNRS 2581, Unite Immunol Mol Parasites, Paris, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Copenhagen; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ndam, NT (corresponding author), Univ Paris 05, UR010, Fac Pharm, IRD, Paris, France.	Nicaise.Ndam@ird.fr	Guitard, Juliette/AAE-6344-2019; Deloron, Philippe/G-6305-2010; Bischoff, Emmanuel/F-1197-2011; Theander, Thor/F-6714-2015	Guitard, Juliette/0000-0002-9782-3577; Deloron, Philippe/0000-0003-4705-2484; Bischoff, Emmanuel/0000-0003-4655-4247; Theander, Thor/0000-0002-3509-7514; Nielsen, Morten Agertoug/0000-0003-2668-4992; Lavstsen, Thomas/0000-0002-3044-4249; Tuikue Ndam, Nicaise/0000-0003-2646-2513; Salanti, Ali/0000-0003-2207-5575	Commission of the European Union [QLK2-CT-2001-01302]; Delegation Generale pour l'Armement [DGA n 22120/DSP/SREAF, n 04 34 025]; Programme PAL+/Fonds National pour la Science; Institut Pasteur; Programme Genopole; Fondation Recherche Medicale; SSVF	Commission of the European Union(European Commission); Delegation Generale pour l'Armement; Programme PAL+/Fonds National pour la Science; Institut Pasteur(European Commission); Programme Genopole; Fondation Recherche Medicale; SSVF	The work received financial support from the Commission of the European Union (grant QLK2-CT-2001-01302, PAMVAC), the Delegation Generale pour l'Armement (DGA n 22120/DSP/SREAF and n 04 34 025), the Programme PAL+/Fonds National pour la Science, the Institut Pasteur, and the Programme Genopole. NTN was supported by a postdoctoral grant from the Fondation Recherche Medicale. AS is supported by a postdoctoral grant from SSVF.	Beeson JG, 2007, AM J TROP MED HYG, V77, P22, DOI 10.4269/ajtmh.2007.77.22; Beeson JG, 1999, J INFECT DIS, V180, P464, DOI 10.1086/314899; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Craig A, 2001, MOL BIOCHEM PARASIT, V115, P129, DOI 10.1016/S0166-6851(01)00275-4; Daily JP, 2005, J INFECT DIS, V191, P1196, DOI 10.1086/428289; Duffy MF, 2005, MOL MICROBIOL, V56, P774, DOI 10.1111/j.1365-2958.2005.04577.x; Duffy MF, 2006, INFECT IMMUN, V74, P4875, DOI 10.1128/IAI.01978-05; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; FRANCIS SE, 2007, INFECT IMMUN; Fried M, 1998, J MOL MED-JMM, V76, P162, DOI 10.1007/s001090050205; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Fried M, 2007, MOL BIOCHEM PARASIT, V155, P57, DOI 10.1016/j.molbiopara.2007.05.010; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gowda ASP, 2007, J BIOL CHEM, V282, P916, DOI 10.1074/jbc.M604741200; Haase RN, 2006, INFECT IMMUN, V74, P3035, DOI 10.1128/IAI.74.5.3035-3038.2006; Jafari-Guemouri S, 2006, MICROBES INFECT, V8, P1663, DOI 10.1016/j.micinf.2006.01.023; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Maubert B, 1999, INFECT IMMUN, V67, P5367, DOI 10.1128/IAI.67.10.5367-5371.1999; Moore JM, 1997, J IMMUNOL METHODS, V209, P93, DOI 10.1016/S0022-1759(97)00162-2; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Ndam NGT, 2005, J INFECT DIS, V192, P331, DOI 10.1086/430933; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Ralph SA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r93; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Sanders PR, 2005, J BIOL CHEM, V280, P40169, DOI 10.1074/jbc.M509631200; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Staalsoe T, 1999, CYTOMETRY, V35, P329, DOI 10.1002/(SICI)1097-0320(19990401)35:4&lt;329::AID-CYTO5&gt;3.0.CO;2-Y; Staalsoe T, 2003, PARASITE IMMUNOL, V25, P421, DOI 10.1111/j.1365-3024.2003.00652.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treutiger CJ, 1997, NAT MED, V3, P1405, DOI 10.1038/nm1297-1405; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466	37	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1855	10.1371/journal.pone.0001855	http://dx.doi.org/10.1371/journal.pone.0001855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365010	gold, Green Submitted, Green Published			2022-12-27	WOS:000260762400016
J	Ptitsyn, A				Ptitsyn, Andrey			Stochastic Resonance Reveals "Pilot Light'' Expression in Mammalian Genes	PLOS ONE			English	Article								Background: Microarrays are widely used for estimation of expression of thousands of genes in a biological sample. The resolution ability of this method is limited by the background noise. Low expressed genes are detected with insufficient reliability and expression of many genes is never detected at all. Methodology/Principal Findings: We have applied the principles of stochastic resonance to detect expression of genes from microarray signals below the background noise level. We report the periodic pattern detected in genes called "Absent'' by traditional analysis. The pattern is consistent with expression of the conventionally detected genes and specific to the tissue of origin. This effect is corroborated by the analysis of oscillating gene expression in mouse (M. musculus) and yeast (S. cerevisae). Conclusion/Significance: Most genes usually considered silent are in fact expressed at a very low level. Stochastic resonance can be applied to detect changes in expression pattern of low-expressed genes as well as for the validation of the probe performance in microarrays.			Ptitsyn, A (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ctr Bioinformat, Ft Collins, CO 80523 USA.	Andrey.Ptitsyn@colostate.edu		Ptitsyn, Andrey/0000-0003-1196-8757				Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Greenwood PE, 1999, PHYS REV E, V60, P4687, DOI 10.1103/PhysRevE.60.4687; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Havel PJ, 2000, P NUTR SOC, V59, P359, DOI 10.1017/S0029665100000410; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Martinez-Merlos MT, 2004, J ENDOCRINOL, V181, P53, DOI 10.1677/joe.0.1810053; Priestley M. B., 1981, SPECTRAL ANAL TIME S; Ptitsyn AA, 2007, PLOS COMPUT BIOL, V3, P1108, DOI 10.1371/journal.pcbi.0030120; Ptitsyn AA, 2006, PLOS COMPUT BIOL, V2, P126, DOI 10.1371/journal.pcbi.0020016; Ptitsyn AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S10; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Refinetti Roberto, 2005, J Circadian Rhythms, V3, P4, DOI 10.1186/1740-3391-3-4; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873; Zvonic S, 2007, J BONE MINER RES, V22, P357, DOI 10.1359/jbmr.061114	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1842	10.1371/journal.pone.0001842	http://dx.doi.org/10.1371/journal.pone.0001842			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365000	gold, Green Published, Green Submitted			2022-12-27	WOS:000260762400006
J	Cousillas, H; George, I; Henry, L; Richard, JP; Hausberger, M				Cousillas, Hugo; George, Isabelle; Henry, Laurence; Richard, Jean-Pierre; Hausberger, Martine			Linking Social and Vocal Brains: Could Social Segregation Prevent a Proper Development of a Central Auditory Area in a Female Songbird?	PLOS ONE			English	Article							FUNCTIONAL-ORGANIZATION; EUROPEAN STARLINGS; ZEBRA FINCHES; HUMAN SPEECH; EXPERIENCE; FOREBRAIN; BIRDSONG; SPECIALIZATION; RESPONSES; CENTERS	Direct social contact and social interaction affect speech development in human infants and are required in order to maintain perceptual abilities; however the processes involved are still poorly known. In the present study, we tested the hypothesis that social segregation during development would prevent the proper development of a central auditory area, using a "classical" animal model of vocal development, a songbird. Based on our knowledge of European starling, we raised young female starlings with peers and only adult male tutors. This ensured that female would show neither social bond with nor vocal copying from males. Electrophysiological recordings performed when these females were adult revealed perceptual abnormalities: they presented a larger auditory area, a lower proportion of specialized neurons and a larger proportion of generalist sites than wild-caught females, whereas these characteristics were similar to those observed in socially deprived (physically separated) females. These results confirmed and added to earlier results for males, suggesting that the degree of perceptual deficiency reflects the degree of social separation. To our knowledge, this report constitutes the first evidence that social segregation can, as much as physical separation, alter the development of a central auditory area.	[Cousillas, Hugo; George, Isabelle; Henry, Laurence; Richard, Jean-Pierre; Hausberger, Martine] Univ Rennes 1, UMR 6552, CNRS, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Cousillas, H (corresponding author), Univ Rennes 1, UMR 6552, CNRS, Rennes, France.	hugo.cousillas@univ-rennes1.fr	George, Isabelle/A-7770-2008	George, Isabelle/0000-0002-4842-4959	French Research Ministry [COG169b]	French Research Ministry(Ministry of Research, France)	This study was supported by a grant from the French Research Ministry, COG169b, Perception, plasticite et vie sociale: Perturbation et recuperation du traitement de l'information auditive. Perspective comparative animal/humain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRET-HAUSBERGER M, 1989, Bioacoustics, V2, P137; ADRETHAUSBERGER M, 1982, BEHAV ECOL SOCIOBIOL, V11, P241, DOI 10.1007/BF00299300; ADRETHAUSBERGER M, 1990, ETHOLOGY, V84, P265; ADRETHAUSBERGER M, 1988, BEHAVIOUR, V107, P138, DOI 10.1163/156853988X00322; Allen R E, 1982, Child Abuse Negl, V6, P299, DOI 10.1016/0145-2134(82)90033-3; Bahrick LE, 2000, DEV PSYCHOL, V36, P190, DOI 10.1037//0012-1649.36.2.190; Baptista Luis F., 1997, P23, DOI 10.1017/CBO9780511758843.003; BERTIN A, 2007, DEV PSYCHOBIOL, DOI DOI 10.1002/DEV:362-374; BISCHOF HJ, 1985, BRAIN RES, V326, P370, DOI 10.1016/0006-8993(85)90048-4; Bolhuis JJ, 1999, ANIM BEHAV, V58, P1285, DOI 10.1006/anbe.1999.1266; Brooks R, 2002, DEV PSYCHOL, V38, P958, DOI 10.1037//0012-1649.38.6.958; Capsius B, 1999, HEARING RES, V136, P91, DOI 10.1016/S0378-5955(99)00112-4; Capsius B, 1996, HEARING RES, V96, P59, DOI 10.1016/0378-5955(96)00038-X; Ceponiene R, 2003, P NATL ACAD SCI USA, V100, P5567, DOI 10.1073/pnas.0835631100; Cousillas H, 2005, HEARING RES, V207, P10, DOI 10.1016/j.heares.2005.01.008; Cousillas H, 2004, EUR J NEUROSCI, V19, P3343, DOI 10.1111/j.0953-816X.2004.03376.x; Cousillas H, 2006, NATURWISSENSCHAFTEN, V93, P588, DOI 10.1007/s00114-006-0148-4; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EENS M, 1989, ARDEA, V77, P75; George I, 2004, J PHYSIOL-PARIS, V98, P385, DOI 10.1016/j.jphysparis.2005.09.021; George I, 2005, J COMP NEUROL, V488, P48, DOI 10.1002/cne.20584; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; HAUSBERGER M, 1991, BIRD BEHAV, V9, P81, DOI 10.3727/015613890791749127; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; Hausberger M, 1995, BEHAV PROCESS, V35, P83, DOI 10.1016/0376-6357(95)00053-4; Hausberger Martine, 1997, P128, DOI 10.1017/CBO9780511758843.008; Henry L, 2001, CR ACAD SCI III-VIE, V324, P1167, DOI 10.1016/S0764-4469(01)01394-4; HMCCARTNEY K, 1984, DEV PSYCHOL, V20, P244; Houx BB, 1999, ANIM BEHAV, V57, P837; Hultsch DF, 1999, PSYCHOL AGING, V14, P245, DOI 10.1037/0882-7974.14.2.245; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9645, DOI 10.1073/pnas.1733998100; LEPPELSACK HJ, 1976, J COMP PHYSIOL, V107, P263, DOI 10.1007/BF00656737; LOGAN JS, 1991, J ACOUST SOC AM, V89, P874, DOI 10.1121/1.1894649; Poirier C, 2004, J COMP PSYCHOL, V118, P179, DOI 10.1037/0735-7036.118.2.179; PUEL JL, 1988, BRAIN RES, V447, P380, DOI 10.1016/0006-8993(88)91144-4; Revelle W., 1992, HDB EMOTION MEMORY R, P113; RICHARD JP, 1995, J NEUROSCI METH, V61, P99, DOI 10.1016/0165-0270(95)00029-T; ROUSSEAU F, 2008, SELECTIVE ATTE UNPUB; SNOWDON CT, 1997, EDS SOCIAL INFLUENCE; Sturdy CB, 2001, ANIM BEHAV, V62, P1207, DOI 10.1006/anbe.2001.1864; Theunissen FE, 1998, J NEUROSCI, V18, P3786; WEST MJ, 1983, WILSON BULL, V95, P635; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745	45	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2008	3	5							e2194	10.1371/journal.pone.0002194	http://dx.doi.org/10.1371/journal.pone.0002194			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	391UK	18493580	Green Published, gold, Green Submitted			2022-12-27	WOS:000262258700003
J	Harms, H; Prass, K; Meisel, C; Klehmet, J; Rogge, W; Drenckhahn, C; Goehler, J; Bereswill, S; Goebel, U; Wernecke, KD; Wolf, T; Arnold, G; Halle, E; Volk, HD; Dirnagl, U; Meisel, A				Harms, Hendrik; Prass, Konstantin; Meisel, Christian; Klehmet, Juliane; Rogge, Witold; Drenckhahn, Christoph; Goehler, Jos; Bereswill, Stefan; Goebel, Ulf; Wernecke, Klaus Dieter; Wolf, Tilo; Arnold, Guy; Halle, Elke; Volk, Hans-Dieter; Dirnagl, Ulrich; Meisel, Andreas			Preventive Antibacterial Therapy in Acute Ischemic Stroke: A Randomized Controlled Trial	PLOS ONE			English	Article							DR EXPRESSION; PNEUMONIA; INFECTION; ASPIRATION; MORTALITY; COMPLICATIONS; PREDICTORS; DYSPHAGIA; DEATH; ADULTS	Background: Pneumonia is a major risk factor of death after acute stroke. In a mouse model, preventive antibacterial therapy with moxifloxacin not only prevents the development of post-stroke infections, it also reduces mortality, and improves neurological outcome significantly. In this study we investigate whether this approach is effective in stroke patients. Methods: Preventive ANtibacterial THERapy in acute Ischemic Stroke (PANTHERIS) is a randomized, double-blind, placebo-controlled trial in 80 patients with severe, non-lacunar, ischemic stroke (NIHSS. 11) in the middle cerebral artery (MCA) territory. Patients received either intravenous moxifloxacin (400 mg daily) or placebo for 5 days starting within 36 hours after stroke onset. Primary endpoint was infection within 11 days. Secondary endpoints included neurological outcome, survival, development of stroke-induced immunodepression, and induction of bacterial resistance. Findings: On intention-to treat analysis (79 patients), the infection rate at day 11 in the moxifloxacin treated group was 15.4% compared to 32.5% in the placebo treated group (p = 0.114). On per protocol analysis (n = 66), moxifloxacin significantly reduced infection rate from 41.9% to 17.1% (p = 0.032). Stroke associated infections were associated with a lower survival rate. In this study, neurological outcome and survival were not significantly influenced by treatment with moxifloxacin. Frequency of fluoroquinolone resistance in both treatment groups did not differ. On logistic regression analysis, treatment arm as well as the interaction between treatment arm and monocytic HLA-DR expression (a marker for immunodepression) at day 1 after stroke onset was independently and highly predictive for post-stroke infections. Interpretation: PANTHERIS suggests that preventive administration of moxifloxacin is superior in reducing infections after severe non-lacunar ischemic stroke compared to placebo. In addition, the results emphasize the pivotal role of immunodepression in developing post-stroke infections.	[Harms, Hendrik; Klehmet, Juliane; Drenckhahn, Christoph; Goehler, Jos; Dirnagl, Ulrich; Meisel, Andreas] Univ Med Berlin, Dept Neurol, Charite, Berlin, Germany; [Bereswill, Stefan; Goebel, Ulf; Halle, Elke] Univ Med Berlin, Dept Microbiol, Charite, Berlin, Germany; [Meisel, Christian; Volk, Hans-Dieter] Univ Med Berlin, Inst Med Immunol, Charite, Berlin, Germany; [Wernecke, Klaus Dieter] Univ Med Berlin, Dept Biometrics & Clin Epidemiol, Charite, Berlin, Germany; [Prass, Konstantin] Landesklinikum Waldviertel Horn, Dept Neurol, Horn, Austria; [Rogge, Witold] Unfallkrankenhaus Berlin, Dept Neurol, Berlin, Germany; [Arnold, Guy] Klin Sindelfingen Boblingen, Dept Neurol, Sindelfingen, Germany; [Wolf, Tilo] James Cook Univ Hosp, Dept Neurol, Middlesbrough, Cleveland, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; James Cook University Hospital	Harms, H (corresponding author), Univ Med Berlin, Dept Neurol, Charite, Berlin, Germany.	andreas.meisel@charite.de	volk, hans-dieter/AAV-8053-2021	volk, hans-dieter/0000-0002-7743-6668; Meisel, Andreas/0000-0001-7233-5342; Meisel, Christian/0000-0003-0222-991X; Dirnagl, Ulrich/0000-0003-0755-6119	Heritage Pusch; Hermann and Lilly Schilling Foundation; Charite Universitaetsmedizin Berlin [Althoff Fellowship]; Bayer HealthCare AG; Bayer Vital GmbH; Helmholtz Association	Heritage Pusch; Hermann and Lilly Schilling Foundation; Charite Universitaetsmedizin Berlin; Bayer HealthCare AG(Bayer AGBayer Healthcare Pharmaceuticals); Bayer Vital GmbH(Bayer AG); Helmholtz Association(Helmholtz Association)	This study was funded by the Heritage Pusch, the Hermann and Lilly Schilling Foundation, and the Charite Universitaetsmedizin Berlin (Althoff Fellowship to AM) and supported by the Bayer HealthCare AG and Bayer Vital GmbH, and the Helmholtz Association. The funding sources had no role in the study design, the collection, the analysis, and interpretation of data, in the writing of the report, and the decision to submit the article for publication. The authors were solely responsible for the trial protocol, the statistical plan, and had full access to the data.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Asadullah K, 1995, Eur J Emerg Med, V2, P184, DOI 10.1097/00063110-199512000-00003; Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; Brott T, 1989, STROKE, V46, P660; Brunner E, 2002, NONPARAMETRIC ANAL L; Castillo J, 1998, STROKE, V29, P2455, DOI 10.1161/01.STR.29.12.2455; Chamorro A, 2005, STROKE, V36, P1495, DOI 10.1161/01.STR.0000170644.15504.49; Chamorro A, 2007, J NEUROL SCI, V252, P29, DOI 10.1016/j.jns.2006.10.001; Clarke J, 2005, LANCET, V365, P764, DOI 10.1016/S0140-6736(05)17983-5; Davenport RJ, 1996, STROKE, V27, P415, DOI 10.1161/01.STR.27.3.415; DEPIPPO KL, 1994, NEUROLOGY, V44, P1655, DOI 10.1212/WNL.44.9.1655; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Dziewas R, 2004, J NEUROL NEUROSUR PS, V75, P852, DOI 10.1136/jnnp.2003.019075; El Solh A, 2003, INTENS CARE MED, V29, P1451, DOI 10.1007/s00134-003-1870-4; Gleeson K, 1997, CHEST, V111, P1266, DOI 10.1378/chest.111.5.1266; Grau AJ, 1999, J NEUROL SCI, V171, P115, DOI 10.1016/S0022-510X(99)00261-0; Hamidon B. B., 2003, SMJ Singapore Medical Journal, V44, P344; HENON H, 1995, STROKE, V26, P392, DOI 10.1161/01.STR.26.3.392; Heuschmann PU, 2004, ARCH INTERN MED, V164, P1761, DOI 10.1001/archinte.164.16.1761; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Hinchey JA, 2005, STROKE, V36, P1972, DOI 10.1161/01.STR.0000177529.86868.8d; HUXLEY EJ, 1978, AM J MED, V64, P564, DOI 10.1016/0002-9343(78)90574-0; Johnston KC, 1998, STROKE, V29, P447, DOI 10.1161/01.STR.29.2.447; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Khaja AM, 2007, LANCET, V369, P319, DOI 10.1016/S0140-6736(07)60154-8; Kong KH, 1998, ARCH PHYS MED REHAB, V79, P1535, DOI 10.1016/S0003-9993(98)90415-4; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Lekkou A, 2004, CLIN DIAGN LAB IMMUN, V11, P161, DOI 10.1128/CDLI.11.1.161-167.2004; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; MAHONEY F I, 1965, Md State Med J, V14, P61; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meisel C, 2004, STROKE, V35, P2, DOI 10.1161/01.STR.0000109041.89959.4C; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; Nakajima M, 2006, ACTA NEUROL SCAND, V113, P36, DOI 10.1111/j.1600-0404.2005.00534.x; Nakajoh K, 2000, J INTERN MED, V247, P39, DOI 10.1046/j.1365-2796.2000.00565.x; Perry L, 2001, DYSPHAGIA, V16, P7, DOI 10.1007/PL00021290; Porzecanski I, 2006, CHEST, V130, P597, DOI 10.1378/chest.130.2.597; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Prass K, 2006, STROKE, V37, P2607, DOI 10.1161/01.STR.0000240409.68739.2b; Qiang YZ, 2002, J ANTIMICROB CHEMOTH, V49, P549, DOI 10.1093/jac/49.3.549; Schaumann R, 2000, INT J ANTIMICROB AG, V16, P225, DOI 10.1016/S0924-8579(00)00186-2; Strohmeyer JC, 2003, CYTOM PART B-CLIN CY, V53B, P54, DOI 10.1002/cyto.b.10031; TAVES DR, 1974, CLIN PHARMACOL THER, V15, P443; Toni D, 2004, CEREBROVASC DIS, V17, P30, DOI 10.1159/000074818; Vargas M, 2006, STROKE, V37, P461, DOI 10.1161/01.STR.0000199138.73365.b3; Vernino S, 2003, STROKE, V34, P1828, DOI 10.1161/01.STR.0000080534.98416.A0	49	181	197	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2158	10.1371/journal.pone.0002158	http://dx.doi.org/10.1371/journal.pone.0002158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18478129	Green Submitted, gold, Green Published			2022-12-27	WOS:000262172800023
J	Canter, JA; Olson, LM; Spencer, K; Schnetz-Boutaud, N; Anderson, B; Hauser, MA; Schmidt, S; Postel, EA; Agarwal, A; Pericak-Vance, MA; Sternberg, P; Haines, JL				Canter, Jeffrey A.; Olson, Lana M.; Spencer, Kylee; Schnetz-Boutaud, Nathalie; Anderson, Brent; Hauser, Michael A.; Schmidt, Silke; Postel, Eric A.; Agarwal, Anita; Pericak-Vance, Margaret A.; Sternberg, Paul, Jr.; Haines, Jonathan L.			Mitochondrial DNA Polymorphism A4917G Is Independently Associated with Age-Related Macular Degeneration	PLOS ONE			English	Article								The objective of this study was to determine if MTND2* LHON4917G (4917G), a specific non-synonymous polymorphism in the mitochondrial genome previously associated with neurodegenerative phenotypes, is associated with increased risk for age-related macular degeneration (AMD). A preliminary study of 393 individuals (293 cases and 100 controls) ascertained at Vanderbilt revealed an increased occurrence of 4917G in cases compared to controls (15.4% vs. 9.0%, p = 0.11). Since there was a significant age difference between cases and controls in this initial analysis, we extended the study by selecting Caucasian pairs matched at the exact age at examination. From the 1547 individuals in the Vanderbilt/Duke AMD population association study (including 157 in the preliminary study), we were able to match 560 (280 cases and 280 unaffected) on exact age at examination. This study population was genotyped for 4917G plus specific AMD-associated nuclear genome polymorphisms in CFH, LOC387715 and ApoE. Following adjustment for the listed nuclear genome polymorphisms, 4917G independently predicts the presence of AMD (OR = 2.16, 95% CI 1.20-3.91, p = 0.01). In conclusion, a specific mitochondrial polymorphism previously implicated in other neurodegenerative phenotypes (4917G) appears to convey risk for AMD independent of recently discovered nuclear DNA polymorphisms.	[Canter, Jeffrey A.; Olson, Lana M.; Spencer, Kylee; Schnetz-Boutaud, Nathalie; Anderson, Brent; Haines, Jonathan L.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37203 USA; [Agarwal, Anita; Sternberg, Paul, Jr.] Vanderbilt Univ, Med Ctr, Dept Ophthalmol, Nashville, TN USA; [Hauser, Michael A.; Schmidt, Silke] Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC USA; [Postel, Eric A.] Duke Univ, Med Ctr, Duke Eye Ctr, Durham, NC USA; [Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, Inst Human Genom, Miami, FL USA	Vanderbilt University; Vanderbilt University; Duke University; Duke University; University of Miami	Canter, JA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37203 USA.	jeff.canter@vanderbilt.edu	Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728	Vanderbilt University Medical Center Clinical Research Center [M01 RR00095];  [EY12118]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [U10EY012118, R01EY012118] Funding Source: NIH RePORTER	Vanderbilt University Medical Center Clinical Research Center; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grant EY12118 (to M. A. P.-V and J.L.H.) and by the Vanderbilt University Medical Center Clinical Research Center (grant M01 RR00095).	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; CANN RL, 1984, GENETICS, V106, P479; Canter JA, 2008, PHARMACOGENOMICS J, V8, P71, DOI 10.1038/sj.tpj.6500470; *CDCP, 2004, PREV VIS IMP SEL EY; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hammond CJ, 2002, OPHTHALMOLOGY, V109, P730, DOI 10.1016/S0161-6420(01)01049-1; Hulgan T, 2005, AIDS, V19, P1341, DOI 10.1097/01.aids.0000180786.02930.a1; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Liang FQ, 2004, EXP EYE RES, V78, P1069, DOI 10.1016/j.exer.2004.02.003; Ohia SE, 2005, MUTAT RES-FUND MOL M, V579, P22, DOI 10.1016/j.mrfmmm.2005.03.025; Postel EA, 2005, AM J OPHTHALMOL, V139, P820, DOI 10.1016/j.ajo.2004.12.029; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Schmidt Silke, 2002, Ophthalmic Genet, V23, P209, DOI 10.1076/opge.23.4.209.13883; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Torroni A, 1996, GENETICS, V144, P1835; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8739, DOI 10.1073/pnas.91.19.8739; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482	22	79	84	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2008	3	5							e2091	10.1371/journal.pone.0002091	http://dx.doi.org/10.1371/journal.pone.0002091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	382YX	18461138	gold, Green Published, Green Submitted			2022-12-27	WOS:000261642400014
J	Bagramyan, K; Barash, JR; Arnon, SS; Kalkum, M				Bagramyan, Karine; Barash, Jason R.; Arnon, Stephen S.; Kalkum, Markus			Attomolar Detection of Botulinum Toxin Type A in Complex Biological Matrices	PLOS ONE			English	Article								Background: A highly sensitive, rapid and cost efficient method that can detect active botulinum neurotoxin (BoNT) in complex biological samples such as foods or serum is desired in order to 1) counter the potential bioterrorist threat 2) enhance food safety 3) enable future pharmacokinetic studies in medical applications that utilize BoNTs. Methodology/Principal Findings: Here we describe a botulinum neurotoxin serotype A assay with a large immuno-sorbent surface area (BoNT/A ALISSA) that captures a low number of toxin molecules and measures their intrinsic metalloprotease activity with a fluorogenic substrate. In direct comparison with the "gold standard'' mouse bioassay, the ALISSA is four to five orders of magnitudes more sensitive and considerably faster. Our method reaches attomolar sensitivities in serum, milk, carrot juice, and in the diluent fluid used in the mouse assay. ALISSA has high specificity for the targeted type A toxin when tested against alternative proteases including other BoNT serotypes and trypsin, and it detects the holotoxin as well as the multi-protein complex form of BoNT/A. The assay was optimized for temperature, substrate concentration, size and volume proportions of the immuno-sorbent matrix, enrichment and reaction times. Finally, a kinetic model is presented that is consistent with the observed improvement in sensitivity. Conclusions/Significance: The sensitivity, specificity, speed and simplicity of the BoNT ALISSA should make this method attractive for diagnostic, biodefense and pharmacological applications.	[Bagramyan, Karine; Kalkum, Markus] Beckman Res Inst City Hope, Div Immunol, Duarte, CA USA; [Barash, Jason R.; Arnon, Stephen S.] Calif Dept Publ Hlth, Infant Botulism Treatment & Prevent Program, Richmond, CA USA	City of Hope; Beckman Research Institute of City of Hope; California Department of Public Health	Bagramyan, K (corresponding author), Beckman Res Inst City Hope, Div Immunol, Duarte, CA USA.	mkalkum@coh.org	Taylor, Graham/A-4027-2012; Pacific-Southwest, RCE/B-6155-2009	Kalkum, Markus/0000-0002-9506-671X	Pacific South West Regional Center for Excellence; NIH [AI-65359-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER	Pacific South West Regional Center for Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Pacific South West Regional Center for Excellence, NIH grant AI-65359-03 (P.I. Dr. Alan Barbour).	Ahmed SA, 2004, PROTEIN J, V23, P445; Ahmed SA, 2001, J PROTEIN CHEM, V20, P221, DOI 10.1023/A:1010952025677; Aoki KR, 2001, EUR J NEUROL, V8, P21, DOI 10.1046/j.1468-1331.2001.00035.x; Arnon SS, 2006, NEW ENGL J MED, V354, P462, DOI 10.1056/NEJMoa051926; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Barr JR, 2005, EMERG INFECT DIS, V11, P1578, DOI 10.3201/eid1110.041279; Beseler-Soto B, 2003, REV NEUROLOGIA, V37, P444, DOI 10.33588/rn.3705.2003250; Boyer AE, 2005, ANAL CHEM, V77, P3916, DOI 10.1021/ac050485f; Cai SO, 1999, BIOCHEMISTRY-US, V38, P6903, DOI 10.1021/bi990086c; Cai SW, 2001, BIOCHEMISTRY-US, V40, P15327, DOI 10.1021/bi011350g; Centers for Disease Control Prevention, 1998, HDB EP CLIN LAB WORK, P1; Chao HY, 2004, TOXICON, V43, P27, DOI 10.1016/j.toxicon.2003.10.013; Chen F, 1998, INFECT IMMUN, V66, P2420, DOI 10.1128/IAI.66.6.2420-2425.1998; Chertow DS, 2006, JAMA-J AM MED ASSOC, V296, P2476, DOI 10.1001/jama.296.20.2476; Crowner BE, 2007, CLIN NEUROPHARMACOL, V30, P310, DOI 10.1097/WNF.0B013E31804B1A0D; EKONG TAN, 1995, J IMMUNOL METHODS, V180, P181, DOI 10.1016/0022-1759(94)00313-L; Ferreira JL, 2003, J AOAC INT, V86, P314; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Jankovic J, 2004, J NEUROL NEUROSUR PS, V75, P951, DOI 10.1136/jnnp.2003.034702; Kalb SR, 2006, ANAL BIOCHEM, V351, P84, DOI 10.1016/j.ab.2006.01.027; Kalb SR, 2005, ANAL CHEM, V77, P6140, DOI 10.1021/ac0511748; KAUTTER DA, 1977, J ASSOC OFF ANA CHEM, V60, P541; KOEPKE R, 2008, PEDIATRICS IN PRESS; Kukreja R, 2005, J BIOL CHEM, V280, P39346, DOI 10.1074/jbc.M508463200; KURAZONO H, 1992, J BIOL CHEM, V267, P14721; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Liu W, 2003, P NATL ACAD SCI USA, V100, P13621, DOI 10.1073/pnas.2233819100; Long SS, 2007, PEDIATR INFECT DIS J, V26, P261, DOI 10.1097/01.inf.0000256442.06231.17; LOSIKOFF ME, 1978, APPL ENVIRON MICROB, V36, P386, DOI 10.1128/AEM.36.2.386-388.1978; Marks JD, 2004, MOVEMENT DISORD, V19, pS101, DOI 10.1002/mds.20023; Mason JT, 2006, NAT PROTOC, V1, P2003, DOI 10.1038/nprot.2006.331; Mason JT, 2006, NAT BIOTECHNOL, V24, P555, DOI 10.1038/nbt1201; MELLMAN I, 1988, CURR OPIN IMMUNOL, V1, P16, DOI 10.1016/0952-7915(88)90046-5; Min D, 2004, P NATL ACAD SCI USA, V101, P14701, DOI 10.1073/pnas.0404107101; Partikian A, 2007, J CHILD NEUROL, V22, P1235, DOI 10.1177/0883073807306269; Ravichandran E, 2007, INFECT IMMUN, V75, P3043, DOI 10.1128/IAI.01893-06; Ravichandran E, 2006, J PHARMACOL EXP THER, V318, P1343, DOI 10.1124/jpet.106.104661; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4; SAMSONOV V G, 1979, Biokhimiya, V44, P1192; SCHANTZ EJ, 1978, J ASSOC OFF ANA CHEM, V61, P96; SCHANTZ EJ, 1992, MICROBIOL REV, V56, P80, DOI 10.1128/MMBR.56.1.80-99.1992; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Schmidt JJ, 2003, APPL ENVIRON MICROB, V69, P297, DOI 10.1128/AEM.69.1.297-303.2003; Sharma SK, 2006, APPL ENVIRON MICROB, V72, P1231, DOI 10.1128/AEM.72.2.1231-1238.2006; Sharma SK, 2003, TOXICON, V41, P321, DOI 10.1016/S0041-0101(02)00309-4; Simpson LL, 2001, J BIOL CHEM, V276, P27034, DOI 10.1074/jbc.M102172200; Sobel J, 2004, EMERG INFECT DIS, V10, P1606, DOI 10.3201/eid1009.030745; SUGIYAMA H, 1980, MICROBIOL REV, V44, P419, DOI 10.1128/MMBR.44.3.419-448.1980; Varnum SM, 2006, ANAL CHIM ACTA, V570, P137, DOI 10.1016/j.aca.2006.04.047; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102; Werner SB, 2000, CLIN INFECT DIS, V31, P1018, DOI 10.1086/318134; Zhang L, 2003, GENE, V315, P21, DOI 10.1016/S0378-1119(03)00792-3	56	90	101	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2041	10.1371/journal.pone.0002041	http://dx.doi.org/10.1371/journal.pone.0002041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446228	Green Submitted, Green Published, gold			2022-12-27	WOS:000261572300013
J	Donati, G; Gatta, R; Dolfini, D; Fossati, A; Ceribelli, M; Mantovani, R				Donati, Giacomo; Gatta, Raffaella; Dolfini, Diletta; Fossati, Andrea; Ceribelli, Michele; Mantovani, Roberto			An NF-Y-Dependent Switch of Positive and Negative Histone Methyl Marks on CCAAT Promoters	PLOS ONE			English	Article							H2B UBIQUITYLATION; TRANSCRIPTION FACTORS; GENE-EXPRESSION; CBF/NF-Y; BINDING; H3; UBIQUITINATION; RECRUITMENT; TRIMETHYLATION; CHROMATIN	Background: Histone tails have a plethora of different post-translational modifications, which are located differently in "open'' and "closed'' parts of genomes. H3K4me3/H3K79me2 and H4K20me3 are among the histone marks associated with the early establishment of active and inactive chromatin, respectively. One of the most widespread promoter elements is the CCAAT box, bound by the NF-Y trimer. Two of NF-Y subunits have an H2A-H2B-like structure. Principal findings: We established the causal relationship between NF-Y binding and positioning of methyl marks, by ChIP analysis of mouse and human cells infected with a dominant negative NF-YA: a parallel decrease in NF-Y binding, H3K4me3, H3K79me2 and transcription was observed in promoters that are dependent upon NF-Y. On the contrary, changes in the levels of H3K9-14ac were more subtle. Components of the H3K4 methylating MLL complex are not recruited in the absence of NF-Y. As for repressed promoters, NF-Y removal leads to a decrease in the H4K20me3 mark and deposition of H3K4me3. Conclusions: Two relevant findings are reported: (i) NF-Y gains access to its genomic locations independently from the presence of methyl histone marks, either positive or negative; (ii) NF-Y binding has profound positive or negative consequences on the deposition of histone methyl marks. Therefore NF-Y is a fundamental switch at the heart of decision between gene activation and repression in CCAAT regulated genes.	[Donati, Giacomo; Gatta, Raffaella; Dolfini, Diletta; Fossati, Andrea; Ceribelli, Michele; Mantovani, Roberto] Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy	University of Milan	Donati, G (corresponding author), Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy.	mantor@unimi.it	DOLFINI, DILETTA/D-8286-2017; Fossati, Andrea/AAN-3814-2020	Fossati, Andrea/0000-0001-9368-4058; DOLFINI, DILETTA/0000-0002-5346-6096; DONATI, Giacomo/0000-0002-0370-8288	AIRC; PRIN-MIUR; CARIPLO	AIRC(Fondazione AIRC per la ricerca sul cancro); PRIN-MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); CARIPLO(Fondazione Cariplo)	This work was supported by AIRC, PRIN-MIUR and CARIPLO-Nobel grants to RM.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bhattacharya A, 2003, CANCER RES, V63, P8167; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; CERIBELLI M, 2008, MOL CELL BI IN PRESS; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Deng HS, 2007, DEV BIOL, V308, P583, DOI 10.1016/j.ydbio.2007.05.021; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Hu QH, 2006, NUCLEIC ACIDS RES, V34, P6272, DOI 10.1093/nar/gkl801; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Inoue T, 1999, J BIOL CHEM, V274, P32309, DOI 10.1074/jbc.274.45.32309; Kabe Y, 2005, MOL CELL BIOL, V25, P512, DOI 10.1128/MCB.25.1.512-522.2005; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Laribee RN, 2007, GENE DEV, V21, P737, DOI 10.1101/gad.1541507; Laribee RN, 2005, CURR BIOL, V15, P1487, DOI 10.1016/j.cub.2005.07.028; Li Q, 1998, EMBO J, V17, P6300, DOI 10.1093/emboj/17.21.6300; Luger K, 2003, CURR OPIN GENET DEV, V13, P127, DOI 10.1016/S0959-437X(03)00026-1; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Osley MA, 2004, BBA-GENE STRUCT EXPR, V1677, P74, DOI 10.1016/j.bbaexp.2003.10.013; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sinha S, 1996, MOL CELL BIOL, V16, P328; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Suzuki Y, 2004, GENOME RES, V14, P1711, DOI 10.1101/gr.2435604; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Zhu Z, 2005, GENOME RES, V15, P848, DOI 10.1101/gr.3394405	49	24	25	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2008	3	4							e2066	10.1371/journal.pone.0002066	http://dx.doi.org/10.1371/journal.pone.0002066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	381YR	18446193	Green Published, gold, Green Submitted			2022-12-27	WOS:000261572300035
J	Forbes, ML; Horsey, E; Hiller, NL; Buchinsky, FJ; Hayes, JD; Compliment, JM; Hillman, T; Ezzo, S; Shen, K; Keefe, R; Barbadora, K; Post, JC; Hu, FZ; Ehrlich, GD				Forbes, Michael L.; Horsey, Edward; Hiller, N. Luisa; Buchinsky, Farrel J.; Hayes, Jay D.; Compliment, James M.; Hillman, Todd; Ezzo, Suzanne; Shen, Kai; Keefe, Randy; Barbadora, Karen; Post, J. Christopher; Hu, Fen Ze; Ehrlich, Garth D.			Strain-Specific Virulence Phenotypes of Streptococcus pneumoniae Assessed Using the Chinchilla laniger Model of Otitis Media	PLOS ONE			English	Article								Background: Streptococcus pneumoniae [Sp] infection is associated with local and systemic disease. Our current understanding of the differential contributions of genetic strain variation, serotype, and host response to disease phenotype is incomplete. Using the chinchilla model of otitis media [OM] we investigated the disease phenotype generated by the laboratory strain TIGR4 and each of thirteen clinical strains (BS68-75, BS290, BS291, BS293, BS436 and BS437); eleven of the thirteen strains have been genomically sequenced. Methodology/Principal Findings: For each strain 100 colony forming units were injected bilaterally into the tympanic bullae of 6 young adult chinchillas under general anesthesia. All animals were examined daily for local and systemic disease by a blinded observer. Pneumatic otoscopy was used to evaluate local disease, and behavioral assessments served as the measure of systemic disease. Virulence scoring was performed using a 4-point scale to assess four clinical parameters [severity and rapidity of local disease onset; and severity and rapidity of systemic disease onset] during a 10-day evaluation period. Highly significant variation was observed among the strains in their ability to cause disease and moribundity. Conclusions/Significance: As expected, there was a significant correlation between the rapidity of systemic disease onset and severity of systemic disease; however, there was little correlation between the severity of otoscopic changes and severity of systemic disease. Importantly, it was observed that different strains of the same serotype produced as broad an array of disease phenotypes as did strains of different serotypes. We attribute these phenotypic differences among the strains to the high degree of genomic plasticity that we have previously documented.	[Forbes, Michael L.; Horsey, Edward; Hiller, N. Luisa; Buchinsky, Farrel J.; Hayes, Jay D.; Compliment, James M.; Hillman, Todd; Ezzo, Suzanne; Shen, Kai; Keefe, Randy; Post, J. Christopher; Hu, Fen Ze; Ehrlich, Garth D.] Allegheny General Hosp, Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA USA; [Forbes, Michael L.] Allegheny General Hosp, Dept Pediat, Pittsburgh, PA USA; [Buchinsky, Farrel J.; Post, J. Christopher] Allegheny General Hosp, Dept Surg, Pittsburgh, PA USA; [Buchinsky, Farrel J.; Post, J. Christopher; Hu, Fen Ze; Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Pittsburgh, PA USA; [Hillman, Todd] Allegheny General Hosp, Dept Neurosurg, Pittsburgh, PA USA; [Barbadora, Karen] Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA	Allegheny General Hospital; Allegheny General Hospital; Allegheny General Hospital; Drexel University; Allegheny General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ehrlich, GD (corresponding author), Allegheny General Hosp, Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA USA.	gehrlich@wpahs.org	Hiller, N. Luisa/A-3739-2016; Buchinsky, Farrel/AAC-2080-2020	Hiller, N. Luisa/0000-0001-6572-1368; Buchinsky, Farrel/0000-0002-2830-6023; Ehrlich, Garth/0000-0003-1140-6594	Allegheny General Hospital/Allegheny Singer Research Institute; Health Resources and Services Administration; NIH-NIDCD [DC02148, DC04173, DC05659]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005659, R01DC002148, R01DC004173] Funding Source: NIH RePORTER	Allegheny General Hospital/Allegheny Singer Research Institute; Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Allegheny General Hospital/Allegheny Singer Research Institute and grants from the Health Resources and Services Administration and the NIH-NIDCD: DC02148 (GDE), DC04173 (GDE), and DC05659 (JCP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderson EE, 2000, MOL GENET METAB, V71, P451, DOI 10.1006/mgme.2000.3025; Aul JJ, 1998, ANN OTO RHINOL LARYN, V107, P508; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; BLUESTONE CD, 2000, OTITIS MEDIA INFANTS; Bondy J, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e72; BREDIUS RGM, 1994, J INFECT DIS, V170, P848, DOI 10.1093/infdis/170.4.848; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Bruckner R, 2004, INT J MED MICROBIOL, V294, P157, DOI 10.1016/j.ijmm.2004.06.019; Buchinsky FJ, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-56; Dinarello CA, 1997, CHEST, V112, p321S, DOI 10.1378/chest.112.6_Supplement.321S; Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P20, DOI 10.1097/01.blo.0000175124.52590.c0; Ehrlich GD, 2002, JAMA-J AM MED ASSOC, V287, P1710, DOI 10.1001/jama.287.13.1710; Elden LM, 1998, J OTOLARYNGOL, V27, P9; Gibot S, 2002, CRIT CARE MED, V30, P969, DOI 10.1097/00003246-200205000-00003; Grohmann U, 2000, J IMMUNOL, V164, P4197, DOI 10.4049/jimmunol.164.8.4197; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hoffman JA, 2003, PEDIATRICS, V112, P1095, DOI 10.1542/peds.112.5.1095; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Holmes CL, 2003, CHEST, V124, P1103, DOI 10.1378/chest.124.3.1103; JACOBS NM, 1991, AM J DIS CHILD, V145, P70, DOI 10.1001/archpedi.1991.02160010076019; Kaplan B, 1997, PEDIATR INFECT DIS J, V16, pS9, DOI 10.1097/00006454-199702001-00003; Klein JO, 2000, PEDIATR INFECT DIS J, V19, P383, DOI 10.1097/00006454-200004000-00034; Klugman KP, 2001, CURR OPIN INFECT DIS, V14, P173, DOI 10.1097/00001432-200104000-00011; Kornelisse RF, 1996, J INFECT DIS, V173, P1148, DOI 10.1093/infdis/173.5.1148; Lacroix-Desmazes S, 2005, P NATL ACAD SCI USA, V102, P4109, DOI 10.1073/pnas.0500586102; Martens P, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-21; McCool TL, 2002, J EXP MED, V195, P359, DOI 10.1084/jem.20011576; McKessar SJ, 2007, J BACTERIOL, V189, P1342, DOI 10.1128/JB.01170-06; Mira JP, 1999, JAMA-J AM MED ASSOC, V282, P561, DOI 10.1001/jama.282.6.561; Perez-Caballero D, 2004, J IMMUNOL, V173, P6899, DOI 10.4049/jimmunol.173.11.6899; POST JC, 1995, JAMA-J AM MED ASSOC, V273, P1598, DOI 10.1001/jama.273.20.1598; Post JC, 1996, AM J OTOLARYNG, V17, P106, DOI 10.1016/S0196-0709(96)90005-8; Ratner AJ, 2005, P NATL ACAD SCI USA, V102, P3429, DOI 10.1073/pnas.0500599102; Schaaf BM, 2003, AM J RESP CRIT CARE, V168, P476, DOI 10.1164/rccm.200210-1164OC; Shen K, 2006, INFECT IMMUN, V74, P321, DOI 10.1128/IAI.74.1.321-330.2006; Shen K, 2005, INFECT IMMUN, V73, P3479, DOI 10.1128/IAI.73.6.3479-3491.2005; Stuber F, 1996, CRIT CARE MED, V24, P381, DOI 10.1097/00003246-199603000-00004; Tan TQ, 2002, PEDIATR ANN, V31, P241, DOI 10.3928/0090-4481-20020401-08; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Wang XR, 2002, J IMMUNOL, V168, P810, DOI 10.4049/jimmunol.168.2.810; Watanabe E, 2005, CRIT CARE MED, V33, P89, DOI 10.1097/01.CCM.0000150025.79100.7D; Wizemann TM, 2001, INFECT IMMUN, V69, P1593, DOI 10.1128/IAI.69.3.1593-1598.2001	42	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2008	3	4							e1969	10.1371/journal.pone.0001969	http://dx.doi.org/10.1371/journal.pone.0001969			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XD	18398481	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795500034
J	McErlean, P; Shackelton, LA; Andrews, E; Webster, DR; Lambert, SB; Nissen, MD; Sloots, TP; Mackay, IM				McErlean, Peter; Shackelton, Laura A.; Andrews, Emily; Webster, Dale R.; Lambert, Stephen B.; Nissen, Michael D.; Sloots, Theo P.; Mackay, Ian M.			Distinguishing Molecular Features and Clinical Characteristics of a Putative New Rhinovirus Species, Human Rhinovirus C (HRV C)	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; POLYMERASE-CHAIN-REACTION; CELLULAR RECEPTOR; 3-DIMENSIONAL STRUCTURE; PROTOTYPE STRAINS; PROTEIN VP1; SEQUENCE; ILLNESS; RECOMBINATION; POLIOVIRUS	Background: Human rhinoviruses (HRVs) are the most frequently detected pathogens in acute respiratory tract infections (ARTIs) and yet little is known about the prevalence, recurrence, structure and clinical impact of individual members. During 2007, the complete coding sequences of six previously unknown and highly divergent HRV strains were reported. To catalogue the molecular and clinical features distinguishing the divergent HRV strains, we undertook, for the first time, in silico analyses of all available polyprotein sequences and performed retrospective reviews of the medical records of cases in which variants of the prototype strain, HRV-QPM, had been detected. Methodology/Principle Findings: Genomic analyses revealed that the six divergent strains, residing within a clade we previously called HRV A2, had the shortest polyprotein of all picornaviruses investigated. Structure-based amino acid alignments identified conserved motifs shared among members of the genus Rhinovirus as well as substantive deletions and insertions unique to the divergent strains. Deletions mostly affected regions encoding proteins traditionally involved in antigenicity and serving as HRV and HEV receptor footprints. Because the HRV A2 strains cannot yet be cultured, we created homology models of predicted HRV-QPM structural proteins. In silico comparisons confirmed that HRV-QPM was most closely related to the major group HRVs. HRV-QPM was most frequently detected in infants with expiratory wheezing or persistent cough who had been admitted to hospital and required supplemental oxygen. It was the only virus detected in 65% of positive individuals. These observations contributed to an objective clinical impact ranging from mild to severe. Conclusions: The divergent strains did not meet classification requirements for any existing species of the genus Rhinovirus or Enterovirus. HRV A2 strains should be partitioned into at least one new species, putatively called Human rhinovirus C, populated by members detected with high frequency, from individuals with respiratory symptoms requiring hospital admission.	[McErlean, Peter; Andrews, Emily; Lambert, Stephen B.; Nissen, Michael D.; Sloots, Theo P.; Mackay, Ian M.] Royal Childrens Hosp, Sir Albert Sakzewski Virus Res Ctr, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia; [McErlean, Peter; Andrews, Emily; Lambert, Stephen B.; Nissen, Michael D.; Sloots, Theo P.; Mackay, Ian M.] Univ Queensland, Clin & Med Virology Ctr, Brisbane, Qld, Australia; [Shackelton, Laura A.] Penn State Univ, Ctr Infect Dis Dynam, Dept Biol, Mueller Lab, University Pk, PA USA; [Webster, Dale R.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA; [Webster, Dale R.] Univ Calif San Francisco, Biol & Med Informat Program, San Francisco, CA USA; [Webster, Dale R.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Nissen, Michael D.; Sloots, Theo P.] Royal Brisbane Hosp Campus, Queensland Hlth Pathol Serv, Div Microbiol, Brisbane, Qld, Australia; [Nissen, Michael D.; Sloots, Theo P.] Royal Childrens Hosp, Dept Paediat & Child Hlth, Brisbane, Qld, Australia	Royal Children's Hospital Brisbane; University of Queensland; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Queensland Health; Royal Brisbane & Women's Hospital; Royal Children's Hospital Brisbane	McErlean, P (corresponding author), Royal Childrens Hosp, Sir Albert Sakzewski Virus Res Ctr, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia.	ian.mackay@uq.edu.au	Lambert, Stephen B/B-8348-2008; Sloots, Theo P/E-6118-2011; Lambert, Stephen/N-7819-2019; McErlean, Peter/O-5187-2016; Mackay, Ian M/B-2537-2010; Nissen, Michael D/M-6823-2013	Lambert, Stephen B/0000-0002-2709-193X; Lambert, Stephen/0000-0002-2709-193X; Mackay, Ian M/0000-0003-3598-2350; Nissen, Michael D/0000-0003-1686-3313	NHMRC [455905]; Royal Children's Hospital Foundation [912-011, 922-202]; Woolworth's Fresh Futures Programme; SASVRC PhD Scholarship	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Royal Children's Hospital Foundation; Woolworth's Fresh Futures Programme; SASVRC PhD Scholarship	This work was supported by NHMRC Project grant 455905 and the Royal Children's Hospital Foundation grants 912-011 and 922-202 sponsored by the Woolworth's Fresh Futures Programme. PM was supported by a SASVRC PhD Scholarship.	ANDRIES K, 1990, J VIROL, V64, P1117, DOI 10.1128/JVI.64.3.1117-1123.1990; Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Bartlett NW, 2008, NAT MED, V14, P199, DOI 10.1038/nm1713; Belnap DM, 2000, P NATL ACAD SCI USA, V97, P73, DOI 10.1073/pnas.97.1.73; Bhella D, 2004, J BIOL CHEM, V279, P8325, DOI 10.1074/jbc.M311334200; Bialasiewicz S, 2008, J CLIN VIROL, V41, P63, DOI 10.1016/j.jcv.2007.11.001; BLAAS D, 1987, PROTEINS, V2, P263, DOI 10.1002/prot.340020402; Blom N, 1996, PROTEIN SCI, V5, P2203, DOI 10.1002/pro.5560051107; Brown B, 2003, J VIROL, V77, P8973, DOI 10.1128/JVI.77.16.8973-8984.2003; GAMA RE, 1989, J MED VIROL, V28, P73, DOI 10.1002/jmv.1890280204; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAMPARIAN VV, 1987, VIROLOGY, V159, P191; Hayden FG, 2004, REV MED VIROL, V14, P17, DOI 10.1002/rmv.406; He YN, 2001, NAT STRUCT BIOL, V8, P874, DOI 10.1038/nsb1001-874; Hewat EA, 2000, EMBO J, V19, P6317, DOI 10.1093/emboj/19.23.6317; HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839; HORSNELL C, 1995, J GEN VIROL, V76, P2549, DOI 10.1099/0022-1317-76-10-2549; Khan AG, 2007, J VIROL, V81, P4625, DOI 10.1128/JVI.02160-06; Kiang D, 2007, J CLIN VIROL, V38, P227, DOI 10.1016/j.jcv.2006.12.016; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kistler AL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-40; Kolatkar PR, 1999, EMBO J, V18, P6249, DOI 10.1093/emboj/18.22.6249; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Laine P, 2006, J GEN VIROL, V87, P129, DOI 10.1099/vir.0.81137-0; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310; Ledford RM, 2005, ANTIVIR RES, V68, P135, DOI 10.1016/j.antiviral.2005.08.003; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashev AN, 2005, J GEN VIROL, V86, P3281, DOI 10.1099/vir.0.81264-0; Marlovits TC, 1998, J VIROL, V72, P10246, DOI 10.1128/JVI.72.12.10246-10250.1998; McErlean P, 2007, J CLIN VIROL, V39, P67, DOI 10.1016/j.jcv.2007.03.012; MORI J, 1994, J MED VIROL, V44, P323, DOI 10.1002/jmv.1890440403; Neumann E, 2003, J VIROL, V77, P8504, DOI 10.1128/JVI.77.15.8504-8511.2003; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; OLIVEIRA MA, 1993, STRUCTURE, V1, P51, DOI 10.1016/0969-2126(93)90008-5; PALMENBERG AC, 2002, ALIGNMENTS COMP PROF, V42, P149; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Racaniello V.R., 2001, FIELDS VIROLOGY, P455; Rieder Elizabeth, 2002, P61; ROSEN L, 1965, BACTERIOL REV, V29, P173, DOI 10.1128/MMBR.29.2.173-184.1965; Rossmann MG, 2000, VIROLOGY, V269, P239, DOI 10.1006/viro.2000.0258; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Savolainen C, 2004, J GEN VIROL, V85, P2271, DOI 10.1099/vir.0.79897-0; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; Shepherd CM, 2006, NUCLEIC ACIDS RES, V34, pD386, DOI 10.1093/nar/gkj032; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Sloots TP, 2006, EMERG INFECT DIS, V12, P1263, DOI 10.3201/eid1708.051239; Stanway G, 2005, VIRUS TAXONOMY, P757; STIRK HJ, 1994, PROTEIN ENG, V7, P47, DOI 10.1093/protein/7.1.47; Stuart AD, 2002, J VIROL, V76, P7694, DOI 10.1128/JVI.76.15.7694-7704.2002; Tapparel C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-224; Verdaguer N, 2000, J MOL BIOL, V300, P1179, DOI 10.1006/jmbi.2000.3943; Vlasak M, 2005, J VIROL, V79, P7389, DOI 10.1128/JVI.79.12.7389-7395.2005; Vlasak M, 2003, J VIROL, V77, P6923, DOI 10.1128/JVI.77.12.6923-6930.2003; Wainwright C, 2003, NEW ENGL J MED, V349, P27, DOI 10.1056/NEJMoa022226; Xiao C, 2001, J VIROL, V75, P2444, DOI 10.1128/JVI.75.5.2444-2451.2001	61	115	118	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1847	10.1371/journal.pone.0001847	http://dx.doi.org/10.1371/journal.pone.0001847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382652	gold, Green Published, Green Submitted			2022-12-27	WOS:000260795400002
J	Quelard, D; Lavergne, E; Hendaoui, I; Elamaa, H; Tiirola, U; Heljasvaara, R; Pihlajaniemi, T; Clement, B; Musso, O				Quelard, Delphine; Lavergne, Elise; Hendaoui, Ismail; Elamaa, Harri; Tiirola, Ulla; Heljasvaara, Ritva; Pihlajaniemi, Taina; Clement, Bruno; Musso, Orlando			A Cryptic Frizzled Module in Cell Surface Collagen 18 Inhibits Wnt/beta-Catenin Signaling	PLOS ONE			English	Article								Collagens contain cryptic polypeptide modules that regulate major cell functions, such as cell proliferation or death. Collagen XVIII (C18) exists as three amino terminal end variants with specific amino terminal polypeptide modules. We investigated the function of the variant 3 of C18 (V3C18) containing a frizzled module (FZC18), which carries structural identity with the extracellular cysteine-rich domain of the frizzled receptors. We show that V3C18 is a cell surface heparan sulfate proteoglycan, its topology being mediated by the FZC18 module. V3C18 mRNA was expressed at low levels in 21 normal adult human tissues. Its expression was up-regulated in fibrogenesis and in small well-differentiated liver tumors, but decreased in advanced human liver cancers. Low FZC18 immunostaining in liver cancer nodules correlated with markers of high Wnt/beta-catenin activity. V3C18 (M(r) = 170 kD) was proteolytically processed into a cell surface FZC18-containing 50 kD glycoprotein precursor that bound Wnt3a in vitro through FZC18 and suppressed Wnt3a-induced stabilization of beta-catenin. Ectopic expression of either FZC18 ( 35 kD) or its 50 kD precursor inhibited Wnt/beta-catenin signaling in colorectal and liver cancer cell lines, thus downregulating major cell cycle checkpoint gatekeepers cyclin D1 and c-myc and reducing tumor cell growth. By contrast, full-length V3C18 was unable to inhibit Wnt signaling. In summary, we identified a cell-surface signaling pathway whereby FZC18 inhibits Wnt/beta-catenin signaling. The signal, encrypted within cell-surface C18, is released by enzymatic processing as an active frizzled (c) under bar ysteine-(r) under bar ich (d) under bar omain (CRD) that reduces cancer cell growth. Thus, extracellular matrix controls Wnt signaling through a collagen-embedded CRD behaving as a cell-surface sensor of proteolysis, conveying feedback cues to control cancer cell fate.	[Quelard, Delphine; Lavergne, Elise; Hendaoui, Ismail; Clement, Bruno; Musso, Orlando] Univ Rennes 1, INSERM, U620, Rennes, France; [Elamaa, Harri; Tiirola, Ulla; Heljasvaara, Ritva; Pihlajaniemi, Taina] Univ Oulu, Dept Med Biochem & Mol Biol, Biocenter, Oulu, Finland	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; University of Oulu	Quelard, D (corresponding author), Univ Rennes 1, INSERM, U620, Rennes, France.	orlando.musso@rennes.inserm.fr	Clement, Bruno/E-5546-2016; Musso, Orlando/N-5756-2017	Clement, Bruno/0000-0001-8827-146X; Pihlajaniemi, Taina/0000-0002-1664-9045; Musso, Orlando/0000-0001-8881-6925; Heljasvaara, Ritva/0000-0003-4763-3844	Inserm; Universite de Rennes 1; ARC [5158]; Region Bretagne; INCA; Finnish Centre of Excellence Program of Academy of Finland [44843]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Rennes 1; ARC(Australian Research Council); Region Bretagne(Region Bretagne); INCA(Institut National du Cancer (INCA) France); Finnish Centre of Excellence Program of Academy of Finland(Academy of Finland)	Inserm, Universite de Rennes 1, ARC #5158, Region Bretagne, INCA 2007 and Finnish Centre of Excellence Program of Academy of Finland #44843	Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; BENEDETTI EL, 1967, J CELL SCI, V2, P499; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Caldwell GM, 2004, CANCER RES, V64, P883, DOI 10.1158/0008-5472.CAN-03-1346; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Chien AJ, 2007, FRONT BIOSCI-LANDMRK, V12, P448, DOI 10.2741/2074; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Elamaa H, 2003, MATRIX BIOL, V22, P427, DOI 10.1016/S0945-053X(03)00073-8; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Hausmann G, 2007, NAT REV MOL CELL BIO, V8, P331, DOI 10.1038/nrm2141; He BA, 2005, ONCOGENE, V24, P3054, DOI 10.1038/sj.onc.1208511; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; King KL, 1998, ANNU REV PHYSIOL, V60, P601, DOI 10.1146/annurev.physiol.60.1.601; KOVACEVIC Z, 1983, PHYSIOL REV, V63, P547, DOI 10.1152/physrev.1983.63.2.547; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; LeJossic C, 1996, EUR J BIOCHEM, V238, P400, DOI 10.1111/j.1432-1033.1996.0400z.x; Lietard J, 2000, HEPATOLOGY, V32, P1377, DOI 10.1053/jhep.2000.20066; Loeppen S, 2002, CANCER RES, V62, P5685; Melkonyan HS, 1997, P NATL ACAD SCI USA, V94, P13636, DOI 10.1073/pnas.94.25.13636; Michineau S, 2006, BIOCHEMISTRY-US, V45, P2699, DOI 10.1021/bi051674v; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; MURAGAKI Y, 1995, P NATL ACAD SCI USA, V92, P8763, DOI 10.1073/pnas.92.19.8763; Musso O, 1998, HEPATOLOGY, V28, P98, DOI 10.1002/hep.510280115; Musso O, 2001, CANCER RES, V61, P45; Musso O, 2001, HEPATOLOGY, V33, P868, DOI 10.1053/jhep.2001.23189; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Prange W, 2003, J PATHOL, V201, P250, DOI 10.1002/path.1448; Rehn M, 1996, GENOMICS, V32, P436, DOI 10.1006/geno.1996.0139; REHN M, 1995, J BIOL CHEM, V270, P4705, DOI 10.1074/jbc.270.9.4705; REHN M, 1994, P NATL ACAD SCI USA, V91, P4234, DOI 10.1073/pnas.91.10.4234; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; Saarela J, 1998, AM J PATHOL, V153, P611, DOI 10.1016/S0002-9440(10)65603-9; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; Shih YL, 2006, CANCER, V107, P579, DOI 10.1002/cncr.22023; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; VALLET V, 1995, MOL CELL BIOL, V15, P5453; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844; You ZB, 2002, J CELL BIOL, V157, P429, DOI 10.1083/jcb.200201110; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103; Zucman-Rossi J, 2007, ONCOGENE, V26, P774, DOI 10.1038/sj.onc.1209824	54	43	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1878	10.1371/journal.pone.0001878	http://dx.doi.org/10.1371/journal.pone.0001878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382662	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795400013
J	Sato, F; Jin, Z; Schulmann, K; Wang, J; Greenwald, BD; Ito, T; Kan, T; Hamilton, JP; Yang, J; Paun, B; David, S; Olaru, A; Cheng, Y; Mori, Y; Abraham, JM; Yfantis, HG; Wu, TT; Fredericksen, MB; Wang, KK; Canto, M; Romero, Y; Feng, Z; Meltzer, SJ				Sato, Fumiaki; Jin, Zhe; Schulmann, Karsten; Wang, Jean; Greenwald, Bruce D.; Ito, Tetsuo; Kan, Takatsugu; Hamilton, James P.; Yang, Jian; Paun, Bogdan; David, Stefan; Olaru, Alexandru; Cheng, Yulan; Mori, Yuriko; Abraham, John M.; Yfantis, Harris G.; Wu, Tsung-Teh; Fredericksen, Mary B.; Wang, Kenneth K.; Canto, Marcia; Romero, Yvonne; Feng, Ziding; Meltzer, Stephen J.			Three-Tiered Risk Stratification Model to Predict Progression in Barrett's Esophagus Using Epigenetic and Clinical Features	PLOS ONE			English	Article								Background: Barrett's esophagus predisposes to esophageal adenocarcinoma. However, the value of endoscopic surveillance in Barrett's esophagus has been debated because of the low incidence of esophageal adenocarcinoma in Barrett's esophagus. Moreover, high inter-observer and sampling-dependent variation in the histologic staging of dysplasia make clinical risk assessment problematic. In this study, we developed a 3-tiered risk stratification strategy, based on systematically selected epigenetic and clinical parameters, to improve Barrett's esophagus surveillance efficiency. Methods and Findings: We defined high-grade dysplasia as endpoint of progression, and Barrett's esophagus progressor patients as Barrett's esophagus patients with either no dysplasia or low-grade dysplasia who later developed high-grade dysplasia or esophageal adenocarcinoma. We analyzed 4 epigenetic and 3 clinical parameters in 118 Barrett's esophagus tissues obtained from 35 progressor and 27 non-progressor Barrett's esophagus patients from Baltimore Veterans Affairs Maryland Health Care Systems and Mayo Clinic. Based on 2-year and 4-year prediction models using linear discriminant analysis (area under the receiver-operator characteristic (ROC) curve: 0.8386 and 0.7910, respectively), Barrett's esophagus specimens were stratified into high-risk (HR), intermediate-risk (IR), or low-risk (LR) groups. This 3-tiered stratification method retained both the high specificity of the 2-year model and the high sensitivity of the 4-year model. Progression-free survivals differed significantly among the 3 risk groups, with p = 0.0022 (HR vs. IR) and p<0.0001 (HR or IR vs. LR). Incremental value analyses demonstrated that the number of methylated genes contributed most influentially to prediction accuracy. Conclusions: This 3-tiered risk stratification strategy has the potential to exert a profound impact on Barrett's esophagus surveillance accuracy and efficiency.	[Sato, Fumiaki; Jin, Zhe; Wang, Jean; Ito, Tetsuo; Kan, Takatsugu; Hamilton, James P.; Yang, Jian; Paun, Bogdan; David, Stefan; Olaru, Alexandru; Cheng, Yulan; Mori, Yuriko; Abraham, John M.; Canto, Marcia; Meltzer, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; [Sato, Fumiaki; Jin, Zhe; Schulmann, Karsten; Greenwald, Bruce D.; Ito, Tetsuo; Kan, Takatsugu; Hamilton, James P.; Yang, Jian; Paun, Bogdan; David, Stefan; Olaru, Alexandru; Cheng, Yulan; Mori, Yuriko; Abraham, John M.; Meltzer, Stephen J.] Univ Maryland, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD USA; [Schulmann, Karsten] Ruhr Univ Bochum, Med Dept, Bochum, Germany; [Yfantis, Harris G.] Baltimore Veterans Affairs Maryland Hlth Care Syst, Dept Anatom Pathol, Baltimore, MD USA; [Wu, Tsung-Teh] Mayo Clin Fdn, Dept Pathol, Rochester, MN USA; [Fredericksen, Mary B.; Wang, Kenneth K.; Romero, Yvonne] Mayo Clin Fdn, Div Gastroenterol & Hepatol, Rochester, MN USA; [Feng, Ziding] Fred Hutchinson Canc Res Ctr, Public Hlth Sci Div, Seattle, WA USA; [Sato, Fumiaki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Kyoto, Japan	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Ruhr University Bochum; Mayo Clinic; Mayo Clinic; Fred Hutchinson Cancer Center; Kyoto University	Sato, F (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA.	fsato@pharm.kyoto-u.ac.jp	Schulmann, Karsten/N-2230-2016		USPHS [CA85069, CA01808, CA 98450, CA106763, CA097048, CA111603]; Mildred Scheel Foundation of German Cancer Aid; NATIONAL CANCER INSTITUTE [R21CA098450, R01CA097048, R21CA106763, R01CA001808, R01CA111603, U01CA085069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK067872] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Mildred Scheel Foundation of German Cancer Aid(Deutsche Krebshilfe); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	USPHS grants CA85069, CA01808, CA 98450, CA106763, CA097048, CA111603, and the Mildred Scheel Foundation of German Cancer Aid (Deutsche Krebshilfe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, CANCER RES, V65, P828; Alikhan M, 1999, GASTROINTEST ENDOSC, V50, P23, DOI 10.1016/S0016-5107(99)70339-1; Barr H, 2002, GUT, V51, P313, DOI 10.1136/gut.51.3.313; Barrett MT, 1999, NAT GENET, V22, P106, DOI 10.1038/8816; Brock MV, 2003, CLIN CANCER RES, V9, P2912; *BUR USC, 2006, MONTHL POSTC RES POP; Cameron AJ, 1997, AM J GASTROENTEROL, V92, P586; Cameron AJ, 1998, MAYO CLIN PROC, V73, P457; Clark GWB, 1996, DIGEST DIS, V14, P213, DOI 10.1159/000171554; Conio M, 2003, AM J GASTROENTEROL, V98, P1931, DOI 10.1016/S0002-9270(03)00629-4; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; Cossentino Mark J, 2003, Semin Gastrointest Dis, V14, P128; Eaden J, 2001, J PATHOL, V194, P152, DOI 10.1002/path.876; Eads CA, 2001, CANCER RES, V61, P3410; Eads CA, 2000, CANCER RES, V60, P5021; Eisen GM, 2002, GASTROINTEST ENDOSC, V55, P784, DOI 10.1016/S0016-5107(02)70404-5; HAMEETEMAN W, 1989, GASTROENTEROLOGY, V96, P1249, DOI 10.1016/S0016-5085(89)80011-3; Johnston MH, 2005, NAT CLIN PRACT GASTR, V2, P323, DOI 10.1038/ncpgasthep0214; Katz D, 1998, AM J GASTROENTEROL, V93, P536; Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782; LEVINE DS, 1993, GASTROENTEROLOGY, V105, P40, DOI 10.1016/0016-5085(93)90008-Z; MELTZER SJ, 1994, CANCER RES, V54, P3379; Montgomery E, 2001, HUM PATHOL, V32, P379, DOI 10.1053/hupa.2001.23511; Montgomery E, 2001, HUM PATHOL, V32, P368, DOI 10.1053/hupa.2001.23510; Ogino S, 2006, GUT, V55, P1000, DOI 10.1136/gut.2005.082933; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Playford RJ, 2002, GUT, V51, P314, DOI 10.1136/gut.51.3.314; Rabinovitch PS, 2001, AM J GASTROENTEROL, V96, P3071, DOI 10.1111/j.1572-0241.2001.05261.x; Reid BJ, 2001, AM J GASTROENTEROL, V96, P2839; REID BJ, 1988, HUM PATHOL, V19, P166, DOI 10.1016/S0046-8177(88)80344-7; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Rudolph RE, 2000, ANN INTERN MED, V133, P748, DOI 10.7326/0003-4819-133-9-200011070-00026; Rugge M, 2000, AM J SURG PATHOL, V24, P167, DOI 10.1097/00000478-200002000-00001; Sato F, 2006, CANCER-AM CANCER SOC, V106, P483, DOI 10.1002/cncr.21657; Sato F, 2005, CANCER-AM CANCER SOC, V103, P1596, DOI 10.1002/cncr.20938; Sato F, 2002, CANCER RES, V62, P1148; Sato F, 2002, CANCER RES, V62, P6820; Schulmann K, 2005, ONCOGENE, V24, P4138, DOI 10.1038/sj.onc.1208598; Shaheen NJ, 2004, GUT, V53, P1736, DOI 10.1136/gut.2003.033837; Skacel M, 2000, AM J GASTROENTEROL, V95, P3383; Spechler SJ, 2002, NEW ENGL J MED, V346, P836, DOI 10.1056/NEJMcp012118; Srivastava A, 2007, AM J GASTROENTEROL, V102, P483, DOI 10.1111/j.1572-0241.2007.01073.x; STREITZ JM, 1993, J THORAC CARDIOV SUR, V105, P383; STREITZ JM, 1993, J THORAC CARDIOVASC, V105, P387; Takubo K, 2002, SUPERFICIAL ESOPHAGEAL NEOPLASM: PATHOLOGY, DIAGNOSIS, AND THERAPY, P141; Tannapfel A, 2004, DIGEST DIS, V22, P126, DOI 10.1159/000080311; van Rijnsoever M, 2002, GUT, V51, P797, DOI 10.1136/gut.51.6.797; Weston AP, 1999, AM J GASTROENTEROL, V94, P3413, DOI 10.1111/j.1572-0241.1999.01602.x; Zingg JM, 1997, CARCINOGENESIS, V18, P869, DOI 10.1093/carcin/18.5.869	49	59	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2008	3	4							e1890	10.1371/journal.pone.0001890	http://dx.doi.org/10.1371/journal.pone.0001890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370XC	18382671	Green Published, gold, Green Submitted			2022-12-27	WOS:000260795400022
J	Lutz, A; Brefczynski-Lewis, J; Johnstone, T; Davidson, RJ				Lutz, Antoine; Brefczynski-Lewis, Julie; Johnstone, Tom; Davidson, Richard J.			Regulation of the Neural Circuitry of Emotion by Compassion Meditation: Effects of Meditative Expertise	PLOS ONE			English	Article							BRAIN; COGNITION; EMPATHY	Recent brain imaging studies using functional magnetic resonance imaging (fMRI) have implicated insula and anterior cingulate cortices in the empathic response to another's pain. However, virtually nothing is known about the impact of the voluntary generation of compassion on this network. To investigate these questions we assessed brain activity using fMRI while novice and expert meditation practitioners generated a loving-kindness-compassion meditation state. To probe affective reactivity, we presented emotional and neutral sounds during the meditation and comparison periods. Our main hypothesis was that the concern for others cultivated during this form of meditation enhances affective processing, in particular in response to sounds of distress, and that this response to emotional sounds is modulated by the degree of meditation training. The presentation of the emotional sounds was associated with increased pupil diameter and activation of limbic regions (insula and cingulate cortices) during meditation (versus rest). During meditation, activation in insula was greater during presentation of negative sounds than positive or neutral sounds in expert than it was in novice meditators. The strength of activation in insula was also associated with self-reported intensity of the meditation for both groups. These results support the role of the limbic circuitry in emotion sharing. The comparison between meditation vs. rest states between experts and novices also showed increased activation in amygdala, right temporo-parietal junction (TPJ), and right posterior superior temporal sulcus (pSTS) in response to all sounds, suggesting, greater detection of the emotional sounds, and enhanced mentation in response to emotional human vocalizations for experts than novices during meditation. Together these data indicate that the mental expertise to cultivate positive emotion alters the activation of circuitries previously linked to empathy and theory of mind in response to emotional stimuli.	[Lutz, Antoine; Davidson, Richard J.] Univ Wisconsin, Madison, WI 53706 USA; [Brefczynski-Lewis, Julie] West Virginia Univ, Morgantown, WV USA; [Johnstone, Tom] Univ Reading, Reading, England	University of Wisconsin System; University of Wisconsin Madison; West Virginia University; University of Reading	Lutz, A (corresponding author), Univ Wisconsin, Madison, WI 53706 USA.	alutz@wisc.edu; rjdavids@wisc.edu	Johnstone, Tom/C-5909-2011; LUTZ, Antoine/AAE-5114-2020	Johnstone, Tom/0000-0001-8635-8158; LUTZ, Antoine/0000-0002-0258-3233; Davidson, Richard/0000-0002-8506-4964	NCCAM [U01AT002114-01A1]; Fyssen foundation; NIMH [P50-MH069315]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [U01AT002114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH069315] Funding Source: NIH RePORTER	NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Fyssen foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support was provided by NCCAM U01AT002114-01A1, Fyssen foundation to AL and NIMH P50-MH069315 to RJD, and by gifts from Adrianne and Edwin Cook-Ryder, Bryant Wangard and Ralph Robinson, Keith and Arlene Bronstein and the John W. Kluge Foundation. No funders or sponsors participated in the design or conduct of the study, or in the analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Beatty J., 2000, HDB PSYCHOPHYSIOLOGY, P142; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; Brefczynski-Lewis JA, 2007, P NATL ACAD SCI USA, V104, P11483, DOI 10.1073/pnas.0606552104; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; COXRW, 1996, COMPUT BIOMED RES, V29, P162; Dalai Lama, 1995, WORLD TIBETAN BUDDHI; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; Damasio A, 2001, NATURE, V413, P781, DOI 10.1038/35101669; Damasio A, 2000, FEELING WHAT HAPPENS; Davidson RJ, 2004, PHILOS T R SOC B, V359, P1395, DOI 10.1098/rstb.2004.1510; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Gethin Rupert., 1998, FDN BUDDHISM; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Jaffer FA, 1997, JMRI-J MAGN RESON IM, V7, P1122, DOI 10.1002/jmri.1880070627; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Preston S. D., 2002, BEHAV BRAIN SCI, V25, P20, DOI [10.1017/S0140525X02380014, DOI 10.1017/S0140525X023]; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; RUBY P, 2007, SENSORIMOTOR FDN HIG; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Sommerville JA, 2006, PSYCHON B REV, V13, P179, DOI 10.3758/BF03193831; Tankersley D, 2007, NAT NEUROSCI, V10, P150, DOI 10.1038/nn1833; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006	29	479	491	4	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1897	10.1371/journal.pone.0001897	http://dx.doi.org/10.1371/journal.pone.0001897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370KZ	18365029	Green Submitted, gold, Green Published			2022-12-27	WOS:000260762400035
J	Murrell, A; Ito, Y; Verde, G; Huddleston, J; Woodfine, K; Silengo, MC; Spreafico, F; Perotti, D; De Crescenzo, A; Sparago, A; Cerrato, F; Riccio, A				Murrell, Adele; Ito, Yoko; Verde, Gaetano; Huddleston, Joanna; Woodfine, Kathryn; Silengo, Margherita Cirillo; Spreafico, Filippo; Perotti, Daniela; De Crescenzo, Agostina; Sparago, Angela; Cerrato, Flavia; Riccio, Andrea			Distinct Methylation Changes at the IGF2-H19 Locus in Congenital Growth Disorders and Cancer	PLOS ONE			English	Article								Background: Differentially methylated regions (DMRs) are associated with many imprinted genes. In mice methylation at a DMR upstream of the H19 gene known as the Imprint Control region (IC1) is acquired in the male germline and influences the methylation status of DMRs 100 kb away in the adjacent Insulin-like growth factor 2 (Igf2) gene through long-range interactions. In humans, germline-derived or post-zygotically acquired imprinting defects at IC1 are associated with aberrant activation or repression of IGF2, resulting in the congenital growth disorders Beckwith-Wiedemann (BWS) and Silver-Russell (SRS) syndromes, respectively. In Wilms tumour and colorectal cancer, biallelic expression of IGF2 has been observed in association with loss of methylation at a DMR in IGF2. This DMR, known as DMR0, has been shown to be methylated on the silent maternal IGF2 allele presumably with a role in repression. The effect of IGF2 DMR0 methylation changes in the aetiology of BWS or SRS is unknown. Methodology/Principal Findings: We analysed the methylation status of the DMR0 in BWS, SRS and Wilms tumour patients by conventional bisulphite sequencing and pyrosequencing. We show here that, contrary to previous reports, the IGF2 DMR0 is actually methylated on the active paternal allele in peripheral blood and kidney. This is similar to the IC1 methylation status and is inconsistent with the proposed silencing function of the maternal IGF2 allele. Beckwith-Wiedemann and Silver-Russell patients with IC1 methylation defects have similar methylation defects at the IGF2 DMR0, consistent with IC1 regulating methylation at IGF2 in cis. In Wilms tumour, however, methylation profiles of IC1 and IGF2 DMR0 are indicative of methylation changes occurring on both parental alleles rather than in cis. Conclusions/Significance: These results support a model in which DMR0 and IC1 have opposite susceptibilities to global hyper and hypomethylation during tumorigenesis independent of the parent of origin imprint. In contrast, during embryogenesis DMR0 is methylated or demethylated according to the germline methylation imprint at the IC1, indicating different mechanisms of imprinting loss in neoplastic and non-neoplastic cells.	[Murrell, Adele; Ito, Yoko; Huddleston, Joanna; Woodfine, Kathryn] Univ Cambridge, CRUK Cambridge Res Inst, Dept Oncol, Cambridge, England; [Verde, Gaetano; De Crescenzo, Agostina; Sparago, Angela; Cerrato, Flavia; Riccio, Andrea] Seconda Univ Napoli, Dipartimento Sci Ambientali, Caserta, Italy; [De Crescenzo, Agostina; Sparago, Angela; Cerrato, Flavia; Riccio, Andrea] CNR, Inst Genet & Biophys, Naples, Italy; [Silengo, Margherita Cirillo] Univ Turin, Dipartimento Sci Pediatriche Adolescenza, Turin, Italy; [Spreafico, Filippo] Fdn IRCCS Ist Nazionale Tumori, Dept Med Oncol, Pediat Oncol Unit, Milan, Italy; [Perotti, Daniela] Fdn IRCCS Ist Nazionale Tumori, Dept Expt Oncol & Lab, Milan, Italy	CRUK Cambridge Institute; University of Cambridge; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Turin; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Murrell, A (corresponding author), Univ Cambridge, CRUK Cambridge Res Inst, Dept Oncol, Cambridge, England.	amm207@cam.ac.uk	Spreafico, Filippo/K-7813-2016; Verde, Gaetano/U-2749-2017; Perotti, Daniela/C-2013-2017; Sparago, Angela/O-8324-2015; Riccio, Andrea/A-4991-2015; Riccio, Andrea/AAY-7571-2020	Spreafico, Filippo/0000-0002-5587-3509; Verde, Gaetano/0000-0003-4768-0165; Perotti, Daniela/0000-0002-6703-2889; Sparago, Angela/0000-0003-4352-945X; Riccio, Andrea/0000-0001-7990-3576; Riccio, Andrea/0000-0001-7990-3576; Murrell, adele/0000-0003-2647-3511; Silengo, Margherita/0000-0002-6255-1532	CRUK Senior Cancer Research Fellowship; Societa Italiana di Cancerologia; Fondazione Pezcoller fellowship; AICR; MIUR PRIN 2005; Istituto Superiore di Sanita; Associazione Italiana Ricerca sul Cancro; Telethon-Italia [GGP04072]; Associazione Bianca Garavaglia, Busto Arsizio, Varese, Italy	CRUK Senior Cancer Research Fellowship; Societa Italiana di Cancerologia; Fondazione Pezcoller fellowship; AICR; MIUR PRIN 2005(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Istituto Superiore di Sanita; Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Telethon-Italia(Fondazione Telethon); Associazione Bianca Garavaglia, Busto Arsizio, Varese, Italy	This work was supported by CRUK Senior Cancer Research Fellowship (A.M.) and Societa Italiana di Cancerologia and Fondazione Pezcoller fellowship (F.C) and grants from AICR (A.M.), MIUR PRIN 2005 (A.R.), Istituto Superiore di Sanita (A.R.), Associazione Italiana Ricerca sul Cancro (A.R. and D.P.), Telethon-Italia Grant No. GGP04072 (A.R.), and the Associazione Bianca Garavaglia, Busto Arsizio, Varese, Italy (D.P.).	Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bliek J, 2006, AM J HUM GENET, V78, P604, DOI 10.1086/502981; Byun HM, 2007, CANCER RES, V67, P10753, DOI 10.1158/0008-5472.CAN-07-0329; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Cooper MJ, 1996, J UROLOGY, V155, P2120, DOI 10.1016/S0022-5347(01)66120-2; Cooper WN, 2005, EUR J HUM GENET, V13, P1025, DOI 10.1038/sj.ejhg.5201463; Cui HM, 2002, CANCER RES, V62, P6442; Delaval K, 2006, BIOESSAYS, V28, P453, DOI 10.1002/bies.20407; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; FEIL R, 1994, DEVELOPMENT, V120, P2933; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lopes S, 2003, HUM MOL GENET, V12, P295, DOI 10.1093/hmg/ddg022; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Murphy SK, 2006, MOL CANCER RES, V4, P283, DOI 10.1158/1541-7786.MCR-05-0138; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Murrell A, 2001, EMBO REP, V2, P1101, DOI 10.1093/embo-reports/kve248; Netchine I, 2007, J CLIN ENDOCR METAB, V92, P3148, DOI 10.1210/jc.2007-0354; Okamoto K, 1997, P NATL ACAD SCI USA, V94, P5367, DOI 10.1073/pnas.94.10.5367; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; Smith AC, 2007, PEDIATR RES, V61, p43R, DOI 10.1203/pdr.0b013e3180457660; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Sparago A, 2007, HUM MOL GENET, V16, P254, DOI 10.1093/hmg/ddl448; Sullivan MJ, 1999, ONCOGENE, V18, P7527, DOI 10.1038/sj.onc.1203096; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Thorvaldsen JL, 2006, MOL CELL BIOL, V26, P1245, DOI 10.1128/MCB.26.4.1245-1258.2006; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Ulaner GA, 2003, HUM MOL GENET, V12, P535, DOI 10.1093/hmg/ddg034; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989	32	84	86	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1849	10.1371/journal.pone.0001849	http://dx.doi.org/10.1371/journal.pone.0001849			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	370KZ	18365005	Green Published, Green Submitted, gold			2022-12-27	WOS:000260762400011
J	Okanoya, K; Tokimoto, N; Kumazawa, N; Hihara, S; Iriki, A				Okanoya, Kazuo; Tokimoto, Naoko; Kumazawa, Noriko; Hihara, Sayaka; Iriki, Atsushi			Tool-Use Training in a Species of Rodent: The Emergence of an Optimal Motor Strategy and Functional Understanding	PLOS ONE			English	Article							OCTODON-DEGUS; CALEDONIAN CROWS; MIRROR NEURONS; BODY SCHEMA; INTELLIGENCE; EVOLUTION; CORTEX; MONKEYS; PRIMATES; BEHAVIOR	Background: Tool use is defined as the manipulation of an inanimate object to change the position or form of a separate object. The expansion of cognitive niches and tool-use capabilities probably stimulated each other in hominid evolution. To understand the causes of cognitive expansion in humans, we need to know the behavioral and neural basis of tool use. Although a wide range of animals exhibit tool use in nature, most studies have focused on primates and birds on behavioral or psychological levels and did not directly address questions of which neural modifications contributed to the emergence of tool use. To investigate such questions, an animal model suitable for cellular and molecular manipulations is needed. Methodology/Principal Findings: We demonstrated for the first time that rodents can be trained to use tools. Through a step-by-step training procedure, we trained degus (Octodon degus) to use a rake-like tool with their forelimbs to retrieve otherwise out-of-reach rewards. Eventually, they mastered effective use of the tool, moving it in an elegant trajectory. After the degus were well trained, probe tests that examined whether they showed functional understanding of the tool were performed. Degus did not hesitate to use tools of different size, colors, and shapes, but were reluctant to use the tool with a raised nonfunctional blade. Thus, degus understood the functional and physical properties of the tool after extensive training. Conclusions/Significance: Our findings suggest that tool use is not a specific faculty resulting from higher intelligence, but is a specific combination of more general cognitive faculties. Studying the brains and behaviors of trained rodents can provide insights into how higher cognitive functions might be broken down into more general faculties, and also what cellular and molecular mechanisms are involved in the emergence of such cognitive functions.	[Okanoya, Kazuo; Tokimoto, Naoko] RIKEN, Brain Sci Inst, Lab Biolinguist, Saitama, Japan; [Tokimoto, Naoko; Kumazawa, Noriko; Hihara, Sayaka; Iriki, Atsushi] RIKEN, Brain Sci Inst, Lab Symbolic Cognit Dev, Saitama, Japan	RIKEN; RIKEN	Okanoya, K (corresponding author), RIKEN, Brain Sci Inst, Lab Biolinguist, Saitama, Japan.	iriki@brain.riken.jp	Okanoya, Kazuo/F-8528-2010		MEXT, JAPAN [18020035, 18019040]; RIKEN	MEXT, JAPAN(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN	Work supported by a Grant-in-Aid for Scientific Research on Priority Areas, System study on higher-order brain functions, from MEXT, JAPAN, #18020035 to AI and 18019040 to KO. NT was supported by a Special Postdoctoral Research Program from RIKEN.	Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Beck B. B., 1980, ANIMAL TOOL BEHAV US; Braun K, 2000, NEUROSCIENCE, V95, P309; Emery NJ, 2006, PHILOS T R SOC B, V361, P23, DOI 10.1098/rstb.2005.1736; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Ferrari PF, 2005, J COGNITIVE NEUROSCI, V17, P212, DOI 10.1162/0898929053124910; Fujita K, 2003, J EXP PSYCHOL ANIM B, V29, P233, DOI 10.1037/0097-7403.29.3.233; FULK GW, 1976, J MAMMAL, V57, P495, DOI 10.2307/1379298; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hauser MD, 1997, COGNITION, V64, P285, DOI 10.1016/S0010-0277(97)00028-0; Hihara S, 2003, PHYSIOL BEHAV, V78, P427, DOI 10.1016/S0031-9384(02)01006-5; Hihara S, 2006, NEUROPSYCHOLOGIA, V44, P2636, DOI 10.1016/j.neuropsychologia.2005.11.020; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Iriki A, 1996, NEUROREPORT, V7, P2325; Iriki A, 2006, CURR OPIN NEUROBIOL, V16, P660, DOI 10.1016/j.conb.2006.10.008; Ishibashi H, 2000, CAN J PHYSIOL PHARM, V78, P958, DOI 10.1139/cjpp-78-11-958; Lewis JW, 2006, NEUROSCIENTIST, V12, P211, DOI 10.1177/1073858406288327; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; OWNING DH, 1977, BEHAVIOUR, V62, P50; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rocamora N, 1996, J NEUROSCI, V16, P3991; Santos LR, 2006, ANIM COGN, V9, P94, DOI 10.1007/s10071-005-0001-8; Schaefer M, 2004, NEUROREPORT, V15, P1293, DOI 10.1097/01.wnr.0000129573.36301.db; Shuster Gabriela, 1998, ANIM COGN, V1, P71, DOI [10.1007/s100710050009, DOI 10.1007/S100710050009]; Taylor AH, 2007, CURR BIOL, V17, P1504, DOI 10.1016/j.cub.2007.07.057; Tebbich S, 2004, ANIM BEHAV, V67, P689, DOI 10.1016/j.anbehav.2003.08.003; Tokimoto N, 2004, JPN PSYCHOL RES, V46, P255, DOI 10.1111/j.1468-5584.2004.00257.x; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; Wan H, 2001, EUR J NEUROSCI, V14, P118, DOI 10.1046/j.0953-816x.2001.01625.x; WILSON SC, 1982, DEV PSYCHOBIOL, V15, P257, DOI 10.1002/dev.420150309; WILSON SC, 1974, AM ZOOL, V14, P341; WOODS C A, 1975, Mammalian Species, V67, P1	33	45	47	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2008	3	3							e1860	10.1371/journal.pone.0001860	http://dx.doi.org/10.1371/journal.pone.0001860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	370KZ	18365015	gold, Green Submitted, Green Published			2022-12-27	WOS:000260762400021
